A	DT	O
common	JJ	O
human	JJ	O
skin	NN	B-Disease
tumour	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
activating	VBG	O
mutations	NNS	O
in	IN	O
beta-catenin	NN	O
.	.	O

WNT	JJ	O
signalling	NN	O
orchestrates	VBZ	O
a	DT	O
number	NN	O
of	IN	O
developmental	JJ	O
programs	NNS	O
.	.	O

In	IN	O
response	NN	O
to	TO	O
this	DT	O
stimulus	NN	O
,	,	O
cytoplasmic	JJ	O
beta-catenin	NN	O
(	-LRB-	O
encoded	VBN	O
by	IN	O
CTNNB1	NN	O
)	-RRB-	O
is	VBZ	O
stabilized	VBN	O
,	,	O
enabling	VBG	O
downstream	JJ	O
transcriptional	JJ	O
activation	NN	O
by	IN	O
members	NNS	O
of	IN	O
the	DT	O
LEF/TCF	NN	O
family	NN	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
target	NN	O
genes	NNS	O
for	IN	O
beta-catenin/TCF	NN	O
encodes	VBZ	O
c-MYC	NN	O
,	,	O
explaining	VBG	O
why	WRB	O
constitutive	JJ	O
activation	NN	O
of	IN	O
the	DT	O
WNT	JJ	O
pathway	NN	O
can	MD	O
lead	VB	O
to	TO	O
cancer	NN	B-Disease
,	,	O
particularly	RB	O
in	IN	O
the	DT	O
colon	NN	O
.	.	O

Most	JJS	O
colon	NN	B-Disease
cancers	NNS	I-Disease
arise	VBP	O
from	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
protein	NN	O
required	VBN	O
for	IN	O
ubiquitin-mediated	JJ	O
degradation	NN	O
of	IN	O
beta-catenin	NN	O
,	,	O
but	CC	O
a	DT	O
small	JJ	O
percentage	NN	O
of	IN	O
colon	NN	B-Disease
and	CC	I-Disease
some	DT	I-Disease
other	JJ	I-Disease
cancers	NNS	I-Disease
harbour	VBP	O
beta-catenin-stabilizing	JJ	O
mutations	NNS	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
discovered	VBD	O
that	IN	O
transgenic	JJ	O
mice	NNS	O
expressing	VBG	O
an	DT	O
activated	VBN	O
beta-catenin	NN	O
are	VBP	O
predisposed	VBN	O
to	TO	O
developing	VBG	O
skin	NN	B-Disease
tumours	NNS	I-Disease
resembling	VBG	O
pilomatricomas	NNS	B-Disease
.	.	O

Given	VBN	O
that	IN	O
the	DT	O
skin	NN	O
of	IN	O
these	DT	O
adult	JJ	O
mice	NNS	O
also	RB	O
exhibits	VBZ	O
signs	NNS	O
of	IN	O
de	FW	O
novo	FW	O
hair-follicle	NN	O
morphogenesis	NN	O
,	,	O
we	PRP	O
wondered	VBD	O
whether	IN	O
human	JJ	O
pilomatricomas	NNS	B-Disease
might	MD	O
originate	VB	O
from	IN	O
hair	NN	O
matrix	NN	O
cells	NNS	O
and	CC	O
whether	IN	O
they	PRP	O
might	MD	O
possess	VB	O
beta-catenin-stabilizing	JJ	O
mutations	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
explore	VBP	O
the	DT	O
cell	NN	O
origin	NN	O
and	CC	O
aetiology	NN	O
of	IN	O
this	DT	O
common	JJ	O
human	JJ	O
skin	NN	B-Disease
tumour	NN	I-Disease
.	.	O

We	PRP	O
found	VBD	O
nuclear	JJ	O
LEF-1	NN	O
in	IN	O
the	DT	O
dividing	VBG	O
tumour	NN	B-Disease
cells	NNS	O
,	,	O
providing	VBG	O
biochemical	JJ	O
evidence	NN	O
that	IN	O
pilomatricomas	NNS	B-Disease
are	VBP	O
derived	VBN	O
from	IN	O
hair	NN	O
matrix	NN	O
cells	NNS	O
.	.	O

At	IN	O
least	JJS	O
75	CD	O
%	NN	O
of	IN	O
these	DT	O
tumours	NNS	B-Disease
possess	VBP	O
mutations	NNS	O
affecting	VBG	O
the	DT	O
amino-terminal	JJ	O
segment	NN	O
,	,	O
normally	RB	O
involved	VBN	O
in	IN	O
phosphorylation-dependent	JJ	O
,	,	O
ubiquitin-mediated	JJ	O
degradation	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

This	DT	O
percentage	NN	O
of	IN	O
CTNNB1	NN	O
mutations	NNS	O
is	VBZ	O
greater	JJR	O
than	IN	O
in	IN	O
all	DT	O
other	JJ	O
human	JJ	O
tumours	NNS	B-Disease
examined	VBN	O
thus	RB	O
far	RB	O
,	,	O
and	CC	O
directly	RB	O
implicates	VBZ	O
beta-catenin/LEF	NN	O
misregulation	NN	O
as	IN	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
hair	NN	O
matrix	NN	O
cell	NN	O
tumorigenesis	NN	O
in	IN	O
humans	NNS	O
.	.	O

.	.	O

HFE	NN	O
mutations	NNS	O
analysis	NN	O
in	IN	O
711	CD	O
hemochromatosis	NN	B-Disease
probands	NNS	O
:	:	O
evidence	NN	O
for	IN	O
S65C	NN	O
implication	NN	O
in	IN	O
mild	JJ	O
form	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
.	.	O

Hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
(	-LRB-	O
HH	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
common	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
of	IN	O
iron	NN	O
metabolism	NN	O
.	.	O

The	DT	O
HFE	NN	O
candidate	NN	O
gene	NN	O
encoding	VBG	O
an	DT	O
HLA	NN	O
class	NN	O
I-like	JJ	O
protein	NN	O
involved	VBN	O
in	IN	O
HH	NN	B-Disease
was	VBD	O
identified	VBN	O
in	IN	O
1996	CD	O
.	.	O

Two	CD	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
C282Y	NN	O
,	,	O
accounting	VBG	O
for	IN	O
80	CD	O
%	NN	O
to	TO	O
90	CD	O
%	NN	O
of	IN	O
HH	NN	B-Disease
chromosomes	NNS	O
,	,	O
and	CC	O
H63D	NN	O
,	,	O
which	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
representing	VBG	O
40	CD	O
%	NN	O
to	TO	O
70	CD	O
%	NN	O
of	IN	O
non-C282Y	JJ	O
HH	NN	B-Disease
chromosomes	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
on	IN	O
the	DT	O
analysis	NN	O
of	IN	O
C282Y	NN	O
,	,	O
H63D	NN	O
,	,	O
and	CC	O
the	DT	O
193A	NN	O
--	:	O
>	JJR	O
T	NN	O
substitution	NN	O
leading	VBG	O
to	TO	O
the	DT	O
S65C	NN	O
missense	NN	O
substitution	NN	O
in	IN	O
a	DT	O
large	JJ	O
series	NN	O
of	IN	O
probands	NNS	O
and	CC	O
controls	NNS	O
.	.	O

The	DT	O
results	NNS	O
confirm	VBP	O
that	IN	O
the	DT	O
C282Y	NN	O
substitution	NN	O
was	VBD	O
the	DT	O
main	JJ	O
mutation	NN	O
involved	VBN	O
in	IN	O
hemochromatosis	NN	B-Disease
,	,	O
accounting	VBG	O
for	IN	O
85	CD	O
%	NN	O
of	IN	O
carrier	NN	O
chromosomes	NNS	O
,	,	O
whereas	IN	O
the	DT	O
H63D	NN	O
substitution	NN	O
represented	VBD	O
39	CD	O
%	NN	O
of	IN	O
the	DT	O
HH	NN	B-Disease
chromosomes	NNS	O
that	WDT	O
did	VBD	O
not	RB	O
carry	VB	O
the	DT	O
C282Y	NN	O
mutation	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
our	PRP$	O
screening	NN	O
showed	VBD	O
that	IN	O
the	DT	O
S65C	NN	O
substitution	NN	O
was	VBD	O
significantly	RB	O
enriched	JJ	O
in	IN	O
probands	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
chromosome	NN	O
without	IN	O
an	DT	O
assigned	VBN	O
mutation	NN	O
.	.	O

This	DT	O
substitution	NN	O
accounted	VBD	O
for	IN	O
7	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
HH	NN	B-Disease
chromosomes	NNS	O
that	WDT	O
were	VBD	O
neither	DT	O
C282Y	NN	O
nor	CC	O
H63D	NN	O
.	.	O

This	DT	O
enrichment	NN	O
of	IN	O
S65C	NN	O
among	IN	O
HH	NN	B-Disease
chromosomes	NNS	O
suggests	VBZ	O
that	IN	O
the	DT	O
S65C	NN	O
substitution	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
mild	JJ	O
form	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
.	.	O

Germline	NN	O
BRCA1	NN	O
alterations	NNS	O
in	IN	O
a	DT	O
population-based	JJ	O
series	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
cases	NNS	O
.	.	O

The	DT	O
objective	NN	O
of	IN	O
this	DT	O
study	NN	O
was	VBD	O
to	TO	O
provide	VB	O
more	JJR	O
accurate	JJ	O
frequency	NN	O
estimates	NNS	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
1	CD	O
(	-LRB-	O
BRCA1	NN	O
)	-RRB-	O
germline	NN	O
alterations	NNS	O
in	IN	O
the	DT	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
population	NN	O
.	.	O

To	TO	O
achieve	VB	O
this	DT	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
prevalence	NN	O
of	IN	O
BRCA1	NN	O
alterations	NNS	O
in	IN	O
a	DT	O
population-based	JJ	O
series	NN	O
of	IN	O
consecutive	JJ	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
cases	NNS	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
population-based	JJ	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
study	NN	O
reporting	VBG	O
BRCA1	NN	O
alterations	NNS	O
derived	VBN	O
from	IN	O
a	DT	O
comprehensive	JJ	O
screen	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
seven	CD	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
cases	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
BRCA1	NN	O
alterations	NNS	O
using	VBG	O
the	DT	O
RNase	NN	O
mismatch	NN	O
cleavage	NN	O
assay	NN	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Two	CD	O
truncating	JJ	O
mutations	NNS	O
,	,	O
962del4	NN	O
and	CC	O
3600del11	NN	O
,	,	O
were	VBD	O
identified	VBN	O
.	.	O

Both	DT	O
patients	NNS	O
had	VBD	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Several	JJ	O
novel	JJ	O
as	RB	O
well	RB	O
as	IN	O
previously	RB	O
reported	VBN	O
uncharacterized	JJ	O
variants	NNS	O
were	VBD	O
also	RB	O
identified	VBN	O
,	,	O
some	DT	O
of	IN	O
which	WDT	O
were	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
cancer	NN	B-Disease
.	.	O

The	DT	O
frequency	NN	O
distribution	NN	O
of	IN	O
common	JJ	O
polymorphisms	NNS	O
was	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
91	CD	O
Caucasian	JJ	O
cancer	NN	B-Disease
cases	NNS	O
in	IN	O
this	DT	O
series	NN	O
and	CC	O
24	CD	O
sister	NN	O
controls	NNS	O
using	VBG	O
allele-specific	JJ	O
amplification	NN	O
.	.	O

The	DT	O
rare	JJ	O
form	NN	O
of	IN	O
the	DT	O
Q356R	NN	O
polymorphism	NN	O
was	VBD	O
significantly	RB	O
(	-LRB-	O
P	NN	O
=	JJ	O
0	CD	O
.	.	O

03	NN	O
)	-RRB-	O
associated	VBN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
polymorphism	NN	O
may	MD	O
influence	VB	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
risk	NN	O
.	.	O

In	IN	O
summary	NN	O
,	,	O
our	PRP$	O
data	NNS	O
suggest	VBP	O
a	DT	O
role	NN	O
for	IN	O
some	DT	O
uncharacterized	JJ	O
variants	NNS	O
and	CC	O
rare	JJ	O
forms	NNS	O
of	IN	O
polymorphisms	NNS	O
in	IN	O
determining	VBG	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
risk	NN	O
,	,	O
and	CC	O
highlight	VB	O
the	DT	O
necessity	NN	O
to	TO	O
screen	NN	O
for	IN	O
missense	NN	O
alterations	NNS	O
as	RB	O
well	RB	O
as	IN	O
truncating	JJ	O
mutations	NNS	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

Identification	NN	O
of	IN	O
APC2	NN	O
,	,	O
a	DT	O
homologue	NN	O
of	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
tumour	NN	I-Disease
suppressor	NN	O
.	.	O

The	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	I-Disease
APC	NN	I-Disease
)	-RRB-	I-Disease
tumour-suppressor	JJ	O
protein	NN	O
controls	VBZ	O
the	DT	O
Wnt	NN	O
signalling	NN	O
pathway	NN	O
by	IN	O
forming	VBG	O
a	DT	O
complex	NN	O
with	IN	O
glycogen	NN	O
synthase	NN	O
kinase	NN	O
3beta	NN	O
(	-LRB-	O
GSK-3beta	NN	O
)	-RRB-	O
,	,	O
axin/conductin	NN	O
and	CC	O
betacatenin	NN	O
.	.	O

Complex	NN	O
formation	NN	O
induces	VBZ	O
the	DT	O
rapid	JJ	O
degradation	NN	O
of	IN	O
betacatenin	NN	O
.	.	O

In	IN	O
colon	NN	B-Disease
carcinoma	NN	I-Disease
cells	NNS	O
,	,	O
loss	NN	O
of	IN	O
APC	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
accumulation	NN	O
of	IN	O
betacatenin	NN	O
in	IN	O
the	DT	O
nucleus	NN	O
,	,	O
where	WRB	O
it	PRP	O
binds	VBZ	O
to	TO	O
and	CC	O
activates	VBZ	O
the	DT	O
Tcf-4	NN	O
transcription	NN	O
factor	NN	O
(	-LRB-	O
reviewed	VBN	O
in	IN	O
[	-LRB-	O
1	CD	O
]	-RRB-	O
[	-LRB-	O
2	CD	O
]	-RRB-	O
)	-RRB-	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
identification	NN	O
and	CC	O
genomic	JJ	O
structure	NN	O
of	IN	O
APC	NN	O
homologues	NNS	O
.	.	O

Mammalian	JJ	O
APC2	NN	O
,	,	O
which	WDT	O
closely	RB	O
resembles	VBZ	O
APC	NN	O
in	IN	O
overall	JJ	O
domain	NN	O
structure	NN	O
,	,	O
was	VBD	O
functionally	RB	O
analyzed	VBN	O
and	CC	O
shown	VBN	O
to	TO	O
contain	VB	O
two	CD	O
SAMP	NNP	O
domains	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
required	VBN	O
for	IN	O
binding	VBG	O
to	TO	O
conductin	NN	O
.	.	O

Like	IN	O
APC	NN	O
,	,	O
APC2	NN	O
regulates	VBZ	O
the	DT	O
formation	NN	O
of	IN	O
active	JJ	O
betacatenin-Tcf	NN	O
complexes	NNS	O
,	,	O
as	IN	O
demonstrated	VBN	O
using	VBG	O
transient	JJ	O
transcriptional	JJ	O
activation	NN	O
assays	NNS	O
in	IN	O
APC	NN	O
-	:	O
/	:	O
-	:	O
colon	NN	B-Disease
carcinoma	NN	I-Disease
cells	NNS	O
.	.	O

Human	JJ	O
APC2	NN	O
maps	NNS	O
to	TO	O
chromosome	NN	O
19p13	NN	O
.	.	O

3	LS	O
.	.	O

APC	NN	O
and	CC	O
APC2	NN	O
may	MD	O
therefore	RB	O
have	VB	O
comparable	JJ	O
functions	NNS	O
in	IN	O
development	NN	O
and	CC	O
cancer	NN	B-Disease
.	.	O

Familial	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
associated	VBN	O
with	IN	O
recurrent	JJ	O
bacteremic	JJ	B-Disease
infections	NNS	I-Disease
due	JJ	I-Disease
to	TO	I-Disease
Neisseria	NNP	I-Disease
.	.	O

The	DT	O
serum	NN	O
of	IN	O
a	DT	O
29-year	JJ	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
recent	JJ	O
episode	NN	O
of	IN	O
disseminated	VBN	B-Disease
gonococcal	JJ	I-Disease
infection	NN	I-Disease
and	CC	O
a	DT	O
history	NN	O
of	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
and	CC	O
arthritis	NN	B-Disease
as	IN	O
a	DT	O
child	NN	O
was	VBD	O
found	VBN	O
to	TO	O
lack	VB	O
serum	NN	O
hemolytic	JJ	O
complement	NN	O
activity	NN	O
.	.	O

The	DT	O
seventh	JJ	O
component	NN	O
of	IN	O
complement	NN	O
(	-LRB-	O
C7	NN	O
)	-RRB-	O
was	VBD	O
not	RB	O
detected	VBN	O
by	IN	O
functional	JJ	O
or	CC	O
immunochemical	JJ	O
assays	NNS	O
,	,	O
whereas	IN	O
other	JJ	O
components	NNS	O
were	VBD	O
normal	JJ	O
by	IN	O
hemolytic	JJ	O
and	CC	O
immunochemical	JJ	O
assessment	NN	O
.	.	O

Her	PRP$	O
fresh	JJ	O
serum	NN	O
lacked	VBD	O
complement-mediated	JJ	O
bactericidal	JJ	O
activity	NN	O
against	IN	O
Neisseria	NNP	O
gonorrhoeae	NNS	O
,	,	O
but	CC	O
the	DT	O
addition	NN	O
of	IN	O
fresh	JJ	O
normal	JJ	O
serum	NN	O
or	CC	O
purified	VBN	O
C7	NN	O
restored	VBD	O
bactericidal	JJ	O
activity	NN	O
as	RB	O
well	RB	O
as	IN	O
hemolytic	JJ	O
activity	NN	O
.	.	O

The	DT	O
absence	NN	B-Disease
of	IN	I-Disease
functional	JJ	I-Disease
C7	NN	I-Disease
activity	NN	O
could	MD	O
not	RB	O
be	VB	O
accounted	VBN	O
for	IN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
an	DT	O
inhibitor	NN	O
.	.	O

Opsonization	NN	O
and	CC	O
generation	NN	O
of	IN	O
chemotactic	JJ	O
activity	NN	O
functioned	VBD	O
normally	RB	O
.	.	O

Complete	JJ	B-Disease
absence	NN	I-Disease
of	IN	I-Disease
C7	NN	I-Disease
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
one	CD	O
sibling	NN	O
who	WP	O
had	VBD	O
the	DT	O
clinical	JJ	O
syndrome	NN	O
of	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
and	CC	O
arthritis	NN	B-Disease
as	IN	O
a	DT	O
child	NN	O
and	CC	O
in	IN	O
this	DT	O
siblings	NNS	O
clinically	RB	O
well	RB	O
eight-year-old	NN	O
son	NN	O
.	.	O

HLA	NN	O
histocompatibility	NN	O
typing	NN	O
of	IN	O
the	DT	O
family	NN	O
members	NNS	O
did	VBD	O
not	RB	O
demonstrate	VB	O
evidence	NN	O
for	IN	O
genetic	JJ	O
linkage	NN	O
of	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
loci	NNS	O
.	.	O

This	DT	O
report	NN	O
represents	VBZ	O
the	DT	O
first	JJ	O
cases	NNS	O
of	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
infectious	JJ	O
complications	NNS	O
and	CC	O
suggests	VBZ	O
that	IN	O
bactericidal	JJ	O
activity	NN	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
host	NN	O
defense	NN	O
against	IN	O
bacteremic	JJ	B-Disease
neisseria	NN	I-Disease
infections	NNS	I-Disease
.	.	O

GCH1	NN	O
mutation	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
adult-onset	JJ	O
oromandibular	JJ	B-Disease
dystonia	NN	I-Disease
.	.	O

The	DT	O
authors	NNS	O
report	VBP	O
a	DT	O
mutation	NN	O
in	IN	O
exon	NN	O
5	CD	O
of	IN	O
GCH1	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
adult-onset	JJ	O
oromandibular	JJ	B-Disease
dystonia	NN	I-Disease
and	CC	O
no	DT	O
obvious	JJ	O
family	NN	O
history	NN	O
of	IN	O
dystonia	NN	B-Disease
.	.	O

The	DT	O
patient	NN	O
responded	VBD	O
positively	RB	O
to	TO	O
treatment	NN	O
with	IN	O
L-dopa	NN	O
.	.	O

These	DT	O
findings	NNS	O
demonstrate	VBP	O
that	IN	O
GCH1	NN	O
mutations	NNS	O
must	MD	O
be	VB	O
considered	VBN	O
even	RB	O
in	IN	O
patients	NNS	O
with	IN	O
dystonic	JJ	B-Disease
symptoms	NNS	O
not	RB	O
typical	JJ	O
of	IN	O
dopa-responsive	JJ	B-Disease
dystonia	NN	I-Disease
.	.	O

The	DT	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
protein	NN	O
,	,	O
HFE	NN	O
,	,	O
specifically	RB	O
regulates	VBZ	O
transferrin-mediated	JJ	O
iron	NN	O
uptake	NN	O
in	IN	O
HeLa	NN	O
cells	NNS	O
.	.	O

HFE	NN	O
is	VBZ	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
the	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
(	-LRB-	O
Feder	NN	O
,	,	O
J.	NNP	O
N.	NNP	O
,	,	O
Gnirke	NNP	O
,	,	O
A.	NN	O
,	,	O
Thomas	NNP	O
,	,	O
W.	NNP	O
,	,	O
Tsuchihashi	NNP	O
,	,	O
Z.	NNP	O
,	,	O
Ruddy	NNP	O
,	,	O
D.	NNP	O
A.	NNP	O
,	,	O
Basava	NNP	O
,	,	O
A.	NNP	O
,	,	O
Dormishian	NNP	O
,	,	O
F.	NNP	O
,	,	O
Domingo	NNP	O
,	,	O
R.	NNP	O
J.	NNP	O
,	,	O
Ellis	NNP	O
,	,	O
M.	NNP	O
C.	NNP	O
,	,	O
Fullan	NNP	O
,	,	O
A.	NN	O
,	,	O
Hinton	NNP	O
,	,	O
L.	NNP	O
M.	NNP	O
,	,	O
Jones	NNP	O
,	,	O
N.	NNP	O
L.	NNP	O
,	,	O
Kimmel	NNP	O
,	,	O
B.	NNP	O
E.	NNP	O
,	,	O
Kronmal	NNP	O
,	,	O
G.	NNP	O
S.	NNP	O
,	,	O
Lauer	NNP	O
,	,	O
P.	NNP	O
,	,	O
Lee	NNP	O
,	,	O
V.	NNP	O
K.	NNP	O
,	,	O
Loeb	NNP	O
,	,	O
D.	NNP	O
B.	NNP	O
,	,	O
Mapa	NNP	O
,	,	O
F.	NNP	O
A.	NNP	O
,	,	O
McClelland	NNP	O
,	,	O
E.	NNP	O
,	,	O
Meyer	NNP	O
,	,	O
N.	NNP	O
C.	NNP	O
,	,	O
Mintier	NNP	O
,	,	O
G.	NNP	O
A.	NNP	O
,	,	O
Moeller	NNP	O
,	,	O
N.	NNP	O
,	,	O
Moore	NNP	O
,	,	O
T.	NNP	O
,	,	O
Morikang	NNP	O
,	,	O
E.	NNP	O
,	,	O
Prasss	NNP	O
,	,	O
C.	NNP	O
E	NNP	O
.	.	O

,	,	O
Quintana	NNP	O
,	,	O
L.	NNP	O
,	,	O
Starnes	NNP	O
,	,	O
S.	NNP	O
M	NNP	O
.	.	O

,	,	O
Schatzman	NNP	O
,	,	O
R.	NNP	O
C	NNP	O
.	.	O

,	,	O
Brunke	NNP	O
,	,	O
K.	NNP	O
J	NNP	O
.	.	O

,	,	O
Drayna	NNP	O
,	,	O
D.	NNP	O
T.	NNP	O
,	,	O
Risch	NNP	O
,	,	O
N.	NNP	O
J	NNP	O
.	.	O

,	,	O
Bacon	NNP	O
,	,	O
B.	NNP	O
R	NNP	O
.	.	O

,	,	O
and	CC	O
Wolff	NNP	O
,	,	O
R.	NNP	O
R	NNP	O
.	.	O

(	-LRB-	O
1996	CD	O
)	-RRB-	O
Nat	NNP	O
.	.	O

Genet	NNP	O
.	.	O

13	CD	O
,	,	O
399-408	CD	O
)	-RRB-	O
.	.	O

At	IN	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
HFE	NN	O
complexes	NNS	O
with	IN	O
transferrin	NN	O
receptor	NN	O
(	-LRB-	O
TfR	NN	O
)	-RRB-	O
,	,	O
increasing	VBG	O
the	DT	O
dissociation	NN	O
constant	NN	O
of	IN	O
transferrin	NN	O
(	-LRB-	O
Tf	NN	O
)	-RRB-	O
for	IN	O
its	PRP$	O
receptor	NN	O
10-fold	RB	O
(	-LRB-	O
Gross	NNP	O
,	,	O
C.	NNP	O
N	NNP	O
.	.	O

,	,	O
Irrinki	NNP	O
,	,	O
A.	NN	O
,	,	O
Feder	NNP	O
,	,	O
J.	NNP	O
N	NNP	O
.	.	O

,	,	O
and	CC	O
Enns	NNP	O
,	,	O
C	NNP	O
.	.	O

A	DT	O
.	.	O

(	-LRB-	O
1998	CD	O
)	-RRB-	O
J.	NNP	O
Biol	NNP	O
.	.	O

Chem	NNP	O
.	.	O

273	CD	O
,	,	O
22068-22074	CD	O
;	:	O
Feder	NNP	O
,	,	O
J.	NNP	O
N.	NNP	O
,	,	O
Penny	NNP	O
,	,	O
D.	NNP	O
M.	NNP	O
,	,	O
Irrinki	NNP	O
,	,	O
A.	NN	O
,	,	O
Lee	NNP	O
,	,	O
V.	NNP	O
K.	NNP	O
,	,	O
Lebron	NNP	O
,	,	O
J.	NNP	O
A.	NNP	O
,	,	O
Watson	NNP	O
,	,	O
N.	NNP	O
,	,	O
Tsuchihashi	NNP	O
,	,	O
Z.	NNP	O
,	,	O
Sigal	NNP	O
,	,	O
E.	NNP	O
,	,	O
Bjorkman	NNP	O
,	,	O
P.	NNP	O
J.	NNP	O
,	,	O
and	CC	O
Schatzman	NNP	O
,	,	O
R.	NNP	O
C.	NNP	O
(	-LRB-	O
1998	CD	O
)	-RRB-	O
Proc	NNP	O
.	.	O

Natl	NNP	O
.	.	O

Acad	NNP	O
.	.	O

Sci	NNP	O
.	.	O

U	NNP	O
S	NNP	O
A	NNP	O
95	CD	O
,	,	O
1472-1477	CD	O
)	-RRB-	O
.	.	O

HFE	NN	O
does	VBZ	O
not	RB	O
remain	VB	O
at	IN	O
the	DT	O
cell	NN	O
surface	NN	O
,	,	O
but	CC	O
traffics	VBZ	O
with	IN	O
TfR	NN	O
to	TO	O
Tf-positive	JJ	O
internal	JJ	O
compartments	NNS	O
(	-LRB-	O
Gross	NNP	O
et	FW	O
al.	FW	O
,	,	O
1998	CD	O
)	-RRB-	O
.	.	O

Using	VBG	O
a	DT	O
HeLa	NN	O
cell	NN	O
line	NN	O
in	IN	O
which	WDT	O
the	DT	O
expression	NN	O
of	IN	O
HFE	NN	O
is	VBZ	O
controlled	VBN	O
by	IN	O
tetracycline	NN	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
HFE	NN	O
reduces	VBZ	O
55Fe	NN	O
uptake	NN	O
from	IN	O
Tf	NN	O
by	IN	O
33	CD	O
%	NN	O
but	CC	O
does	VBZ	O
not	RB	O
affect	VB	O
the	DT	O
endocytic	JJ	O
or	CC	O
exocytic	JJ	O
rates	NNS	O
of	IN	O
TfR	NN	O
cycling	NN	O
.	.	O

Therefore	RB	O
,	,	O
HFE	NN	O
appears	VBZ	O
to	TO	O
reduce	VB	O
cellular	JJ	O
acquisition	NN	O
of	IN	O
iron	NN	O
from	IN	O
Tf	NN	O
within	IN	O
endocytic	JJ	O
compartments	NNS	O
.	.	O

HFE	NN	O
specifically	RB	O
reduces	VBZ	O
iron	NN	O
uptake	NN	O
from	IN	O
Tf	NN	O
,	,	O
as	IN	O
non-Tf-mediated	JJ	O
iron	NN	O
uptake	NN	O
from	IN	O
Fe-nitrilotriacetic	JJ	O
acid	NN	O
is	VBZ	O
not	RB	O
altered	VBN	O
.	.	O

These	DT	O
results	NNS	O
explain	VBP	O
the	DT	O
decreased	VBN	O
ferritin	NN	O
levels	NNS	O
seen	VBN	O
in	IN	O
our	PRP$	O
HeLa	NN	O
cell	NN	O
system	NN	O
and	CC	O
demonstrate	VBP	O
the	DT	O
specific	JJ	O
control	NN	O
of	IN	O
HFE	NN	O
over	IN	O
the	DT	O
Tf-mediated	JJ	O
pathway	NN	O
of	IN	O
iron	NN	O
uptake	NN	O
.	.	O

These	DT	O
results	NNS	O
also	RB	O
have	VBP	O
implications	NNS	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
cellular	JJ	O
iron	NN	O
homeostasis	NN	O
in	IN	O
organs	NNS	O
such	JJ	O
as	IN	O
the	DT	O
liver	NN	O
,	,	O
pancreas	NN	O
,	,	O
heart	NN	O
,	,	O
and	CC	O
spleen	NN	O
that	WDT	O
are	VBP	O
iron	NN	O
loaded	VBN	O
in	IN	O
hereditary	JJ	B-Disease
hemochromatotic	JJ	I-Disease
individuals	NNS	O
lacking	VBG	O
functional	JJ	O
HFE	NN	O
.	.	O

Mutation	NN	O
and	CC	O
haplotype	NN	O
studies	NNS	O
of	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
reveal	VBP	O
new	JJ	O
ancestral	JJ	O
relationships	NNS	O
and	CC	O
evidence	NN	O
for	IN	O
a	DT	O
high	JJ	O
carrier	NN	O
frequency	NN	O
with	IN	O
reduced	VBN	O
penetrance	NN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessive	JJ	B-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	O
with	IN	O
serositis	NN	B-Disease
or	CC	O
synovitis	NN	B-Disease
.	.	O

The	DT	O
FMF	NN	B-Disease
gene	NN	O
(	-LRB-	O
MEFV	NN	O
)	-RRB-	O
was	VBD	O
cloned	VBN	O
recently	RB	O
,	,	O
and	CC	O
four	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
data	NNS	O
from	IN	O
non-Ashkenazi	JJ	O
Jewish	JJ	O
and	CC	O
Arab	JJ	O
patients	NNS	O
in	IN	O
whom	WP	O
we	PRP	O
had	VBD	O
not	RB	O
originally	RB	O
found	VBN	O
mutations	NNS	O
and	CC	O
from	IN	O
a	DT	O
new	JJ	O
,	,	O
more	RBR	O
ethnically	RB	O
diverse	JJ	O
panel	NN	O
.	.	O

Among	IN	O
90	CD	O
symptomatic	JJ	O
mutation-positive	JJ	O
individuals	NNS	O
,	,	O
11	CD	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
79	CD	O
%	NN	O
of	IN	O
carrier	NN	O
chromosomes	NNS	O
.	.	O

Of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
that	WDT	O
are	VBP	O
novel	JJ	O
,	,	O
one	CD	O
alters	VBZ	O
the	DT	O
same	JJ	O
residue	NN	O
(	-LRB-	O
680	CD	O
)	-RRB-	O
as	IN	O
a	DT	O
previously	RB	O
known	VBN	O
mutation	NN	O
,	,	O
and	CC	O
the	DT	O
other	JJ	O
(	-LRB-	O
P369S	NN	O
)	-RRB-	O
is	VBZ	O
located	JJ	O
in	IN	O
exon	NN	O
3	CD	O
.	.	O

Consistent	JJ	O
with	IN	O
another	DT	O
recent	JJ	O
report	NN	O
,	,	O
the	DT	O
E148Q	NN	O
mutation	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
patients	NNS	O
of	IN	O
several	JJ	O
ethnicities	NNS	O
and	CC	O
on	IN	O
multiple	JJ	O
microsatellite	NN	O
haplotypes	NNS	O
,	,	O
but	CC	O
haplotype	NN	O
data	NNS	O
indicate	VBP	O
an	DT	O
ancestral	JJ	O
relationships	NNS	O
between	IN	O
non-Jewish	JJ	O
Italian	JJ	O
and	CC	O
Ashkenazi	JJ	O
Jewish	JJ	O
patients	NNS	O
with	IN	O
FMF	NN	B-Disease
and	CC	O
other	JJ	O
affected	JJ	O
populations	NNS	O
.	.	O

Among	IN	O
approximately	RB	O
200	CD	O
anonymous	JJ	O
Ashkenazi	NNP	O
Jewish	JJ	O
DNA	NN	O
samples	NNS	O
,	,	O
the	DT	O
MEFV	NN	O
carrier	NN	O
frequency	NN	O
was	VBD	O
21	CD	O
%	NN	O
,	,	O
with	IN	O
E148Q	NN	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
.	.	O

Several	JJ	O
lines	NNS	O
of	IN	O
evidence	NN	O
indicate	VBP	O
reduced	VBN	O
penetrance	NN	O
among	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
,	,	O
especially	RB	O
for	IN	O
E148Q	NN	O
,	,	O
P369S	NN	O
,	,	O
and	CC	O
K695R	NN	O
.	.	O

Nevertheless	RB	O
,	,	O
E148Q	NN	O
helps	VBZ	O
account	VB	O
for	IN	O
recessive	JJ	O
inheritance	NN	O
in	IN	O
an	DT	O
Ashkenazi	NNP	O
family	NN	O
previously	RB	O
reported	VBD	O
as	IN	O
an	DT	O
unusual	JJ	O
case	NN	O
of	IN	O
dominantly	RB	O
inherited	VBN	O
FMF	NN	B-Disease
.	.	O

The	DT	O
presence	NN	O
of	IN	O
three	CD	O
frequent	JJ	O
MEFV	NN	O
mutations	NNS	O
in	IN	O
multiple	JJ	O
Mediterranean	JJ	O
populations	NNS	O
strongly	RB	O
suggests	VBZ	O
a	DT	O
heterozygote	NN	O
advantage	NN	O
in	IN	O
this	DT	O
geographic	JJ	O
region	NN	O
.	.	O

Autoimmune	NN	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
with	IN	O
defective	JJ	O
Fas	NN	O
:	:	O
genotype	NN	O
influences	VBZ	O
penetrance	NN	O
.	.	O

Autoimmune	NN	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ALPS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
disorder	NN	B-Disease
of	IN	I-Disease
lymphocyte	NN	I-Disease
homeostasis	NN	I-Disease
and	CC	I-Disease
immunological	JJ	I-Disease
tolerance	NN	I-Disease
.	.	O

Most	JJS	O
patients	NNS	O
have	VBP	O
a	DT	O
heterozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
APT1	NN	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
Fas	NN	O
(	-LRB-	O
CD95	NN	O
,	,	O
APO-1	NN	O
)	-RRB-	O
,	,	O
mediator	NN	O
of	IN	O
an	DT	O
apoptotic	JJ	O
pathway	NN	O
crucial	JJ	O
to	TO	O
lymphocyte	NN	O
homeostasis	NN	O
.	.	O

Of	IN	O
17	CD	O
unique	JJ	O
APT1	NN	O
mutations	NNS	O
in	IN	O
unrelated	JJ	O
ALPS	NN	B-Disease
probands	NNS	O
,	,	O
12	CD	O
(	-LRB-	O
71	CD	O
%	NN	O
)	-RRB-	O
occurred	VBD	O
in	IN	O
exons	NNS	O
7-9	CD	O
,	,	O
which	WDT	O
encode	VBP	O
the	DT	O
intracellular	JJ	O
portion	NN	O
of	IN	O
Fas	NN	O
.	.	O

In	FW	O
vitro	FW	O
,	,	O
activated	VBN	O
lymphocytes	NNS	O
from	IN	O
all	DT	O
17	CD	O
patients	NNS	O
showed	VBD	O
apoptotic	JJ	O
defects	NNS	O
when	WRB	O
exposed	VBN	O
to	TO	O
an	DT	O
anti-Fas	JJ	O
agonist	NN	O
monoclonal	JJ	O
antibody	NN	O
.	.	O

Similar	JJ	O
defects	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
a	DT	O
Fas-negative	JJ	O
cell	NN	O
line	NN	O
transfected	VBN	O
with	IN	O
cDNAs	NNS	O
bearing	VBG	O
each	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

In	IN	O
cotransfection	NN	O
experiments	NNS	O
,	,	O
Fas	NN	O
constructs	NNS	O
with	IN	O
either	CC	O
intra	NN	O
-	:	O
or	CC	O
extracellular	JJ	O
mutations	NNS	O
caused	VBD	O
dominant	JJ	O
inhibition	NN	O
of	IN	O
apoptosis	NN	O
mediated	VBN	O
by	IN	O
wild-type	JJ	O
Fas	NN	O
.	.	O

Two	CD	O
missense	NN	O
Fas	NN	O
variants	NNS	O
,	,	O
not	RB	O
restricted	JJ	O
to	TO	O
patients	NNS	O
with	IN	O
ALPS	NN	B-Disease
,	,	O
were	VBD	O
identified	VBN	O
.	.	O

Variant	JJ	O
A	NN	O
(	-LRB-	O
-1	CD	O
)	-RRB-	O
T	NN	O
at	IN	O
the	DT	O
Fas	NN	O
signal-sequence	NN	O
cleavage	NN	O
site	NN	O
,	,	O
which	WDT	O
mediates	VBZ	O
apoptosis	NN	O
less	RBR	O
well	RB	O
than	IN	O
wild-type	JJ	O
Fas	NN	O
and	CC	O
is	VBZ	O
partially	RB	O
inhibitory	JJ	O
,	,	O
was	VBD	O
present	JJ	O
in	IN	O
13	CD	O
%	NN	O
of	IN	O
African	JJ	O
American	JJ	O
alleles	NNS	O
.	.	O

Among	IN	O
the	DT	O
ALPS-associated	JJ	O
Fas	NN	O
mutants	NNS	O
,	,	O
dominant	JJ	O
inhibition	NN	O
of	IN	O
apoptosis	NN	O
was	VBD	O
much	RB	O
more	RBR	O
pronounced	JJ	O
in	IN	O
mutants	NNS	O
affecting	VBG	O
the	DT	O
intracellular	JJ	O
,	,	O
versus	CC	O
extracellular	JJ	O
,	,	O
portion	NN	O
of	IN	O
the	DT	O
Fas	NN	O
receptor	NN	O
.	.	O

Mutations	NNS	O
causing	VBG	O
disruption	NN	O
of	IN	O
the	DT	O
intracellular	JJ	O
Fas	NN	O
death	NN	O
domain	NN	O
also	RB	O
showed	VBD	O
a	DT	O
higher	JJR	O
penetrance	NN	O
of	IN	O
ALPS	NN	B-Disease
phenotype	NN	O
features	NNS	O
in	IN	O
mutation-bearing	JJ	O
relatives	NNS	O
.	.	O

Significant	JJ	O
ALPS-related	JJ	O
morbidity	NN	O
occurred	VBD	O
in	IN	O
44	CD	O
%	NN	O
of	IN	O
relatives	NNS	O
with	IN	O
intracellular	JJ	O
mutations	NNS	O
,	,	O
versus	CC	O
0	CD	O
%	NN	O
of	IN	O
relatives	NNS	O
with	IN	O
extracellular	JJ	O
mutations	NNS	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
location	NN	O
of	IN	O
mutations	NNS	O
within	IN	O
APT1	NN	O
strongly	RB	O
influences	VBZ	O
the	DT	O
development	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
ALPS	NNP	B-Disease
.	.	O

Mutational	JJ	O
analysis	NN	O
and	CC	O
genotype-phenotype	NN	O
correlation	NN	O
of	IN	O
29	CD	O
unrelated	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
.	.	O

BACKGROUND	NN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	B-Disease
disease	NN	I-Disease
characterized	VBN	O
by	IN	O
progressive	JJ	O
neurologic	JJ	B-Disease
dysfunction	NN	I-Disease
,	,	O
occasionally	RB	O
associated	VBN	O
with	IN	O
adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
.	.	O

The	DT	O
classic	JJ	O
form	NN	O
of	IN	O
ALD	NNP	B-Disease
usually	RB	O
has	VBZ	O
onset	NN	O
in	IN	O
childhood	NN	O
(	-LRB-	O
childhood	NN	B-Disease
cerebral	JJ	I-Disease
ALD	NN	I-Disease
)	-RRB-	O
,	,	O
with	IN	O
rapid	JJ	O
neurologic	JJ	B-Disease
deterioration	NN	I-Disease
leading	VBG	O
to	TO	O
a	DT	O
vegetative	JJ	O
state	NN	O
.	.	O

Adult-onset	JJ	O
cerebral	JJ	B-Disease
ALD	NN	I-Disease
also	RB	O
presents	VBZ	O
with	IN	O
rapidly	RB	O
progressive	JJ	O
neurologic	JJ	B-Disease
dysfunction	NN	I-Disease
.	.	O

Milder	JJR	O
phenotypes	NNS	O
such	JJ	O
as	IN	O
adrenomyeloneuropathy	NN	B-Disease
and	CC	O
Addison	NNP	B-Disease
disease	NN	I-Disease
only	RB	O
also	RB	O
have	VBP	O
been	VBN	O
recognized	VBN	O
.	.	O

Despite	IN	O
discovery	NN	O
of	IN	O
the	DT	O
causative	JJ	O
gene	NN	O
,	,	O
a	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
diverse	JJ	O
clinical	JJ	O
presentations	NNS	O
remains	VBZ	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O

OBJECTIVES	NNS	O
To	TO	O
conduct	VB	O
mutational	JJ	O
analyses	NNS	O
in	IN	O
29	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
from	IN	O
29	CD	O
unrelated	JJ	O
families	NNS	O
,	,	O
to	TO	O
obtain	VB	O
knowledge	NN	O
of	IN	O
the	DT	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
,	,	O
and	CC	O
to	TO	O
study	VB	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

METHODS	NNS	O
The	DT	O
29	CD	O
patients	NNS	O
comprised	VBN	O
13	CD	O
patients	NNS	O
with	IN	O
childhood	NN	B-Disease
cerebral	JJ	I-Disease
ALD	NN	I-Disease
,	,	O
11	CD	O
patients	NNS	O
with	IN	O
adult-onset	JJ	O
cerebral	JJ	B-Disease
ALD	NN	I-Disease
,	,	O
and	CC	O
5	CD	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	NN	B-Disease
.	.	O

We	PRP	O
conducted	VBD	O
detailed	JJ	O
mutational	JJ	O
analyses	NNS	O
of	IN	O
29	CD	O
unrelated	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
by	IN	O
genomic	JJ	O
Southern	NN	O
blot	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
nucleotide	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
reverse	JJ	O
transcriptase-polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
derived	VBN	O
from	IN	O
total	JJ	O
RNA	NN	O
that	WDT	O
was	VBD	O
extracted	VBN	O
from	IN	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
,	,	O
lymphoblastoid	JJ	O
cells	NNS	O
,	,	O
or	CC	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
.	.	O

RESULTS	NNS	O
Three	CD	O
patients	NNS	O
with	IN	O
adult-onset	JJ	O
cerebral	JJ	B-Disease
ALD	NN	I-Disease
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
large	JJ	O
genomic	JJ	O
rearrangements	NNS	O
.	.	O

The	DT	O
remaining	VBG	O
26	CD	O
patients	NNS	O
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
21	CD	O
independent	JJ	O
mutations	NNS	O
,	,	O
including	VBG	O
12	CD	O
novel	JJ	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
small	JJ	O
nucleotide	NN	O
alterations	NNS	O
in	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
.	.	O

Eighteen	CD	O
(	-LRB-	O
69	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
26	CD	O
mutations	NNS	O
were	VBD	O
missense	NN	O
mutations	NNS	O
.	.	O

Most	JJS	O
missense	NN	O
mutations	NNS	O
involved	VBN	O
amino	NN	O
acids	NNS	O
conserved	VBN	O
in	IN	O
homologous	JJ	O
gene	NN	O
products	NNS	O
,	,	O
including	VBG	O
PMP70	NN	O
,	,	O
mALDRP	NN	O
,	,	O
and	CC	O
Pxa1p	NN	O
.	.	O

The	DT	O
AG	NNP	O
dinucleotide	NN	O
deletion	NN	O
at	IN	O
position	NN	O
1081-1082	CD	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
to	TO	O
be	VB	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
white	JJ	O
patients	NNS	O
(	-LRB-	O
12	CD	O
%	NN	O
-17	CD	O
%	NN	O
)	-RRB-	O
,	,	O
was	VBD	O
also	RB	O
identified	VBN	O
as	IN	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
(	-LRB-	O
12	CD	O
%	NN	O
)	-RRB-	O
.	.	O

All	DT	O
phenotypes	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
protein	NN	O
truncation	NN	O
or	CC	O
subtle	JJ	O
amino	NN	O
acid	NN	O
changes	NNS	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
differences	NNS	O
in	IN	O
phenotypic	JJ	O
expressions	NNS	O
between	IN	O
missense	NN	O
mutations	NNS	O
involving	VBG	O
conserved	VBN	O
amino	NN	O
acids	NNS	O
and	CC	O
those	DT	O
involving	VBG	O
nonconserved	JJ	O
amino	NN	O
acids	NNS	O
.	.	O

CONCLUSIONS	NNS	O
There	EX	O
are	VBP	O
no	DT	O
obvious	JJ	O
correlations	NNS	O
between	IN	O
the	DT	O
phenotypes	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
and	CC	O
their	PRP$	O
genotypes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
other	JJ	O
genetic	JJ	O
or	CC	O
environmental	JJ	O
factors	NNS	O
modify	VBP	O
the	DT	O
phenotypic	JJ	O
expressions	NNS	O
of	IN	O
ALD	NN	B-Disease
.	.	O

.	.	O

Absence	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
chronic	JJ	B-Disease
meningococcemia	NN	I-Disease
presenting	VBG	O
as	IN	O
vasculitis	NN	B-Disease
.	.	O

A	DT	O
previously	RB	O
healthy	JJ	O
40-year-old	JJ	O
man	NN	O
presenting	VBG	O
with	IN	O
fever	NN	B-Disease
,	,	O
arthritis	NN	B-Disease
,	,	O
and	CC	O
cutaneous	JJ	B-Disease
vasculitis	NN	I-Disease
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
chronic	JJ	B-Disease
meningococcemia	NN	I-Disease
.	.	O

Evaluation	NN	O
of	IN	O
his	PRP$	O
complement	NN	O
system	NN	O
showed	VBD	O
an	DT	O
absence	NN	O
of	IN	O
functional	JJ	O
and	CC	O
antigenic	JJ	O
C7	NN	O
,	,	O
compatible	JJ	O
with	IN	O
a	DT	O
complete	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
.	.	O

Study	NN	O
of	IN	O
the	DT	O
patients	NNS	O
family	NN	O
spanning	VBG	O
four	CD	O
generations	NNS	O
showed	VBD	O
heterozygous	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
C7	NN	I-Disease
in	IN	O
five	CD	O
members	NNS	O
.	.	O

Chronic	JJ	B-Disease
neisserial	JJ	I-Disease
infection	NN	I-Disease
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
must	MD	O
be	VB	O
distinguished	VBN	O
from	IN	O
other	JJ	O
causes	NNS	O
of	IN	O
cutaneous	JJ	B-Disease
vasculitis	NN	I-Disease
.	.	O

.	.	O

Genotype	NN	O
and	CC	O
phenotype	NN	O
in	IN	O
patients	NNS	O
with	IN	O
dihydropyrimidine	NN	B-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Dihydropyrimidine	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
DPD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
characterised	VBN	O
by	IN	O
thymine-uraciluria	NN	O
in	IN	O
homozygous	JJ	O
deficient	JJ	O
patients	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
a	DT	O
variable	JJ	O
clinical	JJ	O
phenotype	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
understand	VB	O
the	DT	O
genetic	JJ	O
and	CC	O
phenotypic	JJ	O
basis	NN	O
for	IN	O
DPD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
we	PRP	O
have	VBP	O
reviewed	VBN	O
17	CD	O
families	NNS	O
presenting	VBG	O
22	CD	O
patients	NNS	O
with	IN	O
complete	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
DPD	NN	I-Disease
.	.	O

In	IN	O
this	DT	O
group	NN	O
of	IN	O
patients	NNS	O
,	,	O
7	CD	O
different	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
,	,	O
including	VBG	O
2	CD	O
deletions	NNS	O
[	-LRB-	O
295-298delTCAT	NN	O
,	,	O
1897delC	NN	O
]	-RRB-	O
,	,	O
1	CD	O
splice-site	NN	O
mutation	NN	O
[	-LRB-	O
IVS14	NN	O
+	CC	O
1G	NN	O
>	JJR	O
A	NN	O
)	-RRB-	O
]	-RRB-	O
and	CC	O
4	CD	O
missense	NN	O
mutations	NNS	O
(	-LRB-	O
85T	NN	O
>	JJR	O
C	NN	O
,	,	O
703C	NN	O
>	JJR	O
T	NN	O
,	,	O
2658G	NN	O
>	JJR	O
A	NN	O
,	,	O
2983G	NN	O
>	JJR	O
T	NN	O
)	-RRB-	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
prevalence	NN	O
of	IN	O
the	DT	O
various	JJ	O
mutations	NNS	O
among	IN	O
DPD	NN	B-Disease
patients	NNS	O
has	VBZ	O
shown	VBN	O
that	IN	O
the	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
invariant	JJ	O
splice	NN	O
donor	NN	O
site	NN	O
is	VBZ	O
by	IN	O
far	RB	O
the	DT	O
most	RBS	O
common	JJ	O
(	-LRB-	O
52	CD	O
%	NN	O
)	-RRB-	O
,	,	O
whereas	IN	O
the	DT	O
other	JJ	O
six	CD	O
mutations	NNS	O
are	VBP	O
less	RBR	O
frequently	RB	O
observed	VBN	O
.	.	O

A	DT	O
large	JJ	O
phenotypic	JJ	O
variability	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
,	,	O
with	IN	O
convulsive	JJ	B-Disease
disorders	NNS	I-Disease
,	,	O
motor	NN	B-Disease
retardation	NN	I-Disease
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
being	VBG	O
the	DT	O
most	RBS	O
abundant	JJ	O
manifestations	NNS	O
.	.	O

A	DT	O
clear	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
genotype	NN	O
and	CC	O
phenotype	NN	O
has	VBZ	O
not	RB	O
been	VBN	O
established	VBN	O
.	.	O

An	DT	O
altered	JJ	O
beta-alanine	NN	O
,	,	O
uracil	NN	O
and	CC	O
thymine	NN	O
homeostasis	NN	O
might	MD	O
underlie	VB	O
the	DT	O
various	JJ	O
clinical	JJ	B-Disease
abnormalities	NNS	I-Disease
encountered	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
DPD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
by	IN	O
natural	JJ	O
and	CC	O
amplification	NN	O
created	VBD	O
restriction	NN	O
sites	NNS	O
:	:	O
five	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
most	JJS	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
cases	NNS	O
in	IN	O
Taiwan	NNP	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
a	DT	O
rapid	JJ	O
and	CC	O
simple	JJ	O
method	NN	O
to	TO	O
diagnose	VB	O
the	DT	O
molecular	JJ	O
defects	NNS	O
of	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
Chinese	JJ	O
in	IN	O
Taiwan	NNP	O
.	.	O

This	DT	O
method	NN	O
involves	VBZ	O
the	DT	O
selective	JJ	O
amplification	NN	O
of	IN	O
a	DT	O
DNA	NN	O
fragment	NN	O
from	IN	O
human	JJ	O
G6PD	NN	O
gene	NN	O
with	IN	O
specific	JJ	O
oligonucleotide	NN	O
primers	NNS	O
followed	VBN	O
by	IN	O
digestion	NN	O
with	IN	O
restriction	NN	O
enzymes	NNS	O
that	WDT	O
recognize	VBP	O
artificially	RB	O
created	VBN	O
or	CC	O
naturally	RB	O
occurring	VBG	O
restriction	NN	O
sites	NNS	O
.	.	O

Ninety-four	CD	O
Chinese	JJ	O
males	NNS	O
with	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
were	VBD	O
studied	VBN	O
.	.	O

The	DT	O
results	NNS	O
show	VBP	O
that	IN	O
50	CD	O
%	NN	O
(	-LRB-	O
47	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
were	VBD	O
G	NN	O
to	TO	O
T	NN	O
mutation	NN	O
at	IN	O
nucleotide	NN	O
(	-LRB-	O
nt	NN	O
)	-RRB-	O
1376	CD	O
,	,	O
21	CD	O
.	.	O

3	CD	O
%	NN	O
(	-LRB-	O
20	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
were	VBD	O
G	NN	O
to	TO	O
A	DT	O
mutation	NN	O
at	IN	O
nt	NNS	O
1388	CD	O
,	,	O
7	CD	O
.	.	O

4	CD	O
%	NN	O
(	-LRB-	O
7	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
were	VBD	O
A	DT	O
to	TO	O
G	NN	O
mutation	NN	O
at	IN	O
nt	NNS	O
493	CD	O
,	,	O
7	CD	O
.	.	O

4	CD	O
%	NN	O
(	-LRB-	O
7	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
were	VBD	O
A	DT	O
to	TO	O
G	NN	O
mutation	NN	O
at	IN	O
nt	NNS	O
95	CD	O
,	,	O
4	CD	O
.	.	O

2	CD	O
%	NN	O
(	-LRB-	O
4	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
were	VBD	O
C	NN	O
to	TO	O
T	NN	O
mutation	NN	O
at	IN	O
nt	NNS	O
1024	CD	O
,	,	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
(	-LRB-	O
1	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
was	VBD	O
G	NN	O
to	TO	O
T	NN	O
mutation	NN	O
at	IN	O
nt	NNS	O
392	CD	O
,	,	O
and	CC	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
(	-LRB-	O
1	CD	O
of	IN	O
94	CD	O
)	-RRB-	O
was	VBD	O
G	NN	O
to	TO	O
A	DT	O
mutation	NN	O
at	IN	O
nt	NNS	O
487	CD	O
.	.	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
the	DT	O
former	JJ	O
five	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
more	JJR	O
than	IN	O
90	CD	O
%	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
cases	NNS	O
in	IN	O
Taiwan	NNP	O
.	.	O

Aside	RB	O
from	IN	O
showing	VBG	O
that	IN	O
G	NN	O
to	TO	O
T	NN	O
change	NN	O
at	IN	O
nt	NNS	O
1376	CD	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
,	,	O
our	PRP$	O
research	NN	O
indicates	VBZ	O
that	IN	O
nt	NN	O
493	CD	O
mutation	NN	O
is	VBZ	O
a	DT	O
frequent	JJ	O
mutation	NN	O
among	IN	O
Chinese	JJ	O
in	IN	O
Taiwan	NNP	O
.	.	O

We	PRP	O
compared	VBD	O
G6PD	NN	O
activity	NN	O
among	IN	O
different	JJ	O
mutations	NNS	O
,	,	O
without	IN	O
discovering	VBG	O
significant	JJ	O
differences	NNS	O
between	IN	O
them	PRP	O
.	.	O

Homozygous	JJ	B-Disease
hypobetalipoproteinemia	NN	I-Disease
:	:	O
a	DT	O
disease	NN	O
distinct	JJ	O
from	IN	O
abetalipoproproteinemia	NN	B-Disease
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
.	.	O

apoB	NN	O
DNA	NN	O
,	,	O
RNA	NN	O
,	,	O
and	CC	O
protein	NN	O
from	IN	O
two	CD	O
patients	NNS	O
with	IN	O
homozygous	JJ	B-Disease
hypobetalipoproteinemia	NN	I-Disease
(	-LRB-	O
HBL	NN	B-Disease
)	-RRB-	O
were	VBD	O
evaluated	VBN	O
and	CC	O
compared	VBN	O
with	IN	O
normal	JJ	O
individuals	NNS	O
.	.	O

Southern	NN	O
blot	NN	O
analysis	NN	O
with	IN	O
10	CD	O
different	JJ	O
cDNA	NN	O
probes	NNS	O
revealed	VBD	O
a	DT	O
normal	JJ	O
gene	NN	O
without	IN	O
major	JJ	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
or	CC	O
rearrangements	NNS	O
.	.	O

Northern	NN	O
and	CC	O
slot	NN	O
blot	NN	O
analyses	NNS	O
of	IN	O
total	JJ	O
liver	NN	O
mRNA	NN	O
from	IN	O
HBL	NN	B-Disease
patients	NNS	O
documented	VBD	O
a	DT	O
normal	JJ	O
size	NN	O
apoB	NN	O
mRNA	NN	O
that	WDT	O
was	VBD	O
present	JJ	O
in	IN	O
greatly	RB	O
reduced	VBN	O
quantities	NNS	O
.	.	O

ApoB	NN	O
protein	NN	O
was	VBD	O
detected	VBN	O
within	IN	O
HBL	NN	B-Disease
hepatocytes	NNS	O
utilizing	VBG	O
immunohistochemical	JJ	O
techniques	NNS	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
was	VBD	O
markedly	RB	O
reduced	VBN	O
in	IN	O
quantity	NN	O
when	WRB	O
compared	VBN	O
with	IN	O
control	NN	O
samples	NNS	O
.	.	O

No	DT	O
apoB	NN	O
was	VBD	O
detectable	JJ	O
in	IN	O
the	DT	O
plasma	NN	O
of	IN	O
HBL	NN	B-Disease
individuals	NNS	O
with	IN	O
an	DT	O
ELISA	NN	O
assay	NN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
most	RBS	O
consistent	JJ	O
with	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
portion	NN	O
of	IN	O
the	DT	O
apoB	NN	O
gene	NN	O
in	IN	O
HBL	NN	B-Disease
patients	NNS	O
,	,	O
leading	VBG	O
to	TO	O
an	DT	O
abnormal	JJ	O
apoB	NN	O
protein	NN	O
and	CC	O
apoB	NN	O
mRNA	NN	O
instability	NN	O
.	.	O

These	DT	O
results	NNS	O
are	VBP	O
distinct	JJ	O
from	IN	O
those	DT	O
previously	RB	O
noted	VBN	O
in	IN	O
abetalipoproteinemia	NN	B-Disease
,	,	O
which	WDT	O
was	VBD	O
characterized	VBN	O
by	IN	O
an	DT	O
elevated	JJ	O
level	NN	O
of	IN	O
hepatic	JJ	O
apoB	NN	O
mRNA	NN	O
and	CC	O
accumulation	NN	O
of	IN	O
intracellular	JJ	O
hepatic	JJ	O
apoB	NN	O
protein	NN	O
.	.	O

.	.	O

A	DT	O
population-based	JJ	O
study	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
expression	NN	O
of	IN	O
the	DT	O
hemochromatosis	NN	B-Disease
gene	NN	O
.	.	O

BACKGROUND	NN	O
AND	CC	O
METHODS	NNS	O
Hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
homozygosity	NN	O
for	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
in	IN	O
the	DT	O
hemochromatosis	NN	B-Disease
(	-LRB-	O
HFE	NN	O
)	-RRB-	O
gene	NN	O
on	IN	O
chromosome	NN	O
6	CD	O
,	,	O
elevated	JJ	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
,	,	O
and	CC	O
excess	JJ	B-Disease
iron	NN	I-Disease
deposits	NNS	I-Disease
throughout	IN	O
the	DT	O
body	NN	O
.	.	O

To	TO	O
assess	VB	O
the	DT	O
prevalence	NN	O
and	CC	O
clinical	JJ	O
expression	NN	O
of	IN	O
the	DT	O
HFE	NN	O
gene	NN	O
,	,	O
we	PRP	O
conducted	VBD	O
a	DT	O
population-based	JJ	O
study	NN	O
in	IN	O
Busselton	NNP	O
,	,	O
Australia	NNP	O
.	.	O

In	IN	O
1994	CD	O
,	,	O
we	PRP	O
obtained	VBD	O
blood	NN	O
samples	NNS	O
for	IN	O
the	DT	O
determination	NN	O
of	IN	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
and	CC	O
ferritin	NN	O
levels	NNS	O
and	CC	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
and	CC	O
the	DT	O
H63D	NN	O
mutation	NN	O
(	-LRB-	O
which	WDT	O
may	MD	O
contribute	VB	O
to	TO	O
increased	VBN	O
hepatic	JJ	O
iron	NN	O
levels	NNS	O
)	-RRB-	O
in	IN	O
3011	CD	O
unrelated	JJ	O
white	JJ	O
adults	NNS	O
.	.	O

We	PRP	O
evaluated	VBD	O
all	DT	O
subjects	NNS	O
who	WP	O
had	VBD	O
persistently	RB	O
elevated	JJ	O
transferrin-saturation	NN	O
values	NNS	O
(	-LRB-	O
45	CD	O
percent	NN	O
or	CC	O
higher	JJR	O
)	-RRB-	O
or	CC	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
.	.	O

We	PRP	O
recommended	VBD	O
liver	NN	O
biopsy	NN	O
for	IN	O
subjects	NNS	O
with	IN	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
of	IN	O
300	CD	O
ng	NN	O
per	IN	O
milliliter	NN	O
or	CC	O
higher	JJR	O
.	.	O

The	DT	O
subjects	NNS	O
were	VBD	O
followed	VBN	O
for	IN	O
up	RB	O
to	TO	O
four	CD	O
years	NNS	O
.	.	O

RESULTS	NNS	O
Sixteen	CD	O
of	IN	O
the	DT	O
subjects	NNS	O
(	-LRB-	O
0	CD	O
.	.	O

5	CD	O
percent	NN	O
)	-RRB-	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
,	,	O
and	CC	O
424	CD	O
(	-LRB-	O
14	CD	O
.	.	O

1	CD	O
percent	NN	O
)	-RRB-	O
were	VBD	O
heterozygous	JJ	O
.	.	O

The	DT	O
serum	NN	O
transferrin	NN	O
saturation	NN	O
was	VBD	O
45	CD	O
percent	NN	O
or	CC	O
higher	JJR	O
in	IN	O
15	CD	O
of	IN	O
the	DT	O
16	CD	O
who	WP	O
were	VBD	O
homozygous	JJ	O
;	:	O
in	IN	O
1	CD	O
subject	NN	O
it	PRP	O
was	VBD	O
43	CD	O
percent	NN	O
.	.	O

Four	CD	O
of	IN	O
the	DT	O
homozygous	JJ	O
subjects	NNS	O
had	VBD	O
previously	RB	O
been	VBN	O
given	VBN	O
a	DT	O
diagnosis	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
,	,	O
and	CC	O
12	CD	O
had	VBD	O
not	RB	O
.	.	O

Seven	CD	O
of	IN	O
these	DT	O
12	CD	O
patients	NNS	O
had	VBD	O
elevated	JJ	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
in	IN	O
1994	CD	O
;	:	O
6	CD	O
of	IN	O
the	DT	O
7	CD	O
had	VBD	O
further	JJ	O
increases	NNS	O
in	IN	O
1998	CD	O
,	,	O
and	CC	O
1	CD	O
had	VBD	O
a	DT	O
decrease	NN	O
,	,	O
although	IN	O
the	DT	O
value	NN	O
remained	VBD	O
elevated	JJ	O
.	.	O

The	DT	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
in	IN	O
the	DT	O
four	CD	O
other	JJ	O
homozygous	JJ	O
patients	NNS	O
remained	VBD	O
in	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

Eleven	CD	O
of	IN	O
the	DT	O
16	CD	O
homozygous	JJ	O
subjects	NNS	O
underwent	VBD	O
liver	NN	O
biopsy	NN	O
;	:	O
3	CD	O
had	VBD	O
hepatic	JJ	B-Disease
fibrosis	NN	I-Disease
,	,	O
and	CC	O
1	CD	O
,	,	O
who	WP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
excessive	JJ	B-Disease
alcohol	NN	I-Disease
consumption	NN	I-Disease
,	,	O
had	VBD	O
cirrhosis	NN	B-Disease
and	CC	O
mild	JJ	O
microvesicular	JJ	B-Disease
steatosis	NN	I-Disease
.	.	O

Eight	CD	O
of	IN	O
the	DT	O
16	CD	O
homozygous	JJ	O
subjects	NNS	O
had	VBD	O
clinical	JJ	O
findings	NNS	O
that	WDT	O
were	VBD	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
,	,	O
such	JJ	O
as	IN	O
hepatomegaly	NN	B-Disease
,	,	O
skin	NN	B-Disease
pigmentation	NN	I-Disease
,	,	O
and	CC	O
arthritis	NN	B-Disease
.	.	O

CONCLUSIONS	NNS	O
In	IN	O
a	DT	O
population	NN	O
of	IN	O
white	JJ	O
adults	NNS	O
of	IN	O
northern	JJ	O
European	JJ	O
ancestry	NN	O
,	,	O
0	CD	O
.	.	O

5	CD	O
percent	NN	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
in	IN	O
the	DT	O
HFE	NN	O
gene	NN	O
.	.	O

However	RB	O
,	,	O
only	RB	O
half	NN	O
of	IN	O
those	DT	O
who	WP	O
were	VBD	O
homozygous	JJ	O
had	VBD	O
clinical	JJ	O
features	NNS	O
of	IN	O
hemochromatosis	NN	B-Disease
,	,	O
and	CC	O
one	CD	O
quarter	NN	O
had	VBD	O
serum	NN	O
ferritin	NN	O
levels	NNS	O
that	WDT	O
remained	VBD	O
normal	JJ	O
over	IN	O
a	DT	O
four-year	JJ	O
period	NN	O
.	.	O

Overexpression	NN	O
of	IN	O
DM20	NN	O
messenger	NN	O
RNA	NN	O
in	IN	O
two	CD	O
brothers	NNS	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	B-Disease
,	,	I-Disease
sex-linked	JJ	I-Disease
recessive	JJ	I-Disease
,	,	I-Disease
dysmyelinating	JJ	I-Disease
disease	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
central	JJ	I-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
that	WDT	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
myelin	JJ	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

Only	RB	O
25	CD	O
%	NN	O
of	IN	O
patients	NNS	O
studied	VBN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
have	VBP	O
exonic	JJ	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
,	,	O
the	DT	O
underlying	VBG	O
cause	NN	O
of	IN	O
the	DT	O
disease	NN	O
in	IN	O
the	DT	O
remaining	VBG	O
patients	NNS	O
is	VBZ	O
unknown	JJ	O
.	.	O

The	DT	O
PLP	NN	O
gene	NN	O
encodes	VBZ	O
two	CD	O
major	JJ	O
alternatively	RB	O
spliced	VBN	O
transcripts	NNS	O
called	VBD	O
PLP	NNP	O
and	CC	O
DM20	NN	O
.	.	O

PLP	NNP	O
messenger	NN	O
RNA	NN	O
is	VBZ	O
specifically	RB	O
expressed	VBN	O
in	IN	O
central	JJ	O
nervous	JJ	O
system	NN	O
tissue	NN	O
,	,	O
whereas	IN	O
DM20	NN	O
messenger	NN	O
RNA	NN	O
is	VBZ	O
found	VBN	O
in	IN	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
cardiac	JJ	O
,	,	O
and	CC	O
other	JJ	O
tissues	NNS	O
.	.	O

We	PRP	O
studied	VBD	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
2	CD	O
brothers	NNS	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
who	WP	O
exhibited	VBD	O
no	DT	O
detectable	JJ	O
exonic	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
.	.	O

Examination	NN	O
of	IN	O
RNA	NN	O
from	IN	O
these	DT	O
cells	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
level	NN	O
of	IN	O
DM20	NN	O
messenger	NN	O
RNA	NN	O
is	VBZ	O
elevated	JJ	O
sixfold	JJ	O
relative	JJ	O
to	TO	O
male	JJ	O
control	NN	O
skin	NN	O
fibroblasts	NNS	O
.	.	O

An	DT	O
unrelated	JJ	O
female	JJ	O
carrier	NN	O
,	,	O
also	RB	O
with	IN	O
no	DT	O
detectable	JJ	O
exonic	JJ	O
mutation	NN	O
,	,	O
showed	VBD	O
a	DT	O
threefold	JJ	O
increase	NN	O
in	IN	O
DM20	NN	O
messenger	NN	O
RNA	NN	O
in	IN	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
in	IN	O
some	DT	O
patients	NNS	O
,	,	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
overexpression	NN	O
of	IN	O
PLP	NN	O
gene	NN	O
transcripts	NNS	O
,	,	O
and	CC	O
that	IN	O
in	IN	O
these	DT	O
families	NNS	O
a	DT	O
50	CD	O
%	NN	O
increase	NN	O
of	IN	O
DM20	NN	O
messenger	NN	O
RNA	NN	O
in	IN	O
females	NNS	O
,	,	O
relative	JJ	O
to	TO	O
the	DT	O
increase	NN	O
in	IN	O
affected	VBN	O
males	NNS	O
,	,	O
can	MD	O
identify	VB	O
a	DT	O
female	JJ	O
carrier	NN	O
.	.	O

.	.	O

Homozygosity	NNP	O
for	IN	O
a	DT	O
novel	JJ	O
DTDST	NN	O
mutation	NN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
a	DT	O
'	``	O
broad	JJ	O
bone-platyspondylic	JJ	O
'	''	O
variant	NN	O
of	IN	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
.	.	O

Atypical	JJ	O
or	CC	O
variant	JJ	O
forms	NNS	O
of	IN	O
well-known	JJ	O
chondrodysplasias	NNS	B-Disease
may	MD	O
pose	VB	O
diagnostic	JJ	O
problems	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
girl	NN	O
with	IN	O
clinical	JJ	O
features	NNS	O
suggesting	VBG	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
but	CC	O
with	IN	O
unusual	JJ	O
radiographic	JJ	O
features	NNS	O
including	VBG	O
severe	JJ	O
platyspondyly	NN	B-Disease
,	,	O
wide	JJ	O
metaphyses	NNS	O
,	,	O
and	CC	O
fibular	JJ	O
overgrowth	NN	O
,	,	O
which	WDT	O
are	VBP	O
partially	RB	O
reminiscent	JJ	O
of	IN	O
metatropic	JJ	B-Disease
dysplasia	NN	I-Disease
.	.	O

The	DT	O
diagnosis	NN	O
was	VBD	O
clarified	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
DTDST	NN	O
gene	NN	O
,	,	O
which	WDT	O
revealed	VBD	O
homozygosity	NN	O
for	IN	O
a	DT	O
previously	RB	O
undescribed	JJ	O
mutation	NN	O
leading	VBG	O
to	TO	O
a	DT	O
Q454P	NN	O
substitution	NN	O
in	IN	O
the	DT	O
10th	JJ	O
transmembrane	NN	O
domain	NN	O
of	IN	O
the	DT	O
DTDST	NN	O
sulfate	NN	O
transporter	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
may	MD	O
be	VB	O
of	IN	O
particular	JJ	O
value	NN	O
in	IN	O
such	JJ	O
atypical	JJ	O
cases	NNS	O
.	.	O

.	.	O

Carrier	NN	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
anonymous	JJ	O
DNA	NN	O
polymorphisms	NNS	O
and	CC	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
cDNA	NN	O
.	.	O

We	PRP	O
report	VBP	O
carrier	NN	O
identification	NN	O
and	CC	O
a	DT	O
prenatal	JJ	O
diagnosis	NN	O
using	VBG	O
DNA	NN	O
polymorphisms	NNS	O
in	IN	O
2	CD	O
families	NNS	O
with	IN	O
X-linked	JJ	B-Disease
Pelizaeus-Merzbacher	JJ	I-Disease
disease	NN	I-Disease
(	-LRB-	O
PMD	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
both	DT	O
families	NNS	O
,	,	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
the	DT	O
single	JJ	O
affected	JJ	O
male	NN	O
could	MD	O
be	VB	O
traced	VBN	O
back	RB	O
to	TO	O
his	PRP$	O
unaffected	JJ	O
maternal	JJ	O
grandfather	NN	O
.	.	O

Therefore	RB	O
,	,	O
each	DT	O
family	NN	O
contains	VBZ	O
a	DT	O
new	JJ	O
mutation	NN	O
.	.	O

In	IN	O
the	DT	O
case	NN	O
of	IN	O
the	DT	O
prenatal	JJ	O
diagnosis	NN	O
,	,	O
the	DT	O
fetus	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
cytogenetic	JJ	O
analysis	NN	O
to	TO	O
be	VB	O
a	DT	O
female	NN	O
,	,	O
who	WP	O
we	PRP	O
predict	VBP	O
will	MD	O
be	VB	O
a	DT	O
noncarrier	NN	O
of	IN	O
PMD	NN	B-Disease
based	VBN	O
on	IN	O
her	PRP$	O
genotype	NN	O
with	IN	O
the	DT	O
PLP	NN	O
intragenic	JJ	O
polymorphism	NN	O
.	.	O

.	.	O

Gardner	NNP	B-Disease
syndrome	NN	I-Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
.	.	O

We	PRP	O
described	VBD	O
a	DT	O
15-year-old	JJ	O
boy	NN	O
with	IN	O
Gardner	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
GS	NN	B-Disease
)	-RRB-	O
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
craniofacial	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

High-resolution	JJ	O
banding	NN	O
analysis	NN	O
showed	VBD	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	-LRB-	O
q22	NN	O
.	.	O

1	CD	O
----	:	O
q31	NN	O
1	CD	O
----	:	O
q31	NN	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

The	DT	O
breakpoints	NNS	O
in	IN	O
the	DT	O
present	JJ	O
case	NN	O
and	CC	O
in	IN	O
3	CD	O
previously	RB	O
reported	VBN	O
5q	SYM	O
-	:	O
patients	NNS	O
with	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NNS	I-Disease
suggest	VBP	O
that	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
GS/or	NNP	O
familial	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
FPC	NN	B-Disease
)	-RRB-	O
is	VBZ	O
in	IN	O
the	DT	O
5q22	NN	O
region	NN	O
,	,	O
a	DT	O
result	NN	O
consistent	JJ	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
linkage	NN	O
studies	NNS	O

Type	NN	B-Disease
I	CD	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

A	DT	O
28-base	JJ	O
pair	NN	O
gene	NN	O
deletion	NN	O
causes	VBZ	O
skipping	VBG	O
of	IN	O
exon	NN	O
6	CD	O
during	IN	O
RNA	NN	O
splicing	NN	O
.	.	O

Two	CD	O
variants	NNS	O
of	IN	O
a	DT	O
genetic	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
complement	NN	I-Disease
protein	NN	I-Disease
C2	NN	I-Disease
(	-LRB-	O
C2D	NN	O
)	-RRB-	O
have	VBP	O
been	VBN	O
previously	RB	O
identified	VBN	O
.	.	O

No	DT	O
C2	NN	O
protein	NN	O
translation	NN	O
is	VBZ	O
detected	VBN	O
in	IN	O
type	NN	O
I	CD	O
deficiency	NN	O
,	,	O
while	IN	O
type	NN	O
II	CD	O
deficiency	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
selective	JJ	O
block	NN	O
in	IN	O
C2	NN	O
secretion	NN	O
.	.	O

Type	NN	B-Disease
I	CD	I-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
was	VBD	O
described	VBN	O
in	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
the	DT	O
C2	NN	O
null	JJ	O
allele	NN	O
(	-LRB-	O
C2Q0	NN	O
)	-RRB-	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
haplotype/complotype	NN	O
HLA-A25	NN	O
,	,	O
B18	NN	O
,	,	O
C2Q0	NN	O
,	,	O
BfS	NN	O
,	,	O
C4A4	NN	O
,	,	O
C4B2	NN	O
,	,	O
Drw2	NN	O
;	:	O
this	DT	O
extended	JJ	O
haplotype	NN	O
occurs	VBZ	O
in	IN	O
over	IN	O
90	CD	O
%	NN	O
of	IN	O
C2-deficient	JJ	B-Disease
individuals	NNS	O
(	-LRB-	O
common	JJ	O
complotype/haplotype	NN	O
)	-RRB-	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
type	NN	B-Disease
I	CD	I-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
,	,	O
the	DT	O
C2	NN	O
gene	NN	O
and	CC	O
cDNA	NN	O
were	VBD	O
characterized	VBN	O
from	IN	O
a	DT	O
homozygous	JJ	O
type	NN	B-Disease
I	CD	I-Disease
C2-deficient	JJ	I-Disease
individual	NN	O
with	IN	O
the	DT	O
common	JJ	O
associated	VBN	O
haplotype/complotype	NN	O
.	.	O

We	PRP	O
found	VBD	O
a	DT	O
28-base	JJ	O
pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
type	NN	O
I	CD	O
C2Q0	NN	O
gene	NN	O
,	,	O
beginning	VBG	O
9	CD	O
base	NN	O
pairs	NNS	O
upstream	JJ	O
of	IN	O
the	DT	O
3-end	NN	O
of	IN	O
exon	NN	O
6	CD	O
,	,	O
that	WDT	O
generates	VBZ	O
a	DT	O
C2	NN	O
transcript	NN	O
with	IN	O
a	DT	O
complete	JJ	O
deletion	NN	O
of	IN	O
exon	NN	O
6	CD	O
(	-LRB-	O
134	CD	O
base	NN	O
pair	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
.	.	O

In	IN	O
studies	NNS	O
of	IN	O
eight	CD	O
kindred	NN	O
,	,	O
the	DT	O
28-base	JJ	O
pair	NN	O
deletion	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
all	DT	O
C2Q0	NN	O
alleles	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
common	JJ	O
type	NN	O
I	CD	O
deficient	JJ	O
complotype/haplotype	NN	O
;	:	O
this	DT	O
deletion	NN	O
was	VBD	O
not	RB	O
present	JJ	O
in	IN	O
normal	JJ	O
C2	NN	O
nor	CC	O
in	IN	O
type	NN	B-Disease
II	CD	I-Disease
C2-deficient	JJ	I-Disease
genes	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
1	LS	O
)	-RRB-	O
type	NN	B-Disease
I	CD	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
28-base	JJ	O
pair	NN	O
genomic	JJ	O
deletion	NN	O
that	WDT	O
causes	VBZ	O
skipping	VBG	O
of	IN	O
exon	NN	O
6	CD	O
during	IN	O
RNA	NN	O
splicing	NN	O
,	,	O
resulting	VBG	O
in	IN	O
generation	NN	O
of	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
,	,	O
2	LS	O
)	-RRB-	O
the	DT	O
28-base	JJ	O
pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
type	NN	O
I	CD	O
C2Q0	NN	O
gene	NN	O
is	VBZ	O
strongly	RB	O
associated	VBN	O
with	IN	O
the	DT	O
HLA	NN	O
haplotype/complotype	NN	O
A25	NN	O
,	,	O
B18	NN	O
,	,	O
C2Q0	NN	O
,	,	O
BfS	NN	O
,	,	O
C4A4	NN	O
,	,	O
C4B2	NN	O
,	,	O
Drw2	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
all	DT	O
C2-deficient	JJ	B-Disease
individuals	NNS	O
with	IN	O
this	DT	O
haplotype/complotype	NN	O
will	MD	O
harbor	VB	O
the	DT	O
28-base	JJ	O
pair	NN	O
C2	NN	O
gene	NN	O
deletion	NN	O
,	,	O
and	CC	O
3	LS	O
)	-RRB-	O
type	NN	B-Disease
II	CD	I-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
different	JJ	O
,	,	O
as	IN	O
yet	RB	O
uncharacterized	JJ	O
,	,	O
molecular	JJ	O
genetic	JJ	B-Disease
defect	NN	I-Disease
.	.	O

.	.	O

(	-LRB-	O
Over	IN	O
)	-RRB-	O
correction	NN	O
of	IN	O
FMR1	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
YAC	NN	O
transgenics	NNS	O
:	:	O
behavioral	JJ	O
and	CC	O
physical	JJ	O
features	NNS	O
.	.	O

Fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
common	JJ	O
cause	NN	O
of	IN	O
mental	JJ	B-Disease
retardation	NN	I-Disease
involving	VBG	O
loss	NN	O
of	IN	O
expression	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
.	.	O

The	DT	O
role	NN	O
of	IN	O
FMR1	NN	O
remains	VBZ	O
undetermined	JJ	O
but	CC	O
the	DT	O
protein	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
RNA	NN	O
metabolism	NN	O
.	.	O

Fmr1	NN	O
knockout	NN	O
mice	NNS	O
exhibit	VBP	O
a	DT	O
phenotype	NN	O
with	IN	O
some	DT	O
similarities	NNS	O
to	TO	O
humans	NNS	O
,	,	O
such	JJ	O
as	IN	O
macroorchidism	NN	B-Disease
and	CC	O
behavioral	JJ	O
abnormalities	NNS	O
.	.	O

As	IN	O
a	DT	O
step	NN	O
toward	IN	O
understanding	VBG	O
the	DT	O
function	NN	O
of	IN	O
FMR1	NN	O
and	CC	O
the	DT	O
determination	NN	O
of	IN	O
the	DT	O
potential	NN	O
for	IN	O
therapeutic	JJ	O
approaches	NNS	O
to	TO	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
yeast	NN	O
artificial	JJ	O
chromosome	NN	O
(	-LRB-	O
YAC	NN	O
)	-RRB-	O
transgenic	JJ	O
mice	NNS	O
were	VBD	O
generated	VBN	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
Fmr1	NN	O
knockout	JJ	O
mouse	NN	O
phenotype	NN	O
could	MD	O
be	VB	O
rescued	VBN	O
.	.	O

Several	JJ	O
transgenic	JJ	O
lines	NNS	O
were	VBD	O
generated	VBN	O
that	IN	O
carried	VBD	O
the	DT	O
entire	JJ	O
FMR1	NN	O
locus	NN	O
with	IN	O
extensive	JJ	O
amounts	NNS	O
of	IN	O
flanking	JJ	O
sequence	NN	O
.	.	O

We	PRP	O
observed	VBD	O
that	IN	O
the	DT	O
YAC	NN	O
transgene	NN	O
supported	VBD	O
production	NN	O
of	IN	O
the	DT	O
human	JJ	O
protein	NN	O
(	-LRB-	O
FMRP	NN	O
)	-RRB-	O
which	WDT	O
was	VBD	O
present	JJ	O
at	IN	O
levels	NNS	O
10	CD	O
to	TO	O
15	CD	O
times	NNS	O
that	IN	O
of	IN	O
endogenous	JJ	O
protein	NN	O
and	CC	O
was	VBD	O
expressed	VBN	O
in	IN	O
a	DT	O
cell	NN	O
-	:	O
and	CC	O
tissue-specific	JJ	O
manner	NN	O
.	.	O

Macro-orchidism	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
knockout	JJ	O
mice	NNS	O
carrying	VBG	O
the	DT	O
YAC	NN	O
transgene	NN	O
indicating	VBG	O
functional	JJ	O
rescue	NN	O
by	IN	O
the	DT	O
human	JJ	O
protein	NN	O
.	.	O

Given	VBN	O
the	DT	O
complex	NN	O
behavioral	JJ	O
phenotype	NN	O
in	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
patients	NNS	O
and	CC	O
the	DT	O
mild	JJ	O
phenotype	NN	O
previously	RB	O
reported	VBN	O
for	IN	O
the	DT	O
Fmr1	NN	O
knockout	JJ	O
mouse	NN	O
,	,	O
we	PRP	O
performed	VBD	O
a	DT	O
more	RBR	O
thorough	JJ	O
evaluation	NN	O
of	IN	O
the	DT	O
Fmr1	NN	O
knockout	NN	O
phenotype	NN	O
using	VBG	O
additional	JJ	O
behavioral	JJ	O
assays	NNS	O
that	WDT	O
had	VBD	O
not	RB	O
previously	RB	O
been	VBN	O
reported	VBN	O
for	IN	O
this	DT	O
animal	NN	O
model	NN	O
.	.	O

The	DT	O
mouse	NN	O
displayed	VBD	O
reduced	VBN	O
anxiety-related	JJ	O
responses	NNS	O
with	IN	O
increased	VBN	O
exploratory	JJ	O
behavior	NN	O
.	.	O

FMR1	NN	O
YAC	NN	O
transgenic	JJ	O
mice	NNS	O
overexpressing	VBG	O
the	DT	O
human	JJ	O
protein	NN	O
did	VBD	O
produce	VB	O
opposing	VBG	O
behavioral	JJ	O
responses	NNS	O
and	CC	O
additional	JJ	O
abnormal	JJ	O
behaviors	NNS	O
were	VBD	O
also	RB	O
observed	VBN	O
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
significant	JJ	O
implications	NNS	O
for	IN	O
gene	NN	O
therapy	NN	O
for	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
since	IN	O
overexpression	NN	O
of	IN	O
the	DT	O
gene	NN	O
may	MD	O
harbor	VB	O
its	PRP$	O
own	JJ	O
phenotype	NN	O
.	.	O

.	.	O

Fabry	NN	B-Disease
disease	NN	I-Disease
:	:	O
identification	NN	O
of	IN	O
novel	JJ	O
alpha-galactosidase	NN	O
A	NN	O
mutations	NNS	O
and	CC	O
molecular	JJ	O
carrier	NN	O
detection	NN	O
by	IN	O
use	NN	O
of	IN	O
fluorescent	JJ	O
chemical	NN	O
cleavage	NN	O
of	IN	O
mismatches	NNS	O
.	.	O

Fabry	NN	B-Disease
disease	NN	I-Disease
(	-LRB-	O
FD	NN	B-Disease
)	-RRB-	O
(	-LRB-	O
angiokeratoma	NN	B-Disease
corporis	NN	I-Disease
diffusum	NN	I-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
inborn	JJ	I-Disease
error	NN	I-Disease
of	IN	I-Disease
glycosphingolipid	NN	I-Disease
metabolism	NN	I-Disease
caused	VBN	O
by	IN	O
defects	NNS	O
in	IN	O
the	DT	O
lysosomal	JJ	O
alpha-galactosidase	NN	O
A	NN	O
gene	NN	O
(	-LRB-	O
GLA	NN	O
)	-RRB-	O
.	.	O

The	DT	O
enzymatic	JJ	O
defect	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
systemic	JJ	O
accumulation	NN	O
of	IN	O
neutral	JJ	O
glycosphingolipids	NNS	O
with	IN	O
terminal	JJ	O
alpha-galactosyl	NN	O
moieties	NNS	O
.	.	O

Clinically	RB	O
,	,	O
affected	VBD	O
hemizygous	JJ	O
males	NNS	O
have	VBP	O
angiokeratoma	NN	B-Disease
,	,	O
severe	JJ	B-Disease
acroparesthesia	NN	I-Disease
,	,	O
renal	JJ	B-Disease
failure	NN	I-Disease
,	,	O
and	CC	O
vasculopathy	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
heart	NN	I-Disease
and	CC	I-Disease
brain	NN	I-Disease
.	.	O

While	IN	O
demonstration	NN	O
of	IN	O
alpha-galactosidase	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
leukocytes	NNS	O
is	VBZ	O
diagnostic	JJ	O
in	IN	O
affected	JJ	O
males	NNS	O
,	,	O
enzymatic	JJ	O
detection	NN	O
of	IN	O
female	JJ	O
carriers	NNS	O
is	VBZ	O
often	RB	O
inconclusive	JJ	O
,	,	O
due	JJ	O
to	TO	O
random	JJ	O
X-chromosomal	JJ	O
inactivation	NN	O
,	,	O
underlining	VBG	O
the	DT	O
need	NN	O
of	IN	O
molecular	JJ	O
investigations	NNS	O
for	IN	O
accurate	JJ	O
genetic	JJ	O
counseling	NN	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
chemical	NN	O
cleavage	NN	O
of	IN	O
mismatches	NNS	O
adapted	VBN	O
to	TO	O
fluorescence-based	JJ	O
detection	NN	O
systems	NNS	O
,	,	O
we	PRP	O
have	VBP	O
characterized	VBN	O
the	DT	O
mutations	NNS	O
underlying	VBG	O
alpha-Gal	NN	B-Disease
A	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
16	CD	O
individuals	NNS	O
from	IN	O
six	CD	O
unrelated	JJ	O
families	NNS	O
with	IN	O
FD	NN	B-Disease
.	.	O

The	DT	O
mutational	JJ	O
spectrum	NN	O
included	VBD	O
five	CD	O
missense	NN	O
mutations	NNS	O
(	-LRB-	O
C202W	NN	O
,	,	O
C223G	NN	O
,	,	O
N224D	NN	O
,	,	O
R301Q	NN	O
,	,	O
and	CC	O
Q327K	NN	O
)	-RRB-	O
and	CC	O
one	CD	O
splice-site	NN	O
mutation	NN	O
[	-LRB-	O
IVS3	NN	O
G	NN	O
(	-LRB-	O
-1	CD	O
)	-RRB-	O
--	:	O
>	JJR	O
C	NN	O
]	-RRB-	O
.	.	O

Studies	NNS	O
at	IN	O
the	DT	O
mRNA	NN	O
level	NN	O
showed	VBD	O
that	IN	O
the	DT	O
latter	JJ	O
led	VBN	O
to	TO	O
altered	JJ	O
pre-mRNA	NN	O
splicing	NN	O
with	IN	O
consequent	JJ	O
alteration	NN	O
of	IN	O
the	DT	O
mRNA	NN	O
translational	JJ	O
reading	NN	O
frame	NN	O
and	CC	O
generation	NN	O
of	IN	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
of	IN	O
translation	NN	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
this	DT	O
strategy	NN	O
,	,	O
carrier	NN	O
status	NN	O
was	VBD	O
accurately	RB	O
assessed	VBN	O
in	IN	O
all	DT	O
seven	CD	O
at-risk	JJ	O
females	NNS	O
tested	VBN	O
,	,	O
whereas	IN	O
enzymatic	JJ	O
dosages	NNS	O
failed	VBD	O
to	TO	O
diagnose	VB	O
or	CC	O
exclude	VB	O
heterozygosity	NN	O
.	.	O

.	.	O

Evidence	NN	O
for	IN	O
linkage	NN	O
of	IN	O
bipolar	JJ	B-Disease
disorder	NN	I-Disease
to	TO	O
chromosome	NN	O
18	CD	O
with	IN	O
a	DT	O
parent-of-origin	NN	O
effect	NN	O
.	.	O

A	DT	O
susceptibility	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
18	CD	O
and	CC	O
a	DT	O
parent-of-origin	NN	O
effect	NN	O
have	VBP	O
been	VBN	O
suggested	VBN	O
for	IN	O
bipolar	JJ	B-Disease
affective	JJ	I-Disease
disorder	NN	I-Disease
(	-LRB-	O
BPAD	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
28	CD	O
nuclear	JJ	O
families	NNS	O
selected	VBN	O
for	IN	O
apparent	JJ	O
unilineal	JJ	O
transmission	NN	O
of	IN	O
the	DT	O
BPAD	NN	B-Disease
phenotype	NN	O
,	,	O
by	IN	O
using	VBG	O
31	CD	O
polymorphic	JJ	O
markers	NNS	O
spanning	VBG	O
chromosome	NN	O
18	CD	O
.	.	O

Evidence	NN	O
for	IN	O
linkage	NN	O
was	VBD	O
tested	VBN	O
with	IN	O
affected-sib-pair	NN	O
and	CC	O
LOD	NN	O
score	VBP	O
methods	NNS	O
under	IN	O
two	CD	O
definitions	NNS	O
of	IN	O
the	DT	O
affected	VBN	O
phenotype	NN	O
.	.	O

The	DT	O
affected-sibpair	JJ	O
analyses	NNS	O
indicated	VBD	O
excess	JJ	O
allele	NN	O
sharing	VBG	O
for	IN	O
markers	NNS	O
on	IN	O
18p	NN	O
within	IN	O
the	DT	O
region	NN	O
reported	VBD	O
previously	RB	O
.	.	O

The	DT	O
greatest	JJS	O
sharing	NN	O
was	VBD	O
at	IN	O
D18S37	NN	O
64	CD	O
%	NN	O
in	IN	O
bipolar	JJ	O
and	CC	O
recurrent	JJ	O
unipolar	JJ	O
(	-LRB-	O
RUP	NN	O
)	-RRB-	O
sib	NN	O
pairs	NNS	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

0006	CD	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
excess	JJ	O
sharing	NN	O
of	IN	O
the	DT	O
paternally	RB	O
,	,	O
but	CC	O
not	RB	O
maternally	RB	O
,	,	O
transmitted	VBD	O
alleles	NNS	O
was	VBD	O
observed	VBN	O
at	IN	O
three	CD	O
markers	NNS	O
on	IN	O
18q	NN	O
at	IN	O
D18S41	NN	O
,	,	O
51	CD	O
bipolar	JJ	O
and	CC	O
RUP	NN	O
sib	NN	O
pairs	NNS	O
were	VBD	O
concordant	JJ	O
for	IN	O
paternally	RB	O
transmitted	VBN	O
alleles	NNS	O
,	,	O
and	CC	O
21	CD	O
pairs	NNS	O
were	VBD	O
discordant	JJ	O
(	-LRB-	O
P	NN	O
=	JJ	O
0004	CD	O
)	-RRB-	O
.	.	O

The	DT	O
evidence	NN	O
for	IN	O
linkage	NN	O
to	TO	O
loci	NNS	O
on	IN	O
both	DT	O
18p	NN	O
and	CC	O
18q	NN	O
was	VBD	O
strongest	JJS	O
in	IN	O
the	DT	O
11	CD	O
paternal	JJ	O
pedigrees	NNS	O
,	,	O
i.	FW	O
e	SYM	O
e.	FW	O
,	,	O
those	DT	O
in	IN	O
which	WDT	O
the	DT	O
father	NN	O
or	CC	O
one	CD	O
of	IN	O
the	DT	O
fathers	NNS	O
sibs	NNS	O
is	VBZ	O
affected	VBN	O
.	.	O

In	IN	O
these	DT	O
pedigrees	NNS	O
,	,	O
the	DT	O
greatest	JJS	O
allele	NN	O
sharing	NN	O
(	-LRB-	O
81	CD	O
%	NN	O
;	:	O
P	NN	O
=	JJ	O
.	.	O

00002	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
highest	JJS	O
LOD	NN	O
score	NN	O
(	-LRB-	O
3	CD	O
.	.	O

51	CD	O
;	:	O
phi	NN	O
=	JJ	O
0	CD	O
.	.	O

0	CD	O
)	-RRB-	O
were	VBD	O
observed	VBN	O
at	IN	O
D18S41	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
further	JJ	O
support	NN	O
for	IN	O
linkage	NN	O
of	IN	O
BPAD	NN	B-Disease
to	TO	O
chromosome	NN	O
18	CD	O
and	CC	O
the	DT	O
first	JJ	O
molecular	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
parent-of-origin	NN	O
effect	NN	O
operating	NN	O
in	IN	O
this	DT	O
disorder	NN	O
.	.	O

The	DT	O
number	NN	O
of	IN	O
loci	NNS	O
involved	VBN	O
,	,	O
and	CC	O
their	PRP$	O
precise	JJ	O
location	NN	O
,	,	O
require	VBP	O
further	JJ	O
study	NN	O

BRCA1	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
population-based	JJ	O
sample	NN	O
of	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

BACKGROUND	NN	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
in	IN	O
some	DT	O
families	NNS	O
.	.	O

However	RB	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
contribution	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
to	TO	O
breast	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
DNA	NN	O
samples	NNS	O
from	IN	O
women	NNS	O
enrolled	VBN	O
in	IN	O
a	DT	O
population-based	JJ	O
study	NN	O
of	IN	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
to	TO	O
assess	VB	O
the	DT	O
spectrum	NN	O
and	CC	O
frequency	NN	O
of	IN	O
germ-line	NN	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

METHODS	NNS	O
.	.	O

We	PRP	O
studied	VBD	O
80	CD	O
women	NNS	O
in	IN	O
whom	WP	O
breast	NN	B-Disease
cancer	NN	I-Disease
was	VBD	O
diagnosed	VBN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
35	CD	O
,	,	O
and	CC	O
who	WP	O
were	VBD	O
not	RB	O
selected	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
family	NN	O
history	NN	O
.	.	O

Genomic	JJ	O
DNA	NN	O
was	VBD	O
studied	VBN	O
for	IN	O
BRCA1	NN	O
mutations	NNS	O
by	IN	O
analysis	NN	O
involving	VBG	O
single-strand	JJ	O
conformation	NN	O
polymorphisms	NNS	O
and	CC	O
with	IN	O
allele-specific	JJ	O
assays	NNS	O
.	.	O

Alterations	NNS	O
were	VBD	O
defined	VBN	O
by	IN	O
DNA	NN	O
sequencing	NN	O
.	.	O

RESULTS	NNS	O
.	.	O

Germ-line	NN	O
BRCA1	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
6	CD	O
of	IN	O
the	DT	O
80	CD	O
women	NNS	O
.	.	O

Four	CD	O
additional	JJ	O
rare	JJ	O
sequence	NN	O
variants	NNS	O
of	IN	O
unknown	JJ	O
functional	JJ	O
importance	NN	O
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
and	CC	O
three	CD	O
of	IN	O
the	DT	O
rare	JJ	O
sequence	NN	O
variants	NNS	O
were	VBD	O
found	VBN	O
among	IN	O
the	DT	O
39	CD	O
women	NNS	O
who	WP	O
reported	VBD	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

None	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
and	CC	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
rare	JJ	O
variants	NNS	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
reference	NN	O
population	NN	O
of	IN	O
73	CD	O
unrelated	JJ	O
subjects	NNS	O
.	.	O

CONCLUSIONS	NNS	O
.	.	O

Alterations	NNS	O
in	IN	O
BRCA1	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
approximately	RB	O
10	CD	O
percent	NN	O
of	IN	O
this	DT	O
cohort	NN	O
of	IN	O
young	JJ	O
women	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
risk	NN	O
of	IN	O
harboring	VBG	O
a	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
limited	VBN	O
to	TO	O
women	NNS	O
with	IN	O
family	NN	O
histories	NNS	O
of	IN	O
breast	NN	B-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

These	DT	O
results	NNS	O
represent	VBP	O
a	DT	O
minimal	JJ	O
estimate	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

Comprehensive	NNP	O
methods	NNS	O
of	IN	O
identifying	VBG	O
BRCA1	NN	O
mutations	NNS	O
and	CC	O
understanding	VBG	O
their	PRP$	O
importance	NN	O
will	MD	O
be	VB	O
needed	VBN	O
before	IN	O
testing	NN	O
of	IN	O
women	NNS	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
can	MD	O
be	VB	O
undertaken	VBN	O
.	.	O

.	.	O

Retinoschisin	NNP	O
,	,	O
the	DT	O
X-linked	JJ	B-Disease
retinoschisis	NN	I-Disease
protein	NN	O
,	,	O
is	VBZ	O
a	DT	O
secreted	VBN	O
photoreceptor	NN	O
protein	NN	O
,	,	O
and	CC	O
is	VBZ	O
expressed	VBN	O
and	CC	O
released	VBN	O
by	IN	O
Weri-Rb1	NN	O
cells	NNS	O
.	.	O

X-linked	JJ	B-Disease
retinoschisis	NN	I-Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
microcystic-like	JJ	O
changes	NNS	O
of	IN	O
the	DT	O
macular	JJ	O
region	NN	O
and	CC	O
schisis	NN	O
within	IN	O
the	DT	O
inner	JJ	O
retinal	JJ	O
layers	NNS	O
,	,	O
leading	VBG	O
to	TO	O
visual	JJ	B-Disease
deterioration	NN	I-Disease
in	IN	O
males	NNS	O
.	.	O

Many	JJ	O
missense	NN	O
and	CC	O
protein-truncating	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
causative	JJ	O
gene	NN	O
RS1	NN	O
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
and	CC	O
are	VBP	O
thought	VBN	O
to	TO	O
be	VB	O
inactivating	VBG	O
.	.	O

RS1	NN	O
encodes	VBZ	O
a	DT	O
224	CD	O
amino	NN	O
acid	NN	O
protein	NN	O
,	,	O
retinoschisin	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
a	DT	O
discoidin	NN	O
domain	NN	O
but	CC	O
is	VBZ	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

We	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
polyclonal	JJ	O
antibody	NN	O
against	IN	O
a	DT	O
peptide	NN	O
from	IN	O
a	DT	O
unique	JJ	O
region	NN	O
within	IN	O
retinoschisin	NN	O
,	,	O
which	WDT	O
detects	VBZ	O
a	DT	O
protein	NN	O
of	IN	O
approximately	RB	O
28	CD	O
kDa	NN	O
in	IN	O
retinal	JJ	O
samples	NNS	O
reduced	VBN	O
with	IN	O
dithiothreitol	NN	O
,	,	O
but	CC	O
multimers	NNS	O
sized	VBD	O
>	JJR	O
40	CD	O
kDa	NN	O
under	IN	O
non-reducing	JJ	O
conditions	NNS	O
.	.	O

A	DT	O
screen	NN	O
of	IN	O
human	JJ	O
tissues	NNS	O
with	IN	O
this	DT	O
antibody	NN	O
reveals	VBZ	O
retinoschisin	NN	O
to	TO	O
be	VB	O
retina	NN	O
specific	JJ	O
and	CC	O
the	DT	O
antibody	NN	O
detects	VBZ	O
a	DT	O
protein	NN	O
of	IN	O
similar	JJ	O
size	NN	O
in	IN	O
bovine	JJ	O
and	CC	O
murine	JJ	O
retinae	NN	O
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
expression	NN	O
pattern	NN	O
in	IN	O
the	DT	O
retina	NN	O
of	IN	O
both	CC	O
RS1	NN	O
mRNA	NN	O
(	-LRB-	O
using	VBG	O
in	FW	O
situ	FW	O
hybridization	NN	O
with	IN	O
riboprobes	NNS	O
)	-RRB-	O
and	CC	O
retinoschisin	NN	O
(	-LRB-	O
using	VBG	O
immunohistochemistry	NN	O
)	-RRB-	O
.	.	O

The	DT	O
antisense	JJ	O
riboprobe	NN	O
detected	VBD	O
RS1	NN	O
mRNA	NN	O
only	RB	O
in	IN	O
the	DT	O
photoreceptor	NN	O
layer	NN	O
but	CC	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
present	JJ	O
both	CC	O
in	IN	O
the	DT	O
photoreceptors	NNS	O
and	CC	O
within	IN	O
the	DT	O
inner	JJ	O
portions	NNS	O
of	IN	O
the	DT	O
retina	NN	O
.	.	O

Furthermore	RB	O
,	,	O
differentiated	VBN	O
retinoblastoma	NN	B-Disease
cells	NNS	O
(	-LRB-	O
Weri-Rb1	NN	O
cells	NNS	O
)	-RRB-	O
were	VBD	O
found	VBN	O
to	TO	O
express	VB	O
RS1	NN	O
mRNA	NN	O
and	CC	O
to	TO	O
release	VB	O
retinoschisin	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
retinoschisin	NN	O
is	VBZ	O
released	VBN	O
by	IN	O
photo-receptors	NNS	O
and	CC	O
has	VBZ	O
functions	NNS	O
within	IN	O
the	DT	O
inner	JJ	O
retinal	JJ	O
layers	NNS	O
.	.	O

Thus	RB	O
,	,	O
X-linked	JJ	B-Disease
retinoschisis	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
abnormalities	NNS	O
in	IN	O
a	DT	O
putative	JJ	O
secreted	VBN	O
photoreceptor	NN	O
protein	NN	O
and	CC	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
secreted	VBN	O
photo-receptor	NN	O
protein	NN	O
associated	VBN	O
with	IN	O
a	DT	O
retinal	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

.	.	O

Aberrant	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
CHM	NN	B-Disease
gene	NN	O
is	VBZ	O
a	DT	O
significant	JJ	O
cause	NN	O
of	IN	O
choroideremia	NN	B-Disease
.	.	O

Choroideremia	NN	B-Disease
(	-LRB-	O
CHM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
progressive	JJ	I-Disease
degeneration	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
choroid	NN	I-Disease
and	CC	I-Disease
retina	NN	I-Disease
.	.	O

12	CD	O
%	NN	O
of	IN	O
unrelated	JJ	O
male	JJ	O
patients	NNS	O
carry	VBP	O
deletions	NNS	O
of	IN	O
the	DT	O
partially	RB	O
cloned	VBN	O
CHM	NN	B-Disease
gene	NN	O
.	.	O

In	IN	O
Finland	NNP	O
,	,	O
there	EX	O
are	VBP	O
more	JJR	O
than	IN	O
120	CD	O
living	NN	O
CHM	NN	B-Disease
patients	NNS	O
belonging	VBG	O
to	TO	O
eight	CD	O
apparently	RB	O
unrelated	JJ	O
pedigrees	NNS	O
.	.	O

Molecular	JJ	O
deletions	NNS	O
involving	VBG	O
the	DT	O
CHM	NN	B-Disease
gene	NN	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
three	CD	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
screened	VBN	O
the	DT	O
remaining	VBG	O
five	CD	O
families	NNS	O
for	IN	O
point	NN	O
mutations	NNS	O
.	.	O

In	IN	O
one	CD	O
large	JJ	O
family	NN	O
a	DT	O
single	JJ	O
nucleotide	NN	O
(	-LRB-	O
T	NN	O
)	-RRB-	O
insertion	NN	O
into	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
exon	NN	O
C	NN	O
leads	VBZ	O
to	TO	O
two	CD	O
aberrantly	RB	O
spliced	VBN	O
mRNAs	NNS	O
both	CC	O
producing	VBG	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
.	.	O

The	DT	O
mutation	NN	O
can	MD	O
be	VB	O
assayed	VBN	O
easily	RB	O
by	IN	O
amplification	NN	O
and	CC	O
digestion	NN	O
with	IN	O
Msel	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
provide	VBP	O
additional	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
pathogenetic	JJ	O
role	NN	O
of	IN	O
CHM	NN	B-Disease
mutations	NNS	O
and	CC	O
provide	VB	O
a	DT	O
diagnostic	JJ	O
tool	NN	O
for	IN	O
one	CD	O
fifth	NN	O
of	IN	O
the	DT	O
worlds	NNS	O
known	VBN	O
CHM	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
:	:	O
a	DT	O
novel	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
in	IN	O
6	CD	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
presenting	VBG	O
with	IN	O
5	CD	O
different	JJ	O
phenotypes	NNS	O
.	.	O

Fragments	NNS	O
of	IN	O
the	DT	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
cDNA	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
adolescent	JJ	B-Disease
ALD	NN	I-Disease
were	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
subcloned	VBN	O
.	.	O

Bidirectional	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	VBG	O
ALD	NN	B-Disease
gene	NN	O
disclosed	VBD	O
a	DT	O
cytosine	NN	O
to	TO	O
guanine	NN	O
transversion	NN	O
at	IN	O
nucleotide	NN	O
1451	CD	O
in	IN	O
exon	NN	O
five	CD	O
,	,	O
resulting	VBG	O
in	IN	O
substitution	NN	O
of	IN	O
proline	NN	O
484	CD	O
by	IN	O
arginine	NN	O
.	.	O

Five	CD	O
of	IN	O
nine	CD	O
siblings	NNS	O
of	IN	O
the	DT	O
patient	NN	O
,	,	O
comprising	VBG	O
two	CD	O
cerebral	JJ	B-Disease
ALD	NN	I-Disease
,	,	O
one	CD	O
adrenomyeloneuropathy	NN	B-Disease
,	,	O
one	CD	O
Addison	NNP	B-Disease
only	RB	I-Disease
as	RB	O
well	RB	O
as	IN	O
the	DT	O
symptomatic	JJ	O
mother	NN	O
(	-LRB-	O
all	DT	O
accumulating	VBG	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
)	-RRB-	O
carried	VBD	O
this	DT	O
mutation	NN	O
,	,	O
which	WDT	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
the	DT	O
unaffected	JJ	O
persons	NNS	O
,	,	O
in	IN	O
five	CD	O
unrelated	JJ	O
ALD	NN	B-Disease
patients	NNS	O
,	,	O
and	CC	O
in	IN	O
twenty	CD	O
controls	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
this	DT	O
missense	NN	O
mutation	NN	O
generated	VBD	O
the	DT	O
disease	NN	O
per	FW	O
se	FW	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
metabolic	JJ	O
defect	NN	O
;	:	O
the	DT	O
different	JJ	O
phenotypes	NNS	O
,	,	O
however	RB	O
,	,	O
must	MD	O
have	VB	O
originated	VBN	O
by	IN	O
means	NNS	O
of	IN	O
additional	JJ	O
pathogenetic	JJ	O
factors	NNS	O
.	.	O

.	.	O

Statistical	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
model	NN	O
in	IN	O
von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
disease	NN	I-Disease
,	,	O
and	CC	O
in	IN	O
sporadic	JJ	B-Disease
cerebellar	NN	I-Disease
haemangioblastoma	NN	I-Disease
and	CC	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
unilateral	JJ	B-Disease
and	CC	I-Disease
bilateral	JJ	I-Disease
retinoblastoma	NN	I-Disease
led	VBD	O
Knudson	NNP	O
to	TO	O
propose	VB	O
that	IN	O
hereditary	JJ	B-Disease
tumours	NNS	I-Disease
may	MD	O
arise	VB	O
by	IN	O
a	DT	O
single	JJ	O
event	NN	O
and	CC	O
sporadic	JJ	B-Disease
tumours	NNS	I-Disease
by	IN	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
suggested	VBN	O
recently	RB	O
that	IN	O
sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
may	MD	O
arise	VB	O
from	IN	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

We	PRP	O
analysed	VBD	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
symptomatic	JJ	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
(	-LRB-	O
n	NN	O
=	JJ	O
26	CD	O
)	-RRB-	O
and	CC	O
cerebellar	NN	B-Disease
haemangioblastoma	NN	I-Disease
(	-LRB-	O
n	NN	O
=	JJ	O
68	CD	O
)	-RRB-	O
in	IN	O
109	CD	O
patients	NNS	O
with	IN	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	I-Disease
VHL	NN	I-Disease
)	-RRB-	I-Disease
disease	NN	I-Disease
,	,	O
and	CC	O
compared	VBD	O
them	PRP	O
to	TO	O
104	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
and	CC	O
43	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	B-Disease
cerebellar	NN	I-Disease
haemangioblastoma	NN	I-Disease
.	.	O

The	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
and	CC	O
cerebellar	NN	B-Disease
haemangioblastoma	NN	I-Disease
in	IN	O
VHL	NN	B-Disease
disease	NN	I-Disease
were	VBD	O
compatible	JJ	O
with	IN	O
a	DT	O
single	JJ	O
mutation	NN	O
model	NN	O
,	,	O
whereas	IN	O
the	DT	O
age	NN	O
incidence	NN	O
curves	NNS	O
for	IN	O
sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
and	CC	O
cerebellar	NN	B-Disease
haemangioblastoma	NN	I-Disease
suggested	VBD	O
a	DT	O
two	CD	O
stage	NN	O
mutation	NN	O
process	NN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
functioning	VBG	O
as	IN	O
a	DT	O
recessive	JJ	O
tumour	NN	B-Disease
suppressor	NN	O
gene	NN	O
.	.	O

Sporadic	JJ	B-Disease
cerebellar	NN	I-Disease
haemangioblastoma	NN	I-Disease
and	CC	O
some	DT	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
may	MD	O
arise	VB	O
from	IN	O
somatic	JJ	O
mutations	NNS	O
inactivating	VBG	O
both	CC	O
alleles	NNS	O
at	IN	O
the	DT	O
VHL	NN	B-Disease
locus	NN	O
.	.	O

.	.	O

Characterization	NN	O
of	IN	O
a	DT	O
germline	NN	O
mosaicism	NN	O
in	IN	O
families	NNS	O
with	IN	O
Lowe	NNP	B-Disease
syndrome	NN	I-Disease
,	,	O
and	CC	O
identification	NN	O
of	IN	O
seven	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
OCRL1	NN	O
gene	NN	O
.	.	O

The	DT	O
oculocerebrorenal	JJ	B-Disease
syndrome	NN	I-Disease
of	IN	I-Disease
Lowe	NNP	I-Disease
(	-LRB-	O
OCRL	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
major	JJ	O
abnormalities	NNS	B-Disease
of	IN	I-Disease
eyes	NNS	I-Disease
,	,	I-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
,	,	I-Disease
and	CC	I-Disease
kidneys	NNS	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
OCRL1	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
.	.	O

OCRL1	NN	O
encodes	VBZ	O
a	DT	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5-biphosphate	NN	O
(	-LRB-	O
PtdIns	NN	O
[	-LRB-	O
4	CD	O
,	,	O
5	CD	O
]	-RRB-	O
P2	NN	O
)	-RRB-	O
5-phosphatase	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
OCRL1	NN	O
gene	NN	O
in	IN	O
eight	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
OCRL	NN	B-Disease
and	CC	O
have	VBP	O
found	VBN	O
seven	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
one	CD	O
recurrent	JJ	O
in-frame	RB	O
deletion	NN	O
.	.	O

Among	IN	O
the	DT	O
new	JJ	O
mutations	NNS	O
,	,	O
two	CD	O
nonsense	NN	O
mutations	NNS	O
(	-LRB-	O
R317X	NN	O
and	CC	O
E558X	NN	O
)	-RRB-	O
and	CC	O
three	CD	O
other	JJ	O
frameshift	NN	O
mutations	NNS	O
caused	VBD	O
premature	JJ	O
termination	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
,	,	O
R483G	NN	O
,	,	O
was	VBD	O
located	VBN	O
in	IN	O
the	DT	O
highly	RB	O
conserved	VBN	O
PtdIns	NN	O
(	-LRB-	O
4	CD	O
,	,	O
5	CD	O
)	-RRB-	O
P2	NN	O
5-phosphatase	NN	O
domain	NN	O
.	.	O

Finally	RB	O
,	,	O
one	CD	O
frameshift	NN	O
mutation	NN	O
,	,	O
2799delC	NN	O
,	,	O
modifies	VBZ	O
the	DT	O
C-terminal	JJ	O
part	NN	O
of	IN	O
OCRL1	NN	O
,	,	O
with	IN	O
an	DT	O
extension	NN	O
of	IN	O
six	CD	O
amino	NN	O
acids	NNS	O
.	.	O

Altogether	RB	O
,	,	O
70	CD	O
%	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
are	VBP	O
located	JJ	O
in	IN	O
exon	NN	O
15	CD	O
,	,	O
and	CC	O
52	CD	O
%	NN	O
of	IN	O
all	DT	O
mutations	NNS	O
cluster	NN	O
in	IN	O
exons	NNS	O
11-15	CD	O
.	.	O

We	PRP	O
also	RB	O
identified	VBD	O
two	CD	O
new	JJ	O
microsatellite	NN	O
markers	NNS	O
for	IN	O
the	DT	O
OCRL1	NN	O
locus	NN	O
,	,	O
and	CC	O
we	PRP	O
detected	VBD	O
a	DT	O
germline	NN	O
mosaicism	NN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

This	DT	O
observation	NN	O
has	VBZ	O
direct	JJ	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counseling	NN	O
of	IN	O
Lowe	NNP	B-Disease
syndrome	NN	I-Disease
families	NNS	O
.	.	O

.	.	O

Aminoglycoside	NNP	O
antibiotics	NNS	O
restore	VB	O
dystrophin	NN	O
function	NN	O
to	TO	O
skeletal	JJ	O
muscles	NNS	O
of	IN	O
mdx	NN	O
mice	NNS	O
.	.	O

Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
,	,	O
leading	VBG	O
to	TO	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
dystrophin	NN	O
protein	NN	O
in	IN	O
striated	JJ	O
muscle	NN	O
.	.	O

A	DT	O
significant	JJ	O
number	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
premature	JJ	O
stop	NN	O
codons	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
observation	NN	O
that	IN	O
aminoglycoside	NN	O
treatment	NN	O
can	MD	O
suppress	VB	O
stop	VB	O
codons	NNS	O
in	IN	O
cultured	VBN	O
cells	NNS	O
,	,	O
we	PRP	O
tested	VBD	O
the	DT	O
effect	NN	O
of	IN	O
gentamicin	NN	O
on	IN	O
cultured	VBN	O
muscle	NN	O
cells	NNS	O
from	IN	O
the	DT	O
mdx	NN	O
mouse	NN	O
-	:	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
DMD	NNP	B-Disease
that	WDT	O
possesses	VBZ	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
in	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
.	.	O

Exposure	NN	O
of	IN	O
mdx	NN	O
myotubes	NNS	O
to	TO	O
gentamicin	NN	O
led	VBD	O
to	TO	O
the	DT	O
expression	NN	O
and	CC	O
localization	NN	O
of	IN	O
dystrophin	NN	O
to	TO	O
the	DT	O
cell	NN	O
membrane	NN	O
.	.	O

We	PRP	O
then	RB	O
evaluated	VBD	O
the	DT	O
effects	NNS	O
of	IN	O
differing	VBG	O
dosages	NNS	O
of	IN	O
gentamicin	NN	O
on	IN	O
expression	NN	O
and	CC	O
functional	JJ	O
protection	NN	O
of	IN	O
the	DT	O
muscles	NNS	O
of	IN	O
mdx	NN	O
mice	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
treatment	NN	O
regimen	NN	O
that	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
dystrophin	NN	O
in	IN	O
the	DT	O
cell	NN	O
membrane	NN	O
in	IN	O
all	DT	O
striated	JJ	O
muscles	NNS	O
examined	VBN	O
and	CC	O
that	IN	O
provided	VBN	O
functional	JJ	O
protection	NN	O
against	IN	O
muscular	JJ	B-Disease
injury	NN	I-Disease
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
our	PRP$	O
results	NNS	O
are	VBP	O
the	DT	O
first	JJ	O
to	TO	O
demonstrate	VB	O
that	IN	O
aminoglycosides	NNS	O
can	MD	O
suppress	VB	O
stop	VB	O
codons	NNS	O
not	RB	O
only	RB	O
in	FW	O
vitro	FW	O
but	CC	O
also	RB	O
in	FW	O
vivo	FW	O
.	.	O

Furthermore	RB	O
,	,	O
these	DT	O
results	NNS	O
raise	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
novel	JJ	O
treatment	NN	O
regimen	NN	O
for	IN	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
and	CC	O
other	JJ	O
diseases	NNS	O
caused	VBN	O
by	IN	O
premature	JJ	O
stop	NN	O
codon	NN	O
mutations	NNS	O
.	.	O

This	DT	O
treatment	NN	O
could	MD	O
prove	VB	O
effective	JJ	O
in	IN	O
up	RB	O
to	TO	O
15	CD	O
%	NN	O
of	IN	O
patients	NNS	O
with	IN	O
DMD	NN	B-Disease
.	.	O

.	.	O

Molecular	JJ	O
and	CC	O
metabolic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
metabolic	JJ	B-Disease
disorder	NN	I-Disease
normotriglyceridemic	JJ	B-Disease
abetalipoproteinemia	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
described	VBN	O
a	DT	O
disorder	NN	O
,	,	O
normotriglyceridemic	JJ	B-Disease
abetalipoproteinemia	NN	I-Disease
,	,	O
that	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
the	DT	O
virtual	JJ	O
absence	NN	O
of	IN	O
plasma	NN	O
low	JJ	O
density	NN	O
lipoproteins	NNS	O
and	CC	O
complete	JJ	O
absence	NN	O
of	IN	O
apoB-100	NN	O
,	,	O
but	CC	O
with	IN	O
apparently	RB	O
normal	JJ	O
secretion	NN	O
of	IN	O
triglyceride-rich	JJ	O
lipoproteins	NNS	O
containing	VBG	O
apoB-48	NN	O
.	.	O

The	DT	O
patients	NNS	O
plasma	NN	O
lipoproteins	NNS	O
were	VBD	O
shown	VBN	O
on	IN	O
polyacrylamide	NN	O
gels	NNS	O
and	CC	O
by	IN	O
antibody	NN	O
mapping	NN	O
to	TO	O
have	VB	O
a	DT	O
new	JJ	O
truncated	VBN	O
apoB	NN	O
variant	NN	O
,	,	O
apoB-50	NN	O
,	,	O
circulating	VBG	O
along	IN	O
with	IN	O
her	PRP$	O
apoB-48	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
this	DT	O
individual	JJ	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
C-to-T	JJ	O
nucleotide	NN	O
substitution	NN	O
at	IN	O
apoB	NN	O
codon	NN	O
2252	CD	O
,	,	O
which	WDT	O
produces	VBZ	O
a	DT	O
premature	JJ	O
in-frame	RB	O
stop	VB	O
codon	NN	O
.	.	O

Thus	RB	O
,	,	O
this	DT	O
is	VBZ	O
a	DT	O
rare	JJ	O
example	NN	O
of	IN	O
homozygous	JJ	B-Disease
hypobetalipoproteinemia	NN	I-Disease
.	.	O

Electron	NNP	O
photomicrographs	NNS	O
revealed	VBD	O
that	IN	O
the	DT	O
diameters	NNS	O
of	IN	O
particles	NNS	O
in	IN	O
the	DT	O
d	NN	O
less	RBR	O
than	IN	O
1	CD	O
.	.	O

006	CD	O
g/ml	NN	O
lipoprotein	NN	O
fraction	NN	O
,	,	O
in	IN	O
both	CC	O
the	DT	O
postprandial	JJ	O
and	CC	O
postabsorptive	JJ	O
state	NN	O
,	,	O
are	VBP	O
bimodally	RB	O
distributed	VBN	O
.	.	O

The	DT	O
molar	JJ	O
ratio	NN	O
of	IN	O
apoE	NN	O
to	TO	O
apoB	NN	O
in	IN	O
these	DT	O
particles	NNS	O
is	VBZ	O
3	CD	O
.	.	O

5	CD	O
1	CD	O
,	,	O
similar	JJ	O
to	TO	O
normal	JJ	O
VLDL	NN	O
.	.	O

The	DT	O
plasma	NN	O
LDL	NN	O
interval	NN	O
contains	VBZ	O
both	CC	O
spherical	JJ	O
and	CC	O
cuboidal	JJ	O
particles	NNS	O
.	.	O

Autologous	JJ	O
reinfusion	NN	O
of	IN	O
labeled	VBN	O
d	NN	O
less	JJR	O
than	IN	O
1	CD	O
.	.	O

006	CD	O
g/ml	NN	O
lipoproteins	NNS	O
showed	VBD	O
exponential	JJ	O
disappearance	NN	O
from	IN	O
plasma	NN	O
,	,	O
with	IN	O
an	DT	O
apparent	JJ	O
half-removal	JJ	O
time	NN	O
of	IN	O
50	CD	O
min	NN	O
,	,	O
somewhat	RB	O
slower	JJR	O
than	IN	O
for	IN	O
normal	JJ	O
chylomicrons	NNS	O
but	CC	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
for	IN	O
VLDL	NNP	O
.	.	O

The	DT	O
calculated	JJ	O
production	NN	O
rate	NN	O
for	IN	O
apoB	NN	O
was	VBD	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
in	IN	O
this	DT	O
subject	NN	O
.	.	O

von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
type	NN	I-Disease
B	NN	I-Disease
:	:	O
a	DT	O
missense	NN	O
mutation	NN	O
selectively	RB	O
abolishes	VBZ	O
ristocetin-induced	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
binding	NN	O
to	TO	O
platelet	NN	O
glycoprotein	NN	O
Ib	NN	O
.	.	O

von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
(	-LRB-	O
vWF	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
multimeric	JJ	O
glycoprotein	NN	O
that	WDT	O
mediates	VBZ	O
the	DT	O
adhesion	NN	O
of	IN	O
platelets	NNS	O
to	TO	O
the	DT	O
subendothelium	NN	O
by	IN	O
binding	VBG	O
to	TO	O
platelet	NN	O
glycoprotein	NN	O
Ib	NN	O
.	.	O

For	IN	O
human	JJ	O
vWF	NN	O
,	,	O
this	DT	O
interaction	NN	O
can	MD	O
be	VB	O
induced	VBN	O
in	FW	O
vitro	FW	O
by	IN	O
the	DT	O
antibiotic	JJ	O
ristocetin	NN	O
or	CC	O
the	DT	O
snake	NN	O
venom	NN	O
protein	NN	O
botrocetin	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
,	,	O
Gly-561	NN	O
--	:	O
>	JJR	O
Ser	NN	O
,	,	O
was	VBD	O
identified	VBN	O
within	IN	O
the	DT	O
proposed	VBN	O
glycoprotein	NN	O
Ib	NN	O
binding	NN	O
domain	NN	O
of	IN	O
vWF	NN	O
in	IN	O
the	DT	O
proband	NN	O
with	IN	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
type	NN	I-Disease
B	NN	I-Disease
,	,	O
a	DT	O
unique	JJ	O
variant	JJ	O
characterized	VBN	O
by	IN	O
no	DT	O
ristocetin-induced	JJ	O
,	,	O
but	CC	O
normal	JJ	O
botrocetin-induced	JJ	O
,	,	O
binding	VBG	O
to	TO	O
glycoprotein	NN	O
Ib	NN	O
.	.	O

The	DT	O
corresponding	JJ	O
mutant	JJ	O
recombinant	JJ	O
protein	NN	O
,	,	O
rvWF	NN	O
(	-LRB-	O
G561S	NN	O
)	-RRB-	O
,	,	O
formed	VBD	O
normal	JJ	O
multimers	NNS	O
and	CC	O
exhibited	VBD	O
the	DT	O
same	JJ	O
functional	JJ	O
defect	NN	O
as	IN	O
the	DT	O
patients	NNS	O
plasma	NN	O
vWF	NN	O
,	,	O
confirming	VBG	O
that	IN	O
this	DT	O
mutation	NN	O
causes	VBZ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
type	NN	I-Disease
B	NN	I-Disease
.	.	O

These	DT	O
data	NNS	O
show	VBP	O
that	IN	O
botrocetin	NN	O
and	CC	O
ristocetin	NN	O
cofactor	NN	O
activities	NNS	O
of	IN	O
vWF	NN	O
can	MD	O
be	VB	O
dissociated	VBN	O
by	IN	O
a	DT	O
point	NN	O
mutation	NN	O
and	CC	O
confirm	VBP	O
that	IN	O
these	DT	O
mediators	NNS	O
promote	VBP	O
vWF	NN	O
binding	NN	O
to	TO	O
platelets	NNS	O
by	IN	O
different	JJ	O
mechanisms	NNS	O
.	.	O

The	DT	O
normal	JJ	O
botrocetin-induced	JJ	O
binding	NN	O
and	CC	O
the	DT	O
defective	JJ	O
ristocetin-induced	JJ	O
binding	NN	O
of	IN	O
rvWF	NN	O
(	-LRB-	O
G561S	NN	O
)	-RRB-	O
suggest	VBP	O
that	IN	O
the	DT	O
primary	JJ	O
defect	NN	O
in	IN	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
type	NN	I-Disease
B	NN	I-Disease
may	MD	O
be	VB	O
a	DT	O
failure	NN	O
of	IN	O
normal	JJ	O
allosteric	JJ	O
regulation	NN	O
of	IN	O
the	DT	O
glycoprotein	NN	O
Ib	NN	O
binding	NN	O
function	NN	O
of	IN	O
vWF	NN	O
.	.	O

.	.	O

A	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
20	CD	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
20	CD	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
show	VBP	O
positive	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
chromosome	NN	O
17q12	NN	O
for	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
.	.	O

BRCA1	NN	O
mutations	NNS	O
cosegregating	VBG	O
with	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
16	CD	O
families	NNS	O
,	,	O
including	VBG	O
1	CD	O
family	NN	O
with	IN	O
a	DT	O
case	NN	O
of	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
.	.	O

Nine	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

The	DT	O
majority	NN	O
of	IN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
generate	VB	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
leading	VBG	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
truncated	VBN	O
BRCA1	NN	O
protein	NN	O
of	IN	O
2	CD	O
%	NN	O
-88	CD	O
%	NN	O
of	IN	O
the	DT	O
expected	VBN	O
normal	JJ	O
length	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
altered	VBD	O
the	DT	O
RING	NN	O
finger	NN	O
domain	NN	O
.	.	O

Sequencing	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
led	VBD	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
12	CD	O
families	NNS	O
,	,	O
and	CC	O
cDNA	NN	O
analysis	NN	O
revealed	VBD	O
an	DT	O
abnormal	JJ	O
or	CC	O
missing	JJ	O
BRCA1	NN	O
transcript	NN	O
in	IN	O
4	CD	O
of	IN	O
the	DT	O
8	CD	O
remaining	VBG	O
families	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
eight	CD	O
mutations	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
a	DT	O
reduced	VBN	O
quantity	NN	O
of	IN	O
BRCA1	NN	O
transcript	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
4	CD	O
of	IN	O
the	DT	O
20	CD	O
families	NNS	O
,	,	O
but	CC	O
only	RB	O
1	CD	O
of	IN	O
these	DT	O
was	VBD	O
clearly	RB	O
linked	VBN	O
to	TO	O
BRCA1	NN	O
.	.	O

It	PRP	O
is	VBZ	O
expected	VBN	O
that	IN	O
the	DT	O
majority	NN	O
of	IN	O
clear	JJ	O
examples	NNS	O
of	IN	O
the	DT	O
breast-ovarian	JJ	B-Disease
syndrome	NN	I-Disease
will	MD	O
be	VB	O
associated	VBN	O
with	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
BRCA1	NN	O
.	.	O

.	.	O

Assignment	NN	O
of	IN	O
the	DT	O
human	JJ	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
gene	NN	O
SGLT1	NN	O
to	TO	O
chromosome	NN	O
22q13	NN	O
.1	NN	O
.	.	O

The	DT	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
gene	NN	O
SGLT1	NN	O
encodes	VBZ	O
the	DT	O
primary	JJ	O
carrier	NN	O
protein	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
uptake	NN	O
of	IN	O
the	DT	O
dietary	JJ	O
sugars	NNS	O
glucose	NN	O
and	CC	O
galactose	NN	O
from	IN	O
the	DT	O
intestinal	JJ	O
lumen	NN	O
.	.	O

SGLT1	NN	O
transport	NN	O
activity	NN	O
is	VBZ	O
currently	RB	O
exploited	VBN	O
in	IN	O
oral	JJ	O
rehydration	NN	O
therapy	NN	O
.	.	O

The	DT	O
75-kDa	JJ	O
glycoprotein	NN	O
is	VBZ	O
localized	JJ	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
of	IN	O
the	DT	O
intestinal	JJ	O
epithelium	NN	O
and	CC	O
is	VBZ	O
predicted	VBN	O
to	TO	O
comprise	VB	O
12	CD	O
membrane	NN	O
spans	NNS	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
with	IN	O
the	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
glucose/galactose	NN	I-Disease
malabsorption	NN	I-Disease
,	,	O
the	DT	O
underlying	VBG	O
cause	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
SGLT1	NN	O
,	,	O
and	CC	O
the	DT	O
Asp28	NN	O
--	:	O
>	JJR	O
Asn	NN	O
change	NN	O
was	VBD	O
demonstrated	VBN	O
in	FW	O
vitro	FW	O
to	TO	O
eliminate	VB	O
SGLT1	NN	O
transport	NN	O
activity	NN	O
.	.	O

The	DT	O
SGLT1	NN	O
gene	NN	O
was	VBD	O
previously	RB	O
shown	VBN	O
to	TO	O
reside	VB	O
on	IN	O
the	DT	O
distal	JJ	O
q	NN	O
arm	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
(	-LRB-	O
11	CD	O
.	.	O

2	CD	O
--	:	O
>	JJR	O
qter	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
a	DT	O
cosmid	NN	O
probe	NN	O
for	IN	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
,	,	O
which	WDT	O
refines	VBZ	O
the	DT	O
localization	NN	O
to	TO	O
22q13	NN	O
.	.	O

1	CD	O
,	,	O
and	CC	O
provide	VBP	O
an	DT	O
example	NN	O
of	IN	O
the	DT	O
utility	NN	O
of	IN	O
the	DT	O
SGLT1	NN	O
probe	NN	O
as	IN	O
a	DT	O
diagnostic	JJ	O
for	IN	O
genetic	JJ	B-Disease
diseases	NNS	I-Disease
associated	VBN	O
with	IN	O
translocations	NNS	O
of	IN	O
chromosome	NN	O
22	CD	O
.	.	O

A	DT	O
pseudodeficiency	NN	O
allele	NN	O
common	JJ	O
in	IN	O
non-Jewish	JJ	O
Tay-Sachs	JJ	B-Disease
carriers	NNS	O
:	:	O
implications	NNS	O
for	IN	O
carrier	NN	O
screening	NN	O
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
beta-hexosaminidase	NN	I-Disease
A	NN	I-Disease
(	-LRB-	O
Hex	NN	O
A	NN	O
)	-RRB-	O
activity	NN	O
typically	RB	O
results	VBZ	O
in	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
.	.	O

However	RB	O
,	,	O
healthy	JJ	O
subjects	NNS	O
found	VBD	O
to	TO	O
be	VB	O
deficient	JJ	B-Disease
in	IN	I-Disease
Hex	NNP	I-Disease
A	NNP	I-Disease
activity	NN	O
(	-LRB-	O
i.	NN	O
e.	VBN	O
,	,	O
pseudodeficient	JJ	O
)	-RRB-	O
by	IN	O
means	NNS	O
of	IN	O
in	FW	O
vitro	FW	O
biochemical	JJ	O
tests	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
HEXA	NN	O
gene	NN	O
of	IN	O
one	CD	O
pseudodeficient	JJ	O
subject	NN	O
and	CC	O
identified	VBD	O
both	CC	O
a	DT	O
C739-to-T	NN	O
substitution	NN	O
that	WDT	O
changes	VBZ	O
Arg247	NN	O
----	:	O
Trp	NN	O
on	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
previously	RB	O
identified	VBN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
mutation	NN	O
on	IN	O
the	DT	O
second	JJ	O
allele	NN	O
.	.	O

Six	CD	O
additional	JJ	O
pseudodeficient	JJ	O
subjects	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
C739-to-T	NN	O
mutation	NN	O
.	.	O

This	DT	O
allele	NN	O
accounted	VBD	O
for	IN	O
32	CD	O
%	NN	O
(	-LRB-	O
20/62	CD	O
)	-RRB-	O
of	IN	O
non-Jewish	JJ	O
enzyme-defined	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
carriers	NNS	O
but	CC	O
for	IN	O
none	NN	O
of	IN	O
36	CD	O
Jewish	JJ	O
enzyme-defined	JJ	O
carriers	NNS	O
who	WP	O
did	VBD	O
not	RB	O
have	VB	O
one	CD	O
of	IN	O
three	CD	O
known	JJ	O
mutations	NNS	O
common	JJ	O
to	TO	O
this	DT	O
group	NN	O
.	.	O

The	DT	O
C739-to-T	JJ	O
allele	NN	O
,	,	O
together	RB	O
with	IN	O
a	DT	O
"	''	O
true	JJ	O
"	''	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
allele	NN	O
,	,	O
causes	VBZ	O
Hex	NNP	O
A	NNP	O
pseudodeficiency	NN	O
.	.	O

Given	VBN	O
both	CC	O
the	DT	O
large	JJ	O
proportion	NN	O
of	IN	O
non-Jewish	JJ	O
carriers	NNS	O
with	IN	O
this	DT	O
allele	NN	O
and	CC	O
that	IN	O
standard	JJ	O
biochemical	JJ	O
screening	NN	O
can	MD	O
not	RB	O
differentiate	VB	O
between	IN	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
C739-to-T	NN	O
mutations	NNS	O
and	CC	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
carriers	NNS	O
,	,	O
DNA	NN	O
testing	NN	O
for	IN	O
this	DT	O
mutation	NN	O
in	IN	O
at-risk	JJ	O
couples	NNS	O
is	VBZ	O
essential	JJ	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
two	CD	O
different	JJ	O
infantile	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
mutations	NNS	O
in	IN	O
a	DT	O
Cajun	JJ	O
population	NN	O
.	.	O

A	DT	O
study	NN	O
was	VBD	O
undertaken	VBN	O
to	TO	O
characterize	VB	O
the	DT	O
mutation	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
responsible	JJ	O
for	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
in	IN	O
a	DT	O
Cajun	JJ	O
population	NN	O
in	IN	O
southwest	NN	O
Louisiana	NNP	O
and	CC	O
to	TO	O
identify	VB	O
the	DT	O
origins	NNS	O
of	IN	O
these	DT	O
mutations	NNS	O
.	.	O

Eleven	CD	O
of	IN	O
12	CD	O
infantile	JJ	O
TSD	NN	B-Disease
alleles	NNS	O
examined	VBN	O
in	IN	O
six	CD	O
families	NNS	O
had	VBD	O
the	DT	O
beta-hexosaminidase	NN	O
A	NN	O
(	-LRB-	O
Hex	NN	O
A	NN	O
)	-RRB-	O
alpha-subunit	NN	O
exon	NN	O
11	CD	O
insertion	NN	O
mutation	NN	O
that	WDT	O
is	VBZ	O
present	JJ	O
in	IN	O
approximately	RB	O
70	CD	O
%	NN	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
TSD	NNP	B-Disease
heterozygotes	NNS	O
.	.	O

The	DT	O
mutation	NN	O
in	IN	O
the	DT	O
remaining	VBG	O
allele	NN	O
was	VBD	O
a	DT	O
single-base	JJ	O
transition	NN	O
in	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
the	DT	O
alpha-subunit	NN	O
intron	NN	O
9	CD	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
origins	NNS	O
of	IN	O
these	DT	O
two	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
Cajun	NNP	O
population	NN	O
,	,	O
the	DT	O
TSD	NNP	B-Disease
carrier	NN	O
status	NN	O
was	VBD	O
enzymatically	RB	O
determined	VBN	O
for	IN	O
90	CD	O
members	NNS	O
of	IN	O
four	CD	O
of	IN	O
the	DT	O
six	CD	O
families	NNS	O
,	,	O
and	CC	O
extensive	JJ	O
pedigrees	NNS	O
were	VBD	O
constructed	VBN	O
for	IN	O
all	DT	O
carriers	NNS	O
.	.	O

A	DT	O
single	JJ	O
ancestral	JJ	O
couple	NN	O
from	IN	O
France	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
common	JJ	O
to	TO	O
most	JJS	O
of	IN	O
the	DT	O
carriers	NNS	O
of	IN	O
the	DT	O
exon	NN	O
11	CD	O
insertion	NN	O
.	.	O

Pedigree	NN	O
data	NNS	O
suggest	VBP	O
that	IN	O
this	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
in	IN	O
the	DT	O
Cajun	NNP	O
population	NN	O
since	IN	O
its	PRP$	O
founding	NN	O
over	IN	O
2	CD	O
centuries	NNS	O
ago	RB	O
and	CC	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
widely	RB	O
distributed	VBN	O
within	IN	O
the	DT	O
population	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
intron	NN	O
9	CD	O
mutation	NN	O
apparently	RB	O
was	VBD	O
introduced	VBN	O
within	IN	O
the	DT	O
last	JJ	O
century	NN	O
and	CC	O
probably	RB	O
is	VBZ	O
limited	VBN	O
to	TO	O
a	DT	O
few	JJ	O
Louisiana	NNP	O
families	NNS	O
.	.	O

.	.	O

Canavan	NN	B-Disease
disease	NN	I-Disease
:	:	O
genomic	JJ	O
organization	NN	O
and	CC	O
localization	NN	O
of	IN	O
human	JJ	O
ASPA	NN	O
to	TO	O
17p13-ter	NN	O
and	CC	O
conservation	NN	O
of	IN	O
the	DT	O
ASPA	NN	O
gene	NN	O
during	IN	O
evolution	NN	O
.	.	O

Canavan	NN	B-Disease
disease	NN	I-Disease
,	,	O
or	CC	O
spongy	JJ	B-Disease
degeneration	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
brain	NN	I-Disease
,	,	O
is	VBZ	O
a	DT	O
severe	JJ	O
leukodystrophy	NN	B-Disease
caused	VBN	O
by	IN	O
the	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
aspartoacylase	NN	I-Disease
(	-LRB-	O
ASPA	NN	O
)	-RRB-	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
missense	NN	O
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
human	JJ	O
ASPA	NN	O
coding	VBG	O
sequence	NN	O
from	IN	O
patients	NNS	O
with	IN	O
Canavan	NN	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
human	JJ	O
ASPA	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
found	VBN	O
to	TO	O
span	VB	O
29	CD	O
kb	NN	O
of	IN	O
the	DT	O
genome	NN	O
.	.	O

Human	JJ	O
aspartoacylase	NN	O
is	VBZ	O
coded	VBN	O
by	IN	O
six	CD	O
exons	NNS	O
intervened	VBN	O
by	IN	O
five	CD	O
introns	NNS	O
.	.	O

The	DT	O
exons	NNS	O
vary	VBP	O
from	IN	O
94	CD	O
(	-LRB-	O
exon	NN	O
III	CD	O
)	-RRB-	O
to	TO	O
514	CD	O
(	-LRB-	O
exon	NN	O
VI	NNP	O
)	-RRB-	O
bases	NNS	O
.	.	O

The	DT	O
exon/intron	NN	O
splice	NN	O
junction	NN	O
sites	NNS	O
follow	VBP	O
the	DT	O
gt/ag	NN	O
consensus	NN	O
sequence	NN	O
rule	NN	O
.	.	O

Southern	NN	O
blot	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
human/mouse	JJ	O
somatic	JJ	O
cell	NN	O
hybrid	NN	O
cell	NN	O
lines	NNS	O
localized	JJ	O
ASPA	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
17	CD	O
.	.	O

The	DT	O
human	JJ	O
ASPA	NN	O
locus	NN	O
was	VBD	O
further	JJ	O
mapped	VBN	O
in	IN	O
the	DT	O
17p13-ter	JJ	O
region	NN	O
by	IN	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

The	DT	O
bovine	JJ	O
aspa	NN	O
gene	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
cloned	VBN	O
,	,	O
and	CC	O
its	PRP$	O
exon/intron	JJ	O
organization	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
human	JJ	O
gene	NN	O
.	.	O

The	DT	O
500-base	JJ	O
sequence	NN	O
upstream	JJ	O
of	IN	O
the	DT	O
initiator	NN	O
ATG	NN	O
codon	NN	O
in	IN	O
the	DT	O
human	JJ	O
gene	NN	O
and	CC	O
that	IN	O
in	IN	O
the	DT	O
bovine	JJ	O
gene	NN	O
are	VBP	O
77	CD	O
%	NN	O
identical	JJ	O
.	.	O

Human	JJ	O
ASPA	NN	O
coding	VBG	O
sequences	NNS	O
cross-hybridize	VBP	O
with	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
yeast	NN	O
,	,	O
chicken	NN	O
,	,	O
rabbit	NN	O
,	,	O
cow	NN	O
,	,	O
dog	NN	O
,	,	O
mouse	NN	O
,	,	O
rat	NN	O
,	,	O
and	CC	O
monkey	NN	O
.	.	O

The	DT	O
specificity	NN	O
of	IN	O
cross-species	NNS	O
hybridization	NN	O
of	IN	O
coding	VBG	O
sequences	NNS	O
suggests	VBZ	O
that	IN	O
aspartoacylase	NN	O
has	VBZ	O
been	VBN	O
conserved	VBN	O
during	IN	O
evolution	NN	O
.	.	O

It	PRP	O
should	MD	O
now	RB	O
be	VB	O
possible	JJ	O
to	TO	O
identify	VB	O
mutations	NNS	O
in	IN	O
the	DT	O
noncoding	JJ	O
genomic	JJ	O
sequences	NNS	O
that	WDT	O
lead	VBP	O
to	TO	O
Canavan	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
to	TO	O
study	VB	O
the	DT	O
regulation	NN	O
of	IN	O
ASPA	NN	O
.	.	O

.	.	O

Adrenoleukodystrophy	NNP	B-Disease
:	:	O
survey	NN	O
of	IN	O
303	CD	O
cases	NNS	O
:	:	O
biochemistry	NN	O
,	,	O
diagnosis	NN	O
,	,	O
and	CC	O
therapy	NN	O
.	.	O

Adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
genetically	RB	O
determined	VBN	O
disorder	NN	O
associated	VBN	O
with	IN	O
progressive	JJ	B-Disease
central	JJ	I-Disease
demyelination	NN	I-Disease
and	CC	O
adrenal	JJ	B-Disease
cortical	JJ	I-Disease
insufficiency	NN	I-Disease
.	.	O

All	DT	O
affected	VBN	O
persons	NNS	O
show	VBP	O
increased	VBN	O
levels	NNS	O
of	IN	O
saturated	JJ	O
unbranched	JJ	O
very-long-chain	NN	O
fatty	JJ	O
acids	NNS	O
,	,	O
particularly	RB	O
hexacosanoate	NN	O
(	-LRB-	O
C26	NN	O
0	CD	O
)	-RRB-	O
,	,	O
because	IN	O
of	IN	O
impaired	JJ	O
capacity	NN	O
to	TO	O
degrade	VB	O
these	DT	O
acids	NNS	O
.	.	O

This	DT	O
degradation	NN	O
normally	RB	O
takes	VBZ	O
place	NN	O
in	IN	O
a	DT	O
subcellular	JJ	O
organelle	NN	O
called	VBD	O
the	DT	O
peroxisome	NN	O
,	,	O
and	CC	O
ALD	NNP	B-Disease
,	,	O
together	RB	O
with	IN	O
Zellwegers	NNS	B-Disease
cerebrohepatorenal	JJ	I-Disease
syndrome	NN	I-Disease
,	,	O
is	VBZ	O
now	RB	O
considered	VBN	O
to	TO	O
belong	VB	O
to	TO	O
the	DT	O
newly	RB	O
formed	VBN	O
category	NN	O
of	IN	O
peroxisomal	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Biochemical	JJ	O
assays	NNS	O
permit	VBP	O
prenatal	JJ	O
diagnosis	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
identification	NN	O
of	IN	O
most	JJS	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
303	CD	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
in	IN	O
217	CD	O
kindreds	NNS	O
.	.	O

These	DT	O
patients	NNS	O
show	VBP	O
a	DT	O
wide	JJ	O
phenotypic	JJ	O
variation	NN	O
.	.	O

Sixty	CD	O
percent	NN	O
of	IN	O
patients	NNS	O
had	VBD	O
childhood	NN	O
ALD	NN	B-Disease
and	CC	O
17	CD	O
%	NN	O
adrenomyeloneuropathy	NN	B-Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
X-linked	JJ	O
,	,	O
with	IN	O
the	DT	O
gene	NN	O
mapped	VBN	O
to	TO	O
Xq28	NN	O
.	.	O

Neonatal	JJ	B-Disease
ALD	NN	I-Disease
,	,	O
a	DT	O
distinct	JJ	O
entity	NN	O
with	IN	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
and	CC	O
points	NNS	O
of	IN	O
resemblance	NN	O
to	TO	O
Zellwegers	NNP	B-Disease
syndrome	NN	I-Disease
,	,	O
accounted	VBD	O
for	IN	O
7	CD	O
%	NN	O
of	IN	O
the	DT	O
cases	NNS	O
.	.	O

Although	IN	O
excess	JJ	O
C26	NN	O
0	CD	O
in	IN	O
the	DT	O
brain	NN	O
of	IN	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
is	VBZ	O
partially	RB	O
of	IN	O
dietary	JJ	O
origin	NN	O
,	,	O
dietary	JJ	O
C26	NN	O
0	CD	O
restriction	NN	O
did	VBD	O
not	RB	O
produce	VB	O
clear	JJ	O
benefit	NN	O
.	.	O

Bone	NN	O
marrow	NN	O
transplant	NN	O
lowered	VBD	O
the	DT	O
plasma	NN	O
C26	NN	O
0	CD	O
level	NN	O
but	CC	O
failed	VBD	O
to	TO	O
arrest	VB	O
neurological	JJ	O
progression	NN	O
.	.	O

.	.	O

French	JJ	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
patients	NNS	O
do	VBP	O
not	RB	O
exhibit	VB	O
gametic	JJ	O
segregation	NN	O
distortion	NN	O
:	:	O
a	DT	O
sperm	NN	O
typing	NN	O
analysis	NN	O
.	.	O

Segregation	NN	O
distortion	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
to	TO	O
occur	VB	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
the	DT	O
trinucleotide	JJ	B-Disease
repeat	NN	I-Disease
disorders	NNS	I-Disease
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
a	DT	O
sperm	NN	O
typing	NN	O
study	NN	O
performed	VBN	O
in	IN	O
patients	NNS	O
of	IN	O
Japanese	JJ	O
descent	NN	O
with	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
,	,	O
it	PRP	O
was	VBD	O
reported	VBN	O
that	IN	O
disease	NN	O
alleles	NNS	O
are	VBP	O
preferentially	RB	O
transmitted	VBN	O
during	IN	O
meiosis	NN	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
sperm	NN	O
typing	NN	O
study	NN	O
of	IN	O
five	CD	O
MJD	NN	B-Disease
patients	NNS	O
of	IN	O
French	JJ	O
descent	NN	O
and	CC	O
analysis	NN	O
of	IN	O
the	DT	O
pooled	JJ	O
data	NN	O
shows	VBZ	O
a	DT	O
ratio	NN	O
of	IN	O
mutant	JJ	O
to	TO	O
normal	JJ	O
alleles	NNS	O
of	IN	O
379	CD	O
436	CD	O
(	-LRB-	O
46	CD	O
.	.	O

5	CD	O
53	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
does	VBZ	O
not	RB	O
support	VB	O
meiotic	JJ	O
segregation	NN	O
distortion	NN	O
.	.	O

To	TO	O
confirm	VB	O
these	DT	O
results	NNS	O
,	,	O
sperm	NN	O
typing	NN	O
analysis	NN	O
was	VBD	O
also	RB	O
performed	VBN	O
using	VBG	O
a	DT	O
polymorphic	JJ	O
marker	NN	O
,	,	O
D14S1050	NN	O
,	,	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
MJD1	NN	O
gene	NN	O
.	.	O

Among	IN	O
910	CD	O
sperm	NN	O
analyzed	VBN	O
,	,	O
the	DT	O
allele	NN	O
linked	VBN	O
to	TO	O
the	DT	O
disease	NN	O
chromosome	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
50	CD	O
.	.	O

3	CD	O
%	NN	O
of	IN	O
the	DT	O
samples	NNS	O
and	CC	O
the	DT	O
allele	NN	O
linked	VBN	O
to	TO	O
the	DT	O
normal	JJ	O
chromosome	NN	O
was	VBD	O
found	VBN	O
in	IN	O
49	CD	O
.	.	O

6	CD	O
%	NN	O
of	IN	O
the	DT	O
sperm	NN	O
.	.	O

The	DT	O
difference	NN	O
in	IN	O
frequency	NN	O
of	IN	O
these	DT	O
two	CD	O
alleles	NNS	O
is	VBZ	O
not	RB	O
significant	JJ	O
(	-LRB-	O
P	NN	O
=	JJ	O
0	CD	O
.	.	O

8423	NN	O
)	-RRB-	O
.	.	O

Likelihood-based	JJ	O
analysis	NN	O
of	IN	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
single	JJ	O
sperm	NN	O
data	NNS	O
using	VBG	O
the	DT	O
SPERMSEG	NN	O
program	NN	O
also	RB	O
showed	VBD	O
no	DT	O
support	NN	O
for	IN	O
segregation	NN	O
distortion	NN	O
at	IN	O
the	DT	O
gamete	NN	O
level	NN	O
in	IN	O
this	DT	O
patient	NN	O
population	NN	O
.	.	O

The	DT	O
previous	JJ	O
report	NN	O
on	IN	O
the	DT	O
Japanese	JJ	O
patients	NNS	O
also	RB	O
suggested	VBD	O
that	IN	O
disease	NN	O
allele	NN	O
stability	NN	O
may	MD	O
be	VB	O
influenced	VBN	O
by	IN	O
a	DT	O
trans	JJ	O
effect	NN	O
of	IN	O
an	DT	O
intragenic	JJ	O
polymorphism	NN	O
(	-LRB-	O
987	CD	O
G/C	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
wild-type	JJ	O
allele	NN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
French	JJ	O
patients	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
this	DT	O
polymorphism	NN	O
.	.	O

However	RB	O
,	,	O
analysis	NN	O
of	IN	O
the	DT	O
variance	NN	O
in	IN	O
repeat	NN	O
number	NN	O
in	IN	O
sperm	NN	O
from	IN	O
the	DT	O
French	JJ	O
MJD	NN	B-Disease
patients	NNS	O
overlapped	VBD	O
significantly	RB	O
with	IN	O
the	DT	O
variance	NN	O
in	IN	O
repeat	NN	O
number	NN	O
observed	VBN	O
in	IN	O
the	DT	O
C/C	NN	O
homozygous	JJ	O
Japanese	JJ	O
patients	NNS	O
.	.	O

Nebulin	NNP	O
seen	VBN	O
in	IN	O
DMD	NNP	B-Disease
males	NNS	O
including	VBG	O
one	CD	O
patient	NN	O
with	IN	O
a	DT	O
large	JJ	O
DNA	NN	O
deletion	NN	O
encompassing	VBG	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
nebulin	NN	O
in	IN	O
a	DT	O
muscle	NN	O
specimen	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
due	JJ	O
to	TO	O
a	DT	O
large	JJ	O
deletion	NN	O
precludes	VBZ	O
the	DT	O
possibility	NN	O
that	IN	O
this	DT	O
protein	NN	O
is	VBZ	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
product	NN	O
.	.	O

.	.	O

The	DT	O
human	JJ	O
gene	NN	O
for	IN	O
alkaptonuria	NN	B-Disease
(	-LRB-	O
AKU	NN	B-Disease
)	-RRB-	O
maps	VBZ	O
to	TO	O
chromosome	NN	O
3q	NN	O
.	.	O

Alkaptonuria	NN	B-Disease
(	-LRB-	O
AKU	NN	B-Disease
;	:	O
McKusick	NNP	O
no.	NNP	O
203500	CD	O
)	-RRB-	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
the	DT	O
lack	NN	O
of	IN	O
homogentisic	JJ	O
acid	NN	O
oxidase	NN	O
activity	NN	O
.	.	O

Patients	NNS	O
excrete	VBP	O
large	JJ	O
amounts	NNS	O
of	IN	O
homogentisic	JJ	O
acid	NN	O
in	IN	O
their	PRP$	O
urine	NN	O
and	CC	O
a	DT	O
black	JJ	O
ochronotic	JJ	O
pigment	NN	O
is	VBZ	O
deposited	VBN	O
in	IN	O
their	PRP$	O
cartilage	NN	O
and	CC	O
collagenous	JJ	O
tissues	NNS	O
.	.	O

Ochronosis	NNP	B-Disease
is	VBZ	O
the	DT	O
predominant	JJ	O
clinical	JJ	O
complication	NN	O
of	IN	O
the	DT	O
disease	NN	O
leading	VBG	O
to	TO	O
ochronotic	JJ	B-Disease
arthropathy	NN	I-Disease
,	,	O
dark	JJ	O
urine	NN	O
,	,	O
pigment	NN	O
changes	NNS	O
of	IN	O
the	DT	O
skin	NN	O
,	,	O
and	CC	O
other	JJ	O
clinical	JJ	O
features	NNS	O
.	.	O

A	DT	O
mutation	NN	O
causing	VBG	O
alkaptonuria	NN	B-Disease
in	IN	O
the	DT	O
mouse	NN	O
has	VBZ	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
16	CD	O
.	.	O

Considering	VBG	O
conserved	VBN	O
synteny	NN	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
map	VB	O
the	DT	O
human	JJ	O
gene	NN	O
to	TO	O
chromosome	NN	O
3q	NN	O
in	IN	O
six	CD	O
alkaptonuria	NN	B-Disease
pedigrees	NNS	O
of	IN	O
Slovak	JJ	O
origin	NN	O
.	.	O

.	.	O

The	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
responsible	JJ	O
for	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
,	,	O
is	VBZ	O
mutated	VBN	O
in	IN	O
human	JJ	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Although	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
cancer	NN	B-Disease
in	IN	O
the	DT	O
world	NN	O
,	,	O
genetic	JJ	O
changes	NNS	O
during	IN	O
its	PRP$	O
carcinogenesis	NN	O
are	VBP	O
not	RB	O
well	RB	O
understood	VBN	O
.	.	O

Since	IN	O
some	DT	O
gastric	JJ	B-Disease
cancers	NNS	I-Disease
are	VBP	O
considered	VBN	O
to	TO	O
originate	VB	O
from	IN	O
the	DT	O
intestinal	JJ	O
metaplasia	NN	O
,	,	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
,	,	O
the	DT	O
mutation	NN	O
of	IN	O
which	WDT	O
causes	VBZ	O
adenomatous	JJ	B-Disease
polyps	NNS	I-Disease
in	IN	I-Disease
the	DT	I-Disease
colon	NN	I-Disease
,	,	O
is	VBZ	O
associated	VBN	O
with	IN	O
carcinogenesis	NN	O
of	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Based	VBN	O
on	IN	O
this	DT	O
idea	NN	O
,	,	O
DNAs	NNS	O
isolated	VBN	O
from	IN	O
gastric	JJ	B-Disease
cancers	NNS	I-Disease
were	VBD	O
examined	VBN	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
RNase	NN	O
protection	NN	O
analysis	NN	O
coupled	VBN	O
with	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
followed	VBN	O
by	IN	O
sequencing	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
.	.	O

By	IN	O
screening	VBG	O
nearly	RB	O
one-half	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
44	CD	O
tumors	NNS	B-Disease
,	,	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
three	CD	O
tumors	NNS	B-Disease
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
a	DT	O
nonsense	NN	O
mutation	NN	O
,	,	O
and	CC	O
a	DT	O
5-base	JJ	O
pair	NN	O
deletion	NN	O
resulting	VBG	O
in	IN	O
a	DT	O
frame	NN	O
shift	NN	O
which	WDT	O
causes	VBZ	O
truncation	NN	O
of	IN	O
the	DT	O
gene	NN	O
product	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
also	RB	O
plays	VBZ	O
an	DT	O
important	JJ	O
role	NN	O
during	IN	O
the	DT	O
carcinogenesis	NN	O
of	IN	O
at	IN	O
least	JJS	O
some	DT	O
gastric	JJ	B-Disease
cancers	NNS	I-Disease
.	.	O

.	.	O

Molecular	JJ	O
epidemiology	NN	O
of	IN	O
C9	NN	B-Disease
deficiency	NN	I-Disease
heterozygotes	NNS	O
with	IN	O
an	DT	O
Arg95Stop	NN	O
mutation	NN	O
of	IN	O
the	DT	O
C9	NN	O
gene	NN	O
in	IN	O
Japan	NNP	O
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
ninth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
human	JJ	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C9	NN	O
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
complement	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Japan	NNP	O
,	,	O
with	IN	O
an	DT	O
incidence	NN	O
of	IN	O
approximately	RB	O
one	CD	O
homozygote	NN	O
in	IN	O
1000	CD	O
,	,	O
but	CC	O
is	VBZ	O
very	RB	O
rare	JJ	O
in	IN	O
other	JJ	O
countries	NNS	O
.	.	O

Genetic	JJ	O
analyses	NNS	O
of	IN	O
Japanese	JJ	O
C9	NN	B-Disease
deficiency	NN	I-Disease
have	VBP	O
shown	VBN	O
that	IN	O
a	DT	O
C-to-T	JJ	O
transition	NN	O
leading	VBG	O
to	TO	O
TGA	NNP	O
stop	VB	O
codon	NN	O
for	IN	O
Arg95	NN	O
in	IN	O
exon	NN	O
4	CD	O
of	IN	O
the	DT	O
C9	NN	O
gene	NN	O
(	-LRB-	O
Arg95Stop	NN	O
)	-RRB-	O
is	VBZ	O
common	JJ	O
in	IN	O
Japanese	JJ	O
C9	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

To	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
of	IN	O
heterozygous	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
Arg95Stop	NN	O
mutation	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
population	NN	O
,	,	O
we	PRP	O
collected	VBD	O
DNA	NN	O
samples	NNS	O
from	IN	O
300	CD	O
individuals	NNS	O
in	IN	O
two	CD	O
of	IN	O
the	DT	O
four	CD	O
main	JJ	O
islands	NNS	O
of	IN	O
Japan	NNP	O
.	.	O

Heterozygote	NN	O
detection	NN	O
was	VBD	O
performed	VBN	O
with	IN	O
an	DT	O
allele-specific	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
system	NN	O
designed	VBN	O
to	TO	O
detect	VB	O
exclusively	RB	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
alleles	NNS	O
,	,	O
followed	VBN	O
by	IN	O
confirmation	NN	O
with	IN	O
PCR/single-strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Twenty	CD	O
individuals	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
Arg95Stop	NN	O
mutation	NN	O
.	.	O

None	NN	O
was	VBD	O
homozygous	JJ	O
.	.	O

The	DT	O
prevalence	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
Arg95Stop	NN	O
mutation	NN	O
was	VBD	O
6	CD	O
.	.	O

7	CD	O
%	NN	O
(	-LRB-	O
20/300	CD	O
)	-RRB-	O
.	.	O

An	DT	O
estimated	JJ	O
frequency	NN	O
(	-LRB-	O
0	CD	O
.	.	O

12	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
complete	JJ	O
C9	NN	B-Disease
deficiency	NN	I-Disease
due	JJ	O
to	TO	O
homozygous	JJ	O
Arg95Stop	NN	O
mutation	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
frequencies	NNS	O
determined	VBN	O
by	IN	O
serological	JJ	O
studies	NNS	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
female	JJ	O
Lesch-Nyhan	JJ	B-Disease
patient	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
the	DT	O
X-linked	JJ	O
recessive	JJ	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
hypoxanthine	NN	B-Disease
phosphoribosyltransferase	NN	I-Disease
[	-LRB-	I-Disease
HPRT	NN	I-Disease
]	-RRB-	I-Disease
deficiency	NN	I-Disease
)	-RRB-	O
.	.	O

Cytogenetic	JJ	O
and	CC	O
carrier	NN	O
studies	NNS	O
revealed	VBD	O
structurally	RB	O
normal	JJ	O
chromosomes	NNS	O
for	IN	O
this	DT	O
patient	NN	O
and	CC	O
her	PRP$	O
parents	NNS	O
and	CC	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
arose	VBD	O
through	IN	O
a	DT	O
de	FW	O
novo	FW	O
gametic	JJ	O
event	NN	O
.	.	O

Comparison	NN	O
of	IN	O
this	DT	O
patients	NNS	O
DNA	NN	O
with	IN	O
the	DT	O
DNA	NN	O
of	IN	O
her	PRP$	O
parents	NNS	O
revealed	VBD	O
that	IN	O
a	DT	O
microdeletion	NN	O
,	,	O
which	WDT	O
occurred	VBD	O
within	IN	O
a	DT	O
maternal	JJ	O
gamete	NN	O
and	CC	O
involved	VBD	O
the	DT	O
entire	JJ	O
HPRT	NN	O
gene	NN	O
,	,	O
was	VBD	O
partially	RB	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

Somatic	JJ	O
cell	NN	O
hybrids	NNS	O
,	,	O
generated	VBN	O
to	TO	O
separate	VB	O
maternal	JJ	O
and	CC	O
paternal	JJ	O
X	NN	O
chromosomes	NNS	O
,	,	O
showed	VBD	O
that	IN	O
expression	NN	O
of	IN	O
two	CD	O
additional	JJ	O
X-linked	JJ	O
enzymes	NNS	O
,	,	O
phosphoglycerate	JJ	O
kinase	NN	O
and	CC	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
,	,	O
were	VBD	O
expressed	VBN	O
only	RB	O
in	IN	O
cells	NNS	O
that	WDT	O
contained	VBD	O
the	DT	O
maternal	JJ	O
X	NN	O
chromosome	NN	O
,	,	O
suggesting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
functionally	RB	O
inactive	JJ	O
paternal	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

Furthermore	RB	O
,	,	O
comparison	NN	O
of	IN	O
methylation	NN	O
patterns	NNS	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
the	DT	O
HPRT	NN	O
gene	NN	O
known	VBN	O
to	TO	O
be	VB	O
important	JJ	O
in	IN	O
gene	NN	O
regulation	NN	O
revealed	VBD	O
differences	NNS	O
between	IN	O
DNA	NN	O
from	IN	O
the	DT	O
father	NN	O
and	CC	O
the	DT	O
patient	NN	O
,	,	O
in	IN	O
keeping	VBG	O
with	IN	O
an	DT	O
active	JJ	O
HPRT	NN	O
locus	NN	O
in	IN	O
the	DT	O
father	NN	O
and	CC	O
an	DT	O
inactive	JJ	O
HPRT	NN	O
locus	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Together	RB	O
these	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
nonrandom	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
cytogenetically	RB	O
normal	JJ	O
paternal	JJ	O
X	NN	O
chromosome	NN	O
and	CC	O
a	DT	O
microdeletion	NN	O
of	IN	O
the	DT	O
HPRT	NN	O
gene	NN	O
on	IN	O
an	DT	O
active	JJ	O
maternal	JJ	O
X	NN	O
chromosome	NN	O
were	VBD	O
responsible	JJ	O
for	IN	O
the	DT	O
absence	NN	O
of	IN	O
HPRT	NNP	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

.	.	O

Changes	NNS	O
at	IN	O
P183	NN	O
of	IN	O
emerin	NN	O
weaken	VBP	O
its	PRP$	O
protein-protein	JJ	O
interactions	NNS	O
resulting	VBG	O
in	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Emery-Dreifuss	JJ	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
characterized	VBN	O
by	IN	O
early	JJ	O
contractures	NNS	B-Disease
of	IN	I-Disease
the	DT	I-Disease
elbows	NNS	I-Disease
,	,	I-Disease
Achilles	NNPS	I-Disease
tendons	NNS	I-Disease
and	CC	I-Disease
spine	NN	I-Disease
,	,	O
slowly	RB	O
progressive	JJ	O
muscle	NN	B-Disease
wasting	VBG	I-Disease
and	CC	O
weakness	NN	B-Disease
,	,	O
and	CC	O
cardiomyopathy	NN	B-Disease
associated	VBN	O
with	IN	O
cardiac	JJ	B-Disease
conduction	NN	I-Disease
defects	NNS	I-Disease
.	.	O

The	DT	O
emerin	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq28	NN	O
and	CC	O
encodes	VBZ	O
a	DT	O
34-kDa	JJ	O
serine-rich	JJ	O
protein	NN	O
,	,	O
emerin	NN	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
localized	JJ	O
to	TO	O
the	DT	O
nuclear	JJ	O
envelope	NN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
tissues	NNS	O
,	,	O
including	VBG	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
.	.	O

Mutations	NNS	O
spanning	VBG	O
the	DT	O
emerin	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
EDMD	NN	B-Disease
.	.	O

We	PRP	O
present	VBP	O
here	RB	O
the	DT	O
effect	NN	O
,	,	O
on	IN	O
emerin	NN	O
protein	NN	O
expression	NN	O
,	,	O
of	IN	O
two	CD	O
missense	NN	O
mutations	NNS	O
identified	VBN	O
in	IN	O
unrelated	JJ	O
EDMD	NN	B-Disease
patients	NNS	O
.	.	O

These	DT	O
alterations	NNS	O
predict	VBP	O
the	DT	O
replacement	NN	O
of	IN	O
a	DT	O
proline	NN	O
residue	NN	O
at	IN	O
position	NN	O
183	CD	O
with	IN	O
either	CC	O
a	DT	O
histidine	NN	O
or	CC	O
a	DT	O
threonine	NN	O
.	.	O

Biochemical	JJ	O
analysis	NN	O
has	VBZ	O
demonstrated	VBN	O
that	IN	O
the	DT	O
mobility	NN	O
and	CC	O
expression	NN	O
levels	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
forms	NNS	O
of	IN	O
emerin	NN	O
are	VBP	O
indistinguishable	JJ	O
from	IN	O
that	DT	O
of	IN	O
wild-type	JJ	O
emerin	NN	O
,	,	O
but	CC	O
that	IN	O
they	PRP	O
have	VBP	O
weakened	VBN	O
interactions	NNS	O
with	IN	O
nuclear	JJ	O
lamina	NN	O
components	NNS	O
.	.	O

In	IN	O
comparison	NN	O
with	IN	O
the	DT	O
usual	JJ	O
EDMD	NN	B-Disease
phenotype	NN	O
,	,	O
patients	NNS	O
with	IN	O
P183	NN	O
missense	NN	O
mutations	NNS	O
have	VBP	O
a	DT	O
later	JJ	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
first	JJ	O
symptoms	NNS	O
,	,	O
elbow	NN	B-Disease
contractures	NNS	I-Disease
,	,	O
ankle	NN	B-Disease
contractures	NNS	I-Disease
,	,	O
upper	JJ	B-Disease
limb	NN	I-Disease
weakness	NN	I-Disease
and	CC	O
lower	JJR	B-Disease
limb	NN	I-Disease
weakness	NN	I-Disease
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
difference	NN	O
for	IN	O
the	DT	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
cardiac	JJ	B-Disease
involvement	NN	I-Disease
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
protein	NN	O
studies	NNS	O
on	IN	O
patients	NNS	O
with	IN	O
missense	NN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
the	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
EDMD	NN	B-Disease
.	.	O

These	DT	O
studies	NNS	O
demonstrate	VBP	O
the	DT	O
importance	NN	O
of	IN	O
proline	NN	O
183	CD	O
for	IN	O
the	DT	O
proper	JJ	O
structure/function	NN	O
of	IN	O
emerin	NN	O
.	.	O

.	.	O

Decreased	VBN	O
expression	NN	O
of	IN	O
BRCA1	NN	O
accelerates	VBZ	O
growth	NN	O
and	CC	O
is	VBZ	O
often	RB	O
present	JJ	O
during	IN	O
sporadic	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
progression	NN	O
.	.	O

We	PRP	O
have	VBP	O
characterized	VBN	O
expression	NN	O
of	IN	O
the	DT	O
familial	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
gene	NN	O
,	,	O
BRCA1	NN	O
,	,	O
in	IN	O
cases	NNS	O
of	IN	O
non-hereditary	JJ	B-Disease
(	-LRB-	I-Disease
sporadic	JJ	I-Disease
)	-RRB-	I-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
and	CC	O
analyzed	VBD	O
the	DT	O
effect	NN	O
of	IN	O
antisense	JJ	O
inhibition	NN	O
of	IN	O
BRCA1	NN	O
on	IN	O
the	DT	O
proliferative	JJ	O
rate	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

BRCA1	NN	O
mRNA	NN	O
levels	NNS	O
are	VBP	O
markedly	RB	O
decreased	VBN	O
during	IN	O
the	DT	O
transition	NN	O
from	IN	O
carcinoma	NN	B-Disease
in	FW	I-Disease
situ	FW	I-Disease
to	TO	O
invasive	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Experimental	JJ	O
inhibition	NN	O
of	IN	O
BRCA1	NN	O
expression	NN	O
with	IN	O
antisense	JJ	O
oligonucleotides	NNS	O
produced	VBD	O
accelerated	VBN	O
growth	NN	O
of	IN	O
normal	JJ	O
and	CC	O
malignant	JJ	O
mammary	JJ	O
cells	NNS	O
,	,	O
but	CC	O
had	VBD	O
no	DT	O
effect	NN	O
on	IN	O
non-mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

These	DT	O
studies	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NN	O
may	MD	O
normally	RB	O
serve	VB	O
as	IN	O
a	DT	O
negative	JJ	O
regulator	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cell	NN	O
growth	NN	O
whose	WP$	O
function	NN	O
is	VBZ	O
compromised	VBN	O
in	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
either	CC	O
by	IN	O
direct	JJ	O
mutation	NN	O
or	CC	O
alterations	NNS	O
in	IN	O
gene	NN	O
expression	NN	O
.	.	O

.	.	O

Additional	JJ	O
copies	NNS	O
of	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
gene	NN	O
causing	VBG	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
arise	VB	O
by	IN	O
separate	JJ	O
integration	NN	O
into	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
.	.	O

The	DT	O
proteolipid	NN	O
protein	NN	O
gene	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
is	VBZ	O
normally	RB	O
present	JJ	O
at	IN	O
chromosome	NN	O
Xq22	NN	O
.	.	O

Mutations	NNS	O
and	CC	O
duplications	NNS	O
of	IN	O
this	DT	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
PMD	NN	B-Disease
)	-RRB-	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
two	CD	O
new	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
males	NNS	O
affected	VBN	O
with	IN	O
PMD	NN	B-Disease
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
copy	NN	O
of	IN	O
PLP	NN	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	O
normal	JJ	O
copy	NN	O
on	IN	O
Xq22	NN	O
.	.	O

In	IN	O
the	DT	O
first	JJ	O
family	NN	O
,	,	O
the	DT	O
extra	JJ	O
copy	NN	O
was	VBD	O
first	JJ	O
detected	VBN	O
by	IN	O
the	DT	O
presence	NN	O
of	IN	O
heterozygosity	NN	O
of	IN	O
the	DT	O
AhaII	NN	O
dimorphism	NN	O
within	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
FISH	NN	O
analysis	NN	O
showed	VBD	O
an	DT	O
additional	JJ	O
copy	NN	O
of	IN	O
PLP	NN	O
in	IN	O
Xp22	NN	O
.	.	O

1	CD	O
,	,	O
although	IN	O
no	DT	O
chromosomal	JJ	O
rearrangements	NNS	O
could	MD	O
be	VB	O
detected	VBN	O
by	IN	O
standard	JJ	O
karyotype	NN	O
analysis	NN	O
.	.	O

Another	DT	O
three	CD	O
affected	VBN	O
males	NNS	O
from	IN	O
the	DT	O
family	NN	O
had	VBD	O
similar	JJ	O
findings	NNS	O
.	.	O

In	IN	O
a	DT	O
second	JJ	O
unrelated	JJ	O
family	NN	O
with	IN	O
signs	NNS	O
of	IN	O
PMD	NN	B-Disease
,	,	O
cytogenetic	JJ	O
analysis	NN	O
showed	VBD	O
a	DT	O
pericentric	JJ	O
inversion	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
.	.	O

In	IN	O
the	DT	O
inv	NN	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
carried	VBN	O
by	IN	O
several	JJ	O
affected	JJ	O
family	NN	O
members	NNS	O
,	,	O
FISH	NN	O
showed	VBD	O
PLP	NN	O
signals	NNS	O
at	IN	O
Xp11	NN	O
.	.	O

4	CD	O
and	CC	O
Xq22	NN	O
.	.	O

A	DT	O
third	JJ	O
family	NN	O
has	VBZ	O
previously	RB	O
been	VBN	O
reported	VBN	O
,	,	O
in	IN	O
which	WDT	O
affected	VBD	O
members	NNS	O
had	VBD	O
an	DT	O
extra	JJ	O
copy	NN	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
detected	VBN	O
at	IN	O
Xq26	NN	O
in	IN	O
a	DT	O
chromosome	NN	O
with	IN	O
an	DT	O
otherwise	RB	O
normal	JJ	O
banding	NN	O
pattern	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
three	CD	O
separate	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
PLP	NNP	O
is	VBZ	O
duplicated	JJ	O
at	IN	O
a	DT	O
noncontiguous	JJ	O
site	NN	O
suggests	VBZ	O
that	IN	O
such	JJ	O
duplications	NNS	O
could	MD	O
be	VB	O
a	DT	O
relatively	RB	O
common	JJ	O
but	CC	O
previously	RB	O
undetected	JJ	O
cause	NN	O
of	IN	O
genetic	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Linkage	NN	O
relationships	NNS	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
C1	NN	O
gene	NN	O
and	CC	O
a	DT	O
cytochrome	NN	O
P450	NN	O
gene	NN	O
(	-LRB-	O
CYP2A	NN	O
)	-RRB-	O
to	TO	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
genetic	JJ	O
linkage	NN	O
of	IN	O
two	CD	O
markers	NNS	O
,	,	O
the	DT	O
apolipoprotein	NN	O
C1	NN	O
(	-LRB-	O
APOC1	NN	O
)	-RRB-	O
gene	NN	O
and	CC	O
a	DT	O
cytochrome	NN	O
P450	NN	O
(	-LRB-	O
CYP2A	NN	O
)	-RRB-	O
gene	NN	O
,	,	O
in	IN	O
relation	NN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

A	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
of	IN	O
9	CD	O
.	.	O

29	CD	O
at	IN	O
2	CD	O
cM	NN	O
was	VBD	O
observed	VBN	O
for	IN	O
APOC1-DM	NN	O
,	,	O
with	IN	O
a	DT	O
lod	NN	O
score	NN	O
of	IN	O
8	CD	O
.	.	O

55	CD	O
at	IN	O
4	CD	O
cM	NN	O
for	IN	O
CYP2A-DM	NN	O
.	.	O

These	DT	O
two	CD	O
markers	NNS	O
also	RB	O
show	VBP	O
close	JJ	O
linkage	NN	O
to	TO	O
each	DT	O
other	JJ	O
(	-LRB-	O
theta	JJ	O
max	NN	O
=	JJ	O
0	CD	O
.	.	O

05	NN	O
,	,	O
Zmax	NN	O
=	JJ	O
9	CD	O
.	.	O

09	NN	O
)	-RRB-	O
.	.	O

From	IN	O
examination	NN	O
of	IN	O
the	DT	O
genotypes	NNS	O
of	IN	O
the	DT	O
recombinant	JJ	O
individuals	NNS	O
,	,	O
CYP2A	NN	O
appears	VBZ	O
to	TO	O
map	VB	O
proximal	JJ	O
to	TO	O
DM	NN	O
because	IN	O
in	IN	O
one	CD	O
recombinant	JJ	O
individual	JJ	O
CYP2A	NN	O
,	,	O
APOC2	NN	O
and	CC	O
CKMM	NN	O
had	VBD	O
all	DT	O
recombined	VBN	O
with	IN	O
DM	NN	O
.	.	O

Evidence	NN	O
from	IN	O
another	DT	O
CYP2A-DM	NN	O
recombinant	JJ	O
individual	JJ	O
places	NNS	O
CYP2A	NN	O
proximal	JJ	O
to	TO	O
APOC2	NN	O
and	CC	O
CKMM	NN	O
.	.	O

Localisation	NN	O
of	IN	O
CYP2A	NN	O
on	IN	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
also	RB	O
suggests	VBZ	O
that	IN	O
it	PRP	O
is	VBZ	O
proximal	JJ	O
to	TO	O
DM	NN	O
and	CC	O
APOC2/C1/E	NN	O
gene	NN	O
cluster	NN	O
.	.	O

beta-galactosidase	NN	O
gene	NN	O
mutations	NNS	O
affecting	VBG	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
elastin-binding	JJ	O
protein	NN	O
in	IN	O
GM1-gangliosidosis	JJ	B-Disease
patients	NNS	O
with	IN	O
cardiac	JJ	B-Disease
involvement	NN	I-Disease
.	.	O

GM1-gangliosidosis	NN	B-Disease
is	VBZ	O
a	DT	O
lysosomal	JJ	B-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
acid	NN	I-Disease
beta-galactosidase	NN	I-Disease
(	-LRB-	O
GLB1	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
five	CD	O
new	JJ	O
beta-galactosidase	NN	O
gene	NN	O
mutations	NNS	O
in	IN	O
nine	CD	O
Italian	JJ	O
patients	NNS	O
and	CC	O
one	CD	O
fetus	NN	O
,	,	O
segregating	VBG	O
in	IN	O
seven	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
eight	CD	O
patients	NNS	O
with	IN	O
the	DT	O
infantile	JJ	O
,	,	O
severe	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
presented	VBD	O
cardiac	JJ	B-Disease
involvement	NN	I-Disease
,	,	O
a	DT	O
feature	NN	O
rarely	RB	O
associated	VBN	O
with	IN	O
GM1-gangliosidosis	NN	B-Disease
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
patients	NNS	O
RNA	NN	O
and	CC	O
DNA	NN	O
identified	VBD	O
two	CD	O
new	JJ	O
RNA	NN	O
splicing	NN	O
defects	NNS	O
,	,	O
three	CD	O
new	JJ	O
and	CC	O
three	CD	O
previously	RB	O
described	VBN	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
patients	NNS	O
with	IN	O
cardiac	JJ	B-Disease
involvement	NN	I-Disease
were	VBD	O
homozygous	JJ	O
for	IN	O
one	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
R59H	NN	O
,	,	O
Y591C	NN	O
,	,	O
Y591N	NN	O
,	,	O
or	CC	O
IVS14-2A	NN	O
>	JJR	O
G	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
all	DT	O
other	JJ	O
patients	NNS	O
were	VBD	O
compound	JJ	O
heterozygous	JJ	O
for	IN	O
one	CD	O
of	IN	O
the	DT	O
following	VBG	O
mutations	NNS	O
R201H	NN	O
,	,	O
R482H	NN	O
,	,	O
G579D	NN	O
,	,	O
IVS8	NN	O
+	CC	O
2T	NN	O
>	JJR	O
C.	FW	O
Although	IN	O
we	PRP	O
could	MD	O
not	RB	O
directly	RB	O
correlate	VB	O
the	DT	O
presence	NN	O
of	IN	O
cardiac	JJ	B-Disease
abnormalities	NNS	I-Disease
with	IN	O
specific	JJ	O
genetic	JJ	B-Disease
lesions	NNS	I-Disease
,	,	O
the	DT	O
mutations	NNS	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
cardiomyopathy	NN	B-Disease
fell	VBD	O
in	IN	O
the	DT	O
GLB1	NN	O
cDNA	NN	O
region	NN	O
common	JJ	O
to	TO	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
Hbeta-Gal-related	JJ	O
protein	NN	O
,	,	O
also	RB	O
known	VBN	O
as	IN	O
the	DT	O
elastin	NN	O
binding	NN	O
protein	NN	O
(	-LRB-	O
EBP	NN	O
)	-RRB-	O
.	.	O

Consequently	RB	O
,	,	O
both	DT	O
molecules	NNS	O
are	VBP	O
affected	VBN	O
by	IN	O
the	DT	O
mutations	NNS	O
,	,	O
and	CC	O
they	PRP	O
may	MD	O
contribute	VB	O
differently	RB	O
to	TO	O
the	DT	O
occurrence	NN	O
of	IN	O
specific	JJ	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

.	.	O

Exclusion	NN	O
of	IN	O
linkage	NN	O
between	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
and	CC	O
the	DT	O
human	JJ	O
serum	NN	O
amyloid	NN	O
A	NN	O
(	-LRB-	O
SAA	NN	O
)	-RRB-	O
gene	NN	O
cluster	NN	O
.	.	O

We	PRP	O
studied	VBD	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
and	CC	O
the	DT	O
serum	NN	O
amyloid	NN	O
A	NN	O
(	-LRB-	O
SAA	NN	O
)	-RRB-	O
genes	NNS	O
by	IN	O
comparing	VBG	O
alleles	NNS	O
of	IN	O
a	DT	O
highly	RB	O
polymorphic	JJ	O
dinucleotide	NN	O
repeat	NN	O
and	CC	O
a	DT	O
conventional	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	-LRB-	O
RFLP	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
SAA	NN	O
gene	NN	O
cluster	NN	O
in	IN	O
Israeli	JJ	O
FMF	NN	B-Disease
kindreds	NNS	O
.	.	O

By	IN	O
haplotype	NN	O
analysis	NN	O
,	,	O
our	PRP$	O
data	NNS	O
indicate	VBP	O
a	DT	O
minimum	JJ	O
crossover	JJ	O
frequency	NN	O
of	IN	O
22	CD	O
%	NN	O
between	IN	O
the	DT	O
SAA	NN	O
gene	NN	O
marker	NN	O
and	CC	O
FMF	NN	B-Disease
.	.	O

By	IN	O
conventional	JJ	O
linkage	NN	O
analysis	NN	O
this	DT	O
eliminates	VBZ	O
a	DT	O
minimum	NN	O
of	IN	O
10	CD	O
.	.	O

4	CD	O
cM	NN	O
including	VBG	O
and	CC	O
surrounding	VBG	O
the	DT	O
SAA	NN	O
gene	NN	O
cluster	NN	O
as	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
FMF	NN	B-Disease
mutation	NN	O
although	IN	O
SAA	NN	O
proteins	NNS	O
are	VBP	O
prominent	JJ	O
physiologic	JJ	O
markers	NNS	O
of	IN	O
the	DT	O
acute	JJ	O
attacks	NNS	O
.	.	O

Mice	NNS	O
deficient	JJ	B-Disease
in	IN	I-Disease
Six5	NN	I-Disease
develop	VBP	O
cataracts	NNS	B-Disease
:	:	O
implications	NNS	O
for	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Expansion	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
the	DT	O
3	CD	O
UTR	NN	O
of	IN	O
the	DT	O
gene	NN	O
DMPK	NN	O
at	IN	O
the	DT	O
DM1	NN	O
locus	NN	O
on	IN	O
chromosome	NN	O
19	CD	O
causes	VBZ	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
a	DT	O
dominantly	RB	B-Disease
inherited	VBN	I-Disease
disease	NN	I-Disease
characterized	VBN	O
by	IN	O
skeletal	JJ	O
muscle	NN	B-Disease
dystrophy	NN	I-Disease
and	CC	O
myotonia	NN	B-Disease
,	,	O
cataracts	NNS	B-Disease
and	CC	O
cardiac	JJ	B-Disease
conduction	NN	I-Disease
defects	NNS	I-Disease
.	.	O

Targeted	VBN	O
deletion	NN	O
of	IN	O
Dm15	NN	O
,	,	O
the	DT	O
mouse	NN	O
orthologue	NN	O
of	IN	O
human	JJ	O
DMPK	NN	O
,	,	O
produced	VBD	O
mice	NNS	O
with	IN	O
a	DT	O
mild	JJ	O
myopathy	NN	B-Disease
and	CC	O
cardiac	JJ	B-Disease
conduction	NN	I-Disease
abnormalities	NNS	I-Disease
,	,	O
but	CC	O
without	IN	O
other	JJ	O
features	NNS	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
such	JJ	O
as	IN	O
myotonia	NN	B-Disease
and	CC	O
cataracts	NNS	B-Disease
.	.	O

We	PRP	O
,	,	O
and	CC	O
others	NNS	O
,	,	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
repeat	NN	O
expansion	NN	O
decreases	VBZ	O
expression	NN	O
of	IN	O
the	DT	O
adjacent	JJ	O
gene	NN	O
SIX5	NN	O
(	-LRB-	O
refs	NNS	O
7	CD	O
,	,	O
8	CD	O
)	-RRB-	O
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
homeodomain	NN	O
transcription	NN	O
factor	NN	O
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
SIX5	NN	B-Disease
deficiency	NN	I-Disease
contributes	VBZ	O
to	TO	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
phenotype	NN	O
,	,	O
we	PRP	O
disrupted	VBD	O
mouse	NN	O
Six5	NN	O
by	IN	O
replacing	VBG	O
the	DT	O
first	JJ	O
exon	NN	O
with	IN	O
a	DT	O
beta-galactosidase	NN	O
reporter	NN	O
.	.	O

Six5-mutant	JJ	O
mice	NNS	O
showed	VBD	O
reporter	NN	O
expression	NN	O
in	IN	O
multiple	JJ	O
tissues	NNS	O
,	,	O
including	VBG	O
the	DT	O
developing	VBG	O
lens	NN	O
.	.	O

Homozygous	JJ	O
mutant	JJ	O
mice	NNS	O
had	VBD	O
no	DT	O
apparent	JJ	O
abnormalities	NNS	B-Disease
of	IN	I-Disease
skeletal	JJ	I-Disease
muscle	NN	I-Disease
function	NN	I-Disease
,	,	O
but	CC	O
developed	VBD	O
lenticular	JJ	B-Disease
opacities	NNS	I-Disease
at	IN	O
a	DT	O
higher	JJR	O
rate	NN	O
than	IN	O
controls	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
SIX5	NN	B-Disease
deficiency	NN	I-Disease
contributes	VBZ	O
to	TO	O
the	DT	O
cataract	NN	B-Disease
phenotype	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
and	CC	O
that	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
represents	VBZ	O
a	DT	O
multigenic	JJ	B-Disease
disorder	NN	I-Disease
.	.	O

.	.	O

Screening	VBG	O
for	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
patients	NNS	O
:	:	O
61	CD	O
new	JJ	O
patients	NNS	O
and	CC	O
a	DT	O
summary	NN	O
of	IN	O
150	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
screening	NN	O
for	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
in	IN	O
61	CD	O
new	JJ	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
patients	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
summary	NN	O
of	IN	O
the	DT	O
results	NNS	O
of	IN	O
150	CD	O
patients	NNS	O
.	.	O

Examination	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
based	VBN	O
on	IN	O
a	DT	O
ribonuclease	NN	O
protection	NN	O
assay	NN	O
coupled	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
,	,	O
disclosed	VBD	O
mutations	NNS	O
that	WDT	O
were	VBD	O
considered	VBN	O
to	TO	O
cause	VB	O
significant	JJ	O
defects	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
product	NN	O
in	IN	O
97	CD	O
of	IN	O
150	CD	O
unrelated	JJ	O
FAP	NN	B-Disease
patients	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
revealed	VBD	O
the	DT	O
following	VBG	O
characteristics	NNS	O
of	IN	O
the	DT	O
germ-line	NN	O
mutations	NNS	O
of	IN	O
APC	NN	O
1	CD	O
)	-RRB-	O
the	DT	O
great	JJ	O
majority	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
truncate	VB	O
the	DT	O
APC	NN	B-Disease
product	NN	O
;	:	O
2	LS	O
)	-RRB-	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
located	JJ	O
within	IN	O
the	DT	O
first	JJ	O
half	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
;	:	O
3	LS	O
)	-RRB-	O
no	DT	O
correlation	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
locations	NNS	O
of	IN	O
germ-line	NN	O
mutations	NNS	O
and	CC	O
extracolonic	JJ	O
manifestations	NNS	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
;	:	O
4	LS	O
)	-RRB-	O
more	JJR	O
than	IN	O
80	CD	O
%	NN	O
of	IN	O
base	NN	O
substitutions	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
were	VBD	O
from	IN	O
cytosine	NN	O
to	TO	O
other	JJ	O
nucleotides	NNS	O
,	,	O
nearly	RB	O
one-third	NN	O
of	IN	O
which	WDT	O
occurred	VBD	O
at	IN	O
the	DT	O
GpG	NN	O
site	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
information	NN	O
helpful	JJ	O
to	TO	O
an	DT	O
understanding	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
and	CC	O
will	MD	O
also	RB	O
contribute	VB	O
to	TO	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
members	NNS	O
in	IN	O
FAP	NN	B-Disease
families	NNS	O
.	.	O

.	.	O

Hereditary	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
C5	NN	I-Disease
in	IN	O
association	NN	O
with	IN	O
discoid	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
.	.	O

A	DT	O
29-year-old	JJ	O
woman	NN	O
with	IN	O
discoid	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
had	VBD	O
undetectable	JJ	O
classic	JJ	O
pathway	NN	O
complement	NN	O
activity	NN	O
.	.	O

Hypocomplementemia	NN	B-Disease
was	VBD	O
due	JJ	O
to	TO	O
selective	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
C5	NN	I-Disease
.	.	O

One	CD	O
of	IN	O
her	PRP$	O
children	NNS	O
was	VBD	O
also	RB	O
deficient	JJ	O
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
documented	VBN	O
case	NN	O
of	IN	O
an	DT	O
association	NN	O
between	IN	O
discoid	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
and	CC	O
C5	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Isolation	NN	O
,	,	O
genomic	JJ	O
organization	NN	O
,	,	O
and	CC	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
mouse	NN	O
and	CC	O
rat	NN	O
homologs	NNS	O
of	IN	O
MEFV	NN	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
familial	JJ	B-Disease
mediterranean	JJ	I-Disease
fever	NN	I-Disease
.	.	O

Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessive	JJ	B-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	B-Disease
with	IN	O
serositis	NN	B-Disease
or	CC	O
synovitis	NN	B-Disease
.	.	O

Recently	RB	O
the	DT	O
FMF	NN	B-Disease
gene	NN	O
(	-LRB-	O
MEFV	NN	O
)	-RRB-	O
was	VBD	O
cloned	VBN	O
;	:	O
the	DT	O
protein	NN	O
product	NN	O
,	,	O
pyrin/marenostrin	NN	O
,	,	O
is	VBZ	O
thought	VBN	O
to	TO	O
regulate	VB	O
inflammation	NN	O
in	IN	O
myeloid	JJ	O
cells	NNS	O
.	.	O

In	IN	O
this	DT	O
manuscript	NN	O
we	PRP	O
report	VBP	O
the	DT	O
mouse	NN	O
and	CC	O
rat	NN	O
homologs	NNS	O
of	IN	O
MEFV	NN	O
.	.	O

The	DT	O
murine	JJ	O
gene	NN	O
contains	VBZ	O
ten	CD	O
exons	NNS	O
with	IN	O
a	DT	O
coding	NN	O
sequence	NN	O
of	IN	O
2304	CD	O
bp	NN	O
,	,	O
while	IN	O
the	DT	O
rat	NN	O
homolog	NN	O
has	VBZ	O
nine	CD	O
exons	NNS	O
with	IN	O
a	DT	O
coding	NN	O
sequence	NN	O
of	IN	O
2253	CD	O
bp	NN	O
.	.	O

A	DT	O
considerable	JJ	O
amino	NN	O
acid	NN	O
sequence	NN	O
homology	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	JJ	O
(	-LRB-	O
47	CD	O
.	.	O

6	CD	O
%	NN	O
identity	NN	O
and	CC	O
65	CD	O
.	.	O

5	CD	O
%	NN	O
similarity	NN	O
)	-RRB-	O
and	CC	O
between	IN	O
the	DT	O
mouse	NN	O
and	CC	O
rat	NN	O
genes	NNS	O
(	-LRB-	O
73	CD	O
.	.	O

5	CD	O
%	NN	O
identity	NN	O
and	CC	O
82	CD	O
.	.	O

1	CD	O
%	NN	O
similarity	NN	O
)	-RRB-	O
.	.	O

The	DT	O
predicted	VBN	O
rodent	JJ	O
proteins	NNS	O
have	VBP	O
several	JJ	O
important	JJ	O
domains	NNS	O
and	CC	O
signals	NNS	O
found	VBN	O
in	IN	O
human	JJ	O
pyrin	NN	O
,	,	O
including	VBG	O
a	DT	O
B-box	JJ	O
zinc	NN	O
finger	NN	O
domain	NN	O
,	,	O
Robbins-Dingwall	NNP	O
nuclear	JJ	O
localization	NN	O
signal	NN	O
,	,	O
and	CC	O
coiled-coil	JJ	O
domain	NN	O
.	.	O

However	RB	O
,	,	O
perhaps	RB	O
because	IN	O
of	IN	O
an	DT	O
ancient	JJ	O
frame-shift	NN	O
mutation	NN	O
,	,	O
neither	CC	O
the	DT	O
mouse	NN	O
nor	CC	O
the	DT	O
rat	NN	O
protein	NN	O
has	VBZ	O
an	DT	O
intact	JJ	O
C-terminal	JJ	O
B30	NN	O
.	.	O

2	CD	O
domain	NN	O
,	,	O
in	IN	O
which	WDT	O
most	RBS	O
FMF-associated	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
human	JJ	O
MEFV	NN	O
.	.	O

Nevertheless	RB	O
,	,	O
like	IN	O
the	DT	O
human	JJ	O
gene	NN	O
,	,	O
mouse	NN	O
Mefv	NNP	O
is	VBZ	O
expressed	VBN	O
in	IN	O
peripheral	JJ	O
blood	NN	O
granulocytes	NNS	O
but	CC	O
not	RB	O
lymphocytes	NNS	O
.	.	O

Consistent	JJ	O
with	IN	O
its	PRP$	O
expression	NN	O
in	IN	O
granulocytes	NNS	O
,	,	O
Mefv	NNP	O
was	VBD	O
detected	VBN	O
at	IN	O
high	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
primary	JJ	O
follicles	NNS	O
and	CC	O
marginal	JJ	O
zones	NNS	O
of	IN	O
the	DT	O
splenic	JJ	O
white	JJ	O
pulp	NN	O
.	.	O

Mefv	NNP	O
is	VBZ	O
localized	JJ	O
on	IN	O
mouse	NN	O
Chromosome	NN	O
(	-LRB-	O
Chr	NN	O
)	-RRB-	O
16	CD	O
,	,	O
region	NN	O
A3-B1	NN	O
,	,	O
extending	VBG	O
a	DT	O
region	NN	O
of	IN	O
synteny	NN	O
with	IN	O
human	JJ	O
Chr	NN	O
16p13	NN	O
.	.	O

3	LS	O
.	.	O

Development	NN	O
of	IN	O
knockout	NN	O
and	CC	O
knockin	VBG	O
mouse	NN	O
models	NNS	O
may	MD	O
provide	VB	O
further	JJ	O
insights	NNS	O
into	IN	O
the	DT	O
functional	JJ	O
evolution	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

Analysis	NN	O
of	IN	O
X-chromosome	NN	O
inactivation	NN	O
and	CC	O
presumptive	JJ	O
expression	NN	O
of	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
gene	NN	O
in	IN	O
hematopoietic	JJ	O
cell	NN	O
lineages	NNS	O
of	IN	O
a	DT	O
thrombocytopenic	JJ	O
carrier	NN	O
female	NN	O
of	IN	O
WAS	NNP	B-Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
thrombocytopenic	JJ	B-Disease
female	JJ	O
belonging	VBG	O
to	TO	O
a	DT	O
pedigree	NN	O
with	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
.	.	O

Restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	-LRB-	O
RFLP	NN	O
)	-RRB-	O
analysis	NN	O
with	IN	O
probe	NN	O
M27	NN	O
beta	NN	O
,	,	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
WAS	NNP	B-Disease
gene	NN	O
,	,	O
demonstrated	VBD	O
that	IN	O
she	PRP	O
is	VBZ	O
a	DT	O
carrier	NN	O
of	IN	O
WAS	NNP	B-Disease
.	.	O

Both	DT	O
small-sized	JJ	O
and	CC	O
normal-sized	JJ	O
platelets	NNS	O
were	VBD	O
present	JJ	O
,	,	O
suggesting	VBG	O
that	IN	O
,	,	O
unlike	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
WAS	NNP	B-Disease
carriers	NNS	O
,	,	O
she	PRP	O
does	VBZ	O
not	RB	O
manifest	JJ	O
nonrandom	JJ	O
X-chromosome	NN	O
inactivation	NN	O
in	IN	O
the	DT	O
thrombopoietic	JJ	O
cell	NN	O
lineage	NN	O
.	.	O

Study	NN	O
of	IN	O
X-chromosome	NN	O
inactivation	NN	O
by	IN	O
means	NNS	O
of	IN	O
RFLP	NN	O
and	CC	O
methylation	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
pattern	NN	O
of	IN	O
X-chromosome	NN	O
inactivation	NN	O
was	VBD	O
nonrandom	JJ	O
in	IN	O
T	NN	O
lymphocytes	NNS	O
,	,	O
but	CC	O
random	JJ	O
in	IN	O
granulocytes	NNS	O
.	.	O

While	IN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
complete	JJ	O
report	NN	O
on	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
thrombocytopenia	NN	B-Disease
in	IN	O
a	DT	O
carrier	NN	O
female	NN	O
of	IN	O
WAS	NNP	B-Disease
as	IN	O
the	DT	O
result	NN	O
of	IN	O
atypical	JJ	O
lyonization	NN	O
,	,	O
it	PRP	O
also	RB	O
suggests	VBZ	O
that	IN	O
expression	NN	O
of	IN	O
the	DT	O
WAS	NNP	B-Disease
gene	NN	O
occurs	VBZ	O
at	IN	O
(	-LRB-	O
or	CC	O
extends	VBZ	O
up	RP	O
to	TO	O
)	-RRB-	O
a	DT	O
later	JJ	O
stage	NN	O
than	IN	O
the	DT	O
multipotent	JJ	O
stem	NN	O
cell	NN	O
along	IN	O
the	DT	O
hematopoietic	JJ	O
differentiation	NN	O
pathway	NN	O
.	.	O

.	.	O

hCds1-mediated	JJ	O
phosphorylation	NN	O
of	IN	O
BRCA1	NN	O
regulates	VBZ	O
the	DT	O
DNA	NN	O
damage	NN	O
response	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

1	LS	O
)	-RRB-	O
tumour	NN	B-Disease
suppressor	NN	O
gene	NN	O
are	VBP	O
found	VBN	O
in	IN	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
families	NNS	O
with	IN	O
inherited	VBN	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
and	CC	O
about	IN	O
half	NN	O
of	IN	O
the	DT	O
families	NNS	O
with	IN	O
only	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

Although	IN	O
the	DT	O
biochemical	JJ	O
function	NN	O
of	IN	O
BRCA1	NN	O
is	VBZ	O
not	RB	O
well	RB	O
understood	VBN	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
for	IN	O
DNA	NN	O
damage	NN	O
repair	NN	O
and	CC	O
cell-cycle	JJ	O
checkpoint	NN	O
.	.	O

BRCA1	NN	O
exists	VBZ	O
in	IN	O
nuclear	JJ	O
foci	NNS	O
but	CC	O
is	VBZ	O
hyperphosphorylated	VBN	O
and	CC	O
disperses	VBZ	O
after	IN	O
DNA	NN	O
damage	NN	O
.	.	O

It	PRP	O
is	VBZ	O
not	RB	O
known	VBN	O
whether	IN	O
BRCA1	NN	O
phosphorylation	NN	O
and	CC	O
dispersion	NN	O
and	CC	O
its	PRP$	O
function	NN	O
in	IN	O
DNA	NN	O
damage	NN	O
response	NN	O
are	VBP	O
related	JJ	O
.	.	O

In	IN	O
yeast	NN	O
the	DT	O
DNA	NN	O
damage	NN	O
response	NN	O
and	CC	O
the	DT	O
replication-block	NN	O
checkpoint	NN	O
are	VBP	O
mediated	VBN	O
partly	RB	O
through	IN	O
the	DT	O
Cds1	NN	O
kinase	NN	O
family	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
the	DT	O
human	JJ	O
Cds1	NN	O
kinase	NN	O
(	-LRB-	O
hCds1/Chk2	NN	O
)	-RRB-	O
regulates	VBZ	O
BRCA1	NN	O
function	NN	O
after	IN	O
DNA	NN	O
damage	NN	O
by	IN	O
phosphorylating	VBG	O
serine	NN	O
988	CD	O
of	IN	O
BRCA1	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
hCds1	NN	O
and	CC	O
BRCA1	NN	O
interact	VBP	O
and	CC	O
co-localize	VBP	O
within	IN	O
discrete	JJ	O
nuclear	JJ	O
foci	NNS	O
but	CC	O
separate	JJ	O
after	IN	O
gamma	NN	O
irradiation	NN	O
.	.	O

Phosphorylation	NN	O
of	IN	O
BRCA1	NN	O
at	IN	O
serine	NN	O
988	CD	O
is	VBZ	O
required	VBN	O
for	IN	O
the	DT	O
release	NN	O
of	IN	O
BRCA1	NN	O
from	IN	O
hCds1	NN	O
.	.	O

This	DT	O
phosphorylation	NN	O
is	VBZ	O
also	RB	O
important	JJ	O
for	IN	O
the	DT	O
ability	NN	O
of	IN	O
BRCA1	NN	O
to	TO	O
restore	VB	O
survival	NN	O
after	IN	O
DNA	NN	O
damage	NN	O
in	IN	O
the	DT	O
BRCA1-mutated	JJ	O
cell	NN	O
line	NN	O
HCC1937	NN	O
.	.	O

.	.	O

Ataxin-3	NN	O
with	IN	O
an	DT	O
altered	JJ	O
conformation	NN	O
that	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

Spinocerebellar	JJ	B-Disease
ataxia	NN	I-Disease
type-3	NN	I-Disease
or	CC	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
SCA3/MJD	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
CAG/polyglutamine	NN	B-Disease
repeat	NN	I-Disease
disease	NN	I-Disease
family	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
of	IN	O
disorders	NNS	O
,	,	O
a	DT	O
normally	RB	O
polymorphic	JJ	O
CAG	NN	O
repeat	NN	O
becomes	VBZ	O
expanded	VBN	O
,	,	O
resulting	VBG	O
in	IN	O
expression	NN	O
of	IN	O
an	DT	O
expanded	VBN	O
polyglutamine	NN	O
domain	NN	O
in	IN	O
the	DT	O
disease	NN	O
gene	NN	O
product	NN	O
.	.	O

Experimental	JJ	O
models	NNS	O
of	IN	O
polyglutamine	NN	B-Disease
disease	NN	I-Disease
implicate	VBP	O
the	DT	O
nucleus	NN	O
in	IN	O
pathogenesis	NN	O
;	:	O
however	RB	O
,	,	O
the	DT	O
link	NN	O
between	IN	O
intranuclear	JJ	O
expression	NN	O
of	IN	O
expanded	VBN	O
polyglutamine	NN	O
and	CC	O
neuronal	JJ	B-Disease
dysfunction	NN	I-Disease
remains	VBZ	O
unclear	JJ	O
.	.	O

Here	RB	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
ataxin-3	NN	O
,	,	O
the	DT	O
disease	NN	O
protein	NN	O
in	IN	O
SCA3/MJD	NN	O
,	,	O
adopts	VBZ	O
a	DT	O
unique	JJ	O
conformation	NN	O
when	WRB	O
expressed	VBN	O
within	IN	O
the	DT	O
nucleus	NN	O
of	IN	O
transfected	VBN	O
cells	NNS	O
.	.	O

The	DT	O
monoclonal	JJ	O
antibody	NN	O
1C2	NN	O
is	VBZ	O
known	VBN	O
preferentially	RB	O
to	TO	O
bind	VB	O
expanded	VBN	O
polyglutamine	NN	O
,	,	O
but	CC	O
we	PRP	O
find	VBP	O
that	IN	O
it	PRP	O
also	RB	O
binds	VBZ	O
a	DT	O
fragment	NN	O
of	IN	O
ataxin-3	NN	O
containing	VBG	O
a	DT	O
normal	JJ	O
glutamine	NN	O
repeat	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
expression	NN	O
of	IN	O
ataxin-3	NN	O
within	IN	O
the	DT	O
nucleus	NN	O
exposes	VBZ	O
the	DT	O
glutamine	NN	O
domain	NN	O
of	IN	O
the	DT	O
full-length	JJ	O
non-pathological	JJ	O
protein	NN	O
,	,	O
allowing	VBG	O
it	PRP	O
to	TO	O
bind	VB	O
the	DT	O
monoclonal	JJ	O
antibody	NN	O
1C2	NN	O
.	.	O

Fractionation	NN	O
and	CC	O
immunochemical	JJ	O
experiments	NNS	O
indicate	VBP	O
that	IN	O
this	DT	O
novel	JJ	O
conformation	NN	O
of	IN	O
intranuclear	JJ	O
ataxin-3	NN	O
is	VBZ	O
not	RB	O
due	JJ	O
to	TO	O
proteolysis	NN	O
,	,	O
suggesting	VBG	O
instead	RB	O
that	IN	O
association	NN	O
with	IN	O
nuclear	JJ	O
protein	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
alters	VBZ	O
the	DT	O
structure	NN	O
of	IN	O
full-length	JJ	O
ataxin-3	NN	O
which	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
.	.	O

This	DT	O
conformationally	RB	O
altered	JJ	O
ataxin-3	NN	O
is	VBZ	O
bound	VBN	O
to	TO	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

The	DT	O
pathological	JJ	O
form	NN	O
of	IN	O
ataxin-3	NN	O
with	IN	O
an	DT	O
expanded	VBN	O
polyglutamine	NN	O
domain	NN	O
also	RB	O
associates	VBZ	O
with	IN	O
the	DT	O
nuclear	JJ	O
matrix	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
an	DT	O
early	JJ	O
event	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
SCA3/MJD	NN	O
may	MD	O
be	VB	O
an	DT	O
altered	JJ	O
conformation	NN	O
of	IN	O
ataxin-3	NN	O
within	IN	O
the	DT	O
nucleus	NN	O
that	WDT	O
exposes	VBZ	O
the	DT	O
polyglutamine	NN	O
domain	NN	O
.	.	O

.	.	O

A	DT	O
zinc	NN	O
finger	NN	O
truncation	NN	O
of	IN	O
murine	JJ	O
WT1	NN	O
results	VBZ	O
in	IN	O
the	DT	O
characteristic	JJ	O
urogenital	JJ	B-Disease
abnormalities	NNS	I-Disease
of	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
-	:	O
suppressor	NN	O
gene	NN	O
,	,	O
WT1	NN	O
,	,	O
plays	VBZ	O
a	DT	O
key	JJ	O
role	NN	O
in	IN	O
urogenital	JJ	O
development	NN	O
,	,	O
and	CC	O
WT1	NN	B-Disease
dysfunction	NN	I-Disease
is	VBZ	O
implicated	VBN	O
in	IN	O
both	CC	O
neoplastic	JJ	B-Disease
(	-LRB-	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
,	,	O
mesothelioma	NN	B-Disease
,	,	O
leukemias	NNS	B-Disease
,	,	O
and	CC	O
breast	NN	B-Disease
cancer	NN	I-Disease
)	-RRB-	O
and	CC	O
nonneoplastic	JJ	B-Disease
(	-LRB-	O
glomerulosclerosis	NN	B-Disease
)	-RRB-	O
disease	NN	O
.	.	O

The	DT	O
analysis	NN	O
of	IN	O
diseases	NNS	O
linked	VBN	O
specifically	RB	O
with	IN	O
WT1	NN	O
mutations	NNS	O
,	,	O
such	JJ	O
as	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
DDS	NN	B-Disease
)	-RRB-	O
,	,	O
can	MD	O
provide	VB	O
valuable	JJ	O
insight	NN	O
concerning	VBG	O
the	DT	O
role	NN	O
of	IN	O
WT1	NN	O
in	IN	O
development	NN	O
and	CC	O
disease	NN	O
.	.	O

DDS	NN	B-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
childhood	NN	O
disease	NN	O
characterized	VBN	O
by	IN	O
a	DT	O
nephropathy	NN	B-Disease
involving	VBG	O
mesangial	JJ	B-Disease
sclerosis	NN	I-Disease
,	,	O
XY	NN	O
pseudohermaphroditism	NN	B-Disease
,	,	O
and/or	CC	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
(	-LRB-	O
WT	NN	B-Disease
)	-RRB-	O
.	.	O

DDS	NN	B-Disease
patients	NNS	O
are	VBP	O
constitutionally	RB	O
heterozygous	JJ	O
for	IN	O
exonic	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
WT1	NN	O
,	,	O
which	WDT	O
include	VBP	O
mutations	NNS	O
predicted	VBN	O
to	TO	O
truncate	VB	O
the	DT	O
protein	NN	O
within	IN	O
the	DT	O
C-terminal	JJ	O
zinc	NN	O
finger	NN	O
(	-LRB-	O
ZF	NN	O
)	-RRB-	O
region	NN	O
.	.	O

We	PRP	O
report	VBP	O
that	IN	O
heterozygosity	NN	O
for	IN	O
a	DT	O
targeted	VBN	O
murine	JJ	O
Wt1	NN	O
allele	NN	O
,	,	O
Wt1	NN	O
(	-LRB-	O
tmT396	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
truncates	VBZ	O
ZF3	NN	O
at	IN	O
codon	NN	O
396	CD	O
,	,	O
induces	VBZ	O
mesangial	JJ	B-Disease
sclerosis	NN	I-Disease
characteristic	NN	O
of	IN	O
DDS	NN	B-Disease
in	IN	O
adult	JJ	O
heterozygous	JJ	O
and	CC	O
chimeric	JJ	O
mice	NNS	O
.	.	O

Male	JJ	B-Disease
genital	JJ	I-Disease
defects	NNS	I-Disease
also	RB	O
were	VBD	O
evident	JJ	O
and	CC	O
there	EX	O
was	VBD	O
a	DT	O
single	JJ	O
case	NN	O
of	IN	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
in	IN	O
which	WDT	O
the	DT	O
transcript	NN	O
of	IN	O
the	DT	O
nontargeted	JJ	O
allele	NN	O
showed	VBD	O
an	DT	O
exon	NN	O
9	CD	O
skipping	VBG	O
event	NN	O
,	,	O
implying	VBG	O
a	DT	O
causal	JJ	O
link	NN	O
between	IN	O
Wt1	NN	B-Disease
dysfunction	NN	I-Disease
and	CC	O
Wilms	NN	B-Disease
tumorigenesis	NN	I-Disease
in	IN	O
mice	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mutant	JJ	O
WT1	NN	O
(	-LRB-	O
tmT396	NN	O
)	-RRB-	O
protein	NN	O
accounted	VBD	O
for	IN	O
only	RB	O
5	CD	O
%	NN	O
of	IN	O
WT1	NN	O
in	IN	O
both	CC	O
heterozygous	JJ	O
embryonic	JJ	O
stem	NN	O
cells	NNS	O
and	CC	O
the	DT	O
WT	NNP	B-Disease
.	.	O

This	DT	O
has	VBZ	O
implications	NNS	O
regarding	VBG	O
the	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
the	DT	O
mutant	JJ	O
allele	NN	O
exerts	VBZ	O
its	PRP$	O
effect	NN	O
.	.	O

Heterogeneity	NN	O
of	IN	O
"	``	O
Mediterranean	JJ	O
type	NN	O
"	''	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
Spain	NNP	O
and	CC	O
description	NN	O
of	IN	O
two	CD	O
new	JJ	O
variants	NNS	O
associated	VBN	O
with	IN	O
favism	NN	B-Disease
.	.	O

Glucose-6-phosphate	JJ	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
;	:	O
EC	NNP	O
1	CD	O
.	.	O

1	LS	O
.	.	O

1	LS	O
.	.	O

49	CD	O
from	IN	O
thirty-six	CD	O
unrelated	JJ	O
Spanish	JJ	O
males	NNS	O
was	VBD	O
partially	RB	O
purified	VBN	O
from	IN	O
blood	NN	O
,	,	O
and	CC	O
the	DT	O
variants	NNS	O
were	VBD	O
characterized	VBN	O
biochemically	RB	O
and	CC	O
electrophoretically	RB	O
according	VBG	O
to	TO	O
the	DT	O
methods	NNS	O
recommended	VBN	O
by	IN	O
the	DT	O
world	NN	O
Health	NNP	O
Organization	NNP	O
.	.	O

Subjects	NNS	O
were	VBD	O
from	IN	O
multiple	JJ	O
geographic	JJ	O
regions	NNS	O
within	IN	O
Spain	NNP	O
,	,	O
and	CC	O
all	DT	O
suffered	VBN	O
from	IN	O
hemolytic	JJ	B-Disease
anemia	NN	I-Disease
,	,	O
either	CC	O
acute	JJ	O
(	-LRB-	O
34	CD	O
cases	NNS	O
)	-RRB-	O
or	CC	O
chronic	JJ	O
nonspherocytic	JJ	O
(	-LRB-	O
2	CD	O
cases	NNS	O
)	-RRB-	O
.	.	O

Almost	RB	O
all	PDT	O
the	DT	O
variants	NNS	O
studied	VBN	O
presented	VBD	O
residual	JJ	O
erythrocyte	NN	O
G6PD	NN	O
activity	NN	O
ranging	VBG	O
from	IN	O
0	CD	O
to	TO	O
10	CD	O
%	NN	O
of	IN	O
normal	JJ	O
,	,	O
and	CC	O
five	CD	O
different	JJ	O
mutants	NNS	O
were	VBD	O
responsible	JJ	O
for	IN	O
the	DT	O
deficient	JJ	O
phenotype	NN	O
.	.	O

Three	CD	O
variants	NNS	O
were	VBD	O
similar	JJ	O
to	TO	O
others	NNS	O
previously	RB	O
described	VBN	O
G6PD	NN	O
Mediterranean	JJ	O
(	-LRB-	O
11	CD	O
cases	NNS	O
)	-RRB-	O
,	,	O
G6PD	NN	O
Athens-like	JJ	O
(	-LRB-	O
3	CD	O
cases	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
G6PD	NNP	O
Union	NNP	O
(	-LRB-	O
2	CD	O
cases	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
remaining	VBG	O
variants	NNS	O
were	VBD	O
different	JJ	O
from	IN	O
the	DT	O
numerous	JJ	O
variants	NNS	O
already	RB	O
reported	VBD	O
and	CC	O
have	VBP	O
been	VBN	O
considered	VBN	O
as	IN	O
new	JJ	O
mutants	NNS	O
.	.	O

Provisionally	RB	O
they	PRP	O
are	VBP	O
called	VBN	O
G6PD	NN	O
Betica	NN	O
(	-LRB-	O
19	CD	O
cases	NNS	O
)	-RRB-	O
and	CC	O
G6PD	NN	O
Menorca	NN	O
(	-LRB-	O
1	CD	O
case	NN	O
)	-RRB-	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
constitutes	VBZ	O
the	DT	O
first	JJ	O
attempt	NN	O
to	TO	O
characterize	VB	O
the	DT	O
deficient	JJ	B-Disease
G6PD	NN	I-Disease
variants	NNS	O
found	VBN	O
in	IN	O
Spain	NNP	O
and	CC	O
supplies	NNS	O
new	JJ	O
data	NNS	O
on	IN	O
the	DT	O
relationship	NN	O
between	IN	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
deficient	JJ	O
variants	NNS	O
and	CC	O
their	PRP$	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

The	DT	O
most	RBS	O
important	JJ	O
findings	NNS	O
can	MD	O
be	VB	O
summarized	VBN	O
as	IN	O
follows	VBZ	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
The	DT	O
Spanish	JJ	O
population	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
an	DT	O
important	JJ	O
heterogeneity	NN	O
in	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

(	-LRB-	O
2	LS	O
)	-RRB-	O
Although	IN	O
G6PD	NN	O
Mediterranean	NNP	O
is	VBZ	O
very	RB	O
frequent	JJ	O
,	,	O
it	PRP	O
presents	VBZ	O
a	DT	O
relatively	RB	O
high	JJ	O
degree	NN	O
of	IN	O
polymorphism	NN	O
.	.	O

(	-LRB-	O
3	LS	O
)	-RRB-	O
Favism	NNP	B-Disease
has	VBZ	O
been	VBN	O
observed	VBN	O
associated	VBN	O
with	IN	O
all	DT	O
kinds	NNS	O
of	IN	O
variants	NNS	O
described	VBN	O
here	RB	O
.	.	O

(	-LRB-	O
4	LS	O
)	-RRB-	O
G6PD	NN	O
Betica	NN	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
variant	JJ	O
found	VBN	O
in	IN	O
subjects	NNS	O
of	IN	O
Southern	NNP	O
Spanish	NNP	O
origin	NN	O
,	,	O
has	VBZ	O
been	VBN	O
observed	VBN	O
associated	VBN	O
with	IN	O
favism	NN	B-Disease
in	IN	O
all	DT	O
cases	NNS	O
except	IN	O
one	CD	O
.	.	O

Early	RB	O
onset	NN	O
of	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
emerin	NN	O
gene	NN	O
deletion	NN	O
.	.	O

A	DT	O
boy	NN	O
developed	VBD	O
contractures	NNS	B-Disease
of	IN	I-Disease
the	DT	I-Disease
Achilles	NNPS	I-Disease
tendons	NNS	I-Disease
at	IN	O
3	CD	O
years	NNS	O
and	CC	O
of	IN	O
the	DT	O
postcervical	JJ	O
muscles	NNS	O
at	IN	O
7	CD	O
years	NNS	O
,	,	O
although	IN	O
neither	DT	O
contractures	NNS	B-Disease
of	IN	I-Disease
the	DT	I-Disease
elbows	NNS	I-Disease
nor	CC	O
cardiac	JJ	B-Disease
abnormality	NN	I-Disease
were	VBD	O
recognized	VBN	O
by	IN	O
the	DT	O
age	NN	O
of	IN	O
9	CD	O
years	NNS	O
.	.	O

Muscle	NN	O
computed	VBD	O
tomography	NN	O
scanning	NN	O
revealed	VBD	O
changes	NNS	O
characteristic	JJ	O
of	IN	O
muscle	NN	O
involvement	NN	O
.	.	O

Emerin	NNP	O
was	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
biopsied	VBN	O
muscle	NN	O
,	,	O
and	CC	O
RT-PCR	NN	O
and	CC	O
PCR-based	JJ	O
genomic	JJ	O
DNA	NN	O
analyses	NNS	O
of	IN	O
the	DT	O
emerin	NN	O
gene	NN	O
demonstrated	VBD	O
no	DT	O
amplification	NN	O
product	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

These	DT	O
results	NNS	O
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
of	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
,	,	O
and	CC	O
reinforce	VB	O
the	DT	O
necessity	NN	O
of	IN	O
molecular	JJ	O
genetic	JJ	O
diagnosis	NN	O
of	IN	O
the	DT	O
membrane	NN	O
protein	NN	O
emerin	NN	O
in	IN	O
younger	JJR	O
patients	NNS	O
with	IN	O
possible	JJ	O
EDMD	NN	B-Disease
before	IN	O
appearance	NN	O
of	IN	O
the	DT	O
typical	JJ	O
symptoms	NNS	O
,	,	O
to	TO	O
avoid	VB	O
sudden	JJ	B-Disease
cardiac	JJ	I-Disease
death	NN	I-Disease
.	.	O

.	.	O

PRAD1	NN	O
,	,	O
a	DT	O
candidate	NN	O
BCL1	NN	O
oncogene	NN	O
:	:	O
mapping	NN	O
and	CC	O
expression	NN	O
in	IN	O
centrocytic	JJ	B-Disease
lymphoma	NN	I-Disease
.	.	O

Rearrangement	NN	O
of	IN	O
the	DT	O
BCL1	NN	O
(	-LRB-	O
B-cell	NN	O
lymphoma	NN	O
1	CD	O
)	-RRB-	O
region	NN	O
on	IN	O
chromosome	NN	O
11q13	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
highly	RB	O
characteristic	JJ	O
of	IN	O
centrocytic	JJ	B-Disease
lymphoma	NN	I-Disease
and	CC	O
also	RB	O
is	VBZ	O
found	VBN	O
infrequently	RB	O
in	IN	O
other	JJ	O
B-cell	NN	B-Disease
neoplasms	NNS	I-Disease
.	.	O

Rearrangement	NN	O
is	VBZ	O
thought	VBN	O
to	TO	O
deregulate	VB	O
a	DT	O
nearby	JJ	O
protooncogene	NN	O
,	,	O
but	CC	O
transcribed	VBN	O
sequences	NNS	O
in	IN	O
the	DT	O
immediate	JJ	O
vicinity	NN	O
of	IN	O
BCL1	NN	O
breakpoints	NNS	O
had	VBD	O
not	RB	O
been	VBN	O
identified	VBN	O
.	.	O

PRAD1	NN	O
,	,	O
previously	RB	O
designated	VBN	O
D11S287E	NN	O
,	,	O
was	VBD	O
identified	VBN	O
on	IN	O
11q13	NN	O
as	IN	O
a	DT	O
chromosomal	JJ	O
breakpoint	NN	O
region	NN	O
rearranged	VBN	O
with	IN	O
the	DT	O
parathyroid	JJ	O
hormone	NN	O
gene	NN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
parathyroid	JJ	B-Disease
adenomas	NNS	I-Disease
;	:	O
this	DT	O
highly	RB	O
conserved	VBN	O
putative	JJ	O
oncogene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
cyclin	NN	O
,	,	O
has	VBZ	O
been	VBN	O
linked	VBN	O
to	TO	O
BCL1	NN	O
and	CC	O
implicated	VBN	O
also	RB	O
in	IN	O
subsets	NNS	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
squamous	JJ	I-Disease
cell	NN	I-Disease
neoplasms	NNS	I-Disease
with	IN	O
11q13	NN	O
amplification	NN	O
.	.	O

We	PRP	O
report	VBP	O
pulsed-field	JJ	O
gel	NN	O
electrophoresis	NN	O
data	NNS	O
showing	VBG	O
BCL1	NN	O
and	CC	O
PRAD1	NN	O
to	TO	O
be	VB	O
no	RB	O
more	JJR	O
than	IN	O
130	CD	O
kilobases	NNS	O
apart	RB	O
.	.	O

PRAD1	NN	O
mRNA	NN	O
is	VBZ	O
abundantly	RB	O
expressed	VBN	O
in	IN	O
seven	CD	O
of	IN	O
seven	CD	O
centrocytic	JJ	B-Disease
lymphomas	NNS	I-Disease
(	-LRB-	O
Kiel	NNP	O
classification	NN	O
)	-RRB-	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
13	CD	O
closely	RB	O
related	JJ	O
but	CC	O
noncentrocytic	JJ	B-Disease
lymphomas	NNS	I-Disease
.	.	O

Three	CD	O
of	IN	O
the	DT	O
seven	CD	O
centrocytic	JJ	B-Disease
lymphomas	NNS	I-Disease
had	VBD	O
detectable	JJ	O
BCL1	NN	O
DNA	NN	O
rearrangement	NN	O
.	.	O

Also	RB	O
,	,	O
two	CD	O
unusual	JJ	O
cases	NNS	O
of	IN	O
CLL	NN	O
with	IN	O
BCL1	NN	O
rearrangement	NN	O
overexpressed	VBN	O
PRAD1	NN	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
five	CD	O
CLL	NN	O
controls	NNS	O
.	.	O

Thus	RB	O
,	,	O
PRAD1	NN	O
is	VBZ	O
an	DT	O
excellent	JJ	O
candidate	NN	O
"	''	O
BCL1	NN	O
oncogene	NN	O
.	.	O
"	''	O

Its	PRP$	O
overexpression	NN	O
may	MD	O
be	VB	O
a	DT	O
key	JJ	O
consequence	NN	O
of	IN	O
rearrangement	NN	O
of	IN	O
the	DT	O
BCL1	NN	O
vicinity	NN	O
in	IN	O
B-cell	NN	B-Disease
neoplasms	NNS	I-Disease
and	CC	O
a	DT	O
unifying	JJ	O
pathogenetic	JJ	O
feature	NN	O
in	IN	O
centrocytic	JJ	B-Disease
lymphoma	NN	I-Disease
.	.	O

Adrenoleukodystrophy	NN	B-Disease
:	:	O
increased	VBN	O
plasma	NN	O
content	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
.	.	O

With	IN	O
a	DT	O
new	JJ	O
method	NN	O
we	PRP	O
measured	VBD	O
the	DT	O
saturated	JJ	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
in	IN	O
the	DT	O
plasma	NN	O
of	IN	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
hemizygotes	NNS	O
,	,	O
ALD	NN	B-Disease
heterozygotes	NNS	O
,	,	O
and	CC	O
controls	NNS	O
.	.	O

ALD	NN	B-Disease
hemizygotes	NNS	O
showed	VBD	O
increased	VBN	O
levels	NNS	O
of	IN	O
hexacosanoate	NN	O
(	-LRB-	O
C26	NN	O
fatty	JJ	O
acid	NN	O
)	-RRB-	O
which	WDT	O
represented	VBD	O
0	CD	O
.	.	O

081	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

0066	CD	O
%	NN	O
(	-LRB-	O
SEM	NN	O
)	-RRB-	O
of	IN	O
total	JJ	O
fatty	JJ	O
acids	NNS	O
,	,	O
compared	VBN	O
to	TO	O
0	CD	O
.	.	O

015	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

0032	CD	O
%	NN	O
in	IN	O
the	DT	O
controls	NNS	O
.	.	O

C25	CD	O
,	,	O
C24	NN	O
,	,	O
and	CC	O
C23	NN	O
fatty	JJ	O
acids	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
,	,	O
but	CC	O
the	DT	O
C22	NN	O
and	CC	O
C20	NN	O
fatty	JJ	O
acids	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

C26	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
in	IN	O
most	JJS	O
ALD	NN	B-Disease
heterozygotes	NNS	O
,	,	O
with	IN	O
a	DT	O
mean	JJ	O
level	NN	O
0	CD	O
.	.	O

057	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

0063	CD	O
%	NN	O
of	IN	O
total	JJ	O
fatty	JJ	O
acids	NNS	O
.	.	O

The	DT	O
technique	NN	O
can	MD	O
be	VB	O
used	VBN	O
for	IN	O
diagnosis	NN	O
and	CC	O
carrier	NN	O
identification	NN	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
evaluation	NN	O
of	IN	O
therapy	NN	O
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
inhibits	VBZ	O
in	FW	O
vitro	FW	O
growth	NN	O
of	IN	O
Plasmodium	NN	O
falciparum	NN	O
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
;	:	I-Disease
EC	NNP	I-Disease
1	CD	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

49	CD	I-Disease
)	-RRB-	I-Disease
-	:	I-Disease
deficient	JJ	I-Disease
red	JJ	O
blood	NN	O
cells	NNS	O
from	IN	O
male	JJ	O
hemizygotes	NNS	O
and	CC	O
female	JJ	O
heterozygotes	NNS	O
from	IN	O
the	DT	O
island	NN	O
of	IN	O
Sardinia	NNP	O
were	VBD	O
studied	VBN	O
for	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
support	VB	O
growth	NN	O
in	FW	O
vitro	FW	O
of	IN	O
the	DT	O
malaria-causing	JJ	O
organism	NN	O
Plasmodium	NN	O
falciparum	NN	O
.	.	O

Parasite	NN	O
growth	NN	O
was	VBD	O
approximately	RB	O
one-third	JJ	O
of	IN	O
normal	JJ	O
in	IN	O
both	CC	O
hemi	NN	O
-	:	O
and	CC	O
heterozygotes	NNS	O
for	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

In	IN	O
Sardinians	NNPS	O
with	IN	O
the	DT	O
beta	NN	O
0-thalassemia	NN	O
trait	NN	O
,	,	O
parasite	NN	O
growth	NN	O
was	VBD	O
normal	JJ	O
except	IN	O
when	WRB	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
occurred	VBD	O
together	RB	O
with	IN	O
the	DT	O
thalassemia	NN	B-Disease
trait	NN	O
.	.	O

The	DT	O
data	NNS	O
support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
may	MD	O
confer	VB	O
a	DT	O
selective	JJ	O
advantage	NN	O
in	IN	O
a	DT	O
malarious	JJ	B-Disease
area	NN	O
;	:	O
the	DT	O
female	JJ	O
heterozygote	NN	O
may	MD	O
be	VB	O
at	IN	O
a	DT	O
particular	JJ	O
advantage	NN	O
because	IN	O
resistance	NN	O
to	TO	O
malaria	NN	B-Disease
equals	VBZ	O
that	IN	O
of	IN	O
male	JJ	O
hemizygotes	NNS	O
,	,	O
but	CC	O
the	DT	O
risk	NN	O
of	IN	O
fatal	JJ	B-Disease
hemolysis	NN	I-Disease
may	MD	O
be	VB	O
less	RBR	O
.	.	O

However	RB	O
,	,	O
more	RBR	O
female	JJ	O
heterozygotes	NNS	O
must	MD	O
be	VB	O
studied	VBN	O
to	TO	O
confirm	VB	O
this	DT	O
hypothesis	NN	O
.	.	O

No	DT	O
protective	JJ	O
effect	NN	O
of	IN	O
beta	NN	O
0-thalassemia	NN	O
trait	NN	O
could	MD	O
be	VB	O
demonstrated	VBN	O
in	FW	O
vitro	FW	O
.	.	O

Heterozygous	JJ	B-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
angioedema	NN	B-Disease
,	,	O
myasthenia	NN	B-Disease
gravis	NN	I-Disease
,	,	O
and	CC	O
systemic	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
patient	NN	O
with	IN	O
myasthenia	NN	B-Disease
gravis	NN	I-Disease
,	,	O
systemic	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
,	,	O
and	CC	O
angioedema	NN	B-Disease
associated	VBN	O
with	IN	O
heterozygous	JJ	O
complement	NN	B-Disease
factor	NN	I-Disease
2	CD	I-Disease
(	-LRB-	I-Disease
C2	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
.	.	O

The	DT	O
significance	NN	O
of	IN	O
this	DT	O
association	NN	O
is	VBZ	O
controversial	JJ	O
,	,	O
though	IN	O
the	DT	O
association	NN	O
of	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
certain	JJ	O
histocompatibility	NN	O
antigens	NNS	O
suggests	VBZ	O
possible	JJ	O
linkage	NN	O
to	TO	O
immune	JJ	O
response	NN	O
genes	NNS	O
.	.	O

To	TO	O
our	PRP$	O
knowledge	NN	O
this	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
heterozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
association	NN	O
with	IN	O
this	DT	O
combination	NN	O
of	IN	O
autoimmune	JJ	B-Disease
disorders	NNS	I-Disease
,	,	O
and	CC	O
we	PRP	O
discuss	VBP	O
the	DT	O
aetiological	JJ	O
implications	NNS	O
.	.	O

.	.	O

Inherited	VBN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
recurrent	JJ	O
infections	NNS	O
and	CC	O
glomerulonephritis	NN	B-Disease
.	.	O

A	DT	O
10-year-old	JJ	O
Laotian	JJ	O
boy	NN	O
had	VBD	O
homozygous	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
third	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
and	CC	O
recurrent	JJ	O
bacterial	JJ	B-Disease
infections	NNS	I-Disease
beginning	VBG	O
at	IN	O
age	NN	O
5	CD	O
months	NNS	O
.	.	O

Cellular	JJ	O
and	CC	O
humoral	JJ	O
immunity	NN	O
were	VBD	O
normal	JJ	O
,	,	O
as	IN	O
were	VBD	O
polymorphonuclear	JJ	O
leukocyte	NN	O
chemotaxis	NN	O
and	CC	O
bactericidal	JJ	O
activities	NNS	O
.	.	O

Serum	NN	O
complement-mediated	JJ	O
hemolytic	JJ	O
,	,	O
chemotactic	JJ	O
,	,	O
and	CC	O
opsonic	JJ	O
activities	NNS	O
were	VBD	O
deficient	JJ	O
.	.	O

In	FW	O
vitro	FW	O
addition	NN	O
of	IN	O
purified	VBN	O
C3	NN	O
to	TO	O
patient	NN	O
serum	NN	O
restored	VBD	O
hemolytic	JJ	O
complement	NN	O
to	TO	O
normal	JJ	O
levels	NNS	O
,	,	O
and	CC	O
plasma	NN	O
infusion	NN	O
during	IN	O
each	DT	O
of	IN	O
four	CD	O
episodes	NNS	O
of	IN	O
pneumonia	NN	B-Disease
significantly	RB	O
enhanced	VBD	O
serum	NN	O
opsonic	JJ	O
activity	NN	O
for	IN	O
as	RB	O
long	JJ	O
as	IN	O
36	CD	O
hours	NNS	O
.	.	O

A	DT	O
renal	JJ	O
biopsy	NN	O
specimen	NN	O
revealed	VBD	O
mesangiopathic	JJ	B-Disease
glomerulonephritis	NN	I-Disease
,	,	O
although	IN	O
significant	JJ	O
levels	NNS	O
of	IN	O
circulating	VBG	O
IgG	NN	O
immune	JJ	O
complexes	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
.	.	O

These	DT	O
findings	NNS	O
further	RB	O
support	VBP	O
the	DT	O
association	NN	O
of	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
immune-complex	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
suggest	VBP	O
that	IN	O
plasma	NN	O
infusion	NN	O
may	MD	O
be	VB	O
an	DT	O
adjunct	NN	O
to	TO	O
antibiotic	JJ	O
therapy	NN	O
in	IN	O
the	DT	O
management	NN	O
of	IN	O
severe	JJ	O
pyogenic	JJ	B-Disease
infections	NNS	I-Disease
in	IN	O
patients	NNS	O
with	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Southern	NN	O
analysis	NN	O
reveals	VBZ	O
a	DT	O
large	JJ	O
deletion	NN	O
at	IN	O
the	DT	O
hypoxanthine	NN	O
phosphoribosyltransferase	NN	O
locus	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Whole	JJ	O
genomic	JJ	O
hprt	NN	O
clones	NNS	O
were	VBD	O
used	VBN	O
in	IN	O
Southern	NN	O
analysis	NN	O
to	TO	O
screen	VB	O
the	DT	O
integrity	NN	O
of	IN	O
the	DT	O
hprt	NN	O
gene	NN	O
in	IN	O
a	DT	O
family	NN	O
that	WDT	O
includes	VBZ	O
a	DT	O
patient	NN	O
with	IN	O
HPRT	NN	B-Disease
enzyme	NN	I-Disease
deficiency	NN	I-Disease
causal	JJ	O
to	TO	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
5	CD	O
kb	NN	O
DNA	NN	O
sequence	NN	O
deletion	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
its	PRP$	O
endpoints	NNS	O
in	IN	O
the	DT	O
first	JJ	O
and	CC	O
third	JJ	O
introns	NNS	O
.	.	O

The	DT	O
probes	NNS	O
identified	VBD	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
female	JJ	O
family	NN	O
members	NNS	O
,	,	O
aided	VBN	O
by	IN	O
an	DT	O
RFLP	NN	O
carried	VBN	O
by	IN	O
the	DT	O
mothers	NNS	O
normal	JJ	O
X-chromosome	NN	O
.	.	O

.	.	O

Association	NNP	O
of	IN	O
BRCA1	NN	O
with	IN	O
the	DT	O
hRad50-hMre11-p95	NN	O
complex	NN	O
and	CC	O
the	DT	O
DNA	NN	O
damage	NN	O
response	NN	O
.	.	O

BRCA1	NN	O
encodes	VBZ	O
a	DT	O
tumor	NN	B-Disease
suppressor	NN	O
that	WDT	O
is	VBZ	O
mutated	VBN	O
in	IN	O
familial	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

Here	RB	O
,	,	O
it	PRP	O
is	VBZ	O
shown	VBN	O
that	IN	O
BRCA1	NN	O
interacts	VBZ	O
in	FW	O
vitro	FW	O
and	CC	O
in	FW	O
vivo	FW	O
with	IN	O
hRad50	NN	O
,	,	O
which	WDT	O
forms	VBZ	O
a	DT	O
complex	NN	O
with	IN	O
hMre11	NN	O
and	CC	O
p95/nibrin	NN	O
.	.	O

Upon	IN	O
irradiation	NN	O
,	,	O
BRCA1	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
discrete	JJ	O
foci	NNS	O
in	IN	O
the	DT	O
nucleus	NN	O
,	,	O
which	WDT	O
colocalize	VBP	O
with	IN	O
hRad50	NN	O
.	.	O

Formation	NN	O
of	IN	O
irradiation-induced	JJ	O
foci	NNS	O
positive	JJ	O
for	IN	O
BRCA1	NN	O
,	,	O
hRad50	NN	O
,	,	O
hMre11	NN	O
,	,	O
or	CC	O
p95	NN	O
was	VBD	O
dramatically	RB	O
reduced	VBN	O
in	IN	O
HCC/1937	NN	O
breast	NN	B-Disease
cancer	NN	I-Disease
cells	NNS	O
carrying	VBG	O
a	DT	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
BRCA1	NN	O
but	CC	O
was	VBD	O
restored	VBN	O
by	IN	O
transfection	NN	O
of	IN	O
wild-type	JJ	O
BRCA1	NN	O
.	.	O

Ectopic	JJ	O
expression	NN	O
of	IN	O
wild-type	JJ	O
,	,	O
but	CC	O
not	RB	O
mutated	VBN	O
,	,	O
BRCA1	NN	O
in	IN	O
these	DT	O
cells	NNS	O
rendered	VBD	O
them	PRP	O
less	RBR	O
sensitive	JJ	O
to	TO	O
the	DT	O
DNA	NN	O
damage	NN	O
agent	NN	O
,	,	O
methyl	NN	O
methanesulfonate	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NN	O
is	VBZ	O
important	JJ	O
for	IN	O
the	DT	O
cellular	JJ	O
responses	NNS	O
to	TO	O
DNA	NN	O
damage	NN	O
that	WDT	O
are	VBP	O
mediated	VBN	O
by	IN	O
the	DT	O
hRad50-hMre11-p95	NN	O
complex	NN	O
.	.	O

.	.	O

Nebulin	NNP	O
and	CC	O
titin	NN	O
expression	NN	O
in	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
appears	VBZ	O
normal	JJ	O
.	.	O

Monoclonal	JJ	O
antibodies	NNS	O
which	WDT	O
recognize	VBP	O
different	JJ	O
epitopes	NNS	O
on	IN	O
either	CC	O
titin	NN	O
or	CC	O
nebulin	NN	O
show	VBP	O
normal	JJ	O
staining	NN	O
patterns	NNS	O
on	IN	O
frozen	JJ	O
sections	NNS	O
of	IN	O
three	CD	O
muscle	NN	O
biopsies	NNS	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

Gel	NN	O
electrophoresis	NN	O
and	CC	O
immunoblotting	NN	O
performed	VBN	O
on	IN	O
two	CD	O
of	IN	O
these	DT	O
muscle	NN	O
biopsies	NNS	O
show	VBP	O
the	DT	O
normal	JJ	O
pattern	NN	O
of	IN	O
titin	NN	O
and	CC	O
nebulin	NN	O
polypeptides	NNS	O
.	.	O

Since	IN	O
the	DT	O
donor	NN	O
of	IN	O
one	CD	O
of	IN	O
these	DT	O
biopsies	NNS	O
has	VBZ	O
a	DT	O
large	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
5-region	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
,	,	O
our	PRP$	O
results	NNS	O
argue	VBP	O
against	IN	O
the	DT	O
recent	JJ	O
proposal	NN	O
that	WDT	O
nebulin	NN	O
is	VBZ	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
DMD	NNP	B-Disease
.	.	O

.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
kinase	NN	O
is	VBZ	O
a	DT	O
component	NN	O
of	IN	O
neuromuscular	JJ	O
junctions	NNS	O
.	.	O

The	DT	O
clinical	JJ	O
manifestation	NN	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
correlated	VBN	O
to	TO	O
the	DT	O
extent	NN	O
of	IN	O
expansion	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
[	-LRB-	O
CTG	NN	O
]	-RRB-	O
n	NN	O
DNA	NN	O
motif	NN	O
.	.	O

Recent	JJ	O
studies	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
this	DT	O
trinucleotide	NN	O
motif	NN	O
forms	NNS	O
part	NN	O
of	IN	O
the	DT	O
last	JJ	O
,	,	O
3	CD	O
untranslated	JJ	O
exon	NN	O
of	IN	O
a	DT	O
gene	NN	O
which	WDT	O
potentially	RB	O
encodes	VBZ	O
multiple	JJ	O
protein	NN	O
isoforms	NNS	O
of	IN	O
a	DT	O
serine/threonine	NN	O
protein	NN	O
kinase	NN	O
(	-LRB-	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
protein	NN	O
kinase	NN	O
,	,	O
DM-PK	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
on	IN	O
the	DT	O
development	NN	O
of	IN	O
antisera	NNS	O
against	IN	O
synthetic	JJ	O
DM-PK	NN	O
peptide	NN	O
antigens	NNS	O
and	CC	O
their	PRP$	O
use	NN	O
in	IN	O
biochemical	JJ	O
and	CC	O
histochemical	JJ	O
studies	NNS	O
.	.	O

Immunoreactive	JJ	O
DM-kinase	NN	O
protein	NN	O
of	IN	O
53	CD	O
kD	NN	O
is	VBZ	O
present	JJ	O
at	IN	O
low	JJ	O
levels	NNS	O
in	IN	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
extracts	NNS	O
of	IN	O
DM	NN	B-Disease
patients	NNS	O
and	CC	O
normal	JJ	O
controls	NNS	O
.	.	O

Immunohistochemical	JJ	O
staining	NN	O
revealed	VBD	O
that	IN	O
DM-PK	NN	O
is	VBZ	O
localised	JJ	O
prominently	RB	O
at	IN	O
sites	NNS	O
of	IN	O
neuromuscular	JJ	O
and	CC	O
myotendinous	JJ	O
junctions	NNS	O
(	-LRB-	O
NMJs	NNS	O
and	CC	O
MTJs	NNS	O
)	-RRB-	O
of	IN	O
human	JJ	O
and	CC	O
rodent	JJ	O
skeletal	JJ	O
muscles	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
very	RB	O
low	JJ	O
levels	NNS	O
of	IN	O
immunoreactive	JJ	O
DM-PK	NN	O
protein	NN	O
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
sarcoplasm	NN	O
of	IN	O
predominantly	RB	O
type	NN	O
I	CD	O
fibres	NNS	O
in	IN	O
various	JJ	O
muscles	NNS	O
.	.	O

Strikingly	RB	O
,	,	O
presence	NN	O
of	IN	O
the	DT	O
protein	NN	O
can	MD	O
also	RB	O
be	VB	O
demonstrated	VBN	O
for	IN	O
NMJs	NNS	O
of	IN	O
muscular	JJ	O
tissues	NNS	O
of	IN	O
adult	JJ	O
and	CC	O
congenital	JJ	O
cases	NNS	O
of	IN	O
DM	NN	B-Disease
,	,	O
with	IN	O
no	DT	O
gross	JJ	O
changes	NNS	O
in	IN	O
structural	JJ	O
organisation	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
provide	VBP	O
a	DT	O
basis	NN	O
for	IN	O
further	JJ	O
characterisation	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
kinase	NN	O
in	IN	O
protein	NN	O
assembly	NN	O
processes	NNS	O
or	CC	O
signal	NN	O
mediation	NN	O
at	IN	O
synaptic	JJ	O
sites	NNS	O
and	CC	O
ultimately	RB	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
complex	NN	O
pathophysiology	NN	O
of	IN	O
DM	NN	B-Disease
.	.	O

.	.	O

New	JJ	O
genetic	JJ	O
variants	NNS	O
of	IN	O
glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
in	IN	O
Italy	NNP	O
.	.	O

Six	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
human	JJ	O
erythrocyte	NN	O
G6PD	NN	O
have	VBP	O
been	VBN	O
characterized	VBN	O
.	.	O

All	DT	O
of	IN	O
them	PRP	O
were	VBD	O
found	VBN	O
in	IN	O
Italian	JJ	O
males	NNS	O
and	CC	O
all	DT	O
were	VBD	O
associated	VBN	O
with	IN	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
but	CC	O
only	RB	O
two	CD	O
with	IN	O
signs	NNS	O
of	IN	O
haemolysis	NN	B-Disease
.	.	O

These	DT	O
and	CC	O
other	JJ	O
variants	NNS	O
reported	VBN	O
in	IN	O
the	DT	O
literature	NN	O
,	,	O
which	WDT	O
must	MD	O
thus	RB	O
far	RB	O
be	VB	O
regarded	VBN	O
as	IN	O
sporadic	JJ	O
,	,	O
are	VBP	O
found	VBN	O
to	TO	O
map	VB	O
in	IN	O
parts	NNS	O
of	IN	O
Italy	NNP	O
where	WRB	O
common	JJ	O
types	NNS	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
are	VBP	O
also	RB	O
prevalent	JJ	O
.	.	O

.	.	O

ATM-heterozygous	JJ	O
germline	NN	O
mutations	NNS	O
contribute	VBP	O
to	TO	O
breast	NN	B-Disease
cancer-susceptibility	NN	O
.	.	O

Approximately	RB	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
-1	CD	O
%	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
has	VBZ	O
been	VBN	O
estimated	VBN	O
to	TO	O
be	VB	O
heterozygous	JJ	O
for	IN	O
a	DT	O
germline	NN	O
mutation	NN	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
(	-LRB-	O
MIM	NNP	O
208900	CD	O
)	-RRB-	O
.	.	O

The	DT	O
finding	NN	O
that	IN	O
ATM-heterozygotes	NNS	O
have	VBP	O
an	DT	O
increased	VBN	O
relative	JJ	O
risk	NN	O
for	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
was	VBD	O
supported	VBN	O
by	IN	O
some	DT	O
studies	NNS	O
but	CC	O
not	RB	O
confirmed	VBN	O
by	IN	O
others	NNS	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
this	DT	O
discrepancy	NN	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
frequency	NN	O
of	IN	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
selected	VBN	O
group	NN	O
of	IN	O
Dutch	JJ	O
patients	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
in	IN	O
normal	JJ	O
blood	NN	O
lymphocytes	NNS	O
,	,	O
using	VBG	O
the	DT	O
protein-truncation	JJ	O
test	NN	O
followed	VBN	O
by	IN	O
genomic-sequence	NN	O
analysis	NN	O
.	.	O

A	DT	O
high	JJ	O
percentage	NN	O
of	IN	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
was	VBD	O
demonstrated	VBN	O
among	IN	O
patients	NNS	O
with	IN	O
sporadic	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
82	CD	O
patients	NNS	O
included	VBD	O
in	IN	O
this	DT	O
study	NN	O
had	VBD	O
developed	VBN	O
breast	NN	B-Disease
cancer	NN	I-Disease
at	IN	O
age	NN	O
<	JJR	O
45	CD	O
and	CC	O
had	VBD	O
survived	VBN	O
>	JJR	O
/	:	O
=	JJ	O
5	CD	O
years	NNS	O
(	-LRB-	O
mean	VB	O
15	CD	O
years	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
in	IN	O
33	CD	O
(	-LRB-	O
40	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
patients	NNS	O
a	DT	O
contralateral	JJ	O
breast	NN	O
tumor	NN	O
had	VBD	O
been	VBN	O
diagnosed	VBN	O
.	.	O

Among	IN	O
these	DT	O
patients	NNS	O
we	PRP	O
identified	VBD	O
seven	CD	O
(	-LRB-	O
8	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
ATM	NNP	O
germline	NN	O
mutations	NNS	O
,	,	O
of	IN	O
which	WDT	O
five	CD	O
are	VBP	O
distinct	JJ	O
.	.	O

One	CD	O
splice-site	NN	O
mutation	NN	O
(	-LRB-	O
IVS10-6T	NN	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
was	VBD	O
detected	VBN	O
three	CD	O
times	NNS	O
in	IN	O
our	PRP$	O
series	NN	O
.	.	O

Four	CD	O
heterozygous	JJ	O
carriers	NNS	O
were	VBD	O
patients	NNS	O
with	IN	O
bilateral	JJ	O
breast	NN	O
cancer	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
mutations	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
study	NN	O
are	VBP	O
"	''	O
A-T	NN	O
disease-causing	NN	O
"	''	O
mutations	NNS	O
that	WDT	O
might	MD	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
in	IN	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
ATM	NNP	O
heterozygotes	NNS	O
have	VBP	O
an	DT	O
approximately	RB	O
ninefold-increased	JJ	O
risk	NN	O
of	IN	O
developing	VBG	O
a	DT	O
type	NN	O
of	IN	O
breast	NN	O
cancer	NN	O
characterized	VBN	O
by	IN	O
frequent	JJ	O
bilateral	JJ	O
occurrence	NN	O
,	,	O
early	JJ	O
age	NN	O
at	IN	O
onset	NN	O
,	,	O
and	CC	O
long-term	JJ	O
survival	NN	O
.	.	O

The	DT	O
specific	JJ	O
characteristics	NNS	O
of	IN	O
our	PRP$	O
population	NN	O
of	IN	O
patients	NNS	O
may	MD	O
explain	VB	O
why	WRB	O
such	PDT	O
a	DT	O
high	JJ	O
frequency	NN	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
other	JJ	O
series	NN	O
.	.	O

Autoimmune	NN	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ALPS	NN	B-Disease
)	-RRB-	O
in	IN	O
a	DT	O
child	NN	O
from	IN	O
consanguineous	JJ	O
parents	NNS	O
:	:	O
a	DT	O
dominant	JJ	O
or	CC	O
recessive	JJ	O
disease	NN	O
?	.	O

Autoimmune	NN	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ALPS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
characterized	VBN	O
by	IN	O
autoimmune	JJ	O
features	NNS	O
and	CC	O
lymphoproliferations	NNS	O
and	CC	O
is	VBZ	O
generally	RB	O
caused	VBN	O
by	IN	O
defective	JJ	O
Fas-mediated	JJ	O
apoptosis	NN	O
.	.	O

This	DT	O
report	NN	O
describes	VBZ	O
a	DT	O
child	NN	O
with	IN	O
clinical	JJ	O
features	NNS	O
of	IN	O
ALPS	NN	B-Disease
without	IN	O
detectable	JJ	O
Fas	NN	O
expression	NN	O
on	IN	O
freshly	RB	O
isolated	VBN	O
blood	NN	O
leukocytes	NNS	O
.	.	O

Detection	NN	O
of	IN	O
FAS	NN	O
transcripts	NNS	O
via	IN	O
real-time	JJ	O
quantitative	JJ	O
PCR	NN	O
made	VBD	O
a	DT	O
severe	JJ	O
transcriptional	JJ	O
defect	NN	O
unlikely	JJ	O
.	.	O

Sequencing	NN	O
of	IN	O
the	DT	O
FAS	NN	O
gene	NN	O
revealed	VBD	O
a	DT	O
20-nucleotide	JJ	O
duplication	NN	O
in	IN	O
the	DT	O
last	JJ	O
exon	NN	O
affecting	VBG	O
the	DT	O
cytoplasmic	JJ	O
signaling	NN	O
domain	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
homozygous	JJ	O
for	IN	O
this	DT	O
mutation	NN	O
,	,	O
whereas	IN	O
the	DT	O
consanguineous	JJ	O
parents	NNS	O
and	CC	O
the	DT	O
siblings	NNS	O
were	VBD	O
heterozygous	JJ	O
.	.	O

The	DT	O
patient	NN	O
reported	VBN	O
here	RB	O
is	VBZ	O
a	DT	O
human	JJ	O
homologue	NN	O
of	IN	O
the	DT	O
Fas-null	JJ	O
mouse	NN	O
,	,	O
inasmuch	NN	O
as	IN	O
she	PRP	O
carries	VBZ	O
an	DT	O
autosomal	JJ	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
FAS	NN	O
gene	NN	O
and	CC	O
she	PRP	O
shows	VBZ	O
the	DT	O
severe	JJ	O
and	CC	O
accelerated	VBD	O
ALPS	NNP	B-Disease
phenotype	NN	O
.	.	O

The	DT	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
did	VBD	O
not	RB	O
have	VB	O
the	DT	O
ALPS	NN	B-Disease
phenotype	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
disease-causing	JJ	O
FAS	NN	O
mutation	NN	O
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
autosomal	JJ	O
recessive	JJ	O
.	.	O

.	.	O

A	DT	O
prevalent	JJ	O
mutation	NN	O
for	IN	O
galactosemia	NN	B-Disease
among	IN	O
black	JJ	O
Americans	NNPS	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
define	VB	O
the	DT	O
mutation	NN	O
causing	VBG	O
galactosemia	NN	B-Disease
in	IN	O
patients	NNS	O
of	IN	O
black	JJ	O
American	JJ	O
origin	NN	O
who	WP	O
have	VBP	O
no	DT	O
galactose-1-phosphate	NN	O
uridyltransferase	NN	O
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
activity	NN	O
in	IN	O
erythrocytes	NNS	O
but	CC	O
good	JJ	O
clinical	JJ	O
outcome	NN	O
.	.	O

METHODS	NNS	O
We	PRP	O
discovered	VBD	O
a	DT	O
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transition	NN	O
at	IN	O
base-pair	NN	O
1158	CD	O
of	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
that	WDT	O
results	VBZ	O
in	IN	O
a	DT	O
serine-to-leucine	NN	O
substitution	NN	O
at	IN	O
codon	NN	O
135	CD	O
(	-LRB-	O
S135L	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
developed	VBD	O
a	DT	O
method	NN	O
with	IN	O
which	WDT	O
to	TO	O
screen	VB	O
populations	NNS	O
for	IN	O
its	PRP$	O
prevalence	NN	O
.	.	O

We	PRP	O
compared	VBD	O
galactose-1-phosphate	NN	O
uridyltransferase	NN	O
among	IN	O
erythrocytes	NNS	O
,	,	O
leukocytes	NNS	O
,	,	O
and	CC	O
transformed	VBN	O
lymphoblasts	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
total	JJ	O
body	NN	O
oxidation	NN	O
of	IN	O
D	NN	O
-	:	O
(	-LRB-	O
13C	NN	O
)	-RRB-	O
-	:	O
galactose	NN	O
to	TO	O
13CO2	NN	O
among	IN	O
three	CD	O
genotypes	NNS	O
for	IN	O
GALT	NNP	O
(	-LRB-	O
S135L/S135L	NNP	O
,	,	O
Q188R/Q188R	NN	O
,	,	O
and	CC	O
Normal/Normal	NNP	O
)	-RRB-	O
.	.	O

RESULTS	NNS	O
We	PRP	O
found	VBD	O
a	DT	O
48	CD	O
%	NN	O
prevalence	NN	O
of	IN	O
the	DT	O
S135L	NN	O
mutation	NN	O
among	IN	O
17	CD	O
black	JJ	O
American	JJ	O
patients	NNS	O
with	IN	O
classic	JJ	B-Disease
galactosemia	NN	I-Disease
and	CC	O
a	DT	O
1	CD	O
%	NN	O
prevalence	NN	O
in	IN	O
a	DT	O
population	NN	O
of	IN	O
50	CD	O
black	JJ	O
Americans	NNPS	O
without	IN	O
galactosemia	NNS	B-Disease
.	.	O

The	DT	O
S135L	NN	O
mutation	NN	O
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
84	CD	O
white	JJ	O
patients	NNS	O
with	IN	O
G/G	NN	O
galactosemia	NN	B-Disease
nor	CC	O
in	IN	O
87	CD	O
white	JJ	O
control	NN	O
subjects	NNS	O
without	IN	O
galactosemia	NN	B-Disease
.	.	O

We	PRP	O
found	VBD	O
normal	JJ	O
whole	JJ	O
body	NN	O
oxidation	NN	O
of	IN	O
D	NN	O
-	:	O
(	-LRB-	O
13C	NN	O
)	-RRB-	O
-	:	O
galactose	NN	O
by	IN	O
the	DT	O
patient	NN	O
homozygous	JJ	O
for	IN	O
S135L	NN	O
and	CC	O
various	JJ	O
degrees	NNS	O
of	IN	O
enzyme	NN	O
impairment	NN	O
among	IN	O
different	JJ	O
tissues	NNS	O
.	.	O

CONCLUSIONS	NNS	O
The	DT	O
S135L	NN	O
mutation	NN	O
in	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
is	VBZ	O
a	DT	O
prevalent	JJ	O
cause	NN	O
of	IN	O
galactosemia	NN	B-Disease
among	IN	O
black	JJ	O
patients	NNS	O
.	.	O

Because	IN	O
GALT	NN	O
activity	NN	O
varies	VBZ	O
in	IN	O
different	JJ	O
tissues	NNS	O
of	IN	O
patients	NNS	O
homozygous	JJ	O
for	IN	O
S135L	NN	O
,	,	O
they	PRP	O
may	MD	O
have	VB	O
a	DT	O
better	JJR	O
clinical	JJ	O
outcome	NN	O
than	IN	O
patients	NNS	O
who	WP	O
are	VBP	O
homozygous	JJ	O
for	IN	O
Q188R	NN	O
when	WRB	O
both	DT	O
are	VBP	O
treated	VBN	O
from	IN	O
infancy	NN	O
.	.	O

.	.	O

Constitutive	JJ	O
and	CC	O
regulated	JJ	O
modes	NNS	O
of	IN	O
splicing	NN	O
produce	VBP	O
six	CD	O
major	JJ	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
protein	NN	O
kinase	NN	O
(	-LRB-	O
DMPK	NN	O
)	-RRB-	O
isoforms	NNS	O
with	IN	O
distinct	JJ	O
properties	NNS	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
prevalent	JJ	O
inherited	VBN	B-Disease
neuromuscular	JJ	I-Disease
disease	NN	I-Disease
in	IN	O
adults	NNS	O
.	.	O

The	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
is	VBZ	O
a	DT	O
CTG	NNP	O
triplet	NN	O
repeat	NN	O
expansion	NN	O
in	IN	O
the	DT	O
3-untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
protein	NN	O
kinase	NN	O
(	-LRB-	O
DMPK	NN	O
)	-RRB-	O
gene	NN	O
,	,	O
consisting	VBG	O
of	IN	O
15	CD	O
exons	NNS	O
.	.	O

Using	VBG	O
a	DT	O
transgenic	JJ	O
DMPK-overexpressor	NN	O
mouse	NN	O
model	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
here	RB	O
that	IN	O
the	DT	O
endogenous	JJ	O
mouse	NN	O
DMPK	NN	O
gene	NN	O
and	CC	O
the	DT	O
human	JJ	O
DMPK	NN	O
transgene	NN	O
produce	VBP	O
six	CD	O
major	JJ	O
alternatively	RB	O
spliced	VBN	O
mRNAs	NNS	O
which	WDT	O
have	VBP	O
almost	RB	O
identical	JJ	O
cell	NN	O
type-dependent	JJ	O
distribution	NN	O
frequencies	NNS	O
and	CC	O
expression	NN	O
patterns	NNS	O
.	.	O

Use	NN	O
of	IN	O
a	DT	O
cryptic	JJ	O
5	CD	O
splice	NN	O
site	NN	O
in	IN	O
exon	NN	O
8	CD	O
,	,	O
which	WDT	O
results	VBZ	O
in	IN	O
absence	NN	O
or	CC	O
presence	NN	O
of	IN	O
15	CD	O
nucleotides	NNS	O
specifying	VBG	O
a	DT	O
VSGGG	NN	O
peptide	NN	O
motif	NN	O
,	,	O
and/or	CC	O
use	NN	O
of	IN	O
a	DT	O
cryptic	JJ	O
3	CD	O
splice	NN	O
site	NN	O
in	IN	O
exon	NN	O
14	CD	O
,	,	O
which	WDT	O
leads	VBZ	O
to	TO	O
a	DT	O
frameshift	NN	O
in	IN	O
the	DT	O
mRNA	NN	O
reading	NN	O
frame	NN	O
,	,	O
occur	VBP	O
as	IN	O
independent	JJ	O
stochastic	JJ	O
events	NNS	O
in	IN	O
all	DT	O
tissues	NNS	O
examined	VBN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
excision	NN	O
of	IN	O
exons	NNS	O
13/14	CD	O
that	WDT	O
causes	VBZ	O
a	DT	O
frameshift	NN	O
and	CC	O
creates	VBZ	O
a	DT	O
C-terminally	RB	O
truncated	VBN	O
protein	NN	O
is	VBZ	O
clearly	RB	O
cell	NN	O
type	NN	O
dependent	JJ	O
and	CC	O
occurs	VBZ	O
predominantly	RB	O
in	IN	O
smooth	JJ	O
muscle	NN	O
.	.	O

We	PRP	O
generated	VBD	O
all	DT	O
six	CD	O
full-length	JJ	O
mouse	NN	O
cDNAs	NNS	O
that	WDT	O
result	VBP	O
from	IN	O
combinations	NNS	O
of	IN	O
these	DT	O
three	CD	O
major	JJ	O
splicing	NN	O
events	NNS	O
and	CC	O
show	VBP	O
that	IN	O
their	PRP$	O
transfection	NN	O
into	IN	O
cells	NNS	O
in	IN	O
culture	NN	O
leads	VBZ	O
to	TO	O
production	NN	O
of	IN	O
four	CD	O
different	JJ	O
approximately	RB	O
74	CD	O
kDa	NN	O
full-length	JJ	O
(	-LRB-	O
heart	NN	O
-	:	O
,	,	O
skeletal	JJ	O
muscle	NN	O
-	:	O
or	CC	O
brain-specific	JJ	O
)	-RRB-	O
and	CC	O
two	CD	O
C-terminally	RB	O
truncated	VBN	O
approximately	RB	O
68	CD	O
kDa	NN	O
(	-LRB-	O
smooth	JJ	O
muscle-specific	JJ	O
)	-RRB-	O
isoforms	NNS	O
.	.	O

Information	NN	O
on	IN	O
DMPK	NN	O
mRNA	NN	O
and	CC	O
protein	NN	O
isoform	NN	O
expression	NN	O
patterns	NNS	O
will	MD	O
be	VB	O
useful	JJ	O
for	IN	O
recognizing	VBG	O
differential	JJ	O
effects	NNS	O
of	IN	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
(	-LRB-	O
n	NN	O
)	-RRB-	O
expansion	NN	O
in	IN	O
DM	NN	B-Disease
manifestation	NN	O
.	.	O

.	.	O

Linkage	NN	O
analysis	NN	O
in	IN	O
a	DT	O
large	JJ	O
Brazilian	JJ	O
family	NN	O
with	IN	O
van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
suggests	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
susceptibility	NN	O
locus	NN	O
for	IN	O
cleft	NN	B-Disease
palate	NN	I-Disease
at	IN	O
17p11.2-11	NN	O
.1	NN	O
.	.	O

van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
VWS	NN	B-Disease
)	-RRB-	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
1q32-41	NN	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
pits	NNS	B-Disease
and/or	CC	I-Disease
sinuses	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
lower	JJR	I-Disease
lip	NN	I-Disease
,	,	O
cleft	NN	B-Disease
lip/palate	NN	I-Disease
(	-LRB-	O
CL/P	NN	B-Disease
)	-RRB-	O
,	,	O
cleft	NN	B-Disease
palate	NN	I-Disease
(	-LRB-	O
CP	NN	B-Disease
)	-RRB-	O
,	,	O
bifid	JJ	B-Disease
uvula	NN	I-Disease
,	,	O
and	CC	O
hypodontia	NN	B-Disease
(	-LRB-	O
H	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
VWS	NNP	B-Disease
,	,	O
which	WDT	O
has	VBZ	O
incomplete	JJ	O
penetrance	NN	O
,	,	O
is	VBZ	O
highly	RB	O
variable	JJ	O
.	.	O

Both	CC	O
the	DT	O
occurrence	NN	O
of	IN	O
CL/P	NN	B-Disease
and	CC	O
CP	NN	B-Disease
within	IN	O
the	DT	O
same	JJ	O
genealogy	NN	O
and	CC	O
a	DT	O
recurrence	NN	O
risk	NN	O
<	JJR	O
40	CD	O
%	NN	O
for	IN	O
CP	NN	B-Disease
among	IN	O
descendants	NNS	O
with	IN	O
VWS	NNS	B-Disease
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
development	NN	O
of	IN	O
clefts	NNS	B-Disease
in	IN	O
this	DT	O
syndrome	NN	O
is	VBZ	O
influenced	VBN	O
by	IN	O
modifying	VBG	O
genes	NNS	O
at	IN	O
other	JJ	O
loci	NNS	O
.	.	O

To	TO	O
test	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
have	VBP	O
conducted	VBN	O
linkage	NN	O
analysis	NN	O
in	IN	O
a	DT	O
large	JJ	O
Brazilian	JJ	O
kindred	NN	O
with	IN	O
VWS	NNS	B-Disease
,	,	O
considering	VBG	O
as	IN	O
affected	VBN	O
the	DT	O
individuals	NNS	O
with	IN	O
CP	NN	B-Disease
,	,	O
regardless	RB	O
of	IN	O
whether	IN	O
it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
other	JJ	O
clinical	JJ	O
signs	NNS	O
of	IN	O
VWS	NNS	B-Disease
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
gene	NN	O
at	IN	O
17p11	NN	O
.	.	O

2-11	CD	O
2-11	CD	O
.	.	O

1	CD	O
,	,	O
together	RB	O
with	IN	O
the	DT	O
VWS	NN	B-Disease
gene	NN	O
at	IN	O
1p32-41	NN	O
,	,	O
enhances	VBZ	O
the	DT	O
probability	NN	O
of	IN	O
CP	NN	B-Disease
in	IN	O
an	DT	O
individual	JJ	O
carrying	VBG	O
the	DT	O
two	CD	O
at-risk	JJ	O
genes	NNS	O
.	.	O

If	IN	O
this	DT	O
hypothesis	NN	O
is	VBZ	O
confirmed	VBN	O
in	IN	O
other	JJ	O
VWS	NNS	B-Disease
pedigrees	NNS	O
,	,	O
it	PRP	O
will	MD	O
represent	VB	O
one	CD	O
of	IN	O
the	DT	O
first	JJ	O
examples	NNS	O
of	IN	O
a	DT	O
gene	NN	O
,	,	O
mapped	VBN	O
through	IN	O
linkage	NN	O
analysis	NN	O
,	,	O
which	WDT	O
modifies	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
major	JJ	O
gene	NN	O
.	.	O

Diverse	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
gene	NN	O
cause	NN	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
mild	JJ	O
or	CC	O
severe	JJ	O
hemolytic	JJ	B-Disease
anemia	NN	I-Disease
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
;	:	I-Disease
EC	NNP	I-Disease
1	CD	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

49	CD	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
common	JJ	O
genetic	JJ	B-Disease
abnormality	NN	I-Disease
affecting	VBG	O
an	DT	O
estimated	VBN	O
400	CD	O
million	CD	O
people	NNS	O
worldwide	RB	O
.	.	O

Clinical	JJ	O
and	CC	O
biochemical	JJ	O
analyses	NNS	O
have	VBP	O
identified	VBN	O
many	JJ	O
variants	NNS	O
exhibiting	VBG	O
a	DT	O
range	NN	O
of	IN	O
phenotypes	NNS	O
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
well	RB	O
characterized	VBN	O
from	IN	O
the	DT	O
hematological	JJ	O
point	NN	O
of	IN	O
view	NN	O
.	.	O

However	RB	O
,	,	O
until	IN	O
now	RB	O
,	,	O
their	PRP$	O
precise	JJ	O
molecular	JJ	O
basis	NN	O
has	VBZ	O
remained	VBN	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
seven	CD	O
mutant	JJ	O
G6PD	NN	O
alleles	NNS	O
.	.	O

In	IN	O
the	DT	O
nondeficient	JJ	O
polymorphic	JJ	O
African	JJ	O
variant	NN	O
G6PD	NN	O
A	NN	O
we	PRP	O
have	VBP	O
found	VBN	O
a	DT	O
single	JJ	O
point	NN	O
mutation	NN	O
.	.	O

The	DT	O
other	JJ	O
six	CD	O
mutants	NNS	O
investigated	VBN	O
were	VBD	O
all	DT	O
associated	VBN	O
with	IN	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

In	IN	O
one	CD	O
of	IN	O
the	DT	O
commonest	JJS	O
,	,	O
G6PD	NN	O
Mediterranean	NNP	O
,	,	O
which	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
favism	NN	B-Disease
among	IN	O
other	JJ	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
a	DT	O
single	JJ	O
amino	NN	O
acid	NN	O
replacement	NN	O
was	VBD	O
found	VBN	O
(	-LRB-	O
serine	NN	O
----	:	O
phenylalanine	NN	O
)	-RRB-	O
it	PRP	O
must	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
decreased	VBN	O
stability	NN	O
and	CC	O
the	DT	O
reduced	VBN	O
catalytic	JJ	O
efficiency	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
.	.	O

Single	JJ	O
point	NN	O
mutations	NNS	O
were	VBD	O
also	RB	O
found	VBN	O
in	IN	O
G6PD	NN	O
Metaponto	NNP	O
(	-LRB-	O
Southern	NNP	O
Italy	NNP	O
)	-RRB-	O
and	CC	O
in	IN	O
G6PD	NN	O
Ilesha	NN	O
(	-LRB-	O
Nigeria	NNP	O
)	-RRB-	O
,	,	O
which	WDT	O
are	VBP	O
asymptomatic	JJ	O
,	,	O
and	CC	O
in	IN	O
G6PD	NN	O
Chatham	NNP	O
,	,	O
which	WDT	O
was	VBD	O
observed	VBN	O
in	IN	O
an	DT	O
Indian	JJ	O
boy	NN	O
with	IN	O
neonatal	JJ	B-Disease
jaundice	NN	I-Disease
.	.	O

In	IN	O
G6PD	NN	O
"	''	O
Matera	NNP	O
,	,	O
"	''	O
which	WDT	O
is	VBZ	O
now	RB	O
known	VBN	O
to	TO	O
be	VB	O
the	DT	O
same	JJ	O
as	IN	O
G6PD	NN	O
A	NN	O
-	:	O
,	,	O
two	CD	O
separate	JJ	O
point	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
is	VBZ	O
the	DT	O
same	JJ	O
as	IN	O
in	IN	O
G6PD	NN	O
A	NN	O
.	.	O

In	IN	O
G6PD	NN	O
Santiago	NNP	O
,	,	O
a	DT	O
de	FW	O
novo	FW	O
mutation	NN	O
(	-LRB-	O
glycine	NN	O
----	:	O
arginine	NN	O
)	-RRB-	O
is	VBZ	O
associated	VBN	O
with	IN	O
severe	JJ	O
chronic	JJ	O
hemolytic	JJ	B-Disease
anemia	NN	I-Disease
.	.	O

The	DT	O
mutations	NNS	O
observed	VBN	O
show	VBP	O
a	DT	O
striking	JJ	O
predominance	NN	O
of	IN	O
C	NN	O
----	:	O
T	NN	O
transitions	NNS	O
,	,	O
with	IN	O
CG	NN	O
doublets	NNS	O
involved	VBN	O
in	IN	O
four	CD	O
of	IN	O
seven	CD	O
cases	NNS	O
.	.	O

Thus	RB	O
,	,	O
diverse	JJ	O
point	NN	O
mutations	NNS	O
may	MD	O
account	VB	O
largely	RB	O
for	IN	O
the	DT	O
phenotypic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Increased	VBN	O
high-density	JJ	O
lipoprotein	NN	O
levels	NNS	O
caused	VBN	O
by	IN	O
a	DT	O
common	JJ	O
cholesteryl-ester	NN	O
transfer	NN	O
protein	NN	O
gene	NN	O
mutation	NN	O
.	.	O

BACKGROUND	NN	O
AND	CC	O
METHODS	NNS	O
.	.	O

The	DT	O
plasma	NN	O
cholesteryl-ester	NN	O
transfer	NN	O
protein	NN	O
(	-LRB-	O
CETP	NN	O
)	-RRB-	O
catalyzes	VBZ	O
the	DT	O
transfer	NN	O
of	IN	O
cholesteryl	NN	O
esters	NNS	O
from	IN	O
high-density	JJ	O
lipoprotein	NN	O
(	-LRB-	O
HDL	NN	O
)	-RRB-	O
to	TO	O
other	JJ	O
lipoproteins	NNS	O
.	.	O

We	PRP	O
recently	RB	O
described	VBD	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
increased	VBN	O
HDL	NN	O
levels	NNS	O
and	CC	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
due	JJ	O
to	TO	O
a	DT	O
splicing	NN	O
defect	NN	O
of	IN	O
the	DT	O
CETP	NN	O
gene	NN	O
.	.	O

To	TO	O
assess	VB	O
the	DT	O
frequency	NN	O
and	CC	O
phenotype	NN	O
of	IN	O
this	DT	O
condition	NN	O
,	,	O
we	PRP	O
screened	VBD	O
11	CD	O
additional	JJ	O
families	NNS	O
with	IN	O
high	JJ	O
HDL	NN	O
levels	NNS	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
radioimmunoassay	NN	O
for	IN	O
CETP	NN	O
and	CC	O
DNA	NN	O
analysis	NN	O
.	.	O

RESULTS	NNS	O
.	.	O

We	PRP	O
found	VBD	O
the	DT	O
same	JJ	O
CETP	NN	O
gene	NN	O
mutation	NN	O
in	IN	O
four	CD	O
families	NNS	O
from	IN	O
three	CD	O
different	JJ	O
regions	NNS	O
of	IN	O
Japan	NNP	O
.	.	O

Analysis	NN	O
of	IN	O
restriction-fragment-length	JJ	O
polymorphisms	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
CETP	NN	O
allele	NN	O
showed	VBD	O
that	IN	O
all	DT	O
probands	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
the	DT	O
identical	JJ	O
haplotype	NN	O
.	.	O

Family	NNP	O
members	NNS	O
homozygous	JJ	O
for	IN	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
n	NN	O
=	JJ	O
10	CD	O
)	-RRB-	O
had	VBD	O
moderate	JJ	O
hypercholesterolemia	NN	B-Disease
(	-LRB-	O
mean	NN	O
total	JJ	O
cholesterol	NN	O
level	NN	O
[	-LRB-	O
+	CC	O
/	:	O
-	:	O
SD	NN	O
]	-RRB-	O
,	,	O
7	CD	O
.	.	O

01	NN	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

83	CD	O
mmol	NN	O
per	IN	O
liter	NN	O
)	-RRB-	O
,	,	O
markedly	RB	O
increased	VBD	O
levels	NNS	O
of	IN	O
HDL	NN	O
cholesterol	NN	O
(	-LRB-	O
4	CD	O
.	.	O

24	CD	O
+	CC	O
/	:	O
-	:	O
1	CD	O
.	.	O

01	NN	O
mmol	NN	O
per	IN	O
liter	NN	O
)	-RRB-	O
and	CC	O
apolipoprotein	NN	O
A-I	NN	O
,	,	O
and	CC	O
decreased	VBD	O
levels	NNS	O
of	IN	O
low-density	JJ	O
lipoprotein	NN	O
cholesterol	NN	O
(	-LRB-	O
1	CD	O
.	.	O

99	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

80	CD	O
mmol	NN	O
per	IN	O
liter	NN	O
)	-RRB-	O
and	CC	O
apolipoprotein	NN	O
B.	NNP	O
Members	NNP	O
heterozygous	JJ	O
for	IN	O
the	DT	O
deficiency	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
20	CD	O
)	-RRB-	O
,	,	O
whose	WP$	O
CETP	NN	O
levels	NNS	O
were	VBD	O
in	IN	O
the	DT	O
lower	JJR	O
part	NN	O
of	IN	O
the	DT	O
normal	JJ	O
range	NN	O
,	,	O
had	VBD	O
moderately	RB	O
increased	VBN	O
levels	NNS	O
of	IN	O
HDL	NN	O
cholesterol	NN	O
and	CC	O
apolipoprotein	NN	O
A-I	NN	O
and	CC	O
an	DT	O
increased	VBN	O
ratio	NN	O
of	IN	O
HDL	NN	O
subclass	NN	O
2	CD	O
to	TO	O
HDL	NNP	O
subclass	NN	O
3	CD	O
,	,	O
as	IN	O
compared	VBN	O
with	IN	O
unaffected	JJ	O
family	NN	O
members	NNS	O
(	-LRB-	O
1	CD	O
.	.	O

5	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

8	CD	O
vs.	CC	O
0	CD	O
.	.	O

7	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

4	LS	O
)	-RRB-	O
.	.	O

CETP	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
not	RB	O
found	VBN	O
in	IN	O
six	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
elevated	JJ	O
HDL	NN	O
cholesterol	NN	O
levels	NNS	O
who	WP	O
were	VBD	O
from	IN	O
different	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
.	.	O

CONCLUSIONS	NNS	O
.	.	O

CETP	NN	B-Disease
deficiency	NN	I-Disease
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	O
frequent	JJ	O
cause	NN	O
of	IN	O
increased	VBN	O
HDL	NN	O
levels	NNS	O
in	IN	O
the	DT	O
population	NN	O
of	IN	O
Japan	NNP	O
,	,	O
possibly	RB	O
because	IN	O
of	IN	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

The	DT	O
results	NNS	O
that	IN	O
we	PRP	O
observed	VBD	O
in	IN	O
heterozygotes	NNS	O
suggest	VBP	O
that	IN	O
CETP	NN	O
normally	RB	O
plays	VBZ	O
a	DT	O
part	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
levels	NNS	O
of	IN	O
HDL	NN	O
subclass	NN	O
2	CD	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
premature	JJ	B-Disease
atherosclerosis	NN	I-Disease
in	IN	O
the	DT	O
families	NNS	O
with	IN	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

In	IN	O
fact	NN	O
,	,	O
the	DT	O
lipoprotein	NN	O
profile	NN	O
of	IN	O
persons	NNS	O
with	IN	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
potentially	RB	O
antiatherogenic	JJ	O
and	CC	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
life	NN	O
span	NN	O
.	.	O

Hereditary	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
and	CC	O
recurrent	JJ	O
meningococcal	JJ	B-Disease
infection	NN	I-Disease
:	:	O
investigations	NNS	O
of	IN	O
an	DT	O
Irish	JJ	O
family	NN	O
using	VBG	O
a	DT	O
novel	JJ	O
haemolytic	JJ	O
screening	NN	O
assay	NN	O
for	IN	O
complement	NN	O
activity	NN	O
and	CC	O
C7	NN	O
M/N	NN	O
allotyping	NN	O
.	.	O

Terminal	JJ	B-Disease
complement	NN	I-Disease
component	NN	I-Disease
deficiency	NN	I-Disease
predisposes	VBZ	O
to	TO	O
meningococcal	JJ	B-Disease
infection	NN	I-Disease
and	CC	O
is	VBZ	O
inherited	VBN	O
in	IN	O
an	DT	O
autosomal	JJ	O
co-dominant	JJ	O
manner	NN	O
.	.	O

An	DT	O
Irish	JJ	O
family	NN	O
is	VBZ	O
described	VBN	O
,	,	O
in	IN	O
which	WDT	O
2	CD	O
of	IN	O
3	CD	O
brothers	NNS	O
had	VBD	O
recurrent	JJ	O
meningococcal	JJ	B-Disease
infection	NN	I-Disease
.	.	O

A	DT	O
novel	JJ	O
screening	NN	O
assay	NN	O
was	VBD	O
used	VBN	O
to	TO	O
investigate	VB	O
for	IN	O
terminal	JJ	B-Disease
complement	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
the	DT	O
2	CD	O
affected	VBN	O
brothers	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
completely	RB	B-Disease
deficient	JJ	I-Disease
in	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C7	NN	O
)	-RRB-	O
.	.	O

Enzyme-linked	JJ	O
immunosorbent	JJ	O
assay	NN	O
for	IN	O
C7	NN	O
revealed	VBD	O
lower	JJR	O
than	IN	O
normal	JJ	O
levels	NNS	O
in	IN	O
the	DT	O
remaining	VBG	O
brother	NN	O
and	CC	O
parents	NNS	O
.	.	O

C7	NN	O
M/N	NN	O
protein	NN	O
polymorphism	NN	O
allotyping	NN	O
,	,	O
used	VBN	O
to	TO	O
investigate	VB	O
the	DT	O
segregation	NN	O
of	IN	O
the	DT	O
C7	NN	B-Disease
deficiency	NN	I-Disease
genes	NNS	O
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
apparently	RB	O
complement	NN	O
sufficient	JJ	O
brother	NN	O
was	VBD	O
heterozygous	JJ	O
C7	NN	B-Disease
deficient	JJ	I-Disease
and	CC	O
a	DT	O
carrier	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
deficiency	NN	O
genes	NNS	O
.	.	O

Complement	NN	O
screening	NN	O
should	MD	O
be	VB	O
carried	VBN	O
out	RP	O
in	IN	O
any	DT	O
individual	JJ	O
suffering	NN	O
recurrent	JJ	O
meningococcal	JJ	B-Disease
infection	NN	I-Disease
or	CC	O
infection	NN	O
with	IN	O
an	DT	O
uncommon	JJ	O
meningococcal	JJ	B-Disease
serogroup	NN	O
.	.	O

Identification	NN	O
of	IN	O
complement	NN	B-Disease
deficient	JJ	I-Disease
patients	NNS	O
allows	VBZ	O
the	DT	O
implementation	NN	O
of	IN	O
strategies	NNS	O
to	TO	O
prevent	VB	O
recurrent	JJ	O
infection	NN	O
.	.	O

.	.	O

Mild	JJ	O
and	CC	O
severe	JJ	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
associated	VBN	O
with	IN	O
deletions	NNS	O
in	IN	O
Xp21	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
over	IN	O
300	CD	O
patients	NNS	O
suffering	VBG	O
from	IN	O
Duchenne	NNP	B-Disease
or	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
or	CC	O
BMD	NN	B-Disease
)	-RRB-	O
.	.	O

Deletions	NNS	O
have	VBP	O
been	VBN	O
characterised	VBN	O
which	WDT	O
encompass	VBP	O
either	CC	O
the	DT	O
pERT87	NN	O
(	-LRB-	O
DXS164	NN	O
)	-RRB-	O
locus	NN	O
only	RB	O
,	,	O
the	DT	O
XJ1	NN	O
.	.	O

1	CD	O
(	-LRB-	O
DXS206	NN	O
)	-RRB-	O
and	CC	O
HIP25	NN	O
loci	NNS	O
only	RB	O
,	,	O
or	CC	O
all	DT	O
three	CD	O
loci	NNS	O
.	.	O

These	DT	O
loci	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
lie	VB	O
within	IN	O
the	DT	O
DMD	NNP	B-Disease
region	NN	O
covering	VBG	O
several	JJ	O
hundred	CD	O
kilobases	NNS	O
(	-LRB-	O
kb	NN	O
)	-RRB-	O
of	IN	O
DNA	NN	O
.	.	O

One	CD	O
mildly	RB	O
affected	VBN	O
BMD	NNP	B-Disease
patient	NN	O
possesses	VBZ	O
a	DT	O
deletion	NN	O
of	IN	O
at	IN	O
least	JJS	O
110	CD	O
kb	NN	O
including	VBG	O
exons	NNS	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

Other	JJ	O
patients	NNS	O
with	IN	O
similar	JJ	O
exon	NN	O
deletions	NNS	O
,	,	O
or	CC	O
smaller	JJR	O
deletions	NNS	O
,	,	O
show	VBP	O
the	DT	O
more	RBR	O
severe	JJ	O
phenotype	NN	O
typical	JJ	O
of	IN	O
DMD	NNP	B-Disease
.	.	O

We	PRP	O
conclude	VBP	O
from	IN	O
these	DT	O
studies	NNS	O
that	IN	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
phenotype	NN	O
can	MD	O
not	RB	O
be	VB	O
explained	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
deletion	NN	O
.	.	O

We	PRP	O
discuss	VBP	O
this	DT	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
candidate	NN	O
gene	NN	O
sequences	NNS	O
.	.	O

Meiotic	JJ	O
segregation	NN	O
analysis	NN	O
of	IN	O
RB1	NN	O
alleles	NNS	O
in	IN	O
retinoblastoma	NN	B-Disease
pedigrees	NNS	O
by	IN	O
use	NN	O
of	IN	O
single-sperm	JJ	O
typing	NN	O
.	.	O

In	IN	O
hereditary	JJ	B-Disease
retinoblastoma	NN	I-Disease
,	,	O
different	JJ	O
epidemiological	JJ	O
studies	NNS	O
have	VBP	O
indicated	VBN	O
a	DT	O
preferential	JJ	O
paternal	JJ	O
transmission	NN	O
of	IN	O
mutant	JJ	O
retinoblastoma	NN	B-Disease
alleles	NNS	O
to	TO	O
offspring	NN	O
,	,	O
suggesting	VBG	O
the	DT	O
occurrence	NN	O
of	IN	O
a	DT	O
meiotic	JJ	O
drive	NN	O
.	.	O

To	TO	O
investigate	VB	O
this	DT	O
mechanism	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
sperm	NN	O
samples	NNS	O
from	IN	O
six	CD	O
individuals	NNS	O
from	IN	O
five	CD	O
unrelated	JJ	O
families	NNS	O
affected	VBN	O
with	IN	O
hereditary	JJ	B-Disease
retinoblastoma	NN	I-Disease
.	.	O

Single-sperm	JJ	O
typing	NN	O
techniques	NNS	O
were	VBD	O
performed	VBN	O
for	IN	O
each	DT	O
sample	NN	O
by	IN	O
study	NN	O
of	IN	O
two	CD	O
informative	JJ	O
short	JJ	O
tandem	JJ	O
repeats	NNS	O
located	JJ	O
either	RB	O
in	IN	O
or	CC	O
close	VB	O
to	TO	O
the	DT	O
retinoblastoma	NN	B-Disease
gene	NN	O
(	-LRB-	O
RB1	NN	O
)	-RRB-	O
.	.	O

The	DT	O
segregation	NN	O
probability	NN	O
of	IN	O
mutant	JJ	O
RB1	NN	O
alleles	NNS	O
in	IN	O
sperm	NN	O
samples	NNS	O
was	VBD	O
assessed	VBN	O
by	IN	O
use	NN	O
of	IN	O
the	DT	O
SPERMSEG	NNP	O
program	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
experimental	JJ	O
parameters	NNS	O
,	,	O
recombination	NN	O
fractions	NNS	O
between	IN	O
the	DT	O
markers	NNS	O
,	,	O
and	CC	O
segregation	NN	O
parameters	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
2	CD	O
,	,	O
952	CD	O
single	JJ	O
sperm	NN	O
from	IN	O
the	DT	O
six	CD	O
donors	NNS	O
were	VBD	O
analyzed	VBN	O
.	.	O

We	PRP	O
detected	VBD	O
a	DT	O
significant	JJ	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
data	NNS	O
as	IN	O
a	DT	O
whole	JJ	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

0099	CD	O
)	-RRB-	O
and	CC	O
a	DT	O
significant	JJ	O
heterogeneity	NN	O
in	IN	O
the	DT	O
segregation	NN	O
rate	NN	O
across	IN	O
donors	NNS	O
(	-LRB-	O
.	.	O

0092	NN	O
)	-RRB-	O
.	.	O

Further	JJ	O
analysis	NN	O
shows	VBZ	O
that	IN	O
this	DT	O
result	NN	O
can	MD	O
be	VB	O
explained	VBN	O
by	IN	O
segregation	NN	O
distortion	NN	O
in	IN	O
favor	NN	O
of	IN	O
the	DT	O
normal	JJ	O
allele	NN	O
in	IN	O
one	CD	O
donor	NN	O
only	RB	O
and	CC	O
that	IN	O
it	PRP	O
does	VBZ	O
not	RB	O
provide	VB	O
evidence	NN	O
of	IN	O
a	DT	O
significant	JJ	O
segregation	NN	O
distortion	NN	O
in	IN	O
the	DT	O
other	JJ	O
donors	NNS	O
.	.	O

The	DT	O
segregation	NN	O
distortion	NN	O
favoring	VBG	O
the	DT	O
mutant	JJ	O
RB1	NN	O
allele	NN	O
does	VBZ	O
not	RB	O
seem	VB	O
to	TO	O
occur	VB	O
during	IN	O
spermatogenesis	NN	O
,	,	O
and	CC	O
,	,	O
thus	RB	O
,	,	O
meiotic	JJ	O
drive	NN	O
may	MD	O
result	VB	O
either	CC	O
from	IN	O
various	JJ	O
mechanisms	NNS	O
,	,	O
including	VBG	O
a	DT	O
fertilization	NN	O
advantage	NN	O
or	CC	O
a	DT	O
better	JJR	O
mobility	NN	O
in	IN	O
sperm	NN	O
bearing	VBG	O
a	DT	O
mutant	JJ	O
RB1	NN	O
gene	NN	O
,	,	O
or	CC	O
from	IN	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
defectively	RB	O
imprinted	JJ	O
gene	NN	O
located	VBN	O
on	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

Functional	JJ	O
differences	NNS	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
product	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
phenotypic	JJ	O
variation	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
non-syndromic	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
(	-LRB-	O
DFNB4	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
PDS	NN	B-Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
transmembrane	JJ	O
protein	NN	O
,	,	O
known	VBN	O
as	IN	O
pendrin	NN	O
,	,	O
which	WDT	O
functions	VBZ	O
as	IN	O
a	DT	O
transporter	NN	O
of	IN	O
iodide	NN	O
and	CC	O
chloride	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
non-syndromic	JJ	I-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
at	IN	O
the	DT	O
DFNB4	NN	B-Disease
locus	NN	O
on	IN	O
chromosome	NN	O
7q31	NN	O
.	.	O

A	DT	O
screen	NN	O
of	IN	O
20	CD	O
individuals	NNS	O
from	IN	O
the	DT	O
midwestern	JJ	O
USA	NN	O
with	IN	O
non-syndromic	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
and	CC	O
dilated	JJ	O
vestibular	JJ	O
aqueducts	NNS	O
identified	VBD	O
three	CD	O
people	NNS	O
(	-LRB-	O
15	CD	O
%	NN	O
)	-RRB-	O
with	IN	O
PDS	NN	B-Disease
mutations	NNS	O
.	.	O

To	TO	O
determine	VB	O
whether	IN	O
PDS	NN	B-Disease
mutations	NNS	O
in	IN	O
individuals	NNS	O
with	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
differ	VBP	O
functionally	RB	O
from	IN	O
PDS	NN	B-Disease
mutations	NNS	O
in	IN	O
individuals	NNS	O
with	IN	O
non-syndromic	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
,	,	O
we	PRP	O
compared	VBD	O
three	CD	O
common	JJ	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
allele	NN	O
variants	NNS	O
(	-LRB-	O
L236P	NN	O
,	,	O
T416P	NN	O
and	CC	O
E384G	NN	O
)	-RRB-	O
,	,	O
with	IN	O
three	CD	O
PDS	NN	B-Disease
mutations	NNS	O
reported	VBD	O
only	RB	O
in	IN	O
individuals	NNS	O
with	IN	O
non-syndromic	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
(	-LRB-	O
V480D	NN	O
,	,	O
V653A	NN	O
and	CC	O
I490L/G497S	NN	O
)	-RRB-	O
.	.	O

The	DT	O
mutations	NNS	O
associated	VBN	O
with	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
have	VBP	O
complete	JJ	O
loss	NN	O
of	IN	O
pendrin-induced	JJ	O
chloride	NN	O
and	CC	O
iodide	NN	O
transport	NN	O
,	,	O
while	IN	O
alleles	NNS	O
unique	JJ	O
to	TO	O
people	NNS	O
with	IN	O
DFNB4	NN	B-Disease
are	VBP	O
able	JJ	O
to	TO	O
transport	VB	O
both	CC	O
iodide	NN	O
and	CC	O
chloride	NN	O
,	,	O
albeit	IN	O
at	IN	O
a	DT	O
much	RB	O
lower	JJR	O
level	NN	O
than	IN	O
wild-type	JJ	O
pendrin	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
this	DT	O
residual	JJ	O
level	NN	O
of	IN	O
anion	NN	O
transport	NN	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
eliminate	VB	O
or	CC	O
postpone	VB	O
the	DT	O
onset	NN	O
of	IN	O
goiter	NN	B-Disease
in	IN	O
individuals	NNS	O
with	IN	O
DFNB4	NN	B-Disease
.	.	O

We	PRP	O
propose	VBP	O
a	DT	O
model	NN	O
for	IN	O
pendrin	NN	O
function	NN	O
in	IN	O
the	DT	O
thyroid	NN	O
in	IN	O
which	WDT	O
pendrin	NN	O
transports	VBZ	O
iodide	NN	O
across	IN	O
the	DT	O
apical	JJ	O
membrane	NN	O
of	IN	O
the	DT	O
thyrocyte	NN	O
into	IN	O
the	DT	O
colloid	NN	O
space	NN	O
.	.	O

.	.	O

Late-onset	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
:	:	O
molecular	JJ	O
pathology	NN	O
in	IN	O
two	CD	O
siblings	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
new	JJ	O
allele	NN	O
at	IN	O
the	DT	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
locus	NN	O
causing	VBG	O
late-onset	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
that	DT	O
allele	NN	O
arginine84	NN	O
,	,	O
a	DT	O
residue	NN	O
that	WDT	O
is	VBZ	O
highly	RB	O
conserved	VBN	O
in	IN	O
the	DT	O
arylsulfatase	NN	O
gene	NN	O
family	NN	O
,	,	O
is	VBZ	O
replaced	VBN	O
by	IN	O
glutamine	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
alleles	NNS	O
that	WDT	O
cause	VBP	O
early-onset	JJ	O
MLD	NN	B-Disease
,	,	O
the	DT	O
arginine84	NN	O
to	TO	O
glutamine	NN	O
substitution	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
some	DT	O
residual	JJ	O
ARSA	NN	O
activity	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
genotypes	NNS	O
,	,	O
ARSA	NNP	O
activities	NNS	O
,	,	O
and	CC	O
clinical	JJ	O
data	NNS	O
on	IN	O
4	CD	O
individuals	NNS	O
carrying	VBG	O
the	DT	O
allele	NN	O
of	IN	O
81	CD	O
patients	NNS	O
with	IN	O
MLD	NN	B-Disease
examined	VBN	O
,	,	O
further	RB	O
validates	VBZ	O
the	DT	O
concept	NN	O
that	IN	O
different	JJ	O
degrees	NNS	O
of	IN	O
residual	JJ	O
ARSA	NN	O
activity	NN	O
are	VBP	O
the	DT	O
basis	NN	O
of	IN	O
phenotypical	JJ	O
variation	NN	O
in	IN	O
MLD	NN	B-Disease
.	.	O

.	.	O

Defective	JJ	O
CD95/APO	NN	O
-1	CD	O
/	:	O
Fas	NN	O
signal	NN	O
complex	NN	O
formation	NN	O
in	IN	O
the	DT	O
human	JJ	O
autoimmune	JJ	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
,	,	I-Disease
type	NN	I-Disease
Ia	NN	I-Disease
.	.	O

Heterozygous	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CD95	NN	O
(	-LRB-	O
APO-1	NN	O
/	:	O
Fas	NN	O
)	-RRB-	O
receptor	NN	O
occur	VBP	O
in	IN	O
most	JJS	O
individuals	NNS	O
with	IN	O
autoimmune	JJ	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ALPS	NN	B-Disease
)	-RRB-	O
and	CC	O
dominantly	RB	O
interfere	VB	O
with	IN	O
apoptosis	NN	O
by	IN	O
an	DT	O
unknown	JJ	O
mechanism	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
local	JJ	O
or	CC	O
global	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
cytoplasmic	JJ	O
death	NN	O
domain	NN	O
from	IN	O
nine	CD	O
independent	JJ	O
ALPS	NNP	B-Disease
CD95	NN	O
death-domain	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
a	DT	O
failure	NN	O
to	TO	O
bind	VB	O
the	DT	O
FADD/MORT1	NN	O
signaling	NN	O
protein	NN	O
.	.	O

Despite	IN	O
heterozygosity	NN	O
for	IN	O
the	DT	O
abnormal	JJ	O
allele	NN	O
,	,	O
lymphocytes	NNS	O
from	IN	O
ALPS	NN	B-Disease
patients	NNS	O
showed	VBD	O
markedly	RB	O
decreased	VBN	O
FADD	NN	O
association	NN	O
and	CC	O
a	DT	O
loss	NN	O
of	IN	O
caspase	NN	O
recruitment	NN	O
and	CC	O
activation	NN	O
after	IN	O
CD95	NN	O
crosslinking	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
intracytoplasmic	JJ	O
CD95	NN	O
mutations	NNS	O
in	IN	O
ALPS	NNP	B-Disease
impair	VBP	O
apoptosis	NN	O
chiefly	RB	O
by	IN	O
disrupting	VBG	O
death-domain	JJ	O
interactions	NNS	O
with	IN	O
the	DT	O
signaling	NN	O
protein	NN	O
FADD/MORT1	NN	O
.	.	O

.	.	O

Classical	JJ	B-Disease
galactosemia	NN	I-Disease
and	CC	O
mutations	NNS	O
at	IN	O
the	DT	O
galactose-1-phosphate	NN	O
uridyl	NN	O
transferase	NN	O
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

Classical	JJ	B-Disease
galactosemia	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	O
in	IN	O
activity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
galactose-1-phosphate	NN	O
uridyl	NN	O
transferase	NN	O
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
,	,	O
in	IN	O
turn	NN	O
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
GALT	NNP	O
gene	NN	O
.	.	O

The	DT	O
disorder	NN	O
exhibits	VBZ	O
considerable	JJ	O
allelic	JJ	O
heterogeneity	NN	O
and	CC	O
,	,	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
1998	CD	O
,	,	O
more	JJR	O
than	IN	O
150	CD	O
different	JJ	O
base	NN	O
changes	NNS	O
were	VBD	O
recorded	VBN	O
in	IN	O
24	CD	O
different	JJ	O
populations	NNS	O
and	CC	O
ethnic	JJ	O
groups	NNS	O
in	IN	O
15	CD	O
countries	NNS	O
worldwide	RB	O
.	.	O

The	DT	O
mutations	NNS	O
most	RBS	O
frequently	RB	O
cited	VBN	O
are	VBP	O
Q188R	NN	O
,	,	O
K285N	NN	O
,	,	O
S135L	NN	O
,	,	O
and	CC	O
N314D	NN	O
.	.	O

Q188R	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
European	JJ	O
populations	NNS	O
or	CC	O
in	IN	O
those	DT	O
predominantly	RB	O
of	IN	O
European	JJ	O
descent	NN	O
.	.	O

Overall	RB	O
,	,	O
it	PRP	O
accounts	VBZ	O
for	IN	O
60-70	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
chromosomes	NNS	O
,	,	O
but	CC	O
there	EX	O
are	VBP	O
significant	JJ	O
differences	NNS	O
in	IN	O
its	PRP$	O
relative	JJ	O
frequency	NN	O
in	IN	O
individual	JJ	O
populations	NNS	O
.	.	O

Individuals	NNS	O
homoallelic	JJ	O
for	IN	O
Q188R	NN	O
tend	VBP	O
to	TO	O
have	VB	O
a	DT	O
severe	JJ	O
phenotype	NN	O
and	CC	O
this	DT	O
is	VBZ	O
in	IN	O
keeping	VBG	O
with	IN	O
the	DT	O
virtually	RB	O
complete	JJ	O
loss	NN	O
of	IN	O
enzyme	NN	O
activity	NN	O
observed	VBN	O
in	IN	O
in	FW	O
vitro	FW	O
expression	NN	O
systems	NNS	O
.	.	O

Globally	RB	O
,	,	O
K285N	NN	O
is	VBZ	O
rarer	JJR	O
,	,	O
but	CC	O
in	IN	O
many	JJ	O
European	JJ	O
populations	NNS	O
it	PRP	O
can	MD	O
be	VB	O
found	VBN	O
on	IN	O
25-40	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
chromosomes	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
invariably	RB	O
associated	VBN	O
with	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
.	.	O

S135L	NN	O
is	VBZ	O
found	VBN	O
almost	RB	O
exclusively	RB	O
in	IN	O
African	JJ	O
Americans	NNPS	O
.	.	O

In	FW	O
vitro	FW	O
expression	NN	O
results	NNS	O
are	VBP	O
discrepant	JJ	O
,	,	O
but	CC	O
some	DT	O
individuals	NNS	O
carrying	VBG	O
S135L	NN	O
appear	VBP	O
to	TO	O
exhibit	VB	O
GALT	NNP	O
activity	NN	O
in	IN	O
some	DT	O
tissues	NNS	O
.	.	O

Duarte	NNP	O
1	CD	O
(	-LRB-	O
or	CC	O
Los	NNP	O
Angeles	NNP	O
)	-RRB-	O
and	CC	O
Duarte	NNP	O
2	CD	O
(	-LRB-	O
or	CC	O
Duarte	NNP	O
)	-RRB-	O
variants	NNS	O
carry	VBP	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
,	,	O
N314D	NN	O
,	,	O
even	RB	O
though	IN	O
D1	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
increased	VBN	O
erythrocyte	NN	O
GALT	NN	O
activity	NN	O
and	CC	O
D2	NN	O
with	IN	O
reduced	VBN	O
activity	NN	O
.	.	O

N314D	NN	O
is	VBZ	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
other	JJ	O
base	NN	O
changes	NNS	O
that	WDT	O
differ	VBP	O
on	IN	O
the	DT	O
D1	NN	O
and	CC	O
D2	NN	O
alleles	NNS	O
.	.	O

N314D	NN	O
does	VBZ	O
not	RB	O
impair	VB	O
GALT	NN	O
activity	NN	O
in	IN	O
in	FW	O
vitro	FW	O
expression	NN	O
systems	NNS	O
.	.	O

However	RB	O
,	,	O
there	EX	O
are	VBP	O
differences	NNS	O
in	IN	O
the	DT	O
abundance	NN	O
of	IN	O
GALT	NNP	O
protein	NN	O
in	IN	O
lymphoblastoid	JJ	O
cells	NNS	O
lines	NNS	O
from	IN	O
D2	NN	O
and	CC	O
D1	NN	O
individuals	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
unclear	JJ	O
whether	IN	O
the	DT	O
specific	JJ	O
molecular	JJ	O
changes	NNS	O
that	WDT	O
distinguish	VBP	O
the	DT	O
D1	NN	O
and	CC	O
D2	NN	O
alleles	NNS	O
account	VBP	O
for	IN	O
the	DT	O
different	JJ	O
activities	NNS	O
.	.	O

The	DT	O
considerable	JJ	O
genetic	JJ	O
heterogeneity	NN	O
documented	VBN	O
to	TO	O
date	NN	O
undoubtedly	RB	O
contributes	VBZ	O
to	TO	O
the	DT	O
phenotypic	JJ	O
heterogeneity	NN	O
that	WDT	O
is	VBZ	O
observed	VBN	O
in	IN	O
galactosemia	NN	B-Disease
.	.	O

The	DT	O
additional	JJ	O
effects	NNS	O
of	IN	O
nonallelic	JJ	O
variation	NN	O
and	CC	O
other	JJ	O
constitutional	JJ	O
factors	NNS	O
on	IN	O
phenotypic	JJ	O
variability	NN	O
remain	VBP	O
to	TO	O
be	VB	O
elucidated	VBN	O
.	.	O

.	.	O

X-linked	JJ	B-Disease
retinoschisis	NN	I-Disease
with	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
.	.	O

BACKGROUND	NN	O
X-linked	JJ	B-Disease
retinoschisis	NN	I-Disease
(	-LRB-	O
XLRS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
relatively	RB	O
rare	JJ	O
vitreoretinal	JJ	B-Disease
dystrophy	NN	I-Disease
that	WDT	O
causes	VBZ	O
visual	JJ	B-Disease
loss	NN	I-Disease
in	IN	O
young	JJ	O
men	NNS	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
this	DT	O
disease	NN	O
,	,	O
designated	VBN	O
XLRS1	NN	O
,	,	O
was	VBD	O
identified	VBN	O
,	,	O
and	CC	O
several	JJ	O
deleterious	JJ	O
gene	NN	O
mutations	NNS	O
were	VBD	O
reported	VBN	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
analyze	VB	O
Japanese	JJ	O
patients	NNS	O
clinically	RB	O
diagnosed	VBD	O
as	IN	O
having	VBG	O
XLRS	NN	B-Disease
formutational	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
.	.	O

METHODS	NNS	O
Ten	CD	O
patients	NNS	O
with	IN	O
XLRS	NN	B-Disease
underwent	VBD	O
full	JJ	O
ophthalmologic	JJ	O
examination	NN	O
,	,	O
including	VBG	O
slitlamp	NN	O
biomicroscopy	NN	O
and	CC	O
dilated	JJ	O
funduscopy	NN	O
.	.	O

Genomic	JJ	O
DNA	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
leukocytes	NNS	O
,	,	O
and	CC	O
all	DT	O
exons	NNS	O
of	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
were	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
analyzed	VBN	O
using	VBG	O
a	DT	O
direct	JJ	O
sequencing	NN	O
method	NN	O
.	.	O

RESULTS	NNS	O
Point	VBP	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
10	CD	O
patients	NNS	O
.	.	O

The	DT	O
mutations	NNS	O
were	VBD	O
identical	JJ	O
in	IN	O
each	DT	O
of	IN	O
2	CD	O
pairs	NNS	O
of	IN	O
brothers	NNS	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
point	NN	O
mutations	NNS	O
represented	VBD	O
missense	NN	O
mutations	NNS	O
,	,	O
1	CD	O
was	VBD	O
a	DT	O
nonsense	NN	O
mutation	NN	O
,	,	O
and	CC	O
1	CD	O
was	VBD	O
a	DT	O
frameshift	NN	O
mutation	NN	O
.	.	O

Five	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
are	VBP	O
newly	RB	O
reported	VBN	O
herein	RB	O
.	.	O

CONCLUSIONS	NNS	O
The	DT	O
discovery	NN	O
of	IN	O
new	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
this	DT	O
study	NN	O
increases	VBZ	O
the	DT	O
available	JJ	O
information	NN	O
regarding	VBG	O
the	DT	O
spectrum	NN	O
of	IN	O
genetic	JJ	B-Disease
abnormalities	NNS	I-Disease
and	CC	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
XLRS	NN	B-Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
limited	JJ	O
data	NNS	O
failed	VBD	O
to	TO	O
reveal	VB	O
a	DT	O
correlation	NN	O
between	IN	O
mutation	NN	O
and	CC	O
disease	NN	O
phenotype	NN	O
.	.	O

CLINICAL	JJ	O
RELEVANCE	NN	O
Identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
and	CC	O
expanded	VBN	O
information	NN	O
on	IN	O
clinical	JJ	O
manifestations	NNS	O
will	MD	O
facilitate	VB	O
early	JJ	O
diagnosis	NN	O
,	,	O
appropriate	JJ	O
early	JJ	O
therapy	NN	O
,	,	O
and	CC	O
genetic	JJ	O
counseling	NN	O
regarding	VBG	O
the	DT	O
prognosis	NN	O
of	IN	O
XLRS	NN	B-Disease
.	.	O

.	.	O

Relationship	NN	O
among	IN	O
genotype	NN	O
,	,	O
biochemical	JJ	O
phenotype	NN	O
,	,	O
and	CC	O
cognitive	JJ	O
performance	NN	O
in	IN	O
females	NNS	O
with	IN	O
phenylalanine	NN	B-Disease
hydroxylase	NN	I-Disease
deficiency	NN	I-Disease
:	:	O
report	NN	O
from	IN	O
the	DT	O
Maternal	NNP	B-Disease
Phenylketonuria	NNP	I-Disease
Collaborative	NNP	O
Study	NNP	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
examine	VB	O
the	DT	O
relationship	NN	O
of	IN	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
genotypes	NNS	O
to	TO	O
biochemical	JJ	O
phenotype	NN	O
and	CC	O
cognitive	JJ	O
development	NN	O
in	IN	O
maternal	JJ	B-Disease
phenylketonuria	NN	I-Disease
(	-LRB-	O
PKU	NN	B-Disease
)	-RRB-	O
.	.	O

METHODOLOGY	NN	O
PAH	NN	O
gene	NN	O
mutations	NNS	O
were	VBD	O
examined	VBN	O
in	IN	O
222	CD	O
hyperphenylalaninemic	JJ	B-Disease
females	NNS	O
enrolled	VBN	O
in	IN	O
the	DT	O
Maternal	JJ	B-Disease
PKU	NNP	I-Disease
Collaborative	NNP	O
Study	NNP	O
(	-LRB-	O
MPKUCS	NNP	O
)	-RRB-	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
84	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
,	,	O
and	CC	O
complete	JJ	O
genotype	NN	O
was	VBD	O
obtained	VBN	O
in	IN	O
199	CD	O
individuals	NNS	O
.	.	O

Based	VBN	O
on	IN	O
previous	JJ	O
knowledge	NN	O
about	IN	O
mutation-phenotype	JJ	O
associations	NNS	O
,	,	O
78	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
could	MD	O
be	VB	O
assigned	VBN	O
to	TO	O
one	CD	O
of	IN	O
four	CD	O
classes	NNS	O
of	IN	O
severity	NN	O
(	-LRB-	O
severe	JJ	O
PKU	NN	B-Disease
,	,	O
moderate	JJ	O
PKU	NNP	B-Disease
,	,	O
mild	JJ	O
PKU	NNP	B-Disease
,	,	O
and	CC	O
mild	JJ	B-Disease
hyperphenylalaninemia	NN	I-Disease
[	-LRB-	O
MHP	NN	B-Disease
]	-RRB-	O
)	-RRB-	O
.	.	O

Then	RB	O
,	,	O
189	CD	O
MPKUCS	NN	O
subjects	NNS	O
were	VBD	O
grouped	VBN	O
according	VBG	O
to	TO	O
the	DT	O
various	JJ	O
combinations	NNS	O
of	IN	O
mutation	NN	O
classifications	NNS	O
.	.	O

The	DT	O
sample	NN	O
sizes	NNS	O
were	VBD	O
large	JJ	O
enough	RB	O
for	IN	O
statistical	JJ	O
testing	NN	O
in	IN	O
four	CD	O
groups	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
mutation	NN	O
that	WDT	O
completely	RB	O
abolishes	VBZ	O
enzyme	NN	O
activity	NN	O
.	.	O

These	DT	O
patients	NNS	O
are	VBP	O
considered	VBN	O
functionally	RB	O
hemizygous	JJ	O
.	.	O

RESULTS	NNS	O
The	DT	O
biochemical	JJ	O
phenotype	NN	O
predicted	VBN	O
from	IN	O
the	DT	O
genotype	NN	O
in	IN	O
functionally	RB	O
hemizygous	JJ	O
patients	NNS	O
was	VBD	O
related	JJ	O
significantly	RB	O
to	TO	O
the	DT	O
assigned	VBN	O
phenylalanine	NN	O
level	NN	O
.	.	O

Cognitive	JJ	O
performance	NN	O
(	-LRB-	O
IQ	NNP	O
)	-RRB-	O
was	VBD	O
also	RB	O
significantly	RB	O
related	JJ	O
to	TO	O
genotype	NN	O
.	.	O

The	DT	O
IQ	NNP	O
of	IN	O
PAH-deficient	JJ	B-Disease
mothers	NNS	O
with	IN	O
a	DT	O
severe	JJ	O
PKU	NN	B-Disease
mutation	NN	O
in	IN	O
combination	NN	O
with	IN	O
a	DT	O
MHP	NN	B-Disease
mutation	NN	O
or	CC	O
a	DT	O
mild	JJ	O
PKU	NN	B-Disease
mutation	NN	O
was	VBD	O
99	CD	O
and	CC	O
96	CD	O
,	,	O
respectively	RB	O
,	,	O
whereas	IN	O
the	DT	O
IQ	NNP	O
of	IN	O
PKU	NNP	B-Disease
mothers	NNS	O
with	IN	O
two	CD	O
severe	JJ	O
PKU	NN	B-Disease
mutations	NNS	O
or	CC	O
with	IN	O
one	CD	O
severe	JJ	O
and	CC	O
one	CD	O
moderate	JJ	O
PKU	NN	B-Disease
mutation	NN	O
was	VBD	O
83	CD	O
and	CC	O
84	CD	O
,	,	O
respectively	RB	O
.	.	O

Of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
PKU	NN	B-Disease
,	,	O
92	CD	O
%	NN	O
had	VBD	O
been	VBN	O
treated	VBN	O
during	IN	O
childhood	NN	O
.	.	O

Those	DT	O
who	WP	O
were	VBD	O
untreated	JJ	O
or	CC	O
treated	VBN	O
late	RB	O
had	VBD	O
lower	JJR	O
than	IN	O
average	JJ	O
IQ	NNP	O
scores	NNS	O
for	IN	O
their	PRP$	O
group	NN	O
of	IN	O
mutation	NN	O
combinations	NNS	O
.	.	O

Females	NNS	O
with	IN	O
moderate	JJ	O
or	CC	O
mild	JJ	O
PKU	NN	B-Disease
who	WP	O
were	VBD	O
treated	VBN	O
early	RB	O
and	CC	O
treated	VBN	O
for	IN	O
>	JJR	O
6	CD	O
years	NNS	O
showed	VBD	O
IQ	NNP	O
scores	NNS	O
10	CD	O
points	NNS	O
above	IN	O
average	NN	O
for	IN	O
their	PRP$	O
group	NN	O
.	.	O

CONCLUSIONS	NNS	O
The	DT	O
reproductive	JJ	O
outcome	NN	O
in	IN	O
maternal	JJ	B-Disease
phenylketonuria	NN	I-Disease
is	VBZ	O
dependent	JJ	O
on	IN	O
prenatal	JJ	O
metabolic	JJ	O
control	NN	O
and	CC	O
postnatal	JJ	O
environmental	JJ	O
circumstances	NNS	O
.	.	O

Both	DT	O
factors	NNS	O
depend	VBP	O
on	IN	O
the	DT	O
intellectual	JJ	O
resources	NNS	O
of	IN	O
the	DT	O
mother	NN	O
with	IN	O
PKU	NN	B-Disease
.	.	O

The	DT	O
significant	JJ	O
relationship	NN	O
among	IN	O
genotype	NN	O
,	,	O
biochemical	JJ	O
phenotype	NN	O
,	,	O
and	CC	O
cognitive	JJ	O
performance	NN	O
observed	VBN	O
in	IN	O
the	DT	O
present	JJ	O
study	NN	O
is	VBZ	O
of	IN	O
importance	NN	O
for	IN	O
the	DT	O
development	NN	O
of	IN	O
an	DT	O
optimal	JJ	O
strategy	NN	O
for	IN	O
future	JJ	O
treatment	NN	O
of	IN	O
females	NNS	O
with	IN	O
PKU	NN	B-Disease
who	WP	O
plan	VBP	O
pregnancy	NN	O
.	.	O

.	.	O

Uncoupling	NN	O
of	IN	O
hypomyelination	NN	B-Disease
and	CC	O
glial	JJ	B-Disease
cell	NN	I-Disease
death	NN	I-Disease
by	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
gene	NN	O
.	.	O

Proteolipid	JJ	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
;	:	O
M	NN	O
(	-LRB-	O
r	NN	O
)	-RRB-	O
30	CD	O
,	,	O
000	CD	O
)	-RRB-	O
is	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
major	JJ	O
polytopic	JJ	O
membrane	NN	O
protein	NN	O
in	IN	O
myelin	JJ	O
but	CC	O
its	PRP$	O
cellular	JJ	O
function	NN	O
remains	VBZ	O
obscure	JJ	O
.	.	O

Neurological	JJ	O
mutant	JJ	O
mice	NNS	O
can	MD	O
often	RB	O
provide	VB	O
model	NN	O
systems	NNS	O
for	IN	O
human	JJ	O
genetic	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
X-chromosome-linked	JJ	O
PLP	NN	O
gene	NN	O
are	VBP	O
lethal	JJ	O
,	,	O
identified	VBN	O
first	RB	O
in	IN	O
the	DT	O
jimpy	NN	O
mouse	NN	O
and	CC	O
subsequently	RB	O
in	IN	O
patients	NNS	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
unexplained	JJ	O
phenotype	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
includes	VBZ	O
degeneration	NN	B-Disease
and	CC	I-Disease
premature	JJ	I-Disease
cell	NN	I-Disease
death	NN	I-Disease
of	IN	I-Disease
oligodendrocytes	NNS	I-Disease
with	IN	O
associated	VBN	O
hypomyelination	NN	B-Disease
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
a	DT	O
new	JJ	O
mouse	NN	O
mutant	JJ	O
rumpshaker	NN	O
is	VBZ	O
defined	VBN	O
by	IN	O
the	DT	O
amino-acid	JJ	O
substitution	NN	O
Ile-to-Thr	NN	O
at	IN	O
residue	NN	O
186	CD	O
in	IN	O
a	DT	O
membrane-embedded	JJ	O
domain	NN	O
of	IN	O
PLP	NN	O
.	.	O

Surprisingly	RB	O
,	,	O
rumpshaker	NN	O
mice	NNS	O
,	,	O
although	IN	O
myelin-deficient	JJ	B-Disease
,	,	O
have	VBP	O
normal	JJ	O
longevity	NN	O
and	CC	O
a	DT	O
full	JJ	O
complement	NN	O
of	IN	O
morphologically	RB	O
normal	JJ	O
oligodendrocytes	NNS	O
.	.	O

Hypomyelination	NN	B-Disease
can	MD	O
thus	RB	O
be	VB	O
genetically	RB	O
separated	VBN	O
from	IN	O
the	DT	O
PLP-dependent	JJ	O
oligodendrocyte	NN	B-Disease
degeneration	NN	I-Disease
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
PLP	NN	O
has	VBZ	O
a	DT	O
vital	JJ	O
function	NN	O
in	IN	O
glial	JJ	O
cell	NN	O
development	NN	O
,	,	O
distinct	JJ	O
from	IN	O
its	PRP$	O
later	JJ	O
role	NN	O
in	IN	O
myelin	JJ	O
assembly	NN	O
,	,	O
and	CC	O
that	IN	O
this	DT	O
dichotomy	NN	O
of	IN	O
action	NN	O
may	MD	O
explain	VB	O
the	DT	O
clinical	JJ	O
spectrum	NN	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

.	.	O

Mutational	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
HGO	NNP	O
gene	NN	O
in	IN	O
Finnish	JJ	O
alkaptonuria	NN	B-Disease
patients	NNS	O
.	.	O

Alkaptonuria	NN	B-Disease
(	-LRB-	O
AKU	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
prototypic	JJ	O
inborn	JJ	B-Disease
error	NN	I-Disease
of	IN	I-Disease
metabolism	NN	I-Disease
,	,	O
has	VBZ	O
recently	RB	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
loss	NN	O
of	IN	O
function	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
homogentisate-1	NN	O
,	,	O
2-dioxygenase	JJ	O
gene	NN	O
(	-LRB-	O
HGO	NN	O
)	-RRB-	O
.	.	O

So	RB	O
far	RB	O
17	CD	O
mutations	NNS	O
have	VBP	O
been	VBN	O
characterised	VBN	O
in	IN	O
AKU	NN	B-Disease
patients	NNS	O
of	IN	O
different	JJ	O
ethnic	JJ	O
origin	NN	O
.	.	O

We	PRP	O
describe	VBP	O
three	CD	O
novel	JJ	O
mutations	NNS	O
(	-LRB-	O
R58fs	NNS	O
,	,	O
R330S	NN	O
,	,	O
and	CC	O
H371R	NN	O
)	-RRB-	O
and	CC	O
one	CD	O
common	JJ	O
AKU	NN	B-Disease
mutation	NN	O
(	-LRB-	O
M368V	NN	O
)	-RRB-	O
,	,	O
detected	VBN	O
by	IN	O
mutational	JJ	O
and	CC	O
polymorphism	NN	O
analysis	NN	O
of	IN	O
the	DT	O
HGO	NNP	O
gene	NN	O
in	IN	O
five	CD	O
Finnish	JJ	O
AKU	NN	B-Disease
pedigrees	NNS	O
.	.	O

The	DT	O
three	CD	O
novel	JJ	O
AKU	NN	B-Disease
mutations	NNS	O
are	VBP	O
most	RBS	O
likely	JJ	O
specific	JJ	O
for	IN	O
the	DT	O
Finnish	JJ	O
population	NN	O
and	CC	O
have	VBP	O
originated	VBN	O
recently	RB	O
.	.	O

.	.	O

Putative	JJ	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
gene	NN	O
shares	NNS	O
unexpected	JJ	O
homology	NN	O
with	IN	O
ABC	NNP	O
transporters	NNS	O
.	.	O

Adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
disease	NN	I-Disease
affecting	VBG	O
1/20	CD	O
,	,	O
000	CD	O
males	NNS	O
either	CC	O
as	IN	O
cerebral	JJ	B-Disease
ALD	NN	I-Disease
in	IN	O
childhood	NN	O
or	CC	O
as	IN	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
in	IN	O
adults	NNS	O
.	.	O

Childhood	NN	O
ALD	NN	B-Disease
is	VBZ	O
the	DT	O
more	RBR	O
severe	JJ	O
form	NN	O
,	,	O
with	IN	O
onset	NN	O
of	IN	O
neurological	JJ	O
symptoms	NNS	O
between	IN	O
5-12	CD	O
years	NNS	O
of	IN	O
age	NN	O
.	.	O

Central	NNP	B-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
demyelination	NN	I-Disease
progresses	VBZ	O
rapidly	RB	O
and	CC	O
death	NN	O
occurs	VBZ	O
within	IN	O
a	DT	O
few	JJ	O
years	NNS	O
.	.	O

AMN	NNP	B-Disease
is	VBZ	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
with	IN	O
onset	NN	O
at	IN	O
15-30	CD	O
years	NNS	O
of	IN	O
age	NN	O
and	CC	O
a	DT	O
more	RBR	O
progressive	JJ	O
course	NN	O
.	.	O

Adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
(	-LRB-	O
Addisons	JJ	B-Disease
disease	NN	I-Disease
)	-RRB-	O
may	MD	O
remain	VB	O
the	DT	O
only	JJ	O
clinical	JJ	O
manifestation	NN	O
of	IN	O
ALD	NN	B-Disease
.	.	O

The	DT	O
principal	JJ	O
biochemical	JJ	O
abnormality	NN	O
of	IN	O
ALD	NN	B-Disease
is	VBZ	O
the	DT	O
accumulation	NN	O
of	IN	O
very-long-chain	JJ	O
fatty	JJ	O
acids	NNS	O
(	-LRB-	O
VLCFA	NN	O
)	-RRB-	O
because	IN	O
of	IN	O
impaired	JJ	O
beta-oxidation	NN	O
in	IN	O
peroxisomes	NNS	O
.	.	O

The	DT	O
normal	JJ	O
oxidation	NN	O
of	IN	O
VLCFA-CoA	NN	O
in	IN	O
patients	NNS	O
fibroblasts	NNS	O
suggested	VBD	O
that	IN	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
the	DT	O
VLCFA-CoA	NN	O
synthetase	NN	O
could	MD	O
be	VB	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
ALD	NNP	B-Disease
.	.	O

Here	RB	O
we	PRP	O
use	VBP	O
positional	JJ	O
cloning	VBG	O
to	TO	O
identify	VB	O
a	DT	O
gene	NN	O
partially	RB	O
deleted	VBN	O
in	IN	O
6	CD	O
of	IN	O
85	CD	O
independent	JJ	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
.	.	O

In	IN	O
familial	JJ	O
cases	NNS	O
,	,	O
the	DT	O
deletions	NNS	O
segregated	VBN	O
with	IN	O
the	DT	O
disease	NN	O
.	.	O

An	DT	O
identical	JJ	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
brothers	NNS	O
presenting	VBG	O
with	IN	O
different	JJ	O
clinical	JJ	O
ALD	NN	B-Disease
phenotypes	NNS	O
.	.	O

Candidate	NN	O
exons	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
computer	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
sequences	NNS	O
and	CC	O
used	VBN	O
to	TO	O
isolate	VB	O
complementary	JJ	O
DNAs	NNS	O
by	IN	O
exon	NN	O
connection	NN	O
and	CC	O
screening	NN	O
of	IN	O
cDNA	NN	O
libraries	NNS	O
.	.	O

The	DT	O
deduced	VBN	O
protein	NN	O
sequence	NN	O
shows	VBZ	O
significant	JJ	O
sequence	NN	O
identity	NN	O
to	TO	O
a	DT	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
of	IN	O
M	NN	O
(	-LRB-	O
r	NN	O
)	-RRB-	O
70K	NN	O
that	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
peroxisome	NN	O
biogenesis	NN	O
and	CC	O
belongs	VBZ	O
to	TO	O
the	DT	O
ATP-binding	JJ	O
cassette	NN	O
superfamily	NN	O
of	IN	O
transporters	NNS	O
.	.	O

.	.	O

Cardiac	JJ	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
channel	NN	O
dysfunction	NN	O
in	IN	O
Brugada	NNP	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
aggravated	VBN	O
by	IN	O
beta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
-	:	O
subunit	NN	O
.	.	O

BACKGROUND	NN	O
Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
human	JJ	O
cardiac	JJ	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
channel	NN	O
alpha-subunit	NN	O
(	-LRB-	O
hH1	NN	O
)	-RRB-	O
are	VBP	O
responsible	JJ	O
for	IN	O
chromosome	NN	O
3-linked	JJ	O
congenital	JJ	B-Disease
long-QT	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
LQT3	NN	B-Disease
)	-RRB-	O
and	CC	O
idiopathic	JJ	B-Disease
ventricular	JJ	I-Disease
fibrillation	NN	I-Disease
(	-LRB-	O
IVF	NN	B-Disease
)	-RRB-	O
.	.	O

An	DT	O
auxiliary	NN	O
beta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
-	:	O
subunit	NN	O
,	,	O
widely	RB	O
expressed	VBN	O
in	IN	O
excitable	JJ	O
tissues	NNS	O
,	,	O
shifts	VBZ	O
the	DT	O
voltage	NN	O
dependence	NN	O
of	IN	O
steady-state	JJ	O
inactivation	NN	O
toward	IN	O
more	RBR	O
negative	JJ	O
potentials	NNS	O
and	CC	O
restores	VBZ	O
normal	JJ	O
gating	VBG	O
kinetics	NNS	O
of	IN	O
brain	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
channels	NNS	O
expressed	VBN	O
in	IN	O
Xenopus	NN	O
oocytes	NNS	O
but	CC	O
has	VBZ	O
little	JJ	O
if	IN	O
any	DT	O
functional	JJ	O
effect	NN	O
on	IN	O
the	DT	O
cardiac	JJ	O
isoform	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
characterize	VBP	O
the	DT	O
altered	JJ	O
effects	NNS	O
of	IN	O
a	DT	O
human	JJ	O
beta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
-	:	O
subunit	NN	O
(	-LRB-	O
hbeta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
)	-RRB-	O
on	IN	O
the	DT	O
heterologously	RB	O
expressed	VBN	O
hH1	NN	O
mutation	NN	O
(	-LRB-	O
T1620M	NN	O
)	-RRB-	O
previously	RB	O
associated	VBN	O
with	IN	O
IVF	NN	B-Disease
.	.	O

METHODS	NNS	O
AND	CC	O
RESULTS	NNS	O
When	WRB	O
expressed	VBN	O
alone	RB	O
in	IN	O
Xenopus	NN	O
oocytes	NNS	O
,	,	O
T1620M	NN	O
exhibited	VBD	O
no	DT	O
persistent	JJ	O
currents	NNS	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
the	DT	O
LQT3	NN	B-Disease
mutant	NN	O
channels	NNS	O
,	,	O
but	CC	O
the	DT	O
midpoint	NN	O
of	IN	O
steady-state	JJ	O
inactivation	NN	O
(	-LRB-	O
V	NN	O
(	-LRB-	O
1/2	CD	O
)	-RRB-	O
)	-RRB-	O
was	VBD	O
significantly	RB	O
shifted	VBN	O
toward	IN	O
more	RBR	O
positive	JJ	O
potentials	NNS	O
than	IN	O
for	IN	O
wild-type	JJ	O
hH1	NN	O
.	.	O

Coexpression	NN	O
of	IN	O
hbeta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
did	VBD	O
not	RB	O
significantly	RB	O
alter	VB	O
current	JJ	O
decay	NN	O
or	CC	O
recovery	NN	O
from	IN	O
inactivation	NN	O
of	IN	O
wild-type	JJ	O
hH1	NN	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
further	RB	O
shifted	VBD	O
the	DT	O
V	NN	O
(	-LRB-	O
1/2	CD	O
)	-RRB-	O
and	CC	O
accelerated	VBD	O
the	DT	O
recovery	NN	O
from	IN	O
inactivation	NN	O
of	IN	O
T1620M	NN	O
.	.	O

Oocyte	NN	O
macropatch	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
activation	NN	O
kinetics	NNS	O
of	IN	O
T1620M	NN	O
were	VBD	O
normal	JJ	O
.	.	O

CONCLUSIONS	NNS	O
It	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
coexpression	NN	O
of	IN	O
hbeta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
exposes	VBZ	O
a	DT	O
more	RBR	O
severe	JJ	O
functional	JJ	O
defect	NN	O
that	WDT	O
results	VBZ	O
in	IN	O
a	DT	O
greater	JJR	O
overlap	VBP	O
in	IN	O
the	DT	O
relationship	NN	O
between	IN	O
channel	NN	O
inactivation	NN	O
and	CC	O
activation	NN	O
(	-LRB-	O
window	NN	O
current	JJ	O
)	-RRB-	O
in	IN	O
T1620M	NN	O
,	,	O
which	WDT	O
is	VBZ	O
proposed	VBN	O
to	TO	O
be	VB	O
a	DT	O
potential	JJ	O
pathophysiological	JJ	O
mechanism	NN	O
of	IN	O
IVF	NN	B-Disease
in	FW	O
vivo	FW	O
.	.	O

One	CD	O
possible	JJ	O
explanation	NN	O
for	IN	O
our	PRP$	O
finding	NN	O
is	VBZ	O
an	DT	O
altered	JJ	O
alpha	NN	O
-	:	O
/	:	O
beta	NN	O
(	-LRB-	O
1	CD	O
)	-RRB-	O
-	:	O
subunit	NN	O
association	NN	O
in	IN	O
the	DT	O
mutant	NN	O
.	.	O

.	.	O

Autosomal	JJ	B-Disease
recessive	JJ	I-Disease
familial	JJ	I-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
with	IN	O
continued	JJ	O
secretion	NN	O
of	IN	O
mutant	JJ	O
weakly	RB	O
active	JJ	O
vasopressin	NN	O
.	.	O

Familial	JJ	B-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
post-natal	JJ	O
development	NN	O
of	IN	O
arginine	NN	B-Disease
vasopressin	NN	I-Disease
(	-LRB-	I-Disease
AVP	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
due	JJ	O
to	TO	O
mutations	NNS	O
in	IN	O
the	DT	O
AVP	NN	O
gene	NN	O
.	.	O

All	DT	O
published	VBN	O
mutations	NNS	O
affect	VBP	O
the	DT	O
signal	NN	O
peptide	NN	O
or	CC	O
the	DT	O
neurophysin-II	JJ	O
carrier	NN	O
protein	NN	O
and	CC	O
are	VBP	O
presumed	VBN	O
to	TO	O
interfere	VB	O
with	IN	O
processing	NN	O
of	IN	O
the	DT	O
preprohormone	NN	O
,	,	O
leading	VBG	O
to	TO	O
neuronal	JJ	B-Disease
damage	NN	I-Disease
.	.	O

We	PRP	O
studied	VBD	O
an	DT	O
unusual	JJ	O
Palestinian	NN	O
family	NN	O
consisting	VBG	O
of	IN	O
asymptomatic	JJ	O
first	JJ	O
cousin	NN	O
parents	NNS	O
and	CC	O
three	CD	O
children	NNS	O
affected	VBN	O
with	IN	O
neurohypophyseal	JJ	B-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
,	,	O
suggesting	VBG	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
.	.	O

All	DT	O
three	CD	O
affected	JJ	O
children	NNS	O
were	VBD	O
homozygous	JJ	O
and	CC	O
the	DT	O
parents	NNS	O
heterozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
novel	JJ	O
mutation	NN	O
(	-LRB-	O
C301	NN	O
-	:	O
>	JJR	O
T	NN	O
)	-RRB-	O
in	IN	O
exon	NN	O
1	CD	O
,	,	O
replacing	VBG	O
Pro7	NN	O
of	IN	O
mature	JJ	O
AVP	NN	O
with	IN	O
Leu	NN	O
(	-LRB-	O
Leu-AVP	NN	O
)	-RRB-	O
.	.	O

Leu-AVP	NN	O
was	VBD	O
a	DT	O
weak	JJ	O
agonist	NN	O
with	IN	O
approximately	RB	O
30-fold	RB	O
reduced	VBN	O
binding	NN	O
to	TO	O
the	DT	O
human	JJ	O
V2	NN	O
receptor	NN	O
.	.	O

Measured	VBN	O
by	IN	O
radioimmunoassay	NN	O
with	IN	O
a	DT	O
synthetic	JJ	O
Leu-AVP	JJ	O
standard	NN	O
,	,	O
serum	NN	O
Leu-AVP	NN	O
levels	NNS	O
were	VBD	O
elevated	JJ	O
in	IN	O
all	DT	O
three	CD	O
children	NNS	O
and	CC	O
further	RB	O
increased	VBN	O
during	IN	O
water	NN	O
deprivation	NN	O
to	TO	O
as	RB	O
high	JJ	O
as	IN	O
30	CD	O
times	NNS	O
normal	JJ	O
.	.	O

The	DT	O
youngest	JJS	O
child	NN	O
(	-LRB-	O
2	CD	O
years	NNS	O
old	JJ	O
)	-RRB-	O
was	VBD	O
only	RB	O
mildly	RB	O
affected	VBN	O
but	CC	O
had	VBD	O
Leu-AVP	JJ	O
levels	NNS	O
similar	JJ	O
to	TO	O
her	PRP$	O
severely	RB	O
affected	VBN	O
8-year-old	JJ	O
brother	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
unknown	JJ	O
mechanisms	NNS	O
may	MD	O
partially	RB	O
compensate	VB	O
for	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
active	JJ	I-Disease
AVP	NN	I-Disease
in	IN	O
very	RB	O
young	JJ	O
children	NNS	O
.	.	O

.	.	O

Autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
linked	VBN	O
to	TO	O
the	DT	O
chromosome	NN	O
11p13	NN	O
markers	NNS	O
catalase	NN	O
and	CC	O
D11S151	NN	O
in	IN	O
a	DT	O
large	JJ	O
Dutch	JJ	O
family	NN	O
.	.	O

In	IN	O
a	DT	O
large	JJ	O
pedigree	NN	O
with	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
,	,	O
we	PRP	O
found	VBD	O
close	RB	O
linkage	NN	O
between	IN	O
the	DT	O
aniridia	NN	B-Disease
locus	NN	O
AN2	NN	O
and	CC	O
the	DT	O
markers	NNS	O
catalase	NN	O
(	-LRB-	O
CAT	NN	O
)	-RRB-	O
(	-LRB-	O
zeta	NN	O
=	JJ	O
7	CD	O
.	.	O

27	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
)	-RRB-	O
and	CC	O
D11S151	NN	O
(	-LRB-	O
zeta	NN	O
=	JJ	O
3	CD	O
.	.	O

86	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

10	CD	O
)	-RRB-	O
flanking	VBG	O
the	DT	O
AN2	NN	O
locus	NN	O
on	IN	O
11p13	NN	O
.	.	O

Positive	JJ	O
lod	NN	O
scores	NNS	O
were	VBD	O
also	RB	O
obtained	VBN	O
for	IN	O
the	DT	O
11p13	NN	O
----	:	O
11p14	NN	O
markers	NNS	O
D11S16	NN	O
and	CC	O
FSHB	NN	O
with	IN	O
the	DT	O
linkage	NN	O
group	NN	O
CAT/AN2/D11S151	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
mutation	NN	O
at	IN	O
the	DT	O
AN2	NN	O
locus	NN	O
on	IN	O
11p13	NN	O
.	.	O

We	PRP	O
have	VBP	O
excluded	VBN	O
linkage	NN	O
(	-LRB-	O
zeta	NN	O
less	JJR	O
than	IN	O
-2	CD	O
at	IN	O
theta	NN	O
less	RBR	O
than	IN	O
0	CD	O
.	.	O

18	CD	O
)	-RRB-	O
between	IN	O
the	DT	O
aniridia	NN	B-Disease
and	CC	O
the	DT	O
chromosome	NN	O
2p25	CD	O
marker	NN	O
D2S1	NN	O
(	-LRB-	O
linked	VBN	O
to	TO	O
ACP1	NN	O
)	-RRB-	O
.	.	O

Knobloch	NNP	B-Disease
syndrome	NN	I-Disease
involving	VBG	O
midline	NN	B-Disease
scalp	NN	I-Disease
defect	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
frontal	JJ	I-Disease
region	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
4-year-old	JJ	O
boy	NN	O
with	IN	O
Knobloch	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

He	PRP	O
has	VBZ	O
vitreoretinal	JJ	B-Disease
degeneration	NN	I-Disease
,	,	O
high	JJ	B-Disease
myopia	NN	I-Disease
,	,	O
cataract	NN	B-Disease
,	,	O
telecanthus	NN	B-Disease
,	,	O
hypertelorism	NN	B-Disease
,	,	O
and	CC	O
a	DT	O
high-arched	JJ	B-Disease
palate	NN	I-Disease
.	.	O

He	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
defect	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
anterior	JJ	I-Disease
midline	NN	I-Disease
scalp	NN	I-Disease
with	IN	O
involvement	NN	O
of	IN	O
the	DT	O
frontal	JJ	O
bone	NN	O
as	IN	O
documented	VBN	O
by	IN	O
a	DT	O
computed	JJ	O
tomography	NN	O
(	-LRB-	O
CT	NN	O
)	-RRB-	O
scan	VBP	O
.	.	O

The	DT	O
brain	NN	O
was	VBD	O
normal	JJ	O
on	IN	O
CT	NN	O
scan	VB	O
and	CC	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
review	NN	O
of	IN	O
the	DT	O
23	CD	O
published	VBN	O
cases	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O

Our	PRP$	O
patient	NN	O
illustrates	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
investigating	VBG	O
for	IN	O
underlying	VBG	O
ocular	JJ	O
and	CC	O
central	JJ	O
nervous	JJ	O
system	NN	O
pathology	NN	O
whenever	WRB	O
midline	NN	B-Disease
scalp	NN	I-Disease
defects	NNS	I-Disease
are	VBP	O
present	JJ	O
.	.	O

.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
:	:	O
phenotypic	JJ	O
variability	NN	O
in	IN	O
two	CD	O
families	NNS	O
carrying	VBG	O
the	DT	O
same	JJ	O
PDS	NN	B-Disease
missense	NN	O
mutation	NN	O
.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
comprises	VBZ	O
congenital	JJ	B-Disease
sensorineural	JJ	I-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
,	,	O
thyroid	NN	B-Disease
goiter	NN	I-Disease
,	,	O
and	CC	O
positive	JJ	O
perchlorate	NN	O
discharge	NN	O
test	NN	O
.	.	O

Recently	RB	O
,	,	O
this	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
an	DT	O
anion	NN	O
transporter	NN	O
called	VBN	O
pendrin	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
two	CD	O
consanguineous	JJ	O
large	JJ	O
families	NNS	O
from	IN	O
Southern	NNP	O
Tunisia	NNP	O
comprising	VBG	O
a	DT	O
total	NN	O
of	IN	O
23	CD	O
individuals	NNS	O
affected	VBN	O
with	IN	O
profound	JJ	O
congenital	JJ	B-Disease
deafness	NN	I-Disease
;	:	O
the	DT	O
same	JJ	O
missense	NN	O
mutation	NN	O
,	,	O
L445W	NN	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
affected	VBN	O
individuals	NNS	O
.	.	O

A	DT	O
widened	VBD	B-Disease
vestibular	JJ	I-Disease
aqueduct	NN	I-Disease
was	VBD	O
found	VBN	O
in	IN	O
all	DT	O
patients	NNS	O
who	WP	O
underwent	VBD	O
computed	JJ	O
tomography	NN	O
(	-LRB-	O
CT	NN	O
)	-RRB-	O
scan	VBP	O
exploration	NN	O
of	IN	O
the	DT	O
inner	JJ	O
ear	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
goiter	NN	B-Disease
was	VBD	O
present	JJ	O
in	IN	O
only	RB	O
11	CD	O
affected	VBD	O
individuals	NNS	O
,	,	O
who	WP	O
interestingly	RB	O
had	VBD	O
a	DT	O
normal	JJ	O
result	NN	O
of	IN	O
the	DT	O
perchlorate	NN	O
discharge	NN	O
test	NN	O
whenever	WRB	O
performed	VBN	O
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
question	VBP	O
the	DT	O
sensitivity	NN	O
of	IN	O
the	DT	O
perchlorate	NN	O
test	NN	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
support	VBP	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
in	IN	O
the	DT	O
assessment	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
severe	JJ	O
to	TO	O
profound	JJ	O
congenital	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
associated	VBN	O
with	IN	O
inner	JJ	B-Disease
ear	NN	I-Disease
morphological	JJ	I-Disease
anomaly	RB	I-Disease
even	RB	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
thyroid	NN	B-Disease
goiter	NN	I-Disease
.	.	O

.	.	O

The	DT	O
type	NN	O
of	IN	O
somatic	JJ	O
mutation	NN	O
at	IN	O
APC	NN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
is	VBZ	O
determined	VBN	O
by	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
germline	NN	O
mutation	NN	O
:	:	O
a	DT	O
new	JJ	O
facet	NN	O
to	TO	O
Knudson	NNP	O
's	POS	O
'	``	O
two-hit	JJ	O
'	''	O
hypothesis	NN	O
.	.	O

APC	NN	O
is	VBZ	O
often	RB	O
cited	VBN	O
as	IN	O
a	DT	O
prime	JJ	O
example	NN	O
of	IN	O
a	DT	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
.	.	O

Truncating	VBG	O
germline	NN	O
and	CC	O
somatic	JJ	O
mutations	NNS	O
(	-LRB-	O
or	CC	O
,	,	O
infrequently	RB	O
,	,	O
allelic	JJ	O
loss	NN	O
)	-RRB-	O
occur	VBP	O
in	IN	O
tumors	NNS	B-Disease
in	IN	O
FAP	NN	B-Disease
(	-LRB-	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
)	-RRB-	O
.	.	O

Most	JJS	O
sporadic	JJ	B-Disease
colorectal	JJ	I-Disease
cancers	NNS	I-Disease
also	RB	O
have	VBP	O
two	CD	O
APC	NN	B-Disease
mutations	NNS	O
.	.	O

Clues	NNS	O
from	IN	O
attenuated	VBN	B-Disease
polyposis	NN	I-Disease
,	,	O
missense	NN	O
germline	NN	O
variants	NNS	O
with	IN	O
mild	JJ	O
disease	NN	O
and	CC	O
the	DT	O
somatic	JJ	O
mutation	NN	O
cluster	NN	O
region	NN	O
(	-LRB-	O
codons	NNS	O
1	CD	O
,	,	O
250-1	CD	O
,	,	O
450	CD	O
)	-RRB-	O
indicate	VBP	O
,	,	O
however	RB	O
,	,	O
that	IN	O
APC	NN	B-Disease
mutations	NNS	O
might	MD	O
not	RB	O
result	VB	O
in	IN	O
simple	JJ	O
loss	NN	O
of	IN	O
protein	NN	O
function	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
FAP	NN	B-Disease
patients	NNS	O
with	IN	O
germline	NN	O
APC	NN	B-Disease
mutations	NNS	O
within	IN	O
a	DT	O
small	JJ	O
region	NN	O
(	-LRB-	O
codons	NNS	O
1	CD	O
,	,	O
194-1	CD	O
,	,	O
392	CD	O
at	IN	O
most	JJS	O
)	-RRB-	O
mainly	RB	O
show	VBP	O
allelic	JJ	O
loss	NN	O
in	IN	O
their	PRP$	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
other	JJ	O
FAP	NN	B-Disease
patients	NNS	O
,	,	O
whose	WP$	O
second	JJ	O
hits	NNS	O
tend	VBP	O
to	TO	O
occur	VB	O
by	IN	O
truncating	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
mutation	NN	O
cluster	NN	O
region	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
different	JJ	O
APC	NN	B-Disease
mutations	NNS	O
provide	VBP	O
cells	NNS	O
with	IN	O
different	JJ	O
selective	JJ	O
advantages	NNS	O
,	,	O
with	IN	O
mutations	NNS	O
close	RB	O
to	TO	O
codon	NN	O
1	CD	O
,	,	O
300	CD	O
providing	VBG	O
the	DT	O
greatest	JJS	O
advantage	NN	O
.	.	O

Allelic	JJ	O
loss	NN	O
is	VBZ	O
selected	VBN	O
strongly	RB	O
in	IN	O
cells	NNS	O
with	IN	O
one	CD	O
mutation	NN	O
near	IN	O
codon	NN	O
1	CD	O
,	,	O
300	CD	O
.	.	O

A	DT	O
different	JJ	O
germline-somatic	JJ	O
APC	NN	B-Disease
mutation	NN	O
association	NN	O
exists	VBZ	O
in	IN	O
FAP	NN	B-Disease
desmoids	NNS	I-Disease
.	.	O

APC	NN	O
is	VBZ	O
not	RB	O
,	,	O
therefore	RB	O
,	,	O
a	DT	O
classical	JJ	O
tumor	NN	B-Disease
suppressor	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
also	RB	O
indicate	VBP	O
a	DT	O
new	JJ	O
mechanism	NN	O
for	IN	O
disease	NN	O
severity	NN	O
if	IN	O
a	DT	O
broader	JJR	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
is	VBZ	O
selected	VBN	O
in	IN	O
tumors	NNS	B-Disease
,	,	O
the	DT	O
somatic	JJ	O
mutation	NN	O
rate	NN	O
is	VBZ	O
effectively	RB	O
higher	JJR	O
and	CC	O
more	RBR	O
tumors	NNS	B-Disease
grow	VBP	O
.	.	O

.	.	O

Purification	NN	O
of	IN	O
human	JJ	O
very-long-chain	JJ	O
acyl-coenzyme	NN	O
A	NN	O
dehydrogenase	NN	O
and	CC	O
characterization	NN	O
of	IN	O
its	PRP$	O
deficiency	NN	O
in	IN	O
seven	CD	O
patients	NNS	O
.	.	O

Mitochondrial	JJ	O
very-long-chain	JJ	O
acyl-coenzyme	NN	O
A	NN	O
dehydrogenase	NN	O
(	-LRB-	O
VLCAD	NN	O
)	-RRB-	O
was	VBD	O
purified	VBN	O
from	IN	O
human	JJ	O
liver	NN	O
.	.	O

The	DT	O
molecular	JJ	O
masses	NNS	O
of	IN	O
the	DT	O
native	JJ	O
enzyme	NN	O
and	CC	O
the	DT	O
subunit	NN	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
154	CD	O
and	CC	O
70	CD	O
kD	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
enzyme	NN	O
was	VBD	O
found	VBN	O
to	TO	O
catalyze	VB	O
the	DT	O
major	JJ	O
part	NN	O
of	IN	O
mitochondrial	JJ	O
palmitoylcoenzyme	NN	O
A	DT	O
dehydrogenation	NN	O
in	IN	O
liver	NN	O
,	,	O
heart	NN	O
,	,	O
skeletal	JJ	O
muscle	NN	O
,	,	O
and	CC	O
skin	NN	O
fibroblasts	NNS	O
(	-LRB-	O
89-97	CD	O
,	,	O
86-99	CD	O
,	,	O
96-99	CD	O
,	,	O
and	CC	O
78-87	CD	O
%	NN	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

Skin	NN	O
fibroblasts	NNS	O
from	IN	O
26	CD	O
patients	NNS	O
suspected	VBN	O
of	IN	O
having	VBG	O
a	DT	O
disorder	NN	O
of	IN	O
mitochondrial	JJ	O
beta-oxidation	NN	O
were	VBD	O
analyzed	VBN	O
for	IN	O
VLCAD	NN	O
protein	NN	O
using	VBG	O
immunoblotting	NN	O
,	,	O
and	CC	O
7	CD	O
of	IN	O
them	PRP	O
contained	VBD	O
undetectable	JJ	O
or	CC	O
trace	NN	O
levels	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
.	.	O

The	DT	O
seven	CD	O
deficient	JJ	O
fibroblast	NN	O
lines	NNS	O
were	VBD	O
characterized	VBN	O
by	IN	O
measuring	VBG	O
acyl-coenzyme	NN	O
A	NN	O
dehydrogenation	NN	O
activities	NNS	O
,	,	O
overall	JJ	O
palmitic	JJ	O
acid	NN	O
oxidation	NN	O
,	,	O
and	CC	O
VLCAD	NN	O
protein	NN	O
synthesis	NN	O
using	VBG	O
pulse-chase	JJ	O
,	,	O
further	JJ	O
confirming	VBG	O
the	DT	O
diagnosis	NN	O
of	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

These	DT	O
results	NNS	O
suggested	VBD	O
the	DT	O
heterogenous	JJ	O
nature	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
causing	VBG	O
the	DT	O
deficiency	NN	O
in	IN	O
the	DT	O
seven	CD	O
patients	NNS	O
.	.	O

Clinically	RB	O
,	,	O
all	DT	O
patients	NNS	O
with	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
exhibited	VBD	O
cardiac	JJ	B-Disease
disease	NN	I-Disease
.	.	O

At	IN	O
least	JJS	O
four	CD	O
of	IN	O
them	PRP	O
presented	VBN	O
with	IN	O
hypertrophic	JJ	B-Disease
cardiomyopathy	NN	I-Disease
.	.	O

This	DT	O
frequency	NN	O
(	-LRB-	O
>	JJR	O
57	CD	O
%	NN	O
)	-RRB-	O
was	VBD	O
much	RB	O
higher	JJR	O
than	IN	O
that	DT	O
observed	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
other	JJ	O
disorders	NNS	O
of	IN	O
mitochondrial	JJ	O
long-chain	JJ	O
fatty	JJ	O
acid	NN	O
oxidation	NN	O
that	WDT	O
may	MD	O
be	VB	O
accompanied	VBN	O
by	IN	O
cardiac	JJ	B-Disease
disease	NN	I-Disease
in	IN	O
infants	NNS	O
.	.	O

.	.	O

A	DT	O
germ	NN	O
line	NN	O
mutation	NN	O
within	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
for	IN	O
the	DT	O
putative	JJ	O
5-phosphoribosyl-1-pyrophosphate	JJ	O
binding	NN	O
site	NN	O
of	IN	O
hypoxanthine-guanine	JJ	O
phosphoribosyltransferase	NN	O
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
Lesch-Nyhan	JJ	B-Disease
patient	NN	O
:	:	O
missense	NN	O
mutations	NNS	O
within	IN	O
a	DT	O
functionally	RB	O
important	JJ	O
region	NN	O
probably	RB	O
cause	VBP	O
disease	NN	O
.	.	O

Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
complete	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
hypoxanthine	NN	I-Disease
guanine	NN	I-Disease
phosphoribosyltransferase	NN	I-Disease
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
germ	NN	O
line	NN	O
mutations	NNS	O
.	.	O

Identification	NN	O
of	IN	O
each	DT	O
mutant	JJ	O
gene	NN	O
provides	VBZ	O
valuable	JJ	O
information	NN	O
as	IN	O
to	TO	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
that	WDT	O
occurs	VBZ	O
spontaneously	RB	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
newly	RB	O
identified	VBN	O
HPRT	NN	O
mutation	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
patient	NN	O
with	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

This	DT	O
gene	NN	O
,	,	O
designated	VBN	O
HPRT	NNP	O
Tokyo	NNP	O
,	,	O
had	VBD	O
a	DT	O
single	JJ	O
nucleotide	NN	O
change	NN	O
from	IN	O
G	NN	O
to	TO	O
A	DT	O
,	,	O
as	IN	O
identified	VBN	O
by	IN	O
sequencing	NN	O
cDNA	NN	O
amplified	VBN	O
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

Allele	NN	O
specific	JJ	O
oligonucleotide	NN	O
hybridization	NN	O
analysis	NN	O
using	VBG	O
amplified	VBN	O
genomic	JJ	O
DNA	NN	O
showed	VBD	O
that	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
was	VBD	O
transmitted	VBN	O
from	IN	O
the	DT	O
maternal	JJ	O
germ	NN	O
line	NN	O
.	.	O

This	DT	O
mutation	NN	O
would	MD	O
lead	VB	O
to	TO	O
an	DT	O
amino	NN	O
acid	NN	O
substitution	NN	O
of	IN	O
Asp	NN	O
for	IN	O
Gly	NN	O
at	IN	O
the	DT	O
amino	NN	O
acid	NN	O
position	NN	O
140	CD	O
located	JJ	O
within	IN	O
the	DT	O
putative	JJ	O
5-phosphoribosyl-1-pyrophosphate	NN	O
(	-LRB-	O
PRPP	NN	O
)	-RRB-	O
binding	NN	O
region	NN	O
.	.	O

Missense	NN	O
mutations	NNS	O
in	IN	O
human	JJ	O
HPRT	NN	B-Disease
deficient	JJ	I-Disease
patients	NNS	O
thus	RB	O
far	RB	O
reported	VBN	O
tend	VBP	O
to	TO	O
accumulate	VB	O
in	IN	O
this	DT	O
functionally	RB	O
active	JJ	O
region	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
comparison	NN	O
of	IN	O
the	DT	O
data	NNS	O
suggested	VBD	O
that	IN	O
both	CC	O
missense	NN	O
and	CC	O
synonymous	JJ	O
mutations	NNS	O
can	MD	O
occur	VB	O
at	IN	O
any	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
the	DT	O
human	JJ	O
germ	NN	O
line	NN	O
HPRT	NN	O
gene	NN	O
,	,	O
but	CC	O
that	IN	O
a	DT	O
limited	JJ	O
percentage	NN	O
of	IN	O
all	PDT	O
the	DT	O
missense	NN	O
mutations	NNS	O
cause	VBP	O
disease	NN	O
.	.	O

The	DT	O
probability	NN	O
that	IN	O
a	DT	O
mutation	NN	O
will	MD	O
cause	VB	O
disease	NN	O
tends	VBZ	O
to	TO	O
be	VB	O
higher	JJR	O
when	WRB	O
the	DT	O
missense	NN	O
mutation	NN	O
is	VBZ	O
within	IN	O
a	DT	O
functionally	RB	O
important	JJ	O
sequence	NN	O
.	.	O

.	.	O

In	FW	O
vitro	FW	O
and	CC	O
in	FW	O
vivo	FW	O
correlations	NNS	O
for	IN	O
I65T	NN	O
and	CC	O
M1V	NN	O
mutations	NNS	O
at	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
locus	NN	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
locus	NN	O
are	VBP	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
hyperphenylalaninemia	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
described	VBN	O
four	CD	O
mutations	NNS	O
(	-LRB-	O
M1V	NN	O
,	,	O
IVS12nt1	NN	O
,	,	O
R408W	NN	O
,	,	O
and	CC	O
S349P	NN	O
)	-RRB-	O
at	IN	O
the	DT	O
PAH	NN	O
locus	NN	O
in	IN	O
French	JJ	O
Canadians	NNPS	O
with	IN	O
ancestry	NN	O
in	IN	O
eastern	JJ	O
Quebec	NNP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
identification	NN	O
of	IN	O
another	DT	O
mutation	NN	O
,	,	O
on	IN	O
a	DT	O
haplotype	NN	O
9	CD	O
chromosome	NN	O
,	,	O
which	WDT	O
converts	VBZ	O
codon	NN	O
65	CD	O
from	IN	O
isoleucine	NN	O
(	-LRB-	O
ATT	NN	O
)	-RRB-	O
to	TO	O
threonine	NN	O
(	-LRB-	O
ACT	NN	O
)	-RRB-	O
,	,	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
I65T	NN	O
mutation	NN	O
in	IN	O
COS	NN	O
cells	NNS	O
demonstrating	VBG	O
75	CD	O
%	NN	O
loss	NN	O
of	IN	O
both	CC	O
immunoreactive	JJ	O
protein	NN	O
and	CC	O
enzyme	NN	O
activity	NN	O
,	,	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
expression	NN	O
analysis	NN	O
of	IN	O
the	DT	O
most	RBS	O
prevalent	JJ	O
PKU	NNP	B-Disease
allele	NN	O
(	-LRB-	O
M1V	NN	O
)	-RRB-	O
in	IN	O
eastern	JJ	O
Quebec	NNP	O
,	,	O
showing	VBG	O
nondetectable	JJ	O
levels	NNS	O
of	IN	O
PAH	NN	O
protein	NN	O
and	CC	O
activity	NN	O
,	,	O
a	DT	O
finding	NN	O
compatible	JJ	O
with	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
translation	NN	O
initiation	NN	O
codon	NN	O
.	.	O

Homozygosity	NN	O
for	IN	O
M1V	NN	O
and	CC	O
codominant	NN	O
inheritance	NN	O
of	IN	O
I65T/R408W	NN	O
were	VBD	O
both	DT	O
associated	VBN	O
with	IN	O
classical	JJ	B-Disease
phenylketonuria	NN	I-Disease
.	.	O

.	.	O

Experimental	JJ	O
hemochromatosis	NN	B-Disease
due	JJ	O
to	TO	O
MHC	NN	O
class	NN	O
I	CD	O
HFE	NN	B-Disease
deficiency	NN	I-Disease
:	:	O
immune	JJ	O
status	NN	O
and	CC	O
iron	NN	O
metabolism	NN	O
.	.	O

The	DT	O
puzzling	JJ	O
linkage	NN	O
between	IN	O
genetic	JJ	O
hemochromatosis	NN	B-Disease
and	CC	O
histocompatibility	NN	O
loci	NNS	O
became	VBD	O
even	RB	O
more	RBR	O
so	RB	O
when	WRB	O
the	DT	O
gene	NN	O
involved	VBN	O
,	,	O
HFE	NN	O
,	,	O
was	VBD	O
identified	VBN	O
.	.	O

Indeed	RB	O
,	,	O
within	IN	O
the	DT	O
well	RB	O
defined	VBN	O
,	,	O
mainly	RB	O
peptide-binding	JJ	O
,	,	O
MHC	NN	O
class	NN	O
I	CD	O
family	NN	O
of	IN	O
molecules	NNS	O
,	,	O
HFE	NN	O
seems	VBZ	O
to	TO	O
perform	VB	O
an	DT	O
unusual	JJ	O
yet	RB	O
essential	JJ	O
function	NN	O
.	.	O

As	IN	O
yet	RB	O
,	,	O
our	PRP$	O
understanding	NN	O
of	IN	O
HFE	NN	O
function	NN	O
in	IN	O
iron	NN	O
homeostasis	NN	O
is	VBZ	O
only	RB	O
partial	JJ	O
;	:	O
an	DT	O
even	RB	O
more	RBR	O
open	JJ	O
question	NN	O
is	VBZ	O
its	PRP$	O
possible	JJ	O
role	NN	O
in	IN	O
the	DT	O
immune	JJ	O
system	NN	O
.	.	O

To	TO	O
advance	VB	O
on	IN	O
both	DT	O
of	IN	O
these	DT	O
avenues	NNS	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
deletion	NN	O
of	IN	O
HFE	NN	O
alpha1	NN	O
and	CC	O
alpha2	NN	O
putative	JJ	O
ligand	NN	O
binding	NN	O
domains	NNS	O
in	FW	O
vivo	FW	O
.	.	O

HFE-deficient	JJ	B-Disease
animals	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
a	DT	O
comprehensive	JJ	O
set	NN	O
of	IN	O
metabolic	JJ	O
and	CC	O
immune	JJ	O
parameters	NNS	O
.	.	O

Faithfully	RB	O
mimicking	VBG	O
human	JJ	O
hemochromatosis	NN	B-Disease
,	,	O
mice	NNS	O
homozygous	JJ	O
for	IN	O
this	DT	O
deletion	NN	O
develop	VB	O
iron	NN	O
overload	NN	O
,	,	O
characterized	VBN	O
by	IN	O
a	DT	O
higher	JJR	O
plasma	NN	O
iron	NN	O
content	NN	O
and	CC	O
a	DT	O
raised	VBN	O
transferrin	NN	O
saturation	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
elevated	JJ	O
hepatic	JJ	O
iron	NN	O
load	NN	O
.	.	O

The	DT	O
primary	JJ	O
defect	NN	O
could	MD	O
,	,	O
indeed	RB	O
,	,	O
be	VB	O
traced	VBN	O
to	TO	O
an	DT	O
augmented	JJ	O
duodenal	JJ	O
iron	NN	O
absorption	NN	O
.	.	O

In	IN	O
parallel	NN	O
,	,	O
measurement	NN	O
of	IN	O
the	DT	O
gut	NN	O
mucosal	JJ	O
iron	NN	O
content	NN	O
as	RB	O
well	RB	O
as	IN	O
iron	NN	O
regulatory	JJ	O
proteins	NNS	O
allows	VBZ	O
a	DT	O
more	RBR	O
informed	JJ	O
evaluation	NN	O
of	IN	O
various	JJ	O
hypotheses	NNS	O
regarding	VBG	O
the	DT	O
precise	JJ	O
role	NN	O
of	IN	O
HFE	NN	O
in	IN	O
iron	NN	O
homeostasis	NN	O
.	.	O

Finally	RB	O
,	,	O
an	DT	O
extensive	JJ	O
phenotyping	NN	O
of	IN	O
primary	JJ	O
and	CC	O
secondary	JJ	O
lymphoid	JJ	O
organs	NNS	O
including	VBG	O
the	DT	O
gut	NN	O
provides	VBZ	O
no	DT	O
compelling	JJ	O
evidence	NN	O
for	IN	O
an	DT	O
obvious	JJ	O
immune-linked	JJ	O
function	NN	O
for	IN	O
HFE	NN	O
.	.	O

.	.	O

[	-LRB-	O
Genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
:	:	O
mutant	JJ	O
alleles	NNS	O
of	IN	O
G6PD	NN	O
in	IN	O
the	DT	O
Shekii	NNP	O
district	NN	O
of	IN	O
Azerbaijan	NNP	O
]	-RRB-	O
Examination	NN	O
on	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
349	CD	O
patients	NNS	O
of	IN	O
Shekii	NNP	O
district	NN	O
hospital	NN	O
(	-LRB-	O
Azerbaijan	NNP	O
)	-RRB-	O
revealed	VBD	O
16	CD	O
hemi	NN	O
-	:	O
,	,	O
4	CD	O
homo	NN	O
-	:	O
and	CC	O
9	CD	O
heterozygotic	JJ	O
carriers	NNS	O
of	IN	O
the	DT	O
defect	NN	O
.	.	O

Gd	SYM	O
-	:	O
frequency	NN	O
,	,	O
calculated	VBN	O
from	IN	O
the	DT	O
data	NNS	O
obtained	VBN	O
(	-LRB-	O
7	CD	O
.	.	O

7	CD	O
%	NN	O
)	-RRB-	O
,	,	O
may	MD	O
be	VB	O
compared	VBN	O
to	TO	O
neighbouring	JJ	O
regions	NNS	O
frequencies	NNS	O
(	-LRB-	O
6-30	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Carriers	NNS	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
are	VBP	O
residents	NNS	O
of	IN	O
11	CD	O
villages	NNS	O
located	JJ	O
in	IN	O
Alasani-Aphtalan	JJ	O
valley	NN	O
,	,	O
highly	RB	O
endemic	JJ	O
with	IN	O
malaria	NN	B-Disease
in	IN	O
the	DT	O
past	NN	O
;	:	O
nearly	RB	O
all	DT	O
marriages	NNS	O
are	VBP	O
endogamic	JJ	O
.	.	O

Physico-chemical	JJ	O
and	CC	O
kinetic	JJ	O
study	NN	O
of	IN	O
10	CD	O
mutant	JJ	O
forms	NNS	O
of	IN	O
G6PD	NN	O
,	,	O
according	VBG	O
to	TO	O
WHO	WP	O
program	NN	O
,	,	O
led	VBD	O
to	TO	O
identification	NN	O
of	IN	O
5	CD	O
variants	NNS	O
of	IN	O
the	DT	O
II	CD	O
class	NN	O
(	-LRB-	O
Shekii	NNP	O
,	,	O
Bideiz	NNP	O
,	,	O
Shirin-Bulakh	NNP	O
,	,	O
Okhut	NNP	O
I	NNP	O
and	CC	O
Zakataly	NNP	O
)	-RRB-	O
and	CC	O
2	CD	O
variants	NNS	O
of	IN	O
the	DT	O
III	NNP	O
class	NN	O
(	-LRB-	O
Okhut	NN	O
II	CD	O
and	CC	O
Martinique-like	JJ	O
)	-RRB-	O
.	.	O

Resemblance	NN	O
of	IN	O
the	DT	O
majority	NN	O
of	IN	O
variants	NNS	O
in	IN	O
electrophoretic	JJ	O
mobility	NN	O
and	CC	O
the	DT	O
level	NN	O
of	IN	O
erythrocyte	NN	O
enzyme	NN	O
activity	NN	O
permit	VBP	O
to	TO	O
suggest	VB	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
common	JJ	O
parental	JJ	O
mutant	JJ	O
G6PD	NN	O
allele	NN	O
distributed	VBN	O
in	IN	O
this	DT	O
area	NN	O
.	.	O

[	-LRB-	O
Gd	SYM	O
-	:	O
allele	NN	O
distribution	NN	O
patterns	NNS	O
in	IN	O
Azerbaijan	NNP	O
.	.	O

III	NNP	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
mutant	JJ	O
forms	NNS	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
]	-RRB-	O
In	IN	O
28	CD	O
families	NNS	O
with	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
living	NN	O
in	IN	O
3	CD	O
settlements	NNS	O
of	IN	O
Shekii	NNP	O
district	NN	O
of	IN	O
Azerbaijan	NNP	O
11	CD	O
G6PD	NN	O
variants	NNS	O
of	IN	O
II	CD	O
and	CC	O
III	CD	O
classes	NNS	O
differing	VBG	O
by	IN	O
kinetic	JJ	O
properties	NNS	O
were	VBD	O
identified	VBN	O
according	VBG	O
WHO	WP	O
program	NN	O
.	.	O

9	CD	O
of	IN	O
them	PRP	O
are	VBP	O
characterized	VBN	O
with	IN	O
the	DT	O
same	JJ	O
electrophoretic	JJ	O
mobility	NN	O
.	.	O

Comparison	NN	O
of	IN	O
G6PD	NN	O
spectra	NNS	O
in	IN	O
two	CD	O
subpopulations	NNS	O
and	CC	O
in	IN	O
a	DT	O
mixed	JJ	O
group	NN	O
permits	VBZ	O
to	TO	O
make	VB	O
a	DT	O
conclusion	NN	O
about	IN	O
existence	NN	O
of	IN	O
common	JJ	O
and	CC	O
rare	JJ	O
G6PD	NN	O
alleles	NNS	O
in	IN	O
examined	VBN	O
population	NN	O
.	.	O

They	PRP	O
distribute	VBP	O
by	IN	O
gene	NN	O
drift	NN	O
supported	VBN	O
by	IN	O
natural	JJ	O
selection	NN	O
.	.	O

Among	IN	O
7	CD	O
samples	NNS	O
of	IN	O
G6PD	NN	O
with	IN	O
normal	JJ	O
and	CC	O
increased	VBD	O
activity	NN	O
two	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
IV	CD	O
class	NN	O
--	:	O
Nukha	NN	O
and	CC	O
Bash-Kungut	NNP	O
--	:	O
were	VBD	O
found	VBN	O
.	.	O

.	.	O

Determination	NN	O
of	IN	O
carrier	NN	O
status	NN	O
for	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
by	IN	O
flow	NN	O
cytometric	JJ	O
analysis	NN	O
of	IN	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
protein	NN	O
expression	NN	O
in	IN	O
peripheral	JJ	O
blood	NN	O
mononuclear	JJ	O
cells	NNS	O
.	.	O

The	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
defects	NNS	O
in	IN	O
the	DT	O
WAS	NNP	B-Disease
protein	NN	O
(	-LRB-	O
WASP	NNP	O
)	-RRB-	O
gene	NN	O
on	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
.	.	O

Previous	JJ	O
study	NN	O
disclosed	VBD	O
that	IN	O
flow	NN	O
cytometric	JJ	O
analysis	NN	O
of	IN	O
intracellular	JJ	O
WASP	NNP	O
expression	NN	O
(	-LRB-	O
FCM-WASP	NN	O
analysis	NN	O
)	-RRB-	O
in	IN	O
lymphocytes	NNS	O
was	VBD	O
useful	JJ	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
WAS	NN	B-Disease
patients	NNS	O
.	.	O

Lymphocytes	NNS	O
from	IN	O
all	DT	O
WAS	NNS	B-Disease
patients	NNS	O
showed	VBD	O
WASPdim	NNP	O
instead	RB	O
of	IN	O
WASPbright	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
FCM-WASP	NN	O
analysis	NN	O
in	IN	O
monocytes	NNS	O
could	MD	O
be	VB	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
the	DT	O
WAS	NNP	B-Disease
carrier	NN	O
diagnosis	NN	O
.	.	O

Monocytes	NNS	O
from	IN	O
all	DT	O
nine	CD	O
WAS	NNP	B-Disease
carriers	NNS	O
showed	VBD	O
varied	JJ	O
population	NN	O
of	IN	O
WASPdim	NN	O
together	RB	O
with	IN	O
WASPbright	NN	O
.	.	O

None	NN	O
of	IN	O
control	NN	O
individuals	NNS	O
possessed	VBD	O
the	DT	O
WASPdim	NNP	O
population	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
lymphocytes	NNS	O
from	IN	O
all	PDT	O
the	DT	O
carriers	NNS	O
except	IN	O
two	CD	O
lacked	VBD	O
the	DT	O
WASPdim	NNP	O
population	NN	O
.	.	O

The	DT	O
difference	NN	O
of	IN	O
the	DT	O
WASPdim	NNP	O
population	NN	O
in	IN	O
monocytes	NNS	O
and	CC	O
lymphocytes	NNS	O
observed	VBN	O
in	IN	O
WAS	NNP	B-Disease
carriers	NNS	O
suggests	VBZ	O
that	IN	O
WASP	NNP	O
plays	VBZ	O
a	DT	O
more	RBR	O
critical	JJ	O
role	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
lymphocytes	NNS	O
than	IN	O
in	IN	O
that	DT	O
of	IN	O
monocytes	NNS	O
.	.	O

The	DT	O
present	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
skewed	JJ	O
X-chromosomal	JJ	O
inactivation	NN	O
pattern	NN	O
observed	VBN	O
in	IN	O
WAS	NNP	B-Disease
carrier	NN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
is	VBZ	O
not	RB	O
fixed	VBN	O
at	IN	O
the	DT	O
hemopoietic	JJ	O
stem	NN	O
cell	NN	O
level	NN	O
but	CC	O
progresses	VBZ	O
after	IN	O
the	DT	O
lineage	NN	O
commitment	NN	O
.	.	O

.	.	O

Linkage	NN	O
of	IN	O
DNA	NN	O
markers	NNS	O
at	IN	O
Xq28	NN	O
to	TO	O
adrenoleukodystrophy	NN	B-Disease
and	CC	O
adrenomyeloneuropathy	NN	B-Disease
present	JJ	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
large	JJ	O
kindred	NN	O
that	WDT	O
contained	VBD	O
patients	NNS	O
with	IN	O
either	CC	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
or	CC	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
pedigree	NN	O
clearly	RB	O
supported	VBD	O
the	DT	O
X-linked	JJ	O
mode	NN	O
of	IN	O
inheritance	NN	O
of	IN	O
the	DT	O
nonneonatal	JJ	O
form	NN	O
of	IN	O
ALD/AMN	NN	O
.	.	O

Analysis	NN	O
with	IN	O
DNA	NN	O
markers	NNS	O
at	IN	O
Xq28	NN	O
suggested	VBD	O
segregation	NN	O
of	IN	O
both	CC	O
ALD	NN	B-Disease
and	CC	O
AMN	NN	B-Disease
with	IN	O
an	DT	O
identical	JJ	O
haplotype	NN	O
.	.	O

This	DT	O
indicated	VBD	O
that	IN	O
nonneonatal	JJ	O
ALD	NN	B-Disease
and	CC	O
AMN	NNP	B-Disease
are	VBP	O
caused	VBN	O
by	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
same	JJ	O
gene	NN	O
at	IN	O
Xq28	NN	O
.	.	O

It	PRP	O
showed	VBD	O
,	,	O
furthermore	RB	O
,	,	O
that	IN	O
phenotypic	JJ	O
differences	NNS	O
between	IN	O
ALD	NNP	B-Disease
and	CC	O
AMN	NNP	B-Disease
are	VBP	O
not	RB	O
necessarily	RB	O
the	DT	O
consequence	NN	O
of	IN	O
allelic	JJ	O
heterogeneity	NN	O
due	JJ	O
to	TO	O
different	JJ	O
mutations	NNS	O
within	IN	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

The	DT	O
maximal	JJ	O
lod	NN	O
score	NN	O
for	IN	O
linkage	NN	O
of	IN	O
the	DT	O
ALD/AMN	NN	O
gene	NN	O
and	CC	O
the	DT	O
multiallelic	JJ	O
anonymous	JJ	O
DNA	NN	O
marker	NN	O
at	IN	O
DXS52	NN	O
was	VBD	O
3	CD	O
.	.	O

0	CD	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

00	CD	O
.	.	O

This	DT	O
made	VBD	O
a	DT	O
prenatal	JJ	O
or	CC	O
presymptomatic	JJ	O
diagnosis	NN	O
and	CC	O
heterozygote	NN	O
detection	NN	O
by	IN	O
DNA	NN	O
analysis	NN	O
with	IN	O
this	DT	O
marker	NN	O
reliable	JJ	O
.	.	O

Further	JJ	O
investigation	NN	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
intron	NN	O
9	CD	O
donor	NN	O
splice	NN	O
site	NN	O
mutation	NN	O
frequently	RB	O
found	VBN	O
in	IN	O
non-Jewish	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
patients	NNS	O
from	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
.	.	O

In	IN	O
a	DT	O
previous	JJ	O
study	NN	O
we	PRP	O
found	VBD	O
that	IN	O
a	DT	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
causing	VBG	O
mutation	NN	O
in	IN	O
the	DT	O
intron	NN	O
9	CD	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
occurs	VBZ	O
at	IN	O
high	JJ	O
frequency	NN	O
in	IN	O
non-Jewish	JJ	O
patients	NNS	O
and	CC	O
carriers	NNS	O
from	IN	O
the	DT	O
British	JJ	O
Isles	NNP	O
.	.	O

It	PRP	O
was	VBD	O
found	VBN	O
more	RBR	O
frequently	RB	O
in	IN	O
subjects	NNS	O
of	IN	O
Irish	JJ	O
,	,	O
Scottish	JJ	O
,	,	O
and	CC	O
Welsh	NNP	O
origin	NN	O
compared	VBN	O
with	IN	O
English	JJ	O
origin	NN	O
(	-LRB-	O
63	CD	O
%	NN	O
and	CC	O
31	CD	O
%	NN	O
respectively	RB	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
tested	VBN	O
,	,	O
in	IN	O
a	DT	O
blind	JJ	O
study	NN	O
,	,	O
26	CD	O
American	JJ	O
TSD	NNP	B-Disease
carriers	NNS	O
and	CC	O
28	CD	O
non-carriers	NNS	O
who	WP	O
have	VBP	O
British	JJ	O
ancestry	NN	O
for	IN	O
the	DT	O
intron	NN	O
9	CD	O
splice	NN	O
site	NN	O
mutation	NN	O
.	.	O

Six	CD	O
of	IN	O
the	DT	O
carriers	NNS	O
and	CC	O
none	NN	O
of	IN	O
the	DT	O
controls	NNS	O
were	VBD	O
positive	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
.	.	O

All	DT	O
six	CD	O
had	VBD	O
Irish	JJ	O
ancestry	NN	O
,	,	O
compared	VBN	O
with	IN	O
nine	CD	O
of	IN	O
the	DT	O
20	CD	O
other	JJ	O
(	-LRB-	O
intron	NN	O
9	CD	O
mutation	NN	O
negative	JJ	O
)	-RRB-	O
TSD	NN	B-Disease
carriers	NNS	O
(	-LRB-	O
p	NN	O
<	JJR	O
0	CD	O
.	.	O

05	NN	O
)	-RRB-	O
.	.	O

These	DT	O
results	NNS	O
confirm	VBP	O
the	DT	O
previously	RB	O
found	VBN	O
high	JJ	O
frequency	NN	O
of	IN	O
the	DT	O
intron	NN	O
9	CD	O
mutation	NN	O
in	IN	O
non-Jewish	JJ	O
TSD	NN	B-Disease
families	NNS	O
of	IN	O
British	JJ	O
Isles	NNS	O
,	,	O
particularly	RB	O
Irish	JJ	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
reinforce	VB	O
the	DT	O
need	NN	O
to	TO	O
screen	VB	O
such	JJ	O
families	NNS	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
murine	JJ	O
homologues	NNS	O
of	IN	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
(	-LRB-	O
Hdh	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
alpha-adducin	NN	O
gene	NN	O
(	-LRB-	O
Add1	NN	O
)	-RRB-	O
map	NN	O
to	TO	O
mouse	NN	O
chromosome	NN	O
5	CD	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
conserved	VBN	O
synteny	NN	O
with	IN	O
human	JJ	O
chromosome	NN	O
4p16	NN	O
.3	NN	O
.	.	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
severe	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
neurodegenerative	JJ	I-Disease
disorder	NN	I-Disease
associated	VBN	O
with	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
(	-LRB-	O
IT15	NN	O
)	-RRB-	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
reported	VBD	O
the	DT	O
cloning	NN	O
of	IN	O
Hdh	NN	O
,	,	O
the	DT	O
murine	JJ	O
homologue	NN	O
of	IN	O
IT15	NN	O
.	.	O

Here	RB	O
,	,	O
using	VBG	O
an	DT	O
interspecific	JJ	O
backcross	NN	O
,	,	O
we	PRP	O
have	VBP	O
mapped	VBN	O
both	DT	O
Hdh	NN	O
and	CC	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
human	JJ	O
alpha-adducin	NN	O
(	-LRB-	O
Add1	NN	O
)	-RRB-	O
,	,	O
a	DT	O
membrane-associated	JJ	O
cytoskeletal	JJ	O
protein	NN	O
gene	NN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
genes	NNS	O
map	VBP	O
in	IN	O
the	DT	O
same	JJ	O
position	NN	O
on	IN	O
mouse	NN	O
chromosome	NN	O
5	CD	O
in	IN	O
a	DT	O
region	NN	O
associated	VBN	O
with	IN	O
ancestral	JJ	O
chromosomal	JJ	O
rearrangements	NNS	O
and	CC	O
show	VBP	O
no	DT	O
recombination	NN	O
with	IN	O
D5H4S43	NN	O
,	,	O
D5H4S115	NN	O
,	,	O
and	CC	O
D5H4S62	NN	O
,	,	O
the	DT	O
murine	JJ	O
homologues	NNS	O
of	IN	O
D4S43	NN	O
,	,	O
D4S115	NN	O
,	,	O
and	CC	O
D4S62	NN	O
,	,	O
respectively	RB	O
.	.	O

Further	JJ	O
mapping	NN	O
studies	NNS	O
of	IN	O
humans	NNS	O
,	,	O
mice	NNS	O
,	,	O
and	CC	O
other	JJ	O
mammalian	JJ	O
species	NNS	O
should	MD	O
reveal	VB	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
rearrangements	NNS	O
affecting	VBG	O
this	DT	O
chromosomal	JJ	O
segment	NN	O
during	IN	O
mammalian	JJ	O
evolution	NN	O
.	.	O

.	.	O

Linkage	NN	O
analysis	NN	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
C2	NN	O
gene	NN	O
and	CC	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
on	IN	O
human	JJ	O
chromosome	NN	O
19	CD	O
reveals	VBZ	O
linkage	NN	O
disequilibrium	NN	O
in	IN	O
a	DT	O
French-Canadian	JJ	O
population	NN	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
human	JJ	O
apolipoprotein	NN	O
C2	NN	O
(	-LRB-	O
APOC2	NN	O
)	-RRB-	O
,	,	O
situated	VBN	O
on	IN	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
19	CD	O
,	,	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
adult	JJ	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

Six	CD	O
APOC2	NN	O
RFLPs	NNS	O
(	-LRB-	O
TaqI	NN	O
,	,	O
BglI	NN	O
,	,	O
BanI	NN	O
,	,	O
BamHI	NN	O
,	,	O
NcoI	NN	O
,	,	O
and	CC	O
AvaII	NN	O
)	-RRB-	O
have	VBP	O
been	VBN	O
identified	VBN	O
to	TO	O
date	NN	O
.	.	O

We	PRP	O
have	VBP	O
conducted	VBN	O
a	DT	O
comprehensive	JJ	O
DM	NN	B-Disease
linkage	NN	O
study	NN	O
utilizing	VBG	O
all	DT	O
six	CD	O
RFLPs	NNS	O
and	CC	O
involving	VBG	O
50	CD	O
families	NNS	O
and	CC	O
372	CD	O
individuals	NNS	O
.	.	O

The	DT	O
most	RBS	O
informative	JJ	O
RFLPs	NNS	O
are	VBP	O
,	,	O
in	IN	O
descending	VBG	O
order	NN	O
,	,	O
NcoI	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
6	CD	O
.	.	O

64	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

05	NN	O
)	-RRB-	O
,	,	O
BglI	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
6	CD	O
.	.	O

12	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

05	NN	O
)	-RRB-	O
,	,	O
AvaII	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
6	CD	O
.	.	O

02	NN	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

03	NN	O
)	-RRB-	O
,	,	O
BanI	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
5	CD	O
.	.	O

76	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

04	NN	O
)	-RRB-	O
,	,	O
TaqI	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
4	CD	O
.	.	O

29	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

06	NN	O
)	-RRB-	O
,	,	O
and	CC	O
BamHI	NN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
1	CD	O
.	.	O

75	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

01	NN	O
)	-RRB-	O
.	.	O

A	DT	O
substantial	JJ	O
increase	NN	O
in	IN	O
the	DT	O
lod	NN	O
scores	NNS	O
over	IN	O
those	DT	O
seen	VBN	O
with	IN	O
the	DT	O
individual	JJ	O
RFLPs	NNS	O
was	VBD	O
obtained	VBN	O
when	WRB	O
the	DT	O
linkage	NN	O
of	IN	O
the	DT	O
entire	JJ	O
APOC2	NN	O
haplotype	NN	O
(	-LRB-	O
composed	VBN	O
of	IN	O
the	DT	O
six	CD	O
RFLPs	NNS	O
)	-RRB-	O
was	VBD	O
studied	VBN	O
(	-LRB-	O
lod	NN	O
=	JJ	O
17	CD	O
.	.	O

87	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

04	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
observed	VBN	O
significant	JJ	O
inter-APOC2	NN	O
RFLP	NN	O
linkage	NN	O
disequilibrium	NN	O
.	.	O

Consequently	RB	O
,	,	O
the	DT	O
three	CD	O
most	RBS	O
informative	JJ	O
RFLPs	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
to	TO	O
be	VB	O
BanI	NN	O
,	,	O
TaqI	NN	O
,	,	O
and	CC	O
either	CC	O
BglI	NN	O
,	,	O
AvaII	NN	O
,	,	O
or	CC	O
NcoI	NN	O
polymorphisms	NNS	O
.	.	O

We	PRP	O
also	RB	O
demonstrate	VBP	O
linkage	NN	O
disequilibrium	NN	O
between	IN	O
DM	NN	O
and	CC	O
APOC2	NN	O
in	IN	O
our	PRP$	O
French-Canadian	JJ	O
population	NN	O
(	-LRB-	O
standardized	JJ	O
disequilibrium	NN	O
constant	JJ	O
phi	NN	O
=	JJ	O
.	.	O

22	CD	O
,	,	O
chi	NN	O
2	CD	O
=	JJ	O
5	CD	O
.	.	O

12	CD	O
,	,	O
df	NN	O
=	JJ	O
1	CD	O
,	,	O
P	NN	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

04	NN	O
)	-RRB-	O
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
disequilibrium	NN	O
between	IN	O
APOC2	NN	O
and	CC	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
.	.	O

A	DT	O
retrospective	JJ	O
anonymous	JJ	O
pilot	NN	O
study	NN	O
in	IN	O
screening	VBG	O
newborns	NNS	O
for	IN	O
HFE	NN	O
mutations	NNS	O
in	IN	O
Scandinavian	JJ	O
populations	NNS	O
.	.	O

We	PRP	O
have	VBP	O
retrospectively	RB	O
analyzed	VBN	O
837	CD	O
random	JJ	O
anonymized	JJ	O
dried	VBN	O
blood	NN	O
spot	NN	O
(	-LRB-	O
DBS	NN	O
)	-RRB-	O
samples	NNS	O
from	IN	O
neonatal	JJ	O
screening	NN	O
programs	NNS	O
in	IN	O
Scandinavia	NNP	O
for	IN	O
mutations	NNS	O
in	IN	O
HFE	NN	O
,	,	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
hemochromatosis	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
C282Y	NN	O
allele	NN	O
frequencies	NNS	O
of	IN	O
2	CD	O
.	.	O

3	CD	O
%	NN	O
(	-LRB-	O
+	CC	O
2	CD	O
.	.	O

0	CD	O
%	NN	O
)	-RRB-	O
(	-LRB-	O
-1	CD	O
.	.	O

3	CD	O
%	NN	O
)	-RRB-	O
in	IN	O
Greenland	NNP	O
,	,	O
4	CD	O
.	.	O

5	CD	O
%	NN	O
+	CC	O
/	:	O
-1	CD	O
.	.	O

9	CD	O
%	NN	O
in	IN	O
Iceland	NNP	O
,	,	O
5	CD	O
.	.	O

1	CD	O
%	NN	O
+	CC	O
/	:	O
-2	CD	O
.	.	O

3	CD	O
%	NN	O
in	IN	O
the	DT	O
Faeroe	NNP	O
Islands	NNPS	O
,	,	O
and	CC	O
8	CD	O
.	.	O

2	CD	O
%	NN	O
+	CC	O
/	:	O
-2	CD	O
.	.	O

7	CD	O
%	NN	O
in	IN	O
Denmark	NNP	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
HFE	NN	O
mutations	NNS	O
in	IN	O
Denmark	NNP	O
suggests	VBZ	O
that	IN	O
population	NN	O
screening	NN	O
for	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
could	MD	O
be	VB	O
highly	RB	O
advantageous	JJ	O
in	IN	O
terms	NNS	O
of	IN	O
preventive	JJ	O
health	NN	O
care	NN	O
.	.	O

Long-term	JJ	O
follow-up	NN	O
evaluation	NN	O
of	IN	O
C282Y	NN	O
homozygotes	NNS	O
and	CC	O
H63D/C282Y	NN	O
compound	NN	O
heterozygotes	NNS	O
will	MD	O
give	VB	O
an	DT	O
indication	NN	O
of	IN	O
the	DT	O
penetrance	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

Hereditary	JJ	O
TP53	NN	O
codon	NN	O
292	CD	O
and	CC	O
somatic	JJ	O
P16INK4A	NN	O
codon	NN	O
94	CD	O
mutations	NNS	O
in	IN	O
a	DT	O
Li-Fraumeni	JJ	B-Disease
syndrome	NN	I-Disease
family	NN	O
.	.	O

Li-Fraumeni	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	I-Disease
that	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
various	JJ	O
types	NNS	O
of	IN	O
cancer	NN	B-Disease
in	IN	O
childhood	NN	O
and	CC	O
adult	JJ	O
cases	NNS	O
.	.	O

Although	IN	O
hereditary	JJ	O
TP53	NN	O
mutation	NN	O
is	VBZ	O
very	RB	O
rare	JJ	O
in	IN	O
different	JJ	O
human	JJ	O
cancers	NNS	B-Disease
,	,	O
it	PRP	O
has	VBZ	O
been	VBN	O
frequently	RB	O
reported	VBN	O
in	IN	O
Li-Fraumeni	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
hereditary	JJ	O
mutations	NNS	O
of	IN	O
TP57KIP2	NN	O
,	,	O
P15INK4B	NN	O
,	,	O
and	CC	O
P16INK4A	NN	O
,	,	O
which	WDT	O
affect	VBP	O
the	DT	O
cell	NN	O
cycle	NN	O
similar	JJ	O
to	TO	O
TP53	NN	O
,	,	O
were	VBD	O
observed	VBN	O
in	IN	O
some	DT	O
types	NNS	O
of	IN	O
cancer	NN	B-Disease
.	.	O

In	IN	O
a	DT	O
Turkish	JJ	O
family	NN	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Li-Fraumeni	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
we	PRP	O
analyzed	VBD	O
the	DT	O
mutation	NN	O
pattern	NN	O
of	IN	O
TP53	NN	O
,	,	O
P57KIP2	NN	O
,	,	O
P15INK4B	NN	O
,	,	O
and	CC	O
P16INK4A	NN	O
in	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
,	,	O
and	CC	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	-LRB-	O
homo/hemizygous	JJ	O
deletion	NN	O
)	-RRB-	O
pattern	NN	O
of	IN	O
TP53	NN	O
and	CC	O
P15INK4B/P16INK4A	NN	O
in	IN	O
two	CD	O
tumor	NN	B-Disease
tissues	NNS	O
.	.	O

The	DT	O
propositus	NN	O
had	VBD	O
a	DT	O
seminoma	NN	B-Disease
,	,	O
his	PRP$	O
daughter	NN	O
a	DT	O
medulloblastoma	NN	B-Disease
,	,	O
and	CC	O
one	CD	O
of	IN	O
his	PRP$	O
healthy	JJ	O
cousins	NNS	O
,	,	O
a	DT	O
TP53	NN	O
codon	NN	O
292	CD	O
missense	NN	O
point	NN	O
mutation	NN	O
(	-LRB-	O
AAA	NN	O
--	:	O
>	JJR	O
ATA	NN	O
;	:	O
Lys	NNP	O
--	:	O
>	JJR	O
Ile	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
.	.	O

Tumor	NN	O
tissue	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
propositus	NN	O
with	IN	O
the	DT	O
seminoma	NN	B-Disease
revealed	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
TP53	NN	O
gene	NN	O
.	.	O

In	IN	O
the	DT	O
analyses	NNS	O
of	IN	O
tumor	NN	B-Disease
tissues	NNS	O
from	IN	O
the	DT	O
propositus	NN	O
and	CC	O
his	PRP$	O
daughter	NN	O
,	,	O
a	DT	O
P16INK4A	NN	O
codon	NN	O
94	CD	O
missense	NN	O
point	NN	O
mutation	NN	O
(	-LRB-	O
GCG	NN	O
--	:	O
>	JJR	O
GAG	NN	O
;	:	O
Ala	NNP	O
--	:	O
>	JJR	O
Glu	NN	O
)	-RRB-	O
was	VBD	O
observed	VBN	O
with	IN	O
the	DT	O
hereditary	JJ	O
TP53	NN	O
mutation	NN	O
.	.	O

P16INK4A	NN	O
codon	NN	O
94	CD	O
mutation	NN	O
observed	VBN	O
in	IN	O
our	PRP$	O
family	NN	O
is	VBZ	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
Li-Fraumeni	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

No	DT	O
other	JJ	O
gene	NN	O
alteration	NN	O
in	IN	O
TP53	NN	O
,	,	O
P57KIP2	NN	O
,	,	O
P15INK4B	NN	O
,	,	O
and	CC	O
P16INK4A	NN	O
was	VBD	O
observed	VBN	O
.	.	O

Existence	NN	O
of	IN	O
the	DT	O
P16INK4A	NN	O
mutation	NN	O
and	CC	O
the	DT	O
hereditary	JJ	O
TP53	NN	O
mutation	NN	O
with	IN	O
or	CC	O
without	IN	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
TP53	NN	O
gene	NN	O
(	-LRB-	O
seminoma/medulloblastoma	NN	O
)	-RRB-	O
may	MD	O
be	VB	O
evidence	NN	O
for	IN	O
a	DT	O
common	JJ	O
mechanism	NN	O
involved	VBN	O
in	IN	O
tumorogenesis	NN	B-Disease
.	.	O

The	DT	O
gene	NN	O
alterations	NNS	O
in	IN	O
TP53	NN	O
and	CC	O
P16INK4A	NN	O
genes	NNS	O
may	MD	O
be	VB	O
used	VBN	O
as	IN	O
tumor	NN	B-Disease
markers	NNS	O
in	IN	O
our	PRP$	O
family	NN	O
.	.	O

.	.	O

An	DT	O
amino-acid	JJ	O
substitution	NN	O
involved	VBN	O
in	IN	O
phenylketonuria	NN	B-Disease
is	VBZ	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
DNA	NN	O
haplotype	NN	O
2	CD	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
human	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
hepatic	JJ	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
,	,	O
phenylalanine	NN	O
4-monooxygenase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

PKU	NNP	B-Disease
is	VBZ	O
a	DT	O
common	JJ	O
inborn	JJ	B-Disease
error	NN	I-Disease
of	IN	I-Disease
amino-acid	JJ	I-Disease
metabolism	NN	I-Disease
in	IN	O
caucasian	JJ	O
populations	NNS	O
and	CC	O
approximately	RB	O
1	CD	O
in	IN	O
50	CD	O
individuals	NNS	O
are	VBP	O
carriers	NNS	O
of	IN	O
a	DT	O
PKU	NNP	B-Disease
allele	NN	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
PKU	NNP	B-Disease
,	,	O
we	PRP	O
characterized	VBD	O
twelve	CD	O
restriction	NN	O
fragment-length	JJ	O
polymorphism	NN	O
(	-LRB-	O
RFLP	NN	O
)	-RRB-	O
haplotypes	NNS	O
of	IN	O
the	DT	O
PAH	NN	O
locus	NN	O
in	IN	O
the	DT	O
northern	JJ	O
European	JJ	O
population	NN	O
and	CC	O
observed	VBN	O
that	IN	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
PKU	NNP	B-Disease
alleles	NNS	O
in	IN	O
this	DT	O
population	NN	O
are	VBP	O
confined	VBN	O
to	TO	O
four	CD	O
common	JJ	O
RFLP	NN	O
haplotypes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
recently	RB	O
reported	VBN	O
a	DT	O
splicing	NN	O
mutation	NN	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
that	WDT	O
is	VBZ	O
associated	VBN	O
with	IN	O
RFLP	NN	O
haplotype	NN	O
3	CD	O
which	WDT	O
is	VBZ	O
present	JJ	O
at	IN	O
about	IN	O
40	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
the	DT	O
molecular	JJ	B-Disease
lesion	NN	I-Disease
associated	VBN	O
with	IN	O
the	DT	O
RFLP	NN	O
haplotype	NN	O
2	CD	O
mutant	JJ	O
allele	NN	O
.	.	O

This	DT	O
defect	NN	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
C-to-T	JJ	O
transition	NN	O
in	IN	O
exon	NN	O
12	CD	O
resulting	VBG	O
in	IN	O
an	DT	O
amino-acid	JJ	O
substitution	NN	O
(	-LRB-	O
Arg	NN	O
to	TO	O
Trp	NN	O
)	-RRB-	O
at	IN	O
residue	NN	O
408	CD	O
of	IN	O
PAH	NN	O
.	.	O

Direct	JJ	O
hybridization	NN	O
analysis	NN	O
of	IN	O
the	DT	O
point	NN	O
mutation	NN	O
using	VBG	O
a	DT	O
specific	JJ	O
oligonucleotide	NN	O
probe	NN	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
also	RB	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
RFLP	NN	O
haplotype	NN	O
2	CD	O
alleles	NNS	O
that	WDT	O
make	VBP	O
up	RP	O
about	IN	O
20	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
PAH	NN	O
genes	NNS	O

The	DT	O
effects	NNS	O
of	IN	O
dystrophin	NN	O
gene	NN	O
mutations	NNS	O
on	IN	O
the	DT	O
ERG	NNP	O
in	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
.	.	O

PURPOSE	NN	O
.	.	O

The	DT	O
authors	NNS	O
earlier	RBR	O
findings	NNS	O
of	IN	O
a	DT	O
negative	JJ	O
electroretinogram	NN	O
(	-LRB-	O
ERG	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
led	VBD	O
them	PRP	O
to	TO	O
investigate	VB	O
dystrophin	NN	O
gene	NN	O
deletions	NNS	O
and	CC	O
ERGs	NNS	O
in	IN	O
five	CD	O
boys	NNS	O
with	IN	O
DMD	NN	B-Disease
.	.	O

The	DT	O
authors	NNS	O
wanted	VBD	O
to	TO	O
determined	VBN	O
whether	IN	O
there	EX	O
were	VBD	O
similar	JJ	O
ERG	NN	O
findings	NNS	O
in	IN	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
DMD	NNP	B-Disease
,	,	O
the	DT	O
mdx	NN	O
mouse	NN	O
.	.	O

METHODS	NNS	O
.	.	O

Ganzfeld	JJ	O
ERGs	NNS	O
were	VBD	O
recorded	VBN	O
in	IN	O
five	CD	O
boys	NNS	O
with	IN	O
DMD	NN	B-Disease
after	IN	O
a	DT	O
complete	JJ	O
ophthalmic	JJ	O
examination	NN	O
.	.	O

The	DT	O
dystrophin	NN	O
gene	NN	O
was	VBD	O
analyzed	VBN	O
by	IN	O
Southern	NN	O
blot	NN	O
hybridization	NN	O
.	.	O

ERGs	NNS	O
were	VBD	O
recorded	VBN	O
in	IN	O
anesthetized	JJ	O
mdx	NN	O
and	CC	O
control	NN	O
mice	NNS	O
with	IN	O
a	DT	O
modified	VBN	O
Grass	NN	O
photostimulator	NN	O
(	-LRB-	O
Grass	NN	O
Instrument	NNP	O
Company	NNP	O
,	,	O
Quincy	NNP	O
,	,	O
MA	NNP	O
)	-RRB-	O
.	.	O

RESULTS	NNS	O
.	.	O

Ophthalmic	JJ	O
examinations	NNS	O
in	IN	O
all	DT	O
five	CD	O
boys	NNS	O
had	VBD	O
normal	JJ	O
findings	NNS	O
,	,	O
yet	RB	O
an	DT	O
abnormal	JJ	O
negative	JJ	O
ERG	NN	O
was	VBD	O
recorded	VBN	O
for	IN	O
each	DT	O
subject	NN	O
.	.	O

The	DT	O
subjects	NNS	O
gene	NN	O
deletions	NNS	O
were	VBD	O
variable	JJ	O
,	,	O
ranging	VBG	O
from	IN	O
large	JJ	O
deletions	NNS	O
to	TO	O
no	DT	O
detectable	JJ	O
deletions	NNS	O
.	.	O

The	DT	O
ERGs	NNS	O
of	IN	O
the	DT	O
mdx	NN	O
mice	NNS	O
were	VBD	O
normal	JJ	O
and	CC	O
did	VBD	O
not	RB	O
differ	VB	O
significantly	RB	O
from	IN	O
those	DT	O
of	IN	O
the	DT	O
control	NN	O
mice	NNS	O
.	.	O

CONCLUSIONS	NNS	O
.	.	O

The	DT	O
authors	NNS	O
believe	VBP	O
the	DT	O
unique	JJ	O
ERG	NN	O
recorded	VBN	O
for	IN	O
the	DT	O
human	JJ	O
subjects	NNS	O
is	VBZ	O
a	DT	O
manifestation	NN	O
of	IN	O
DMD	NN	B-Disease
associated	VBN	O
with	IN	O
defects	NNS	O
at	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
locus	NN	O
and	CC	O
represents	VBZ	O
a	DT	O
new	JJ	O
clinical	JJ	O
entity	NN	O
.	.	O

The	DT	O
ERG	NN	O
of	IN	O
the	DT	O
mdx	NN	O
mouse	NN	O
may	MD	O
be	VB	O
spared	VBN	O
for	IN	O
several	JJ	O
reasons	NNS	O
,	,	O
including	VBG	O
milder	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
mouse	NN	O
gene	NN	O
defect	NN	O
,	,	O
differences	NNS	O
in	IN	O
muscle	NN	O
and	CC	O
retinal	JJ	O
gene	NN	O
product	NN	O
,	,	O
or	CC	O
species	NNS	O
differences	NNS	O
in	IN	O
the	DT	O
biochemical	JJ	O
role	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

The	DT	O
ERG	NN	O
shows	VBZ	O
promise	NN	O
of	IN	O
becoming	VBG	O
a	DT	O
noninvasive	JJ	O
diagnostic	JJ	O
tool	NN	O
for	IN	O
DMD	NNP	B-Disease
and	CC	O
its	PRP$	O
milder	JJ	O
allelic	JJ	O
forms	NNS	O
.	.	O

.	.	O

Eight	CD	O
novel	JJ	O
inactivating	VBG	O
germ	NN	O
line	NN	O
mutations	NNS	O
at	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
identified	VBN	O
by	IN	O
denaturing	VBG	O
gradient	NN	O
gel	NN	O
electrophoresis	NN	O
.	.	O

Familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
dominantly	RB	O
inherited	VBN	O
condition	NN	O
predisposing	VBG	O
to	TO	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
recent	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
responsible	JJ	O
gene	NN	O
(	-LRB-	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
or	CC	O
APC	NN	B-Disease
)	-RRB-	O
has	VBZ	O
facilitated	VBN	O
the	DT	O
search	NN	O
for	IN	O
germ	NN	O
line	NN	O
mutations	NNS	O
in	IN	O
affected	JJ	O
individuals	NNS	O
.	.	O

Previous	JJ	O
authors	NNS	O
have	VBP	O
used	VBN	O
the	DT	O
RNase	NN	O
protection	NN	O
assay	NN	O
and	CC	O
the	DT	O
single-strand	JJ	O
conformation	NN	O
polymorphisms	NNS	O
procedure	NN	O
to	TO	O
screen	NN	O
for	IN	O
mutations	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
we	PRP	O
used	VBD	O
denaturing	VBG	O
gradient	NN	O
gel	NN	O
electrophoresis	NN	O
(	-LRB-	O
DGGE	NN	O
)	-RRB-	O
.	.	O

DGGE	NN	O
analysis	NN	O
of	IN	O
10	CD	O
APC	NN	B-Disease
exons	NNS	O
(	-LRB-	O
4	CD	O
,	,	O
5	CD	O
,	,	O
7	CD	O
,	,	O
8	CD	O
,	,	O
9	CD	O
,	,	O
10	CD	O
,	,	O
12	CD	O
,	,	O
13	CD	O
,	,	O
14	CD	O
,	,	O
and	CC	O
part	NN	O
of	IN	O
15	CD	O
)	-RRB-	O
in	IN	O
33	CD	O
unrelated	JJ	O
Dutch	JJ	O
FAP	NN	B-Disease
patients	NNS	O
has	VBZ	O
led	VBN	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
eight	CD	O
novel	JJ	O
germ	NN	O
line	NN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
stop	NN	O
codons	NNS	O
or	CC	O
frameshifts	NNS	O
.	.	O

The	DT	O
results	NNS	O
reported	VBN	O
here	RB	O
indicate	VBP	O
that	IN	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
an	DT	O
extremely	RB	O
heterogeneous	JJ	O
spectrum	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
;	:	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
all	PDT	O
the	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
this	DT	O
study	NN	O
are	VBP	O
chain	NN	O
terminating	VBG	O
;	:	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
DGGE	NN	O
represents	VBZ	O
a	DT	O
rapid	JJ	O
and	CC	O
sensitive	JJ	O
technique	NN	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
unusually	RB	O
large	JJ	O
APC	NN	B-Disease
gene	NN	O
.	.	O

An	DT	O
extension	NN	O
of	IN	O
the	DT	O
DGGE	NN	O
analysis	NN	O
to	TO	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
in	IN	O
a	DT	O
sufficient	JJ	O
number	NN	O
of	IN	O
clinically	RB	O
well-characterized	JJ	O
,	,	O
unrelated	JJ	O
patients	NNS	O
will	MD	O
facilitate	VB	O
the	DT	O
establishment	NN	O
of	IN	O
genotype-phenotype	JJ	O
correlations	NNS	O
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
extremely	RB	O
heterogeneous	JJ	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
spread	VBN	O
throughout	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
the	DT	O
large	JJ	O
APC	NN	B-Disease
gene	NN	O
among	IN	O
the	DT	O
FAP	NN	B-Disease
patients	NNS	O
indicates	VBZ	O
that	IN	O
this	DT	O
approach	NN	O
may	MD	O
not	RB	O
be	VB	O
useful	JJ	O
as	IN	O
a	DT	O
rapid	JJ	O
presymptomatic	JJ	O
diagnostic	JJ	O
procedure	NN	O
in	IN	O
a	DT	O
routine	JJ	O
laboratory	NN	O
.	.	O

Nevertheless	RB	O
,	,	O
the	DT	O
above	JJ	O
DGGE	NN	O
approach	NN	O
has	VBZ	O
incidentally	RB	O
led	VBN	O
to	TO	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
common	JJ	O
polymorphism	NN	O
in	IN	O
exon	NN	O
13	CD	O
.	.	O

Such	JJ	O
intragenic	JJ	O
polymorphisms	NNS	O
offer	VBP	O
a	DT	O
practical	JJ	O
approach	NN	O
to	TO	O
a	DT	O
more	RBR	O
rapid	JJ	O
procedure	NN	O
for	IN	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
FAP	NN	B-Disease
by	IN	O
linkage	NN	O
analysis	NN	O
in	IN	O
informative	JJ	O
families	NNS	O
.	.	O

.	.	O

Novel	JJ	O
mutations	NNS	O
in	IN	O
XLRS1	NN	O
causing	VBG	O
retinoschisis	NN	B-Disease
,	,	O
including	VBG	O
first	JJ	O
evidence	NN	O
of	IN	O
putative	JJ	O
leader	NN	O
sequence	NN	O
change	NN	O
.	.	O

Juvenile	JJ	B-Disease
retinoschisis	NN	I-Disease
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
XLRS1	NN	O
gene	NN	O
.	.	O

We	PRP	O
screened	VBD	O
31	CD	O
new	JJ	O
unrelated	JJ	O
patients	NNS	O
and	CC	O
families	NNS	O
for	IN	O
XLRS1	NN	O
mutations	NNS	O
in	IN	O
addition	NN	O
to	TO	O
previously	RB	O
reported	VBN	O
mutations	NNS	O
for	IN	O
60	CD	O
of	IN	O
our	PRP$	O
families	NNS	O
(	-LRB-	O
Retinoschisis	NNP	B-Disease
Consortium	NNP	O
,	,	O
Hum	NNP	O
Mol	NNP	O
Genet	NNP	O
1998	CD	O
;	:	O
7	CD	O
1185-1192	CD	O
)	-RRB-	O
.	.	O

Twenty-three	CD	O
different	JJ	O
mutations	NNS	O
including	VBG	O
12	CD	O
novel	JJ	O
ones	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
28	CD	O
patients	NNS	O
.	.	O

Mutations	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
study	NN	O
include	VBP	O
19	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
two	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
one	CD	O
intragenic	JJ	O
deletion	NN	O
,	,	O
four	CD	O
microdeletions	NNS	O
,	,	O
one	CD	O
insertion	NN	O
,	,	O
and	CC	O
one	CD	O
intronic	JJ	O
sequence	NN	O
substitution	NN	O
that	WDT	O
is	VBZ	O
likely	JJ	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
splice	NN	O
site	NN	O
defect	NN	O
.	.	O

Two	CD	O
novel	JJ	O
mutations	NNS	O
,	,	O
c.	VBP	O
38T	NN	O
--	:	O
>	JJR	O
C	NN	O
(	-LRB-	O
L13P	NN	O
)	-RRB-	O
and	CC	O
c.	NN	O
667T	NN	O
--	:	O
>	JJR	O
C	NN	O
(	-LRB-	O
C223R	NN	O
)	-RRB-	O
,	,	O
respectively	RB	O
,	,	O
present	JJ	O
the	DT	O
first	JJ	O
genetic	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
functional	JJ	O
significance	NN	O
of	IN	O
the	DT	O
putative	JJ	O
leader	NN	O
peptide	NN	O
sequence	NN	O
and	CC	O
for	IN	O
the	DT	O
functional	JJ	O
significance	NN	O
at	IN	O
the	DT	O
carboxyl	JJ	O
terminal	NN	O
of	IN	O
the	DT	O
XLRS1	NN	O
protein	NN	O
beyond	IN	O
the	DT	O
discoidin	NN	O
domain	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
25	CD	O
of	IN	O
the	DT	O
families	NNS	O
were	VBD	O
localized	JJ	O
to	TO	O
exons	NNS	O
4-6	CD	O
,	,	O
emphasizing	VBG	O
the	DT	O
critical	JJ	O
functional	JJ	O
significance	NN	O
of	IN	O
the	DT	O
discoidin	NN	O
domain	NN	O
of	IN	O
the	DT	O
XLRS1	NN	O
protein	NN	O

Clinical	JJ	O
use	NN	O
of	IN	O
DNA	NN	O
markers	NNS	O
linked	VBN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Seventy	CD	O
families	NNS	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
known	VBN	O
to	TO	O
the	DT	O
Institute	NNP	O
of	IN	O
Child	NNP	O
Health	NNP	O
fall	VB	O
into	IN	O
three	CD	O
categories	NNS	O
with	IN	O
respect	NN	O
to	TO	O
potential	JJ	O
linkage	NN	O
analysis	NN	O
with	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
DNA	NN	O
markers	NNS	O
RC8	NN	O
and	CC	O
L1	NN	O
.	.	O

28	CD	O
that	WDT	O
bridge	VBP	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

Families	NNS	O
in	IN	O
which	WDT	O
there	EX	O
is	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
obligatory	JJ	O
female	JJ	O
heterozygote	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
13	CD	O
)	-RRB-	O
.	.	O

Here	RB	O
prediction	NN	O
and	CC	O
exclusion	NN	O
of	IN	O
DMD	NNP	B-Disease
gene	NN	O
transmission	NN	O
may	MD	O
be	VB	O
possible	JJ	O
,	,	O
the	DT	O
accuracy	NN	O
being	VBG	O
dependent	JJ	O
on	IN	O
the	DT	O
closeness	NN	O
of	IN	O
the	DT	O
linkage	NN	O
of	IN	O
the	DT	O
DNA	NN	O
marker	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
to	TO	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
;	:	O
an	DT	O
illustrative	JJ	O
case	NN	O
is	VBZ	O
reported	VBN	O
.	.	O

Families	NNS	O
in	IN	O
which	WDT	O
there	EX	O
is	VBZ	O
a	DT	O
single	JJ	O
affected	JJ	O
boy	NN	O
,	,	O
who	WP	O
also	RB	O
has	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
healthy	JJ	O
brothers	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
26	CD	O
)	-RRB-	O
.	.	O

Given	VBN	O
an	DT	O
informative	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
(	-LRB-	O
RFLP	NN	O
)	-RRB-	O
,	,	O
the	DT	O
probability	NN	O
that	IN	O
the	DT	O
boy	NN	O
represents	VBZ	O
a	DT	O
new	JJ	O
mutation	NN	O
can	MD	O
be	VB	O
reassessed	VBN	O
;	:	O
it	PRP	O
is	VBZ	O
also	RB	O
possible	JJ	O
to	TO	O
exclude	VB	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
in	IN	O
a	DT	O
sister	NN	O
.	.	O

Families	NNS	O
with	IN	O
a	DT	O
single	JJ	O
affected	JJ	O
boy	NN	O
with	IN	O
no	DT	O
brother	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
30	CD	O
)	-RRB-	O
.	.	O

Here	RB	O
exclusion	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
in	IN	O
a	DT	O
sister	NN	O
may	MD	O
be	VB	O
possible	JJ	O
.	.	O

Only	RB	O
in	IN	O
one	CD	O
family	NN	O
was	VBD	O
there	EX	O
no	DT	O
possibility	NN	O
of	IN	O
useful	JJ	O
linkage	NN	O
analysis	NN	O
.	.	O

The	DT	O
linkage	NN	O
analysis	NN	O
required	VBN	O
is	VBZ	O
described	VBN	O
,	,	O
and	CC	O
the	DT	O
need	NN	O
to	TO	O
check	VB	O
DMD	NNP	B-Disease
families	NNS	O
for	IN	O
informative	JJ	O
RFLPs	NNS	O
is	VBZ	O
stressed	VBN	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
patients	NNS	O
of	IN	O
Chinese	JJ	O
descent	NN	O
and	CC	O
identification	NN	O
of	IN	O
new	JJ	O
base	NN	O
substitutions	NNS	O
in	IN	O
the	DT	O
human	JJ	O
G6PD	NN	O
gene	NN	O
.	.	O

The	DT	O
underlying	JJ	O
DNA	NN	O
changes	NNS	O
associated	VBN	O
with	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
-	:	I-Disease
deficient	JJ	I-Disease
Asians	NNPS	O
have	VBP	O
not	RB	O
been	VBN	O
extensively	RB	O
investigated	VBN	O
.	.	O

To	TO	O
fill	VB	O
this	DT	O
gap	NN	O
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
G6PD	NN	O
gene	NN	O
of	IN	O
43	CD	O
G6PD-deficient	JJ	B-Disease
Chinese	JJ	O
whose	WP$	O
G6PD	NN	O
was	VBD	O
well	RB	O
characterized	VBN	O
biochemically	RB	O
.	.	O

DNA	NN	O
samples	NNS	O
were	VBD	O
obtained	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
of	IN	O
these	DT	O
individuals	NNS	O
for	IN	O
sequencing	NN	O
using	VBG	O
a	DT	O
direct	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
sequencing	NN	O
procedure	NN	O
.	.	O

From	IN	O
these	DT	O
43	CD	O
samples	NNS	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
five	CD	O
different	JJ	O
types	NNS	O
of	IN	O
nucleotide	NN	O
substitutions	NNS	O
in	IN	O
the	DT	O
G6PD	NN	O
gene	NN	O
at	IN	O
cDNA	NN	O
1388	CD	O
from	IN	O
G	NN	O
to	TO	O
A	NN	O
(	-LRB-	O
Arg	NN	O
to	TO	O
His	PRP$	O
)	-RRB-	O
;	:	O
at	IN	O
cDNA	NN	O
1376	CD	O
from	IN	O
G	NN	O
to	TO	O
T	NN	O
(	-LRB-	O
Arg	NN	O
to	TO	O
Leu	NN	O
)	-RRB-	O
;	:	O
at	IN	O
cDNA	NN	O
1024	CD	O
from	IN	O
C	NN	O
to	TO	O
T	NN	O
(	-LRB-	O
Leu	NN	O
to	TO	O
Phe	NN	O
)	-RRB-	O
;	:	O
at	IN	O
cDNA	NN	O
392	CD	O
from	IN	O
G	NN	O
to	TO	O
T	NN	O
(	-LRB-	O
Gly	NN	O
to	TO	O
Val	NN	O
)	-RRB-	O
;	:	O
at	IN	O
cDNA	NN	O
95	CD	O
from	IN	O
A	DT	O
to	TO	O
G	NN	O
(	-LRB-	O
His	PRP$	O
to	TO	O
Arg	NN	O
)	-RRB-	O
.	.	O

These	DT	O
five	CD	O
nucleotide	NN	O
substitutions	NNS	O
account	VBP	O
for	IN	O
over	IN	O
83	CD	O
%	NN	O
of	IN	O
our	PRP$	O
43	CD	O
G6PD-deficient	JJ	B-Disease
samples	NNS	O
and	CC	O
these	DT	O
substitutions	NNS	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
non-Asians	NNS	O
.	.	O

The	DT	O
substitutions	NNS	O
found	VBN	O
at	IN	O
cDNA	NN	O
392	CD	O
and	CC	O
cDNA	NN	O
1024	CD	O
are	VBP	O
new	JJ	O
findings	NNS	O
.	.	O

The	DT	O
substitutions	NNS	O
at	IN	O
cDNA	NN	O
1376	CD	O
and	CC	O
1388	CD	O
account	NN	O
for	IN	O
over	IN	O
50	CD	O
%	NN	O
of	IN	O
the	DT	O
43	CD	O
samples	NNS	O
examined	VBN	O
indicating	VBG	O
a	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
these	DT	O
two	CD	O
alleles	NNS	O
among	IN	O
G6PD-deficient	JJ	B-Disease
Chinese	JJ	O
.	.	O

Our	PRP$	O
findings	NNS	O
add	VBP	O
support	NN	O
to	TO	O
the	DT	O
notion	NN	O
that	IN	O
diverse	JJ	O
point	NN	O
mutations	NNS	O
may	MD	O
account	VB	O
largely	RB	O
for	IN	O
much	JJ	O
of	IN	O
the	DT	O
phenotypic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Norrie	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
:	:	O
characterization	NN	O
of	IN	O
deletions	NNS	O
and	CC	O
possible	JJ	O
function	NN	O
.	.	O

Positional	JJ	O
cloning	NN	O
experiments	NNS	O
have	VBP	O
resulted	VBN	O
recently	RB	O
in	IN	O
the	DT	O
isolation	NN	O
of	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
pseudoglioma	NN	B-Disease
;	:	O
NDP	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
severe	JJ	O
X-linked	JJ	B-Disease
neurodevelopmental	JJ	I-Disease
disorder	NN	I-Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
and	CC	O
analysis	NN	O
of	IN	O
human	JJ	O
genomic	JJ	O
DNA	NN	O
clones	NNS	O
encompassing	VBG	O
the	DT	O
NDP	NN	B-Disease
gene	NN	O
.	.	O

The	DT	O
gene	NN	O
spans	VBZ	O
28	CD	O
kb	NN	O
and	CC	O
consists	VBZ	O
of	IN	O
3	CD	O
exons	NNS	O
,	,	O
the	DT	O
first	JJ	O
of	IN	O
which	WDT	O
is	VBZ	O
entirely	RB	O
contained	VBN	O
within	IN	O
the	DT	O
5	CD	O
untranslated	JJ	O
region	NN	O
.	.	O

Detailed	JJ	O
analysis	NN	O
of	IN	O
genomic	JJ	O
deletions	NNS	O
in	IN	O
Norrie	NNP	B-Disease
patients	NNS	O
shows	VBZ	O
that	IN	O
they	PRP	O
are	VBP	O
heterogeneous	JJ	O
,	,	O
both	CC	O
in	IN	O
size	NN	O
and	CC	O
in	IN	O
position	NN	O
.	.	O

By	IN	O
PCR	NN	O
analysis	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
expression	NN	O
of	IN	O
the	DT	O
NDP	NN	B-Disease
gene	NN	O
was	VBD	O
not	RB	O
confined	VBN	O
to	TO	O
the	DT	O
eye	NN	O
or	CC	O
to	TO	O
the	DT	O
brain	NN	O
.	.	O

An	DT	O
extensive	JJ	O
DNA	NN	O
and	CC	O
protein	NN	O
sequence	NN	O
comparison	NN	O
between	IN	O
the	DT	O
human	JJ	O
NDP	NN	B-Disease
gene	NN	O
and	CC	O
related	JJ	O
genes	NNS	O
from	IN	O
the	DT	O
database	NN	O
revealed	VBD	O
homology	NN	O
with	IN	O
cysteine-rich	JJ	O
protein-binding	JJ	O
domains	NNS	O
of	IN	O
immediate	JJ	O
--	:	O
early	JJ	O
genes	NNS	O
implicated	VBN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
cell	NN	O
proliferation	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
NDP	NN	O
is	VBZ	O
a	DT	O
molecule	NN	O
related	VBN	O
in	IN	O
function	NN	O
to	TO	O
these	DT	O
genes	NNS	O
and	CC	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
a	DT	O
pathway	NN	O
that	WDT	O
regulates	VBZ	O
neural	JJ	O
cell	NN	O
differentiation	NN	O
and	CC	O
proliferation	NN	O
.	.	O

.	.	O

Prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Wolman	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Two	CD	O
pregnancies	NNS	O
at	IN	O
risk	NN	O
for	IN	O
Wolman	JJ	B-Disease
disease	NN	I-Disease
were	VBD	O
monitored	VBN	O
by	IN	O
assay	NN	O
and	CC	O
electrophoresis	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
in	IN	O
cultured	VBN	O
amniotic-fluid	NN	O
cells	NNS	O
.	.	O

Cells	NNS	O
from	IN	O
patient	NN	O
1	CD	O
had	VBD	O
5	CD	O
%	NN	O
of	IN	O
control	NN	O
levels	NNS	O
of	IN	O
acid	NN	O
lipase	NN	O
,	,	O
using	VBG	O
14C-triolein	NN	O
as	IN	O
substrate	NN	O
;	:	O
however	RB	O
,	,	O
when	WRB	O
artificial	JJ	O
substrates	NNS	O
(	-LRB-	O
esters	NNS	O
of	IN	O
4-methylumbelliferone	NN	O
and	CC	O
p-nitrophenol	NN	O
)	-RRB-	O
were	VBD	O
used	VBN	O
to	TO	O
measure	VB	O
acid	NN	O
lipase	NN	O
,	,	O
these	DT	O
cells	NNS	O
had	VBD	O
30	CD	O
%	NN	O
of	IN	O
control	NN	O
levels	NNS	O
.	.	O

Electrophoresis	NN	O
of	IN	O
cell	NN	O
extracts	NNS	O
revealed	VBD	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
A	NN	O
form	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
Wolman	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Analysis	NN	O
of	IN	O
fetal	JJ	O
tissues	NNS	O
following	VBG	O
prostaglandin	NN	O
termination	NN	O
of	IN	O
this	DT	O
pregnancy	NN	O
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
.	.	O

Assay	NN	O
of	IN	O
fetal-skin	JJ	O
fibroblasts	NNS	O
with	IN	O
14C-triolein	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
artificial	JJ	O
substrates	NNS	O
,	,	O
showed	VBD	O
marked	JJ	O
deficiency	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
activity	NN	O
.	.	O

Electrophoresis	NN	O
of	IN	O
fetal-tissue	JJ	O
extracts	NNS	O
also	RB	O
demonstrated	VBD	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
A	NN	O
form	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
.	.	O

Amniotic-fluid	JJ	O
cells	NNS	O
from	IN	O
patient	NN	O
2	CD	O
showed	VBD	O
normal	JJ	O
levels	NNS	O
of	IN	O
acid	NN	O
lipase	NN	O
with	IN	O
all	DT	O
substrates	NNS	O
tested	VBN	O
;	:	O
the	DT	O
electrophoretic	JJ	O
pattern	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
was	VBD	O
normal	JJ	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
Wolman	JJ	B-Disease
disease	NN	I-Disease
be	VB	O
made	VBN	O
using	VBG	O
the	DT	O
radioassay	NN	O
of	IN	O
acid	NN	O
lipase	NN	O
and/or	CC	O
electrophoresis	NN	O
.	.	O

.	.	O

Somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
in	IN	O
sporadic	JJ	B-Disease
ovarian	JJ	I-Disease
tumours	NNS	I-Disease
.	.	O

The	DT	O
BRCA1	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
17q21	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
syndrome	NN	I-Disease
of	IN	O
increased	VBN	O
susceptibility	NN	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
but	CC	O
no	DT	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
tumours	NNS	B-Disease
have	VBP	O
yet	RB	O
been	VBN	O
described	VBN	O
.	.	O

To	TO	O
study	VB	O
the	DT	O
potential	JJ	O
role	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
sporadic	JJ	O
carcinogenesis	NN	O
,	,	O
we	PRP	O
analysed	VBD	O
the	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
tumour	NN	B-Disease
and	CC	O
normal	JJ	O
fractions	NNS	O
of	IN	O
47	CD	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
for	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
using	VBG	O
the	DT	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
technique	NN	O
.	.	O

We	PRP	O
now	RB	O
describe	VBP	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
of	IN	O
four	CD	O
tumours	NNS	B-Disease
which	WDT	O
also	RB	O
had	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	-LRB-	O
LOH	NN	O
)	-RRB-	O
at	IN	O
a	DT	O
BRCA1	NN	O
intragenic	JJ	O
marker	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
support	VBP	O
a	DT	O
tumour	NN	B-Disease
suppressor	NN	O
mechanism	NN	O
for	IN	O
BRCA1	NN	O
;	:	O
somatic	JJ	O
mutations	NNS	O
and	CC	O
LOH	NN	O
may	MD	O
result	VB	O
in	IN	O
inactivation	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
at	IN	O
least	JJS	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
.	.	O

.	.	O

Skewed	JJ	O
X	NN	O
inactivation	NN	O
in	IN	O
a	DT	O
female	JJ	O
MZ	JJ	O
twin	JJ	O
results	NNS	O
in	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

One	CD	O
of	IN	O
female	JJ	O
MZ	JJ	O
twins	NNS	O
presented	VBN	O
with	IN	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Physical	JJ	O
examination	NN	O
,	,	O
creatine	NN	O
phosphokinase	NN	O
levels	NNS	O
,	,	O
and	CC	O
muscle	NN	O
biopsy	NN	O
were	VBD	O
consistent	JJ	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

However	RB	O
,	,	O
because	IN	O
of	IN	O
her	PRP$	O
sex	NN	O
she	PRP	O
was	VBD	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
limb-girdle	JJ	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

With	IN	O
cDNA	NN	O
probes	NNS	O
to	TO	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
,	,	O
a	DT	O
gene	NN	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
twins	NNS	O
and	CC	O
their	PRP$	O
mother	NN	O
.	.	O

The	DT	O
de	FW	O
novo	FW	O
mutation	NN	O
which	WDT	O
arose	VBD	O
in	IN	O
the	DT	O
mother	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
novel	JJ	O
junction	NN	O
fragments	NNS	O
generated	VBN	O
by	IN	O
HindIII	NN	O
,	,	O
PstI	NN	O
,	,	O
or	CC	O
TaqI	NN	O
when	WRB	O
probed	VBN	O
with	IN	O
cDNA8	NN	O
.	.	O

Additional	JJ	O
evidence	NN	O
of	IN	O
a	DT	O
large	JJ	O
gene	NN	O
deletion	NN	O
was	VBD	O
given	VBN	O
by	IN	O
novel	JJ	O
SfiI	NN	O
junction	NN	O
fragments	NNS	O
detected	VBN	O
by	IN	O
probes	NNS	O
p20	NN	O
,	,	O
J-Bir	NN	O
,	,	O
and	CC	O
J-66	NN	O
on	IN	O
pulsed-field	JJ	O
gel	NN	O
electrophoresis	NN	O
(	-LRB-	O
PFGE	NN	O
)	-RRB-	O
.	.	O

Immunoblot	NN	O
analysis	NN	O
of	IN	O
muscle	NN	O
from	IN	O
the	DT	O
affected	VBN	O
twin	NN	O
showed	VBD	O
dystrophin	NN	O
of	IN	O
normal	JJ	O
size	NN	O
but	CC	O
of	IN	O
reduced	VBN	O
amount	NN	O
.	.	O

Immunofluorescent	JJ	O
visualization	NN	O
of	IN	O
dystrophin	NN	O
revealed	VBD	O
foci	NNS	O
of	IN	O
dystrophin-positive	JJ	O
fibers	NNS	O
adjacent	JJ	O
to	TO	O
foci	NNS	O
of	IN	O
dystrophin-negative	JJ	O
fibers	NNS	O
.	.	O

These	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
affected	VBN	O
twin	NN	O
is	VBZ	O
a	DT	O
manifesting	VBG	O
carrier	NN	O
of	IN	O
an	DT	O
abnormal	JJ	O
DMD	NN	B-Disease
gene	NN	O
,	,	O
her	PRP$	O
myopathy	NN	B-Disease
being	VBG	O
a	DT	O
direct	JJ	O
result	NN	O
of	IN	O
underexpression	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

Cytogenetic	JJ	O
analysis	NN	O
revealed	VBD	O
normal	JJ	O
karyotypes	NNS	O
,	,	O
eliminating	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
translocation	NN	O
affecting	VBG	O
DMD	NNP	B-Disease
gene	NN	O
function	NN	O
.	.	O

Both	DT	O
linkage	NN	O
analysis	NN	O
and	CC	O
DNA	NN	O
fingerprint	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
each	DT	O
twin	NN	O
has	VBZ	O
two	CD	O
different	JJ	O
X	NN	O
chromosomes	NNS	O
,	,	O
eliminating	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
as	IN	O
a	DT	O
mechanism	NN	O
for	IN	O
DMD	NN	B-Disease
expression	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
methylation	NN	O
differences	NNS	O
of	IN	O
the	DT	O
paternal	JJ	O
and	CC	O
maternal	JJ	O
X	NN	O
chromosomes	NNS	O
in	IN	O
these	DT	O
MZ	JJ	O
twins	NNS	O
,	,	O
we	PRP	O
propose	VBP	O
uneven	JJ	O
lyonization	NN	O
(	-LRB-	O
X	NN	O
chromosome	NN	O
inactivation	NN	O
)	-RRB-	O
as	IN	O
the	DT	O
underlying	VBG	O
mechanism	NN	O
for	IN	O
disease	NN	O
expression	NN	O
in	IN	O
the	DT	O
affected	VBN	O
female	NN	O
.	.	O

.	.	O

Coincident	JJ	O
Kaposi	NN	B-Disease
sarcoma	NN	I-Disease
and	CC	O
T-cell	NN	B-Disease
lymphoma	NN	I-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
24	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
eczema	NN	B-Disease
,	,	O
recurrent	JJ	O
mild	JJ	O
infections	NNS	O
,	,	O
and	CC	O
thrombocytopenia	NN	B-Disease
consistent	JJ	O
with	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
presented	VBN	O
with	IN	O
a	DT	O
mediastinal	JJ	O
mass	NN	O
,	,	O
generalized	VBN	O
lymphadenopathy	NN	B-Disease
,	,	O
splenomegaly	NN	B-Disease
,	,	O
and	CC	O
severe	JJ	O
thrombocytopenia	NN	B-Disease
.	.	O

Studies	NNS	O
of	IN	O
immune	JJ	O
function	NN	O
including	VBG	O
immunoglobulin	NN	O
levels	NNS	O
and	CC	O
T-cell	NN	O
subsets	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

Furthermore	RB	O
,	,	O
his	PRP$	O
T	NN	O
lymphocytes	NNS	O
proliferated	VBD	O
normally	RB	O
in	IN	O
response	NN	O
to	TO	O
phytohemagglutinin	NN	O
,	,	O
concanavalin	NN	O
A	NN	O
,	,	O
and	CC	O
the	DT	O
combination	NN	O
of	IN	O
neuraminidase/galactose	NN	O
oxidase	NN	O
.	.	O

However	RB	O
,	,	O
their	PRP$	O
proliferative	JJ	O
responses	NNS	O
to	TO	O
anti-CD43	JJ	O
antibody	NN	O
and	CC	O
periodate	NN	O
were	VBD	O
diminished	VBN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
WAS	NNP	B-Disease
.	.	O

An	DT	O
initial	JJ	O
inguinal	JJ	O
lymph	NN	O
node	NN	O
biopsy	NN	O
surprisingly	RB	O
revealed	VBD	O
Kaposi	NN	B-Disease
sarcoma	NN	I-Disease
.	.	O

However	RB	O
,	,	O
following	VBG	O
splenectomy	NN	O
to	TO	O
increase	VB	O
the	DT	O
platelet	NN	O
count	NN	O
,	,	O
biopsy	NN	O
of	IN	O
the	DT	O
mediastinal	JJ	O
mass	NN	O
revealed	VBD	O
T-cell	NN	B-Disease
large	JJ	I-Disease
cell	NN	I-Disease
lymphoma	NN	I-Disease
.	.	O

Studies	NNS	O
of	IN	O
biopsied	VBN	O
tissue	NN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
Epstein-Barr	JJ	B-Disease
virus	NN	I-Disease
and	CC	O
cytomegalovirus	NN	B-Disease
were	VBD	O
negative	JJ	O
,	,	O
as	IN	O
were	VBD	O
studies	NNS	O
of	IN	O
blood	NN	O
,	,	O
including	VBG	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
human	JJ	B-Disease
immunodeficiency	NN	I-Disease
virus	NN	I-Disease
(	-LRB-	O
HIV	NN	B-Disease
)	-RRB-	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
Kaposi	NN	B-Disease
sarcoma	NN	I-Disease
arising	VBG	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
congenital	JJ	B-Disease
immunodeficiency	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

Although	IN	O
Kaposi	NN	B-Disease
sarcoma	NN	I-Disease
can	MD	O
arise	VB	O
in	IN	O
the	DT	O
face	NN	O
of	IN	O
the	DT	O
severe	JJ	O
immunosuppression	NN	O
that	WDT	O
follows	VBZ	O
allograft	NN	O
transplantation	NN	O
and	CC	O
in	IN	O
patients	NNS	O
infected	VBN	O
with	IN	O
HIV	NN	B-Disease
,	,	O
we	PRP	O
postulate	VBP	O
that	IN	O
longevity	NN	O
in	IN	O
the	DT	O
face	NN	O
of	IN	O
mild	JJ	O
immunosuppression	NN	O
was	VBD	O
the	DT	O
major	JJ	O
factor	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
Kaposi	NN	B-Disease
sarcoma	NN	I-Disease
in	IN	O
this	DT	O
patient	NN	O
.	.	O

.	.	O

Treatment	NN	O
of	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
:	:	O
effects	NNS	O
of	IN	O
chenodeoxycholic	JJ	O
acid	NN	O
,	,	O
pravastatin	NN	O
,	,	O
and	CC	O
combined	VBN	O
use	NN	O
.	.	O

Treatments	NNS	O
by	IN	O
oral	JJ	O
administration	NN	O
of	IN	O
chenodeoxycholic	JJ	O
acid	NN	O
(	-LRB-	O
CDCA	NN	O
)	-RRB-	O
alone	RB	O
,	,	O
3-hydroxy-3-methylglutaryl	NN	O
(	-LRB-	O
HMG	NN	O
)	-RRB-	O
CoA	NN	O
reductase	NN	O
inhibitor	NN	O
(	-LRB-	O
pravastatin	NN	O
)	-RRB-	O
alone	RB	O
,	,	O
and	CC	O
combination	NN	O
of	IN	O
the	DT	O
two	CD	O
drugs	NNS	O
were	VBD	O
attempted	VBN	O
for	IN	O
7	CD	O
patients	NNS	O
with	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
.	.	O

CDCA	NN	O
treatment	NN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
300	CD	O
mg/day	NN	O
reduced	VBD	O
serum	NN	O
cholestanol	NN	O
(	-LRB-	O
67	CD	O
.	.	O

3	CD	O
%	NN	O
reduction	NN	O
)	-RRB-	O
,	,	O
lathosterol	NN	O
(	-LRB-	O
50	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
,	,	O
campesterol	NN	O
(	-LRB-	O
61	CD	O
.	.	O

7	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
sitosterol	NN	O
(	-LRB-	O
12	CD	O
.	.	O

7	CD	O
%	NN	O
)	-RRB-	O
.	.	O

However	RB	O
,	,	O
the	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
changed	VBD	O
to	TO	O
be	VB	O
"	''	O
atherogenic	JJ	O
"	''	O
;	:	O
total	JJ	O
cholesterol	NN	O
,	,	O
triglyceride	NN	O
and	CC	O
low-density	JJ	O
lipoprotein	NN	O
(	-LRB-	O
LDL	NN	O
)	-RRB-	O
-	:	O
cholesterol	NN	O
were	VBD	O
increased	VBN	O
,	,	O
while	IN	O
high-density	JJ	O
lipoprotein	NN	O
(	-LRB-	O
HDL	NN	O
)	-RRB-	O
-	:	O
cholesterol	NN	O
was	VBD	O
decreased	VBN	O
.	.	O

Contrarily	RB	O
,	,	O
pravastatin	NN	O
at	IN	O
a	DT	O
dose	NN	O
of	IN	O
10	CD	O
mg/day	NN	O
improved	VBD	O
the	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
to	TO	O
be	VB	O
markedly	RB	O
"	''	O
anti-atherogenic	JJ	O
"	''	O
,	,	O
but	CC	O
the	DT	O
reductions	NNS	O
of	IN	O
cholestanol	NN	O
(	-LRB-	O
30	CD	O
.	.	O

4	CD	O
%	NN	O
)	-RRB-	O
,	,	O
lathosterol	NN	O
(	-LRB-	O
44	CD	O
.	.	O

0	CD	O
%	NN	O
)	-RRB-	O
,	,	O
campesterol	NN	O
(	-LRB-	O
22	CD	O
.	.	O

9	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
sitosterol	NN	O
(	-LRB-	O
9	CD	O
.	.	O

6	CD	O
%	NN	O
)	-RRB-	O
were	VBD	O
inadequate	JJ	O
.	.	O

Combined	JJ	O
treatment	NN	O
with	IN	O
CDCA	NN	O
and	CC	O
pravastatin	NN	O
showed	VBD	O
good	JJ	O
overlapping	VBG	O
of	IN	O
the	DT	O
effects	NNS	O
of	IN	O
each	DT	O
drug	NN	O
alone	RB	O
.	.	O

The	DT	O
sera	NN	O
of	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
apparently	RB	O
more	JJR	O
"	''	O
anti-atherogenic	JJ	O
"	''	O
than	IN	O
those	DT	O
after	IN	O
CDCA	NN	O
treatment	NN	O
.	.	O

Serum	NN	O
cholestanol	NN	O
concentration	NN	O
was	VBD	O
still	RB	O
2	CD	O
.	.	O

7	CD	O
times	NNS	O
higher	JJR	O
than	IN	O
in	IN	O
controls	NNS	O
,	,	O
but	CC	O
the	DT	O
serum	NN	O
lathosterol	NN	O
level	NN	O
was	VBD	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
enhancement	NN	O
of	IN	O
overall	JJ	O
cholesterol	NN	O
synthesis	NN	O
in	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
sufficiently	RB	O
suppressed	VBN	O
.	.	O

Plant	NN	O
sterol	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

The	DT	O
combination	NN	O
of	IN	O
CDCA	NNP	O
and	CC	O
pravastatin	NN	O
was	VBD	O
a	DT	O
good	JJ	O
treatment	NN	O
for	IN	O
CTX	NNP	B-Disease
,	,	O
based	VBN	O
on	IN	O
the	DT	O
improvement	NN	O
of	IN	O
serum	NN	O
lipoprotein	NN	O
metabolism	NN	O
,	,	O
the	DT	O
suppression	NN	O
of	IN	O
cholesterol	NN	O
synthesis	NN	O
,	,	O
and	CC	O
reductions	NNS	O
of	IN	O
cholestanol	NN	O
and	CC	O
plant	NN	O
sterol	NN	O
levels	NNS	O
.	.	O

In	IN	O
all	DT	O
of	IN	O
7	CD	O
patients	NNS	O
,	,	O
the	DT	O
progression	NN	O
of	IN	O
disease	NN	O
was	VBD	O
arrested	VBN	O
,	,	O
but	CC	O
dramatic	JJ	O
effects	NNS	O
on	IN	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
xanthoma	NN	B-Disease
,	,	O
and	CC	O
electrophysiological	JJ	O
findings	NNS	O
could	MD	O
not	RB	O
be	VB	O
found	VBN	O
after	IN	O
the	DT	O
treatment	NN	O
of	IN	O
these	DT	O
drugs	NNS	O

Combined	JJ	B-Disease
genetic	JJ	I-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
C6	NN	I-Disease
and	CC	I-Disease
C7	NN	I-Disease
in	IN	O
man	NN	O
.	.	O

By	IN	O
routine	JJ	O
screening	NN	O
of	IN	O
sera	NNS	O
,	,	O
a	DT	O
subject	NN	O
was	VBD	O
discovered	VBN	O
who	WP	O
showed	VBD	O
a	DT	O
sub-total	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
C6	NN	I-Disease
and	CC	I-Disease
C7	NN	I-Disease
.	.	O

No	DT	O
clinical	JJ	O
disease	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
this	DT	O
deficiency	NN	O
which	WDT	O
was	VBD	O
transmitted	VBN	O
through	IN	O
the	DT	O
subjects	NNS	O
family	NN	O
as	IN	O
a	DT	O
single	JJ	O
genetic	JJ	O
characteristic	JJ	O
,	,	O
the	DT	O
C6	NN	B-Disease
deficiency	NN	I-Disease
being	VBG	O
associated	VBN	O
with	IN	O
a	DT	O
silent	JJ	O
allele	NN	O
at	IN	O
the	DT	O
structural	JJ	O
locus	NN	O
.	.	O

The	DT	O
propositus	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
low	JJ	O
quantities	NNS	O
of	IN	O
an	DT	O
abnormal	JJ	O
C6	NN	O
which	WDT	O
was	VBD	O
both	DT	O
antigenically	RB	O
deficient	JJ	O
and	CC	O
smaller	JJR	O
in	IN	O
size	NN	O
than	IN	O
normal	JJ	O
C6	NN	O
(	-LRB-	O
110	CD	O
,	,	O
000	CD	O
daltons	NNS	O
compared	VBN	O
with	IN	O
140	CD	O
,	,	O
000	CD	O
daltons	NNS	O
)	-RRB-	O
and	CC	O
small	JJ	O
quantities	NNS	O
of	IN	O
apparently	RB	O
normal	JJ	O
C7	NN	O
.	.	O

It	PRP	O
is	VBZ	O
concluded	VBN	O
that	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
explanation	NN	O
for	IN	O
this	DT	O
defect	NN	O
is	VBZ	O
that	IN	O
the	DT	O
subject	NN	O
has	VBZ	O
a	DT	O
structural	JJ	O
mutation	NN	O
in	IN	O
his	PRP$	O
C6	NN	O
gene	NN	O
which	WDT	O
produces	VBZ	O
hyopsynthesis	NN	O
not	RB	O
only	RB	O
of	IN	O
C6	NN	O
but	CC	O
also	RB	O
of	IN	O
the	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
for	IN	O
C7	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
the	DT	O
possibility	NN	O
that	IN	O
C6	NN	O
and	CC	O
C7	NN	O
may	MD	O
function	VB	O
as	IN	O
a	DT	O
single	JJ	O
genetic	JJ	O
unit	NN	O
and	CC	O
that	IN	O
the	DT	O
primary	JJ	O
transcript	NN	O
copied	VBD	O
from	IN	O
the	DT	O
genome	NN	O
includes	VBZ	O
information	NN	O
for	IN	O
both	DT	O
proteins	NNS	O
.	.	O

.	.	O

Partial	JJ	O
deletion	NN	O
8q	NN	O
without	IN	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
:	:	O
a	DT	O
recognisable	JJ	O
syndrome	NN	O
.	.	O

We	PRP	O
report	VBP	O
two	CD	O
de	FW	O
novo	FW	O
cases	NNS	O
of	IN	O
del	DT	O
(	-LRB-	O
8	CD	O
)	-RRB-	O
(	-LRB-	O
pter	NN	O
----	:	O
q24	NN	O
.	.	O

1	LS	O
)	-RRB-	O
with	IN	O
breakpoints	NNS	O
involving	VBG	O
the	DT	O
distal	JJ	O
part	NN	O
of	IN	O
band	NN	O
8q24	NN	O
.	.	O

1	CD	O
1	CD	O
.	.	O

The	DT	O
clinical	JJ	O
features	NNS	O
were	VBD	O
similar	JJ	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
obvious	JJ	O
stigmata	NN	O
of	IN	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
LGS	NN	B-Disease
)	-RRB-	O
.	.	O

There	EX	O
are	VBP	O
three	CD	O
other	JJ	O
cases	NNS	O
reported	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
chromosome	NN	O
8	CD	O
at	IN	O
approximately	RB	O
the	DT	O
same	JJ	O
breakpoint	NN	O
,	,	O
one	CD	O
without	IN	O
LGS	NNP	B-Disease
and	CC	O
some	DT	O
similarities	NNS	O
to	TO	O
our	PRP$	O
cases	NNS	O
,	,	O
the	DT	O
other	JJ	O
two	CD	O
with	IN	O
LGS	NN	B-Disease
.	.	O

Our	PRP$	O
findings	NNS	O
would	MD	O
support	VB	O
the	DT	O
observation	NN	O
that	IN	O
the	DT	O
critical	JJ	O
segment	NN	O
for	IN	O
the	DT	O
assignment	NN	O
of	IN	O
LGS	NNP	B-Disease
is	VBZ	O
proximal	JJ	O
to	TO	O
or	CC	O
involves	VBZ	O
the	DT	O
proximal	JJ	O
part	NN	O
of	IN	O
8q24	NN	O
.	.	O

1	CD	O
,	,	O
but	CC	O
a	DT	O
review	NN	O
of	IN	O
published	VBN	O
reports	NNS	O
suggests	VBZ	O
that	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
LGS	NNP	B-Disease
may	MD	O
be	VB	O
a	DT	O
more	RBR	O
complex	JJ	O
issue	NN	O

Iron-dependent	JJ	O
self-assembly	NN	O
of	IN	O
recombinant	JJ	O
yeast	NN	O
frataxin	NN	O
:	:	O
implications	NNS	O
for	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
.	.	O

Frataxin	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
the	DT	O
primary	JJ	O
cause	NN	O
of	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
,	,	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
cardiodegenerative	NN	I-Disease
and	CC	I-Disease
neurodegenerative	JJ	I-Disease
disease	NN	I-Disease
.	.	O

Frataxin	NN	O
is	VBZ	O
a	DT	O
nuclear-encoded	JJ	O
mitochondrial	JJ	O
protein	NN	O
that	WDT	O
is	VBZ	O
widely	RB	O
conserved	VBN	O
among	IN	O
eukaryotes	NNS	O
.	.	O

Genetic	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
yeast	NN	O
frataxin	NN	O
homologue	NN	O
(	-LRB-	O
Yfh1p	NN	O
)	-RRB-	O
results	VBZ	O
in	IN	O
mitochondrial	JJ	B-Disease
iron	NN	I-Disease
accumulation	NN	I-Disease
and	CC	O
hypersensitivity	NN	B-Disease
to	TO	I-Disease
oxidative	JJ	I-Disease
stress	NN	I-Disease
.	.	O

Increased	VBN	O
iron	NN	O
deposition	NN	O
and	CC	O
evidence	NN	O
of	IN	O
oxidative	JJ	O
damage	NN	O
have	VBP	O
also	RB	O
been	VBN	O
observed	VBN	O
in	IN	O
cardiac	JJ	O
tissue	NN	O
and	CC	O
cultured	VBN	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
FRDA	NN	B-Disease
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
frataxin	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
mitochondrial	JJ	O
iron	NN	O
homeostasis	NN	O
and	CC	O
protection	NN	O
from	IN	O
iron-induced	JJ	O
formation	NN	O
of	IN	O
free	JJ	O
radicals	NNS	O
.	.	O

The	DT	O
functional	JJ	O
mechanism	NN	O
of	IN	O
frataxin	NN	O
,	,	O
however	RB	O
,	,	O
is	VBZ	O
still	RB	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
expressed	VBN	O
the	DT	O
mature	JJ	O
form	NN	O
of	IN	O
Yfh1p	NN	O
(	-LRB-	O
mYfh1p	NN	O
)	-RRB-	O
in	IN	O
Escherichia	FW	O
coli	FW	O
and	CC	O
have	VBP	O
analyzed	VBN	O
its	PRP$	O
function	NN	O
in	FW	O
vitro	FW	O
.	.	O

Isolated	VBN	O
mYfh1p	NN	O
is	VBZ	O
a	DT	O
soluble	JJ	O
monomer	NN	O
(	-LRB-	O
13	CD	O
,	,	O
783	CD	O
Da	NN	O
)	-RRB-	O
that	WDT	O
contains	VBZ	O
no	DT	O
iron	NN	O
and	CC	O
shows	VBZ	O
no	DT	O
significant	JJ	O
tendency	NN	O
to	TO	O
self-associate	VB	O
.	.	O

Aerobic	JJ	O
addition	NN	O
of	IN	O
ferrous	JJ	O
iron	NN	O
to	TO	O
mYfh1p	NN	O
results	NNS	O
in	IN	O
assembly	NN	O
of	IN	O
regular	JJ	O
spherical	JJ	O
multimers	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
mass	NN	O
of	IN	O
approximately	RB	O
1	CD	O
.	.	O

1	CD	O
MDa	NN	O
(	-LRB-	O
megadaltons	NNS	O
)	-RRB-	O
and	CC	O
a	DT	O
diameter	NN	O
of	IN	O
13	CD	O
+	CC	O
/	:	O
-2	CD	O
nm	NN	O
.	.	O

Each	DT	O
multimer	NN	O
consists	VBZ	O
of	IN	O
approximately	RB	O
60	CD	O
subunits	NNS	O
and	CC	O
can	MD	O
sequester	VB	O
>	JJR	O
3	CD	O
,	,	O
000	CD	O
atoms	NNS	O
of	IN	O
iron	NN	O
.	.	O

Titration	NN	O
of	IN	O
mYfh1p	NN	O
with	IN	O
increasing	VBG	O
iron	NN	O
concentrations	NNS	O
supports	VBZ	O
a	DT	O
stepwise	JJ	O
mechanism	NN	O
of	IN	O
multimer	NN	O
assembly	NN	O
.	.	O

Sequential	JJ	O
addition	NN	O
of	IN	O
an	DT	O
iron	NN	O
chelator	NN	O
and	CC	O
a	DT	O
reducing	VBG	O
agent	NN	O
results	NNS	O
in	IN	O
quantitative	JJ	O
iron	NN	O
release	NN	O
with	IN	O
concomitant	JJ	O
disassembly	NN	O
of	IN	O
the	DT	O
multimer	NN	O
,	,	O
indicating	VBG	O
that	IN	O
mYfh1p	NN	O
sequesters	VBZ	O
iron	NN	O
in	IN	O
an	DT	O
available	JJ	O
form	NN	O
.	.	O

In	IN	O
yeast	NN	O
mitochondria	NN	O
,	,	O
native	JJ	O
mYfh1p	NN	O
exists	VBZ	O
as	IN	O
monomer	NN	O
and	CC	O
a	DT	O
higher-order	JJ	O
species	NNS	O
with	IN	O
a	DT	O
molecular	JJ	O
weight	NN	O
>	JJR	O
600	CD	O
,	,	O
000	CD	O
.	.	O

After	IN	O
addition	NN	O
of	IN	O
(	-LRB-	O
55	CD	O
)	-RRB-	O
Fe	NNP	O
to	TO	O
the	DT	O
medium	NN	O
,	,	O
immunoprecipitates	NNS	O
of	IN	O
this	DT	O
species	NNS	O
contain	VBP	O
>	JJR	O
16	CD	O
atoms	NNS	O
of	IN	O
(	-LRB-	O
55	CD	O
)	-RRB-	O
Fe	NNP	O
per	IN	O
molecule	NN	O
of	IN	O
mYfh1p	NN	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
iron-dependent	JJ	O
self-assembly	NN	O
of	IN	O
recombinant	JJ	O
mYfh1p	NN	O
reflects	VBZ	O
a	DT	O
physiological	JJ	O
role	NN	O
for	IN	O
frataxin	NN	O
in	IN	O
mitochondrial	JJ	O
iron	NN	O
sequestration	NN	O
and	CC	O
bioavailability	NN	O
.	.	O

.	.	O

Human	JJ	O
mutations	NNS	O
in	IN	O
glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
reflect	VBP	O
evolutionary	JJ	O
history	NN	O
.	.	O

Glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
cytosolic	JJ	O
enzyme	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
housekeeping	JJ	O
X-linked	JJ	O
gene	NN	O
whose	WP$	O
main	JJ	O
function	NN	O
is	VBZ	O
to	TO	O
produce	VB	O
NADPH	NN	O
,	,	O
a	DT	O
key	JJ	O
electron	NN	O
donor	NN	O
in	IN	O
the	DT	O
defense	NN	O
against	IN	O
oxidizing	VBG	O
agents	NNS	O
and	CC	O
in	IN	O
reductive	JJ	O
biosynthetic	JJ	O
reactions	NNS	O
.	.	O

Inherited	VBN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
either	CC	O
episodic	JJ	B-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
(	-LRB-	O
triggered	VBN	O
by	IN	O
fava	NN	O
beans	NNS	O
or	CC	O
other	JJ	O
agents	NNS	O
)	-RRB-	O
or	CC	O
life-long	JJ	B-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
.	.	O

We	PRP	O
show	VBP	O
here	RB	O
that	IN	O
an	DT	O
evolutionary	JJ	O
analysis	NN	O
is	VBZ	O
a	DT	O
key	JJ	O
to	TO	O
understanding	VBG	O
the	DT	O
biology	NN	O
of	IN	O
a	DT	O
housekeeping	JJ	O
gene	NN	O
.	.	O

From	IN	O
the	DT	O
alignment	NN	O
of	IN	O
the	DT	O
amino	NN	O
acid	NN	O
(	-LRB-	O
aa	NN	O
)	-RRB-	O
sequence	NN	O
of	IN	O
52	CD	O
glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
species	NNS	O
from	IN	O
42	CD	O
different	JJ	O
organisms	NNS	O
,	,	O
we	PRP	O
found	VBD	O
a	DT	O
striking	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
aa	NN	O
replacements	NNS	O
that	WDT	O
cause	VBP	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
humans	NNS	O
and	CC	O
the	DT	O
sequence	NN	O
conservation	NN	O
of	IN	O
G6PD	NN	O
two-thirds	NNS	O
of	IN	O
such	JJ	O
replacements	NNS	O
are	VBP	O
in	IN	O
highly	RB	O
and	CC	O
moderately	RB	O
conserved	VBN	O
(	-LRB-	O
50-99	CD	O
%	NN	O
)	-RRB-	O
aa	NN	O
;	:	O
relatively	RB	O
few	JJ	O
are	VBP	O
in	IN	O
fully	RB	O
conserved	VBN	O
aa	NN	O
(	-LRB-	O
where	WRB	O
they	PRP	O
might	MD	O
be	VB	O
lethal	JJ	O
)	-RRB-	O
or	CC	O
in	IN	O
poorly	RB	O
conserved	VBN	O
aa	NN	O
,	,	O
where	WRB	O
presumably	RB	O
they	PRP	O
simply	RB	O
would	MD	O
not	RB	O
cause	VB	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
notion	NN	O
that	IN	O
all	DT	O
human	JJ	O
mutants	NNS	O
have	VBP	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
that	IN	O
null	JJ	O
mutations	NNS	O
are	VBP	O
lethal	JJ	O
at	IN	O
some	DT	O
stage	NN	O
of	IN	O
development	NN	O
.	.	O

Comparing	VBG	O
the	DT	O
distribution	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
a	DT	O
human	JJ	O
housekeeping	JJ	O
gene	NN	O
with	IN	O
evolutionary	JJ	O
conservation	NN	O
is	VBZ	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
pinpointing	VBG	O
amino	NN	O
acid	NN	O
residues	NNS	O
important	JJ	O
for	IN	O
the	DT	O
stability	NN	O
or	CC	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
corresponding	JJ	O
protein	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
current	JJ	O
explosive	JJ	O
increase	NN	O
in	IN	O
full	JJ	O
genome	NN	O
sequencing	NN	O
projects	NNS	O
,	,	O
this	DT	O
tool	NN	O
will	MD	O
become	VB	O
rapidly	RB	O
available	JJ	O
for	IN	O
numerous	JJ	O
other	JJ	O
genes	NNS	O
.	.	O

.	.	O

Regionally	RB	O
clustered	VBN	O
APC	NN	B-Disease
mutations	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
and	CC	O
occur	VB	O
at	IN	O
a	DT	O
high	JJ	O
frequency	NN	O
in	IN	O
new	JJ	O
mutation	NN	O
cases	NNS	O
of	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
.	.	O

Germline	NN	O
mutation	NN	O
in	IN	O
APC	NN	O
at	IN	O
5q21-22	JJ	O
results	NNS	O
in	IN	O
the	DT	O
dominantly	RB	O
inherited	VBN	O
syndrome	NN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
.	.	O

Somatic	JJ	O
mutation	NN	O
in	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
an	DT	O
early	JJ	O
event	NN	O
in	IN	O
colorectal	JJ	O
tumourigenesis	NN	O
.	.	O

Both	DT	O
types	NNS	O
of	IN	O
mutation	NN	O
are	VBP	O
concentrated	VBN	O
in	IN	O
the	DT	O
5	CD	O
half	NN	O
of	IN	O
exon	NN	O
15	CD	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
and	CC	O
heteroduplex	JJ	O
analysis	NN	O
to	TO	O
screen	NN	O
for	IN	O
variants	NNS	O
in	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
a	DT	O
total	NN	O
of	IN	O
45	CD	O
affected	VBN	O
but	CC	O
unrelated	JJ	O
individuals	NNS	O
.	.	O

Eighteen	CD	O
patients	NNS	O
had	VBD	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
the	DT	O
disease	NN	O
;	:	O
of	IN	O
these	DT	O
11	CD	O
were	VBD	O
classified	VBN	O
as	IN	O
having	VBG	O
a	DT	O
severe	JJ	O
phenotype	NN	O
,	,	O
based	VBN	O
on	IN	O
an	DT	O
early	JJ	O
age	NN	O
at	IN	O
presentation	NN	O
or	CC	O
cancer	NN	B-Disease
development	NN	O
.	.	O

This	DT	O
compared	VBN	O
with	IN	O
6	CD	O
of	IN	O
27	CD	O
familial	JJ	O
cases	NNS	O
.	.	O

A	DT	O
5	CD	O
bp	NN	O
deletion	NN	O
at	IN	O
codon	NN	O
1309	CD	O
reported	VBD	O
to	TO	O
occur	VB	O
in	IN	O
10-15	CD	O
%	NN	O
of	IN	O
unselected	JJ	O
APC	NN	B-Disease
patients	NNS	O
worldwide	RB	O
,	,	O
was	VBD	O
found	VBN	O
in	IN	O
5	CD	O
of	IN	O
the	DT	O
18	CD	O
new	JJ	O
mutation	NN	O
cases	NNS	O
and	CC	O
4	CD	O
of	IN	O
the	DT	O
27	CD	O
familial	JJ	O
cases	NNS	O
all	DT	O
nine	CD	O
were	VBD	O
classed	VBN	O
as	IN	O
severe	JJ	O
.	.	O

A	DT	O
further	JJ	O
3	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
1	CD	O
familial	JJ	O
mutation	NN	O
were	VBD	O
located	JJ	O
downstream	RB	O
from	IN	O
codon	NN	O
1309	CD	O
,	,	O
these	DT	O
individuals	NNS	O
similarly	RB	O
being	VBG	O
classed	VBN	O
as	IN	O
phenotypically	RB	O
severe	JJ	O
.	.	O

In	IN	O
contrast	NN	O
all	DT	O
of	IN	O
the	DT	O
APC	NN	B-Disease
mutations	NNS	O
detected	VBN	O
in	IN	O
affected	JJ	O
individuals	NNS	O
with	IN	O
an	DT	O
average	JJ	O
phenotype	NN	O
were	VBD	O
located	JJ	O
prior	RB	O
to	TO	O
codon	NN	O
1309	CD	O
.	.	O

The	DT	O
frequent	JJ	O
association	NN	O
of	IN	O
a	DT	O
severe	JJ	O
phenotype	NN	O
with	IN	O
fresh	JJ	O
mutation	NN	O
may	MD	O
explain	VB	O
the	DT	O
apparent	JJ	O
conflict	NN	O
of	IN	O
a	DT	O
high	JJ	O
mutation	NN	O
rate	NN	O
(	-LRB-	O
20-30	CD	O
%	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
condition	NN	O
,	,	O
which	WDT	O
on	IN	O
average	NN	O
,	,	O
is	VBZ	O
lethal	JJ	O
at	IN	O
a	DT	O
post-reproductive	JJ	O
age	NN	O
.	.	O

.	.	O

Analysis	NN	O
of	IN	O
alkaptonuria	NN	B-Disease
(	-LRB-	O
AKU	NN	B-Disease
)	-RRB-	O
mutations	NNS	O
and	CC	O
polymorphisms	NNS	O
reveals	VBZ	O
that	IN	O
the	DT	O
CCC	NN	O
sequence	NN	O
motif	NN	O
is	VBZ	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
in	IN	O
the	DT	O
homogentisate	NN	O
1,2	CD	O
dioxygenase	NN	O
gene	NN	O
(	-LRB-	O
HGO	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
recently	RB	O
showed	VBD	O
that	IN	O
alkaptonuria	NN	B-Disease
(	-LRB-	O
AKU	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
loss-of-function	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
homogentisate	NN	O
1	CD	O
,	,	O
2	CD	O
dioxygenase	NN	O
gene	NN	O
(	-LRB-	O
HGO	NN	O
)	-RRB-	O
.	.	O

Herein	RB	O
we	PRP	O
describe	VBP	O
haplotype	NN	O
and	CC	O
mutational	JJ	O
analyses	NNS	O
of	IN	O
HGO	NNP	O
in	IN	O
seven	CD	O
new	JJ	O
AKU	NNP	B-Disease
pedigrees	NNS	O
.	.	O

These	DT	O
analyses	NNS	O
identified	VBD	O
two	CD	O
novel	JJ	O
single-nucleotide	JJ	O
polymorphisms	NNS	O
(	-LRB-	O
INV4	NN	O
+	CC	O
31A	NN	O
--	:	O
>	JJR	O
G	NN	O
and	CC	O
INV11	NN	O
+	CC	O
18A	NN	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
and	CC	O
six	CD	O
novel	JJ	O
AKU	NN	B-Disease
mutations	NNS	O
(	-LRB-	O
INV1-1G	NN	O
--	:	O
>	JJR	O
A	DT	O
,	,	O
W60G	NN	O
,	,	O
Y62C	NN	O
,	,	O
A122D	NN	O
,	,	O
P230T	NN	O
,	,	O
and	CC	O
D291E	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
further	RB	O
illustrates	VBZ	O
the	DT	O
remarkable	JJ	O
allelic	JJ	O
heterogeneity	NN	O
found	VBN	O
in	IN	O
AKU	NNP	B-Disease
.	.	O

Reexamination	NN	O
of	IN	O
all	DT	O
29	CD	O
mutations	NNS	O
and	CC	O
polymorphisms	NNS	O
thus	RB	O
far	RB	O
described	VBN	O
in	IN	O
HGO	NNP	O
shows	VBZ	O
that	IN	O
these	DT	O
nucleotide	NN	O
changes	NNS	O
are	VBP	O
not	RB	O
randomly	RB	O
distributed	VBN	O
;	:	O
the	DT	O
CCC	NN	O
sequence	NN	O
motif	NN	O
and	CC	O
its	PRP$	O
inverted	JJ	O
complement	NN	O
,	,	O
GGG	NN	O
,	,	O
are	VBP	O
preferentially	RB	O
mutated	VBN	O
.	.	O

These	DT	O
analyses	NNS	O
also	RB	O
demonstrated	VBD	O
that	IN	O
the	DT	O
nucleotide	NN	O
substitutions	NNS	O
in	IN	O
HGO	NNP	O
do	VBP	O
not	RB	O
involve	VB	O
CpG	NN	O
dinucleotides	NNS	O
,	,	O
which	WDT	O
illustrates	VBZ	O
important	JJ	O
differences	NNS	O
between	IN	O
HGO	NNP	O
and	CC	O
other	JJ	O
genes	NNS	O
for	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
mutation	NN	O
at	IN	O
specific	JJ	O
short-sequence	NN	O
motifs	NNS	O
.	.	O

Because	IN	O
the	DT	O
CCC	NN	O
sequence	NN	O
motifs	NNS	O
comprise	VBP	O
a	DT	O
significant	JJ	O
proportion	NN	O
(	-LRB-	O
34	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
all	DT	O
mutated	VBN	O
bases	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
observed	VBN	O
in	IN	O
HGO	NNP	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
CCC	NN	O
triplet	NN	O
is	VBZ	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
in	IN	O
HGO	NNP	O
.	.	O

Further	JJ	O
evidence	NN	O
for	IN	O
heterogeneity	NN	O
of	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

Four	CD	O
new	JJ	O
G6PD	NN	O
variants	NNS	O
have	VBP	O
been	VBN	O
characterized	VBN	O
in	IN	O
individuals	NNS	O
from	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

This	DT	O
study	NN	O
demonstrates	VBZ	O
that	IN	O
the	DT	O
previously	RB	O
reported	VBN	O
Markham	NNP	O
variant	NN	O
and	CC	O
the	DT	O
newly	RB	O
characterized	VBN	O
Salata	NNP	O
variant	NN	O
may	MD	O
be	VB	O
widely	RB	O
distributed	VBN	O
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

Th	NN	O
data	NNS	O
presented	VBN	O
here	RB	O
together	RB	O
with	IN	O
those	DT	O
of	IN	O
previously	RB	O
published	VBN	O
studies	NNS	O
demonstrate	VBP	O
a	DT	O
degree	NN	O
of	IN	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
that	WDT	O
is	VBZ	O
much	RB	O
higher	JJR	O
than	IN	O
that	DT	O
in	IN	O
other	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
world	NN	O
where	WRB	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
common	JJ	O
.	.	O

.	.	O

Overgrowth	NN	B-Disease
of	IN	I-Disease
oral	JJ	I-Disease
mucosa	NN	I-Disease
and	CC	I-Disease
facial	JJ	I-Disease
skin	NN	I-Disease
,	,	O
a	DT	O
novel	JJ	O
feature	NN	O
of	IN	O
aspartylglucosaminuria	NN	B-Disease
.	.	O

Aspartylglucosaminuria	NN	B-Disease
(	-LRB-	O
AGU	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
lysosomal	JJ	B-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
aspartylglucosaminidase	NN	I-Disease
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
.	.	O

The	DT	O
main	JJ	O
symptom	NN	O
is	VBZ	O
progressive	JJ	O
mental	JJ	B-Disease
retardation	NN	I-Disease
.	.	O

A	DT	O
spectrum	NN	O
of	IN	O
different	JJ	O
mutations	NNS	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
this	DT	O
disease	NN	O
,	,	O
one	CD	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
Cys163Ser	NN	O
)	-RRB-	O
being	VBG	O
responsible	JJ	O
for	IN	O
the	DT	O
majority	NN	O
of	IN	O
Finnish	JJ	O
cases	NNS	O
.	.	O

We	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
examine	VB	O
66	CD	O
Finnish	JJ	O
AGU	NN	B-Disease
patients	NNS	O
for	IN	O
changes	NNS	O
in	IN	O
the	DT	O
oral	JJ	O
mucosa	NN	O
and	CC	O
44	CD	O
of	IN	O
these	DT	O
for	IN	O
changes	NNS	O
in	IN	O
facial	JJ	O
skin	NN	O
.	.	O

Biopsy	NN	O
specimens	NNS	O
of	IN	O
16	CD	O
oral	JJ	O
lesions	NNS	O
,	,	O
12	CD	O
of	IN	O
them	PRP	O
associated	VBN	O
with	IN	O
the	DT	O
teeth	NNS	O
,	,	O
plus	CC	O
two	CD	O
facial	JJ	B-Disease
lesions	NNS	I-Disease
were	VBD	O
studied	VBN	O
histologically	RB	O
.	.	O

Immunohistochemical	JJ	O
staining	NN	O
for	IN	O
AGA	NNP	O
was	VBD	O
performed	VBN	O
on	IN	O
15	CD	O
oral	JJ	O
specimens	NNS	O
.	.	O

Skin	NN	O
was	VBD	O
seborrhoeic	JJ	O
in	IN	O
adolescent	JJ	O
and	CC	O
adult	JJ	O
patients	NNS	O
,	,	O
with	IN	O
erythema	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
facial	JJ	I-Disease
skin	NN	I-Disease
already	RB	O
common	JJ	O
in	IN	O
childhood	NN	O
.	.	O

Of	IN	O
44	CD	O
patients	NNS	O
,	,	O
nine	CD	O
(	-LRB-	O
20	CD	O
%	NN	O
)	-RRB-	O
had	VBD	O
facial	JJ	B-Disease
angiofibromas	NNS	I-Disease
,	,	O
tumours	NNS	B-Disease
primarily	RB	O
occurring	VBG	O
in	IN	O
association	NN	O
with	IN	O
tuberous	JJ	B-Disease
sclerosis	NN	I-Disease
.	.	O

Oedemic	JJ	B-Disease
buccal	JJ	I-Disease
mucosa	NN	I-Disease
(	-LRB-	O
leucoedema	NN	B-Disease
)	-RRB-	O
and	CC	O
gingival	JJ	B-Disease
overgrowths	NNS	I-Disease
were	VBD	O
more	RBR	O
frequent	JJ	O
in	IN	O
AGU	NN	B-Disease
patients	NNS	O
than	IN	O
in	IN	O
controls	NNS	O
(	-LRB-	O
p	NN	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
)	-RRB-	O
.	.	O

Of	IN	O
16	CD	O
oral	JJ	B-Disease
mucosal	JJ	I-Disease
lesions	NNS	I-Disease
studied	VBN	O
histologically	RB	O
,	,	O
15	CD	O
represented	VBD	O
fibroepithelial	JJ	B-Disease
or	CC	I-Disease
epithelial	JJ	I-Disease
hyperplasias	NN	I-Disease
and	CC	O
were	VBD	O
reactive	JJ	O
in	IN	O
nature	NN	O
.	.	O

Cytoplasmic	JJ	O
vacuolisation	NN	O
was	VBD	O
evident	JJ	O
in	IN	O
four	CD	O
.	.	O

Immunohistochemically	RB	O
,	,	O
expression	NN	O
of	IN	O
AGA	NNP	O
in	IN	O
AGU	NNP	B-Disease
patients	NNS	O
mucosal	JJ	B-Disease
lesions	NNS	I-Disease
did	VBD	O
not	RB	O
differ	VB	O
from	IN	O
that	DT	O
seen	VBN	O
in	IN	O
corresponding	JJ	O
lesions	NNS	O
of	IN	O
normal	JJ	O
subjects	NNS	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
mucosal	JJ	B-Disease
overgrowth	NN	I-Disease
in	IN	O
AGU	NN	B-Disease
patients	NNS	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
directly	RB	O
associated	VBN	O
with	IN	O
lysosomal	JJ	O
storage	NN	O
or	CC	O
with	IN	O
alterations	NNS	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
AGA	NN	O
expression	NN	O
.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
galactosemia	NN	B-Disease
(	-LRB-	O
type	NN	O
1	CD	O
)	-RRB-	O
mutations	NNS	O
in	IN	O
Japanese	JJ	O
.	.	O

We	PRP	O
characterized	VBD	O
two	CD	O
novel	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
galactose-1-phosphate	NN	O
uridyltransferase	NN	O
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
GALT	NNP	B-Disease
deficiency	NN	I-Disease
and	CC	O
identified	VBD	O
N314D	NN	O
and	CC	O
R333W	NN	O
mutations	NNS	O
,	,	O
previously	RB	O
found	VBN	O
in	IN	O
Caucasians	NNPS	O
.	.	O

One	CD	O
novel	JJ	O
missense	NN	O
mutation	NN	O
was	VBD	O
an	DT	O
G-to-A	JJ	O
transition	NN	O
in	IN	O
exon	NN	O
8	CD	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
arginine	NN	O
by	IN	O
histidine	NN	O
at	IN	O
the	DT	O
codon	NN	O
231	CD	O
(	-LRB-	O
R231H	NN	O
)	-RRB-	O
.	.	O

GALT	NN	O
activity	NN	O
of	IN	O
the	DT	O
R231H	NN	O
mutant	JJ	O
construct	NN	O
was	VBD	O
reduced	VBN	O
to	TO	O
15	CD	O
%	NN	O
of	IN	O
normal	JJ	O
controls	NNS	O
in	IN	O
a	DT	O
COS	NN	O
cell	NN	O
expression	NN	O
system	NN	O
.	.	O

The	DT	O
other	JJ	O
was	VBD	O
a	DT	O
splicing	NN	O
mutation	NN	O
,	,	O
an	DT	O
A-to-G	JJ	O
transition	NN	O
at	IN	O
the	DT	O
38th	JJ	O
nucleotide	NN	O
in	IN	O
exon	NN	O
3	CD	O
(	-LRB-	O
318A	NN	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
38-bp	JJ	O
deletion	NN	O
in	IN	O
the	DT	O
GALT	NNP	O
cDNA	NN	O
by	IN	O
activating	VBG	O
a	DT	O
cryptic	JJ	O
splice	NN	O
acceptor	NN	O
site	NN	O
.	.	O

In	IN	O
seven	CD	O
Japanese	JJ	O
families	NNS	O
(	-LRB-	O
14	CD	O
alleles	NNS	O
for	IN	O
classic	JJ	O
form	NN	O
and	CC	O
one	CD	O
allele	NN	O
for	IN	O
Duarte	NNP	O
variant	NN	O
)	-RRB-	O
with	IN	O
GALT	NNP	B-Disease
deficiency	NN	I-Disease
,	,	O
the	DT	O
R231H	NN	O
and	CC	O
318A	NN	O
--	:	O
>	JJR	O
G	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
only	RB	O
on	IN	O
both	DT	O
alleles	NNS	O
of	IN	O
the	DT	O
proband	NN	O
.	.	O

The	DT	O
N314D	NN	O
and	CC	O
R333W	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
on	IN	O
one	CD	O
allele	NN	O
each	DT	O
.	.	O

The	DT	O
Q188R	NN	O
was	VBD	O
prevalent	JJ	O
in	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
but	CC	O
not	RB	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

The	DT	O
N314D	NN	O
mutation	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
Duarte	NNP	O
variant	NN	O
in	IN	O
Japanese	JJ	O
persons	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
the	DT	O
United	NNP	O
States	NNPS	O
.	.	O

We	PRP	O
speculate	VBP	O
that	IN	O
classic	JJ	B-Disease
galactosemia	NN	I-Disease
mutations	NNS	O
appear	VBP	O
to	TO	O
differ	VB	O
between	IN	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
patients	NNS	O
.	.	O

Our	PRP$	O
limited	JJ	O
data	NNS	O
set	VBN	O
on	IN	O
galactosemia	NN	B-Disease
mutations	NNS	O
in	IN	O
Japanese	JJ	O
suggests	VBZ	O
that	IN	O
the	DT	O
N314D	NN	O
GALT	NN	O
mutation	NN	O
encoding	VBG	O
the	DT	O
Duarte	NNP	O
variant	JJ	O
arose	VBD	O
before	IN	O
Asian	JJ	O
and	CC	O
Caucasian	JJ	O
people	NNS	O
diverged	JJ	O
and	CC	O
that	IN	O
classic	JJ	B-Disease
galactosemia	NN	I-Disease
mutations	NNS	O
arose	VBD	O
and/or	CC	O
accumulated	VBN	O
after	IN	O
the	DT	O
divergence	NN	O
of	IN	O
Asian	JJ	O
and	CC	O
Caucasian	JJ	O
populations	NNS	O
.	.	O

.	.	O

Linkage	NN	O
disequilibrium	NN	O
mapping	NN	O
in	IN	O
isolated	VBN	O
founder	NN	O
populations	NNS	O
:	:	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
in	IN	O
Finland	NNP	O
.	.	O

Linkage	NN	O
disequilibrium	NN	O
mapping	NN	O
in	IN	O
isolated	VBN	O
populations	NNS	O
provides	VBZ	O
a	DT	O
powerful	JJ	O
tool	NN	O
for	IN	O
fine	JJ	O
structure	NN	O
localization	NN	O
of	IN	O
disease	NN	O
genes	NNS	O
.	.	O

Here	RB	O
,	,	O
Luria	NNP	O
and	CC	O
Delbrucks	NNP	O
classical	JJ	O
methods	NNS	O
for	IN	O
analysing	VBG	O
bacterial	JJ	O
cultures	NNS	O
are	VBP	O
adapted	VBN	O
to	TO	O
the	DT	O
study	NN	O
of	IN	O
human	JJ	O
isolated	VBN	O
founder	NN	O
populations	NNS	O
in	IN	O
order	NN	O
to	TO	O
estimate	VB	O
(	-LRB-	O
i	LS	O
)	-RRB-	O
the	DT	O
recombination	NN	O
fraction	NN	O
between	IN	O
a	DT	O
disease	NN	O
locus	NN	O
and	CC	O
a	DT	O
marker	NN	O
;	:	O
(	-LRB-	O
ii	LS	O
)	-RRB-	O
the	DT	O
expected	VBN	O
degree	NN	O
of	IN	O
allelic	JJ	O
homogeneity	NN	O
in	IN	O
a	DT	O
population	NN	O
;	:	O
and	CC	O
(	-LRB-	O
iii	LS	O
)	-RRB-	O
the	DT	O
mutation	NN	O
rate	NN	O
of	IN	O
marker	NN	O
loci	NNS	O
.	.	O

Using	VBG	O
these	DT	O
methods	NNS	O
,	,	O
we	PRP	O
report	VBP	O
striking	JJ	O
linkage	NN	O
disequilibrium	NN	O
for	IN	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
(	-LRB-	O
DTD	NN	B-Disease
)	-RRB-	O
in	IN	O
Finland	NNP	O
indicating	VBG	O
that	IN	O
the	DT	O
DTD	NN	B-Disease
gene	NN	O
should	MD	O
lie	VB	O
within	IN	O
0	CD	O
.	.	O

06	NN	O
centimorgans	NNS	O
(	-LRB-	O
or	CC	O
about	IN	O
60	CD	O
kilobases	NNS	O
)	-RRB-	O
of	IN	O
the	DT	O
CSF1R	NN	O
gene	NN	O
.	.	O

Predictions	NNS	O
about	IN	O
allelic	JJ	O
homogeneity	NN	O
in	IN	O
Finland	NNP	O
and	CC	O
mutation	NN	O
rates	NNS	O
in	IN	O
simple	JJ	O
sequence	NN	O
repeats	NNS	O
are	VBP	O
confirmed	VBN	O
by	IN	O
independent	JJ	O
observations	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
TNFRSF11A	NN	O
,	,	O
affecting	VBG	O
the	DT	O
signal	NN	O
peptide	NN	O
of	IN	O
RANK	NN	O
,	,	O
cause	VB	O
familial	JJ	B-Disease
expansile	NN	I-Disease
osteolysis	NN	I-Disease
.	.	O

Familial	JJ	B-Disease
expansile	NN	I-Disease
osteolysis	NN	I-Disease
(	-LRB-	O
FEO	NN	B-Disease
,	,	O
MIM	NNP	O
174810	CD	O
)	-RRB-	O
is	VBZ	O
a	DT	O
rare	JJ	O
,	,	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
bone	NN	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
focal	JJ	O
areas	NNS	O
of	IN	O
increased	VBN	B-Disease
bone	NN	I-Disease
remodelling	NN	I-Disease
.	.	O

The	DT	O
osteolytic	JJ	B-Disease
lesions	NNS	I-Disease
,	,	O
which	WDT	O
develop	VBP	O
usually	RB	O
in	IN	O
the	DT	O
long	JJ	O
bones	NNS	O
during	IN	O
early	JJ	O
adulthood	NN	O
,	,	O
show	VBP	O
increased	VBN	O
osteoblast	NN	O
and	CC	O
osteoclast	NN	O
activity	NN	O
.	.	O

Our	PRP$	O
previous	JJ	O
linkage	NN	O
studies	NNS	O
mapped	VBD	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
FEO	NNP	B-Disease
to	TO	O
an	DT	O
interval	NN	O
of	IN	O
less	JJR	O
than	IN	O
5	CD	O
cM	NN	O
between	IN	O
D18S64	NN	O
and	CC	O
D18S51	NN	O
on	IN	O
chromosome	NN	O
18q21	NN	O
.	.	O

2-21	CD	O
2-21	CD	O
.	.	O

3	CD	O
in	IN	O
a	DT	O
large	JJ	O
Northern	NN	O
Irish	JJ	O
family	NN	O
.	.	O

The	DT	O
gene	NN	O
encoding	NN	O
receptor	NN	O
activator	NN	O
of	IN	O
nuclear	JJ	O
factor-kappa	NN	O
B	NN	O
(	-LRB-	O
RANK	NN	O
;	:	O
ref	NN	O
.	.	O

5	LS	O
)	-RRB-	O
,	,	O
TNFRSF11A	NN	O
,	,	O
maps	VBZ	O
to	TO	O
this	DT	O
region	NN	O
.	.	O

RANK	NN	O
is	VBZ	O
essential	JJ	O
in	IN	O
osteoclast	NN	O
formation	NN	O
.	.	O

We	PRP	O
identified	VBD	O
two	CD	O
heterozygous	JJ	O
insertion	NN	O
mutations	NNS	O
in	IN	O
exon	NN	O
1	CD	O
of	IN	O
TNFRSF11A	NN	O
in	IN	O
affected	VBN	O
members	NNS	O
of	IN	O
four	CD	O
families	NNS	O
with	IN	O
FEO	NN	B-Disease
or	CC	O
familial	JJ	B-Disease
Paget	NN	I-Disease
disease	NN	I-Disease
of	IN	I-Disease
bone	NN	I-Disease
(	-LRB-	O
PDB	NN	B-Disease
)	-RRB-	O
.	.	O

One	CD	O
was	VBD	O
a	DT	O
duplication	NN	O
of	IN	O
18	CD	O
bases	NNS	O
and	CC	O
the	DT	O
other	JJ	O
a	DT	O
duplication	NN	O
of	IN	O
27	CD	O
bases	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
affected	VBD	O
the	DT	O
signal	NN	O
peptide	NN	O
region	NN	O
of	IN	O
the	DT	O
RANK	NN	O
molecule	NN	O
.	.	O

Expression	NN	O
of	IN	O
recombinant	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
RANK	NN	O
proteins	NNS	O
revealed	VBD	O
perturbations	NNS	O
in	IN	O
expression	NN	O
levels	NNS	O
and	CC	O
lack	NN	O
of	IN	O
normal	JJ	O
cleavage	NN	O
of	IN	O
the	DT	O
signal	NN	O
peptide	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
caused	VBD	O
an	DT	O
increase	NN	O
in	IN	O
RANK-mediated	JJ	O
nuclear	JJ	O
factor-kappaB	NN	O
(	-LRB-	O
NF-kappaB	NN	O
)	-RRB-	O
signalling	NN	O
in	FW	O
vitro	FW	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
activating	VBG	O
mutation	NN	O
.	.	O

Adrenoleukodystrophy-related	JJ	O
protein	NN	O
can	MD	O
compensate	VB	O
functionally	RB	O
for	IN	O
adrenoleukodystrophy	NN	B-Disease
protein	NN	I-Disease
deficiency	NN	I-Disease
(	-LRB-	O
X-ALD	NN	B-Disease
)	-RRB-	O
:	:	O
implications	NNS	O
for	IN	O
therapy	NN	O
.	.	O

Inherited	VBN	B-Disease
defects	NNS	I-Disease
in	IN	O
the	DT	O
peroxisomal	JJ	O
ATP-binding	JJ	O
cassette	NN	O
(	-LRB-	O
ABC	NNP	O
)	-RRB-	O
transporter	NN	O
adrenoleukodystrophy	NN	B-Disease
protein	NN	O
(	-LRB-	O
ALDP	NN	O
)	-RRB-	O
lead	VBP	O
to	TO	O
the	DT	O
lethal	JJ	O
peroxisomal	JJ	B-Disease
disorder	NN	I-Disease
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
X-ALD	NN	B-Disease
)	-RRB-	O
,	,	O
for	IN	O
which	WDT	O
no	DT	O
efficient	JJ	O
treatment	NN	O
has	VBZ	O
been	VBN	O
established	VBN	O
so	RB	O
far	RB	O
.	.	O

Three	CD	O
other	JJ	O
peroxisomal	JJ	O
ABC	NNP	O
transporters	NNS	O
currently	RB	O
are	VBP	O
known	VBN	O
adrenoleukodystrophy-related	JJ	O
protein	NN	O
(	-LRB-	O
ALDRP	NN	O
)	-RRB-	O
,	,	O
70	CD	O
kDa	NN	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
(	-LRB-	O
PMP70	NN	O
)	-RRB-	O
and	CC	O
PMP70	NN	O
-	:	O
related	JJ	O
protein	NN	O
.	.	O

By	IN	O
using	VBG	O
transient	JJ	O
and	CC	O
stable	JJ	O
overexpression	NN	O
of	IN	O
human	JJ	O
cDNAs	NNS	O
encoding	VBG	O
ALDP	NN	O
and	CC	O
its	PRP$	O
closest	JJS	O
relative	JJ	O
ALDRP	NN	O
,	,	O
we	PRP	O
could	MD	O
restore	VB	O
the	DT	O
impaired	JJ	O
peroxisomal	JJ	O
beta-oxidation	NN	O
in	IN	O
fibroblasts	NNS	O
of	IN	O
X-ALD	NN	B-Disease
patients	NNS	O
.	.	O

The	DT	O
pathognomonic	JJ	O
accumulation	NN	O
of	IN	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
could	MD	O
also	RB	O
be	VB	O
prevented	VBN	O
by	IN	O
overexpression	NN	O
of	IN	O
ALDRP	NN	O
in	IN	O
immortalized	VBN	O
X-ALD	NN	O
cells	NNS	O
.	.	O

Immunofluorescence	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
functional	JJ	O
replacement	NN	O
of	IN	O
ALDP	NN	O
by	IN	O
ALDRP	NN	O
was	VBD	O
not	RB	O
due	JJ	O
to	TO	O
stabilization	NN	O
of	IN	O
the	DT	O
mutated	VBN	O
ALDP	NN	O
itself	PRP	O
.	.	O

Moreover	RB	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
restore	VB	O
the	DT	O
peroxisomal	JJ	O
beta-oxidation	NN	O
defect	NN	O
in	IN	O
the	DT	O
liver	NN	O
of	IN	O
ALDP-deficient	JJ	O
mice	NNS	O
by	IN	O
stimulation	NN	O
of	IN	O
ALDRP	NN	O
and	CC	O
PMP70	NN	O
gene	NN	O
expression	NN	O
through	IN	O
a	DT	O
dietary	JJ	O
treatment	NN	O
with	IN	O
the	DT	O
peroxisome	NN	O
proliferator	NN	O
fenofibrate	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
correction	NN	O
of	IN	O
the	DT	O
biochemical	JJ	O
defect	NN	O
in	IN	O
X-ALD	NN	B-Disease
could	MD	O
be	VB	O
possible	JJ	O
by	IN	O
drug-induced	JJ	O
overexpression	NN	O
or	CC	O
ectopic	JJ	O
expression	NN	O
of	IN	O
ALDRP	NN	O
.	.	O

.	.	O

The	DT	O
normal	JJ	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
allele	NN	O
,	,	O
or	CC	O
a	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
,	,	O
influences	VBZ	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
HD	NN	B-Disease
.	.	O

We	PRP	O
evaluated	VBD	O
the	DT	O
hypothesis	NN	O
that	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
influenced	VBN	O
by	IN	O
the	DT	O
normal	JJ	O
HD	NN	B-Disease
allele	NN	O
by	IN	O
comparing	VBG	O
transmission	NN	O
patterns	NNS	O
of	IN	O
genetically	RB	O
linked	VBN	O
markers	NNS	O
at	IN	O
the	DT	O
D4S10	NN	O
locus	NN	O
in	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
against	IN	O
age	NN	O
at	IN	O
onset	NN	O
in	IN	O
the	DT	O
affected	VBN	O
offspring	NN	O
.	.	O

Analysis	NN	O
of	IN	O
information	NN	O
from	IN	O
21	CD	O
sibships	NNS	O
in	IN	O
14	CD	O
kindreds	NNS	O
showed	VBD	O
a	DT	O
significant	JJ	O
tendency	NN	O
for	IN	O
sibs	NNS	O
who	WP	O
have	VBP	O
similar	JJ	O
onset	NN	O
ages	NNS	O
to	TO	O
share	VB	O
the	DT	O
same	JJ	O
D4S10	NN	O
allele	NN	O
from	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
.	.	O

Affected	VBN	O
sibs	NNS	O
who	WP	O
inherited	VBD	O
different	JJ	O
D4S10	NN	O
alleles	NNS	O
from	IN	O
the	DT	O
normal	JJ	O
parent	NN	O
tended	VBD	O
to	TO	O
have	VB	O
more	JJR	O
variable	JJ	O
ages	NNS	O
at	IN	O
onset	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
expression	NN	O
of	IN	O
HD	NN	B-Disease
is	VBZ	O
modulated	VBN	O
by	IN	O
the	DT	O
normal	JJ	O
HD	NN	B-Disease
allele	NN	O
or	CC	O
by	IN	O
a	DT	O
closely	RB	O
linked	VBN	O
locus	NN	O
.	.	O

.	.	O

Synergistic	JJ	O
effect	NN	O
of	IN	O
histone	NN	O
hyperacetylation	NN	O
and	CC	O
DNA	NN	O
demethylation	NN	O
in	IN	O
the	DT	O
reactivation	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
.	.	O

Most	JJS	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
patients	NNS	O
have	VBP	O
expansion	NN	O
of	IN	O
a	DT	O
(	-LRB-	O
CGG	NN	O
)	-RRB-	O
(	-LRB-	O
n	NN	O
)	-RRB-	O
sequence	NN	O
with	IN	O
>	JJR	O
200	CD	O
repeats	NNS	O
(	-LRB-	O
full	JJ	O
mutation	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
responsible	JJ	O
for	IN	O
this	DT	O
condition	NN	O
.	.	O

Hypermethylation	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
repeat	NN	O
and	CC	O
of	IN	O
the	DT	O
FMR1	NN	O
promoter	NN	O
is	VBZ	O
almost	RB	O
always	RB	O
present	JJ	O
and	CC	O
apparently	RB	O
suppresses	VBZ	O
transcription	NN	O
,	,	O
resulting	VBG	O
in	IN	O
absence	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
protein	NN	O
.	.	O

We	PRP	O
recently	RB	O
showed	VBD	O
that	IN	O
transcriptional	JJ	O
reactivation	NN	O
of	IN	O
FMR1	NN	O
full	JJ	O
mutations	NNS	O
can	MD	O
be	VB	O
achieved	VBN	O
by	IN	O
inducing	VBG	O
DNA	NN	O
demethylation	NN	O
with	IN	O
5-azadeoxycytidine	NN	O
(	-LRB-	O
5-azadC	NN	O
)	-RRB-	O
.	.	O

The	DT	O
level	NN	O
of	IN	O
histone	NN	O
acetylation	NN	O
is	VBZ	O
another	DT	O
important	JJ	O
factor	NN	O
in	IN	O
regulating	VBG	O
gene	NN	O
expression	NN	O
;	:	O
therefore	RB	O
,	,	O
we	PRP	O
treated	VBD	O
lymphoblastoid	JJ	O
cell	NN	O
lines	NNS	O
of	IN	O
non-mosaic	JJ	O
full	JJ	O
mutation	NN	O
patients	NNS	O
with	IN	O
three	CD	O
drugs	NNS	O
capable	JJ	O
of	IN	O
inducing	VBG	O
histone	NN	O
hyperacetylation	NN	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
consistent	JJ	O
,	,	O
although	IN	O
modest	JJ	O
,	,	O
reactivation	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
with	IN	O
4-phenylbutyrate	JJ	O
,	,	O
sodium	NN	O
butyrate	NN	O
and	CC	O
trichostatin	NN	O
A	NN	O
,	,	O
as	IN	O
shown	VBN	O
by	IN	O
RT-PCR	NN	O
.	.	O

However	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
combining	VBG	O
these	DT	O
drugs	NNS	O
with	IN	O
5-azadC	JJ	O
results	NNS	O
in	IN	O
a	DT	O
2	LS	O
-	:	O
to	TO	O
5-fold	JJ	O
increase	NN	O
in	IN	O
FMR1	NN	O
mRNA	NN	O
levels	NNS	O
obtained	VBN	O
with	IN	O
5-azadC	NN	O
alone	RB	O
,	,	O
thus	RB	O
showing	VBG	O
a	DT	O
marked	JJ	O
synergistic	JJ	O
effect	NN	O
of	IN	O
histone	NN	O
hyperacetylation	NN	O
and	CC	O
DNA	NN	O
demethylation	NN	O
in	IN	O
the	DT	O
reactivation	NN	O
of	IN	O
FMR1	NN	O
full	JJ	O
mutations	NNS	O
.	.	O

.	.	O

Genetic	JJ	O
heterogeneity	NN	O
in	IN	O
X-linked	JJ	B-Disease
amelogenesis	NN	I-Disease
imperfecta	NN	I-Disease
.	.	O

The	DT	O
AMELX	NN	O
gene	NN	O
located	JJ	O
at	IN	O
Xp22	NN	O
.	.	O

1-p22	NN	O
.	.	O

3	CD	O
encodes	VBZ	O
for	IN	O
the	DT	O
enamel	NN	O
protein	NN	O
amelogenin	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
as	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
inherited	VBN	B-Disease
dental	JJ	I-Disease
abnormality	NN	I-Disease
X-linked	JJ	B-Disease
amelogenesis	NN	I-Disease
imperfecta	NN	I-Disease
(	-LRB-	O
XAI	NN	B-Disease
)	-RRB-	O
.	.	O

Three	CD	O
families	NNS	O
with	IN	O
XAI	NNP	B-Disease
have	VBP	O
been	VBN	O
investigated	VBN	O
using	VBG	O
polymorphic	JJ	O
DNA	NN	O
markers	NNS	O
flanking	VBG	O
the	DT	O
position	NN	O
of	IN	O
AMELX	NNP	O
.	.	O

Using	VBG	O
two-point	JJ	O
linkage	NN	O
analysis	NN	O
,	,	O
linkage	NN	O
was	VBD	O
established	VBN	O
between	IN	O
XAI	NNP	B-Disease
and	CC	O
several	JJ	O
of	IN	O
these	DT	O
markers	NNS	O
in	IN	O
two	CD	O
families	NNS	O
,	,	O
with	IN	O
a	DT	O
combined	JJ	O
lod	NN	O
score	NN	O
of	IN	O
6	CD	O
.	.	O

05	NN	O
for	IN	O
DXS16	NN	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

04	NN	O
04	CD	O
.	.	O

This	DT	O
supports	VBZ	O
the	DT	O
involvement	NN	O
of	IN	O
AMELX	NNP	O
,	,	O
located	JJ	O
close	RB	O
to	TO	O
DXS16	NN	O
,	,	O
in	IN	O
the	DT	O
XAI	NNP	B-Disease
disease	NN	I-Disease
process	NN	O
(	-LRB-	O
AIH1	NN	O
)	-RRB-	O
in	IN	O
those	DT	O
families	NNS	O
.	.	O

Using	VBG	O
multipoint	JJ	O
linkage	NN	O
analysis	NN	O
,	,	O
the	DT	O
combined	JJ	O
maximum	NN	O
lod	NN	O
score	NN	O
for	IN	O
these	DT	O
two	CD	O
families	NNS	O
was	VBD	O
7	CD	O
.	.	O

30	CD	O
for	IN	O
a	DT	O
location	NN	O
of	IN	O
AIH1	NN	O
at	IN	O
2	CD	O
cM	NN	O
distal	JJ	O
to	TO	O
DXS16	NN	O
.	.	O

The	DT	O
support	NN	O
interval	NN	O
around	IN	O
this	DT	O
location	NN	O
extended	VBD	O
about	IN	O
8	CD	O
cM	NN	O
proximal	JJ	O
to	TO	O
DXS92	NN	O
,	,	O
and	CC	O
the	DT	O
AIH1	NN	O
location	NN	O
could	MD	O
not	RB	O
be	VB	O
precisely	RB	O
defined	VBN	O
by	IN	O
multipoint	JJ	O
mapping	NN	O
.	.	O

Study	NN	O
of	IN	O
recombination	NN	O
events	NNS	O
indicated	VBD	O
that	IN	O
AIH1	NN	O
lies	VBZ	O
in	IN	O
the	DT	O
interval	NN	O
between	IN	O
DXS143	NN	O
and	CC	O
DXS85	NN	O
.	.	O

There	EX	O
was	VBD	O
significant	JJ	O
evidence	NN	O
against	IN	O
linkage	NN	O
to	TO	O
this	DT	O
region	NN	O
in	IN	O
the	DT	O
third	JJ	O
family	NN	O
,	,	O
indicating	VBG	O
locus	NN	O
heterogeneity	NN	O
in	IN	O
XAI	NNP	B-Disease
.	.	O

Further	JJ	O
analysis	NN	O
with	IN	O
markers	NNS	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
showed	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
DXS144E	NN	O
and	CC	O
F9	NN	O
with	IN	O
no	DT	O
recombination	NN	O
with	IN	O
either	DT	O
of	IN	O
these	DT	O
markers	NNS	O
.	.	O

Two-point	JJ	O
analysis	NN	O
gave	VBD	O
a	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
at	IN	O
DXS144E	NN	O
with	IN	O
a	DT	O
maximum	NN	O
lod	NN	O
score	NN	O
of	IN	O
2	CD	O
.	.	O

83	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
,	,	O
with	IN	O
a	DT	O
peak	JJ	O
lod	NN	O
score	NN	O
in	IN	O
multipoint	JJ	O
linkage	NN	O
analysis	NN	O
of	IN	O
2	CD	O
.	.	O

84	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

The	DT	O
support	NN	O
interval	NN	O
extended	VBD	O
9	CD	O
cM	NN	O
proximal	JJ	O
to	TO	O
DXS144E	NN	O
and	CC	O
14	CD	O
cM	NN	O
distal	JJ	O
to	TO	O
F9	NN	O
.	.	O

(	-LRB-	O
ABSTRACT	NN	O
TRUNCATED	VBN	O
AT	IN	O
250	CD	O
WORDS	NNS	O
)	-RRB-	O
.	.	O

Anonymous	JJ	O
marker	NN	O
loci	NNS	O
within	IN	O
400	CD	O
kb	NN	O
of	IN	O
HLA-A	NN	O
generate	VBP	O
haplotypes	NNS	O
in	IN	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
the	DT	O
hemochromatosis	NN	B-Disease
gene	NN	O
(	-LRB-	O
HFE	NN	O
)	-RRB-	O
The	DT	O
hemochromatosis	NN	B-Disease
gene	NN	O
(	-LRB-	O
HFE	NN	O
)	-RRB-	O
maps	VBZ	O
to	TO	O
6p21	VB	O
.	.	O

3	CD	O
and	CC	O
is	VBZ	O
less	RBR	O
than	IN	O
1	CD	O
cM	NN	O
from	IN	O
the	DT	O
HLA	NN	O
class	NN	O
I	CD	O
genes	NNS	O
;	:	O
however	RB	O
,	,	O
the	DT	O
precise	JJ	O
physical	JJ	O
location	NN	O
of	IN	O
the	DT	O
gene	NN	O
has	VBZ	O
remained	VBN	O
elusive	JJ	O
and	CC	O
controversial	JJ	O
.	.	O

The	DT	O
unambiguous	JJ	O
identification	NN	O
of	IN	O
a	DT	O
crossover	NN	O
event	NN	O
within	IN	O
hemochromatosis	NN	B-Disease
families	NNS	O
is	VBZ	O
very	RB	O
difficult	JJ	O
;	:	O
it	PRP	O
is	VBZ	O
particularly	RB	O
hampered	VBN	O
by	IN	O
the	DT	O
variability	NN	O
of	IN	O
the	DT	O
phenotypic	JJ	O
expression	NN	O
as	RB	O
well	RB	O
as	IN	O
by	IN	O
the	DT	O
sex	NN	O
-	:	O
and	CC	O
age-related	JJ	O
penetrance	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

For	IN	O
these	DT	O
practical	JJ	O
considerations	NNS	O
,	,	O
traditional	JJ	O
linkage	NN	O
analysis	NN	O
could	MD	O
prove	VB	O
of	IN	O
limited	JJ	O
value	NN	O
in	IN	O
further	JJ	O
refining	NN	O
the	DT	O
extrapolated	VBN	O
physical	JJ	O
position	NN	O
of	IN	O
HFE	NN	O
.	.	O

We	PRP	O
therefore	RB	O
embarked	VBD	O
upon	IN	O
a	DT	O
linkage-disequilibrium	NN	O
analysis	NN	O
of	IN	O
HFE	NN	O
and	CC	O
normal	JJ	O
chromosomes	NNS	O
from	IN	O
the	DT	O
Brittany	NNP	O
population	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
report	NN	O
,	,	O
66	CD	O
hemochromatosis	NN	B-Disease
families	NNS	O
yielding	VBG	O
151	CD	O
hemochromatosis	NN	B-Disease
chromosomes	NNS	O
and	CC	O
182	CD	O
normal	JJ	O
chromosomes	NNS	O
were	VBD	O
RFLP-typed	JJ	O
with	IN	O
a	DT	O
battery	NN	O
of	IN	O
probes	NNS	O
,	,	O
including	VBG	O
two	CD	O
newly	RB	O
derived	VBN	O
polymorphic	JJ	O
markers	NNS	O
from	IN	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
and	CC	O
HLA-F	NN	O
loci	NNS	O
located	JJ	O
150	CD	O
and	CC	O
250	CD	O
kb	NN	O
telomeric	JJ	O
to	TO	O
HLA-A	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
strong	JJ	O
peak	NN	O
of	IN	O
existing	VBG	O
linkage	NN	O
disequilibrium	NN	O
focused	VBD	O
within	IN	O
the	DT	O
i82-to-6	NN	O
.	.	O

7	CD	O
interval	NN	O
(	-LRB-	O
approximately	RB	O
250	CD	O
kb	NN	O
)	-RRB-	O
.	.	O

The	DT	O
zone	NN	O
of	IN	O
linkage	NN	O
disequilibrium	NN	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
i97	NN	O
locus	NN	O
,	,	O
positioned	JJ	O
30	CD	O
kb	NN	O
proximal	JJ	O
to	TO	O
i82	NN	O
,	,	O
and	CC	O
the	DT	O
HLA-F	NN	O
gene	NN	O
,	,	O
found	VBD	O
250	CD	O
kb	NN	O
distal	JJ	O
to	TO	O
HLA-A	NN	O
,	,	O
markers	NNS	O
of	IN	O
which	WDT	O
display	VBP	O
no	DT	O
significant	JJ	O
association	NN	O
with	IN	O
HFE	NN	O
.	.	O

These	DT	O
data	NNS	O
support	VBP	O
the	DT	O
possibility	NN	O
that	IN	O
HFE	NN	O
resides	VBZ	O
within	IN	O
the	DT	O
400-kb	JJ	O
expanse	NN	O
of	IN	O
DNA	NN	O
between	IN	O
i97	NN	O
and	CC	O
HLA-F	NN	O
.	.	O

Alternatively	RB	O
,	,	O
the	DT	O
very	RB	O
tight	JJ	O
association	NN	O
of	IN	O
HLA-A3	NN	O
and	CC	O
allele	NN	O
1	CD	O
of	IN	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
locus	NN	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
are	VBP	O
comprised	VBN	O
by	IN	O
the	DT	O
major	JJ	O
ancestral	JJ	O
or	CC	O
founder	NN	O
HFE	NN	O
haplotype	NN	O
in	IN	O
Brittany	NNP	O
,	,	O
supports	VBZ	O
the	DT	O
possibility	NN	O
that	IN	O
the	DT	O
disease	NN	O
gene	NN	O
may	MD	O
reside	VB	O
immediately	RB	O
telomeric	JJ	O
to	TO	O
the	DT	O
6	CD	O
.	.	O

7	CD	O
locus	NN	O
within	IN	O
the	DT	O
linkage-disequilibrium	NN	O
zone	NN	O
.	.	O

Additionally	RB	O
,	,	O
hemochromatosis	NN	B-Disease
haplotypes	NNS	O
possessing	VBG	O
HLA-A11	NN	O
and	CC	O
the	DT	O
low-frequency	NN	O
HLA-F	NN	O
polymorphism	NN	O
(	-LRB-	O
allele	NN	O
2	CD	O
)	-RRB-	O
are	VBP	O
supportive	JJ	O
of	IN	O
a	DT	O
separate	JJ	O
founder	NN	O
chromosome	NN	O
containing	VBG	O
a	DT	O
second	JJ	O
,	,	O
independently	RB	O
arising	VBG	O
mutant	JJ	O
allele	NN	O
.	.	O

Overall	RB	O
,	,	O
the	DT	O
establishment	NN	O
of	IN	O
a	DT	O
likely	JJ	O
"	''	O
hemochromatosis	NN	B-Disease
critical	JJ	O
region	NN	O
"	''	O
centromeric	JJ	O
boundary	NN	O
and	CC	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
linkage-disequilibrium	NN	O
zone	NN	O
both	CC	O
significantly	RB	O
contribute	VBP	O
to	TO	O
a	DT	O
reduction	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
DNA	NN	O
required	VBN	O
to	TO	O
be	VB	O
searched	VBN	O
for	IN	O
novel	JJ	O
coding	VBG	O
sequences	NNS	O
constituting	VBG	O
the	DT	O
HFE	NN	B-Disease
defect	NN	I-Disease

Natural	JJ	O
selection	NN	O
of	IN	O
hemi	NN	O
-	:	O
and	CC	O
heterozygotes	NNS	O
for	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Africa	NNP	O
by	IN	O
resistance	NN	O
to	TO	O
severe	JJ	O
malaria	NN	B-Disease
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
enzymopathy	NN	B-Disease
of	IN	O
humans	NNS	O
,	,	O
affects	VBZ	O
over	IN	O
400	CD	O
million	CD	O
people	NNS	O
.	.	O

The	DT	O
geographical	JJ	O
correlation	NN	O
of	IN	O
its	PRP$	O
distribution	NN	O
with	IN	O
the	DT	O
historical	JJ	O
endemicity	NN	O
of	IN	O
malaria	NN	B-Disease
suggests	VBZ	O
that	IN	O
this	DT	O
disorder	NN	O
has	VBZ	O
risen	VBN	O
in	IN	O
frequency	NN	O
through	IN	O
natural	JJ	O
selection	NN	O
by	IN	O
malaria	NN	B-Disease
.	.	O

However	RB	O
,	,	O
attempts	VBZ	O
to	TO	O
confirm	VB	O
that	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
protective	JJ	O
in	IN	O
case-control	JJ	O
studies	NNS	O
of	IN	O
malaria	NN	B-Disease
have	VBP	O
yielded	VBN	O
conflicting	JJ	O
results	NNS	O
.	.	O

Hence	RB	O
,	,	O
for	IN	O
this	DT	O
X-linked	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
whether	IN	O
both	DT	O
male	JJ	O
hemizygotes	NNS	O
and	CC	O
female	JJ	O
heterozygotes	NNS	O
are	VBP	O
protected	VBN	O
or	CC	O
,	,	O
as	IN	O
frequently	RB	O
suggested	VBN	O
,	,	O
only	RB	O
females	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
how	WRB	O
much	JJ	O
protection	NN	O
may	MD	O
be	VB	O
afforded	VBN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
,	,	O
in	IN	O
two	CD	O
large	JJ	O
case-control	JJ	O
studies	NNS	O
of	IN	O
over	IN	O
2	CD	O
,	,	O
000	CD	O
African	JJ	O
children	NNS	O
,	,	O
the	DT	O
common	JJ	O
African	JJ	O
form	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
G6PD	NN	B-Disease
A	NN	I-Disease
-	:	I-Disease
)	-RRB-	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
46-58	CD	O
%	NN	O
reduction	NN	O
in	IN	O
risk	NN	O
of	IN	O
severe	JJ	O
malaria	NN	B-Disease
for	IN	O
both	DT	O
female	JJ	O
heterozygotes	NNS	O
and	CC	O
male	JJ	O
hemizygotes	NNS	O
.	.	O

A	DT	O
mathematical	JJ	O
model	NN	O
incorporating	VBG	O
the	DT	O
measured	VBN	O
selective	JJ	O
advantage	NN	O
against	IN	O
malaria	NN	B-Disease
suggests	VBZ	O
that	IN	O
a	DT	O
counterbalancing	VBG	O
selective	JJ	O
disadvantage	NN	O
,	,	O
associated	VBN	O
with	IN	O
this	DT	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
has	VBZ	O
retarded	VBN	O
its	PRP$	O
rise	NN	O
in	IN	O
frequency	NN	O
in	IN	O
malaria-endemic	JJ	O
regions	NNS	O
.	.	O

Although	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
now	RB	O
regarded	VBN	O
as	IN	O
a	DT	O
generally	RB	O
benign	JJ	O
disorder	NN	O
,	,	O
in	IN	O
earlier	JJR	O
environmental	JJ	O
conditions	NNS	O
it	PRP	O
could	MD	O
have	VB	O
been	VBN	O
significantly	RB	O
disadvantageous	JJ	O
.	.	O

.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
chromosome	NN	O
15	CD	O
.	.	O

A	DT	O
clinical	JJ	O
discussion	NN	O
of	IN	O
20	CD	O
cases	NNS	O
.	.	O

A	DT	O
chromosome	NN	B-Disease
15	CD	I-Disease
anomaly	NN	I-Disease
was	VBD	O
observed	VBN	O
in	IN	O
12	CD	O
of	IN	O
20	CD	O
patients	NNS	O
,	,	O
17	CD	O
of	IN	O
whom	WP	O
were	VBD	O
clinically	RB	O
suspected	VBN	O
of	IN	O
having	VBG	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
eight	CD	O
cases	NNS	O
with	IN	O
15q11-12	JJ	O
deletion	NN	O
were	VBD	O
very	RB	O
similar	JJ	O
to	TO	O
those	DT	O
originally	RB	O
described	VBN	O
in	IN	O
PWS	NNP	B-Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
the	DT	O
group	NN	O
of	IN	O
normal	JJ	O
karyotype	NN	O
patients	NNS	O
is	VBZ	O
heterogeneous	JJ	O
,	,	O
and	CC	O
their	PRP$	O
features	NNS	O
do	VBP	O
not	RB	O
strictly	RB	O
correspond	VBP	O
to	TO	O
the	DT	O
clinical	JJ	O
definition	NN	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
hypothesis	NN	O
that	IN	O
PWS	NN	B-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
deletion	NN	O
of	IN	O
15q11-12	NN	O
can	MD	O
neither	CC	O
explain	VB	O
the	DT	O
apparently	RB	O
balanced	JJ	O
translocations	NNS	O
of	IN	O
chromosome	NN	O
15	CD	O
nor	CC	O
account	NN	O
for	IN	O
the	DT	O
small	JJ	O
supernumerary	JJ	O
metacentric	JJ	O
chromosomes	NNS	O
corresponding	VBG	O
to	TO	O
an	DT	O
isochromosome	JJ	O
15	CD	O
for	IN	O
band	NN	O
15q11	NN	O
observed	VBN	O
in	IN	O
some	DT	O
cases	NNS	O
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
phenylketonuria	NN	B-Disease
and	CC	O
related	JJ	O
hyperphenylalaninemias	NNS	B-Disease
:	:	O
mutations	NNS	O
and	CC	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
producing	VBG	O
phenylketonuria	NN	B-Disease
or	CC	O
hyperphenylalaninemia	NN	B-Disease
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
many	JJ	O
patients	NNS	O
from	IN	O
various	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

These	DT	O
mutations	NNS	O
all	DT	O
exhibit	VBP	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
association	NN	O
with	IN	O
specific	JJ	O
restriction	NN	O
fragment-length	JJ	O
polymorphism	NN	O
haplotypes	NNS	O
at	IN	O
the	DT	O
PAH	NN	O
locus	NN	O
.	.	O

About	IN	O
50	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
single-base	JJ	O
substitutions	NNS	O
,	,	O
including	VBG	O
six	CD	O
nonsense	NN	O
mutations	NNS	O
and	CC	O
eight	CD	O
splicing	NN	O
mutations	NNS	O
,	,	O
with	IN	O
the	DT	O
remainder	NN	O
being	VBG	O
missense	NN	O
mutations	NNS	O
.	.	O

One	CD	O
splicing	NN	O
mutation	NN	O
results	VBZ	O
in	IN	O
a	DT	O
3	CD	O
amino	NN	O
acid	NN	O
in-frame	RB	O
insertion	NN	O
.	.	O

Two	CD	O
or	CC	O
3	CD	O
large	JJ	O
deletions	NNS	O
,	,	O
2	CD	O
single	JJ	O
codon	NN	O
deletions	NNS	O
,	,	O
and	CC	O
2	CD	O
single	JJ	O
base	NN	O
deletions	NNS	O
have	VBP	O
been	VBN	O
found	VBN	O
.	.	O

Twelve	CD	O
of	IN	O
the	DT	O
missense	NN	O
mutations	NNS	O
apparently	RB	O
result	VBP	O
from	IN	O
the	DT	O
methylation	NN	O
and	CC	O
subsequent	JJ	O
deamination	NN	O
of	IN	O
highly	RB	O
mutagenic	JJ	O
CpG	NN	O
dinucleotides	NNS	O
.	.	O

Recurrent	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
at	IN	O
several	JJ	O
of	IN	O
these	DT	O
sites	NNS	O
,	,	O
producing	VBG	O
associations	NNS	O
with	IN	O
different	JJ	O
haplotypes	NNS	O
in	IN	O
different	JJ	O
populations	NNS	O
.	.	O

About	IN	O
half	NN	O
of	IN	O
all	DT	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
examined	VBN	O
by	IN	O
in	FW	O
vitro	FW	O
expression	NN	O
analysis	NN	O
,	,	O
and	CC	O
a	DT	O
significant	JJ	O
correlation	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
between	IN	O
residual	JJ	O
PAH	NN	O
activity	NN	O
and	CC	O
disease	NN	O
phenotype	NN	O
.	.	O

Since	IN	O
continuing	VBG	O
advances	NNS	O
in	IN	O
molecular	JJ	O
methodologies	NNS	O
have	VBP	O
dramatically	RB	O
accelerated	VBN	O
the	DT	O
rate	NN	O
in	IN	O
which	WDT	O
new	JJ	O
mutations	NNS	O
are	VBP	O
being	VBG	O
identified	VBN	O
and	CC	O
characterized	VBN	O
,	,	O
this	DT	O
register	NN	O
of	IN	O
mutations	NNS	O
will	MD	O
be	VB	O
updated	VBN	O
periodically	RB	O
.	.	O

.	.	O

The	DT	O
intron	NN	O
7	CD	O
donor	NN	O
splice	NN	O
site	NN	O
transition	NN	O
:	:	O
a	DT	O
second	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
mutation	NN	O
in	IN	O
French	JJ	O
Canada	NNP	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
hexosaminidase	NN	O
A	NN	O
(	-LRB-	O
HEXA	NN	O
)	-RRB-	O
gene	NN	O
which	WDT	O
cause	VBP	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
have	VBP	O
elevated	JJ	O
frequency	NN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
and	CC	O
French-Canadian	JJ	O
populations	NNS	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
TSD	NNP	B-Disease
allele	NN	O
in	IN	O
the	DT	O
French-Canadian	JJ	O
population	NN	O
associated	VBN	O
with	IN	O
the	DT	O
infantile	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
mutation	NN	O
,	,	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
+	CC	O
1	CD	O
position	NN	O
of	IN	O
intron	NN	O
7	CD	O
,	,	O
abolishes	VBZ	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
.	.	O

Cultured	VBN	O
human	JJ	O
fibroblasts	NNS	O
from	IN	O
a	DT	O
compound	NN	O
heterozygote	NN	O
for	IN	O
this	DT	O
transition	NN	O
(	-LRB-	O
and	CC	O
for	IN	O
a	DT	O
deletion	NN	O
mutation	NN	O
)	-RRB-	O
produce	VBP	O
no	DT	O
detectable	JJ	O
HEXA	NN	O
mRNA	NN	O
.	.	O

The	DT	O
intron	NN	O
7	CD	O
+	CC	O
1	CD	O
mutation	NN	O
occurs	VBZ	O
in	IN	O
the	DT	O
base	NN	O
adjacent	JJ	O
to	TO	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
adult-onset	JJ	O
TSD	NN	B-Disease
mutation	NN	O
(	-LRB-	O
G805A	NN	O
)	-RRB-	O
.	.	O

In	IN	O
both	DT	O
mutations	NNS	O
a	DT	O
restriction	NN	O
site	NN	O
for	IN	O
the	DT	O
endonuclease	NN	O
EcoRII	NN	O
is	VBZ	O
abolished	VBN	O
.	.	O

Unambiguous	JJ	O
diagnosis	NN	O
,	,	O
therefore	RB	O
,	,	O
requires	VBZ	O
allele-specific	JJ	O
oligonucleotide	NN	O
hybridization	NN	O
to	TO	O
distinguish	VB	O
between	IN	O
these	DT	O
two	CD	O
mutant	JJ	O
alleles	NNS	O
.	.	O

The	DT	O
intron	NN	O
7	CD	O
+	CC	O
1	CD	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Obligate	VB	O
heterozygotes	NNS	O
for	IN	O
the	DT	O
intron	NN	O
7	CD	O
+	CC	O
1	CD	O
mutation	NN	O
were	VBD	O
born	VBN	O
in	IN	O
the	DT	O
Saguenay-Lac-St-Jean	JJ	O
region	NN	O
of	IN	O
Quebec	NNP	O
.	.	O

The	DT	O
most	RBS	O
recent	JJ	O
ancestors	NNS	O
common	JJ	O
to	TO	O
obligate	JJ	O
carriers	NNS	O
of	IN	O
this	DT	O
mutation	NN	O
were	VBD	O
from	IN	O
the	DT	O
Charlevoix	NNP	O
region	NN	O
of	IN	O
the	DT	O
province	NN	O
of	IN	O
Quebec	NNP	O
.	.	O

This	DT	O
mutation	NN	O
thus	RB	O
has	VBZ	O
a	DT	O
different	JJ	O
geographic	JJ	O
centre	NN	O
of	IN	O
diffusion	NN	O
and	CC	O
is	VBZ	O
probably	RB	O
less	RBR	O
common	JJ	O
than	IN	O
the	DT	O
exon	NN	O
1	CD	O
deletion	NN	O
TSD	NN	B-Disease
mutation	NN	O
in	IN	O
French	JJ	O
Canadians	NNPS	O
.	.	O

Neither	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
France	NNP	O
,	,	O
the	DT	O
ancestral	JJ	O
homeland	NN	O
of	IN	O
French	JJ	O
Canada	NNP	O
.	.	O

.	.	O

Recessively	RB	O
inherited	VBN	O
multiple	JJ	B-Disease
epiphyseal	NN	I-Disease
dysplasia	NN	I-Disease
with	IN	O
normal	JJ	O
stature	NN	O
,	,	O
club	NN	B-Disease
foot	NN	I-Disease
,	,	O
and	CC	O
double	JJ	B-Disease
layered	JJ	I-Disease
patella	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
DTDST	NN	O
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
observed	VBN	O
over	IN	O
25	CD	O
different	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
sulphate	NN	O
transporter	NN	O
gene	NN	O
(	-LRB-	O
DTDST	NN	O
)	-RRB-	O
in	IN	O
association	NN	O
with	IN	O
the	DT	O
recessive	JJ	B-Disease
disorders	NNS	I-Disease
achondrogenesis	NN	B-Disease
1B	NN	I-Disease
,	,	O
atelosteogenesis	NN	B-Disease
2	CD	I-Disease
,	,	O
and	CC	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
.	.	O

The	DT	O
c862t	NN	O
(	-LRB-	O
R279W	NN	O
)	-RRB-	O
transition	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
mutation	NN	O
in	IN	O
non-Finnish	JJ	O
patients	NNS	O
,	,	O
but	CC	O
in	IN	O
these	DT	O
disorders	NNS	O
it	PRP	O
is	VBZ	O
usually	RB	O
combined	VBN	O
with	IN	O
other	JJ	O
DTDST	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
had	VBD	O
not	RB	O
seen	VBN	O
a	DT	O
case	NN	O
of	IN	O
homozygosity	NN	O
for	IN	O
c862t	NN	O
(	-LRB-	O
R279W	NN	O
)	-RRB-	O
until	IN	O
we	PRP	O
analysed	VBD	O
DNA	NN	O
from	IN	O
a	DT	O
36	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
tall-normal	JJ	O
stature	NN	O
(	-LRB-	O
180	CD	O
cm	NN	O
)	-RRB-	O
who	WP	O
asked	VBD	O
for	IN	O
genetic	JJ	O
counselling	NN	O
for	IN	O
suspected	VBN	O
multiple	JJ	B-Disease
epiphyseal	NN	I-Disease
dysplasia	NN	I-Disease
.	.	O

He	PRP	O
was	VBD	O
treated	VBN	O
for	IN	O
club	NN	B-Disease
foot	NN	I-Disease
and	CC	O
hip	NN	B-Disease
dysplasia	NN	I-Disease
at	IN	O
birth	NN	O
.	.	O

Skeletal	JJ	O
changes	NNS	O
consistent	JJ	O
with	IN	O
multiple	JJ	B-Disease
epiphyseal	NN	I-Disease
dysplasia	NN	I-Disease
,	,	O
with	IN	O
the	DT	O
peculiar	JJ	O
finding	NN	O
of	IN	O
a	DT	O
double	JJ	B-Disease
layered	JJ	I-Disease
patella	NN	I-Disease
,	,	O
were	VBD	O
recognised	VBN	O
during	IN	O
childhood	NN	O
.	.	O

Cleft	NN	B-Disease
palate	NN	I-Disease
,	,	O
swelling	VBG	B-Disease
of	IN	I-Disease
the	DT	I-Disease
ear	NN	I-Disease
pinna	NN	I-Disease
,	,	O
and	CC	O
hitch	NN	B-Disease
hiker	NN	I-Disease
thumb	NN	I-Disease
were	VBD	O
absent	JJ	O
.	.	O

He	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
,	,	O
and	CC	O
both	DT	O
healthy	JJ	O
parents	NNS	O
heterozygous	JJ	O
,	,	O
for	IN	O
the	DT	O
R279W	NN	O
mutation	NN	O
in	IN	O
DTDST	NNP	O
,	,	O
and	CC	O
his	PRP$	O
fibroblasts	NNS	O
showed	VBD	O
a	DT	O
sulphate	NN	O
incorporation	NN	O
defect	NN	O
typical	JJ	O
of	IN	O
DTDST	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Counselling	VBG	O
was	VBD	O
given	VBN	O
for	IN	O
a	DT	O
recessive	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
thereby	RB	O
considerably	RB	O
reducing	VBG	O
the	DT	O
probability	NN	O
of	IN	O
affected	VBN	O
offspring	NN	O
.	.	O

Multiple	JJ	B-Disease
epiphyseal	NN	I-Disease
dysplasia	NN	I-Disease
is	VBZ	O
more	RBR	O
frequently	RB	O
caused	VBN	O
by	IN	O
dominant	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
COMP	NN	O
(	-LRB-	O
EDM1	NN	B-Disease
,	,	O
McKusick	NNP	O
132400	CD	O
)	-RRB-	O
and	CC	O
COL9A2	NN	O
genes	NNS	O
(	-LRB-	O
EDM2	NN	B-Disease
,	,	O
McKusick	NNP	O
600204	CD	O
)	-RRB-	O
.	.	O

A	DT	O
few	JJ	O
other	JJ	O
patients	NNS	O
and	CC	O
families	NNS	O
with	IN	O
features	NNS	O
similar	JJ	O
to	TO	O
our	PRP$	O
proband	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
previously	RB	O
and	CC	O
considered	VBN	O
to	TO	O
have	VB	O
autosomal	JJ	O
recessive	JJ	O
MED	NN	B-Disease
(	-LRB-	O
EDM4	NN	B-Disease
,	,	O
McKusick	NNP	O
226900	CD	O
)	-RRB-	O
.	.	O

This	DT	O
observation	NN	O
confirms	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
this	DT	O
entity	NN	O
and	CC	O
assigns	VBZ	O
it	PRP	O
to	TO	O
the	DT	O
phenotypic	JJ	O
spectrum	NN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
DTDST	NN	O
locus	NN	O
.	.	O

.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
:	:	O
size	NN	O
-	:	O
and	CC	O
sex-dependent	JJ	O
dynamics	NNS	O
of	IN	O
CTG	NNP	O
meiotic	JJ	O
instability	NN	O
,	,	O
and	CC	O
somatic	JJ	O
mosaicism	NN	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
progressive	JJ	O
neuromuscular	JJ	B-Disease
disorder	NN	I-Disease
which	WDT	O
results	VBZ	O
from	IN	O
elongations	NNS	O
of	IN	O
an	DT	O
unstable	JJ	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
,	,	O
located	JJ	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
.	.	O

A	DT	O
correlation	NN	O
has	VBZ	O
been	VBN	O
demonstrated	VBN	O
between	IN	O
the	DT	O
increase	NN	O
in	IN	O
the	DT	O
repeat	NN	O
number	NN	O
of	IN	O
this	DT	O
sequence	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
clinical	JJ	O
status	NN	O
of	IN	O
patients	NNS	O
can	MD	O
not	RB	O
be	VB	O
unambiguously	RB	O
ascertained	VBN	O
solely	RB	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
number	NN	O
of	IN	O
CTG	NNP	O
repeats	NNS	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
exclusive	JJ	O
maternal	JJ	O
inheritance	NN	O
of	IN	O
the	DT	O
congenital	JJ	O
form	NN	O
remains	VBZ	O
unexplained	JJ	O
.	.	O

Our	PRP$	O
observation	NN	O
of	IN	O
differently	RB	O
sized	VBN	O
repeats	NNS	O
in	IN	O
various	JJ	O
DM	NN	B-Disease
tissues	NNS	O
from	IN	O
the	DT	O
same	JJ	O
individual	NN	O
may	MD	O
explain	VB	O
why	WRB	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
mutation	NN	O
observed	VBN	O
in	IN	O
lymphocytes	NNS	O
does	VBZ	O
not	RB	O
necessarily	RB	O
correlate	VB	O
with	IN	O
the	DT	O
severity	NN	O
and	CC	O
nature	NN	O
of	IN	O
symptoms	NNS	O
.	.	O

Through	IN	O
a	DT	O
molecular	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
142	CD	O
families	NNS	O
including	VBG	O
418	CD	O
DM	NN	B-Disease
patients	NNS	O
,	,	O
we	PRP	O
have	VBP	O
investigated	VBN	O
the	DT	O
dynamics	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
meiotic	JJ	O
instability	NN	O
.	.	O

A	DT	O
positive	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
repeat	NN	O
and	CC	O
the	DT	O
intergenerational	JJ	O
enlargement	NN	O
was	VBD	O
observed	VBN	O
similarly	RB	O
through	IN	O
male	NN	O
and	CC	O
female	JJ	O
meioses	NNS	O
for	IN	O
<	JJR	O
or	CC	O
=	JJ	O
0	CD	O
.	.	O

5-kb	JJ	O
CTG	NN	O
sequences	NNS	O
.	.	O

Beyond	IN	O
0	CD	O
.	.	O

5	CD	O
kb	NN	O
,	,	O
the	DT	O
intergenerational	JJ	O
variation	NN	O
was	VBD	O
more	RBR	O
important	JJ	O
through	IN	O
female	JJ	O
meioses	NNS	O
,	,	O
whereas	IN	O
a	DT	O
tendency	NN	O
to	TO	O
compression	NN	O
was	VBD	O
observed	VBN	O
almost	RB	O
exclusively	RB	O
in	IN	O
male	JJ	O
meioses	NNS	O
,	,	O
for	IN	O
>	JJR	O
or	CC	O
=	JJ	O
1	CD	O
.	.	O

5-kb	JJ	O
fragments	NNS	O
.	.	O

This	DT	O
implies	VBZ	O
a	DT	O
size	NN	O
-	:	O
and	CC	O
sex-dependent	JJ	O
meiotic	JJ	O
instability	NN	O
.	.	O

Moreover	RB	O
,	,	O
segregation	NN	O
analysis	NN	O
supports	VBZ	O
the	DT	O
hypothesis	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
familial	JJ	O
predisposition	NN	O
for	IN	O
the	DT	O
occurrence	NN	O
of	IN	O
the	DT	O
congenital	JJ	O
form	NN	O
.	.	O

Finally	RB	O
,	,	O
this	DT	O
analysis	NN	O
reveals	VBZ	O
a	DT	O
significant	JJ	O
excess	NN	O
of	IN	O
transmitting	VBG	O
grandfathers	NNS	O
partially	RB	O
accounted	VBD	O
for	IN	O
by	IN	O
increased	VBN	O
fertility	NN	O
in	IN	O
affected	VBN	O
males	NNS	O

Fatal	JJ	O
pyoderma	NN	B-Disease
gangrenosum	NN	I-Disease
in	IN	O
association	NN	O
with	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Although	IN	O
pyoderma	NN	B-Disease
gangrenosum	NN	I-Disease
(	-LRB-	O
PG	NN	B-Disease
)	-RRB-	O
is	VBZ	O
often	RB	O
associated	VBN	O
with	IN	O
systemic	JJ	B-Disease
diseases	NNS	I-Disease
,	,	O
it	PRP	O
has	VBZ	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
association	NN	O
with	IN	O
congenital	JJ	B-Disease
complement	NN	I-Disease
deficiencies	NNS	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
an	DT	O
aggressive	JJ	O
and	CC	O
ultimately	RB	O
fatal	JJ	O
case	NN	O
of	IN	O
PG	NN	B-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
congenital	JJ	O
C7	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Deficiencies	NNS	B-Disease
of	IN	I-Disease
C7	NN	I-Disease
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
decreased	VBN	O
neutrophil	NN	O
chemotaxis	NN	O
,	,	O
phagocytosis	NN	O
,	,	O
and	CC	O
opsonization	NN	O
,	,	O
similar	JJ	O
to	TO	O
the	DT	O
immunologic	JJ	B-Disease
abnormalities	NNS	I-Disease
described	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
PG	NN	B-Disease
.	.	O

Our	PRP$	O
patients	NNS	O
decreased	VBD	O
complement	NN	O
level	NN	O
,	,	O
if	IN	O
not	RB	O
directly	RB	O
related	JJ	O
to	TO	O
the	DT	O
development	NN	O
of	IN	O
PG	NN	B-Disease
,	,	O
may	MD	O
have	VB	O
contributed	VBN	O
to	TO	O
the	DT	O
aggressive	JJ	O
nature	NN	O
of	IN	O
her	PRP$	O
disease	NN	O
.	.	O

.	.	O

Emerin	NNP	B-Disease
deficiency	NN	I-Disease
at	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Emery-Dreifuss	JJ	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
STA	NN	O
gene	NN	O
at	IN	O
the	DT	O
Xq28	NN	O
locus	NN	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
.	.	O

This	DT	O
gene	NN	O
encodes	VBZ	O
a	DT	O
hitherto	RB	O
unknown	JJ	O
protein	NN	O
named	VBN	O
emerin	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
subcellular	JJ	O
localization	NN	O
of	IN	O
emerin	NN	O
,	,	O
we	PRP	O
raised	VBD	O
two	CD	O
antisera	NNS	O
against	IN	O
synthetic	JJ	O
peptide	NN	O
fragments	NNS	O
predicted	VBN	O
from	IN	O
emerin	NN	O
cDNA	NN	O
.	.	O

Using	VBG	O
both	DT	O
antisera	NNS	O
,	,	O
we	PRP	O
found	VBD	O
positive	JJ	O
nuclear	JJ	O
membrane	NN	O
staining	NN	O
in	IN	O
skeletal	JJ	O
,	,	O
cardiac	JJ	O
and	CC	O
smooth	JJ	O
muscles	NNS	O
in	IN	O
the	DT	O
normal	JJ	O
controls	NNS	O
and	CC	O
in	IN	O
patients	NNS	O
with	IN	O
neuromuscular	JJ	B-Disease
diseases	NNS	I-Disease
other	JJ	O
than	IN	O
EDMD	NN	B-Disease
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
deficiency	NN	O
in	IN	O
immunofluorescent	JJ	O
staining	NN	O
of	IN	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
from	IN	O
EDMD	NN	B-Disease
patients	NNS	O
was	VBD	O
observed	VBN	O
.	.	O

A	DT	O
34	CD	O
kD	NN	O
protein	NN	O
is	VBZ	O
immunoreactive	JJ	O
with	IN	O
the	DT	O
antisera	NNS	O
--	:	O
the	DT	O
protein	NN	O
is	VBZ	O
equivalent	JJ	O
to	TO	O
that	DT	O
predicted	VBN	O
for	IN	O
emerin	NN	O
.	.	O

Together	RB	O
,	,	O
our	PRP$	O
findings	NNS	O
suggest	VBP	O
the	DT	O
specific	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
emerin	NN	I-Disease
in	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
of	IN	O
muscle	NN	O
cells	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
EDMD	NN	B-Disease
.	.	O

.	.	O

A	DT	O
p16INK4a-insensitive	JJ	O
CDK4	NN	O
mutant	JJ	O
targeted	VBN	O
by	IN	O
cytolytic	JJ	O
T	NN	O
lymphocytes	NNS	O
in	IN	O
a	DT	O
human	JJ	O
melanoma	NN	B-Disease
.	.	O

A	DT	O
mutated	VBN	O
cyclin-dependent	JJ	O
kinase	NN	O
4	CD	O
(	-LRB-	O
CDK4	NN	O
)	-RRB-	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
tumor-specific	JJ	O
antigen	NN	O
recognized	VBN	O
by	IN	O
HLA-A2	NN	O
.	.	O

1-restricted	JJ	O
autologous	JJ	O
cytolytic	JJ	O
T	NN	O
lymphocytes	NNS	O
(	-LRB-	O
CTLs	NNS	O
)	-RRB-	O
in	IN	O
a	DT	O
human	JJ	O
melanoma	NN	B-Disease
.	.	O

The	DT	O
mutated	VBN	O
CDK4	NN	O
allele	NN	O
was	VBD	O
present	JJ	O
in	IN	O
autologous	JJ	O
cultured	VBN	O
melanoma	NN	B-Disease
cells	NNS	O
and	CC	O
metastasis	NN	O
tissue	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
the	DT	O
patients	NNS	O
lymphocytes	NNS	O
.	.	O

The	DT	O
mutation	NN	O
,	,	O
an	DT	O
arginine-to-cysteine	JJ	O
exchange	NN	O
at	IN	O
residue	NN	O
24	CD	O
,	,	O
was	VBD	O
part	NN	O
of	IN	O
the	DT	O
CDK4	NN	O
peptide	NN	O
recognized	VBN	O
by	IN	O
CTLs	NNS	O
and	CC	O
prevented	VBD	O
binding	NN	O
of	IN	O
the	DT	O
CDK4	NN	O
inhibitor	NN	O
p16INK4a	NN	O
,	,	O
but	CC	O
not	RB	O
of	IN	O
p21	NN	O
or	CC	O
of	IN	O
p27KIP1	NN	O
.	.	O

The	DT	O
same	JJ	O
mutation	NN	O
was	VBD	O
found	VBN	O
in	IN	O
one	CD	O
additional	JJ	O
melanoma	NN	B-Disease
among	IN	O
28	CD	O
melanomas	NNS	B-Disease
analyzed	VBN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
mutation	NN	O
of	IN	O
CDK4	NN	O
can	MD	O
create	VB	O
a	DT	O
tumor-specific	JJ	O
antigen	NN	O
and	CC	O
can	MD	O
disrupt	VB	O
the	DT	O
cell-cycle	JJ	O
regulation	NN	O
exerted	VBN	O
by	IN	O
the	DT	O
tumor	NN	B-Disease
suppressor	NN	O
p16INK4a	NN	O
.	.	O

.	.	O

Molecular	JJ	O
analysis	NN	O
in	IN	O
familial	JJ	B-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
:	:	O
early	JJ	O
diagnosis	NN	O
of	IN	O
an	DT	O
asymptomatic	JJ	O
carrier	NN	O
.	.	O

Familial	JJ	B-Disease
neurohypophyseal	NN	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
(	-LRB-	O
FNDI	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
hormone	NN	I-Disease
arginine	NN	I-Disease
vasopressin	NN	I-Disease
(	-LRB-	O
AVP	NN	O
)	-RRB-	O
and	CC	O
is	VBZ	O
transmitted	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
trait	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
we	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
AVP-neurophysin	NN	O
II	CD	O
(	-LRB-	O
AVP-NPII	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
a	DT	O
Spanish	JJ	O
kindred	NN	O
.	.	O

Studies	NNS	O
were	VBD	O
performed	VBN	O
on	IN	O
seven	CD	O
members	NNS	O
(	-LRB-	O
four	CD	O
clinically	RB	O
affected	VBN	O
)	-RRB-	O
of	IN	O
the	DT	O
family	NN	O
.	.	O

Patients	NNS	O
were	VBD	O
diagnosed	VBN	O
at	IN	O
the	DT	O
Hospital	NNP	O
Universitario	NNP	O
Gregorio	NNP	O
Maranon	NNP	O
(	-LRB-	O
Madrid	NNP	O
,	,	O
Spain	NNP	O
)	-RRB-	O
.	.	O

The	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
AVP-NPII	NN	O
gene	NN	O
of	IN	O
all	DT	O
family	NN	O
members	NNS	O
was	VBD	O
amplified	VBN	O
by	IN	O
PCR	NN	O
and	CC	O
sequenced	VBN	O
.	.	O

All	DT	O
affected	VBN	O
individuals	NNS	O
presented	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
G1757	NN	O
--	:	O
>	JJR	O
A	NN	O
)	-RRB-	O
that	WDT	O
replaces	VBZ	O
glycine	NN	O
at	IN	O
position	NN	O
23	CD	O
with	IN	O
arginine	NN	O
within	IN	O
the	DT	O
NPII	NN	O
domain	NN	O
.	.	O

The	DT	O
substitution	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
restriction	NN	O
endonuclease	NN	O
analysis	NN	O
and	CC	O
was	VBD	O
present	JJ	O
in	IN	O
heterozygosis	NN	O
.	.	O

Additionally	RB	O
,	,	O
one	CD	O
of	IN	O
the	DT	O
asymptomatic	JJ	O
relatives	NNS	O
(	-LRB-	O
a	DT	O
girl	NN	O
8	CD	O
months	NNS	O
old	JJ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
study	NN	O
)	-RRB-	O
was	VBD	O
identified	VBN	O
as	IN	O
carrier	NN	O
of	IN	O
the	DT	O
same	JJ	O
mutation	NN	O
and	CC	O
developed	VBD	O
the	DT	O
disease	NN	O
3	CD	O
months	NNS	O
later	RB	O
.	.	O

The	DT	O
alteration	NN	O
found	VBN	O
in	IN	O
the	DT	O
second	JJ	O
exon	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
this	DT	O
family	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
,	,	O
as	IN	O
all	DT	O
individuals	NNS	O
harboring	VBG	O
the	DT	O
mutation	NN	O
had	VBD	O
been	VBN	O
previously	RB	O
diagnosed	VBN	O
or	CC	O
have	VBP	O
eventually	RB	O
developed	VBN	O
FNDI	NN	B-Disease
.	.	O

Identification	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
defect	NN	O
underlying	VBG	O
FNDI	NNP	B-Disease
in	IN	O
affected	JJ	O
families	NNS	O
is	VBZ	O
a	DT	O
powerful	JJ	O
tool	NN	O
for	IN	O
early	JJ	O
asymptomatic	JJ	O
diagnosis	NN	O
in	IN	O
infants	NNS	O
.	.	O

.	.	O

Sialophorin	NNP	O
,	,	O
a	DT	O
surface	NN	O
sialoglycoprotein	NN	O
defective	JJ	O
in	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
is	VBZ	O
involved	VBN	O
in	IN	O
human	JJ	O
T	NN	O
lymphocyte	NN	O
proliferation	NN	O
.	.	O

The	DT	O
mAb	NN	O
L10	NN	O
was	VBD	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
distribution	NN	O
and	CC	O
the	DT	O
function	NN	O
of	IN	O
sialophorin	NN	O
,	,	O
the	DT	O
heavily	RB	O
glycosylated	VBN	O
surface	NN	O
molecule	NN	O
that	WDT	O
is	VBZ	O
deficient/defective	JJ	O
in	IN	O
lymphocytes	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
the	DT	O
X-linked	JJ	B-Disease
immunodeficiency	NN	I-Disease
Wiskott-Aldrich	JJ	I-Disease
syndrome	NN	I-Disease
.	.	O

Dual-parameter	JJ	O
FACS	NN	O
analysis	NN	O
indicated	VBD	O
that	IN	O
sialophorin	NN	O
is	VBZ	O
expressed	VBN	O
on	IN	O
CD4	NN	O
+	CC	O
and	CC	O
CD8	NN	O
+	CC	O
lymphocytes	NNS	O
,	,	O
on	IN	O
a	DT	O
subpopulation	NN	O
of	IN	O
peripheral	JJ	O
blood	NN	O
B	NN	O
lymphocytes	NNS	O
,	,	O
on	IN	O
all	DT	O
thymocytes	NNS	O
,	,	O
and	CC	O
on	IN	O
a	DT	O
subpopulation	NN	O
of	IN	O
bone	NN	O
marrow	NN	O
cells	NNS	O
.	.	O

Functional	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
L10	NN	O
mAb	NN	O
stimulates	VBZ	O
the	DT	O
proliferation	NN	O
of	IN	O
peripheral	JJ	O
blood	NN	O
T	NN	O
lymphocytes	NNS	O
as	IN	O
measured	VBN	O
by	IN	O
stimulation	NN	O
of	IN	O
[	-LRB-	O
3H	NN	O
]	-RRB-	O
thymidine	NN	O
incorporation	NN	O
.	.	O

The	DT	O
time	NN	O
course	NN	O
and	CC	O
magnitude	NN	O
of	IN	O
increased	VBN	O
[	-LRB-	O
3H	NN	O
]	-RRB-	O
thymidine	NN	O
incorporation	NN	O
by	IN	O
T	NN	O
lymphocytes	NNS	O
in	IN	O
response	NN	O
to	TO	O
L10	NN	O
mAb	NN	O
paralleled	VBD	O
that	IN	O
induced	VBN	O
by	IN	O
anti-CD3	JJ	O
mAb	NN	O
.	.	O

Effective	JJ	O
stimulation	NN	O
was	VBD	O
dependent	JJ	O
on	IN	O
the	DT	O
presence	NN	O
of	IN	O
monocytes	NNS	O
and	CC	O
the	DT	O
Fc	NN	O
portion	NN	O
of	IN	O
L10	NN	O
mAb	NN	O
.	.	O

Stimulation	NN	O
of	IN	O
lymphocytes	NNS	O
by	IN	O
L10	NN	O
,	,	O
like	IN	O
stimulation	NN	O
by	IN	O
anti-CD3	JJ	O
mAb	NN	O
,	,	O
involves	VBZ	O
increased	VBN	O
expression	NN	O
of	IN	O
4F2	NN	O
,	,	O
HLA-DR	NN	O
,	,	O
and	CC	O
IL-2-R	NN	O
.	.	O

These	DT	O
observations	NNS	O
suggest	VBP	O
that	IN	O
sialophorin	NN	O
functions	NNS	O
in	IN	O
T	NN	O
cell	NN	O
activation	NN	O
.	.	O

.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
rat	NN	O
spinocerebellar	NN	O
ataxia	NN	O
type	NN	O
3	CD	O
gene	NN	O
.	.	O

Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
belongs	VBZ	O
to	TO	O
a	DT	O
group	NN	O
of	IN	O
clinically	RB	O
and	CC	O
genetically	RB	O
heterogeneous	JJ	O
neurodegenerative	JJ	B-Disease
disorders	NNS	I-Disease
characterized	VBN	O
by	IN	O
progressive	JJ	B-Disease
cerebellar	NN	I-Disease
ataxia	NN	I-Disease
.	.	O

The	DT	O
disease-causing	NN	O
mutation	NN	O
has	VBZ	O
recently	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
unstable	JJ	O
and	CC	O
expanded	VBN	O
(	-LRB-	O
CAG	NN	O
)	-RRB-	O
n	NN	O
trinucleotide	JJ	O
repeat	NN	O
in	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

In	IN	O
Caucasians	NNPS	O
,	,	O
repeat	NN	O
expansions	NNS	O
in	IN	O
the	DT	O
MJD1	NN	O
gene	NN	O
have	VBP	O
also	RB	O
been	VBN	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
clinically	RB	O
distinct	JJ	O
autosomal	JJ	O
dominant	JJ	O
spinocerebellar	NN	B-Disease
ataxia	NN	I-Disease
type	NN	I-Disease
3	CD	I-Disease
(	-LRB-	O
SCA3	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
gain	VB	O
insight	NN	O
into	IN	O
the	DT	O
biology	NN	O
of	IN	O
the	DT	O
MJD1/SCA3	NN	O
gene	NN	O
we	PRP	O
cloned	VBD	O
the	DT	O
rat	NN	O
homologue	NN	O
and	CC	O
studied	VBD	O
its	PRP$	O
expression	NN	O
.	.	O

The	DT	O
rat	NN	O
and	CC	O
human	JJ	O
ataxin-3	NN	O
genes	NNS	O
are	VBP	O
highly	RB	O
homologous	JJ	O
with	IN	O
an	DT	O
overall	JJ	O
sequence	NN	O
identity	NN	O
of	IN	O
approximately	RB	O
88	CD	O
%	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
C-terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
putative	JJ	O
protein	NN	O
differs	VBZ	O
strongly	RB	O
from	IN	O
the	DT	O
published	VBN	O
human	JJ	O
sequence	NN	O
.	.	O

The	DT	O
(	-LRB-	O
CAG	NN	O
)	-RRB-	O
n	NN	O
block	NN	O
in	IN	O
the	DT	O
rat	NN	O
cDNA	NN	O
consists	VBZ	O
of	IN	O
just	RB	O
three	CD	O
interrupted	JJ	O
units	NNS	O
suggesting	VBG	O
that	IN	O
a	DT	O
long	JJ	O
polyglutamine	NN	O
stretch	NN	O
is	VBZ	O
not	RB	O
essential	JJ	O
for	IN	O
the	DT	O
normal	JJ	O
function	NN	O
of	IN	O
the	DT	O
ataxin-3	NN	O
protein	NN	O
in	IN	O
rodents	NNS	O
.	.	O

The	DT	O
expression	NN	O
pattern	NN	O
of	IN	O
the	DT	O
SCA3	NN	O
gene	NN	O
in	IN	O
various	JJ	O
rat	NN	O
and	CC	O
human	JJ	O
tissues	NNS	O
was	VBD	O
investigated	VBN	O
by	IN	O
Northern	NN	O
blot	NN	O
analyses	NNS	O
.	.	O

The	DT	O
mature	JJ	O
transcript	NN	O
is	VBZ	O
approximately	RB	O
6	CD	O
kb	NN	O
in	IN	O
length	NN	O
.	.	O

In	IN	O
rat	NN	O
testis	NN	O
,	,	O
a	DT	O
smaller	JJR	O
transcript	NN	O
of	IN	O
1	CD	O
.	.	O

3	CD	O
kb	NN	O
was	VBD	O
identified	VBN	O
.	.	O

Transcription	NN	O
of	IN	O
rsca3	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
most	JJS	O
rat	NN	O
tissues	NNS	O
including	VBG	O
brain	NN	O
.	.	O

Analyzing	VBG	O
the	DT	O
expression	NN	O
level	NN	O
of	IN	O
the	DT	O
SCA3	NN	O
gene	NN	O
in	IN	O
several	JJ	O
human	JJ	O
brain	NN	O
sections	NNS	O
revealed	VBD	O
no	DT	O
significant	JJ	O
higher	JJR	O
mRNA	NN	O
level	NN	O
in	IN	O
regions	NNS	O
predominantly	RB	O
affected	VBN	O
in	IN	O
MJD	NN	B-Disease
.	.	O

Thus	RB	O
additional	JJ	O
molecules	NNS	O
and/or	CC	O
regulatory	JJ	O
events	NNS	O
are	VBP	O
necessary	JJ	O
to	TO	O
explain	VB	O
the	DT	O
exclusive	JJ	O
degeneration	NN	B-Disease
of	IN	I-Disease
certain	JJ	I-Disease
brain	NN	I-Disease
areas	NNS	I-Disease
.	.	O

The	DT	O
alveolar	JJ	B-Disease
rhabdomyosarcoma	NN	I-Disease
PAX3/FKHR	NN	O
fusion	NN	O
protein	NN	O
is	VBZ	O
a	DT	O
transcriptional	JJ	O
activator	NN	O
.	.	O

Chimeric	JJ	O
transcription	NN	O
factors	NNS	O
,	,	O
created	VBN	O
by	IN	O
gene	NN	O
fusions	NNS	O
as	IN	O
the	DT	O
result	NN	O
of	IN	O
chromosomal	JJ	O
translocations	NNS	O
,	,	O
have	VBP	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
several	JJ	O
pathologically	RB	O
disparate	JJ	O
solid	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

The	DT	O
PAX3/FKHR	NN	O
fusion	NN	O
gene	NN	O
,	,	O
formed	VBN	O
by	IN	O
a	DT	O
t	NN	O
(	-LRB-	O
2	CD	O
;	:	O
13	CD	O
)	-RRB-	O
(	-LRB-	O
q35	NN	O
;	:	O
q14	NN	O
)	-RRB-	O
in	IN	O
alveolar	JJ	B-Disease
rhabdomyosarcoma	NN	I-Disease
,	,	O
encodes	VBZ	O
a	DT	O
hybrid	NN	O
protein	NN	O
that	WDT	O
contains	VBZ	O
both	DT	O
PAX3	NN	O
DNA	NN	O
binding	NN	O
domains	NNS	O
,	,	O
the	DT	O
paired	JJ	O
box	NN	O
and	CC	O
homeodomain	NN	O
,	,	O
linked	VBN	O
to	TO	O
the	DT	O
bisected	VBN	O
DNA	NN	O
binding	NN	O
domain	NN	O
of	IN	O
FKHR	NN	O
,	,	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
forkhead	NN	O
family	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
PAX3	NN	O
and	CC	O
PAX3/FKHR	NN	O
display	VBP	O
similar	JJ	O
,	,	O
but	CC	O
not	RB	O
identical	JJ	O
transactivation	NN	O
activities	NNS	O
when	WRB	O
tested	VBN	O
with	IN	O
model	NN	O
Pax	NN	O
recognition	NN	O
sequences	NNS	O
.	.	O

No	DT	O
functional	JJ	O
role	NN	O
could	MD	O
be	VB	O
ascribed	VBN	O
solely	RB	O
to	TO	O
the	DT	O
residual	JJ	O
FKHR	NN	O
binding	NN	O
domain	NN	O
present	JJ	O
in	IN	O
the	DT	O
fusion	NN	O
protein	NN	O
,	,	O
but	CC	O
FKHR	NNP	O
was	VBD	O
found	VBN	O
to	TO	O
contribute	VB	O
a	DT	O
strong	JJ	O
carboxyl	JJ	O
terminal	JJ	O
activation	NN	O
domain	NN	O
replacing	VBG	O
the	DT	O
one	CD	O
located	JJ	O
in	IN	O
the	DT	O
unrearranged	JJ	O
PAX3	NN	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
native	JJ	O
PAX3/FKHR	NN	O
protein	NN	O
present	JJ	O
in	IN	O
tumor	NN	B-Disease
cells	NNS	O
with	IN	O
this	DT	O
translocation	NN	O
has	VBZ	O
transcriptional	JJ	O
characteristics	NNS	O
similar	JJ	O
to	TO	O
the	DT	O
in	FW	O
vitro	FW	O
expressed	VBN	O
protein	NN	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
the	DT	O
PAX3/FKHR	NN	O
hybrid	NN	O
protein	NN	O
to	TO	O
bind	VB	O
DNA	NN	O
in	IN	O
a	DT	O
sequence	NN	O
specific	JJ	O
manner	NN	O
and	CC	O
to	TO	O
transactivate	VB	O
the	DT	O
expression	NN	O
of	IN	O
artificial	JJ	O
reporter	NN	O
genes	NNS	O
suggests	VBZ	O
that	IN	O
its	PRP$	O
aberrant	JJ	O
expression	NN	O
could	MD	O
subvert	VB	O
the	DT	O
transcriptional	JJ	O
programs	NNS	O
that	WDT	O
normally	RB	O
control	VBP	O
the	DT	O
growth	NN	O
,	,	O
differentiation	NN	O
,	,	O
and	CC	O
survival	NN	O
of	IN	O
primitive	JJ	O
myogenic	JJ	O
precursors	NNS	O
in	FW	O
vivo	FW	O
.	.	O

.	.	O

Myotonia	NN	B-Disease
levior	NN	I-Disease
is	VBZ	O
a	DT	O
chloride	NN	B-Disease
channel	NN	I-Disease
disorder	NN	I-Disease
.	.	O

The	DT	O
group	NN	O
of	IN	O
dominant	JJ	B-Disease
non-dystrophic	JJ	I-Disease
myotonias	NNS	I-Disease
,	,	O
comprising	VBG	O
disorders	NNS	O
characterized	VBN	O
by	IN	O
clinically	RB	O
similar	JJ	O
forms	NNS	O
of	IN	O
myogenic	JJ	O
muscle	NN	O
stiffness	NN	O
,	,	O
is	VBZ	O
genetically	RB	O
inhomogeneous	JJ	O
.	.	O

Dominant	JJ	B-Disease
myotonia	NN	I-Disease
congenita	NN	I-Disease
(	-LRB-	O
Thomsens	NNS	B-Disease
disease	NN	I-Disease
)	-RRB-	O
is	VBZ	O
linked	VBN	O
to	TO	O
CLCN1	NN	O
,	,	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
major	JJ	O
muscle	NN	O
chloride	NN	O
channel	NN	O
,	,	O
localized	JJ	O
on	IN	O
chromosome	NN	O
7q35	CD	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
dominant	JJ	B-Disease
myotonias	NNS	I-Disease
sensitive	JJ	O
to	TO	O
potassium	NN	O
are	VBP	O
caused	VBN	O
by	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
SCN4A	NN	O
on	IN	O
chromosome	NN	O
17q	NN	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
alpha	NN	O
subunit	NN	O
of	IN	O
the	DT	O
adult	JJ	O
skeletal	JJ	O
muscle	NN	O
sodium	NN	O
channel	NN	O
.	.	O

No	DT	O
linkage	NN	O
or	CC	O
molecular	JJ	O
genetic	JJ	O
data	NNS	O
are	VBP	O
as	RB	O
yet	RB	O
available	JJ	O
on	IN	O
myotonia	NN	B-Disease
levior	NN	I-Disease
characterized	VBN	O
by	IN	O
milder	JJR	O
symptoms	NNS	O
and	CC	O
later	RB	O
onset	NN	O
of	IN	O
myotonia	NN	B-Disease
than	IN	O
in	IN	O
Thomsens	NNP	B-Disease
disease	NN	I-Disease
,	,	O
and	CC	O
absence	NN	O
of	IN	O
muscle	NN	B-Disease
hypertrophy	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
CLCN1	NN	O
Gln-552-Arg	NN	O
substitution	NN	O
for	IN	O
a	DT	O
family	NN	O
with	IN	O
dominant	JJ	O
inheritance	NN	O
previously	RB	O
diagnosed	VBD	O
to	TO	O
have	VB	O
myotonia	NN	B-Disease
levior	NN	I-Disease
.	.	O

Thus	RB	O
,	,	O
this	DT	O
disorder	NN	O
appears	VBZ	O
as	IN	O
a	DT	O
variant	NN	O
of	IN	O
Thomsens	NNS	B-Disease
disease	NN	I-Disease
due	JJ	O
to	TO	O
mutations	NNS	O
leading	VBG	O
to	TO	O
low	JJ	O
clinical	JJ	O
expressivity	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
Ile-290-Met	NN	O
CLCN1	NN	O
mutation	NN	O
for	IN	O
a	DT	O
typical	JJ	O
Thomsen	NNP	O
pedigree	NN	O
.	.	O

In	IN	O
another	DT	O
family	NN	O
previously	RB	O
diagnosed	VBD	O
as	IN	O
having	VBG	O
Thomsens	NNS	B-Disease
disease	NN	I-Disease
,	,	O
we	PRP	O
unexpectedly	RB	O
found	VBD	O
a	DT	O
CLCN1	NN	O
14	CD	O
bp	NN	O
deletion	NN	O
known	VBN	O
to	TO	O
cause	VB	O
recessive	JJ	B-Disease
myotonia	NN	I-Disease
,	,	O
and	CC	O
a	DT	O
rare	JJ	O
Trp-118-Gly	JJ	O
polymorphism	NN	O
.	.	O

.	.	O

Markedly	RB	O
accelerated	VBN	O
catabolism	NN	O
of	IN	O
apolipoprotein	NN	O
A-II	NN	O
(	-LRB-	O
ApoA-II	NN	O
)	-RRB-	O
and	CC	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
containing	VBG	O
ApoA-II	NN	O
in	IN	O
classic	JJ	O
lecithin	NN	O
:	:	O
cholesterol	NN	B-Disease
acyltransferase	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
fish-eye	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Classic	JJ	B-Disease
(	-LRB-	I-Disease
complete	JJ	I-Disease
)	-RRB-	I-Disease
lecithin	NN	I-Disease
cholesterol	NN	I-Disease
acyltransferase	NN	I-Disease
(	-LRB-	I-Disease
LCAT	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
and	CC	O
Fish-eye	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
partial	JJ	B-Disease
LCAT	NN	I-Disease
deficiency	NN	I-Disease
)	-RRB-	O
are	VBP	O
genetic	JJ	O
syndromes	NNS	O
associated	VBN	O
with	IN	O
markedly	RB	O
decreased	VBN	O
plasma	NN	O
levels	NNS	O
of	IN	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
(	-LRB-	O
HDL	NN	O
)	-RRB-	O
cholesterol	NN	O
but	CC	O
not	RB	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
atherosclerotic	JJ	B-Disease
cardiovascular	JJ	I-Disease
disease	NN	I-Disease
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
metabolism	NN	O
of	IN	O
the	DT	O
HDL	NN	O
apolipoproteins	NNS	O
(	-LRB-	O
apo	NN	O
)	-RRB-	O
apoA-I	NN	O
and	CC	O
apoA-II	NN	O
in	IN	O
a	DT	O
total	NN	O
of	IN	O
five	CD	O
patients	NNS	O
with	IN	O
LCAT	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
one	CD	O
with	IN	O
classic	JJ	B-Disease
LCAT	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
four	CD	O
with	IN	O
Fish-eye	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Plasma	NN	O
levels	NNS	O
of	IN	O
apoA-II	NN	O
were	VBD	O
decreased	VBN	O
to	TO	O
a	DT	O
proportionately	RB	O
greater	JJR	O
extent	NN	O
(	-LRB-	O
23	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	-RRB-	O
than	IN	O
apoA-I	NN	O
(	-LRB-	O
30	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
plasma	NN	O
concentrations	NNS	O
of	IN	O
HDL	NN	O
particles	NNS	O
containing	VBG	O
both	CC	O
apoA-I	NN	O
and	CC	O
apoA-II	NN	O
(	-LRB-	O
LpA-I	NN	O
A-II	NN	O
)	-RRB-	O
were	VBD	O
much	RB	O
lower	JJR	O
(	-LRB-	O
18	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	-RRB-	O
than	IN	O
those	DT	O
of	IN	O
particles	NNS	O
containing	VBG	O
only	RB	O
apoA-I	NN	O
(	-LRB-	O
LpA-I	NN	O
)	-RRB-	O
(	-LRB-	O
51	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	-RRB-	O
.	.	O

The	DT	O
metabolic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
low	JJ	O
levels	NNS	O
of	IN	O
apoA-II	NN	O
and	CC	O
LpA-I	NN	O
A-II	NN	O
was	VBD	O
investigated	VBN	O
in	IN	O
all	DT	O
five	CD	O
patients	NNS	O
using	VBG	O
both	CC	O
exogenous	JJ	O
radiotracer	NN	O
and	CC	O
endogenous	JJ	O
stable	JJ	O
isotope	NN	O
labeling	NN	O
techniques	NNS	O
.	.	O

The	DT	O
mean	NN	O
plasma	NN	O
residence	NN	O
time	NN	O
of	IN	O
apoA-I	NN	O
was	VBD	O
decreased	VBN	O
at	IN	O
2	CD	O
.	.	O

08	NN	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

27	CD	O
d	NN	O
(	-LRB-	O
controls	NNS	O
4	CD	O
.	.	O

74	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

65	CD	O
days	NNS	O
)	-RRB-	O
;	:	O
however	RB	O
,	,	O
the	DT	O
residence	NN	O
time	NN	O
of	IN	O
apoA-II	NN	O
was	VBD	O
even	RB	O
shorter	JJR	O
at	IN	O
1	CD	O
.	.	O

66	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

24	CD	O
d	NN	O
(	-LRB-	O
controls	NNS	O
5	CD	O
.	.	O

25	CD	O
+	CC	O
/	:	O
-	:	O
0	CD	O
.	.	O

61	CD	O
d	NN	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
catabolism	NN	O
of	IN	O
apoA-I	NN	O
in	IN	O
LpA-I	NN	O
A-II	NN	O
was	VBD	O
substantially	RB	O
faster	JJR	O
than	IN	O
that	DT	O
of	IN	O
apoA-I	NN	O
in	IN	O
LpA-I	NN	O
.	.	O

In	IN	O
summary	NN	O
,	,	O
genetic	JJ	O
syndromes	NNS	O
of	IN	O
either	CC	O
complete	JJ	B-Disease
or	CC	I-Disease
partial	JJ	I-Disease
LCAT	NN	I-Disease
deficiency	NN	I-Disease
result	VBP	O
in	IN	O
low	JJ	O
levels	NNS	O
of	IN	O
HDL	NN	O
through	IN	O
preferential	JJ	O
hypercatabolism	NN	O
of	IN	O
apoA-II	NN	O
and	CC	O
HDL	NN	O
particles	NNS	O
containing	VBG	O
apoA-II	NN	O
.	.	O

Because	IN	O
LpA-I	NN	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
to	TO	O
be	VB	O
more	RBR	O
protective	JJ	O
than	IN	O
LpA-I	NN	O
A-II	NN	O
against	IN	O
atherosclerosis	NN	B-Disease
,	,	O
this	DT	O
selective	JJ	O
effect	NN	O
on	IN	O
the	DT	O
metabolism	NN	O
of	IN	O
LpA-I	NN	O
A-II	NN	O
may	MD	O
provide	VB	O
a	DT	O
potential	JJ	O
explanation	NN	O
why	WRB	O
patients	NNS	O
with	IN	O
classic	JJ	B-Disease
LCAT	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
Fish-eye	JJ	B-Disease
disease	NN	I-Disease
are	VBP	O
not	RB	O
at	IN	O
increased	VBN	O
risk	NN	O
for	IN	O
premature	JJ	O
atherosclerosis	NN	B-Disease
despite	IN	O
markedly	RB	O
decreased	VBN	O
levels	NNS	O
of	IN	O
HDL	NN	O
cholesterol	NN	O
and	CC	O
apoA-I	NN	O

The	DT	O
identical	JJ	O
5	CD	O
'	''	O
splice-site	JJ	O
acceptor	NN	O
mutation	NN	O
in	IN	O
five	CD	O
attenuated	VBD	B-Disease
APC	NN	I-Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
demonstrates	VBZ	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
predispose	VB	O
carriers	NNS	O
to	TO	O
multiple	JJ	O
adenomatous	JJ	B-Disease
polyps	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
colon	NN	I-Disease
and	CC	I-Disease
rectum	NN	I-Disease
and	CC	O
to	TO	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Mutations	NNS	O
located	JJ	O
at	IN	O
the	DT	O
extreme	JJ	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
however	RB	O
,	,	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
less	RBR	O
severe	JJ	O
disease	NN	O
known	VBN	O
as	IN	O
attenuated	VBN	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
AAPC	NN	B-Disease
)	-RRB-	O
.	.	O

Many	JJ	O
individuals	NNS	O
with	IN	O
AAPC	NNP	B-Disease
develop	VBP	O
relatively	RB	O
few	JJ	O
colorectal	JJ	B-Disease
polyps	NNS	I-Disease
but	CC	O
are	VBP	O
still	RB	O
at	IN	O
high	JJ	O
risk	NN	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
5	CD	O
APC	NN	B-Disease
germline	NN	O
mutation	NN	O
in	IN	O
five	CD	O
separately	RB	O
ascertained	VBD	O
AAPC	NNP	B-Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
,	,	O
Canada	NNP	O
.	.	O

This	DT	O
disease-causing	NN	O
mutation	NN	O
is	VBZ	O
a	DT	O
single	JJ	O
basepair	NN	O
change	NN	O
(	-LRB-	O
G	NN	O
to	TO	O
A	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
splice-acceptor	JJ	O
region	NN	O
of	IN	O
APC	NN	B-Disease
intron	NN	O
3	CD	O
that	WDT	O
creates	VBZ	O
a	DT	O
mutant	JJ	O
RNA	NN	O
without	IN	O
exon	NN	O
4	CD	O
of	IN	O
APC	NN	O
.	.	O

The	DT	O
observation	NN	O
of	IN	O
the	DT	O
same	JJ	O
APC	NN	B-Disease
mutation	NN	O
in	IN	O
five	CD	O
families	NNS	O
from	IN	O
the	DT	O
same	JJ	O
geographic	JJ	O
area	NN	O
demonstrates	VBZ	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Furthermore	RB	O
,	,	O
the	DT	O
identification	NN	O
of	IN	O
this	DT	O
germline	NN	O
mutation	NN	O
strengthens	VBZ	O
the	DT	O
correlation	NN	O
between	IN	O
the	DT	O
5	CD	O
location	NN	O
of	IN	O
an	DT	O
APC	NN	B-Disease
disease-causing	NN	O
mutation	NN	O
and	CC	O
the	DT	O
attenuated	VBN	B-Disease
polyposis	NN	I-Disease
phenotype	NN	O
.	.	O

.	.	O

Linkage	NN	O
of	IN	O
aspartylglucosaminuria	NN	B-Disease
(	-LRB-	O
AGU	NN	B-Disease
)	-RRB-	O
to	TO	O
marker	NN	O
loci	NNS	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

Aspartylglucosaminuria	NN	B-Disease
(	-LRB-	O
AGU	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
deficient	JJ	O
activity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
aspartylglucosaminidase	NN	O
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
.	.	O

The	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
AGA	NNP	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
the	DT	O
region	NN	O
4q21-qter	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
map	NN	O
position	NN	O
of	IN	O
the	DT	O
AGU	NN	O
locus	NN	O
in	IN	O
relation	NN	O
to	TO	O
other	JJ	O
marker	NN	O
loci	NNS	O
on	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
using	VBG	O
linkage	NN	O
analyses	NNS	O
.	.	O

Restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
alleles	NNS	O
for	IN	O
the	DT	O
ADH2	NN	O
,	,	O
ADH3	NN	O
,	,	O
EGF	NN	O
,	,	O
FG	NN	O
alpha	NN	O
and	CC	O
FG	NN	O
beta	NN	O
loci	NNS	O
and	CC	O
blood	NN	O
group	NN	O
antigens	NNS	O
for	IN	O
the	DT	O
MNS	NN	O
locus	NN	O
were	VBD	O
determined	VBN	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
12	CD	O
Finnish	JJ	O
AGU	NN	B-Disease
families	NNS	O
.	.	O

The	DT	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
reduced	VBN	O
activity	NN	O
of	IN	O
AGA	NNP	O
in	IN	O
lymphocytes	NNS	O
.	.	O

Linkage	NN	O
studies	NNS	O
were	VBD	O
performed	VBN	O
using	VBG	O
both	CC	O
pairwise	JJ	O
and	CC	O
multipoint	JJ	O
analyses	NNS	O
.	.	O

Loose	JJ	O
linkage	NN	O
of	IN	O
the	DT	O
AGU	NN	B-Disease
locus	NN	O
to	TO	O
the	DT	O
FG	NN	O
and	CC	O
MNS	NN	O
loci	NNS	O
was	VBD	O
observed	VBN	O
(	-LRB-	O
z	SYM	O
=	SYM	O
1	CD	O
.	.	O

16	CD	O
,	,	O
z	SYM	O
=	SYM	O
1	CD	O
.	.	O

39	CD	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

Multipoint	JJ	O
analysis	NN	O
to	TO	O
the	DT	O
fixed	JJ	O
map	NN	O
[	-LRB-	O
ADH	NN	O
-	:	O
(	-LRB-	O
0	CD	O
.	.	O

03	NN	O
)	-RRB-	O
-	:	O
EGF	NN	O
-	:	O
(	-LRB-	O
0	CD	O
.	.	O

35	CD	O
)	-RRB-	O
-	:	O
FG	SYM	O
-	:	O
(	-LRB-	O
0	CD	O
.	.	O

11	CD	O
)	-RRB-	O
-	:	O
MNS	NN	O
]	-RRB-	O
suggests	VBZ	O
that	IN	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
AGU	NN	O
locus	NN	O
is	VBZ	O
0	CD	O
.	.	O

05-0	CD	O
.	.	O

30	CD	O
recombination	NN	O
units	NNS	O
distal	JJ	O
to	TO	O
MNS	NN	O
(	-LRB-	O
z	SYM	O
=	JJ	O
3	CD	O
.	.	O

03	NN	O
)	-RRB-	O
.	.	O

The	DT	O
order	NN	O
cen-ADH-EGF-FG-MNS-AGU	NN	O
is	VBZ	O
35	CD	O
times	NNS	O
more	RBR	O
likely	JJ	O
than	IN	O
the	DT	O
next	JJ	O
best	JJS	O
order	NN	O
cen-ADH-EGF-AGU-FG-MNS	NN	O
.	.	O

Linkage	NN	O
analysis	NN	O
in	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
and	CC	O
application	NN	O
in	IN	O
post	NN	O
-	:	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
linkage	NN	O
analysis	NN	O
with	IN	O
the	DT	O
DNA	NN	O
markers	NNS	O
DXS52	NN	O
and	CC	O
the	DT	O
clotting	NN	O
factor	NN	O
VIII	CD	O
gene	NN	O
(	-LRB-	O
F8C	NN	O
)	-RRB-	O
,	,	O
in	IN	O
several	JJ	O
large	JJ	O
families	NNS	O
with	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
tight	JJ	O
linkage	NN	O
to	TO	O
DXS52	NN	O
could	MD	O
be	VB	O
extended	VBN	O
giving	VBG	O
a	DT	O
maximal	JJ	O
LOD	NN	O
score	NN	O
of	IN	O
22	CD	O
.	.	O

5	CD	O
at	IN	O
1	CD	O
cM	NN	O
.	.	O

F8C	NN	O
was	VBD	O
also	RB	O
tightly	RB	O
linked	VBN	O
to	TO	O
ALD	NN	B-Disease
with	IN	O
a	DT	O
maximal	JJ	O
LOD	NN	O
score	NN	O
of	IN	O
7	CD	O
.	.	O

8	CD	O
without	IN	O
recombination	NN	O
.	.	O

Multipoint	JJ	O
linkage	NN	O
analysis	NN	O
with	IN	O
the	DT	O
markers	NNS	O
DXS304	NN	O
,	,	O
DXS52	NN	O
,	,	O
and	CC	O
F8C	NN	O
indicated	VBD	O
that	IN	O
both	CC	O
the	DT	O
gene	NN	O
for	IN	O
ALD	NN	B-Disease
and	CC	O
for	IN	O
F8C	NN	O
are	VBP	O
distal	JJ	O
to	TO	O
DXS52	NN	O
.	.	O

In	IN	O
four	CD	O
patients	NNS	O
with	IN	O
ALD	NN	B-Disease
,	,	O
no	DT	O
major	JJ	O
structural	JJ	O
rearrangement	NN	O
in	IN	O
the	DT	O
Xqter	NN	O
region	NN	O
was	VBD	O
observed	VBN	O
;	:	O
in	IN	O
particular	JJ	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
abnormalities	NNS	B-Disease
in	IN	I-Disease
the	DT	I-Disease
vision	NN	I-Disease
blindness	NN	I-Disease
genes	NNS	I-Disease
.	.	O

DNA	NN	O
analysis	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
of	IN	O
use	NN	O
in	IN	O
determination	NN	O
of	IN	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
females	NNS	O
at	IN	O
risk	NN	O
,	,	O
for	IN	O
the	DT	O
determination	NN	O
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
a	DT	O
particular	JJ	O
family	NN	O
,	,	O
and	CC	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

Multicentric	JJ	O
origin	NN	O
of	IN	O
hemochromatosis	NN	B-Disease
gene	NN	O
(	-LRB-	O
HFE	NN	O
)	-RRB-	O
mutations	NNS	O
.	.	O

Genetic	JJ	B-Disease
hemochromatosis	NN	I-Disease
(	-LRB-	O
GH	NN	B-Disease
)	-RRB-	O
is	VBZ	O
believed	VBN	O
to	TO	O
be	VB	O
a	DT	O
disease	NN	O
restricted	JJ	O
to	TO	O
those	DT	O
of	IN	O
European	JJ	O
ancestry	NN	O
.	.	O

In	IN	O
northwestern	JJ	O
Europe	NNP	O
,	,	O
>	JJR	O
80	CD	O
%	NN	O
of	IN	O
GH	NN	B-Disease
patients	NNS	O
are	VBP	O
homozygous	JJ	O
for	IN	O
one	CD	O
mutation	NN	O
,	,	O
the	DT	O
substitution	NN	O
of	IN	O
tyrosine	NN	O
for	IN	O
cysteine	NN	O
at	IN	O
position	NN	O
282	CD	O
(	-LRB-	O
C282Y	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
unprocessed	JJ	O
protein	NN	O
.	.	O

In	IN	O
a	DT	O
proportion	NN	O
of	IN	O
GH	NN	B-Disease
patients	NNS	O
,	,	O
two	CD	O
mutations	NNS	O
are	VBP	O
present	JJ	O
,	,	O
C282Y	NN	O
and	CC	O
H63D	NN	O
.	.	O

The	DT	O
clinical	JJ	O
significance	NN	O
of	IN	O
this	DT	O
second	JJ	O
mutation	NN	O
is	VBZ	O
such	JJ	O
that	IN	O
it	PRP	O
appears	VBZ	O
to	TO	O
predispose	VB	O
1	CD	O
%	NN	O
-2	CD	O
%	NN	O
of	IN	O
compound	NN	O
heterozygotes	NNS	O
to	TO	O
expression	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
distribution	NN	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
differ	VBP	O
,	,	O
C282Y	NN	O
being	VBG	O
limited	VBN	O
to	TO	O
those	DT	O
of	IN	O
northwestern	JJ	O
European	JJ	O
ancestry	NN	O
and	CC	O
H63D	NN	O
being	VBG	O
found	VBN	O
at	IN	O
allele	NN	O
frequencies	NNS	O
>	JJR	O
5	CD	O
%	NN	O
,	,	O
in	IN	O
Europe	NNP	O
,	,	O
in	IN	O
countries	NNS	O
bordering	VBG	O
the	DT	O
Mediterranean	NNP	O
,	,	O
in	IN	O
the	DT	O
Middle	NNP	O
East	NNP	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
Indian	JJ	O
subcontinent	NN	O
.	.	O

The	DT	O
C282Y	NN	O
mutation	NN	O
occurs	VBZ	O
on	IN	O
a	DT	O
haplotype	NN	O
that	WDT	O
extends	VBZ	O
<	JJR	O
/	:	O
=	JJ	O
6	CD	O
Mb	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
mutation	NN	O
has	VBZ	O
arisen	VBN	O
during	IN	O
the	DT	O
past	JJ	O
2	CD	O
,	,	O
000	CD	O
years	NNS	O
.	.	O

The	DT	O
H63D	NN	O
mutation	NN	O
is	VBZ	O
older	JJR	O
and	CC	O
does	VBZ	O
not	RB	O
occur	VB	O
on	IN	O
such	PDT	O
a	DT	O
large	JJ	O
extended	JJ	O
haplotype	NN	O
,	,	O
the	DT	O
haplotype	NN	O
in	IN	O
this	DT	O
case	NN	O
extending	VBG	O
<	JJR	O
/	:	O
=	JJ	O
700	CD	O
kb	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
finding	NN	O
of	IN	O
the	DT	O
H63D	NN	O
and	CC	O
C282Y	NN	O
mutations	NNS	O
on	IN	O
new	JJ	O
haplotypes	NNS	O
.	.	O

In	IN	O
Sri	NNP	O
Lanka	NNP	O
we	PRP	O
have	VBP	O
found	VBN	O
H63D	NN	O
on	IN	O
three	CD	O
new	JJ	O
haplotypes	NNS	O
and	CC	O
have	VBP	O
found	VBN	O
C282Y	NN	O
on	IN	O
one	CD	O
new	JJ	O
haplotype	NN	O
,	,	O
demonstrating	VBG	O
that	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
arisen	VBN	O
independently	RB	O
on	IN	O
this	DT	O
island	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
HFE	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
the	DT	O
subject	NN	O
of	IN	O
selection	NN	O
pressure	NN	O
.	.	O

These	DT	O
selection	NN	O
pressures	NNS	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
infectious	JJ	B-Disease
diseases	NNS	I-Disease
,	,	O
environmental	JJ	O
conditions	NNS	O
,	,	O
or	CC	O
other	JJ	O
genetic	JJ	B-Disease
disorders	NNS	I-Disease
such	JJ	O
as	IN	O
anemia	NN	B-Disease
.	.	O

Identification	NN	O
and	CC	O
localization	NN	O
of	IN	O
mutations	NNS	O
at	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
locus	NN	O
by	IN	O
ribonuclease	NN	O
A	NN	O
cleavage	NN	O
.	.	O

Many	JJ	O
mutations	NNS	O
leading	VBG	O
to	TO	O
human	JJ	O
disease	NN	O
are	VBP	O
the	DT	O
result	NN	O
of	IN	O
single	JJ	O
DNA	NN	O
base	NN	O
pair	NN	O
changes	NNS	O
that	WDT	O
can	MD	O
not	RB	O
be	VB	O
identified	VBN	O
by	IN	O
Southern	NN	O
analysis	NN	O
.	.	O

This	DT	O
has	VBZ	O
prompted	VBN	O
the	DT	O
development	NN	O
of	IN	O
alternative	JJ	O
assays	NNS	O
for	IN	O
point	NN	O
mutation	NN	O
detection	NN	O
.	.	O

The	DT	O
recently	RB	O
described	VBN	O
ribonuclease	NN	O
A	NN	O
cleavage	NN	O
procedure	NN	O
,	,	O
with	IN	O
a	DT	O
polyuridylic	JJ	O
acid-paper	NN	O
affinity	NN	O
chromatography	NN	O
step	NN	O
,	,	O
has	VBZ	O
been	VBN	O
used	VBN	O
to	TO	O
identify	VB	O
the	DT	O
mutational	JJ	O
lesions	NNS	O
in	IN	O
the	DT	O
hypoxanthine	NN	O
phosphoribosyltransferase	NN	O
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
messenger	NN	O
RNAs	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Distinctive	JJ	O
ribonuclease	NN	O
A	DT	O
cleavage	NN	O
patterns	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
messenger	NN	O
RNA	NN	O
from	IN	O
5	CD	O
of	IN	O
14	CD	O
Lesch-Nyhan	JJ	B-Disease
patients	NNS	O
who	WP	O
were	VBD	O
chosen	VBN	O
because	IN	O
no	DT	O
HPRT	NNP	O
Southern	NNP	O
or	CC	O
Northern	NN	O
blotting	NN	O
pattern	NN	O
changes	NNS	O
had	VBD	O
been	VBN	O
found	VBN	O
.	.	O

This	DT	O
approach	NN	O
now	RB	O
allows	VBZ	O
HPRT	NN	O
mutation	NN	O
detection	NN	O
in	IN	O
50	CD	O
percent	NN	O
of	IN	O
the	DT	O
cases	NNS	O
of	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
polyuridylic	JJ	O
acid-paper	NN	O
affinity	NN	O
procedure	NN	O
provides	VBZ	O
a	DT	O
general	JJ	O
method	NN	O
for	IN	O
analysis	NN	O
of	IN	O
low	JJ	O
abundance	NN	O
messenger	NN	O
RNAs	NNS	O
.	.	O

.	.	O

MEFV-Gene	NN	O
analysis	NN	O
in	IN	O
armenian	JJ	O
patients	NNS	O
with	IN	O
Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
:	:	O
diagnostic	JJ	O
value	NN	O
and	CC	O
unfavorable	JJ	O
renal	JJ	O
prognosis	NN	O
of	IN	O
the	DT	O
M694V	NN	O
homozygous	JJ	O
genotype-genetic	JJ	O
and	CC	O
therapeutic	JJ	O
implications	NNS	O
.	.	O

Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessively	RB	B-Disease
inherited	VBN	I-Disease
disorder	NN	I-Disease
that	WDT	O
is	VBZ	O
common	JJ	O
in	IN	O
patients	NNS	O
of	IN	O
Armenian	JJ	O
ancestry	NN	O
.	.	O

To	TO	O
date	NN	O
,	,	O
its	PRP$	O
diagnosis	NN	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
made	VBN	O
only	RB	O
retrospectively	RB	O
,	,	O
is	VBZ	O
one	CD	O
of	IN	O
exclusion	NN	O
,	,	O
based	VBN	O
entirely	RB	O
on	IN	O
nonspecific	JJ	O
clinical	JJ	O
signs	NNS	O
that	IN	O
result	VBP	O
from	IN	O
serosal	JJ	B-Disease
inflammation	NN	I-Disease
and	CC	O
that	DT	O
may	MD	O
lead	VB	O
to	TO	O
unnecessary	JJ	O
surgery	NN	O
.	.	O

Renal	JJ	B-Disease
amyloidosis	NN	I-Disease
,	,	O
prevented	VBN	O
by	IN	O
colchicine	NN	O
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
severe	JJ	O
complication	NN	O
of	IN	O
FMF	NN	B-Disease
,	,	O
a	DT	O
disorder	NN	O
associated	VBN	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
MEFV	NN	O
gene	NN	O
.	.	O

To	TO	O
evaluate	VB	O
the	DT	O
diagnostic	JJ	O
and	CC	O
prognostic	JJ	O
value	NN	O
of	IN	O
MEFV-gene	JJ	O
analysis	NN	O
,	,	O
we	PRP	O
investigated	VBD	O
90	CD	O
Armenian	JJ	O
FMF	NN	B-Disease
patients	NNS	O
from	IN	O
77	CD	O
unrelated	JJ	O
families	NNS	O
that	WDT	O
were	VBD	O
not	RB	O
selected	VBN	O
through	IN	O
genetic-linkage	NN	O
analysis	NN	O
.	.	O

Eight	CD	O
mutations	NNS	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
(	-LRB-	O
R408Q	NN	O
)	-RRB-	O
is	VBZ	O
new	JJ	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
account	VB	O
for	IN	O
93	CD	O
%	NN	O
of	IN	O
the	DT	O
163	CD	O
independent	JJ	O
FMF	NN	B-Disease
alleles	NNS	O
,	,	O
with	IN	O
both	DT	O
FMF	NN	B-Disease
alleles	NNS	O
identified	VBN	O
in	IN	O
89	CD	O
%	NN	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

In	IN	O
several	JJ	O
instances	NNS	O
,	,	O
family	NN	O
studies	NNS	O
provided	VBD	O
molecular	JJ	O
evidence	NN	O
for	IN	O
pseudodominant	JJ	O
transmission	NN	O
and	CC	O
incomplete	JJ	O
penetrance	NN	O
of	IN	O
the	DT	O
disease	NN	O
phenotype	NN	O
.	.	O

The	DT	O
M694V	NN	O
homozygous	JJ	O
genotype	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
higher	JJR	O
prevalence	NN	O
of	IN	O
renal	JJ	B-Disease
amyloidosis	NN	I-Disease
and	CC	O
arthritis	NN	B-Disease
,	,	O
compared	VBN	O
with	IN	O
other	JJ	O
genotypes	NNS	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

0002	NN	O
and	CC	O
P	NN	O
=	JJ	O
.	.	O

006	CD	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

The	DT	O
demonstration	NN	O
of	IN	O
both	CC	O
the	DT	O
diagnostic	JJ	O
and	CC	O
prognostic	JJ	O
value	NN	O
of	IN	O
MEFV	NN	O
analysis	NN	O
and	CC	O
particular	JJ	O
modes	NNS	O
of	IN	O
inheritance	NN	O
should	MD	O
lead	VB	O
to	TO	O
new	JJ	O
ways	NNS	O
for	IN	O
management	NN	O
of	IN	O
FMF-including	JJ	O
genetic	JJ	O
counseling	NN	O
and	CC	O
therapeutic	JJ	O
decisions	NNS	O
in	IN	O
affected	JJ	O
families	NNS	O
.	.	O

Identification	NN	O
and	CC	O
localization	NN	O
of	IN	O
huntingtin	NN	O
in	IN	O
brain	NN	O
and	CC	O
human	JJ	O
lymphoblastoid	JJ	O
cell	NN	O
lines	NNS	O
with	IN	O
anti-fusion	JJ	O
protein	NN	O
antibodies	NNS	O
.	.	O

The	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
phenotype	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
expansion	NN	O
of	IN	O
a	DT	O
trinucleotide	JJ	O
repeat	NN	O
in	IN	O
the	DT	O
IT15	NN	O
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
predicted	VBN	O
to	TO	O
encode	VB	O
a	DT	O
348-kDa	JJ	O
protein	NN	O
named	VBN	O
huntington	NN	O
.	.	O

We	PRP	O
used	VBD	O
polyclonal	JJ	O
and	CC	O
monoclonal	JJ	O
anti-fusion	JJ	O
protein	NN	O
antibodies	NNS	O
to	TO	O
identify	VB	O
native	JJ	O
huntingtin	NN	O
in	IN	O
rat	NN	O
,	,	O
monkey	NN	O
,	,	O
and	CC	O
human	JJ	O
.	.	O

Western	NN	O
blots	NNS	O
revealed	VBD	O
a	DT	O
protein	NN	O
with	IN	O
the	DT	O
expected	VBN	O
molecular	JJ	O
weight	NN	O
which	WDT	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
soluble	JJ	O
fraction	NN	O
of	IN	O
rat	NN	O
and	CC	O
monkey	NN	O
brain	NN	O
tissues	NNS	O
and	CC	O
lymphoblastoid	JJ	O
cells	NNS	O
from	IN	O
control	NN	O
cases	NNS	O
.	.	O

In	IN	O
lymphoblastoid	JJ	O
cell	NN	O
lines	NNS	O
from	IN	O
juvenile-onset	JJ	O
heterozygote	NN	O
HD	NN	B-Disease
cases	NNS	O
,	,	O
both	CC	O
normal	JJ	O
and	CC	O
mutant	JJ	O
huntingtin	NN	O
are	VBP	O
expressed	VBN	O
,	,	O
and	CC	O
increasing	VBG	O
repeat	NN	O
expansion	NN	O
leads	VBZ	O
to	TO	O
lower	JJR	O
levels	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
protein	NN	O
.	.	O

Immunocytochemistry	NN	O
indicates	VBZ	O
that	IN	O
huntingtin	NN	O
is	VBZ	O
located	JJ	O
in	IN	O
neurons	NNS	O
throughout	IN	O
the	DT	O
brain	NN	O
,	,	O
with	IN	O
the	DT	O
highest	JJS	O
levels	NNS	O
evident	JJ	O
in	IN	O
larger	JJR	O
neurons	NNS	O
.	.	O

In	IN	O
the	DT	O
human	JJ	O
striatum	NN	O
,	,	O
huntingtin	NN	O
is	VBZ	O
enriched	VBN	O
in	IN	O
a	DT	O
patch-like	JJ	O
distribution	NN	O
,	,	O
potentially	RB	O
corresponding	VBG	O
to	TO	O
the	DT	O
first	JJ	O
areas	NNS	O
affected	VBN	O
in	IN	O
HD	NN	B-Disease
.	.	O

Subcellular	JJ	O
localization	NN	O
of	IN	O
huntingtin	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
a	DT	O
cytosolic	JJ	O
protein	NN	O
primarily	RB	O
found	VBN	O
in	IN	O
somatodendritic	JJ	O
regions	NNS	O
.	.	O

Huntingtin	NN	O
appears	VBZ	O
to	TO	O
particularly	RB	O
associate	VB	O
with	IN	O
microtubules	NNS	O
,	,	O
although	IN	O
some	DT	O
is	VBZ	O
also	RB	O
associated	VBN	O
with	IN	O
synaptic	JJ	O
vesicles	NNS	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
localization	NN	O
of	IN	O
huntingtin	NN	O
in	IN	O
association	NN	O
with	IN	O
microtubules	NNS	O
,	,	O
we	PRP	O
speculate	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
impairs	VBZ	O
the	DT	O
cytoskeletal	JJ	O
anchoring	NN	O
or	CC	O
transport	NN	O
of	IN	O
mitochondria	NN	O
,	,	O
vesicles	NNS	O
,	,	O
or	CC	O
other	JJ	O
organelles	NNS	O
or	CC	O
molecules	NNS	O
.	.	O

.	.	O

Correlation	NN	O
between	IN	O
the	DT	O
location	NN	O
of	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B-Disease
polyps	NNS	I-Disease
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
patients	NNS	O
.	.	O

Recently	RB	O
we	PRP	O
have	VBP	O
isolated	VBN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
which	WDT	O
causes	VBZ	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
,	,	O
and	CC	O
its	PRP$	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
substantial	JJ	O
number	NN	O
of	IN	O
FAP	NN	B-Disease
patients	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
this	DT	O
information	NN	O
,	,	O
we	PRP	O
compared	VBD	O
the	DT	O
location	NN	O
of	IN	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
22	CD	O
unrelated	JJ	O
patients	NNS	O
(	-LRB-	O
12	CD	O
of	IN	O
whom	WP	O
have	VBP	O
been	VBN	O
reported	VBN	O
previously	RB	O
)	-RRB-	O
with	IN	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B-Disease
polyps	NNS	I-Disease
developed	VBN	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
;	:	O
17	CD	O
were	VBD	O
sparse	JJ	O
types	NNS	O
and	CC	O
five	CD	O
were	VBD	O
profuse	JJ	O
types	NNS	O
.	.	O

All	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
considered	VBN	O
to	TO	O
cause	VB	O
truncation	NN	O
of	IN	O
the	DT	O
gene	NN	O
product	NN	O
by	IN	O
frame-shift	NN	O
due	JJ	O
to	TO	O
deletion	NN	O
(	-LRB-	O
14	CD	O
cases	NNS	O
)	-RRB-	O
or	CC	O
nonsense	NN	O
mutation	NN	O
(	-LRB-	O
seven	CD	O
cases	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
location	NN	O
of	IN	O
the	DT	O
germ-line	NN	O
mutations	NNS	O
seems	VBZ	O
to	TO	O
correlate	VB	O
with	IN	O
the	DT	O
two	CD	O
clinical	JJ	O
types	NNS	O
;	:	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
five	CD	O
FAP	NN	B-Disease
patients	NNS	O
with	IN	O
profuse	JJ	O
polyps	NNS	B-Disease
were	VBD	O
observed	VBN	O
between	IN	O
codon	NN	O
1250	CD	O
and	CC	O
codon	NN	O
1464	CD	O
,	,	O
whereas	IN	O
mutations	NNS	O
in	IN	O
17	CD	O
FAP	NN	B-Disease
patients	NNS	O
with	IN	O
fewer	JJR	O
polyps	NNS	B-Disease
were	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
other	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

The	DT	O
result	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
number	NN	O
of	IN	O
colorectal	JJ	B-Disease
polyps	NNS	I-Disease
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
difference	NN	O
in	IN	O
the	DT	O
stability	NN	O
or	CC	O
biological	JJ	O
function	NN	O
of	IN	O
the	DT	O
truncated	VBN	O
APC	NN	B-Disease
protein	NN	O
.	.	O

.	.	O

Duchenne/Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
:	:	O
correlation	NN	O
of	IN	O
phenotype	NN	O
by	IN	O
electroretinography	NN	O
with	IN	O
sites	NNS	O
of	IN	O
dystrophin	NN	O
mutations	NNS	O
.	.	O

The	DT	O
dark-adapted	JJ	O
electroretinogram	NN	O
(	-LRB-	O
ERG	NN	O
)	-RRB-	O
of	IN	O
patients	NNS	O
with	IN	O
Duchenne	NN	B-Disease
and	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD/BMD	NN	O
)	-RRB-	O
shows	VBZ	O
a	DT	O
marked	JJ	O
reduction	NN	O
in	IN	O
b-wave	JJ	O
amplitude	NN	O
.	.	O

Genotype-phenotype	JJ	O
studies	NNS	O
of	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
DMD	NNP	B-Disease
show	VBP	O
position-specific	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
upon	IN	O
the	DT	O
phenotype	NN	O
mice	NNS	O
with	IN	O
5	CD	O
defects	NNS	O
of	IN	O
dystrophin	NN	O
have	VBP	O
normal	JJ	O
ERGs	NNS	O
,	,	O
those	DT	O
with	IN	O
defects	NNS	O
in	IN	O
the	DT	O
central	JJ	O
region	NN	O
have	VBP	O
a	DT	O
normal	JJ	O
b-wave	NN	O
amplitude	NN	O
associated	VBN	O
with	IN	O
prolonged	JJ	O
implicit	JJ	O
times	NNS	O
for	IN	O
both	CC	O
the	DT	O
b-wave	NN	O
and	CC	O
oscillatory	JJ	O
potentials	NNS	O
,	,	O
and	CC	O
mice	NNS	O
with	IN	O
3	CD	O
defects	NNS	O
have	VBP	O
a	DT	O
phenotype	NN	O
similar	JJ	O
to	TO	O
that	DT	O
seen	VBN	O
in	IN	O
DMD/BMD	NN	O
patients	NNS	O
.	.	O

The	DT	O
mouse	NN	O
studies	NNS	O
suggest	VBP	O
a	DT	O
key	JJ	O
role	NN	O
for	IN	O
the	DT	O
carboxyl	JJ	O
terminal	JJ	O
dystrophin	NN	O
isoform	NN	O
,	,	O
Dp260	NN	O
,	,	O
in	IN	O
retinal	JJ	O
electrophysiology	NN	O
.	.	O

We	PRP	O
have	VBP	O
undertaken	VBN	O
a	DT	O
systematic	JJ	O
evaluation	NN	O
of	IN	O
DMD/BMD	NN	O
patients	NNS	O
through	IN	O
clinical	JJ	O
examination	NN	O
and	CC	O
review	NN	O
of	IN	O
the	DT	O
literature	NN	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
position-specific	JJ	O
effects	NNS	O
of	IN	O
mutations	NNS	O
noted	VBN	O
in	IN	O
the	DT	O
mouse	NN	O
are	VBP	O
present	JJ	O
in	IN	O
man	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
,	,	O
in	IN	O
man	NN	O
,	,	O
a	DT	O
wider	JJR	O
variation	NN	O
of	IN	O
DMD	NN	B-Disease
defects	NNS	I-Disease
correlate	VBP	O
with	IN	O
reductions	NNS	O
in	IN	O
the	DT	O
b-wave	JJ	O
amplitude	NN	O
.	.	O

Individuals	NNS	O
with	IN	O
normal	JJ	O
ERGs	NNS	O
have	VBP	O
mutations	NNS	O
predominantly	RB	O
located	JJ	O
5	CD	O
of	IN	O
the	DT	O
transcript	NN	O
initiation	NN	O
site	NN	O
of	IN	O
Dp260	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
most	RBS	O
important	JJ	O
determinant	NN	O
in	IN	O
the	DT	O
ERG	NNP	O
b-wave	NN	O
phenotype	NN	O
is	VBZ	O
the	DT	O
mutation	NN	O
position	NN	O
,	,	O
rather	RB	O
than	IN	O
muscle	NN	B-Disease
disease	NN	I-Disease
severity	NN	O
.	.	O

Forty-six	CD	O
per	IN	O
cent	NN	O
of	IN	O
patients	NNS	O
with	IN	O
mutations	NNS	O
5	CD	O
of	IN	O
the	DT	O
Dp260	NN	O
transcript	NN	O
start	NN	O
site	NN	O
have	VBP	O
abnormal	JJ	O
ERGs	NNS	O
,	,	O
as	IN	O
opposed	VBN	O
to	TO	O
94	CD	O
%	NN	O
with	IN	O
more	JJR	O
distal	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
human	JJ	O
genotype-phenotype	NN	O
correlations	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
role	NN	O
for	IN	O
Dp260	NN	O
in	IN	O
normal	JJ	O
retinal	JJ	O
electrophysiology	NN	O
and	CC	O
may	MD	O
also	RB	O
reflect	VB	O
the	DT	O
expression	NN	O
of	IN	O
other	JJ	O
C-terminal	JJ	O
dystrophin	NN	O
isoforms	NNS	O
and	CC	O
their	PRP$	O
contributions	NNS	O
to	TO	O
retinal	JJ	O
signal	NN	O
transmission	NN	O
.	.	O

.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	NN	B-Disease
mutations	NNS	O
and	CC	O
one	CD	O
polymorphism	NN	O
:	:	O
implications	NNS	O
for	IN	O
structure-function	JJ	O
analysis	NN	O
of	IN	O
human	JJ	O
galactose-1-phosphate	NN	O
uridyltransferase	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	NN	B-Disease
mutations	NNS	O
,	,	O
L74P	NN	O
and	CC	O
F171S	NN	O
,	,	O
and	CC	O
one	CD	O
polymorphism	NN	O
,	,	O
S135L	NN	O
,	,	O
in	IN	O
human	JJ	O
galactose-1-phosphate	NN	O
uridyltransferase	NN	O
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
.	.	O

Both	DT	O
galactosemia	NN	B-Disease
mutations	NNS	O
result	VBP	O
in	IN	O
reduced	VBN	O
enzymatic	JJ	O
activity	NN	O
when	WRB	O
reconstructed	VBN	O
in	IN	O
the	DT	O
cDNA	NN	O
and	CC	O
overexpressed	VBN	O
.	.	O

The	DT	O
polymorphism	NN	O
,	,	O
in	IN	O
contrast	NN	O
,	,	O
has	VBZ	O
near	IN	O
normal	JJ	O
activity	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
affect	VBP	O
evolutionarily	RB	O
conserved	VBN	O
residues	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
they	PRP	O
are	VBP	O
functionally	RB	O
important	JJ	O
,	,	O
while	IN	O
the	DT	O
polymorphism	NN	O
occurs	VBZ	O
in	IN	O
a	DT	O
nonconserved	JJ	O
domain	NN	O
which	WDT	O
is	VBZ	O
presumably	RB	O
not	RB	O
critical	JJ	O
for	IN	O
enzymatic	JJ	O
function	NN	O
.	.	O

The	DT	O
F171S	NN	O
mutation	NN	O
is	VBZ	O
close	JJ	O
to	TO	O
the	DT	O
putative	JJ	O
active-site	NN	O
nucleophile	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
further	RB	O
support	VBP	O
the	DT	O
notion	NN	O
of	IN	O
molecular	JJ	O
heterogeneity	NN	O
of	IN	O
galactosemia	NN	B-Disease
and	CC	O
suggest	VBP	O
that	IN	O
galactosemia	NN	B-Disease
mutations	NNS	O
and	CC	O
GALT	NNP	O
polymorphisms	NNS	O
may	MD	O
be	VB	O
useful	JJ	O
tools	NNS	O
in	IN	O
highlighting	VBG	O
different	JJ	O
functional	JJ	O
domains	NNS	O
in	IN	O
human	JJ	O
GALT	NNP	O
.	.	O

.	.	O

Gaucher	NN	B-Disease
disease	NN	I-Disease
:	:	O
the	DT	O
origins	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
N370S	NN	O
and	CC	O
84GG	NN	O
acid	NN	O
beta-glucosidase	NN	O
mutations	NNS	O
.	.	O

Type	NN	O
1	CD	O
Gaucher	NN	B-Disease
disease	NN	I-Disease
(	-LRB-	O
GD	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
non-neuronopathic	JJ	O
lysosomal	JJ	B-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
,	,	O
results	VBZ	O
from	IN	O
the	DT	O
deficient	JJ	O
activity	NN	O
of	IN	O
acid	NN	O
beta-glucosidase	NN	O
(	-LRB-	O
GBA	NN	O
)	-RRB-	O
.	.	O

Type	NN	O
1	CD	O
disease	NN	O
is	VBZ	O
panethnic	JJ	O
but	CC	O
is	VBZ	O
more	RBR	O
prevalent	JJ	O
in	IN	O
individuals	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
(	-LRB-	O
AJ	NNP	O
)	-RRB-	O
descent	NN	O
.	.	O

Of	IN	O
the	DT	O
causative	JJ	O
GBA	NN	O
mutations	NNS	O
,	,	O
N370S	NN	O
is	VBZ	O
particularly	RB	O
frequent	JJ	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
,	,	O
(	-LRB-	O
q	JJ	O
approximately	RB	O
.	.	O

03	NN	O
)	-RRB-	O
,	,	O
whereas	IN	O
the	DT	O
84GG	NN	O
insertion	NN	O
(	-LRB-	O
q	NN	O
approximately	RB	O
.	.	O

003	CD	O
)	-RRB-	O
occurs	VBZ	O
exclusively	RB	O
in	IN	O
the	DT	O
Ashkenazim	NNP	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
genetic	JJ	O
history	NN	O
of	IN	O
these	DT	O
mutations	NNS	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
,	,	O
short	JJ	O
tandem	JJ	O
repeat	NN	O
(	-LRB-	O
STR	NN	O
)	-RRB-	O
markers	NNS	O
were	VBD	O
used	VBN	O
to	TO	O
map	VB	O
a	DT	O
9	CD	O
.	.	O

3-cM	JJ	O
region	NN	O
containing	VBG	O
the	DT	O
GBA	NN	O
locus	NN	O
and	CC	O
to	TO	O
genotype	NN	O
261	CD	O
AJ	NN	O
N370S	NN	O
chromosomes	NNS	O
,	,	O
60	CD	O
European	JJ	O
non-Jewish	JJ	O
N370S	NN	O
chromosomes	NNS	O
,	,	O
and	CC	O
62	CD	O
AJ	NN	O
84GG	NN	O
chromosomes	NNS	O
.	.	O

A	DT	O
highly	RB	O
conserved	VBN	O
haplotype	NN	O
at	IN	O
four	CD	O
markers	NNS	O
flanking	JJ	O
GBA	NN	O
(	-LRB-	O
PKLR	NN	O
,	,	O
D1S1595	NN	O
,	,	O
D1S2721	NN	O
,	,	O
and	CC	O
D1S2777	NN	O
)	-RRB-	O
was	VBD	O
observed	VBN	O
on	IN	O
both	CC	O
the	DT	O
AJ	NN	O
chromosomes	NNS	O
and	CC	O
the	DT	O
non-Jewish	JJ	O
N370S	NN	O
chromosomes	NNS	O
,	,	O
suggesting	VBG	O
the	DT	O
occurrence	NN	O
of	IN	O
a	DT	O
founder	NN	O
common	JJ	O
to	TO	O
both	DT	O
populations	NNS	O
.	.	O

Of	IN	O
note	NN	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
different	JJ	O
divergent	JJ	O
haplotypes	NNS	O
suggested	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
de	FW	O
novo	FW	O
,	,	O
recurrent	JJ	O
N370S	NN	O
mutations	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
different	JJ	O
conserved	VBN	O
haplotype	NN	O
at	IN	O
these	DT	O
markers	NNS	O
was	VBD	O
identified	VBN	O
on	IN	O
the	DT	O
84GG	NN	O
chromosomes	NNS	O
,	,	O
which	WDT	O
was	VBD	O
unique	JJ	O
to	TO	O
the	DT	O
AJ	NNP	O
population	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
linkage	NN	O
disequilibrium	NN	O
(	-LRB-	O
LD	NN	O
)	-RRB-	O
delta	NN	O
values	NNS	O
,	,	O
the	DT	O
non-Jewish	JJ	O
European	JJ	O
N370S	NN	O
chromosomes	NNS	O
had	VBD	O
greater	JJR	O
haplotype	NN	O
diversity	NN	O
and	CC	O
less	JJR	O
LD	NN	O
at	IN	O
the	DT	O
markers	NNS	O
flanking	VBG	O
the	DT	O
conserved	VBN	O
haplotype	NN	O
than	IN	O
did	VBD	O
the	DT	O
AJ	NNP	O
N370S	NN	O
chromosomes	NNS	O
.	.	O

This	DT	O
finding	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
N370S	NN	O
mutation	NN	O
in	IN	O
the	DT	O
non-Jewish	JJ	O
European	JJ	O
population	NN	O
prior	RB	O
to	TO	O
the	DT	O
founding	NN	O
of	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
.	.	O

Coalescence	NN	O
analyses	NNS	O
for	IN	O
the	DT	O
N370S	NN	O
and	CC	O
84GG	NN	O
mutations	NNS	O
estimated	VBD	O
similar	JJ	O
coalescence	NN	O
times	NNS	O
,	,	O
of	IN	O
48	CD	O
and	CC	O
55.5	CD	O
generations	NNS	O
ago	RB	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
these	DT	O
studies	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
significant	JJ	O
bottleneck	NN	O
occurring	VBG	O
in	IN	O
the	DT	O
AJ	NNP	O
population	NN	O
during	IN	O
the	DT	O
first	JJ	O
millennium	NNP	O
,	,	O
when	WRB	O
the	DT	O
population	NN	O
became	VBD	O
established	VBN	O
in	IN	O
Europe	NNP	O
.	.	O

Investigation	NN	O
of	IN	O
thermoregulatory	JJ	O
characteristics	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
survey	NN	O
instrument	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
assess	VB	O
temperature	NN	O
regulation	NN	O
characteristics	NNS	O
in	IN	O
children	NNS	O
with	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
compared	VBN	O
to	TO	O
3	CD	O
control	NN	O
groups	NNS	O
sibs	NNS	O
of	IN	O
PWS	NN	B-Disease
patients	NNS	O
(	-LRB-	O
SIB	NN	O
)	-RRB-	O
,	,	O
neurodevelopmentally	RB	B-Disease
handicapped	JJ	I-Disease
children	NNS	O
(	-LRB-	O
ND	NN	O
)	-RRB-	O
,	,	O
and	CC	O
age	NN	O
and	CC	O
gender	NN	O
matched	VBD	O
well	RB	O
children	NNS	O
(	-LRB-	O
WC	NN	O
)	-RRB-	O
.	.	O

Significant	JJ	O
differences	NNS	O
were	VBD	O
found	VBN	O
between	IN	O
PWS	NN	B-Disease
patients	NNS	O
,	,	O
SIB	NN	O
controls	NNS	O
,	,	O
and	CC	O
WC	NN	O
controls	NNS	O
in	IN	O
the	DT	O
prevalence	NN	O
of	IN	O
febrile	JJ	O
convulsions	NNS	O
,	,	O
fever-associated	JJ	O
symptoms	NNS	O
,	,	O
and	CC	O
temperature	NN	O
less	JJR	O
than	IN	O
94	CD	O
degrees	NNS	O
F.	NNP	O
No	NNP	O
differences	NNS	O
were	VBD	O
noted	VBN	O
in	IN	O
any	DT	O
variable	JJ	O
between	IN	O
the	DT	O
PWS	NN	B-Disease
patients	NNS	O
and	CC	O
the	DT	O
ND	NN	O
controls	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
abnormalities	NNS	O
are	VBP	O
not	RB	O
unique	JJ	O
to	TO	O
PWS	NNP	B-Disease
,	,	O
but	CC	O
can	MD	O
occur	VB	O
in	IN	O
any	DT	O
neurodevelopmentally	RB	B-Disease
handicapped	JJ	I-Disease
individual	NN	O
,	,	O
further	JJ	O
suggesting	VBG	O
these	DT	O
do	VBP	O
not	RB	O
necessarily	RB	O
reflect	VB	O
syndrome-specific	JJ	O
hypothalamic	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

.	.	O

Abnormal	JJ	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
in	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
.	.	O

The	DT	O
plasma	NN	O
lipoprotein	NN	O
profiles	NNS	O
and	CC	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
(	-LRB-	O
HDL	NN	O
)	-RRB-	O
were	VBD	O
characterized	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
genetic	JJ	B-Disease
disease	NN	I-Disease
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
.	.	O

Abnormalities	NNS	B-Disease
in	IN	I-Disease
the	DT	I-Disease
HDL	NN	I-Disease
may	MD	O
contribute	VB	O
to	TO	O
their	PRP$	O
increased	VBN	O
atherogenesis	NN	O
and	CC	O
excessive	JJ	O
deposits	NNS	O
of	IN	O
tissue	NN	O
sterols	NNS	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
low	JJ	O
or	CC	O
low-normal	JJ	O
concentrations	NNS	O
of	IN	O
plasma	NN	O
cholesterol	NN	O
(	-LRB-	O
165	CD	O
+	CC	O
/	:	O
-	:	O
25	CD	O
mg/dl	NN	O
)	-RRB-	O
and	CC	O
low	JJ	O
density	NN	O
lipoproteins	NNS	O
(	-LRB-	O
LDL	NN	O
)	-RRB-	O
.	.	O

The	DT	O
mean	NN	O
HDL-cholesterol	NN	O
concentration	NN	O
in	IN	O
the	DT	O
CTX	NNP	B-Disease
plasmas	NNS	O
was	VBD	O
14	CD	O
.	.	O

5	CD	O
+	CC	O
/	:	O
-	:	O
3	CD	O
.	.	O

2	CD	O
mg/dl	NN	O
,	,	O
about	IN	O
one-third	NN	O
the	DT	O
normal	JJ	O
value	NN	O
.	.	O

The	DT	O
low	JJ	O
HDL-cholesterol	NN	O
reflects	VBZ	O
a	DT	O
low	JJ	O
concentration	NN	O
and	CC	O
an	DT	O
abnormal	JJ	O
lipid	NN	O
composition	NN	O
of	IN	O
the	DT	O
plasma	NN	O
HDL	NN	O
.	.	O

Relative	JJ	O
to	TO	O
normal	JJ	O
HDL	NN	O
,	,	O
the	DT	O
cholesteryl	NN	O
esters	NNS	O
are	VBP	O
low	JJ	O
,	,	O
free	JJ	O
cholesterol	NN	O
and	CC	O
phospholipids	NNS	O
essentially	RB	O
normal	JJ	O
,	,	O
and	CC	O
triglycerides	NNS	O
increased	VBN	O
.	.	O

The	DT	O
ratio	NN	O
of	IN	O
apoprotein	NN	O
(	-LRB-	O
apo	NN	O
)	-RRB-	O
to	TO	O
total	JJ	O
cholesterol	NN	O
in	IN	O
the	DT	O
HDL	NN	O
of	IN	O
CTX	NNP	B-Disease
was	VBD	O
two	CD	O
to	TO	O
three	CD	O
times	NNS	O
greater	JJR	O
than	IN	O
normal	JJ	O
.	.	O

In	IN	O
the	DT	O
CTX	NNP	B-Disease
HDL	NNP	O
,	,	O
the	DT	O
ratio	NN	O
of	IN	O
apoAI	NN	O
to	TO	O
apoAII	NN	O
was	VBD	O
high	JJ	O
,	,	O
the	DT	O
proportion	NN	O
of	IN	O
apoC	NN	O
low	JJ	O
,	,	O
and	CC	O
a	DT	O
normally	RB	O
minor	JJ	O
form	NN	O
of	IN	O
apoAI	NN	O
increased	VBD	O
relative	JJ	O
to	TO	O
other	JJ	O
forms	NNS	O
.	.	O

The	DT	O
HDL	NN	O
in	IN	O
electron	NN	O
micrographs	NNS	O
appeared	VBD	O
normal	JJ	O
morphologically	RB	O
and	CC	O
in	IN	O
particle	NN	O
size	NN	O
.	.	O

The	DT	O
abnormalities	NNS	O
in	IN	O
lipoprotein	NN	O
distribution	NN	O
profile	NN	O
and	CC	O
composition	NN	O
of	IN	O
the	DT	O
plasma	NN	O
HDL	NN	O
result	VBP	O
from	IN	O
metabolic	JJ	O
defects	NNS	O
that	WDT	O
are	VBP	O
not	RB	O
understood	VBN	O
but	CC	O
may	MD	O
be	VB	O
linked	VBN	O
to	TO	O
the	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
bile	NN	O
acid	NN	O
synthesis	NN	O
in	IN	O
CTX	NNP	B-Disease
.	.	O

As	IN	O
a	DT	O
consequence	NN	O
,	,	O
it	PRP	O
is	VBZ	O
probable	JJ	O
that	IN	O
the	DT	O
normal	JJ	O
functions	NNS	O
of	IN	O
the	DT	O
HDL	NNP	O
,	,	O
possibly	RB	O
including	VBG	O
modulation	NN	O
of	IN	O
LDL-cholesterol	NN	O
uptake	NN	O
and	CC	O
the	DT	O
removal	NN	O
of	IN	O
excess	JJ	O
cholesterol	NN	O
from	IN	O
peripheral	JJ	O
tissues	NNS	O
,	,	O
are	VBP	O
perturbed	VBN	O
significantly	RB	O
in	IN	O
this	DT	O
disease	NN	O
.	.	O

Splicing	VBG	O
defects	NNS	O
in	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
gene	NN	O
,	,	O
ATM	NNP	O
:	:	O
underlying	VBG	O
mutations	NNS	O
and	CC	O
consequences	NNS	O
.	.	O

Mutations	NNS	O
resulting	VBG	O
in	IN	O
defective	JJ	O
splicing	NN	O
constitute	VBP	O
a	DT	O
significant	JJ	O
proportion	NN	O
(	-LRB-	O
30/62	CD	O
[	-LRB-	O
48	CD	O
%	NN	O
]	-RRB-	O
)	-RRB-	O
of	IN	O
a	DT	O
new	JJ	O
series	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
AT	IN	B-Disease
)	-RRB-	O
that	WDT	O
were	VBD	O
detected	VBN	O
by	IN	O
the	DT	O
protein-truncation	JJ	O
assay	NN	O
followed	VBN	O
by	IN	O
sequence	NN	O
analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
.	.	O

Fewer	JJR	O
than	IN	O
half	NN	O
of	IN	O
the	DT	O
splicing	NN	O
mutations	NNS	O
involved	VBD	O
the	DT	O
canonical	JJ	O
AG	NNP	O
splice-acceptor	NN	O
site	NN	O
or	CC	O
GT	NN	O
splice-donor	NN	O
site	NN	O
.	.	O

A	DT	O
higher	JJR	O
percentage	NN	O
of	IN	O
mutations	NNS	O
occurred	VBD	O
at	IN	O
less	JJR	O
stringently	RB	O
conserved	VBN	O
sites	NNS	O
,	,	O
including	VBG	O
silent	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
last	JJ	O
nucleotide	NN	O
of	IN	O
exons	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
nucleotides	NNS	O
other	JJ	O
than	IN	O
the	DT	O
conserved	VBN	O
AG	NNP	O
and	CC	O
GT	NN	O
in	IN	O
the	DT	O
consensus	NN	O
splice	NN	O
sites	NNS	O
,	,	O
and	CC	O
creation	NN	O
of	IN	O
splice-acceptor	NN	O
or	CC	O
splice-donor	NN	O
sites	NNS	O
in	IN	O
either	CC	O
introns	NNS	O
or	CC	O
exons	NNS	O
.	.	O

These	DT	O
splicing	NN	O
mutations	NNS	O
led	VBD	O
to	TO	O
a	DT	O
variety	NN	O
of	IN	O
consequences	NNS	O
,	,	O
including	VBG	O
exon	NN	O
skipping	VBG	O
and	CC	O
,	,	O
to	TO	O
a	DT	O
lesser	JJR	O
degree	NN	O
,	,	O
intron	NN	O
retention	NN	O
,	,	O
activation	NN	O
of	IN	O
cryptic	JJ	O
splice	NN	O
sites	NNS	O
,	,	O
or	CC	O
creation	NN	O
of	IN	O
new	JJ	O
splice	NN	O
sites	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
5	CD	O
of	IN	O
12	CD	O
nonsense	NN	O
mutations	NNS	O
and	CC	O
1	CD	O
missense	NN	O
mutation	NN	O
were	VBD	O
associated	VBN	O
with	IN	O
deletion	NN	O
in	IN	O
the	DT	O
cDNA	NN	O
of	IN	O
the	DT	O
exons	NNS	O
in	IN	O
which	WDT	O
the	DT	O
mutations	NNS	O
occurred	VBD	O
.	.	O

No	DT	O
ATM	NNP	O
protein	NN	O
was	VBD	O
detected	VBN	O
by	IN	O
western	NN	O
blotting	NN	O
in	IN	O
any	DT	O
AT	IN	B-Disease
cell	NN	O
line	NN	O
in	IN	O
which	WDT	O
splicing	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Several	JJ	O
cases	NNS	O
of	IN	O
exon	NN	O
skipping	VBG	O
in	IN	O
both	CC	O
normal	JJ	O
controls	NNS	O
and	CC	O
patients	NNS	O
for	IN	O
whom	WP	O
no	DT	O
underlying	VBG	O
defect	NN	O
could	MD	O
be	VB	O
found	VBN	O
in	IN	O
genomic	JJ	O
DNA	NN	O
were	VBD	O
also	RB	O
observed	VBN	O
,	,	O
suggesting	VBG	O
caution	NN	O
in	IN	O
the	DT	O
interpretation	NN	O
of	IN	O
exon	NN	O
deletions	NNS	O
observed	VBN	O
in	IN	O
ATM	NNP	O
cDNA	NN	O
when	WRB	O
there	EX	O
is	VBZ	O
no	DT	O
accompanying	VBG	O
identification	NN	O
of	IN	O
genomic	JJ	O
mutations	NNS	O
.	.	O

.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
cathepsin	NN	O
C	NN	O
gene	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
Papillon-Lefevre	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Papillon-Lefevre	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PLS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterised	VBN	O
by	IN	O
palmoplantar	NN	B-Disease
hyperkeratosis	NN	I-Disease
and	CC	O
severe	JJ	O
early	JJ	O
onset	NN	O
periodontitis	NN	B-Disease
that	WDT	O
results	VBZ	O
in	IN	O
the	DT	O
premature	JJ	O
loss	NN	O
of	IN	O
the	DT	O
primary	JJ	O
and	CC	O
secondary	JJ	O
dentitions	NNS	O
.	.	O

A	DT	O
major	JJ	O
gene	NN	O
locus	NN	O
for	IN	O
PLS	NN	B-Disease
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
a	DT	O
2	CD	O
.	.	O

8	CD	O
cM	NN	O
interval	NN	O
on	IN	O
chromosome	NN	O
11q14	NN	O
.	.	O

Correlation	NN	O
of	IN	O
physical	JJ	O
and	CC	O
genetic	JJ	O
maps	NNS	O
of	IN	O
this	DT	O
interval	NN	O
indicate	VBP	O
it	PRP	O
includes	VBZ	O
at	IN	O
least	JJS	O
40	CD	O
ESTs	NNS	O
and	CC	O
six	CD	O
known	JJ	O
genes	NNS	O
including	VBG	O
the	DT	O
lysosomal	JJ	O
protease	NN	O
cathepsin	NN	O
C	NN	O
gene	NN	O
(	-LRB-	O
CTSC	NN	O
)	-RRB-	O
.	.	O

The	DT	O
CTSC	NN	O
message	NN	O
is	VBZ	O
expressed	VBN	O
at	IN	O
high	JJ	O
levels	NNS	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
immune	JJ	O
cells	NNS	O
including	VBG	O
polymorphonuclear	JJ	O
leucocytes	NNS	O
,	,	O
macrophages	NNS	O
,	,	O
and	CC	O
their	PRP$	O
precursors	NNS	O
.	.	O

By	IN	O
RT-PCR	NN	O
,	,	O
we	PRP	O
found	VBD	O
CTSC	NNP	O
is	VBZ	O
also	RB	O
expressed	VBN	O
in	IN	O
epithelial	JJ	O
regions	NNS	O
commonly	RB	O
affected	VBN	O
by	IN	O
PLS	NN	B-Disease
,	,	O
including	VBG	O
the	DT	O
palms	NNS	O
,	,	O
soles	NNS	O
,	,	O
knees	NNS	O
,	,	O
and	CC	O
oral	JJ	O
keratinised	JJ	O
gingiva	NN	O
.	.	O

The	DT	O
4	CD	O
.	.	O

7	CD	O
kb	NN	O
CTSC	NN	O
gene	NN	O
consists	VBZ	O
of	IN	O
two	CD	O
exons	NNS	O
.	.	O

Sequence	NN	O
analysis	NN	O
of	IN	O
CTSC	NN	O
from	IN	O
subjects	NNS	O
affected	VBN	O
with	IN	O
PLS	NN	B-Disease
from	IN	O
five	CD	O
consanguineous	JJ	O
Turkish	JJ	O
families	NNS	O
identified	VBD	O
four	CD	O
different	JJ	O
mutations	NNS	O
.	.	O

An	DT	O
exon	NN	O
1	CD	O
nonsense	NN	O
mutation	NN	O
(	-LRB-	O
856C	NN	O
--	:	O
>	JJR	O
T	NN	O
)	-RRB-	O
introduces	VBZ	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
286	CD	O
.	.	O

Three	CD	O
exon	NN	O
2	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
including	VBG	O
a	DT	O
single	JJ	O
nucleotide	NN	O
deletion	NN	O
(	-LRB-	O
2692delA	NN	O
)	-RRB-	O
of	IN	O
codon	NN	O
349	CD	O
introducing	VBG	O
a	DT	O
frameshift	NN	O
and	CC	O
premature	JJ	O
termination	NN	O
codon	NN	O
,	,	O
a	DT	O
2	CD	O
bp	NN	O
deletion	NN	O
(	-LRB-	O
2673-2674delCT	NN	O
)	-RRB-	O
that	WDT	O
results	VBZ	O
in	IN	O
introduction	NN	O
of	IN	O
a	DT	O
stop	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
343	CD	O
,	,	O
and	CC	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
substitution	NN	O
in	IN	O
codon	NN	O
429	CD	O
(	-LRB-	O
2931G	NN	O
--	:	O
>	JJR	O
A	NN	O
)	-RRB-	O
introducing	VBG	O
a	DT	O
premature	JJ	O
termination	NN	O
codon	NN	O
.	.	O

All	DT	O
PLS	NN	B-Disease
patients	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
cathepsin	NN	O
C	NN	O
mutations	NNS	O
inherited	VBN	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

Parents	NNS	O
and	CC	O
sibs	NNS	O
heterozygous	JJ	O
for	IN	O
cathepsin	NN	O
C	NN	O
mutations	NNS	O
do	VBP	O
not	RB	O
show	VB	O
either	CC	O
the	DT	O
palmoplantar	NN	B-Disease
hyperkeratosis	NN	I-Disease
or	CC	O
severe	JJ	O
early	JJ	O
onset	NN	O
periodontitis	NN	B-Disease
characteristic	NN	O
of	IN	O
PLS	NN	B-Disease
.	.	O

A	DT	O
more	JJR	O
complete	JJ	O
understanding	NN	O
of	IN	O
the	DT	O
functional	JJ	O
physiology	NN	O
of	IN	O
cathepsin	NN	O
C	NN	O
carries	VBZ	O
significant	JJ	O
implications	NNS	O
for	IN	O
understanding	VBG	O
normal	JJ	O
and	CC	O
abnormal	JJ	O
skin	NN	O
development	NN	O
and	CC	O
periodontal	JJ	B-Disease
disease	NN	I-Disease
susceptibility	NN	O

Identification	NN	O
of	IN	O
a	DT	O
single	JJ	O
nucleotide	NN	O
change	NN	O
in	IN	O
the	DT	O
hypoxanthine-guanine	JJ	O
phosphoribosyltransferase	NN	O
gene	NN	O
(	-LRB-	O
HPRTYale	NN	O
)	-RRB-	O
responsible	JJ	O
for	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Complete	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
hypoxanthine-guanine	JJ	I-Disease
phosphoribosyltransferase	NN	I-Disease
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
causes	VBZ	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Previous	JJ	O
characterization	NN	O
of	IN	O
a	DT	O
mutant	JJ	O
form	NN	O
of	IN	O
HPRT	NNP	O
,	,	O
HPRTYale	NN	O
,	,	O
from	IN	O
a	DT	O
subject	JJ	O
with	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
revealed	VBD	O
normal	JJ	O
mRNA	NN	O
and	CC	O
protein	NN	O
concentrations	NNS	O
,	,	O
no	DT	O
residual	JJ	O
catalytic	JJ	O
activity	NN	O
,	,	O
and	CC	O
cathodal	JJ	O
migration	NN	O
upon	IN	O
PAGE	NN	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
HPRTYale	NN	O
cDNA	NN	O
.	.	O

The	DT	O
nucleotide	NN	O
sequence	NN	O
of	IN	O
full-length	JJ	O
HPRTYale	NN	O
cDNA	NN	O
revealed	VBD	O
a	DT	O
single	JJ	O
nucleotide	NN	O
substitution	NN	O
compared	VBN	O
with	IN	O
normal	JJ	O
HPRT	NN	O
cDNA	NN	O
G	NN	O
----	:	O
C	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
211	CD	O
.	.	O

This	DT	O
transversion	NN	O
predicts	VBZ	O
substitution	NN	O
of	IN	O
arginine	NN	O
for	IN	O
glycine	NN	O
at	IN	O
amino	NN	O
acid	NN	O
position	NN	O
71	CD	O
,	,	O
explaining	VBG	O
the	DT	O
cathodal	JJ	O
migration	NN	O
of	IN	O
HPRTYale	NN	O
.	.	O

Chou-Fasman	NNP	O
secondary	JJ	O
structure	NN	O
analysis	NN	O
predicts	VBZ	O
a	DT	O
change	NN	O
in	IN	O
the	DT	O
probability	NN	O
of	IN	O
beta-turn	JJ	O
formation	NN	O
in	IN	O
the	DT	O
region	NN	O
containing	VBG	O
the	DT	O
mutation	NN	O
.	.	O

Inclusion	NN	O
of	IN	O
the	DT	O
bulky	JJ	O
arginine	NN	O
side	NN	O
chain	NN	O
in	IN	O
place	NN	O
of	IN	O
glycine	NN	O
probably	RB	O
disrupts	VBZ	O
protein	NN	O
folding	JJ	O
as	RB	O
well	RB	O
.	.	O

Cloning	NN	O
mutant	JJ	O
forms	NNS	O
of	IN	O
cDNA	NN	O
allows	VBZ	O
identification	NN	O
of	IN	O
specific	JJ	O
mutations	NNS	O
,	,	O
provides	VBZ	O
insight	NN	O
into	IN	O
mutational	JJ	O
mechanisms	NNS	O
,	,	O
and	CC	O
facilitates	VBZ	O
structure-function	JJ	O
analysis	NN	O
of	IN	O
mutant	JJ	O
proteins	NNS	O
.	.	O

.	.	O

Molecular	JJ	O
detection	NN	O
of	IN	O
chromosomal	JJ	O
translocations	NNS	O
that	WDT	O
disrupt	VBP	O
the	DT	O
putative	JJ	O
retinoblastoma	NN	B-Disease
susceptibility	NN	O
locus	NN	O
.	.	O

A	DT	O
candidate	NN	O
DNA	NN	O
sequence	NN	O
with	IN	O
many	JJ	O
of	IN	O
the	DT	O
properties	NNS	O
predicted	VBN	O
for	IN	O
the	DT	O
retinoblastoma	NN	B-Disease
susceptibility	NN	O
(	-LRB-	O
RB1	NN	O
)	-RRB-	O
locus	NN	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
(	-LRB-	O
S.	NNP	O
H.	NNP	O
Friend	NN	O
,	,	O
R.	NNP	O
Bernards	NNP	O
,	,	O
S.	NNP	O
Rogelj	NNP	O
,	,	O
R.	NNP	O
A.	NNP	O
Weinberg	NNP	O
,	,	O
J.	NNP	O
M.	NNP	O
Rapaport	NNP	O
,	,	O
D.	NNP	O
M.	NNP	O
Albert	NNP	O
,	,	O
and	CC	O
T.	NNP	O
P.	NNP	O
Dryja	NNP	O
,	,	O
Nature	NNP	O
[	-LRB-	O
London	NNP	O
]	-RRB-	O
323	CD	O
643-645	CD	O
,	,	O
1986	CD	O
)	-RRB-	O
.	.	O

The	DT	O
large	JJ	O
size	NN	O
of	IN	O
this	DT	O
gene	NN	O
(	-LRB-	O
ca.	FW	O
200	CD	O
kilobases	NNS	O
[	-LRB-	O
kb	NN	O
]	-RRB-	O
)	-RRB-	O
and	CC	O
its	PRP$	O
multiple	JJ	O
dispersed	JJ	O
exons	NNS	O
(	-LRB-	O
Wiggs	NNP	O
et	FW	O
al.	FW	O
,	,	O
N.	NNP	O
Engl	NNP	O
.	.	O

J.	NNP	O
Med	NNP	O
.	.	O

318	CD	O
151-157	CD	O
,	,	O
1988	CD	O
)	-RRB-	O
complicate	VBP	O
molecular	JJ	O
screening	NN	O
strategies	NNS	O
important	JJ	O
in	IN	O
prenatal	JJ	O
and	CC	O
presymptomatic	JJ	O
diagnosis	NN	O
and	CC	O
in	IN	O
carrier	NN	O
detection	NN	O
.	.	O

Here	RB	O
we	PRP	O
used	VBD	O
field	NN	O
inversion	NN	O
gel	NN	O
electrophoresis	NN	O
(	-LRB-	O
FIGE	NN	O
)	-RRB-	O
to	TO	O
construct	VB	O
a	DT	O
restriction	NN	O
map	NN	O
of	IN	O
approximately	RB	O
1	CD	O
,	,	O
000	CD	O
kb	NN	O
of	IN	O
DNA	NN	O
surrounding	VBG	O
the	DT	O
RB1	NN	O
locus	NN	O
and	CC	O
to	TO	O
detect	VB	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
in	IN	O
three	CD	O
retinoblastoma	NN	B-Disease
patients	NNS	O
.	.	O

DNA	NN	O
probes	NNS	O
from	IN	O
either	CC	O
the	DT	O
5	CD	O
or	CC	O
3	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
were	VBD	O
used	VBN	O
to	TO	O
detect	VB	O
a	DT	O
250-kb	JJ	O
EagI	NN	O
restriction	NN	O
fragment	NN	O
in	IN	O
DNA	NN	O
from	IN	O
unaffected	JJ	O
individuals	NNS	O
.	.	O

Both	DT	O
probes	NNS	O
identified	VBD	O
an	DT	O
additional	JJ	O
hybridizing	VBG	O
fragment	NN	O
in	IN	O
the	DT	O
DNA	NN	O
from	IN	O
each	DT	O
patient	NN	O
,	,	O
permitting	VBG	O
the	DT	O
breakpoints	NNS	O
in	IN	O
all	DT	O
three	CD	O
to	TO	O
be	VB	O
mapped	VBN	O
within	IN	O
the	DT	O
cloned	VBN	O
RB1	NN	O
gene	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
breakpoint	NN	O
in	IN	O
one	CD	O
translocation	NN	O
cell	NN	O
line	NN	O
allowed	VBD	O
the	DT	O
RB1	NN	O
gene	NN	O
to	TO	O
be	VB	O
oriented	VBN	O
with	IN	O
its	PRP$	O
5	CD	O
end	NN	O
toward	IN	O
the	DT	O
centromere	NN	O
.	.	O

The	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
also	RB	O
appeared	VBD	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
clustering	NN	O
of	IN	O
sites	NNS	O
for	IN	O
several	JJ	O
infrequently	RB	O
cleaving	VBG	O
restriction	NN	O
enzymes	NNS	O
,	,	O
indicating	VBG	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
HpaII	NN	O
tiny	JJ	O
fragment	NN	O
island	NN	O
.	.	O

The	DT	O
detection	NN	O
and	CC	O
mapping	NN	O
of	IN	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
of	IN	O
all	DT	O
three	CD	O
retinoblastoma	NN	B-Disease
patients	NNS	O
to	TO	O
within	IN	O
the	DT	O
putative	JJ	O
RB1	NN	O
gene	NN	O
substantiated	VBD	O
the	DT	O
authenticity	NN	O
of	IN	O
this	DT	O
candidate	NN	O
sequence	NN	O
and	CC	O
demonstrated	VBD	O
the	DT	O
utility	NN	O
of	IN	O
FIGE	NNP	O
in	IN	O
detecting	VBG	O
chromosomal	JJ	O
rearrangements	NNS	O
affecting	VBG	O
this	DT	O
locus	NN	O
.	.	O

Constitutional	NNP	O
mutations	NNS	O
in	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
characterised	VBN	O
by	IN	O
a	DT	O
typical	JJ	O
nephropathy	NN	B-Disease
,	,	O
genital	JJ	B-Disease
abnormalities	NNS	I-Disease
and	CC	O
also	RB	O
predisposes	VBZ	O
to	TO	O
the	DT	O
development	NN	O
of	IN	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
.	.	O

These	DT	O
patients	NNS	O
eventually	RB	O
go	VBP	O
into	IN	O
end	NN	O
stage	NN	O
renal	JJ	B-Disease
failure	NN	I-Disease
.	.	O

A	DT	O
candidate	NN	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
gene	NN	O
,	,	O
WT1	NN	O
,	,	O
from	IN	O
the	DT	O
11p13	NN	O
chromosome	NN	O
region	NN	O
has	VBZ	O
recently	RB	O
been	VBN	O
cloned	VBN	O
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
the	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
constitutional	JJ	O
cells	NNS	O
from	IN	O
eight	CD	O
patients	NNS	O
and	CC	O
have	VBP	O
shown	VBN	O
heterozygous	JJ	O
mutations	NNS	O
in	IN	O
six	CD	O
of	IN	O
them	PRP	O
.	.	O

Four	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
in	IN	O
exon	NN	O
9	CD	O
,	,	O
all	DT	O
resulting	VBG	O
in	IN	O
missense	NN	O
mutations	NNS	O
.	.	O

Three	CD	O
were	VBD	O
at	IN	O
nucleotide	NN	O
position	NN	O
1180	CD	O
resulting	VBG	O
in	IN	O
an	DT	O
arg	NN	O
>	JJR	O
trp	NN	O
amino	NN	O
acid	NN	O
change	NN	O
.	.	O

The	DT	O
other	JJ	O
was	VBD	O
at	IN	O
position	NN	O
1186	CD	O
converting	VBG	O
an	DT	O
asp	NN	O
>	JJR	O
asn	NN	O
in	IN	O
the	DT	O
predicted	VBN	O
resultant	JJ	O
protein	NN	O
.	.	O

One	CD	O
patient	NN	O
had	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
8	CD	O
,	,	O
converting	VBG	O
an	DT	O
arg	NN	O
>	JJR	O
his	PRP$	O
.	.	O

A	DT	O
single	JJ	O
base	NN	O
pair	NN	O
insertion	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
821	CD	O
in	IN	O
exon	NN	O
6	CD	O
resulted	VBD	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
in	IN	O
the	DT	O
last	JJ	O
patient	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
find	VB	O
a	DT	O
mutation	NN	O
in	IN	O
one	CD	O
patient	NN	O
despite	IN	O
complete	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
genomic	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
last	JJ	O
patient	NN	O
carried	VBD	O
a	DT	O
constitutional	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
11p13	NN	O
region	NN	O
and	CC	O
no	DT	O
additional	JJ	O
mutation	NN	O
was	VBD	O
found	VBN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
and	CC	O
phenotypic	JJ	O
expression	NN	O
.	.	O

These	DT	O
results	NNS	O
further	RB	O
demonstrate	VBP	O
that	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
is	VBZ	O
important	JJ	O
in	IN	O
both	CC	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
kidney	NN	O
and	CC	O
the	DT	O
genito-urinary	JJ	O
system	NN	O
.	.	O

.	.	O

Four	CD	O
novel	JJ	O
PEPD	NN	O
alleles	NNS	O
causing	VBG	O
prolidase	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
PEPD	NN	O
locus	NN	O
cause	NN	O
prolidase	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
McKusick	NN	O
170100	CD	O
)	-RRB-	O
,	,	O
a	DT	O
rare	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
iminodipeptiduria	NN	B-Disease
,	,	O
skin	NN	B-Disease
ulcers	NNS	I-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
recurrent	JJ	O
infections	NNS	O
.	.	O

Four	CD	O
PEPD	NN	O
mutations	NNS	O
from	IN	O
five	CD	O
severely	RB	O
affected	VBN	O
individuals	NNS	O
were	VBD	O
characterized	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
reverse-transcribed	JJ	O
,	,	O
PCR-amplified	JJ	O
(	-LRB-	O
RT-PCR	NN	O
)	-RRB-	O
cDNA	NN	O
.	.	O

We	PRP	O
used	VBD	O
SSCP	NN	O
analysis	NN	O
on	IN	O
four	CD	O
overlapping	VBG	O
cDNA	NN	O
fragments	NNS	O
covering	VBG	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
PEPD	NN	O
gene	NN	O
and	CC	O
detected	VBD	O
abnormal	JJ	O
SSCP	NN	O
bands	NNS	O
for	IN	O
the	DT	O
fragment	NN	O
spanning	VBG	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
exons	NNS	O
13-15	CD	O
in	IN	O
three	CD	O
of	IN	O
the	DT	O
probands	NNS	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
cDNAs	NNS	O
showed	VBD	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
,	,	O
1342	CD	O
substitution	NN	O
(	-LRB-	O
G448R	NN	O
)	-RRB-	O
in	IN	O
two	CD	O
patients	NNS	O
and	CC	O
a	DT	O
3-bp	JJ	O
deletion	NN	O
(	-LRB-	O
delta	NN	O
E452	NN	O
or	CC	O
delta	NN	O
E453	NN	O
)	-RRB-	O
in	IN	O
another	DT	O
.	.	O

In	IN	O
the	DT	O
other	JJ	O
two	CD	O
probands	NNS	O
the	DT	O
amplified	VBN	O
products	NNS	O
were	VBD	O
of	IN	O
reduced	VBN	O
size	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
these	DT	O
mutant	JJ	O
cDNAs	NNS	O
revealed	VBD	O
a	DT	O
deletion	NN	O
of	IN	O
exon	NN	O
5	CD	O
in	IN	O
one	CD	O
patient	NN	O
and	CC	O
of	IN	O
exon	NN	O
7	CD	O
in	IN	O
the	DT	O
other	JJ	O
.	.	O

Intronic	JJ	O
sequences	NNS	O
flanking	VBG	O
exons	NNS	O
5	CD	O
and	CC	O
7	CD	O
were	VBD	O
identified	VBN	O
using	VBG	O
inverse	JJ	O
PCR	NN	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Conventional	JJ	O
PCR	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
then	RB	O
established	VBD	O
the	DT	O
intron-exon	JJ	O
borders	NNS	O
of	IN	O
the	DT	O
mutant	JJ	O
genomic	JJ	O
DNA	NN	O
revealing	VBG	O
two	CD	O
splice	NN	O
acceptor	NN	O
mutations	NNS	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
C	NN	O
substitution	NN	O
at	IN	O
position	NN	O
-1	CD	O
of	IN	O
intron	NN	O
4	CD	O
and	CC	O
an	DT	O
A	NN	O
--	:	O
>	JJR	O
G	NN	O
substitution	NN	O
at	IN	O
position	NN	O
-2	CD	O
of	IN	O
intron	NN	O
6	CD	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
severe	JJ	O
form	NN	O
of	IN	O
prolidase	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
multiple	JJ	O
PEPD	NN	O
alleles	NNS	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
we	PRP	O
attempt	VBP	O
to	TO	O
begin	VB	O
the	DT	O
process	NN	O
of	IN	O
describing	VBG	O
these	DT	O
alleles	NNS	O
and	CC	O
cataloging	VBG	O
their	PRP$	O
phenotypic	JJ	O
expression	NN	O
.	.	O

.	.	O

Translocation	NN	O
t	NN	O
(	-LRB-	O
5	CD	O
;	:	O
11	CD	O
)	-RRB-	O
(	-LRB-	O
q13	NN	O
.1	NN	O
;	:	O
p13	NN	O
)	-RRB-	O
associated	VBN	O
with	IN	O
familial	JJ	O
isolated	VBN	B-Disease
aniridia	NN	I-Disease
.	.	O

A	DT	O
father	NN	O
and	CC	O
daughter	NN	O
with	IN	O
isolated	VBN	B-Disease
aniridia	NN	I-Disease
were	VBD	O
observed	VBN	O
to	TO	O
have	VB	O
an	DT	O
apparently	RB	O
balanced	JJ	O
,	,	O
reciprocal	JJ	O
translocation	NN	O
involving	VBG	O
chromosomes	NNS	O
5	CD	O
and	CC	O
11	CD	O
[	-LRB-	O
t	NN	O
(	-LRB-	O
5	CD	O
;	:	O
11	CD	O
)	-RRB-	O
(	-LRB-	O
q13	NN	O
.	.	O

1	CD	O
;	:	O
p13	NN	O
)	-RRB-	O
]	-RRB-	O
.	.	O

No	DT	O
other	JJ	O
clinical	JJ	O
characteristics	NNS	O
often	RB	O
associated	VBN	O
with	IN	O
the	DT	O
deletion	NN	O
of	IN	O
11p13	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

This	DT	O
finding	NN	O
,	,	O
in	IN	O
association	NN	O
with	IN	O
3	CD	O
other	JJ	O
instances	NNS	O
of	IN	O
single	JJ	O
breaks	NNS	O
at	IN	O
11p13	NN	O
and	CC	O
aniridia	NN	B-Disease
,	,	O
supports	VBZ	O
the	DT	O
assignment	NN	O
of	IN	O
AN2	NN	O
to	TO	O
11p13	NN	O
.	.	O

Genotype-phenotype	JJ	O
analysis	NN	O
in	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
and	CC	O
identification	NN	O
of	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
associated	VBN	O
with	IN	O
a	DT	O
milder	JJR	O
phenotype	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
emerin	NN	O
gene	NN	O
in	IN	O
22	CD	O
families	NNS	O
with	IN	O
Emery-Dreifuss	JJ	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EMD	NN	B-Disease
)	-RRB-	O
revealed	VBD	O
mutations	NNS	O
in	IN	O
21	CD	O
(	-LRB-	O
95	CD	O
%	NN	O
)	-RRB-	O
,	,	O
confirming	VBG	O
that	IN	O
emerin	NN	O
mutations	NNS	O
can	MD	O
be	VB	O
identified	VBN	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
families	NNS	O
with	IN	O
X-linked	JJ	B-Disease
EMD	NN	I-Disease
.	.	O

Most	JJS	O
emerin	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
absence	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
three	CD	O
mutations	NNS	O
(	-LRB-	O
a	DT	O
missense	NN	O
mutation	NN	O
Pro183Thr	NN	O
and	CC	O
two	CD	O
in-frame	RB	O
deletions	NNS	O
removing	VBG	O
residues	NNS	O
95-99	CD	O
and	CC	O
236-241	CD	O
,	,	O
respectively	RB	O
)	-RRB-	O
were	VBD	O
unusual	JJ	O
in	IN	O
being	VBG	O
associated	VBN	O
with	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
protein	NN	O
.	.	O

The	DT	O
phenotype	NN	O
in	IN	O
these	DT	O
families	NNS	O
was	VBD	O
compared	VBN	O
in	IN	O
detail	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
features	NNS	O
in	IN	O
cases	NNS	O
with	IN	O
typical	JJ	O
null	JJ	O
mutations	NNS	O
.	.	O

For	IN	O
the	DT	O
in-frame	RB	O
deletions	NNS	O
there	EX	O
were	VBD	O
no	DT	O
significant	JJ	O
differences	NNS	O
.	.	O

In	IN	O
the	DT	O
family	NN	O
with	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
the	DT	O
phenotype	NN	O
was	VBD	O
milder	JJ	O
.	.	O

Age	NN	O
at	IN	O
onset	NN	O
was	VBD	O
later	RB	O
for	IN	O
first	JJ	O
symptoms	NNS	O
and	CC	O
for	IN	O
development	NN	O
of	IN	O
ankle	NN	B-Disease
contractures	NNS	I-Disease
and	CC	O
muscle	NN	B-Disease
weakness	NN	I-Disease
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
diagnostic	JJ	O
implications	NNS	O
as	RB	O
well	RB	O
as	IN	O
pointing	VBG	O
to	TO	O
functionally	RB	O
important	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
emerin	NN	O
protein	NN	O
.	.	O

.	.	O

Asef	NNP	O
,	,	O
a	DT	O
link	NN	O
between	IN	O
the	DT	O
tumor	NN	B-Disease
suppressor	NN	O
APC	NN	O
and	CC	O
G-protein	NN	O
signaling	NN	O
.	.	O

The	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
gene	NN	O
(	-LRB-	O
APC	NN	O
)	-RRB-	O
is	VBZ	O
mutated	VBN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
and	CC	O
in	IN	O
sporadic	JJ	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

Here	RB	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
product	NN	O
is	VBZ	O
shown	VBN	O
to	TO	O
bind	VB	O
through	IN	O
its	PRP$	O
armadillo	NN	O
repeat	NN	O
domain	NN	O
to	TO	O
a	DT	O
Rac-specific	JJ	O
guanine	NN	O
nucleotide	NN	O
exchange	NN	O
factor	NN	O
(	-LRB-	O
GEF	NN	O
)	-RRB-	O
,	,	O
termed	VBN	O
Asef	NNP	O
.	.	O

Endogenous	JJ	O
APC	NN	O
colocalized	VBD	O
with	IN	O
Asef	NN	O
in	IN	O
mouse	NN	O
colon	NN	O
epithelial	JJ	O
cells	NNS	O
and	CC	O
neuronal	JJ	O
cells	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
APC	NN	O
enhanced	VBD	O
the	DT	O
GEF	NN	O
activity	NN	O
of	IN	O
Asef	NNP	O
and	CC	O
stimulated	VBN	O
Asef-mediated	JJ	O
cell	NN	O
flattening	NN	O
,	,	O
membrane	NN	O
ruffling	NN	O
,	,	O
and	CC	O
lamellipodia	NN	O
formation	NN	O
in	IN	O
MDCK	NN	O
cells	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
APC-Asef	NN	O
complex	NN	O
may	MD	O
regulate	VB	O
the	DT	O
actin	NN	O
cytoskeletal	JJ	O
network	NN	O
,	,	O
cell	NN	O
morphology	NN	O
and	CC	O
migration	NN	O
,	,	O
and	CC	O
neuronal	JJ	O
function	NN	O
.	.	O

.	.	O

Localization	NN	O
of	IN	O
the	DT	O
region	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
locus	NN	O
on	IN	O
the	DT	O
mouse	NN	O
X	NN	O
chromosome	NN	O
.	.	O

Recent	JJ	O
progress	NN	O
has	VBZ	O
resulted	VBN	O
in	IN	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
mutated	VBN	O
in	IN	O
Duchenne	NNP	B-Disease
and	CC	I-Disease
the	DT	I-Disease
milder	JJ	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophies	NNS	I-Disease
being	VBG	O
cloned	VBN	O
and	CC	O
has	VBZ	O
suggested	VBN	O
that	IN	O
the	DT	O
gene	NN	O
itself	PRP	O
extends	VBZ	O
over	IN	O
1	CD	O
,	,	O
000	CD	O
to	TO	O
2	CD	O
,	,	O
000	CD	O
kilobases	NNS	O
(	-LRB-	O
kb	NN	O
)	-RRB-	O
.	.	O

To	TO	O
study	VB	O
how	WRB	O
mutations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
affect	VB	O
muscle	NN	O
development	NN	O
and	CC	O
integrity	NN	O
,	,	O
it	PRP	O
would	MD	O
be	VB	O
of	IN	O
interest	NN	O
to	TO	O
have	VB	O
available	JJ	O
a	DT	O
mouse	NN	O
model	NN	O
of	IN	O
the	DT	O
human	JJ	O
disease	NN	O
.	.	O

The	DT	O
mouse	NN	O
mdx	NN	O
mutation	NN	O
affects	VBZ	O
muscle	NN	O
and	CC	O
confers	VBZ	O
a	DT	O
mild	JJ	O
dystrophic	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
clear	JJ	O
whether	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
equivalent	JJ	O
to	TO	O
Duchenne/Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
in	IN	O
man	NN	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
the	DT	O
use	NN	O
of	IN	O
two	CD	O
sequences	NNS	O
from	IN	O
the	DT	O
human	JJ	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
that	WDT	O
cross-hybridize	VBP	O
to	TO	O
mouse	NN	O
X-linked	JJ	O
sequences	NNS	O
to	TO	O
localize	VB	O
the	DT	O
gene	NN	O
homologous	JJ	O
to	TO	O
DMD	NNP	B-Disease
in	IN	O
the	DT	O
mouse	NN	O
.	.	O

Both	DT	O
sequences	NNS	O
map	VBP	O
to	TO	O
the	DT	O
region	NN	O
of	IN	O
10	CD	O
centimorgan	NN	O
lying	VBG	O
between	IN	O
the	DT	O
Tabby	NNP	O
(	-LRB-	O
Ta	NNP	O
)	-RRB-	O
and	CC	O
St14-1	NN	O
(	-LRB-	O
DxPas8	NN	O
)	-RRB-	O
loci	NNS	O
,	,	O
close	RB	O
to	TO	O
the	DT	O
phosphorylase	NN	O
b	NN	O
kinase	NN	O
locus	NN	O
(	-LRB-	O
Phk	NN	O
)	-RRB-	O
.	.	O

By	IN	O
analogy	NN	O
with	IN	O
the	DT	O
human	JJ	O
X-chromosome	NN	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
region	NN	O
in	IN	O
the	DT	O
mouse	NN	O
around	IN	O
the	DT	O
G6pd	NN	O
and	CC	O
St14-1	NN	O
loci	NNS	O
may	MD	O
contain	VB	O
two	CD	O
genes	NNS	O
corresponding	VBG	O
to	TO	O
distinct	JJ	O
human	JJ	O
myopathies	NNS	B-Disease
Emery	NNP	B-Disease
Dreifuss	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
which	WDT	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
closely	RB	O
linked	VBN	O
to	TO	O
St14-1	NN	O
in	IN	O
man	NN	O
and	CC	O
the	DT	O
DMD	NNP	B-Disease
homologue	NN	O
described	VBN	O
here	RB	O
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
hexosaminidase	NN	B-Disease
A	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
pseudodeficiency	NN	O
in	IN	O
the	DT	O
Berks	NNP	O
County	NNP	O
Pennsylvania	NNP	O
Dutch	NNP	O
.	.	O

Following	VBG	O
the	DT	O
birth	NN	O
of	IN	O
two	CD	O
infants	NNS	O
with	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
non-Jewish	JJ	O
,	,	O
Pennsylvania	NNP	O
Dutch	NNP	O
kindred	NN	O
was	VBD	O
screened	VBN	O
for	IN	O
TSD	NNP	B-Disease
carriers	NNS	O
using	VBG	O
the	DT	O
biochemical	JJ	O
assay	NN	O
.	.	O

A	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
individuals	NNS	O
who	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
TSD	NN	B-Disease
heterozygotes	NNS	O
was	VBD	O
detected	VBN	O
(	-LRB-	O
Kelly	NNP	O
et	FW	O
al.	FW	O
,	,	O
1975	CD	O
)	-RRB-	O
.	.	O

Clinical	JJ	O
and	CC	O
biochemical	JJ	O
evidence	NN	O
suggested	VBD	O
that	IN	O
the	DT	O
increased	VBN	O
carrier	NN	O
frequency	NN	O
was	VBD	O
due	JJ	O
to	TO	O
at	IN	O
least	JJS	O
two	CD	O
altered	JJ	O
alleles	NNS	O
for	IN	O
the	DT	O
hexosaminidase	NN	O
A	NN	O
alpha-subunit	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
two	CD	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
this	DT	O
Pennsylvania	NNP	O
Dutch	NNP	O
kindred	NN	O
,	,	O
and	CC	O
one	CD	O
polymorphism	NN	O
.	.	O

One	CD	O
allele	NN	O
,	,	O
reported	VBD	O
originally	RB	O
in	IN	O
a	DT	O
French	JJ	O
TSD	NN	B-Disease
patient	NN	O
(	-LRB-	O
Akli	JJ	O
et	FW	O
al.	FW	O
,	,	O
1991	CD	O
)	-RRB-	O
,	,	O
is	VBZ	O
a	DT	O
GT	NN	O
--	:	O
>	JJR	O
AT	IN	O
transition	NN	O
at	IN	O
the	DT	O
donor	NN	O
splice-site	NN	O
of	IN	O
intron	NN	O
9	CD	O
.	.	O

The	DT	O
second	JJ	O
,	,	O
a	DT	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transition	NN	O
at	IN	O
nucleotide	NN	O
739	CD	O
(	-LRB-	O
Arg247Trp	NN	O
)	-RRB-	O
,	,	O
has	VBZ	O
been	VBN	O
shown	VBN	O
by	IN	O
Triggs-Raine	NNP	O
et	FW	O
al.	FW	O
(	-LRB-	O
1992	CD	O
)	-RRB-	O
to	TO	O
be	VB	O
a	DT	O
clinically	RB	O
benign	JJ	O
"	''	O
pseudodeficient	NN	O
"	''	O
allele	NN	O
associated	VBN	O
with	IN	O
reduced	VBN	O
enzyme	NN	O
activity	NN	O
against	IN	O
artificial	JJ	O
substrate	NN	O
.	.	O

Finally	RB	O
,	,	O
a	DT	O
polymorphism	NN	O
[	-LRB-	O
G	NN	O
--	:	O
>	JJR	O
A	NN	O
(	-LRB-	O
759	CD	O
)	-RRB-	O
]	-RRB-	O
,	,	O
which	WDT	O
leaves	VBZ	O
valine	NN	O
at	IN	O
codon	NN	O
253	CD	O
unchanged	JJ	O
,	,	O
is	VBZ	O
described	VBN	O
.	.	O

Gene	NNP	O
transfer	NN	O
and	CC	O
expression	NN	O
of	IN	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
enzyme	NN	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

A	DT	O
full-length	JJ	O
complementary	JJ	O
DNA	NN	O
clone	NN	O
of	IN	O
human	JJ	O
PAH	NN	O
was	VBD	O
inserted	VBN	O
into	IN	O
a	DT	O
eukaryotic	JJ	O
expression	NN	O
vector	NN	O
and	CC	O
transferred	VBN	O
into	IN	O
mouse	NN	O
NIH3T3	NN	O
cells	NNS	O
which	WDT	O
do	VBP	O
not	RB	O
normally	RB	O
express	VB	O
PAH	NN	O
.	.	O

The	DT	O
transformed	VBN	O
mouse	NN	O
cells	NNS	O
expressed	VBD	O
PAH	NN	O
messenger	NN	O
RNA	NN	O
,	,	O
immunoreactive	JJ	O
protein	NN	O
,	,	O
and	CC	O
enzymatic	JJ	O
activity	NN	O
that	WDT	O
are	VBP	O
characteristic	JJ	O
of	IN	O
the	DT	O
normal	JJ	O
human	JJ	O
liver	NN	O
products	NNS	O
,	,	O
demonstrating	VBG	O
that	IN	O
a	DT	O
single	JJ	O
gene	NN	O
contains	VBZ	O
all	DT	O
of	IN	O
the	DT	O
necessary	JJ	O
genetic	JJ	O
information	NN	O
to	TO	O
code	NN	O
for	IN	O
functional	JJ	O
PAH	NN	O
.	.	O

These	DT	O
results	NNS	O
support	VBP	O
the	DT	O
use	NN	O
of	IN	O
the	DT	O
human	JJ	O
PAH	NN	O
probe	NN	O
in	IN	O
prenatal	JJ	O
diagnosis	NN	O
and	CC	O
detection	NN	O
of	IN	O
carriers	NNS	O
,	,	O
to	TO	O
provide	VB	O
new	JJ	O
opportunities	NNS	O
for	IN	O
the	DT	O
biochemical	JJ	O
characterization	NN	O
of	IN	O
normal	JJ	O
and	CC	O
mutant	JJ	O
enzymes	NNS	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
investigation	NN	O
of	IN	O
alternative	JJ	O
genetic	JJ	O
therapies	NNS	O
for	IN	O
PKU	NNP	B-Disease
.	.	O

.	.	O

Macular	JJ	B-Disease
dystrophy	NN	I-Disease
associated	VBN	O
with	IN	O
mutations	NNS	O
at	IN	O
codon	NN	O
172	CD	O
in	IN	O
the	DT	O
human	JJ	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
slow	JJ	O
gene	NN	O
.	.	O

BACKGROUND	NN	O
Recently	RB	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
slow	JJ	O
(	-LRB-	O
rds	NNS	O
)	-RRB-	O
gene	NN	O
which	WDT	O
codes	VBZ	O
for	IN	O
peripherin-rds	NNS	O
have	VBP	O
been	VBN	O
implicated	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
retinitis	NN	I-Disease
pigmentosa	NN	I-Disease
.	.	O

Because	IN	O
this	DT	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
both	CC	O
rods	NNS	O
and	CC	O
cones	NNS	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
rds	NN	O
gene	NN	O
might	MD	O
be	VB	O
expected	VBN	O
to	TO	O
cause	VB	O
degeneration	NN	O
affecting	VBG	O
either	CC	O
the	DT	O
scotopic	JJ	O
or	CC	O
photopic	JJ	O
systems	NNS	O
.	.	O

Mutations	NNS	O
at	IN	O
codon	NN	O
172	CD	O
of	IN	O
the	DT	O
rds	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
three	CD	O
families	NNS	O
with	IN	O
autosomal	JJ	O
dominantly	RB	O
inherited	VBN	O
,	,	O
progressive	JJ	O
macular	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

METHODS	NNS	O
Affected	VBN	O
individuals	NNS	O
underwent	VBD	O
ophthalmic	JJ	O
examination	NN	O
,	,	O
scotopic	JJ	O
perimetry	NN	O
,	,	O
dark	JJ	O
adaptometry	NN	O
,	,	O
measurement	NN	O
of	IN	O
color-contrast	JJ	O
sensitivity	NN	O
,	,	O
and	CC	O
electroretinography	NN	O
to	TO	O
characterize	VB	O
the	DT	O
photoreceptor	NN	O
dysfunction	NN	O
.	.	O

RESULTS	NNS	O
In	IN	O
all	DT	O
but	IN	O
one	CD	O
affected	VBD	O
member	NN	O
,	,	O
symptoms	NNS	O
of	IN	O
progressive	JJ	O
central	JJ	O
visual	JJ	B-Disease
loss	NN	I-Disease
developed	VBN	O
in	IN	O
the	DT	O
third	JJ	O
or	CC	O
fourth	JJ	O
decade	NN	O
of	IN	O
life	NN	O
accompanied	VBN	O
by	IN	O
central	JJ	B-Disease
scotoma	NN	I-Disease
and	CC	O
well-demarcated	JJ	O
atrophy	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
retinal	JJ	I-Disease
pigment	NN	I-Disease
epithelium	NN	I-Disease
and	CC	O
choriocapillaris	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
macula	NN	I-Disease
.	.	O

In	IN	O
general	JJ	O
,	,	O
cone	NN	O
and	CC	O
rod	NN	O
thresholds	NNS	O
were	VBD	O
elevated	JJ	O
,	,	O
and	CC	O
color-contrast	JJ	O
sensitivity	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
the	DT	O
central	JJ	O
visual	JJ	O
field	NN	O
.	.	O

Peripherally	RB	O
,	,	O
the	DT	O
scotopic	JJ	O
sensitivities	NNS	O
were	VBD	O
normal	JJ	O
,	,	O
as	IN	O
was	VBD	O
the	DT	O
recovery	NN	O
from	IN	O
bleach	NN	O
.	.	O

Cone	NNP	O
electroretinograms	NNS	O
were	VBD	O
diminished	VBN	O
in	IN	O
amplitude	NN	O
,	,	O
and	CC	O
delayed	VBN	O
in	IN	O
all	DT	O
affected	VBN	O
adults	NNS	O
except	IN	O
one	CD	O
.	.	O

Rod	NNP	O
electroretinograms	NNS	O
were	VBD	O
normal	JJ	O
or	CC	O
near	IN	O
normal	JJ	O
in	IN	O
amplitude	NN	O
,	,	O
and	CC	O
had	VBD	O
normal	JJ	O
implicit	JJ	O
times	NNS	O
.	.	O

Affected	VBN	O
asymptomatic	JJ	O
children	NNS	O
had	VBD	O
macular	JJ	O
changes	NNS	O
,	,	O
abnormal	JJ	O
color-contrast	JJ	O
sensitivity	NN	O
,	,	O
and	CC	O
reduced	VBD	O
pattern	NN	O
and	CC	O
cone	NN	O
electroretinograms	NNS	O
.	.	O

CONCLUSION	NN	O
These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
rds	NN	O
gene	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
as	IN	O
a	DT	O
macular	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
with	IN	O
evidence	NN	O
of	IN	O
primary	JJ	O
cone	NN	B-Disease
dysfunction	NN	I-Disease
and	CC	O
preservation	NN	O
of	IN	O
peripheral	JJ	O
rod	NN	O
function	NN	O
.	.	O

.	.	O

Glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
:	:	O
Gd	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
Alexandra	NNP	O
associated	VBN	O
with	IN	O
neonatal	JJ	B-Disease
jaundice	NN	I-Disease
and	CC	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Camperdown	NNP	O
in	IN	O
a	DT	O
young	JJ	O
man	NN	O
with	IN	O
lamellar	JJ	B-Disease
cataracts	NNS	I-Disease
.	.	O

Two	CD	O
male	JJ	O
subjects	NNS	O
are	VBP	O
described	VBN	O
,	,	O
with	IN	O
unusual	JJ	O
clinical	JJ	O
presentations	NNS	O
and	CC	O
with	IN	O
hitherto	RB	O
undescribed	JJ	O
G6PD	NN	O
variants	NNS	O
.	.	O

The	DT	O
first	JJ	O
,	,	O
of	IN	O
Italian	JJ	O
extraction	NN	O
,	,	O
suffered	VBN	O
from	IN	O
severe	JJ	O
neonatal	JJ	B-Disease
jaundice	NN	I-Disease
following	VBG	O
maternal	JJ	O
ingestion	NN	O
of	IN	O
fresh	JJ	O
broad	JJ	O
beans	NNS	O
(	-LRB-	O
Vicia	NNP	O
fava	NN	O
)	-RRB-	O
both	CC	O
prenatally	RB	O
and	CC	O
postnatally	RB	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
enzymatic	JJ	O
defect	NN	O
was	VBD	O
much	RB	O
more	RBR	O
severe	JJ	O
in	IN	O
the	DT	O
neonatal	JJ	O
period	NN	O
than	IN	O
on	IN	O
retesting	NN	O
in	IN	O
adolescence	NN	O
,	,	O
when	WRB	O
biochemical	JJ	O
characterization	NN	O
showed	VBD	O
unique	JJ	O
features	NNS	O
which	WDT	O
justify	VBP	O
designation	NN	O
as	IN	O
a	DT	O
new	JJ	O
variant	JJ	O
Gd	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
Alexandra	NNP	O
.	.	O

The	DT	O
second	JJ	O
patient	NN	O
,	,	O
a	DT	O
boy	NN	O
of	IN	O
Maltese	JJ	O
extraction	NN	O
who	WP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
bilateral	JJ	B-Disease
lamellar	NN	I-Disease
cataracts	NNS	I-Disease
at	IN	O
the	DT	O
age	NN	O
of	IN	O
4	CD	O
years	NNS	O
,	,	O
was	VBD	O
identified	VBN	O
as	IN	O
G6PD	NN	B-Disease
deficient	JJ	I-Disease
only	RB	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
a	DT	O
survey	NN	O
of	IN	O
children	NNS	O
of	IN	O
Mediterranean	JJ	O
origin	NN	O
with	IN	O
unexplained	JJ	O
cataract	NN	B-Disease
formation	NN	O
;	:	O
he	PRP	O
has	VBZ	O
approximately	RB	O
15	CD	O
%	NN	O
of	IN	O
normal	JJ	O
enzyme	NN	O
activity	NN	O
,	,	O
with	IN	O
another	DT	O
unique	JJ	O
combination	NN	O
of	IN	O
biochemical	JJ	O
characteristics	NNS	O
which	WDT	O
has	VBZ	O
led	VBN	O
to	TO	O
its	PRP$	O
designation	NN	O
as	IN	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Camperdown	NNP	O
.	.	O

Although	IN	O
this	DT	O
association	NN	O
may	MD	O
be	VB	O
coincidental	JJ	O
,	,	O
it	PRP	O
prompts	VBZ	O
further	JJ	O
attention	NN	O
to	TO	O
the	DT	O
possibility	NN	O
that	IN	O
under	IN	O
certain	JJ	O
circumstances	NNS	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
may	MD	O
favor	VB	O
cataract	NN	B-Disease
formation	NN	O
.	.	O

The	DT	O
two	CD	O
cases	NNS	O
illustrate	VBP	O
the	DT	O
value	NN	O
of	IN	O
characterization	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
enzyme	NN	O
whenever	WRB	O
unexpected	JJ	O
clinical	JJ	O
or	CC	O
laboratory	JJ	O
results	NNS	O
are	VBP	O
obtained	VBN	O
.	.	O

.	.	O

DNA	NN	O
restriction	NN	O
fragments	NNS	O
associated	VBN	O
with	IN	O
alpha	NN	O
1-antitrypsin	JJ	O
indicate	VBP	O
a	DT	O
single	JJ	O
origin	NN	O
for	IN	O
deficiency	NN	O
allele	NN	O
PI	NN	O
Z	NN	O
.	.	O

The	DT	O
alpha	NN	O
1-protease	NN	O
inhibitor	NN	O
,	,	O
or	CC	O
alpha-antitrypsin	NN	O
(	-LRB-	O
AAT	NN	O
)	-RRB-	O
,	,	O
a	DT	O
major	JJ	O
plasma	NN	O
inhibitor	NN	O
of	IN	O
leukocyte	NN	O
elastase	NN	O
and	CC	O
bacterial	JJ	O
proteases	NNS	O
,	,	O
is	VBZ	O
encoded	VBN	O
at	IN	O
the	DT	O
PI	NN	O
locus	NN	O
on	IN	O
chromosome	NN	O
14	CD	O
(	-LRB-	O
14q24	NN	O
.	.	O

3-q32	NN	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

A	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
AAT	NN	I-Disease
in	IN	O
individuals	NNS	O
homozygous	JJ	O
for	IN	O
the	DT	O
PI	NN	O
Z	NN	O
allele	NN	O
occurs	VBZ	O
in	IN	O
about	IN	O
1	CD	O
in	IN	O
2	CD	O
,	,	O
000-8	CD	O
,	,	O
000	CD	O
caucasians	NNS	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
early	JJ	O
adult	JJ	O
onset	NN	O
emphysema	NN	B-Disease
and	CC	O
liver	NN	B-Disease
disease	NN	I-Disease
in	IN	O
childhood	NN	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
used	VBN	O
DNA	NN	O
polymorphisms	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
AAT	NN	O
gene	NN	O
to	TO	O
investigate	VB	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
PI	NN	O
Z	NN	O
allele	NN	O
.	.	O

Using	VBG	O
two	CD	O
genomic	JJ	O
probes	NNS	O
extending	VBG	O
into	IN	O
the	DT	O
5	CD	O
and	CC	O
3	CD	O
flanking	NN	O
regions	NNS	O
,	,	O
respectively	RB	O
,	,	O
we	PRP	O
have	VBP	O
identified	VBN	O
eight	CD	O
polymorphic	JJ	O
restriction	NN	O
sites	NNS	O
.	.	O

Extensive	JJ	O
linkage	NN	O
disequilibrium	NN	O
occurs	VBZ	O
throughout	IN	O
the	DT	O
probed	VBN	O
region	NN	O
with	IN	O
the	DT	O
PI	NN	O
Z	NN	O
allele	NN	O
,	,	O
but	CC	O
not	RB	O
with	IN	O
normal	JJ	O
PI	NN	O
M	NN	O
alleles	NNS	O
.	.	O

The	DT	O
Z	NN	O
allele	NN	O
occurs	VBZ	O
mainly	RB	O
with	IN	O
one	CD	O
haplotype	NN	O
,	,	O
indicating	VBG	O
a	DT	O
single	JJ	O
,	,	O
relatively	RB	O
recent	JJ	O
,	,	O
origin	NN	O
in	IN	O
caucasians	NNS	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
in	IN	O
transgenic	JJ	O
mice	NNS	O
expressing	VBG	O
an	DT	O
expanded	VBN	O
CUG	NN	O
repeat	NN	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
in	IN	O
adult	JJ	O
humans	NNS	O
,	,	O
results	VBZ	O
from	IN	O
expansion	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
DMPK	NN	O
gene	NN	O
.	.	O

The	DT	O
mutant	JJ	O
DMPK	NN	O
messenger	NN	O
RNA	NN	O
(	-LRB-	O
mRNA	NN	O
)	-RRB-	O
contains	VBZ	O
an	DT	O
expanded	VBN	O
CUG	NN	O
repeat	NN	O
and	CC	O
is	VBZ	O
retained	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
.	.	O

We	PRP	O
have	VBP	O
expressed	VBN	O
an	DT	O
untranslated	JJ	O
CUG	NN	O
repeat	NN	O
in	IN	O
an	DT	O
unrelated	JJ	O
mRNA	NN	O
in	IN	O
transgenic	JJ	O
mice	NNS	O
.	.	O

Mice	NNS	O
that	WDT	O
expressed	VBD	O
expanded	VBN	O
CUG	NNP	O
repeats	NNS	O
developed	VBD	O
myotonia	NN	B-Disease
and	CC	O
myopathy	NN	B-Disease
,	,	O
whereas	IN	O
mice	NNS	O
expressing	VBG	O
a	DT	O
nonexpanded	JJ	O
repeat	NN	O
did	VBD	O
not	RB	O
.	.	O

Thus	RB	O
,	,	O
transcripts	NNS	O
with	IN	O
expanded	VBN	O
CUG	NNP	O
repeats	NNS	O
are	VBP	O
sufficient	JJ	O
to	TO	O
generate	VB	O
a	DT	O
DM	NN	B-Disease
phenotype	NN	O
.	.	O

This	DT	O
result	NN	O
supports	VBZ	O
a	DT	O
role	NN	O
for	IN	O
RNA	NN	O
gain	NN	O
of	IN	O
function	NN	O
in	IN	O
disease	NN	O
pathogenesis	NN	O
.	.	O

.	.	O

Submicroscopic	JJ	O
deletion	NN	O
in	IN	O
cousins	NNS	O
with	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
causes	VBZ	O
a	DT	O
grandmatrilineal	NN	O
inheritance	NN	O
pattern	NN	O
:	:	O
effects	NNS	O
of	IN	O
imprinting	VBG	O
.	.	O

The	DT	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
critical	JJ	O
region	NN	O
on	IN	O
15q11-q13	NN	O
is	VBZ	O
subject	JJ	O
to	TO	O
imprinting	VBG	O
.	.	O

PWS	NN	B-Disease
becomes	VBZ	O
apparent	JJ	O
when	WRB	O
genes	NNS	O
on	IN	O
the	DT	O
paternally	RB	O
inherited	VBN	O
chromosome	NN	O
are	VBP	O
not	RB	O
expressed	VBN	O
.	.	O

Familial	JJ	B-Disease
PWS	NN	I-Disease
is	VBZ	O
rare	JJ	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
a	DT	O
male	NN	O
and	CC	O
a	DT	O
female	JJ	O
paternal	JJ	O
first	JJ	O
cousin	NN	O
both	DT	O
have	VBP	O
PWS	NN	B-Disease
with	IN	O
cytogenetically	RB	O
normal	JJ	O
karyotypes	NNS	O
.	.	O

Fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
(	-LRB-	O
FISH	NN	O
)	-RRB-	O
analysis	NN	O
shows	VBZ	O
a	DT	O
submicroscopic	JJ	O
deletion	NN	O
of	IN	O
SNRPN	NNP	O
,	,	O
but	CC	O
not	RB	O
the	DT	O
closely	RB	O
associated	VBN	O
loci	NNS	O
D15S10	NN	O
,	,	O
D15S11	NN	O
,	,	O
D15S63	NN	O
,	,	O
and	CC	O
GABRB3	NN	O
.	.	O

The	DT	O
cousins	NNS	O
fathers	NNS	O
and	CC	O
two	CD	O
paternal	JJ	O
aunts	NNS	O
have	VBP	O
the	DT	O
same	JJ	O
deletion	NN	O
and	CC	O
are	VBP	O
clinically	RB	O
normal	JJ	O
.	.	O

The	DT	O
grandmother	NN	O
of	IN	O
the	DT	O
cousins	NNS	O
is	VBZ	O
deceased	VBN	O
and	CC	O
not	RB	O
available	JJ	O
for	IN	O
study	NN	O
,	,	O
and	CC	O
their	PRP$	O
grandfather	NN	O
is	VBZ	O
not	RB	O
deleted	VBN	O
for	IN	O
SNRPN	NNP	O
.	.	O

DNA	NN	O
methylation	NN	O
analysis	NN	O
of	IN	O
D15S63	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
an	DT	O
abnormality	NN	O
of	IN	O
the	DT	O
imprinting	VBG	O
center	NN	O
associated	VBN	O
with	IN	O
PWS	NN	B-Disease
.	.	O
"	''	O

Grandmatrilineal	NN	O
"	''	O
inheritance	NN	O
occurs	VBZ	O
when	WRB	O
a	DT	O
woman	NN	O
with	IN	O
deletion	NN	O
of	IN	O
an	DT	O
imprinted	VBN	O
,	,	O
paternally	RB	O
expressed	VBN	O
gene	NN	O
is	VBZ	O
at	IN	O
risk	NN	O
of	IN	O
having	VBG	O
affected	VBN	O
grandchildren	NNS	O
through	IN	O
her	PRP$	O
sons	NNS	O
.	.	O

In	IN	O
this	DT	O
case	NN	O
,	,	O
PWS	NN	B-Disease
does	VBZ	O
not	RB	O
become	VB	O
evident	JJ	O
as	RB	O
long	RB	O
as	IN	O
the	DT	O
deletion	NN	O
is	VBZ	O
passed	VBN	O
through	IN	O
the	DT	O
matrilineal	JJ	O
line	NN	O
.	.	O

This	DT	O
represents	VBZ	O
a	DT	O
unique	JJ	O
inheritance	NN	O
pattern	NN	O
due	JJ	O
to	TO	O
imprinting	VBG	O
.	.	O

.	.	O

Expression	NN	O
and	CC	O
imprinting	VBG	O
of	IN	O
MAGEL2	NN	O
suggest	VBP	O
a	DT	O
role	NN	O
in	IN	O
Prader-willi	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
the	DT	O
homologous	JJ	O
murine	JJ	O
imprinting	VBG	O
phenotype	NN	O
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
the	DT	O
loss	NN	O
of	IN	O
expression	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
in	IN	O
chromosome	NN	O
15q11-q13	NN	O
.	.	O

Affected	VBN	O
individuals	NNS	O
exhibit	VBP	O
neonatal	JJ	B-Disease
hypotonia	NN	I-Disease
,	,	O
developmental	JJ	B-Disease
delay	NN	I-Disease
and	CC	O
childhood-onset	JJ	B-Disease
obesity	NN	I-Disease
.	.	O

Necdin	NNP	O
,	,	O
a	DT	O
protein	NN	O
implicated	VBN	O
in	IN	O
the	DT	O
terminal	JJ	O
differentiation	NN	O
of	IN	O
neurons	NNS	O
,	,	O
is	VBZ	O
the	DT	O
only	JJ	O
PWS	NN	B-Disease
candidate	NN	O
gene	NN	O
to	TO	O
reduce	VB	O
viability	NN	O
when	WRB	O
disrupted	VBN	O
in	IN	O
a	DT	O
mouse	NN	O
model	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
characterized	VBN	O
MAGEL2	NN	O
(	-LRB-	O
also	RB	O
known	VBN	O
as	IN	O
NDNL1	NN	O
)	-RRB-	O
,	,	O
a	DT	O
gene	NN	O
with	IN	O
51	CD	O
%	NN	O
amino	NN	O
acid	NN	O
sequence	NN	O
similarity	NN	O
to	TO	O
necdin	NN	O
and	CC	O
located	JJ	O
41	CD	O
kb	NN	O
distal	JJ	O
to	TO	O
NDN	NNP	O
in	IN	O
the	DT	O
PWS	NNP	B-Disease
deletion	NN	O
region	NN	O
.	.	O

MAGEL2	NN	O
is	VBZ	O
expressed	VBN	O
predominantly	RB	O
in	IN	O
brain	NN	O
,	,	O
the	DT	O
primary	JJ	O
tissue	NN	O
affected	VBN	O
in	IN	O
PWS	NNP	B-Disease
and	CC	O
in	IN	O
several	JJ	O
fetal	JJ	O
tissues	NNS	O
as	IN	O
shown	VBN	O
by	IN	O
northern	JJ	O
blot	NN	O
analysis	NN	O
.	.	O

MAGEL2	NN	O
is	VBZ	O
imprinted	VBN	O
with	IN	O
monoallelic	JJ	O
expression	NN	O
in	IN	O
control	NN	O
brain	NN	O
,	,	O
and	CC	O
paternal-only	JJ	O
expression	NN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
as	IN	O
demonstrated	VBN	O
by	IN	O
its	PRP$	O
lack	NN	O
of	IN	O
expression	NN	O
in	IN	O
brain	NN	O
from	IN	O
a	DT	O
PWS-affected	JJ	O
individual	NN	O
.	.	O

The	DT	O
orthologous	JJ	O
mouse	NN	O
gene	NN	O
(	-LRB-	O
Magel2	NN	O
)	-RRB-	O
is	VBZ	O
located	JJ	O
within	IN	O
150	CD	O
kb	NN	O
of	IN	O
NDN	NNP	O
,	,	O
is	VBZ	O
imprinted	VBN	O
with	IN	O
paternal-only	JJ	O
expression	NN	O
and	CC	O
is	VBZ	O
expressed	VBN	O
predominantly	RB	O
in	IN	O
late	JJ	O
developmental	JJ	O
stages	NNS	O
and	CC	O
adult	JJ	O
brain	NN	O
as	IN	O
shown	VBN	O
by	IN	O
northern	JJ	O
blotting	NN	O
,	,	O
RT-PCR	NN	O
and	CC	O
whole-mount	JJ	O
RNA	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

Magel2	NN	O
distribution	NN	O
partially	RB	O
overlaps	VBZ	O
that	IN	O
of	IN	O
NDN	NNP	O
,	,	O
with	IN	O
strong	JJ	O
expression	NN	O
being	VBG	O
detected	VBN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
in	IN	O
mid-gestation	JJ	O
mouse	NN	O
embryos	NNS	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
,	,	O
although	IN	O
loss	NN	O
of	IN	O
necdin	NN	O
expression	NN	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
the	DT	O
neonatal	JJ	O
presentation	NN	O
of	IN	O
PWS	NNP	B-Disease
,	,	O
loss	NN	O
of	IN	O
MAGEL2	NN	O
may	MD	O
be	VB	O
critical	JJ	O
to	TO	O
abnormalities	NNS	B-Disease
in	IN	I-Disease
brain	NN	I-Disease
development	NN	I-Disease
and	CC	O
dysmorphic	JJ	B-Disease
features	NNS	I-Disease
in	IN	O
individuals	NNS	O
with	IN	O
PWS	NN	B-Disease
.	.	O

.	.	O

A	DT	O
single	JJ	O
origin	NN	O
of	IN	O
phenylketonuria	NN	B-Disease
in	IN	O
Yemenite	NNP	O
Jews	NNPS	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
metabolic	JJ	B-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
recessive	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
hepatic	JJ	O
enzyme	NN	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

The	DT	O
incidence	NN	O
of	IN	O
PKU	NN	B-Disease
varies	VBZ	O
widely	RB	O
across	IN	O
different	JJ	O
geographic	JJ	O
areas	NNS	O
,	,	O
and	CC	O
is	VBZ	O
highest	JJS	O
(	-LRB-	O
about	IN	O
1	CD	O
in	IN	O
5	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
)	-RRB-	O
in	IN	O
Ireland	NNP	O
and	CC	O
western	JJ	O
Scotland	NNP	O
,	,	O
and	CC	O
among	IN	O
Yemenite	NNP	O
Jews	NNPS	O
.	.	O

A	DT	O
limited	JJ	O
number	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
account	VBP	O
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
PKU	NN	B-Disease
cases	NNS	O
in	IN	O
the	DT	O
European	JJ	O
population	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
a	DT	O
single	JJ	O
molecular	JJ	O
defect	NN	O
--	:	O
a	DT	O
deletion	NN	O
spanning	VBG	O
the	DT	O
third	JJ	O
exon	NN	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
--	:	O
is	VBZ	O
responsible	JJ	O
for	IN	O
all	PDT	O
the	DT	O
PKU	NN	B-Disease
cases	NNS	O
among	IN	O
the	DT	O
Yemenite	NNP	O
Jews	NNPS	O
.	.	O

Examination	NN	O
of	IN	O
a	DT	O
random	JJ	O
sample	NN	O
of	IN	O
Yemenite	NNP	O
Jews	NNPS	O
using	VBG	O
a	DT	O
molecular	JJ	O
probe	NN	O
that	WDT	O
detects	VBZ	O
the	DT	O
carriers	NNS	O
of	IN	O
this	DT	O
deletion	NN	O
indicated	VBD	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
the	DT	O
defective	JJ	O
gene	NN	O
in	IN	O
this	DT	O
community	NN	O
.	.	O

Although	IN	O
the	DT	O
deleted	VBN	O
PAH	NN	O
gene	NN	O
was	VBD	O
traced	VBN	O
to	TO	O
25	CD	O
different	JJ	O
locations	NNS	O
throughout	IN	O
Yemen	NNP	O
,	,	O
family	NN	O
histories	NNS	O
and	CC	O
official	JJ	O
documents	NNS	O
of	IN	O
the	DT	O
Yemenite	NNP	O
Jewish	NNP	O
community	NN	O
showed	VBD	O
that	IN	O
the	DT	O
common	JJ	O
ancestor	NN	O
of	IN	O
all	PDT	O
the	DT	O
carriers	NNS	O
of	IN	O
this	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
lived	VBD	O
in	IN	O
Sana	NNP	O
,	,	O
the	DT	O
capital	NN	O
of	IN	O
Yemen	NNP	O
,	,	O
before	IN	O
the	DT	O
eighteenth	JJ	O
century	NN	O
.	.	O

.	.	O

High	JJ	O
resolution	NN	O
genetic	JJ	O
analysis	NN	O
suggests	VBZ	O
one	CD	O
ancestral	JJ	O
predisposing	VBG	O
haplotype	NN	O
for	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
mutation	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
amplification	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
trinucleotide	NN	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
in	IN	O
over	IN	O
99	CD	O
%	NN	O
of	IN	O
the	DT	O
global	JJ	O
DM	NN	B-Disease
population	NN	O
.	.	O

It	PRP	O
is	VBZ	O
in	IN	O
complete	JJ	O
linkage	NN	O
disequilibrium	NN	O
with	IN	O
an	DT	O
Alu	NN	O
element	NN	O
polymorphism	NN	O
within	IN	O
the	DT	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
DM	NN	B-Disease
is	VBZ	O
a	DT	O
consequence	NN	O
of	IN	O
one	CD	O
or	CC	O
few	JJ	O
ancestral	JJ	O
mutations	NNS	O
.	.	O

A	DT	O
recent	JJ	O
analysis	NN	O
utilizing	VBG	O
this	DT	O
polymorphism	NN	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
flanking	JJ	O
dinucleotide	NN	O
marker	NN	O
,	,	O
suggested	VBD	O
that	IN	O
similar	JJ	O
to	TO	O
Fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
DM	NN	B-Disease
exhibited	VBD	O
a	DT	O
founder	NN	O
effect	NN	O
(	-LRB-	O
Imbert	NNP	O
et	FW	O
al.	FW	O
,	,	O
1993	CD	O
Nature	NNP	O
Genet	NNP	O
.	.	O

4	CD	O
,	,	O
72-76	CD	O
)	-RRB-	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
low	JJ	O
reproductive	JJ	O
fitness	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
congenital	JJ	O
DM	NN	B-Disease
(	-LRB-	O
the	DT	O
endpoint	NN	O
of	IN	O
genetic	JJ	O
anticipation	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
)	-RRB-	O
suggests	VBZ	O
a	DT	O
higher	JJR	O
rate	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
high	JJ	O
resolution	NN	O
genetic	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
using	VBG	O
PCR	NN	O
based	JJ	O
assays	NNS	O
of	IN	O
nine	CD	O
polymorphisms	NNS	O
,	,	O
spanning	VBG	O
a	DT	O
physical	JJ	O
distance	NN	O
of	IN	O
30	CD	O
kb	NN	O
,	,	O
within	IN	O
and	CC	O
immediately	RB	O
flanking	VBG	O
the	DT	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
.	.	O

The	DT	O
persistent	JJ	O
complete	JJ	O
allelic	JJ	O
association	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
with	IN	O
all	PDT	O
these	DT	O
polymorphisms	NNS	O
provides	VBZ	O
further	JJ	O
support	NN	O
to	TO	O
previous	JJ	O
observations	NNS	O
and	CC	O
suggests	VBZ	O
more	RBR	O
strongly	RB	O
that	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
occurred	VBD	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
a	DT	O
particular	JJ	O
haplotype	NN	O
in	IN	O
which	WDT	O
the	DT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
became	VBD	O
inherently	RB	O
unstable	JJ	O
and	CC	O
therefore	RB	O
predisposed	VBN	O
to	TO	O
amplification	NN	O
.	.	O

Identification	NN	O
and	CC	O
rapid	JJ	O
detection	NN	O
of	IN	O
three	CD	O
Tay-Sachs	JJ	B-Disease
mutations	NNS	O
in	IN	O
the	DT	O
Moroccan	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

Infantile	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
that	WDT	O
result	VBP	O
in	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
beta-hexosaminidase	NN	O
A	NN	O
activity	NN	O
.	.	O

It	PRP	O
is	VBZ	O
well	RB	O
known	VBN	O
that	IN	O
an	DT	O
elevated	JJ	O
frequency	NN	O
of	IN	O
TSD	NN	B-Disease
mutations	NNS	O
exists	VBZ	O
among	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
.	.	O

More	RBR	O
recently	RB	O
it	PRP	O
has	VBZ	O
become	VBN	O
apparent	JJ	O
that	IN	O
elevated	JJ	O
carrier	NN	O
frequencies	NNS	O
for	IN	O
TSD	NNP	B-Disease
also	RB	O
occur	VBP	O
in	IN	O
several	JJ	O
other	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
including	VBG	O
Moroccan	NNP	O
Jews	NNPS	O
,	,	O
a	DT	O
subgroup	NN	O
of	IN	O
Sephardic	NNP	O
Jews	NNPS	O
.	.	O

Elsewhere	RB	O
we	PRP	O
reported	VBD	O
an	DT	O
in-frame	RB	O
deletion	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
adjacent	JJ	O
phenylalanine	NN	O
codons	NNS	O
at	IN	O
position	NN	O
304	CD	O
or	CC	O
305	CD	O
(	-LRB-	O
delta	NN	O
F304/305	NN	O
)	-RRB-	O
in	IN	O
one	CD	O
HEXA	NN	O
allele	NN	O
of	IN	O
a	DT	O
Moroccan	JJ	O
Jewish	JJ	O
TSD	NN	B-Disease
patient	NN	O
and	CC	O
in	IN	O
three	CD	O
obligate	JJ	O
carriers	NNS	O
from	IN	O
six	CD	O
unrelated	JJ	O
Moroccan	NNP	O
Jewish	NNP	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
identified	VBN	O
two	CD	O
additional	JJ	O
mutations	NNS	O
within	IN	O
exon	NN	O
5	CD	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
that	WDT	O
account	VBP	O
for	IN	O
the	DT	O
remaining	VBG	O
TSD	NN	B-Disease
alleles	NNS	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
carriers	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
is	VBZ	O
a	DT	O
novel	JJ	O
C-to-G	NN	O
transversion	NN	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
replacement	NN	O
of	IN	O
Tyr180	NN	O
by	IN	O
a	DT	O
stop	NN	O
codon	NN	O
.	.	O

The	DT	O
other	JJ	O
mutation	NN	O
is	VBZ	O
a	DT	O
G-to-A	JJ	O
transition	NN	O
resulting	VBG	O
in	IN	O
an	DT	O
Arg170-to-Gln	NN	O
substitution	NN	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
at	IN	O
a	DT	O
CpG	NN	O
site	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
infant	NN	O
with	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
was	VBD	O
described	VBN	O
elsewhere	RB	O
.	.	O

Analysis	NN	O
of	IN	O
nine	CD	O
obligate	JJ	O
carriers	NNS	O
from	IN	O
seven	CD	O
unrelated	JJ	O
families	NNS	O
showed	VBD	O
that	IN	O
four	CD	O
harbor	VBP	O
the	DT	O
delta	NN	O
F304/305	NN	O
mutation	NN	O
,	,	O
two	CD	O
the	DT	O
Arg170	NN	O
----	:	O
Gln	NN	O
mutation	NN	O
,	,	O
and	CC	O
one	CD	O
the	DT	O
Tyr180	NN	O
----	:	O
Stop	VB	O
mutation	NN	O
.	.	O

We	PRP	O
also	RB	O
have	VBP	O
developed	VBN	O
rapid	JJ	O
,	,	O
nonradioactive	JJ	O
assays	NNS	O
for	IN	O
the	DT	O
detection	NN	O
of	IN	O
each	DT	O
mutation	NN	O
,	,	O
which	WDT	O
should	MD	O
be	VB	O
helpful	JJ	O
for	IN	O
carrier	NN	O
screening	NN	O
.	.	O

.	.	O

Mapping	NN	O
of	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
the	DT	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
to	TO	O
mouse	NN	O
chromosome	NN	O
8	CD	O
.	.	O

ATP7B	NN	O
,	,	O
the	DT	O
gene	NN	O
altered	VBN	O
in	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
WD	NN	B-Disease
)	-RRB-	O
patients	NNS	O
,	,	O
lies	VBZ	O
in	IN	O
a	DT	O
block	NN	O
of	IN	O
homology	NN	O
shared	VBN	O
between	IN	O
human	JJ	O
chromosome	NN	O
13q14	NN	O
and	CC	O
the	DT	O
central	JJ	O
region	NN	O
of	IN	O
mouse	NN	O
chromosome	NN	O
14	CD	O
.	.	O

However	RB	O
,	,	O
we	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
murine	JJ	O
homologue	NN	O
of	IN	O
ATP7B	NN	O
(	-LRB-	O
Atp7b	NN	O
)	-RRB-	O
to	TO	O
mouse	NN	O
chromosome	NN	O
8	CD	O
by	IN	O
somatic	JJ	O
cell	NN	O
hybrid	NN	O
analysis	NN	O
.	.	O

Analysis	NN	O
of	IN	O
80	CD	O
interspecific	JJ	O
backcross	NN	O
offspring	NN	O
was	VBD	O
used	VBN	O
to	TO	O
position	VB	O
Atp7b	NN	O
close	NN	O
to	TO	O
D8Mit3	NN	O
and	CC	O
another	DT	O
ATPase	NN	O
locus	NN	O
,	,	O
Atp4b	NN	O
,	,	O
on	IN	O
mouse	NN	O
chromosome	NN	O
8	CD	O
.	.	O

ATP4B	NN	O
lies	VBZ	O
in	IN	O
13q34	NN	O
and	CC	O
is	VBZ	O
separated	VBN	O
from	IN	O
ATP7B	NN	O
by	IN	O
several	JJ	O
loci	NNS	O
whose	WP$	O
mouse	NN	O
homologues	NNS	O
map	VBP	O
to	TO	O
mouse	NN	O
chromosome	NN	O
14	CD	O
.	.	O

The	DT	O
assignment	NN	O
of	IN	O
Atp7b	NN	O
to	TO	O
mouse	NN	O
chromosome	NN	O
8	CD	O
identifies	VBZ	O
a	DT	O
previously	RB	O
unrecognized	JJ	O
region	NN	O
of	IN	O
homology	NN	O
between	IN	O
this	DT	O
chromosome	NN	O
and	CC	O
human	JJ	O
chromosome	NN	O
13	CD	O
.	.	O

This	DT	O
assignment	NN	O
suggests	VBZ	O
a	DT	O
possible	JJ	O
location	NN	O
for	IN	O
the	DT	O
toxic	JJ	O
milk	NN	O
mutation	NN	O
in	IN	O
the	DT	O
mouse	NN	O
,	,	O
which	WDT	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
as	IN	O
a	DT	O
homologue	NN	O
of	IN	O
WD	NN	B-Disease
.	.	O

.	.	O

Characteristics	NNS	O
of	IN	O
intergenerational	JJ	O
contractions	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

In	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
size	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
the	DT	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
generally	RB	O
increases	VBZ	O
in	IN	O
successive	JJ	O
generations	NNS	O
with	IN	O
clinical	JJ	O
evidence	NN	O
of	IN	O
anticipation	NN	O
.	.	O

However	RB	O
,	,	O
there	EX	O
have	VBP	O
also	RB	O
been	VBN	O
cases	NNS	O
with	IN	O
an	DT	O
intergenerational	JJ	O
contraction	NN	O
of	IN	O
the	DT	O
repeat	NN	O
.	.	O

We	PRP	O
examined	VBD	O
1	CD	O
,	,	O
489	CD	O
DM	NN	B-Disease
parent-offspring	NN	O
pairs	NNS	O
,	,	O
of	IN	O
which	WDT	O
95	CD	O
(	-LRB-	O
6	CD	O
.	.	O

4	CD	O
%	NN	O
)	-RRB-	O
showed	VBD	O
such	JJ	O
contractions	NNS	O
in	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
(	-LRB-	O
PBL	NN	O
)	-RRB-	O
.	.	O

In	IN	O
56	CD	O
of	IN	O
the	DT	O
95	CD	O
pairs	NNS	O
,	,	O
clinical	JJ	O
data	NNS	O
allowed	VBD	O
an	DT	O
analysis	NN	O
of	IN	O
their	PRP$	O
anticipation	NN	O
status	NN	O
.	.	O

It	PRP	O
is	VBZ	O
surprising	JJ	O
that	IN	O
anticipation	NN	O
occurred	VBD	O
in	IN	O
27	CD	O
(	-LRB-	O
48	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
these	DT	O
56	CD	O
pairs	NNS	O
,	,	O
while	IN	O
none	NN	O
clearly	RB	O
showed	VBD	O
a	DT	O
later	JJ	O
onset	NN	O
of	IN	O
DM	NN	B-Disease
in	IN	O
the	DT	O
symptomatic	JJ	O
offspring	NN	O
.	.	O

The	DT	O
contraction	NN	O
occurred	VBD	O
in	IN	O
76	CD	O
(	-LRB-	O
10	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
753	CD	O
paternal	JJ	O
transmissions	NNS	O
and	CC	O
in	IN	O
19	CD	O
(	-LRB-	O
3	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
736	CD	O
maternal	JJ	O
transmissions	NNS	O
.	.	O

Anticipation	NN	O
was	VBD	O
observed	VBN	O
more	RBR	O
frequently	RB	O
in	IN	O
maternal	JJ	O
(	-LRB-	O
85	CD	O
%	NN	O
)	-RRB-	O
than	IN	O
in	IN	O
paternal	JJ	O
(	-LRB-	O
37	CD	O
%	NN	O
)	-RRB-	O
transmissions	NNS	O
(	-LRB-	O
P	NN	O
<	JJR	O
.	.	O

001	CD	O
)	-RRB-	O
.	.	O

The	DT	O
parental	JJ	O
repeat	NN	O
size	NN	O
correlated	VBD	O
with	IN	O
the	DT	O
size	NN	O
of	IN	O
intergenerational	JJ	O
contraction	NN	O
(	-LRB-	O
r2	NN	O
=	JJ	O
.	.	O

50	CD	O
,	,	O
P	NN	O
<	JJR	O
<	JJR	O
.	.	O

001	CD	O
)	-RRB-	O
,	,	O
and	CC	O
the	DT	O
slope	NN	O
of	IN	O
linear	JJ	O
regression	NN	O
was	VBD	O
steeper	JJR	O
in	IN	O
paternal	JJ	O
(	-LRB-	O
-	:	O
.	.	O

62	CD	O
)	-RRB-	O
than	IN	O
in	IN	O
maternal	JJ	O
(	-LRB-	O
-	:	O
.	.	O

30	CD	O
)	-RRB-	O
transmissions	NNS	O
(	-LRB-	O
P	NN	O
<	JJR	O
<	JJR	O
.	.	O

001	CD	O
)	-RRB-	O
.	.	O

Sixteen	CD	O
DM	NN	B-Disease
parents	NNS	O
had	VBD	O
multiple	JJ	O
DM	NN	B-Disease
offspring	NN	O
with	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
contractions	NNS	O
.	.	O

This	DT	O
frequency	NN	O
was	VBD	O
higher	JJR	O
than	IN	O
the	DT	O
frequency	NN	O
expected	VBN	O
from	IN	O
the	DT	O
probability	NN	O
of	IN	O
the	DT	O
repeat	NN	O
contractions	NNS	O
(	-LRB-	O
6	CD	O
.	.	O

4	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
size	NN	O
of	IN	O
DM	NN	B-Disease
sib	NN	O
population	NN	O
(	-LRB-	O
1	CD	O
.	.	O

54	CD	O
DM	NN	B-Disease
offspring	NN	O
per	IN	O
DM	NN	B-Disease
parent	NN	O
,	,	O
in	IN	O
968	CD	O
DM	NN	B-Disease
parents	NNS	O
)	-RRB-	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
intergenerational	JJ	O
contractions	NNS	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
in	IN	O
leukocyte	NN	O
DNA	NN	O
frequently	RB	O
accompanies	VBZ	O
apparent	JJ	O
anticipation	NN	O
,	,	O
especially	RB	O
when	WRB	O
DM	NN	B-Disease
is	VBZ	O
maternally	RB	O
transmitted	VBN	O
,	,	O
and	CC	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
the	DT	O
paternal	JJ	O
origin	NN	O
of	IN	O
the	DT	O
repeat	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
repeat	NN	O
contraction	NN	O
in	IN	O
a	DT	O
sibling	NN	O
increase	VB	O
the	DT	O
probability	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
contraction	NN	O

Splice-site	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
may	MD	O
result	VB	O
in	IN	O
intrafamilial	JJ	O
variability	NN	O
for	IN	O
deafness	NN	B-Disease
in	IN	O
Pendred	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
recessive	JJ	B-Disease
inherited	VBN	I-Disease
disorder	NN	I-Disease
that	WDT	O
consists	VBZ	O
of	IN	O
developmental	JJ	B-Disease
abnormalities	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
cochlea	NN	I-Disease
,	,	O
sensorineural	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
,	,	O
and	CC	O
diffuse	JJ	B-Disease
thyroid	NN	I-Disease
enlargement	NN	I-Disease
(	-LRB-	O
goiter	NN	B-Disease
)	-RRB-	O
.	.	O

This	DT	O
disorder	NN	O
may	MD	O
account	VB	O
for	IN	O
up	RB	O
to	TO	O
10	CD	O
%	NN	O
of	IN	O
cases	NNS	O
of	IN	O
hereditary	JJ	B-Disease
deafness	NN	I-Disease
.	.	O

The	DT	O
disease	NN	O
gene	NN	O
(	-LRB-	O
PDS	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
7q22-q31	NN	O
,	,	O
and	CC	O
encodes	VBZ	O
a	DT	O
chloride-iodide	NN	O
transport	NN	O
protein	NN	O
.	.	O

We	PRP	O
performed	VBD	O
mutation	NN	O
analysis	NN	O
of	IN	O
individual	JJ	O
exons	NNS	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
in	IN	O
one	CD	O
Spanish	JJ	O
family	NN	O
that	WDT	O
shows	VBZ	O
intrafamilial	JJ	O
variability	NN	O
of	IN	O
the	DT	O
deafness	NN	B-Disease
phenotype	NN	O
(	-LRB-	O
two	CD	O
patients	NNS	O
with	IN	O
profound	JJ	O
and	CC	O
one	CD	O
with	IN	O
moderate-severe	JJ	O
deafness	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
new	JJ	O
splice-site	NN	O
mutation	NN	O
affecting	VBG	O
intron	NN	O
4	CD	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
,	,	O
at	IN	O
nucleotide	NN	O
position	NN	O
639	CD	O
+	CC	O
7	CD	O
.	.	O

RNA	NN	O
analysis	NN	O
from	IN	O
lymphocytes	NNS	O
of	IN	O
the	DT	O
affected	JJ	O
patients	NNS	O
showed	VBD	O
that	IN	O
mutation	NN	O
639	CD	O
+	CC	O
7A	NN	O
--	:	O
>	JJR	O
G	NN	O
generates	VBZ	O
a	DT	O
new	JJ	O
donor	NN	O
splice	NN	O
site	NN	O
,	,	O
leading	VBG	O
to	TO	O
an	DT	O
mRNA	NN	O
with	IN	O
an	DT	O
insertion	NN	O
of	IN	O
six	CD	O
nucleotides	NNS	O
from	IN	O
intron	NN	O
4	CD	O
of	IN	O
PDS	NN	O
.	.	O

Since	IN	O
the	DT	O
newly	RB	O
created	VBN	O
donor	NN	O
splice	NN	O
site	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
compete	VB	O
with	IN	O
the	DT	O
normal	JJ	O
one	CD	O
,	,	O
variations	NNS	O
of	IN	O
the	DT	O
levels	NNS	O
of	IN	O
normal	JJ	O
and	CC	O
aberrant	JJ	O
transcripts	NNS	O
of	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
in	IN	O
the	DT	O
cochlea	NN	O
may	MD	O
explain	VB	O
the	DT	O
variability	NN	O
in	IN	O
the	DT	O
deafness	NN	B-Disease
presentation	NN	O
.	.	O

.	.	O

Heterozygous	JJ	O
loss	NN	O
of	IN	O
Six5	NN	O
in	IN	O
mice	NNS	O
is	VBZ	O
sufficient	JJ	O
to	TO	O
cause	VB	O
ocular	JJ	O
cataracts	NNS	B-Disease
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	O
characterized	VBN	O
by	IN	O
skeletal	JJ	O
muscle	NN	B-Disease
wasting	NN	I-Disease
,	,	O
myotonia	NN	B-Disease
,	,	O
cardiac	JJ	B-Disease
arrhythmia	NN	I-Disease
,	,	O
hyperinsulinaemia	NN	B-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
and	CC	O
ocular	JJ	O
cataracts	NNS	B-Disease
.	.	O

The	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
DM	NN	B-Disease
is	VBZ	O
a	DT	O
CTG	NNP	O
repeat	NN	O
expansion	NN	O
located	JJ	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
DMPK	NN	O
and	CC	O
5	CD	O
of	IN	O
a	DT	O
homeodomain-encoding	JJ	O
gene	NN	O
,	,	O
SIX5	NN	O
(	-LRB-	O
formerly	RB	O
DMAHP	NN	O
;	:	O
refs	NNS	O
2-5	CD	O
)	-RRB-	O
.	.	O

There	EX	O
are	VBP	O
three	CD	O
mechanisms	NNS	O
by	IN	O
which	WDT	O
CTG	NNP	O
expansion	NN	O
can	MD	O
result	VB	O
in	IN	O
DM	NN	B-Disease
.	.	O

First	RB	O
,	,	O
repeat	NN	O
expansion	NN	O
may	MD	O
alter	VB	O
the	DT	O
processing	NN	O
or	CC	O
transport	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
DMPK	NN	O
mRNA	NN	O
and	CC	O
consequently	RB	O
reduce	VB	O
DMPK	NN	O
levels	NNS	O
.	.	O

Second	RB	O
,	,	O
CTG	NNP	O
expansion	NN	O
may	MD	O
establish	VB	O
a	DT	O
region	NN	O
of	IN	O
heterochromatin	NN	O
3	CD	O
of	IN	O
the	DT	O
repeat	NN	O
sequence	NN	O
and	CC	O
decrease	VB	O
SIX5	NN	O
transcription	NN	O
.	.	O

Third	NNP	O
,	,	O
toxic	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
repeat	NN	O
expansion	NN	O
may	MD	O
be	VB	O
intrinsic	JJ	O
to	TO	O
the	DT	O
repeated	JJ	O
elements	NNS	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
DNA	NN	O
or	CC	O
RNA	NN	O
(	-LRB-	O
refs	NNS	O
10	CD	O
,	,	O
11	CD	O
)	-RRB-	O
.	.	O

Previous	JJ	O
studies	NNS	O
have	VBP	O
demonstrated	VBN	O
that	IN	O
a	DT	O
dose-dependent	JJ	O
loss	NN	O
of	IN	O
Dm15	NN	O
(	-LRB-	O
the	DT	O
mouse	NN	O
DMPK	NN	O
homologue	NN	O
)	-RRB-	O
in	IN	O
mice	NNS	O
produces	VBZ	O
a	DT	O
partial	JJ	O
DM	NN	B-Disease
phenotype	NN	O
characterized	VBN	O
by	IN	O
decreased	VBN	O
development	NN	O
of	IN	O
skeletal	JJ	O
muscle	NN	O
force	NN	O
and	CC	O
cardiac	JJ	B-Disease
conduction	NN	I-Disease
disorders	NNS	I-Disease
.	.	O

To	TO	O
test	VB	O
the	DT	O
role	NN	O
of	IN	O
Six5	NN	O
loss	NN	O
in	IN	O
DM	NN	B-Disease
,	,	O
we	PRP	O
have	VBP	O
analysed	VBN	O
a	DT	O
strain	NN	O
of	IN	O
mice	NNS	O
in	IN	O
which	WDT	O
Six5	NN	O
was	VBD	O
deleted	VBN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
rate	NN	O
and	CC	O
severity	NN	O
of	IN	O
cataract	NN	B-Disease
formation	NN	O
is	VBZ	O
inversely	RB	O
related	JJ	O
to	TO	O
Six5	NN	O
dosage	NN	O
and	CC	O
is	VBZ	O
temporally	RB	O
progressive	JJ	O
.	.	O

Six5	NN	O
+	CC	O
/	:	O
-	:	O
and	CC	O
Six5	NN	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
show	VBP	O
increased	VBN	O
steady-state	JJ	O
levels	NNS	O
of	IN	O
the	DT	O
Na	NN	O
+	CC	O
/	:	O
K	NN	O
+	CC	O
-	:	O
ATPase	NN	O
alpha-1	NN	O
subunit	NN	O
and	CC	O
decreased	VBD	O
Dm15	NN	O
mRNA	NN	O
levels	NNS	O
.	.	O

Thus	RB	O
,	,	O
altered	JJ	O
ion	NN	O
homeostasis	NN	O
within	IN	O
the	DT	O
lens	NN	O
may	MD	O
contribute	VB	O
to	TO	O
cataract	NN	B-Disease
formation	NN	O
.	.	O

As	IN	O
ocular	JJ	O
cataracts	NNS	B-Disease
are	VBP	O
a	DT	O
characteristic	JJ	O
feature	NN	O
of	IN	O
DM	NN	B-Disease
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
decreased	VBN	O
SIX5	NN	O
transcription	NN	O
is	VBZ	O
important	JJ	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
DM	NN	B-Disease
.	.	O

Our	PRP$	O
data	NNS	O
support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
DM	NN	B-Disease
is	VBZ	O
a	DT	O
contiguous	JJ	O
gene	NN	O
syndrome	NN	O
associated	VBN	O
with	IN	O
the	DT	O
partial	JJ	O
loss	NN	O
of	IN	O
both	CC	O
DMPK	NN	O
and	CC	O
SIX5	NN	O
.	.	O

.	.	O

Cis	NN	O
and	CC	O
trans	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
mutation	NN	O
in	IN	O
a	DT	O
cell	NN	O
culture	NN	O
model	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
a	DT	O
CTG	NNP	O
expansion	NN	O
in	IN	O
the	DT	O
3-untranslated	JJ	O
region	NN	O
(	-LRB-	O
3-UTR	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
DM	NN	B-Disease
protein	NN	O
kinase	NN	O
gene	NN	O
(	-LRB-	O
DMPK	NN	O
)	-RRB-	O
,	,	O
but	CC	O
the	DT	O
mechanism	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
of	IN	O
pathogenesis	NN	O
remain	VBP	O
unknown	JJ	O
.	.	O

Studies	NNS	O
using	VBG	O
DM	NN	B-Disease
patient	NN	O
materials	NNS	O
have	VBP	O
often	RB	O
produced	VBN	O
confusing	JJ	O
results	NNS	O
.	.	O

Therefore	RB	O
,	,	O
to	TO	O
study	VB	O
the	DT	O
effects	NNS	O
of	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
in	IN	O
a	DT	O
controlled	JJ	O
environment	NN	O
,	,	O
we	PRP	O
have	VBP	O
established	VBN	O
a	DT	O
cell	NN	O
culture	NN	O
model	NN	O
system	NN	O
using	VBG	O
C2C12	NN	O
mouse	NN	O
myoblasts	NNS	O
.	.	O

By	IN	O
expressing	VBG	O
chimeric	JJ	O
reporter	NN	O
constructs	NNS	O
containing	VBG	O
a	DT	O
reporter	NN	O
gene	NN	O
fused	VBN	O
to	TO	O
a	DT	O
human	JJ	O
DMPK	NN	O
3-UTR	NN	O
,	,	O
we	PRP	O
identified	VBD	O
both	CC	O
cis	NN	O
and	CC	O
trans	JJ	O
effects	NNS	O
that	WDT	O
are	VBP	O
mediated	VBN	O
by	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
show	VBP	O
that	IN	O
a	DT	O
mutant	JJ	O
DMPK	NN	O
3-UTR	NN	O
,	,	O
with	IN	O
as	IN	O
few	JJ	O
as	IN	O
57	CD	O
CTGs	NNS	O
,	,	O
had	VBD	O
a	DT	O
negative	JJ	O
cis	NN	O
effect	NN	O
on	IN	O
protein	NN	O
expression	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
the	DT	O
aggregation	NN	O
of	IN	O
reporter	NN	O
transcripts	NNS	O
into	IN	O
discrete	JJ	O
nuclear	JJ	O
foci	NNS	O
.	.	O

We	PRP	O
determined	VBD	O
by	IN	O
deletion	NN	O
analysis	NN	O
that	IN	O
an	DT	O
expanded	VBN	O
(	-LRB-	O
CTG	NNP	O
)	-RRB-	O
(	-LRB-	O
n	NN	O
)	-RRB-	O
tract	NN	O
alone	RB	O
was	VBD	O
sufficient	JJ	O
to	TO	O
mediate	VB	O
these	DT	O
cis	JJ	O
effects	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
in	IN	O
contrast	NN	O
to	TO	O
the	DT	O
normal	JJ	O
DMPK	NN	O
3-UTR	NN	O
mRNA	NN	O
,	,	O
a	DT	O
mutant	JJ	O
DMPK	NN	O
3-UTR	NN	O
mRNA	NN	O
with	IN	O
(	-LRB-	O
CUG	NN	O
)	-RRB-	O
(	-LRB-	O
200	CD	O
)	-RRB-	O
selectively	RB	O
inhibited	VBD	O
myogenic	JJ	O
differentiation	NN	O
of	IN	O
C2C12	NN	O
myoblasts	NNS	O
.	.	O

Genetic	JJ	O
analysis	NN	O
and	CC	O
the	DT	O
Cre	NNP	O
-	:	O
loxP	NN	O
system	NN	O
were	VBD	O
used	VBN	O
to	TO	O
clearly	RB	O
demonstrate	VB	O
that	IN	O
the	DT	O
myoblast	NN	O
fusion	NN	O
defect	NN	O
could	MD	O
be	VB	O
rescued	VBN	O
by	IN	O
eliminating	VBG	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
DMPK	NN	O
3-UTR	NN	O
transcript	NN	O
.	.	O

Characterization	NN	O
of	IN	O
spontaneous	JJ	O
deletion	NN	O
events	NNS	O
mapped	VBD	O
the	DT	O
inhibitory	JJ	O
effect	NN	O
to	TO	O
the	DT	O
(	-LRB-	O
CTG	NNP	O
)	-RRB-	O
(	-LRB-	O
n	NN	O
)	-RRB-	O
expansion	NN	O
and/or	CC	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
the	DT	O
DMPK	NN	O
3-UTR	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
the	DT	O
DM	NN	B-Disease
mutation	NN	O
acts	VBZ	O
in	IN	O
cis	NN	O
to	TO	O
reduce	VB	O
protein	NN	O
production	NN	O
(	-LRB-	O
consistent	JJ	O
with	IN	O
DMPK	NN	B-Disease
haploinsufficiency	NN	I-Disease
)	-RRB-	O
and	CC	O
in	IN	O
trans	JJ	O
as	IN	O
a	DT	O
riboregulator	NN	O
to	TO	O
inhibit	VB	O
myogenesis	NN	O
.	.	O

.	.	O

Intelligence	NNP	O
quotient	JJ	O
profile	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
intergenerational	JJ	O
deficit	NN	O
,	,	O
and	CC	O
correlation	NN	O
with	IN	O
CTG	NNP	O
amplification	NN	O
.	.	O

An	DT	O
abbreviated	JJ	O
Wechsler	NNP	O
Adult	NN	O
Intelligence	NNP	O
Scale	NNP	O
Revised	VBN	O
(	-LRB-	O
WAIS-R	NN	O
)	-RRB-	O
was	VBD	O
used	VBN	O
to	TO	O
assess	VB	O
verbal	JJ	O
and	CC	O
arithmetical	JJ	O
cognitive	JJ	O
performance	NN	O
in	IN	O
55	CD	O
subjects	NNS	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
,	,	O
covering	VBG	O
all	DT	O
grades	NNS	O
of	IN	O
disease	NN	O
severity	NN	O
,	,	O
and	CC	O
31	CD	O
controls	NNS	O
at	IN	O
50	CD	O
%	NN	O
risk	NN	O
of	IN	O
inheriting	VBG	O
DM	NN	B-Disease
.	.	O

Scaled	VBN	O
scores	NNS	O
from	IN	O
the	DT	O
assessment	NN	O
were	VBD	O
converted	VBN	O
into	IN	O
an	DT	O
intelligence	NN	O
quotient	NN	O
(	-LRB-	O
IQ	NNP	O
)	-RRB-	O
estimation	NN	O
on	IN	O
each	DT	O
person	NN	O
.	.	O

Significant	JJ	O
IQ	NNP	O
differences	NNS	O
were	VBD	O
found	VBN	O
between	IN	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
all	DT	O
55	CD	O
DM	NN	B-Disease
subjects	NNS	O
(	-LRB-	O
mean	VB	O
90	CD	O
.	.	O

2	CD	O
,	,	O
SD	NN	O
16	CD	O
.	.	O

1	LS	O
)	-RRB-	O
and	CC	O
31	CD	O
controls	NNS	O
(	-LRB-	O
102	CD	O
.	.	O

6	CD	O
,	,	O
SD	NN	O
9	CD	O
.	.	O

4	LS	O
)	-RRB-	O
,	,	O
with	IN	O
no	DT	O
sex	NN	O
differences	NNS	O
in	IN	O
either	DT	O
group	NN	O
;	:	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
15	CD	O
affected	VBN	O
parents	NNS	O
(	-LRB-	O
99	CD	O
.	.	O

3	CD	O
,	,	O
SD	NN	O
12	CD	O
.	.	O

2	LS	O
)	-RRB-	O
and	CC	O
their	PRP$	O
affected	JJ	O
children	NNS	O
(	-LRB-	O
88	CD	O
.	.	O

1	CD	O
,	,	O
SD	NN	O
17	CD	O
.	.	O

2	LS	O
)	-RRB-	O
,	,	O
where	WRB	O
significance	NN	O
was	VBD	O
dependent	JJ	O
on	IN	O
parental	JJ	O
sex	NN	O
being	VBG	O
female	JJ	O
;	:	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
15	CD	O
pairs	NNS	O
of	IN	O
affected	VBN	O
sibs	NNS	O
(	-LRB-	O
89	CD	O
.	.	O

6	CD	O
,	,	O
SD	NN	O
13	CD	O
.	.	O

2	LS	O
)	-RRB-	O
and	CC	O
their	PRP$	O
normal	JJ	O
sibs	NNS	O
(	-LRB-	O
100	CD	O
.	.	O

2	CD	O
,	,	O
SD	NN	O
7	CD	O
.	.	O

6	CD	O
)	-RRB-	O
.	.	O

IQ	NNP	O
steadily	RB	O
declined	VBD	O
as	IN	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
the	DT	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
signs	NNS	O
and	CC	O
symptoms	NNS	O
decreased	VBD	O
,	,	O
and	CC	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
the	DT	O
CTG	NNP	O
expansion	NN	O
size	NN	O
increased	VBD	O
.	.	O

The	DT	O
correlation	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
more	RBR	O
linear	JJ	O
with	IN	O
age	NN	O
of	IN	O
onset	NN	O
.	.	O

The	DT	O
correlation	NN	O
of	IN	O
IQ	NNP	O
difference	NN	O
and	CC	O
CTG	NN	O
expansion	NN	O
difference	NN	O
in	IN	O
both	CC	O
the	DT	O
DM	NN	B-Disease
parent-child	JJ	O
pairs	NNS	O
and	CC	O
normal	JJ	O
sib-affected	JJ	O
sib	NN	O
pairs	NNS	O
was	VBD	O
poor	JJ	O
,	,	O
indicating	VBG	O
that	IN	O
CTG	NNP	O
expansion	NN	O
is	VBZ	O
not	RB	O
a	DT	O
reliable	JJ	O
predictor	NN	O
of	IN	O
IQ	NNP	O
either	CC	O
in	IN	O
individual	JJ	O
persons	NNS	O
or	CC	O
families	NNS	O
.	.	O

Further	JJ	O
analysis	NN	O
of	IN	O
cognitive	JJ	O
function	NN	O
in	IN	O
DM	NN	B-Disease
is	VBZ	O
required	VBN	O
to	TO	O
clarify	VB	O
specific	JJ	O
deficits	NNS	O
characteristic	JJ	O
of	IN	O
this	DT	O
patient	NN	O
group	NN	O

Complement	NN	B-Disease
factor	NN	I-Disease
2	CD	I-Disease
deficiency	NN	I-Disease
:	:	O
a	DT	O
clinical	JJ	O
and	CC	O
serological	JJ	O
family	NN	O
study	NN	O
.	.	O

Inherited	VBN	B-Disease
complement	NN	I-Disease
deficiencies	NNS	I-Disease
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
connective	JJ	O
tissue	NN	O
diseases	NNS	O
.	.	O

A	DT	O
family	NN	O
with	IN	O
inherited	VBN	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
factor	NN	I-Disease
2	CD	I-Disease
(	-LRB-	O
C2	NN	O
)	-RRB-	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
two	CD	O
family	NN	O
members	NNS	O
with	IN	O
homozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
developed	VBD	O
cutaneous	JJ	B-Disease
vasculitis	NN	I-Disease
and	CC	O
sicca	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
other	JJ	O
family	NN	O
members	NNS	O
had	VBD	O
heterozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
each	DT	O
member	NN	O
had	VBD	O
the	DT	O
HLA-A25	NN	O
,	,	O
B18	NN	O
,	,	O
DR2	NN	O
(	-LRB-	O
w15	NN	O
)	-RRB-	O
haplotype	NN	O
.	.	O

The	DT	O
mother	NN	O
had	VBD	O
seropositive	JJ	B-Disease
rheumatoid	JJ	I-Disease
arthritis	NN	I-Disease
.	.	O

Further	JJ	O
studies	NNS	O
showed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
cryoglobulins	NNS	O
,	,	O
antibodies	NNS	O
against	IN	O
endothelial	JJ	O
cells	NNS	O
,	,	O
and	CC	O
anticardiolipin	JJ	O
antibodies	NNS	O
.	.	O

.	.	O

Oncogenic	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
exon	NN	O
20	CD	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
in	IN	O
families	NNS	O
showing	VBG	O
incomplete	JJ	O
penetrance	NN	O
and	CC	O
mild	JJ	O
expression	NN	O
of	IN	O
the	DT	O
retinoblastoma	NN	B-Disease
phenotype	NN	O
.	.	O

The	DT	O
retinoblastoma-predisposition	NN	O
gene	NN	O
,	,	O
RB1	NN	O
,	,	O
segregates	VBZ	O
as	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
trait	NN	O
with	IN	O
high	JJ	O
(	-LRB-	O
90	CD	O
%	NN	O
)	-RRB-	O
penetrance	NN	O
.	.	O

Certain	JJ	O
families	NNS	O
,	,	O
however	RB	O
,	,	O
show	VBP	O
an	DT	O
unusual	JJ	O
low-penetrance	JJ	O
phenotype	NN	O
with	IN	O
many	JJ	O
individuals	NNS	O
being	VBG	O
unaffected	JJ	O
,	,	O
unilaterally	RB	O
affected	VBN	O
,	,	O
or	CC	O
with	IN	O
evidence	NN	O
of	IN	O
spontaneously	RB	O
regressed	VBN	O
tumors	NNS	B-Disease
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
PCR	NN	O
sequencing	NN	O
to	TO	O
study	VB	O
two	CD	O
such	JJ	O
families	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
exon	NN	O
20	CD	O
of	IN	O
RB1	NN	O
in	IN	O
both	DT	O
cases	NNS	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
a	DT	O
C	NN	O
----	:	O
T	NN	O
transition	NN	O
in	IN	O
codon	NN	O
661	CD	O
converts	VBZ	O
an	DT	O
arginine	NN	O
(	-LRB-	O
CGG	NN	O
)	-RRB-	O
to	TO	O
a	DT	O
tryptophan	NN	O
(	-LRB-	O
TGG	NN	O
)	-RRB-	O
codon	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
incomplete	JJ	O
penetrance	NN	O
and	CC	O
mild	JJ	O
phenotypic	JJ	O
expression	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
virtually	RB	O
all	DT	O
patients	NNS	O
,	,	O
possibly	RB	O
indicating	VBG	O
that	IN	O
single	JJ	O
amino	NN	O
acid	NN	O
changes	NNS	O
may	MD	O
modify	VB	O
protein	NN	O
structure/function	NN	O
such	JJ	O
that	IN	O
tumorigenesis	NN	O
is	VBZ	O
not	RB	O
inevitable	JJ	O
.	.	O

In	IN	O
the	DT	O
second	JJ	O
family	NN	O
the	DT	O
mutation	NN	O
in	IN	O
codon	NN	O
675	CD	O
is	VBZ	O
a	DT	O
G	NN	O
----	:	O
T	NN	O
transversion	NN	O
that	WDT	O
converts	VBZ	O
a	DT	O
glutamine	NN	O
(	-LRB-	O
GAA	NN	O
)	-RRB-	O
to	TO	O
a	DT	O
stop	NN	O
(	-LRB-	O
TAA	NN	O
)	-RRB-	O
codon	NN	O
.	.	O

However	RB	O
,	,	O
this	DT	O
mutation	NN	O
also	RB	O
occurs	VBZ	O
near	IN	O
a	DT	O
potential	JJ	O
cryptic	JJ	O
splice	NN	O
acceptor	NN	O
site	NN	O
,	,	O
raising	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
alternative	JJ	O
splicing	NN	O
resulting	VBG	O
in	IN	O
a	DT	O
less	JJR	O
severely	RB	O
disrupted	VBN	O
protein	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
a	DT	O
novel	JJ	O
R21X	NN	O
mutation	NN	O
in	IN	O
the	DT	O
liver-type	JJ	O
arginase	NN	O
gene	NN	O
(	-LRB-	O
ARG1	NN	O
)	-RRB-	O
in	IN	O
four	CD	O
Portuguese	NN	O
patients	NNS	O
with	IN	O
argininemia	NN	B-Disease
.	.	O

Argininemia	NN	B-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
autossomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
deficiency	NN	B-Disease
in	IN	I-Disease
the	DT	I-Disease
cytosolic	JJ	I-Disease
liver-type	JJ	I-Disease
arginase	NN	I-Disease
enzyme	NN	I-Disease
(	-LRB-	O
L-arginine	NN	O
urea-hydrolase	NN	O
;	:	O
E.	NNP	O
C.	NNP	O
3	CD	O
.	.	O

5	CD	O
.	.	O

3	LS	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
investigate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
argininemia	NN	B-Disease
in	IN	O
four	CD	O
unrelated	JJ	O
Portuguese	NN	O
patients	NNS	O
(	-LRB-	O
two	CD	O
from	IN	O
northern	JJ	O
Portugal	NNP	O
and	CC	O
two	CD	O
from	IN	O
Madeira	NNP	O
Island	NNP	O
)	-RRB-	O
we	PRP	O
performed	VBD	O
a	DT	O
DNA	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
all	PDT	O
the	DT	O
exons	NNS	O
and	CC	O
exon/intron	NN	O
boundaries	NNS	O
of	IN	O
the	DT	O
liver-type	JJ	O
arginase	NN	O
gene	NN	O
(	-LRB-	O
ARG1	NN	O
)	-RRB-	O
.	.	O

All	DT	O
patients	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
newly	RB	O
identified	VBN	O
C	NN	O
-	:	O
>	JJR	O
T	NN	O
transition	NN	O
in	IN	O
codon	NN	O
21	CD	O
(	-LRB-	O
exon	NN	O
2	CD	O
)	-RRB-	O
substituting	VBG	O
arginine	NN	O
for	IN	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
(	-LRB-	O
R21X	NN	O
CGA	NN	O
to	TO	O
TGA	NN	O
)	-RRB-	O
and	CC	O
generating	VBG	O
a	DT	O
NlaIII	NN	O
restriction	NN	O
site	NN	O
.	.	O

Restriction	NN	O
digestion	NN	O
following	VBG	O
PCR	NN	O
amplification	NN	O
of	IN	O
ARG1	NN	O
exon	NN	O
2	CD	O
confirmed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
mutation	NN	O
.	.	O

A	DT	O
mutation	NN	O
in	IN	O
the	DT	O
pleckstrin	NN	O
homology	NN	O
(	-LRB-	O
PH	NN	O
)	-RRB-	O
domain	NN	O
of	IN	O
the	DT	O
FGD1	NN	O
gene	NN	O
in	IN	O
an	DT	O
Italian	JJ	O
family	NN	O
with	IN	O
faciogenital	JJ	B-Disease
dysplasia	NN	I-Disease
(	-LRB-	O
Aarskog-Scott	NN	B-Disease
syndrome	NN	I-Disease
)	-RRB-	O
.	.	O

Aarskog-Scott	NNP	B-Disease
Syndrome	NN	I-Disease
(	-LRB-	O
AAS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
disorder	NN	I-Disease
characterised	VBN	O
by	IN	O
short	JJ	B-Disease
stature	NN	I-Disease
and	CC	O
multiple	JJ	O
facial	JJ	B-Disease
,	,	I-Disease
limb	NN	I-Disease
and	CC	I-Disease
genital	JJ	I-Disease
abnormalities	NNS	I-Disease
.	.	O

A	DT	O
gene	NN	O
,	,	O
FGD1	NN	O
,	,	O
altered	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
AAS	NN	B-Disease
phenotype	NN	O
,	,	O
has	VBZ	O
been	VBN	O
identified	VBN	O
and	CC	O
found	VBN	O
to	TO	O
encode	VB	O
a	DT	O
protein	NN	O
with	IN	O
homology	NN	O
to	TO	O
Rho/Rac	NNP	O
guanine	NN	O
nucleotide	NN	O
exchange	NN	O
factors	NNS	O
(	-LRB-	O
Rho/Rac	NNP	O
GEF	NNP	O
)	-RRB-	O
.	.	O

However	RB	O
,	,	O
since	IN	O
this	DT	O
original	JJ	O
report	NN	O
on	IN	O
identification	NN	O
of	IN	O
a	DT	O
mutated	VBN	O
FGD1	NN	O
gene	NN	O
in	IN	O
an	DT	O
AAS	NN	B-Disease
patient	NN	O
,	,	O
no	DT	O
additional	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
FGD1	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
analysed	VBD	O
13	CD	O
independent	JJ	O
patients	NNS	O
with	IN	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
AAS	NNP	B-Disease
.	.	O

One	CD	O
patient	NN	O
presented	VBD	O
a	DT	O
mutation	NN	O
that	WDT	O
results	VBZ	O
in	IN	O
a	DT	O
nucleotide	NN	O
change	NN	O
in	IN	O
exon	NN	O
10	CD	O
of	IN	O
the	DT	O
FGD1	NN	O
gene	NN	O
(	-LRB-	O
G2559	NN	O
>	JJR	O
A	NN	O
)	-RRB-	O
substituting	VBG	O
a	DT	O
Gln	NN	O
for	IN	O
Arg	NN	O
in	IN	O
position	NN	O
610	CD	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
found	VBN	O
to	TO	O
segregate	VB	O
with	IN	O
the	DT	O
AAS	NNP	B-Disease
phenotype	NN	O
in	IN	O
affected	VBN	O
males	NNS	O
and	CC	O
carrier	NN	O
females	NNS	O
in	IN	O
the	DT	O
family	NN	O
of	IN	O
this	DT	O
patient	NN	O
.	.	O

Interestingly	RB	O
,	,	O
Arg-610	NN	O
is	VBZ	O
located	JJ	O
within	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
pleckstrin	NN	O
homology	NN	O
(	-LRB-	O
PH	NN	O
)	-RRB-	O
domains	NNS	O
of	IN	O
the	DT	O
FGD1	NN	O
gene	NN	O
and	CC	O
it	PRP	O
corresponds	VBZ	O
to	TO	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
which	WDT	O
has	VBZ	O
been	VBN	O
involved	VBN	O
in	IN	O
InsP	NN	O
binding	NN	O
in	IN	O
PH	NN	O
domains	NNS	O
of	IN	O
other	JJ	O
proteins	NNS	O
.	.	O

The	DT	O
same	JJ	O
residue	NN	O
is	VBZ	O
often	RB	O
mutated	VBN	O
in	IN	O
the	DT	O
Brutons	NNPS	O
tyrosine	NN	O
kinase	NN	O
(	-LRB-	O
Btk	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
an	DT	O
X-linked	JJ	B-Disease
agammaglobulinemia	NN	I-Disease
.	.	O

The	DT	O
Arg610Gln	NN	O
mutation	NN	O
represents	VBZ	O
the	DT	O
first	JJ	O
case	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
PH	NN	O
domain	NN	O
of	IN	O
the	DT	O
FGD1	NN	O
gene	NN	O
and	CC	O
additional	JJ	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
PH	NN	O
domains	NNS	O
can	MD	O
be	VB	O
associated	VBN	O
to	TO	O
human	JJ	O
diseases	NNS	O
.	.	O

.	.	O

Localization	NN	O
of	IN	O
histidase	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
region	NN	O
12q22	NN	O
----	:	O
q24	NN	O
.1	NN	O
and	CC	O
mouse	NN	O
chromosome	NN	O
region	NN	O
10C2	CD	O
----	:	O
D1	NN	O
.	.	O

The	DT	O
human	JJ	O
gene	NN	O
for	IN	O
histidase	NN	O
(	-LRB-	O
histidine	NN	O
ammonia-lyase	NN	O
;	:	O
HAL	NNP	O
)	-RRB-	O
,	,	O
the	DT	O
enzyme	NN	O
deficient	JJ	O
in	IN	O
histidinemia	NN	B-Disease
,	,	O
was	VBD	O
assigned	VBN	O
to	TO	O
human	JJ	O
chromosome	NN	O
12	CD	O
by	IN	O
Southern	NN	O
blot	NN	O
analysis	NN	O
of	IN	O
human	JJ	O
X	NN	O
mouse	NN	O
somatic	JJ	O
cell	NN	O
hybrid	NN	O
DNA	NN	O
.	.	O

The	DT	O
gene	NN	O
was	VBD	O
sublocalized	VBN	O
to	TO	O
region	NN	O
12q22	NN	O
----	:	O
q24	NN	O
.	.	O

1	CD	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
,	,	O
using	VBG	O
a	DT	O
human	JJ	O
histidase	NN	O
cDNA	NN	O
.	.	O

The	DT	O
homologous	JJ	O
locus	NN	O
in	IN	O
the	DT	O
mouse	NN	O
(	-LRB-	O
Hal	NNP	O
)	-RRB-	O
was	VBD	O
mapped	VBN	O
to	TO	O
region	NN	O
10C2	NN	O
----	:	O
D1	NN	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
,	,	O
using	VBG	O
a	DT	O
cell	NN	O
line	NN	O
from	IN	O
a	DT	O
mouse	NN	O
homozygous	JJ	O
for	IN	O
a	DT	O
1	CD	O
.	.	O

10	CD	O
Robertsonian	JJ	O
translocation	NN	O
.	.	O

These	DT	O
assignments	NNS	O
extend	VBP	O
the	DT	O
conserved	VBN	O
syntenic	JJ	O
region	NN	O
between	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
and	CC	O
mouse	NN	O
chromosome	NN	O
10	CD	O
that	WDT	O
includes	VBZ	O
the	DT	O
genes	NNS	O
for	IN	O
phenylalanine	NN	O
hydroxylase	NN	O
,	,	O
gamma	NN	O
interferon	NN	O
,	,	O
peptidase	NN	O
,	,	O
and	CC	O
citrate	NN	O
synthase	NN	O
.	.	O

The	DT	O
localization	NN	O
of	IN	O
histidase	NN	O
to	TO	O
mouse	NN	O
chromosome	NN	O
10	CD	O
suggests	VBZ	O
that	IN	O
the	DT	O
histidase	NN	O
regulatory	JJ	O
locus	NN	O
(	-LRB-	O
Hsd	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
histidinemia	NN	O
mutation	NN	O
(	-LRB-	O
his	PRP$	O
)	-RRB-	O
,	,	O
which	WDT	O
are	VBP	O
both	DT	O
known	VBN	O
to	TO	O
be	VB	O
on	IN	O
chromosome	NN	O
10	CD	O
,	,	O
may	MD	O
be	VB	O
alleles	NNS	O
of	IN	O
the	DT	O
histidase	JJ	O
structural	JJ	O
gene	NN	O
locus	NN	O
.	.	O

Noninvasive	JJ	O
test	NN	O
for	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
using	VBG	O
hair	NN	O
root	NN	O
analysis	NN	O
.	.	O

Identification	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
and	CC	O
the	DT	O
repeat-amplification	NN	O
mechanism	NN	O
causing	VBG	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
led	VBD	O
to	TO	O
development	NN	O
of	IN	O
reliable	JJ	O
DNA-based	JJ	O
diagnostic	JJ	O
methods	NNS	O
,	,	O
including	VBG	O
Southern	NN	O
blot	NN	O
hybridization	NN	O
and	CC	O
PCR	NN	O
.	.	O

Both	DT	O
methods	NNS	O
are	VBP	O
performed	VBN	O
on	IN	O
DNA	NN	O
isolated	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
and	CC	O
measure	VB	O
the	DT	O
repeat	NN	O
size	NN	O
in	IN	O
FMR1	NN	O
.	.	O

Using	VBG	O
an	DT	O
immunocytochemical	JJ	O
technique	NN	O
on	IN	O
blood	NN	O
smears	NNS	O
,	,	O
we	PRP	O
recently	RB	O
developed	VBD	O
a	DT	O
novel	JJ	O
test	NN	O
for	IN	O
identification	NN	O
of	IN	O
patients	NNS	O
with	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

This	DT	O
method	NN	O
,	,	O
also	RB	O
called	VBN	O
"	''	O
antibody	NN	O
test	NN	O
,	,	O
"	''	O
uses	VBZ	O
monoclonal	JJ	O
antibodies	NNS	O
against	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
product	NN	O
(	-LRB-	O
FMRP	NN	O
)	-RRB-	O
and	CC	O
is	VBZ	O
based	VBN	O
on	IN	O
absence	NN	O
of	IN	O
FMRP	NN	O
in	IN	O
patients	NNS	O
cells	NNS	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
a	DT	O
new	JJ	O
diagnostic	JJ	O
test	NN	O
to	TO	O
identify	VB	O
male	JJ	O
patients	NNS	O
with	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
lack	NN	O
of	IN	O
FMRP	NN	O
in	IN	O
their	PRP$	O
hair	NN	O
roots	NNS	O
.	.	O

Expression	NN	O
of	IN	O
FMRP	NN	O
in	IN	O
hair	NN	O
roots	NNS	O
was	VBD	O
studied	VBN	O
by	IN	O
use	NN	O
of	IN	O
an	DT	O
FMRP-specific	JJ	O
antibody	NN	O
test	NN	O
,	,	O
and	CC	O
the	DT	O
percentage	NN	O
of	IN	O
FMRP-expressing	JJ	O
hair	NN	O
roots	NNS	O
in	IN	O
controls	NNS	O
and	CC	O
in	IN	O
male	JJ	O
fragile	JJ	B-Disease
X	NN	I-Disease
patients	NNS	O
was	VBD	O
determined	VBN	O
.	.	O

Control	NNP	O
individuals	NNS	O
showed	VBD	O
clear	JJ	O
expression	NN	O
of	IN	O
FMRP	NN	O
in	IN	O
nearly	RB	O
every	DT	O
hair	NN	O
root	NN	O
,	,	O
whereas	IN	O
male	JJ	O
fragile	JJ	B-Disease
X	NN	I-Disease
patients	NNS	O
lacked	VBD	O
expression	NN	O
of	IN	O
FMRP	NN	O
in	IN	O
almost	RB	O
all	DT	O
their	PRP$	O
hair	NN	O
roots	NNS	O
.	.	O

Mentally	RB	B-Disease
retarded	VBN	I-Disease
female	JJ	O
patients	NNS	O
with	IN	O
a	DT	O
full	JJ	O
mutation	NN	O
showed	VBD	O
FMRP	NN	O
expression	NN	O
in	IN	O
only	RB	O
some	DT	O
of	IN	O
their	PRP$	O
hair	NN	O
roots	NNS	O
(	-LRB-	O
<	JJR	O
55	CD	O
%	NN	O
)	-RRB-	O
,	,	O
and	CC	O
no	DT	O
overlap	VBP	O
with	IN	O
normal	JJ	O
female	JJ	O
controls	NNS	O
was	VBD	O
observed	VBN	O
.	.	O

The	DT	O
advantages	NNS	O
of	IN	O
this	DT	O
test	NN	O
are	VBP	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
plucking	VBG	O
of	IN	O
hair	NN	O
follicles	NNS	O
does	VBZ	O
no	DT	O
appreciable	JJ	O
harm	NN	O
to	TO	O
the	DT	O
mentally	RB	B-Disease
retarded	JJ	I-Disease
patient	NN	O
,	,	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
hairs	NNS	O
can	MD	O
be	VB	O
sent	VBN	O
in	IN	O
a	DT	O
simple	JJ	O
envelope	NN	O
to	TO	O
a	DT	O
diagnostic	JJ	O
center	NN	O
,	,	O
and	CC	O
(	-LRB-	O
3	LS	O
)	-RRB-	O
the	DT	O
result	NN	O
of	IN	O
the	DT	O
test	NN	O
is	VBZ	O
available	JJ	O
within	IN	O
5	CD	O
h	NN	O
of	IN	O
plucking	VBG	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
this	DT	O
test	NN	O
enabled	VBD	O
us	PRP	O
to	TO	O
identify	VB	O
two	CD	O
fragile	JJ	B-Disease
X	NN	I-Disease
patients	NNS	O
who	WP	O
did	VBD	O
not	RB	O
show	VB	O
the	DT	O
full	JJ	O
mutation	NN	O
by	IN	O
analysis	NN	O
of	IN	O
DNA	NN	O
isolated	VBN	O
from	IN	O
blood	NN	O
cells	NNS	O
.	.	O

.	.	O

Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
:	:	O
detection	NN	O
of	IN	O
mutations	NNS	O
Thr181	NN	O
----	:	O
Pro	FW	O
and	CC	O
Leu223	NN	O
----	:	O
Pro	FW	O
in	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
gene	NN	O
,	,	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

A	DT	O
family	NN	O
with	IN	O
an	DT	O
apparent	JJ	O
history	NN	O
of	IN	O
X-linked	JJ	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
presented	VBN	O
for	IN	O
genetic	JJ	O
counseling	NN	O
,	,	O
requesting	VBG	O
carrier	NN	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
.	.	O

RFLP	NN	O
analysis	NN	O
using	VBG	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
probe	NN	O
was	VBD	O
uninformative	JJ	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

A	DT	O
prenatal	JJ	O
diagnosis	NN	O
on	IN	O
a	DT	O
chorionic	JJ	O
villus	NN	O
sample	NN	O
(	-LRB-	O
CVS	NN	O
)	-RRB-	O
was	VBD	O
carried	VBN	O
out	RP	O
using	VBG	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
analysis	NN	O
of	IN	O
a	DT	O
variant	NN	O
in	IN	O
exon	NN	O
4	CD	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
.	.	O

The	DT	O
fetus	NN	O
was	VBD	O
predicted	VBN	O
to	TO	O
be	VB	O
unaffected	JJ	O
.	.	O

Sequencing	NN	O
of	IN	O
the	DT	O
exon	NN	O
from	IN	O
the	DT	O
CVS	NNP	O
,	,	O
the	DT	O
predicted-carrier	NN	O
mother	NN	O
,	,	O
and	CC	O
the	DT	O
obligate-carrier	NN	O
grandmother	NN	O
revealed	VBD	O
an	DT	O
A-to-C	JJ	O
change	NN	O
at	IN	O
nucleotide	NN	O
541	CD	O
in	IN	O
the	DT	O
two	CD	O
women	NNS	O
but	CC	O
not	RB	O
in	IN	O
the	DT	O
fetus	NN	O
.	.	O

As	IN	O
this	DT	O
change	NN	O
results	VBZ	O
in	IN	O
a	DT	O
Thr-to-Pro	NNP	O
change	NN	O
at	IN	O
amino	NN	O
acid	NN	O
181	CD	O
in	IN	O
a	DT	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
predicted	VBN	O
to	TO	O
be	VB	O
part	NN	O
of	IN	O
a	DT	O
transmembrane	JJ	O
segment	NN	O
,	,	O
it	PRP	O
was	VBD	O
concluded	VBN	O
that	IN	O
this	DT	O
was	VBD	O
the	DT	O
mutation	NN	O
causing	VBG	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
in	IN	O
a	DT	O
second	JJ	O
family	NN	O
,	,	O
an	DT	O
exon	NN	O
5	CD	O
variant	JJ	O
band	NN	O
pattern	NN	O
on	IN	O
SSCP	NN	O
analysis	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
sequencing	NN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
T-to-C	JJ	O
change	NN	O
at	IN	O
nucleotide	NN	O
668	CD	O
.	.	O

This	DT	O
results	VBZ	O
in	IN	O
a	DT	O
Leu-to-Pro	NNP	O
change	NN	O
in	IN	O
a	DT	O
carrier	NN	O
mother	NN	O
and	CC	O
in	IN	O
her	PRP$	O
two	CD	O
affected	JJ	O
sons	NNS	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
further	JJ	O
examples	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
PLP	NN	O
that	WDT	O
cause	VBP	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
illustrate	VBP	O
the	DT	O
value	NN	O
of	IN	O
SSCP	NN	O
in	IN	O
genetic	JJ	O
analysis	NN	O
.	.	O

.	.	O

A	DT	O
normal	JJ	O
male	NN	O
with	IN	O
an	DT	O
inherited	VBN	O
deletion	NN	O
of	IN	O
one	CD	O
exon	NN	O
within	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

We	PRP	O
describe	VBP	O
two	CD	O
brothers	NNS	O
with	IN	O
identical	JJ	O
inherited	VBN	O
deletions	NNS	O
of	IN	O
one	CD	O
single	JJ	O
exon	NN	O
within	IN	O
the	DT	O
middle	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
;	:	O
one	CD	O
brother	NN	O
has	VBZ	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
diagnosed	VBD	O
at	IN	O
11	CD	O
years	NNS	O
of	IN	O
age	NN	O
,	,	O
whereas	IN	O
the	DT	O
older	JJR	O
brother	NN	O
is	VBZ	O
normal	JJ	O
at	IN	O
18	CD	O
.	.	O

These	DT	O
results	NNS	O
have	VBP	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counselling	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
in	IN	O
families	NNS	O
with	IN	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

.	.	O

Small	JJ	O
deletions	NNS	O
in	IN	O
the	DT	O
type	NN	O
II	CD	O
collagen	NN	O
triple	JJ	O
helix	NN	O
produce	VBP	O
kniest	NN	B-Disease
dysplasia	NN	I-Disease
.	.	O

Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
is	VBZ	O
a	DT	O
moderately	RB	O
severe	JJ	O
type	NN	B-Disease
II	CD	I-Disease
collagenopathy	NN	I-Disease
,	,	O
characterized	VBN	O
by	IN	O
short	JJ	O
trunk	NN	O
and	CC	O
limbs	NNS	O
,	,	O
kyphoscoliosis	NN	B-Disease
,	,	O
midface	JJ	B-Disease
hypoplasia	NN	I-Disease
,	,	O
severe	JJ	O
myopia	NN	B-Disease
,	,	O
and	CC	O
hearing	NN	B-Disease
loss	NN	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
type	NN	O
II	CD	O
collagen	NN	O
(	-LRB-	O
COL2A1	NN	O
)	-RRB-	O
,	,	O
the	DT	O
predominant	JJ	O
protein	NN	O
of	IN	O
cartilage	NN	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
Kniest	NN	B-Disease
dysplasia	NN	I-Disease
.	.	O

All	DT	O
but	CC	O
two	CD	O
of	IN	O
these	DT	O
previously	RB	O
described	VBN	O
mutations	NNS	O
cause	VBP	O
in-frame	RB	O
deletions	NNS	O
in	IN	O
type	NN	O
II	CD	O
collagen	NN	O
,	,	O
either	CC	O
by	IN	O
small	JJ	O
deletions	NNS	O
in	IN	O
the	DT	O
gene	NN	O
or	CC	O
splice	NN	O
site	NN	O
alterations	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
all	DT	O
but	CC	O
one	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
is	VBZ	O
located	JJ	O
between	IN	O
exons	NNS	O
12	CD	O
and	CC	O
24	CD	O
in	IN	O
the	DT	O
COL2A1	NN	O
gene	NN	O
.	.	O

We	PRP	O
used	VBD	O
heteroduplex	JJ	O
analysis	NN	O
to	TO	O
identify	VB	O
sequence	NN	O
anomalies	NNS	O
in	IN	O
five	CD	O
individuals	NNS	O
with	IN	O
Kniest	NN	B-Disease
dysplasia	NN	I-Disease
.	.	O

Sequencing	NN	O
of	IN	O
the	DT	O
index	NN	O
patients	NNS	O
genomic	JJ	O
DNA	NN	O
identified	VBN	O
four	CD	O
new	JJ	O
dominant	JJ	O
mutations	NNS	O
in	IN	O
COL2A1	NN	O
that	WDT	O
result	VBP	O
in	IN	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
a	DT	O
21-bp	JJ	O
deletion	NN	O
in	IN	O
exon	NN	O
16	CD	O
,	,	O
an	DT	O
18-bp	JJ	O
deletion	NN	O
in	IN	O
exon	NN	O
19	CD	O
,	,	O
and	CC	O
4-bp	JJ	O
deletions	NNS	O
in	IN	O
the	DT	O
splice	NN	O
donor	NN	O
sites	NNS	O
of	IN	O
introns	NNS	O
14	CD	O
and	CC	O
20	CD	O
.	.	O

A	DT	O
previously	RB	O
described	VBN	O
28-bp	JJ	O
deletion	NN	O
at	IN	O
the	DT	O
COL2A1	NN	O
exon	NN	O
12-intron	JJ	O
12	CD	O
junction	NN	O
,	,	O
deleting	VBG	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
fifth	JJ	O
case	NN	O
.	.	O

The	DT	O
latter	JJ	O
three	CD	O
mutations	NNS	O
are	VBP	O
predicted	VBN	O
to	TO	O
result	VB	O
in	IN	O
exon	NN	O
skipping	VBG	O
in	IN	O
the	DT	O
mRNA	NN	O
encoded	VBN	O
from	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
results	VBZ	O
from	IN	O
shorter	JJR	O
type	NN	O
II	CD	O
collagen	NN	O
monomers	NNS	O
,	,	O
and	CC	O
support	VBP	O
the	DT	O
hypothesis	NN	O
that	IN	O
alteration	NN	O
of	IN	O
a	DT	O
specific	JJ	O
COL2A1	NN	O
domain	NN	O
,	,	O
which	WDT	O
may	MD	O
span	VB	O
from	IN	O
exons	NNS	O
12	CD	O
to	TO	O
24	CD	O
,	,	O
leads	VBZ	O
to	TO	O
the	DT	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
phenotype	NN	O
.	.	O

.	.	O

Adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
and	CC	O
a	DT	O
cytogenetic	JJ	O
deletion	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
resulting	VBG	O
from	IN	O
a	DT	O
maternal	JJ	O
intrachromosomal	JJ	O
insertion	NN	O
.	.	O

We	PRP	O
present	VBP	O
the	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
findings	NNS	O
in	IN	O
an	DT	O
institutionalised	JJ	O
adult	JJ	O
patient	NN	O
originally	RB	O
referred	VBN	O
for	IN	O
autism	NN	B-Disease
.	.	O

A	DT	O
high	JJ	O
risk	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
was	VBD	O
predicted	VBN	O
when	WRB	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
,	,	O
del	FW	O
(	-LRB-	O
5	CD	O
)	-RRB-	O
(	-LRB-	O
q15q22	NN	O
.	.	O

3	LS	O
)	-RRB-	O
,	,	O
was	VBD	O
detected	VBN	O
in	IN	O
her	PRP$	O
lymphocytes	NNS	O
and	CC	O
deletion	NN	O
of	IN	O
the	DT	O
MCC	NN	O
and	CC	O
APC	NN	B-Disease
genes	NNS	O
confirmed	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
.	.	O

Adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
and	CC	O
carcinoma	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
rectum	NN	I-Disease
were	VBD	O
subsequently	RB	O
diagnosed	VBN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

She	PRP	O
was	VBD	O
profoundly	RB	O
mentally	RB	B-Disease
retarded	JJ	I-Disease
,	,	O
autistic	JJ	B-Disease
,	,	O
and	CC	O
had	VBD	O
minor	JJ	O
dysmorphic	JJ	B-Disease
features	NNS	I-Disease
consistent	JJ	O
with	IN	O
those	DT	O
of	IN	O
previous	JJ	O
patients	NNS	O
with	IN	O
similar	JJ	O
deletions	NNS	O
.	.	O

The	DT	O
deletion	NN	O
arose	VBD	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
recombination	NN	O
within	IN	O
the	DT	O
small	JJ	O
insertion	NN	O
loop	NN	O
formed	VBN	O
at	IN	O
meiosis	NN	O
by	IN	O
the	DT	O
direct	JJ	O
insertion	NN	O
(	-LRB-	O
dir	NN	O
ins	NNS	O
(	-LRB-	O
5	CD	O
)	-RRB-	O
(	-LRB-	O
q22	NN	O
.	.	O

3q14	NN	O
.	.	O

2q15	NN	O
)	-RRB-	O
)	-RRB-	O
found	VBN	O
in	IN	O
the	DT	O
patients	NNS	O
mother	NN	O
.	.	O

This	DT	O
family	NN	O
further	RB	O
confirms	VBZ	O
the	DT	O
cytogenetic	JJ	O
mapping	NN	O
of	IN	O
both	CC	O
MCC	NN	O
and	CC	O
APC	NN	B-Disease
genes	NNS	O
to	TO	O
5q22	NN	O
and	CC	O
comparison	NN	O
with	IN	O
other	JJ	O
recent	JJ	O
cases	NNS	O
suggests	VBZ	O
that	IN	O
both	DT	O
genes	NNS	O
and	CC	O
their	PRP$	O
closely	RB	O
linked	VBN	O
markers	NNS	O
lie	VBP	O
within	IN	O
the	DT	O
5q22	NN	O
.	.	O

1	CD	O
subband	NN	O

Somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
:	:	O
mutation	NN	O
cluster	NN	O
region	NN	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

We	PRP	O
examined	VBD	O
somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
in	IN	O
63	CD	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
(	-LRB-	O
16	CD	O
adenomas	NNS	B-Disease
and	CC	O
47	CD	O
carcinomas	NNS	B-Disease
)	-RRB-	O
developed	VBN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
and	CC	O
non-FAP	JJ	O
patients	NNS	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
(	-LRB-	O
LOH	NN	O
)	-RRB-	O
at	IN	O
the	DT	O
APC	NN	B-Disease
locus	NN	O
in	IN	O
30	CD	O
tumors	NNS	B-Disease
,	,	O
43	CD	O
other	JJ	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
.	.	O

Twenty-one	CD	O
of	IN	O
them	PRP	O
were	VBD	O
point	NN	O
mutations	NNS	O
;	:	O
16	CD	O
nonsense	NN	O
and	CC	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
and	CC	O
three	CD	O
occurred	VBD	O
in	IN	O
introns	NNS	O
at	IN	O
the	DT	O
splicing	NN	O
site	NN	O
.	.	O

Twenty-two	CD	O
tumors	NNS	B-Disease
had	VBD	O
frameshift	NN	O
mutations	NNS	O
due	JJ	O
to	TO	O
deletion	NN	O
or	CC	O
insertion	NN	O
;	:	O
nineteen	CD	O
of	IN	O
them	PRP	O
were	VBD	O
deletions	NNS	O
of	IN	O
one	CD	O
to	TO	O
31	CD	O
bp	NN	O
and	CC	O
three	CD	O
were	VBD	O
a	DT	O
1-bp	JJ	O
insertion	NN	O
.	.	O

One	CD	O
tumor	NN	B-Disease
had	VBD	O
a	DT	O
1-bp	JJ	O
deletion	NN	O
in	IN	O
an	DT	O
intron	NN	O
near	IN	O
the	DT	O
splicing	NN	O
site	NN	O
.	.	O

Hence	RB	O
,	,	O
41	CD	O
(	-LRB-	O
95	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
43	CD	O
mutations	NNS	O
resulted	VBD	O
in	IN	O
truncation	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
protein	NN	O
.	.	O

Over	IN	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
were	VBD	O
clustered	VBN	O
within	IN	O
a	DT	O
small	JJ	O
region	NN	O
of	IN	O
exon	NN	O
15	CD	O
,	,	O
designated	VBN	O
as	IN	O
MCR	NN	O
(	-LRB-	O
mutation	NN	O
cluster	NN	O
region	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
accounted	VBD	O
for	IN	O
less	JJR	O
than	IN	O
10	CD	O
%	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
.	.	O

Combining	VBG	O
these	DT	O
data	NNS	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
LOH	NNP	O
,	,	O
more	JJR	O
than	IN	O
80	CD	O
%	NN	O
of	IN	O
tumors	NNS	B-Disease
(	-LRB-	O
14	CD	O
adenomas	NNS	B-Disease
and	CC	O
39	CD	O
carcinomas	NNS	B-Disease
)	-RRB-	O
had	VBD	O
at	IN	O
least	JJS	O
one	CD	O
mutation	NN	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
of	IN	O
which	WDT	O
more	JJR	O
than	IN	O
60	CD	O
%	NN	O
(	-LRB-	O
9	CD	O
adenomas	NNS	B-Disease
and	CC	O
23	CD	O
carcinomas	NNS	B-Disease
)	-RRB-	O
had	VBD	O
two	CD	O
mutations	NNS	O
.	.	O

These	DT	O
results	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
somatic	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
development	NN	O
of	IN	O
a	DT	O
great	JJ	O
majority	NN	O
of	IN	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

.	.	O

Identification	NN	O
of	IN	O
an	DT	O
altered	JJ	O
splice	NN	O
site	NN	O
in	IN	O
Ashkenazi	NNP	O
Tay-Sachs	NNPS	B-Disease
disease	NN	I-Disease
.	.	O

Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
resulting	VBG	O
from	IN	O
mutation	NN	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
encoding	VBG	O
the	DT	O
alpha-subunit	NN	O
of	IN	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
,	,	O
beta-N-acetylhexosaminidase	NN	O
A	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

A	DT	O
relatively	RB	O
high	JJ	O
frequency	NN	O
of	IN	O
carriers	NNS	O
(	-LRB-	O
1/27	CD	O
)	-RRB-	O
of	IN	O
a	DT	O
lethal	JJ	O
,	,	O
infantile	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
found	VBN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
yet	RB	O
evident	JJ	O
whether	IN	O
this	DT	O
has	VBZ	O
resulted	VBN	O
from	IN	O
a	DT	O
founder	NN	O
effect	NN	O
and	CC	O
random	JJ	O
genetic	JJ	O
drift	NN	O
or	CC	O
from	IN	O
a	DT	O
selective	JJ	O
advantage	NN	O
of	IN	O
heterozygotes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
single-base	NN	O
mutation	NN	O
in	IN	O
a	DT	O
cloned	VBN	O
fragment	NN	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
from	IN	O
an	DT	O
Ashkenazi	NNP	O
Jewish	NNP	O
patient	NN	O
.	.	O

This	DT	O
change	NN	O
,	,	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
C	NN	O
for	IN	O
G	NN	O
in	IN	O
the	DT	O
first	JJ	O
nucleotide	NN	O
of	IN	O
intron	NN	O
12	CD	O
is	VBZ	O
expected	VBN	O
to	TO	O
result	VB	O
in	IN	O
defective	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
messenger	NN	O
RNA	NN	O
.	.	O

A	DT	O
test	NN	O
for	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
based	VBN	O
on	IN	O
amplification	NN	O
of	IN	O
DNA	NN	O
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
rection	NN	O
and	CC	O
cleavage	NN	O
of	IN	O
a	DT	O
DdeI	NN	O
restriction	NN	O
site	NN	O
generated	VBN	O
by	IN	O
the	DT	O
mutation	NN	O
revealed	VBD	O
that	IN	O
this	DT	O
case	NN	O
and	CC	O
two	CD	O
other	JJ	O
cases	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
,	,	O
infantile	JJ	O
form	NN	O
of	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
are	VBP	O
heterozygous	JJ	O
for	IN	O
two	CD	O
different	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
occurrence	NN	O
of	IN	O
multiple	JJ	O
mutant	JJ	O
alleles	NNS	O
warrants	NNS	O
further	RB	O
examination	NN	O
of	IN	O
the	DT	O
selective	JJ	O
advantage	NN	O
hypothesis	NN	O
.	.	O

.	.	O

Coats	NNP	B-Disease
'	POS	I-Disease
disease	NN	I-Disease
of	IN	O
the	DT	O
retina	NN	O
(	-LRB-	O
unilateral	JJ	B-Disease
retinal	JJ	I-Disease
telangiectasis	NN	I-Disease
)	-RRB-	O
caused	VBN	O
by	IN	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NN	O
gene	NN	O
:	:	O
a	DT	O
role	NN	O
for	IN	O
norrin	NN	O
in	IN	O
retinal	JJ	O
angiogenesis	NN	O
.	.	O

Coats	NNP	B-Disease
disease	NN	I-Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
abnormal	JJ	B-Disease
retinal	JJ	I-Disease
vascular	JJ	I-Disease
development	NN	I-Disease
(	-LRB-	O
so-called	JJ	O
retinal	JJ	B-Disease
telangiectasis	NN	I-Disease
)	-RRB-	O
which	WDT	O
results	VBZ	O
in	IN	O
massive	JJ	O
intraretinal	JJ	B-Disease
and	CC	I-Disease
subretinal	JJ	I-Disease
lipid	NN	I-Disease
accumulation	NN	I-Disease
(	-LRB-	O
exudative	JJ	B-Disease
retinal	JJ	I-Disease
detachment	NN	I-Disease
)	-RRB-	O
.	.	O

The	DT	O
classical	JJ	O
form	NN	O
of	IN	O
Coats	NNP	B-Disease
disease	NN	I-Disease
is	VBZ	O
almost	RB	O
invariably	RB	O
isolated	VBN	O
,	,	O
unilateral	JJ	O
and	CC	O
seen	VBN	O
in	IN	O
males	NNS	O
.	.	O

A	DT	O
female	JJ	O
with	IN	O
a	DT	O
unilateral	JJ	O
variant	NN	O
of	IN	O
Coats	NNP	B-Disease
disease	NN	I-Disease
gave	VBD	O
birth	NN	O
to	TO	O
a	DT	O
son	NN	O
affected	VBN	O
by	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Both	DT	O
carried	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
within	IN	O
the	DT	O
NDP	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
Xp11	NN	O
.	.	O

2	CD	O
2	CD	O
.	.	O

Subsequently	RB	O
analysis	NN	O
of	IN	O
the	DT	O
retinas	NN	O
of	IN	O
nine	CD	O
enucleated	JJ	O
eyes	NNS	O
from	IN	O
males	NNS	O
with	IN	O
Coats	NNP	B-Disease
disease	NN	I-Disease
demonstrated	VBD	O
in	IN	O
one	CD	O
a	DT	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NN	O
gene	NN	O
which	WDT	O
was	VBD	O
not	RB	O
present	JJ	O
within	IN	O
non-retinal	JJ	O
tissue	NN	O
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
Coats	NNP	B-Disease
telangiectasis	NN	I-Disease
is	VBZ	O
secondary	JJ	O
to	TO	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
NDP	NN	O
gene	NN	O
which	WDT	O
results	VBZ	O
in	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
norrin	NN	I-Disease
(	-LRB-	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
NDP	NN	O
gene	NN	O
)	-RRB-	O
within	IN	O
the	DT	O
developing	VBG	O
retina	NN	O
.	.	O

This	DT	O
supports	VBZ	O
recent	JJ	O
observations	NNS	O
that	IN	O
the	DT	O
protein	NN	O
is	VBZ	O
critical	JJ	O
for	IN	O
normal	JJ	O
retinal	JJ	O
vasculogenesis	NN	O
.	.	O

Trisomy	NNP	B-Disease
15	CD	I-Disease
with	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
15	CD	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
due	JJ	O
to	TO	O
maternal	JJ	B-Disease
disomy	NN	I-Disease
.	.	O

Uniparental	JJ	B-Disease
disomy	NN	I-Disease
has	VBZ	O
recently	RB	O
been	VBN	O
recognized	VBN	O
to	TO	O
cause	VB	O
human	JJ	O
disorders	NNS	O
,	,	O
including	VBG	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
particularly	RB	O
instructive	JJ	O
case	NN	O
which	WDT	O
raises	VBZ	O
important	JJ	O
issues	NNS	O
concerning	VBG	O
the	DT	O
mechanisms	NNS	O
producing	VBG	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
and	CC	O
whose	WP$	O
evaluation	NN	O
provides	VBZ	O
evidence	NN	O
that	IN	O
trisomy	NN	O
may	MD	O
precede	VB	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
in	IN	O
a	DT	O
fetus	NN	O
.	.	O

Chorionic	NNP	O
villus	VBZ	O
sampling	NN	O
performed	VBN	O
for	IN	O
advanced	JJ	O
maternal	JJ	O
age	NN	O
revealed	VBD	O
trisomy	NN	B-Disease
15	CD	I-Disease
in	IN	O
all	DT	O
direct	JJ	O
and	CC	O
cultured	VBN	O
cells	NNS	O
,	,	O
though	IN	O
the	DT	O
fetus	NN	O
appeared	VBD	O
normal	JJ	O
.	.	O

Chromosome	NN	O
analysis	NN	O
of	IN	O
amniocytes	NNS	O
obtained	VBN	O
at	IN	O
15	CD	O
wk	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
over	IN	O
100	CD	O
cells	NNS	O
studied	VBN	O
.	.	O

The	DT	O
child	NN	O
was	VBD	O
hypotonic	JJ	B-Disease
at	IN	O
birth	NN	O
,	,	O
and	CC	O
high-resolution	JJ	O
banding	NN	O
failed	VBD	O
to	TO	O
reveal	VB	O
the	DT	O
deletion	NN	O
of	IN	O
15q11-13	NN	O
,	,	O
a	DT	O
deletion	NN	O
which	WDT	O
is	VBZ	O
found	VBN	O
in	IN	O
50	CD	O
%	NN	O
-70	CD	O
%	NN	O
of	IN	O
patients	NNS	O
with	IN	O
PWS	NN	B-Disease
.	.	O

Over	IN	O
time	NN	O
,	,	O
typical	JJ	O
features	NNS	O
of	IN	O
PWS	NN	B-Disease
developed	VBD	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
analysis	NN	O
using	VBG	O
probes	NNS	O
for	IN	O
chromosome	NN	O
15	CD	O
revealed	VBD	O
maternal	JJ	O
disomy	NN	O
.	.	O

Maternal	JJ	O
nondisjunction	NN	O
with	IN	O
fertilization	NN	O
of	IN	O
a	DT	O
disomic	JJ	O
egg	NN	O
by	IN	O
a	DT	O
normal	JJ	O
sperm	NN	O
,	,	O
followed	VBN	O
by	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
15	CD	O
,	,	O
is	VBZ	O
a	DT	O
likely	JJ	O
cause	NN	O
of	IN	O
confined	VBN	O
placental	JJ	O
mosaicism	NN	O
and	CC	O
uniparental	JJ	B-Disease
disomy	NN	I-Disease
in	IN	O
this	DT	O
case	NN	O
of	IN	O
PWS	NNP	B-Disease
,	,	O
and	CC	O
advanced	VBD	O
maternal	JJ	O
age	NN	O
may	MD	O
be	VB	O
a	DT	O
predisposing	NN	O
factor	NN	O
.	.	O

.	.	O

Genetic	JJ	O
defect	NN	B-Disease
in	IN	I-Disease
secretion	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
C5	NN	I-Disease
in	IN	O
mice	NNS	O
.	.	O

A	DT	O
genetic	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
(	-LRB-	I-Disease
C5	NN	I-Disease
)	-RRB-	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement1-3	NN	I-Disease
,	,	O
a	DT	O
serum	NN	O
glycoprotein	NN	O
of	IN	O
molecular	JJ	O
weight	NN	O
(	-LRB-	O
MW	NN	O
)	-RRB-	O
220	CD	O
,	,	O
000	CD	O
(	-LRB-	O
ref	NN	O
.	.	O

4	LS	O
)	-RRB-	O
,	,	O
has	VBZ	O
been	VBN	O
found	VBN	O
in	IN	O
39	CD	O
%	NN	O
of	IN	O
inbred	JJ	O
strains	NNS	O
of	IN	O
mice3	NN	O
.	.	O

Sera	NNP	O
of	IN	O
deficient	JJ	O
mice	NNS	O
lack	VBP	O
detectable	JJ	O
C5	NN	O
activity	NN	O
and	CC	O
protein2	NN	O
,	,	O
3	CD	O
.	.	O

In	IN	O
addition	NN	O
deficient	JJ	O
mice	NNS	O
produce	VBP	O
antibody	NN	O
to	TO	O
mouse	NN	O
C5	NN	O
when	WRB	O
injected	VBN	O
with	IN	O
sera	NNS	O
from	IN	O
C5	NN	O
sufficient	JJ	O
(	-LRB-	O
normal	JJ	O
)	-RRB-	O
strains	NNS	O
.	.	O

Levy	NNP	O
et	FW	O
al.	FW	O
5	CD	O
showed	VBD	O
that	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
between	IN	O
C5	NN	O
deficient	JJ	O
(	-LRB-	O
B10	NN	O
.	.	O

D2/old	NN	O
line	NN	O
)	-RRB-	O
macrophages	NNS	O
and	CC	O
either	CC	O
C5	NN	O
sufficient	JJ	O
(	-LRB-	O
B10	NN	O
.	.	O

D2/new	NN	O
line	NN	O
)	-RRB-	O
mouse	NN	O
kidney	NN	O
or	CC	O
chicken	NN	O
erythroblasts	NNS	O
secreted	VBN	O
haemolytically	RB	O
active	JJ	O
mouse	NN	O
C5	NN	O
in	FW	O
vitro	FW	O
.	.	O

Several	JJ	O
possible	JJ	O
molecular	JJ	O
mechanisms	NNS	O
to	TO	O
account	VB	O
for	IN	O
the	DT	O
findings	NNS	O
were	VBD	O
considered	VBN	O
,	,	O
but	CC	O
insufficient	JJ	O
direct	JJ	O
data	NNS	O
were	VBD	O
available	JJ	O
to	TO	O
choose	VB	O
among	IN	O
them	PRP	O
.	.	O

We	PRP	O
recently	RB	O
reported	VBD	O
that	IN	O
mouse	NN	O
(	-LRB-	O
CD	NN	O
.	.	O

1	CD	O
strain	NN	O
)	-RRB-	O
peritoneal	JJ	O
cells	NNS	O
in	IN	O
culture	NN	O
synthesise	NN	O
and	CC	O
secrete	VB	O
a	DT	O
single	JJ	O
chain	NN	O
precursor	NN	O
,	,	O
pro-C5	NN	O
(	-LRB-	O
MW	NN	O
approximately	RB	O
210	CD	O
,	,	O
000	CD	O
)	-RRB-	O
,	,	O
of	IN	O
the	DT	O
two-chain	JJ	O
(	-LRB-	O
alpha	NN	O
chain	NN	O
,	,	O
125	CD	O
,	,	O
000	CD	O
and	CC	O
beta	NN	O
chain	NN	O
83	CD	O
,	,	O
000	CD	O
MW	NN	O
)	-RRB-	O
C5	NN	O
protein6	NN	O
.	.	O

Radiolabelled	JJ	O
precursor	NN	O
C5	NN	O
was	VBD	O
contained	VBN	O
within	IN	O
the	DT	O
cells	NNS	O
and	CC	O
was	VBD	O
secreted	VBN	O
into	IN	O
the	DT	O
tissue	NN	O
culture	NN	O
media	NNS	O
.	.	O

Using	VBG	O
similar	JJ	O
methods	NNS	O
,	,	O
we	PRP	O
now	RB	O
find	VBP	O
that	IN	O
C5	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
each	DT	O
of	IN	O
five	CD	O
different	JJ	O
mouse	NN	O
strains	NNS	O
(	-LRB-	O
AKR	NN	O
,	,	O
SWR	NN	O
,	,	O
DBA/2J8	NN	O
A/HeJ	NN	O
and	CC	O
B10	NN	O
.	.	O

D2/old	NN	O
line	NN	O
)	-RRB-	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
failure	NN	O
in	IN	O
secretion	NN	O
of	IN	O
C5	NN	O
protein	NN	O
and	CC	O
not	RB	O
to	TO	O
a	DT	O
failure	NN	O
in	IN	O
biosynthesis	NN	O
of	IN	O
pro-C5	NN	O

WASP	NNP	O
gene	NN	O
mutations	NNS	O
in	IN	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
X-linked	JJ	B-Disease
thrombocytopenia	NN	I-Disease
.	.	O

The	DT	O
WASP	NNP	O
gene	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
cloned	VBN	O
from	IN	O
Xp11	NN	O
.	.	O

23	CD	O
and	CC	O
shown	VBN	O
to	TO	O
be	VB	O
mutated	VBN	O
in	IN	O
three	CD	O
patients	NNS	O
with	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
a	DT	O
screening	NN	O
protocol	NN	O
for	IN	O
identifying	VBG	O
WASP	NNP	O
gene	NN	O
alterations	NNS	O
in	IN	O
genomic	JJ	O
DNA	NN	O
and	CC	O
have	VBP	O
identified	VBN	O
a	DT	O
spectrum	NN	O
of	IN	O
novel	JJ	O
mutations	NNS	O
in	IN	O
12	CD	O
additional	JJ	O
unrelated	JJ	O
families	NNS	O
.	.	O

These	DT	O
missense	NN	O
,	,	O
nonsense	NN	O
and	CC	O
frameshift	NN	O
mutations	NNS	O
involve	VBP	O
eight	CD	O
of	IN	O
the	DT	O
12	CD	O
exons	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
creating	VBG	O
premature	JJ	O
termination	NN	O
codons	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
lack	NN	O
of	IN	O
detectable	JJ	O
mRNA	NN	O
on	IN	O
Northern	NN	O
blots	NNS	O
.	.	O

Four	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
Leu27Phe	NN	O
,	,	O
Thr48Ile	NN	O
,	,	O
Val75Met	NN	O
and	CC	O
Arg477Lys	NNS	O
,	,	O
were	VBD	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
congenital	JJ	B-Disease
thrombocytopenia	NN	I-Disease
and	CC	O
no	DT	O
clinically	RB	O
evident	JJ	O
immune	JJ	O
defect	NN	O
indicating	VBG	O
that	IN	O
the	DT	O
WASP	NNP	O
gene	NN	O
is	VBZ	O
the	DT	O
site	NN	O
for	IN	O
mutations	NNS	O
in	IN	O
X-linked	JJ	B-Disease
thrombocytopenia	NN	I-Disease
as	RB	O
well	RB	O
as	IN	O
in	IN	O
WAS	NNP	B-Disease
.	.	O

A	DT	O
T-cell	NN	O
line	NN	O
from	IN	O
a	DT	O
WAS	NNP	B-Disease
patient	NN	O
contained	VBD	O
two	CD	O
independent	JJ	O
DNA	NN	O
alterations	NNS	O
,	,	O
a	DT	O
constitutional	JJ	O
frameshift	NN	O
mutation	NN	O
,	,	O
also	RB	O
present	JJ	O
in	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
from	IN	O
the	DT	O
patient	NN	O
,	,	O
and	CC	O
compensatory	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
unique	JJ	O
to	TO	O
the	DT	O
cell	NN	O
line	NN	O
.	.	O

The	DT	O
distribution	NN	O
of	IN	O
eight	CD	O
missense	NN	O
mutations	NNS	O
provides	VBZ	O
valuable	JJ	O
information	NN	O
on	IN	O
amino	NN	O
acids	NNS	O
which	WDT	O
are	VBP	O
essential	JJ	O
for	IN	O
normal	JJ	O
protein	NN	O
function	NN	O
,	,	O
and	CC	O
suggests	VBZ	O
that	IN	O
sites	NNS	O
in	IN	O
the	DT	O
first	JJ	O
two	CD	O
exons	NNS	O
are	VBP	O
hot-spots	NNS	O
for	IN	O
mutation	NN	O
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
by	IN	O
multiple	JJ	O
SSCP	NN	O
.	.	O

A	DT	O
combination	NN	O
of	IN	O
multiplex	JJ	O
PCR	NN	O
with	IN	O
the	DT	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
technique	NN	O
was	VBD	O
employed	VBN	O
to	TO	O
screen	VB	O
for	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
dystrophin	NN	O
gene	NN	O
.	.	O

Co-amplification	NN	O
of	IN	O
11	CD	O
exons	NNS	O
from	IN	O
genomic	JJ	O
DNA	NN	O
of	IN	O
Duchenne	NNP	B-Disease
and	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD/BMD	NN	O
)	-RRB-	O
patients	NNS	O
with	IN	O
no	DT	O
deletion	NN	O
or	CC	O
duplication	NN	O
was	VBD	O
performed	VBN	O
and	CC	O
the	DT	O
samples	NNS	O
subjected	VBN	O
to	TO	O
multiple	JJ	O
SSCP	NN	O
analysis	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
case	NN	O
of	IN	O
a	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
a	DT	O
Duchenne	NNP	B-Disease
patient	NN	O
identified	VBN	O
by	IN	O
this	DT	O
approach	NN	O
.	.	O

The	DT	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
termination	NN	O
codon	NN	O
within	IN	O
exon	NN	O
8	CD	O
of	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
.	.	O

It	PRP	O
is	VBZ	O
predicted	VBN	O
to	TO	O
cause	VB	O
a	DT	O
very	RB	O
premature	JJ	O
translational	JJ	O
termination	NN	O
accounting	NN	O
for	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
observed	VBN	O
.	.	O

The	DT	O
patient	NN	O
inherited	VBN	O
this	DT	O
mutation	NN	O
from	IN	O
his	PRP$	O
mother	NN	O
.	.	O

In	IN	O
addition	NN	O
the	DT	O
analysis	NN	O
revealed	VBD	O
5	CD	O
polymorphisms	NNS	O
useful	JJ	O
for	IN	O
internal	JJ	O
control	NN	O
.	.	O

.	.	O

Molecular	JJ	O
mechanisms	NNS	O
of	IN	O
oncogenic	JJ	O
mutations	NNS	O
in	IN	O
tumors	NNS	B-Disease
from	IN	O
patients	NNS	O
with	IN	O
bilateral	JJ	B-Disease
and	CC	I-Disease
unilateral	JJ	I-Disease
retinoblastoma	NN	I-Disease
.	.	O

The	DT	O
RB1	NN	O
gene	NN	O
from	IN	O
12	CD	O
human	JJ	O
retinoblastoma	NN	B-Disease
tumors	NNS	I-Disease
has	VBZ	O
been	VBN	O
analyzed	VBN	O
exon-by-exon	JJ	O
with	IN	O
the	DT	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
technique	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
all	DT	O
tumors	NNS	B-Disease
,	,	O
and	CC	O
one-third	NN	O
of	IN	O
the	DT	O
tumors	NNS	B-Disease
had	VBD	O
independent	JJ	O
mutations	NNS	O
in	IN	O
both	DT	O
alleles	NNS	O
neither	DT	O
of	IN	O
which	WDT	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
germ	NN	O
line	NN	O
,	,	O
confirming	VBG	O
their	PRP$	O
true	JJ	O
sporadic	JJ	O
nature	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
two-thirds	NNS	O
of	IN	O
the	DT	O
tumors	NNS	B-Disease
only	RB	O
one	CD	O
mutation	NN	O
was	VBD	O
found	VBN	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
loss-of-heterozygosity	NN	O
theory	NN	O
of	IN	O
tumorigenesis	NN	O
.	.	O

Point	NN	O
mutations	NNS	O
,	,	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
were	VBD	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transitions	NNS	O
,	,	O
were	VBD	O
the	DT	O
most	RBS	O
common	JJ	O
abnormality	NN	O
and	CC	O
usually	RB	O
resulted	VBD	O
in	IN	O
the	DT	O
conversion	NN	O
of	IN	O
an	DT	O
arginine	NN	O
codon	NN	O
to	TO	O
a	DT	O
stop	NN	O
codon	NN	O
.	.	O

Small	JJ	O
deletions	NNS	O
were	VBD	O
the	DT	O
second	JJ	O
most	RBS	O
common	JJ	O
abnormality	NN	O
and	CC	O
most	RBS	O
often	RB	O
created	VBN	O
a	DT	O
downstream	JJ	O
stop	NN	O
codon	NN	O
as	IN	O
the	DT	O
result	NN	O
of	IN	O
a	DT	O
reading	NN	O
frameshift	NN	O
.	.	O

Deletions	NNS	O
and	CC	O
point	NN	O
mutations	NNS	O
also	RB	O
affected	VBD	O
splice	NN	O
junctions	NNS	O
.	.	O

Direct	JJ	O
repeats	NNS	O
were	VBD	O
present	JJ	O
at	IN	O
the	DT	O
breakpoint	NN	O
junctions	NNS	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
deletions	NNS	O
,	,	O
supporting	VBG	O
a	DT	O
slipped-mispairing	JJ	O
mechanism	NN	O
.	.	O

Point	NN	O
mutations	NNS	O
generally	RB	O
produced	VBD	O
DNA	NN	O
sequences	NNS	O
which	WDT	O
resulted	VBD	O
in	IN	O
perfect	JJ	O
homology	NN	O
with	IN	O
endogenous	JJ	O
sequences	NNS	O
which	WDT	O
lay	VBD	O
within	IN	O
14	CD	O
bp	NN	O
.	.	O

.	.	O

PAX6	NN	O
gene	NN	O
dosage	NN	O
effect	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
congenital	JJ	B-Disease
cataracts	NNS	I-Disease
,	,	O
aniridia	NN	B-Disease
,	,	O
anophthalmia	NN	B-Disease
and	CC	O
central	JJ	B-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
defects	NNS	I-Disease
.	.	O

The	DT	O
human	JJ	O
eye	NN	O
malformation	NN	O
aniridia	NN	B-Disease
results	VBZ	O
from	IN	O
haploinsufficiency	NN	B-Disease
of	IN	I-Disease
PAX6	NN	I-Disease
,	,	O
a	DT	O
paired	JJ	O
box	NN	O
DNA-binding	JJ	O
protein	NN	O
.	.	O

To	TO	O
study	VB	O
this	DT	O
dosage	NN	O
effect	NN	O
,	,	O
we	PRP	O
characterized	VBD	O
two	CD	O
PAX6	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
family	NN	O
segregating	VBG	O
aniridia	NN	B-Disease
and	CC	O
a	DT	O
milder	JJR	O
syndrome	NN	O
consisting	VBG	O
of	IN	O
congenital	JJ	B-Disease
cataracts	NNS	I-Disease
and	CC	O
late	JJ	O
onset	NN	O
corneal	NN	B-Disease
dystrophy	NN	I-Disease
.	.	O

The	DT	O
nonsense	NN	O
mutations	NNS	O
,	,	O
at	IN	O
codons	NNS	O
103	CD	O
and	CC	O
353	CD	O
,	,	O
truncate	VBP	O
PAX6	NN	O
within	IN	O
the	DT	O
N-terminal	JJ	O
paired	JJ	O
and	CC	O
C-terminal	JJ	O
PST	NN	O
domains	NNS	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
wild-type	JJ	O
PST	NN	O
domain	NN	O
activates	VBZ	O
transcription	NN	O
autonomously	RB	O
and	CC	O
the	DT	O
mutant	JJ	O
form	NN	O
has	VBZ	O
partial	JJ	O
activity	NN	O
.	.	O

A	DT	O
compound	NN	O
heterozygote	NN	O
had	VBD	O
severe	JJ	O
craniofacial	NN	B-Disease
and	CC	I-Disease
central	JJ	I-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
defects	NNS	I-Disease
and	CC	O
no	DT	B-Disease
eyes	NNS	I-Disease
.	.	O

The	DT	O
pattern	NN	O
of	IN	O
malformations	NNS	O
is	VBZ	O
similar	JJ	O
to	TO	O
that	DT	O
in	IN	O
homozygous	JJ	O
Sey	NN	O
mice	NNS	O
and	CC	O
suggests	VBZ	O
a	DT	O
critical	JJ	O
role	NN	O
for	IN	O
PAX6	NN	O
in	IN	O
controlling	VBG	O
the	DT	O
migration	NN	O
and	CC	O
differentiation	NN	O
of	IN	O
specific	JJ	O
neuronal	JJ	O
progenitor	NN	O
cells	NNS	O
in	IN	O
the	DT	O
brain	NN	O
.	.	O

.	.	O

Hereditary	JJ	B-Disease
C7	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Diagnosis	NN	O
and	CC	O
HLA	NN	O
studies	NNS	O
in	IN	O
a	DT	O
French-Canadian	JJ	O
family	NN	O
.	.	O

The	DT	O
serum	NN	O
of	IN	O
a	DT	O
44-yr-old	JJ	O
woman	NN	O
of	IN	O
French-Canadian	JJ	O
descent	NN	O
having	VBG	O
a	DT	O
B-27	NN	O
positive	JJ	O
ankylosing	NN	B-Disease
spondylitis	NN	I-Disease
was	VBD	O
deficient	JJ	B-Disease
in	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C7	NN	O
)	-RRB-	O
as	IN	O
determined	VBN	O
by	IN	O
hemolytic	JJ	O
and	CC	O
immunochemical	JJ	O
methods	NNS	O
.	.	O

No	DT	O
inhibitor	NN	O
against	IN	O
C7	NN	O
was	VBD	O
detected	VBN	O
,	,	O
and	CC	O
the	DT	O
levels	NNS	O
of	IN	O
all	DT	O
other	JJ	O
complement	NN	O
components	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

No	DT	O
deficiency	NN	O
in	IN	O
the	DT	O
opsonic	JJ	O
activity	NN	O
of	IN	O
the	DT	O
serum	NN	O
was	VBD	O
found	VBN	O
,	,	O
and	CC	O
the	DT	O
results	NNS	O
of	IN	O
basic	JJ	O
coagulation	NN	O
studies	NNS	O
of	IN	O
the	DT	O
plasma	NN	O
were	VBD	O
normal	JJ	O
.	.	O

On	IN	O
investigation	NN	O
of	IN	O
the	DT	O
patients	NNS	O
family	NN	O
,	,	O
two	CD	O
sisters	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
same	JJ	O
deficiency	NN	O
but	CC	O
were	VBD	O
otherwise	RB	O
in	IN	O
good	JJ	O
health	NN	O
.	.	O

The	DT	O
seven	CD	O
other	JJ	O
siblings	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
while	IN	O
the	DT	O
paternal	JJ	O
aunt	NN	O
had	VBD	O
a	DT	O
normal	JJ	O
C7	NN	O
level	NN	O
.	.	O

In	IN	O
the	DT	O
third	JJ	O
generation	NN	O
,	,	O
six	CD	O
children	NNS	O
of	IN	O
the	DT	O
three	CD	O
homozygous	JJ	O
sisters	NNS	O
and	CC	O
five	CD	O
children	NNS	O
of	IN	O
heterozygotes	NNS	O
were	VBD	O
available	JJ	O
for	IN	O
testing	NN	O
.	.	O

Studies	NNS	O
of	IN	O
the	DT	O
HLA	NN	O
antigens	NNS	O
in	IN	O
all	PDT	O
the	DT	O
22	CD	O
subjects	NNS	O
and	CC	O
in	IN	O
three	CD	O
spouses	NNS	O
indicated	VBD	O
no	DT	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
CM	NN	B-Disease
deficienty	NN	I-Disease
and	CC	O
the	DT	O
HLA	NN	O
system	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
simultaneous	JJ	O
occurrence	NN	O
of	IN	O
two	CD	O
hereditary	JJ	O
complement	NN	B-Disease
deficiencies	NNS	I-Disease
(	-LRB-	I-Disease
C2	NN	I-Disease
and	CC	I-Disease
C7	NN	I-Disease
)	-RRB-	I-Disease
was	VBD	O
discovered	VBN	O
in	IN	O
one	CD	O
family	NN	O
of	IN	O
this	DT	O
remarkable	JJ	O
kindred	NN	O
.	.	O

.	.	O

Alstrom	NN	B-Disease
syndrome	NN	I-Disease
:	:	O
further	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
2p13	NN	O
.	.	O

Alstrom	NN	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
,	,	O
sensorineural	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
,	,	O
early-onset	JJ	O
obesity	NN	B-Disease
,	,	O
and	CC	O
non-insulin-dependent	JJ	B-Disease
diabetes	NN	I-Disease
mellitus	NN	I-Disease
.	.	O

The	DT	O
gene	NN	O
for	IN	O
Alstrom	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ALMS1	NN	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
previously	RB	O
localized	JJ	O
to	TO	O
human	JJ	O
chromosome	NN	O
2p13	NN	O
by	IN	O
homozygosity	NN	O
mapping	NN	O
in	IN	O
two	CD	O
distinct	JJ	O
isolated	VBN	O
populations	NNS	O
-	:	O
French	JJ	O
Acadian	JJ	O
and	CC	O
North	JJ	O
African	JJ	O
.	.	O

Pair-wise	JJ	O
analyses	NNS	O
resulted	VBD	O
in	IN	O
maximum	NN	O
lod	NN	O
(	-LRB-	O
logarithm	NN	O
of	IN	O
the	DT	O
odds	NNS	O
ratio	NN	O
)	-RRB-	O
scores	NNS	O
of	IN	O
3	CD	O
.	.	O

84	CD	O
and	CC	O
2	CD	O
.	.	O

9	CD	O
,	,	O
respectively	RB	O
.	.	O

To	TO	O
confirm	VB	O
these	DT	O
findings	NNS	O
,	,	O
a	DT	O
large	JJ	O
linkage	NN	O
study	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
twelve	CD	O
additional	JJ	O
families	NNS	O
segregating	VBG	O
for	IN	O
Alstrom	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
maximum	NN	O
two-point	JJ	O
lod	NN	O
score	NN	O
of	IN	O
7	CD	O
.	.	O

13	CD	O
(	-LRB-	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
)	-RRB-	O
for	IN	O
marker	NN	O
D2S2110	NN	O
and	CC	O
a	DT	O
maximum	NN	O
cumulative	JJ	O
multipoint	NN	O
lod	NN	O
score	NN	O
of	IN	O
9	CD	O
.	.	O

16	CD	O
for	IN	O
marker	NN	O
D2S2110	NN	O
were	VBD	O
observed	VBN	O
,	,	O
further	RB	O
supporting	VBG	O
linkage	NN	O
to	TO	O
chromosome	NN	O
2p13	NN	O
.	.	O

No	DT	O
evidence	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
these	DT	O
families	NNS	O
.	.	O

Meiotic	JJ	O
recombination	NN	O
events	NNS	O
have	VBP	O
localized	VBN	O
the	DT	O
critical	JJ	O
region	NN	O
containing	VBG	O
ALMS1	NN	O
to	TO	O
a	DT	O
6	CD	O
.	.	O

1-cM	JJ	O
interval	NN	O
flanked	VBN	O
by	IN	O
markers	NNS	O
D2S327	NN	O
and	CC	O
D2S286	NN	O
.	.	O

A	DT	O
fine	JJ	O
resolution	NN	O
radiation	NN	O
hybrid	NN	O
map	NN	O
of	IN	O
31	CD	O
genes	NNS	O
and	CC	O
markers	NNS	O
has	VBZ	O
been	VBN	O
constructed	VBN	O
.	.	O

Haplotype	NN	O
and	CC	O
multipoint	NN	O
linkage	NN	O
analysis	NN	O
in	IN	O
Finnish	JJ	O
choroideremia	NN	B-Disease
families	NNS	O
.	.	O

Multipoint	JJ	O
linkage	NN	O
analysis	NN	O
of	IN	O
choroideremia	NN	B-Disease
(	-LRB-	O
TCD	NN	B-Disease
)	-RRB-	O
and	CC	O
seven	CD	O
X	NN	O
chromosomal	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
(	-LRB-	O
RFLPs	NNS	O
)	-RRB-	O
was	VBD	O
carried	VBN	O
out	RP	O
in	IN	O
18	CD	O
Finnish	JJ	O
TCD	NN	B-Disease
families	NNS	O
.	.	O

The	DT	O
data	NNS	O
place	NN	O
TCD	NN	B-Disease
distal	JJ	O
to	TO	O
PGK	NN	O
and	CC	O
DXS72	NN	O
,	,	O
very	RB	O
close	RB	O
to	TO	O
DXYS1	NN	O
and	CC	O
DXYS5	NN	O
(	-LRB-	O
Zmax	NN	O
=	JJ	O
24	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
)	-RRB-	O
and	CC	O
proximal	JJ	O
to	TO	O
DXYS4	NN	O
and	CC	O
DXYS12	NN	O
.	.	O

This	DT	O
agrees	VBZ	O
with	IN	O
the	DT	O
data	NNS	O
obtained	VBN	O
from	IN	O
other	JJ	O
linkage	NN	O
studies	NNS	O
and	CC	O
from	IN	O
physical	JJ	O
mapping	NN	O
.	.	O

All	PDT	O
the	DT	O
TCD	NN	B-Disease
males	NNS	O
and	CC	O
carrier	NN	O
females	NNS	O
studied	VBN	O
have	VBP	O
the	DT	O
same	JJ	O
DXYS1	NN	O
allele	NN	O
in	IN	O
coupling	NN	O
with	IN	O
TCD	NN	B-Disease
.	.	O

In	IN	O
Northeastern	NNP	O
Finland	NNP	O
,	,	O
66/69	CD	O
chromosomes	NNS	O
carrying	VBG	O
TCD	NN	B-Disease
had	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
at	IN	O
loci	NNS	O
DXS72	NN	O
,	,	O
DXYS1	NN	O
,	,	O
DXYS4	NN	O
,	,	O
and	CC	O
DXYS12	NN	O
.	.	O

The	DT	O
same	JJ	O
haplotype	NN	O
is	VBZ	O
seen	VBN	O
in	IN	O
only	RB	O
15/99	CD	O
chromosomes	NNS	O
not	RB	O
carrying	VBG	O
TCD	NN	B-Disease
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
71/104	CD	O
non-TCD	JJ	O
chromosomes	NNS	O
,	,	O
the	DT	O
haplotype	NN	O
at	IN	O
six	CD	O
marker	NN	O
loci	NNS	O
is	VBZ	O
different	JJ	O
from	IN	O
those	DT	O
seen	VBN	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
76	CD	O
TCD	NN	B-Disease
chromosomes	NNS	O
.	.	O

This	DT	O
supports	VBZ	O
the	DT	O
previously	RB	O
described	VBN	O
hypothesis	NN	O
that	IN	O
the	DT	O
large	JJ	O
Northern	NN	O
Finnish	JJ	O
choroideremia	NN	B-Disease
pedigrees	NNS	O
,	,	O
comprising	VBG	O
a	DT	O
total	NN	O
of	IN	O
over	IN	O
80	CD	O
living	NN	O
patients	NNS	O
representing	VBG	O
more	JJR	O
than	IN	O
a	DT	O
fifth	NN	O
of	IN	O
all	DT	O
TCD	NN	B-Disease
patients	NNS	O
described	VBD	O
worldwide	RB	O
,	,	O
carry	VBP	O
the	DT	O
same	JJ	O
mutation	NN	O
.	.	O

These	DT	O
linkage	NN	O
and	CC	O
haplotype	NN	O
data	NNS	O
provide	VBP	O
improved	JJ	O
opportunities	NNS	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
based	VBN	O
on	IN	O
RFLP	NN	O
studies	NNS	O
.	.	O

.	.	O

Genetic	JJ	O
heterogeneity	NN	O
at	IN	O
the	DT	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
locus	NN	O
in	IN	O
southern	JJ	O
Italy	NNP	O
:	:	O
a	DT	O
study	NN	O
on	IN	O
a	DT	O
population	NN	O
from	IN	O
the	DT	O
Matera	NNP	O
district	NN	O
.	.	O

Glucose-6-phosphate	JJ	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
analyzed	VBN	O
by	IN	O
gel	NN	O
electrophoresis	NN	O
and	CC	O
by	IN	O
quantitative	JJ	O
assay	NN	O
in	IN	O
an	DT	O
unselected	JJ	O
sample	NN	O
of	IN	O
1524	CD	O
schoolboys	NNS	O
from	IN	O
the	DT	O
province	NN	O
of	IN	O
Matera	NNP	O
(	-LRB-	O
Lucania	NNP	O
)	-RRB-	O
in	IN	O
southern	JJ	O
Italy	NNP	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
43	CD	O
subjects	NNS	O
with	IN	O
a	DT	O
G6PD	NN	O
variant	NN	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
31	CD	O
had	VBD	O
severe	JJ	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
nine	CD	O
had	VBD	O
mild	JJ	O
to	TO	O
moderate	JJ	O
deficiency	NN	O
,	,	O
and	CC	O
three	CD	O
had	VBD	O
a	DT	O
non-deficient	JJ	O
electrophoretic	JJ	O
variant	NN	O
.	.	O

The	DT	O
overall	JJ	O
rate	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
2	CD	O
.	.	O

6	CD	O
%	NN	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
ranging	VBG	O
from	IN	O
7	CD	O
.	.	O

2	CD	O
%	NN	O
on	IN	O
the	DT	O
Ionian	NNP	O
Coast	NNP	O
to	TO	O
zero	VB	O
on	IN	O
the	DT	O
eastern	JJ	O
side	NN	O
of	IN	O
the	DT	O
Lucanian	NNP	O
Apennines	NNPS	O
,	,	O
appears	VBZ	O
to	TO	O
be	VB	O
inversely	RB	O
related	JJ	O
to	TO	O
the	DT	O
distance	NN	O
of	IN	O
each	DT	O
town	NN	O
examined	VBN	O
from	IN	O
the	DT	O
Ionian	NNP	O
Coast	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
geographic	JJ	O
distribution	NN	O
may	MD	O
reflect	VB	O
,	,	O
at	IN	O
least	JJS	O
in	IN	O
part	NN	O
,	,	O
gene	NN	O
flow	NN	O
from	IN	O
Greek	JJ	O
settlers	NNS	O
.	.	O

Biochemical	JJ	O
characterization	NN	O
has	VBZ	O
shown	VBN	O
that	IN	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
this	DT	O
population	NN	O
is	VBZ	O
accounted	VBN	O
for	IN	O
by	IN	O
G6PD	NN	O
Mediterranean	NNP	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
have	VBP	O
found	VBN	O
several	JJ	O
examples	NNS	O
of	IN	O
two	CD	O
other	JJ	O
known	JJ	O
polymorphic	JJ	O
variants	NNS	O
(	-LRB-	O
G6PD	NN	O
Cagliari	NN	O
and	CC	O
G6PD	NN	O
A	NN	O
-	:	O
)	-RRB-	O
;	:	O
three	CD	O
new	JJ	O
polymorphic	JJ	O
variants	NNS	O
,	,	O
G6PD	NN	O
Metaponto	NNP	O
(	-LRB-	O
class	NN	O
III	CD	O
)	-RRB-	O
,	,	O
G6PD	NN	O
Montalbano	NNP	O
(	-LRB-	O
class	NN	O
III	CD	O
)	-RRB-	O
,	,	O
and	CC	O
G6PD	NN	O
Pisticci	NN	O
(	-LRB-	O
class	NN	O
IV	CD	O
)	-RRB-	O
;	:	O
and	CC	O
two	CD	O
sporadic	JJ	O
variants	NNS	O
,	,	O
G6PD	NN	O
Tursi	NN	O
(	-LRB-	O
class	NN	O
III	CD	O
)	-RRB-	O
and	CC	O
G6PD	NN	O
Ferrandina	NN	O
(	-LRB-	O
class	NN	O
II	CD	O
)	-RRB-	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
marked	JJ	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
within	IN	O
a	DT	O
relatively	RB	O
narrow	JJ	O
geographic	JJ	O
area	NN	O
and	CC	O
they	PRP	O
prove	VBP	O
the	DT	O
presence	NN	O
in	IN	O
the	DT	O
Italian	JJ	O
peninsula	NN	O
of	IN	O
a	DT	O
gene	NN	O
(	-LRB-	O
GdA	NN	O
-	:	O
)	-RRB-	O
regarded	VBN	O
as	IN	O
characteristically	RB	O
African	JJ	O
.	.	O

Defective	JJ	O
CTLA-4	NN	O
cycling	NN	O
pathway	NN	O
in	IN	O
Chediak-Higashi	NNP	B-Disease
syndrome	NN	I-Disease
:	:	O
a	DT	O
possible	JJ	O
mechanism	NN	O
for	IN	O
deregulation	NN	O
of	IN	O
T	NN	O
lymphocyte	NN	O
activation	NN	O
.	.	O

Cytotoxic	JJ	O
T	NN	O
lymphocyte-associated	JJ	O
antigen	NN	O
4	CD	O
(	-LRB-	O
CTLA-4	NN	O
,	,	O
also	RB	O
known	VBN	O
as	IN	O
CD152	NN	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
play	VB	O
a	DT	O
major	JJ	O
role	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
T	NN	O
cell	NN	O
activation	NN	O
.	.	O

Its	PRP$	O
membrane	NN	O
expression	NN	O
is	VBZ	O
highly	RB	O
regulated	VBN	O
by	IN	O
endocytosis	NN	O
and	CC	O
trafficking	NN	O
through	IN	O
the	DT	O
secretory	JJ	O
lysosome	NN	O
pathway	NN	O
.	.	O

Chediak-Higashi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
CHS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
lysosomal	JJ	O
trafficking	NN	O
regulator	NN	O
gene	NN	O
,	,	O
LYST	NN	O
.	.	O

It	PRP	O
results	VBZ	O
in	IN	O
defective	JJ	O
membrane	NN	O
targeting	NN	O
of	IN	O
the	DT	O
proteins	NNS	O
present	JJ	O
in	IN	O
secretory	JJ	O
lysosomes	NNS	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
features	NNS	O
,	,	O
including	VBG	O
a	DT	O
lymphoproliferative	JJ	B-Disease
syndrome	NN	I-Disease
with	IN	O
hemophagocytosis	NN	B-Disease
.	.	O

The	DT	O
murine	JJ	O
equivalent	NN	O
of	IN	O
CHS	NNP	B-Disease
,	,	O
beige	JJ	O
mice	NNS	O
,	,	O
present	JJ	O
similar	JJ	O
characteristics	NNS	O
but	CC	O
do	VBP	O
not	RB	O
develop	VB	O
the	DT	O
lymphoproliferative	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

We	PRP	O
show	VBP	O
herein	RB	O
that	IN	O
CTLA-4	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
enlarged	JJ	O
,	,	O
abnormal	JJ	O
vesicles	NNS	O
in	IN	O
CHS	NN	B-Disease
T	NN	O
cells	NNS	O
and	CC	O
is	VBZ	O
not	RB	O
properly	RB	O
expressed	VBN	O
at	IN	O
the	DT	O
cell	NN	O
surface	NN	O
after	IN	O
T	NN	O
cell	NN	O
activation	NN	O
,	,	O
whereas	IN	O
its	PRP$	O
surface	NN	O
expression	NN	O
is	VBZ	O
not	RB	O
impaired	JJ	O
.	.	O

It	PRP	O
is	VBZ	O
therefore	RB	O
proposed	VBN	O
that	IN	O
the	DT	O
defective	JJ	O
surface	NN	O
expression	NN	O
of	IN	O
CTLA-4	NN	O
by	IN	O
CHS	NN	B-Disease
T	NN	O
cells	NNS	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
lymphoproliferative	JJ	B-Disease
disease	NN	I-Disease
.	.	O

This	DT	O
observation	NN	O
may	MD	O
provide	VB	O
insight	NN	O
into	IN	O
the	DT	O
role	NN	O
of	IN	O
CTLA-4	NN	O
in	IN	O
humans	NNS	O
.	.	O

.	.	O

Beta-catenin	NN	O
accumulation	NN	O
and	CC	O
mutation	NN	O
of	IN	O
the	DT	O
CTNNB1	NN	O
gene	NN	O
in	IN	O
hepatoblastoma	NN	B-Disease
.	.	O

Hepatoblastoma	NN	B-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
malignant	JJ	B-Disease
tumor	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
liver	NN	I-Disease
that	WDT	O
occurs	VBZ	O
in	IN	O
children	NNS	O
at	IN	O
an	DT	O
average	JJ	O
age	NN	O
of	IN	O
2	CD	O
to	TO	O
3	CD	O
years	NNS	O
.	.	O

Epidemiologic	JJ	O
studies	NNS	O
have	VBP	O
shown	VBN	O
an	DT	O
increased	VBN	O
frequency	NN	O
of	IN	O
this	DT	O
tumor	NN	B-Disease
type	NN	O
in	IN	O
families	NNS	O
affected	VBN	O
by	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
.	.	O

In	IN	O
addition	NN	O
to	TO	O
the	DT	O
epidemiologic	JJ	O
data	NNS	O
,	,	O
molecular	JJ	O
genetic	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
inactivation	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
tumor	NN	I-Disease
suppressor	NN	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
hepatoblastoma	NN	B-Disease
tumorigenesis	NN	O
.	.	O

A	DT	O
major	JJ	O
function	NN	O
of	IN	O
APC	NN	O
is	VBZ	O
the	DT	O
downregulation	NN	O
of	IN	O
beta-catenin	NN	O
,	,	O
a	DT	O
transcription-activating	JJ	O
protein	NN	O
with	IN	O
oncogenic	JJ	O
potential	NN	O
.	.	O

In	IN	O
an	DT	O
ongoing	JJ	O
immunohistochemical	JJ	O
study	NN	O
of	IN	O
beta-catenin	NN	O
expression	NN	O
in	IN	O
sporadic	JJ	O
cases	NNS	O
of	IN	O
tumor	NN	B-Disease
types	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
,	,	O
we	PRP	O
observed	VBD	O
increased	VBD	O
beta-catenin	NN	O
levels	NNS	O
in	IN	O
the	DT	O
cytoplasm	NN	O
and	CC	O
in	IN	O
the	DT	O
nuclei	NNS	O
of	IN	O
three	CD	O
investigated	VBN	O
hepatoblastomas	NNS	B-Disease
.	.	O

Sequencing	NN	O
of	IN	O
exon	NN	O
3	CD	O
of	IN	O
the	DT	O
beta-catenin	NN	O
gene	NN	O
(	-LRB-	O
CTNNB1	NN	O
)	-RRB-	O
revealed	VBD	O
an	DT	O
activating	VBG	O
mutation	NN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
tumor	NN	B-Disease
samples	NNS	O
.	.	O

Our	PRP$	O
data	NNS	O
indicate	VBP	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	IN	O
beta-catenin	NN	O
accumulation	NN	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
hepatoblastoma	NN	B-Disease
and	CC	O
that	IN	O
activating	VBG	O
mutations	NNS	O
of	IN	O
the	DT	O
beta-catenin	NN	O
gene	NN	O
may	MD	O
substitute	VB	O
biallelic	JJ	O
APC	NN	O
inactivation	NN	O
in	IN	O
this	DT	O
tumor	NN	B-Disease
type	NN	O
.	.	O

Genes	NNS	O
Chromosomes	NNS	O
Cancer	NN	O
25	CD	O
399-402	CD	O
,	,	O
1999	CD	O
.	.	O

.	.	O

Sequence	NN	O
of	IN	O
DNA	NN	O
flanking	NN	O
the	DT	O
exons	NNS	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
,	,	O
and	CC	O
identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
rapid	JJ	O
identification	NN	O
of	IN	O
mutations	NNS	O
causing	VBG	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
requires	VBZ	O
the	DT	O
capacity	NN	O
to	TO	O
readily	RB	O
screen	VB	O
the	DT	O
regions	NNS	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
most	RBS	O
likely	JJ	O
to	TO	O
be	VB	O
affected	VBN	O
by	IN	O
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
sequenced	VBN	O
the	DT	O
portions	NNS	O
of	IN	O
the	DT	O
introns	NNS	O
flanking	VBG	O
each	DT	O
of	IN	O
the	DT	O
14	CD	O
HEXA	NN	O
exons	NNS	O
in	IN	O
order	NN	O
to	TO	O
specify	VB	O
oligonucleotide	NN	O
primers	NNS	O
for	IN	O
the	DT	O
PCR-dependent	JJ	O
amplification	NN	O
of	IN	O
each	DT	O
exon	NN	O
and	CC	O
splice-junction	NN	O
sequence	NN	O
.	.	O

The	DT	O
amplified	VBN	O
products	NNS	O
were	VBD	O
analyzed	VBN	O
,	,	O
by	IN	O
electrophoresis	NN	O
in	IN	O
nondenaturing	JJ	O
polyacrylamide	NN	O
gels	NNS	O
,	,	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
either	CC	O
heteroduplexes	NNS	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
annealing	NN	O
of	IN	O
normal	JJ	O
and	CC	O
mutant	JJ	O
DNA	NN	O
strands	NNS	O
,	,	O
or	CC	O
single-strand	JJ	O
conformational	JJ	O
polymorphisms	NNS	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
,	,	O
derived	VBN	O
from	IN	O
the	DT	O
renaturation	NN	O
of	IN	O
single-stranded	JJ	O
DNA	NN	O
.	.	O

Five	CD	O
novel	JJ	O
mutations	NNS	O
from	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
patients	NNS	O
were	VBD	O
detected	VBN	O
a	DT	O
5-bp	JJ	O
deletion	NN	O
of	IN	O
TCTCC	NN	O
in	IN	O
IVS-9	NN	O
;	:	O
a	DT	O
2-bp	JJ	O
deletion	NN	O
of	IN	O
TG	NN	O
in	IN	O
exon	NN	O
5	CD	O
;	:	O
G78	CD	O
to	TO	O
A	DT	O
,	,	O
giving	VBG	O
a	DT	O
stop	NN	O
codon	NN	O
in	IN	O
exon	NN	O
1	CD	O
;	:	O
G533	NN	O
to	TO	O
T	NN	O
in	IN	O
exon	NN	O
5	CD	O
,	,	O
producing	VBG	O
the	DT	O
third	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
detected	VBN	O
at	IN	O
this	DT	O
site	NN	O
;	:	O
and	CC	O
G	NN	O
to	TO	O
C	NN	O
at	IN	O
position	NN	O
1	CD	O
of	IN	O
IVS-2	NN	O
,	,	O
expected	VBN	O
to	TO	O
produce	VB	O
abnormal	JJ	O
splicing	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
two	CD	O
mutations	NNS	O
,	,	O
(	-LRB-	O
G1496	NN	O
to	TO	O
A	DT	O
in	IN	O
exon	NN	O
13	CD	O
and	CC	O
a	DT	O
4-bp	JJ	O
insertion	NN	O
in	IN	O
exon	NN	O
11	CD	O
)	-RRB-	O
that	WDT	O
have	VBP	O
previously	RB	O
been	VBN	O
reported	VBN	O
were	VBD	O
identified	VBN	O
.	.	O

.	.	O

In	FW	O
vivo	FW	O
modulation	NN	O
of	IN	O
Hmgic	JJ	O
reduces	VBZ	O
obesity	NN	B-Disease
.	.	O

The	DT	O
HMGI	NN	O
family	NN	O
of	IN	O
proteins	NNS	O
consists	VBZ	O
of	IN	O
three	CD	O
members	NNS	O
,	,	O
HMGIC	NN	O
,	,	O
HMGI	NN	O
and	CC	O
HMGI	NN	O
(	-LRB-	O
Y	NN	O
)	-RRB-	O
,	,	O
that	WDT	O
function	VBP	O
as	IN	O
architectural	JJ	O
factors	NNS	O
and	CC	O
are	VBP	O
essential	JJ	O
components	NNS	O
of	IN	O
the	DT	O
enhancesome	NN	O
.	.	O

HMGIC	NN	O
is	VBZ	O
predominantly	RB	O
expressed	VBN	O
in	IN	O
proliferating	VBG	O
,	,	O
undifferentiated	JJ	O
mesenchymal	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
not	RB	O
detected	VBN	O
in	IN	O
adult	JJ	O
tissues	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
disrupted	VBN	O
and	CC	O
misexpressed	VBN	O
in	IN	O
a	DT	O
number	NN	O
of	IN	O
mesenchymal	JJ	B-Disease
tumour	NN	I-Disease
cell	NN	O
types	NNS	O
,	,	O
including	VBG	O
fat-cell	NN	B-Disease
tumours	NNS	I-Disease
(	-LRB-	O
lipomas	NNS	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
Hmgic	JJ	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
have	VBP	O
a	DT	O
deficiency	NN	O
in	IN	O
fat	JJ	O
tissue	NN	O
.	.	O

To	TO	O
study	VB	O
its	PRP$	O
role	NN	O
in	IN	O
adipogenesis	NN	O
and	CC	O
obesity	NN	B-Disease
,	,	O
we	PRP	O
examined	VBD	O
Hmgic	JJ	O
expression	NN	O
in	IN	O
the	DT	O
adipose	NN	O
tissue	NN	O
of	IN	O
adult	JJ	O
,	,	O
obese	JJ	B-Disease
mice	NNS	O
.	.	O

Mice	NNS	O
with	IN	O
a	DT	O
partial	JJ	B-Disease
or	CC	I-Disease
complete	JJ	I-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
Hmgic	JJ	I-Disease
resisted	VBD	O
diet-induced	JJ	O
obesity	NN	B-Disease
.	.	O

Disruption	NN	O
of	IN	O
Hmgic	JJ	O
caused	VBD	O
a	DT	O
reduction	NN	O
in	IN	O
the	DT	O
obesity	NN	B-Disease
induced	VBN	O
by	IN	O
leptin	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
Lepob/Lepob	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
gene-dose-dependent	JJ	O
manner	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
implicate	VBP	O
a	DT	O
role	NN	O
for	IN	O
HMGIC	NN	O
in	IN	O
fat-cell	NN	O
proliferation	NN	O
,	,	O
indicating	VBG	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
an	DT	O
adipose-specific	JJ	O
target	NN	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
obesity	NN	B-Disease
.	.	O

.	.	O

Prenatal	JJ	O
diagnosis	NN	O
by	IN	O
FISH	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
duplication	NN	O
of	IN	O
PLP	NN	O
gene	NN	O
.	.	O

A	DT	O
diagnosis	NN	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MIM	NNP	O
312080	CD	O
)	-RRB-	O
was	VBD	O
made	VBN	O
in	IN	O
a	DT	O
young	JJ	O
boy	NN	O
.	.	O

No	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
had	VBD	O
been	VBN	O
found	VBN	O
.	.	O

The	DT	O
boys	NNS	O
maternal	JJ	O
aunt	NN	O
came	VBD	O
for	IN	O
prenatal	JJ	O
diagnosis	NN	O
when	WRB	O
16	CD	O
+	CC	O
weeks	NNS	O
pregnant	JJ	O
and	CC	O
carrying	VBG	O
a	DT	O
male	JJ	O
fetus	NN	O
.	.	O

Samples	NNS	O
were	VBD	O
tested	VBN	O
for	IN	O
duplication	NN	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
,	,	O
by	IN	O
interphase	NN	O
FISH	NN	O
,	,	O
in	IN	O
lymphocyte	NN	O
preparations	NNS	O
from	IN	O
the	DT	O
proband	NN	O
,	,	O
his	PRP$	O
aunt	NN	O
and	CC	O
an	DT	O
amniotic	JJ	O
fluid	NN	O
cell	NN	O
preparation	NN	O
from	IN	O
the	DT	O
fetus	NN	O
.	.	O

The	DT	O
proband	NN	O
was	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
the	DT	O
duplication	NN	O
,	,	O
thus	RB	O
confirming	VBG	O
the	DT	O
diagnosis	NN	O
of	IN	O
Pelizaeus	NNP	B-Disease
Merzbacher	NNP	I-Disease
disease	NN	I-Disease
,	,	O
but	CC	O
neither	CC	O
the	DT	O
aunt	NN	O
nor	CC	O
the	DT	O
fetus	NN	O
carried	VBD	O
a	DT	O
duplication	NN	O
.	.	O

.	.	O

Somatic	JJ	O
rearrangement	NN	O
of	IN	O
chromosome	NN	O
14	CD	O
in	IN	O
human	JJ	O
lymphocytes	NNS	O
.	.	O

Ataxia-telangiectasia	NN	B-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
genetic	JJ	B-Disease
disorder	NN	I-Disease
associated	VBN	O
with	IN	O
immune	JJ	B-Disease
deficiency	NN	I-Disease
,	,	O
chromosome	NN	B-Disease
instability	NN	I-Disease
,	,	O
and	CC	O
a	DT	O
predisposition	NN	O
to	TO	O
lymphoid	JJ	B-Disease
malignancy	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
detected	VBN	O
chromosomally	RB	O
anomalous	JJ	O
clones	NNS	O
of	IN	O
lymphocytes	NNS	O
in	IN	O
eight	CD	O
patients	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
.	.	O

Chromosome	NN	O
banding	NN	O
disclosed	VBD	O
that	IN	O
the	DT	O
clones	NNS	O
are	VBP	O
consistently	RB	O
marked	VBN	O
by	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
(	-LRB-	O
q	NN	O
)	-RRB-	O
of	IN	O
chromosome	NN	O
14	CD	O
.	.	O

A	DT	O
translocation	NN	O
involving	VBG	O
14q	NN	O
was	VBD	O
found	VBN	O
in	IN	O
clones	NNS	O
obtained	VBN	O
from	IN	O
seven	CD	O
of	IN	O
the	DT	O
eight	CD	O
patients	NNS	O
whereas	IN	O
a	DT	O
ring	NN	O
14	CD	O
chromosome	NN	O
was	VBD	O
found	VBN	O
in	IN	O
a	DT	O
clone	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
other	JJ	O
.	.	O

These	DT	O
findings	NNS	O
as	RB	O
well	RB	O
as	IN	O
data	NNS	O
obtained	VBN	O
by	IN	O
others	NNS	O
for	IN	O
patients	NNS	O
with	IN	O
ataxia-telangiectasia	NN	B-Disease
suggest	VBP	O
that	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
14q	NN	O
is	VBZ	O
the	DT	O
initial	JJ	O
chromosomal	JJ	O
change	NN	O
in	IN	O
lymphocyte	NN	O
clones	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
.	.	O

Chromosomes	NNS	O
of	IN	O
lymphocytes	NNS	O
from	IN	O
one	CD	O
of	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
studied	VBN	O
before	IN	O
and	CC	O
after	IN	O
the	DT	O
onset	NN	O
of	IN	O
chronic	JJ	B-Disease
lymphocytic	JJ	I-Disease
leukemia	NN	I-Disease
.	.	O

Before	IN	O
leukemia	NN	B-Disease
was	VBD	O
diagnosed	VBN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
lymphocyte	NN	O
clone	NN	O
with	IN	O
a	DT	O
14q	NN	O
translocation	NN	O
.	.	O

This	DT	O
clone	NN	O
appears	VBZ	O
to	TO	O
have	VB	O
given	VBN	O
rise	NN	O
to	TO	O
the	DT	O
leukemic	JJ	B-Disease
cells	NNS	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
structural	JJ	O
rearrangement	NN	O
of	IN	O
14q	NN	O
is	VBZ	O
directly	RB	O
related	JJ	O
to	TO	O
abnormal	JJ	O
growth	NN	O
of	IN	O
lymphocytes	NNS	O
and	CC	O
that	IN	O
it	PRP	O
may	MD	O
be	VB	O
a	DT	O
step	NN	O
toward	IN	O
the	DT	O
development	NN	O
of	IN	O
lymphoid	JJ	B-Disease
malignancies	NNS	I-Disease
.	.	O

Increasing	VBG	O
evidence	NN	O
,	,	O
provided	VBN	O
by	IN	O
others	NNS	O
,	,	O
for	IN	O
the	DT	O
nonrandom	JJ	O
involvement	NN	O
of	IN	O
14q	NN	O
in	IN	O
African-type	JJ	O
Burkitts	NNS	B-Disease
lymphoma	NN	I-Disease
and	CC	O
other	JJ	O
lymphoid	JJ	B-Disease
neoplasms	NNS	I-Disease
further	RB	O
strengthens	VBZ	O
this	DT	O
hypothesis	NN	O
.	.	O

.	.	O

Two	CD	O
missense	NN	O
mutations	NNS	O
causing	VBG	O
mild	JJ	O
hyperphenylalaninemia	NN	B-Disease
associated	VBN	O
with	IN	O
DNA	NN	O
haplotype	NN	O
12	CD	O
.	.	O

The	DT	O
genetic	JJ	B-Disease
defects	NNS	I-Disease
responsible	JJ	O
for	IN	O
most	JJS	O
phenylketonuria	NNS	B-Disease
(	-LRB-	O
PKU	NN	B-Disease
)	-RRB-	O
and	CC	O
hyperphenylalaninemia	NN	B-Disease
(	-LRB-	O
HPA	NN	B-Disease
)	-RRB-	O
cases	NNS	O
are	VBP	O
located	JJ	O
in	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

Approximately	RB	O
50-60	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
Caucasians	NNPS	O
and	CC	O
are	VBP	O
reflected	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
clinical	JJ	O
severities	NNS	O
.	.	O

Most	JJS	O
mutations	NNS	O
are	VBP	O
linked	VBN	O
to	TO	O
specific	JJ	O
haplotypes	NNS	O
,	,	O
as	IN	O
defined	VBN	O
by	IN	O
eight	CD	O
polymorphic	JJ	O
restriction	NN	O
sites	NNS	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
.	.	O

We	PRP	O
hypothesized	VBD	O
that	IN	O
there	EX	O
is	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
mild	JJ	O
mutation	NN	O
linked	VBN	O
to	TO	O
haplotype	NN	O
12	CD	O
in	IN	O
the	DT	O
Swedish	JJ	O
PKU/HPA	NN	O
population	NN	O
,	,	O
since	IN	O
7	CD	O
of	IN	O
8	CD	O
patients	NNS	O
carrying	VBG	O
haplotype	NN	O
12	CD	O
had	VBD	O
mild	JJ	O
HPA	NN	B-Disease
.	.	O

Sequence	NN	O
analysis	NN	O
revealed	VBD	O
a	DT	O
C-to-G	NN	O
transversion	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
322	CD	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
substitution	NN	O
of	IN	O
glycine	NN	O
for	IN	O
alanine	NN	O
,	,	O
in	IN	O
four	CD	O
mutant	JJ	O
haplotype	NN	O
12	CD	O
genes	NNS	O
,	,	O
and	CC	O
a	DT	O
G-to-A	JJ	O
transition	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
408	CD	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	O
substitution	NN	O
of	IN	O
glutamine	NN	O
for	IN	O
arginine	NN	O
,	,	O
in	IN	O
another	DT	O
three	CD	O
mutant	JJ	O
haplotype	NN	O
12	CD	O
genes	NNS	O
.	.	O

These	DT	O
mutations	NNS	O
segregated	VBN	O
with	IN	O
mutant	JJ	O
haplotype	NN	O
12	CD	O
alleles	NNS	O
in	IN	O
nuclear	JJ	O
families	NNS	O
but	CC	O
were	VBD	O
not	RB	O
present	JJ	O
on	IN	O
normal	JJ	O
or	CC	O
other	JJ	O
mutant	JJ	O
alleles	NNS	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
tested	VBN	O
in	IN	O
a	DT	O
eukaryotic	JJ	O
expression	NN	O
system	NN	O
in	IN	O
which	WDT	O
enzyme	NN	O
activities	NNS	O
of	IN	O
different	JJ	O
mutant	JJ	O
PAH	NN	O
enzymes	NNS	O
reflect	VBP	O
the	DT	O
relative	JJ	O
severities	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
,	,	O
although	IN	O
these	DT	O
in	FW	O
vitro	FW	O
activities	NNS	O
can	MD	O
not	RB	O
be	VB	O
translated	VBN	O
directly	RB	O
into	IN	O
in	FW	O
vivo	FW	O
hepatic	JJ	O
activities	NNS	O
.	.	O

The	DT	O
A322G	NN	O
mutant	JJ	O
PAH	NN	O
had	VBD	O
about	IN	O
75	CD	O
%	NN	O
and	CC	O
the	DT	O
R408Q	NN	O
mutant	JJ	O
PAH	NN	O
about	IN	O
55	CD	O
%	NN	O
of	IN	O
the	DT	O
wild-type	JJ	O
PAH	NN	O
enzyme	NN	O
activity	NN	O
.	.	O

These	DT	O
in	FW	O
vitro	FW	O
activities	NNS	O
are	VBP	O
the	DT	O
highest	JJS	O
reported	VBN	O
for	IN	O
mutant	JJ	O
PAH	NN	O
enzymes	NNS	O
produced	VBN	O
in	IN	O
the	DT	O
same	JJ	O
expression	NN	O
system	NN	O
.	.	O

(	-LRB-	O
ABSTRACT	NN	O
TRUNCATED	VBN	O
AT	IN	O
250	CD	O
WORDS	NNS	O
)	-RRB-	O
.	.	O

Genomic	JJ	O
organization	NN	O
of	IN	O
the	DT	O
adrenoleukodystrophy	NN	B-Disease
gene	NN	O
.	.	O

Adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
frequent	JJ	O
peroxisomal	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
is	VBZ	O
a	DT	O
severe	JJ	O
neurodegenerative	JJ	B-Disease
disease	NN	I-Disease
associated	VBN	O
with	IN	O
an	DT	O
impairment	NN	B-Disease
of	IN	I-Disease
very	RB	I-Disease
long	JJ	I-Disease
chain	NN	I-Disease
fatty	JJ	I-Disease
acids	NNS	I-Disease
beta-oxidation	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
recently	RB	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	VBG	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
ALD	NNP	B-Disease
,	,	O
located	JJ	O
in	IN	O
Xq28	NN	O
.	.	O

It	PRP	O
encodes	VBZ	O
a	DT	O
new	JJ	O
member	NN	O
of	IN	O
the	DT	O
"	''	O
ABC	NNP	O
"	''	O
superfamily	NN	O
of	IN	O
membrane-associated	JJ	O
transporters	NNS	O
that	WDT	O
shows	VBZ	O
,	,	O
in	IN	O
particular	JJ	O
,	,	O
significant	JJ	O
homology	NN	O
to	TO	O
the	DT	O
70-kDa	JJ	O
peroxisomal	JJ	O
membrane	NN	O
protein	NN	O
(	-LRB-	O
PMP70	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
detailed	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
structure	NN	O
.	.	O

It	PRP	O
extends	VBZ	O
over	IN	O
21	CD	O
kb	NN	O
and	CC	O
consists	VBZ	O
of	IN	O
10	CD	O
exons	NNS	O
.	.	O

To	TO	O
facilitate	VB	O
the	DT	O
detection	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
ALD	NN	B-Disease
patients	NNS	O
,	,	O
we	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
intronic	JJ	O
sequences	NNS	O
flanking	VBG	O
the	DT	O
exons	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
sequence	NN	O
of	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
and	CC	O
of	IN	O
the	DT	O
immediate	JJ	O
5	CD	O
promoter	NN	O
region	NN	O
.	.	O

Sequences	NNS	O
present	JJ	O
in	IN	O
distal	JJ	O
exons	NNS	O
cross-hybridize	VBP	O
strongly	RB	O
to	TO	O
additional	JJ	O
sequences	NNS	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

The	DT	O
ALD	NN	B-Disease
gene	NN	O
has	VBZ	O
been	VBN	O
positioned	VBN	O
on	IN	O
a	DT	O
pulsed-field	JJ	O
map	NN	O
between	IN	O
DXS15	NN	O
and	CC	O
the	DT	O
L1CAM	NN	O
gene	NN	O
,	,	O
about	IN	O
650	CD	O
kb	NN	O
upstream	RB	O
from	IN	O
the	DT	O
color	NN	O
pigment	NN	O
genes	NNS	O
.	.	O

The	DT	O
frequent	JJ	O
occurrence	NN	O
of	IN	O
color	NN	O
vision	NN	O
anomalies	NNS	O
observed	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
the	DT	O
adult	JJ	O
onset	NN	O
form	NN	O
of	IN	O
ALD	NN	B-Disease
)	-RRB-	O
thus	RB	O
does	VBZ	O
not	RB	O
represent	VB	O
a	DT	O
contiguous	JJ	B-Disease
gene	NN	I-Disease
syndrome	NN	I-Disease
but	CC	O
a	DT	O
secondary	JJ	O
manifestation	NN	O
of	IN	O
ALD	NN	B-Disease
.	.	O

.	.	O

BRCA1	NN	O
interacts	VBZ	O
with	IN	O
components	NNS	O
of	IN	O
the	DT	O
histone	NN	O
deacetylase	NN	O
complex	NN	O
.	.	O

Germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
tumor-suppressor	JJ	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
susceptibility	NN	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

BRCA1	NN	O
contains	VBZ	O
a	DT	O
carboxyl-terminal	JJ	O
domain	NN	O
(	-LRB-	O
BRCT	NN	O
)	-RRB-	O
that	WDT	O
is	VBZ	O
shared	VBN	O
with	IN	O
several	JJ	O
other	JJ	O
proteins	NNS	O
involved	VBN	O
in	IN	O
maintaining	VBG	O
genome	NN	O
integrity	NN	O
.	.	O

In	IN	O
an	DT	O
effort	NN	O
to	TO	O
understand	VB	O
the	DT	O
function	NN	O
of	IN	O
BRCA1	NN	O
,	,	O
we	PRP	O
sought	VBD	O
to	TO	O
isolate	VB	O
proteins	NNS	O
that	WDT	O
interact	VBP	O
with	IN	O
the	DT	O
BRCT	NN	O
domain	NN	O
.	.	O

Purified	VBN	O
BRCT	NN	O
polypeptide	NN	O
was	VBD	O
used	VBN	O
as	IN	O
a	DT	O
probe	NN	O
to	TO	O
screen	VB	O
a	DT	O
human	JJ	O
placenta	NN	O
cDNA	NN	O
expression	NN	O
library	NN	O
by	IN	O
Far	NNP	O
Western	NNP	O
analysis	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
BRCA1	NN	O
interacts	VBZ	O
in	FW	O
vivo	FW	O
and	CC	O
in	FW	O
vitro	FW	O
with	IN	O
the	DT	O
Rb-binding	JJ	O
proteins	NNS	O
,	,	O
RbAp46	NN	O
and	CC	O
RbAp48	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
with	IN	O
Rb	NN	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
BRCT	NN	O
domain	NN	O
associates	VBZ	O
with	IN	O
the	DT	O
histone	NN	O
deacetylases	NNS	O
HDAC1	NN	O
and	CC	O
HDAC2	NN	O
.	.	O

These	DT	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
BRCA1	NN	O
interacts	VBZ	O
with	IN	O
components	NNS	O
of	IN	O
the	DT	O
histone	NN	O
deacetylase	NN	O
complex	NN	O
,	,	O
and	CC	O
therefore	RB	O
may	MD	O
explain	VB	O
the	DT	O
involvement	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
multiple	JJ	O
processes	NNS	O
such	JJ	O
as	IN	O
transcription	NN	O
,	,	O
DNA	NN	O
repair	NN	O
,	,	O
and	CC	O
recombination	NN	O
.	.	O

.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
KIT	NN	O
and	CC	O
PDGFRA	NN	O
genes	NNS	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
piebaldism	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
shown	VBN	O
that	IN	O
human	JJ	O
piebaldism	NN	B-Disease
results	VBZ	O
from	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
KIT	NN	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
the	DT	O
receptor	NN	O
for	IN	O
the	DT	O
mast/stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
and	CC	O
is	VBZ	O
located	JJ	O
in	IN	O
chromosome	NN	O
segment	NN	O
4q12	NN	O
.	.	O

Using	VBG	O
DNA	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
piebaldism	NN	B-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
multiple	JJ	B-Disease
congenital	JJ	I-Disease
anomalies	NNS	I-Disease
associated	VBN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XY	NN	O
,	,	O
del	FW	O
(	-LRB-	O
4	LS	O
)	-RRB-	O
(	-LRB-	O
q12q21	NN	O
.	.	O

1	LS	O
)	-RRB-	O
karyotype	NN	O
,	,	O
we	PRP	O
carried	VBD	O
out	RP	O
quantitative	JJ	O
Southern	NN	O
blot	NN	O
hybridization	NN	O
analyses	NNS	O
of	IN	O
the	DT	O
KIT	NN	O
gene	NN	O
and	CC	O
the	DT	O
adjacent	JJ	O
PDGFRA	NN	O
(	-LRB-	O
platelet-derived	JJ	O
growth	NN	O
factor	NN	O
receptor	NN	O
alpha	NN	O
subunit	NN	O
)	-RRB-	O
genes	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
hemizygous	JJ	O
for	IN	O
both	CC	O
the	DT	O
KIT	NN	O
and	CC	O
PDGFRA	NN	O
genes	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
both	DT	O
of	IN	O
these	DT	O
genes	NNS	O
are	VBP	O
included	VBN	O
within	IN	O
the	DT	O
deleted	VBN	O
region	NN	O
.	.	O

Therefore	RB	O
,	,	O
deletion	NN	O
of	IN	O
the	DT	O
KIT	NN	O
and	CC	O
PDGFRA	NN	O
genes	NNS	O
may	MD	O
account	VB	O
for	IN	O
the	DT	O
piebald	NN	B-Disease
phenotype	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

Glucose-6-phosphate	JJ	O
dehydrogenase	NN	O
variants	NNS	O
and	CC	O
their	PRP$	O
frequency	NN	O
in	IN	O
Guangdong	NNP	O
,	,	O
China	NNP	O
.	.	O

Erythrocyte	NN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
was	VBD	O
characterized	VBN	O
in	IN	O
blood	NN	O
samples	NNS	O
obtained	VBN	O
from	IN	O
97	CD	O
randomly	RB	O
selected	VBN	O
males	NNS	O
with	IN	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
from	IN	O
various	JJ	O
regions	NNS	O
of	IN	O
Guangdong	NNP	O
Province	NNP	O
,	,	O
China	NNP	O
.	.	O

Nine	CD	O
new	JJ	O
variants	NNS	O
(	-LRB-	O
Gd	NNP	O
Kaiping	NNP	O
,	,	O
Gd	NNP	O
Boluo	NNP	O
,	,	O
Gd	NNP	O
Huiyang	NNP	O
,	,	O
Gd	NNP	O
Gaomin	NNP	O
,	,	O
Gd	NNP	O
Qing-Baijiang	NNP	O
,	,	O
Gd	NNP	O
Gaozhou	NNP	O
,	,	O
Gd	NNP	O
Huazhou	NNP	O
,	,	O
Gd	NNP	O
Nanhai	NNP	O
,	,	O
and	CC	O
Gd	NNP	O
Guangzhou	NNP	O
)	-RRB-	O
were	VBD	O
identified	VBN	O
.	.	O

Of	IN	O
the	DT	O
31	CD	O
variants	NNS	O
found	VBN	O
in	IN	O
this	DT	O
province	NN	O
,	,	O
Gd	NNP	O
Kaiping	NNP	O
,	,	O
Gd	NNP	O
Taiwan-Hakka	NNP	O
,	,	O
Gd	NNP	O
Haad	NNP	O
Yai	NNP	O
,	,	O
Gd	NNP	O
Haad	NNP	O
Yai-like	JJ	O
and	CC	O
Gd	JJ	O
Huiyang	NN	O
occurred	VBD	O
most	RBS	O
frequently	RB	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
each	DT	O
variant	NN	O
was	VBD	O
calculated	VBN	O
.	.	O

The	DT	O
results	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
high	JJ	O
in	IN	O
this	DT	O
area	NN	O
.	.	O

.	.	O

A	DT	O
common	JJ	O
molecular	JJ	O
basis	NN	O
for	IN	O
rearrangement	NN	B-Disease
disorders	NNS	I-Disease
on	IN	O
chromosome	NN	O
22q11	NN	O
.	.	O

The	DT	O
chromosome	NN	O
22q11	NN	O
region	NN	O
is	VBZ	O
susceptible	JJ	O
to	TO	O
rearrangements	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
congenital	JJ	B-Disease
anomaly	JJ	I-Disease
disorders	NNS	I-Disease
and	CC	O
malignant	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

Three	CD	O
congenital	JJ	B-Disease
anomaly	NN	I-Disease
disorders	NNS	I-Disease
,	,	O
cat-eye	NN	B-Disease
syndrome	NN	I-Disease
,	,	O
der	NN	B-Disease
(	-LRB-	I-Disease
)	-RRB-	I-Disease
syndrome	NN	I-Disease
and	CC	O
velo-cardio-facial	JJ	B-Disease
syndrome/DiGeorge	NN	O
syndrome	NN	B-Disease
(	-LRB-	O
VCFS/DGS	NN	O
)	-RRB-	O
are	VBP	O
associated	VBN	O
with	IN	O
tetrasomy	NN	O
,	,	O
trisomy	NN	O
or	CC	O
monosomy	NN	O
,	,	O
respectively	RB	O
,	,	O
for	IN	O
part	NN	O
of	IN	O
chromosome	NN	O
22q11	NN	O
.	.	O

VCFS/DGS	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
syndrome	NN	O
associated	VBN	O
with	IN	O
22q11	NN	O
rearrangements	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
determine	VB	O
whether	IN	O
there	EX	O
are	VBP	O
particular	JJ	O
regions	NNS	O
on	IN	O
22q11	NN	O
that	WDT	O
are	VBP	O
prone	JJ	O
to	TO	O
rearrangements	NNS	O
,	,	O
the	DT	O
deletion	NN	O
end-points	NNS	O
in	IN	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
VCFS/DGS	NN	O
patients	NNS	O
were	VBD	O
defined	VBN	O
by	IN	O
haplotype	NN	O
analysis	NN	O
.	.	O

Most	JJS	O
VCFS/DGS	NN	O
patients	NNS	O
have	VBP	O
a	DT	O
similar	JJ	O
3	CD	O
Mb	NN	O
deletion	NN	O
,	,	O
some	DT	O
have	VBP	O
a	DT	O
nested	JJ	O
distal	JJ	O
deletion	NN	O
breakpoint	NN	O
resulting	VBG	O
in	IN	O
a	DT	O
1	CD	O
.	.	O

5	CD	O
Mb	NN	O
deletion	NN	O
and	CC	O
a	DT	O
few	JJ	O
rare	JJ	O
patients	NNS	O
have	VBP	O
unique	JJ	O
deletions	NNS	O
or	CC	O
translocations	NNS	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
the	DT	O
disorder	NN	O
in	IN	O
the	DT	O
population	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
most	JJS	O
cases	NNS	O
occur	VBP	O
sporadically	RB	O
suggest	VBP	O
that	IN	O
sequences	NNS	O
at	IN	O
or	CC	O
near	IN	O
the	DT	O
breakpoints	NNS	O
confer	VBP	O
susceptibility	NN	O
to	TO	O
chromosome	NN	O
rearrangements	NNS	O
.	.	O

To	TO	O
investigate	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
developed	VBD	O
hamster-human	JJ	O
somatic	JJ	O
hybrid	NN	O
cell	NN	O
lines	NNS	O
from	IN	O
VCFS/DGS	NN	O
patients	NNS	O
with	IN	O
all	DT	O
three	CD	O
classes	NNS	O
of	IN	O
deletions	NNS	O
and	CC	O
we	PRP	O
now	RB	O
show	VBP	O
that	IN	O
the	DT	O
breakpoints	NNS	O
occur	VBP	O
within	IN	O
similar	JJ	O
low	JJ	O
copy	NN	O
repeats	NNS	O
,	,	O
termed	VBN	O
LCR22s	NNS	O
.	.	O

To	TO	O
support	VB	O
this	DT	O
idea	NN	O
further	RB	O
,	,	O
we	PRP	O
identified	VBD	O
a	DT	O
family	NN	O
that	WDT	O
carries	VBZ	O
an	DT	O
interstitial	JJ	O
duplication	NN	O
of	IN	O
the	DT	O
same	JJ	O
3	CD	O
Mb	NN	O
region	NN	O
that	WDT	O
is	VBZ	O
deleted	VBN	O
in	IN	O
VCFS/DGS	NN	O
patients	NNS	O
.	.	O

We	PRP	O
present	VBP	O
models	NNS	O
to	TO	O
explain	VB	O
how	WRB	O
the	DT	O
LCR22s	NNS	O
can	MD	O
mediate	VB	O
different	JJ	O
homologous	JJ	O
recombination	NN	O
events	NNS	O
,	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
number	NN	O
of	IN	O
rearrangements	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
congenital	JJ	B-Disease
anomaly	JJ	I-Disease
disorders	NNS	I-Disease
.	.	O

We	PRP	O
identified	VBD	O
five	CD	O
additional	JJ	O
copies	NNS	O
of	IN	O
the	DT	O
LCR22	NN	O
on	IN	O
22q11	NN	O
that	WDT	O
may	MD	O
mediate	VB	O
other	JJ	O
rearrangements	NNS	O
leading	VBG	O
to	TO	O
disease	NN	O
.	.	O

Typical	JJ	O
and	CC	O
partial	JJ	O
cat	NN	B-Disease
eye	NN	I-Disease
syndrome	NN	I-Disease
:	:	O
identification	NN	O
of	IN	O
the	DT	O
marker	NN	O
chromosome	NN	O
by	IN	O
FISH	NN	O
.	.	O

Three	CD	O
children	NNS	O
are	VBP	O
reported	VBN	O
with	IN	O
typical	JJ	O
cat	NN	B-Disease
eye	NN	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
CES	NN	B-Disease
)	-RRB-	O
and	CC	O
three	CD	O
more	JJR	O
children	NNS	O
with	IN	O
partial	JJ	O
CES	NN	B-Disease
because	IN	O
of	IN	O
absence	NN	O
of	IN	O
coloboma	NN	O
,	,	O
in	IN	O
which	WDT	O
the	DT	O
supernumerary	JJ	O
marker	NN	O
chromosome	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
FISH	NN	O
.	.	O

Using	VBG	O
a	DT	O
genomic	JJ	O
library	NN	O
,	,	O
and	CC	O
also	RB	O
a	DT	O
centromeric	JJ	O
and	CC	O
particularly	RB	O
a	DT	O
cosmid	NN	O
probe	NN	O
of	IN	O
22q11	NN	O
,	,	O
partial	JJ	O
tetrasomy	NN	B-Disease
was	VBD	O
shown	VBN	O
in	IN	O
all	DT	O
cases	NNS	O
.	.	O

.	.	O

An	DT	O
intrachromosomal	JJ	O
insertion	NN	O
causing	VBG	O
5q22	NN	O
deletion	NN	O
and	CC	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
in	IN	O
two	CD	O
generations	NNS	O
.	.	O

We	PRP	O
report	VBP	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
FAPC	NN	B-Disease
)	-RRB-	O
with	IN	O
epidermoid	NN	B-Disease
cysts	NNS	I-Disease
,	,	O
osteomata	NN	B-Disease
,	,	O
and	CC	O
areas	NNS	O
of	IN	O
congenital	JJ	B-Disease
hypertrophy	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
retinal	JJ	I-Disease
pigment	NN	I-Disease
epithelium	NN	I-Disease
(	-LRB-	O
CHRPEs	NNS	B-Disease
)	-RRB-	O
in	IN	O
a	DT	O
male	JJ	O
patient	NN	O
and	CC	O
his	PRP$	O
maternal	JJ	O
aunt	NN	O
,	,	O
both	DT	O
of	IN	O
whom	WP	O
suffered	VBD	O
a	DT	O
mild	JJ	O
to	TO	O
moderate	JJ	O
degree	NN	O
of	IN	O
mental	JJ	B-Disease
handicap	NN	I-Disease
.	.	O

Both	DT	O
had	VBD	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	-LRB-	O
del	FW	O
(	-LRB-	O
5	CD	O
)	-RRB-	O
(	-LRB-	O
q22q23	NN	O
.	.	O

2	LS	O
)	-RRB-	O
)	-RRB-	O
.	.	O

Two	CD	O
other	JJ	O
normal	JJ	O
family	NN	O
members	NNS	O
had	VBD	O
the	DT	O
underlying	VBG	O
direct	JJ	O
insertion	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
(	-LRB-	O
dir	NN	O
ins	NNS	O
(	-LRB-	O
5	CD	O
)	-RRB-	O
(	-LRB-	O
q31	NN	O
.	.	O

3q22q23	NN	O
3q22q23	NN	O
.	.	O

2	LS	O
)	-RRB-	O
)	-RRB-	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
and	CC	O
fluorescent	JJ	O
hybridisation	NN	O
studies	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
loci	NNS	O
D5S37	NN	O
and	CC	O
D5S98	NN	O
are	VBP	O
outside	IN	O
the	DT	O
deletion	NN	O
whereas	IN	O
loci	NNS	O
detected	VBN	O
by	IN	O
probes	NNS	O
EF5	NN	O
.	.	O

44	CD	O
and	CC	O
YN5	NN	O
.	.	O

48	CD	O
are	VBP	O
lost	VBN	O
.	.	O

As	IN	O
expected	VBN	O
,	,	O
the	DT	O
molecular	JJ	O
analyses	NNS	O
indicate	VBP	O
loss	NN	O
of	IN	O
one	CD	O
allele	NN	O
at	IN	O
the	DT	O
MCC	NN	O
and	CC	O
APC	NN	B-Disease
loci	NNS	O
.	.	O

The	DT	O
APC	NN	B-Disease
gene	NN	O
is	VBZ	O
located	JJ	O
within	IN	O
band	NN	O
5q22	NN	O
.	.	O

Familial	JJ	O
direct	JJ	O
insertions	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
recurrent	JJ	O
microdeletion	NN	O
syndromes	NNS	O
.	.	O

Cloning	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
region	NN	O
in	IN	O
yeast	NN	O
artificial	JJ	O
chromosomes	NNS	O
.	.	O

The	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
has	VBZ	O
been	VBN	O
localized	JJ	O
to	TO	O
a	DT	O
2	CD	O
.	.	O

5	CD	O
million	CD	O
base	NN	O
pair	NN	O
(	-LRB-	O
Mb	NN	O
)	-RRB-	O
region	NN	O
between	IN	O
the	DT	O
loci	NNS	O
D4S10	NN	O
and	CC	O
D4S168	NN	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
4	CD	O
.	.	O

As	IN	O
part	NN	O
of	IN	O
a	DT	O
strategy	NN	O
to	TO	O
clone	NN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
its	PRP$	O
chromosomal	JJ	O
location	NN	O
,	,	O
we	PRP	O
isolated	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
the	DT	O
HD	NN	B-Disease
region	NN	O
as	IN	O
a	DT	O
set	NN	O
of	IN	O
overlapping	VBG	O
yeast	NN	O
artificial	JJ	O
chromosome	NN	O
(	-LRB-	O
YAC	NN	O
)	-RRB-	O
clones	NNS	O
.	.	O

Twenty-eight	CD	O
YAC	NN	O
clones	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
screening	VBG	O
human	JJ	O
YAC	NN	O
libraries	NNS	O
with	IN	O
twelve	CD	O
PCR-based	JJ	O
sequence-tagged	JJ	O
sites	NNS	O
(	-LRB-	O
STSs	NNS	O
)	-RRB-	O
from	IN	O
the	DT	O
region	NN	O
.	.	O

We	PRP	O
assembled	VBD	O
the	DT	O
YAC	NN	O
clones	NNS	O
into	IN	O
overlapping	VBG	O
sets	NNS	O
by	IN	O
hybridizing	VBG	O
them	PRP	O
to	TO	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
DNA	NN	O
probes	NNS	O
from	IN	O
the	DT	O
HD	NN	B-Disease
region	NN	O
,	,	O
including	VBG	O
the	DT	O
STSs	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
isolated	VBD	O
the	DT	O
ends	NNS	O
of	IN	O
the	DT	O
human	JJ	O
DNA	NN	O
inserts	NNS	O
of	IN	O
most	JJS	O
of	IN	O
the	DT	O
YAC	NN	O
clones	NNS	O
to	TO	O
assist	VB	O
in	IN	O
the	DT	O
construction	NN	O
of	IN	O
the	DT	O
contig	NN	O
.	.	O

Although	IN	O
almost	RB	O
half	DT	O
of	IN	O
the	DT	O
YACs	NNS	O
appear	VBP	O
to	TO	O
contain	VB	O
chimeric	JJ	O
inserts	NNS	O
and	CC	O
several	JJ	O
contain	VBP	O
internal	JJ	O
deletions	NNS	O
or	CC	O
other	JJ	O
rearrangements	NNS	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
obtain	VB	O
over	IN	O
2	CD	O
.	.	O

2	CD	O
Mb	NN	O
of	IN	O
the	DT	O
HD	NN	B-Disease
region	NN	O
in	IN	O
YACs	NNS	O
,	,	O
including	VBG	O
one	CD	O
continuous	JJ	O
segment	NN	O
of	IN	O
2	CD	O
.	.	O

0	CD	O
Mb	NN	O
covering	VBG	O
the	DT	O
region	NN	O
that	IN	O
most	JJS	O
likely	JJ	O
contains	VBZ	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
.	.	O

Ten	CD	O
of	IN	O
the	DT	O
twenty	CD	O
eight	CD	O
YAC	NN	O
clones	NNS	O
comprise	VBP	O
a	DT	O
minimal	JJ	O
set	NN	O
spanning	VBG	O
the	DT	O
2	CD	O
.	.	O

2	CD	O
Mb	NN	O
.	.	O

These	DT	O
clones	NNS	O
provide	VBP	O
reagents	NNS	O
for	IN	O
the	DT	O
complete	JJ	O
characterization	NN	O
of	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
genome	NN	O
and	CC	O
for	IN	O
the	DT	O
eventual	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
.	.	O

Three	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
five	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
hereditary	JJ	O
protein	NN	B-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
type	NN	I-Disease
I	CD	I-Disease
.	.	O

A	DT	O
panel	NN	O
of	IN	O
eight	CD	O
unrelated	JJ	O
subjects	NNS	O
with	IN	O
inherited	VBN	O
type	NN	B-Disease
I	CD	I-Disease
protein	NN	I-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
was	VBD	O
screened	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
PROS1	NN	O
gene	NN	O
.	.	O

In	IN	O
five	CD	O
subjects	NNS	O
an	DT	O
abnormality	NN	O
was	VBD	O
found	VBN	O
but	CC	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
remaining	VBG	O
three	CD	O
subjects	NNS	O
.	.	O

Two	CD	O
subjects	NNS	O
shared	VBD	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
at	IN	O
position	NN	O
+	CC	O
5	CD	O
of	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
consensus	NN	O
sequence	NN	O
of	IN	O
intron	NN	O
10	CD	O
.	.	O

Also	RB	O
in	IN	O
two	CD	O
subjects	NNS	O
an	DT	O
A	NN	O
--	:	O
>	JJR	O
T	NN	O
transversion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
stopcodon	NN	O
of	IN	O
the	DT	O
PROS1	NN	O
gene	NN	O
;	:	O
this	DT	O
transversion	NN	O
predicts	VBZ	O
a	DT	O
protein	NN	O
S	NN	O
molecule	NN	O
that	WDT	O
is	VBZ	O
extended	VBN	O
by	IN	O
14	CD	O
amino	NN	O
acids	NNS	O
.	.	O

The	DT	O
fifth	JJ	O
subject	NN	O
was	VBD	O
found	VBN	O
to	TO	O
possess	VB	O
two	CD	O
sequence	NN	O
abnormalities	NNS	O
.	.	O

One	CD	O
allele	NN	O
carried	VBD	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
near	IN	O
the	DT	O
donor	NN	O
splice	NN	O
junction	NN	O
of	IN	O
intron	NN	O
2	CD	O
,	,	O
but	CC	O
this	DT	O
abnormality	NN	O
is	VBZ	O
probably	RB	O
neutral	JJ	O
,	,	O
since	IN	O
it	PRP	O
was	VBD	O
inherited	VBN	O
from	IN	O
the	DT	O
parent	NN	O
with	IN	O
normal	JJ	O
protein	NN	O
S	NN	O
antigen	NN	O
levels	NNS	O
.	.	O

In	IN	O
the	DT	O
other	JJ	O
allele	NN	O
a	DT	O
single	JJ	O
T	NN	O
insertion	NN	O
in	IN	O
codon	NN	O
-25	CD	O
was	VBD	O
found	VBN	O
.	.	O

Analysis	NN	O
of	IN	O
platelet	NN	O
RNA	NN	O
showed	VBD	O
that	IN	O
only	RB	O
the	DT	O
mRNA	NN	O
with	IN	O
the	DT	O
A	NN	O
--	:	O
>	JJR	O
T	NN	O
mutation	NN	O
in	IN	O
the	DT	O
stopcodon	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
amounts	NNS	O
comparable	JJ	O
to	TO	O
wildtype	JJ	O
RNA	NN	O
.	.	O

mRNA	NN	O
from	IN	O
the	DT	O
alleles	NNS	O
with	IN	O
the	DT	O
other	JJ	O
two	CD	O
mutations	NNS	O
was	VBD	O
either	CC	O
undetectable	JJ	O
or	CC	O
present	JJ	O
in	IN	O
greatly	RB	O
reduced	VBN	O
amounts	NNS	O
.	.	O

The	DT	O
latter	JJ	O
indicates	VBZ	O
that	IN	O
a	DT	O
mRNA	NN	O
based	VBN	O
approach	NN	O
is	VBZ	O
not	RB	O
feasible	JJ	O
for	IN	O
the	DT	O
genetic	JJ	O
analysis	NN	O
of	IN	O
protein	NN	B-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
type	NN	I-Disease
I.	NN	O
.	.	O

A	DT	O
potential	JJ	O
animal	NN	O
model	NN	O
for	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
through	IN	O
introduction	NN	O
of	IN	O
HPRT	NN	O
mutations	NNS	O
into	IN	O
mice	NNS	O
.	.	O

The	DT	O
human	JJ	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
neurological	JJ	B-Disease
and	CC	I-Disease
behavioural	JJ	I-Disease
disorder	NN	I-Disease
,	,	O
affecting	VBG	O
only	RB	O
males	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
caused	VBN	O
by	IN	O
an	DT	O
inherited	VBN	B-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
level	NN	O
of	IN	O
activity	NN	O
of	IN	O
the	DT	O
purine	NN	O
salvage	NN	O
enzyme	NN	O
hypoxanthine-guanosine	NN	O
phosphoribosyl	NN	O
transferase	NN	O
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
.	.	O

How	WRB	O
the	DT	O
resulting	VBG	O
alterations	NNS	O
in	IN	O
purine	NN	O
metabolism	NN	O
lead	NN	O
to	TO	O
the	DT	O
severe	JJ	O
symptoms	NNS	O
characteristic	JJ	O
of	IN	O
Lesch-Nyhan	JJ	B-Disease
patients	NNS	O
is	VBZ	O
still	RB	O
not	RB	O
understood	VBN	O
.	.	O

No	DT	O
mutations	NNS	O
at	IN	O
the	DT	O
Hprt	NN	O
locus	NN	O
leading	VBG	O
to	TO	O
loss	NN	O
of	IN	O
activity	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
in	IN	O
laboratory	NN	O
animals	NNS	O
.	.	O

To	TO	O
derive	VB	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
we	PRP	O
have	VBP	O
used	VBN	O
cultured	VBN	O
mouse	NN	O
embryonic	JJ	O
stem	NN	O
cells	NNS	O
,	,	O
mutagenized	VBN	O
by	IN	O
retroviral	JJ	O
insertion	NN	O
and	CC	O
selected	VBN	O
for	IN	O
loss	NN	O
of	IN	O
HPRT	NN	O
activity	NN	O
,	,	O
to	TO	O
construct	VB	O
chimaeric	JJ	O
mice	NNS	O
.	.	O

Two	CD	O
clonal	JJ	O
lines	NNS	O
carrying	VBG	O
different	JJ	O
mutant	JJ	O
Hprt	NN	O
alleles	NNS	O
have	VBP	O
given	VBN	O
rise	NN	O
to	TO	O
germ	NN	O
cells	NNS	O
in	IN	O
chimaeras	NNS	O
,	,	O
allowing	VBG	O
the	DT	O
derivation	NN	O
of	IN	O
strains	NNS	O
of	IN	O
mutant	JJ	O
mice	NNS	O
having	VBG	O
the	DT	O
same	JJ	O
biochemical	JJ	O
defect	NN	O
as	IN	O
Lesch-Nyhan	JJ	B-Disease
patients	NNS	O
.	.	O

Male	JJ	O
mice	NNS	O
carrying	VBG	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
are	VBP	O
viable	JJ	O
and	CC	O
analysis	NN	O
of	IN	O
their	PRP$	O
cells	NNS	O
shows	VBZ	O
a	DT	O
total	JJ	O
lack	NN	O
of	IN	O
HPRT	NN	O
activity	NN	O
.	.	O

.	.	O

Duplicational	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
locus	NN	O
:	:	O
its	PRP$	O
frequency	NN	O
,	,	O
distribution	NN	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
phenotypegenotype	NN	O
correlation	NN	O
.	.	O

Partial	JJ	O
gene	NN	O
deletion	NN	O
is	VBZ	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
mutation	NN	O
leading	VBG	O
to	TO	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
and	CC	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
BMD	NN	B-Disease
)	-RRB-	O
.	.	O

Partial	JJ	O
gene	NN	O
duplication	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
recognized	VBN	O
in	IN	O
a	DT	O
few	JJ	O
cases	NNS	O
.	.	O

We	PRP	O
have	VBP	O
conducted	VBN	O
a	DT	O
survey	NN	O
for	IN	O
duplication	NN	O
in	IN	O
72	CD	O
unrelated	JJ	O
nondeletion	JJ	O
patients	NNS	O
,	,	O
analyzed	VBN	O
by	IN	O
Southern	NN	O
blot	NN	O
hybridization	NN	O
with	IN	O
clones	NNS	O
representing	VBG	O
the	DT	O
entire	JJ	O
DMD	NNP	B-Disease
cDNA	NN	O
.	.	O

With	IN	O
careful	JJ	O
quantitative	JJ	O
analysis	NN	O
of	IN	O
hybridization	NN	O
band	NN	O
intensity	NN	O
,	,	O
10	CD	O
cases	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
a	DT	O
duplication	NN	O
of	IN	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
a	DT	O
frequency	NN	O
of	IN	O
14	CD	O
%	NN	O
for	IN	O
nondeletion	JJ	O
cases	NNS	O
(	-LRB-	O
10/72	CD	O
)	-RRB-	O
,	,	O
or	CC	O
6	CD	O
%	NN	O
for	IN	O
all	DT	O
cases	NNS	O
(	-LRB-	O
10/181	CD	O
)	-RRB-	O
.	.	O

The	DT	O
extent	NN	O
of	IN	O
these	DT	O
duplications	NNS	O
has	VBZ	O
been	VBN	O
characterized	VBN	O
according	VBG	O
to	TO	O
the	DT	O
published	VBN	O
exon-containing	JJ	O
HindIII	NN	O
fragment	NN	O
map	NN	O
,	,	O
and	CC	O
in	IN	O
six	CD	O
of	IN	O
the	DT	O
10	CD	O
duplications	NNS	O
a	DT	O
novel	JJ	O
restriction	NN	O
fragment	NN	O
that	WDT	O
spanned	VBD	O
the	DT	O
duplication	NN	O
junction	NN	O
was	VBD	O
detected	VBN	O
.	.	O

The	DT	O
resulting	VBG	O
translational	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
mRNA	NN	O
has	VBZ	O
been	VBN	O
predicted	VBN	O
for	IN	O
nine	CD	O
duplications	NNS	O
.	.	O

A	DT	O
shift	NN	O
of	IN	O
the	DT	O
reading	NN	O
frame	NN	O
was	VBD	O
predicted	VBN	O
in	IN	O
four	CD	O
of	IN	O
the	DT	O
six	CD	O
DMD	NN	B-Disease
cases	NNS	O
and	CC	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
intermediate	JJ	O
cases	NNS	O
,	,	O
while	IN	O
the	DT	O
reading	NN	O
frame	NN	O
remained	VBD	O
uninterrupted	JJ	O
in	IN	O
both	CC	O
BMD	NN	B-Disease
cases	NNS	O
.	.	O

RFLP	NN	O
and	CC	O
quantitative	JJ	O
Southern	NN	O
blot	NN	O
analyses	NNS	O
revealed	VBD	O
a	DT	O
grandpaternal	JJ	O
origin	NN	O
of	IN	O
duplication	NN	O
in	IN	O
four	CD	O
families	NNS	O
and	CC	O
grandmaternal	JJ	O
origin	NN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
all	DT	O
five	CD	O
families	NNS	O
,	,	O
the	DT	O
duplication	NN	O
was	VBD	O
found	VBN	O
to	TO	O
originate	VB	O
from	IN	O
a	DT	O
single	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

Unequal	JJ	O
sister-chromatid	JJ	O
exchange	NN	O
is	VBZ	O
proposed	VBN	O
to	TO	O
be	VB	O
the	DT	O
mechanism	NN	O
for	IN	O
the	DT	O
formation	NN	O
of	IN	O
these	DT	O
duplications	NNS	O
.	.	O

.	.	O

Molecular	JJ	O
evidence	NN	O
for	IN	O
new	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
in	IN	O
Lesch-Nyhan	JJ	B-Disease
patients	NNS	O
.	.	O

Hypoxanthine-guanine	JJ	O
phosphoribosyltransferase	NN	O
(	-LRB-	O
HPRT	NN	O
;	:	O
EC2	NN	O
.	.	O

4	LS	O
.	.	O

2	LS	O
.	.	O

8	CD	O
)	-RRB-	O
,	,	O
which	WDT	O
functions	VBZ	O
in	IN	O
the	DT	O
metabolic	JJ	O
salvage	NN	O
of	IN	O
purines	NNS	O
,	,	O
is	VBZ	O
encoded	VBN	O
by	IN	O
an	DT	O
X-linked	JJ	O
gene	NN	O
in	IN	O
man	NN	O
.	.	O

Partial	JJ	O
HPRT	NN	B-Disease
deficiencies	NNS	I-Disease
are	VBP	O
associated	VBN	O
with	IN	O
gouty	JJ	B-Disease
arthritis	NN	I-Disease
,	,	O
while	IN	O
absence	NN	O
of	IN	O
activity	NN	O
results	NNS	O
in	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
L-N	NN	B-Disease
)	-RRB-	O
.	.	O

L-N	NN	B-Disease
patients	NNS	O
fail	VBP	O
to	TO	O
reproduce	VB	O
and	CC	O
the	DT	O
heterozygous	JJ	O
state	NN	O
appears	VBZ	O
to	TO	O
confer	VB	O
no	DT	O
selective	JJ	O
advantage	NN	O
.	.	O

Thus	RB	O
,	,	O
Haldanes	NNP	O
principle	NN	O
predicts	VBZ	O
that	IN	O
new	JJ	O
mutations	NNS	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
must	MD	O
occur	VB	O
frequently	RB	O
in	IN	O
order	NN	O
for	IN	O
L-N	NN	B-Disease
syndrome	NN	I-Disease
to	TO	O
be	VB	O
maintained	VBN	O
in	IN	O
the	DT	O
population	NN	O
.	.	O

This	DT	O
constant	JJ	O
introduction	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
would	MD	O
be	VB	O
expected	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
heterogeneous	JJ	O
collection	NN	O
of	IN	O
genetic	JJ	B-Disease
lesions	NNS	I-Disease
,	,	O
some	DT	O
of	IN	O
which	WDT	O
may	MD	O
be	VB	O
novel	JJ	O
.	.	O

As	IN	O
we	PRP	O
report	VBP	O
here	RB	O
,	,	O
the	DT	O
mutations	NNS	O
in	IN	O
the	DT	O
hprt	NN	O
gene	NN	O
of	IN	O
seven	CD	O
L-N	NN	B-Disease
patients	NNS	O
,	,	O
selected	VBN	O
from	IN	O
an	DT	O
initial	JJ	O
survey	NN	O
of	IN	O
28	CD	O
patients	NNS	O
,	,	O
have	VBP	O
been	VBN	O
characterized	VBN	O
and	CC	O
all	DT	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
distinctly	RB	O
different	JJ	O
,	,	O
as	IN	O
predicted	VBN	O
.	.	O

The	DT	O
origin	NN	O
of	IN	O
one	CD	O
unusual	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
DNA	NN	O
from	IN	O
four	CD	O
generations	NNS	O
of	IN	O
family	NN	O
members	NNS	O
.	.	O

Further	JJ	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
origin	NN	O
of	IN	O
new	JJ	O
mutations	NNS	O
at	IN	O
the	DT	O
hprt	NN	O
locus	NN	O
should	MD	O
aid	VB	O
in	IN	O
resolving	VBG	O
the	DT	O
issue	NN	O
of	IN	O
an	DT	O
apparent	JJ	O
difference	NN	O
in	IN	O
the	DT	O
frequency	NN	O
of	IN	O
hprt	NN	O
mutations	NNS	O
in	IN	O
males	NNS	O
and	CC	O
females	NNS	O

The	DT	O
mapping	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
from	IN	O
the	DT	O
human	JJ	O
X-linked	JJ	B-Disease
Duchenne	NN	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
to	TO	O
the	DT	O
mouse	NN	O
X	NN	O
chromosome	NN	O
.	.	O

The	DT	O
recent	JJ	O
discovery	NN	O
of	IN	O
sequences	NNS	O
at	IN	O
the	DT	O
site	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
in	IN	O
humans	NNS	O
has	VBZ	O
opened	VBN	O
up	RP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
detailed	JJ	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
genes	NNS	O
in	IN	O
humans	NNS	O
and	CC	O
in	IN	O
related	JJ	O
mammalian	JJ	O
species	NNS	O
.	.	O

Until	IN	O
relatively	RB	O
recently	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
obvious	JJ	O
mouse	NN	O
model	NN	O
of	IN	O
this	DT	O
genetic	JJ	B-Disease
disease	NN	I-Disease
for	IN	O
the	DT	O
development	NN	O
of	IN	O
therapeutic	JJ	O
strategies	NNS	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
a	DT	O
mouse	NN	O
X-linked	JJ	O
mutant	JJ	O
showing	VBG	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
mdx	NN	O
,	,	O
has	VBZ	O
provided	VBN	O
a	DT	O
candidate	NN	O
mouse	NN	O
genetic	JJ	O
homologue	NN	O
to	TO	O
the	DT	O
DMD	NN	B-Disease
locus	NN	O
;	:	O
the	DT	O
relatively	RB	O
mild	JJ	O
pathological	JJ	O
features	NNS	O
of	IN	O
mdx	NN	O
suggest	VBP	O
it	PRP	O
may	MD	O
have	VB	O
more	RBR	O
in	IN	O
common	JJ	O
with	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
type	NN	O
at	IN	O
the	DT	O
same	JJ	O
human	JJ	O
locus	NN	O
,	,	O
however	RB	O
.	.	O

But	CC	O
the	DT	O
close	JJ	O
genetic	JJ	O
linkage	NN	O
of	IN	O
mdx	NN	O
to	TO	O
G6PD	NN	O
and	CC	O
Hprt	NN	O
on	IN	O
the	DT	O
mouse	NN	O
X	NN	O
chromosome	NN	O
,	,	O
coupled	VBN	O
with	IN	O
its	PRP$	O
comparatively	RB	O
mild	JJ	O
pathology	NN	O
,	,	O
have	VBP	O
suggested	VBN	O
that	IN	O
the	DT	O
mdx	NN	O
mutation	NN	O
may	MD	O
instead	RB	O
correspond	VB	O
to	TO	O
Emery	NNP	B-Disease
Dreifuss	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
which	WDT	O
itself	PRP	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
DNA	NN	O
markers	NNS	O
at	IN	O
Xq28-qter	NN	O
in	IN	O
the	DT	O
region	NN	O
of	IN	O
G6PD	NN	O
on	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

Using	VBG	O
an	DT	O
interspecific	JJ	O
mouse	NN	O
domesticus/spretus	NN	O
cross	NN	O
,	,	O
segregating	VBG	O
for	IN	O
a	DT	O
variety	NN	O
of	IN	O
markers	NNS	O
on	IN	O
the	DT	O
mouse	NN	O
X	NN	O
chromosome	NN	O
,	,	O
we	PRP	O
have	VBP	O
positioned	VBN	O
on	IN	O
the	DT	O
mouse	NN	O
X	NN	O
chromosome	NN	O
sequences	NNS	O
homologous	JJ	O
to	TO	O
a	DT	O
DMD	NNP	B-Disease
cDNA	NN	O
clone	NN	O
.	.	O

These	DT	O
sequences	NNS	O
map	VBP	O
provocatively	RB	O
close	JJ	O
to	TO	O
the	DT	O
mdx	NN	O
mutation	NN	O
and	CC	O
unexpectedly	RB	O
distant	JJ	O
from	IN	O
sparse	JJ	O
fur	NN	O
,	,	O
spf	NN	O
,	,	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
OTC	NNP	O
(	-LRB-	O
ornithine	JJ	O
transcarbamylase	NN	O
)	-RRB-	O
which	WDT	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
DMD	NNP	B-Disease
on	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
the	DT	O
alkaptonuria	NN	B-Disease
mouse	NN	O
model	NN	O
.	.	O

Alkaptonuria	NN	B-Disease
(	-LRB-	O
aku	NN	B-Disease
)	-RRB-	O
,	,	O
an	DT	O
inborn	JJ	B-Disease
error	NN	I-Disease
of	IN	I-Disease
metabolism	NN	I-Disease
caused	VBN	O
by	IN	O
the	DT	O
loss	NN	O
of	IN	O
homogentisate	NN	O
1	CD	O
,	,	O
2-dioxygenase	NN	O
(	-LRB-	O
HGD	NN	O
)	-RRB-	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
in	IN	O
a	DT	O
mouse	NN	O
model	NN	O
created	VBN	O
by	IN	O
ethylnitrosourea	NN	O
mutagenesis	NN	O
but	CC	O
the	DT	O
mutation	NN	O
in	IN	O
these	DT	O
mice	NNS	O
has	VBZ	O
not	RB	O
previously	RB	O
been	VBN	O
identified	VBN	O
.	.	O

We	PRP	O
used	VBD	O
RT-PCR	NN	O
to	TO	O
amplify	VB	O
the	DT	O
Hgd	NN	O
cDNA	NN	O
from	IN	O
Hgd	NN	O
(	-LRB-	O
aku	NN	O
)	-RRB-	O
/	:	O
Hgd	NN	O
(	-LRB-	O
aku	NN	O
)	-RRB-	O
mice	NNS	O
.	.	O

Two	CD	O
products	NNS	O
shorter	JJR	O
than	IN	O
the	DT	O
wild-type	JJ	O
product	NN	O
were	VBD	O
amplified	VBN	O
.	.	O

Restriction	NN	O
mapping	NN	O
and	CC	O
DNA	NN	O
sequencing	NN	O
were	VBD	O
then	RB	O
used	VBN	O
to	TO	O
identify	VB	O
the	DT	O
Hgd	NN	O
(	-LRB-	O
aku	NN	O
)	-RRB-	O
mouse	NN	O
mutation	NN	O
,	,	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
single	JJ	O
base	NN	O
change	NN	O
in	IN	O
a	DT	O
splice	NN	O
donor	NN	O
consensus	NN	O
sequence	NN	O
,	,	O
causing	VBG	O
exon	NN	O
skipping	VBG	O
and	CC	O
frame-shifted	JJ	O
products	NNS	O
.	.	O

This	DT	O
base	NN	O
change	NN	O
allowed	VBD	O
us	PRP	O
to	TO	O
create	VB	O
a	DT	O
non-radioactive	JJ	O
genotyping	NN	O
assay	NN	O
for	IN	O
this	DT	O
allele	NN	O
.	.	O

Common	JJ	O
sequence	NN	O
motifs	NNS	O
at	IN	O
the	DT	O
rearrangement	NN	O
sites	NNS	O
of	IN	O
a	DT	O
constitutional	JJ	O
X/autosome	NN	O
translocation	NN	O
and	CC	O
associated	VBN	O
deletion	NN	O
.	.	O

Reciprocal	JJ	O
chromosome	NN	O
translocations	NNS	O
are	VBP	O
common	JJ	O
de	FW	O
novo	FW	O
rearrangements	NNS	O
that	WDT	O
occur	VBP	O
randomly	RB	O
throughout	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

To	TO	O
learn	VB	O
about	IN	O
causative	JJ	O
mechanisms	NNS	O
,	,	O
we	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
a	DT	O
cytologically	RB	O
balanced	JJ	O
constitutional	JJ	O
reciprocal	JJ	O
translocation	NN	O
,	,	O
t	NN	O
(	-LRB-	O
X	NN	O
;	:	O
4	LS	O
)	-RRB-	O
(	-LRB-	O
p21	NN	O
.	.	O

2	CD	O
;	:	O
q31	NN	O
.	.	O

22	CD	O
)	-RRB-	O
,	,	O
present	JJ	O
in	IN	O
a	DT	O
girl	NN	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

Physical	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
derivative	JJ	O
chromosomes	NNS	O
,	,	O
after	IN	O
their	PRP$	O
separation	NN	O
in	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
,	,	O
reveals	VBZ	O
that	IN	O
the	DT	O
translocation	NN	O
disrupts	VBZ	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
in	IN	O
Xp21	NN	O
within	IN	O
the	DT	O
18-kb	JJ	O
intron	NN	O
16	CD	O
.	.	O

Restriction	NN	O
mapping	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
clones	NNS	O
that	WDT	O
span	VBP	O
both	DT	O
translocation	NN	O
breakpoints	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
corresponding	JJ	O
normal	JJ	O
regions	NNS	O
indicate	VBP	O
the	DT	O
loss	NN	O
of	IN	O
approximately	RB	O
5	CD	O
kb	NN	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
the	DT	O
derivative	JJ	O
X	NN	O
chromosome	NN	O
,	,	O
with	IN	O
4-6	CD	O
bp	NN	O
deleted	VBN	O
from	IN	O
chromosome	NN	O
4	CD	O
.	.	O

RFLP	NN	O
and	CC	O
Southern	NN	O
analyses	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
de	FW	O
novo	FW	O
translocation	NN	O
is	VBZ	O
a	DT	O
paternal	JJ	O
origin	NN	O
and	CC	O
that	IN	O
the	DT	O
fathers	NNS	O
X	NN	O
chromosome	NN	O
contains	VBZ	O
the	DT	O
DNA	NN	O
that	WDT	O
is	VBZ	O
deleted	VBN	O
in	IN	O
the	DT	O
derivative	JJ	O
X.	NNP	O
Most	RBS	O
likely	JJ	O
,	,	O
deletion	NN	O
and	CC	O
translation	NN	O
arose	VBD	O
simultaneously	RB	O
from	IN	O
a	DT	O
complex	JJ	O
rearrangement	NN	O
event	NN	O
that	WDT	O
involves	VBZ	O
three	CD	O
chromosomal	JJ	O
breakpoints	NNS	O
.	.	O

Short	JJ	O
regions	NNS	O
of	IN	O
sequence	NN	O
homology	NN	O
were	VBD	O
present	JJ	O
at	IN	O
the	DT	O
three	CD	O
sites	NNS	O
.	.	O

A	DT	O
5-bp	JJ	O
sequence	NN	O
,	,	O
GGAAT	NN	O
,	,	O
found	VBD	O
exactly	RB	O
at	IN	O
the	DT	O
translocation	NN	O
breakpoints	NNS	O
on	IN	O
both	CC	O
normal	JJ	O
chromosomes	NNS	O
X	NN	O
and	CC	O
4	CD	O
,	,	O
has	VBZ	O
been	VBN	O
preserved	VBN	O
only	RB	O
on	IN	O
the	DT	O
der	NN	O
(	-LRB-	O
4	CD	O
)	-RRB-	O
chromosome	NN	O
.	.	O

It	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
X-derived	JJ	O
sequence	NN	O
GGAATCA	NN	O
has	VBZ	O
been	VBN	O
lost	VBN	O
in	IN	O
the	DT	O
formation	NN	O
of	IN	O
the	DT	O
der	NN	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
chromosome	NN	O
,	,	O
as	IN	O
it	PRP	O
matches	VBZ	O
an	DT	O
inverted	JJ	O
GAATCA	NN	O
sequence	NN	O
present	JJ	O
on	IN	O
the	DT	O
opposite	JJ	O
strand	NN	O
exactly	RB	O
at	IN	O
the	DT	O
other	JJ	O
end	NN	O
of	IN	O
the	DT	O
deleted	VBN	O
5-kb	JJ	O
fragment	NN	O
.	.	O

The	DT	O
human	JJ	O
factor	NN	O
IX	CD	O
gene	NN	O
as	IN	O
germline	NN	O
mutagen	NN	O
test	NN	O
:	:	O
samples	NNS	O
from	IN	O
Mainland	NNP	O
China	NNP	O
have	VBP	O
the	DT	O
putatively	RB	O
endogenous	JJ	O
pattern	NN	O
of	IN	O
mutation	NN	O
.	.	O

Germline	NN	O
mutations	NNS	O
are	VBP	O
the	DT	O
major	JJ	O
source	NN	O
of	IN	O
genetic	JJ	O
variation	NN	O
that	WDT	O
allows	VBZ	O
a	DT	O
species	NNS	O
to	TO	O
evolve	VB	O
over	IN	O
time	NN	O
but	CC	O
at	IN	O
the	DT	O
cost	NN	O
of	IN	O
Mendelian	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
genetic	JJ	O
predisposition	NN	O
to	TO	O
multifactorial	JJ	B-Disease
diseases	NNS	I-Disease
.	.	O

Previous	JJ	O
analyses	NNS	O
have	VBP	O
revealed	VBN	O
that	IN	O
the	DT	O
pattern	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
factor	NN	O
IX	CD	O
gene	NN	O
(	-LRB-	O
F9	NN	O
)	-RRB-	O
is	VBZ	O
similar	JJ	O
among	IN	O
a	DT	O
variety	NN	O
of	IN	O
ethnically	RB	O
and	CC	O
geographically	RB	O
diverse	JJ	O
populations	NNS	O
and	CC	O
compatible	JJ	O
with	IN	O
the	DT	O
ancient	JJ	O
pattern	NN	O
that	WDT	O
has	VBZ	O
shaped	VBN	O
the	DT	O
mammalian	JJ	O
genome	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
compare	VBP	O
the	DT	O
pattern	NN	O
of	IN	O
germline	NN	O
mutation	NN	O
in	IN	O
a	DT	O
population	NN	O
of	IN	O
hemophilia	NN	B-Disease
B	NN	I-Disease
patients	NNS	O
from	IN	O
Mainland	NNP	O
China	NNP	O
(	-LRB-	O
n	NN	O
=	JJ	O
66	CD	O
)	-RRB-	O
to	TO	O
that	DT	O
in	IN	O
U.	NNP	O
S.	NNP	O
Caucasians	NNPS	O
,	,	O
Blacks	NNPS	O
,	,	O
and	CC	O
Mexican	JJ	O
Hispanics	NNPS	O
and	CC	O
stratify	VB	O
by	IN	O
disease	NN	O
severity	NN	O
and	CC	O
ethnicity	NN	O
.	.	O

The	DT	O
similar	JJ	O
pattern	NN	O
of	IN	O
germline	NN	O
mutation	NN	O
in	IN	O
all	DT	O
ethnic	JJ	O
groups	NNS	O
studied	VBN	O
to	TO	O
date	NN	O
provides	VBZ	O
additional	JJ	O
data	NNS	O
compatible	JJ	O
with	IN	O
the	DT	O
inference	NN	O
that	WDT	O
endogenous	JJ	O
processes	NNS	O
predominate	VBP	O
in	IN	O
germline	NN	O
mutations	NNS	O
.	.	O

Phenotype	NN	O
heterogeneity	NN	O
among	IN	O
hemizygotes	NNS	O
in	IN	O
a	DT	O
family	NN	O
biochemically	RB	O
screened	VBN	O
for	IN	O
adrenoleukodystrophy	NN	B-Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
two	CD	O
clinically	RB	O
,	,	O
neurologically	RB	O
normal	JJ	O
relatives	NNS	O
of	IN	O
a	DT	O
boy	NN	O
affected	VBN	O
by	IN	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
;	:	O
they	PRP	O
were	VBD	O
found	VBN	O
repeatedly	RB	O
to	TO	O
have	VB	O
the	DT	O
biochemical	JJ	O
defect	NN	O
of	IN	O
an	DT	O
ALD	NN	B-Disease
hemizygote	NN	O
.	.	O

The	DT	O
assay	NN	O
consisted	VBD	O
in	IN	O
the	DT	O
determination	NN	O
of	IN	O
very-long-chain	JJ	O
fatty	JJ	O
acids	NNS	O
in	IN	O
lyophilized	VBN	O
and	CC	O
reconstituted	VBN	O
plasma	NN	O
.	.	O

While	IN	O
no	DT	O
evidence	NN	O
of	IN	O
neurologic	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
leukodystrophy	NN	B-Disease
or	CC	O
myeloneuropathy	NN	B-Disease
)	-RRB-	O
was	VBD	O
present	JJ	O
in	IN	O
these	DT	O
hemizygotes	NNS	O
,	,	O
adrenocortical	JJ	B-Disease
insufficiency	NN	I-Disease
provoking	VBG	O
compensatory	JJ	O
high	JJ	O
ACTH	NN	O
release	NN	O
was	VBD	O
found	VBN	O
in	IN	O
both	DT	O
.	.	O

These	DT	O
findings	NNS	O
should	MD	O
be	VB	O
taken	VBN	O
into	IN	O
consideration	NN	O
when	WRB	O
counseling	VBG	O
families	NNS	O
in	IN	O
which	WDT	O
cases	NNS	O
with	IN	O
clinically	RB	O
expressed	VBN	O
ALD	NN	B-Disease
are	VBP	O
represented	VBN	O
in	IN	O
several	JJ	O
generations	NNS	O
.	.	O

.	.	O

Novel	JJ	O
mutations	NNS	O
of	IN	O
the	DT	O
ATP7B	NN	O
gene	NN	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Wilson	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
WD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
copper	NN	O
accumulation	NN	O
in	IN	O
the	DT	O
liver	NN	O
,	,	O
brain	NN	O
,	,	O
kidneys	NNS	O
,	,	O
and	CC	O
corneas	NNS	O
,	,	O
and	CC	O
culminating	VBG	O
in	IN	O
copper	NN	O
toxication	NN	O
in	IN	O
these	DT	O
organs	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
analyzed	VBD	O
mutations	NNS	O
of	IN	O
the	DT	O
responsible	JJ	O
gene	NN	O
,	,	O
ATP7B	NN	O
,	,	O
in	IN	O
four	CD	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
WD	NN	B-Disease
.	.	O

By	IN	O
direct	JJ	O
sequencing	NN	O
,	,	O
we	PRP	O
identified	VBD	O
five	CD	O
mutations	NNS	O
,	,	O
of	IN	O
which	WDT	O
two	CD	O
were	VBD	O
novel	JJ	O
,	,	O
and	CC	O
16	CD	O
polymorphisms	NNS	O
,	,	O
of	IN	O
which	WDT	O
6	CD	O
were	VBD	O
novel	JJ	O
.	.	O

The	DT	O
mutations	NNS	O
2871delC	NN	O
and	CC	O
2513delA	NN	O
shift	NN	O
the	DT	O
reading	NN	O
frame	NN	O
so	IN	O
that	IN	O
truncated	VBN	O
abnormal	JJ	O
protein	NN	O
is	VBZ	O
expected	VBN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
these	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
hepatic-type	NN	O
of	IN	O
early	JJ	O
onset	NN	O
,	,	O
the	DT	O
mutations	NNS	O
A874V	NN	O
,	,	O
R778L	NN	O
,	,	O
and	CC	O
3892delGTC	NN	O
were	VBD	O
either	CC	O
missense	NN	O
mutations	NNS	O
or	CC	O
in	IN	O
frame	NN	O
1-amino	NN	O
acid	NN	O
deletion	NN	O
,	,	O
and	CC	O
occurred	VBD	O
in	IN	O
the	DT	O
patients	NNS	O
with	IN	O
hepato-neurologic	JJ	O
type	NN	O
of	IN	O
late	JJ	O
onset	NN	O
.	.	O

The	DT	O
mutations	NNS	O
2871delC	NN	O
and	CC	O
R778L	NN	O
have	VBP	O
been	VBN	O
previously	RB	O
reported	VBN	O
in	IN	O
a	DT	O
relatively	RB	O
large	JJ	O
number	NN	O
of	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

In	IN	O
particular	JJ	O
,	,	O
R778L	NN	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
more	RBR	O
prevalent	JJ	O
in	IN	O
Asian	JJ	O
countries	NNS	O
than	IN	O
in	IN	O
other	JJ	O
countries	NNS	O
of	IN	O
the	DT	O
world	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
the	DT	O
mutations	NNS	O
tend	VBP	O
to	TO	O
occur	VB	O
in	IN	O
a	DT	O
population-specific	JJ	O
manner	NN	O
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
accumulation	NN	O
of	IN	O
the	DT	O
types	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
WD	NN	B-Disease
will	MD	O
facilitate	VB	O
the	DT	O
fast	JJ	O
and	CC	O
effective	JJ	O
genetic	JJ	O
diagnosis	NN	O
of	IN	O
WD	NN	B-Disease
in	IN	O
Japanese	JJ	O
patients	NNS	O
.	.	O

.	.	O

Structural	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
5	CD	O
'	''	O
region	NN	O
of	IN	O
mouse	NN	O
and	CC	O
human	JJ	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
genes	NNS	O
reveals	VBZ	O
conservation	NN	O
of	IN	O
putative	JJ	O
promoter	NN	O
region	NN	O
and	CC	O
di	FW	O
-	:	O
and	CC	O
trinucleotide	JJ	O
polymorphisms	NNS	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
cloned	VBN	O
and	CC	O
characterized	VBN	O
the	DT	O
murine	JJ	O
homologue	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
gene	NN	O
and	CC	O
shown	VBN	O
that	IN	O
it	PRP	O
maps	VBZ	O
to	TO	O
mouse	NN	O
chromosome	NN	O
5	CD	O
within	IN	O
a	DT	O
region	NN	O
of	IN	O
conserved	VBN	O
synteny	NN	O
with	IN	O
human	JJ	O
chromosome	NN	O
4p16	NN	O
.	.	O

3	CD	O
3	CD	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
a	DT	O
detailed	JJ	O
comparison	NN	O
of	IN	O
the	DT	O
sequence	NN	O
of	IN	O
the	DT	O
putative	JJ	O
promoter	NN	O
and	CC	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
5	CD	O
genomic	JJ	O
region	NN	O
of	IN	O
the	DT	O
murine	NN	O
(	-LRB-	O
Hdh	NN	O
)	-RRB-	O
and	CC	O
human	JJ	O
HD	NN	B-Disease
genes	NNS	O
encompassing	VBG	O
the	DT	O
first	JJ	O
five	CD	O
exons	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
in	IN	O
this	DT	O
region	NN	O
these	DT	O
two	CD	O
genes	NNS	O
share	VBP	O
identical	JJ	O
exon	NN	O
boundaries	NNS	O
,	,	O
but	CC	O
have	VBP	O
different-size	JJ	O
introns	NNS	O
.	.	O

Two	CD	O
dinucleotide	NN	O
(	-LRB-	O
CT	NN	O
)	-RRB-	O
and	CC	O
one	CD	O
trinucleotide	NN	O
intronic	JJ	O
polymorphism	NN	O
in	IN	O
Hdh	NN	O
and	CC	O
an	DT	O
intronic	JJ	O
CA	NNP	O
polymorphism	NN	O
in	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
were	VBD	O
identified	VBN	O
.	.	O

Comparison	NN	O
of	IN	O
940-bp	JJ	O
sequence	NN	O
5	CD	O
to	TO	O
the	DT	O
putative	JJ	O
translation	NN	O
start	NN	O
site	NN	O
reveals	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
region	NN	O
(	-LRB-	O
78	CD	O
.	.	O

8	CD	O
%	NN	O
nucleotide	NN	O
identity	NN	O
)	-RRB-	O
between	IN	O
Hdh	NN	O
and	CC	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
from	IN	O
nucleotide	NN	O
-56	CD	O
to	TO	O
-206	CD	O
(	-LRB-	O
of	IN	O
Hdh	NN	O
)	-RRB-	O
.	.	O

Neither	DT	O
Hdh	NN	O
nor	CC	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
have	VBP	O
typical	JJ	O
TATA	NN	O
or	CC	O
CCAAT	NN	O
elements	NNS	O
,	,	O
but	CC	O
both	DT	O
show	VBP	O
one	CD	O
putative	JJ	O
AP2	NN	O
binding	NN	O
site	NN	O
and	CC	O
numerous	JJ	O
potential	JJ	O
Sp1	NN	O
binding	NN	O
sites	NNS	O
.	.	O

The	DT	O
high	JJ	O
sequence	NN	O
identity	NN	O
between	IN	O
Hdh	NN	O
and	CC	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
for	IN	O
approximately	RB	O
200	CD	O
bp	NN	O
5	CD	O
to	TO	O
the	DT	O
putative	JJ	O
translation	NN	O
start	NN	O
site	NN	O
indicates	VBZ	O
that	IN	O
these	DT	O
sequences	NNS	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
regulating	VBG	O
expression	NN	O
of	IN	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O

Complement	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
nephritis	NN	B-Disease
.	.	O

A	DT	O
report	NN	O
of	IN	O
a	DT	O
family	NN	O
.	.	O

A	DT	O
family	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
three	CD	O
children	NNS	O
had	VBD	O
homozygous	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
C3	NN	I-Disease
and	CC	O
in	IN	O
which	WDT	O
both	CC	O
parents	NNS	O
and	CC	O
two	CD	O
other	JJ	O
children	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
C3	NN	O
null	JJ	O
gene	NN	O
.	.	O

One	CD	O
child	NN	O
with	IN	O
heterozygous	JJ	O
C3	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
membranoproliferative	JJ	O
glomerulonephritis	NN	B-Disease
;	:	O
proteinuria	NN	B-Disease
and/or	CC	O
microscopical	JJ	O
haematuria	NN	B-Disease
was	VBD	O
present	JJ	O
in	IN	O
all	DT	O
three	CD	O
homozygous	JJ	O
C3-deficient	JJ	B-Disease
children	NNS	O
.	.	O

All	DT	O
children	NNS	O
with	IN	O
homozygous	JJ	O
or	CC	O
heterozygous	JJ	O
C3	NN	B-Disease
deficiency	NN	I-Disease
were	VBD	O
,	,	O
to	TO	O
a	DT	O
varying	VBG	O
degree	NN	O
,	,	O
susceptible	JJ	O
to	TO	O
infection	NN	O
.	.	O

The	DT	O
only	JJ	O
child	NN	O
of	IN	O
the	DT	O
family	NN	O
with	IN	O
normal	JJ	O
complement	NN	O
had	VBD	O
no	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
infection	NN	O
and	CC	O
no	DT	O
renal	JJ	B-Disease
disease	NN	I-Disease
.	.	O

This	DT	O
family	NN	O
study	NN	O
provides	VBZ	O
further	JJ	O
support	NN	O
for	IN	O
the	DT	O
proposal	NN	O
that	WDT	O
C3	NN	B-Disease
deficiency	NN	I-Disease
predisposes	VBZ	O
to	TO	O
nephritis	NN	B-Disease
.	.	O

.	.	O

Cytogenetic	JJ	O
investigations	NNS	O
in	IN	O
families	NNS	O
with	IN	O
ataxia-telangiectasia	NN	B-Disease
.	.	O

Chromosomal	JJ	O
studies	NNS	O
were	VBD	O
performed	VBN	O
on	IN	O
peripheral	JJ	O
blood	NN	O
lymphocytes	NNS	O
and	CC	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
five	CD	O
Israeli-Moroccan	JJ	O
families	NNS	O
with	IN	O
ataxia-telangiectasia	NN	B-Disease
.	.	O

A	DT	O
total	NN	O
of	IN	O
24	CD	O
individuals	NNS	O
,	,	O
including	VBG	O
seven	CD	O
propositi	NNS	O
,	,	O
was	VBD	O
investigated	VBN	O
.	.	O

Among	IN	O
the	DT	O
probands	NNS	O
,	,	O
significantly	RB	O
elevated	JJ	O
rates	NNS	O
of	IN	O
chromosome	NN	O
damage	NN	O
were	VBD	O
observed	VBN	O
in	IN	O
both	CC	O
blood	NN	O
and	CC	O
skin	NN	O
.	.	O

Skin	NN	O
fibroblasts	NNS	O
of	IN	O
affected	JJ	O
individuals	NNS	O
showed	VBD	O
several	JJ	O
orders	NNS	O
of	IN	O
magnitude	NN	O
more	RBR	O
chromosome	NN	O
breakage	NN	O
than	IN	O
lymphocytes	NNS	O
.	.	O

Increased	VBN	O
rates	NNS	O
of	IN	O
chromosome	NN	O
damage	NN	O
were	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
the	DT	O
fibroblasts	NNS	O
of	IN	O
some	DT	O
phenotypically	RB	O
normal	JJ	O
family	NN	O
members	NNS	O
(	-LRB-	O
obligate	JJ	O
heterozygotes	NNS	O
and	CC	O
sibs	NNS	O
)	-RRB-	O
when	WRB	O
compared	VBN	O
to	TO	O
normal	JJ	O
controls	NNS	O
.	.	O

An	DT	O
apparent	JJ	O
abnormal	JJ	O
clone	NN	O
of	IN	O
cells	NNS	O
,	,	O
possessing	VBG	O
a	DT	O
large	JJ	O
acrocentric	JJ	O
marker	NN	O
chromosome	NN	O
(	-LRB-	O
14q	NN	O
+	CC	O
)	-RRB-	O
,	,	O
was	VBD	O
observed	VBN	O
in	IN	O
varying	VBG	O
proportions	NNS	O
among	IN	O
cells	NNS	O
of	IN	O
all	PDT	O
the	DT	O
propositi	NN	O
(	-LRB-	O
2-5	CD	O
%	NN	O
of	IN	O
lymphocytes	NNS	O
;	:	O
1-9	CD	O
%	NN	O
of	IN	O
fibroblasts	NNS	O
)	-RRB-	O
.	.	O

.	.	O

Predominance	NN	O
of	IN	O
the	DT	O
adrenomyeloneuropathy	JJ	B-Disease
phenotype	NN	O
of	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
in	IN	O
The	DT	O
Netherlands	NNPS	O
:	:	O
a	DT	O
survey	NN	O
of	IN	O
30	CD	O
kindreds	NNS	O
.	.	O

X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
X-ALD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
of	IN	O
peroxisomal	JJ	O
beta-oxidation	NN	O
associated	VBN	O
with	IN	O
accumulation	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long-chain	JJ	O
fatty	JJ	O
acids	NNS	O
,	,	O
which	WDT	O
results	VBZ	O
in	IN	O
central	JJ	O
and	CC	O
peripheral	JJ	O
demyelination	NN	B-Disease
and	CC	O
in	IN	O
impaired	JJ	B-Disease
function	NN	I-Disease
of	IN	I-Disease
adrenal	JJ	I-Disease
cortex	NN	I-Disease
and	CC	I-Disease
testes	NNS	I-Disease
.	.	O

The	DT	O
phenotypic	JJ	O
expression	NN	O
is	VBZ	O
highly	RB	O
variable	JJ	O
,	,	O
childhood	NN	B-Disease
cerebral	JJ	I-Disease
ALD	NN	I-Disease
(	-LRB-	O
CCALD	NN	B-Disease
)	-RRB-	O
and	CC	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
being	VBG	O
the	DT	O
main	JJ	O
variants	NNS	O
.	.	O

We	PRP	O
explored	VBD	O
the	DT	O
30	CD	O
Dutch	JJ	O
kindreds	NNS	O
well	RB	O
known	VBN	O
to	TO	O
the	DT	O
Dutch	JJ	O
X-ALD/AMN	NN	O
Study	NNP	O
Group	NNP	O
and	CC	O
phenotyped	JJ	O
77	CD	O
male	JJ	O
patients	NNS	O
35	CD	O
(	-LRB-	O
46	CD	O
%	NN	O
)	-RRB-	O
had	VBD	O
AMN	NNP	B-Disease
and	CC	O
24	CD	O
(	-LRB-	O
31	CD	O
%	NN	O
)	-RRB-	O
CCALD	NN	B-Disease
or	CC	O
adolescent	JJ	B-Disease
cerebral	JJ	I-Disease
ALD	NN	I-Disease
(	-LRB-	O
AdolCALD	NN	B-Disease
)	-RRB-	O
.	.	O

These	DT	O
percentages	NNS	O
differ	VBP	O
significantly	RB	O
from	IN	O
previous	JJ	O
reports	NNS	O
,	,	O
in	IN	O
which	WDT	O
25	CD	O
to	TO	O
28	CD	O
%	NN	O
of	IN	O
the	DT	O
patients	NNS	O
developed	VBD	O
AMN	NNP	B-Disease
and	CC	O
53	CD	O
to	TO	O
57	CD	O
%	NN	O
CCALD	NN	B-Disease
or	CC	O
AdolCALD	NN	B-Disease
.	.	O

Our	PRP$	O
findings	NNS	O
indicate	VBP	O
that	DT	O
--	:	O
at	IN	O
least	JJS	O
in	IN	O
the	DT	O
Netherlands	NNP	O
--	:	O
AMN	NNP	B-Disease
may	MD	O
be	VB	O
the	DT	O
most	RBS	O
frequent	JJ	O
phenotype	NN	O
of	IN	O
X-ALD	NN	B-Disease
.	.	O

.	.	O

Three	CD	O
novel	JJ	O
aniridia	NN	B-Disease
mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
PAX6	NN	O
gene	NN	O
.	.	O

Aniridia	NN	B-Disease
(	-LRB-	O
iris	NN	B-Disease
hypoplasia	NN	I-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
congenital	JJ	I-Disease
disorder	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
eye	NN	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
aniridia	NN	B-Disease
(	-LRB-	O
PAX6	NN	O
)	-RRB-	O
gene	NN	O
have	VBP	O
now	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
many	JJ	O
patients	NNS	O
from	IN	O
various	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

In	IN	O
the	DT	O
study	NN	O
reported	VBD	O
here	RB	O
we	PRP	O
describe	VBP	O
PAX6	NN	O
mutations	NNS	O
in	IN	O
one	CD	O
sporadic	JJ	O
and	CC	O
five	CD	O
familial	JJ	O
cases	NNS	O
with	IN	O
aniridia	NN	B-Disease
.	.	O

Of	IN	O
the	DT	O
four	CD	O
different	JJ	O
mutations	NNS	O
identified	VBN	O
,	,	O
one	CD	O
was	VBD	O
identical	JJ	O
to	TO	O
a	DT	O
previously	RB	O
reported	VBN	O
mutation	NN	O
(	-LRB-	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transition	NN	O
at	IN	O
codon	NN	O
240	CD	O
)	-RRB-	O
,	,	O
and	CC	O
three	CD	O
were	VBD	O
novel	JJ	O
two	CD	O
in	IN	O
the	DT	O
glycine-rich	JJ	O
region	NN	O
and	CC	O
one	CD	O
in	IN	O
the	DT	O
proline/serine/threonine-rich	JJ	O
(	-LRB-	O
PST	NN	O
)	-RRB-	O
region	NN	O
.	.	O

One	CD	O
PAX6	NN	O
mutation	NN	O
found	VBN	O
in	IN	O
the	DT	O
PST	NN	O
region	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
cataracts	NNS	B-Disease
in	IN	O
an	DT	O
aniridia	NN	B-Disease
family	NN	O
.	.	O

Another	DT	O
splice	NN	O
mutation	NN	O
in	IN	O
the	DT	O
PST	NN	O
domain	NN	O
occurred	VBD	O
in	IN	O
an	DT	O
aniridia	NN	B-Disease
patient	NN	O
with	IN	O
anosmia	NN	B-Disease
(	-LRB-	O
inability	NN	O
to	TO	O
smell	NN	O
)	-RRB-	O
.	.	O

The	DT	O
six	CD	O
new	JJ	O
aniridia	NN	B-Disease
cases	NNS	O
reported	VBN	O
here	RB	O
have	VBP	O
mutations	NNS	O
predicted	VBN	O
to	TO	O
generate	VB	O
incomplete	JJ	O
PAX6	NN	O
proteins	NNS	O
.	.	O

These	DT	O
results	NNS	O
support	VBP	O
the	DT	O
theory	NN	O
that	WDT	O
human	JJ	O
aniridia	NN	B-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
haploinsufficiency	NN	B-Disease
of	IN	I-Disease
PAX6	NN	I-Disease
.	.	O

.	.	O

Hepatoblastoma	NNP	B-Disease
,	,	O
pigmented	JJ	B-Disease
ocular	JJ	I-Disease
fundus	NN	I-Disease
lesions	NNS	I-Disease
and	CC	O
jaw	NN	B-Disease
lesions	NNS	I-Disease
in	IN	O
Gardner	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

Hepatoblastoma	NN	B-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
neoplasm	NN	B-Disease
of	IN	O
infants	NNS	O
and	CC	O
children	NNS	O
only	RB	O
recently	RB	O
documented	VBN	O
in	IN	O
association	NN	O
with	IN	O
hereditary	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
colon	NN	I-Disease
[	-LRB-	O
Kingston	NNP	O
et	FW	O
al.	FW	O
,	,	O
1983	CD	O
]	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
four	CD	O
children	NNS	O
with	IN	O
hepatoblastoma	NN	B-Disease
from	IN	O
four	CD	O
unrelated	JJ	O
families	NNS	O
with	IN	O
Gardner	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
GS	NN	B-Disease
)	-RRB-	O
.	.	O

One	CD	O
child	NN	O
,	,	O
now	RB	O
19	CD	O
years	NNS	O
old	JJ	O
,	,	O
survived	VBD	O
after	IN	O
a	DT	O
resection	NN	O
of	IN	O
a	DT	O
hepatoblastoma	NN	B-Disease
in	IN	O
infancy	NN	O
and	CC	O
recently	RB	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
GS	NN	B-Disease
.	.	O

He	PRP	O
has	VBZ	O
an	DT	O
associated	JJ	O
odontoma	NN	B-Disease
and	CC	O
pigmented	JJ	B-Disease
ocular	JJ	I-Disease
fundus	NN	I-Disease
lesions	NNS	I-Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
clinical	JJ	O
markers	NNS	O
of	IN	O
GS	NN	B-Disease
.	.	O

Many	JJ	O
individuals	NNS	O
in	IN	O
these	DT	O
four	CD	O
GS	NN	B-Disease
families	NNS	O
,	,	O
both	DT	O
affected	VBN	O
and	CC	O
at	IN	O
risk	NN	O
,	,	O
have	VBP	O
osteomatous	JJ	B-Disease
jaw	NN	I-Disease
lesions	NNS	I-Disease
and	CC	O
pigmented	JJ	B-Disease
ocular	JJ	I-Disease
fundus	NN	I-Disease
lesions	NNS	I-Disease
.	.	O

A	DT	O
search	NN	O
for	IN	O
colonic	JJ	B-Disease
polyps	NNS	I-Disease
should	MD	O
be	VB	O
made	VBN	O
in	IN	O
families	NNS	O
of	IN	O
infants	NNS	O
and	CC	O
children	NNS	O
with	IN	O
hepatoblastoma	NN	B-Disease
.	.	O

If	IN	O
the	DT	O
child	NN	O
survives	VBZ	O
,	,	O
he	PRP	O
or	CC	O
she	PRP	O
should	MD	O
be	VB	O
monitored	VBN	O
for	IN	O
the	DT	O
later	JJ	O
appearance	NN	O
of	IN	O
colonic	JJ	B-Disease
polyps	NNS	I-Disease
.	.	O

The	DT	O
finding	NN	O
of	IN	O
jaw	NN	B-Disease
lesions	NNS	I-Disease
and/or	CC	O
pigmented	JJ	B-Disease
ocular	JJ	I-Disease
fundus	NN	I-Disease
lesions	NNS	I-Disease
in	IN	O
relatives	NNS	O
at	IN	O
risk	NN	O
are	VBP	O
indications	NNS	O
of	IN	O
the	DT	O
possible	JJ	O
presence	NN	O
of	IN	O
the	DT	O
GS	NN	B-Disease
gene	NN	O
.	.	O

Mutation	NN	O
spectrum	NN	O
in	IN	O
the	DT	O
CHM	NN	B-Disease
gene	NN	O
of	IN	O
Danish	JJ	O
and	CC	O
Swedish	JJ	O
choroideremia	NN	B-Disease
patients	NNS	O
.	.	O

The	DT	O
recent	JJ	O
isolation	NN	O
of	IN	O
the	DT	O
complete	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
the	DT	O
choroideremia	NN	B-Disease
(	-LRB-	O
CHM	NN	B-Disease
)	-RRB-	O
gene	NN	O
and	CC	O
the	DT	O
characterization	NN	O
of	IN	O
the	DT	O
exon-intron	JJ	O
boundaries	NNS	O
has	VBZ	O
paved	VBN	O
the	DT	O
way	NN	O
to	TO	O
mutation	NN	O
detection	NN	O
in	IN	O
patients	NNS	O
with	IN	O
classical	JJ	O
choroideremia	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
mutation	NN	O
screening	NN	O
in	IN	O
patients	NNS	O
from	IN	O
15	CD	O
Danish	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
by	IN	O
using	VBG	O
Southern	NN	O
blot	NN	O
hybridization	NN	O
and	CC	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
PCR-SSCP	NN	O
)	-RRB-	O
technique	NN	O
.	.	O

Causative	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CHM	NN	B-Disease
gene	NN	O
were	VBD	O
detected	VBN	O
in	IN	O
at	IN	O
least	JJS	O
12	CD	O
families	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
a	DT	O
substantial	JJ	O
part	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
can	MD	O
be	VB	O
identified	VBN	O
by	IN	O
this	DT	O
approach	NN	O
.	.	O

In	IN	O
four	CD	O
of	IN	O
these	DT	O
families	NNS	O
deletions	NNS	O
of	IN	O
different	JJ	O
sizes	NNS	O
were	VBD	O
found	VBN	O
.	.	O

Thus	RB	O
,	,	O
in	IN	O
one	CD	O
patient	NN	O
,	,	O
the	DT	O
deletion	NN	O
resulted	VBD	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
only	RB	O
one	CD	O
exon	NN	O
,	,	O
while	IN	O
in	IN	O
another	DT	O
the	DT	O
deletion	NN	O
comprised	VBD	O
the	DT	O
entire	JJ	O
CHM	NN	B-Disease
gene	NN	O
.	.	O

Mapping	NN	O
of	IN	O
the	DT	O
deletion	NN	O
endpoints	NNS	O
in	IN	O
these	DT	O
four	CD	O
patients	NNS	O
and	CC	O
in	IN	O
another	DT	O
11	CD	O
male	NN	O
patients	NNS	O
with	IN	O
sizeable	JJ	O
deletions	NNS	O
enabled	VBD	O
us	PRP	O
to	TO	O
construct	VB	O
a	DT	O
very	RB	O
detailed	JJ	O
map	NN	O
of	IN	O
intervals	NNS	O
2	CD	O
and	CC	O
3	CD	O
of	IN	O
Xq21	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
11	CD	O
Danish	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
at	IN	O
least	JJS	O
8	CD	O
causative	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
by	IN	O
PCR-SSCP	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
CHM	NN	B-Disease
gene	NN	O
mutations	NNS	O
detected	VBD	O
thus	RB	O
far	RB	O
in	IN	O
choroideremia	NN	B-Disease
patients	NNS	O
give	VBP	O
rise	NN	O
to	TO	O
the	DT	O
introduction	NN	O
of	IN	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
.	.	O

.	.	O

Diverse	JJ	O
point	NN	O
mutations	NNS	O
result	VBP	O
in	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
polymorphism	NN	O
in	IN	O
Taiwan	NNP	O
.	.	O

Glucose-6-PHOSPHATE	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
;	:	I-Disease
EC	NNP	I-Disease
1.1	CD	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

49	CD	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
human	JJ	O
enzymopathy	NN	B-Disease
,	,	O
affecting	VBG	O
more	JJR	O
than	IN	O
200	CD	O
million	CD	O
people	NNS	O
worldwide	RB	O
.	.	O

Although	IN	O
greater	JJR	O
than	IN	O
400	CD	O
variants	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
based	VBN	O
on	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
criteria	NNS	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
these	DT	O
G6PD	NN	B-Disease
deficiencies	NNS	I-Disease
.	.	O

Recently	RB	O
,	,	O
the	DT	O
gene	NN	O
that	WDT	O
encodes	VBZ	O
human	JJ	O
G6PD	NN	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
,	,	O
which	WDT	O
enables	VBZ	O
us	PRP	O
to	TO	O
examine	VB	O
directly	RB	O
the	DT	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	O
at	IN	O
the	DT	O
DNA	NN	O
level	NN	O
.	.	O

During	IN	O
the	DT	O
past	JJ	O
10	CD	O
years	NNS	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
G6PD	NN	O
activity	NN	O
in	IN	O
21	CD	O
,	,	O
271	CD	O
newborn	JJ	O
Chinese	JJ	O
infants	NNS	O
(	-LRB-	O
11	CD	O
,	,	O
400	CD	O
males	NNS	O
and	CC	O
9	CD	O
,	,	O
871	CD	O
females	NNS	O
)	-RRB-	O
and	CC	O
identified	VBN	O
314	CD	O
(	-LRB-	O
2	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
males	NNS	O
and	CC	O
246	CD	O
(	-LRB-	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
females	NNS	O
having	VBG	O
low	JJ	O
G6PD	NN	O
activity	NN	O
.	.	O

The	DT	O
G6PD	NN	O
gene	NN	O
from	IN	O
10	CD	O
randomly	RB	O
selected	VBN	O
affected	JJ	O
individuals	NNS	O
and	CC	O
their	PRP$	O
relatives	NNS	O
was	VBD	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
amplified	VBD	O
,	,	O
subcloned	VBN	O
,	,	O
and	CC	O
sequenced	VBN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
at	IN	O
least	JJS	O
four	CD	O
types	NNS	O
of	IN	O
mutation	NN	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
G6PD	NN	O
polymorphism	NN	O
in	IN	O
Taiwan	NNP	O
.	.	O

The	DT	O
first	JJ	O
type	NN	O
of	IN	O
mutation	NN	O
(	-LRB-	O
487	CD	O
G	NN	O
----	:	O
A	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
in	IN	O
an	DT	O
affected	JJ	O
Chinese	JJ	O
with	IN	O
a	DT	O
G	NN	O
to	TO	O
A	DT	O
change	NN	O
at	IN	O
nucleotide	NN	O
487	CD	O
,	,	O
which	WDT	O
results	VBZ	O
in	IN	O
a	DT	O
(	-LRB-	O
163	CD	O
)	-RRB-	O
Gly	RB	O
to	TO	O
Ser	NN	O
substitution	NN	O
.	.	O

The	DT	O
second	JJ	O
type	NN	O
of	IN	O
mutation	NN	O
(	-LRB-	O
493	CD	O
A	DT	O
----	:	O
G	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
novel	JJ	O
mutation	NN	O
that	WDT	O
has	VBZ	O
not	RB	O
been	VBN	O
reported	VBN	O
in	IN	O
any	DT	O
other	JJ	O
ethnic	JJ	O
group	NN	O
and	CC	O
was	VBD	O
identified	VBN	O
in	IN	O
two	CD	O
affected	VBD	O
Chinese	NNP	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
an	DT	O
A	NN	O
to	TO	O
G	NN	O
change	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
493	CD	O
,	,	O
producing	VBG	O
an	DT	O
(	-LRB-	O
165	CD	O
)	-RRB-	O
Asn	NN	O
to	TO	O
Asp	NN	O
substitution	NN	O
.	.	O

Interestingly	RB	O
,	,	O
the	DT	O
487	CD	O
G	NN	O
----	:	O
A	NN	O
and	CC	O
493	CD	O
A	DT	O
----	:	O
G	NN	O
mutations	NNS	O
create	VBP	O
Alu	NN	O
I	NN	O
and	CC	O
Ava	NN	O
II	CD	O
recognition	NN	O
sites	NNS	O
,	,	O
respectively	RB	O
,	,	O
which	WDT	O
enabled	VBD	O
us	PRP	O
to	TO	O
rapidly	RB	O
detect	VB	O
these	DT	O
two	CD	O
mutations	NNS	O
by	IN	O
PCR/restriction	NN	O
enzyme	NN	O
(	-LRB-	O
RE	NN	O
)	-RRB-	O
digestion	NN	O
method	NN	O
.	.	O

The	DT	O
third	JJ	O
mutation	NN	O
(	-LRB-	O
1376	CD	O
G	NN	O
----	:	O
T	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
in	IN	O
four	CD	O
affected	VBD	O
Chinese	NNP	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
a	DT	O
G	NN	O
to	TO	O
T	NN	O
change	NN	O
at	IN	O
nucleotide	NN	O
position	NN	O
1376	CD	O
that	WDT	O
results	VBZ	O
in	IN	O
an	DT	O
(	-LRB-	O
459	CD	O
)	-RRB-	O
Arg	NN	O
to	TO	O
Leu	NN	O
substitution	NN	O
.	.	O

The	DT	O
1376	CD	O
G	NN	O
----	:	O
T	NN	O
mutation	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
the	DT	O
dominant	JJ	O
allele	NN	O
that	WDT	O
causes	VBZ	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Taiwan	NNP	O
.	.	O

Finally	RB	O
,	,	O
two	CD	O
affected	VBD	O
Chinese	JJ	O
were	VBD	O
identified	VBN	O
as	IN	O
having	VBG	O
the	DT	O
fourth	JJ	O
mutation	NN	O
(	-LRB-	O
1388	CD	O
G	NN	O
----	:	O
A	NN	O
)	-RRB-	O
.	.	O

This	DT	O
mutation	NN	O
causes	VBZ	O
a	DT	O
G	NN	O
to	TO	O
A	DT	O
change	NN	O
at	IN	O
nucleotide	NN	O
1388	CD	O
that	WDT	O
produces	VBZ	O
an	DT	O
(	-LRB-	O
463	CD	O
)	-RRB-	O
Arg	NN	O
to	TO	O
His	PRP$	O
substitution	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
provide	VBP	O
the	DT	O
direct	JJ	O
proof	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
Chinese	JJ	O
populations	NNS	O
of	IN	O
Taiwan	NNP	O
and	CC	O
the	DT	O
PCR/RE	NN	O
digestion	NN	O
method	NN	O
is	VBZ	O
suitable	JJ	O
for	IN	O
simultaneous	JJ	O
detection	NN	O
of	IN	O
the	DT	O
487	CD	O
G	NN	O
----	:	O
A	NN	O
and	CC	O
493	CD	O
A	DT	O
----	:	O
G	NN	O
mutations	NNS	O
.	.	O

Fas	NN	O
preassociation	NN	O
required	VBN	O
for	IN	O
apoptosis	NN	O
signaling	NN	O
and	CC	O
dominant	JJ	O
inhibition	NN	O
by	IN	O
pathogenic	JJ	O
mutations	NNS	O
.	.	O

Heterozygous	JJ	O
mutations	NNS	O
encoding	VBG	O
abnormal	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
death	NN	O
receptor	NN	O
Fas	NN	O
dominantly	RB	O
interfere	VBP	O
with	IN	O
Fas-induced	JJ	O
lymphocyte	NN	O
apoptosis	NN	O
in	IN	O
human	JJ	O
autoimmune	JJ	B-Disease
lymphoproliferative	JJ	I-Disease
syndrome	NN	I-Disease
.	.	O

This	DT	O
effect	NN	O
,	,	O
rather	RB	O
than	IN	O
depending	VBG	O
on	IN	O
ligand-induced	JJ	O
receptor	NN	O
oligomerization	NN	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
stem	VB	O
from	IN	O
ligand	NN	O
-	:	O
independent	JJ	O
interaction	NN	O
of	IN	O
wild-type	JJ	O
and	CC	O
mutant	JJ	O
Fas	NN	O
receptors	NNS	O
through	IN	O
a	DT	O
specific	JJ	O
region	NN	O
in	IN	O
the	DT	O
extracellular	JJ	O
domain	NN	O
.	.	O

Preassociated	NNP	O
Fas	NN	O
complexes	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
living	NN	O
cells	NNS	O
by	IN	O
means	NNS	O
of	IN	O
fluorescence	NN	O
resonance	NN	O
energy	NN	O
transfer	NN	O
between	IN	O
variants	NNS	O
of	IN	O
green	JJ	O
fluorescent	JJ	O
protein	NN	O
.	.	O

These	DT	O
results	NNS	O
show	VBP	O
that	IN	O
formation	NN	O
of	IN	O
preassociated	JJ	O
receptor	NN	O
complexes	NNS	O
is	VBZ	O
necessary	JJ	O
for	IN	O
Fas	NN	O
signaling	NN	O
and	CC	O
dominant	JJ	O
interference	NN	O
in	IN	O
human	JJ	O
disease	NN	O
.	.	O

.	.	O

Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
in	IN	O
the	DT	O
colchicine	NN	O
era	NN	O
:	:	O
the	DT	O
fate	NN	O
of	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
demonstrate	VB	O
the	DT	O
effect	NN	O
of	IN	O
prophylactic	NN	O
colchicine	NN	O
treatment	NN	O
on	IN	O
the	DT	O
natural	JJ	O
history	NN	O
of	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
family	NN	O
is	VBZ	O
presented	VBN	O
with	IN	O
6	CD	O
out	IN	O
of	IN	O
9	CD	O
siblings	NNS	O
affected	VBN	O
by	IN	O
FMF	NN	B-Disease
.	.	O

Each	DT	O
patient	NN	O
represents	VBZ	O
a	DT	O
different	JJ	O
stage	NN	O
of	IN	O
the	DT	O
amyloidotic	JJ	B-Disease
kidney	NN	I-Disease
disease	NN	I-Disease
of	IN	O
FMF	NN	B-Disease
and	CC	O
the	DT	O
effect	NN	O
of	IN	O
continuous	JJ	O
colchicine	NN	O
treatment	NN	O
on	IN	O
its	PRP$	O
course	NN	O
.	.	O

Considered	VBN	O
together	RB	O
,	,	O
the	DT	O
members	NNS	O
of	IN	O
this	DT	O
family	NN	O
present	JJ	O
an	DT	O
almost	RB	O
complete	JJ	O
clinical	JJ	O
,	,	O
genetic	JJ	O
,	,	O
and	CC	O
behavioral	JJ	O
picture	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

.	.	O

Two	CD	O
new	JJ	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
mutations	NNS	O
in	IN	O
a	DT	O
juvenile	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
patient	NN	O
.	.	O

Fragments	NNS	O
of	IN	O
the	DT	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
gene	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
juvenile-onset	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
were	VBD	O
amplified	VBN	O
by	IN	O
PCR	NN	O
and	CC	O
ligated	VBN	O
into	IN	O
MP13	NN	O
cloning	NN	O
vectors	NNS	O
.	.	O

Clones	NNS	O
hybridizing	VBG	O
with	IN	O
cDNA	NN	O
for	IN	O
human	JJ	O
ARSA	NNP	O
were	VBD	O
selected	VBN	O
,	,	O
examined	VBN	O
for	IN	O
appropriate	JJ	O
size	NN	O
inserts	NNS	O
,	,	O
and	CC	O
used	VBN	O
to	TO	O
prepare	VB	O
single-stranded	JJ	O
phage	NN	O
DNA	NN	O
.	.	O

Examination	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
and	CC	O
most	JJS	O
of	IN	O
the	DT	O
intronic	JJ	O
sequence	NN	O
revealed	VBD	O
two	CD	O
putative	JJ	O
disease-related	JJ	O
mutations	NNS	O
.	.	O

One	CD	O
,	,	O
a	DT	O
point	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
3	CD	O
,	,	O
resulted	VBD	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
isoleucine	NN	O
by	IN	O
serine	NN	O
.	.	O

Introduction	NN	O
of	IN	O
this	DT	O
alteration	NN	O
into	IN	O
the	DT	O
normal	JJ	O
ARSA	NNP	O
cDNA	NN	O
sequence	NN	O
resulted	VBD	O
in	IN	O
a	DT	O
substantial	JJ	O
decrease	NN	O
in	IN	O
ARSA	NN	O
activity	NN	O
on	IN	O
transient	JJ	O
expression	NN	O
in	IN	O
cultured	VBN	O
baby	NN	O
hamster	NN	O
kidney	NN	O
cells	NNS	O
.	.	O

About	IN	O
5	CD	O
%	NN	O
of	IN	O
the	DT	O
control	NN	O
expression	NN	O
was	VBD	O
observed	VBN	O
,	,	O
suggesting	VBG	O
a	DT	O
small	JJ	O
residual	JJ	O
activity	NN	O
in	IN	O
the	DT	O
mutated	VBN	O
ARSA	NNP	O
.	.	O

The	DT	O
second	JJ	O
mutation	NN	O
,	,	O
a	DT	O
G-to-A	JJ	O
transition	NN	O
,	,	O
occurred	VBD	O
in	IN	O
the	DT	O
other	JJ	O
allele	NN	O
and	CC	O
resulted	VBD	O
in	IN	O
an	DT	O
altered	JJ	O
splice-recognition	NN	O
sequence	NN	O
between	IN	O
exon	NN	O
7	CD	O
and	CC	O
the	DT	O
following	VBG	O
intron	NN	O
.	.	O

The	DT	O
mutation	NN	O
also	RB	O
resulted	VBD	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
a	DT	O
restriction	NN	O
site	NN	O
.	.	O

Apparently	RB	O
normal	JJ	O
levels	NNS	O
of	IN	O
mRNA	NN	O
were	VBD	O
generated	VBN	O
from	IN	O
this	DT	O
allele	NN	O
,	,	O
but	CC	O
no	DT	O
ARSA	NN	O
activity	NN	O
or	CC	O
immuno-cross-reactive	JJ	O
material	NN	O
could	MD	O
be	VB	O
detected	VBN	O
.	.	O

A	DT	O
collection	NN	O
of	IN	O
DNA	NN	O
samples	NNS	O
from	IN	O
known	VBN	O
or	CC	O
suspected	VBN	O
MLD	NN	B-Disease
patients	NNS	O
,	,	O
members	NNS	O
of	IN	O
their	PRP$	O
families	NNS	O
,	,	O
and	CC	O
normal	JJ	O
controls	NNS	O
was	VBD	O
screened	VBN	O
for	IN	O
these	DT	O
mutations	NNS	O
.	.	O

Four	CD	O
additional	JJ	O
individuals	NNS	O
carrying	VBG	O
each	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
found	VBN	O
among	IN	O
the	DT	O
nearly	RB	O
100	CD	O
MLD	NN	B-Disease
patients	NNS	O
in	IN	O
the	DT	O
sample	NN	O
.	.	O

Gene	NNP	O
segregation	NN	O
in	IN	O
the	DT	O
original	JJ	O
patients	NNS	O
family	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
available	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
data	NNS	O
.	.	O

No	DT	O
individuals	NNS	O
homozygous	JJ	O
for	IN	O
either	DT	O
of	IN	O
these	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

However	RB	O
,	,	O
combinations	NNS	O
with	IN	O
other	JJ	O
MLD	NN	B-Disease
mutations	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
point	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
3	CD	O
does	VBZ	O
result	VB	O
in	IN	O
some	DT	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
late-onset	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
splice-site	NN	O
mutation	NN	O
following	VBG	O
exon	NN	O
7	CD	O
produces	VBZ	O
late-infantile	JJ	O
MLD	NN	B-Disease
when	WRB	O
combined	VBN	O
with	IN	O
other	JJ	O
enzyme-null	JJ	O
mutations	NNS	O
,	,	O
implying	VBG	O
that	IN	O
it	PRP	O
is	VBZ	O
completely	RB	O
silent	JJ	O
enzymatically	RB	O
.	.	O

.	.	O

Null	JJ	O
mutation	NN	O
of	IN	O
the	DT	O
murine	JJ	O
ATP7B	NN	O
(	-LRB-	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
)	-RRB-	O
gene	NN	O
results	VBZ	O
in	IN	O
intracellular	JJ	B-Disease
copper	NN	I-Disease
accumulation	NN	I-Disease
and	CC	O
late-onset	JJ	B-Disease
hepatic	JJ	I-Disease
nodular	JJ	I-Disease
transformation	NN	I-Disease
.	.	O

The	DT	O
Atp7b	NN	O
protein	NN	O
is	VBZ	O
a	DT	O
copper-transporting	JJ	O
ATPase	NN	O
expressed	VBN	O
predominantly	RB	O
in	IN	O
the	DT	O
liver	NN	O
and	CC	O
to	TO	O
a	DT	O
lesser	JJR	O
extent	NN	O
in	IN	O
most	JJS	O
other	JJ	O
tissues	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
ATP7B	NN	O
gene	NN	O
lead	NN	O
to	TO	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
,	,	O
a	DT	O
copper	NN	B-Disease
toxicity	NN	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
dramatic	JJ	O
build-up	NN	O
of	IN	O
intracellular	JJ	O
hepatic	JJ	O
copper	NN	O
with	IN	O
subsequent	JJ	O
hepatic	JJ	B-Disease
and	CC	I-Disease
neuro-logical	JJ	I-Disease
abnormalities	NNS	I-Disease
.	.	O

Using	VBG	O
homologous	JJ	O
recombination	NN	O
to	TO	O
disrupt	VB	O
the	DT	O
normal	JJ	O
translation	NN	O
of	IN	O
ATP7B	NN	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
strain	NN	O
of	IN	O
mice	NNS	O
that	WDT	O
are	VBP	O
homozygous	JJ	O
mutants	NNS	O
(	-LRB-	O
null	JJ	O
)	-RRB-	O
for	IN	O
the	DT	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
.	.	O

The	DT	O
ATP7B	NN	O
null	JJ	O
mice	NNS	O
display	VBP	O
a	DT	O
gradual	JJ	O
accumulation	NN	O
of	IN	O
hepatic	JJ	O
copper	NN	O
that	WDT	O
increases	VBZ	O
to	TO	O
a	DT	O
level	NN	O
60-fold	RB	O
greater	JJR	O
than	IN	O
normal	JJ	O
by	IN	O
5	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

An	DT	O
increase	NN	O
in	IN	O
copper	NN	O
concentration	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
the	DT	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
placenta	NN	O
and	CC	O
lactating	NN	O
mammary	JJ	O
glands	NNS	O
of	IN	O
homo-zygous	JJ	O
mutants	NNS	O
,	,	O
although	IN	O
milk	NN	O
from	IN	O
the	DT	O
mutant	JJ	O
glands	NNS	O
was	VBD	O
copper	NN	B-Disease
deficient	JJ	I-Disease
.	.	O

Morphological	JJ	B-Disease
abnormalities	NNS	I-Disease
resembling	VBG	O
cirrhosis	NN	B-Disease
developed	VBD	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
the	DT	O
livers	NNS	O
from	IN	O
homozygous	JJ	O
mutants	NNS	O
older	JJR	O
than	IN	O
7	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Progeny	NN	O
of	IN	O
the	DT	O
homozygous	JJ	O
mutant	JJ	O
females	NNS	O
demonstrated	VBD	O
neurological	JJ	B-Disease
abnormalities	NNS	I-Disease
and	CC	O
growth	NN	B-Disease
retardation	NN	I-Disease
characteristic	NN	O
of	IN	O
copper	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Copper	NN	O
concentration	NN	O
in	IN	O
the	DT	O
livers	NNS	O
of	IN	O
the	DT	O
newborn	JJ	O
homozygous	JJ	O
null	JJ	O
mutants	NNS	O
was	VBD	O
decreased	VBN	O
dramatically	RB	O
.	.	O

In	IN	O
summary	NN	O
,	,	O
inactivation	NN	O
of	IN	O
the	DT	O
murine	JJ	O
ATP7B	NN	O
gene	NN	O
produces	VBZ	O
a	DT	O
form	NN	O
of	IN	O
cirrhotic	JJ	B-Disease
liver	NN	I-Disease
disease	NN	I-Disease
that	WDT	O
resembles	VBZ	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
in	IN	O
humans	NNS	O
and	CC	O
the	DT	O
toxic	JJ	O
milk	NN	O
phenotype	NN	O
in	IN	O
the	DT	O
mouse	NN	O
.	.	O

.	.	O

Adrenoleukodystrophy	NN	B-Disease
and	CC	O
adrenomyeloneuropathy	NN	B-Disease
associated	VBN	O
with	IN	O
partial	JJ	O
adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
in	IN	O
three	CD	O
generations	NNS	O
of	IN	O
a	DT	O
kindred	NN	O
.	.	O

Four	CD	O
cases	NNS	O
of	IN	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
and	CC	O
one	CD	O
case	NN	O
of	IN	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
have	VBP	O
developed	VBN	O
in	IN	O
a	DT	O
kindred	NN	O
over	IN	O
three	CD	O
generations	NNS	O
demonstrating	VBG	O
that	IN	O
AMN	NNP	B-Disease
is	VBZ	O
a	DT	O
clinical	JJ	O
variant	NN	O
of	IN	O
ALD	NN	B-Disease
.	.	O

Pituitary-adrenal	JJ	O
function	NN	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
10	CD	O
family	NN	O
members	NNS	O
,	,	O
including	VBG	O
two	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
four	CD	O
females	NNS	O
identified	VBN	O
as	IN	O
carriers	NNS	O
of	IN	O
ALD/AMN	NN	O
.	.	O

No	DT	O
pituitary-adrenal	JJ	B-Disease
abnormality	NN	I-Disease
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
carriers	NNS	O
.	.	O

However	RB	O
,	,	O
basal	JJ	O
morning	NN	O
plasma	NN	O
adrenocorticotropic	JJ	O
hormone	NN	O
(	-LRB-	O
ACTH	NN	O
)	-RRB-	O
levels	NNS	O
were	VBD	O
markedly	RB	O
elevated	JJ	O
in	IN	O
the	DT	O
two	CD	O
males	NNS	O
with	IN	O
ALD	NN	B-Disease
and	CC	O
AMN	NNP	B-Disease
,	,	O
despite	IN	O
the	DT	O
fact	NN	O
that	IN	O
they	PRP	O
had	VBD	O
no	DT	O
clinical	JJ	O
signs	NNS	O
of	IN	O
adrenal	JJ	B-Disease
insufficiency	NN	I-Disease
and	CC	O
that	IN	O
morning	NN	O
plasma	NN	O
cortisol	NN	O
levels	NNS	O
and	CC	O
their	PRP$	O
response	NN	O
to	TO	O
maximal	JJ	O
exogenous	JJ	O
ACTH	NN	O
stimulation	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
integrated	VBN	O
24-hour	JJ	O
response	NN	O
to	TO	O
the	DT	O
administration	NN	O
were	VBD	O
also	RB	O
subnormal	JJ	O
in	IN	O
these	DT	O
two	CD	O
cases	NNS	O
.	.	O

Thus	RB	O
,	,	O
people	NNS	O
with	IN	O
ALD	NN	B-Disease
and	CC	O
AMN	NNP	B-Disease
may	MD	O
have	VB	O
subclinical	JJ	O
partial	JJ	O
adrenocrotical	JJ	B-Disease
insufficiency	NN	I-Disease
.	.	O

No	DT	O
other	JJ	O
endocrinologic	JJ	B-Disease
dysfunction	NN	I-Disease
was	VBD	O
identified	VBN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ALD-gene	NN	O
of	IN	O
20	CD	O
families	NNS	O
with	IN	O
adrenoleukodystrophy/adrenomyeloneuropathy	NN	O
.	.	O

Adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
,	,	O
an	DT	O
X-linked	JJ	B-Disease
inherited	VBN	I-Disease
metabolic	JJ	I-Disease
disorder	NN	I-Disease
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
inborn	JJ	B-Disease
peroxisomal	JJ	I-Disease
disease	NN	I-Disease
.	.	O

It	PRP	O
leads	VBZ	O
to	TO	O
demyelination	NN	B-Disease
in	IN	I-Disease
the	DT	I-Disease
central	JJ	I-Disease
and	CC	I-Disease
peripheral	JJ	I-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
.	.	O

Defective	JJ	O
beta-oxidation	NN	O
of	IN	O
saturated	JJ	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	-LRB-	O
VLCFAs	NNS	O
;	:	O
C22	NN	O
0-C26	NN	O
0	CD	O
)	-RRB-	O
in	IN	O
peroxisomes	NNS	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
lead	VB	O
to	TO	O
an	DT	O
accumulation	NN	O
of	IN	O
VLCFAs	NNS	O
in	IN	O
leukoid	NN	O
areas	NNS	O
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
peripheral	JJ	O
nerves	NNS	O
,	,	O
adrenal	JJ	O
gland	NN	O
,	,	O
and	CC	O
blood	NN	O
.	.	O

The	DT	O
ALD	NN	B-Disease
gene	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
identified	VBN	O
and	CC	O
encodes	VBZ	O
a	DT	O
745-amino-acid	JJ	O
protein	NN	O
.	.	O

We	PRP	O
screened	VBD	O
patients	NNS	O
with	IN	O
adrenoleukodystrophy/adrenomyeloneuropathy	NN	O
(	-LRB-	O
ALD/AMN	NN	O
)	-RRB-	O
from	IN	O
20	CD	O
kindreds	NNS	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
.	.	O

Eleven	CD	O
missense	NN	O
and	CC	O
two	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
five	CD	O
deletions	NNS	O
,	,	O
and	CC	O
one	CD	O
insertion	NN	O
were	VBD	O
detected	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
eight	CD	O
reverse	JJ	O
transcribed	VBN	O
fragments	NNS	O
of	IN	O
the	DT	O
ALD-gene	NN	O
mRNA	NN	O
.	.	O

Four	CD	O
mutations	NNS	O
could	MD	O
be	VB	O
shown	VBN	O
to	TO	O
be	VB	O
de	FW	O
novo	FW	O
.	.	O

All	DT	O
mutations	NNS	O
could	MD	O
be	VB	O
confirmed	VBN	O
in	IN	O
carriers	NNS	O
by	IN	O
sequencing	NN	O
genomic	JJ	O
DNA	NN	O
.	.	O

No	DT	O
correlation	NN	O
between	IN	O
the	DT	O
type	NN	O
of	IN	O
mutation	NN	O
and	CC	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
phenotype	NN	O
could	MD	O
be	VB	O
observed	VBN	O
.	.	O

The	DT	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
of	IN	O
30	CD	O
healthy	JJ	O
persons	NNS	O
.	.	O

.	.	O

Gonosomal	JJ	O
mosaicism	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
patients	NNS	O
:	:	O
involvement	NN	O
of	IN	O
mitotic	JJ	O
events	NNS	O
in	IN	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
variation	NN	O
and	CC	O
selection	NN	O
against	IN	O
extreme	JJ	O
expansion	NN	O
in	IN	O
sperm	NN	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
abnormal	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
polymorphic	JJ	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
,	,	O
located	JJ	O
in	IN	O
the	DT	O
DM	NN	B-Disease
protein	NN	O
kinase	NN	O
gene	NN	O
.	.	O

We	PRP	O
determined	VBD	O
the	DT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
lengths	NNS	O
in	IN	O
a	DT	O
broad	JJ	O
range	NN	O
of	IN	O
tissue	NN	O
DNAs	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
mild	JJ	O
,	,	O
classical	JJ	O
,	,	O
or	CC	O
congenital	JJ	O
manifestation	NN	O
of	IN	O
DM	NN	B-Disease
.	.	O

Differences	NNS	O
in	IN	O
the	DT	O
repeat	NN	O
length	NN	O
were	VBD	O
seen	VBN	O
in	IN	O
somatic	JJ	O
tissues	NNS	O
from	IN	O
single	JJ	O
DM	NN	B-Disease
individuals	NNS	O
and	CC	O
twins	NNS	O
.	.	O

Repeats	NNS	O
appeared	VBD	O
to	TO	O
expand	VB	O
to	TO	O
a	DT	O
similar	JJ	O
extent	NN	O
in	IN	O
tissues	NNS	O
originating	VBG	O
from	IN	O
the	DT	O
same	JJ	O
embryonal	JJ	O
origin	NN	O
.	.	O

In	IN	O
most	JJS	O
male	JJ	O
patients	NNS	O
carrying	VBG	O
intermediate	JJ	O
-	:	O
or	CC	O
small-sized	JJ	O
expansions	NNS	O
in	IN	O
blood	NN	O
,	,	O
the	DT	O
repeat	NN	O
lengths	NNS	O
covered	VBD	O
a	DT	O
markedly	RB	O
wider	JJR	O
range	NN	O
in	IN	O
sperm	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
male	JJ	O
patients	NNS	O
with	IN	O
large	JJ	O
allele	NN	O
expansions	NNS	O
in	IN	O
blood	NN	O
(	-LRB-	O
>	JJR	O
700	CD	O
CTGs	NNS	O
)	-RRB-	O
had	VBD	O
similar	JJ	O
or	CC	O
smaller	JJR	O
repeats	NNS	O
in	IN	O
sperm	NN	O
,	,	O
when	WRB	O
detectable	JJ	O
.	.	O

Sperm	NN	O
alleles	NNS	O
with	IN	O
>	JJR	O
1	CD	O
,	,	O
000	CD	O
CTGs	NNS	O
were	VBD	O
not	RB	O
seen	VBN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
DM	NN	B-Disease
patients	NNS	O
can	MD	O
be	VB	O
considered	VBN	O
gonosomal	JJ	O
mosaics	NNS	O
,	,	O
i.	FW	O
e	SYM	O
e.	FW	O
,	,	O
combined	JJ	O
somatic	JJ	O
and	CC	O
germ-line	JJ	O
tissue	NN	O
mosaics	NNS	O
.	.	O

Most	JJS	O
remarkably	RB	O
,	,	O
we	PRP	O
observed	VBD	O
multiple	JJ	O
cases	NNS	O
where	WRB	O
the	DT	O
length	NN	O
distributions	NNS	O
of	IN	O
intermediate	JJ	O
-	:	O
or	CC	O
small-sized	JJ	O
alleles	NNS	O
in	IN	O
fathers	NNS	O
sperm	NN	O
were	VBD	O
significantly	RB	O
different	JJ	O
from	IN	O
that	DT	O
in	IN	O
their	PRP$	O
offsprings	NNS	O
blood	NN	O
.	.	O

Our	PRP$	O
combined	VBN	O
findings	NNS	O
indicate	VBP	O
that	IN	O
intergenerational	JJ	O
length	NN	O
changes	NNS	O
in	IN	O
the	DT	O
unstable	JJ	O
CTG	NNP	O
repeat	NN	O
are	VBP	O
most	RBS	O
likely	JJ	O
to	TO	O
occur	VB	O
during	IN	O
early	JJ	O
embryonic	JJ	O
mitotic	JJ	O
divisions	NNS	O
in	IN	O
both	DT	O
somatic	JJ	O
and	CC	O
germ-line	JJ	O
tissue	NN	O
formation	NN	O
.	.	O

Both	CC	O
the	DT	O
initial	JJ	O
CTG	NNP	O
length	NN	O
,	,	O
the	DT	O
overall	JJ	O
number	NN	O
of	IN	O
cell	NN	O
divisions	NNS	O
involved	VBN	O
in	IN	O
tissue	NN	O
formation	NN	O
,	,	O
and	CC	O
perhaps	RB	O
a	DT	O
specific	JJ	O
selection	NN	O
process	NN	O
in	IN	O
spermatogenesis	NN	O
may	MD	O
influence	VB	O
the	DT	O
dynamics	NNS	O
of	IN	O
this	DT	O
process	NN	O
.	.	O

A	DT	O
model	NN	O
explaining	VBG	O
mitotic	JJ	O
instability	NN	O
and	CC	O
sex-dependent	JJ	O
segregation	NN	O
phenomena	NNS	O
in	IN	O
DM	NN	B-Disease
manifestation	NN	O
is	VBZ	O
discussed	VBN	O

Combined	JJ	O
analysis	NN	O
of	IN	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
linkage	NN	O
to	TO	O
1q24-25	CD	O
:	:	O
results	NNS	O
from	IN	O
772	CD	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
families	NNS	O
from	IN	O
the	DT	O
International	NNP	O
Consortium	NNP	O
for	IN	O
Prostate	NNP	B-Disease
Cancer	NNP	I-Disease
Genetics	NNP	O
.	.	O

A	DT	O
previous	JJ	O
linkage	NN	O
study	NN	O
provided	VBD	O
evidence	NN	O
for	IN	O
a	DT	O
prostate	NN	B-Disease
cancer-susceptibility	NN	O
locus	NN	O
at	IN	O
1q24-25	CD	O
.	.	O

Subsequent	JJ	O
reports	NNS	O
in	IN	O
additional	JJ	O
collections	NNS	O
of	IN	O
families	NNS	O
have	VBP	O
yielded	VBN	O
conflicting	JJ	O
results	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
evidence	NN	O
for	IN	O
locus	NN	O
heterogeneity	NN	O
has	VBZ	O
been	VBN	O
provided	VBN	O
by	IN	O
the	DT	O
identification	NN	O
of	IN	O
other	JJ	O
putative	JJ	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
loci	NNS	O
on	IN	O
Xq27-28	NN	O
,	,	O
1q42-43	NN	O
,	,	O
and	CC	O
1p36	NN	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
describes	VBZ	O
a	DT	O
combined	JJ	O
analysis	NN	O
for	IN	O
six	CD	O
markers	NNS	O
in	IN	O
the	DT	O
1q24-25	CD	O
region	NN	O
in	IN	O
772	CD	O
families	NNS	O
affected	VBN	O
by	IN	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
and	CC	O
ascertained	VBN	O
by	IN	O
the	DT	O
members	NNS	O
of	IN	O
the	DT	O
International	NNP	O
Consortium	NNP	O
for	IN	O
Prostate	NNP	B-Disease
Cancer	NNP	I-Disease
Genetics	NNP	O
(	-LRB-	O
ICPCG	NNP	O
)	-RRB-	O
from	IN	O
North	NNP	O
America	NNP	O
,	,	O
Australia	NNP	O
,	,	O
Finland	NNP	O
,	,	O
Norway	NNP	O
,	,	O
Sweden	NNP	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
.	.	O

Overall	RB	O
,	,	O
there	EX	O
was	VBD	O
some	DT	O
evidence	NN	O
for	IN	O
linkage	NN	O
,	,	O
with	IN	O
a	DT	O
peak	NN	O
parametric	JJ	O
multipoint	JJ	O
LOD	NN	O
score	NN	O
assuming	VBG	O
heterogeneity	NN	O
(	-LRB-	O
HLOD	NN	O
)	-RRB-	O
of	IN	O
1	CD	O
.	.	O

40	CD	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

01	NN	O
)	-RRB-	O
at	IN	O
D1S212	NN	O
.	.	O

The	DT	O
estimated	VBN	O
proportion	NN	O
of	IN	O
families	NNS	O
(	-LRB-	O
alpha	NN	O
)	-RRB-	O
linked	VBN	O
to	TO	O
the	DT	O
locus	NN	O
was	VBD	O
.	.	O

06	NN	O
(	-LRB-	O
1-LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

01	SYM	O
-	:	O
.	.	O

12	CD	O
)	-RRB-	O
.	.	O

This	DT	O
evidence	NN	O
was	VBD	O
not	RB	O
observed	VBN	O
by	IN	O
a	DT	O
nonparametric	JJ	O
approach	NN	O
,	,	O
presumably	RB	O
because	IN	O
of	IN	O
the	DT	O
extensive	JJ	O
heterogeneity	NN	O
.	.	O

Further	RB	O
parametric	JJ	O
analysis	NN	O
revealed	VBD	O
a	DT	O
significant	JJ	O
effect	NN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
male-to-male	JJ	O
disease	NN	O
transmission	NN	O
within	IN	O
the	DT	O
families	NNS	O
.	.	O

In	IN	O
the	DT	O
subset	NN	O
of	IN	O
491	CD	O
such	JJ	O
families	NNS	O
,	,	O
the	DT	O
peak	NN	O
HLOD	NN	O
was	VBD	O
2	CD	O
.	.	O

In	IN	O
the	DT	O
subset	NN	O
of	IN	O
491	CD	O
such	JJ	O
families	NNS	O
,	,	O
the	DT	O
peak	NN	O
HLOD	NN	O
was	VBD	O
2	CD	O
.	.	O

56	CD	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

0006	CD	O
)	-RRB-	O
and	CC	O
alpha	NN	O
=	JJ	O
.	.	O

11	CD	O
(	-LRB-	O
1-LOD	NN	O
support	NN	O
interval	NN	O
.	.	O

04	SYM	O
-	:	O
.	.	O

19	CD	O
)	-RRB-	O
,	,	O
compared	VBN	O
with	IN	O
HLODs	NNS	O
of	IN	O
0	CD	O
in	IN	O
the	DT	O
remaining	VBG	O
281	CD	O
families	NNS	O
.	.	O

Within	IN	O
the	DT	O
families	NNS	O
with	IN	O
male-to-male	JJ	O
disease	NN	O
transmission	NN	O
,	,	O
alpha	NN	O
increased	VBD	O
with	IN	O
the	DT	O
early	JJ	O
mean	NN	O
age	NN	O
at	IN	O
diagnosis	NN	O
(	-LRB-	O
<	JJR	O
65	CD	O
years	NNS	O
,	,	O
alpha	NN	O
=	JJ	O
.	.	O

19	CD	O
,	,	O
with	IN	O
1-LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

06	SYM	O
-	:	O
.	.	O

34	CD	O
)	-RRB-	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
affected	VBN	O
family	NN	O
members	NNS	O
(	-LRB-	O
five	CD	O
or	CC	O
more	JJR	O
family	NN	O
members	NNS	O
,	,	O
alpha	NN	O
=	JJ	O
.	.	O

15	CD	O
,	,	O
with	IN	O
1-LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

04	SYM	O
-	:	O
.	.	O

28	CD	O
)	-RRB-	O
.	.	O

The	DT	O
highest	JJS	O
value	NN	O
of	IN	O
alpha	NN	O
was	VBD	O
observed	VBN	O
for	IN	O
the	DT	O
48	CD	O
families	NNS	O
that	WDT	O
met	VBD	O
all	DT	O
three	CD	O
criteria	NNS	O
(	-LRB-	O
peak	NN	O
HLOD	NN	O
=	JJ	O
2	CD	O
.	.	O

25	CD	O
,	,	O
P	NN	O
=	JJ	O
.	.	O

001	CD	O
,	,	O
alpha	NN	O
=	JJ	O
.	.	O

29	CD	O
,	,	O
with	IN	O
1-LOD	JJ	O
support	NN	O
interval	NN	O
.	.	O

08	SYM	O
-	:	O
.	.	O

53	CD	O
)	-RRB-	O
.	.	O

These	DT	O
results	NNS	O
support	VBP	O
the	DT	O
finding	NN	O
of	IN	O
a	DT	O
prostate	NN	B-Disease
cancer-susceptibility	NN	O
gene	NN	O
linked	VBN	O
to	TO	O
1q24-25	CD	O
,	,	O
albeit	IN	O
in	IN	O
a	DT	O
defined	VBN	O
subset	NN	O
of	IN	O
prostate	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

Although	IN	O
HPC1	NN	O
accounts	NNS	O
for	IN	O
only	RB	O
a	DT	O
small	JJ	O
proportion	NN	O
of	IN	O
all	DT	O
families	NNS	O
affected	VBN	O
by	IN	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
,	,	O
it	PRP	O
appears	VBZ	O
to	TO	O
play	VB	O
a	DT	O
more	RBR	O
prominent	JJ	O
role	NN	O
in	IN	O
the	DT	O
subset	NN	O
of	IN	O
families	NNS	O
with	IN	O
several	JJ	O
members	NNS	O
affected	VBN	O
at	IN	O
an	DT	O
early	JJ	O
age	NN	O
and	CC	O
with	IN	O
male-to-male	JJ	O
disease	NN	O
transmission	NN	O
.	.	O

A	DT	O
novel	JJ	O
disease	NN	O
with	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
mitochondrial	JJ	I-Disease
very-long-chain	JJ	I-Disease
acyl-CoA	NN	I-Disease
dehydrogenase	NN	I-Disease
.	.	O

Palmitoyl-CoA	NN	O
dehydrogenase	NN	O
activity	NN	O
in	IN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
seven	CD	O
patients	NNS	O
with	IN	O
unidentified	JJ	O
defects	NNS	O
of	IN	O
fatty	JJ	O
acid	NN	O
oxidation	NN	O
was	VBD	O
measured	VBN	O
in	IN	O
the	DT	O
presence	NN	O
and	CC	O
absence	NN	O
of	IN	O
antibodies	NNS	O
against	IN	O
medium-chain	JJ	O
,	,	O
long-chain	JJ	O
,	,	O
and	CC	O
very-long-chain	JJ	O
acyl-CoA	NN	O
dehydrogenases	NNS	O
(	-LRB-	O
VLCAD	NN	O
)	-RRB-	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
patients	NNS	O
,	,	O
4-5	CD	O
month	NN	O
old	JJ	O
boys	NNS	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
novel	JJ	O
disease	NN	O
,	,	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
as	IN	O
judged	VBN	O
from	IN	O
the	DT	O
results	NNS	O
of	IN	O
very	RB	O
low	JJ	O
palmitoyl-CoA	NN	O
dehydrogenase	NN	O
activity	NN	O
and	CC	O
the	DT	O
lack	NN	O
of	IN	O
immunoreactivity	NN	O
toward	IN	O
antibody	NN	O
raised	VBD	O
to	TO	O
purified	VBN	O
VLCAD	NNP	O
.	.	O

.	.	O

Inherited	VBN	O
WT1	NN	O
mutation	NN	O
in	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Patients	NNS	O
with	IN	O
the	DT	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
,	,	O
genital	JJ	B-Disease
anomalies	NNS	I-Disease
,	,	O
and	CC	O
nephropathy	NN	B-Disease
)	-RRB-	O
have	VBP	O
been	VBN	O
demonstrated	VBN	O
to	TO	O
carry	VB	O
de	FW	O
novo	FW	O
constitutional	JJ	O
mutations	NNS	O
in	IN	O
WT1	NN	O
,	,	O
the	DT	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
gene	NN	O
at	IN	O
chromosome	NN	O
11p13	NN	O
.	.	O

We	PRP	O
report	VBP	O
three	CD	O
new	JJ	O
cases	NNS	O
,	,	O
two	CD	O
carrying	VBG	O
a	DT	O
previously	RB	O
described	VBN	O
WT1	NN	O
exon	NN	O
9	CD	O
mutation	NN	O
and	CC	O
one	CD	O
with	IN	O
a	DT	O
novel	JJ	O
WT1	NN	O
exon	NN	O
8	CD	O
mutation	NN	O
.	.	O

However	RB	O
,	,	O
unlike	IN	O
patients	NNS	O
in	IN	O
previous	JJ	O
reports	NNS	O
,	,	O
one	CD	O
of	IN	O
our	PRP$	O
three	CD	O
patients	NNS	O
inherited	VBN	O
the	DT	O
affected	VBN	O
allele	NN	O
from	IN	O
his	PRP$	O
phenotypically	RB	O
unaffected	JJ	O
father	NN	O
.	.	O

This	DT	O
observation	NN	O
indicates	VBZ	O
that	IN	O
the	DT	O
WT1	NN	O
exon	NN	O
9	CD	O
mutation	NN	O
affecting	VBG	O
394Arg	NN	O
demonstrated	VBD	O
in	IN	O
over	IN	O
one-half	NN	O
of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
the	DT	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
may	MD	O
exhibit	VB	O
incomplete	JJ	O
penetrance	NN	O
.	.	O

Consequently	RB	O
,	,	O
familial	JJ	O
studies	NNS	O
in	IN	O
patients	NNS	O
affected	VBN	O
by	IN	O
this	DT	O
syndrome	NN	O
are	VBP	O
recommended	VBN	O
.	.	O

.	.	O

Glucose/galactose	NN	B-Disease
malabsorption	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
defect	NN	O
in	IN	O
the	DT	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
.	.	O

Glucose/galactose	NN	B-Disease
malabsorption	NN	I-Disease
(	-LRB-	O
GGM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
manifesting	VBG	O
within	IN	O
the	DT	O
first	JJ	O
weeks	NNS	O
of	IN	O
life	NN	O
and	CC	O
characterized	VBN	O
by	IN	O
a	DT	O
selective	JJ	O
failure	NN	O
to	TO	O
absorb	VB	O
dietary	JJ	O
glucose	NN	O
and	CC	O
galactose	NN	O
from	IN	O
the	DT	O
intestine	NN	O
.	.	O

The	DT	O
consequent	JJ	O
severe	JJ	O
diarrhoea	NN	B-Disease
and	CC	O
dehydration	NN	B-Disease
are	VBP	O
usually	RB	O
fatal	JJ	O
unless	IN	O
these	DT	O
sugars	NNS	O
are	VBP	O
eliminated	VBN	O
from	IN	O
the	DT	O
diet	NN	O
.	.	O

Intestinal	JJ	O
biopsies	NNS	O
of	IN	O
GGM	NN	B-Disease
patients	NNS	O
have	VBP	O
revealed	VBN	O
a	DT	O
specific	JJ	O
defect	NN	O
in	IN	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
-	:	O
dependent	JJ	O
absorption	NN	O
of	IN	O
glucose	NN	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
.	.	O

Normal	JJ	O
glucose	NN	O
absorption	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
the	DT	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
in	IN	O
the	DT	O
brush	NN	O
border	NN	O
membrane	NN	O
of	IN	O
the	DT	O
intestinal	JJ	O
epithelium	NN	O
.	.	O

Cellular	JJ	O
influx	NN	O
is	VBZ	O
driven	VBN	O
by	IN	O
the	DT	O
transmembrane	NN	O
Na	NN	O
+	CC	O
electrochemical	JJ	O
potential	JJ	O
gradient	NN	O
;	:	O
thereafter	RB	O
the	DT	O
sugar	NN	O
moves	VBZ	O
to	TO	O
the	DT	O
blood	NN	O
across	IN	O
the	DT	O
basolateral	JJ	O
membrane	NN	O
via	IN	O
the	DT	O
facilitated	VBN	O
glucose	NN	O
carrier	NN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
a	DT	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
from	IN	O
normal	JJ	O
human	JJ	O
ileum	NN	O
and	CC	O
shown	VBN	O
that	IN	O
this	DT	O
gene	NN	O
,	,	O
SGLT1	NN	O
,	,	O
resides	VBZ	O
on	IN	O
the	DT	O
distal	JJ	O
q	NN	O
arm	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
amplified	VBN	O
SGLT1	NN	O
complementary	JJ	O
DNA	NN	O
and	CC	O
genomic	JJ	O
DNA	NN	O
from	IN	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
affected	VBN	O
with	IN	O
GGM	NN	B-Disease
by	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

Sequence	NN	O
analysis	NN	O
of	IN	O
the	DT	O
amplified	VBN	O
products	NNS	O
has	VBZ	O
revealed	VBN	O
a	DT	O
single	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
SGLT1	NN	O
which	WDT	O
cosegregates	VBZ	O
with	IN	O
the	DT	O
GGM	NN	B-Disease
phenotype	NN	O
and	CC	O
results	VBZ	O
in	IN	O
a	DT	O
complete	JJ	O
loss	NN	O
of	IN	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
-	:	O
dependent	JJ	O
glucose	NN	O
transport	NN	O
in	IN	O
Xenopus	NN	O
oocytes	NNS	O
injected	VBN	O
with	IN	O
this	DT	O
complementary	JJ	O
RNA	NN	O
.	.	O

.	.	O

Atm	NN	O
and	CC	O
Bax	NN	O
cooperate	VBP	O
in	IN	O
ionizing	VBG	O
radiation-induced	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
.	.	O

Ataxia-telangiectasia	NN	B-Disease
is	VBZ	O
a	DT	O
hereditary	JJ	B-Disease
multisystemic	JJ	I-Disease
disease	NN	I-Disease
resulting	VBG	O
from	IN	O
mutations	NNS	O
of	IN	O
ataxia	NN	B-Disease
telangiectasia	NN	I-Disease
,	,	O
mutated	VBN	O
(	-LRB-	O
ATM	NNP	O
)	-RRB-	O
and	CC	O
is	VBZ	O
characterized	VBN	O
by	IN	O
neurodegeneration	NN	B-Disease
,	,	O
cancer	NN	B-Disease
,	,	O
immune	JJ	B-Disease
defects	NNS	I-Disease
,	,	O
and	CC	O
hypersensitivity	NN	B-Disease
to	TO	I-Disease
ionizing	VBG	I-Disease
radiation	NN	I-Disease
.	.	O

The	DT	O
molecular	JJ	O
details	NNS	O
of	IN	O
ATM	NNP	O
function	NN	O
in	IN	O
the	DT	O
nervous	JJ	O
system	NN	O
are	VBP	O
unclear	JJ	O
,	,	O
although	IN	O
the	DT	O
neurological	JJ	B-Disease
lesion	NN	I-Disease
in	IN	O
ataxia-telangiectasia	NN	B-Disease
becomes	VBZ	O
apparent	JJ	O
early	RB	O
in	IN	O
life	NN	O
,	,	O
suggesting	VBG	O
a	DT	O
developmental	JJ	O
origin	NN	O
.	.	O

The	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
(	-LRB-	O
CNS	NN	O
)	-RRB-	O
of	IN	O
Atm-null	JJ	O
mice	NNS	O
shows	VBZ	O
a	DT	O
pronounced	JJ	O
defect	NN	O
in	IN	O
apoptosis	NN	O
induced	VBN	O
by	IN	O
genotoxic	JJ	O
stress	NN	O
,	,	O
suggesting	VBG	O
ATM	NNP	O
functions	VBZ	O
to	TO	O
eliminate	VB	O
neurons	NNS	O
with	IN	O
excessive	JJ	O
genomic	JJ	O
damage	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
the	DT	O
death	NN	O
effector	NN	O
Bax	NN	O
is	VBZ	O
required	VBN	O
for	IN	O
a	DT	O
large	JJ	O
proportion	NN	O
of	IN	O
Atm-dependent	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
developing	VBG	O
CNS	NN	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
(	-LRB-	O
IR	NN	O
)	-RRB-	O
.	.	O

Although	IN	O
many	JJ	O
of	IN	O
the	DT	O
same	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
CNS	NN	O
in	IN	O
both	CC	O
Bax	NN	O
-	:	O
/	:	O
-	:	O
and	CC	O
Atm	SYM	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
were	VBD	O
radioresistant	JJ	O
,	,	O
mice	NNS	O
nullizygous	JJ	O
for	IN	O
both	DT	O
Bax	NN	O
and	CC	O
Atm	NN	O
showed	VBD	O
additional	JJ	O
reduction	NN	O
in	IN	O
IR-induced	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
CNS	NN	O
.	.	O

Therefore	RB	O
,	,	O
although	IN	O
the	DT	O
major	JJ	O
IR-induced	JJ	O
apoptotic	JJ	O
pathway	NN	O
in	IN	O
the	DT	O
CNS	NN	O
requires	VBZ	O
Atm	NNP	O
and	CC	O
Bax	NN	O
,	,	O
a	DT	O
p53-dependent	JJ	O
collateral	NN	O
pathway	NN	O
exists	VBZ	O
that	DT	O
has	VBZ	O
both	DT	O
Atm	NN	O
-	:	O
and	CC	O
Bax-independent	JJ	O
branches	NNS	O
.	.	O

Further	RB	O
,	,	O
Atm	NN	O
-	:	O
and	CC	O
Bax-dependent	JJ	O
apoptosis	NN	O
in	IN	O
the	DT	O
CNS	NN	O
also	RB	O
required	VBD	O
caspase-3	NN	O
activation	NN	O
.	.	O

These	DT	O
data	NNS	O
implicate	VBP	O
Bax	NN	O
and	CC	O
caspase-3	NN	O
as	IN	O
death	NN	O
effectors	NNS	O
in	IN	O
neurodegenerative	JJ	O
pathways	NNS	O
.	.	O

.	.	O

Novel	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
mutations	NNS	O
from	IN	O
China	NNP	O
.	.	O

We	PRP	O
describe	VBP	O
three	CD	O
HEXA	NN	O
mutations	NNS	O
associated	VBN	O
with	IN	O
infantile	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
in	IN	O
three	CD	O
unrelated	JJ	O
nonconsanguineous	JJ	O
Chinese	JJ	O
families	NNS	O
.	.	O

Novel	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
two	CD	O
of	IN	O
these	DT	O
families	NNS	O
.	.	O

The	DT	O
third	JJ	O
is	VBZ	O
a	DT	O
previously	RB	O
reported	VBN	O
mutation	NN	O
(	-LRB-	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
at	IN	O
nt	NNS	O
1444	CD	O
)	-RRB-	O
(	-LRB-	O
Nakano	NNP	O
et	FW	O
al.	FW	O
,	,	O
1988	CD	O
)	-RRB-	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
PCR	NN	O
products	NNS	O
identified	VBD	O
a	DT	O
novel	JJ	O
insertion	NN	O
of	IN	O
an	DT	O
A	NN	O
after	IN	O
nt	NNS	O
547	CD	O
in	IN	O
family	NN	O
1	CD	O
.	.	O

This	DT	O
change	NN	O
generates	VBZ	O
an	DT	O
early	JJ	O
termination	NN	O
codon	NN	O
6	CD	O
bp	NN	O
downstream	RB	O
from	IN	O
the	DT	O
insertion	NN	O
site	NN	O
.	.	O

Allele-specific	JJ	O
oligonucleotide	NN	O
hybridization	NN	O
confirmed	VBD	O
homozygosity	NN	O
in	IN	O
the	DT	O
proband	NN	O
.	.	O

Single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
of	IN	O
amplified	VBN	O
exon	NN	O
13	CD	O
revealed	VBD	O
a	DT	O
T	NN	O
--	:	O
>	JJR	O
C	NN	O
transition	NN	O
at	IN	O
nt	NNS	O
1453	CD	O
with	IN	O
the	DT	O
corresponding	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
W485R	NN	O
in	IN	O
the	DT	O
second	JJ	O
family	NN	O
.	.	O

This	DT	O
mutation	NN	O
creates	VBZ	O
an	DT	O
Fnu4HI	NN	O
restriction	NN	O
site	NN	O
.	.	O

The	DT	O
proband	NN	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
this	DT	O
allele	NN	O
.	.	O

When	WRB	O
the	DT	O
site-specific	JJ	O
mutagenized	JJ	O
alpha	NN	O
cDNA	NN	O
carrying	VBG	O
the	DT	O
T	NN	O
--	:	O
>	JJR	O
C	NN	O
transition	NN	O
at	IN	O
nt	NNS	O
1453	CD	O
was	VBD	O
expressed	VBN	O
in	IN	O
COS	NN	O
1	CD	O
cells	NNS	O
hexosaminidase	NN	O
S	NN	O
activity	NN	O
was	VBD	O
not	RB	O
detectable	JJ	O
above	IN	O
background	NN	O
.	.	O

A	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
at	IN	O
nt	NNS	O
1444	CD	O
(	-LRB-	O
exon	NN	O
13	CD	O
)	-RRB-	O
corresponding	VBG	O
to	TO	O
the	DT	O
E482K	NN	O
substitution	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
third	JJ	O
family	NN	O
.	.	O

This	DT	O
mutation	NN	O
occurs	VBZ	O
at	IN	O
a	DT	O
CpG	NN	O
dinucleotide	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
an	DT	O
Italian	JJ	O
TSD	NN	B-Disease
proband	NN	O
and	CC	O
causes	VBZ	O
defective	JJ	O
intracellular	JJ	O
transport	NN	O
of	IN	O
the	DT	O
alpha-subunit	NN	O
from	IN	O
the	DT	O
rough	JJ	O
endoplasmic	JJ	O
reticulum	NN	O
to	TO	O
the	DT	O
Golgi	NN	O
apparatus	NN	O
.	.	O

Glucose	NN	B-Disease
6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
incidence	NN	O
of	IN	O
hematologic	JJ	B-Disease
malignancy	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
evaluated	VBN	O
the	DT	O
hypothesis	NN	O
of	IN	O
a	DT	O
negative	JJ	O
association	NN	O
between	IN	O
glucose	NN	B-Disease
6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
and	CC	O
cancer	NN	B-Disease
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
481	CD	O
Sardinian	JJ	O
males	NNS	O
with	IN	O
hematological	JJ	B-Disease
malignancies	NNS	I-Disease
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
not	RB	O
different	JJ	O
from	IN	O
the	DT	O
incidence	NN	O
in	IN	O
a	DT	O
group	NN	O
of	IN	O
16	CD	O
,	,	O
219	CD	O
controls	NNS	O
.	.	O

The	DT	O
same	JJ	O
conclusion	NN	O
resulted	VBD	O
from	IN	O
the	DT	O
comparison	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
expression	NN	O
of	IN	O
the	DT	O
GdB	NN	O
gene	NN	O
in	IN	O
23	CD	O
heterozygous	JJ	O
women	NNS	O
having	VBG	O
a	DT	O
clonal	JJ	O
hematologic	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
a	DT	O
control	NN	O
group	NN	O
of	IN	O
37	CD	O
healthy	JJ	O
heterozygotes	NNS	O
.	.	O

Therefore	RB	O
at	IN	O
present	JJ	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
that	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
has	VBZ	O
a	DT	O
protective	JJ	O
effect	NN	O
against	IN	O
development	NN	O
of	IN	O
hematologic	JJ	B-Disease
neoplasms	NNS	I-Disease
.	.	O

.	.	O

A	DT	O
physical	JJ	O
map	NN	O
and	CC	O
candidate	NN	O
genes	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
region	NN	O
on	IN	O
chromosome	NN	O
17q12-21	NN	O
.	.	O

We	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
physical	JJ	O
map	NN	O
of	IN	O
a	DT	O
4	CD	O
cM	NN	O
region	NN	O
on	IN	O
chromosome	NN	O
17q12-21	NN	O
that	WDT	O
contains	VBZ	O
the	DT	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
gene	NN	O
BRCA1	NN	O
.	.	O

The	DT	O
map	NN	O
comprises	VBZ	O
a	DT	O
contig	NN	O
of	IN	O
137	CD	O
overlapping	VBG	O
yeast	NN	O
artificial	JJ	O
chromosomes	NNS	O
and	CC	O
P1	NN	O
clones	NNS	O
,	,	O
onto	IN	O
which	WDT	O
we	PRP	O
have	VBP	O
placed	VBN	O
112	CD	O
PCR	NN	O
markers	NNS	O
.	.	O

We	PRP	O
have	VBP	O
localized	VBN	O
more	JJR	O
than	IN	O
20	CD	O
genes	NNS	O
on	IN	O
this	DT	O
map	NN	O
,	,	O
ten	CD	O
of	IN	O
which	WDT	O
had	VBD	O
not	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
region	NN	O
previously	RB	O
,	,	O
and	CC	O
have	VB	O
isolated	VBN	O
30	CD	O
cDNA	NN	O
clones	NNS	O
representing	VBG	O
partial	JJ	O
sequences	NNS	O
of	IN	O
as	RB	O
yet	RB	O
unidentified	JJ	O
genes	NNS	O
.	.	O

Two	CD	O
genes	NNS	O
that	WDT	O
lie	VBP	O
within	IN	O
a	DT	O
narrow	JJ	O
region	NN	O
defined	VBN	O
by	IN	O
meiotic	JJ	O
breakpoints	NNS	O
in	IN	O
BRCA1	NN	O
patients	NNS	O
have	VBP	O
been	VBN	O
sequenced	VBN	O
in	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
patients	NNS	O
without	IN	O
revealing	VBG	O
any	DT	O
deleterious	JJ	O
mutations	NNS	O
.	.	O

These	DT	O
new	JJ	O
reagents	NNS	O
should	MD	O
facilitate	VB	O
the	DT	O
identification	NN	O
of	IN	O
BRCA1	NN	O
.	.	O

.	.	O

Sulfate	NN	O
transport	NN	O
is	VBZ	O
not	RB	O
impaired	JJ	O
in	IN	O
pendred	JJ	B-Disease
syndrome	NN	I-Disease
thyrocytes	NNS	O
.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
syndromic	JJ	B-Disease
deafness	NN	I-Disease
,	,	O
characterized	VBN	O
by	IN	O
dyshormonogenic	JJ	B-Disease
goiter	NN	I-Disease
associated	VBN	O
with	IN	O
sensory-neural	JJ	B-Disease
deafness	NN	I-Disease
.	.	O

The	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
disease	NN	O
(	-LRB-	O
PDS	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
,	,	O
but	CC	O
its	PRP$	O
function	NN	O
is	VBZ	O
as	RB	O
yet	RB	O
unknown	JJ	O
and	CC	O
the	DT	O
connection	NN	O
between	IN	O
thyroid	NN	B-Disease
goiter	NN	I-Disease
and	CC	O
sensory-neural	JJ	B-Disease
deafness	NN	I-Disease
remains	VBZ	O
an	DT	O
enigma	NN	O
.	.	O

PDS	NN	O
codes	NNS	O
for	IN	O
a	DT	O
novel	JJ	O
protein	NN	O
,	,	O
pendrin	NN	O
,	,	O
which	WDT	O
is	VBZ	O
closely	RB	O
related	JJ	O
to	TO	O
a	DT	O
number	NN	O
of	IN	O
sufate	NN	O
transporters	NNS	O
.	.	O

Mechanisms	NNS	O
by	IN	O
which	WDT	O
abnormal	JJ	O
sulfate	NN	O
transport	NN	O
could	MD	O
deleteriously	RB	O
affect	VB	O
iodide	NN	O
organification	NN	O
have	VBP	O
been	VBN	O
proposed	VBN	O
.	.	O

We	PRP	O
tested	VBD	O
sulfate	NN	O
transport	NN	O
in	IN	O
thyrocytes	NNS	O
obtained	VBN	O
from	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
and	CC	O
found	VBD	O
that	IN	O
it	PRP	O
was	VBD	O
not	RB	O
defective	JJ	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
pendrin	NN	O
in	IN	O
fact	NN	O
may	MD	O
not	RB	O
be	VB	O
a	DT	O
sulfate	NN	O
transporter	NN	O
,	,	O
and	CC	O
emphasizes	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
functional	JJ	O
studies	NNS	O
on	IN	O
this	DT	O
novel	JJ	O
protein	NN	O
.	.	O

.	.	O

Spinal	JJ	B-Disease
xanthomatosis	NN	I-Disease
:	:	O
a	DT	O
variant	NN	O
of	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
seven	CD	O
Dutch	JJ	O
patients	NNS	O
from	IN	O
six	CD	O
families	NNS	O
with	IN	O
a	DT	O
slowly	RB	O
progressive	JJ	O
,	,	O
mainly	RB	O
spinal	JJ	B-Disease
cord	NN	I-Disease
syndrome	NN	I-Disease
that	WDT	O
remained	VBD	O
for	IN	O
many	JJ	O
years	NNS	O
the	DT	O
sole	JJ	O
expression	NN	O
of	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
.	.	O

MRI	NNP	O
demonstrated	VBD	O
white	JJ	B-Disease
matter	NN	I-Disease
abnormalities	NNS	I-Disease
in	IN	O
the	DT	O
lateral	JJ	O
and	CC	O
dorsal	NN	O
columns	NNS	O
of	IN	O
the	DT	O
spinal	JJ	O
cord	NN	O
.	.	O

Post-mortem	NN	O
examination	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
patients	NNS	O
showed	VBD	O
extensive	JJ	O
myelin	JJ	O
loss	NN	O
in	IN	O
these	DT	O
columns	NNS	O
.	.	O

An	DT	O
array	NN	O
of	IN	O
genotypes	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
spinal	JJ	B-Disease
xanthomatosis	NN	I-Disease
is	VBZ	O
a	DT	O
clinical	JJ	O
and	CC	O
radiological	JJ	O
separate	JJ	O
entity	NN	O
of	IN	O
CTX	NNP	B-Disease
that	WDT	O
should	MD	O
be	VB	O
included	VBN	O
in	IN	O
the	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
chronic	JJ	B-Disease
myelopathy	NN	I-Disease
.	.	O

.	.	O

The	DT	O
exon	NN	O
13	CD	O
duplication	NN	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
is	VBZ	O
a	DT	O
founder	NN	O
mutation	NN	O
present	JJ	O
in	IN	O
geographically	RB	O
diverse	JJ	O
populations	NNS	O
.	.	O

The	DT	O
BRCA1	NN	O
Exon	NN	O
13	CD	O
Duplication	NN	O
Screening	NNP	O
Group	NNP	O
.	.	O

Recently	RB	O
,	,	O
a	DT	O
6-kb	JJ	O
duplication	NN	O
of	IN	O
exon	NN	O
13	CD	O
,	,	O
which	WDT	O
creates	VBZ	O
a	DT	O
frameshift	NN	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
in	IN	O
three	CD	O
unrelated	JJ	O
U.	NNP	O
S	NN	O
S.	NNP	O
families	NNS	O
of	IN	O
European	JJ	O
ancestry	NN	O
and	CC	O
in	IN	O
one	CD	O
Portuguese	NN	O
family	NN	O
.	.	O

Here	RB	O
,	,	O
our	PRP$	O
goal	NN	O
was	VBD	O
to	TO	O
estimate	VB	O
the	DT	O
frequency	NN	O
and	CC	O
geographic	JJ	O
diversity	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
this	DT	O
duplication	NN	O
.	.	O

To	TO	O
do	VB	O
this	DT	O
,	,	O
a	DT	O
collaborative	JJ	O
screening	NN	O
study	NN	O
was	VBD	O
set	VBN	O
up	RP	O
that	DT	O
involved	VBN	O
39	CD	O
institutions	NNS	O
from	IN	O
19	CD	O
countries	NNS	O
and	CC	O
included	VBD	O
3	CD	O
,	,	O
580	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
the	DT	O
disease	NN	O
and	CC	O
934	CD	O
early-onset	JJ	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
cases	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
11	CD	O
additional	JJ	O
families	NNS	O
carrying	VBG	O
this	DT	O
mutation	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
Australia	NNP	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
,	,	O
Belgium	NNP	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
,	,	O
Canada	NNP	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
,	,	O
Great	JJ	O
Britain	NNP	O
(	-LRB-	O
6	CD	O
)	-RRB-	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
States	NNPS	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
.	.	O

Haplotyping	VBG	O
showed	VBD	O
that	IN	O
they	PRP	O
are	VBP	O
likely	JJ	O
to	TO	O
derive	VB	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
,	,	O
possibly	RB	O
of	IN	O
northern	JJ	O
British	JJ	O
origin	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
it	PRP	O
is	VBZ	O
strongly	RB	O
advisable	JJ	O
,	,	O
for	IN	O
laboratories	NNS	O
carrying	VBG	O
out	RP	O
screening	VBG	O
either	CC	O
in	IN	O
English-speaking	JJ	O
countries	NNS	O
or	CC	O
in	IN	O
countries	NNS	O
with	IN	O
historical	JJ	O
links	NNS	O
with	IN	O
Britain	NNP	O
,	,	O
to	TO	O
include	VB	O
within	IN	O
their	PRP$	O
BRCA1	NN	O
screening	NN	O
protocols	NNS	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction-based	JJ	O
assay	NN	O
described	VBN	O
in	IN	O
this	DT	O
report	NN	O
.	.	O

Germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
in	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
provide	VBP	O
evidence	NN	O
for	IN	O
a	DT	O
genotype-phenotype	JJ	O
correlation	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
,	,	O
discovered	VBN	O
in	IN	O
1994	CD	O
,	,	O
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
80-90	CD	O
%	NN	O
lifetime	NN	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
analysed	VBN	O
60	CD	O
families	NNS	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
for	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
.	.	O

Twenty-two	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
32	CD	O
families	NNS	O
(	-LRB-	O
53	CD	O
%	NN	O
)	-RRB-	O
,	,	O
of	IN	O
which	WDT	O
14	CD	O
are	VBP	O
previously	RB	O
unreported	JJ	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
significant	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
and	CC	O
the	DT	O
ratio	NN	O
of	IN	O
breast	NN	B-Disease
to	TO	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
incidence	NN	O
within	IN	O
each	DT	O
family	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
suggest	VBP	O
a	DT	O
transition	NN	O
in	IN	O
risk	NN	O
such	JJ	O
that	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
3	CD	O
third	NN	O
of	IN	O
the	DT	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
a	DT	O
lower	JJR	O
proportion	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Haplotype	NN	O
analysis	NN	O
supports	VBZ	O
previous	JJ	O
data	NNS	O
which	WDT	O
suggest	VBP	O
some	DT	O
BRCA1	NN	O
mutation	NN	O
carriers	NNS	O
have	VBP	O
common	JJ	O
ancestors	NNS	O
;	:	O
however	RB	O
,	,	O
we	PRP	O
have	VBP	O
found	VBN	O
at	IN	O
least	JJS	O
two	CD	O
examples	NNS	O
where	WRB	O
recurrent	JJ	O
mutations	NNS	O
appear	VBP	O
to	TO	O
have	VB	O
arisen	VBN	O
independently	RB	O
.	.	O

.	.	O

Inactivation	NN	O
of	IN	O
the	DT	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
mouse	NN	O
gene	NN	O
leads	VBZ	O
to	TO	O
early	JJ	O
embryonic	JJ	B-Disease
lethality	NN	I-Disease
without	IN	O
iron	NN	O
accumulation	NN	O
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
ataxia	NN	I-Disease
,	,	O
is	VBZ	O
caused	VBN	O
in	IN	O
almost	RB	O
all	DT	O
cases	NNS	O
by	IN	O
homozygous	JJ	O
intronic	JJ	O
expansions	NNS	O
resulting	VBG	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
frataxin	NN	O
,	,	O
a	DT	O
mitochondrial	JJ	O
protein	NN	O
conserved	VBN	O
through	IN	O
evolution	NN	O
,	,	O
and	CC	O
involved	VBN	O
in	IN	O
mitochondrial	JJ	O
iron	NN	O
homeostasis	NN	O
.	.	O

Yeast	NN	O
knockout	NN	O
models	NNS	O
,	,	O
and	CC	O
histological	JJ	O
and	CC	O
biochemical	JJ	O
data	NNS	O
from	IN	O
patient	NN	O
heart	NN	O
biopsies	NNS	O
or	CC	O
autopsies	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
frataxin	NN	O
defect	NN	O
causes	VBZ	O
a	DT	O
specific	JJ	O
iron-sulfur	JJ	B-Disease
protein	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
mitochondrial	JJ	O
iron	NN	O
accumulation	NN	O
leading	VBG	O
to	TO	O
the	DT	O
pathological	JJ	O
changes	NNS	O
.	.	O

Affected	VBN	O
human	JJ	O
tissues	NNS	O
are	VBP	O
rarely	RB	O
available	JJ	O
to	TO	O
further	JJ	O
examine	VB	O
this	DT	O
hypothesis	NN	O
.	.	O

To	TO	O
study	VB	O
the	DT	O
mechanism	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
mouse	NN	O
model	NN	O
by	IN	O
deletion	NN	O
of	IN	O
exon	NN	O
4	CD	O
leading	VBG	O
to	TO	O
inactivation	NN	O
of	IN	O
the	DT	O
Frda	NN	B-Disease
gene	NN	O
product	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
homozygous	JJ	O
deletions	NNS	O
cause	VBP	O
embryonic	JJ	B-Disease
lethality	NN	I-Disease
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
implantation	NN	O
,	,	O
demonstrating	VBG	O
an	DT	O
important	JJ	O
role	NN	O
for	IN	O
frataxin	NN	O
during	IN	O
early	JJ	O
development	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
milder	JJ	O
phenotype	NN	O
in	IN	O
humans	NNS	O
is	VBZ	O
due	JJ	O
to	TO	O
residual	JJ	O
frataxin	NN	O
expression	NN	O
associated	VBN	O
with	IN	O
the	DT	O
expansion	NN	O
mutations	NNS	O
.	.	O

Surprisingly	RB	O
,	,	O
in	IN	O
the	DT	O
frataxin	NN	O
knockout	JJ	O
mouse	NN	O
,	,	O
no	DT	O
iron	NN	O
accumulation	NN	O
was	VBD	O
observed	VBN	O
during	IN	O
embryonic	JJ	O
resorption	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
cell	NN	O
death	NN	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
mechanism	NN	O
independent	JJ	O
of	IN	O
iron	NN	O
accumulation	NN	O
.	.	O

.	.	O

A	DT	O
glycine250	NN	O
--	:	O
>	JJR	O
aspartate	NN	O
substitution	NN	O
in	IN	O
the	DT	O
alpha-subunit	NN	O
of	IN	O
hexosaminidase	NN	O
A	NN	O
causes	VBZ	O
juvenile-onset	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
in	IN	O
a	DT	O
Lebanese-Canadian	JJ	O
family	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
juvenile	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
in	IN	O
two	CD	O
sibs	NNS	O
of	IN	O
Lebanese-Maronite	JJ	O
origin	NN	O
is	VBZ	O
described	VBN	O
.	.	O

An	DT	O
mRNA-containing	JJ	O
extract	NN	O
of	IN	O
cultured	VBN	O
fibroblasts	NNS	O
obtained	VBN	O
from	IN	O
one	CD	O
of	IN	O
the	DT	O
probands	NNS	O
was	VBD	O
used	VBN	O
as	IN	O
a	DT	O
template	NN	O
to	TO	O
amplify	VB	O
the	DT	O
coding	NN	O
sequence	NN	O
of	IN	O
the	DT	O
hexosaminidase	NN	O
A	NN	O
(	-LRB-	O
Hex	NN	O
A	NN	O
)	-RRB-	O
alpha-subunit	NN	O
.	.	O

Sequencing	NN	O
of	IN	O
amplified	VBN	O
cDNA	NN	O
fragments	NNS	O
revealed	VBD	O
a	DT	O
single	JJ	O
alteration	NN	O
,	,	O
guanine	NN	O
to	TO	O
adenine	NN	O
at	IN	O
nt	NNS	O
749	CD	O
creating	VBG	O
a	DT	O
G250D	NN	O
mutation	NN	O
.	.	O

The	DT	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
new	JJ	O
recognition	NN	O
site	NN	O
for	IN	O
the	DT	O
restriction	NN	O
enzyme	NN	O
Eco	NNP	O
RV	NN	O
,	,	O
permitting	VBG	O
identification	NN	O
of	IN	O
heterozygotes	NNS	O
for	IN	O
this	DT	O
allele	NN	O
following	VBG	O
PCR	NN	O
amplification	NN	O
and	CC	O
Eco	NN	O
RV	NN	O
digestion	NN	O
of	IN	O
exon	NN	O
7	CD	O
sequences	NNS	O
from	IN	O
genomic	JJ	O
DNA	NN	O
templates	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
test	VB	O
the	DT	O
effect	NN	O
of	IN	O
this	DT	O
substitution	NN	O
,	,	O
an	DT	O
in	FW	O
vitro	FW	O
mutagenized	VBN	O
cDNA	NN	O
construct	NN	O
was	VBD	O
introduced	VBN	O
into	IN	O
a	DT	O
mammalian	JJ	O
expression	NN	O
vector	NN	O
and	CC	O
transfected	VBN	O
into	IN	O
monkey	NN	O
Cos-1	NN	O
cells	NNS	O
separately	RB	O
or	CC	O
along	RB	O
with	IN	O
a	DT	O
beta-cDNA	NN	O
expression	NN	O
vector	NN	O
.	.	O

When	WRB	O
the	DT	O
mutant	JJ	O
alpha-cDNA	NN	O
was	VBD	O
the	DT	O
only	JJ	O
gene	NN	O
introduced	VBN	O
into	IN	O
COS	NN	O
cells	NNS	O
no	DT	O
enzymatic	JJ	O
activity	NN	O
above	IN	O
endogenous	JJ	O
COS	NN	O
cell	NN	O
activity	NN	O
was	VBD	O
detected	VBN	O
.	.	O

Cotransfection	NN	O
of	IN	O
normal	JJ	O
alpha-cDNA	NN	O
and	CC	O
beta-cDNA	NN	O
followed	VBN	O
by	IN	O
immunoprecipitation	NN	O
of	IN	O
human	JJ	O
Hex	NN	O
A	NN	O
resulted	VBD	O
in	IN	O
20-fold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
ratio	NN	O
between	IN	O
positive	JJ	O
and	CC	O
negative	JJ	O
(	-LRB-	O
mock	JJ	O
transfection	NN	O
)	-RRB-	O
control	NN	O
values	NNS	O
.	.	O

This	DT	O
allowed	VBD	O
the	DT	O
detection	NN	O
of	IN	O
some	DT	O
residual	JJ	O
activity	NN	O
(	-LRB-	O
12	CD	O
%	NN	O
of	IN	O
the	DT	O
positive	JJ	O
control	NN	O
)	-RRB-	O
when	WRB	O
the	DT	O
mutant	JJ	O
alpha-cDNA	NN	O
replaced	VBD	O
its	PRP$	O
wild-type	JJ	O
counterpart	NN	O
.	.	O

The	DT	O
predicted	VBN	O
protein	NN	O
environment	NN	O
in	IN	O
which	WDT	O
the	DT	O
mutation	NN	O
occurs	VBZ	O
is	VBZ	O
compared	VBN	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
adult-onset	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
Gly269	NN	O
--	:	O
>	JJR	O
Ser	NN	O
substitution	NN	O
in	IN	O
exon	NN	O
7	CD	O
.	.	O

(	-LRB-	O
ABSTRACT	NN	O
TRUNCATED	VBN	O
AT	IN	O
250	CD	O
WORDS	NNS	O
)	-RRB-	O
.	.	O

Restriction	NN	O
of	IN	O
ocular	JJ	O
fundus	NN	O
lesions	NNS	O
to	TO	O
a	DT	O
specific	JJ	O
subgroup	NN	O
of	IN	O
APC	NN	B-Disease
mutations	NNS	O
in	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
patients	NNS	O
.	.	O

In	IN	O
humans	NNS	O
,	,	O
alteration	NN	O
of	IN	O
the	DT	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
,	,	O
APC	NN	B-Disease
,	,	O
causes	VBZ	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
,	,	O
a	DT	O
condition	NN	O
causing	VBG	O
predisposition	NN	O
to	TO	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
syndrome	NN	O
inconsistently	RB	O
associates	VBZ	O
characteristic	JJ	O
patches	NNS	O
of	IN	O
congenital	JJ	B-Disease
hypertrophy	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
retinal	JJ	I-Disease
pigment	NN	I-Disease
epithelium	NN	I-Disease
(	-LRB-	O
CHRPE	NN	B-Disease
)	-RRB-	O
.	.	O

Ocular	JJ	O
examination	NN	O
revealed	VBD	O
that	IN	O
patients	NNS	O
expressing	VBG	O
CHRPE	NNP	B-Disease
tend	VB	O
to	TO	O
cluster	VB	O
within	IN	O
specific	JJ	O
families	NNS	O
.	.	O

The	DT	O
exact	JJ	O
APC	NN	B-Disease
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
42	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

In	IN	O
all	DT	O
cases	NNS	O
these	DT	O
mutations	NNS	O
were	VBD	O
predicted	VBN	O
to	TO	O
lead	VB	O
to	TO	O
the	DT	O
synthesis	NN	O
of	IN	O
a	DT	O
truncated	VBN	O
protein	NN	O
.	.	O

The	DT	O
extent	NN	O
of	IN	O
CHRPE	NNP	B-Disease
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
dependent	JJ	O
on	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
mutation	NN	O
along	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

CHRPE	JJ	B-Disease
lesions	NNS	O
are	VBP	O
almost	RB	O
always	RB	O
absent	JJ	O
if	IN	O
the	DT	O
mutation	NN	O
occurs	VBZ	O
before	IN	O
exon	NN	O
9	CD	O
,	,	O
but	CC	O
are	VBP	O
systematically	RB	O
present	JJ	O
if	IN	O
it	PRP	O
occurs	VBZ	O
after	IN	O
this	DT	O
exon	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
range	NN	O
of	IN	O
phenotypic	JJ	O
expression	NN	O
observed	VBN	O
among	IN	O
affected	JJ	O
patients	NNS	O
may	MD	O
result	VB	O
in	IN	O
part	NN	O
from	IN	O
different	JJ	O
allelic	JJ	O
manifestations	NNS	O
of	IN	O
APC	NN	B-Disease
mutations	NNS	O
.	.	O

.	.	O

Linkage	NN	O
analysis	NN	O
of	IN	O
26	CD	O
Canadian	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
breast-ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
26	CD	O
Canadian	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
for	IN	O
linkage	NN	O
to	TO	O
markers	NNS	O
flanking	VBG	O
the	DT	O
BRCA1	NN	O
gene	NN	O
on	IN	O
chromosome	NN	O
17q12-q21	NN	O
.	.	O

Of	IN	O
the	DT	O
15	CD	O
families	NNS	O
that	WDT	O
contain	VBP	O
cases	NNS	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
94	CD	O
%	NN	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
linked	VBN	O
to	TO	O
BRCA1	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
overall	JJ	O
evidence	NN	O
of	IN	O
linkage	NN	O
in	IN	O
the	DT	O
group	NN	O
of	IN	O
10	CD	O
families	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
without	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

A	DT	O
genetic	JJ	O
recombinant	JJ	O
in	IN	O
a	DT	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
family	NN	O
indicates	VBZ	O
a	DT	O
placement	NN	O
of	IN	O
BRCA1	NN	O
telomeric	JJ	O
to	TO	O
D17S776	NN	O
,	,	O
and	CC	O
helps	VBZ	O
to	TO	O
define	VB	O
the	DT	O
region	NN	O
of	IN	O
assignment	NN	O
of	IN	O
the	DT	O
cancer	NN	B-Disease
susceptibility	NN	O
gene	NN	O
.	.	O

Other	JJ	O
cancers	NNS	B-Disease
of	IN	O
interest	NN	O
that	WDT	O
appeared	VBD	O
in	IN	O
the	DT	O
BRCA1-linked	JJ	O
families	NNS	O
included	VBD	O
primary	JJ	B-Disease
peritoneal	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
cancer	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
fallopian	JJ	I-Disease
tube	NN	I-Disease
,	,	O
and	CC	O
malignant	JJ	B-Disease
melanoma	NN	I-Disease
.	.	O

.	.	O

Malignant	JJ	B-Disease
neoplasms	NNS	I-Disease
in	IN	O
the	DT	O
families	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
ataxia-telangiectasia	NN	B-Disease
.	.	O

Ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
syndrome	NN	I-Disease
associated	VBN	O
with	IN	O
a	DT	O
greatly	RB	O
increased	VBN	O
incidence	NN	O
of	IN	O
malignant	JJ	B-Disease
neoplasms	NNS	I-Disease
in	IN	O
homozygous	JJ	O
affected	JJ	O
individuals	NNS	O
.	.	O

Heterozygotes	NNS	O
for	IN	O
the	DT	O
gene	NN	O
for	IN	O
A-T	NN	B-Disease
are	VBP	O
thought	VBN	O
to	TO	O
comprise	VB	O
about	IN	O
1	CD	O
%	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
and	CC	O
,	,	O
therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
know	VB	O
whether	IN	O
this	DT	O
gene	NN	O
also	RB	O
predisposes	VBZ	O
the	DT	O
heterozygous	JJ	O
carrier	NN	O
to	TO	O
cancers	NNS	B-Disease
.	.	O

Heterozygous	JJ	O
carriers	NNS	O
of	IN	O
this	DT	O
gene	NN	O
are	VBP	O
common	JJ	O
among	IN	O
the	DT	O
close	JJ	O
relatives	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
A-T	NN	B-Disease
,	,	O
although	IN	O
individual	JJ	O
carriers	NNS	O
can	MD	O
not	RB	O
be	VB	O
identified	VBN	O
by	IN	O
any	DT	O
clinical	JJ	O
criterion	NN	O
or	CC	O
laboratory	NN	O
test	NN	O
.	.	O

For	IN	O
this	DT	O
reason	NN	O
,	,	O
we	PRP	O
compared	VBD	O
the	DT	O
incidence	NN	O
of	IN	O
death	NN	O
from	IN	O
malignant	JJ	B-Disease
neoplasms	NNS	I-Disease
in	IN	O
2	CD	O
families	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
A-T	NN	B-Disease
to	TO	O
that	DT	O
expected	VBN	O
in	IN	O
a	DT	O
random	JJ	O
sample	NN	O
of	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

There	EX	O
were	VBD	O
59	CD	O
deaths	NNS	O
from	IN	O
malignant	JJ	B-Disease
neoplasms	NNS	I-Disease
in	IN	O
relatives	NNS	O
dying	VBG	O
before	IN	O
age	NN	O
75	CD	O
,	,	O
compared	VBN	O
to	TO	O
42	CD	O
.	.	O

6	CD	O
expected	VBN	O
(	-LRB-	O
p	NN	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

02	NN	O
)	-RRB-	O
.	.	O

For	IN	O
A-T	JJ	B-Disease
heterozygotes	NNS	O
younger	JJR	O
than	IN	O
age	NN	O
45	CD	O
,	,	O
the	DT	O
risk	NN	O
of	IN	O
dying	VBG	O
from	IN	O
a	DT	O
malignant	JJ	B-Disease
neoplasm	NN	I-Disease
was	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
greater	JJR	O
than	IN	O
5	CD	O
times	NNS	O
the	DT	O
risk	NN	O
for	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

A-T	NN	B-Disease
heterozygotes	NNS	O
may	MD	O
comprise	VB	O
more	JJR	O
than	IN	O
5	CD	O
%	NN	O
of	IN	O
all	DT	O
persons	NNS	O
dying	VBG	O
from	IN	O
a	DT	O
cancer	NN	B-Disease
before	IN	O
age	NN	O
45	CD	O
.	.	O

The	DT	O
incidence	NN	O
of	IN	O
ovarian	JJ	B-Disease
,	,	I-Disease
gastric	JJ	I-Disease
,	,	I-Disease
and	CC	I-Disease
biliary	JJ	I-Disease
system	NN	I-Disease
carcinomas	NNS	I-Disease
and	CC	O
of	IN	O
leukemia	NN	B-Disease
and	CC	O
lymphoma	NN	B-Disease
was	VBD	O
increased	VBN	O
in	IN	O
these	DT	O
A-T	JJ	B-Disease
families	NNS	O
.	.	O

Other	JJ	O
neoplasms	NNS	B-Disease
that	WDT	O
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
this	DT	O
gene	NN	O
in	IN	O
heterozygotes	NNS	O
include	VBP	O
pancreatic	JJ	B-Disease
,	,	I-Disease
basal	JJ	I-Disease
cell	NN	I-Disease
,	,	I-Disease
colonic	JJ	I-Disease
,	,	I-Disease
breast	NN	I-Disease
,	,	I-Disease
and	CC	I-Disease
cervical	JJ	I-Disease
carcinomas	NNS	I-Disease
.	.	O

Molecular	JJ	O
genetics	NNS	O
of	IN	O
PKU	NNP	B-Disease
in	IN	O
eastern	JJ	O
Europe	NNP	O
:	:	O
a	DT	O
nonsense	NN	O
mutation	NN	O
associated	VBN	O
with	IN	O
haplotype	NN	O
4	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
genetic	JJ	B-Disease
disorder	NN	I-Disease
secondary	JJ	O
to	TO	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
hepatic	JJ	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

Several	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
have	VBP	O
recently	RB	O
been	VBN	O
reported	VBN	O
,	,	O
and	CC	O
linkage	NN	O
disequilibrium	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
RFLP	NN	O
haplotypes	NNS	O
and	CC	O
specific	JJ	O
mutations	NNS	O
.	.	O

A	DT	O
new	JJ	O
molecular	JJ	B-Disease
lesion	NN	I-Disease
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
exon	NN	O
7	CD	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
in	IN	O
a	DT	O
Hungarian	JJ	O
PKU	NN	B-Disease
patient	NN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
PCR-amplified	JJ	O
DNA	NN	O
.	.	O

The	DT	O
C-to-T	JJ	O
transition	NN	O
causes	VBZ	O
the	DT	O
substitution	NN	O
of	IN	O
Arg243	NN	O
to	TO	O
a	DT	O
termination	NN	O
codon	NN	O
,	,	O
and	CC	O
the	DT	O
mutant	JJ	O
allele	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
haplotype	NN	O
4	CD	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
two	CD	O
of	IN	O
nine	CD	O
mutant	JJ	O
haplotype	NN	O
4	CD	O
alleles	NNS	O
among	IN	O
Eastern	JJ	O
Europeans	NNPS	O
and	CC	O
is	VBZ	O
not	RB	O
present	JJ	O
among	IN	O
Western	JJ	O
Europeans	NNPS	O
and	CC	O
Asians	NNPS	O
.	.	O

The	DT	O
rarity	NN	O
of	IN	O
this	DT	O
mutant	JJ	O
allele	NN	O
and	CC	O
its	PRP$	O
restricted	JJ	O
geographic	JJ	O
distribution	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
mutational	JJ	O
event	NN	O
occurred	VBD	O
recently	RB	O
on	IN	O
a	DT	O
normal	JJ	O
haplotype	NN	O
4	CD	O
background	NN	O
in	IN	O
Eastern	NNP	O
Europe	NNP	O
.	.	O

.	.	O

Isolation	NN	O
of	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
BRCA1	NN	O
and	CC	O
genetic	JJ	O
mapping	NN	O
to	TO	O
mouse	NN	O
chromosome	NN	O
11	CD	O
.	.	O

The	DT	O
BRCA1	NN	O
gene	NN	O
is	VBZ	O
in	IN	O
large	JJ	O
part	NN	O
responsible	JJ	O
for	IN	O
hereditary	JJ	B-Disease
human	JJ	I-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
of	IN	O
the	DT	O
murine	JJ	O
Brca1	NN	O
homologue	NN	O
cDNA	NN	O
clones	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
identified	VBD	O
genomic	JJ	O
P1	NN	O
clones	NNS	O
that	WDT	O
contain	VBP	O
most	RBS	O
,	,	O
if	IN	O
not	RB	O
all	DT	O
,	,	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NN	O
locus	NN	O
.	.	O

DNA	NN	O
sequence	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	JJ	O
coding	NN	O
regions	NNS	O
are	VBP	O
75	CD	O
%	NN	O
identical	JJ	O
at	IN	O
the	DT	O
nucleotide	NN	O
level	NN	O
while	IN	O
the	DT	O
predicted	VBN	O
amino	NN	O
acid	NN	O
identity	NN	O
is	VBZ	O
only	RB	O
58	CD	O
%	NN	O
.	.	O

A	DT	O
DNA	NN	O
sequence	NN	O
variant	NN	O
in	IN	O
the	DT	O
Brca1	NN	O
locus	NN	O
was	VBD	O
identified	VBN	O
and	CC	O
used	VBN	O
to	TO	O
map	VB	O
this	DT	O
gene	NN	O
on	IN	O
a	DT	O
(	-LRB-	O
Mus	NN	O
m.	VBN	O
musculus	JJ	O
Czech	NNP	O
II	CD	O
x	CC	O
C57BL/KsJ	NN	O
)	-RRB-	O
F1	NN	O
x	CC	O
C57BL/KsJ	NN	O
intersubspecific	JJ	O
backcross	NN	O
to	TO	O
distal	JJ	O
mouse	NN	O
chromosome	NN	O
11	CD	O
.	.	O

The	DT	O
mapping	NN	O
of	IN	O
this	DT	O
gene	NN	O
to	TO	O
a	DT	O
region	NN	O
highly	RB	O
syntenic	JJ	O
with	IN	O
human	JJ	O
chromosome	NN	O
17	CD	O
,	,	O
coupled	VBN	O
with	IN	O
Southern	NNP	O
and	CC	O
Northern	NNP	O
analyses	NNS	O
,	,	O
confirms	VBZ	O
that	IN	O
we	PRP	O
isolated	VBD	O
the	DT	O
murine	JJ	O
Brca1	NN	O
homologue	NN	O
rather	RB	O
than	IN	O
a	DT	O
related	JJ	O
RING	NN	O
finger	NN	O
gene	NN	O
.	.	O

The	DT	O
isolation	NN	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NN	O
homologue	NN	O
will	MD	O
facilitate	VB	O
the	DT	O
creation	NN	O
of	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
germline	NN	O
BRCA1	NN	B-Disease
defects	NNS	I-Disease
.	.	O

.	.	O

Human	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
sixth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
and	CC	O
no	DT	O
haemostasis	NN	B-Disease
abnormality	NN	I-Disease
.	.	O

A	DT	O
case	NN	O
of	IN	O
human	JJ	O
complete	JJ	O
C6	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
reported	VBN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
a	DT	O
31	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
,	,	O
was	VBD	O
seen	VBN	O
on	IN	O
the	DT	O
occasion	NN	O
of	IN	O
an	DT	O
isolated	VBN	O
episode	NN	O
of	IN	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
.	.	O

Serum	NN	O
complement	NN	O
hemolytic	JJ	O
and	CC	O
bactericidal	JJ	O
activities	NNS	O
were	VBD	O
lacking	VBG	O
and	CC	O
could	MD	O
be	VB	O
restored	VBN	O
to	TO	O
normal	JJ	O
by	IN	O
addition	NN	O
of	IN	O
appropriate	JJ	O
amounts	NNS	O
of	IN	O
purified	VBN	O
C6	NN	O
.	.	O

No	DT	O
hemostatic	JJ	B-Disease
abnormalities	NNS	I-Disease
were	VBD	O
observed	VBN	O
.	.	O

.	.	O

The	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
:	:	O
refinement	NN	O
of	IN	O
the	DT	O
localization	NN	O
on	IN	O
Xp	NN	O
and	CC	O
identification	NN	O
of	IN	O
another	DT	O
closely	RB	O
linked	VBN	O
marker	NN	O
locus	NN	O
,	,	O
OATL1	NN	O
.	.	O

The	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
has	VBZ	O
previously	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
proximal	JJ	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
between	IN	O
the	DT	O
DXS14	NN	O
and	CC	O
DXS7	NN	O
loci	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
further	JJ	O
segregation	NN	O
analysis	NN	O
has	VBZ	O
been	VBN	O
performed	VBN	O
using	VBG	O
a	DT	O
newly	RB	O
identified	VBN	O
WAS	NNP	B-Disease
family	NN	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
additional	JJ	O
marker	NN	O
probe	NN	O
,	,	O
HOATL1	NN	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
WAS	NNP	B-Disease
and	CC	O
OATL1	NNP	O
loci	NNS	O
(	-LRB-	O
Z	NN	O
=	JJ	O
6	CD	O
.	.	O

08	NN	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
)	-RRB-	O
and	CC	O
localize	VB	O
the	DT	O
TIMP	NN	O
,	,	O
OATL1	NN	O
,	,	O
DXS255	NN	O
,	,	O
and	CC	O
WAS	NNP	B-Disease
loci	NNS	O
distal	JJ	O
to	TO	O
DXS146	NN	O
and	CC	O
the	DT	O
OATL1	NN	O
and	CC	O
WAS	NN	B-Disease
loci	NNS	O
proximal	JJ	O
to	TO	O
TIMP	NN	O
.	.	O

These	DT	O
linkage	NN	O
data	NNS	O
narrow	VBP	O
the	DT	O
boundaries	NNS	O
within	IN	O
which	WDT	O
the	DT	O
WAS	NNP	B-Disease
locus	NN	O
maps	VBZ	O
to	TO	O
the	DT	O
chromosomal	JJ	O
region	NN	O
bracketed	VBN	O
by	IN	O
TIMP	NN	O
and	CC	O
DXS146	NN	O
and	CC	O
support	VBP	O
the	DT	O
loci	NNS	O
order	NN	O
Xpter-DXS7-TIMP	NN	O
-	:	O
(	-LRB-	O
OATL1	NN	O
,	,	O
WAS	NNP	O
,	,	O
DXS255	NN	O
)	-RRB-	O
-	:	O
DXS146	NN	O
.	.	O

Hereditary	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
third	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
a	DT	O
child	NN	O
with	IN	O
fever	NN	B-Disease
,	,	O
skin	NN	B-Disease
rash	NN	I-Disease
,	,	O
and	CC	O
arthralgias	NNS	B-Disease
:	:	O
response	NN	O
to	TO	O
transfusion	NN	O
of	IN	O
whole	JJ	O
blood	NN	O
.	.	O

A	DT	O
previously	RB	O
well	RB	O
34-month-old	JJ	O
male	NN	O
presenting	VBG	O
with	IN	O
fever	NN	B-Disease
,	,	O
skin	NN	B-Disease
rash	NN	I-Disease
,	,	O
and	CC	O
arthralgias	NNS	B-Disease
was	VBD	O
found	VBN	O
to	TO	O
lack	VB	O
C3	NN	O
by	IN	O
immunochemical	NN	O
(	-LRB-	O
undetectable	JJ	O
)	-RRB-	O
and	CC	O
hemolytic	JJ	O
(	-LRB-	O
1	CD	O
%	NN	O
normal	JJ	O
)	-RRB-	O
assays	NNS	O
.	.	O

No	DT	O
infectious	JJ	O
agent	NN	O
could	MD	O
be	VB	O
demonstrated	VBN	O
.	.	O

Protein	NN	O
levels	NNS	O
of	IN	O
Clq	NN	O
.	.	O

C4	NN	O
,	,	O
C5	NN	O
,	,	O
properdin	NN	O
,	,	O
and	CC	O
C3b-INA	NN	O
and	CC	O
hemolytic	JJ	O
activities	NNS	O
of	IN	O
complement	NN	O
components	NNS	O
C1	NN	O
to	TO	O
C9	NN	O
except	IN	O
C3	NN	O
were	VBD	O
normal	JJ	O
or	CC	O
elevated	JJ	O
;	:	O
total	JJ	O
hemolytic	JJ	O
complement	NN	O
activity	NN	O
was	VBD	O
13	CD	O
%	NN	O
of	IN	O
normal	JJ	O
and	CC	O
was	VBD	O
reconstituted	VBN	O
by	IN	O
purified	VBN	O
C3	NN	O
.	.	O

Properdin	NN	O
factor	NN	O
B	NN	O
was	VBD	O
702	CD	O
(	-LRB-	O
normal	JJ	O
175	CD	O
to	TO	O
275	CD	O
)	-RRB-	O
mug/ml	NN	O
,	,	O
and	CC	O
was	VBD	O
not	RB	O
cleaver	VB	O
upon	IN	O
addition	NN	O
of	IN	O
zymosan	NN	O
or	CC	O
cobra	NN	O
venom	NN	O
factor	NN	O
.	.	O

The	DT	O
serum	NN	O
had	VBD	O
normal	JJ	O
immune	JJ	O
adherence	NN	O
activity	NN	O
,	,	O
but	CC	O
was	VBD	O
deficient	JJ	O
in	IN	O
ability	NN	O
to	TO	O
opsonize	VB	O
Candida	NN	O
albicans	NNS	O
for	IN	O
uptake	NN	O
and	CC	O
Escherichia	FW	O
coli	FW	O
for	IN	O
killing	VBG	O
by	IN	O
neurophils	NNS	O
,	,	O
generate	VBP	O
neutrophil	NN	O
chemotactic	JJ	O
factors	NNS	O
and	CC	O
inhibit	VBP	O
the	DT	O
growth	NN	O
of	IN	O
E.	FW	O
coli	FW	O
;	:	O
these	DT	O
activities	NNS	O
were	VBD	O
restored	VBN	O
by	IN	O
purified	VBN	O
C3	NN	O
.	.	O

A	DT	O
transfusion	NN	O
of	IN	O
320	CD	O
ml	NN	O
1-hour-old	JJ	O
normal	JJ	O
whole	JJ	O
blood	NN	O
on	IN	O
the	DT	O
fifty-second	JJ	O
day	NN	O
resulted	VBD	O
in	IN	O
transitory	JJ	O
elevation	NN	O
of	IN	O
the	DT	O
C3	NN	O
level	NN	O
to	TO	O
25	CD	O
mg/dl	NN	O
with	IN	O
a	DT	O
fall-off	NN	O
(	-LRB-	O
approximately	RB	O
21/2	CD	O
%	NN	O
per	IN	O
hour	NN	O
)	-RRB-	O
to	TO	O
undetectable	JJ	O
levels	NNS	O
by	IN	O
69	CD	O
hours	NNS	O
;	:	O
it	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
disappearance	NN	O
of	IN	O
the	DT	O
skin	NN	B-Disease
rash	NN	I-Disease
and	CC	O
arthralgias	NNS	B-Disease
and	CC	O
return	VB	O
to	TO	O
normal	JJ	O
of	IN	O
the	DT	O
previously	RB	O
elevated	JJ	O
temperature	NN	O
and	CC	O
CRP	NN	O
levels	NNS	O
.	.	O

C3	NN	O
levels	NNS	O
in	IN	O
family	NN	O
members	NNS	O
(	-LRB-	O
seven	CD	O
of	IN	O
24	CD	O
half-normal	JJ	O
)	-RRB-	O
,	,	O
lack	NN	O
of	IN	O
anti-C3	JJ	O
activity	NN	O
,	,	O
normal	JJ	O
C3b-INA	NN	O
levels	NNS	O
and	CC	O
a	DT	O
normal	JJ	O
rate	NN	O
of	IN	O
catabolism	NN	O
of	IN	O
transfused	VBN	O
C3	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
deficiency	NN	O
was	VBD	O
inherited	VBN	O
with	IN	O
autosomal	JJ	O
codominance	NN	O
and	CC	O
involved	VBN	O
decreased	VBN	B-Disease
synthesis	NN	I-Disease
of	IN	I-Disease
C3	NN	I-Disease
.	.	O

Thus	RB	O
,	,	O
this	DT	O
child	NN	O
is	VBZ	O
a	DT	O
unique	JJ	O
individual	NN	O
with	IN	O
inherited	VBN	B-Disease
C3	NN	I-Disease
deficiency	NN	I-Disease
presenting	VBG	O
with	IN	O
absence	NN	O
of	IN	O
repeated	VBN	O
infections	NNS	O
,	,	O
whose	WP$	O
symptoms	NNS	O
of	IN	O
fever	NN	B-Disease
,	,	O
skin	NN	B-Disease
rash	NN	I-Disease
,	,	O
and	CC	O
arthralgia	NN	B-Disease
were	VBD	O
abated	VBN	O
by	IN	O
whole	JJ	O
blood	NN	O
transfusion	NN	O
.	.	O

.	.	O

Cloning	NN	O
of	IN	O
breakpoints	NNS	O
of	IN	O
a	DT	O
chromosome	NN	O
translocation	NN	O
identifies	VBZ	O
the	DT	O
AN2	NN	O
locus	NN	O
.	.	O

Chromosome	NN	O
translocations	NNS	O
involving	VBG	O
11p13	NN	O
have	VBP	O
been	VBN	O
associated	VBN	O
with	IN	O
familial	JJ	B-Disease
aniridia	NN	I-Disease
in	IN	O
two	CD	O
kindreds	NNS	O
highlighting	VBG	O
the	DT	O
chromosomal	JJ	O
localization	NN	O
of	IN	O
the	DT	O
AN2	NN	O
locus	NN	O
.	.	O

This	DT	O
locus	NN	O
is	VBZ	O
also	RB	O
part	NN	O
of	IN	O
the	DT	O
WAGR	NN	B-Disease
complex	NN	O
(	-LRB-	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
,	,	O
aniridia	NN	B-Disease
,	,	O
genitourinary	JJ	B-Disease
abnormalities	NNS	I-Disease
,	,	O
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
)	-RRB-	O
.	.	O

In	IN	O
one	CD	O
kindred	NN	O
,	,	O
the	DT	O
translocation	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
,	,	O
and	CC	O
probes	NNS	O
for	IN	O
this	DT	O
region	NN	O
were	VBD	O
used	VBN	O
to	TO	O
identify	VB	O
and	CC	O
clone	NN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
translocation	NN	O
in	IN	O
the	DT	O
second	JJ	O
kindred	NN	O
.	.	O

Comparison	NN	O
of	IN	O
phage	NN	O
restriction	NN	O
maps	NNS	O
exclude	VBP	O
the	DT	O
presence	NN	O
of	IN	O
any	DT	O
sizable	JJ	O
deletion	NN	O
in	IN	O
this	DT	O
case	NN	O
.	.	O

Sequences	NNS	O
at	IN	O
the	DT	O
chromosome	NN	O
11	CD	O
breakpoint	NN	O
are	VBP	O
conserved	VBN	O
in	IN	O
multiple	JJ	O
species	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
translocation	NN	O
falls	VBZ	O
within	IN	O
the	DT	O
AN2	NN	O
gene	NN	O
.	.	O

.	.	O

Study	NN	O
of	IN	O
the	DT	O
voltage-gated	JJ	O
sodium	NN	O
channel	NN	O
beta	NN	O
1	CD	O
subunit	NN	O
gene	NN	O
(	-LRB-	O
SCN1B	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
benign	JJ	B-Disease
familial	JJ	I-Disease
infantile	JJ	I-Disease
convulsions	NNS	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
BFIC	NN	B-Disease
)	-RRB-	O
.	.	O

Benign	JJ	B-Disease
familial	JJ	I-Disease
infantile	JJ	I-Disease
convulsions	NNS	I-Disease
(	-LRB-	O
BFIC	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
epilepsy	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

This	DT	O
syndrome	NN	O
has	VBZ	O
been	VBN	O
recently	RB	O
described	VBN	O
in	IN	O
Italian	JJ	O
and	CC	O
French	JJ	O
pedigrees	NNS	O
.	.	O

Patients	NNS	O
present	JJ	O
with	IN	O
partial	JJ	O
,	,	O
then	RB	O
generalized	VBN	O
seizures	NNS	O
,	,	O
with	IN	O
onset	NN	O
at	IN	O
age	NN	O
three	CD	O
months	NNS	O
.	.	O

The	DT	O
seizures	NNS	O
usually	RB	O
spontaneously	RB	O
cease	VB	O
after	IN	O
one	CD	O
year	NN	O
without	IN	O
treatment	NN	O
,	,	O
leaving	VBG	O
no	DT	O
neurological	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
BFIC	NNP	B-Disease
to	TO	O
chromosome	NN	O
19q	NN	O
in	IN	O
five	CD	O
Italian	JJ	O
pedigrees	NNS	O
.	.	O

The	DT	O
sodium	NN	O
channel	NN	O
beta1	NN	O
subunit	NN	O
gene	NN	O
(	-LRB-	O
SCN1B	NN	O
)	-RRB-	O
maps	VBZ	O
to	TO	O
this	DT	O
candidate	NN	O
region	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
one	CD	O
Australian	JJ	O
pedigree	NN	O
with	IN	O
generalized	VBN	B-Disease
epilepsy	NN	I-Disease
and	CC	I-Disease
febrile	NN	I-Disease
seizures	NNS	I-Disease
"	''	I-Disease
plus	CC	I-Disease
"	''	I-Disease
(	-LRB-	O
GEFS	NN	O
+	CC	O
)	-RRB-	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
SCN1B	NN	O
cosegregates	NNS	O
with	IN	O
the	DT	O
GEFS	NN	O
+	CC	O
phenotype	NN	O
.	.	O

BFIC	NN	B-Disease
and	CC	O
GEFS	NN	O
+	CC	O
have	VBP	O
clinical	JJ	O
features	NNS	O
in	IN	O
common	JJ	O
,	,	O
therefore	RB	O
SCN1B	NN	O
is	VBZ	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
BFIC	NNP	B-Disease
.	.	O

We	PRP	O
studied	VBD	O
SCN1B	NN	O
exons	NNS	O
1	CD	O
,	,	O
2	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
,	,	O
and	CC	O
5	CD	O
,	,	O
using	VBG	O
four	CD	O
SSCP	NN	O
methods	NNS	O
in	IN	O
10	CD	O
Caucasian	JJ	O
BFIC	NN	B-Disease
probands	NNS	O
of	IN	O
Western	NNP	O
Europe	NNP	O
.	.	O

We	PRP	O
found	VBD	O
no	DT	O
exon	NN	O
variants	NNS	O
.	.	O

One	CD	O
variant	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
intron	NN	O
5	CD	O
(	-LRB-	O
IVS5-10C	NN	O
>	JJR	O
G	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
did	VBD	O
not	RB	O
segregate	VB	O
with	IN	O
BFIC	NN	B-Disease
and	CC	O
was	VBD	O
observed	VBN	O
in	IN	O
9	CD	O
.	.	O

2	CD	O
%	NN	O
controls	NNS	O
.	.	O

A	DT	O
second	JJ	O
variant	NN	O
in	IN	O
intron	NN	O
5	CD	O
was	VBD	O
identified	VBN	O
(	-LRB-	O
IVS5	NN	O
+	CC	O
30G	NN	O
>	JJR	O
A	NN	O
)	-RRB-	O
.	.	O

It	PRP	O
was	VBD	O
rare	JJ	O
,	,	O
as	IN	O
not	RB	O
observed	VBN	O
in	IN	O
controls	NNS	O
,	,	O
but	CC	O
not	RB	O
segregating	VBG	O
with	IN	O
the	DT	O
BFIC	NN	B-Disease
phenotype	NN	O
.	.	O

Brain	NN	B-Disease
disease	NN	I-Disease
and	CC	O
molecular	JJ	O
analysis	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Abnormal	JJ	O
amplification	NN	O
of	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
on	IN	O
chromosome	NN	O
19	CD	O
is	VBZ	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

Expansion	NN	O
of	IN	O
the	DT	O
repeat	NN	O
has	VBZ	O
been	VBN	O
correlated	VBN	O
with	IN	O
severity	NN	O
of	IN	O
several	JJ	O
clinical	JJ	O
features	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
performed	VBD	O
extensive	JJ	O
cognitive	JJ	O
testing	NN	O
,	,	O
cerebral	JJ	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
(	-LRB-	O
MRI	NNP	O
)	-RRB-	O
and	CC	O
a	DT	O
molecular	JJ	O
analysis	NN	O
in	IN	O
28	CD	O
cases	NNS	O
of	IN	O
DM	NN	B-Disease
to	TO	O
determine	VB	O
the	DT	O
relationship	NN	O
between	IN	O
the	DT	O
molecular	JJ	O
defect	NN	O
and	CC	O
brain	NN	B-Disease
disease	NN	I-Disease
.	.	O

Performance	NNP	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
cognitive	JJ	O
tests	NNS	O
was	VBD	O
pathological	JJ	O
in	IN	O
10	CD	O
cases	NNS	O
.	.	O

Fourteen	CD	O
patients	NNS	O
had	VBD	O
subcortical	JJ	O
white	JJ	B-Disease
matter	NN	I-Disease
lesions	NNS	I-Disease
on	IN	O
MRI	NNP	O
,	,	O
14	CD	O
had	VBD	O
cerebral	JJ	B-Disease
atrophy	NN	I-Disease
.	.	O

Amplification	NN	O
of	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
showed	VBD	O
a	DT	O
strong	JJ	O
correlation	NN	O
with	IN	O
cognitive	JJ	O
test	NN	O
deficits	NNS	O
when	WRB	O
exceeding	VBG	O
a	DT	O
length	NN	O
of	IN	O
over	IN	O
1000	CD	O
trinucleotides	NNS	O
.	.	O

MRI	NNP	O
lesions	NNS	O
were	VBD	O
associated	VBN	O
with	IN	O
impaired	JJ	O
psychometric	JJ	O
performance	NN	O
,	,	O
but	CC	O
MRI	NNP	O
and	CC	O
molecular	JJ	O
findings	NNS	O
were	VBD	O
only	RB	O
weakly	RB	O
related	JJ	O
.	.	O

Disease	NN	O
duration	NN	O
influenced	VBD	O
the	DT	O
appearance	NN	O
and	CC	O
amount	NN	O
of	IN	O
white	JJ	B-Disease
matter	NN	I-Disease
lesions	NNS	I-Disease
on	IN	O
MRI	NNP	O
.	.	O

Quantification	NN	O
of	IN	O
CTG	NNP	O
repeat	NN	O
size	NN	O
may	MD	O
allow	VB	O
an	DT	O
early	JJ	O
estimate	NN	O
on	IN	O
the	DT	O
probability	NN	O
of	IN	O
brain	NN	O
involvement	NN	O
in	IN	O
DM	NN	B-Disease
;	:	O
cognitive	JJ	B-Disease
dysfunction	NN	I-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
white	JJ	B-Disease
matter	NN	I-Disease
lesions	NNS	I-Disease
and	CC	O
cerebral	JJ	B-Disease
atrophy	NN	I-Disease
later	RB	O
on	IN	O
in	IN	O
the	DT	O
course	NN	O
.	.	O

.	.	O

A	DT	O
highly	RB	O
accurate	JJ	O
,	,	O
low	JJ	O
cost	NN	O
test	NN	O
for	IN	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

The	DT	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
widespread	JJ	O
use	NN	O
of	IN	O
BRCA1	NN	O
testing	NN	O
has	VBZ	O
been	VBN	O
limited	VBN	O
to	TO	O
date	NN	O
by	IN	O
three	CD	O
principal	JJ	O
concerns	NNS	O
the	DT	O
fear	NN	O
of	IN	O
loss	NN	O
of	IN	O
health	NN	O
and	CC	O
life	NN	O
insurance	NN	O
,	,	O
the	DT	O
uncertain	JJ	O
clinical	JJ	O
value	NN	O
of	IN	O
a	DT	O
positive	JJ	O
test	NN	O
result	NN	O
,	,	O
and	CC	O
the	DT	O
current	JJ	O
lack	NN	O
of	IN	O
an	DT	O
inexpensive	JJ	O
and	CC	O
sensitive	JJ	O
screening	JJ	O
test	NN	O
for	IN	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
have	VBP	O
developed	VBN	O
an	DT	O
inexpensive	JJ	O
system	NN	O
for	IN	O
gene	NN	O
mutational	JJ	O
scanning	NN	O
,	,	O
based	VBN	O
on	IN	O
a	DT	O
combination	NN	O
of	IN	O
extensive	JJ	O
multiplex	JJ	O
PCR	NN	O
amplification	NN	O
and	CC	O
two	CD	O
dimensional	JJ	O
electrophoresis	NN	O
.	.	O

The	DT	O
efficiency	NN	O
of	IN	O
this	DT	O
system	NN	O
,	,	O
as	IN	O
a	DT	O
screening	JJ	O
test	NN	O
for	IN	O
BRCA1	NN	O
mutations	NNS	O
,	,	O
was	VBD	O
evaluated	VBN	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
60	CD	O
samples	NNS	O
from	IN	O
high	JJ	O
risk	NN	O
women	NNS	O
,	,	O
14	CD	O
of	IN	O
which	WDT	O
contained	VBD	O
a	DT	O
previously	RB	O
identified	VBN	O
mutation	NN	O
in	IN	O
BRCA1	NN	O
.	.	O

All	DT	O
14	CD	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
an	DT	O
additional	JJ	O
five	CD	O
that	WDT	O
had	VBD	O
previously	RB	O
escaped	VBN	O
detection	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
the	DT	O
19	CD	O
mutations	NNS	O
,	,	O
a	DT	O
total	NN	O
of	IN	O
15	CD	O
different	JJ	O
polymorphic	JJ	O
variants	NNS	O
were	VBD	O
scored	VBN	O
,	,	O
most	JJS	O
of	IN	O
which	WDT	O
were	VBD	O
recurring	VBG	O
.	.	O

All	DT	O
were	VBD	O
confirmed	VBN	O
by	IN	O
nucleotide	NN	O
sequencing	NN	O
.	.	O

The	DT	O
cost	NN	O
of	IN	O
screening	VBG	O
per	IN	O
sample	NN	O
was	VBD	O
calculated	VBN	O
to	TO	O
be	VB	O
approximately	RB	O
US	NNP	O
$	$	O
70	CD	O
for	IN	O
the	DT	O
manual	JJ	O
technique	NN	O
used	VBN	O
in	IN	O
this	DT	O
study	NN	O
,	,	O
and	CC	O
may	MD	O
be	VB	O
reduced	VBN	O
to	TO	O
approximately	RB	O
US	NNP	O
$	$	O
10	CD	O
with	IN	O
the	DT	O
introduction	NN	O
of	IN	O
commercially	RB	O
available	JJ	O
PCR	NN	O
robotics	NNS	O
and	CC	O
fluorescent	JJ	O
imaging	NN	O
.	.	O

Implementation	NN	O
of	IN	O
this	DT	O
method	NN	O
of	IN	O
mutation	NN	O
screening	NN	O
in	IN	O
the	DT	O
research	NN	O
and	CC	O
clinical	JJ	O
setting	NN	O
should	MD	O
permit	VB	O
rapid	JJ	O
accrual	NN	O
of	IN	O
quantitative	JJ	O
data	NNS	O
on	IN	O
genotype-phenotype	JJ	O
associations	NNS	O
for	IN	O
the	DT	O
evaluation	NN	O
of	IN	O
diagnostic	JJ	O
testing	NN	O
.	.	O

.	.	O

Germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
Korean	JJ	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
patients	NNS	O
.	.	O

We	PRP	O
extensively	RB	O
analyzed	VBD	O
genomic	JJ	O
DNA	NN	O
and	CC	O
messenger	NN	O
RNA	NN	O
(	-LRB-	O
mRNA	NN	O
)	-RRB-	O
from	IN	O
62	CD	O
unrelated	JJ	O
Korean	JJ	O
patients	NNS	O
with	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
for	IN	O
identification	NN	O
of	IN	O
germline	NN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
adopted	VBD	O
both	CC	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
analysis	NN	O
and	CC	O
a	DT	O
method	NN	O
of	IN	O
analysis	NN	O
involving	VBG	O
the	DT	O
reverse	JJ	O
transcription-polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
RT-PCR	NN	O
)	-RRB-	O
followed	VBN	O
by	IN	O
a	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
(	-LRB-	O
PTT	NN	O
)	-RRB-	O
.	.	O

DNA	NN	O
sequencing	NN	O
confirmed	VBD	O
all	DT	O
alterations	NNS	O
represented	VBN	O
by	IN	O
aberrant	JJ	O
bands	NNS	O
.	.	O

Germline	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
38	CD	O
patients	NNS	O
(	-LRB-	O
61	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Nineteen	CD	O
of	IN	O
the	DT	O
detected	VBN	O
mutations	NNS	O
were	VBD	O
presumed	VBN	O
to	TO	O
be	VB	O
novel	JJ	O
,	,	O
thus	RB	O
emphasizing	VBG	O
the	DT	O
heterogeneity	NN	O
of	IN	O
the	DT	O
mutational	JJ	O
spectrum	NN	O
in	IN	O
Korean	JJ	O
FAP	NN	B-Disease
patients	NNS	O
.	.	O

In	IN	O
the	DT	O
initial	JJ	O
48	CD	O
patients	NNS	O
,	,	O
SSCP	NN	O
analysis	NN	O
was	VBD	O
followed	VBN	O
by	IN	O
PTT	NNP	O
for	IN	O
those	DT	O
patients	NNS	O
for	IN	O
whom	WP	O
no	DT	O
detectable	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
by	IN	O
SSCP	NN	O
.	.	O

Using	VBG	O
this	DT	O
combined	JJ	O
approach	NN	O
,	,	O
we	PRP	O
identified	VBD	O
germline	NN	O
APC	NN	B-Disease
gene	NN	O
mutations	NNS	O
in	IN	O
29	CD	O
of	IN	O
the	DT	O
48	CD	O
FAP	NN	B-Disease
patients	NNS	O
(	-LRB-	O
60	CD	O
%	NN	O
)	-RRB-	O
,	,	O
including	VBG	O
6	CD	O
patients	NNS	O
in	IN	O
whom	WP	O
SSCP	NN	O
analysis	NN	O
failed	VBD	O
to	TO	O
distinguish	VB	O
the	DT	O
mutant	JJ	O
allele	NN	O
.	.	O

In	IN	O
the	DT	O
14	CD	O
later	JJ	O
patients	NNS	O
,	,	O
we	PRP	O
identified	VBD	O
truncating	JJ	O
mutations	NNS	O
in	IN	O
9	CD	O
patients	NNS	O
(	-LRB-	O
64	CD	O
%	NN	O
)	-RRB-	O
using	VBG	O
PTT	NNP	O
only	RB	O
.	.	O

Our	PRP$	O
results	NNS	O
confirm	VBP	O
that	IN	O
the	DT	O
mutation	NN	O
detection	NN	O
rate	NN	O
with	IN	O
PTT	NNP	O
was	VBD	O
superior	JJ	O
to	TO	O
that	DT	O
with	IN	O
SSCP	NN	O
,	,	O
and	CC	O
suggest	VBP	O
that	IN	O
PTT	NNP	O
would	MD	O
be	VB	O
a	DT	O
more	RBR	O
practical	JJ	O
screening	NN	O
method	NN	O
to	TO	O
detect	VB	O
germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
.	.	O

Homozygosity	NN	O
mapping	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
microcephaly	NN	B-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
short	JJ	B-Disease
stature	NN	I-Disease
to	TO	O
a	DT	O
Cohen	NNP	B-Disease
syndrome	NN	I-Disease
region	NN	O
on	IN	O
8q21.3-8q22	JJ	O
.1	NN	O
:	:	O
redefining	VBG	O
a	DT	O
clinical	JJ	O
entity	NN	O
.	.	O

A	DT	O
syndrome	NN	O
of	IN	O
microcephaly	NN	B-Disease
,	,	O
progressive	JJ	O
postnatal	JJ	B-Disease
growth	NN	I-Disease
deficiency	NN	I-Disease
,	,	O
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
was	VBD	O
observed	VBN	O
in	IN	O
two	CD	O
brothers	NNS	O
and	CC	O
their	PRP$	O
cousin	NN	O
from	IN	O
a	DT	O
multiply	VBP	O
consanguineous	JJ	O
kindred	NN	O
of	IN	O
Lebanese	JJ	O
descent	NN	O
.	.	O

Hypotonia	NNP	B-Disease
,	,	O
chorioretinal	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
and	CC	O
myopia	NN	B-Disease
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
condition	NN	O
varied	VBD	O
among	IN	O
the	DT	O
closely	RB	O
related	JJ	O
patients	NNS	O
.	.	O

Because	IN	O
of	IN	O
absence	NN	O
of	IN	O
a	DT	O
distinctive	JJ	O
facial	JJ	O
appearance	NN	O
,	,	O
the	DT	O
degree	NN	O
of	IN	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
short	JJ	B-Disease
stature	NN	I-Disease
,	,	O
the	DT	O
initially	RB	O
considered	VBN	O
clinical	JJ	O
diagnosis	NN	O
of	IN	O
Cohen	NNP	B-Disease
syndrome	NN	I-Disease
was	VBD	O
withdrawn	VBN	O
and	CC	O
a	DT	O
novel	JJ	O
genetic	JJ	O
entity	NN	O
was	VBD	O
assumed	VBN	O
.	.	O

Homozygosity	NN	O
mapping	NN	O
in	IN	O
this	DT	O
family	NN	O
assigned	VBN	O
the	DT	O
gene	NN	O
to	TO	O
a	DT	O
26	CD	O
.	.	O

8-cM	NN	O
region	NN	O
on	IN	O
the	DT	O
chromosome	NN	O
band	NN	O
8q21	NN	O
.	.	O

3	CD	O
-22	CD	O
.	.	O

1	CD	O
,	,	O
between	IN	O
the	DT	O
microsatellites	NNS	O
at	IN	O
D8S270	NN	O
and	CC	O
D8S514	NN	O
.	.	O

The	DT	O
maximum	NN	O
two-point	JJ	O
LOD	NN	O
score	NN	O
was	VBD	O
found	VBN	O
for	IN	O
marker	NN	O
at	IN	O
D8S267	NN	O
(	-LRB-	O
Zmax	NN	O
=	JJ	O
3	CD	O
.	.	O

.	.	O

237	CD	O
at	IN	O
Omax	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
)	-RRB-	O
.	.	O

Intriguingly	RB	O
enough	RB	O
,	,	O
the	DT	O
identified	VBN	O
gene	NN	O
region	NN	O
overlaps	VBZ	O
the	DT	O
refined	JJ	O
gene	NN	O
region	NN	O
for	IN	O
Cohen	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
COH1	NN	O
)	-RRB-	O
[	-LRB-	O
Kolehmainen	NNP	O
et	FW	O
al.	FW	O
,	,	O
1997	CD	O
Euro	NNP	O
J	NNP	O
Hum	NNP	O
Genet	NNP	O
5	CD	O
206-213	CD	O
]	-RRB-	O
.	.	O

This	DT	O
fact	NN	O
encourages	VBZ	O
the	DT	O
hypothesis	NN	O
that	IN	O
the	DT	O
described	VBN	O
kindred	NN	O
segregates	VBZ	O
for	IN	O
a	DT	O
variant	NN	O
of	IN	O
Cohen	NNP	B-Disease
syndrome	NN	I-Disease
and	CC	O
suggests	VBZ	O
a	DT	O
redefinition	NN	O
of	IN	O
its	PRP$	O
phenotype	NN	O

Spontaneous	JJ	O
reversion	NN	O
of	IN	O
novel	JJ	O
Lesch-Nyhan	JJ	B-Disease
mutation	NN	O
by	IN	O
HPRT	NN	O
gene	NN	O
rearrangement	NN	O
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
an	DT	O
unusual	JJ	O
patient	NN	O
with	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
has	VBZ	O
suggested	VBN	O
that	IN	O
the	DT	O
mutation	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
partial	JJ	O
HPRT	NN	O
gene	NN	O
duplication	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
the	DT	O
cloning	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
HPRT	NN	O
cDNA	NN	O
which	WDT	O
shows	VBZ	O
the	DT	O
precise	JJ	O
duplication	NN	O
of	IN	O
exons	NNS	O
2	CD	O
and	CC	O
3	CD	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
an	DT	O
internal	JJ	O
duplication	NN	O
of	IN	O
16-20	CD	O
kilobases	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
structure	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
duplication	NN	O
was	VBD	O
not	RB	O
generated	VBN	O
by	IN	O
a	DT	O
single	JJ	O
unequal	JJ	O
crossing-over	NN	O
event	NN	O
between	IN	O
two	CD	O
normal	JJ	O
HPRT	NN	O
alleles	NNS	O
.	.	O

Growth	NN	O
of	IN	O
Epstein-Barr	JJ	B-Disease
virus-transformed	JJ	O
lymphoblasts	NNS	O
from	IN	O
this	DT	O
patient	NN	O
in	IN	O
selective	JJ	O
medium	NN	O
has	VBZ	O
permitted	VBN	O
isolation	NN	O
of	IN	O
spontaneous	JJ	O
HPRT	NN	O
+	CC	O
revertants	NNS	O
of	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
reversion	NN	O
event	NN	O
involves	VBZ	O
a	DT	O
second	JJ	O
major	JJ	O
HPRT	NN	O
gene	NN	O
rearrangement	NN	O
where	WRB	O
most	RBS	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
duplicated	JJ	O
portion	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
gene	NN	O
is	VBZ	O
deleted	VBN	O
.	.	O

The	DT	O
original	JJ	O
mutation	NN	O
therefore	RB	O
has	VBZ	O
the	DT	O
potential	NN	O
for	IN	O
spontaneous	JJ	O
somatic	JJ	O
reversion	NN	O
.	.	O

This	DT	O
may	MD	O
explain	VB	O
the	DT	O
relatively	RB	O
mild	JJ	O
symptoms	NNS	O
of	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
exhibited	VBD	O
by	IN	O
this	DT	O
patient	NN	O
.	.	O

.	.	O

Nephropathy	NN	B-Disease
in	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Nephropathy	NN	B-Disease
was	VBD	O
detected	VBN	O
in	IN	O
five	CD	O
of	IN	O
32	CD	O
patients	NNS	O
with	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
who	WP	O
were	VBD	O
participating	VBG	O
in	IN	O
a	DT	O
study	NN	O
of	IN	O
transfer	NN	O
factor	NN	O
(	-LRB-	O
TF	NN	O
)	-RRB-	O
therapy	NN	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
,	,	O
nephropathy	NN	B-Disease
was	VBD	O
present	JJ	O
before	IN	O
TF	NN	O
and	CC	O
did	VBD	O
not	RB	O
appear	VB	O
changed	VBN	O
by	IN	O
TF	NN	O
therapy	NN	O
.	.	O

One	CD	O
of	IN	O
these	DT	O
patients	NNS	O
subsequently	RB	O
developed	VBD	O
progressive	JJ	O
renal	JJ	B-Disease
failure	NN	I-Disease
requiring	VBG	O
dialysis	NN	O
beginning	NN	O
51/2	CD	O
years	NNS	O
after	IN	O
TF	NN	O
therapy	NN	O
.	.	O

In	IN	O
two	CD	O
patients	NNS	O
,	,	O
decreased	VBD	O
renal	JJ	O
function	NN	O
appeared	VBD	O
very	RB	O
soon	RB	O
after	IN	O
the	DT	O
administration	NN	O
of	IN	O
TF	NN	O
.	.	O

One	CD	O
patient	NN	O
showed	VBD	O
gradually	RB	O
decreasing	VBG	O
renal	JJ	O
function	NN	O
beginning	VBG	O
after	IN	O
two	CD	O
years	NNS	O
of	IN	O
TF	NN	O
therapy	NN	O
.	.	O

An	DT	O
additional	JJ	O
patient	NN	O
was	VBD	O
identified	VBN	O
who	WP	O
died	VBD	O
with	IN	O
renal	JJ	B-Disease
failure	NN	I-Disease
without	IN	O
having	VBG	O
received	VBN	O
TF	NN	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
renal	JJ	B-Disease
failure	NN	I-Disease
occurs	VBZ	O
in	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
more	RBR	O
frequently	RB	O
than	IN	O
generally	RB	O
recognized	VBN	O
and	CC	O
that	IN	O
administration	NN	O
of	IN	O
TF	NN	O
may	MD	O
precipitate	VB	O
or	CC	O
accelerate	VB	O
the	DT	O
renal	JJ	B-Disease
disease	NN	I-Disease
in	IN	O
patients	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O

.	.	O

Aniridia-associated	JJ	O
cytogenetic	JJ	O
rearrangements	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
position	NN	O
effect	NN	O
may	MD	O
cause	VB	O
the	DT	O
mutant	JJ	O
phenotype	NN	O
.	.	O

Current	JJ	O
evidence	NN	O
suggests	VBZ	O
that	IN	O
aniridia	NN	B-Disease
(	-LRB-	O
absence	NN	B-Disease
of	IN	I-Disease
iris	NN	I-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
11p13	NN	O
.	.	O

We	PRP	O
present	VBP	O
the	DT	O
further	JJ	O
characterisation	NN	O
of	IN	O
two	CD	O
aniridia	NN	B-Disease
pedigrees	NNS	O
in	IN	O
which	WDT	O
the	DT	O
disease	NN	O
segregates	VBZ	O
with	IN	O
chromosomal	JJ	O
rearrangements	NNS	O
which	WDT	O
involve	VBP	O
11p13	NN	O
but	CC	O
do	VBP	O
not	RB	O
disrupt	VB	O
the	DT	O
PAX6	NN	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
three	CD	O
human	JJ	O
YAC	NN	O
clones	NNS	O
which	WDT	O
encompass	VBP	O
the	DT	O
PAX6	NN	O
locus	NN	O
and	CC	O
we	PRP	O
have	VBP	O
used	VBN	O
these	DT	O
to	TO	O
show	VB	O
that	IN	O
in	IN	O
both	DT	O
cases	NNS	O
the	DT	O
chromosomal	JJ	O
breakpoint	NN	O
is	VBZ	O
at	IN	O
least	JJS	O
85	CD	O
kb	NN	O
distal	JJ	O
of	IN	O
the	DT	O
3	CD	O
end	NN	O
of	IN	O
PAX6	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
of	IN	O
PAX6	NN	O
is	VBZ	O
apparently	RB	O
free	JJ	O
of	IN	O
mutations	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
on	IN	O
the	DT	O
rearranged	VBN	O
chromosome	NN	O
11	CD	O
is	VBZ	O
in	IN	O
an	DT	O
inappropriate	JJ	O
chromatin	NN	O
environment	NN	O
for	IN	O
normal	JJ	O
expression	NN	O
and	CC	O
therefore	RB	O
that	IN	O
a	DT	O
position	NN	O
effect	NN	O
is	VBZ	O
the	DT	O
underlying	VBG	O
mechanism	NN	O
of	IN	O
disease	NN	O
in	IN	O
these	DT	O
families	NNS	O
.	.	O

.	.	O

Genetic	JJ	O
cholesteryl	NN	B-Disease
ester	NN	I-Disease
transfer	NN	I-Disease
protein	NN	I-Disease
deficiency	NN	I-Disease
caused	VBN	O
by	IN	O
two	CD	O
prevalent	JJ	O
mutations	NNS	O
as	IN	O
a	DT	O
major	JJ	O
determinant	NN	O
of	IN	O
increased	VBN	O
levels	NNS	O
of	IN	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
cholesterol	NN	O
.	.	O

Genetic	JJ	O
determinants	NNS	O
of	IN	O
HDL	NN	O
cholesterol	NN	O
(	-LRB-	O
HDL-C	NN	O
)	-RRB-	O
levels	NNS	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
are	VBP	O
poorly	RB	O
understood	VBN	O
.	.	O

We	PRP	O
previously	RB	O
described	VBD	O
plasma	NN	O
cholesteryl	NN	B-Disease
ester	NN	I-Disease
transfer	NN	I-Disease
protein	NN	I-Disease
(	-LRB-	I-Disease
CETP	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
due	JJ	O
to	TO	O
an	DT	O
intron	NN	O
14	CD	O
G	NN	O
(	-LRB-	O
+	CC	O
1	LS	O
)	-RRB-	O
-	:	O
to-A	NN	O
mutation	NN	O
(	-LRB-	O
Int14	NN	O
A	NN	O
)	-RRB-	O
in	IN	O
several	JJ	O
families	NNS	O
with	IN	O
very	RB	O
high	JJ	O
HDL-C	NN	O
levels	NNS	O
in	IN	O
Japan	NNP	O
.	.	O

Subjects	NNS	O
with	IN	O
HDL-C	NN	O
>	JJR	O
or	CC	O
=	JJ	O
100	CD	O
mg/dl	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
130	CD	O
)	-RRB-	O
were	VBD	O
screened	VBN	O
by	IN	O
PCR	NN	O
single	JJ	O
strand	NN	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
of	IN	O
the	DT	O
CETP	NN	O
gene	NN	O
.	.	O

Two	CD	O
other	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
by	IN	O
DNA	NN	O
sequencing	NN	O
or	CC	O
primer-mediated	JJ	O
restriction	NN	O
map	NN	O
modification	NN	O
of	IN	O
PCR	NN	O
products	NNS	O
a	DT	O
novel	JJ	O
intron	NN	O
14	CD	O
splice	NN	O
donor	NN	O
site	NN	O
mutation	NN	O
caused	VBN	O
by	IN	O
a	DT	O
T	NN	O
insertion	NN	O
at	IN	O
position	NN	O
+	CC	O
3	CD	O
from	IN	O
the	DT	O
exon14/intron14	NN	O
boundary	NN	O
(	-LRB-	O
Int14	NN	O
T	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
Asp442	NN	O
to	TO	O
Gly	NN	O
)	-RRB-	O
within	IN	O
exon	NN	O
15	CD	O
(	-LRB-	O
D442G	NN	O
)	-RRB-	O
.	.	O

The	DT	O
Int14	NN	O
T	NN	O
mutation	NN	O
was	VBD	O
only	RB	O
found	VBN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
D442G	NN	O
and	CC	O
Int14	NN	O
A	NN	O
mutations	NNS	O
were	VBD	O
highly	RB	O
prevalent	JJ	O
in	IN	O
subjects	NNS	O
with	IN	O
HDL-C	NN	O
>	JJR	O
or	CC	O
=	JJ	O
60	CD	O
mg/dl	NN	O
,	,	O
with	IN	O
combined	JJ	O
allele	NN	O
frequencies	NNS	O
of	IN	O
9	CD	O
%	NN	O
,	,	O
12	CD	O
%	NN	O
,	,	O
21	CD	O
%	NN	O
and	CC	O
43	CD	O
%	NN	O
for	IN	O
HDL-C	NN	O
60-79	CD	O
,	,	O
80-99	CD	O
,	,	O
100-119	CD	O
,	,	O
and	CC	O
>	JJR	O
or	CC	O
=	JJ	O
120	CD	O
mg/dl	NN	O
,	,	O
respectively	RB	O
.	.	O

Furthermore	RB	O
,	,	O
prevalences	NNS	O
of	IN	O
the	DT	O
D442G	NN	O
and	CC	O
Int14	NN	O
A	NN	O
mutations	NNS	O
were	VBD	O
extremely	RB	O
high	JJ	O
in	IN	O
a	DT	O
general	JJ	O
sample	NN	O
of	IN	O
Japanese	JJ	O
men	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
236	CD	O
)	-RRB-	O
,	,	O
with	IN	O
heterozygote	NN	O
frequencies	NNS	O
of	IN	O
7	CD	O
%	NN	O
and	CC	O
2	CD	O
%	NN	O
,	,	O
respectively	RB	O
.	.	O

These	DT	O
two	CD	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
about	RB	O
10	CD	O
%	NN	O
of	IN	O
the	DT	O
total	JJ	O
variance	NN	O
of	IN	O
HDL-C	NN	O
in	IN	O
this	DT	O
population	NN	O
.	.	O

The	DT	O
phenotype	NN	O
in	IN	O
a	DT	O
genetic	JJ	O
compound	NN	O
heterozygote	NN	O
(	-LRB-	O
Int14	NN	O
T	NN	O
and	CC	O
Int14	NN	O
A	NN	O
)	-RRB-	O
was	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
Int14	NN	O
A	NN	O
homozygotes	NNS	O
(	-LRB-	O
no	DT	O
detectable	JJ	O
CETP	NN	O
and	CC	O
markedly	RB	O
increased	VBD	O
HDL-C	NN	O
)	-RRB-	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
Int14	NN	O
T	NN	O
produces	VBZ	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

In	IN	O
four	CD	O
D442G	NN	O
homozygotes	NNS	O
,	,	O
mean	VB	O
HDL-C	NN	O
levels	NNS	O
(	-LRB-	O
86	CD	O
+	CC	O
/	:	O
-	:	O
26	CD	O
mg/dl	NN	O
)	-RRB-	O
were	VBD	O
lower	JJR	O
than	IN	O
in	IN	O
Int14	NN	O
A	NN	O
homozygotes	NNS	O
(	-LRB-	O
158	CD	O
+	CC	O
/	:	O
-	:	O
35	CD	O
mg/dl	NN	O
)	-RRB-	O
,	,	O
reflecting	VBG	O
residual	JJ	O
CETP	NN	O
activity	NN	O
in	IN	O
plasma	NN	O
.	.	O

In	IN	O
47	CD	O
D442G	NN	O
heterozygotes	NNS	O
,	,	O
mean	VB	O
HDL-C	NN	O
levels	NNS	O
were	VBD	O
91	CD	O
+	CC	O
/	:	O
-	:	O
23	CD	O
mg/dl	NN	O
,	,	O
similar	JJ	O
to	TO	O
the	DT	O
level	NN	O
in	IN	O
D442G	NN	O
homozygotes	NNS	O
,	,	O
and	CC	O
significantly	RB	O
greater	JJR	O
than	IN	O
mean	VB	O
HDL-C	NN	O
levels	NNS	O
in	IN	O
Int14	NN	O
A	NN	O
heterozygotes	NNS	O
(	-LRB-	O
69	CD	O
+	CC	O
/	:	O
-	:	O
15	CD	O
mg/dl	NN	O
)	-RRB-	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
D442G	NN	O
mutation	NN	O
acts	VBZ	O
differently	RB	O
to	TO	O
the	DT	O
null	JJ	O
mutations	NNS	O
with	IN	O
weaker	JJR	O
effects	NNS	O
on	IN	O
HDL	NN	O
in	IN	O
the	DT	O
homozygous	JJ	O
state	NN	O
and	CC	O
stronger	JJR	O
effects	NNS	O
in	IN	O
the	DT	O
heterozygotes	NNS	O
,	,	O
suggesting	VBG	O
dominant	JJ	O
expression	NN	O
of	IN	O
a	DT	O
partially	RB	O
defective	JJ	O
allele	NN	O
.	.	O

CETP	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
reflecting	VBG	O
two	CD	O
prevalent	JJ	O
mutations	NNS	O
(	-LRB-	O
D442G	NN	O
and	CC	O
Int14	NN	O
A	NN	O
)	-RRB-	O
,	,	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
genetic	JJ	B-Disease
deficiency	NN	I-Disease
state	NN	O
which	WDT	O
is	VBZ	O
sufficiently	RB	O
common	JJ	O
to	TO	O
explain	VB	O
a	DT	O
significant	JJ	O
fraction	NN	O
of	IN	O
the	DT	O
variation	NN	O
in	IN	O
HDL-C	NN	O
in	IN	O
the	DT	O
general	JJ	O
population	NN	O
.	.	O

.	.	O

X-linked	JJ	B-Disease
glucose-6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
Mus	NN	O
musculus	NN	O
.	.	O

A	DT	O
mouse	NN	O
with	IN	O
X-linked	JJ	B-Disease
glucose-6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
has	VBZ	O
been	VBN	O
recovered	VBN	O
in	IN	O
offspring	NN	O
of	IN	O
1-ethyl-1-nitrosourea-treated	JJ	O
male	JJ	O
mice	NNS	O
.	.	O

The	DT	O
activity	NN	O
alteration	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
blood	NN	O
but	CC	O
can	MD	O
also	RB	O
be	VB	O
observed	VBN	O
in	IN	O
other	JJ	O
tissue	NN	O
extracts	NNS	O
.	.	O

Hemizygous	JJ	O
,	,	O
heterozygous	JJ	O
,	,	O
and	CC	O
homozygous	JJ	O
mutants	NNS	O
have	VBP	O
,	,	O
respectively	RB	O
,	,	O
about	IN	O
15	CD	O
,	,	O
60	CD	O
,	,	O
and	CC	O
15	CD	O
%	NN	O
G6PD	NN	O
remaining	VBG	O
activity	NN	O
in	IN	O
the	DT	O
blood	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
wild	JJ	O
type	NN	O
.	.	O

Erythrocyte	NN	O
indices	NNS	O
did	VBD	O
not	RB	O
show	VB	O
differences	NNS	O
between	IN	O
mutants	NNS	O
and	CC	O
wild	JJ	O
types	NNS	O
.	.	O

The	DT	O
mutation	NN	O
does	VBZ	O
not	RB	O
affect	VB	O
the	DT	O
electrophoretic	JJ	O
migration	NN	O
,	,	O
the	DT	O
isoelectric	JJ	O
point	NN	O
,	,	O
or	CC	O
the	DT	O
thermal	JJ	O
stability	NN	O
.	.	O

Kinetic	JJ	O
properties	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
Km	NN	O
for	IN	O
glucose-6-phosphate	NN	O
or	CC	O
for	IN	O
NADP	NNP	O
and	CC	O
the	DT	O
relative	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
,	,	O
showed	VBD	O
no	DT	O
differences	NNS	O
between	IN	O
wild	JJ	O
types	NNS	O
and	CC	O
mutants	NNS	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
the	DT	O
relative	JJ	O
utilization	NN	O
of	IN	O
deamino-NADP	NN	O
which	WDT	O
was	VBD	O
significantly	RB	O
lower	JJR	O
in	IN	O
mutants	NNS	O
.	.	O

This	DT	O
is	VBZ	O
presently	RB	O
the	DT	O
only	JJ	O
animal	NN	O
model	NN	O
for	IN	O
X-linked	JJ	B-Disease
G6PD	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
humans	NNS	O
.	.	O

.	.	O

Human	JJ	O
glycine	NN	O
decarboxylase	NN	O
gene	NN	O
(	-LRB-	O
GLDC	NN	O
)	-RRB-	O
and	CC	O
its	PRP$	O
highly	RB	O
conserved	VBN	O
processed	VBN	O
pseudogene	NN	O
(	-LRB-	O
psiGLDC	NN	O
)	-RRB-	O
:	:	O
their	PRP$	O
structure	NN	O
and	CC	O
expression	NN	O
,	,	O
and	CC	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
large	JJ	O
deletion	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
nonketotic	JJ	B-Disease
hyperglycinemia	NN	I-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
glycine	NN	O
decarboxylase	NN	O
gene	NN	O
(	-LRB-	O
GLDC	NN	O
)	-RRB-	O
cause	VBP	O
nonketotic	JJ	B-Disease
hyperglycinemia	NN	I-Disease
(	-LRB-	O
NKH	NN	B-Disease
)	-RRB-	O
,	,	O
an	DT	O
in-born	JJ	B-Disease
error	NN	I-Disease
of	IN	I-Disease
metabolism	NN	I-Disease
characterized	VBN	O
by	IN	O
severe	JJ	O
neurological	JJ	B-Disease
disturbance	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
structure	NN	O
of	IN	O
GLDC	NN	O
and	CC	O
of	IN	O
its	PRP$	O
pseudogene	NN	O
(	-LRB-	O
psiGLDC	NN	O
)	-RRB-	O
and	CC	O
studied	VBN	O
their	PRP$	O
expression	NN	O
for	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
NKH	NN	B-Disease
.	.	O

The	DT	O
GLDC	NN	O
gene	NN	O
spans	VBZ	O
at	IN	O
least	JJS	O
135	CD	O
kb	NN	O
and	CC	O
consists	VBZ	O
of	IN	O
25	CD	O
exons	NNS	O
.	.	O

All	DT	O
donor	NN	O
and	CC	O
acceptor	NN	O
sites	NNS	O
adhere	VBP	O
to	TO	O
the	DT	O
canonical	JJ	O
GT-AG	NN	O
rule	NN	O
,	,	O
except	IN	O
for	IN	O
the	DT	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
21	CD	O
,	,	O
where	WRB	O
a	DT	O
variant	JJ	O
form	NN	O
GC	NN	O
is	VBZ	O
used	VBN	O
instead	RB	O
of	IN	O
GT	NN	O
.	.	O

The	DT	O
transcription	NN	O
initiation	NN	O
site	NN	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
a	DT	O
residue	NN	O
163	CD	O
bp	NN	O
upstream	RB	O
from	IN	O
the	DT	O
translation	NN	O
initiation	NN	O
triplet	NN	O
by	IN	O
primer	NN	O
extension	NN	O
analysis	NN	O
.	.	O

The	DT	O
psiGLDC	NN	O
gene	NN	O
has	VBZ	O
no	DT	O
intron	NN	O
and	CC	O
shares	NNS	O
97	CD	O
.	.	O

5	CD	O
%	NN	O
homology	NN	O
with	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
functional	JJ	O
GLDC	NNP	O
,	,	O
suggesting	VBG	O
that	IN	O
psiGLDC	NN	O
is	VBZ	O
a	DT	O
processed	VBN	O
pseudogene	NN	O
that	WDT	O
arose	VBD	O
from	IN	O
the	DT	O
GLDC	NN	O
transcript	NN	O
about	IN	O
4-8	CD	O
million	CD	O
years	NNS	O
ago	RB	O
.	.	O

RNA	NN	O
blotting	NN	O
analysis	NN	O
has	VBZ	O
revealed	VBN	O
that	IN	O
GLDC	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
human	JJ	O
liver	NN	O
,	,	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
and	CC	O
placenta	NN	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
examined	VBN	O
a	DT	O
patient	NN	O
with	IN	O
NKH	NN	B-Disease
with	IN	O
no	DT	O
detectable	JJ	O
GLDC	NN	O
mRNA	NN	O
in	IN	O
his	PRP$	O
lymphoblasts	NNS	O
.	.	O

Exons	NNS	O
1-3	CD	O
of	IN	O
the	DT	O
functional	JJ	O
GLDC	NN	O
gene	NN	O
from	IN	O
this	DT	O
patient	NN	O
are	VBP	O
not	RB	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
,	,	O
whereas	IN	O
those	DT	O
from	IN	O
control	JJ	O
subjects	NNS	O
are	VBP	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
large	JJ	O
homozygous	JJ	O
deletion	NN	O
(	-LRB-	O
at	IN	O
least	JJS	O
30	CD	O
kb	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
have	VBP	O
devised	VBN	O
a	DT	O
semi-quantitative	JJ	O
PCR	NN	O
to	TO	O
estimate	VB	O
the	DT	O
number	NN	O
of	IN	O
GLDC	NN	O
alleles	NNS	O
by	IN	O
using	VBG	O
psiGLDC	NN	O
as	IN	O
an	DT	O
internal	JJ	O
control	NN	O
and	CC	O
have	VBP	O
confirmed	VBN	O
the	DT	O
homozygosity	NN	O
and	CC	O
heterozygosity	NN	O
of	IN	O
the	DT	O
deletion	NN	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
parents	NNS	O
,	,	O
respectively	RB	O
.	.	O

Structural	JJ	O
information	NN	O
of	IN	O
GLDC	NN	O
and	CC	O
psiGLDC	NN	O
should	MD	O
facilitate	VB	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
NKH	NN	B-Disease
.	.	O

Growth	NN	B-Disease
retardation	NN	I-Disease
and	CC	O
tumour	NN	B-Disease
inhibition	NN	O
by	IN	O
BRCA1	NN	O
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
predispose	VBP	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
but	CC	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
sporadic	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
has	VBZ	O
previously	RB	O
been	VBN	O
elusive	JJ	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
retroviral	JJ	O
transfer	NN	O
of	IN	O
the	DT	O
wild-type	JJ	O
BRCA1	NN	O
gene	NN	O
inhibits	VBZ	O
growth	NN	O
in	FW	O
vitro	FW	O
of	IN	O
all	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
cell	NN	O
lines	NNS	O
tested	VBN	O
,	,	O
but	CC	O
not	RB	O
colon	NN	B-Disease
or	CC	I-Disease
lung	NN	I-Disease
cancer	NN	I-Disease
cells	NNS	O
or	CC	O
fibroblasts	NNS	O
.	.	O

Mutant	JJ	O
BRCA1	NN	O
has	VBZ	O
no	DT	O
effect	NN	O
on	IN	O
growth	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
cells	NNS	O
;	:	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
cell	NN	O
growth	NN	O
is	VBZ	O
not	RB	O
affected	VBN	O
by	IN	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
5	CD	O
portion	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
but	CC	O
is	VBZ	O
inhibited	VBN	O
by	IN	O
3	CD	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

Development	NN	O
of	IN	O
MCF-7	NN	B-Disease
tumours	NNS	I-Disease
in	IN	O
nude	JJ	O
mice	NNS	O
is	VBZ	O
inhibited	VBN	O
when	WRB	O
MCF-7	NN	O
cells	NNS	O
are	VBP	O
transfected	VBN	O
with	IN	O
wild-type	JJ	O
,	,	O
but	CC	O
not	RB	O
mutant	JJ	O
,	,	O
BRCA1	NN	O
.	.	O

Most	RBS	O
importantly	RB	O
,	,	O
among	IN	O
mice	NNS	O
with	IN	O
established	JJ	O
MCF-7	NN	B-Disease
tumours	NNS	I-Disease
,	,	O
peritoneal	JJ	O
treatment	NN	O
with	IN	O
a	DT	O
retroviral	JJ	O
vector	NN	O
expressing	VBG	O
wild-type	JJ	O
BRCA1	NN	O
significantly	RB	O
inhibits	VBZ	O
tumour	NN	B-Disease
growth	NN	O
and	CC	O
increased	VBD	O
survival	NN	O
.	.	O

.	.	O

Striking	VBG	O
prevalence	NN	O
of	IN	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
in	IN	O
"	``	O
healthy	JJ	O
"	''	O
w27	NN	O
positive	JJ	O
males	NNS	O
and	CC	O
females	NNS	O
.	.	O

Ankylosing	VBG	B-Disease
spondylitis	NN	I-Disease
is	VBZ	O
diagnosed	VBN	O
once	RB	O
or	CC	O
twice	RB	O
in	IN	O
each	DT	O
1000	CD	O
males	NNS	O
and	CC	O
one	CD	O
tenth	NN	O
as	IN	O
frequently	RB	O
in	IN	O
females	NNS	O
,	,	O
but	CC	O
the	DT	O
true	JJ	O
prevalence	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Indentification	NN	O
of	IN	O
genetic	JJ	O
marker	NN	O
,	,	O
HL-A	NN	O
W27	NN	O
,	,	O
for	IN	O
susceptible	JJ	O
persons	NNS	O
has	VBZ	O
provided	VBN	O
a	DT	O
tool	NN	O
facilitating	VBG	O
epidemiologic	JJ	O
studies	NNS	O
and	CC	O
allowing	VBG	O
identification	NN	O
of	IN	O
"	''	O
control	NN	O
"	''	O
populations	NNS	O
without	IN	O
the	DT	O
marker	NN	O
.	.	O

Evaluation	NN	O
by	IN	O
postal	JJ	O
questionnaires	NNS	O
,	,	O
and	CC	O
pelvic	JJ	O
radiography	NN	O
of	IN	O
78	CD	O
HL-A	NN	O
27W-positive	JJ	O
blood	NN	O
donors	NNS	O
selected	VBN	O
from	IN	O
a	DT	O
group	NN	O
of	IN	O
apparently	RB	O
healthy	JJ	O
subjects	NNS	O
revealed	VBD	O
14	CD	O
who	WP	O
satisfied	VBD	O
the	DT	O
criteria	NNS	O
for	IN	O
definite	JJ	O
ankylosing	NN	B-Disease
spondylitis	NNS	I-Disease
.	.	O

The	DT	O
prevalence	NN	O
was	VBD	O
similar	JJ	O
in	IN	O
both	CC	O
sexes	NNS	O
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
twenty-six	CD	O
W27-negative	JJ	O
controls	NNS	O
matched	VBN	O
for	IN	O
race	NN	O
,	,	O
sex	NN	O
,	,	O
and	CC	O
age	NN	O
failed	VBD	O
to	TO	O
yield	VB	O
a	DT	O
single	JJ	O
case	NN	O
.	.	O

For	IN	O
a	DT	O
person	NN	O
of	IN	O
either	CC	O
sex	NN	O
with	IN	O
HL-A	NN	O
W27	NN	O
,	,	O
there	EX	O
appears	VBZ	O
to	TO	O
be	VB	O
about	IN	O
a	DT	O
20	CD	O
per	IN	O
cent	NN	O
chance	NN	O
that	WDT	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
will	MD	O
develop	VB	O
,	,	O
suggesting	VBG	O
a	DT	O
prevalence	NN	O
of	IN	O
10	CD	O
to	TO	O
15	CD	O
per	IN	O
thousand	CD	O
.	.	O

Hitherto	NNP	O
accepted	VBD	O
figures	NNS	O
may	MD	O
underestimate	VB	O
the	DT	O
frequency	NN	O
by	IN	O
a	DT	O
factor	NN	O
of	IN	O
10	CD	O
to	TO	O
20	CD	O
.	.	O

.	.	O

Rapid	JJ	O
detection	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
by	IN	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
.	.	O

More	JJR	O
than	IN	O
75	CD	O
%	NN	O
of	IN	O
the	DT	O
reported	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
gene	NN	O
,	,	O
BRCA1	NN	O
,	,	O
result	VBP	O
in	IN	O
truncated	VBN	O
proteins	NNS	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
the	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
(	-LRB-	O
PTT	NN	O
)	-RRB-	O
to	TO	O
screen	VB	O
for	IN	O
mutations	NNS	O
in	IN	O
exon	NN	O
11	CD	O
,	,	O
which	WDT	O
encodes	VBZ	O
61	CD	O
%	NN	O
of	IN	O
BRCA1	NN	O
.	.	O

In	IN	O
45	CD	O
patients	NNS	O
from	IN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
we	PRP	O
found	VBD	O
six	CD	O
novel	JJ	O
mutations	NNS	O
two	CD	O
single	JJ	O
nucleotide	NN	O
insertions	NNS	O
,	,	O
three	CD	O
small	JJ	O
deletions	NNS	O
(	-LRB-	O
1-5	CD	O
bp	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
nonsense	NN	O
mutation	NN	O
identified	VBD	O
two	CD	O
unrelated	JJ	O
families	NNS	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
amplify	VB	O
the	DT	O
remaining	VBG	O
coding	NN	O
region	NN	O
by	IN	O
RT-PCR	NN	O
using	VBG	O
lymphocyte	NN	O
RNA	NN	O
.	.	O

Combined	VBN	O
with	IN	O
PTT	NNP	O
,	,	O
we	PRP	O
detected	VBD	O
aberrantly	RB	O
spliced	VBN	O
products	NNS	O
affecting	VBG	O
exons	NNS	O
5	CD	O
and	CC	O
6	CD	O
in	IN	O
one	CD	O
of	IN	O
two	CD	O
BRCA1-linked	JJ	O
families	NNS	O
examined	VBN	O
.	.	O

The	DT	O
protein	NN	O
truncation	NN	O
test	NN	O
promises	VBZ	O
to	TO	O
become	VB	O
a	DT	O
valuable	JJ	O
technique	NN	O
in	IN	O
detecting	VBG	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

.	.	O

New	NNP	O
variant	JJ	O
in	IN	O
exon	NN	O
3	CD	O
of	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

A	DT	O
C	NN	O
--	:	O
greater	JJR	O
than	IN	O
G	NN	O
transversion	NN	O
has	VBZ	O
been	VBN	O
found	VBN	O
in	IN	O
exon	NN	O
3	CD	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
of	IN	O
affected	VBN	O
males	NNS	O
and	CC	O
their	PRP$	O
mother	NN	O
in	IN	O
a	DT	O
single	JJ	O
sibship	NN	O
with	IN	O
Pelizaeus-merzbacher	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
PMD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
transversion	NN	O
should	MD	O
not	RB	O
result	VB	O
in	IN	O
an	DT	O
amino	NN	O
acid	NN	O
change	NN	O
in	IN	O
the	DT	O
protein	NN	O
but	CC	O
it	PRP	O
does	VBZ	O
result	VB	O
in	IN	O
the	DT	O
loss	NN	O
of	IN	O
a	DT	O
HaeIII	NN	O
restriction	NN	O
endonuclease	NN	O
cleavage	NN	O
site	NN	O
.	.	O

It	PRP	O
is	VBZ	O
concordant	JJ	O
with	IN	O
the	DT	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

One-hundred-ten	JJ	O
unrelated	JJ	O
X	NN	O
chromosomes	NNS	O
are	VBP	O
negative	JJ	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

No	DT	O
other	JJ	O
sequence	NN	O
defect	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
PLP	NN	O
exons	NNS	O
of	IN	O
the	DT	O
affected	VBN	O
males	NNS	O
.	.	O

The	DT	O
cause	NN	O
of	IN	O
disease	NN	O
in	IN	O
this	DT	O
family	NN	O
remains	VBZ	O
unknown	JJ	O
,	,	O
but	CC	O
the	DT	O
association	NN	O
between	IN	O
this	DT	O
rare	JJ	O
mutation	NN	O
and	CC	O
PMD	NN	B-Disease
is	VBZ	O
intriguing	JJ	O
.	.	O

The	DT	O
mutation	NN	O
can	MD	O
serve	VB	O
as	IN	O
a	DT	O
marker	NN	O
for	IN	O
following	VBG	O
segregation	NN	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
.	.	O

.	.	O

Variants	NNS	O
of	IN	O
erythrocyte	NN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
in	IN	O
Bulgarian	JJ	O
populations	NNS	O
.	.	O

Ten	CD	O
variants	NNS	O
of	IN	O
erythrocyte	NN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
were	VBD	O
identified	VBN	O
in	IN	O
22	CD	O
patients	NNS	O
with	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
from	IN	O
three	CD	O
districts	NNS	O
of	IN	O
Bulgaria	NNP	O
.	.	O

Corinth-like	JJ	O
and	CC	O
Fayoum-like	JJ	O
variants	NNS	O
were	VBD	O
the	DT	O
most	RBS	O
frequent	JJ	O
;	:	O
Mediterranean	NNP	O
,	,	O
Ohut	NNP	O
II	NNP	O
,	,	O
Kilgore	NNP	O
,	,	O
Boston	NNP	O
,	,	O
Poznan	NNP	O
,	,	O
and	CC	O
Panay	NNP	O
variants	NNS	O
and	CC	O
two	CD	O
new	JJ	O
variants	NNS	O
,	,	O
Petrich	NNP	O
and	CC	O
Gotze	NNP	O
Delchev	NNP	O
,	,	O
were	VBD	O
each	DT	O
found	VBN	O
in	IN	O
one	CD	O
or	CC	O
two	CD	O
carriers	NNS	O
.	.	O

No	DT	O
correlation	NN	O
was	VBD	O
revealed	VBN	O
between	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
polymorphism	NN	O
.	.	O

.	.	O

The	DT	O
C282Y	NN	O
mutation	NN	O
causing	VBG	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
does	VBZ	O
not	RB	O
produce	VB	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

Targeted	JJ	O
mutagenesis	NN	O
was	VBD	O
used	VBN	O
to	TO	O
produce	VB	O
two	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
murine	JJ	O
hemochromatosis	NN	B-Disease
gene	NN	O
(	-LRB-	O
Hfe	NN	O
)	-RRB-	O
locus	NN	O
.	.	O

The	DT	O
first	JJ	O
mutation	NN	O
deletes	VBZ	O
a	DT	O
large	JJ	O
portion	NN	O
of	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
,	,	O
generating	VBG	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

The	DT	O
second	JJ	O
mutation	NN	O
introduces	VBZ	O
a	DT	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
C282Y	NN	O
)	-RRB-	O
into	IN	O
the	DT	O
Hfe	NN	O
locus	NN	O
,	,	O
but	CC	O
otherwise	RB	O
leaves	VBZ	O
the	DT	O
gene	NN	O
intact	JJ	O
.	.	O

This	DT	O
mutation	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
the	DT	O
disease-causing	NN	O
mutation	NN	O
in	IN	O
patients	NNS	O
with	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
.	.	O

Mice	NNS	O
carrying	VBG	O
each	DT	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
bred	VBN	O
and	CC	O
analyzed	VBN	O
.	.	O

Homozygosity	NNP	O
for	IN	O
either	DT	O
mutation	NN	O
results	VBZ	O
in	IN	O
postnatal	JJ	O
iron	NN	O
loading	NN	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
the	DT	O
null	JJ	O
mutation	NN	O
are	VBP	O
more	RBR	O
severe	JJ	O
than	IN	O
the	DT	O
effects	NNS	O
of	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
.	.	O

Mice	NNS	O
heterozygous	NN	O
for	IN	O
either	CC	O
mutation	NN	O
accumulate	VBP	O
more	JJR	O
iron	NN	O
than	IN	O
normal	JJ	O
controls	NNS	O
.	.	O

Interestingly	RB	O
,	,	O
although	IN	O
liver	NN	O
iron	NN	O
stores	NNS	O
are	VBP	O
greatly	RB	O
increased	VBN	O
,	,	O
splenic	JJ	O
iron	NN	O
is	VBZ	O
decreased	VBN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
C282Y	NN	O
mutation	NN	O
does	VBZ	O
not	RB	O
result	VB	O
in	IN	O
a	DT	O
null	JJ	O
allele	NN	O
.	.	O

.	.	O

Regional	NNP	O
localisation	NN	O
of	IN	O
the	DT	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
locus	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
9q13	NN	O
----	:	O
q21	NN	O
.1	NN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
assigned	VBN	O
the	DT	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
locus	NN	O
(	-LRB-	O
FRDA	NN	O
)	-RRB-	O
to	TO	O
chromosome	NN	O
9	CD	O
;	:	O
the	DT	O
current	JJ	O
maximal	JJ	O
lod	NN	O
score	NN	O
between	IN	O
FRDA	NNP	O
and	CC	O
MCT112	NN	O
(	-LRB-	O
D9S15	NN	O
)	-RRB-	O
is	VBZ	O
greater	JJR	O
than	IN	O
50	CD	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

The	DT	O
physical	JJ	O
assignment	NN	O
of	IN	O
the	DT	O
locus	NN	O
defined	VBN	O
by	IN	O
MCT112	NN	O
,	,	O
and	CC	O
hence	RB	O
FRDA	NNP	O
,	,	O
has	VBZ	O
not	RB	O
been	VBN	O
determined	VBN	O
,	,	O
although	IN	O
linkage	NN	O
analysis	NN	O
of	IN	O
MCT112	NN	O
with	IN	O
other	JJ	O
chromosome	NN	O
9	CD	O
markers	NNS	O
inferred	VBD	O
a	DT	O
location	NN	O
close	NN	O
to	TO	O
the	DT	O
centromere	NN	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
in	FW	O
situ	FW	O
hybridisation	NN	O
with	IN	O
MCT112	NN	O
,	,	O
a	DT	O
corresponding	JJ	O
cosmid	NN	O
MJ1	NN	O
,	,	O
and	CC	O
DR47	NN	O
(	-LRB-	O
D9S5	NN	O
)	-RRB-	O
,	,	O
coupled	VBN	O
with	IN	O
mapping	NN	O
studies	NNS	O
on	IN	O
hybrid	NN	O
cell	NN	O
panels	NNS	O
,	,	O
to	TO	O
define	VB	O
more	RBR	O
precisely	RB	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
disease	NN	O
locus	NN	O
.	.	O

The	DT	O
in	FW	O
situ	FW	O
location	NN	O
of	IN	O
all	DT	O
three	CD	O
probes	NNS	O
is	VBZ	O
9q13	NN	O
----	:	O
q21	NN	O
.	.	O

1	CD	O
,	,	O
distal	JJ	O
to	TO	O
the	DT	O
variable	JJ	O
heterochromatin	NN	O
region	NN	O
.	.	O

Physical	JJ	O
assignment	NN	O
of	IN	O
FRDA	NNP	O
will	MD	O
allow	VB	O
us	PRP	O
to	TO	O
identify	VB	O
hybrid	JJ	O
cell	NN	O
lines	NNS	O
containing	VBG	O
the	DT	O
mutated	VBN	O
gene	NN	O
.	.	O

Mxi1	NN	O
mutations	NNS	O
in	IN	O
human	JJ	O
neurofibrosarcomas	NNS	B-Disease
.	.	O

Mxi1	NN	O
is	VBZ	O
thought	VBN	O
to	TO	O
negatively	RB	O
regulate	VB	O
Myc	NN	O
function	NN	O
and	CC	O
may	MD	O
therefore	RB	O
be	VB	O
a	DT	O
potential	JJ	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
.	.	O

Little	JJ	O
effort	NN	O
has	VBZ	O
yet	RB	O
been	VBN	O
made	VBN	O
to	TO	O
find	VB	O
alterations	NNS	O
involving	VBG	O
this	DT	O
gene	NN	O
in	IN	O
human	JJ	O
solid	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

We	PRP	O
screened	VBD	O
31	CD	O
human	JJ	O
gastric	JJ	B-Disease
cancers	NNS	I-Disease
,	,	O
7	CD	O
esophageal	NN	B-Disease
cancers	NNS	I-Disease
,	,	O
85	CD	O
bone	NN	B-Disease
and	CC	I-Disease
soft	JJ	I-Disease
tissue	NN	I-Disease
tumors	NNS	I-Disease
of	IN	O
various	JJ	O
types	NNS	O
,	,	O
including	VBG	O
4	CD	O
neurofibrosarcomas	NNS	B-Disease
.	.	O

We	PRP	O
also	RB	O
examined	VBD	O
29	CD	O
human	JJ	O
tumor	NN	B-Disease
cell	NN	O
lines	NNS	O
consisting	VBG	O
of	IN	O
12	CD	O
esophageal	NN	B-Disease
cancers	NNS	I-Disease
,	,	O
7	CD	O
glioma/glioblastomas	NNS	O
and	CC	O
10	CD	O
others	NNS	O
for	IN	O
Mxi1	NN	O
mutations	NNS	O
in	IN	O
exons	NNS	O
1	CD	O
,	,	O
2	CD	O
,	,	O
4	CD	O
(	-LRB-	O
HLH	JJ	O
domain	NN	O
)	-RRB-	O
,	,	O
5	CD	O
and	CC	O
6	CD	O
.	.	O

Polymerase	NN	O
chain	NN	O
reaction-single-strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
PCR-SSCP	NN	O
)	-RRB-	O
and	CC	O
subsequent	JJ	O
sequencing	NN	O
revealed	VBD	O
three	CD	O
distinct	JJ	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
intron-exon	JJ	O
boundary	NN	O
upstream	RB	O
from	IN	O
exon	NN	O
6	CD	O
.	.	O

We	PRP	O
discovered	VBD	O
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
GCA	NN	O
to	TO	O
GTA	NN	O
(	-LRB-	O
Ala	NN	O
54	CD	O
Val	NN	O
)	-RRB-	O
,	,	O
in	IN	O
exon	NN	O
2	CD	O
in	IN	O
a	DT	O
neurofibrosarcoma	NN	B-Disease
patient	NN	O
(	-LRB-	O
case	NN	O
1	CD	O
)	-RRB-	O
,	,	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
AAA	NNP	O
to	TO	O
CAA	NNP	O
(	-LRB-	O
Lys	NNP	O
118	CD	O
Gln	NN	O
)	-RRB-	O
and	CC	O
GAA	NN	O
to	TO	O
GGA	NN	O
(	-LRB-	O
Glu	NN	O
154	CD	O
Gly	NN	O
)	-RRB-	O
in	IN	O
exon	NN	O
5	CD	O
of	IN	O
another	DT	O
neurofibrosarcoma	NN	B-Disease
patient	NN	O
(	-LRB-	O
case	NN	O
2	CD	O
)	-RRB-	O
,	,	O
and	CC	O
3	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
GTG	NNP	O
to	TO	O
GCG	NNP	O
(	-LRB-	O
Val	NN	O
179	CD	O
Ala	NN	O
)	-RRB-	O
,	,	O
GTT	NN	O
to	TO	O
GCT	NN	O
(	-LRB-	O
Val	NN	O
181	CD	O
Ala	NN	O
)	-RRB-	O
and	CC	O
TTC	NN	O
to	TO	O
CTC	NNP	O
(	-LRB-	O
Phe	NNP	O
186	CD	O
Leu	NN	O
)	-RRB-	O
,	,	O
in	IN	O
a	DT	O
third	JJ	O
neurofibrosarcoma	NN	B-Disease
patient	NN	O
(	-LRB-	O
case	NN	O
3	CD	O
)	-RRB-	O
.	.	O

In	IN	O
case	NN	O
3	CD	O
,	,	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
by	IN	O
informative	JJ	O
(	-LRB-	O
TTC	NN	O
)	-RRB-	O
3	CD	O
/	:	O
(	-LRB-	O
TTC	NN	O
)	-RRB-	O
2	CD	O
polymorphism	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
mutations	NNS	O
occur	VBP	O
in	IN	O
the	DT	O
Mxi1	NN	O
gene	NN	O
in	IN	O
neurofibrosarcoma	NN	B-Disease
.	.	O

Missense	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
functional	JJ	O
domain	NN	O
of	IN	O
Mxi1	NN	O
in	IN	O
these	DT	O
cases	NNS	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
neurofibrosarcoma	NN	B-Disease
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
essential	JJ	B-Disease
fructosuria	NN	I-Disease
:	:	O
molecular	JJ	O
cloning	NN	O
and	CC	O
mutational	JJ	O
analysis	NN	O
of	IN	O
human	JJ	O
ketohexokinase	NN	O
(	-LRB-	O
fructokinase	NN	O
)	-RRB-	O
.	.	O

Essential	JJ	B-Disease
fructosuria	NN	I-Disease
is	VBZ	O
one	CD	O
of	IN	O
the	DT	O
oldest	JJS	O
known	JJ	O
inborn	JJ	B-Disease
errors	NNS	I-Disease
of	IN	I-Disease
metabolism	NN	I-Disease
.	.	O

It	PRP	O
is	VBZ	O
a	DT	O
benign	JJ	O
condition	NN	O
which	WDT	O
is	VBZ	O
believed	VBN	O
to	TO	O
result	VB	O
from	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
hepatic	JJ	I-Disease
fructokinase	NN	I-Disease
(	-LRB-	O
ketohexokinase	NN	O
,	,	O
KHK	NN	O
,	,	O
E.	NNP	O
C.	NNP	O
2	CD	O
.	.	O

7	CD	O
.	.	O

1	LS	O
.	.	O

3	LS	O
)	-RRB-	O
.	.	O

This	DT	O
enzyme	NN	O
catalyses	VBZ	O
the	DT	O
first	JJ	O
step	NN	O
of	IN	O
metabolism	NN	O
of	IN	O
dietary	JJ	O
fructose	NN	O
,	,	O
conversion	NN	O
of	IN	O
fructose	NN	O
to	TO	O
fructose-1-phosphate	NN	O
.	.	O

Despite	IN	O
the	DT	O
early	JJ	O
recognition	NN	O
of	IN	O
this	DT	O
disorder	NN	O
,	,	O
the	DT	O
primary	JJ	O
structure	NN	O
of	IN	O
human	JJ	O
KHK	NN	O
and	CC	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
essential	JJ	B-Disease
fructosuria	NN	I-Disease
have	VBP	O
not	RB	O
been	VBN	O
previously	RB	O
defined	VBN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
the	DT	O
isolation	NN	O
and	CC	O
sequencing	NN	O
of	IN	O
full-length	JJ	O
cDNA	NN	O
clones	NNS	O
encoding	VBG	O
human	JJ	O
ketohexokinase	NN	O
are	VBP	O
described	VBN	O
.	.	O

Alternative	JJ	O
mRNA	NN	O
species	NNS	O
and	CC	O
alternative	JJ	O
KHK	NN	O
isozymes	NNS	O
are	VBP	O
produced	VBN	O
by	IN	O
alternative	JJ	O
polyadenylation	NN	O
and	CC	O
splicing	NN	O
of	IN	O
the	DT	O
KHK	NN	O
gene	NN	O
.	.	O

The	DT	O
KHK	NN	O
proteins	NNS	O
show	VBP	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
sequence	NN	O
conservation	NN	O
relative	JJ	O
to	TO	O
rat	NN	O
KHK	NN	O
.	.	O

Direct	JJ	O
evidence	NN	O
that	IN	O
mutation	NN	O
of	IN	O
the	DT	O
KHK	NNP	O
structural	JJ	O
gene	NN	O
is	VBZ	O
the	DT	O
cause	NN	O
of	IN	O
essential	JJ	B-Disease
fructosuria	NN	I-Disease
was	VBD	O
also	RB	O
obtained	VBN	O
.	.	O

In	IN	O
a	DT	O
well-characterized	JJ	O
family	NN	O
,	,	O
in	IN	O
which	WDT	O
three	CD	O
of	IN	O
eight	CD	O
siblings	NNS	O
have	VBP	O
fructosuria	NN	B-Disease
,	,	O
all	DT	O
affected	VBD	O
individuals	NNS	O
are	VBP	O
compound	JJ	O
heterozygotes	NNS	O
for	IN	O
two	CD	O
mutations	NNS	O
Gly40Arg	NN	O
and	CC	O
Ala43Thr	NN	O
.	.	O

Both	DT	O
mutations	NNS	O
result	VBP	O
from	IN	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transitions	NNS	O
,	,	O
and	CC	O
each	DT	O
alters	VBZ	O
the	DT	O
same	JJ	O
conserved	VBN	O
region	NN	O
of	IN	O
the	DT	O
KHK	NN	O
protein	NN	O
.	.	O

Neither	DT	O
mutation	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
a	DT	O
sample	NN	O
of	IN	O
52	CD	O
unrelated	JJ	O
control	NN	O
individuals	NNS	O
.	.	O

An	DT	O
additional	JJ	O
conservative	JJ	O
amino	NN	O
acid	NN	O
change	NN	O
(	-LRB-	O
Val49IIe	NN	O
)	-RRB-	O
was	VBD	O
present	JJ	O
on	IN	O
the	DT	O
KHK	NNP	O
allele	NN	O
bearing	NN	O
Ala43Thr	NN	O

Loss	NN	O
of	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
gene	NN	O
product	NN	O
causes	VBZ	O
oxidative	JJ	O
damage	NN	O
in	IN	O
target	NN	O
organs	NNS	O
.	.	O

Ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
markedly	RB	O
increased	VBN	O
sensitivity	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
,	,	O
increased	VBD	O
incidence	NN	O
of	IN	O
cancer	NN	B-Disease
,	,	O
and	CC	O
neurodegeneration	NN	B-Disease
,	,	O
especially	RB	O
of	IN	O
the	DT	O
cerebellar	JJ	O
Purkinje	NN	O
cells	NNS	O
.	.	O

Ionizing	VBG	O
radiation	NN	O
oxidizes	VBZ	O
macromolecules	NNS	O
and	CC	O
causes	VBZ	O
tissue	NN	O
damage	NN	O
through	IN	O
the	DT	O
generation	NN	O
of	IN	O
reactive	JJ	O
oxygen	NN	O
species	NNS	O
(	-LRB-	O
ROS	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
therefore	RB	O
hypothesized	VBD	O
that	IN	O
A-T	NN	B-Disease
is	VBZ	O
due	JJ	O
to	TO	O
oxidative	JJ	O
damage	NN	O
resulting	VBG	O
from	IN	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
A-T	NN	B-Disease
gene	NN	O
product	NN	O
.	.	O

To	TO	O
assess	VB	O
this	DT	O
hypothesis	NN	O
,	,	O
we	PRP	O
employed	VBD	O
an	DT	O
animal	NN	O
model	NN	O
of	IN	O
A-T	NN	B-Disease
,	,	O
the	DT	O
mouse	NN	O
with	IN	O
a	DT	O
disrupted	VBN	O
Atm	NN	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
organs	NNS	O
which	WDT	O
develop	VBP	O
pathologic	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
Atm-deficient	JJ	O
mice	NNS	O
are	VBP	O
targets	NNS	O
of	IN	O
oxidative	JJ	O
damage	NN	O
,	,	O
and	CC	O
that	IN	O
cerebellar	NN	O
Purkinje	NN	O
cells	NNS	O
are	VBP	O
particularly	RB	O
affected	VBN	O
.	.	O

These	DT	O
observations	NNS	O
provide	VBP	O
a	DT	O
mechanistic	JJ	O
basis	NN	O
for	IN	O
the	DT	O
A-T	NN	B-Disease
phenotype	NN	O
and	CC	O
lay	VBD	O
a	DT	O
rational	JJ	O
foundation	NN	O
for	IN	O
therapeutic	JJ	O
intervention	NN	O
.	.	O

.	.	O

Family	NNP	O
studies	NNS	O
in	IN	O
Bechterew	NNP	B-Disease
's	POS	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
)	-RRB-	O
III	CD	O
.	.	O

Genetics	NNP	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
segregation	NN	O
analyses	NNS	O
in	IN	O
75	CD	O
families	NNS	O
where	WRB	O
the	DT	O
proband	NN	O
had	VBD	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
,	,	O
are	VBP	O
presented	VBN	O
.	.	O

Of	IN	O
the	DT	O
278	CD	O
adult	NN	O
,	,	O
living	VBG	O
first	JJ	O
degree	NN	O
relatives	NNS	O
,	,	O
approximately	RB	O
85	CD	O
%	NN	O
cooperated	VBD	O
in	IN	O
the	DT	O
study	NN	O
.	.	O

Clinical	JJ	O
and	CC	O
radiographical	JJ	O
examinations	NNS	O
were	VBD	O
performed	VBN	O
and	CC	O
HLA	NN	O
typing	NN	O
was	VBD	O
conducted	VBN	O
.	.	O

The	DT	O
results	NNS	O
were	VBD	O
in	IN	O
agreement	NN	O
with	IN	O
our	PRP$	O
hypothesis	NN	O
that	IN	O
ankylosing	VBG	B-Disease
spondylitis	NN	I-Disease
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
syndrome	NN	O
where	WRB	O
different	JJ	O
genetic	JJ	O
factors	NNS	O
interact	VBP	O
.	.	O

Such	JJ	O
known	JJ	O
factors	NNS	O
are	VBP	O
HLA	NN	O
B27	NN	O
associated	VBN	O
disease	NN	O
susceptibility	NN	O
,	,	O
susceptibility	NN	O
to	TO	O
psoriatic	JJ	B-Disease
arthropathy	NN	I-Disease
and	CC	O
susceptibility	NN	O
to	TO	O
entero-arthropathy	NN	B-Disease
.	.	O

Radiographical	JJ	O
sacro-iliitis	NN	B-Disease
was	VBD	O
restricted	JJ	O
to	TO	O
HLA	NN	O
B27	NN	O
positive	JJ	O
relatives	NNS	O
,	,	O
and	CC	O
was	VBD	O
more	RBR	O
frequently	RB	O
found	VBN	O
in	IN	O
relatives	NNS	O
to	TO	O
probands	NNS	O
with	IN	O
psoriasis	NN	B-Disease
than	IN	O
in	IN	O
relatives	NNS	O
to	TO	O
probands	NNS	O
without	IN	O
psoriasis	NN	B-Disease
.	.	O

Environmental	JJ	O
factors	NNS	O
(	-LRB-	O
intestinal	JJ	O
bacteria	NNS	O
)	-RRB-	O
are	VBP	O
known	VBN	O
to	TO	O
trigger	VB	O
the	DT	O
disease	NN	O
at	IN	O
least	JJS	O
in	IN	O
some	DT	O
persons	NNS	O
,	,	O
and	CC	O
we	PRP	O
have	VBP	O
postulated	VBN	O
that	IN	O
all	DT	O
or	CC	O
most	JJS	O
of	IN	O
them	PRP	O
have	VBP	O
the	DT	O
predisposition	NN	O
to	TO	O
develop	VB	O
disease	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
syndrome	NN	O
has	VBZ	O
a	DT	O
multifactorial	JJ	O
etiology	NN	O
.	.	O

The	DT	O
phenotypic	JJ	O
expressions	NNS	O
of	IN	O
the	DT	O
different	JJ	O
genetic	JJ	O
predispositions	NNS	O
involved	VBN	O
,	,	O
include	VBP	O
sacro-iliitis	NN	B-Disease
,	,	O
psoriasis	NN	B-Disease
,	,	O
acute	JJ	B-Disease
anterior	JJ	I-Disease
uveitis	NN	I-Disease
,	,	O
peripheral	JJ	O
arthropathy	NN	B-Disease
and	CC	O
inflammatory	JJ	B-Disease
bowel	NN	I-Disease
disease	NN	I-Disease
.	.	O

We	PRP	O
suggest	VBP	O
the	DT	O
descriptive	JJ	O
name	NN	O
HEREDITARY	JJ	B-Disease
MULTIFOCAL	JJ	I-Disease
RELAPSING	NN	I-Disease
INFLAMMATION	NN	I-Disease
(	-LRB-	O
HEMRI	NN	B-Disease
)	-RRB-	O
for	IN	O
this	DT	O
syndrome	NN	O
.	.	O

Ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
,	,	O
psoriatic	JJ	B-Disease
arthropathy	NN	I-Disease
and	CC	O
entero-arthropathy	NN	B-Disease
may	MD	O
be	VB	O
regarded	VBN	O
as	IN	O
clinical	JJ	O
sub-types	NNS	O
of	IN	O
the	DT	O
syndrome	NN	O
.	.	O

.	.	O

Chromosome	NN	O
mapping	NN	O
of	IN	O
the	DT	O
rod	NN	O
photoreceptor	NN	O
cGMP	NN	O
phosphodiesterase	NN	O
beta-subunit	NN	O
gene	NN	O
in	IN	O
mouse	NN	O
and	CC	O
human	JJ	O
:	:	O
tight	JJ	O
linkage	NN	O
to	TO	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
region	NN	O
(	-LRB-	O
4p16	CD	O
.3	NN	O
)	-RRB-	O
.	.	O

The	DT	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
mouse	NN	O
(	-LRB-	O
gene	NN	O
symbol	NN	O
,	,	O
rd	NN	O
)	-RRB-	O
is	VBZ	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
certain	JJ	O
forms	NNS	O
of	IN	O
human	JJ	O
hereditary	JJ	B-Disease
retinopathies	NNS	I-Disease
.	.	O

Recent	JJ	O
findings	NNS	O
of	IN	O
a	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
the	DT	O
rd	NN	O
mouse	NN	O
PDE	NN	O
beta-subunit	NN	O
gene	NN	O
(	-LRB-	O
Pdeb	NN	O
)	-RRB-	O
prompted	VBD	O
us	PRP	O
to	TO	O
investigate	VB	O
the	DT	O
chromosome	NN	O
locations	NNS	O
of	IN	O
the	DT	O
mouse	NN	O
and	CC	O
human	JJ	O
genes	NNS	O
.	.	O

We	PRP	O
have	VBP	O
utilized	VBN	O
backcross	JJ	O
analysis	NN	O
in	IN	O
mice	NNS	O
to	TO	O
verify	VB	O
and	CC	O
define	VB	O
more	JJR	O
precisely	RB	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
Pdeb	NN	O
locus	NN	O
6	CD	O
.	.	O

1	CD	O
+	CC	O
/	:	O
-	:	O
2	CD	O
.	.	O

3	CD	O
cM	NN	O
distal	JJ	O
of	IN	O
Mgsa	NN	O
on	IN	O
mouse	NN	O
chromosome	NN	O
5	CD	O
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
that	IN	O
the	DT	O
human	JJ	O
gene	NN	O
(	-LRB-	O
PDEB	NN	O
)	-RRB-	O
maps	VBZ	O
to	TO	O
4p16	VB	O
.	.	O

3	CD	O
,	,	O
very	RB	O
close	RB	O
to	TO	O
the	DT	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
region	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
comparative	JJ	O
map	NN	O
for	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
shows	VBZ	O
that	IN	O
the	DT	O
mouse	NN	O
homologue	NN	O
of	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
will	MD	O
reside	VB	O
on	IN	O
chromosome	NN	O
5	CD	O
.	.	O

Linkage	NN	O
of	IN	O
the	DT	O
mouse	NN	O
Pdeb	NN	O
locus	NN	O
with	IN	O
other	JJ	O
homologues	NNS	O
in	IN	O
the	DT	O
human	JJ	O
4p16	NN	O
.	.	O

3	CD	O
region	NN	O
is	VBZ	O
maintained	VBN	O
but	CC	O
gene	NN	O
order	NN	O
is	VBZ	O
not	RB	O
,	,	O
suggesting	VBG	O
at	IN	O
least	JJS	O
three	CD	O
possible	JJ	O
sites	NNS	O
for	IN	O
the	DT	O
corresponding	JJ	O
mouse	NN	O
HD	NN	B-Disease
gene	NN	O
.	.	O

Hereditary	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
man	NN	O
.	.	O

II	NNP	O
.	.	O

Biological	JJ	O
properties	NNS	O
of	IN	O
C5-deficient	JJ	B-Disease
human	JJ	O
serum	NN	O
.	.	O

The	DT	O
first	JJ	O
known	JJ	O
human	JJ	O
kindred	NN	O
with	IN	O
hereditary	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C5	NN	O
)	-RRB-	O
was	VBD	O
documented	VBN	O
in	IN	O
the	DT	O
accompanying	VBG	O
report	NN	O
.	.	O

This	DT	O
study	NN	O
examines	VBZ	O
several	JJ	O
biological	JJ	O
properties	NNS	O
of	IN	O
C5-deficient	JJ	B-Disease
(	-LRB-	O
C5D	NN	B-Disease
)	-RRB-	O
human	JJ	O
serum	NN	O
,	,	O
particularly	RB	O
sera	NNS	O
obtained	VBN	O
from	IN	O
two	CD	O
C5D	NN	B-Disease
homozygotes	NNS	O
.	.	O

The	DT	O
proband	NN	O
,	,	O
who	WP	O
has	VBZ	O
inactive	JJ	O
systemic	JJ	B-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
is	VBZ	O
completely	RB	O
lacking	VBG	O
C5	NN	O
,	,	O
while	IN	O
her	PRP$	O
healthy	JJ	O
half-sister	NN	O
has	VBZ	O
1-2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
levels	NNS	O
.	.	O

Both	DT	O
sera	NNS	O
were	VBD	O
severely	RB	O
impaired	JJ	O
in	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
generate	VB	O
chemotactic	JJ	O
activity	NN	O
for	IN	O
normal	JJ	O
human	JJ	O
neutrophils	NNS	O
upon	IN	O
incubation	NN	O
with	IN	O
aggregated	JJ	O
human	JJ	O
gamma-globulin	NN	O
or	CC	O
Escherichia	FW	O
coli	FW	O
endotoxin	NN	O
.	.	O

This	DT	O
function	NN	O
was	VBD	O
fully	RB	O
restored	VBN	O
in	IN	O
the	DT	O
siblings	NNS	O
serum	NN	O
,	,	O
and	CC	O
substantially	RB	O
improved	VBN	O
in	IN	O
the	DT	O
probands	NNS	O
serum	NN	O
,	,	O
by	IN	O
addition	NN	O
of	IN	O
highly	RB	O
purified	VBN	O
human	JJ	O
C5	NN	O
to	TO	O
normal	JJ	O
serum	NN	O
concentrations	NNS	O
.	.	O

Sera	NNP	O
from	IN	O
eight	CD	O
family	NN	O
members	NNS	O
who	WP	O
were	VBD	O
apparently	RB	O
heterozygous	JJ	O
for	IN	O
C5	NN	B-Disease
deficiency	NN	I-Disease
gave	VBD	O
normal	JJ	O
chemotactic	JJ	O
scores	NNS	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
C5D	NN	B-Disease
serum	NN	O
to	TO	O
opsonize	VB	O
Saccharomyces	FW	O
cerevisiae	FW	O
(	-LRB-	O
bakers	NNS	O
yeast	NN	O
)	-RRB-	O
or	CC	O
Candida	NN	O
albicans	NNS	O
for	IN	O
ingestion	NN	O
by	IN	O
normal	JJ	O
neutrophils	NNS	O
was	VBD	O
completely	RB	O
normal	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
C5D	NN	B-Disease
serum	NN	O
was	VBD	O
capable	JJ	O
of	IN	O
promoting	VBG	O
normal	JJ	O
phagocytosis	NN	O
and	CC	O
intracellular	JJ	O
killing	NN	O
of	IN	O
Staphylococcus	FW	O
aureus	FW	O
.	.	O

The	DT	O
probands	NNS	O
serum	NN	O
was	VBD	O
incapable	JJ	O
of	IN	O
mediating	VBG	O
lysis	NN	O
of	IN	O
erythrocytes	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
paroxysmal	JJ	B-Disease
nocturnal	JJ	I-Disease
hemoglobinuria	NN	I-Disease
in	IN	O
both	CC	O
the	DT	O
sucrose	NN	O
hemolysia	NN	O
and	CC	O
acid	NN	O
hemolysis	NN	O
tests	NNS	O
,	,	O
and	CC	O
also	RB	O
lacked	VBD	O
bactericidal	JJ	O
activity	NN	O
against	IN	O
sensitized	VBN	O
or	CC	O
unsensitized	JJ	O
Salmonella	FW	O
typhi	FW	O
.	.	O

The	DT	O
siblings	NNS	O
serum	NN	O
,	,	O
containing	VBG	O
only	RB	O
1-2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
C5	NN	O
,	,	O
effectively	RB	O
lysed	VBD	O
S.	NNP	O
typhi	NNS	O
,	,	O
but	CC	O
only	RB	O
at	IN	O
eightfold	RB	O
lower	JJR	O
serum	NN	O
dilutions	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
normals	NNS	O
.	.	O

These	DT	O
findings	NNS	O
underscore	VBP	O
the	DT	O
critical	JJ	O
role	NN	O
of	IN	O
C5	NN	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
chemotactic	JJ	O
activity	NN	O
and	CC	O
in	IN	O
cytolytic	JJ	O
reactions	NNS	O
,	,	O
as	IN	O
opposed	VBN	O
to	TO	O
a	DT	O
nonobligatory	JJ	O
or	CC	O
minimal	JJ	O
role	NN	O
in	IN	O
opsonization	NN	O
,	,	O
at	IN	O
least	JJS	O
for	IN	O
the	DT	O
organisms	NNS	O
under	IN	O
study	NN	O
.	.	O

.	.	O

The	DT	O
gene	NN	O
for	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
,	,	O
MEFV	NN	O
,	,	O
is	VBZ	O
expressed	VBN	O
in	IN	O
early	JJ	O
leukocyte	NN	O
development	NN	O
and	CC	O
is	VBZ	O
regulated	VBN	O
in	IN	O
response	NN	O
to	TO	O
inflammatory	JJ	O
mediators	NNS	O
.	.	O

Familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessive	JJ	B-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
episodes	NNS	O
of	IN	O
fever	NN	B-Disease
and	CC	O
neutrophil-mediated	JJ	B-Disease
serosal	JJ	I-Disease
inflammation	NN	I-Disease
.	.	O

We	PRP	O
recently	RB	O
identified	VBD	O
the	DT	O
gene	NN	O
causing	VBG	O
FMF	NN	B-Disease
,	,	O
designated	VBN	O
MEFV	NN	O
,	,	O
and	CC	O
found	VBD	O
it	PRP	O
to	TO	O
be	VB	O
expressed	VBN	O
in	IN	O
mature	JJ	O
neutrophils	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
functions	VBZ	O
as	IN	O
an	DT	O
inflammatory	JJ	O
regulator	NN	O
.	.	O

To	TO	O
facilitate	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
the	DT	O
normal	JJ	O
function	NN	O
of	IN	O
MEFV	NN	O
,	,	O
we	PRP	O
extended	VBD	O
our	PRP$	O
previous	JJ	O
studies	NNS	O
.	.	O

MEFV	NN	O
messenger	NN	O
RNA	NN	O
was	VBD	O
detected	VBN	O
by	IN	O
reverse	JJ	O
transcriptase-polymerase	NN	O
chain	NN	O
reaction	NN	O
in	IN	O
bone	NN	O
marrow	NN	O
leukocytes	NNS	O
,	,	O
with	IN	O
differential	JJ	O
expression	NN	O
observed	VBN	O
among	IN	O
cells	NNS	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

CD34	NN	O
hematopoietic	JJ	O
stem-cell	NN	O
cultures	NNS	O
induced	VBD	O
toward	IN	O
the	DT	O
granulocytic	JJ	O
lineage	NN	O
expressed	VBD	O
MEFV	NN	O
at	IN	O
the	DT	O
myelocyte	JJ	O
stage	NN	O
,	,	O
concurrently	RB	O
with	IN	O
lineage	NN	O
commitment	NN	O
.	.	O

The	DT	O
prepromyelocytic	JJ	O
cell	NN	O
line	NN	O
HL60	NN	O
expressed	VBD	O
MEFV	NN	O
only	RB	O
at	IN	O
granulocytic	JJ	O
and	CC	O
monocytic	JJ	O
differentiation	NN	O
.	.	O

MEFV	NN	O
was	VBD	O
also	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
monocytic	JJ	O
cell	NN	O
lines	NNS	O
U937	NN	O
and	CC	O
THP-1	NN	O
.	.	O

Among	IN	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
,	,	O
MEFV	NN	O
expression	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
neutrophils	NNS	O
,	,	O
eosinophils	NNS	O
,	,	O
and	CC	O
to	TO	O
varying	VBG	O
degrees	NNS	O
,	,	O
monocytes	NNS	O
.	.	O

Consistent	JJ	O
with	IN	O
the	DT	O
tissue	NN	O
specificity	NN	O
of	IN	O
expression	NN	O
,	,	O
complete	JJ	O
sequencing	NN	O
and	CC	O
analysis	NN	O
of	IN	O
upstream	JJ	O
regulatory	JJ	O
regions	NNS	O
of	IN	O
MEFV	NN	O
revealed	VBD	O
homology	NN	O
to	TO	O
myeloid-specific	JJ	O
promoters	NNS	O
and	CC	O
to	TO	O
more	RBR	O
broadly	RB	O
expressed	VBN	O
inflammatory	JJ	O
promoter	NN	O
elements	NNS	O
.	.	O

In	FW	O
vitro	FW	O
stimulation	NN	O
of	IN	O
monocytes	NNS	O
with	IN	O
the	DT	O
proinflammatory	JJ	O
agents	NNS	O
interferon	NN	O
(	-LRB-	O
IFN	NN	O
)	-RRB-	O
gamma	NN	O
,	,	O
tumor	NN	B-Disease
necrosis	NN	O
factor	NN	O
,	,	O
and	CC	O
lipopolysaccharide	NN	O
induced	VBD	O
MEFV	NN	O
expression	NN	O
,	,	O
whereas	IN	O
the	DT	O
antiinflammatory	JJ	O
cytokines	NNS	O
interleukin	NN	O
(	-LRB-	O
IL	NN	O
)	-RRB-	O
4	CD	O
,	,	O
IL-10	NN	O
,	,	O
and	CC	O
transforming	VBG	O
growth	NN	O
factor	NN	O
beta	NN	O
inhibited	VBD	O
such	JJ	O
expression	NN	O
.	.	O

Induction	NN	O
by	IN	O
IFN-gamma	NN	O
occurred	VBD	O
rapidly	RB	O
and	CC	O
was	VBD	O
resistant	JJ	O
to	TO	O
cycloheximide	NN	O
.	.	O

IFN-alpha	NN	O
also	RB	O
induced	VBD	O
MEFV	NN	O
expression	NN	O
.	.	O

In	IN	O
granulocytes	NNS	O
,	,	O
MEFV	NN	O
was	VBD	O
up-regulated	VBN	O
by	IN	O
IFN-gamma	NN	O
and	CC	O
the	DT	O
combination	NN	O
of	IN	O
IFN-alpha	NN	O
and	CC	O
colchicine	NN	O
.	.	O

These	DT	O
results	NNS	O
refine	VBP	O
understanding	NN	O
of	IN	O
MEFV	NN	O
by	IN	O
placing	VBG	O
the	DT	O
gene	NN	O
in	IN	O
the	DT	O
myelomonocytic-specific	JJ	O
proinflammatory	JJ	O
pathway	NN	O
and	CC	O
identifying	VBG	O
it	PRP	O
as	IN	O
an	DT	O
IFN-gamma	NN	O
immediate	JJ	O
early	JJ	O
gene	NN	O
.	.	O

.	.	O

Spectrum	NN	O
of	IN	O
hSNF5/INI1	NN	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
human	JJ	O
cancer	NN	B-Disease
and	CC	O
genotype-phenotype	JJ	O
correlations	NNS	O
.	.	O

The	DT	O
hSNF5/INI1	NN	O
gene	NN	O
which	WDT	O
encodes	VBZ	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
SWI/SNF	NN	O
chromatin	NN	O
ATP-dependent	JJ	O
remodeling	NN	O
complex	NN	O
,	,	O
is	VBZ	O
a	DT	O
new	JJ	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
localized	JJ	O
on	IN	O
chromosome	NN	O
22q11	NN	O
.	.	O

2	CD	O
and	CC	O
recently	RB	O
shown	VBN	O
to	TO	O
be	VB	O
mutated	VBN	O
in	IN	O
malignant	JJ	B-Disease
rhabdoid	NN	I-Disease
tumors	NNS	I-Disease
.	.	O

We	PRP	O
have	VBP	O
searched	VBN	O
for	IN	O
hSNF5/INI1	NN	O
mutations	NNS	O
in	IN	O
229	CD	O
tumors	NNS	B-Disease
of	IN	O
various	JJ	O
origins	NNS	O
using	VBG	O
a	DT	O
screening	NN	O
method	NN	O
based	VBN	O
on	IN	O
denaturing	VBG	O
high-performance	JJ	O
liquid	JJ	O
chromatography	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
31	CD	O
homozygous	JJ	O
deletions	NNS	O
and	CC	O
36	CD	O
point	NN	O
alterations	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Point	NN	O
mutations	NNS	O
were	VBD	O
scattered	VBN	O
along	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
and	CC	O
included	VBD	O
15	CD	O
nonsense	NN	O
,	,	O
15	CD	O
frameshift	NN	O
,	,	O
three	CD	O
splice	NN	O
site	NN	O
,	,	O
two	CD	O
missense	NN	O
and	CC	O
one	CD	O
editing	NN	O
mutations	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
retrieved	VBN	O
in	IN	O
most	JJS	O
rhabdoid	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
whatever	WDT	O
their	PRP$	O
sites	NNS	O
of	IN	O
occurrence	NN	O
,	,	O
indicating	VBG	O
the	DT	O
common	JJ	O
pathogenetic	JJ	O
origin	NN	O
of	IN	O
these	DT	O
tumors	NNS	B-Disease
.	.	O

Recurrent	JJ	O
hSNF5/INI1	NN	O
alterations	NNS	O
were	VBD	O
also	RB	O
observed	VBN	O
in	IN	O
choroid	NN	B-Disease
plexus	NN	I-Disease
carcinomas	NNS	I-Disease
and	CC	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
central	JJ	O
primitive	JJ	O
neuroectodermal	JJ	B-Disease
tumors	NNS	I-Disease
(	-LRB-	O
cPNETs	NNS	O
)	-RRB-	O
and	CC	O
medulloblastomas	NNS	B-Disease
.	.	O

In	IN	O
contrast	NN	O
,	,	O
hSNF5/INI1	NN	O
point	NN	O
mutations	NNS	O
were	VBD	O
not	RB	O
detected	VBN	O
in	IN	O
breast	NN	B-Disease
cancers	NNS	I-Disease
,	,	O
Wilms	NN	B-Disease
tumors	NNS	I-Disease
,	,	O
gliomas	NNS	B-Disease
,	,	O
ependymomas	NNS	B-Disease
,	,	O
sarcomas	NNS	B-Disease
and	CC	O
other	JJ	O
tumor	NN	B-Disease
types	NNS	O
,	,	O
even	RB	O
though	IN	O
most	JJS	O
analyzed	VBN	O
cases	NNS	O
harbored	VBD	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
at	IN	O
22q11	NN	O
.	.	O

2	CD	O
loci	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
rhabdoid	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
choroid	NN	B-Disease
plexus	NN	I-Disease
carcinomas	NNS	I-Disease
and	CC	O
a	DT	O
subset	NN	O
of	IN	O
medulloblastomas	NNS	B-Disease
and	CC	O
cPNETs	NNS	O
share	VBP	O
common	JJ	O
pathways	NNS	O
of	IN	O
oncogenesis	NN	O
related	JJ	O
to	TO	O
hSNF5/INI1	NN	O
alteration	NN	O
and	CC	O
that	IN	O
hSNF5/INI1	NN	O
mutations	NNS	O
define	VBP	O
a	DT	O
genetically	RB	O
homogeneous	JJ	O
family	NN	O
of	IN	O
highly	RB	O
aggressive	JJ	O
cancers	NNS	B-Disease
mainly	RB	O
occurring	VBG	O
in	IN	O
young	JJ	O
children	NNS	O
and	CC	O
frequently	RB	O
,	,	O
but	CC	O
not	RB	O
always	RB	O
,	,	O
exhibiting	VBG	O
a	DT	O
rhabdoid	JJ	B-Disease
phenotype	NN	O

Heterogeneity	NN	O
of	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
Algeria	NNP	O
.	.	O

Study	NNP	O
in	IN	O
Northern	NNP	O
Algeria	NNP	O
with	IN	O
description	NN	O
of	IN	O
five	CD	O
new	JJ	O
variants	NNS	O
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
was	VBD	O
found	VBN	O
in	IN	O
3	CD	O
.	.	O

2	CD	O
%	NN	O
of	IN	O
the	DT	O
male	JJ	O
population	NN	O
living	NN	O
in	IN	O
the	DT	O
urban	JJ	O
area	NN	O
of	IN	O
Algiers	NNP	O
.	.	O

The	DT	O
deficient	JJ	O
subjects	NNS	O
originated	VBD	O
from	IN	O
multiple	JJ	O
geographic	JJ	O
regions	NNS	O
of	IN	O
Northern	JJ	O
Algeria	NNP	O
,	,	O
with	IN	O
prevalence	NN	O
of	IN	O
individuals	NNS	O
of	IN	O
Berber-Kabyle	JJ	O
origin	NN	O
.	.	O

Red	JJ	O
blood	NN	O
cell	NN	O
G6PD	NN	O
was	VBD	O
partially	RB	O
purified	VBN	O
and	CC	O
characterized	VBN	O
in	IN	O
deficient	JJ	O
males	NNS	O
from	IN	O
17	CD	O
families	NNS	O
,	,	O
and	CC	O
six	CD	O
different	JJ	O
variants	NNS	O
were	VBD	O
found	VBN	O
.	.	O

Among	IN	O
them	PRP	O
,	,	O
only	RB	O
one	CD	O
,	,	O
the	DT	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Kabyle	NNP	O
variant	NN	O
,	,	O
had	VBD	O
been	VBN	O
previously	RB	O
described	VBN	O
.	.	O

It	PRP	O
was	VBD	O
detected	VBN	O
in	IN	O
nine	CD	O
families	NNS	O
.	.	O

The	DT	O
other	JJ	O
five	CD	O
variants	NNS	O
were	VBD	O
new	JJ	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Laghouat	NNP	O
(	-LRB-	O
four	CD	O
cases	NNS	O
)	-RRB-	O
,	,	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Blida	NNP	O
(	-LRB-	O
one	CD	O
case	NN	O
)	-RRB-	O
,	,	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Thenia	NNP	O
(	-LRB-	O
one	CD	O
case	NN	O
)	-RRB-	O
,	,	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Titteri	NN	O
(	-LRB-	O
one	CD	O
case	NN	O
)	-RRB-	O
,	,	O
and	CC	O
Gd	NN	O
(	-LRB-	O
-	:	O
)	-RRB-	O
Alger	NNP	O
(	-LRB-	O
two	CD	O
brothers	NNS	O
)	-RRB-	O
.	.	O

Strikingly	RB	O
,	,	O
the	DT	O
common	JJ	O
Mediterranean	JJ	O
variant	NN	O
was	VBD	O
not	RB	O
found	VBN	O
.	.	O

G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
heterogeneous	JJ	O
in	IN	O
northern	JJ	O
Algeria	NNP	O
where	WRB	O
autochtonous	JJ	O
variants	NNS	O
seem	VBP	O
to	TO	O
prevail	VB	O
.	.	O

The	DT	O
Kabyle	NNP	O
variant	NN	O
may	MD	O
be	VB	O
common	JJ	O
in	IN	O
this	DT	O
country	NN	O
.	.	O

Fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
without	IN	O
CCG	NNP	O
amplification	NN	O
has	VBZ	O
an	DT	O
FMR1	NN	O
deletion	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
patient	NN	O
with	IN	O
typical	JJ	O
clinical	JJ	O
features	NNS	O
of	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
but	CC	O
without	IN	O
cytogenetic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
or	CC	O
an	DT	O
amplified	VBN	O
CCG	NNP	O
trinucleotide	JJ	O
repeat	NN	O
fragment	NN	O
.	.	O

The	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
previously	RB	O
uncharacterized	JJ	O
submicroscopic	JJ	O
deletion	NN	O
encompassing	VBG	O
the	DT	O
CCG	NNP	O
repeat	NN	O
,	,	O
the	DT	O
entire	JJ	O
FMR1	NN	O
gene	NN	O
and	CC	O
about	IN	O
2	CD	O
.	.	O

5	CD	O
megabases	NNS	O
of	IN	O
flanking	JJ	O
sequences	NNS	O
.	.	O

This	DT	O
finding	NN	O
confirms	VBZ	O
that	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
phenotype	NN	O
can	MD	O
exist	VB	O
,	,	O
without	IN	O
amplification	NN	O
of	IN	O
the	DT	O
CCG	NNP	O
repeat	NN	O
or	CC	O
cytogenetic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
,	,	O
and	CC	O
that	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
genetically	RB	O
homogeneous	JJ	O
disorder	NN	O
involving	VBG	O
FMR1	NN	O
.	.	O

We	PRP	O
also	RB	O
found	VBD	O
random	JJ	O
X-inactivation	NN	O
in	IN	O
the	DT	O
mother	NN	O
of	IN	O
the	DT	O
patient	NN	O
who	WP	O
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
a	DT	O
carrier	NN	O
of	IN	O
this	DT	O
deletion	NN	O
.	.	O

Confirmation	NN	O
of	IN	O
linkage	NN	O
of	IN	O
Van	NNP	B-Disease
der	NNP	I-Disease
Woude	NNP	I-Disease
syndrome	NN	I-Disease
to	TO	O
chromosome	NN	O
1q32	NN	O
:	:	O
evidence	NN	O
of	IN	O
association	NN	O
with	IN	O
STR	NN	O
alleles	NNS	O
suggests	VBZ	O
possible	JJ	O
unique	JJ	O
origin	NN	O
of	IN	O
the	DT	O
disease	NN	O
mutation	NN	O
.	.	O

Van	NNP	B-Disease
der	NNP	I-Disease
Woude	NNP	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
VWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
craniofacial	JJ	I-Disease
disorder	NN	I-Disease
with	IN	O
high	JJ	O
penetrance	NN	O
and	CC	O
variable	JJ	O
expression	NN	O
.	.	O

Its	PRP$	O
clinical	JJ	O
features	NNS	O
are	VBP	O
variably	RB	O
expressed	VBN	O
,	,	O
but	CC	O
include	VBP	O
cleft	NN	B-Disease
lip	NN	I-Disease
and/or	CC	O
cleft	NN	B-Disease
palate	NN	I-Disease
,	,	O
lip	NN	B-Disease
pits	NNS	I-Disease
and	CC	O
hypodontia	NN	B-Disease
.	.	O

All	DT	O
VWS	NNS	B-Disease
families	NNS	O
studied	VBN	O
to	TO	O
date	NN	O
map	NN	O
the	DT	O
disease	NN	O
gene	NN	O
to	TO	O
a	DT	O
<	JJR	O
2	CD	O
cM	NN	O
region	NN	O
of	IN	O
chromosome	NN	O
1q32	NN	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
locus	NN	O
heterogeneity	NN	O
.	.	O

The	DT	O
aim	NN	O
of	IN	O
this	DT	O
study	NN	O
is	VBZ	O
to	TO	O
refine	VB	O
the	DT	O
localization	NN	O
of	IN	O
the	DT	O
VWS	NN	B-Disease
gene	NN	O
and	CC	O
to	TO	O
further	RB	O
assess	VB	O
possible	JJ	O
heterogeneity	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
four	CD	O
multiplex	JJ	O
VWS	NNS	B-Disease
families	NNS	O
.	.	O

All	DT	O
available	JJ	O
members	NNS	O
were	VBD	O
clinically	RB	O
assessed	VBN	O
and	CC	O
genotyped	VBN	O
for	IN	O
19	CD	O
short	JJ	O
tandem	JJ	O
repeat	NN	O
markers	NNS	O
on	IN	O
chromosome	NN	O
1	CD	O
in	IN	O
the	DT	O
VWS	NNP	B-Disease
candidate	NN	O
gene	NN	O
region	NN	O
.	.	O

We	PRP	O
performed	VBD	O
two-point	JJ	O
and	CC	O
multipoint	JJ	O
limit	NN	O
of	IN	O
detection	NN	O
(	-LRB-	O
LOD	NN	O
)	-RRB-	O
score	NN	O
analyses	NNS	O
using	VBG	O
a	DT	O
high	JJ	O
penetrance	NN	O
autosomal	JJ	O
dominant	JJ	O
model	NN	O
.	.	O

All	DT	O
families	NNS	O
showed	VBD	O
positive	JJ	O
LOD	NN	O
scores	NNS	O
without	IN	O
any	DT	O
recombination	NN	O
in	IN	O
the	DT	O
candidate	NN	O
region	NN	O
.	.	O

The	DT	O
largest	JJS	O
two-point	JJ	O
LOD	NN	O
score	NN	O
was	VBD	O
5	CD	O
.	.	O

87	CD	O
87	CD	O
.	.	O

Our	PRP$	O
assay	NN	O
method	NN	O
for	IN	O
short	JJ	O
tandem	JJ	O
repeat	NN	O
(	-LRB-	O
STR	NN	O
)	-RRB-	O
markers	NNS	O
provided	VBN	O
highly	RB	O
accurate	JJ	O
size	NN	O
estimation	NN	O
of	IN	O
marker	NN	O
allele	NN	O
fragment	NN	O
sizes	NNS	O
,	,	O
and	CC	O
therefore	RB	O
enabled	VBD	O
us	PRP	O
to	TO	O
determine	VB	O
the	DT	O
specific	JJ	O
alleles	NNS	O
segregating	VBG	O
with	IN	O
the	DT	O
VWS	NN	B-Disease
gene	NN	O
in	IN	O
each	DT	O
of	IN	O
our	PRP$	O
four	CD	O
families	NNS	O
.	.	O

We	PRP	O
observed	VBD	O
a	DT	O
striking	JJ	O
pattern	NN	O
of	IN	O
STR	NN	O
allele	NN	O
sharing	VBG	O
at	IN	O
several	JJ	O
closely	RB	O
linked	VBN	O
loci	NNS	O
among	IN	O
our	PRP$	O
four	CD	O
Caucasian	JJ	O
VWS	NNS	B-Disease
families	NNS	O
recruited	VBN	O
at	IN	O
three	CD	O
different	JJ	O
locations	NNS	O
in	IN	O
the	DT	O
US	NNP	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
unique	JJ	O
origin	NN	O
for	IN	O
a	DT	O
mutation	NN	O
responsible	JJ	O
for	IN	O
many	JJ	O
or	CC	O
most	RBS	O
cases	NNS	O
of	IN	O
VWS	NNS	B-Disease
.	.	O

The	DT	O
carrier	NN	O
frequency	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
185delAG	NN	O
mutation	NN	O
is	VBZ	O
approximately	RB	O
1	CD	O
percent	NN	O
in	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
individuals	NNS	O
.	.	O

Since	IN	O
BRCA1	NN	O
,	,	O
the	DT	O
first	JJ	O
major	JJ	O
gene	NN	O
responsible	JJ	O
for	IN	O
inherited	VBN	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
,	,	O
was	VBD	O
cloned	VBN	O
,	,	O
more	JJR	O
than	IN	O
50	CD	O
unique	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
the	DT	O
germline	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

In	IN	O
high-risk	JJ	O
pedigrees	NNS	O
,	,	O
female	JJ	O
carriers	NNS	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
have	VBP	O
an	DT	O
80-90	CD	O
%	NN	O
lifetime	NN	O
risk	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
,	,	O
and	CC	O
a	DT	O
40-50	CD	O
%	NN	O
risk	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
mutation	NN	O
stats	NNS	O
of	IN	O
individuals	NNS	O
unselected	JJ	O
for	IN	O
breast	NN	B-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
has	VBZ	O
not	RB	O
been	VBN	O
determined	VBN	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
known	VBN	O
whether	IN	O
mutations	NNS	O
in	IN	O
such	JJ	O
individuals	NNS	O
confer	VBP	O
the	DT	O
same	JJ	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
as	IN	O
in	IN	O
individuals	NNS	O
from	IN	O
the	DT	O
high-risk	JJ	O
families	NNS	O
studied	VBN	O
so	RB	O
far	RB	O
.	.	O

Following	VBG	O
the	DT	O
finding	NN	O
of	IN	O
a	DT	O
185delAG	NN	O
frameshift	NN	O
mutation	NN	O
in	IN	O
several	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
breast/ovarian	JJ	O
families	NNS	O
,	,	O
we	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
frequency	NN	O
of	IN	O
this	DT	O
mutation	NN	O
in	IN	O
858	CD	O
Ashkenazim	NN	O
seeking	VBG	O
genetic	JJ	O
testing	NN	O
for	IN	O
conditions	NNS	O
unrelated	JJ	O
to	TO	O
cancer	NN	B-Disease
,	,	O
and	CC	O
in	IN	O
815	CD	O
reference	NN	O
individuals	NNS	O
not	RB	O
selected	VBN	O
for	IN	O
ethnic	JJ	O
origin	NN	O
.	.	O

We	PRP	O
observed	VBD	O
the	DT	O
185delAG	NN	O
mutation	NN	O
in	IN	O
0	CD	O
.	.	O

9	CD	O
%	NN	O
of	IN	O
Ashkenazim	NNP	O
(	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
limit	NN	O
,	,	O
0	CD	O
.	.	O

4-1	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
in	IN	O
none	NN	O
of	IN	O
the	DT	O
reference	NN	O
samples	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
suggest	VBP	O
that	IN	O
one	CD	O
in	IN	O
a	DT	O
hundred	CD	O
women	NNS	O
of	IN	O
Ashkenazi	NNP	O
descent	NN	O
may	MD	O
be	VB	O
at	IN	O
especially	RB	O
high	JJ	O
risk	NN	O
of	IN	O
developing	VBG	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Targeted	VBN	O
modification	NN	O
of	IN	O
the	DT	O
apolipoprotein	NN	O
B	NN	O
gene	NN	O
results	VBZ	O
in	IN	O
hypobetalipoproteinemia	NN	B-Disease
and	CC	O
developmental	JJ	B-Disease
abnormalities	NNS	I-Disease
in	IN	O
mice	NNS	O
.	.	O

Familial	JJ	B-Disease
hypobetalipoproteinemia	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
codominant	JJ	I-Disease
disorder	NN	I-Disease
resulting	VBG	O
in	IN	O
a	DT	O
dramatic	JJ	O
reduction	NN	O
in	IN	O
plasma	NN	O
concentrations	NNS	O
of	IN	O
apolipoprotein	NN	O
(	-LRB-	O
apo	NN	O
)	-RRB-	O
B	NN	O
,	,	O
cholesterol	NN	O
,	,	O
and	CC	O
beta-migrating	JJ	O
lipoproteins	NNS	O
.	.	O

A	DT	O
benefit	NN	O
of	IN	O
hypobetalipoproteinemia	NN	B-Disease
is	VBZ	O
that	IN	O
mildly	RB	O
affected	VBN	O
individuals	NNS	O
may	MD	O
be	VB	O
protected	VBN	O
from	IN	O
coronary	JJ	B-Disease
vascular	JJ	I-Disease
disease	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
gene	NN	O
targeting	VBG	O
to	TO	O
generate	VB	O
mice	NNS	O
with	IN	O
a	DT	O
modified	VBN	O
Apob	NN	O
allele	NN	O
.	.	O

Mice	NNS	O
containing	VBG	O
this	DT	O
allele	NN	O
display	VBP	O
all	DT	O
of	IN	O
the	DT	O
hallmarks	NNS	O
of	IN	O
human	JJ	O
hypobetalipoproteinemia	NN	B-Disease
they	PRP	O
produce	VBP	O
a	DT	O
truncated	VBN	O
apoB	NN	O
protein	NN	O
,	,	O
apoB70	NN	O
,	,	O
and	CC	O
have	VBP	O
markedly	RB	O
decreased	VBN	O
plasma	NN	O
concentrations	NNS	O
of	IN	O
apoB	NN	O
,	,	O
beta-lipoproteins	NNS	O
,	,	O
and	CC	O
total	JJ	O
cholesterol	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
mice	NNS	O
manifest	VBP	O
several	JJ	O
characteristics	NNS	O
that	WDT	O
are	VBP	O
occasionally	RB	O
observed	VBN	O
in	IN	O
human	JJ	O
hypobetalipoproteinemia	NN	B-Disease
,	,	O
including	VBG	O
reduced	VBN	O
plasma	NN	O
triglyceride	NN	O
concentrations	NNS	O
,	,	O
fasting	VBG	O
chylomicronemia	NN	B-Disease
,	,	O
and	CC	O
reduced	VBD	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
cholesterol	NN	O
.	.	O

An	DT	O
unexpected	JJ	O
finding	NN	O
is	VBZ	O
that	IN	O
the	DT	O
modified	VBN	O
Apob	NN	O
allele	NN	O
is	VBZ	O
strongly	RB	O
associated	VBN	O
with	IN	O
exencephalus	NN	B-Disease
and	CC	O
hydrocephalus	NN	B-Disease
.	.	O

These	DT	O
mice	NNS	O
should	MD	O
help	VB	O
increase	VB	O
our	PRP$	O
understanding	NN	O
of	IN	O
hypobetalipoproteinemia	NN	B-Disease
,	,	O
atherogenesis	NN	B-Disease
,	,	O
and	CC	O
the	DT	O
etiology	NN	O
of	IN	O
exencephalus	NN	B-Disease
and	CC	O
hydrocephalus	NN	B-Disease
.	.	O

.	.	O

Common	JJ	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
do	VBP	O
not	RB	O
contribute	VB	O
to	TO	O
early	JJ	O
prostate	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
Jewish	JJ	O
men	NNS	O
.	.	O

BACKGROUND	NN	O
Families	NNS	O
with	IN	O
a	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
,	,	O
and	CC	O
subsequently	RB	O
shown	VBN	O
to	TO	O
have	VB	O
terminating	VBG	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
,	,	O
appear	VBP	O
to	TO	O
have	VB	O
a	DT	O
higher	JJR	O
incidence	NN	O
of	IN	O
prostate	NN	B-Disease
cancer	NN	I-Disease
among	IN	O
male	JJ	O
relatives	NNS	O
.	.	O

We	PRP	O
aimed	VBD	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
common	JJ	O
germline	NN	O
mutations	NNS	O
of	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
in	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
men	NNS	O
predisposed	VBD	O
them	PRP	O
to	TO	O
prostate	NN	B-Disease
cancer	NN	I-Disease
.	.	O

METHODS	NNS	O
We	PRP	O
examined	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
83	CD	O
(	-LRB-	O
for	IN	O
BRCA1	NN	O
185delAG	NN	O
)	-RRB-	O
or	CC	O
82	CD	O
(	-LRB-	O
for	IN	O
BRCA2	NN	O
6174delT	NN	O
)	-RRB-	O
Ashkenazi	JJ	O
Jewish	JJ	O
prostate	NN	B-Disease
cancer	NN	I-Disease
patients	NNS	O
,	,	O
most	JJS	O
of	IN	O
whom	WP	O
were	VBD	O
treated	VBN	O
at	IN	O
a	DT	O
relatively	RB	O
young	JJ	O
age	NN	O
,	,	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
germline	NN	O
mutation	NN	O
in	IN	O
each	DT	O
gene	NN	O
seen	VBN	O
in	IN	O
the	DT	O
Ashkenazi	NNP	O
population	NN	O
.	.	O

RESULTS	NNS	O
Our	PRP$	O
study	NN	O
should	MD	O
have	VB	O
been	VBN	O
able	JJ	O
to	TO	O
detect	VB	O
a	DT	O
4-5-fold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
risk	NN	O
of	IN	O
prostate	NN	B-Disease
cancer	NN	I-Disease
due	JJ	O
to	TO	O
mutation	NN	O
of	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
.	.	O

However	RB	O
,	,	O
only	RB	O
one	CD	O
(	-LRB-	O
1	CD	O
.	.	O

15	CD	O
%	NN	O
;	:	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0-3	CD	O
.	.	O

6	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
BRCA1	NN	O
mutant	JJ	O
allele	NN	O
,	,	O
and	CC	O
only	RB	O
two	CD	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
BRCA2	NN	O
mutation	NN	O
(	-LRB-	O
2	CD	O
.	.	O

4	CD	O
%	NN	O
;	:	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
0-6	CD	O
.	.	O

2	CD	O
%	NN	O
)	-RRB-	O
.	.	O

CONCLUSIONS	NNS	O
The	DT	O
incidence	NN	O
of	IN	O
each	DT	O
of	IN	O
the	DT	O
germline	NN	O
mutations	NNS	O
in	IN	O
these	DT	O
prostate	NN	B-Disease
cancer	NN	I-Disease
patients	NNS	O
closely	RB	O
matched	VBD	O
their	PRP$	O
incidence	NN	O
(	-LRB-	O
about	IN	O
1	CD	O
%	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
general	JJ	O
Ashkenazi	NNP	O
Jewish	NNP	O
population	NN	O
.	.	O

This	DT	O
suggests	VBZ	O
that	IN	O
unlike	IN	O
cases	NNS	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
,	,	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
do	VBP	O
not	RB	O
significantly	RB	O
predispose	VB	O
men	NNS	O
to	TO	O
prostate	NN	B-Disease
cancer	NN	I-Disease

Two	CD	O
new	JJ	O
variants	NNS	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
associated	VBN	O
with	IN	O
hereditary	JJ	B-Disease
non-spherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
:	:	O
G6PD	NN	O
Wayne	NNP	O
and	CC	O
G6PD	NNP	O
Huron	NNP	O
.	.	O

Two	CD	O
new	JJ	O
deficient	JJ	O
variants	NNS	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
causing	VBG	O
hereditary	JJ	B-Disease
nonspherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
(	-LRB-	O
HNSHA	NN	B-Disease
)	-RRB-	O
are	VBP	O
described	VBN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
are	VBP	O
unique	JJ	O
and	CC	O
they	PRP	O
have	VBP	O
been	VBN	O
named	VBN	O
G6PD	NNP	O
Wayne	NNP	O
and	CC	O
G6PD	NNP	O
Huron	NNP	O
.	.	O

Patients	NNS	O
with	IN	O
G6PD	NN	O
Wayne	NNP	O
underwent	VBD	O
splenectomy	NN	O
and	CC	O
no	DT	O
objective	JJ	O
improvement	NN	O
was	VBD	O
noted	VBN	O
.	.	O

The	DT	O
patients	NNS	O
with	IN	O
G6PD	NN	O
Huron	NN	O
were	VBD	O
under	IN	O
medical	JJ	O
observation	NN	O
for	IN	O
a	DT	O
considerable	JJ	O
period	NN	O
of	IN	O
time	NN	O
without	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
being	VBG	O
entertained	VBN	O
because	IN	O
the	DT	O
family	NN	O
was	VBD	O
of	IN	O
Northern	JJ	O
European	JJ	O
origin	NN	O
.	.	O

Since	IN	O
sporadic	JJ	O
variants	NNS	O
of	IN	O
G6PD	NN	O
causing	VBG	O
HNSHA	NN	B-Disease
show	NN	O
no	DT	O
special	JJ	O
racial	JJ	O
predilection	NN	O
,	,	O
the	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
should	MD	O
always	RB	O
be	VB	O
considered	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
.	.	O

.	.	O

The	DT	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
gene	NN	O
in	IN	O
North	JJ	O
American	JJ	O
Jewish	JJ	O
populations	NNS	O
:	:	O
geographic	JJ	O
variations	NNS	O
and	CC	O
origin	NN	O
.	.	O

From	IN	O
data	NNS	O
collected	VBN	O
in	IN	O
a	DT	O
North	JJ	O
American	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
heterozygote	NN	O
screening	NN	O
program	NN	O
,	,	O
the	DT	O
TSD	NNP	B-Disease
carrier	NN	O
frequency	NN	O
among	IN	O
46	CD	O
,	,	O
304	CD	O
Jewish	JJ	O
individuals	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
.	.	O

0324	NN	O
(	-LRB-	O
1	CD	O
in	IN	O
31	CD	O
individuals	NNS	O
)	-RRB-	O
.	.	O

This	DT	O
frequency	NN	O
is	VBZ	O
consistent	JJ	O
with	IN	O
earlier	JJR	O
estimates	NNS	O
based	VBN	O
on	IN	O
TSD	NNP	B-Disease
incidence	NN	O
data	NNS	O
.	.	O

TSD	NNP	B-Disease
carrier	NN	O
frequencies	NNS	O
were	VBD	O
then	RB	O
examined	VBN	O
by	IN	O
single	JJ	O
country	NN	O
and	CC	O
single	JJ	O
region	NN	O
of	IN	O
origin	NN	O
in	IN	O
28	CD	O
,	,	O
029	CD	O
Jews	NNPS	O
within	IN	O
this	DT	O
sample	NN	O
for	IN	O
whom	WP	O
such	JJ	O
data	NNS	O
were	VBD	O
available	JJ	O
for	IN	O
analysis	NN	O
.	.	O

Jews	NNS	O
with	IN	O
Polish	JJ	O
and/or	CC	O
Russian	JJ	O
ancestry	NN	O
constituted	VBD	O
88	CD	O
%	NN	O
of	IN	O
this	DT	O
sample	NN	O
and	CC	O
had	VBD	O
a	DT	O
TSD	NNP	B-Disease
carrier	NN	O
frequency	NN	O
of	IN	O
.	.	O

0327	CD	O
.	.	O

No	DT	O
TSD	NN	B-Disease
carriers	NNS	O
were	VBD	O
observed	VBN	O
among	IN	O
the	DT	O
166	CD	O
Jews	NNPS	O
of	IN	O
Near	IN	O
Eastern	NNP	O
origins	NNS	O
.	.	O

Relative	JJ	O
to	TO	O
Jews	NNPS	O
of	IN	O
Polish	NNP	O
and	CC	O
Russian	NNP	O
origins	NNS	O
,	,	O
there	EX	O
was	VBD	O
at	IN	O
least	JJS	O
a	DT	O
twofold	JJ	O
increase	NN	O
in	IN	O
the	DT	O
TSD	NNP	B-Disease
carrier	NN	O
frequency	NN	O
in	IN	O
Jews	NNS	O
of	IN	O
Austrian	JJ	O
,	,	O
Hungarian	JJ	O
,	,	O
and	CC	O
Czechoslovakian	JJ	O
origins	NNS	O
(	-LRB-	O
P	NN	O
less	JJR	O
than	IN	O
.	.	O

005	CD	O
)	-RRB-	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
TSD	NNP	B-Disease
gene	NN	O
proliferated	VBD	O
among	IN	O
the	DT	O
antecedents	NNS	O
of	IN	O
modern	JJ	O
Ashkenazi	NNP	O
Jewry	NNP	O
after	IN	O
the	DT	O
Second	JJ	O
Diaspora	NN	O
(	-LRB-	O
70	CD	O
A.	NN	O
D.	NNP	O
)	-RRB-	O
and	CC	O
before	IN	O
their	PRP$	O
major	JJ	O
migrations	NNS	O
to	TO	O
regions	NNS	O
of	IN	O
Poland	NNP	O
and	CC	O
Russia	NNP	O
(	-LRB-	O
before	IN	O
1100	CD	O
A.	NN	O
D.	NNP	O
)	-RRB-	O
.	.	O

Novel	JJ	O
inherited	VBN	O
mutations	NNS	O
and	CC	O
variable	JJ	O
expressivity	NN	O
of	IN	O
BRCA1	NN	O
alleles	NNS	O
,	,	O
including	VBG	O
the	DT	O
founder	NN	O
mutation	NN	O
185delAG	NN	O
in	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
families	NNS	O
.	.	O

Thirty-seven	CD	O
families	NNS	O
with	IN	O
four	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
or	CC	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
were	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
.	.	O

Twelve	CD	O
different	JJ	O
germ-line	NN	O
mutations	NNS	O
,	,	O
four	CD	O
novel	JJ	O
and	CC	O
eight	CD	O
previously	RB	O
observed	VBN	O
,	,	O
were	VBD	O
detected	VBN	O
in	IN	O
16	CD	O
families	NNS	O
.	.	O

Five	CD	O
families	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
descent	NN	O
carried	VBD	O
the	DT	O
185delAG	NN	O
mutation	NN	O
and	CC	O
shared	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
at	IN	O
eight	CD	O
polymorphic	JJ	O
markers	NNS	O
spanning	VBG	O
approximately	RB	O
850	CD	O
kb	NN	O
at	IN	O
BRCA1	NN	O
.	.	O

Expressivity	NN	O
of	IN	O
185delAG	NNP	O
in	IN	O
these	DT	O
families	NNS	O
varied	VBD	O
,	,	O
from	IN	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
without	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Mutation	NN	O
4184delTCAA	NN	O
occurred	VBD	O
independently	RB	O
in	IN	O
two	CD	O
families	NNS	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
,	,	O
penetrance	NN	O
was	VBD	O
complete	JJ	O
,	,	O
with	IN	O
females	NNS	O
developing	VBG	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
or	CC	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
and	CC	O
the	DT	O
male	JJ	O
carrier	NN	O
developing	VBG	O
prostatic	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
whereas	IN	O
,	,	O
in	IN	O
the	DT	O
other	JJ	O
family	NN	O
,	,	O
penetrance	NN	O
was	VBD	O
incomplete	JJ	O
and	CC	O
only	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
occurred	VBD	O
,	,	O
diagnosed	VBD	O
at	IN	O
ages	NNS	O
38-81	CD	O
years	NNS	O
.	.	O

Two	CD	O
novel	JJ	O
nonsense	NN	O
mutations	NNS	O
led	VBD	O
to	TO	O
the	DT	O
loss	NN	O
of	IN	O
mutant	JJ	O
BRCA1	NN	O
transcript	NN	O
in	IN	O
families	NNS	O
with	IN	O
10	CD	O
and	CC	O
6	CD	O
cases	NNS	O
of	IN	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
and	CC	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

A	DT	O
665-nt	JJ	O
segment	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
3-UTR	NN	O
and	CC	O
1	CD	O
.	.	O

3	CD	O
kb	NN	O
of	IN	O
genomic	JJ	O
sequence	NN	O
including	VBG	O
the	DT	O
putative	JJ	O
promoter	NN	O
region	NN	O
were	VBD	O
invariant	JJ	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
analysis	NN	O
in	IN	O
13	CD	O
families	NNS	O
without	IN	O
coding-sequence	NN	O
mutations	NNS	O
.	.	O

Overall	RB	O
in	IN	O
our	PRP$	O
series	NN	O
,	,	O
BRCA1	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
26	CD	O
families	NNS	O
16	CD	O
with	IN	O
positive	JJ	O
BRCA1	NN	O
lod	NN	O
scores	NNS	O
,	,	O
7	CD	O
with	IN	O
negative	JJ	O
lod	NN	O
scores	NNS	O
(	-LRB-	O
reflecting	VBG	O
multiple	JJ	O
sporadic	JJ	O
breast	NN	B-Disease
cancers	NNS	I-Disease
)	-RRB-	O
,	,	O
and	CC	O
3	CD	O
not	RB	O
tested	VBN	O
for	IN	O
linkage	NN	O
.	.	O

Three	CD	O
other	JJ	O
families	NNS	O
have	VBP	O
positive	JJ	O
lod	NN	O
scores	NNS	O
for	IN	O
linkage	NN	O
to	TO	O
BRCA2	NN	O
,	,	O
but	CC	O
13	CD	O
families	NNS	O
without	IN	O
detected	VBN	O
BRCA1	NN	O
mutations	NNS	O
have	VBP	O
negative	JJ	O
lod	NN	O
scores	NNS	O
for	IN	O
both	DT	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
.	.	O

Transgenic	JJ	O
mice	NNS	O
carrying	VBG	O
large	JJ	O
human	JJ	O
genomic	JJ	O
sequences	NNS	O
with	IN	O
expanded	VBN	O
CTG	NNP	O
repeat	NN	O
mimic	VB	O
closely	RB	O
the	DT	O
DM	NN	B-Disease
CTG	NNP	O
repeat	NN	O
intergenerational	JJ	O
and	CC	O
somatic	JJ	O
instability	NN	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
CTG	NNP	O
repeat	NN	O
expansion	NN	O
in	IN	O
the	DT	O
3UTR	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
protein	NN	O
kinase	NN	O
(	-LRB-	O
DMPK	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

A	DT	O
very	RB	O
high	JJ	O
level	NN	O
of	IN	O
instability	NN	O
is	VBZ	O
observed	VBN	O
through	IN	O
successive	JJ	O
generations	NNS	O
and	CC	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
repeat	NN	O
is	VBZ	O
generally	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
and	CC	O
with	IN	O
age	NN	O
at	IN	O
onset	NN	O
.	.	O

Furthermore	RB	O
,	,	O
tissues	NNS	O
from	IN	O
DM	NN	B-Disease
patients	NNS	O
exhibit	VBP	O
somatic	JJ	O
mosaicism	NN	O
that	WDT	O
increases	VBZ	O
with	IN	O
age	NN	O
.	.	O

We	PRP	O
generated	VBD	O
transgenic	JJ	O
mice	NNS	O
carrying	VBG	O
large	JJ	O
human	JJ	O
genomic	JJ	O
sequences	NNS	O
with	IN	O
20	CD	O
,	,	O
55	CD	O
or	CC	O
>	JJR	O
300	CD	O
CTG	NN	O
,	,	O
cloned	VBN	O
from	IN	O
patients	NNS	O
from	IN	O
the	DT	O
same	JJ	O
affected	JJ	O
DM	NN	B-Disease
family	NN	O
.	.	O

Using	VBG	O
large	JJ	O
human	JJ	O
flanking	JJ	O
sequences	NNS	O
and	CC	O
a	DT	O
large	JJ	O
amplification	NN	O
,	,	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
the	DT	O
intergenerational	JJ	O
CTG	NNP	O
repeat	NN	O
instability	NN	O
is	VBZ	O
reproduced	VBN	O
in	IN	O
mice	NNS	O
,	,	O
with	IN	O
a	DT	O
strong	JJ	O
bias	NN	O
towards	IN	O
expansions	NNS	O
and	CC	O
with	IN	O
the	DT	O
same	JJ	O
sex	NN	O
-	:	O
and	CC	O
size-dependent	JJ	O
characteristics	NNS	O
as	IN	O
in	IN	O
humans	NNS	O
.	.	O

Moreover	RB	O
,	,	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
instability	NN	O
,	,	O
increasing	VBG	O
with	IN	O
age	NN	O
,	,	O
can	MD	O
be	VB	O
observed	VBN	O
in	IN	O
tissues	NNS	O
and	CC	O
in	IN	O
sperm	NN	O
.	.	O

Although	IN	O
we	PRP	O
did	VBD	O
not	RB	O
observe	VB	O
dramatic	JJ	O
expansions	NNS	O
(	-LRB-	O
or	CC	O
big	JJ	O
jumps	NNS	O
over	IN	O
several	JJ	O
hundred	CD	O
CTG	NNP	O
repeats	NNS	O
)	-RRB-	O
as	IN	O
in	IN	O
congenital	JJ	O
forms	NNS	O
of	IN	O
DM	NN	B-Disease
,	,	O
our	PRP$	O
model	NN	O
carrying	VBG	O
>	JJR	O
300	CD	O
CTG	NN	O
is	VBZ	O
the	DT	O
first	JJ	O
to	TO	O
show	VB	O
instability	NN	O
so	RB	O
close	RB	O
to	TO	O
the	DT	O
human	JJ	O
DM	NN	B-Disease
situation	NN	O
.	.	O

Our	PRP$	O
three	CD	O
models	NNS	O
carrying	VBG	O
different	JJ	O
sizes	NNS	O
of	IN	O
CTG	NNP	O
repeat	NN	O
provide	VBP	O
insight	NN	O
on	IN	O
the	DT	O
different	JJ	O
factors	NNS	O
modulating	VBG	O
the	DT	O
CTG	NNP	O
repeat	NN	O
instability	NN	O
.	.	O

.	.	O

Linkage	NN	O
of	IN	O
gene	NN	O
for	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
MHC	NN	O
in	IN	O
man	NN	O
.	.	O

Family	NNP	O
study	NN	O
of	IN	O
a	DT	O
further	JJ	O
case	NN	O
.	.	O

Close	JJ	O
linkage	NN	O
between	IN	O
HL-A	NN	O
and	CC	O
C2	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
first	RB	O
reported	VBN	O
by	IN	O
FU	NNP	O
and	CC	O
co-workers	NNS	O
in	IN	O
1974	CD	O
.	.	O

We	PRP	O
present	VBP	O
here	RB	O
a	DT	O
pedigree	NN	O
of	IN	O
a	DT	O
31-year-old	JJ	O
C2-deficient	JJ	B-Disease
individual	NN	O
with	IN	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Hodgkins	NNS	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
following	VBG	O
markers	NNS	O
were	VBD	O
tested	VBN	O
C2	NN	O
levels	NNS	O
,	,	O
factor	NN	O
B	NN	O
polymorphism	NN	O
,	,	O
blood	NN	O
groups	NNS	O
,	,	O
and	CC	O
enzyme	NN	O
typing	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
close	VB	O
linkage	NN	O
between	IN	O
HL-A	NN	O
and	CC	O
C2	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
both	DT	O
parents	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
Bf	NN	O
(	-LRB-	O
HL-A	NN	O
linked	VBN	O
,	,	O
electrophoretic	JJ	O
variation	NN	O
of	IN	O
B	NN	O
)	-RRB-	O
.	.	O

The	DT	O
two	CD	O
HL-A	NN	O
haplotypes	NNS	O
closely	RB	O
linked	VBN	O
to	TO	O
C2	NN	B-Disease
deficiency	NN	I-Disease
are	VBP	O
different	JJ	O
2	CD	O
,	,	O
W18	NN	O
and	CC	O
W24	NN	O
,	,	O
W18	NN	O
.	.	O

They	PRP	O
share	VBP	O
,	,	O
however	RB	O
,	,	O
the	DT	O
SD2	NN	O
antigen	NN	O
W18	NN	O
and	CC	O
the	DT	O
LD	NN	O
type	NN	O
7a	NN	O
.	.	O

.	.	O

Age	NN	O
of	IN	O
onset	NN	O
in	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
:	:	O
sex	NN	O
specific	JJ	O
influence	NN	O
of	IN	O
apolipoprotein	NN	O
E	NN	O
genotype	NN	O
and	CC	O
normal	JJ	O
CAG	NN	O
repeat	NN	O
length	NN	O
.	.	O

Age	NN	O
of	IN	O
onset	NN	O
(	-LRB-	O
AO	JJ	O
)	-RRB-	O
of	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
correlated	VBN	O
with	IN	O
the	DT	O
length	NN	O
of	IN	O
an	DT	O
expanded	VBN	O
CAG	NN	O
repeat	NN	O
in	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
.	.	O

Apolipoprotein	NN	O
E	NN	O
(	-LRB-	O
APOE	NN	O
)	-RRB-	O
genotype	NN	O
,	,	O
in	IN	O
turn	NN	O
,	,	O
is	VBZ	O
known	VBN	O
to	TO	O
influence	VB	O
AO	JJ	O
in	IN	O
Alzheimer	NN	B-Disease
disease	NN	I-Disease
,	,	O
rendering	VBG	O
the	DT	O
APOE	NN	O
gene	NN	O
a	DT	O
likely	JJ	O
candidate	NN	O
to	TO	O
affect	VB	O
AO	JJ	O
in	IN	O
other	JJ	O
neurological	JJ	B-Disease
diseases	NNS	I-Disease
too	RB	O
.	.	O

We	PRP	O
therefore	RB	O
determined	VBD	O
APOE	NNP	O
genotype	NN	O
and	CC	O
normal	JJ	O
CAG	NN	O
repeat	NN	O
length	NN	O
in	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
for	IN	O
138	CD	O
HD	NN	B-Disease
patients	NNS	O
who	WP	O
were	VBD	O
previously	RB	O
analysed	VBN	O
with	IN	O
respect	NN	O
to	TO	O
CAG	NN	O
repeat	NN	O
length	NN	O
.	.	O

Genotyping	VBG	O
for	IN	O
APOE	NNP	O
was	VBD	O
performed	VBN	O
blind	JJ	O
to	TO	O
clinical	JJ	O
information	NN	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
highlighting	VBG	O
the	DT	O
effect	NN	O
of	IN	O
the	DT	O
normal	JJ	O
repeat	NN	O
length	NN	O
upon	IN	O
AO	JJ	O
in	IN	O
maternally	RB	O
inherited	VBN	O
HD	NN	B-Disease
and	CC	O
in	IN	O
male	JJ	O
patients	NNS	O
,	,	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
APOE	NNP	O
epsilon2epsilon3	NN	O
genotype	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
significantly	RB	O
earlier	JJR	O
AO	JJ	O
in	IN	O
males	NNS	O
than	IN	O
in	IN	O
females	NNS	O
.	.	O

Such	PDT	O
a	DT	O
sex	NN	O
difference	NN	O
in	IN	O
AO	JJ	O
was	VBD	O
not	RB	O
apparent	JJ	O
for	IN	O
any	DT	O
of	IN	O
the	DT	O
other	JJ	O
APOE	NN	O
genotypes	NNS	O
.	.	O

Our	PRP$	O
findings	NNS	O
suggest	VBP	O
that	IN	O
subtle	JJ	O
differences	NNS	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
neurodegeneration	NN	B-Disease
in	IN	O
HD	NN	B-Disease
may	MD	O
allow	VB	O
interacting	VBG	O
genes	NNS	O
to	TO	O
exert	VB	O
gender	NN	O
specific	JJ	O
effects	NNS	O
upon	IN	O
AO	JJ	O
.	.	O

Genetic	JJ	O
linkage	NN	O
map	NN	O
of	IN	O
six	CD	O
polymorphic	JJ	O
DNA	NN	O
markers	NNS	O
around	IN	O
the	DT	O
gene	NN	O
for	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
on	IN	O
chromosome	NN	O
5	CD	O
.	.	O

A	DT	O
genetic	JJ	O
linkage	NN	O
map	NN	O
of	IN	O
six	CD	O
polymorphic	JJ	O
DNA	NN	O
markers	NNS	O
close	RB	O
to	TO	O
the	DT	O
gene	NN	O
(	-LRB-	O
APC	NN	O
)	-RRB-	O
for	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
on	IN	O
chromosome	NN	O
5q	NN	O
is	VBZ	O
reported	VBN	O
.	.	O

One	CD	O
hundred	CD	O
fifty-five	CD	O
typed	VBD	O
members	NNS	O
of	IN	O
nine	CD	O
FAP	NN	B-Disease
kindred	NN	O
provided	VBD	O
more	JJR	O
than	IN	O
90	CD	O
meioses	NNS	O
for	IN	O
linkage	NN	O
analysis	NN	O
.	.	O

A	DT	O
number	NN	O
of	IN	O
crucial	JJ	O
recombination	NN	O
events	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
which	WDT	O
are	VBP	O
informative	JJ	O
at	IN	O
three	CD	O
or	CC	O
more	JJR	O
loci	NNS	O
,	,	O
allowing	VBG	O
confident	JJ	O
ordering	VBG	O
of	IN	O
parts	NNS	O
of	IN	O
the	DT	O
map	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
,	,	O
with	IN	O
all	DT	O
families	NNS	O
showing	VBG	O
linkage	NN	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
chromosome	NN	O
5	CD	O
marker	NN	O
to	TO	O
the	DT	O
gene	NN	O
.	.	O

Recombination	NN	O
data	NNS	O
and	CC	O
two-point	JJ	O
linkage	NN	O
analysis	NN	O
support	VBP	O
a	DT	O
locus	NN	O
order	NN	O
of	IN	O
centromere-pi	JJ	O
227-C11P11-ECB27-L5	NN	O
.	.	O

62-APC-EF5	CD	O
62-APC-EF5	NN	O
.	.	O

44-YN5	NN	O
44-YN5	NN	O
.	.	O

48-telomer	JJ	O
e	LS	O
,	,	O
although	IN	O
EF5	NN	O
.	.	O

44	CD	O
could	MD	O
lie	VB	O
in	IN	O
the	DT	O
interval	NN	O
L5	NN	O
.	.	O

62-APC	NN	O
or	CC	O
ECB27-L5	NN	O
.	.	O

62	CD	O
.	.	O

No	DT	O
recombinants	NNS	O
were	VBD	O
identified	VBN	O
between	IN	O
APC	NN	O
and	CC	O
either	CC	O
EF5	NN	O
.	.	O

44	CD	O
or	CC	O
YN5	NN	O
.	.	O

48	CD	O
,	,	O
but	CC	O
published	VBN	O
deletion	NN	O
mapping	NN	O
in	IN	O
colorectal	JJ	B-Disease
carcinomas	NNS	I-Disease
and	CC	O
linkage	NN	O
analysis	NN	O
in	IN	O
FAP	NN	B-Disease
suggest	VBP	O
that	IN	O
YN5	NN	O
.	.	O

48	CD	O
is	VBZ	O
1-3	CD	O
cM	NN	O
from	IN	O
APC	NN	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
suggests	VBZ	O
that	IN	O
YN5	NN	O
.	.	O

48	CD	O
and	CC	O
L5	NN	O
.	.	O

62	CD	O
delineate	VBP	O
a	DT	O
small	JJ	O
region	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
within	IN	O
which	WDT	O
the	DT	O
EF5	NN	O
.	.	O

44	CD	O
locus	NN	O
lies	VBZ	O
very	RB	O
close	JJ	O
to	TO	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

These	DT	O
data	NNS	O
not	RB	O
only	RB	O
allow	VB	O
use	NN	O
of	IN	O
flanking	JJ	O
markers	NNS	O
for	IN	O
presymptomatic	JJ	O
diagnosis	NN	O
of	IN	O
FAP	NN	B-Disease
but	CC	O
also	RB	O
provide	VBP	O
a	DT	O
high-density	JJ	O
map	NN	O
of	IN	O
the	DT	O
region	NN	O
for	IN	O
isolation	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
itself	PRP	O
and	CC	O
for	IN	O
further	JJ	O
assessment	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
chromosome	NN	O
5	CD	O
deletions	NNS	O
in	IN	O
the	DT	O
biology	NN	O
of	IN	O
sporadic	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
novel	JJ	O
arginine	NN	O
vasopressin	NN	O
defect	NN	O
by	IN	O
dideoxy	JJ	O
fingerprinting	NN	O
.	.	O

Autosomal	JJ	B-Disease
dominant	JJ	I-Disease
neurohypophyseal	JJ	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
is	VBZ	O
a	DT	O
familial	JJ	O
form	NN	O
of	IN	O
diabetes	NN	B-Disease
insipidus	NN	I-Disease
.	.	O

This	DT	O
disorder	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
variable	JJ	O
levels	NNS	O
of	IN	O
arginine	NN	O
vasopressin	NN	O
(	-LRB-	O
AVP	NN	O
)	-RRB-	O
and	CC	O
diabetes	NN	B-Disease
insipidus	NN	I-Disease
of	IN	O
varying	VBG	O
severity	NN	O
,	,	O
which	WDT	O
responds	VBZ	O
to	TO	O
exogenous	JJ	O
AVP	NN	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
neurohypophyseal	JJ	I-Disease
diabetes	NN	I-Disease
insipidus	NN	I-Disease
,	,	O
the	DT	O
AVP	NN	O
genes	NNS	O
of	IN	O
members	NNS	O
of	IN	O
a	DT	O
large	JJ	O
kindred	NN	O
were	VBD	O
analyzed	VBN	O
.	.	O

A	DT	O
new	JJ	O
method	NN	O
,	,	O
called	VBN	O
dideoxy	JJ	O
fingerprinting	NN	O
,	,	O
was	VBD	O
used	VBN	O
to	TO	O
detect	VB	O
an	DT	O
AVP	NN	O
mutation	NN	O
that	WDT	O
was	VBD	O
characterized	VBN	O
by	IN	O
DNA	NN	O
sequencing	NN	O
.	.	O

The	DT	O
novel	JJ	O
defect	NN	O
found	VBN	O
changes	NNS	O
the	DT	O
last	JJ	O
codon	NN	O
of	IN	O
the	DT	O
AVP	NN	O
signal	NN	O
peptide	NN	O
from	IN	O
alanine	NN	O
to	TO	O
threonine	NN	O
,	,	O
which	WDT	O
should	MD	O
perturb	VB	O
cleavage	NN	O
of	IN	O
mature	JJ	O
AVP	NN	O
from	IN	O
its	PRP$	O
precursor	NN	O
protein	NN	O
and	CC	O
inhibit	VB	O
its	PRP$	O
secretion	NN	O
or	CC	O
action	NN	O
.	.	O

.	.	O

Association	NNP	O
of	IN	O
the	DT	O
APC	NN	B-Disease
tumor	NN	I-Disease
suppressor	NN	O
protein	NN	O
with	IN	O
catenins	NNS	O
.	.	O

Mutations	NNS	O
of	IN	O
APC	NN	O
appear	VBP	O
to	TO	O
initiate	VB	O
sporadic	JJ	O
and	CC	O
inherited	VBN	O
forms	NNS	O
of	IN	O
human	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Although	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
been	VBN	O
well	RB	O
characterized	VBN	O
,	,	O
little	JJ	O
is	VBZ	O
known	VBN	O
about	IN	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
product	NN	O
.	.	O

Two	CD	O
cellular	JJ	O
proteins	NNS	O
that	WDT	O
associate	VBP	O
with	IN	O
APC	NN	B-Disease
were	VBD	O
identified	VBN	O
by	IN	O
nucleotide	NN	O
sequence	NN	O
analysis	NN	O
and	CC	O
peptide	NN	O
mapping	NN	O
as	IN	O
the	DT	O
E-cadherin-associated	JJ	O
proteins	NNS	O
alpha	NN	O
-	:	O
and	CC	O
beta-catenin	NN	O
.	.	O

A	DT	O
27-residue	JJ	O
fragment	NN	O
of	IN	O
APC	NN	O
containing	VBG	O
a	DT	O
15-amino	JJ	O
acid	NN	O
repeat	NN	O
was	VBD	O
sufficient	JJ	O
for	IN	O
the	DT	O
interaction	NN	O
with	IN	O
the	DT	O
catenins	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
an	DT	O
important	JJ	O
link	NN	O
between	IN	O
tumor	NN	B-Disease
initiation	NN	O
and	CC	O
cell	NN	O
adhesion	NN	O
.	.	O

.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
gene	NN	O
for	IN	O
muscle-type	JJ	O
creatine	NN	O
kinase	NN	O
(	-LRB-	O
CKMM	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
genetic	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
gene	NN	O
for	IN	O
creatine	NN	O
kinase	NN	O
muscle	NN	O
type	NN	O
(	-LRB-	O
CKMM	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
gene	NN	O
for	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
a	DT	O
panel	NN	O
of	IN	O
65	CD	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
families	NNS	O
from	IN	O
Canada	NNP	O
and	CC	O
the	DT	O
Netherlands	NNP	O
,	,	O
a	DT	O
maximum	NN	O
lod	NN	O
score	NN	O
(	-LRB-	O
Zmax	NN	O
)	-RRB-	O
of	IN	O
22	CD	O
.	.	O

8	CD	O
at	IN	O
a	DT	O
recombination	NN	O
frequency	NN	O
(	-LRB-	O
theta	NN	O
)	-RRB-	O
of	IN	O
0	CD	O
.	.	O

03	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

Tight	JJ	O
linkage	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
for	IN	O
CKMM	NNP	O
and	CC	O
the	DT	O
gene	NN	O
for	IN	O
apolipoprotein	NN	O
C2	NN	O
(	-LRB-	O
ApoC2	NN	O
)	-RRB-	O
.	.	O

This	DT	O
establishes	VBZ	O
CKMM	NNP	O
as	IN	O
a	DT	O
useful	JJ	O
marker	NN	O
for	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease

Discordant	JJ	O
clinical	JJ	O
outcome	NN	O
in	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
relatives	NNS	O
showing	VBG	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
>	JJR	O
700	CD	O
repeats	NNS	O
.	.	O

A	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
family	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
which	WDT	O
discordant	JJ	O
DM	NN	B-Disease
phenotypes	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
children	NNS	O
of	IN	O
two	CD	O
affected	JJ	O
sisters	NNS	O
with	IN	O
similar	JJ	O
CTG	NNP	O
expansion	NN	O
and	CC	O
clinical	JJ	O
manifestations	NNS	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
congenital	JJ	O
as	RB	O
well	RB	O
as	IN	O
early	JJ	O
severe	JJ	O
childhood	NN	O
and	CC	O
later	RB	O
childhood	NN	O
onset	NN	O
DM	NN	B-Disease
coexist	VBP	O
.	.	O

This	DT	O
observation	NN	O
strengthens	VBZ	O
the	DT	O
limited	JJ	O
ability	NN	O
of	IN	O
lymphocytes	NNS	O
CTG	NNP	O
repeat	NN	O
number	NN	O
analysis	NN	O
in	IN	O
predicting	VBG	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
DM	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

Constitutional	NNP	O
von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
(	-LRB-	O
VHL	NN	B-Disease
)	-RRB-	O
gene	NN	O
deletions	NNS	O
detected	VBN	O
in	IN	O
VHL	NN	B-Disease
families	NNS	O
by	IN	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	I-Disease
VHL	NN	I-Disease
)	-RRB-	I-Disease
disease	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominantly	RB	I-Disease
inherited	VBN	I-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
predisposing	VBG	O
to	TO	O
a	DT	O
variety	NN	O
of	IN	O
tumor	NN	B-Disease
types	NNS	O
that	WDT	O
include	VBP	O
retinal	JJ	O
hemangioblastomas	NNS	B-Disease
,	,	O
hemangioblastomas	NNS	B-Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
,	,	O
pancreatic	JJ	B-Disease
cysts	NNS	I-Disease
and	CC	I-Disease
tumors	NNS	I-Disease
,	,	O
pheochromocytomas	NNS	B-Disease
,	,	O
endolymphatic	JJ	B-Disease
sac	NN	I-Disease
tumors	NNS	I-Disease
,	,	O
and	CC	O
epididymal	JJ	B-Disease
cystadenomas	NNS	I-Disease
[	-LRB-	O
W.	NNP	O
M.	NNP	O
Linehan	NNP	O
et	FW	O
al.	FW	O
,	,	O
J.	NNP	O
Am	NNP	O
.	.	O

Med	NNP	O
.	.	O

Assoc.	NNP	O
,	,	O
273	CD	O
564-570	CD	O
,	,	O
1995	CD	O
;	:	O
E.	NNP	O
A.	NNP	O
Maher	NNP	O
and	CC	O
W.	NNP	O
G.	NNP	O
Kaelin	NNP	O
,	,	O
Jr.	NNP	O
,	,	O
Medicine	NNP	O
(	-LRB-	O
Baltimore	NNP	O
)	-RRB-	O
,	,	O
76	CD	O
381-391	CD	O
,	,	O
1997	CD	O
;	:	O
W.	NNP	O
M.	NNP	O
Linehan	NNP	O
and	CC	O
R.	NNP	O
D.	NNP	O
Klausner	NNP	O
,	,	O
In	NNP	O
B.	NNP	O
Vogelstein	NNP	O
and	CC	O
K.	NNP	O
Kinzler	NNP	O
(	-LRB-	O
eds	NNS	O
.	.	O
)	-RRB-	O

,	,	O
The	DT	O
Genetic	JJ	O
Basis	NN	O
of	IN	O
Human	JJ	O
Cancer	NN	O
,	,	O
pp.	VBP	O
455-473	CD	O
,	,	O
McGraw-Hill	NNP	O
,	,	O
1998	CD	O
]	-RRB-	O
.	.	O

The	DT	O
VHL	NN	B-Disease
gene	NN	O
was	VBD	O
localized	JJ	O
to	TO	O
chromosome	NN	O
3p25-26	NN	O
and	CC	O
cloned	VBN	O
[	-LRB-	O
F.	NNP	O
Latif	NNP	O
et	FW	O
al.	FW	O
,	,	O
Science	NNP	O
(	-LRB-	O
Washington	NNP	O
DC	NNP	O
)	-RRB-	O
,	,	O
260	CD	O
1317-1320	CD	O
,	,	O
1993	CD	O
]	-RRB-	O
.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
the	DT	O
majority	NN	O
of	IN	O
VHL	NN	B-Disease
kindreds	NNS	O
.	.	O

The	DT	O
reported	VBN	O
frequency	NN	O
of	IN	O
detection	NN	O
of	IN	O
VHL	NN	B-Disease
germline	NN	O
mutations	NNS	O
has	VBZ	O
varied	VBN	O
from	IN	O
39	CD	O
to	TO	O
80	CD	O
%	NN	O
(	-LRB-	O
J.	NNP	O
M.	NNP	O
Whaley	NNP	O
et	FW	O
al.	FW	O
,	,	O
Am	VBP	O
.	.	O

J.	NNP	O
Hum	NNP	O
.	.	O

Genet.	NNP	O
,	,	O
55	CD	O
1092-1102	CD	O
,	,	O
1994	CD	O
;	:	O
Clinical	JJ	O
Research	NNP	O
Group	NNP	O
for	IN	O
Japan	NNP	O
,	,	O
Hum	NNP	O
.	.	O

Mol	NNP	O
.	.	O

Genet.	NNP	O
,	,	O
4	CD	O
2233-2237	CD	O
,	,	O
1995	CD	O
;	:	O
F.	NNP	O
Chen	NNP	O
et	FW	O
al.	FW	O
,	,	O
Hum	NNP	O
.	.	O

Mutat.	NNP	O
,	,	O
5	CD	O
66-75	CD	O
,	,	O
1995	CD	O
;	:	O
E.	NNP	O
R.	NNP	O
Maher	NNP	O
et	FW	O
al.	FW	O
,	,	O
J.	NNP	O
Med	NNP	O
.	.	O

Genet.	NNP	O
,	,	O
33	CD	O
328-332	CD	O
,	,	O
1996	CD	O
;	:	O
B.	NNP	O
Zbar	NNP	O
,	,	O
Cancer	NNP	O
Surv.	NNP	O
,	,	O
25	CD	O
219-232	CD	O
,	,	O
1995	CD	O
)	-RRB-	O
.	.	O

Recently	RB	O
a	DT	O
quantitative	JJ	O
Southern	NN	O
blotting	NN	O
procedure	NN	O
was	VBD	O
found	VBN	O
to	TO	O
improve	VB	O
this	DT	O
frequency	NN	O
(	-LRB-	O
C.	FW	O
Stolle	FW	O
et	FW	O
al.	FW	O
,	,	O
Hum	NNP	O
.	.	O

Mutat.	NNP	O
,	,	O
12	CD	O
417-423	CD	O
,	,	O
1998	CD	O
)	-RRB-	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
use	NN	O
of	IN	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
(	-LRB-	O
FISH	NN	O
)	-RRB-	O
as	IN	O
a	DT	O
method	NN	O
to	TO	O
detect	VB	O
and	CC	O
characterize	VB	O
VHL	NN	B-Disease
germline	NN	O
deletions	NNS	O
.	.	O

We	PRP	O
reexamined	VBD	O
a	DT	O
group	NN	O
of	IN	O
VHL	NN	B-Disease
patients	NNS	O
shown	VBN	O
previously	RB	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
and	CC	O
sequencing	NN	O
analysis	NN	O
not	RB	O
to	TO	O
harbor	VB	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NN	B-Disease
locus	NN	O
.	.	O

We	PRP	O
found	VBD	O
constitutional	JJ	O
deletions	NNS	O
in	IN	O
29	CD	O
of	IN	O
30	CD	O
VHL	NN	B-Disease
patients	NNS	O
in	IN	O
this	DT	O
group	NN	O
using	VBG	O
cosmid	NN	O
and	CC	O
P1	NN	O
probes	NNS	O
that	WDT	O
cover	VBP	O
the	DT	O
VHL	NN	B-Disease
locus	NN	O
.	.	O

We	PRP	O
then	RB	O
tested	VBD	O
six	CD	O
phenotypically	RB	O
normal	JJ	O
offspring	NN	O
from	IN	O
four	CD	O
of	IN	O
these	DT	O
VHL	NN	B-Disease
families	NNS	O
two	CD	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
the	DT	O
deletion	NN	O
and	CC	O
the	DT	O
other	JJ	O
four	CD	O
were	VBD	O
deletion-free	JJ	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
germline	NN	O
mosaicism	NN	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
one	CD	O
family	NN	O
.	.	O

In	IN	O
sum	NN	O
,	,	O
FISH	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
a	DT	O
simple	JJ	O
and	CC	O
reliable	JJ	O
method	NN	O
to	TO	O
detect	VB	O
VHL	NN	B-Disease
germline	NN	O
deletions	NNS	O
and	CC	O
practically	RB	O
useful	JJ	O
in	IN	O
cases	NNS	O
where	WRB	O
other	JJ	O
methods	NNS	O
of	IN	O
screening	NN	O
have	VBP	O
failed	VBN	O
to	TO	O
detect	VB	O
a	DT	O
VHL	NN	B-Disease
gene	NN	I-Disease
abnormality	NN	I-Disease

Aberrant	JJ	O
subcellular	JJ	O
localization	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
BRCA1	NN	O
gene	NN	O
product	NN	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
220-kilodalton	JJ	O
nuclear	JJ	O
phosphoprotein	NN	O
in	IN	O
normal	JJ	O
cells	NNS	O
,	,	O
including	VBG	O
breast	NN	O
ductal	JJ	O
epithelial	JJ	O
cells	NNS	O
,	,	O
and	CC	O
in	IN	O
18	CD	O
of	IN	O
20	CD	O
tumor	NN	B-Disease
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
tissues	NNS	O
other	JJ	O
than	IN	O
breast	NN	O
and	CC	O
ovary	NN	O
.	.	O

In	IN	O
16	CD	O
of	IN	O
17	CD	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
lines	NNS	O
and	CC	O
17	CD	O
of	IN	O
17	CD	O
samples	NNS	O
of	IN	O
cells	NNS	O
obtained	VBN	O
from	IN	O
malignant	JJ	O
effusions	NNS	O
,	,	O
however	RB	O
,	,	O
BRCA1	NN	O
localized	JJ	O
mainly	RB	O
in	IN	O
cytoplasm	NN	O
.	.	O

Absence	NN	O
of	IN	O
BRCA1	NN	O
or	CC	O
aberrant	JJ	O
subcellular	JJ	O
location	NN	O
was	VBD	O
also	RB	O
observed	VBN	O
to	TO	O
a	DT	O
variable	JJ	O
extent	NN	O
in	IN	O
histological	JJ	O
sections	NNS	O
of	IN	O
many	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
biopsies	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NN	B-Disease
abnormalities	NNS	I-Disease
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
many	JJ	O
breast	NN	B-Disease
cancers	NNS	I-Disease
,	,	O
sporadic	JJ	O
as	RB	O
well	RB	O
as	IN	O
familial	JJ	O
.	.	O

.	.	O

HLA	NN	O
B27	NN	O
and	CC	O
the	DT	O
genetics	NNS	O
of	IN	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
.	.	O

One	CD	O
hundred	CD	O
and	CC	O
twenty-eight	CD	O
of	IN	O
145	CD	O
patients	NNS	O
with	IN	O
ankylosing	VBG	B-Disease
spondylitis	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
HLA	NN	O
B27	NN	O
positive	JJ	O
.	.	O

Five	CD	O
patients	NNS	O
had	VBD	O
evidence	NN	O
of	IN	O
a	DT	O
sero-negative	JJ	O
peripheral	JJ	B-Disease
arthritis	NN	I-Disease
resembling	VBG	O
peripheral	JJ	B-Disease
psoriatic	JJ	I-Disease
arthritis	NN	I-Disease
and	CC	O
3	CD	O
of	IN	O
these	DT	O
were	VBD	O
B27	NN	O
negative	JJ	O
.	.	O

One	CD	O
further	JJ	O
B27	NN	O
negative	JJ	O
patients	NNS	O
had	VBD	O
a	DT	O
sister	NN	O
with	IN	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
and	CC	O
ulcerative	JJ	B-Disease
colitis	NN	I-Disease
and	CC	O
a	DT	O
mother	NN	O
with	IN	O
ulcerative	JJ	B-Disease
colitis	NN	I-Disease
.	.	O

There	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
a	DT	O
somewhat	RB	O
later	JJ	O
age	NN	O
of	IN	O
onset	NN	O
of	IN	O
symptoms	NNS	O
in	IN	O
B27	NN	O
negative	JJ	O
patients	NNS	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
interpreted	VBN	O
as	IN	O
suggesting	VBG	O
some	DT	O
degree	NN	O
of	IN	O
clinical	JJ	O
and	CC	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
with	IN	O
genes	NNS	O
for	IN	O
psoriasis	NN	B-Disease
and	CC	O
inflammatory	JJ	B-Disease
bowel	NN	I-Disease
disease	NN	I-Disease
being	VBG	O
important	JJ	O
in	IN	O
some	DT	O
individuals	NNS	O
,	,	O
particularly	RB	O
those	DT	O
who	WP	O
are	VBP	O
B27	NN	O
negative	JJ	O
.	.	O

Twenty-five	CD	O
first-degree	JJ	O
relatives	NNS	O
with	IN	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
were	VBD	O
all	DT	O
B27	NN	O
positive	JJ	O
.	.	O

The	DT	O
only	JJ	O
instance	NN	O
of	IN	O
disassociation	NN	O
of	IN	O
B27	NN	O
and	CC	O
spondylitis	NN	B-Disease
in	IN	O
a	DT	O
family	NN	O
was	VBD	O
where	WRB	O
the	DT	O
proband	NN	O
had	VBD	O
ulcerative	JJ	B-Disease
colitis	NN	I-Disease
as	RB	O
well	RB	O
as	IN	O
spondylitis	NNS	B-Disease
.	.	O

Of	IN	O
13	CD	O
B27	NN	O
positive	JJ	O
fathers	NNS	O
3	CD	O
could	MD	O
be	VB	O
diagnosed	VBN	O
as	IN	O
having	VBG	O
definite	JJ	O
ankylosing	NN	B-Disease
spondylitis	NN	I-Disease
(	-LRB-	O
23	CD	O
%	NN	O
)	-RRB-	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
thought	VBN	O
to	TO	O
provide	VB	O
evidence	NN	O
against	IN	O
the	DT	O
concept	NN	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
ankylosing	VBG	B-Disease
spondylitis	NN	I-Disease
is	VBZ	O
not	RB	O
B27	NN	O
but	CC	O
a	DT	O
closely	RB	O
linked	VBN	O
gene	NN	O
and	CC	O
favour	VB	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
environmental	JJ	O
event	NN	O
affecting	VBG	O
approximately	RB	O
one-fifth	JJ	O
of	IN	O
B27	NN	O
positive	JJ	O
males	NNS	O
to	TO	O
result	VB	O
in	IN	O
disease	NN	O
.	.	O

.	.	O

Late	RB	O
infantile	JJ	O
metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
in	IN	O
Israel	NNP	O
.	.	O

Metachromatic	JJ	B-Disease
Leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
neurodegenerative	JJ	B-Disease
disease	NN	I-Disease
in	IN	O
which	WDT	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
,	,	O
Aryl	NN	O
sulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
is	VBZ	O
deficient	JJ	O
.	.	O

The	DT	O
disease	NN	O
is	VBZ	O
inherited	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
and	CC	O
its	PRP$	O
frequency	NN	O
is	VBZ	O
estimated	VBN	O
to	TO	O
be	VB	O
1/40	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
.	.	O

The	DT	O
gene	NN	O
of	IN	O
ARSA	NNP	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
up	RB	O
to	TO	O
now	RB	O
eight	CD	O
mutations	NNS	O
causing	VBG	O
MLD	NN	B-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
.	.	O

Another	DT	O
mutation	NN	O
,	,	O
PD	NN	O
,	,	O
leads	VBZ	O
to	TO	O
the	DT	O
deficiency	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
in	FW	O
vitro	FW	O
(	-LRB-	O
pseudodeficiency	NN	O
)	-RRB-	O
without	IN	O
any	DT	O
known	JJ	O
clinical	JJ	O
effect	NN	O
.	.	O

The	DT	O
PD	NN	O
mutation	NN	O
is	VBZ	O
frequent	JJ	O
in	IN	O
all	DT	O
populations	NNS	O
.	.	O

In	IN	O
Israel	NNP	O
,	,	O
late	JJ	O
infantile	JJ	O
MLD	NN	B-Disease
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
very	RB	O
frequent	JJ	O
in	IN	O
a	DT	O
small	JJ	O
Jewish	JJ	O
isolate	NN	O
,	,	O
the	DT	O
Habbanite	NNP	O
Jews	NNPS	O
(	-LRB-	O
1/75	CD	O
live	JJ	O
births	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
molecular	JJ	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
in	IN	O
the	DT	O
Habbanite	NNP	O
population	NN	O
,	,	O
the	DT	O
mutation	NN	O
occurred	VBD	O
on	IN	O
an	DT	O
allele	NN	O
with	IN	O
the	DT	O
PD	NN	O
mutation	NN	O
.	.	O

The	DT	O
loss	NN	O
of	IN	O
ARSA	NN	O
activity	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
point	NN	O
mutation	NN	O
C	NN	O
>	JJR	O
T	NN	O
leading	VBG	O
to	TO	O
a	DT	O
change	NN	O
of	IN	O
proline	NN	O
to	TO	O
leucine	NN	O
.	.	O

MLD	NN	B-Disease
is	VBZ	O
also	RB	O
frequent	JJ	O
among	IN	O
Moslem	NNP	O
Arabs	NNPS	O
in	IN	O
Jerusalem	NNP	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
a	DT	O
transition	NN	O
G	NN	O
>	JJR	O
A	DT	O
destroying	VBG	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
exon	NN	O
2	CD	O
.	.	O

This	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
late	JJ	O
infantile	JJ	O
MLD	NN	B-Disease
from	IN	O
different	JJ	O
ethnic	JJ	O
groups	NNS	O
.	.	O

The	DT	O
Christian	NNP	O
Arabs	NNPS	O
in	IN	O
Israel	NNP	O
also	RB	O
have	VBP	O
a	DT	O
high	JJ	O
incidence	NN	O
of	IN	O
the	DT	O
disease	NN	O
(	-LRB-	O
1/10	CD	O
,	,	O
000	CD	O
live	JJ	O
births	NNS	O
)	-RRB-	O
;	:	O
the	DT	O
mutation	NN	O
in	IN	O
this	DT	O
population	NN	O
is	VBZ	O
still	RB	O
unknown	JJ	O
.	.	O

Knowledge	NN	O
of	IN	O
the	DT	O
different	JJ	O
mutations	NNS	O
causing	VBG	O
MLD	NN	B-Disease
in	IN	O
these	DT	O
defined	VBN	O
populations	NNS	O
will	MD	O
allow	VB	O
a	DT	O
carrier	NN	O
screening	NN	O
program	NN	O
to	TO	O
be	VB	O
carried	VBN	O
out	RP	O
and	CC	O
prevent	VB	O
the	DT	O
birth	NN	O
of	IN	O
additional	JJ	O
affected	JJ	O
children	NNS	O
.	.	O

.	.	O

Genomic	JJ	O
rearrangements	NNS	O
of	IN	O
the	DT	O
APC	NN	B-Disease
tumor-suppressor	JJ	O
gene	NN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
.	.	O

Germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	I-Disease
APC	NN	I-Disease
)	-RRB-	I-Disease
tumor-suppressor	JJ	O
gene	NN	O
result	NN	O
in	IN	O
the	DT	O
hereditary	JJ	B-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

Almost	RB	O
all	DT	O
APC	NN	B-Disease
mutations	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
identified	VBN	O
are	VBP	O
single-nucleotide	JJ	O
alterations	NNS	O
,	,	O
small	JJ	O
insertions	NNS	O
,	,	O
or	CC	O
small	JJ	O
deletions	NNS	O
that	WDT	O
would	MD	O
truncate	VB	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

No	DT	O
well-characterized	JJ	O
intragenic	JJ	O
rearrangement	NN	O
of	IN	O
APC	NN	O
has	VBZ	O
been	VBN	O
described	VBN	O
,	,	O
and	CC	O
the	DT	O
prevalence	NN	O
of	IN	O
this	DT	O
type	NN	O
of	IN	O
mutation	NN	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
is	VBZ	O
not	RB	O
clear	JJ	O
.	.	O

We	PRP	O
screened	VBD	O
49	CD	O
potential	JJ	O
FAP	NN	B-Disease
families	NNS	O
and	CC	O
identified	VBN	O
26	CD	O
different	JJ	O
germline	NN	O
APC	NN	B-Disease
mutations	NNS	O
in	IN	O
30	CD	O
families	NNS	O
.	.	O

Four	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
were	VBD	O
genomic	JJ	O
rearrangements	NNS	O
resulting	VBG	O
from	IN	O
homologous	JJ	O
and	CC	O
nonhomologous	JJ	O
recombinations	NNS	O
mediated	VBN	O
by	IN	O
Alu	NN	O
elements	NNS	O
.	.	O

Two	CD	O
of	IN	O
these	DT	O
four	CD	O
rearrangements	NNS	O
were	VBD	O
complex	JJ	O
,	,	O
involving	VBG	O
deletion	NN	O
and	CC	O
insertion	NN	O
of	IN	O
nucleotides	NNS	O
.	.	O

Of	IN	O
these	DT	O
four	CD	O
rearrangements	NNS	O
,	,	O
one	CD	O
resulted	VBD	O
in	IN	O
the	DT	O
deletion	NN	O
of	IN	O
exons	NNS	O
11	CD	O
and	CC	O
12	CD	O
and	CC	O
two	CD	O
others	NNS	O
resulted	VBD	O
in	IN	O
either	CC	O
complete	JJ	O
or	CC	O
partial	JJ	O
deletion	NN	O
of	IN	O
exon	NN	O
14	CD	O
.	.	O

The	DT	O
fourth	JJ	O
rearrangement	NN	O
grossly	RB	O
altered	VBD	O
the	DT	O
sequence	NN	O
within	IN	O
intron	NN	O
14	CD	O
.	.	O

Although	IN	O
this	DT	O
rearrangement	NN	O
did	VBD	O
not	RB	O
affect	VB	O
any	DT	O
coding	VBG	O
sequence	NN	O
of	IN	O
APC	NN	O
at	IN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
level	NN	O
,	,	O
it	PRP	O
caused	VBD	O
inappropriate	JJ	O
splicing	NN	O
of	IN	O
exon	NN	O
14	CD	O
.	.	O

These	DT	O
rearrangements	NNS	O
were	VBD	O
initially	RB	O
revealed	VBN	O
by	IN	O
analyzing	VBG	O
cDNAs	NNS	O
and	CC	O
could	MD	O
not	RB	O
have	VB	O
been	VBN	O
identified	VBN	O
by	IN	O
using	VBG	O
mutation	NN	O
detection	NN	O
methods	NNS	O
that	WDT	O
screened	VBD	O
each	DT	O
exon	NN	O
individually	RB	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
a	DT	O
rearrangement	NN	O
that	WDT	O
did	VBD	O
not	RB	O
alter	VB	O
any	DT	O
coding	VBG	O
exons	NNS	O
yet	RB	O
affected	VBD	O
the	DT	O
splicing	NN	O
further	RB	O
underscores	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
using	VBG	O
cDNA	NN	O
for	IN	O
mutation	NN	O
analysis	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
four	CD	O
genomic	JJ	O
rearrangements	NNS	O
among	IN	O
30	CD	O
mutations	NNS	O
suggests	VBZ	O
that	IN	O
genomic	JJ	O
rearrangements	NNS	O
are	VBP	O
frequent	JJ	O
germline	NN	O
APC	NN	B-Disease
mutations	NNS	O
.	.	O

.	.	O

Familial	JJ	B-Disease
male	JJ	I-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
is	VBZ	O
not	RB	O
linked	VBN	O
to	TO	O
the	DT	O
BRCA1	NN	O
locus	NN	O
on	IN	O
chromosome	NN	O
17q	NN	O
.	.	O

Breast	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
men	NNS	O
is	VBZ	O
about	IN	O
a	DT	O
hundredfold	JJ	O
less	JJR	O
common	JJ	O
than	IN	O
in	IN	O
women	NNS	O
and	CC	O
this	DT	O
has	VBZ	O
hindered	VBN	O
research	NN	O
into	IN	O
its	PRP$	O
genetic	JJ	O
basis	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
22	CD	O
families	NNS	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
for	IN	O
linkage	NN	O
to	TO	O
the	DT	O
hereditary	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
locus	NN	O
,	,	O
BRCA1	NN	O
,	,	O
on	IN	O
chromosome	NN	O
17q	NN	O
.	.	O

We	PRP	O
found	VBD	O
strong	JJ	O
evidence	NN	O
against	IN	O
linkage	NN	O
to	TO	O
BRCA1	NN	O
(	-LRB-	O
lod	NN	O
score-16	NN	O
.	.	O

63	CD	O
)	-RRB-	O
and	CC	O
the	DT	O
best	JJS	O
estimate	NN	O
of	IN	O
the	DT	O
proportion	NN	O
of	IN	O
linked	VBN	O
families	NNS	O
was	VBD	O
0	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
CI	NN	O
0-18	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
there	EX	O
is	VBZ	O
a	DT	O
gene	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
other	JJ	O
than	IN	O
BRCA1	NN	O
which	WDT	O
predisposes	VBZ	O
to	TO	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
in	IN	O
women	NNS	O
and	CC	O
which	WDT	O
confers	VBZ	O
a	DT	O
higher	JJR	O
risk	NN	O
of	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
.	.	O

Identification	NN	O
of	IN	O
additional	JJ	O
pedigrees	NNS	O
that	WDT	O
include	VBP	O
cases	NNS	O
of	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
may	MD	O
therefore	RB	O
facilitate	VB	O
the	DT	O
mapping	NN	O
and	CC	O
isolation	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

Evidence	NN	O
for	IN	O
inter-generational	JJ	O
instability	NN	O
in	IN	O
the	DT	O
CAG	NN	O
repeat	NN	O
in	IN	O
the	DT	O
MJD1	NN	O
gene	NN	O
and	CC	O
for	IN	O
conserved	VBN	O
haplotypes	NNS	O
at	IN	O
flanking	JJ	O
markers	NNS	O
amongst	IN	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
with	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
size	NN	O
of	IN	O
the	DT	O
(	-LRB-	O
CAG	NN	O
)	-RRB-	O
n	NN	O
repeat	NN	O
array	NN	O
in	IN	O
the	DT	O
3	CD	O
'	''	O
end	NN	O
of	IN	O
the	DT	O
MJD1	NN	O
gene	NN	O
and	CC	O
the	DT	O
haplotype	NN	O
at	IN	O
a	DT	O
series	NN	O
of	IN	O
microsatellite	NN	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
MJD1	NN	O
gene	NN	O
were	VBD	O
examined	VBN	O
in	IN	O
a	DT	O
large	JJ	O
cohort	NN	O
of	IN	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
affected	VBN	O
with	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VBP	O
five	CD	O
novel	JJ	O
observations	NNS	O
.	.	O

First	RB	O
,	,	O
MJD	NN	B-Disease
is	VBZ	O
associated	VBN	O
with	IN	O
expansion	NN	O
fo	NN	O
the	DT	O
array	NN	O
from	IN	O
the	DT	O
normal	JJ	O
range	NN	O
of	IN	O
14-37	CD	O
repeats	NNS	O
to	TO	O
68-84	CD	O
repeats	NNS	O
in	IN	O
most	JJS	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
,	,	O
but	CC	O
no	DT	O
subjects	NNS	O
were	VBD	O
observed	VBN	O
with	IN	O
expansions	NNS	O
intermediate	JJ	O
in	IN	O
size	NN	O
between	IN	O
those	DT	O
of	IN	O
the	DT	O
normal	JJ	O
and	CC	O
MJD	NN	B-Disease
affected	VBD	O
groups	NNS	O
.	.	O

Second	RB	O
,	,	O
the	DT	O
expanded	VBN	O
allele	NN	O
associated	VBN	O
with	IN	O
MJD	NN	B-Disease
displays	NNS	O
inter-generational	JJ	O
instability	NN	O
,	,	O
particularly	RB	O
in	IN	O
male	JJ	O
meioses	NNS	O
,	,	O
and	CC	O
this	DT	O
instability	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
the	DT	O
clinical	JJ	O
phenomenon	NN	O
of	IN	O
anticipation	NN	O
.	.	O

Third	NNP	O
,	,	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
is	VBZ	O
not	RB	O
only	RB	O
inversely	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
age-of-onset	NN	O
of	IN	O
MJD	NN	B-Disease
(	-LRB-	O
r	NN	O
=	JJ	O
-0.738	CD	O
,	,	O
p	NN	O
<	JJR	O
0.001	CD	O
)	-RRB-	O
,	,	O
but	CC	O
is	VBZ	O
also	RB	O
correlated	VBN	O
with	IN	O
the	DT	O
frequency	NN	O
of	IN	O
other	JJ	O
clinical	JJ	O
features	NNS	O
[	-LRB-	O
e.g.	FW	O
pseudoexophthalmos	FW	O
and	CC	O
pyramidal	JJ	O
signs	NNS	O
were	VBD	O
more	RBR	O
frequent	JJ	O
in	IN	O
subjects	NNS	O
with	IN	O
large	JJ	O
repeats	NNS	O
(	-LRB-	O
p	NN	O
<	JJR	O
0.001	CD	O
and	CC	O
p	NN	O
<	JJR	O
0.05	CD	O
respectively	RB	O
)	-RRB-	O
]	-RRB-	O
.	.	O

Fourth	JJ	O
,	,	O
the	DT	O
disease	NN	O
phenotype	NN	O
is	VBZ	O
significantly	RB	O
more	RBR	O
severe	JJ	O
and	CC	O
had	VBD	O
an	DT	O
early	JJ	O
age	NN	O
of	IN	O
onset	NN	O
(	-LRB-	O
16	CD	O
years	NNS	O
)	-RRB-	O
in	IN	O
a	DT	O
subject	JJ	O
homozygous	JJ	O
for	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
,	,	O
which	WDT	O
contrasts	VBZ	O
with	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
suggests	VBZ	O
that	IN	O
the	DT	O
expanded	VBN	O
allele	NN	O
in	IN	O
the	DT	O
MJD1	NN	O
gene	NN	O
could	MD	O
exert	VB	O
its	PRP$	O
effect	NN	O
either	CC	O
by	IN	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
(	-LRB-	O
putatively	RB	O
excluded	VBN	O
in	IN	O
HD	NN	B-Disease
)	-RRB-	O
or	CC	O
by	IN	O
a	DT	O
gain	NN	O
of	IN	O
function	NN	O
effect	NN	O
as	IN	O
proposed	VBN	O
for	IN	O
HD	NN	B-Disease
.	.	O

Finally	RB	O
,	,	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
subjects	NNS	O
affected	VBN	O
with	IN	O
MJD	NN	B-Disease
share	NN	O
haplotypes	NNS	O
at	IN	O
several	JJ	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
MJD1	NN	O
gene	NN	O
,	,	O
which	WDT	O
are	VBP	O
uncommon	JJ	O
in	IN	O
the	DT	O
normal	JJ	O
Japanese	JJ	O
and	CC	O
Caucasian	JJ	O
population	NN	O
,	,	O
and	CC	O
which	WDT	O
suggests	VBZ	O
the	DT	O
existence	NN	O
either	DT	O
of	IN	O
common	JJ	O
founders	NNS	O
in	IN	O
these	DT	O
populations	NNS	O
or	CC	O
of	IN	O
chromosomes	NNS	O
susceptible	JJ	O
to	TO	O
pathologic	JJ	O
expansion	NN	O
of	IN	O
the	DT	O
CAG	NN	O
repeat	NN	O
in	IN	O
the	DT	O
MJD1	NN	O
gene	NN	O
.	.	O

Familial	JJ	O
Prader-Willi	NN	B-Disease
syndrome	NN	I-Disease
with	IN	O
apparently	RB	O
normal	JJ	O
chromosomes	NNS	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
4	CD	O
sibs	NNS	O
(	-LRB-	O
2F	NN	O
,	,	O
2M	NN	O
)	-RRB-	O
with	IN	O
Prader-Willi	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

Diagnosis	NN	O
was	VBD	O
made	VBN	O
clinically	RB	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
history	NN	O
,	,	O
behavior	NN	O
,	,	O
and	CC	O
physical	JJ	O
findings	NNS	O
in	IN	O
3	CD	O
of	IN	O
the	DT	O
sibs	NNS	O
.	.	O

The	DT	O
other	JJ	O
child	NN	O
had	VBD	O
died	VBN	O
at	IN	O
age	NN	O
10	CD	O
months	NNS	O
with	IN	O
a	DT	O
history	NN	O
and	CC	O
clinical	JJ	O
findings	NNS	O
typical	JJ	O
of	IN	O
first	JJ	O
phase	NN	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

Results	NNS	O
of	IN	O
chromosome	NN	O
studies	NNS	O
on	IN	O
the	DT	O
parents	NNS	O
and	CC	O
surviving	VBG	O
sibs	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

The	DT	O
implications	NNS	O
of	IN	O
this	DT	O
unusual	JJ	O
familial	JJ	O
occurrence	NN	O
for	IN	O
our	PRP$	O
understanding	NN	O
of	IN	O
PWS	NNP	B-Disease
are	VBP	O
discussed	VBN	O
.	.	O

.	.	O

Age	NN	O
at	IN	O
diagnosis	NN	O
as	IN	O
an	DT	O
indicator	NN	O
of	IN	O
eligibility	NN	O
for	IN	O
BRCA1	NN	O
DNA	NN	O
testing	NN	O
in	IN	O
familial	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
searched	VBD	O
for	IN	O
criteria	NNS	O
that	WDT	O
could	MD	O
indicate	VB	O
breast	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
with	IN	O
a	DT	O
high	JJ	O
prior	JJ	O
probability	NN	O
of	IN	O
being	VBG	O
caused	VBN	O
by	IN	O
the	DT	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
susceptibility	NN	O
locus	NN	O
BRCA1	NN	O
on	IN	O
chromosome	NN	O
17	CD	O
.	.	O

To	TO	O
this	DT	O
end	NN	O
,	,	O
we	PRP	O
performed	VBD	O
a	DT	O
linkage	NN	O
study	NN	O
with	IN	O
59	CD	O
consecutively	RB	O
collected	VBN	O
Dutch	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
,	,	O
including	VBG	O
16	CD	O
with	IN	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
used	VBD	O
an	DT	O
intake	NN	O
cut-off	JJ	O
of	IN	O
at	IN	O
least	JJS	O
three	CD	O
first-degree	JJ	O
relatives	NNS	O
with	IN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
at	IN	O
any	DT	O
age	NN	O
.	.	O

Significant	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
was	VBD	O
found	VBN	O
only	RB	O
among	IN	O
the	DT	O
13	CD	O
breast	NN	B-Disease
cancer	NN	I-Disease
families	NNS	O
with	IN	O
a	DT	O
mean	NN	O
age	NN	O
at	IN	O
diagnosis	NN	O
of	IN	O
less	JJR	O
than	IN	O
45	CD	O
years	NNS	O
.	.	O

An	DT	O
unexpectedly	RB	O
low	JJ	O
proportion	NN	O
of	IN	O
the	DT	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
were	VBD	O
estimated	VBN	O
to	TO	O
be	VB	O
linked	VBN	O
to	TO	O
BRCA1	NN	O
,	,	O
which	WDT	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
a	DT	O
founder	NN	O
effect	NN	O
in	IN	O
the	DT	O
Dutch	JJ	O
population	NN	O
.	.	O

Given	VBN	O
the	DT	O
expected	VBN	O
logistical	JJ	O
problems	NNS	O
in	IN	O
clinical	JJ	O
management	NN	O
now	RB	O
that	IN	O
BRCA1	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
,	,	O
we	PRP	O
propose	VBP	O
an	DT	O
interim	JJ	O
period	NN	O
in	IN	O
which	WDT	O
only	RB	O
families	NNS	O
with	IN	O
a	DT	O
strong	JJ	O
positive	JJ	O
family	NN	O
history	NN	O
for	IN	O
early	JJ	O
onset	NN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
will	MD	O
be	VB	O
offered	VBN	O
BRCA1	NN	O
mutation	NN	O
testing	NN	O
.	.	O

.	.	O

Some	DT	O
Mexican	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
revisited	VBN	O
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
appears	VBZ	O
to	TO	O
be	VB	O
fairly	RB	O
common	JJ	O
in	IN	O
Mexico	NNP	O
.	.	O

We	PRP	O
have	VBP	O
now	RB	O
examined	VBN	O
the	DT	O
DNA	NN	O
of	IN	O
three	CD	O
previously	RB	O
reported	VBN	O
electrophoretically	RB	O
fast	RB	O
Mexican	JJ	O
G6PD	NN	O
variants	NNS	O
,	,	O
-	:	O
G6PD	NN	O
Distrito	NNP	O
Federal	NNP	O
,	,	O
G6PD	NNP	O
Tepic	NNP	O
,	,	O
and	CC	O
G6PD	NN	O
Castilla	NNP	O
.	.	O

All	DT	O
three	CD	O
of	IN	O
these	DT	O
variants	NNS	O
,	,	O
believed	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
biochemical	JJ	O
characterization	NN	O
and	CC	O
population	NN	O
origin	NN	O
to	TO	O
be	VB	O
unique	JJ	O
,	,	O
have	VBP	O
the	DT	O
G	NN	O
----	:	O
A	DT	O
transition	NN	O
at	IN	O
nucleotide	NN	O
202	CD	O
and	CC	O
the	DT	O
A	NN	O
----	:	O
G	NN	O
transition	NN	O
at	IN	O
nucleotide	NN	O
376	CD	O
,	,	O
mutations	NNS	O
that	IN	O
we	PRP	O
now	RB	O
recognize	VBP	O
to	TO	O
be	VB	O
characteristic	JJ	O
of	IN	O
G6PD	NN	O
A	NN	O
-	:	O
.	.	O

Two	CD	O
other	JJ	O
Mexican	JJ	O
males	NNS	O
with	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
same	JJ	O
mutation	NN	O
.	.	O

All	DT	O
five	CD	O
have	VBP	O
the	DT	O
(	-LRB-	O
NlaIII/FokI/PvuII	NN	O
/	:	O
PstI	NN	O
)	-RRB-	O
haplotype	NN	O
characteristic	NN	O
of	IN	O
G6PD	NN	O
A	NN	O
-	:	O
in	IN	O
Africa	NNP	O
.	.	O

Since	IN	O
the	DT	O
PvuII	NN	O
+	CC	O
genotype	NN	O
seems	VBZ	O
to	TO	O
be	VB	O
rare	JJ	O
in	IN	O
Europe	NNP	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
all	DT	O
of	IN	O
these	DT	O
G6PD	NN	O
A	NN	O
-	:	O
genes	NNS	O
had	VBD	O
their	PRP$	O
ancient	JJ	O
origin	NN	O
in	IN	O
Africa	NNP	O
,	,	O
although	IN	O
in	IN	O
many	JJ	O
of	IN	O
the	DT	O
Mexican	JJ	O
patients	NNS	O
with	IN	O
G6PD	NN	O
A	NN	O
-202	CD	O
A/376G	NN	O
the	DT	O
gene	NN	O
may	MD	O
have	VB	O
been	VBN	O
imported	VBN	O
more	RBR	O
recently	RB	O
from	IN	O
Spain	NNP	O
,	,	O
where	WRB	O
this	DT	O
variant	NN	O
,	,	O
formerly	RB	O
known	VBN	O
as	IN	O
G6PD	NN	O
Betica	NN	O
,	,	O
is	VBZ	O
also	RB	O
prevalent	JJ	O
.	.	O

.	.	O

Inactivation	NN	O
of	IN	O
germline	NN	O
mutant	JJ	O
APC	NN	B-Disease
alleles	NNS	O
by	IN	O
attenuated	VBN	O
somatic	JJ	O
mutations	NNS	O
:	:	O
a	DT	O
molecular	JJ	O
genetic	JJ	O
mechanism	NN	O
for	IN	O
attenuated	VBN	B-Disease
familial	JJ	I-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
.	.	O

Germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	I-Disease
APC	NN	I-Disease
)	-RRB-	I-Disease
tumor-suppressor	JJ	O
gene	NN	O
result	NN	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

Patients	NNS	O
with	IN	O
FAP	NN	B-Disease
typically	RB	O
develop	VBP	O
hundreds	NNS	O
to	TO	O
thousands	NNS	O
of	IN	O
benign	JJ	B-Disease
colorectal	JJ	I-Disease
tumors	NNS	I-Disease
and	CC	O
early-onset	JJ	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

A	DT	O
subset	NN	O
of	IN	O
germline	NN	O
APC	NN	B-Disease
mutations	NNS	O
results	VBZ	O
in	IN	O
an	DT	O
attenuated	VBN	B-Disease
FAP	NN	I-Disease
(	-LRB-	O
AFAP	NN	B-Disease
)	-RRB-	O
phenotype	NN	O
,	,	O
in	IN	O
which	WDT	O
patients	NNS	O
develop	VBP	O
fewer	JJR	O
tumors	NNS	B-Disease
and	CC	O
develop	VB	O
them	PRP	O
at	IN	O
an	DT	O
older	JJR	O
age	NN	O
.	.	O

Although	IN	O
a	DT	O
genotype-phenotype	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
locations	NNS	O
of	IN	O
APC	NN	B-Disease
germline	NN	O
mutations	NNS	O
and	CC	O
the	DT	O
development	NN	O
of	IN	O
AFAP	NN	B-Disease
has	VBZ	O
been	VBN	O
well	RB	O
documented	VBN	O
,	,	O
the	DT	O
mechanism	NN	O
for	IN	O
AFAP	NNP	B-Disease
has	VBZ	O
not	RB	O
been	VBN	O
well	RB	O
defined	VBN	O
.	.	O

We	PRP	O
investigated	VBD	O
the	DT	O
mechanism	NN	O
for	IN	O
AFAP	NN	B-Disease
in	IN	O
patients	NNS	O
carrying	VBG	O
a	DT	O
mutant	JJ	O
APC	NN	B-Disease
allele	NN	O
(	-LRB-	O
APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
)	-RRB-	O
that	WDT	O
has	VBZ	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
alternatively	RB	O
spliced	VBN	O
region	NN	O
of	IN	O
exon	NN	O
9	CD	O
.	.	O

APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
to	TO	O
down-regulate	VB	O
beta-catenin-regulated	JJ	O
transcription	NN	O
,	,	O
the	DT	O
major	JJ	O
tumor-suppressor	JJ	O
function	NN	O
of	IN	O
APC	NN	O
,	,	O
as	IN	O
did	VBD	O
the	DT	O
wild-type	JJ	O
APC	NN	O
.	.	O

Mutation	NN	O
analysis	NN	O
showed	VBD	O
that	IN	O
both	CC	O
APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
wild-type	JJ	O
APC	NN	B-Disease
alleles	NNS	O
were	VBD	O
somatically	RB	O
mutated	VBN	O
in	IN	O
most	JJS	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
from	IN	O
these	DT	O
patients	NNS	O
.	.	O

Functional	JJ	O
analysis	NN	O
showed	VBD	O
that	IN	O
4666insA	NN	O
,	,	O
a	DT	O
common	JJ	O
somatic	JJ	O
mutation	NN	O
in	IN	O
APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
in	IN	O
these	DT	O
tumors	NNS	B-Disease
,	,	O
did	VBD	O
not	RB	O
inactivate	VB	O
the	DT	O
wild-type	JJ	O
APC	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
indicate	VBP	O
that	IN	O
carriers	NNS	O
of	IN	O
APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
develop	VBP	O
fewer	JJR	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
than	IN	O
do	VBP	O
typical	JJ	O
patients	NNS	O
with	IN	O
FAP	NN	B-Disease
because	IN	O
somatic	JJ	O
inactivation	NN	O
of	IN	O
both	DT	O
APC	NN	B-Disease
alleles	NNS	O
is	VBZ	O
necessary	JJ	O
for	IN	O
colorectal	JJ	O
tumorigenesis	NN	O
.	.	O

However	RB	O
,	,	O
these	DT	O
patients	NNS	O
develop	VBP	O
colorectal	JJ	B-Disease
tumors	NNS	I-Disease
more	RBR	O
frequently	RB	O
than	IN	O
does	VBZ	O
the	DT	O
general	JJ	O
population	NN	O
because	IN	O
APC	NN	O
(	-LRB-	O
AS9	NN	O
)	-RRB-	O
is	VBZ	O
inactivated	VBN	O
by	IN	O
mutations	NNS	O
that	WDT	O
do	VBP	O
not	RB	O
inactivate	VB	O
the	DT	O
wild-type	JJ	O
APC	NN	O
.	.	O

.	.	O

Submicroscopic	JJ	O
deletions	NNS	O
at	IN	O
the	DT	O
WAGR	NN	B-Disease
locus	NN	O
,	,	O
revealed	VBN	O
by	IN	O
nonradioactive	JJ	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

Fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
(	-LRB-	O
FISH	NN	O
)	-RRB-	O
with	IN	O
biotin-labeled	JJ	O
probes	NNS	O
mapping	VBG	O
to	TO	O
11p13	NN	O
has	VBZ	O
been	VBN	O
used	VBN	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deletions	NNS	O
of	IN	O
the	DT	O
WAGR	NNP	B-Disease
(	-LRB-	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
,	,	O
aniridia	NN	B-Disease
,	,	O
genitourinary	JJ	B-Disease
abnormalities	NNS	I-Disease
,	,	O
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
)	-RRB-	O
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
detected	VBN	O
a	DT	O
submicroscopic	JJ	O
11p13	NN	O
deletion	NN	O
in	IN	O
a	DT	O
child	NN	O
with	IN	O
inherited	VBN	O
aniridia	NN	B-Disease
who	WP	O
subsequently	RB	O
presented	VBN	O
with	IN	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
in	IN	O
a	DT	O
horseshoe	NN	O
kidney	NN	O
,	,	O
only	RB	O
revealed	VBD	O
at	IN	O
surgery	NN	O
.	.	O

The	DT	O
mother	NN	O
,	,	O
who	WP	O
has	VBZ	O
aniridia	NN	B-Disease
,	,	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
carry	VB	O
a	DT	O
deletion	NN	O
including	VBG	O
both	CC	O
the	DT	O
aniridia	NN	B-Disease
candidate	NN	O
gene	NN	O
(	-LRB-	O
AN2	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
predisposition	NN	O
gene	NN	O
(	-LRB-	O
WT1	NN	O
)	-RRB-	O
.	.	O

This	DT	O
is	VBZ	O
therefore	RB	O
a	DT	O
rare	JJ	O
case	NN	O
of	IN	O
an	DT	O
inherited	VBN	O
WAGR	NN	B-Disease
deletion	NN	O
.	.	O

Wilms	NN	B-Disease
tumor	NN	I-Disease
has	VBZ	O
so	RB	O
far	RB	O
only	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
sporadic	JJ	O
de	FW	O
novo	FW	O
aniridia	NN	B-Disease
cases	NNS	O
.	.	O

We	PRP	O
have	VBP	O
shown	VBN	O
that	IN	O
a	DT	O
cosmid	NN	O
probe	NN	O
for	IN	O
a	DT	O
candidate	NN	O
aniridia	NN	B-Disease
gene	NN	O
,	,	O
homologous	JJ	O
to	TO	O
the	DT	O
mouse	NN	O
Pax-6	NN	O
gene	NN	O
,	,	O
is	VBZ	O
deleted	VBN	O
in	IN	O
cell	NN	O
lines	NNS	O
from	IN	O
aniridia	NN	B-Disease
patients	NNS	O
with	IN	O
previously	RB	O
characterized	VBN	O
deletions	NNS	O
at	IN	O
11p13	NN	O
,	,	O
while	IN	O
another	DT	O
cosmid	JJ	O
marker	NN	O
mapping	NN	O
between	IN	O
two	CD	O
aniridia-associated	JJ	O
translocation	NN	O
breakpoints	NNS	O
(	-LRB-	O
and	CC	O
hence	RB	O
a	DT	O
second	JJ	O
candidate	NN	O
marker	NN	O
)	-RRB-	O
is	VBZ	O
present	JJ	O
on	IN	O
both	DT	O
chromosomes	NNS	O
.	.	O

These	DT	O
results	NNS	O
support	VBP	O
the	DT	O
Pax-6	NN	O
homologue	NN	O
as	IN	O
a	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
AN2	NN	O
gene	NN	O
.	.	O

FISH	NN	O
with	IN	O
cosmid	NN	O
probes	NNS	O
has	VBZ	O
proved	VBN	O
to	TO	O
be	VB	O
a	DT	O
fast	JJ	O
and	CC	O
reliable	JJ	O
technique	NN	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deletions	NNS	O
.	.	O

It	PRP	O
can	MD	O
be	VB	O
used	VBN	O
with	IN	O
limited	JJ	O
amounts	NNS	O
of	IN	O
material	NN	O
and	CC	O
has	VBZ	O
strong	JJ	O
potential	NN	O
for	IN	O
clinical	JJ	O
applications	NNS	O
.	.	O

.	.	O

Haplotype	NN	O
studies	NNS	O
in	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

In	IN	O
51	CD	O
families	NNS	O
with	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
DNA	NN	O
haplotypes	NNS	O
of	IN	O
dinucleotide	NN	O
repeat	NN	O
polymorphisms	NNS	O
(	-LRB-	O
CA	NNP	O
repeats	NNS	O
)	-RRB-	O
in	IN	O
the	DT	O
13q14	NN	O
.	.	O

3	CD	O
region	NN	O
,	,	O
to	TO	O
examine	VB	O
these	DT	O
markers	NNS	O
for	IN	O
association	NN	O
with	IN	O
the	DT	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
(	-LRB-	O
WND	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
to	TO	O
a	DT	O
marker	NN	O
(	-LRB-	O
D13S133	NN	O
)	-RRB-	O
described	VBD	O
elsewhere	RB	O
,	,	O
we	PRP	O
have	VBP	O
developed	VBN	O
three	CD	O
new	JJ	O
highly	RB	O
polymorphic	JJ	O
markers	NNS	O
(	-LRB-	O
D13S314	NN	O
,	,	O
D13S315	NN	O
,	,	O
and	CC	O
D13S316	NN	O
)	-RRB-	O
close	NN	O
to	TO	O
the	DT	O
WND	NN	B-Disease
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
distribution	NN	O
of	IN	O
marker	NN	O
alleles	NNS	O
at	IN	O
the	DT	O
loci	NNS	O
studied	VBN	O
and	CC	O
have	VBP	O
found	VBN	O
that	IN	O
D13S314	NN	O
,	,	O
D13S133	NN	O
,	,	O
and	CC	O
D13S316	NN	O
each	DT	O
show	NN	O
nonrandom	JJ	O
distribution	NN	O
on	IN	O
chromosomes	NNS	O
carrying	VBG	O
the	DT	O
WND	NN	B-Disease
mutation	NN	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
haplotypes	NNS	O
of	IN	O
these	DT	O
three	CD	O
markers	NNS	O
and	CC	O
have	VBP	O
found	VBN	O
that	IN	O
there	EX	O
are	VBP	O
highly	RB	O
significant	JJ	O
differences	NNS	O
between	IN	O
WND	NNP	B-Disease
and	CC	O
normal	JJ	O
haplotypes	NNS	O
in	IN	O
northern	JJ	O
European	JJ	O
families	NNS	O
.	.	O

These	DT	O
findings	NNS	O
have	VBP	O
important	JJ	O
implications	NNS	O
for	IN	O
mutation	NN	O
detection	NN	O
and	CC	O
molecular	JJ	O
diagnosis	NN	O
in	IN	O
families	NNS	O
with	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Growth	NN	O
hormone	NN	O
treatment	NN	O
increases	VBZ	O
CO	NNP	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
response	NN	O
,	,	O
ventilation	NN	O
and	CC	O
central	JJ	O
inspiratory	JJ	O
drive	NN	O
in	IN	O
children	NNS	O
with	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

We	PRP	O
studied	VBD	O
whether	IN	O
the	DT	O
beneficial	JJ	O
effects	NNS	O
of	IN	O
growth	NN	O
hormone	NN	O
(	-LRB-	O
GH	NN	O
)	-RRB-	O
treatment	NN	O
on	IN	O
growth	NN	O
and	CC	O
body	NN	O
composition	NN	O
in	IN	O
PWS	NNP	B-Disease
are	VBP	O
accompanied	VBN	O
by	IN	O
an	DT	O
improvement	NN	O
in	IN	O
respiratory	JJ	O
function	NN	O
.	.	O

We	PRP	O
measured	VBD	O
resting	VBG	O
ventilation	NN	O
,	,	O
airway	NN	O
occlusion	NN	O
pressure	NN	O
(	-LRB-	O
P	NN	O
(	-LRB-	O
0	CD	O
.	.	O

1	LS	O
)	-RRB-	O
)	-RRB-	O
and	CC	O
ventilatory	JJ	O
response	NN	O
to	TO	O
CO	NNP	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
in	IN	O
nine	CD	O
children	NNS	O
,	,	O
aged	JJ	O
7-14	CD	O
years	NNS	O
,	,	O
before	IN	O
and	CC	O
6-9	CD	O
months	NNS	O
after	IN	O
the	DT	O
start	NN	O
of	IN	O
GH	NN	O
treatment	NN	O
.	.	O

During	IN	O
GH	NN	O
treatment	NN	O
,	,	O
resting	VBG	O
ventilation	NN	O
increased	VBN	O
by	IN	O
26	CD	O
%	NN	O
,	,	O
P	NN	O
(	-LRB-	O
0	CD	O
.	.	O

1	LS	O
)	-RRB-	O
by	IN	O
72	CD	O
%	NN	O
and	CC	O
the	DT	O
response	NN	O
to	TO	O
CO	NNP	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
by	IN	O
65	CD	O
%	NN	O
(	-LRB-	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

002	CD	O
,	,	O
<	JJR	O
0	CD	O
.	.	O

04	NN	O
and	CC	O
<	JJR	O
0	CD	O
.	.	O

02	NN	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

This	DT	O
observed	VBN	O
increase	NN	O
in	IN	O
ventilatory	JJ	O
output	NN	O
was	VBD	O
not	RB	O
correlated	VBN	O
to	TO	O
changes	NNS	O
in	IN	O
body	NN	O
mass	NN	O
index	NN	O
.	.	O

CONCLUSION	NN	O
Treatment	NN	O
of	IN	O
children	NNS	O
with	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
seems	VBZ	O
to	TO	O
have	VB	O
a	DT	O
stimulatory	JJ	O
effect	NN	O
on	IN	O
central	JJ	O
respiratory	JJ	O
structures	NNS	O
.	.	O

The	DT	O
observed	VBN	O
increase	NN	O
in	IN	O
ventilation	NN	O
and	CC	O
inspiratory	JJ	O
drive	NN	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
improved	JJ	O
activity	NN	O
level	NN	O
reported	VBN	O
by	IN	O
parents	NNS	O
of	IN	O
PWS	NNP	B-Disease
children	NNS	O
during	IN	O
growth	NN	O
hormone	NN	O
therapy	NN	O

Somatic	JJ	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
mutation	NN	O
in	IN	O
clear	JJ	O
cell	NN	O
papillary	NN	B-Disease
cystadenoma	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
epididymis	NN	I-Disease
.	.	O

Papillary	JJ	B-Disease
cystadenoma	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
epididymis	NN	I-Disease
is	VBZ	O
an	DT	O
uncommon	JJ	O
benign	JJ	O
lesion	NN	O
that	WDT	O
may	MD	O
occur	VB	O
sporadically	RB	O
or	CC	O
as	IN	O
a	DT	O
manifestation	NN	O
of	IN	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	I-Disease
VHL	NN	I-Disease
)	-RRB-	I-Disease
disease	NN	I-Disease
.	.	O

Neither	DT	O
immunohistochemical	JJ	O
studies	NNS	O
nor	CC	O
molecular	JJ	O
genetic	JJ	O
analyses	NNS	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
have	VBP	O
been	VBN	O
reported	VBN	O
previously	RB	O
for	IN	O
this	DT	O
lesion	NN	O
.	.	O

The	DT	O
authors	NNS	O
describe	VBP	O
two	CD	O
cases	NNS	O
of	IN	O
clear	JJ	O
cell	NN	O
papillary	NN	B-Disease
cystadenoma	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
epididymis	NN	I-Disease
,	,	O
both	DT	O
of	IN	O
which	WDT	O
were	VBD	O
initially	RB	O
confused	VBN	O
with	IN	O
metastatic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
.	.	O

Both	DT	O
lesions	NNS	O
showed	VBD	O
positive	JJ	O
immunohistochemical	JJ	O
staining	NN	O
for	IN	O
low	JJ	O
and	CC	O
intermediate	JJ	O
molecular	JJ	O
weight	NN	O
keratins	NNS	O
(	-LRB-	O
Cam	NN	O
5	CD	O
.	.	O

2	CD	O
and	CC	O
AE1/AE3	NN	O
)	-RRB-	O
,	,	O
EMA	NN	O
,	,	O
vimentin	NN	O
,	,	O
alpha	NN	O
1-antitrypsin	NN	O
,	,	O
and	CC	O
alpha	NN	O
1-antichymotrypsin	NN	O
.	.	O

Each	DT	O
was	VBD	O
negative	JJ	O
for	IN	O
CEA	NNP	O
.	.	O

Because	IN	O
clear	JJ	O
cell	NN	O
papillary	NN	B-Disease
cystadenoma	NN	I-Disease
is	VBZ	O
similar	JJ	O
to	TO	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
histologically	RB	O
,	,	O
and	CC	O
because	IN	O
both	DT	O
occur	VBP	O
as	IN	O
components	NNS	O
of	IN	O
the	DT	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
disease	NN	I-Disease
complex	NN	O
,	,	O
the	DT	O
authors	NNS	O
analyzed	VBD	O
both	DT	O
cases	NNS	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
.	.	O

A	DT	O
somatic	JJ	O
VHL	NN	B-Disease
gene	NN	O
mutation	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
tumors	NNS	B-Disease
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
followed	VBN	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
revealed	VBD	O
a	DT	O
cytosine	NN	O
to	TO	O
thymine	NN	O
transition	NN	O
at	IN	O
nucleotide	NN	O
694	CD	O
,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
replacement	NN	O
of	IN	O
an	DT	O
arginine	NN	O
with	IN	O
a	DT	O
stop	NN	O
codon	NN	O
after	IN	O
the	DT	O
sixth	JJ	O
amino	NN	O
acid	NN	O
of	IN	O
exon	NN	O
3	CD	O
.	.	O

As	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
is	VBZ	O
believed	VBN	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
,	,	O
VHL	NN	B-Disease
gene	NN	O
mutations	NNS	O
may	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
initiation	NN	O
of	IN	O
tumorigenesis	NN	O
in	IN	O
sporadic	JJ	O
cystadenomas	NNS	B-Disease
of	IN	I-Disease
the	DT	I-Disease
epididymis	NN	I-Disease
.	.	O

An	DT	O
evaluation	NN	O
of	IN	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
145	CD	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

Breast	NN	B-Disease
Cancer	NN	I-Disease
Linkage	NN	O
Consortium	NNP	O
.	.	O

The	DT	O
breast-ovary	JJ	B-Disease
cancer-family	NN	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
dominant	JJ	O
predisposition	NN	O
to	TO	O
cancer	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovaries	NNS	I-Disease
which	WDT	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
region	NN	O
17q12-q21	NN	O
.	.	O

The	DT	O
majority	NN	O
,	,	O
but	CC	O
not	RB	O
all	DT	O
,	,	O
of	IN	O
breast-ovary	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
show	VBP	O
linkage	NN	O
to	TO	O
this	DT	O
susceptibility	NN	O
locus	NN	O
,	,	O
designated	VBN	O
BRCA1	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
results	NNS	O
of	IN	O
a	DT	O
linkage	NN	O
analysis	NN	O
of	IN	O
145	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

These	DT	O
families	NNS	O
contain	VBP	O
either	CC	O
a	DT	O
total	NN	O
of	IN	O
three	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
early-onset	JJ	O
(	-LRB-	O
before	IN	O
age	NN	O
60	CD	O
years	NNS	O
)	-RRB-	O
breast	NN	B-Disease
cancer	NN	I-Disease
or	CC	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

All	DT	O
families	NNS	O
contained	VBD	O
at	IN	O
least	JJS	O
one	CD	O
case	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Overall	RB	O
,	,	O
an	DT	O
estimated	VBN	O
76	CD	O
%	NN	O
of	IN	O
the	DT	O
145	CD	O
families	NNS	O
are	VBP	O
linked	VBN	O
to	TO	O
the	DT	O
BRCA1	NN	O
locus	NN	O
.	.	O

None	NN	O
of	IN	O
the	DT	O
13	CD	O
families	NNS	O
with	IN	O
cases	NNS	O
of	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
appear	VBP	O
to	TO	O
be	VB	O
linked	VBN	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
estimated	VBN	O
that	IN	O
92	CD	O
%	NN	O
(	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
76	CD	O
%	NN	O
-100	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
families	NNS	O
with	IN	O
no	DT	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
and	CC	O
with	IN	O
two	CD	O
or	CC	O
more	JJR	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
are	VBP	O
linked	VBN	O
to	TO	O
BRCA1	NN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
breast-ovarian	JJ	B-Disease
cancer-family	NN	I-Disease
syndrome	NN	I-Disease
is	VBZ	O
genetically	RB	O
heterogeneous	JJ	O
.	.	O

However	RB	O
,	,	O
the	DT	O
large	JJ	O
majority	NN	O
of	IN	O
families	NNS	O
with	IN	O
early-onset	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
and	CC	O
with	IN	O
two	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
are	VBP	O
likely	JJ	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

.	.	O

Genetic	JJ	O
analysis	NN	O
in	IN	O
families	NNS	O
with	IN	O
van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
brought	VBN	O
together	RB	O
information	NN	O
on	IN	O
864	CD	O
affected	VBD	O
individuals	NNS	O
in	IN	O
164	CD	O
families	NNS	O
(	-LRB-	O
including	VBG	O
three	CD	O
new	JJ	O
pedigrees	NNS	O
)	-RRB-	O
reported	VBN	O
in	IN	O
the	DT	O
137	CD	O
year	NN	O
period	NN	O
since	IN	O
1845	CD	O
when	WRB	O
Demarquay	NNP	O
first	RB	O
described	VBD	O
a	DT	O
family	NN	O
with	IN	O
what	WP	O
was	VBD	O
later	RB	O
called	VBN	O
van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
VWS	NN	B-Disease
)	-RRB-	O
.	.	O

Both	DT	O
types	NNS	O
of	IN	O
oral	JJ	B-Disease
cleft	NN	I-Disease
,	,	O
cleft	NN	B-Disease
palate	NN	I-Disease
(	-LRB-	O
CP	NN	B-Disease
)	-RRB-	O
and	CC	O
cleft	NN	B-Disease
lip	NN	I-Disease
with	IN	O
or	CC	O
without	IN	O
CP	NN	B-Disease
(	-LRB-	O
CLP	NN	B-Disease
)	-RRB-	O
,	,	O
segregate	VB	O
in	IN	O
these	DT	O
families	NNS	O
together	RB	O
with	IN	O
lower	JJR	O
lip	NN	B-Disease
pits	NNS	I-Disease
or	CC	O
fistulae	NNS	B-Disease
in	IN	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
mode	NN	O
with	IN	O
high	JJ	O
penetrance	NN	O
estimated	VBN	O
to	TO	O
be	VB	O
K	NN	O
=	JJ	O
.	.	O

89	CD	O
and	CC	O
.	.	O

99	CD	O
by	IN	O
different	JJ	O
methods	NNS	O
.	.	O

Cleft	NN	O
types	NNS	O
(	-LRB-	O
CLP	NN	B-Disease
and	CC	O
CP	NN	B-Disease
)	-RRB-	O
occur	VBP	O
in	IN	O
VWS	NNS	B-Disease
in	IN	O
the	DT	O
same	JJ	O
proportions	NNS	O
as	IN	O
in	IN	O
the	DT	O
general	JJ	O
non-VWS	JJ	O
population	NN	O
,	,	O
ie	FW	O
,	,	O
about	IN	O
twice	RB	O
as	RB	O
many	JJ	O
cleft-bearing	JJ	O
individuals	NNS	O
have	VBP	O
CLP	NN	B-Disease
as	IN	O
have	VBP	O
CP	NN	B-Disease
.	.	O

On	IN	O
the	DT	O
other	JJ	O
hand	NN	O
,	,	O
we	PRP	O
do	VBP	O
not	RB	O
find	VB	O
the	DT	O
usually	RB	O
observed	VBN	O
excess	NN	O
of	IN	O
females	NNS	O
with	IN	O
CP	NN	B-Disease
and	CC	O
excess	NN	O
of	IN	O
males	NNS	O
with	IN	O
CLP	NN	B-Disease
;	:	O
in	IN	O
VWS	NNP	B-Disease
the	DT	O
sex	NN	O
ratios	NNS	O
are	VBP	O
more	RBR	O
nearly	RB	O
equal	JJ	O
.	.	O

Lip	NN	B-Disease
pits	NNS	I-Disease
also	RB	O
are	VBP	O
equally	RB	O
distributed	VBN	O
between	IN	O
the	DT	O
sexes	NNS	O
.	.	O

Affected	VBN	O
males	NNS	O
and	CC	O
females	NNS	O
are	VBP	O
equally	RB	O
likely	JJ	O
to	TO	O
transmit	VB	O
VWS	NNP	B-Disease
.	.	O

However	RB	O
,	,	O
there	EX	O
is	VBZ	O
an	DT	O
excess	NN	O
of	IN	O
less	JJR	O
severely	RB	O
affected	VBN	O
individuals	NNS	O
among	IN	O
transmitters	NNS	O
and	CC	O
a	DT	O
deficiency	NN	O
of	IN	O
more	JJR	O
severely	RB	O
affected	VBN	O
,	,	O
brought	VBN	O
about	RB	O
by	IN	O
a	DT	O
proband	NN	O
bias	NN	O
and	CC	O
differential	JJ	O
fecundity	NN	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
VWS	NNP	B-Disease
is	VBZ	O
significantly	RB	O
modified	VBN	O
by	IN	O
the	DT	O
genetic	JJ	O
background	NN	O
More	RBR	O
extreme	JJ	O
phenotypes	NNS	O
in	IN	O
parents	NNS	O
tend	VBP	O
to	TO	O
produce	VB	O
more	JJR	O
extreme	JJ	O
expression	NN	O
in	IN	O
their	PRP$	O
children	NNS	O
.	.	O

For	IN	O
a	DT	O
VWS	NN	B-Disease
gene	NN	O
carrier	NN	O
the	DT	O
relative	JJ	O
risk	NN	O
of	IN	O
transmitting	VBG	O
a	DT	O
cleft	NN	O
is	VBZ	O
26	CD	O
.	.	O

45	CD	O
%	NN	O
;	:	O
that	DT	O
of	IN	O
transmitting	VBG	O
lower	JJR	O
lip	NN	B-Disease
pits	NNS	I-Disease
is	VBZ	O
23	CD	O
.	.	O

55	CD	O
%	NN	O
.	.	O

Three	CD	O
pedigrees	NNS	O
of	IN	O
lip	NN	B-Disease
pits	NNS	I-Disease
in	IN	O
the	DT	O
literature	NN	O
show	NN	O
no	DT	O
clefts	NNS	O
among	IN	O
a	DT	O
significant	JJ	O
number	NN	O
of	IN	O
affected	JJ	O
individuals	NNS	O
.	.	O

Control	NN	O
of	IN	O
gene	NN	O
expression	NN	O
in	IN	O
VWS	NNP	B-Disease
in	IN	O
the	DT	O
three	CD	O
target	NN	O
tissues	NNS	O
appears	VBZ	O
to	TO	O
be	VB	O
independent	JJ	O
and	CC	O
separately	RB	O
designated	VBN	O
.	.	O

Mutation	NN	O
rate	NN	O
of	IN	O
the	DT	O
VWS	NN	B-Disease
gene	NN	O
is	VBZ	O
calculated	VBN	O
to	TO	O
be	VB	O
1	CD	O
.	.	O

8	CD	O
X	NN	O
10	CD	O
(	-LRB-	O
-5	CD	O
)	-RRB-	O

Molecular	JJ	O
and	CC	O
phenotypic	JJ	O
analysis	NN	O
of	IN	O
patients	NNS	O
with	IN	O
deletions	NNS	O
within	IN	O
the	DT	O
deletion-rich	JJ	O
region	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
.	.	O

Eighty	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
or	CC	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
BMD	NN	B-Disease
)	-RRB-	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
deletions	NNS	O
in	IN	O
the	DT	O
major	JJ	O
deletion-rich	JJ	O
region	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
locus	NN	O
.	.	O

This	DT	O
region	NN	O
includes	VBZ	O
the	DT	O
last	JJ	O
five	CD	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA5b-7	NN	O
,	,	O
all	DT	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA8	NN	O
,	,	O
and	CC	O
the	DT	O
first	JJ	O
two	CD	O
exons	NNS	O
detected	VBN	O
by	IN	O
cDNA9	NN	O
.	.	O

These	DT	O
80	CD	O
individuals	NNS	O
account	VBP	O
for	IN	O
approximately	RB	O
75	CD	O
%	NN	O
of	IN	O
109	CD	O
deletions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
detected	VBD	O
among	IN	O
181	CD	O
patients	NNS	O
analyzed	VBN	O
with	IN	O
the	DT	O
entire	JJ	O
dystrophin	NN	O
cDNA	NN	O
.	.	O

Endpoints	NNS	O
for	IN	O
many	JJ	O
of	IN	O
these	DT	O
deletions	NNS	O
were	VBD	O
further	RB	O
characterized	VBN	O
using	VBG	O
two	CD	O
genomic	JJ	O
probes	NNS	O
,	,	O
p20	NN	O
(	-LRB-	O
DXS269	NN	O
;	:	O
Wapenaar	NNP	O
et	FW	O
al.	FW	O
)	-RRB-	O
and	CC	O
GMGX11	NN	O
(	-LRB-	O
DXS239	NN	O
;	:	O
present	JJ	O
paper	NN	O
)	-RRB-	O
.	.	O

Clinical	JJ	O
findings	NNS	O
are	VBP	O
presented	VBN	O
for	IN	O
all	DT	O
80	CD	O
patients	NNS	O
allowing	VBG	O
a	DT	O
correlation	NN	O
of	IN	O
phenotypic	JJ	O
severity	NN	O
with	IN	O
the	DT	O
genotype	NN	O
.	.	O

Thirty-eight	CD	O
independent	JJ	O
patients	NNS	O
were	VBD	O
old	JJ	O
enough	JJ	O
to	TO	O
be	VB	O
classified	VBN	O
as	IN	O
DMD	NNP	B-Disease
,	,	O
BMD	NNP	B-Disease
,	,	O
or	CC	O
intermediate	JJ	O
phenotype	NN	O
and	CC	O
had	VBD	O
deletions	NNS	O
of	IN	O
exons	NNS	O
with	IN	O
sequenced	VBN	O
intron/exon	NN	O
boundaries	NNS	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
eight	CD	O
BMD	NN	B-Disease
patients	NNS	O
and	CC	O
one	CD	O
intermediate	JJ	O
patient	NN	O
had	VBD	O
gene	NN	O
deletions	NNS	O
predicted	VBD	O
to	TO	O
leave	VB	O
the	DT	O
reading	NN	O
frame	NN	O
intact	JJ	O
,	,	O
while	IN	O
21	CD	O
DMD	NN	B-Disease
patients	NNS	O
,	,	O
7	CD	O
intermediate	JJ	O
patients	NNS	O
,	,	O
and	CC	O
1	CD	O
BMD	NN	B-Disease
patient	NN	O
had	VBD	O
gene	NN	O
deletions	NNS	O
predicted	VBD	O
to	TO	O
disrupt	VB	O
the	DT	O
reading	NN	O
frame	NN	O
.	.	O

Thus	RB	O
,	,	O
with	IN	O
two	CD	O
exceptions	NNS	O
,	,	O
frameshift	NN	O
deletions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
resulted	VBD	O
in	IN	O
more	RBR	O
severe	JJ	O
phenotype	NN	O
than	IN	O
did	VBD	O
in-frame	RB	O
deletions	NNS	O
.	.	O

This	DT	O
is	VBZ	O
in	IN	O
agreement	NN	O
with	IN	O
recent	JJ	O
findings	NNS	O
by	IN	O
Baumbach	NNP	O
et	FW	O
al.	FW	O
and	CC	O
Koenig	NNP	O
et	FW	O
al.	FW	O
but	CC	O
is	VBZ	O
in	IN	O
contrast	NN	O
to	TO	O
findings	NNS	O
,	,	O
by	IN	O
Malhotra	NNP	O
et	FW	O
al.	FW	O
at	IN	O
the	DT	O
5	CD	O
'	''	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Proteolipoprotein	NN	O
gene	NN	O
analysis	NN	O
in	IN	O
82	CD	O
patients	NNS	O
with	IN	O
sporadic	JJ	O
Pelizaeus-Merzbacher	NNP	B-Disease
Disease	NN	I-Disease
:	:	O
duplications	NNS	O
,	,	O
the	DT	O
major	JJ	O
cause	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
originate	VB	O
more	RBR	O
frequently	RB	O
in	IN	O
male	JJ	O
germ	NN	O
cells	NNS	O
,	,	O
but	CC	O
point	NN	O
mutations	NNS	O
do	VBP	O
not	RB	O
.	.	O

The	DT	O
Clinical	JJ	O
European	JJ	O
Network	NNP	O
on	IN	O
Brain	NNP	B-Disease
Dysmyelinating	NNP	I-Disease
Disease	NNP	I-Disease
.	.	O

Pelizaeus-Merzbacher	NNP	B-Disease
Disease	NNP	I-Disease
(	-LRB-	O
PMD	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
developmental	JJ	I-Disease
defect	NN	I-Disease
of	IN	I-Disease
myelination	JJ	I-Disease
affecting	VBG	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
and	CC	O
segregating	VBG	O
with	IN	O
the	DT	O
proteolipoprotein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
locus	NN	O
.	.	O

Investigating	VBG	O
82	CD	O
strictly	RB	O
selected	VBN	O
sporadic	JJ	O
cases	NNS	O
of	IN	O
PMD	NN	B-Disease
,	,	O
we	PRP	O
found	VBD	O
PLP	NN	O
mutations	NNS	O
in	IN	O
77	CD	O
%	NN	O
;	:	O
complete	JJ	O
PLP-gene	JJ	O
duplications	NNS	O
were	VBD	O
the	DT	O
most	RBS	O
frequent	JJ	O
abnormality	NN	O
(	-LRB-	O
62	CD	O
%	NN	O
)	-RRB-	O
,	,	O
whereas	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
coding	VBG	O
or	CC	O
splice-site	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
were	VBD	O
involved	VBN	O
less	RBR	O
frequently	RB	O
(	-LRB-	O
38	CD	O
%	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
maternal	JJ	O
status	NN	O
of	IN	O
56	CD	O
cases	NNS	O
to	TO	O
determine	VB	O
the	DT	O
origin	NN	O
of	IN	O
both	DT	O
types	NNS	O
of	IN	O
PLP	NN	O
mutation	NN	O
,	,	O
since	IN	O
this	DT	O
is	VBZ	O
relevant	JJ	O
to	TO	O
genetic	JJ	O
counseling	NN	O
.	.	O

In	IN	O
the	DT	O
22	CD	O
point	NN	O
mutations	NNS	O
,	,	O
68	CD	O
%	NN	O
of	IN	O
mothers	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
a	DT	O
value	NN	O
identical	JJ	O
to	TO	O
the	DT	O
two-thirds	NNS	O
of	IN	O
carrier	NN	O
mothers	NNS	O
that	WDT	O
would	MD	O
be	VB	O
expected	VBN	O
if	IN	O
there	EX	O
were	VBD	O
an	DT	O
equal	JJ	O
mutation	NN	O
rate	NN	O
in	IN	O
male	JJ	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
.	.	O

In	IN	O
sharp	JJ	O
contrast	NN	O
,	,	O
among	IN	O
the	DT	O
34	CD	O
duplicated	JJ	O
cases	NNS	O
,	,	O
91	CD	O
%	NN	O
of	IN	O
mothers	NNS	O
were	VBD	O
carriers	NNS	O
,	,	O
a	DT	O
value	NN	O
significantly	RB	O
(	-LRB-	O
chi2	NN	O
=	JJ	O
9	CD	O
.	.	O

20	CD	O
,	,	O
P	NN	O
<	JJR	O
.	.	O

01	NN	O
)	-RRB-	O
in	IN	O
favor	NN	O
of	IN	O
a	DT	O
male	JJ	O
bias	NN	O
,	,	O
with	IN	O
an	DT	O
estimation	NN	O
of	IN	O
the	DT	O
male/female	NN	O
mutation	NN	O
frequency	NN	O
(	-LRB-	O
k	NN	O
)	-RRB-	O
of	IN	O
9	CD	O
.	.	O

3	CD	O
3	CD	O
.	.	O

Moreover	RB	O
,	,	O
we	PRP	O
observed	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
de	FW	O
novo	FW	O
mutations	NNS	O
between	IN	O
parental	JJ	O
and	CC	O
grandparental	JJ	O
generations	NNS	O
in	IN	O
17	CD	O
three-generation	JJ	O
families	NNS	O
,	,	O
which	WDT	O
allowed	VBD	O
a	DT	O
direct	JJ	O
estimation	NN	O
of	IN	O
the	DT	O
k	NN	O
value	NN	O
(	-LRB-	O
k	NN	O
=	JJ	O
11	CD	O
)	-RRB-	O
.	.	O

Again	RB	O
,	,	O
a	DT	O
significant	JJ	O
male	NN	O
mutation	NN	O
imbalance	NN	O
was	VBD	O
observed	VBN	O
only	RB	O
for	IN	O
the	DT	O
duplications	NNS	O
.	.	O

Haplotype	NN	O
analysis	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
in	IN	O
Turkish	JJ	O
phenylketonuria	NN	B-Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
estimated	VBN	O
the	DT	O
haplotype	NN	O
distribution	NN	O
of	IN	O
mutant	JJ	O
and	CC	O
normal	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
alleles	NNS	O
for	IN	O
17	CD	O
Turkish	JJ	O
phenylketonuria	NN	B-Disease
(	-LRB-	O
PKU	NN	B-Disease
)	-RRB-	O
families	NNS	O
20	CD	O
normal	JJ	O
and	CC	O
27	CD	O
mutated	VBN	O
PAH	NN	O
alleles	NNS	O
could	MD	O
be	VB	O
identified	VBN	O
.	.	O

Of	IN	O
the	DT	O
latter	JJ	O
,	,	O
the	DT	O
most	RBS	O
prevalent	JJ	O
were	VBD	O
associated	VBN	O
with	IN	O
haplotype	NN	O
6	CD	O
(	-LRB-	O
29	CD	O
.	.	O

6	CD	O
%	NN	O
)	-RRB-	O
,	,	O
1	CD	O
(	-LRB-	O
18	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
36	CD	O
(	-LRB-	O
11	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
,	,	O
while	IN	O
the	DT	O
normal	JJ	O
alleles	NNS	O
were	VBD	O
preferentially	RB	O
associated	VBN	O
with	IN	O
haplotype	NN	O
1	CD	O
(	-LRB-	O
20	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Of	IN	O
the	DT	O
19	CD	O
different	JJ	O
haplotypes	NNS	O
observed	VBN	O
,	,	O
5	CD	O
have	VBP	O
not	RB	O
been	VBN	O
described	VBN	O
previously	RB	O
.	.	O

The	DT	O
haplotype	NN	O
distribution	NN	O
differed	VBD	O
significantly	RB	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
Northern	JJ	O
European	JJ	O
population	NN	O
.	.	O

Two	CD	O
of	IN	O
the	DT	O
eight	CD	O
polymorphic	JJ	O
sites	NNS	O
were	VBD	O
in	IN	O
association	NN	O
with	IN	O
PKU	NN	B-Disease
.	.	O

No	DT	O
deletions	NNS	O
of	IN	O
exon	NN	O
sequences	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
families	NNS	O
analysed	VBN	O
.	.	O

Cloning	NN	O
of	IN	O
human	JJ	O
very-long-chain	JJ	O
acyl-coenzyme	NN	O
A	NN	O
dehydrogenase	NN	O
and	CC	O
molecular	JJ	O
characterization	NN	O
of	IN	O
its	PRP$	O
deficiency	NN	O
in	IN	O
two	CD	O
patients	NNS	O
.	.	O

Two	CD	O
overlapping	VBG	O
cDNA	NN	O
clones	NNS	O
(	-LRB-	O
1	CD	O
,	,	O
991	CD	O
bp	NN	O
and	CC	O
736	CD	O
bp	NN	O
,	,	O
respectively	RB	O
)	-RRB-	O
encoding	VBG	O
the	DT	O
precursor	NN	O
of	IN	O
human	JJ	O
mitochondrial	JJ	O
very-long-chain	NN	O
acyl-coenzyme	NN	O
A	NN	O
dehydrogenase	NN	O
(	-LRB-	O
VLCAD	NN	O
)	-RRB-	O
were	VBD	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
.	.	O

The	DT	O
cDNA	NN	O
inserts	NNS	O
of	IN	O
these	DT	O
clones	NNS	O
together	RB	O
encompass	VBP	O
a	DT	O
region	NN	O
of	IN	O
2	CD	O
,	,	O
177	CD	O
bases	NNS	O
,	,	O
encoding	VBG	O
the	DT	O
entire	JJ	O
protein	NN	O
of	IN	O
655	CD	O
amino	NN	O
acids	NNS	O
,	,	O
including	VBG	O
a	DT	O
40-amino	JJ	O
acid	NN	O
leader	NN	O
peptide	NN	O
and	CC	O
a	DT	O
615-amino	JJ	O
acid	NN	O
mature	JJ	O
polypeptide	NN	O
.	.	O

PCR-amplified	JJ	O
VLCAD	NN	O
cDNAs	NNS	O
were	VBD	O
sequenced	VBN	O
in	IN	O
cultured	VBN	O
fibroblasts	NNS	O
from	IN	O
two	CD	O
VLCAD-deficient	JJ	B-Disease
patients	NNS	O
.	.	O

In	IN	O
both	DT	O
patients	NNS	O
,	,	O
a	DT	O
105-bp	JJ	O
deletion	NN	O
encompassing	VBG	O
bases	NNS	O
1078-1182	CD	O
in	IN	O
VLCAD	NNP	O
cDNA	NN	O
was	VBD	O
identified	VBN	O
.	.	O

The	DT	O
deletion	NN	O
seems	VBZ	O
to	TO	O
occur	VB	O
due	JJ	O
to	TO	O
exon	NN	O
skipping	VBG	O
during	IN	O
processing	NN	O
of	IN	O
VLCAD	NNP	O
pre-mRNA	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
demonstration	NN	O
of	IN	O
a	DT	O
mutation	NN	O
causing	VBG	O
VLCAD	NNP	B-Disease
deficiency	NN	I-Disease
.	.	O

Quantitative	JJ	O
cDNA	NN	O
expression	NN	O
of	IN	O
normal	JJ	O
human	JJ	O
VLCAD	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
patients	NNS	O
fibroblasts	NNS	O
,	,	O
using	VBG	O
vaccinia	NN	O
viral	JJ	O
system	NN	O
,	,	O
which	WDT	O
demonstrated	VBD	O
that	IN	O
the	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
normal	JJ	I-Disease
VLCAD	NN	I-Disease
protein	NN	I-Disease
causes	VBZ	O
impaired	JJ	O
long-chain	JJ	O
fatty	JJ	O
acid	NN	O
beta-oxidation	NN	O
activity	NN	O
in	IN	O
the	DT	O
patients	NNS	O
fibroblasts	NNS	O
.	.	O

In	IN	O
patient	NN	O
fibroblasts	NNS	O
,	,	O
raising	VBG	O
VLCAD	JJ	O
activity	NN	O
to	TO	O
approximately	RB	O
20	CD	O
%	NN	O
of	IN	O
normal	JJ	O
control	NN	O
fibroblast	NN	O
activity	NN	O
raised	VBD	O
palmitic	JJ	O
acid	NN	O
beta-oxidation	NN	O
flux	NN	O
to	TO	O
the	DT	O
level	NN	O
found	VBN	O
in	IN	O
control	JJ	O
fibroblasts	NNS	O
,	,	O
which	WDT	O
may	MD	O
offer	VB	O
important	JJ	O
information	NN	O
for	IN	O
the	DT	O
rational	JJ	O
design	NN	O
of	IN	O
future	JJ	O
somatic	JJ	O
gene	NN	O
therapy	NN	O
for	IN	O
VLCAD	NNP	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
and	CC	O
their	PRP$	O
effects	NNS	O
on	IN	O
transcription	NN	O
.	.	O

Inactivation	NN	O
of	IN	O
both	CC	O
alleles	NNS	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
during	IN	O
normal	JJ	O
retinal	JJ	O
development	NN	O
initiates	VBZ	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
retinoblastoma	NN	B-Disease
(	-LRB-	I-Disease
RB	NN	I-Disease
)	-RRB-	I-Disease
tumor	NN	I-Disease
.	.	O

To	TO	O
identify	VB	O
the	DT	O
mutations	NNS	O
which	WDT	O
inactivate	VBP	O
RB1	NN	O
,	,	O
21	CD	O
RB	NN	B-Disease
tumors	NNS	I-Disease
isolated	VBN	O
from	IN	O
19	CD	O
patients	NNS	O
were	VBD	O
analyzed	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
or	CC	O
an	DT	O
RNase	NN	O
protection	NN	O
assay	NN	O
or	CC	O
both	DT	O
.	.	O

Mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
13	CD	O
of	IN	O
21	CD	O
RB	NN	B-Disease
tumors	NNS	I-Disease
;	:	O
in	IN	O
8	CD	O
tumors	NNS	B-Disease
,	,	O
the	DT	O
precise	JJ	O
errors	NNS	O
in	IN	O
nucleotide	NN	O
sequence	NN	O
were	VBD	O
characterized	VBN	O
.	.	O

Each	DT	O
of	IN	O
four	CD	O
germ	NN	O
line	NN	O
mutations	NNS	O
involved	VBD	O
a	DT	O
small	JJ	O
deletion	NN	O
or	CC	O
duplication	NN	O
,	,	O
while	IN	O
three	CD	O
somatic	JJ	O
mutations	NNS	O
were	VBD	O
point	NN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
splice	NN	O
alterations	NNS	O
and	CC	O
loss	NN	O
of	IN	O
an	DT	O
exon	NN	O
from	IN	O
the	DT	O
mature	JJ	O
RB1	NN	O
mRNA	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
in	IN	O
lymphoblasts	NNS	O
of	IN	O
three	CD	O
bilaterally	RB	O
affected	VBN	O
patients	NNS	O
,	,	O
although	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
and	CC	O
transcripts	NNS	O
containing	VBG	O
the	DT	O
mutations	NNS	O
were	VBD	O
obvious	JJ	O
in	IN	O
the	DT	O
RB	NN	B-Disease
tumors	NNS	I-Disease
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
normal	JJ	O
RB1	NN	O
allele	NN	O
.	.	O

The	DT	O
variations	NNS	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
expression	NN	O
of	IN	O
mutant	JJ	O
transcripts	NNS	O
suggest	VBP	O
deregulation	NN	O
of	IN	O
RB1	NN	O
transcription	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
functional	JJ	O
RB1	NN	O
gene	NN	O
product	NN	O
.	.	O

.	.	O

Resolution	NN	O
of	IN	O
the	DT	O
two	CD	O
loci	NNS	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
,	,	O
AN1	NN	O
and	CC	O
AN2	NN	O
,	,	O
to	TO	O
a	DT	O
single	JJ	O
locus	NN	O
on	IN	O
chromosome	NN	O
11p13	NN	O
.	.	O

Two	CD	O
distinct	JJ	O
loci	NNS	O
have	VBP	O
been	VBN	O
proposed	VBN	O
for	IN	O
aniridia	NN	B-Disease
;	:	O
AN1	NN	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
on	IN	O
chromosome	NN	O
2p	NN	O
and	CC	O
AN2	NN	O
for	IN	O
the	DT	O
aniridia	NN	B-Disease
in	IN	O
the	DT	O
WAGR	NNP	B-Disease
contiguous	JJ	I-Disease
gene	NN	I-Disease
syndrome	NN	I-Disease
on	IN	O
chromosome	NN	O
11p13	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
the	DT	O
kindred	NN	O
segregating	VBG	O
for	IN	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
,	,	O
which	WDT	O
suggested	VBD	O
linkage	NN	O
to	TO	O
acid	NN	O
phosphatase-1	NN	O
(	-LRB-	O
ACP1	NN	O
)	-RRB-	O
and	CC	O
led	VBD	O
to	TO	O
the	DT	O
assignment	NN	O
of	IN	O
the	DT	O
AN1	NN	O
locus	NN	O
on	IN	O
chromosome	NN	O
2p	NN	O
,	,	O
has	VBZ	O
been	VBN	O
updated	VBN	O
and	CC	O
expanded	VBN	O
.	.	O

Linkage	NN	O
analysis	NN	O
between	IN	O
the	DT	O
aniridia	NN	B-Disease
phenotype	NN	O
and	CC	O
ACP1	NN	O
does	VBZ	O
not	RB	O
support	VB	O
the	DT	O
original	JJ	O
linkage	NN	O
results	NNS	O
,	,	O
excluding	VBG	O
linkage	NN	O
up	IN	O
to	TO	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

17	CD	O
with	IN	O
Z	NN	O
=	JJ	O
-2	CD	O
.	.	O

Tests	NNS	O
for	IN	O
linkage	NN	O
to	TO	O
other	JJ	O
chromosome	NN	O
2p	NN	O
markers	NNS	O
.	.	O

APOB	NNP	O
,	,	O
D2S71	NN	O
,	,	O
D2S5	NN	O
,	,	O
and	CC	O
D2S1	NN	O
,	,	O
also	RB	O
excluded	VBN	O
linkage	NN	O
to	TO	O
aniridia	NN	B-Disease
.	.	O

Markers	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
isolated	VBN	O
from	IN	O
the	DT	O
chromosome	NN	O
11p13	NN	O
region	NN	O
were	VBD	O
then	RB	O
analyzed	VBN	O
in	IN	O
this	DT	O
aniridia	NN	B-Disease
family	NN	O
.	.	O

Two	CD	O
RFLPs	NNS	O
at	IN	O
the	DT	O
D11S323	NN	O
locus	NN	O
give	VB	O
significant	JJ	O
evidence	NN	O
for	IN	O
linkage	NN	O
.	.	O

The	DT	O
PvuII	NN	O
polymorphism	NN	O
detected	VBN	O
by	IN	O
probe	NN	O
p5S1	NN	O
.	.	O

6	CD	O
detects	VBZ	O
no	DT	O
recombinants	NNS	O
,	,	O
with	IN	O
a	DT	O
maximum	NN	O
lod	NN	O
score	NN	O
of	IN	O
Z	NN	O
=	JJ	O
6	CD	O
.	.	O

97	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

The	DT	O
HaeIII	NN	O
polymorphism	NN	O
detected	VBN	O
by	IN	O
the	DT	O
probe	NN	O
p5BE1	NN	O
.	.	O

2	CD	O
gives	VBZ	O
a	DT	O
maximum	NN	O
lod	NN	O
score	NN	O
of	IN	O
Z	NN	O
=	JJ	O
2	CD	O
.	.	O

57	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

Locus	NN	O
D11S325	NN	O
gives	VBZ	O
a	DT	O
lod	NN	O
score	NN	O
of	IN	O
Z	NN	O
=	JJ	O
1	CD	O
.	.	O

53	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
00	CD	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
a	DT	O
locus	NN	O
for	IN	O
aniridia	NN	B-Disease
(	-LRB-	O
AN1	NN	O
)	-RRB-	O
on	IN	O
chromosome	NN	O
2p	NN	O
has	VBZ	O
been	VBN	O
misassigned	VBN	O
and	CC	O
that	IN	O
this	DT	O
autosomal	JJ	O
dominant	JJ	O
aniridia	NN	B-Disease
family	NN	O
is	VBZ	O
segregating	VBG	O
for	IN	O
an	DT	O
aniridia	NN	B-Disease
mutation	NN	O
linked	VBN	O
to	TO	O
markers	NNS	O
in	IN	O
the	DT	O
11p13	NN	O
region	NN	O
.	.	O

GT	NN	O
to	TO	O
AT	IN	O
transition	NN	O
at	IN	O
a	DT	O
splice	NN	O
donor	NN	O
site	NN	O
causes	VBZ	O
skipping	VBG	O
of	IN	O
the	DT	O
preceding	VBG	O
exon	NN	O
in	IN	O
phenylketonuria	NN	B-Disease
.	.	O

Classical	JJ	B-Disease
Phenylketonuria	NNP	I-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
human	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
hepatic	JJ	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
isolated	VBD	O
several	JJ	O
mutant	JJ	O
PAH	NN	O
cDNA	NN	O
clones	NNS	O
from	IN	O
a	DT	O
PKU	NNP	B-Disease
carrier	NN	O
individual	NN	O
and	CC	O
showed	VBD	O
that	IN	O
they	PRP	O
contained	VBD	O
an	DT	O
internal	JJ	O
116	CD	O
base	NN	O
pair	NN	O
deletion	NN	O
,	,	O
corresponding	VBG	O
precisely	RB	O
to	TO	O
exon	NN	O
12	CD	O
of	IN	O
the	DT	O
human	JJ	O
chromosomal	JJ	O
PAH	NN	O
gene	NN	O
.	.	O

The	DT	O
deletion	NN	O
causes	VBZ	O
the	DT	O
synthesis	NN	O
of	IN	O
a	DT	O
truncated	VBN	O
protein	NN	O
lacking	VBG	O
the	DT	O
C-terminal	JJ	O
52	CD	O
amino	NN	O
acids	NNS	O
.	.	O

Gene	NNP	O
transfer	NN	O
and	CC	O
expression	NN	O
studies	NNS	O
using	VBG	O
the	DT	O
mutant	JJ	O
PAH	NN	O
cDNA	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
deletion	NN	O
abolishes	VBZ	O
PAH	NN	O
activity	NN	O
in	IN	O
the	DT	O
cell	NN	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
protein	NN	O
instability	NN	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
deletion	NN	O
,	,	O
the	DT	O
mutant	JJ	O
chromosomal	JJ	O
PAH	NN	O
gene	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
this	DT	O
individual	JJ	O
and	CC	O
shown	VBN	O
to	TO	O
contain	VB	O
a	DT	O
GT	NN	O
--	:	O
greater	JJR	O
than	IN	O
AT	IN	O
substitution	NN	O
at	IN	O
the	DT	O
5	CD	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
12	CD	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
consequence	NN	O
of	IN	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
mutation	NN	O
in	IN	O
the	DT	O
human	JJ	O
liver	NN	O
is	VBZ	O
the	DT	O
skipping	VBG	O
of	IN	O
the	DT	O
preceding	VBG	O
exon	NN	O
during	IN	O
RNA	NN	O
splicing	NN	O
.	.	O

.	.	O

Clinical	JJ	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
analysis	NN	O
of	IN	O
19	CD	O
Wolfram	NN	B-Disease
syndrome	NN	I-Disease
kindreds	NNS	O
demonstrating	VBG	O
a	DT	O
wide	JJ	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
WFS1	NN	O
.	.	O

Wolfram	NNP	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
neurodegenerative	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
juvenile-onset	JJ	B-Disease
diabetes	NN	I-Disease
mellitus	NN	I-Disease
and	CC	O
progressive	JJ	O
optic	JJ	B-Disease
atrophy	NN	I-Disease
.	.	O

mtDNA	NN	O
deletions	NNS	O
have	VBP	O
been	VBN	O
described	VBN	O
,	,	O
and	CC	O
a	DT	O
gene	NN	O
(	-LRB-	O
WFS1	NN	O
)	-RRB-	O
recently	RB	O
has	VBZ	O
been	VBN	O
identified	VBN	O
,	,	O
on	IN	O
chromosome	NN	O
4p16	NN	O
,	,	O
encoding	VBG	O
a	DT	O
predicted	VBN	O
890	CD	O
amino	NN	O
acid	NN	O
transmembrane	NN	O
protein	NN	O
.	.	O

Direct	JJ	O
DNA	NN	O
sequencing	NN	O
was	VBD	O
done	VBN	O
to	TO	O
screen	VB	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
the	DT	O
WFS1	NN	O
gene	NN	O
in	IN	O
30	CD	O
patients	NNS	O
from	IN	O
19	CD	O
British	JJ	O
kindreds	NNS	O
with	IN	O
Wolfram	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

DNA	NN	O
was	VBD	O
also	RB	O
screened	VBN	O
for	IN	O
structural	JJ	O
rearrangements	NNS	O
(	-LRB-	O
deletions	NNS	O
and	CC	O
duplications	NNS	O
)	-RRB-	O
and	CC	O
point	NN	O
mutations	NNS	O
in	IN	O
mtDNA	NN	O
.	.	O

No	DT	O
pathogenic	JJ	O
mtDNA	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
our	PRP$	O
cohort	NN	O
.	.	O

We	PRP	O
identified	VBD	O
24	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
WFS1	NN	O
gene	NN	O
8	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
8	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
3	CD	O
in-frame	RB	O
deletions	NNS	O
,	,	O
1	CD	O
in-frame	RB	O
insertion	NN	O
,	,	O
and	CC	O
4	CD	O
frameshift	NN	O
mutations	NNS	O
.	.	O

Of	IN	O
these	DT	O
,	,	O
23	CD	O
were	VBD	O
novel	JJ	O
mutations	NNS	O
,	,	O
and	CC	O
most	JJS	O
occurred	VBN	O
in	IN	O
exon	NN	O
8	CD	O
.	.	O

The	DT	O
majority	NN	O
of	IN	O
patients	NNS	O
were	VBD	O
compound	JJ	O
heterozygotes	NNS	O
for	IN	O
two	CD	O
mutations	NNS	O
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
common	JJ	O
founder	NN	O
mutation	NN	O
.	.	O

The	DT	O
data	NNS	O
were	VBD	O
also	RB	O
analyzed	VBN	O
for	IN	O
genotype-phenotype	JJ	O
relationships	NNS	O
.	.	O

Although	IN	O
some	DT	O
interesting	JJ	O
cases	NNS	O
were	VBD	O
noted	VBN	O
,	,	O
consideration	NN	O
of	IN	O
the	DT	O
small	JJ	O
sample	NN	O
size	NN	O
and	CC	O
frequency	NN	O
of	IN	O
each	DT	O
mutation	NN	O
indicated	VBD	O
no	DT	O
clear-cut	JJ	O
correlations	NNS	O
between	IN	O
any	DT	O
of	IN	O
the	DT	O
observed	VBN	O
mutations	NNS	O
and	CC	O
disease	NN	O
severity	NN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
obvious	JJ	O
mutation	NN	O
hot	JJ	O
spots	NNS	O
or	CC	O
clusters	NNS	O
.	.	O

Hence	RB	O
,	,	O
molecular	JJ	O
screening	NN	O
for	IN	O
Wolfram	NNP	B-Disease
syndrome	NN	I-Disease
in	IN	O
affected	JJ	O
families	NNS	O
and	CC	O
for	IN	O
Wolfram	NNP	B-Disease
syndrome-carrier	NN	O
status	NN	O
in	IN	O
subjects	NNS	O
with	IN	O
psychiatric	JJ	B-Disease
disorders	NNS	I-Disease
or	CC	O
diabetes	NN	B-Disease
mellitus	NN	I-Disease
will	MD	O
require	VB	O
complete	JJ	O
analysis	NN	O
of	IN	O
exon	NN	O
8	CD	O
and	CC	O
upstream	JJ	O
exons	NNS	O
.	.	O

.	.	O

Maternal	JJ	B-Disease
uniparental	JJ	I-Disease
disomy	NN	I-Disease
for	IN	I-Disease
chromosome	NN	I-Disease
14	CD	I-Disease
in	IN	O
a	DT	O
boy	NN	O
with	IN	O
a	DT	O
normal	JJ	O
karyotype	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
boy	NN	O
with	IN	O
a	DT	O
maternal	JJ	B-Disease
uniparental	JJ	I-Disease
disomy	NN	I-Disease
for	IN	I-Disease
chromosome	NN	I-Disease
14	CD	I-Disease
(	-LRB-	O
UPD	NN	B-Disease
(	-LRB-	O
14	CD	O
)	-RRB-	O
)	-RRB-	O
.	.	O

At	IN	O
7	CD	O
years	NNS	O
of	IN	O
age	NN	O
he	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
us	PRP	O
by	IN	O
the	DT	O
paediatrician	NN	O
because	IN	O
of	IN	O
symptoms	NNS	O
of	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

He	PRP	O
showed	VBD	O
short	JJ	B-Disease
stature	NN	I-Disease
,	,	O
obesity	NN	B-Disease
,	,	O
mild	JJ	O
developmental	JJ	B-Disease
delay	NN	I-Disease
,	,	O
cryptorchidism	NN	B-Disease
,	,	O
and	CC	O
some	DT	O
mild	JJ	O
dysmorphic	JJ	B-Disease
features	NNS	I-Disease
.	.	O

The	DT	O
history	NN	O
further	RB	O
indicated	VBD	O
intrauterine	JJ	B-Disease
growth	NN	I-Disease
retardation	NN	I-Disease
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
pregnancy	NN	O
.	.	O

His	PRP$	O
mother	NN	O
was	VBD	O
44	CD	O
years	NNS	O
of	IN	O
age	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
birth	NN	O
.	.	O

After	IN	O
birth	NN	O
he	PRP	O
showed	VBD	O
hypotonia	NN	B-Disease
with	IN	O
poor	JJ	O
sucking	NN	O
,	,	O
for	IN	O
which	WDT	O
gavage	NN	O
feeding	NN	O
was	VBD	O
needed	VBN	O
.	.	O

Motor	NNP	O
development	NN	O
was	VBD	O
delayed	VBN	O
.	.	O

After	IN	O
1	CD	O
year	NN	O
he	PRP	O
became	VBD	O
obese	JJ	B-Disease
despite	IN	O
a	DT	O
normal	JJ	O
appetite	NN	O
.	.	O

Recurrent	JJ	O
middle	JJ	B-Disease
ear	NN	I-Disease
infections	NNS	I-Disease
,	,	O
a	DT	O
high	JJ	O
pain	NN	O
threshold	NN	O
,	,	O
and	CC	O
a	DT	O
great	JJ	O
skill	NN	O
with	IN	O
jigsaw	NN	O
puzzles	NNS	O
were	VBD	O
reported	VBN	O
.	.	O

There	EX	O
were	VBD	O
no	DT	O
behavioural	JJ	O
problems	NNS	O
or	CC	O
sleep	VB	O
disturbance	NN	O
.	.	O

Chromosomal	JJ	O
analysis	NN	O
was	VBD	O
normal	JJ	O
(	-LRB-	O
46	CD	O
,	,	O
XY	NN	O
)	-RRB-	O
.	.	O

DNA	NN	O
analysis	NN	O
for	IN	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
showed	VBD	O
no	DT	O
abnormalities	NNS	O
.	.	O

Two	CD	O
years	NNS	O
later	RB	O
he	PRP	O
was	VBD	O
re-examined	VBN	O
because	IN	O
we	PRP	O
thought	VBD	O
his	PRP$	O
features	NNS	O
fitted	VBD	O
the	DT	O
PWS-like	JJ	O
phenotype	NN	O
associated	VBN	O
with	IN	O
maternal	JJ	O
UPD	NN	B-Disease
(	-LRB-	O
14	CD	O
)	-RRB-	O
.	.	O

At	IN	O
that	DT	O
time	NN	O
precocious	JJ	O
puberty	NN	O
was	VBD	O
evident	JJ	O
.	.	O

DNA	NN	O
analysis	NN	O
showed	VBD	O
maternal	JJ	B-Disease
heterodisomy	NN	I-Disease
for	IN	O
chromosome	NN	O
14	CD	O
.	.	O

In	IN	O
all	PDT	O
the	DT	O
previously	RB	O
described	VBN	O
11	CD	O
cases	NNS	O
with	IN	O
maternal	JJ	O
UPD	NN	B-Disease
(	-LRB-	O
14	CD	O
)	-RRB-	O
,	,	O
a	DT	O
Robertsonian	JJ	O
translocation	NN	O
involving	VBG	O
chromosome	NN	O
14	CD	O
was	VBD	O
detected	VBN	O
cytogenetically	RB	O
before	IN	O
DNA	NN	O
analysis	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
report	NN	O
of	IN	O
diagnosis	NN	O
of	IN	O
maternal	JJ	O
UPD	NN	B-Disease
(	-LRB-	O
14	CD	O
)	-RRB-	O
based	VBN	O
on	IN	O
clinical	JJ	O
features	NNS	O
.	.	O

This	DT	O
finding	NN	O
underlines	VBZ	O
the	DT	O
importance	NN	O
of	IN	O
DNA	NN	O
analysis	NN	O
for	IN	O
maternal	JJ	O
UPD	NN	O
(	-LRB-	O
14	CD	O
)	-RRB-	O
in	IN	O
patients	NNS	O
with	IN	O
a	DT	O
similar	JJ	O
PWS-like	JJ	O
phenotype	NN	O
even	RB	O
without	IN	O
previous	JJ	O
identification	NN	O
of	IN	O
a	DT	O
Robertsonian	JJ	O
translocation	NN	O
involving	VBG	O
chromosome	NN	O
14	CD	O
.	.	O

.	.	O

Detection	NN	O
of	IN	O
eight	CD	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
10	CD	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
,	,	O
including	VBG	O
1	CD	O
family	NN	O
with	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
.	.	O

Genetic	JJ	O
epidemiological	JJ	O
evidence	NN	O
suggests	VBZ	O
that	IN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
may	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
approximately	RB	O
one	CD	O
half	NN	O
of	IN	O
early	JJ	O
onset	NN	O
familial	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
and	CC	O
the	DT	O
majority	NN	O
of	IN	O
familial	JJ	B-Disease
breast/ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
recent	JJ	O
cloning	NN	O
of	IN	O
BRCA1	NN	O
allows	VBZ	O
for	IN	O
the	DT	O
direct	JJ	O
detection	NN	O
of	IN	O
mutations	NNS	O
,	,	O
but	CC	O
the	DT	O
feasibility	NN	O
of	IN	O
presymptomatic	JJ	O
screening	NN	O
for	IN	O
cancer	NN	B-Disease
susceptibility	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
analyzed	VBD	O
genomic	JJ	O
DNA	NN	O
from	IN	O
one	CD	O
affected	VBD	O
individual	JJ	O
from	IN	O
each	DT	O
of	IN	O
24	CD	O
families	NNS	O
with	IN	O
at	IN	O
least	JJS	O
three	CD	O
cases	NNS	O
of	IN	O
ovarian	JJ	B-Disease
or	CC	I-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
,	,	O
using	VBG	O
SSCP	NN	O
assays	NNS	O
.	.	O

Variant	JJ	O
SSCP	NN	O
bands	NNS	O
were	VBD	O
subcloned	VBN	O
and	CC	O
sequenced	VBN	O
.	.	O

Allele-specific	JJ	O
oligonucleotide	NN	O
hybridization	NN	O
was	VBD	O
used	VBN	O
to	TO	O
verify	VB	O
sequence	NN	O
changes	NNS	O
and	CC	O
to	TO	O
screen	NN	O
DNA	NN	O
from	IN	O
control	NN	O
individuals	NNS	O
.	.	O

Six	CD	O
frameshift	NN	O
and	CC	O
two	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
10	CD	O
different	JJ	O
families	NNS	O
.	.	O

A	DT	O
frameshift	NN	O
mutation	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
male	JJ	O
proband	NN	O
affected	VBN	O
with	IN	O
both	CC	O
breast	NN	B-Disease
and	CC	I-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
.	.	O

A	DT	O
40-bp	JJ	O
deletion	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
patient	NN	O
who	WP	O
developed	VBD	O
intra-abdominal	JJ	B-Disease
carcinomatosis	NN	I-Disease
1	CD	O
year	NN	O
after	IN	O
prophylactic	JJ	O
oophorectomy	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
detected	VBN	O
throughout	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
only	RB	O
one	CD	O
was	VBD	O
detected	VBN	O
in	IN	O
more	JJR	O
than	IN	O
a	DT	O
single	JJ	O
family	NN	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
that	IN	O
inherited	VBN	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
can	MD	O
occur	VB	O
as	IN	O
a	DT	O
consequence	NN	O
of	IN	O
a	DT	O
wide	JJ	O
array	NN	O
of	IN	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggests	VBZ	O
that	IN	O
development	NN	O
of	IN	O
a	DT	O
screening	JJ	O
test	NN	O
for	IN	O
BRCA1	NN	O
mutations	NNS	O
will	MD	O
be	VB	O
technically	RB	O
challenging	JJ	O
.	.	O

The	DT	O
finding	NN	O
of	IN	O
a	DT	O
mutation	NN	O
in	IN	O
a	DT	O
family	NN	O
with	IN	O
male	JJ	B-Disease
breast	NN	I-Disease
cancer	NN	I-Disease
,	,	O
not	RB	O
previously	RB	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
BRCA1	NN	O
,	,	O
also	RB	O
illustrates	VBZ	O
the	DT	O
potential	JJ	O
difficulties	NNS	O
of	IN	O
genetic	JJ	O
counseling	NN	O
for	IN	O
individuals	NNS	O
known	VBN	O
to	TO	O
carry	VB	O
mutations	NNS	O
.	.	O

.	.	O

Color	NNP	B-Disease
vision	NN	I-Disease
defects	NNS	I-Disease
in	IN	O
adrenomyeloneuropathy	NN	B-Disease
.	.	O

The	DT	O
relationship	NN	O
between	IN	O
abnormal	JJ	B-Disease
color	NN	I-Disease
vision	NN	I-Disease
and	CC	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
was	VBD	O
investigated	VBN	O
in	IN	O
27	CD	O
AMN	NN	B-Disease
patients	NNS	O
and	CC	O
31	CD	O
age-matched	JJ	O
controls	NNS	O
by	IN	O
using	VBG	O
the	DT	O
Farnsworth-Munsell	NNP	O
100	CD	O
Hue	NNP	O
test	NN	O
.	.	O

Twelve	CD	O
(	-LRB-	O
44	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
27	CD	O
patients	NNS	O
showed	VBD	O
test	NN	O
scores	NNS	O
significantly	RB	O
above	IN	O
normal	JJ	O
.	.	O

The	DT	O
axes	NNS	O
of	IN	O
bipolarity	NN	O
determined	VBN	O
by	IN	O
the	DT	O
testing	NN	O
differed	VBD	O
widely	RB	O
between	IN	O
the	DT	O
patients	NNS	O
with	IN	O
abnormal	JJ	O
scores	NNS	O
,	,	O
compatible	JJ	O
with	IN	O
the	DT	O
notion	NN	O
that	IN	O
different	JJ	O
alterations	NNS	O
in	IN	O
visual	JJ	O
pigment	NN	O
genes	NNS	O
occur	VBP	O
in	IN	O
different	JJ	O
AMN	NNP	B-Disease
kindreds	NNS	O
.	.	O

These	DT	O
observations	NNS	O
confirm	VBP	O
our	PRP$	O
earlier	JJR	O
impression	NN	O
that	IN	O
the	DT	O
frequency	NN	O
of	IN	O
abnormal	JJ	B-Disease
color	NN	I-Disease
vision	NN	I-Disease
is	VBZ	O
increased	VBN	O
in	IN	O
these	DT	O
kindreds	NNS	O
,	,	O
and	CC	O
it	PRP	O
supports	VBZ	O
our	PRP$	O
contentions	NNS	O
that	WDT	O
(	-LRB-	O
1	LS	O
)	-RRB-	O
AMN	NNP	B-Disease
(	-LRB-	O
and	CC	O
its	PRP$	O
companion	NN	O
,	,	O
adrenoleukodystrophy	NN	B-Disease
)	-RRB-	O
are	VBP	O
very	RB	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
visual	JJ	O
pigment	NN	O
loci	NNS	O
at	IN	O
Xq28	NN	O
and	CC	O
(	-LRB-	O
2	LS	O
)	-RRB-	O
this	DT	O
proximity	NN	O
might	MD	O
provide	VB	O
the	DT	O
opportunity	NN	O
to	TO	O
observe	VB	O
contiguous	JJ	B-Disease
gene	NN	I-Disease
defects	NNS	I-Disease
.	.	O

.	.	O

Patterns	NN	O
of	IN	O
exon	NN	O
deletions	NNS	O
in	IN	O
Duchenne	NNP	B-Disease
and	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

A	DT	O
panel	NN	O
of	IN	O
patients	NNS	O
with	IN	O
Duchenne	NN	B-Disease
and	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
and	CC	O
BMD	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
screened	VBN	O
with	IN	O
the	DT	O
cDNA	NN	O
probes	NNS	O
Cf56a	NN	O
and	CC	O
Cf23a	NN	O
,	,	O
which	WDT	O
detect	VBP	O
exons	NNS	O
in	IN	O
the	DT	O
central	JJ	O
part	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

One	CD	O
or	CC	O
more	JJR	O
exons	NNS	O
were	VBD	O
deleted	VBN	O
in	IN	O
60	CD	O
%	NN	O
of	IN	O
patients	NNS	O
.	.	O

The	DT	O
deletions	NNS	O
were	VBD	O
mapped	VBN	O
and	CC	O
prove	VB	O
to	TO	O
be	VB	O
heterogeneous	JJ	O
in	IN	O
size	NN	O
and	CC	O
extent	NN	O
,	,	O
particularly	RB	O
in	IN	O
DMD	NNP	B-Disease
.	.	O

Deletions	NNS	O
specific	JJ	O
to	TO	O
DMD	NNP	B-Disease
and	CC	O
to	TO	O
BMD	NNP	B-Disease
are	VBP	O
described	VBN	O
.	.	O

Half	NN	O
of	IN	O
all	DT	O
BMD	NN	B-Disease
patients	NNS	O
have	VBP	O
a	DT	O
deletion	NN	O
of	IN	O
one	CD	O
particular	JJ	O
small	JJ	O
group	NN	O
of	IN	O
exons	NNS	O
;	:	O
smaller	JJR	O
deletions	NNS	O
within	IN	O
this	DT	O
same	JJ	O
group	NN	O
produce	VBP	O
the	DT	O
more	RBR	O
severe	JJ	O
DMD	NN	B-Disease
.	.	O

.	.	O

The	DT	O
LEC	NNP	O
rat	NN	O
has	VBZ	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
copper	NN	O
transporting	VBG	O
ATPase	NN	O
gene	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
.	.	O

The	DT	O
Long-Evans	NNP	O
Cinnamon	NNP	O
(	-LRB-	O
LEC	NNP	O
)	-RRB-	O
rat	NN	O
shows	VBZ	O
similarity	NN	O
to	TO	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
in	IN	O
many	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
features	NNS	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
cDNAs	NNS	O
for	IN	O
the	DT	O
rat	NN	O
gene	NN	O
(	-LRB-	O
Atp7b	NN	O
)	-RRB-	O
homologous	JJ	O
to	TO	O
the	DT	O
human	JJ	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
(	-LRB-	O
ATP7B	NN	O
)	-RRB-	O
and	CC	O
have	VBP	O
used	VBN	O
them	PRP	O
to	TO	O
identify	VB	O
a	DT	O
partial	JJ	O
deletion	NN	O
in	IN	O
the	DT	O
Atp7b	NN	O
gene	NN	O
in	IN	O
the	DT	O
LEC	NNP	O
rat	NN	O
.	.	O

The	DT	O
deletion	NN	O
removes	VBZ	O
at	IN	O
least	JJS	O
900	CD	O
bp	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
at	IN	O
the	DT	O
3	CD	O
end	NN	O
,	,	O
includes	VBZ	O
the	DT	O
crucial	JJ	O
ATP	NN	O
binding	NN	O
domain	NN	O
and	CC	O
extends	VBZ	O
downstream	JJ	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
convincing	JJ	O
evidence	NN	O
for	IN	O
defining	VBG	O
the	DT	O
LEC	NNP	O
rat	NN	O
as	IN	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
.	.	O

This	DT	O
model	NN	O
will	MD	O
be	VB	O
important	JJ	O
for	IN	O
studying	VBG	O
liver	NN	O
pathophysiology	NN	O
,	,	O
for	IN	O
developing	VBG	O
therapy	NN	O
for	IN	O
Wilson	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
for	IN	O
studying	VBG	O
the	DT	O
pathway	NN	O
of	IN	O
copper	NN	O
transport	NN	O
and	CC	O
its	PRP$	O
possible	JJ	O
interaction	NN	O
with	IN	O
other	JJ	O
heavy	JJ	O
metals	NNS	O
.	.	O

.	.	O

Detection	NN	O
of	IN	O
a	DT	O
new	JJ	O
submicroscopic	JJ	O
Norrie	NN	B-Disease
disease	NN	I-Disease
deletion	NN	O
interval	NN	O
with	IN	O
a	DT	O
novel	JJ	O
DNA	NN	O
probe	NN	O
isolated	VBN	O
by	IN	O
differential	JJ	O
Alu	NN	O
PCR	NN	O
fingerprint	NN	O
cloning	NN	O
.	.	O

Differential	JJ	O
Alu	NN	O
PCR	NN	O
fingerprint	NN	O
cloning	NN	O
was	VBD	O
used	VBN	O
to	TO	O
isolate	VB	O
a	DT	O
DNA	NN	O
probe	NN	O
from	IN	O
the	DT	O
Xp11	NN	O
.	.	O

4	CD	O
--	:	O
>	JJR	O
p11	NN	O
.	.	O

21	CD	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

This	DT	O
novel	JJ	O
sequence	NN	O
,	,	O
cpXr318	NN	O
(	-LRB-	O
DXS742	NN	O
)	-RRB-	O
,	,	O
detects	VBZ	O
a	DT	O
new	JJ	O
submicroscopic	JJ	O
deletion	NN	O
interval	NN	O
at	IN	O
the	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
locus	NN	O
(	-LRB-	O
NDP	NN	O
)	-RRB-	O
.	.	O

Combining	VBG	O
our	PRP$	O
data	NNS	O
with	IN	O
the	DT	O
consensus	NN	O
genetic	JJ	O
map	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
,	,	O
we	PRP	O
propose	VBP	O
the	DT	O
physical	JJ	O
order	NN	O
Xcen-DXS14-DXS255	NN	O
-	:	O
(	-LRB-	O
DXS426	NN	O
,	,	O
TIMP	NN	O
)	-RRB-	O
-	:	O
(	-LRB-	O
DXS742	NN	O
-	:	O
(	-LRB-	O
[	-LRB-	O
MAOB-MAOA-DXS7	NN	O
]	-RRB-	O
,	,	O
NDP	NN	O
)	-RRB-	O
-	:	O
DXS77-DXS228	NN	O
)	-RRB-	O
-	:	O
DXS209-DXS148-DXS196	NN	O
-	:	O
+	CC	O
+	CC	O
+	CC	O
Xpter	NNP	O
.	.	O

The	DT	O
cpXr318	NN	O
probe	NN	O
and	CC	O
a	DT	O
subclone	NN	O
from	IN	O
a	DT	O
cosmid	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
DXS7	NN	O
locus	NN	O
were	VBD	O
converted	VBN	O
into	IN	O
sequence-tagged	JJ	O
sites	NNS	O
.	.	O

Finally	RB	O
,	,	O
DXS742	NN	O
,	,	O
DSX7	NN	O
,	,	O
DXS77	NN	O
,	,	O
and	CC	O
MAOA	NNP	O
were	VBD	O
integrated	VBN	O
into	IN	O
a	DT	O
physical	JJ	O
map	NN	O
spanning	VBG	O
the	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
locus	NN	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
normotriglyceridemic	JJ	B-Disease
abetalipoproteinemia	NN	I-Disease
indicates	VBZ	O
a	DT	O
lack	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
apolipoprotein	NN	O
B	NN	O
gene	NN	O
.	.	O

Normotriglyceridemic	JJ	B-Disease
abetalipoproteinemia	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
familial	JJ	B-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
an	DT	O
isolated	VBN	O
deficiency	NN	B-Disease
of	IN	I-Disease
apoB-100	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
reported	VBN	O
a	DT	O
patient	NN	O
with	IN	O
this	DT	O
disease	NN	O
,	,	O
who	WP	O
had	VBD	O
normal	JJ	O
apoB-48	NN	O
but	CC	O
no	DT	O
apoB-100	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
genetic	JJ	B-Disease
abnormalities	NNS	I-Disease
in	IN	O
this	DT	O
family	NN	O
,	,	O
we	PRP	O
studied	VBD	O
the	DT	O
linkage	NN	O
of	IN	O
apoB	NN	O
gene	NN	O
using	VBG	O
three	CD	O
genetic	JJ	O
markers	NNS	O
.	.	O

The	DT	O
proband	NN	O
and	CC	O
her	PRP$	O
affected	JJ	O
brother	NN	O
showed	VBD	O
completely	RB	O
different	JJ	O
apoB	NN	O
gene	NN	O
alleles	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
apoB	NN	O
gene	NN	O
itself	PRP	O
is	VBZ	O
not	RB	O
related	VBN	O
to	TO	O
this	DT	O
disorder	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
an	DT	O
American	JJ	O
case	NN	O
had	VBD	O
a	DT	O
point	NN	O
substitution	NN	O
in	IN	O
the	DT	O
apoB	NN	O
gene	NN	O
generating	VBG	O
an	DT	O
in-frame	RB	O
stop	VB	O
codon	NN	O
.	.	O

These	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
this	DT	O
disorder	NN	O
can	MD	O
be	VB	O
caused	VBN	O
by	IN	O
defect	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
of	IN	O
either	CC	O
an	DT	O
apoB	NN	O
gene	NN	O
or	CC	O
other	JJ	O
genes	NNS	O
.	.	O

.	.	O

Founder	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
in	IN	O
Polish	JJ	O
families	NNS	O
with	IN	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
undertaken	VBN	O
a	DT	O
hospital-based	JJ	O
study	NN	O
,	,	O
to	TO	O
identify	VB	O
possible	JJ	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
founder	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Polish	JJ	O
population	NN	O
.	.	O

The	DT	O
study	NN	O
group	NN	O
consisted	VBD	O
of	IN	O
66	CD	O
Polish	JJ	O
families	NNS	O
with	IN	O
cancer	NN	B-Disease
who	WP	O
have	VBP	O
at	IN	O
least	JJS	O
three	CD	O
related	JJ	O
females	NNS	O
affected	VBN	O
with	IN	O
breast	NN	B-Disease
or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
and	CC	O
who	WP	O
had	VBD	O
cancer	NN	B-Disease
diagnosed	VBD	O
,	,	O
in	IN	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
three	CD	O
affected	VBN	O
females	NNS	O
,	,	O
at	IN	O
age	NN	O
<	JJR	O
50	CD	O
years	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
26	CD	O
families	NNS	O
had	VBD	O
both	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
,	,	O
4	CD	O
families	NNS	O
had	VBD	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
only	RB	O
,	,	O
and	CC	O
36	CD	O
families	NNS	O
had	VBD	O
breast	NN	B-Disease
cancers	NNS	I-Disease
only	RB	O
.	.	O

Genomic	JJ	O
DNA	NN	O
was	VBD	O
prepared	VBN	O
from	IN	O
the	DT	O
peripheral	JJ	O
blood	NN	O
leukocytes	NNS	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
affected	VBN	O
woman	NN	O
from	IN	O
each	DT	O
family	NN	O
.	.	O

The	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
of	IN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
was	VBD	O
screened	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
,	,	O
by	IN	O
use	NN	O
of	IN	O
SSCP	NN	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
observed	VBN	O
variants	NNS	O
.	.	O

Mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
35	CD	O
(	-LRB-	O
53	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
66	CD	O
families	NNS	O
studied	VBN	O
.	.	O

All	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
within	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
.	.	O

BRCA1	NN	B-Disease
abnormalities	NNS	I-Disease
were	VBD	O
identified	VBN	O
in	IN	O
all	DT	O
four	CD	O
families	NNS	O
with	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
only	RB	O
,	,	O
in	IN	O
67	CD	O
%	NN	O
of	IN	O
27	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
and	CC	O
in	IN	O
34	CD	O
%	NN	O
of	IN	O
35	CD	O
families	NNS	O
with	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
only	RB	O
.	.	O

The	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
BRCA2	NN	O
mutation	NN	O
had	VBD	O
the	DT	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

Seven	CD	O
distinct	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
;	:	O
five	CD	O
of	IN	O
these	DT	O
occurred	VBN	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
families	NNS	O
.	.	O

In	IN	O
total	NN	O
,	,	O
recurrent	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
33	CD	O
(	-LRB-	O
94	CD	O
%	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
35	CD	O
families	NNS	O
with	IN	O
detected	VBN	O
mutations	NNS	O
.	.	O

Three	CD	O
BRCA1	NN	B-Disease
abnormalities	NNS	I-Disease
-	:	O
5382insC	NN	O
,	,	O
C61G	NN	O
,	,	O
and	CC	O
4153delA	NN	O
-	:	O
accounted	VBD	O
for	IN	O
51	CD	O
%	NN	O
,	,	O
20	CD	O
%	NN	O
,	,	O
and	CC	O
11	CD	O
%	NN	O
of	IN	O
the	DT	O
identified	VBN	O
mutations	NNS	O
,	,	O
respectively	RB	O
.	.	O

.	.	O

New	NNP	O
founder	NN	O
haplotypes	NNS	O
at	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
locus	NN	O
in	IN	O
southern	JJ	O
Africa	NNP	O
.	.	O

The	DT	O
association	NN	O
between	IN	O
normal	JJ	O
alleles	NNS	O
at	IN	O
the	DT	O
CTG	NNP	O
repeat	NN	O
and	CC	O
two	CD	O
nearby	JJ	O
polymorphisms	NNS	O
in	IN	O
the	DT	O
myotonin	NN	O
protein	NN	O
kinase	NN	O
gene	NN	O
,	,	O
the	DT	O
Alu	NN	O
insertion/deletion	JJ	O
polymorphism	NN	O
and	CC	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
kinase	NN	O
(	-LRB-	O
DMK	NN	O
)	-RRB-	O
(	-LRB-	O
G/T	NN	O
)	-RRB-	O
intron	NN	O
9/HinfI	NN	O
polymorphism	NN	O
,	,	O
has	VBZ	O
been	VBN	O
analyzed	VBN	O
in	IN	O
South	JJ	O
African	JJ	O
Negroids	NNS	O
,	,	O
a	DT	O
population	NN	O
in	IN	O
which	WDT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
has	VBZ	O
not	RB	O
been	VBN	O
described	VBN	O
.	.	O

South	JJ	O
African	JJ	O
Negroids	NNS	O
have	VBP	O
a	DT	O
CTG	NNP	O
allelic	JJ	O
distribution	NN	O
that	WDT	O
is	VBZ	O
significantly	RB	O
different	JJ	O
from	IN	O
that	DT	O
in	IN	O
Caucasoids	NNPS	O
and	CC	O
Japanese	NNPS	O
the	DT	O
CTG	NNP	O
repeat	NN	O
lengths	NNS	O
of	IN	O
>	JJR	O
or	CC	O
=	JJ	O
19	CD	O
are	VBP	O
very	RB	O
rare	JJ	O
.	.	O

The	DT	O
striking	JJ	O
linkage	NN	O
disequilibrium	NN	O
between	IN	O
specific	JJ	O
alleles	NNS	O
at	IN	O
the	DT	O
Alu	NN	O
polymorphism	NN	O
(	-LRB-	O
Alu	NN	O
(	-LRB-	O
ins	NNS	O
)	-RRB-	O
and	CC	O
Alu	NN	O
(	-LRB-	O
del	FW	O
)	-RRB-	O
)	-RRB-	O
,	,	O
the	DT	O
HinfI	NN	O
polymorphism	NN	O
(	-LRB-	O
HinfI-1	NN	O
and	CC	O
HinfI-2	NN	O
)	-RRB-	O
,	,	O
and	CC	O
the	DT	O
CTG	NNP	O
repeat	NN	O
polymorphism	NN	O
seen	VBN	O
in	IN	O
Caucasoid	NNP	O
(	-LRB-	O
Europeans	NNPS	O
and	CC	O
Canadians	NNPS	O
)	-RRB-	O
populations	NNS	O
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
the	DT	O
South	JJ	O
African	JJ	O
Negroid	JJ	O
population	NN	O
.	.	O

Numerous	JJ	O
haplotypes	NNS	O
,	,	O
not	RB	O
previously	RB	O
described	VBN	O
in	IN	O
Europeans	NNPS	O
,	,	O
were	VBD	O
,	,	O
however	RB	O
,	,	O
found	VBN	O
.	.	O

It	PRP	O
thus	RB	O
seems	VBZ	O
likely	JJ	O
that	IN	O
only	RB	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
these	DT	O
"	''	O
African	NNP	O
"	''	O
chromosomes	NNS	O
were	VBD	O
present	JJ	O
in	IN	O
the	DT	O
progenitors	NNS	O
of	IN	O
all	DT	O
non-African	JJ	O
peoples	NNS	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
support	NN	O
for	IN	O
the	DT	O
"	''	O
out	IN	O
of	IN	O
Africa	NNP	O
"	''	O
model	NN	O
for	IN	O
the	DT	O
origin	NN	O
of	IN	O
modern	JJ	O
humans	NNS	O
and	CC	O
suggest	VBP	O
that	IN	O
the	DT	O
rare	JJ	O
ancestral	JJ	O
DM	NN	B-Disease
mutation	NN	O
event	NN	O
may	MD	O
have	VB	O
occurred	VBN	O
after	IN	O
the	DT	O
migration	NN	O
from	IN	O
Africa	NNP	O
,	,	O
hence	RB	O
the	DT	O
absence	NN	O
of	IN	O
DM	NN	B-Disease
in	IN	O
sub-Saharan	JJ	O
Negroid	NNP	O
peoples	NNS	O
.	.	O

.	.	O

Marked	JJ	O
phenotypic	JJ	O
heterogeneity	NN	O
associated	VBN	O
with	IN	O
expansion	NN	O
of	IN	O
a	DT	O
CAG	NN	O
repeat	NN	O
sequence	NN	O
at	IN	O
the	DT	O
spinocerebellar	NN	B-Disease
ataxia	NN	I-Disease
3/Machado-Joseph	NN	I-Disease
disease	NN	I-Disease
locus	NN	O
.	.	O

The	DT	O
spinocerebellar	NN	B-Disease
ataxia	NN	I-Disease
3	CD	I-Disease
locus	NN	O
(	-LRB-	O
SCA3	NN	B-Disease
)	-RRB-	O
for	IN	O
type	NN	B-Disease
I	CD	I-Disease
autosomal	JJ	I-Disease
dominant	JJ	I-Disease
cerebellar	NN	I-Disease
ataxia	NN	I-Disease
(	-LRB-	O
ADCA	NN	B-Disease
type	NN	I-Disease
I	CD	I-Disease
)	-RRB-	O
,	,	O
a	DT	O
clinically	RB	O
and	CC	O
genetically	RB	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
neurodegenerative	JJ	B-Disease
disorders	NNS	I-Disease
,	,	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
14q32	NN	O
.	.	O

1	CD	O
1	CD	O
.	.	O

ADCA	NNP	B-Disease
type	NN	I-Disease
I	CD	I-Disease
patients	NNS	O
from	IN	O
families	NNS	O
segregating	VBG	O
SCA3	NN	B-Disease
share	NN	O
clinical	JJ	O
features	NNS	O
in	IN	O
common	JJ	O
with	IN	O
those	DT	O
with	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
gene	NN	O
of	IN	O
which	WDT	O
maps	VBZ	O
to	TO	O
the	DT	O
same	JJ	O
region	NN	O
.	.	O

We	PRP	O
show	VBP	O
here	RB	O
that	IN	O
the	DT	O
disease	NN	O
gene	NN	O
segregating	VBG	O
in	IN	O
each	DT	O
of	IN	O
three	CD	O
French	JJ	O
ADCA	NN	B-Disease
type	NN	I-Disease
I	CD	I-Disease
kindreds	NNS	O
and	CC	O
in	IN	O
a	DT	O
French	JJ	O
family	NN	O
with	IN	O
neuropathological	JJ	O
findings	NNS	O
suggesting	VBG	O
the	DT	O
ataxochoreic	JJ	O
form	NN	O
of	IN	O
dentatorubropallidoluysian	JJ	B-Disease
atrophy	NN	I-Disease
carries	VBZ	O
an	DT	O
expanded	VBN	O
CAG	NN	O
repeat	NN	O
sequence	NN	O
located	JJ	O
at	IN	O
the	DT	O
same	JJ	O
locus	NN	O
as	IN	O
that	DT	O
for	IN	O
MJD	NN	B-Disease
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
these	DT	O
families	NNS	O
shows	VBZ	O
a	DT	O
strong	JJ	O
negative	JJ	O
correlation	NN	O
between	IN	O
size	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
CAG	NN	O
repeat	NN	O
and	CC	O
age	NN	O
at	IN	O
onset	NN	O
of	IN	O
clinical	JJ	O
disease	NN	O
.	.	O

Instability	NN	O
of	IN	O
the	DT	O
expanded	VBN	O
triplet	NN	O
repeat	NN	O
was	VBD	O
not	RB	O
found	VBN	O
to	TO	O
be	VB	O
affected	VBN	O
by	IN	O
sex	NN	O
of	IN	O
the	DT	O
parent	NN	O
transmitting	VBG	O
the	DT	O
mutation	NN	O
.	.	O

Evidence	NN	O
was	VBD	O
found	VBN	O
for	IN	O
somatic	JJ	O
and	CC	O
gonadal	JJ	O
mosaicism	NN	O
for	IN	O
alleles	NNS	O
carrying	VBG	O
expanded	VBN	O
trinucleotide	JJ	O
repeats	NNS	O
.	.	O

The	DT	O
red-green	JJ	O
visual	JJ	O
pigment	NN	O
gene	NN	O
region	NN	O
in	IN	O
adrenoleukodystrophy	NN	B-Disease
.	.	O

Although	IN	O
recent	JJ	O
data	NNS	O
established	VBD	O
that	IN	O
a	DT	O
specific	JJ	O
very-long-chain	JJ	O
fatty	NN	O
acyl-CoA	NN	O
synthetase	NN	O
is	VBZ	O
defective	JJ	O
in	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
is	VBZ	O
still	RB	O
unidentified	JJ	O
.	.	O

The	DT	O
ALD	NN	B-Disease
locus	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq28	NN	O
,	,	O
like	IN	O
the	DT	O
red	JJ	O
and	CC	O
green	JJ	O
color	NN	O
pigment	NN	O
genes	NNS	O
.	.	O

Abnormal	JJ	B-Disease
color	NN	I-Disease
vision	NN	I-Disease
has	VBZ	O
been	VBN	O
observed	VBN	O
in	IN	O
12	CD	O
of	IN	O
27	CD	O
patients	NNS	O
with	IN	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
ALD	NN	B-Disease
.	.	O

Furthermore	RB	O
,	,	O
rearrangements	NNS	O
of	IN	O
the	DT	O
color	NN	O
vision	NN	O
gene	NN	O
cluster	NN	O
were	VBD	O
found	VBN	O
in	IN	O
four	CD	O
of	IN	O
eight	CD	O
ALD	NN	B-Disease
kindreds	NNS	O
.	.	O

This	DT	O
led	VBD	O
us	PRP	O
to	TO	O
propose	VB	O
that	IN	O
a	DT	O
single	JJ	O
DNA	NN	O
rearrangement	NN	O
could	MD	O
underlie	VB	O
both	DT	O
ALD	NN	B-Disease
and	CC	O
abnormal	JJ	B-Disease
color	NN	I-Disease
vision	NN	I-Disease
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

Study	NN	O
of	IN	O
34	CD	O
French	JJ	O
ALD	NN	B-Disease
patients	NNS	O
failed	VBD	O
to	TO	O
reveal	VB	O
a	DT	O
higher	JJR	O
than	IN	O
expected	VBN	O
frequency	NN	O
of	IN	O
green/red	JJ	O
visual	JJ	O
pigment	NN	O
rearrangements	NNS	O
3	CD	O
to	TO	O
the	DT	O
red/green	JJ	O
color	NN	O
vision	NN	O
gene	NN	O
complex	NN	O
.	.	O

The	DT	O
previous	JJ	O
report	NN	O
of	IN	O
such	JJ	O
rearrangements	NNS	O
was	VBD	O
based	VBN	O
on	IN	O
small	JJ	O
numbers	NNS	O
and	CC	O
lack	NN	O
of	IN	O
knowledge	NN	O
that	IN	O
the	DT	O
frequency	NN	O
of	IN	O
"	''	O
abnormal	JJ	O
"	''	O
color	NN	O
vision	NN	O
arrays	NNS	O
on	IN	O
molecular	JJ	O
analysis	NN	O
was	VBD	O
twice	RB	O
as	RB	O
high	JJ	O
as	IN	O
expected	VBN	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
the	DT	O
frequency	NN	O
of	IN	O
phenotypic	JJ	B-Disease
color	NN	I-Disease
vision	NN	I-Disease
defects	NNS	I-Disease
.	.	O

The	DT	O
red/green	JJ	O
color	NN	O
pigment	NN	O
(	-LRB-	O
R/GCP	NN	O
)	-RRB-	O
region	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
pulsed-field	JJ	O
gel	NN	O
electrophoresis	NN	O
in	IN	O
14	CD	O
of	IN	O
these	DT	O
patients	NNS	O
,	,	O
and	CC	O
we	PRP	O
did	VBD	O
not	RB	O
find	VB	O
any	DT	O
fragment	NN	O
size	NN	O
difference	NN	O
between	IN	O
the	DT	O
patients	NNS	O
and	CC	O
normal	JJ	O
individuals	NNS	O
who	WP	O
have	VBP	O
the	DT	O
same	JJ	O
number	NN	O
of	IN	O
pigment	NN	O
genes	NNS	O
.	.	O

The	DT	O
R/GCP	NN	O
region	NN	O
was	VBD	O
also	RB	O
analyzed	VBN	O
in	IN	O
29	CD	O
French	JJ	O
and	CC	O
seven	CD	O
North	JJ	O
American	JJ	O
ALD	NN	B-Disease
patients	NNS	O
by	IN	O
using	VBG	O
six	CD	O
genomic	JJ	O
DNA	NN	O
probes	NNS	O
,	,	O
isolated	VBN	O
from	IN	O
a	DT	O
cosmid	NN	O
walk	NN	O
,	,	O
that	WDT	O
flank	VBP	O
the	DT	O
color	NN	O
vision	NN	O
genes	NNS	O
.	.	O

No	DT	O
deletions	NNS	O
were	VBD	O
found	VBN	O
with	IN	O
probes	NNS	O
that	WDT	O
lie	VBP	O
3	CD	O
of	IN	O
the	DT	O
green	JJ	O
pigment	NN	O
genes	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
eight	CD	O
previously	RB	O
reported	VBN	O
ALD	NN	B-Disease
individuals	NNS	O
has	VBZ	O
a	DT	O
long	JJ	O
deletion	NN	O
5	CD	O
of	IN	O
the	DT	O
red	JJ	O
pigment	NN	O
gene	NN	O
,	,	O
a	DT	O
deletion	NN	O
causing	VBG	O
blue	JJ	O
cone	NN	O
monochromacy	NN	O
.	.	O

This	DT	O
finding	NN	O
and	CC	O
the	DT	O
previous	JJ	O
findings	NNS	O
of	IN	O
a	DT	O
45	CD	O
%	NN	O
frequency	NN	O
of	IN	O
phenotypic	JJ	O
color	NN	O
vision	NN	O
defects	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
AMN	NNP	B-Disease
may	MD	O
suggest	VB	O
that	IN	O
the	DT	O
ALD/AMN	NN	O
gene	NN	O
lies	VBZ	O
5	CD	O
to	TO	O
the	DT	O
red	JJ	O
pigment	NN	O
gene	NN	O
and	CC	O
that	IN	O
the	DT	O
frequent	JJ	O
phenotypic	JJ	O
color	NN	B-Disease
vision	NN	I-Disease
anomalies	NNS	I-Disease
owe	VBP	O
their	PRP$	O
origin	NN	O
to	TO	O
deleted	VBN	O
DNA	NN	O
that	WDT	O
includes	VBZ	O
regulatory	JJ	O
genes	NNS	O
for	IN	O
color	NN	O
vision	NN	O
.	.	O

It	PRP	O
is	VBZ	O
possible	JJ	O
,	,	O
however	RB	O
,	,	O
that	IN	O
phenotypic	JJ	O
color	NN	B-Disease
vision	NN	I-Disease
anomalies	NNS	I-Disease
in	IN	O
AMN	NNP	B-Disease
may	MD	O
be	VB	O
phenocopies	NNS	O
secondary	JJ	O
to	TO	O
retinal	JJ	O
or	CC	O
neural	JJ	O
involvement	NN	O
by	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
single	JJ	O
case	NN	O
of	IN	O
blue	JJ	O
cone	NN	O
monochromacy	NN	O
may	MD	O
therefore	RB	O
be	VB	O
a	DT	O
fortuitous	JJ	O
coincidence	NN	O
of	IN	O
two	CD	O
diseases	NNS	O
.	.	O

.	.	O

Haim-Munk	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
Papillon-Lefevre	NN	B-Disease
syndrome	NN	I-Disease
are	VBP	O
allelic	JJ	O
mutations	NNS	O
in	IN	O
cathepsin	NN	O
C.	NN	O
Of	IN	O
the	DT	O
many	JJ	O
palmoplantar	JJ	B-Disease
keratoderma	NN	I-Disease
(	-LRB-	I-Disease
PPK	NN	I-Disease
)	-RRB-	I-Disease
conditions	NNS	I-Disease
,	,	O
only	RB	O
Papillon-Lefevre	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PLS	NN	B-Disease
)	-RRB-	O
and	CC	O
Haim-Munk	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
HMS	NNP	B-Disease
)	-RRB-	O
are	VBP	O
associated	VBN	O
with	IN	O
premature	JJ	O
periodontal	JJ	O
destruction	NN	O
.	.	O

Although	IN	O
both	DT	O
PLS	NN	B-Disease
and	CC	O
HMS	NNP	B-Disease
share	VBP	O
the	DT	O
cardinal	JJ	O
features	NNS	O
of	IN	O
PPK	NNP	B-Disease
and	CC	O
severe	JJ	O
periodontitis	NN	B-Disease
,	,	O
a	DT	O
number	NN	O
of	IN	O
additional	JJ	O
findings	NNS	O
are	VBP	O
reported	VBN	O
in	IN	O
HMS	NNP	B-Disease
including	VBG	O
arachnodactyly	RB	B-Disease
,	,	O
acro-osteolysis	NN	B-Disease
,	,	O
atrophic	JJ	B-Disease
changes	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
nails	NNS	I-Disease
,	,	O
and	CC	O
a	DT	O
radiographic	JJ	B-Disease
deformity	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
fingers	NNS	I-Disease
.	.	O

While	IN	O
PLS	NN	B-Disease
cases	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
throughout	IN	O
the	DT	O
world	NN	O
,	,	O
HMS	NNP	B-Disease
has	VBZ	O
only	RB	O
been	VBN	O
described	VBN	O
among	IN	O
descendants	NNS	O
of	IN	O
a	DT	O
religious	JJ	O
isolate	NN	O
originally	RB	O
from	IN	O
Cochin	NNP	O
,	,	O
India	NNP	O
.	.	O

Parental	JJ	O
consanguinity	NN	O
is	VBZ	O
a	DT	O
characteristic	NN	O
of	IN	O
many	JJ	O
cases	NNS	O
of	IN	O
both	DT	O
conditions	NNS	O
.	.	O

Although	IN	O
autosomal	JJ	O
recessive	JJ	O
transmission	NN	O
of	IN	O
PLS	NN	B-Disease
is	VBZ	O
evident	JJ	O
,	,	O
a	DT	O
more	JJR	O
"	''	O
complex	NN	O
"	''	O
autosomal	JJ	O
recessive	JJ	O
pattern	NN	O
of	IN	O
inheritance	NN	O
with	IN	O
phenotypic	JJ	O
influences	NNS	O
from	IN	O
a	DT	O
closely	RB	O
linked	VBN	O
modifying	VBG	O
locus	NN	O
has	VBZ	O
been	VBN	O
hypothesised	VBN	O
for	IN	O
HMS	NNP	B-Disease
.	.	O

Recently	RB	O
,	,	O
mutations	NNS	O
of	IN	O
the	DT	O
cathepsin	NN	O
C	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
as	IN	O
the	DT	O
underlying	JJ	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
PLS	NN	B-Disease
.	.	O

To	TO	O
determine	VB	O
if	IN	O
a	DT	O
cathepsin	NN	O
C	NN	O
mutation	NN	O
is	VBZ	O
also	RB	O
responsible	JJ	O
for	IN	O
HMS	NNP	B-Disease
,	,	O
we	PRP	O
sequenced	VBD	O
the	DT	O
gene	NN	O
in	IN	O
affected	VBN	O
and	CC	O
unaffected	JJ	O
subjects	NNS	O
from	IN	O
the	DT	O
Cochin	NNP	O
isolate	NN	O
in	IN	O
which	WDT	O
both	CC	O
the	DT	O
PLS	NN	B-Disease
and	CC	O
HMS	NNP	B-Disease
phenotypes	NNS	O
appear	VBP	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
identification	NN	O
of	IN	O
a	DT	O
mutation	NN	O
of	IN	O
cathepsin	NN	O
C	NN	O
(	-LRB-	O
exon	NN	O
6	CD	O
,	,	O
2127A	CD	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
that	WDT	O
changes	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
amino	NN	O
acid	NN	O
in	IN	O
the	DT	O
cathepsin	NN	O
C	NN	O
peptide	NN	O
.	.	O

This	DT	O
mutation	NN	O
segregates	VBZ	O
with	IN	O
HMS	NNP	B-Disease
in	IN	O
four	CD	O
nuclear	JJ	O
families	NNS	O
.	.	O

Additionally	RB	O
,	,	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
shared	JJ	O
common	JJ	O
haplotype	NN	O
for	IN	O
genetic	JJ	O
loci	NNS	O
flanking	VBG	O
the	DT	O
cathepsin	NN	O
C	NN	O
gene	NN	O
suggests	VBZ	O
that	IN	O
affected	JJ	O
subjects	NNS	O
descended	VBD	O
from	IN	O
the	DT	O
Cochin	NNP	O
isolate	NN	O
are	VBP	O
homozygous	JJ	O
for	IN	O
a	DT	O
mutation	NN	O
inherited	VBN	O
"	''	O
identical	JJ	O
by	IN	O
descent	NN	O
"	''	O
from	IN	O
a	DT	O
common	JJ	O
ancestor	NN	O
.	.	O

This	DT	O
finding	NN	O
supports	VBZ	O
simple	JJ	O
autosomal	JJ	O
recessive	JJ	O
inheritance	NN	O
for	IN	O
HMS	NNP	B-Disease
in	IN	O
these	DT	O
families	NNS	O
.	.	O

We	PRP	O
also	RB	O
report	VBP	O
a	DT	O
mutation	NN	O
of	IN	O
the	DT	O
same	JJ	O
exon	NN	O
6	CD	O
CTSC	NN	O
codon	NN	O
(	-LRB-	O
2126C	NN	O
--	:	O
>	JJR	O
T	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
Turkish	JJ	O
family	NN	O
with	IN	O
classical	JJ	O
PLS	NN	B-Disease
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
PLS	NN	B-Disease
and	CC	O
HMS	NNP	B-Disease
are	VBP	O
allelic	JJ	O
variants	NNS	O
of	IN	O
cathepsin	NN	O
C	NN	O
gene	NN	O
mutations	NNS	O
.	.	O

.	.	O

X	NN	O
inactivation	NN	O
and	CC	O
somatic	JJ	O
cell	NN	O
selection	NN	O
rescue	NN	O
female	JJ	O
mice	NNS	O
carrying	VBG	O
a	DT	O
Piga-null	NN	O
mutation	NN	O
.	.	O

A	DT	O
somatic	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
X	NN	O
linked	VBN	O
PIGA	NNP	O
gene	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
glycosyl	NN	I-Disease
phosphatidylinositol	NN	I-Disease
(	-LRB-	I-Disease
GPI	NN	I-Disease
)	-RRB-	I-Disease
-	:	I-Disease
anchored	VBN	I-Disease
proteins	NNS	I-Disease
on	IN	O
blood	NN	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
paroxysmal	JJ	B-Disease
nocturnal	JJ	I-Disease
hemoglobinuria	NN	I-Disease
.	.	O

No	DT	O
inherited	VBN	O
form	NN	O
of	IN	O
GPI-anchor	NN	B-Disease
deficiency	NN	I-Disease
has	VBZ	O
been	VBN	O
described	VBN	O
.	.	O

Because	IN	O
conventional	JJ	O
Piga	NNP	O
gene	NN	O
knockout	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
high	JJ	O
embryonic	JJ	B-Disease
lethality	NN	I-Disease
in	IN	O
chimeric	JJ	O
mice	NNS	O
,	,	O
we	PRP	O
used	VBD	O
the	DT	O
Cre/loxP	NN	O
system	NN	O
.	.	O

We	PRP	O
generated	VBD	O
mice	NNS	O
in	IN	O
which	WDT	O
two	CD	O
loxP	NN	O
sites	NNS	O
flank	VBP	O
part	NN	O
of	IN	O
Piga	NNP	O
exon	NN	O
2	CD	O
.	.	O

After	IN	O
crossbreeding	VBG	O
with	IN	O
female	JJ	O
mice	NNS	O
of	IN	O
the	DT	O
EIIa-cre	JJ	O
strain	NN	O
,	,	O
the	DT	O
floxed	JJ	O
allele	NN	O
undergoes	VBZ	O
Cre-mediated	JJ	O
recombination	NN	O
with	IN	O
high	JJ	O
efficiency	NN	O
during	IN	O
early	JJ	O
embryonic	JJ	O
development	NN	O
.	.	O

Because	IN	O
of	IN	O
X	NN	O
chromosome	NN	O
inactivation	NN	O
,	,	O
female	JJ	O
offspring	NN	O
are	VBP	O
mosaic	JJ	O
for	IN	O
cells	NNS	O
that	WDT	O
express	VBP	O
or	CC	O
lack	VBP	O
GPI-linked	JJ	O
proteins	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
mosaic	JJ	O
mice	NNS	O
showed	VBD	O
that	IN	O
in	IN	O
heart	NN	O
,	,	O
lung	NN	O
,	,	O
kidney	NN	O
,	,	O
brain	NN	O
,	,	O
and	CC	O
liver	NN	O
,	,	O
mainly	RB	O
wild-type	JJ	O
Piga	NNP	O
is	VBZ	O
active	JJ	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
tissues	NNS	O
require	VBP	O
GPI-linked	JJ	O
proteins	NNS	O
.	.	O

The	DT	O
salient	JJ	O
exceptions	NNS	O
were	VBD	O
spleen	NN	O
,	,	O
thymus	NN	O
,	,	O
and	CC	O
red	JJ	O
blood	NN	O
cells	NNS	O
,	,	O
which	WDT	O
had	VBD	O
almost	RB	O
equal	JJ	O
numbers	NNS	O
of	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
wild-type	JJ	O
or	CC	O
the	DT	O
recombined	VBN	O
allele	NN	O
,	,	O
implying	VBG	O
that	IN	O
GPI-linked	JJ	O
proteins	NNS	O
are	VBP	O
not	RB	O
essential	JJ	O
for	IN	O
the	DT	O
derivation	NN	O
of	IN	O
these	DT	O
tissues	NNS	O
.	.	O

PIGA	NNP	O
(	-LRB-	O
-	:	O
)	-RRB-	O
cells	NNS	O
had	VBD	O
no	DT	O
growth	NN	O
advantage	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
other	JJ	O
factors	NNS	O
are	VBP	O
needed	VBN	O
for	IN	O
their	PRP$	O
clonal	JJ	O
dominance	NN	O
in	IN	O
patients	NNS	O
with	IN	O
paroxysmal	JJ	B-Disease
nocturnal	JJ	I-Disease
hemoglobinuria	NN	I-Disease
.	.	O

.	.	O

The	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
maps	VBZ	O
to	TO	O
a	DT	O
150	CD	O
kb	NN	O
region	NN	O
on	IN	O
chromosome	NN	O
Xp11	NN	O
.3	NN	O
.	.	O

Norrie	NNP	B-Disease
disease	NN	I-Disease
is	VBZ	O
a	DT	O
human	JJ	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
of	IN	O
unknown	JJ	O
etiology	NN	O
characterized	VBN	O
by	IN	O
congenital	JJ	B-Disease
blindness	NN	I-Disease
,	,	O
sensory	JJ	B-Disease
neural	JJ	I-Disease
deafness	NN	I-Disease
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
.	.	O

This	DT	O
disease	NN	O
gene	NN	O
was	VBD	O
previously	RB	O
linked	VBN	O
to	TO	O
the	DT	O
DXS7	NN	O
(	-LRB-	O
L1	NN	O
.	.	O

28	CD	O
)	-RRB-	O
locus	NN	O
and	CC	O
the	DT	O
MAO	NN	O
genes	NNS	O
in	IN	O
band	NN	O
Xp11	NN	O
.	.	O

3	CD	O
3	CD	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
fine	JJ	O
physical	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
obligate	JJ	O
region	NN	O
containing	VBG	O
the	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
(	-LRB-	O
NDP	NN	O
)	-RRB-	O
defined	VBN	O
by	IN	O
a	DT	O
recombination	NN	O
and	CC	O
by	IN	O
the	DT	O
smallest	JJS	O
submicroscopic	JJ	O
chromosomal	JJ	O
deletion	NN	O
associated	VBN	O
with	IN	O
Norrie	NN	B-Disease
disease	NN	I-Disease
identified	VBN	O
to	TO	O
date	NN	O
.	.	O

Analysis	NN	O
,	,	O
using	VBG	O
in	IN	O
addition	NN	O
two	CD	O
overlapping	VBG	O
YAC	NN	O
clones	NNS	O
from	IN	O
this	DT	O
region	NN	O
,	,	O
allowed	VBD	O
orientation	NN	O
of	IN	O
the	DT	O
MAOA	NNP	O
and	CC	O
MAOB	NNP	O
genes	NNS	O
in	IN	O
a	DT	O
5-3-3-5	CD	O
configuration	NN	O
.	.	O

A	DT	O
recombination	NN	O
event	NN	O
between	IN	O
a	DT	O
(	-LRB-	O
GT	NN	O
)	-RRB-	O
n	NN	O
polymorphism	NN	O
in	IN	O
intron	NN	O
2	CD	O
of	IN	O
the	DT	O
MAOB	NN	O
gene	NN	O
and	CC	O
the	DT	O
NDP	NN	O
locus	NN	O
,	,	O
in	IN	O
a	DT	O
family	NN	O
previously	RB	O
reported	VBD	O
to	TO	O
have	VB	O
a	DT	O
recombination	NN	O
between	IN	O
DXS7	NN	O
and	CC	O
NDP	NN	O
,	,	O
delineates	VBZ	O
a	DT	O
flanking	JJ	O
marker	NN	O
telomeric	JJ	O
to	TO	O
this	DT	O
disease	NN	O
gene	NN	O
.	.	O

An	DT	O
anonymous	JJ	O
DNA	NN	O
probe	NN	O
,	,	O
dc12	NN	O
,	,	O
present	JJ	O
in	IN	O
one	CD	O
of	IN	O
the	DT	O
YACs	NNS	O
and	CC	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
submicroscopic	JJ	O
deletion	NN	O
which	WDT	O
includes	VBZ	O
MAOA	NNP	O
and	CC	O
MAOB	NNP	O
but	CC	O
not	RB	O
L1	NN	O
.	.	O

28	CD	O
,	,	O
serves	VBZ	O
as	IN	O
a	DT	O
flanking	JJ	O
marker	NN	O
centromeric	JJ	O
to	TO	O
the	DT	O
disease	NN	O
gene	NN	O
.	.	O

An	DT	O
Alu-PCR	NN	O
fragment	NN	O
from	IN	O
the	DT	O
right	JJ	O
arm	NN	O
of	IN	O
the	DT	O
MAO	NNP	O
YAC	NN	O
(	-LRB-	O
YMAO	NN	O
.	.	O

AluR	NN	O
)	-RRB-	O
is	VBZ	O
not	RB	O
deleted	VBN	O
in	IN	O
this	DT	O
patient	NN	O
and	CC	O
also	RB	O
delineates	VBZ	O
the	DT	O
centromeric	JJ	O
extent	NN	O
of	IN	O
the	DT	O
obligate	JJ	O
disease	NN	O
region	NN	O
.	.	O

The	DT	O
apparent	JJ	O
order	NN	O
of	IN	O
these	DT	O
loci	NNS	O
is	VBZ	O
telomere	NN	O
.	.	O

DXS7-MAOA-MAOB-NDP-dc12-YMAO	NN	O
DXS7-MAOA-MAOB-NDP-dc12-YMAO	NN	O
.	.	O

AluR	NN	O
.	.	O

centromere	NN	O
.	.	O

Together	RB	O
these	DT	O
data	NNS	O
define	VBP	O
the	DT	O
obligate	JJ	O
region	NN	O
containing	VBG	O
the	DT	O
NDP	NN	O
gene	NN	O
to	TO	O
a	DT	O
chromosomal	JJ	O
segment	NN	O
less	JJR	O
than	IN	O
150	CD	O
kb	NN	O
.	.	O

Molecular	JJ	O
genetics	NNS	O
of	IN	O
the	DT	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
Mediterranean	JJ	O
variant	NN	O
and	CC	O
description	NN	O
of	IN	O
a	DT	O
new	JJ	O
G6PD	NN	O
mutant	NN	O
,	,	O
G6PD	NN	O
Andalus1361A	NN	O
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
;	:	I-Disease
E.	NNP	I-Disease
C.	NNP	I-Disease
1	CD	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

1	LS	I-Disease
.	.	I-Disease

49	CD	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
human	JJ	O
enzymopathy	NN	B-Disease
;	:	O
more	JJR	O
than	IN	O
300	CD	O
different	JJ	O
biochemical	JJ	O
variants	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

In	IN	O
many	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
world	NN	O
the	DT	O
Mediterranean	NNP	O
type	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
prevalent	JJ	O
.	.	O

However	RB	O
,	,	O
G6PD	NN	O
Mediterranean	NNP	O
has	VBZ	O
come	VBN	O
to	TO	O
be	VB	O
regarded	VBN	O
as	IN	O
a	DT	O
generic	JJ	O
term	NN	O
applied	VBD	O
to	TO	O
similar	JJ	O
G6PD	NN	O
mutations	NNS	O
thought	VBD	O
,	,	O
however	RB	O
,	,	O
to	TO	O
represent	VB	O
a	DT	O
somewhat	RB	O
heterogeneous	JJ	O
group	NN	O
.	.	O

A	DT	O
C	NN	O
----	:	O
T	NN	O
mutation	NN	O
at	IN	O
nucleotide	NN	O
563	CD	O
of	IN	O
G6PD	NN	O
Mediterranean	NNP	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
Vulliamy	NNP	O
et	FW	O
al.	FW	O
,	,	O
and	CC	O
the	DT	O
same	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
found	VBN	O
by	IN	O
De	NNP	O
Vita	NNP	O
et	FW	O
al.	FW	O
in	IN	O
G6PD	NN	O
Mediterranean	NNP	O
,	,	O
G6PD	NNP	O
Sassari	NNP	O
,	,	O
and	CC	O
G6PD	NN	O
Cagliari	NNP	O
.	.	O

The	DT	O
latter	JJ	O
subjects	NNS	O
had	VBD	O
an	DT	O
additional	JJ	O
mutation	NN	O
,	,	O
at	IN	O
nucleotide	NN	O
1311	CD	O
,	,	O
that	WDT	O
did	VBD	O
not	RB	O
produce	VB	O
a	DT	O
coding	VBG	O
change	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
genomic	JJ	O
DNA	NN	O
of	IN	O
five	CD	O
patients	NNS	O
--	:	O
four	CD	O
of	IN	O
Spanish	JJ	O
origin	NN	O
and	CC	O
one	CD	O
of	IN	O
Jewish	JJ	O
origin	NN	O
--	:	O
having	VBG	O
enzymatically	RB	O
documented	VBN	O
G6PD	NN	O
Mediterranean	NNP	O
.	.	O

All	DT	O
had	VBD	O
both	CC	O
the	DT	O
mutation	NN	O
at	IN	O
nucleotide	NN	O
563	CD	O
and	CC	O
that	DT	O
at	IN	O
nucleotide	NN	O
1311	CD	O
.	.	O

A	DT	O
sixth	JJ	O
sample	NN	O
,	,	O
resembling	VBG	O
G6PD	NN	O
Mediterranean	JJ	O
kinetically	RB	O
but	CC	O
with	IN	O
a	DT	O
slightly	RB	O
rapid	JJ	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
was	VBD	O
designated	VBN	O
G6PD	NN	O
Andalus	NN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
different	JJ	O
mutation	NN	O
,	,	O
a	DT	O
G	NN	O
----	:	O
A	DT	O
transition	NN	O
at	IN	O
nucleotide	NN	O
1361	CD	O
,	,	O
producing	VBG	O
an	DT	O
arginine-to-histidine	NN	O
substitution	NN	O
.	.	O

These	DT	O
studies	NNS	O
suggest	VBP	O
that	IN	O
G6PD	NN	O
Mediterranean	NNP	O
is	VBZ	O
,	,	O
after	IN	O
all	DT	O
,	,	O
relatively	RB	O
homogeneous	JJ	O
.	.	O

Small	JJ	O
nuclear	JJ	O
ribonucleoprotein	NN	O
polypeptide	NN	O
N	NN	O
(	-LRB-	O
SNRPN	NN	O
)	-RRB-	O
,	,	O
an	DT	O
expressed	VBN	O
gene	NN	O
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
critical	JJ	O
region	NN	O
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
associated	VBN	O
with	IN	O
paternally	RB	O
derived	VBN	O
chromosomal	JJ	O
deletions	NNS	O
in	IN	O
region	NN	O
15q11-13	JJ	O
or	CC	O
with	IN	O
maternal	JJ	B-Disease
disomy	NN	I-Disease
for	IN	I-Disease
chromosome	NN	I-Disease
15	CD	I-Disease
.	.	O

Therefore	RB	O
,	,	O
loss	NN	O
of	IN	O
the	DT	O
expressed	VBN	O
paternal	JJ	O
alleles	NNS	O
of	IN	O
maternally	RB	O
imprinted	JJ	O
genes	NNS	O
must	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
PWS	NN	B-Disease
phenotype	NN	O
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
small	JJ	O
nuclear	JJ	O
RNA	NN	O
associated	VBN	O
polypeptide	NN	O
SmN	NN	O
(	-LRB-	O
SNRPN	NN	O
)	-RRB-	O
to	TO	O
human	JJ	O
chromosome	NN	O
15q12	NN	O
and	CC	O
a	DT	O
processed	VBN	O
pseudogene	NN	O
SNRPNP1	NN	O
to	TO	O
chromosome	NN	O
region	NN	O
6pter-p21	JJ	O
.	.	O

Furthermore	RB	O
,	,	O
SNRPN	NNP	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
minimal	JJ	O
deletion	NN	O
interval	NN	O
that	WDT	O
is	VBZ	O
critical	JJ	O
for	IN	O
PWS	NNP	B-Disease
.	.	O

The	DT	O
fact	NN	O
that	IN	O
the	DT	O
mouse	NN	O
Snrpn	NN	O
gene	NN	O
is	VBZ	O
maternally	RB	O
imprinted	VBN	O
in	IN	O
brain	NN	O
suggests	VBZ	O
that	IN	O
loss	NN	O
of	IN	O
the	DT	O
paternally	RB	O
derived	VBN	O
SNRPN	NNP	O
allele	NN	O
may	MD	O
be	VB	O
involved	VBN	O
in	IN	O
the	DT	O
PWS	NN	B-Disease
phenotype	NN	O
.	.	O

.	.	O

Increased	VBN	O
incidence	NN	O
of	IN	O
cancer	NN	B-Disease
in	IN	O
patients	NNS	O
with	IN	O
cartilage-hair	JJ	B-Disease
hypoplasia	NN	I-Disease
.	.	O

OBJECTIVE	NN	O
Previous	JJ	O
reports	NNS	O
have	VBP	O
suggested	VBN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
among	IN	O
patients	NNS	O
with	IN	O
cartilage-hair	JJ	B-Disease
hypoplasia	NN	I-Disease
(	-LRB-	O
CHH	NN	B-Disease
)	-RRB-	O
.	.	O

This	DT	O
study	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
to	TO	O
further	RB	O
evaluate	VB	O
this	DT	O
risk	NN	O
among	IN	O
patients	NNS	O
with	IN	O
CHH	NN	B-Disease
and	CC	O
their	PRP$	O
first-degree	JJ	O
relatives	NNS	O
.	.	O

STUDY	NN	O
DESIGN	NN	O
One	CD	O
hundred	CD	O
twenty-two	CD	O
patients	NNS	O
with	IN	O
CHH	NN	B-Disease
were	VBD	O
identified	VBN	O
through	IN	O
2	CD	O
countrywide	NN	O
epidemiologic	JJ	O
surveys	NNS	O
in	IN	O
1974	CD	O
and	CC	O
in	IN	O
1986	CD	O
.	.	O

Their	PRP$	O
parents	NNS	O
and	CC	O
nonaffected	JJ	O
siblings	NNS	O
were	VBD	O
identified	VBN	O
through	IN	O
the	DT	O
Population	NNP	O
Register	NNP	O
Center	NNP	O
.	.	O

This	DT	O
cohort	NN	O
underwent	VBD	O
follow-up	NN	O
for	IN	O
cancer	NN	B-Disease
incidence	NN	O
through	IN	O
the	DT	O
Finnish	JJ	O
Cancer	NN	O
Registry	NN	O
to	TO	O
the	DT	O
end	NN	O
of	IN	O
1995	CD	O
.	.	O

RESULTS	NNS	O
A	DT	O
statistically	RB	O
significant	JJ	O
excess	JJ	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
was	VBD	O
seen	VBN	O
among	IN	O
the	DT	O
patients	NNS	O
with	IN	O
CHH	NN	B-Disease
(	-LRB-	O
standardized	JJ	O
incidence	NN	O
ratio	NN	O
6	CD	O
.	.	O

9	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
2	CD	O
.	.	O

3	CD	O
to	TO	O
16	CD	O
)	-RRB-	O
,	,	O
which	WDT	O
was	VBD	O
mainly	RB	O
attributable	JJ	O
to	TO	O
non-Hodgkins	JJ	B-Disease
lymphoma	NN	I-Disease
(	-LRB-	O
standardized	JJ	O
incidence	NN	O
ratio	NN	O
90	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
18	CD	O
to	TO	O
264	CD	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
a	DT	O
significant	JJ	O
excess	JJ	O
risk	NN	O
of	IN	O
basal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
was	VBD	O
seen	VBN	O
(	-LRB-	O
standardized	JJ	O
incidence	NN	O
ratio	NN	O
35	CD	O
,	,	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
7	CD	O
.	.	O

2	CD	O
to	TO	O
102	CD	O
)	-RRB-	O
.	.	O

The	DT	O
cancer	NN	B-Disease
incidence	NN	O
among	IN	O
the	DT	O
siblings	NNS	O
or	CC	O
the	DT	O
parents	NNS	O
did	VBD	O
not	RB	O
differ	VB	O
from	IN	O
the	DT	O
average	JJ	O
cancer	NN	B-Disease
incidence	NN	O
in	IN	O
the	DT	O
Finnish	JJ	O
population	NN	O
.	.	O

CONCLUSIONS	NNS	O
This	DT	O
study	NN	O
confirms	VBZ	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
,	,	O
especially	RB	O
non-Hodgkins	JJ	B-Disease
lymphoma	NN	I-Disease
,	,	O
probably	RB	O
attributable	JJ	O
to	TO	O
defective	JJ	O
immunity	NN	O
,	,	O
among	IN	O
patients	NNS	O
with	IN	O
CHH	NN	B-Disease
.	.	O

Genetic	JJ	O
polymorphism	NN	O
of	IN	O
G6PD	NN	O
in	IN	O
a	DT	O
Bulgarian	JJ	O
population	NN	O
.	.	O

Considerable	JJ	O
genetic	JJ	O
heterogeneity	NN	O
in	IN	O
G6PD	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
Bulgarian	JJ	O
population-14	NN	O
G6PD	NN	O
variants	NNS	O
isolated	VBN	O
from	IN	O
117	CD	O
hemizygous	JJ	O
carriers	NNS	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Of	IN	O
these	DT	O
,	,	O
G6PD	NN	O
Mediterranean	JJ	O
type	NN	O
was	VBD	O
a	DT	O
polymorphic	JJ	O
variant	NN	O
and	CC	O
G6PD	NN	O
Corinth	NN	O
occurred	VBD	O
with	IN	O
high	JJ	O
frequency	NN	O
.	.	O

Two	CD	O
new	JJ	O
variants	NNS	O
were	VBD	O
identified-G6PD	NN	O
Rudosem	NN	O
and	CC	O
G6PD	NN	O
Nedelino	NN	O
.	.	O

In	IN	O
a	DT	O
selected	VBN	O
group	NN	O
of	IN	O
78	CD	O
subjects	NNS	O
with	IN	O
clinical	JJ	O
manifestations	NNS	O
,	,	O
four	CD	O
variants	NNS	O
were	VBD	O
established	VBN	O
G6PD	NN	O
Mediterranian	JJ	O
,	,	O
G6PD	NN	O
Corinth	NNP	O
,	,	O
G6PD	NNP	O
Seattle	NNP	O
and	CC	O
G6PD	NNP	O
Ohut	NNP	O
II	NNP	O
.	.	O

.	.	O

A	DT	O
genetic	JJ	O
etiology	NN	O
for	IN	O
DiGeorge	NNP	B-Disease
syndrome	NN	I-Disease
:	:	O
consistent	JJ	O
deletions	NNS	O
and	CC	O
microdeletions	NNS	O
of	IN	O
22q11	NN	O
.	.	O

DiGeorge	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
DGS	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
developmental	JJ	O
field	NN	O
defect	NN	O
of	IN	O
the	DT	O
third	JJ	O
and	CC	O
fourth	JJ	O
pharyngeal	NN	O
pouches	NNS	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
aplasia	NN	B-Disease
or	CC	I-Disease
hypoplasia	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
thymus	NN	I-Disease
and	CC	I-Disease
parathyroid	JJ	I-Disease
glands	NNS	I-Disease
and	CC	O
by	IN	O
conotruncal	JJ	B-Disease
cardiac	JJ	I-Disease
malformations	NNS	I-Disease
.	.	O

Cytogenetic	JJ	O
studies	NNS	O
support	VBP	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
DGS	NN	B-Disease
critical	JJ	O
region	NN	O
in	IN	O
band	NN	O
22q11	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
results	NNS	O
of	IN	O
clinical	JJ	O
,	,	O
cytogenetic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
studies	NNS	O
of	IN	O
14	CD	O
patients	NNS	O
with	IN	O
DGS	NN	B-Disease
.	.	O

Chromosome	NN	O
analysis	NN	O
,	,	O
utilizing	VBG	O
high-resolution	JJ	O
banding	NN	O
techniques	NNS	O
,	,	O
detected	VBD	O
interstitial	JJ	O
deletions	NNS	O
in	IN	O
five	CD	O
probands	NNS	O
and	CC	O
was	VBD	O
inconclusive	JJ	O
for	IN	O
a	DT	O
deletion	NN	O
in	IN	O
three	CD	O
probands	NNS	O
.	.	O

The	DT	O
remaining	VBG	O
six	CD	O
patients	NNS	O
had	VBD	O
normal	JJ	O
karyotypes	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
molecular	JJ	O
analysis	NN	O
detected	VBD	O
DNA	NN	O
deletions	NNS	O
in	IN	O
all	DT	O
14	CD	O
probands	NNS	O
.	.	O

Two	CD	O
of	IN	O
10	CD	O
loci	NNS	O
tested	VBN	O
,	,	O
D22S75	NN	O
and	CC	O
D22S259	NN	O
,	,	O
are	VBP	O
deleted	VBN	O
in	IN	O
all	DT	O
14	CD	O
patients	NNS	O
.	.	O

A	DT	O
third	JJ	O
locus	NN	O
,	,	O
D22S66	NN	O
,	,	O
is	VBZ	O
deleted	VBN	O
in	IN	O
the	DT	O
eight	CD	O
DGS	NN	B-Disease
probands	NNS	O
tested	VBN	O
.	.	O

Physical	JJ	O
mapping	NN	O
using	VBG	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
places	VBZ	O
D22S66	NN	O
between	IN	O
D22S75	NN	O
and	CC	O
D22S259	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
it	PRP	O
should	MD	O
be	VB	O
deleted	VBN	O
in	IN	O
the	DT	O
remaining	VBG	O
six	CD	O
cases	NNS	O
.	.	O

Parent-of-origin	JJ	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
five	CD	O
families	NNS	O
.	.	O

Four	CD	O
probands	NNS	O
failed	VBD	O
to	TO	O
inherit	VB	O
a	DT	O
maternal	JJ	O
allele	NN	O
,	,	O
and	CC	O
one	CD	O
failed	VBD	O
to	TO	O
inherit	VB	O
a	DT	O
paternal	JJ	O
allele	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
these	DT	O
families	NNS	O
,	,	O
and	CC	O
of	IN	O
six	CD	O
maternally	RB	O
and	CC	O
five	CD	O
paternally	RB	O
derived	VBN	O
unbalanced-translocation	JJ	O
DGS	NN	B-Disease
probands	NNS	O
in	IN	O
the	DT	O
literature	NN	O
,	,	O
parent	NN	O
of	IN	O
origin	NN	O
or	CC	O
imprinting	VBG	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
play	VB	O
an	DT	O
important	JJ	O
role	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
DGS	NN	B-Disease
.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
same	JJ	O
three	CD	O
loci	NNS	O
in	IN	O
all	DT	O
14	CD	O
DGS	NN	B-Disease
probands	NNS	O
begins	VBZ	O
to	TO	O
delineate	VB	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
critical	JJ	O
for	IN	O
DGS	NN	B-Disease
and	CC	O
confirms	VBZ	O
the	DT	O
hypothesis	NN	O
that	IN	O
submicroscopic	JJ	O
deletions	NNS	O
of	IN	O
22q11	NN	O
are	VBP	O
etiologic	JJ	O
in	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
cases	NNS	O
.	.	O

.	.	O

Characterisation	NN	O
of	IN	O
a	DT	O
new	JJ	O
rare	JJ	O
fragile	JJ	O
site	NN	O
easily	RB	O
confused	VBN	O
with	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
.	.	O

A	DT	O
new	JJ	O
fragile	JJ	O
site	NN	O
(	-LRB-	O
FRAXE	NN	O
)	-RRB-	O
in	IN	O
Xq28	NN	O
is	VBZ	O
described	VBN	O
.	.	O

It	PRP	O
appears	VBZ	O
to	TO	O
be	VB	O
a	DT	O
typical	JJ	O
folate	NN	O
sensitive	JJ	O
fragile	JJ	O
site	NN	O
.	.	O

The	DT	O
fragile	JJ	O
site	NN	O
is	VBZ	O
not	RB	O
associated	VBN	O
with	IN	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
it	PRP	O
does	VBZ	O
not	RB	O
give	VB	O
abnormal	JJ	O
results	NNS	O
when	WRB	O
subjected	VBN	O
to	TO	O
Southern	JJ	O
analysis	NN	O
with	IN	O
probe	NN	O
pfxa3	NN	O
which	WDT	O
detects	VBZ	O
the	DT	O
unstable	JJ	O
DNA	NN	O
sequence	NN	O
characteristic	NN	O
of	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

In	FW	O
situ	FW	O
hybridization	NN	O
mapping	NN	O
locates	VBZ	O
the	DT	O
fragile	JJ	O
site	NN	O
between	IN	O
150	CD	O
kb	NN	O
and	CC	O
600	CD	O
kb	NN	O
distal	JJ	O
to	TO	O
FRAXA	NNP	O
.	.	O

The	DT	O
distinction	NN	O
between	IN	O
the	DT	O
two	CD	O
fragile	JJ	O
sites	NNS	O
is	VBZ	O
important	JJ	O
clinically	RB	O
since	IN	O
cytogenetic	JJ	O
detection	NN	O
of	IN	O
FRAXE	NNP	O
,	,	O
without	IN	O
molecular	JJ	O
analysis	NN	O
,	,	O
could	MD	O
result	VB	O
in	IN	O
misdiagnosis	NN	O
of	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

BRCA1	NN	O
mutations	NNS	O
in	IN	O
primary	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
carcinomas	NNS	I-Disease
.	.	O

Loss	NN	O
of	IN	O
heterozygosity	NN	O
data	NNS	O
from	IN	O
familial	JJ	B-Disease
tumors	NNS	I-Disease
suggest	VBP	O
that	IN	O
BRCA1	NN	O
,	,	O
a	DT	O
gene	NN	O
that	WDT	O
confers	VBZ	O
susceptibility	NN	O
to	TO	O
ovarian	JJ	B-Disease
and	CC	I-Disease
early-onset	JJ	I-Disease
breast	NN	B-Disease
cancer	NN	I-Disease
,	,	O
encodes	VBZ	O
a	DT	O
tumor	NN	B-Disease
suppressor	NN	O
.	.	O

The	DT	O
BRCA1	NN	O
region	NN	O
is	VBZ	O
also	RB	O
subject	JJ	O
to	TO	O
allelic	JJ	O
loss	NN	O
in	IN	O
sporadic	JJ	B-Disease
breast	NN	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
,	,	O
an	DT	O
indication	NN	O
that	WDT	O
BRCA1	NN	O
mutations	NNS	O
may	MD	O
occur	VB	O
somatically	RB	O
in	IN	O
these	DT	O
tumors	NNS	B-Disease
.	.	O

The	DT	O
BRCA1	NN	O
coding	VBG	O
region	NN	O
was	VBD	O
examined	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
primary	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
tumors	NNS	I-Disease
that	WDT	O
show	VBP	O
allele	NN	O
loss	NN	O
at	IN	O
the	DT	O
BRCA1	NN	O
locus	NN	O
.	.	O

Mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
3	CD	O
of	IN	O
32	CD	O
breast	NN	O
and	CC	O
1	CD	O
of	IN	O
12	CD	O
ovarian	JJ	B-Disease
carcinomas	NNS	I-Disease
;	:	O
all	DT	O
four	CD	O
mutations	NNS	O
were	VBD	O
germline	NN	O
alterations	NNS	O
and	CC	O
occurred	VBD	O
in	IN	O
early-onset	JJ	O
cancers	NNS	B-Disease
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
mutation	NN	O
of	IN	O
BRCA1	NN	O
may	MD	O
not	RB	O
be	VB	O
critical	JJ	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
the	DT	O
majority	NN	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
that	WDT	O
arise	VBP	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
mutant	JJ	O
germline	NN	O
allele	NN	O
.	.	O

.	.	O

Genomic	JJ	O
structure	NN	O
of	IN	O
the	DT	O
EWS	NN	O
gene	NN	O
and	CC	O
its	PRP$	O
relationship	NN	O
to	TO	O
EWSR1	NN	O
,	,	O
a	DT	O
site	NN	O
of	IN	O
tumor-associated	JJ	O
chromosome	NN	O
translocation	NN	O
.	.	O

The	DT	O
EWS	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
based	VBN	O
on	IN	O
its	PRP$	O
location	NN	O
at	IN	O
the	DT	O
chromosome	NN	O
22	CD	O
breakpoint	NN	O
of	IN	O
the	DT	O
t	NN	O
(	-LRB-	O
11	CD	O
;	:	O
22	CD	O
)	-RRB-	O
(	-LRB-	O
q24	NN	O
;	:	O
q12	NN	O
)	-RRB-	O
translocation	NN	O
that	IN	O
characterizes	VBZ	O
Ewing	NNP	B-Disease
sarcoma	NN	I-Disease
and	CC	O
related	JJ	O
neuroectodermal	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

The	DT	O
EWS	NN	O
gene	NN	O
spans	VBZ	O
about	IN	O
40	CD	O
kb	NN	O
of	IN	O
DNA	NN	O
and	CC	O
is	VBZ	O
encoded	VBN	O
by	IN	O
17	CD	O
exons	NNS	O
.	.	O

The	DT	O
nucleotide	NN	O
sequence	NN	O
of	IN	O
the	DT	O
exons	NNS	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
of	IN	O
the	DT	O
previously	RB	O
described	VBN	O
cDNA	NN	O
.	.	O

The	DT	O
first	JJ	O
7	CD	O
exons	NNS	O
encode	VBP	O
the	DT	O
N-terminal	JJ	O
domain	NN	O
of	IN	O
EWS	NN	O
,	,	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
repeated	VBN	O
degenerated	VBD	O
polypeptide	NN	O
of	IN	O
7	CD	O
to	TO	O
12	CD	O
residues	NNS	O
rich	JJ	O
in	IN	O
tyrosine	NN	O
,	,	O
serine	NN	O
,	,	O
threonine	NN	O
,	,	O
glycine	NN	O
,	,	O
and	CC	O
glutamine	NN	O
.	.	O

Exons	NNS	O
11	CD	O
,	,	O
12	CD	O
,	,	O
and	CC	O
13	CD	O
encode	VBP	O
the	DT	O
putative	JJ	O
RNA	NN	O
binding	NN	O
domain	NN	O
.	.	O

The	DT	O
three	CD	O
glycine	NN	O
-	:	O
and	CC	O
arginine-rich	JJ	O
motifs	NNS	O
of	IN	O
the	DT	O
gene	NN	O
are	VBP	O
mainly	RB	O
encoded	VBN	O
by	IN	O
exons	NNS	O
8-9	CD	O
,	,	O
14	CD	O
,	,	O
and	CC	O
16	CD	O
.	.	O

The	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
the	DT	O
5	CD	O
region	NN	O
of	IN	O
the	DT	O
gene	NN	O
has	VBZ	O
features	NNS	O
of	IN	O
a	DT	O
CpG-rich	JJ	O
island	NN	O
and	CC	O
lacks	VBZ	O
canonical	JJ	O
promoter	NN	O
elements	NNS	O
,	,	O
such	JJ	O
as	IN	O
TATA	NN	O
and	CC	O
CCAAT	NN	O
consensus	NN	O
sequences	NNS	O
.	.	O

Positions	NNS	O
of	IN	O
the	DT	O
chromosome	NN	O
22	CD	O
breakpoints	NNS	O
were	VBD	O
determined	VBN	O
for	IN	O
19	CD	O
Ewing	NNP	B-Disease
tumors	NNS	I-Disease
.	.	O

They	PRP	O
were	VBD	O
localized	JJ	O
in	IN	O
introns	NNS	O
7	CD	O
or	CC	O
8	CD	O
in	IN	O
18	CD	O
cases	NNS	O
and	CC	O
in	IN	O
intron	NN	O
10	CD	O
in	IN	O
1	CD	O
case	NN	O
.	.	O

.	.	O

PAX6	NN	O
mutations	NNS	O
in	IN	O
aniridia	NN	B-Disease
.	.	O

Aniridia	NNP	B-Disease
is	VBZ	O
a	DT	O
congenital	JJ	B-Disease
malformation	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
eye	NN	I-Disease
,	,	O
chiefly	RB	O
characterised	VBN	O
by	IN	O
iris	NN	B-Disease
hypoplasia	NN	I-Disease
,	,	O
which	WDT	O
can	MD	O
cause	VB	O
blindness	NN	B-Disease
.	.	O

The	DT	O
PAX6	NN	O
gene	NN	O
was	VBD	O
isolated	VBN	O
as	IN	O
a	DT	O
candidate	NN	O
aniridia	NN	B-Disease
gene	NN	O
by	IN	O
positional	JJ	O
cloning	NN	O
from	IN	O
the	DT	O
smallest	JJS	O
region	NN	O
of	IN	O
overlap	VBP	O
of	IN	O
aniridia-associated	JJ	O
deletions	NNS	O
.	.	O

Subsequently	RB	O
PAX6	NN	O
intragenic	JJ	O
mutations	NNS	O
were	VBD	O
demonstrated	VBN	O
in	IN	O
Smalleye	NNP	O
,	,	O
a	DT	O
mouse	NN	O
mutant	NN	O
which	WDT	O
is	VBZ	O
an	DT	O
animal	NN	O
model	NN	O
for	IN	O
aniridia	NN	B-Disease
,	,	O
and	CC	O
six	CD	O
human	JJ	O
aniridia	NN	B-Disease
patients	NNS	O
.	.	O

In	IN	O
this	DT	O
paper	NN	O
we	PRP	O
describe	VBP	O
four	CD	O
additional	JJ	O
PAX6	NN	O
point	NN	O
mutations	NNS	O
in	IN	O
aniridia	NN	B-Disease
patients	NNS	O
,	,	O
both	DT	O
sporadic	JJ	O
and	CC	O
familial	JJ	O
.	.	O

These	DT	O
mutations	NNS	O
highlight	VBP	O
regions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
which	WDT	O
are	VBP	O
essential	JJ	O
for	IN	O
normal	JJ	O
PAX6	NN	O
function	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
frequency	NN	O
at	IN	O
which	WDT	O
we	PRP	O
have	VBP	O
found	VBN	O
PAX6	NN	O
mutations	NNS	O
suggests	VBZ	O
that	IN	O
lesions	NNS	O
in	IN	O
PAX6	NN	O
will	MD	O
account	VB	O
for	IN	O
most	JJS	O
cases	NNS	O
of	IN	O
aniridia	NN	B-Disease
.	.	O

.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
in	IN	O
patients	NNS	O
with	IN	O
hereditary	JJ	O
aniridia	NN	B-Disease
.	.	O

The	DT	O
14	CD	O
exons	NNS	O
of	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
analysed	VBN	O
exon-by-exon	JJ	O
using	VBG	O
SSCP	NN	O
in	IN	O
6	CD	O
aniridia	NN	B-Disease
families	NNS	O
.	.	O

In	IN	O
each	DT	O
family	NN	O
band	NN	O
shifts	NNS	O
were	VBD	O
observed	VBN	O
on	IN	O
the	DT	O
SSCP	NN	O
gels	NNS	O
for	IN	O
only	RB	O
one	CD	O
exon	NN	O
and	CC	O
direct	JJ	O
PCR-sequencing	NN	O
revealed	VBD	O
mutations	NNS	O
in	IN	O
each	DT	O
case	NN	O
.	.	O

Two	CD	O
mutations	NNS	O
involved	VBN	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transitions	NNS	O
in	IN	O
CGAarg	NN	O
codons	NNS	O
in	IN	O
exons	NNS	O
9	CD	O
and	CC	O
11	CD	O
.	.	O

Another	DT	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transition	NN	O
converted	VBD	O
a	DT	O
CAG-glutamine	NN	O
to	TO	O
a	DT	O
TAG-stop	NN	O
in	IN	O
exon	NN	O
7	CD	O
.	.	O

Small	JJ	O
insertions	NNS	O
created	VBN	O
frameshifts	NNS	O
which	WDT	O
produced	VBD	O
downstream	JJ	O
stop	NN	O
codons	NNS	O
in	IN	O
another	DT	O
two	CD	O
patients	NNS	O
and	CC	O
an	DT	O
A	NN	O
--	:	O
>	JJR	O
T	NN	O
mutation	NN	O
disrupted	VBD	O
the	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
exon	NN	O
5	CD	O
in	IN	O
the	DT	O
remaining	VBG	O
family	NN	O
.	.	O

Thus	RB	O
,	,	O
complete	JJ	O
inactivation	NN	O
of	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
is	VBZ	O
predicted	VBN	O
in	IN	O
all	DT	O
cases	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
other	JJ	O
affected	JJ	O
members	NNS	O
of	IN	O
the	DT	O
families	NNS	O
showed	VBD	O
that	IN	O
,	,	O
in	IN	O
each	DT	O
case	NN	O
,	,	O
all	DT	O
affected	VBD	O
individuals	NNS	O
carried	VBD	O
the	DT	O
same	JJ	O
family-specific	JJ	O
mutation	NN	O
.	.	O

One	CD	O
polymorphism	NN	O
was	VBD	O
found	VBN	O
in	IN	O
exon	NN	O
7	CD	O
.	.	O

This	DT	O
data	NNS	O
strongly	RB	O
supports	VBZ	O
the	DT	O
candidature	NN	O
of	IN	O
PAX6	NN	O
as	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
hereditary	JJ	O
aniridia	NN	B-Disease
.	.	O

.	.	O

Locus	NN	O
heterogeneity	NN	O
in	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
ataxia	NN	I-Disease
.	.	O

The	DT	O
disease	NN	O
locus	NN	O
was	VBD	O
assigned	VBN	O
to	TO	O
chromosome	NN	O
9	CD	O
and	CC	O
the	DT	O
disease	NN	O
gene	NN	O
,	,	O
STM7/X25	NN	O
,	,	O
has	VBZ	O
been	VBN	O
isolated	VBN	O
.	.	O

To	TO	O
date	VB	O
most	RBS	O
data	NNS	O
suggest	VBP	O
locus	NN	O
homogeneity	NN	O
in	IN	O
FRDA	NNP	B-Disease
.	.	O

We	PRP	O
now	RB	O
provide	VBP	O
strong	JJ	O
evidence	NN	O
of	IN	O
a	DT	O
second	JJ	O
FRDA	NN	B-Disease
locus	NN	O
.	.	O

Studying	VBG	O
two	CD	O
siblings	NNS	O
with	IN	O
FRDA	NN	B-Disease
from	IN	O
two	CD	O
families	NNS	O
we	PRP	O
did	VBD	O
not	RB	O
detect	VB	O
a	DT	O
mutation	NN	O
in	IN	O
STM7/X25	NN	O
.	.	O

Haplotype	NN	O
analysis	NN	O
of	IN	O
the	DT	O
STM7/X25	NN	O
region	NN	O
of	IN	O
chromosome	NN	O
9	CD	O
demonstrated	VBD	O
that	IN	O
the	DT	O
relevant	JJ	O
portion	NN	O
of	IN	O
chromosome	NN	O
9	CD	O
differs	VBZ	O
in	IN	O
the	DT	O
patients	NNS	O
.	.	O

Although	IN	O
the	DT	O
patients	NNS	O
studied	VBN	O
had	VBD	O
typical	JJ	O
FRDA	NNP	B-Disease
,	,	O
one	CD	O
sibpair	NN	O
had	VBD	O
the	DT	O
uncommon	JJ	O
symptom	NN	O
of	IN	O
retained	VBN	O
tendon	NN	O
reflexes	NNS	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
investigate	VB	O
whether	IN	O
retained	VBN	O
tendon	NN	O
reflexes	NNS	O
are	VBP	O
characteristic	JJ	O
of	IN	O
FRDA	NN	B-Disease
caused	VBN	O
by	IN	O
the	DT	O
second	JJ	O
locus	NN	O
,	,	O
FRDA2	NN	O
,	,	O
we	PRP	O
studied	VBD	O
an	DT	O
unrelated	JJ	O
FRDA	NN	B-Disease
patient	NN	O
with	IN	O
retained	VBN	O
tendon	NN	O
reflexes	NNS	O
.	.	O

The	DT	O
observation	NN	O
of	IN	O
typical	JJ	O
mutations	NNS	O
in	IN	O
STM7/X25	NN	O
(	-LRB-	O
GAA	NN	O
expansions	NNS	O
)	-RRB-	O
in	IN	O
this	DT	O
patient	NN	O
demonstrates	VBZ	O
that	IN	O
the	DT	O
two	CD	O
genetically	RB	O
different	JJ	O
forms	NNS	O
of	IN	O
FRDA	NN	B-Disease
can	MD	O
not	RB	O
be	VB	O
distinguished	VBN	O
clinically	RB	O
.	.	O

.	.	O

Haploinsufficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
transcription	NN	I-Disease
factors	NNS	I-Disease
FOXC1	NN	I-Disease
and	CC	I-Disease
FOXC2	NN	I-Disease
results	NNS	O
in	IN	O
aberrant	JJ	O
ocular	JJ	O
development	NN	O
.	.	O

Anterior	NNP	B-Disease
segment	NN	I-Disease
developmental	JJ	I-Disease
disorders	NNS	I-Disease
,	,	O
including	VBG	O
Axenfeld-Rieger	NNP	B-Disease
anomaly	NN	I-Disease
(	-LRB-	O
ARA	NNP	B-Disease
)	-RRB-	O
,	,	O
variably	RB	O
associate	JJ	O
with	IN	O
harmfully	RB	O
elevated	JJ	O
intraocular	JJ	O
pressure	NN	O
(	-LRB-	O
IOP	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
causes	VBZ	O
glaucoma	NN	B-Disease
.	.	O

Clinically	RB	O
observed	VBN	O
dysgenesis	NN	O
does	VBZ	O
not	RB	O
correlate	VB	O
with	IN	O
IOP	NN	O
,	,	O
however	RB	O
,	,	O
and	CC	O
the	DT	O
etiology	NN	O
of	IN	O
glaucoma	NN	B-Disease
development	NN	O
is	VBZ	O
not	RB	O
understood	VBN	O
.	.	O

The	DT	O
forkhead	NN	O
transcription	NN	O
factor	NN	O
genes	NNS	O
Foxc1	NN	O
(	-LRB-	O
formerly	RB	O
Mf1	NN	O
)	-RRB-	O
and	CC	O
Foxc2	NN	O
(	-LRB-	O
formerly	RB	O
Mfh1	NN	O
)	-RRB-	O
are	VBP	O
expressed	VBN	O
in	IN	O
the	DT	O
mesenchyme	NN	O
from	IN	O
which	WDT	O
the	DT	O
ocular	JJ	O
drainage	NN	O
structures	NNS	O
derive	VBP	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
homolog	NN	O
of	IN	O
Foxc1	NN	O
,	,	O
FKHL7	NN	O
,	,	O
cause	VB	O
dominant	JJ	O
anterior	JJ	B-Disease
segment	NN	I-Disease
defects	NNS	I-Disease
and	CC	O
glaucoma	NN	B-Disease
in	IN	O
various	JJ	O
families	NNS	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
Foxc1	NN	O
(	-LRB-	O
+	CC	O
/	:	O
-	:	O
)	-RRB-	O
mice	NNS	O
have	VBP	O
anterior	JJ	B-Disease
segment	NN	I-Disease
abnormalities	NNS	I-Disease
similar	JJ	O
to	TO	O
those	DT	O
reported	VBN	O
in	IN	O
human	JJ	O
patients	NNS	O
.	.	O

These	DT	O
abnormalities	NNS	O
include	VBP	O
small	JJ	O
or	CC	O
absent	JJ	O
Schlemms	NNS	O
canal	NN	O
,	,	O
aberrantly	RB	O
developed	VBD	O
trabecular	JJ	O
meshwork	NN	O
,	,	O
iris	NN	B-Disease
hypoplasia	NN	I-Disease
,	,	O
severely	RB	O
eccentric	JJ	O
pupils	NNS	O
and	CC	O
displaced	JJ	O
Schwalbes	NNS	O
line	NN	O
.	.	O

The	DT	O
penetrance	NN	O
of	IN	O
clinically	RB	O
obvious	JJ	O
abnormalities	NNS	O
varies	VBZ	O
with	IN	O
genetic	JJ	O
background	NN	O
.	.	O

In	IN	O
some	DT	O
affected	VBN	O
eyes	NNS	O
,	,	O
collagen	NN	O
bundles	NNS	O
were	VBD	O
half	JJ	O
normal	JJ	O
diameter	NN	O
,	,	O
or	CC	O
collagen	NN	O
and	CC	O
elastic	JJ	O
tissue	NN	O
were	VBD	O
very	RB	O
sparse	JJ	O
.	.	O

Thus	RB	O
,	,	O
abnormalities	NNS	O
in	IN	O
extracellular	JJ	O
matrix	NN	O
synthesis	NN	O
or	CC	O
organization	NN	O
may	MD	O
contribute	VB	O
to	TO	O
development	NN	O
of	IN	O
the	DT	O
ocular	JJ	O
phenotypes	NNS	O
.	.	O

Despite	IN	O
the	DT	O
abnormalities	NNS	O
in	IN	O
ocular	JJ	O
drainage	NN	O
structures	NNS	O
in	IN	O
Foxc1	NN	O
(	-LRB-	O
+	CC	O
/	:	O
-	:	O
)	-RRB-	O
mice	NNS	O
,	,	O
IOP	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
almost	RB	O
all	DT	O
mice	NNS	O
analyzed	VBN	O
,	,	O
on	IN	O
all	DT	O
genetic	JJ	O
backgrounds	NNS	O
and	CC	O
at	IN	O
all	DT	O
ages	NNS	O
.	.	O

Similar	JJ	O
abnormalities	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
Foxc2	NN	O
(	-LRB-	O
+	CC	O
/	:	O
-	:	O
)	-RRB-	O
mice	NNS	O
,	,	O
but	CC	O
no	DT	O
disease-associated	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
human	JJ	O
homolog	NN	O
FKHL14	NN	O
in	IN	O
32	CD	O
ARA	NNP	B-Disease
patients	NNS	O
.	.	O

Foxc1	NN	O
(	-LRB-	O
+	CC	O
/	:	O
-	:	O
)	-RRB-	O
and	CC	O
Foxc2	NN	O
(	-LRB-	O
+	CC	O
/	:	O
-	:	O
)	-RRB-	O
mice	NNS	O
are	VBP	O
useful	JJ	O
models	NNS	O
for	IN	O
studying	VBG	O
anterior	JJ	O
segment	NN	O
development	NN	O
and	CC	O
its	PRP$	O
anomalies	NNS	O
,	,	O
and	CC	O
may	MD	O
allow	VB	O
identification	NN	O
of	IN	O
genes	NNS	O
that	WDT	O
interact	VBP	O
with	IN	O
Foxc1	NN	O
and	CC	O
Foxc2	NN	O
(	-LRB-	O
or	CC	O
FKHL7	NN	O
and	CC	O
FKHL14	NN	O
)	-RRB-	O
to	TO	O
produce	VB	O
a	DT	O
phenotype	NN	O
with	IN	O
elevated	JJ	O
IOP	NN	O
and	CC	O
glaucoma	NN	B-Disease
.	.	O

.	.	O

The	DT	O
dermatofibrosarcoma	NN	B-Disease
protuberans-associated	JJ	O
collagen	NN	O
type	NN	O
Ialpha1/platelet-derived	JJ	O
growth	NN	O
factor	NN	O
(	-LRB-	O
PDGF	NN	O
)	-RRB-	O
B-chain	JJ	O
fusion	NN	O
gene	NN	O
generates	VBZ	O
a	DT	O
transforming	VBG	O
protein	NN	O
that	WDT	O
is	VBZ	O
processed	VBN	O
to	TO	O
functional	JJ	O
PDGF-BB	NN	O
.	.	O

Dermatofibrosarcoma	NN	B-Disease
protuberans	NNS	I-Disease
(	-LRB-	O
DFSP	NN	B-Disease
)	-RRB-	O
displays	VBZ	O
chromosomal	JJ	O
rearrangements	NNS	O
involving	VBG	O
chromosome	NN	O
17	CD	O
and	CC	O
22	CD	O
,	,	O
which	WDT	O
fuse	NN	O
the	DT	O
collagen	NN	O
type	NN	O
Ialpha1	NN	O
(	-LRB-	O
COLIA1	NN	O
)	-RRB-	O
gene	NN	O
to	TO	O
the	DT	O
platelet-derived	JJ	O
growth	NN	O
factor	NN	O
(	-LRB-	O
PDGF	NN	O
)	-RRB-	O
B-chain	NN	O
(	-LRB-	O
PDGFB	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

To	TO	O
characterize	VB	O
the	DT	O
functional	JJ	O
and	CC	O
structural	JJ	O
properties	NNS	O
of	IN	O
the	DT	O
COLIA1/PDGFB	NN	O
fusion	NN	O
protein	NN	O
,	,	O
we	PRP	O
generated	VBD	O
a	DT	O
stable	JJ	O
NIH3T3	NN	O
cell	NN	O
line	NN	O
that	WDT	O
contained	VBD	O
a	DT	O
tumor-derived	JJ	O
chimeric	JJ	O
gene	NN	O
resulting	VBG	O
from	IN	O
a	DT	O
COIA1	NN	O
intron	NN	O
7-PDGFB	JJ	O
intron	NN	O
1	CD	O
fusion	NN	O
.	.	O

Expression	NN	O
of	IN	O
the	DT	O
fusion	NN	O
protein	NN	O
led	VBD	O
to	TO	O
morphological	JJ	O
transformation	NN	O
and	CC	O
increased	VBD	O
growth	NN	O
rate	NN	O
of	IN	O
these	DT	O
cells	NNS	O
.	.	O

The	DT	O
PDGF	NN	O
receptor	NN	O
kinase	NN	O
inhibitor	NN	O
CGP57148B	NN	O
reversed	VBD	O
the	DT	O
transformed	VBN	O
phenotype	NN	O
and	CC	O
reduced	VBD	O
the	DT	O
growth	NN	O
rate	NN	O
of	IN	O
COLIA1/PDGFB-expressing	JJ	O
cells	NNS	O
but	CC	O
had	VBD	O
no	DT	O
effects	NNS	O
on	IN	O
control	NN	O
cells	NNS	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
dimeric	JJ	O
COLIA1/PDGFB	NN	O
precursors	NNS	O
was	VBD	O
demonstrated	VBN	O
through	IN	O
PDGFB	NN	O
immunoprecipitations	NNS	O
of	IN	O
metabolically	RB	O
labeled	VBN	O
cells	NNS	O
and	CC	O
also	RB	O
by	IN	O
PDGFB	NN	O
immunoprecipitations	NNS	O
followed	VBN	O
by	IN	O
immunoblotting	VBG	O
with	IN	O
COLIA1	NN	O
antibodies	NNS	O
.	.	O

Pulse-chase	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
COLIA1/PDGFB	NN	O
precursor	NN	O
was	VBD	O
processed	VBN	O
to	TO	O
an	DT	O
end	NN	O
product	NN	O
that	WDT	O
was	VBD	O
indistinguishable	JJ	O
from	IN	O
wild-type	JJ	O
PDGF-BB	NN	O
.	.	O

Finally	RB	O
,	,	O
COLIA1/PDGFB-expressing	JJ	O
cells	NNS	O
generated	VBD	O
tumors	NNS	B-Disease
after	IN	O
s.	NN	O
c	NN	O
c.	NN	O
injection	NN	O
into	IN	O
nude	JJ	O
mice	NNS	O
,	,	O
and	CC	O
tumor	NN	B-Disease
growth	NN	O
was	VBD	O
reduced	VBN	O
by	IN	O
treatment	NN	O
with	IN	O
CGP57148B	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
COLIA1/PDGFB	NN	O
fusion	NN	O
associated	VBN	O
with	IN	O
DFSP	NN	B-Disease
contributes	VBZ	O
to	TO	O
tumor	NN	B-Disease
development	NN	O
through	IN	O
ectopic	JJ	O
production	NN	O
of	IN	O
PDGF-BB	NN	O
and	CC	O
the	DT	O
formation	NN	O
of	IN	O
an	DT	O
autocrine	JJ	O
loop	NN	O
.	.	O

Our	PRP$	O
findings	NNS	O
,	,	O
thus	RB	O
,	,	O
suggest	VBP	O
that	IN	O
PDGF	NN	O
receptors	NNS	O
could	MD	O
be	VB	O
a	DT	O
target	NN	O
for	IN	O
pharmacological	JJ	O
treatment	NN	O
of	IN	O
DFSP	NN	B-Disease
and	CC	O
giant	JJ	B-Disease
cell	NN	I-Disease
fibroblastoma	NN	I-Disease
,	,	O
e.	FW	O
g.	FW	O
,	,	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
PDGF	NN	O
receptor	NN	O
kinase	NN	O
inhibitors	NNS	O
such	JJ	O
as	IN	O
CGP57148B	NN	O
.	.	O

Founder	NN	O
effect	NN	O
of	IN	O
a	DT	O
prevalent	JJ	O
phenylketonuria	NN	B-Disease
mutation	NN	O
in	IN	O
the	DT	O
Oriental	JJ	O
population	NN	O
.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
has	VBZ	O
been	VBN	O
identified	VBN	O
in	IN	O
the	DT	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
[	-LRB-	O
PAH	NN	O
;	:	O
phenylalanine	NN	O
4-monooxygenase	NN	O
;	:	O
L-phenylalanine	NN	O
,	,	O
tetrahydrobiopterin	NN	O
oxygen	NN	O
oxidoreductase	NN	O
(	-LRB-	O
4-hydroxylating	NN	O
)	-RRB-	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	CD	O
]	-RRB-	O
gene	NN	O
in	IN	O
a	DT	O
Chinese	JJ	O
patient	NN	O
with	IN	O
classic	JJ	O
phenylketonuria	NN	B-Disease
(	-LRB-	O
PKU	NN	B-Disease
)	-RRB-	O
.	.	O

A	DT	O
G-to-C	NN	O
transition	NN	O
at	IN	O
the	DT	O
second	JJ	O
base	NN	O
of	IN	O
codon	NN	O
413	CD	O
in	IN	O
exon	NN	O
12	CD	O
of	IN	O
the	DT	O
gene	NN	O
results	VBZ	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
Pro413	NN	O
for	IN	O
Arg413	NN	O
in	IN	O
the	DT	O
mutant	JJ	O
protein	NN	O
.	.	O

This	DT	O
mutation	NN	O
(	-LRB-	O
R413P	NN	O
)	-RRB-	O
results	VBZ	O
in	IN	O
negligible	JJ	O
enzymatic	JJ	O
activity	NN	O
when	WRB	O
expressed	VBN	O
in	IN	O
heterologous	JJ	O
mammalian	JJ	O
cells	NNS	O
and	CC	O
is	VBZ	O
compatible	JJ	O
with	IN	O
a	DT	O
classic	JJ	O
PKU	NN	B-Disease
phenotype	NN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

Population	NNP	O
genetic	JJ	O
studies	NNS	O
reveal	VBP	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
tightly	RB	O
linked	VBN	O
to	TO	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
haplotype	NN	O
4	CD	O
,	,	O
which	WDT	O
is	VBZ	O
the	DT	O
predominant	JJ	O
haplotype	NN	O
of	IN	O
the	DT	O
PAH	NN	O
locus	NN	O
in	IN	O
the	DT	O
Oriental	JJ	O
population	NN	O
.	.	O

It	PRP	O
accounts	VBZ	O
for	IN	O
13	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
northern	JJ	O
Chinese	JJ	O
and	CC	O
27	CD	O
%	NN	O
of	IN	O
Japanese	JJ	O
PKU	NN	B-Disease
alleles	NNS	O
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
rare	JJ	O
in	IN	O
southern	JJ	O
Chinese	JJ	O
(	-LRB-	O
2	CD	O
.	.	O

2	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
is	VBZ	O
absent	JJ	O
in	IN	O
the	DT	O
Caucasian	JJ	O
population	NN	O
.	.	O

The	DT	O
data	NNS	O
demonstrate	VBP	O
unambiguously	RB	O
that	IN	O
the	DT	O
mutation	NN	O
occurred	VBD	O
after	IN	O
racial	JJ	O
divergence	NN	O
of	IN	O
Orientals	NNP	O
and	CC	O
Caucasians	NNPS	O
and	CC	O
suggest	VBP	O
that	IN	O
the	DT	O
allele	NN	O
has	VBZ	O
spread	VBN	O
throughout	IN	O
the	DT	O
Orient	NNP	O
by	IN	O
a	DT	O
founder	NN	O
effect	NN	O
.	.	O

Previous	JJ	O
protein	NN	O
polymorphism	NN	O
studies	NNS	O
in	IN	O
eastern	JJ	O
Asia	NNP	O
have	VBP	O
led	VBN	O
to	TO	O
the	DT	O
hypothesis	NN	O
that	IN	O
"	''	O
northern	JJ	O
Mongoloids	NNPS	O
"	''	O
represented	VBD	O
a	DT	O
founding	JJ	O
population	NN	O
in	IN	O
Asia	NNP	O
.	.	O

Our	PRP$	O
results	NNS	O
are	VBP	O
compatible	JJ	O
with	IN	O
this	DT	O
hypothesis	NN	O
in	IN	O
that	IN	O
the	DT	O
PKU	NN	B-Disease
mutation	NN	O
might	MD	O
have	VB	O
occurred	VBN	O
in	IN	O
northern	JJ	O
Mongoloids	NNPS	O
and	CC	O
subsequently	RB	O
spread	VBN	O
to	TO	O
the	DT	O
Chinese	JJ	O
and	CC	O
Japanese	JJ	O
populations	NNS	O
.	.	O

Late-onset	JJ	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
:	:	O
a	DT	O
subset	NN	O
with	IN	O
distinct	JJ	O
clinical	JJ	O
,	,	O
demographic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
characteristics	NNS	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
and	CC	O
characterize	VBP	O
demographic	JJ	O
,	,	O
clinical	JJ	O
,	,	O
and	CC	O
genetic	JJ	O
features	NNS	O
of	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
FMF	NN	B-Disease
)	-RRB-	O
of	IN	O
late	JJ	O
onset	NN	O
,	,	O
all	DT	O
patients	NNS	O
experiencing	VBG	O
their	PRP$	O
first	JJ	O
FMF	NN	B-Disease
attack	NN	O
at	IN	O
age	NN	O
40	CD	O
years	NNS	O
or	CC	O
more	JJR	O
were	VBD	O
identified	VBN	O
using	VBG	O
the	DT	O
computerized	JJ	O
registry	NN	O
of	IN	O
our	PRP$	O
FMF	NN	B-Disease
clinic	NN	O
,	,	O
and	CC	O
then	RB	O
thoroughly	RB	O
interviewed	VBN	O
and	CC	O
examined	VBN	O
.	.	O

The	DT	O
control	NN	O
group	NN	O
consisted	VBD	O
of	IN	O
40	CD	O
consecutive	JJ	O
FMF	NN	B-Disease
patients	NNS	O
,	,	O
who	WP	O
arrived	VBD	O
at	IN	O
the	DT	O
FMF	NN	B-Disease
clinic	NN	O
for	IN	O
their	PRP$	O
regular	JJ	O
follow-up	JJ	O
visit	NN	O
and	CC	O
were	VBD	O
40	CD	O
years	NNS	O
of	IN	O
age	NN	O
or	CC	O
older	JJR	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
the	DT	O
examination	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
in	IN	O
patients	NNS	O
and	CC	O
controls	NNS	O
was	VBD	O
determined	VBN	O
using	VBG	O
a	DT	O
modified	VBN	O
score	NN	O
,	,	O
developed	VBD	O
previously	RB	O
.	.	O

Mutational	JJ	O
analysis	NN	O
in	IN	O
the	DT	O
FMF	NN	B-Disease
gene	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
commercial	JJ	O
kit	NN	O
.	.	O

Only	RB	O
20	CD	O
of	IN	O
4000	CD	O
(	-LRB-	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
patients	NNS	O
had	VBD	O
late-onset	JJ	O
FMF	NN	B-Disease
.	.	O

These	DT	O
patients	NNS	O
were	VBD	O
mostly	RB	O
men	NNS	O
,	,	O
of	IN	O
non-North	JJ	O
African	JJ	O
origin	NN	O
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

05	NN	O
compared	VBN	O
to	TO	O
controls	NNS	O
.	.	O

All	DT	O
had	VBD	O
abdominal	JJ	O
attacks	NNS	O
and	CC	O
in	IN	O
most	JJS	O
these	DT	O
were	VBD	O
the	DT	O
only	JJ	O
manifestation	NN	O
of	IN	O
their	PRP$	O
disease	NN	O
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
001	CD	O
.	.	O

None	NN	O
had	VBD	O
chronic	JJ	O
or	CC	O
prolonged	JJ	O
manifestations	NNS	O
of	IN	O
FMF	NN	B-Disease
,	,	O
for	IN	O
example	NN	O
,	,	O
amyloidosis	NN	B-Disease
,	,	O
chronic	JJ	B-Disease
arthritis	NN	I-Disease
,	,	O
or	CC	O
protracted	JJ	O
myalgia	NN	B-Disease
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
.	.	O

The	DT	O
response	NN	O
to	TO	O
treatment	NN	O
was	VBD	O
good	JJ	O
despite	IN	O
using	VBG	O
low	JJ	O
colchicine	NN	O
dose	NN	O
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

05	NN	O
.	.	O

The	DT	O
overall	JJ	O
severity	NN	O
score	NN	O
indicated	VBD	O
a	DT	O
mild	JJ	O
disease	NN	O
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
.	.	O

Mutational	JJ	O
analysis	NN	O
revealed	VBD	O
absence	NN	O
of	IN	O
M694V	NN	O
homozygosity	NN	O
,	,	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

01	NN	O
,	,	O
compared	VBN	O
to	TO	O
our	PRP$	O
regular	JJ	O
FMF	NNP	B-Disease
population	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
onset	NN	O
of	IN	O
FMF	NN	B-Disease
in	IN	O
a	DT	O
late	JJ	O
age	NN	O
defines	VBZ	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
disease	NN	O
with	IN	O
typical	JJ	O
clinical	JJ	O
,	,	O
demographic	JJ	O
,	,	O
and	CC	O
molecular	JJ	O
genetic	JJ	O
characteristics	NNS	O

Structure	NN	O
of	IN	O
the	DT	O
human	JJ	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
gene	NN	O
SGLT1	NN	O
.	.	O

Intestinal	JJ	O
uptake	NN	O
of	IN	O
dietary	JJ	O
glucose	NN	O
and	CC	O
galactose	NN	O
is	VBZ	O
mediated	VBN	O
by	IN	O
the	DT	O
SGLT1	NN	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
of	IN	O
the	DT	O
brush	NN	O
border	NN	O
.	.	O

An	DT	O
SGLT1	NN	O
missense	NN	O
mutation	NN	O
underlies	VBZ	O
hereditary	JJ	B-Disease
glucose/galactose	NN	I-Disease
malabsorption	NN	I-Disease
,	,	O
characterized	VBN	O
by	IN	O
potentially	RB	O
fatal	JJ	O
diarrhea	NN	B-Disease
;	:	O
conversely	RB	O
,	,	O
oral	JJ	O
rehydration	NN	O
therapy	NN	O
exploits	VBZ	O
normal	JJ	O
transport	NN	O
to	TO	O
alleviate	VB	O
life-threatening	JJ	O
diarrhea	NN	B-Disease
of	IN	O
infectious	JJ	O
origin	NN	O
.	.	O

We	PRP	O
have	VBP	O
mapped	VBN	O
the	DT	O
entire	JJ	O
human	JJ	O
SGLT1	NN	O
Na	NN	O
+	CC	O
/	:	O
glucose	NN	O
cotransporter	NN	O
gene	NN	O
from	IN	O
cosmid	NN	O
and	CC	O
lambda	NN	O
phage	NN	O
clones	NNS	O
representing	VBG	O
a	DT	O
genomic	JJ	O
region	NN	O
of	IN	O
112	CD	O
kilobases	NNS	O
.	.	O

Transcription	NN	O
initiation	NN	O
occurred	VBD	O
from	IN	O
a	DT	O
site	NN	O
27	CD	O
base	NN	O
pairs	NNS	O
3	CD	O
of	IN	O
a	DT	O
TATAA	NN	O
sequence	NN	O
.	.	O

All	DT	O
exon-flanking	JJ	O
regions	NNS	O
were	VBD	O
sequenced	VBN	O
,	,	O
and	CC	O
the	DT	O
entire	JJ	O
112-kilobase	JJ	O
region	NN	O
mapped	VBN	O
with	IN	O
four	CD	O
restriction	NN	O
enzymes	NNS	O
.	.	O

SGLT1	NN	O
is	VBZ	O
comprised	VBN	O
of	IN	O
15	CD	O
exons	NNS	O
(	-LRB-	O
spanning	VBG	O
72	CD	O
kilobases	NNS	O
)	-RRB-	O
;	:	O
a	DT	O
possible	JJ	O
evolutionary	JJ	O
origin	NN	O
from	IN	O
a	DT	O
six-membrane-span	JJ	O
ancestral	JJ	O
precursor	NN	O
via	IN	O
a	DT	O
gene	NN	O
duplication	NN	O
event	NN	O
is	VBZ	O
suggested	VBN	O
from	IN	O
comparison	NN	O
of	IN	O
exons	NNS	O
against	IN	O
protein	NN	O
secondary	JJ	O
structure	NN	O
and	CC	O
from	IN	O
sequence	NN	O
considerations	NNS	O
.	.	O

A	DT	O
new	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
1	CD	O
causing	VBG	O
glucose/galactose	NN	B-Disease
malabsorption	NN	I-Disease
is	VBZ	O
also	RB	O
described	VBN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
-	:	O
dependent	JJ	O
cotransporter	NN	O
gene	NN	O
structure	NN	O
reported	VBD	O
.	.	O

These	DT	O
data	NNS	O
facilitate	VBP	O
the	DT	O
search	NN	O
for	IN	O
new	JJ	O
glucose/galactose	NN	B-Disease
malabsorption-related	JJ	O
mutations	NNS	O
in	IN	O
this	DT	O
important	JJ	O
gene	NN	O
and	CC	O
provide	VB	O
a	DT	O
basis	NN	O
for	IN	O
future	JJ	O
evolutionary	JJ	O
comparisons	NNS	O
with	IN	O
other	JJ	O
Na	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
-	:	O
dependent	JJ	O
cotransporters	NNS	O
.	.	O

.	.	O

ATM	NNP	O
phosphorylates	VBZ	O
p95/nbs1	NN	O
in	IN	O
an	DT	O
S-phase	NN	O
checkpoint	NN	O
pathway	NN	O
.	.	O

The	DT	O
rare	JJ	B-Disease
diseases	NNS	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
AT	IN	B-Disease
)	-RRB-	O
,	,	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
,	,	O
and	CC	O
Nijmegen	NNP	B-Disease
breakage	NN	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
NBS	NN	B-Disease
)	-RRB-	O
,	,	O
with	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
p95/nbs1	NN	O
gene	NN	O
,	,	O
share	VBP	O
a	DT	O
variety	NN	O
of	IN	O
phenotypic	JJ	B-Disease
abnormalities	NNS	I-Disease
such	JJ	O
as	IN	O
chromosomal	JJ	B-Disease
instability	NN	I-Disease
,	,	O
radiation	NN	O
sensitivity	NN	O
and	CC	O
defects	NNS	O
in	IN	O
cell-cycle	JJ	O
checkpoints	NNS	O
in	IN	O
response	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
.	.	O

The	DT	O
ATM	NNP	O
gene	NN	O
encodes	VBZ	O
a	DT	O
protein	NN	O
kinase	NN	O
that	WDT	O
is	VBZ	O
activated	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
or	CC	O
radiomimetic	JJ	O
drugs	NNS	O
,	,	O
whereas	IN	O
p95/nbs1	NN	O
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
protein	NN	O
complex	NN	O
that	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
responses	NNS	O
to	TO	O
DNA	NN	O
double-strand	NN	O
breaks	NNS	O
.	.	O

Here	RB	O
,	,	O
because	IN	O
of	IN	O
the	DT	O
similarities	NNS	O
between	IN	O
AT	NNP	B-Disease
and	CC	O
NBS	NNP	B-Disease
,	,	O
we	PRP	O
evaluated	VBD	O
the	DT	O
functional	JJ	O
interactions	NNS	O
between	IN	O
ATM	NNP	O
and	CC	O
p95/nbs1	NN	O
.	.	O

Activation	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
kinase	NN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
and	CC	O
induction	NN	O
of	IN	O
ATM-dependent	JJ	O
responses	NNS	O
in	IN	O
NBS	NN	B-Disease
cells	NNS	O
indicated	VBD	O
that	IN	O
p95/nbs1	NN	O
may	MD	O
not	RB	O
be	VB	O
required	VBN	O
for	IN	O
signalling	NN	O
to	TO	O
ATM	NNP	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

However	RB	O
,	,	O
p95/nbs1	NN	O
was	VBD	O
phosphorylated	VBN	O
on	IN	O
serine	NN	O
343	CD	O
in	IN	O
an	DT	O
ATM-dependent	JJ	O
manner	NN	O
in	FW	O
vitro	FW	O
and	CC	O
in	FW	O
vivo	FW	O
after	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

A	DT	O
p95/nbs1	NN	O
construct	NN	O
mutated	VBN	O
at	IN	O
the	DT	O
ATM	NNP	O
phosphorylation	NN	O
site	NN	O
abrogated	VBD	O
an	DT	O
S-phase	NN	O
checkpoint	NN	O
induced	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
in	IN	O
normal	JJ	O
cells	NNS	O
and	CC	O
failed	VBD	O
to	TO	O
compensate	VB	O
for	IN	O
this	DT	O
functional	JJ	O
deficiency	NN	O
in	IN	O
NBS	NN	B-Disease
cells	NNS	O
.	.	O

These	DT	O
observations	NNS	O
link	VBP	O
ATM	NNP	O
and	CC	O
p95/nbs1	NN	O
in	IN	O
a	DT	O
common	JJ	O
signalling	NN	O
pathway	NN	O
and	CC	O
provide	VB	O
an	DT	O
explanation	NN	O
for	IN	O
phenotypic	JJ	O
similarities	NNS	O
in	IN	O
these	DT	O
two	CD	O
diseases	NNS	O
.	.	O

.	.	O

Two	CD	O
distinct	JJ	O
mutations	NNS	O
at	IN	O
a	DT	O
single	JJ	O
BamHI	NN	O
site	NN	O
in	IN	O
phenylketonuria	NN	B-Disease
.	.	O

Classical	JJ	B-Disease
phenylketonuria	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
hepatic	JJ	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

The	DT	O
abolition	NN	O
of	IN	O
an	DT	O
invariant	JJ	O
BamHI	NN	O
site	NN	O
located	JJ	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
(	-LRB-	O
exon	NN	O
7	CD	O
)	-RRB-	O
led	VBD	O
to	TO	O
the	DT	O
recognition	NN	O
of	IN	O
two	CD	O
new	JJ	O
point	NN	O
mutations	NNS	O
at	IN	O
codon	NN	O
272	CD	O
and	CC	O
273	CD	O
(	-LRB-	O
272gly	RB	O
----	:	O
stop	VB	O
and	CC	O
273ser	VB	O
----	:	O
phe	NN	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
north	NN	O
eastern	JJ	O
France	NNP	O
or	CC	O
Belgium	NNP	O
and	CC	O
occurred	VBD	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
RFLP	NN	O
haplotype	NN	O
7	CD	O
alleles	NNS	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
supports	VBZ	O
the	DT	O
view	NN	O
that	IN	O
the	DT	O
clinical	JJ	O
heterogeneity	NN	O
in	IN	O
PKU	NNP	B-Disease
is	VBZ	O
accounted	VBN	O
for	IN	O
by	IN	O
the	DT	O
large	JJ	O
variety	NN	O
of	IN	O
mutant	JJ	O
genotypes	NNS	O
associated	VBN	O
with	IN	O
PAH	NN	B-Disease
deficiencies	NNS	I-Disease
.	.	O

.	.	O

Functional	JJ	O
link	NN	O
between	IN	O
ataxia-telangiectasia	NN	B-Disease
and	CC	O
Nijmegen	NN	B-Disease
breakage	NN	I-Disease
syndrome	NN	I-Disease
gene	NN	O
products	NNS	O
.	.	O

Ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
and	CC	O
Nijmegen	NNP	B-Disease
breakage	NN	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
NBS	NN	B-Disease
)	-RRB-	O
are	VBP	O
recessive	JJ	B-Disease
genetic	JJ	I-Disease
disorders	NNS	I-Disease
with	IN	O
susceptibility	NN	O
to	TO	O
cancer	NN	B-Disease
and	CC	O
similar	JJ	O
cellular	JJ	O
phenotypes	NNS	O
.	.	O

The	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
A-T	NN	B-Disease
,	,	O
designated	VBN	O
ATM	NNP	O
,	,	O
is	VBZ	O
a	DT	O
member	NN	O
of	IN	O
a	DT	O
family	NN	O
of	IN	O
kinases	NNS	O
characterized	VBN	O
by	IN	O
a	DT	O
carboxy-terminal	JJ	O
phosphatidylinositol	NN	O
3-kinase-like	JJ	O
domain	NN	O
.	.	O

The	DT	O
NBS1	NN	O
protein	NN	O
is	VBZ	O
specifically	RB	O
mutated	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
Nijmegen	NN	B-Disease
breakage	NN	I-Disease
syndrome	NN	I-Disease
and	CC	O
forms	VBZ	O
a	DT	O
complex	NN	O
with	IN	O
the	DT	O
DNA	NN	O
repair	NN	O
proteins	NNS	O
Rad50	NN	O
and	CC	O
Mrel1	NN	O
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
phosphorylation	NN	O
of	IN	O
NBS1	NN	O
,	,	O
induced	VBN	O
by	IN	O
ionizing	VBG	O
radiation	NN	O
,	,	O
requires	VBZ	O
catalytically	RB	O
active	JJ	O
ATM	NNP	O
.	.	O

Complexes	NNS	O
containing	VBG	O
ATM	NNP	O
and	CC	O
NBS1	NN	O
exist	VBP	O
in	FW	O
vivo	FW	O
in	IN	O
both	DT	O
untreated	JJ	O
cells	NNS	O
and	CC	O
cells	NNS	O
treated	VBN	O
with	IN	O
ionizing	VBG	O
radiation	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
two	CD	O
residues	NNS	O
of	IN	O
NBS1	NN	O
,	,	O
Ser	NN	O
278	CD	O
and	CC	O
Ser	NN	O
343	CD	O
that	WDT	O
are	VBP	O
phosphorylated	VBN	O
in	FW	O
vitro	FW	O
by	IN	O
ATM	NNP	O
and	CC	O
whose	WP$	O
modification	NN	O
in	FW	O
vivo	FW	O
is	VBZ	O
essential	JJ	O
for	IN	O
the	DT	O
cellular	JJ	O
response	NN	O
to	TO	O
DNA	NN	O
damage	NN	O
.	.	O

This	DT	O
response	NN	O
includes	VBZ	O
S-phase	NN	O
checkpoint	NN	O
activation	NN	O
,	,	O
formation	NN	O
of	IN	O
the	DT	O
NBS1/Mrel1/Rad50	NN	O
nuclear	JJ	O
foci	NNS	O
and	CC	O
rescue	NN	O
of	IN	O
hypersensitivity	NN	B-Disease
to	TO	I-Disease
ionizing	VBG	I-Disease
radiation	NN	I-Disease
.	.	O

Together	RB	O
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
a	DT	O
biochemical	JJ	O
link	NN	O
between	IN	O
cell-cycle	JJ	O
checkpoints	NNS	O
activated	VBN	O
by	IN	O
DNA	NN	O
damage	NN	O
and	CC	O
DNA	NN	O
repair	NN	O
in	IN	O
two	CD	O
genetic	JJ	B-Disease
diseases	NNS	I-Disease
with	IN	O
overlapping	VBG	O
phenotypes	NNS	O
.	.	O

.	.	O

Structure	NN	O
and	CC	O
genomic	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
kinase	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

The	DT	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
has	VBZ	O
recently	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
unstable	JJ	O
CTG	NNP	O
trinucleotide	NN	O
repeat	NN	O
located	JJ	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
a	DT	O
gene	NN	O
encoding	VBG	O
for	IN	O
a	DT	O
protein	NN	O
with	IN	O
putative	JJ	O
serine-threonine	JJ	O
protein	NN	O
kinase	NN	O
activity	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
we	PRP	O
present	VBP	O
the	DT	O
genomic	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
human	JJ	O
and	CC	O
murine	JJ	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
these	DT	O
sequences	NNS	O
with	IN	O
each	DT	O
other	JJ	O
and	CC	O
with	IN	O
known	JJ	O
cDNA	NN	O
sequences	NNS	O
from	IN	O
both	DT	O
species	NNS	O
,	,	O
led	VBD	O
us	PRP	O
to	TO	O
predict	VB	O
a	DT	O
translation	NN	O
initiation	NN	O
codon	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
determine	VB	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
.	.	O

Several	JJ	O
polymorphisms	NNS	O
within	IN	O
the	DT	O
human	JJ	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
,	,	O
and	CC	O
PCR	NN	O
assays	NNS	O
to	TO	O
detect	VB	O
two	CD	O
of	IN	O
these	DT	O
are	VBP	O
described	VBN	O
.	.	O

The	DT	O
complete	JJ	O
sequence	NN	O
and	CC	O
characterization	NN	O
of	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
kinase	NN	O
gene	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
identification	NN	O
of	IN	O
novel	JJ	O
polymorphisms	NNS	O
within	IN	O
the	DT	O
gene	NN	O
,	,	O
represent	VBP	O
an	DT	O
important	JJ	O
step	NN	O
in	IN	O
a	DT	O
further	JJ	O
understanding	NN	O
of	IN	O
the	DT	O
genetics	NNS	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
and	CC	O
the	DT	O
molecular	JJ	O
biology	NN	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
novel	JJ	O
imprinted	JJ	O
transcripts	NNS	O
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
and	CC	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
deletion	NN	O
region	NN	O
:	:	O
further	JJ	O
evidence	NN	O
for	IN	O
regional	JJ	O
imprinting	VBG	O
control	NN	O
.	.	O

Deletions	NNS	O
and	CC	O
other	JJ	O
abnormalities	NNS	O
of	IN	O
human	JJ	O
chromosome	NN	O
15q11-q13	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
two	CD	O
developmental	JJ	O
disorders	NNS	O
,	,	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
and	CC	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
.	.	O

Loss	NN	O
of	IN	O
expression	NN	O
of	IN	O
imprinted	JJ	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
PWS	NNP	B-Disease
.	.	O

However	RB	O
,	,	O
the	DT	O
number	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
that	WDT	O
contribute	VBP	O
to	TO	O
PWS	NNP	B-Disease
,	,	O
and	CC	O
the	DT	O
range	NN	O
over	IN	O
which	WDT	O
the	DT	O
imprinting	VBG	O
signal	NN	O
acts	VBZ	O
to	TO	O
silence	NN	O
one	CD	O
copy	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
a	DT	O
parent-of-origin-specific	JJ	O
manner	NN	O
,	,	O
are	VBP	O
unknown	JJ	O
.	.	O

To	TO	O
identify	VB	O
additional	JJ	O
imprinted	JJ	O
genes	NNS	O
that	WDT	O
could	MD	O
contribute	VB	O
to	TO	O
the	DT	O
PWS	NN	B-Disease
phenotype	NN	O
and	CC	O
to	TO	O
understand	VB	O
the	DT	O
regional	JJ	O
control	NN	O
of	IN	O
imprinting	VBG	O
in	IN	O
15q11-q13	NN	O
,	,	O
we	PRP	O
have	VBP	O
constructed	VBN	O
an	DT	O
imprinted	JJ	O
transcript	NN	O
map	NN	O
of	IN	O
the	DT	O
PWS-AS	NN	O
deletion	NN	O
interval	NN	O
.	.	O

The	DT	O
imprinting	VBG	O
status	NN	O
of	IN	O
22	CD	O
expressed	VBN	O
sequence	NN	O
tags	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
radiation-hybrid	JJ	O
human	JJ	O
transcript	NN	O
maps	NNS	O
or	CC	O
physical	JJ	O
maps	NNS	O
was	VBD	O
determined	VBN	O
in	IN	O
a	DT	O
reverse	JJ	O
transcriptase-PCR	NN	O
assay	NN	O
and	CC	O
correlated	VBD	O
with	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
transcripts	NNS	O
on	IN	O
the	DT	O
physical	JJ	O
map	NN	O
.	.	O

Seven	CD	O
new	JJ	O
paternally	RB	O
expressed	VBN	O
transcripts	NNS	O
localize	VBP	O
to	TO	O
an	DT	O
approximately	RB	O
1	CD	O
.	.	O

5-Mb	JJ	O
domain	NN	O
surrounding	VBG	O
the	DT	O
SNRPN-associated	JJ	O
imprinting	VBG	O
center	NN	O
,	,	O
which	WDT	O
already	RB	O
includes	VBZ	O
four	CD	O
imprinted	JJ	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
.	.	O

All	DT	O
other	JJ	O
tested	VBN	O
new	JJ	O
transcripts	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
region	NN	O
were	VBD	O
expressed	VBN	O
from	IN	O
both	DT	O
alleles	NNS	O
.	.	O

A	DT	O
domain	NN	O
of	IN	O
exclusive	JJ	O
paternal	JJ	O
expression	NN	O
surrounding	VBG	O
the	DT	O
imprinting	VBG	O
center	NN	O
suggests	VBZ	O
strong	JJ	O
regional	JJ	O
control	NN	O
of	IN	O
the	DT	O
imprinting	VBG	O
process	NN	O
.	.	O

This	DT	O
study	NN	O
provides	VBZ	O
the	DT	O
means	NNS	O
for	IN	O
further	JJ	O
investigation	NN	O
of	IN	O
additional	JJ	O
genes	NNS	O
that	WDT	O
cause	VBP	O
or	CC	O
modify	VBP	O
the	DT	O
phenotypes	NNS	O
associated	VBN	O
with	IN	O
rearrangements	NNS	O
of	IN	O
15q11-q13	NN	O
.	.	O

Penetrances	NNS	O
of	IN	O
BRCA1	NN	O
1675delA	NN	O
and	CC	O
1135insA	NN	O
with	IN	O
respect	NN	O
to	TO	O
breast	NN	B-Disease
cancer	NN	I-Disease
and	CC	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

For	IN	O
genetic	JJ	O
counseling	NN	O
and	CC	O
predictive	JJ	O
testing	NN	O
in	IN	O
families	NNS	O
with	IN	O
inherited	VBN	B-Disease
breast-ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
penetrances	NNS	O
and	CC	O
expressions	NNS	O
of	IN	O
the	DT	O
underlying	JJ	O
mutations	NNS	O
should	MD	O
be	VB	O
known	VBN	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
reported	VBN	O
two	CD	O
BRCA1	NN	O
founder	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Norwegian	JJ	O
population	NN	O
.	.	O

Index	NNP	O
cases	NNS	O
for	IN	O
the	DT	O
present	JJ	O
study	NN	O
were	VBD	O
found	VBN	O
two	CD	O
different	JJ	O
ways	NNS	O
through	IN	O
a	DT	O
series	NN	O
of	IN	O
consecutive	JJ	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
(	-LRB-	O
n	NN	O
=	JJ	O
16	CD	O
)	-RRB-	O
and	CC	O
through	IN	O
our	PRP$	O
family	NN	O
cancer	NN	B-Disease
clinic	NN	O
(	-LRB-	O
n	NN	O
=	JJ	O
14	CD	O
)	-RRB-	O
.	.	O

Altogether	RB	O
,	,	O
20	CD	O
of	IN	O
the	DT	O
patients	NNS	O
had	VBD	O
BRCA1	NN	O
1675delA	NN	O
,	,	O
and	CC	O
10	CD	O
had	VBD	O
1135insA	NN	O
.	.	O

Their	PRP$	O
relatives	NNS	O
were	VBD	O
described	VBN	O
with	IN	O
respect	NN	O
to	TO	O
absence/presence	NN	O
of	IN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Of	IN	O
133	CD	O
living	NN	O
female	JJ	O
relatives	NNS	O
,	,	O
83	CD	O
(	-LRB-	O
62	CD	O
%	NN	O
)	-RRB-	O
were	VBD	O
tested	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
mutation	NN	O
.	.	O

No	DT	O
difference	NN	O
,	,	O
in	IN	O
penetrance	NN	O
and	CC	O
expression	NN	O
,	,	O
between	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
whereas	IN	O
differences	NNS	O
according	VBG	O
to	TO	O
method	NN	O
of	IN	O
ascertainment	NN	O
were	VBD	O
seen	VBN	O
.	.	O

The	DT	O
overall	JJ	O
findings	NNS	O
were	VBD	O
that	IN	O
disease	NN	O
started	VBD	O
to	TO	O
occur	VB	O
at	IN	O
age	NN	O
30	CD	O
years	NNS	O
and	CC	O
that	IN	O
by	IN	O
age	NN	O
50	CD	O
years	NNS	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
mutation-carrying	JJ	O
women	NNS	O
had	VBD	O
experienced	JJ	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

More	RBR	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
than	IN	O
breast	NN	B-Disease
cancers	NNS	I-Disease
were	VBD	O
recorded	VBN	O
.	.	O

Both	DT	O
penetrance	NN	O
and	CC	O
expression	NN	O
(	-LRB-	O
breast	NN	B-Disease
cancer	NN	I-Disease
vs.	CC	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
)	-RRB-	O
were	VBD	O
different	JJ	O
from	IN	O
those	DT	O
in	IN	O
reports	NNS	O
of	IN	O
the	DT	O
Ashkenazi	NNP	O
founder	NN	O
mutations	NNS	O
.	.	O

Whether	IN	O
the	DT	O
reported	VBN	O
differences	NNS	O
reflect	VBP	O
true	JJ	O
differences	NNS	O
and/or	CC	O
methodological	JJ	O
problems	NNS	O
is	VBZ	O
discussed	VBN	O
.	.	O

An	DT	O
observed	VBN	O
excess	NN	O
of	IN	O
mutation	NN	O
carriers	NNS	O
could	MD	O
not	RB	O
be	VB	O
accounted	VBN	O
for	IN	O
by	IN	O
methodological	JJ	O
problems	NNS	O
;	:	O
possible	JJ	O
explanations	NNS	O
were	VBD	O
a	DT	O
"	''	O
true	JJ	O
"	''	O
low	JJ	O
penetrance	NN	O
or	CC	O
preferential	JJ	O
segregation	NN	O
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
subtotal	JJ	B-Disease
complement	NN	I-Disease
C6	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

A	DT	O
carboxy-terminally	RB	O
truncated	VBN	O
but	CC	O
functionally	RB	O
active	JJ	O
C6	NN	O
.	.	O

Individuals	NNS	O
with	IN	O
subtotal	JJ	B-Disease
complement	NN	I-Disease
C6	NN	I-Disease
deficiency	NN	I-Disease
possess	VBP	O
a	DT	O
C6	NN	O
molecule	NN	O
that	WDT	O
is	VBZ	O
14	CD	O
%	NN	O
shorter	JJR	O
than	IN	O
normal	JJ	O
C6	NN	O
and	CC	O
present	JJ	O
in	IN	O
low	JJ	O
but	CC	O
detectable	JJ	O
concentrations	NNS	O
(	-LRB-	O
1-2	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
mean	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
now	RB	O
show	VBP	O
that	IN	O
this	DT	O
dysmorphic	NN	O
C6	NN	O
is	VBZ	O
bactericidally	RB	O
active	JJ	O
and	CC	O
lacks	VBZ	O
an	DT	O
epitope	NN	O
that	WDT	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
most	RBS	O
carboxy-terminal	JJ	O
part	NN	O
of	IN	O
C6	NN	O
using	VBG	O
C6	NN	O
cDNA	NN	O
fragments	NNS	O
expressed	VBN	O
as	IN	O
fusion	NN	O
proteins	NNS	O
in	IN	O
the	DT	O
pUEX	NN	O
expression	NN	O
system	NN	O
.	.	O

We	PRP	O
thus	RB	O
predicted	VBD	O
that	IN	O
the	DT	O
abnormal	JJ	O
C6	NN	O
molecule	NN	O
might	MD	O
be	VB	O
carboxy-terminally	RB	O
truncated	VBN	O
and	CC	O
sought	VBN	O
a	DT	O
mutation	NN	O
in	IN	O
an	DT	O
area	NN	O
approximately	RB	O
14	CD	O
%	NN	O
from	IN	O
the	DT	O
carboxy-terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

By	IN	O
sequencing	NN	O
PCR-amplified	JJ	O
products	NNS	O
from	IN	O
this	DT	O
region	NN	O
,	,	O
we	PRP	O
found	VBD	O
,	,	O
in	IN	O
three	CD	O
individuals	NNS	O
from	IN	O
two	CD	O
families	NNS	O
,	,	O
a	DT	O
mutation	NN	O
that	WDT	O
might	MD	O
plausibly	RB	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
defect	NN	O
.	.	O

All	DT	O
three	CD	O
have	VBP	O
an	DT	O
abnormal	JJ	O
5	CD	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
15	CD	O
,	,	O
which	WDT	O
would	MD	O
probably	RB	O
prevent	VB	O
splicing	NN	O
.	.	O

An	DT	O
in-frame	RB	O
stop	VB	O
codon	NN	O
is	VBZ	O
found	VBN	O
17	CD	O
codons	NNS	O
downstream	RB	O
from	IN	O
the	DT	O
intron	NN	O
boundary	NN	O
,	,	O
which	WDT	O
would	MD	O
lead	VB	O
to	TO	O
a	DT	O
truncated	VBN	O
polypeptide	NN	O
13	CD	O
.	.	O

5	CD	O
%	NN	O
smaller	JJR	O
than	IN	O
normal	JJ	O
C6	NN	O
.	.	O

This	DT	O
result	NN	O
was	VBD	O
unexpected	JJ	O
,	,	O
as	RB	O
earlier	JJR	O
studies	NNS	O
mapped	VBD	O
the	DT	O
C5b	NN	O
binding	NN	O
site	NN	O
,	,	O
or	CC	O
a	DT	O
putative	JJ	O
enzymatic	JJ	O
region	NN	O
,	,	O
to	TO	O
this	DT	O
part	NN	O
of	IN	O
C6	NN	O
.	.	O

Interestingly	RB	O
,	,	O
all	DT	O
three	CD	O
subjects	NNS	O
were	VBD	O
probably	RB	O
heterozygous	JJ	O
for	IN	O
both	DT	O
subtotal	JJ	B-Disease
C6	NN	I-Disease
and	CC	I-Disease
complete	JJ	I-Disease
C6	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Mutations	NNS	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
in	IN	O
sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
:	:	O
definition	NN	O
of	IN	O
a	DT	O
risk	NN	O
factor	NN	O
for	IN	O
VHL	NN	B-Disease
patients	NNS	O
to	TO	O
develop	VB	O
an	DT	O
RCC	NN	B-Disease
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
nature	NN	O
of	IN	O
somatic	JJ	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	O
VHL	NN	B-Disease
)	-RRB-	O
mutations	NNS	O
,	,	O
we	PRP	O
analyzed	VBD	O
173	CD	O
primary	JJ	O
sporadic	JJ	O
human	JJ	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
for	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
tumor	NN	I-Disease
suppressor	NN	O
gene	NN	O
,	,	O
using	VBG	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
and	CC	O
single-strand	JJ	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
of	IN	O
DNA	NN	O
.	.	O

We	PRP	O
detected	VBD	O
abnormal	JJ	O
SSCP	NN	O
pattern	NN	O
in	IN	O
73	CD	O
samples	NNS	O
.	.	O

After	IN	O
sequencing	NN	O
,	,	O
we	PRP	O
identified	VBD	O
microdeletions	NNS	O
in	IN	O
58	CD	O
%	NN	O
of	IN	O
cases	NNS	O
,	,	O
microinsertions	NNS	O
in	IN	O
17	CD	O
%	NN	O
,	,	O
nonsense	NN	O
mutations	NNS	O
in	IN	O
8	CD	O
%	NN	O
,	,	O
and	CC	O
missense	NN	O
mutations	NNS	O
in	IN	O
17	CD	O
%	NN	O
.	.	O

Among	IN	O
these	DT	O
mutations	NNS	O
,	,	O
50	CD	O
%	NN	O
correspond	VBP	O
to	TO	O
new	JJ	O
mutations	NNS	O
.	.	O

VHL	NN	B-Disease
mutations	NNS	O
were	VBD	O
found	VBN	O
only	RB	O
in	IN	O
the	DT	O
nonpapillary	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
(	-LRB-	O
RCC	NN	B-Disease
)	-RRB-	O
subtype	NN	O
,	,	O
as	IN	O
previously	RB	O
reported	VBN	O
.	.	O

To	TO	O
compare	VB	O
somatic	JJ	O
and	CC	O
germline	NN	O
mutations	NNS	O
,	,	O
we	PRP	O
used	VBD	O
the	DT	O
VHL	NN	B-Disease
database	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
507	CD	O
mutations	NNS	O
.	.	O

The	DT	O
study	NN	O
of	IN	O
mutational	JJ	O
events	NNS	O
revealed	VBD	O
a	DT	O
significant	JJ	O
difference	NN	O
between	IN	O
somatic	JJ	O
and	CC	O
germline	NN	O
mutations	NNS	O
with	IN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
truncated	VBN	O
proteins	NNS	O
observed	VBN	O
in	IN	O
78	CD	O
%	NN	O
of	IN	O
somatic	JJ	O
mutations	NNS	O
vs	CC	O
only	RB	O
37	CD	O
%	NN	O
in	IN	O
germline	NN	O
mutations	NNS	O
(	-LRB-	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

001	CD	O
)	-RRB-	O
.	.	O

We	PRP	O
postulated	VBD	O
that	IN	O
a	DT	O
specific	JJ	O
pattern	NN	O
of	IN	O
VHL	NN	B-Disease
mutations	NNS	O
is	VBZ	O
associated	VBN	O
with	IN	O
sporadic	JJ	B-Disease
RCC	NN	I-Disease
.	.	O

This	DT	O
pattern	NN	O
corresponds	VBZ	O
to	TO	O
mutations	NNS	O
leading	VBG	O
mainly	RB	O
to	TO	O
truncated	VBN	O
proteins	NNS	O
with	IN	O
few	JJ	O
specific	JJ	O
missense	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
then	RB	O
analyzed	VBD	O
the	DT	O
occurrence	NN	O
of	IN	O
RCC	NN	B-Disease
in	IN	O
VHL	NN	B-Disease
families	NNS	O
,	,	O
based	VBN	O
on	IN	O
the	DT	O
nature	NN	O
of	IN	O
mutations	NNS	O
.	.	O

We	PRP	O
observed	VBD	O
RCC	NN	B-Disease
in	IN	O
at	IN	O
least	JJS	O
one	CD	O
member	NN	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
families	NNS	O
in	IN	O
77	CD	O
%	NN	O
of	IN	O
cases	NNS	O
with	IN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
truncated	VBN	O
proteins	NNS	O
versus	CC	O
55	CD	O
%	NN	O
in	IN	O
cases	NNS	O
with	IN	O
missense	NN	O
mutations	NNS	O
(	-LRB-	O
P	NN	O
<	JJR	O
0	CD	O
.	.	O

05	NN	O
)	-RRB-	O
.	.	O

Thus	RB	O
,	,	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
truncated	VBN	O
proteins	NNS	O
may	MD	O
lead	VB	O
to	TO	O
a	DT	O
higher	JJR	O
risk	NN	O
of	IN	O
RCC	NN	B-Disease
in	IN	O
VHL	NN	B-Disease
patients	NNS	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
:	:	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
CUG	NN	O
triplet	NN	O
repeats	NNS	O
in	IN	O
splicing	NN	O
of	IN	O
a	DT	O
novel	JJ	O
DMPK	NN	O
exon	NN	O
and	CC	O
altered	JJ	O
cytoplasmic	JJ	O
DMPK	NN	O
mRNA	NN	O
isoform	NN	O
ratios	NNS	O
.	.	O

The	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
(	-LRB-	O
CTG	NN	O
)	-RRB-	O
n	NN	O
expansion	NN	O
in	IN	O
the	DT	O
3	CD	O
UTR	NN	O
of	IN	O
the	DT	O
DMPK	NN	O
gene	NN	O
causes	VBZ	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
unknown	JJ	O
.	.	O

We	PRP	O
identified	VBD	O
four	CD	O
RNA	NN	O
splicing	NN	O
factors	NNS	O
--	:	O
hnRNP	NN	O
C	NN	O
,	,	O
U2AF	NN	O
(	-LRB-	O
U2	NN	O
auxiliary	JJ	O
factor	NN	O
)	-RRB-	O
,	,	O
PTB	NN	O
(	-LRB-	O
polypyrimidine	NN	O
tract	NN	O
binding	NN	O
protein	NN	O
)	-RRB-	O
,	,	O
and	CC	O
PSF	NN	O
(	-LRB-	O
PTB	NN	O
associated	VBN	O
splicing	NN	O
factor	NN	O
)	-RRB-	O
--	:	O
that	WDT	O
bind	VBP	O
to	TO	O
two	CD	O
short	JJ	O
regions	NNS	O
3	CD	O
of	IN	O
the	DT	O
(	-LRB-	O
CUG	NN	O
)	-RRB-	O
n	NN	O
,	,	O
and	CC	O
found	VBD	O
a	DT	O
novel	JJ	O
3	CD	O
DMPK	NN	O
exon	NN	O
resulting	VBG	O
in	IN	O
an	DT	O
mRNA	NN	O
lacking	VBG	O
the	DT	O
repeats	NNS	O
.	.	O

We	PRP	O
propose	VBP	O
that	IN	O
the	DT	O
(	-LRB-	O
CUG	NN	O
)	-RRB-	O
n	NN	O
is	VBZ	O
an	DT	O
essential	JJ	O
cis	NN	O
acting	VBG	O
element	NN	O
for	IN	O
this	DT	O
splicing	NN	O
event	NN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
(	-LRB-	O
CUG	NN	O
)	-RRB-	O
n	NN	O
containing	VBG	O
mRNAs	NNS	O
,	,	O
the	DT	O
novel	JJ	O
isoform	NN	O
is	VBZ	O
not	RB	O
retained	VBN	O
in	IN	O
the	DT	O
nucleus	NN	O
in	IN	O
DM	NN	B-Disease
cells	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
imbalances	NNS	O
in	IN	O
relative	JJ	O
levels	NNS	O
of	IN	O
cytoplasmic	JJ	O
DMPK	NN	O
mRNA	NN	O
isoforms	NNS	O
and	CC	O
a	DT	O
new	JJ	O
dominant	JJ	O
effect	NN	O
of	IN	O
the	DT	O
mutation	NN	O
on	IN	O
DMPK	NN	O
.	.	O

.	.	O

Mechanism	NN	O
of	IN	O
increased	VBN	O
iron	NN	O
absorption	NN	O
in	IN	O
murine	JJ	O
model	NN	O
of	IN	O
hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
:	:	O
increased	VBN	O
duodenal	JJ	O
expression	NN	O
of	IN	O
the	DT	O
iron	NN	O
transporter	NN	O
DMT1	NN	O
.	.	O

Hereditary	JJ	B-Disease
hemochromatosis	NN	I-Disease
(	-LRB-	O
HH	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
common	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
tissue	NN	O
iron	NN	O
deposition	NN	O
secondary	JJ	O
to	TO	O
excessive	JJ	O
dietary	JJ	O
iron	NN	O
absorption	NN	O
.	.	O

We	PRP	O
recently	RB	O
reported	VBD	O
that	IN	O
HFE	NN	O
,	,	O
the	DT	O
protein	NN	O
defective	JJ	O
in	IN	O
HH	NN	B-Disease
,	,	O
was	VBD	O
physically	RB	O
associated	VBN	O
with	IN	O
the	DT	O
transferrin	NN	O
receptor	NN	O
(	-LRB-	O
TfR	NN	O
)	-RRB-	O
in	IN	O
duodenal	JJ	O
crypt	NN	O
cells	NNS	O
and	CC	O
proposed	VBD	O
that	IN	O
mutations	NNS	O
in	IN	O
HFE	NN	O
attenuate	VBP	O
the	DT	O
uptake	NN	O
of	IN	O
transferrin-bound	JJ	O
iron	NN	O
from	IN	O
plasma	NN	O
by	IN	O
duodenal	JJ	O
crypt	NN	O
cells	NNS	O
,	,	O
leading	VBG	O
to	TO	O
up-regulation	NN	O
of	IN	O
transporters	NNS	O
for	IN	O
dietary	JJ	O
iron	NN	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
tested	VBD	O
the	DT	O
hypothesis	NN	O
that	IN	O
HFE	NN	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
have	VBP	O
increased	VBN	O
duodenal	JJ	O
expression	NN	O
of	IN	O
the	DT	O
divalent	JJ	O
metal	NN	O
transporter	NN	O
(	-LRB-	O
DMT1	NN	O
)	-RRB-	O
.	.	O

By	IN	O
4	CD	O
weeks	NNS	O
of	IN	O
age	NN	O
,	,	O
the	DT	O
HFE	NN	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
demonstrated	VBD	O
iron	NN	O
loading	NN	O
when	WRB	O
compared	VBN	O
with	IN	O
HFE	NN	O
+	CC	O
/	:	O
+	CC	O
littermates	NNS	O
,	,	O
with	IN	O
elevated	JJ	O
transferrin	NN	O
saturations	NNS	O
(	-LRB-	O
68	CD	O
.	.	O

4	CD	O
%	NN	O
vs.	CC	O
49	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
elevated	JJ	O
liver	NN	O
iron	NN	O
concentrations	NNS	O
(	-LRB-	O
985	NNS	O
micrograms	NNS	O
vs.	CC	O
381	CD	O
micrograms	NNS	O
)	-RRB-	O
.	.	O

By	IN	O
using	VBG	O
Northern	NN	O
blot	NN	O
analyses	NNS	O
,	,	O
we	PRP	O
quantitated	VBD	O
duodenal	JJ	O
expression	NN	O
of	IN	O
both	CC	O
classes	NNS	O
of	IN	O
DMT1	NN	O
transcripts	NNS	O
one	CD	O
containing	VBG	O
an	DT	O
iron	NN	O
responsive	JJ	O
element	NN	O
(	-LRB-	O
IRE	NN	O
)	-RRB-	O
,	,	O
called	VBN	O
DMT1	NN	O
(	-LRB-	O
IRE	NN	O
)	-RRB-	O
,	,	O
and	CC	O
one	CD	O
containing	VBG	O
no	DT	O
IRE	NN	O
,	,	O
called	VBN	O
DMT1	NN	O
(	-LRB-	O
non-IRE	JJ	O
)	-RRB-	O
.	.	O

The	DT	O
positive	JJ	O
control	NN	O
for	IN	O
DMT1	NN	O
up-regulation	NN	O
was	VBD	O
a	DT	O
murine	JJ	O
model	NN	O
of	IN	O
dietary	JJ	B-Disease
iron	NN	I-Disease
deficiency	NN	I-Disease
that	WDT	O
demonstrated	VBD	O
greatly	RB	O
increased	VBN	O
levels	NNS	O
of	IN	O
duodenal	JJ	O
DMT1	NN	O
(	-LRB-	O
IRE	NN	O
)	-RRB-	O
mRNA	NN	O
.	.	O

HFE	SYM	O
-	:	O
/	:	O
-	:	O
mice	NNS	O
also	RB	O
demonstrated	VBD	O
an	DT	O
increase	NN	O
in	IN	O
duodenal	JJ	O
DMT1	NN	O
(	-LRB-	O
IRE	NN	O
)	-RRB-	O
mRNA	NN	O
(	-LRB-	O
average	NN	O
7	CD	O
.	.	O

7-fold	JJ	O
)	-RRB-	O
,	,	O
despite	IN	O
their	PRP$	O
elevated	JJ	O
transferrin	NN	O
saturation	NN	O
and	CC	O
hepatic	JJ	O
iron	NN	O
content	NN	O
.	.	O

Duodenal	JJ	O
expression	NN	O
of	IN	O
DMT1	NN	O
(	-LRB-	O
non-IRE	JJ	O
)	-RRB-	O
was	VBD	O
not	RB	O
increased	VBN	O
,	,	O
nor	CC	O
was	VBD	O
hepatic	JJ	O
expression	NN	O
of	IN	O
DMT1	NN	O
increased	VBD	O
.	.	O

These	DT	O
data	NNS	O
support	VBP	O
the	DT	O
model	NN	O
for	IN	O
HH	NN	O
in	IN	O
which	WDT	O
HFE	NN	O
mutations	NNS	O
lead	VBP	O
to	TO	O
inappropriately	RB	O
low	JJ	O
crypt	NN	O
cell	NN	O
iron	NN	O
,	,	O
with	IN	O
resultant	JJ	O
stabilization	NN	O
of	IN	O
DMT1	NN	O
(	-LRB-	O
IRE	NN	O
)	-RRB-	O
mRNA	NN	O
,	,	O
up-regulation	NN	O
of	IN	O
DMT1	NN	O
,	,	O
and	CC	O
increased	VBD	O
absorption	NN	O
of	IN	O
dietary	JJ	O
iron	NN	O
.	.	O

Yeast	NN	O
artificial	JJ	O
chromosomes	NNS	O
for	IN	O
the	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
familial	JJ	B-Disease
polyposis	NN	I-Disease
APC	NN	I-Disease
gene	NN	O
region	NN	O
.	.	O

Two	CD	O
yeast	NN	O
artificial	JJ	O
chromosomes	NNS	O
(	-LRB-	O
YACs	NNS	O
)	-RRB-	O
spanning	VBG	O
a	DT	O
total	JJ	O
distance	NN	O
of	IN	O
1	CD	O
.	.	O

1	CD	O
megabase	NN	O
pairs	NNS	O
of	IN	O
DNA	NN	O
around	IN	O
the	DT	O
MCC	NN	O
(	-LRB-	O
for	IN	O
mutated	VBN	O
in	IN	O
colorectal	JJ	B-Disease
carcinoma	NN	I-Disease
)	-RRB-	O
and	CC	O
APC	NN	B-Disease
(	-LRB-	O
for	IN	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
)	-RRB-	O
genes	NNS	O
at	IN	O
5q21	NN	O
have	VBP	O
been	VBN	O
isolated	VBN	O
and	CC	O
characterized	VBN	O
.	.	O

Starting	VBG	O
from	IN	O
the	DT	O
MCC	NN	O
gene	NN	O
,	,	O
a	DT	O
strategy	NN	O
was	VBD	O
undertaken	VBN	O
to	TO	O
identify	VB	O
constitutional	JJ	O
submicroscopic	JJ	O
deletions	NNS	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
patients	NNS	O
that	WDT	O
might	MD	O
considerably	RB	O
narrow	VB	O
down	RP	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

To	TO	O
this	DT	O
end	NN	O
,	,	O
YACs	NNS	O
identified	VBN	O
by	IN	O
the	DT	O
MCC	NN	O
gene	NN	O
were	VBD	O
screened	VBN	O
across	IN	O
a	DT	O
chromosome	NN	O
5-specific	JJ	O
cosmid	NN	O
library	NN	O
to	TO	O
provide	VB	O
a	DT	O
source	NN	O
of	IN	O
DNA	NN	O
probes	NNS	O
for	IN	O
genomic	JJ	O
scanning	NN	O
.	.	O

The	DT	O
cosmids	NNS	O
isolated	VBN	O
from	IN	O
these	DT	O
experiments	NNS	O
were	VBD	O
used	VBN	O
to	TO	O
screen	VB	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
containing	VBG	O
chromosome	NN	O
5	CD	O
segregated	VBN	O
from	IN	O
patients	NNS	O
suspected	VBN	O
to	TO	O
carry	VB	O
putative	JJ	O
interstitial	JJ	O
deletions	NNS	O
.	.	O

This	DT	O
screening	JJ	O
approach	NN	O
led	VBD	O
to	TO	O
the	DT	O
confirmation	NN	O
of	IN	O
a	DT	O
small	JJ	O
heterozygous	JJ	O
deletion	NN	O
in	IN	O
a	DT	O
polyposis	NN	B-Disease
patient	NN	O
that	WDT	O
overlaps	VBZ	O
one	CD	O
of	IN	O
the	DT	O
two	CD	O
isolated	VBN	O
YACs	NNS	O
.	.	O

This	DT	O
YAC	NN	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
contain	VB	O
the	DT	O
entire	JJ	O
APC	NN	B-Disease
gene	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	O
significant	JJ	O
portion	NN	O
of	IN	O
DNA	NN	O
flanking	NN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
should	MD	O
therefore	RB	O
prove	VB	O
a	DT	O
valuable	JJ	O
resource	NN	O
for	IN	O
functional	JJ	O
studies	NNS	O
by	IN	O
transfer	NN	O
to	TO	O
colorectal	JJ	B-Disease
tumor-derived	JJ	O
cell	NN	O
lines	NNS	O
.	.	O

Analbuminemia	NNP	B-Disease
in	IN	O
an	DT	O
American	JJ	O
Indian	JJ	O
girl	NN	O
.	.	O

Analbuminemia	NNP	B-Disease
was	VBD	O
fortuitously	RB	O
detected	VBN	O
in	IN	O
a	DT	O
nonedematous	JJ	O
12-year-old	JJ	O
American	JJ	O
Indian	JJ	O
girl	NN	O
with	IN	O
atopic	JJ	B-Disease
dermatitis	NN	I-Disease
,	,	O
mild	JJ	O
bronchial	JJ	B-Disease
asthma	NN	I-Disease
,	,	O
a	DT	O
mild	JJ	O
seizure	NN	B-Disease
disorder	NN	I-Disease
,	,	O
and	CC	O
hyperlipoproteinemia	NN	B-Disease
with	IN	O
a	DT	O
corneal	NN	B-Disease
arcus	NN	I-Disease
.	.	O

Immunologic	JJ	O
methods	NNS	O
revealed	VBD	O
trace	NN	O
amounts	NNS	O
(	-LRB-	O
17	CD	O
mg/100	NN	O
ml	NN	O
)	-RRB-	O
of	IN	O
apparently	RB	O
normal	JJ	O
serum	NN	O
albumin	NN	O
.	.	O

The	DT	O
patients	NNS	O
parents	NNS	O
were	VBD	O
remotely	RB	O
related	JJ	O
.	.	O

The	DT	O
pedigree	NN	O
and	CC	O
clinical	JJ	O
findings	NNS	O
were	VBD	O
compatible	JJ	O
with	IN	O
autosomal	JJ	O
recessive	JJ	O
transmission	NN	O
of	IN	O
analbuminemia	NN	B-Disease
.	.	O

Heterozygotes	NNS	O
had	VBD	O
subnormal	JJ	O
levels	NNS	O
of	IN	O
serum	NN	O
albumin	NN	O
.	.	O

The	DT	O
Gc-locus	NN	O
is	VBZ	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
structural	JJ	O
albumin	NN	O
locus	NN	O
.	.	O

Gc-protein	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
together	RB	O
with	IN	O
normal	JJ	O
chromosomal	JJ	O
banding	NN	O
studies	NNS	O
make	VBP	O
it	PRP	O
unlikely	JJ	O
that	IN	O
a	DT	O
chromosomal	JJ	O
deletion	NN	O
caused	VBD	O
analbuminemia	NN	B-Disease
.	.	O

Gc-types	NNS	O
in	IN	O
the	DT	O
family	NN	O
were	VBD	O
compatible	JJ	O
with	IN	O
,	,	O
but	CC	O
did	VBD	O
not	RB	O
prove	VB	O
,	,	O
linkage	NN	O
of	IN	O
analbuminemia	NN	B-Disease
to	TO	O
the	DT	O
Gc-locus	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
a	DT	O
"	''	O
thalassemia	NN	B-Disease
"	''	O
-	:	O
like	IN	O
mutation	NN	O
for	IN	O
this	DT	O
disorder	NN	O
.	.	O

.	.	O

Treatment	NN	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
with	IN	O
growth	NN	O
hormone	NN	O
inhibitors	NNS	O
.	.	O

A	DT	O
controlled	JJ	O
,	,	O
double-blind	JJ	O
therapeutic	JJ	O
trial	NN	O
with	IN	O
the	DT	O
drug	NN	O
mazindol	NN	O
,	,	O
a	DT	O
growth	NN	O
hormone	NN	O
inhibitor	NN	O
,	,	O
was	VBD	O
performed	VBN	O
in	IN	O
a	DT	O
pair	NN	O
of	IN	O
71/2	CD	O
year-old	JJ	O
monozygotic	JJ	O
twins	NNS	O
,	,	O
with	IN	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
rationale	NN	O
for	IN	O
this	DT	O
trial	NN	O
was	VBD	O
based	VBN	O
on	IN	O
a	DT	O
patient	NN	O
(	-LRB-	O
reported	VBN	O
previously	RB	O
)	-RRB-	O
affected	VBD	O
simultaneously	RB	O
with	IN	O
DMD	NN	B-Disease
and	CC	O
growth	NN	B-Disease
hormone	NN	I-Disease
(	-LRB-	I-Disease
GH	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
,	,	O
who	WP	O
is	VBZ	O
showing	VBG	O
a	DT	O
benign	JJ	O
course	NN	O
of	IN	O
the	DT	O
dystrophic	JJ	B-Disease
process	NN	I-Disease
and	CC	O
is	VBZ	O
still	RB	O
walking	VBG	O
at	IN	O
18	CD	O
years	NNS	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
twins	NNS	O
received	VBD	O
2	CD	O
mg	NN	O
of	IN	O
mazindol	NN	O
daily	RB	O
,	,	O
while	IN	O
the	DT	O
other	JJ	O
received	VBD	O
a	DT	O
placebo	NN	O
.	.	O

The	DT	O
assessment	NN	O
,	,	O
repeated	VBN	O
every	DT	O
2	CD	O
months	NNS	O
,	,	O
included	VBD	O
weight	NN	O
and	CC	O
height	NN	O
measurements	NNS	O
,	,	O
functional	JJ	O
and	CC	O
motor	NN	O
ability	NN	O
tests	NNS	O
,	,	O
ergometry	NN	O
and	CC	O
determinations	NNS	O
of	IN	O
serum	NN	O
enzymes	NNS	O
and	CC	O
GH	NN	O
levels	NNS	O
.	.	O

After	IN	O
one	CD	O
year	NN	O
of	IN	O
trial	NN	O
the	DT	O
code	NN	O
was	VBD	O
broken	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
seen	VBN	O
that	IN	O
the	DT	O
twin	NN	O
under	IN	O
placebo	NN	O
treatment	NN	O
was	VBD	O
strikingly	RB	O
worse	JJR	O
than	IN	O
his	PRP$	O
brother	NN	O
,	,	O
the	DT	O
progression	NN	O
of	IN	O
whose	WP$	O
condition	NN	O
was	VBD	O
practically	RB	O
arrested	VBN	O
.	.	O

These	DT	O
results	NNS	O
strongly	RB	O
suggest	VBP	O
that	IN	O
treatment	NN	O
with	IN	O
a	DT	O
GH	NN	O
inhibitor	NN	O
is	VBZ	O
beneficial	JJ	O
for	IN	O
DMD	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
WASP	NNP	O
mutations	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
isolated	VBN	B-Disease
thrombocytopenia	NN	I-Disease
reveals	VBZ	O
allelic	JJ	O
heterogeneity	NN	O
at	IN	O
the	DT	O
WAS	NNP	B-Disease
locus	NN	O
.	.	O

Mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
the	DT	O
recently	RB	O
isolated	VBN	O
WASP	NNP	O
protein	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
identified	VBN	O
as	IN	O
the	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
responsible	JJ	O
for	IN	O
the	DT	O
X-linked	JJ	B-Disease
Wiskott-Aldrich	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
primary	JJ	O
immunodeficiency	NN	B-Disease
disease	NN	I-Disease
associated	VBN	O
with	IN	O
extensive	JJ	O
phenotypic	JJ	O
variability	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
range	NN	O
of	IN	O
WASP	NNP	O
mutations	NNS	O
responsible	JJ	O
for	IN	O
WAS	NNP	B-Disease
,	,	O
we	PRP	O
used	VBD	O
PCR-SSCP	NN	O
analysis	NN	O
to	TO	O
screen	NN	O
for	IN	O
WASP	NNP	O
gene	NN	O
mutation	NN	O
in	IN	O
19	CD	O
unrelated	JJ	O
boys	NNS	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
classical	JJ	O
or	CC	O
attenuated	VBD	O
WAS	NNP	B-Disease
or	CC	O
isolated	VBN	B-Disease
thrombocytopenia	NN	I-Disease
.	.	O

All	DT	O
19	CD	O
patients	NNS	O
had	VBD	O
WASP	NNP	O
mutations	NNS	O
,	,	O
each	DT	O
of	IN	O
which	WDT	O
localized	JJ	O
to	TO	O
the	DT	O
initial	JJ	O
three	CD	O
or	CC	O
terminal	JJ	O
three	CD	O
exons	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
and	CC	O
the	DT	O
majority	NN	O
of	IN	O
which	WDT	O
were	VBD	O
unique	JJ	O
in	IN	O
each	DT	O
case	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
missense	NN	O
mutation	NN	O
which	WDT	O
results	VBZ	O
in	IN	O
substitution	NN	O
of	IN	O
the	DT	O
arginine	NN	O
at	IN	O
WAS	NNP	B-Disease
codon	NN	O
86	CD	O
was	VBD	O
identified	VBN	O
in	IN	O
three	CD	O
boys	NNS	O
with	IN	O
severe	JJ	O
WAS	NNP	B-Disease
as	RB	O
well	RB	O
as	IN	O
in	IN	O
one	CD	O
boy	NN	O
presenting	VBG	O
with	IN	O
thrombocytopenia	NN	B-Disease
alone	RB	O
.	.	O

While	IN	O
the	DT	O
three	CD	O
mutations	NNS	O
found	VBN	O
in	IN	O
the	DT	O
isolated	VBN	B-Disease
thrombocytopenia	NN	I-Disease
patients	NNS	O
leave	VBP	O
the	DT	O
reading	NN	O
frame	NN	O
intact	JJ	O
,	,	O
about	IN	O
one-half	NN	O
of	IN	O
the	DT	O
gene	NN	O
alterations	NNS	O
detected	VBN	O
in	IN	O
both	CC	O
severe	JJ	O
and	CC	O
attenuated	VBD	O
WAS	NNP	B-Disease
patients	NNS	O
result	VBP	O
in	IN	O
frameshifted	JJ	O
transcript	NN	O
and	CC	O
premature	JJ	O
translation	NN	O
termination	NN	O
.	.	O

These	DT	O
findings	NNS	O
therefore	RB	O
confirm	VBP	O
the	DT	O
association	NN	O
of	IN	O
WAS	NNS	B-Disease
with	IN	O
WASP	NNP	O
mutation	NN	O
and	CC	O
identify	VB	O
WASP	NNP	O
mutation	NN	O
as	IN	O
a	DT	O
cause	NN	O
for	IN	O
isolated	VBN	O
congenital	JJ	B-Disease
thrombocytopenia	NN	I-Disease
in	IN	O
males	NNS	O
.	.	O

While	IN	O
the	DT	O
WASP	NNP	O
gene	NN	O
defects	VBZ	O
responsible	JJ	O
for	IN	O
isolated	VBN	B-Disease
thrombocytopenia	NN	I-Disease
and	CC	O
other	JJ	O
mild	JJ	O
presentations	NNS	O
of	IN	O
WAS	NNP	B-Disease
do	VBP	O
not	RB	O
appear	VB	O
distinct	JJ	O
from	IN	O
those	DT	O
resulting	VBG	O
in	IN	O
severe	JJ	O
WAS	NNP	B-Disease
,	,	O
these	DT	O
data	NNS	O
indicate	VBP	O
that	IN	O
analysis	NN	O
of	IN	O
WASP	NNP	O
gene	NN	O
mutation	NN	O
provides	VBZ	O
a	DT	O
valuable	JJ	O
tool	NN	O
for	IN	O
distinguishing	VBG	O
the	DT	O
spectrum	NN	O
of	IN	O
WAS	NN	B-Disease
patients	NNS	O
and	CC	O
the	DT	O
subset	NN	O
of	IN	O
males	NNS	O
with	IN	O
isolated	VBN	B-Disease
thrombocytopenia	NN	I-Disease
who	WP	O
represent	VBP	O
mild	JJ	O
cases	NNS	O
of	IN	O
WAS	NNP	B-Disease
.	.	O

.	.	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
without	IN	O
CAG	NN	O
expansion	NN	O
:	:	O
phenocopies	NNS	O
or	CC	O
errors	NNS	O
in	IN	O
assignment	NN	O
?	.	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
an	DT	O
expanded	VBN	O
CAG	NN	O
repeat	NN	O
within	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
on	IN	O
4p16	NN	O
.	.	O

3	CD	O
(	-LRB-	O
IT15	NN	O
)	-RRB-	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
30	CD	O
of	IN	O
1	CD	O
,	,	O
022	CD	O
affected	VBD	O
persons	NNS	O
(	-LRB-	O
2	CD	O
.	.	O

9	CD	O
%	NN	O
of	IN	O
our	PRP$	O
cohort	NN	O
)	-RRB-	O
did	VBD	O
not	RB	O
have	VB	O
an	DT	O
expanded	VBN	O
CAG	NN	O
in	IN	O
the	DT	O
disease	NN	O
range	NN	O
.	.	O

The	DT	O
reasons	NNS	O
for	IN	O
not	RB	O
observing	VBG	O
expansion	NN	O
in	IN	O
affected	JJ	O
individuals	NNS	O
are	VBP	O
important	JJ	O
for	IN	O
determining	VBG	O
the	DT	O
sensitivity	NN	O
of	IN	O
using	VBG	O
repeat	NN	O
length	NN	O
both	CC	O
for	IN	O
diagnosis	NN	O
of	IN	O
affected	JJ	O
patients	NNS	O
and	CC	O
for	IN	O
predictive	JJ	O
testing	NN	O
programs	NNS	O
and	CC	O
may	MD	O
have	VB	O
biological	JJ	O
relevance	NN	O
for	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
underlying	VBG	O
HD	NN	B-Disease
.	.	O

Here	RB	O
we	PRP	O
show	VBP	O
that	IN	O
the	DT	O
majority	NN	O
(	-LRB-	O
18	CD	O
)	-RRB-	O
of	IN	O
the	DT	O
individuals	NNS	O
with	IN	O
normal	JJ	O
sized	VBN	O
alleles	NNS	O
represent	VBP	O
misdiagnosis	NN	O
,	,	O
sample	NN	O
mix-up	NN	O
,	,	O
or	CC	O
clerical	JJ	O
error	NN	O
.	.	O

The	DT	O
remaining	VBG	O
12	CD	O
patients	NNS	O
represent	VBP	O
possible	JJ	O
phenocopies	NNS	O
for	IN	O
HD	NN	B-Disease
.	.	O

In	IN	O
at	IN	O
least	JJS	O
four	CD	O
cases	NNS	O
,	,	O
family	NN	O
studies	NNS	O
of	IN	O
these	DT	O
phenocopies	NNS	O
excluded	VBN	O
4p16	NN	O
.	.	O

3	CD	O
as	IN	O
the	DT	O
region	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
phenotype	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
that	WDT	O
are	VBP	O
other	JJ	O
than	IN	O
CAG	NN	O
expansion	NN	O
have	VBP	O
not	RB	O
been	VBN	O
excluded	VBN	O
for	IN	O
the	DT	O
remaining	VBG	O
eight	CD	O
cases	NNS	O
;	:	O
however	RB	O
,	,	O
in	IN	O
as	RB	O
many	JJ	O
as	IN	O
seven	CD	O
of	IN	O
these	DT	O
persons	NNS	O
,	,	O
retrospective	JJ	O
review	NN	O
of	IN	O
these	DT	O
patients	NNS	O
clinical	JJ	O
features	NNS	O
identified	VBD	O
characteristics	NNS	O
not	RB	O
typical	JJ	O
for	IN	O
HD	NN	B-Disease
.	.	O

This	DT	O
study	NN	O
shows	VBZ	O
that	IN	O
on	IN	O
rare	JJ	O
occasions	NNS	O
mutations	NNS	O
in	IN	O
other	JJ	O
,	,	O
as-yet-undefined	JJ	O
genes	NNS	O
can	MD	O
present	VB	O
with	IN	O
a	DT	O
clinical	JJ	O
phenotype	NN	O
very	RB	O
similar	JJ	O
to	TO	O
that	DT	O
of	IN	O
HD	NN	B-Disease

Allelic	JJ	O
exclusion	NN	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
in	IN	O
platelets	NNS	O
and	CC	O
T	NN	O
lymphocytes	NNS	O
from	IN	O
a	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
carrier	NN	O
.	.	O

An	DT	O
obligate	JJ	O
carrier	NN	O
of	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
who	WP	O
was	VBD	O
also	RB	O
heterozygous	JJ	O
for	IN	O
the	DT	O
A	NN	O
and	CC	O
B	NN	O
types	NNS	O
of	IN	O
X-linked	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
was	VBD	O
found	VBN	O
.	.	O

With	IN	O
her	PRP$	O
it	PRP	O
became	VBD	O
possible	JJ	O
to	TO	O
determine	VB	O
whether	IN	O
allelic	JJ	O
exclusion	NN	O
occurs	VBZ	O
in	IN	O
particular	JJ	O
cell-types	NNS	O
of	IN	O
the	DT	O
WAS	NNP	B-Disease
carrier	NN	O
.	.	O

If	IN	O
so	RB	O
,	,	O
the	DT	O
remaining	VBG	O
cells	NNS	O
of	IN	O
a	DT	O
particular	JJ	O
cell-type	NN	O
would	MD	O
express	VB	O
only	RB	O
the	DT	O
normal	JJ	O
X	NN	O
chromosome	NN	O
and	CC	O
only	RB	O
one	CD	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
isoenzyme	NN	O
would	MD	O
be	VB	O
demonstrable	JJ	O
.	.	O

This	DT	O
carrier	NN	O
had	VBD	O
only	RB	O
the	DT	O
B	NN	O
isoenzyme	NN	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
in	IN	O
platelets	NNS	O
and	CC	O
thymus-derived	JJ	O
T	NN	O
lymphocytes	NNS	O
,	,	O
although	IN	O
both	DT	O
isoenzymes	NNS	O
A	DT	O
and	CC	O
B	NN	O
were	VBD	O
present	JJ	O
in	IN	O
erythrocytes	NNS	O
and	CC	O
neutrophils	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
selection	NN	O
against	IN	O
the	DT	O
WAS	NNP	B-Disease
gene	NN	O
occurs	VBZ	O
in	IN	O
platelets	NNS	O
and	CC	O
thymus-derived	JJ	O
T	NN	O
lymphocytes	NNS	O
and	CC	O
that	IN	O
the	DT	O
defects	NNS	O
associated	VBN	O
with	IN	O
WAS	NN	B-Disease
expressed	VBN	O
in	IN	O
these	DT	O
cell-types	NNS	O
may	MD	O
be	VB	O
implicated	VBN	O
in	IN	O
the	DT	O
genesis	NN	O
of	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

A	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
sodium/iodide	NN	O
symporter	NN	O
gene	NN	O
in	IN	O
the	DT	O
largest	JJS	O
family	NN	O
with	IN	O
iodide	NN	B-Disease
transport	NN	I-Disease
defect	NN	I-Disease
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
nine	CD	O
children	NNS	O
with	IN	O
an	DT	O
autosomally	RB	O
recessive	JJ	O
form	NN	O
of	IN	O
congenital	JJ	B-Disease
hypothyroidism	NN	I-Disease
due	JJ	O
to	TO	O
an	DT	O
iodide	NN	B-Disease
transport	NN	I-Disease
defect	NN	I-Disease
in	IN	O
a	DT	O
large	JJ	O
Hutterite	NNP	O
family	NN	O
with	IN	O
extensive	JJ	O
consanguinity	NN	O
living	NN	O
in	IN	O
central	JJ	O
Canada	NNP	O
.	.	O

Since	IN	O
the	DT	O
original	JJ	O
report	NN	O
,	,	O
we	PRP	O
have	VBP	O
diagnosed	VBN	O
congenital	JJ	B-Disease
hypothyroidism	NN	I-Disease
by	IN	O
newborn	JJ	O
TSH	NN	O
screening	NN	O
in	IN	O
9	CD	O
additional	JJ	O
children	NNS	O
from	IN	O
the	DT	O
family	NN	O
.	.	O

We	PRP	O
performed	VBD	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
PCR	NN	O
products	NNS	O
of	IN	O
each	DT	O
NIS	NNP	O
(	-LRB-	O
sodium/iodide	JJ	O
symporter	NN	O
)	-RRB-	O
gene	NN	O
exon	NN	O
with	IN	O
flanking	JJ	O
introns	NNS	O
amplified	VBN	O
from	IN	O
genomic	JJ	O
DNA	NN	O
extracted	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
cells	NNS	O
of	IN	O
the	DT	O
patients	NNS	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
novel	JJ	O
NIS	NN	O
gene	NN	O
mutation	NN	O
,	,	O
G395R	NN	O
(	-LRB-	O
Gly395	NN	O
--	:	O
>	JJR	O
Arg	NN	O
;	:	O
GGA	NNP	O
--	:	O
>	JJR	O
AGA	NN	O
)	-RRB-	O
,	,	O
in	IN	O
10	CD	O
patients	NNS	O
examined	VBN	O
in	IN	O
the	DT	O
present	JJ	O
study	NN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
parents	NNS	O
tested	VBN	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
patients	NNS	O
were	VBD	O
homozygous	JJ	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
located	JJ	O
in	IN	O
the	DT	O
10th	JJ	O
transmembrane	NN	O
helix	NN	O
.	.	O

Expression	NN	O
experiments	NNS	O
by	IN	O
transfection	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
NIS	NNP	O
complimentary	JJ	O
DNA	NN	O
into	IN	O
COS-7	NN	O
cells	NNS	O
showed	VBD	O
no	DT	O
perchlorate-sensitive	JJ	O
iodide	NN	O
uptake	NN	O
,	,	O
confirming	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
is	VBZ	O
the	DT	O
direct	JJ	O
cause	NN	O
of	IN	O
the	DT	O
iodide	NN	B-Disease
transport	NN	I-Disease
defect	NN	I-Disease
in	IN	O
these	DT	O
patients	NNS	O
.	.	O

A	DT	O
patient	NN	O
who	WP	O
showed	VBD	O
an	DT	O
intermediate	JJ	O
saliva/serum	NN	O
technetium	NN	O
ratio	NN	O
(	-LRB-	O
14	CD	O
.	.	O

0	CD	O
;	:	O
normal	JJ	O
,	,	O
>	JJR	O
or	CC	O
=	JJ	O
20	CD	O
)	-RRB-	O
and	CC	O
was	VBD	O
considered	VBN	O
to	TO	O
have	VB	O
a	DT	O
partial	JJ	O
or	CC	O
less	RBR	O
severe	JJ	O
defect	NN	O
in	IN	O
the	DT	O
previous	JJ	O
report	NN	O
(	-LRB-	O
IX-24	NN	O
)	-RRB-	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	O
NIS	NN	O
gene	NN	O
mutation	NN	O
.	.	O

It	PRP	O
is	VBZ	O
now	RB	O
possible	JJ	O
to	TO	O
use	VB	O
gene	NN	O
diagnostics	NNS	O
of	IN	O
this	DT	O
unique	JJ	O
NIS	NN	O
mutation	NN	O
to	TO	O
identify	VB	O
patients	NNS	O
with	IN	O
congenital	JJ	B-Disease
hypothyroidism	NN	I-Disease
due	JJ	O
to	TO	O
an	DT	O
iodide	NN	B-Disease
transport	NN	I-Disease
defect	NN	I-Disease
in	IN	O
this	DT	O
family	NN	O
and	CC	O
to	TO	O
determine	VB	O
the	DT	O
carrier	NN	O
state	NN	O
of	IN	O
potential	JJ	O
parents	NNS	O
for	IN	O
genetic	JJ	O
counseling	NN	O
and	CC	O
arranging	VBG	O
rapid	JJ	O
and	CC	O
early	JJ	O
diagnosis	NN	O
of	IN	O
their	PRP$	O
infants	NNS	O
.	.	O

Determination	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
responsible	JJ	O
for	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
in	IN	O
17	CD	O
subjects	NNS	O
.	.	O

Hypoxanthine	NNP	O
--	:	O
guanine	JJ	O
phosphoribosyltransferase	NN	O
(	-LRB-	O
HPRT	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
purine	NN	O
salvage	NN	O
enzyme	NN	O
that	WDT	O
catalyzes	VBZ	O
the	DT	O
conversion	NN	O
of	IN	O
hypoxanthine	NN	O
to	TO	O
inosine	VB	O
monophosphate	NN	O
and	CC	O
guanine	NN	O
to	TO	O
guanosine	NN	O
monophosphate	NN	O
.	.	O

Previous	JJ	O
studies	NNS	O
of	IN	O
mutant	JJ	O
HPRT	NN	O
proteins	NNS	O
analyzed	VBN	O
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
have	VBP	O
shown	VBN	O
a	DT	O
significant	JJ	O
heterogeneity	NN	O
.	.	O

This	DT	O
investigation	NN	O
further	RB	O
verifies	VBZ	O
this	DT	O
heterogeneity	NN	O
and	CC	O
identifies	VBZ	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
and	CC	O
point	NN	O
mutations	NNS	O
.	.	O

The	DT	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction-amplified	JJ	O
product	NN	O
of	IN	O
reverse-transcribed	JJ	O
HPRT	NN	O
mRNA	NN	O
enabled	VBD	O
the	DT	O
rapid	JJ	O
identification	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
17	CD	O
previously	RB	O
uncharacterized	JJ	O
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

A	DT	O
new	JJ	O
CT	NN	O
pattern	NN	O
in	IN	O
adrenoleukodystrophy	NN	B-Disease
.	.	O

A	DT	O
new	JJ	O
CT	NN	O
pattern	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
2	CD	O
patients	NNS	O
with	IN	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
.	.	O

This	DT	O
pattern	NN	O
,	,	O
which	WDT	O
the	DT	O
authors	NNS	O
call	VBP	O
Type	NN	O
II	CD	O
,	,	O
is	VBZ	O
characterized	VBN	O
by	IN	O
the	DT	O
absence	NN	O
of	IN	O
posterior	JJ	O
periventricular	JJ	O
areas	NNS	O
of	IN	O
decreased	VBN	O
attenuation	NN	O
around	IN	O
the	DT	O
trigone	NN	O
on	IN	O
non-contrast	JJ	O
scans	NNS	O
after	IN	O
contrast	NN	O
infusion	NN	O
,	,	O
however	RB	O
,	,	O
there	EX	O
is	VBZ	O
striking	JJ	O
enhancement	NN	O
of	IN	O
various	JJ	O
white-matter	JJ	O
structures	NNS	O
(	-LRB-	O
tracts	NNS	O
or	CC	O
fiber	NN	O
systems	NNS	O
)	-RRB-	O
such	JJ	O
as	IN	O
the	DT	O
internal	JJ	O
capsules	NNS	O
,	,	O
corpus	NN	O
callosum	NN	O
,	,	O
corona	NN	O
radiata	NN	O
,	,	O
forceps	NNS	O
major	JJ	O
,	,	O
and	CC	O
cerebral	JJ	O
peduncles	NNS	O
.	.	O

This	DT	O
is	VBZ	O
different	JJ	O
from	IN	O
numerous	JJ	O
previous	JJ	O
descriptions	NNS	O
of	IN	O
the	DT	O
CT	NN	O
pattern	NN	O
in	IN	O
ALD	NNP	B-Disease
.	.	O

Type	NN	B-Disease
II	CD	I-Disease
ALD	NN	I-Disease
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
have	VB	O
been	VBN	O
seen	VBN	O
in	IN	O
any	DT	O
other	JJ	O
leukoencephalopathy	NN	B-Disease
and	CC	O
is	VBZ	O
probably	RB	O
specific	JJ	O
for	IN	O
a	DT	O
phenotypic	JJ	O
variant	NN	O
or	CC	O
an	DT	O
evolving	VBG	O
stage	NN	O
of	IN	O
ALD	NN	B-Disease
.	.	O

.	.	O

Genetic	JJ	O
analysis	NN	O
,	,	O
phenotypic	JJ	O
diagnosis	NN	O
,	,	O
and	CC	O
risk	NN	O
of	IN	O
venous	JJ	B-Disease
thrombosis	NN	I-Disease
in	IN	O
families	NNS	O
with	IN	O
inherited	VBN	O
deficiencies	NNS	B-Disease
of	IN	I-Disease
protein	NN	I-Disease
S.	NNP	O
Protein	NN	B-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
recognized	VBN	O
risk	NN	O
factor	NN	O
for	IN	O
venous	JJ	B-Disease
thrombosis	NN	I-Disease
.	.	O

Of	IN	O
all	PDT	O
the	DT	O
inherited	VBN	O
thrombophilic	JJ	B-Disease
conditions	NNS	I-Disease
,	,	O
it	PRP	O
remains	VBZ	O
the	DT	O
most	RBS	O
difficult	JJ	O
to	TO	O
diagnose	VB	O
because	IN	O
of	IN	O
phenotypic	JJ	O
variability	NN	O
,	,	O
which	WDT	O
can	MD	O
lead	VB	O
to	TO	O
inconclusive	JJ	O
results	NNS	O
.	.	O

We	PRP	O
have	VBP	O
overcome	VBN	O
this	DT	O
problem	NN	O
by	IN	O
studying	VBG	O
a	DT	O
cohort	NN	O
of	IN	O
patients	NNS	O
from	IN	O
a	DT	O
single	JJ	O
center	NN	O
where	WRB	O
the	DT	O
diagnosis	NN	O
was	VBD	O
confirmed	VBN	O
at	IN	O
the	DT	O
genetic	JJ	O
level	NN	O
.	.	O

Twenty-eight	CD	O
index	NN	O
patients	NNS	O
with	IN	O
protein	NN	B-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
a	DT	O
PROS1	NN	B-Disease
gene	NN	I-Disease
defect	NN	I-Disease
were	VBD	O
studied	VBN	O
,	,	O
together	RB	O
with	IN	O
109	CD	O
first-degree	JJ	O
relatives	NNS	O
.	.	O

To	TO	O
avoid	VB	O
selection	NN	O
bias	NN	O
,	,	O
we	PRP	O
confined	VBD	O
analysis	NN	O
of	IN	O
total	JJ	O
and	CC	O
free	JJ	O
protein	NN	O
S	NN	O
levels	NNS	O
and	CC	O
thrombotic	JJ	O
risk	NN	O
to	TO	O
the	DT	O
patients	NNS	O
relatives	NNS	O
.	.	O

In	IN	O
this	DT	O
group	NN	O
of	IN	O
relatives	NNS	O
,	,	O
a	DT	O
low	JJ	O
free	JJ	O
protein	NN	O
S	NN	O
level	NN	O
was	VBD	O
the	DT	O
most	RBS	O
reliable	JJ	O
predictor	NN	O
of	IN	O
a	DT	O
PROS1	NN	B-Disease
gene	NN	I-Disease
defect	NN	I-Disease
(	-LRB-	O
sensitivity	NN	O
97	CD	O
.	.	O

7	CD	O
%	NN	O
,	,	O
specificity	NN	O
100	CD	O
%	NN	O
)	-RRB-	O
.	.	O

First-degree	JJ	O
relatives	NNS	O
with	IN	O
a	DT	O
PROS1	NN	B-Disease
gene	NN	I-Disease
defect	NN	I-Disease
had	VBD	O
a	DT	O
5	CD	O
.	.	O

0-fold	RB	O
higher	JJR	O
risk	NN	O
of	IN	O
thrombosis	NN	B-Disease
(	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
,	,	O
1	CD	O
.	.	O

5-16	NN	O
.	.	O

8	CD	O
)	-RRB-	O
than	IN	O
those	DT	O
with	IN	O
a	DT	O
normal	JJ	O
PROS1	NN	O
gene	NN	O
and	CC	O
no	DT	O
other	JJ	O
recognized	VBN	O
thrombophilic	JJ	B-Disease
defect	NN	I-Disease
.	.	O

Although	IN	O
pregnancy/puerperium	NN	O
and	CC	O
immobility/trauma	NN	O
were	VBD	O
important	JJ	O
precipitating	VBG	O
factors	NNS	O
for	IN	O
thrombosis	NN	B-Disease
,	,	O
almost	RB	O
half	NN	O
of	IN	O
the	DT	O
events	NNS	O
were	VBD	O
spontaneous	JJ	O
.	.	O

Relatives	NNS	O
with	IN	O
splice-site	NN	O
or	CC	O
major	JJ	O
structural	JJ	O
defects	NNS	B-Disease
in	IN	I-Disease
the	DT	I-Disease
PROS1	NN	I-Disease
gene	NN	I-Disease
were	VBD	O
more	RBR	O
likely	JJ	O
to	TO	O
have	VB	O
had	VBD	O
a	DT	O
thrombotic	JJ	O
event	NN	O
and	CC	O
had	VBD	O
significantly	RB	O
lower	JJR	O
total	NN	O
and	CC	O
free	JJ	O
protein	NN	O
S	NN	O
levels	NNS	O
than	IN	O
those	DT	O
relatives	NNS	O
having	VBG	O
missense	NN	O
mutations	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
persons	NNS	O
with	IN	O
PROS1	NN	B-Disease
gene	NN	I-Disease
defects	NNS	I-Disease
and	CC	O
protein	NN	B-Disease
S	NN	I-Disease
deficiency	NN	I-Disease
are	VBP	O
at	IN	O
increased	VBN	O
risk	NN	O
of	IN	O
thrombosis	NN	B-Disease
and	CC	O
that	IN	O
free	JJ	O
protein	NN	O
S	NN	O
estimation	NN	O
offers	VBZ	O
the	DT	O
most	RBS	O
reliable	JJ	O
way	NN	O
of	IN	O
diagnosing	VBG	O
the	DT	O
deficiency	NN	O
.	.	O

(	-LRB-	O
Blood	NN	O
.	.	O

2000	CD	O
;	:	O
95	CD	O
1935-1941	CD	O
)	-RRB-	O
.	.	O

Severe	JJ	O
clinical	JJ	O
expression	NN	O
in	IN	O
X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

X-linked	JJ	B-Disease
Emery-Dreifuss	JJ	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
relatively	RB	O
rare	JJ	O
benign	JJ	B-Disease
neuromuscular	JJ	I-Disease
disorder	NN	I-Disease
which	WDT	O
can	MD	O
vary	VB	O
remarkably	RB	O
in	IN	O
onset	NN	O
,	,	O
course	NN	O
and	CC	O
severity	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
a	DT	O
TCTAC	NN	O
deletion	NN	O
spanning	VBG	O
the	DT	O
nucleotides	NNS	O
631-635	CD	O
of	IN	O
the	DT	O
emerin	NN	O
gene	NN	O
caused	VBD	O
an	DT	O
unusually	RB	O
severe	JJ	O
disease	NN	O
phenotype	NN	O
including	VBG	O
loss	NN	B-Disease
of	IN	I-Disease
ambulation	NN	I-Disease
and	CC	O
severe	JJ	O
muscle	NN	B-Disease
wasting	VBG	I-Disease
in	IN	O
two	CD	O
affected	JJ	O
brothers	NNS	O
.	.	O

The	DT	O
same	JJ	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
in	IN	O
an	DT	O
unrelated	JJ	O
family	NN	O
showing	VBG	O
a	DT	O
significantly	RB	O
milder	JJ	O
phenotype	NN	O
.	.	O

The	DT	O
interfamilial	JJ	O
heterogeneity	NN	O
in	IN	O
distribution	NN	O
and	CC	O
in	IN	O
severity	NN	O
of	IN	O
the	DT	O
features	NNS	O
in	IN	O
the	DT	O
two	CD	O
families	NNS	O
point	VBP	O
to	TO	O
environmental	JJ	O
or	CC	O
genetic	JJ	O
modification	NN	O
as	IN	O
the	DT	O
cause	NN	O
of	IN	O
clinical	JJ	O
variability	NN	O
in	IN	O
Emery-Dreifuss	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

.	.	O

The	DT	O
gene	NN	O
for	IN	O
spinal	JJ	B-Disease
cerebellar	NN	I-Disease
ataxia	NN	I-Disease
3	CD	O
(	-LRB-	O
SCA3	NN	O
)	-RRB-	O
is	VBZ	O
located	JJ	O
in	IN	O
a	DT	O
region	NN	O
of	IN	O
approximately	RB	O
3	CD	O
cM	NN	O
on	IN	O
chromosome	NN	O
14q24.3-q32	NN	O
.2	NN	O
.	.	O

SCA3	NN	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
spinal	JJ	B-Disease
cerebellar	NN	I-Disease
ataxia	NN	I-Disease
3	CD	O
,	,	O
was	VBD	O
recently	RB	O
mapped	VBN	O
to	TO	O
a	DT	O
15-cM	JJ	O
interval	NN	O
between	IN	O
D14S67	NN	O
and	CC	O
D14S81	NN	O
on	IN	O
chromosome	NN	O
14q	NN	O
,	,	O
by	IN	O
linkage	NN	O
analysis	NN	O
in	IN	O
two	CD	O
families	NNS	O
of	IN	O
French	JJ	O
ancestry	NN	O
.	.	O

The	DT	O
SCA3	NN	O
candidate	NN	O
region	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
refined	VBN	O
by	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
four	CD	O
new	JJ	O
microsatellite	NN	O
markers	NNS	O
(	-LRB-	O
D14S256	NN	O
,	,	O
D14S291	NN	O
,	,	O
D14S280	NN	O
,	,	O
and	CC	O
AFM343vf1	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
same	JJ	O
two	CD	O
families	NNS	O
,	,	O
in	IN	O
which	WDT	O
19	CD	O
additional	JJ	O
individuals	NNS	O
were	VBD	O
genotyped	VBN	O
,	,	O
and	CC	O
in	IN	O
a	DT	O
third	JJ	O
French	JJ	O
family	NN	O
.	.	O

Combined	VBN	O
two-point	JJ	O
linkage	NN	O
analyses	NNS	O
show	VBP	O
that	IN	O
the	DT	O
new	JJ	O
markers	NNS	O
,	,	O
D14S280	NN	O
and	CC	O
AFM343vf1	NN	O
,	,	O
are	VBP	O
tightly	RB	O
linked	VBN	O
to	TO	O
the	DT	O
SCA3	NN	O
locus	NN	O
,	,	O
with	IN	O
maximal	JJ	O
lod	NN	O
scores	NNS	O
,	,	O
at	IN	O
recombination	NN	O
fraction	NN	O
,	,	O
(	-LRB-	O
theta	NN	O
)	-RRB-	O
=	JJ	O
.	.	O

00	CD	O
,	,	O
of	IN	O
7	CD	O
.	.	O

05	NN	O
and	CC	O
13	CD	O
.	.	O

70	CD	O
,	,	O
respectively	RB	O
.	.	O

Combined	VBN	O
multipoint	JJ	O
and	CC	O
recombinant	JJ	O
haplotype	NN	O
analyses	NNS	O
localize	VBP	O
the	DT	O
SCA3	NN	O
locus	NN	O
to	TO	O
a	DT	O
3-cM	JJ	O
interval	NN	O
flanked	VBN	O
by	IN	O
D14S291	NN	O
and	CC	O
D14S81	NN	O
.	.	O

The	DT	O
same	JJ	O
allele	NN	O
for	IN	O
D14S280	NN	O
segregates	VBZ	O
with	IN	O
the	DT	O
disease	NN	O
locus	NN	O
in	IN	O
the	DT	O
three	CD	O
kindreds	NNS	O
.	.	O

This	DT	O
allele	NN	O
is	VBZ	O
frequent	JJ	O
in	IN	O
the	DT	O
French	JJ	O
population	NN	O
,	,	O
however	RB	O
,	,	O
and	CC	O
linkage	NN	O
disequilibrium	NN	O
is	VBZ	O
not	RB	O
clearly	RB	O
established	VBN	O
.	.	O

The	DT	O
SCA3	NN	O
locus	NN	O
remains	VBZ	O
within	IN	O
the	DT	O
29-cM	JJ	O
region	NN	O
on	IN	O
14q24	NN	O
.	.	O

3-q32	NN	O
.	.	O

2	CD	O
containing	VBG	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
Machado-Joseph	NNP	B-Disease
disease	NN	I-Disease
,	,	O
which	WDT	O
is	VBZ	O
clinically	RB	O
related	JJ	O
to	TO	O
the	DT	O
phenotype	NN	O
determined	VBN	O
by	IN	O
SCA3	NN	O
,	,	O
but	CC	O
it	PRP	O
can	MD	O
not	RB	O
yet	RB	O
be	VB	O
concluded	VBN	O
that	IN	O
both	CC	O
diseases	NNS	O
result	VBP	O
from	IN	O
alterations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
childhood-onset	NN	O
Tourette	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
40-year-old	JJ	O
man	NN	O
with	IN	O
childhood-onset	JJ	O
Tourette	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
TS	NN	B-Disease
)	-RRB-	O
developed	VBD	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
believe	VBP	O
this	DT	O
to	TO	O
be	VB	O
the	DT	O
first	JJ	O
reported	VBN	O
case	NN	O
of	IN	O
childhood-onset	JJ	O
TS	NN	B-Disease
with	IN	O
adult	JJ	O
onset	NN	O
HD	NN	B-Disease
.	.	O

Discovery	NNP	O
of	IN	O
other	JJ	O
cases	NNS	O
with	IN	O
both	DT	O
disorders	NNS	O
may	MD	O
provide	VB	O
clues	NNS	O
to	TO	O
the	DT	O
pathophysiology	NN	O
of	IN	O
both	CC	O
conditions	NNS	O
.	.	O

.	.	O

The	DT	O
protein	NN	O
deficient	JJ	O
in	IN	O
Lowe	NNP	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
phosphatidylinositol-4	NN	O
,5	CD	O
-	:	O
bisphosphate	NN	O
5-phosphatase	NN	O
.	.	O

Lowe	NNP	B-Disease
syndrome	NN	I-Disease
,	,	O
also	RB	O
known	VBN	O
as	IN	O
oculocerebrorenal	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
X	NN	O
chromosome-encoded	JJ	O
OCRL	NN	O
gene	NN	O
.	.	O

The	DT	O
OCRL	NN	O
protein	NN	O
is	VBZ	O
51	CD	O
%	NN	O
identical	JJ	O
to	TO	O
inositol	NN	O
polyphosphate	NN	O
5-phosphatase	NN	O
II	CD	O
(	-LRB-	O
5-phosphatase	NN	O
II	CD	O
)	-RRB-	O
from	IN	O
human	JJ	O
platelets	NNS	O
over	IN	O
a	DT	O
span	NN	O
of	IN	O
744	CD	O
aa	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
OCRL	NN	O
may	MD	O
be	VB	O
a	DT	O
similar	JJ	O
enzyme	NN	O
.	.	O

We	PRP	O
engineered	VBD	O
a	DT	O
construct	NN	O
of	IN	O
the	DT	O
OCRL	NN	O
cDNA	NN	O
that	WDT	O
encodes	VBZ	O
amino	NN	O
acids	NNS	O
homologous	JJ	O
to	TO	O
the	DT	O
platelet	NN	O
5-phosphatase	NN	O
for	IN	O
expression	NN	O
in	IN	O
baculovirus-infected	JJ	O
Sf9	NN	O
insect	NN	O
cells	NNS	O
.	.	O

This	DT	O
cDNA	NN	O
encodes	VBZ	O
aa	NN	O
264-968	CD	O
of	IN	O
the	DT	O
OCRL	NN	O
protein	NN	O
.	.	O

The	DT	O
recombinant	JJ	O
protein	NN	O
was	VBD	O
found	VBN	O
to	TO	O
catalyze	VB	O
the	DT	O
reactions	NNS	O
also	RB	O
carried	VBD	O
out	RP	O
by	IN	O
platelet	NN	O
5-phosphatase	NN	O
II	CD	O
.	.	O

Thus	RB	O
OCRL	NN	O
converts	VBZ	O
inositol	NN	O
1	CD	O
,	,	O
4	CD	O
,	,	O
5-trisphosphate	NN	O
to	TO	O
inositol	NN	O
1	CD	O
,	,	O
4-bisphosphate	NN	O
,	,	O
and	CC	O
it	PRP	O
converts	VBZ	O
inositol	NN	O
1	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
,	,	O
5-tetrakisphosphate	NN	O
to	TO	O
inositol	NN	O
1	CD	O
,	,	O
3	CD	O
,	,	O
4-trisphosphate	NN	O
.	.	O

Most	RBS	O
important	JJ	O
,	,	O
the	DT	O
enzyme	NN	O
converts	VBZ	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5-bisphosphate	NN	O
to	TO	O
phosphatidylinositol	NN	O
4-phosphate	NN	O
.	.	O

The	DT	O
relative	JJ	O
ability	NN	O
of	IN	O
OCRL	NN	O
to	TO	O
catalyze	VB	O
the	DT	O
three	CD	O
reactions	NNS	O
is	VBZ	O
different	JJ	O
from	IN	O
that	DT	O
of	IN	O
5-phosphatase	NN	O
II	CD	O
and	CC	O
from	IN	O
that	DT	O
of	IN	O
another	DT	O
5-phosphatase	NN	O
isoenzyme	NN	O
from	IN	O
platelets	NNS	O
,	,	O
5-phosphatase	NN	O
I	PRP	O
.	.	O

The	DT	O
recombinant	JJ	O
OCRL	NN	O
protein	NN	O
hydrolyzes	VBZ	O
the	DT	O
phospholipid	JJ	O
substrate	NN	O
10	CD	O
-	:	O
to	TO	O
30-fold	RB	O
better	JJR	O
than	IN	O
5-phosphatase	NN	O
II	CD	O
,	,	O
and	CC	O
5-phosphatase	NN	O
I	NN	O
does	VBZ	O
not	RB	O
cleave	VB	O
the	DT	O
lipid	NN	O
at	IN	O
all	DT	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
OCRL	NN	O
functions	NNS	O
as	IN	O
a	DT	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5-bisphosphate	JJ	O
5-phosphatase	NN	O
in	IN	O
OCRL-expressing	JJ	O
Sf9	NN	O
cells	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
OCRL	NN	O
is	VBZ	O
mainly	RB	O
a	DT	O
lipid	NN	O
phosphatase	NN	O
that	WDT	O
may	MD	O
control	VB	O
cellular	JJ	O
levels	NNS	O
of	IN	O
a	DT	O
critical	JJ	O
metabolite	NN	O
,	,	O
phosphatidylinositol	NN	O
4	CD	O
,	,	O
5-bisphosphate	NN	O
.	.	O

Deficiency	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
apparently	RB	O
causes	VBZ	O
the	DT	O
protean	JJ	O
manifestations	NNS	O
of	IN	O
Lowe	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

Microdeletions	NNS	O
at	IN	O
chromosome	NN	O
bands	NNS	O
1q32-q41	NN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
Van	NNP	B-Disease
der	NNP	I-Disease
Woude	NNP	I-Disease
syndrome	NN	I-Disease
.	.	O

Van	NNP	B-Disease
der	NNP	I-Disease
Woude	NNP	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
VWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	I-Disease
comprising	VBG	O
cleft	NN	B-Disease
lip	NN	I-Disease
and/or	CC	O
cleft	NN	B-Disease
palate	NN	I-Disease
and	CC	O
lip	NN	B-Disease
pits	NNS	I-Disease
.	.	O

We	PRP	O
reported	VBD	O
previously	RB	O
a	DT	O
family	NN	O
whose	WP$	O
underlying	JJ	O
mutation	NN	O
is	VBZ	O
a	DT	O
500-800	CD	O
kb	NN	O
deletion	NN	O
localized	VBD	O
to	TO	O
chromosome	NN	O
bands	NNS	O
1q32-q41	NN	O
[	-LRB-	O
Sander	NNP	O
et	FW	O
al.	FW	O
,	,	O
1994	CD	O
Hum	NNP	O
Mol	NNP	O
Genet	NNP	O
3	CD	O
576-578	CD	O
]	-RRB-	O
.	.	O

Along	IN	O
with	IN	O
cleft	NN	B-Disease
lip/palate	NN	I-Disease
and	CC	O
lip	NN	B-Disease
pits	NNS	I-Disease
,	,	O
affected	VBD	O
relatives	NNS	O
exhibit	VBP	O
developmental	JJ	B-Disease
delays	NNS	I-Disease
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
function	NN	O
of	IN	O
a	DT	O
gene	NN	O
nearby	RB	O
may	MD	O
also	RB	O
be	VB	O
disrupted	VBN	O
.	.	O

To	TO	O
further	RB	O
localize	VB	O
the	DT	O
VWS	NN	B-Disease
gene	NN	O
we	PRP	O
searched	VBD	O
for	IN	O
other	JJ	O
deletions	NNS	O
that	WDT	O
cause	VBP	O
VWS	NNP	B-Disease
.	.	O

An	DT	O
allele	NN	O
loss	NN	O
assay	NN	O
was	VBD	O
performed	VBN	O
using	VBG	O
a	DT	O
novel	JJ	O
highly	RB	O
polymorphic	JJ	O
marker	NN	O
,	,	O
D1S3753	NN	O
.	.	O

From	IN	O
a	DT	O
panel	NN	O
of	IN	O
37	CD	O
unrelated	JJ	O
individuals	NNS	O
,	,	O
we	PRP	O
detected	VBD	O
an	DT	O
allele	NN	O
loss	NN	O
in	IN	O
one	CD	O
family	NN	O
,	,	O
indicating	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
deletion	NN	O
.	.	O

In	IN	O
this	DT	O
family	NN	O
,	,	O
the	DT	O
phenotype	NN	O
in	IN	O
three	CD	O
generations	NNS	O
of	IN	O
affected	JJ	O
individuals	NNS	O
was	VBD	O
confined	VBN	O
to	TO	O
the	DT	O
cardinal	NN	O
signs	NNS	O
of	IN	O
VWS	NNS	B-Disease
.	.	O

Surprisingly	RB	O
,	,	O
mapping	NN	O
of	IN	O
the	DT	O
new	JJ	O
deletion	NN	O
showed	VBD	O
that	IN	O
it	PRP	O
extended	VBD	O
0	CD	O
.	.	O

2-1	CD	O
Mb	NN	O
beyond	IN	O
the	DT	O
proximal	JJ	O
breakpoint	NN	O
for	IN	O
the	DT	O
deletion	NN	O
described	VBN	O
previously	RB	O
.	.	O

No	DT	O
deletions	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
seven	CD	O
cases	NNS	O
of	IN	O
popliteal	NN	B-Disease
pterygia	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
76	CD	O
cases	NNS	O
of	IN	O
mixed	JJ	O
syndromic	JJ	B-Disease
forms	NNS	I-Disease
of	IN	I-Disease
cleft	NN	I-Disease
lip	NN	I-Disease
and	CC	I-Disease
palate	NN	I-Disease
,	,	O
and	CC	O
178	CD	O
cases	NNS	O
of	IN	O
nonsyndromic	JJ	B-Disease
cleft	NN	I-Disease
lip	NN	I-Disease
and	CC	I-Disease
palate	NN	I-Disease
.	.	O

Mucopolysaccharidosis	NNP	B-Disease
type	NN	I-Disease
IVA	NNP	I-Disease
:	:	O
common	JJ	O
double	JJ	O
deletion	NN	O
in	IN	O
the	DT	O
N-acetylgalactosamine-6-sulfatase	NN	O
gene	NN	O
(	-LRB-	O
GALNS	NN	O
)	-RRB-	O
.	.	O

Mucopolysaccharidosis	NNP	B-Disease
IVA	NNP	I-Disease
(	-LRB-	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
in	IN	I-Disease
N-acetylgalactosamine-6-sulfatase	NN	I-Disease
(	-LRB-	O
GALNS	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
found	VBD	O
two	CD	O
separate	JJ	O
deletions	NNS	O
of	IN	O
nearly	RB	O
8	CD	O
.	.	O

0	CD	O
and	CC	O
6	CD	O
.	.	O

0	CD	O
kb	NN	O
in	IN	O
the	DT	O
GALNS	NN	O
gene	NN	O
,	,	O
including	VBG	O
some	DT	O
exons	NNS	O
.	.	O

There	EX	O
are	VBP	O
Alu	NN	O
repetitive	JJ	O
elements	NNS	O
near	IN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
8	CD	O
.	.	O

0-kb	JJ	O
deletion	NN	O
,	,	O
and	CC	O
this	DT	O
deletion	NN	O
resulted	VBD	O
from	IN	O
an	DT	O
Alu-Alu	NNP	O
recombination	NN	O
.	.	O

The	DT	O
other	JJ	O
6	CD	O
.	.	O

0-kb	JJ	O
deletion	NN	O
involved	VBN	O
illegitimate	JJ	O
recombinational	JJ	O
events	NNS	O
between	IN	O
incomplete	JJ	O
short	JJ	O
direct	JJ	O
repeats	NNS	O
of	IN	O
8	CD	O
bp	NN	O
at	IN	O
deletion	NN	O
breakpoints	NNS	O
.	.	O

The	DT	O
same	JJ	O
rearrangement	NN	O
has	VBZ	O
been	VBN	O
observed	VBN	O
in	IN	O
a	DT	O
heteroallelic	JJ	O
state	NN	O
in	IN	O
four	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
documentation	NN	O
of	IN	O
a	DT	O
common	JJ	O
double	JJ	O
deletion	NN	O
a	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
a	DT	O
member	NN	O
of	IN	O
a	DT	O
gene	NN	O
cluster	NN	O
.	.	O

Segregation	NN	O
analysis	NN	O
of	IN	O
a	DT	O
marker	NN	O
localised	JJ	O
Xp21.2-Xp21	NN	O
.3	NN	O
in	IN	O
Duchenne	NNP	B-Disease
and	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
families	NNS	O
.	.	O

A	DT	O
DNA	NN	O
marker	NN	O
C7	NN	O
,	,	O
localised	JJ	O
Xp21	NN	O
.	.	O

1-Xp21	NN	O
.	.	O

3	CD	O
,	,	O
has	VBZ	O
been	VBN	O
studied	VBN	O
in	IN	O
kindreds	NNS	O
segregating	VBG	O
for	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
and	CC	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
BMD	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
DMD	NNP	B-Disease
families	NNS	O
four	CD	O
crossovers	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
38	CD	O
informative	JJ	O
meioses	NNS	O
between	IN	O
C7	NN	O
and	CC	O
the	DT	O
DMD	NNP	B-Disease
locus	NN	O
(	-LRB-	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

12	CD	O
,	,	O
z	SYM	O
max	NN	O
=	JJ	O
+	CC	O
2	CD	O
.	.	O

72	CD	O
)	-RRB-	O
.	.	O

In	IN	O
BMD	NNP	B-Disease
families	NNS	O
no	DT	O
recombinants	NNS	O
were	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
16	CD	O
informative	JJ	O
meioses	NNS	O
studied	VBN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
in	IN	O
these	DT	O
disorders	NNS	O
being	VBG	O
in	IN	O
the	DT	O
same	JJ	O
region	NN	O
of	IN	O
Xp21	NN	O
.	.	O

Studies	NNS	O
in	IN	O
families	NNS	O
also	RB	O
segregating	VBG	O
for	IN	O
the	DT	O
DNA	NN	O
marker	NN	O
754	CD	O
support	VBP	O
the	DT	O
previously	RB	O
reported	VBN	O
physical	JJ	O
order	NN	O
of	IN	O
these	DT	O
loci	NNS	O
as	IN	O
X	NN	O
centromere-754-DMD-BMD-C7-X	NN	O
telomere	NN	O
.	.	O

A	DT	O
recombination	NN	O
fraction	NN	O
of	IN	O
0	CD	O
.	.	O

11	CD	O
(	-LRB-	O
z	SYM	O
max	NN	O
=	JJ	O
+	CC	O
5	CD	O
.	.	O

58	CD	O
)	-RRB-	O
was	VBD	O
found	VBN	O
between	IN	O
DMD-754	NN	O
by	IN	O
combining	VBG	O
our	PRP$	O
previously	RB	O
published	VBN	O
data	NNS	O
with	IN	O
the	DT	O
data	NNS	O
presented	VBN	O
here	RB	O
.	.	O

C7	NN	O
and	CC	O
754	CD	O
thus	RB	O
provide	VBP	O
good	JJ	O
bridging	VBG	O
markers	NNS	O
for	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
DMD	NNP	B-Disease
and	CC	O
BMD	NNP	B-Disease

Genetic	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
region	NN	O
in	IN	O
a	DT	O
large	JJ	O
breast/ovarian	JJ	O
family	NN	O
:	:	O
refinement	NN	O
of	IN	O
the	DT	O
minimal	JJ	O
region	NN	O
containing	VBG	O
BRCA1	NN	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
a	DT	O
single	JJ	O
multi-affected	JJ	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
pedigree	NN	O
(	-LRB-	O
BOV3	NN	O
)	-RRB-	O
and	CC	O
have	VBP	O
shown	VBN	O
consistent	JJ	O
inheritance	NN	O
of	IN	O
markers	NNS	O
on	IN	O
chromosome	NN	O
17q	NN	O
with	IN	O
the	DT	O
disease	NN	O
confirming	VBG	O
that	IN	O
this	DT	O
family	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
the	DT	O
BRCA1	NN	O
gene	NN	O
.	.	O

Analysis	NN	O
of	IN	O
17q	NN	O
haplotypes	NNS	O
shows	VBZ	O
a	DT	O
recombination	NN	O
event	NN	O
in	IN	O
a	DT	O
bilateral	JJ	O
breast	NN	B-Disease
cancer	NN	I-Disease
case	NN	O
which	WDT	O
suggests	VBZ	O
that	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
lies	VBZ	O
distal	JJ	O
to	TO	O
D17S857	NN	O
;	:	O
D17S857	NN	O
is	VBZ	O
thus	RB	O
the	DT	O
new	JJ	O
proximal	JJ	O
boundary	NN	O
for	IN	O
the	DT	O
region	NN	O
containing	VBG	O
BRCA1	NN	O
.	.	O

Combining	VBG	O
this	DT	O
information	NN	O
with	IN	O
previously	RB	O
published	VBN	O
mapping	NN	O
information	NN	O
suggests	VBZ	O
that	IN	O
BRCA1	NN	O
is	VBZ	O
contained	VBN	O
in	IN	O
a	DT	O
region	NN	O
estimated	VBN	O
at	IN	O
1-1	CD	O
.	.	O

5	CD	O
Mb	NN	O
in	IN	O
length	NN	O
.	.	O

All	DT	O
seven	CD	O
breast	NN	B-Disease
tumour/blood	NN	O
pairs	NNS	O
examined	VBN	O
from	IN	O
this	DT	O
family	NN	O
show	NN	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
in	IN	O
the	DT	O
tumours	NNS	B-Disease
.	.	O

The	DT	O
allel	JJ	O
retained	VBN	O
in	IN	O
each	DT	O
tumour	NN	B-Disease
was	VBD	O
from	IN	O
the	DT	O
disease-bearing	JJ	O
chromosome	NN	O
implicating	VBG	O
BRCA1	NN	O
as	IN	O
a	DT	O
tumour	NN	B-Disease
suppressor	NN	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
sequenced	VBN	O
the	DT	O
17	CD	O
beta-oestradiol	NN	O
dehydrogenase	NN	O
genes	NNS	O
(	-LRB-	O
EDH17B1	NN	O
and	CC	O
EDH17B2	NN	O
)	-RRB-	O
which	WDT	O
have	VBP	O
been	VBN	O
suggested	VBN	O
as	IN	O
candidate	NN	O
genes	NNS	O
for	IN	O
BRCA1	NN	O
in	IN	O
four	CD	O
members	NNS	O
of	IN	O
this	DT	O
family	NN	O
.	.	O

No	DT	O
germline	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
.	.	O

A	DT	O
point	NN	O
mutation	NN	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
Met	NNP	O
on	IN	O
the	DT	O
alpha	NN	O
(	-LRB-	O
2	CD	O
)	-RRB-	O
integrin	NN	O
leads	VBZ	O
to	TO	O
the	DT	O
formation	NN	O
of	IN	O
new	JJ	O
human	JJ	O
platelet	NN	O
alloantigen	NN	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
and	CC	O
affects	VBZ	O
collagen-induced	JJ	O
aggregation	NN	O
.	.	O

A	DT	O
new	JJ	O
platelet-specific	JJ	O
alloantigen	NN	O
,	,	O
termed	VBN	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
,	,	O
was	VBD	O
identified	VBN	O
in	IN	O
a	DT	O
severe	JJ	O
case	NN	O
of	IN	O
neonatal	JJ	B-Disease
alloimmune	JJ	I-Disease
thrombocytopenia	NN	I-Disease
.	.	O

The	DT	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
alloantigen	NN	O
is	VBZ	O
of	IN	O
low	JJ	O
frequency	NN	O
(	-LRB-	O
1/400	CD	O
)	-RRB-	O
in	IN	O
the	DT	O
German	JJ	O
population	NN	O
.	.	O

Immunochemical	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
epitopes	NNS	O
reside	VBP	O
on	IN	O
platelet	NN	O
glycoprotein	NN	O
(	-LRB-	O
GP	NN	O
)	-RRB-	O
Ia	NN	O
.	.	O

Nucleotide	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
GPIa	NN	O
cDNA	NN	O
derived	VBN	O
from	IN	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
-	:	O
positive	JJ	O
platelets	NNS	O
showed	VBD	O
C	NN	O
(	-LRB-	O
2531	CD	O
)	-RRB-	O
--	:	O
>	JJR	O
T	NN	O
(	-LRB-	O
2531	CD	O
)	-RRB-	O
point	NN	O
mutation	NN	O
,	,	O
resulting	VBG	O
in	IN	O
Thr	NNP	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
Met	NNP	O
dimorphism	NN	O
.	.	O

Analysis	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
from	IN	O
22	CD	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
-	:	O
negative	JJ	O
normal	JJ	O
individuals	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
is	VBZ	O
encoded	VBN	O
by	IN	O
ACG	NN	O
(	-LRB-	O
2532	CD	O
)	-RRB-	O
(	-LRB-	O
90	CD	O
.	.	O

9	CD	O
%	NN	O
)	-RRB-	O
or	CC	O
ACA	NN	O
(	-LRB-	O
2532	CD	O
)	-RRB-	O
(	-LRB-	O
9	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
.	.	O

To	TO	O
establish	VB	O
a	DT	O
DNA	NN	O
typing	NN	O
technique	NN	O
,	,	O
we	PRP	O
elucidated	VBD	O
the	DT	O
organization	NN	O
of	IN	O
the	DT	O
GPIa	NN	O
gene	NN	O
adjacent	JJ	O
to	TO	O
the	DT	O
polymorphic	JJ	O
bases	NNS	O
.	.	O

The	DT	O
introns	NNS	O
(	-LRB-	O
421	CD	O
bp	NN	O
and	CC	O
1	CD	O
.	.	O

2	CD	O
kb	NN	O
)	-RRB-	O
encompass	VBP	O
a	DT	O
142-bp	JJ	O
exon	NN	O
with	IN	O
the	DT	O
2	CD	O
polymorphic	JJ	O
bases	NNS	O
2531	CD	O
and	CC	O
2532	CD	O
.	.	O

Polymerase	NN	O
chain	NN	O
reaction-restriction	NN	O
fragment	NN	O
length	NN	O
polymorphism	NN	O
analysis	NN	O
on	IN	O
DNA	NN	O
derived	VBN	O
from	IN	O
100	CD	O
donors	NNS	O
using	VBG	O
the	DT	O
restriction	NN	O
enzyme	NN	O
Mae	NNP	O
III	NNP	O
showed	VBD	O
that	IN	O
the	DT	O
Met	NNP	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
form	NN	O
of	IN	O
GPIa	NN	O
is	VBZ	O
restricted	JJ	O
to	TO	O
Sit	VB	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
phenotype	NN	O
.	.	O

Analysis	NN	O
of	IN	O
stable	JJ	O
Chinese	JJ	O
hamster	NN	O
ovary	NN	O
transfectants	NNS	O
expressing	VBG	O
allele-specific	JJ	O
recombinant	JJ	O
forms	NNS	O
of	IN	O
GPIa	NN	O
showed	VBD	O
that	IN	O
anti-Sit	JJ	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
exclusively	RB	O
reacted	VBD	O
with	IN	O
the	DT	O
Glu	NNP	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Met	NNP	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
,	,	O
but	CC	O
not	RB	O
with	IN	O
the	DT	O
Glu	NNP	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
and	CC	O
the	DT	O
Lys	NNP	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
isoforms	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
anti-Br	JJ	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
(	-LRB-	O
HPA-5b	NN	O
)	-RRB-	O
only	RB	O
recognized	VBD	O
the	DT	O
Lys	NNP	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
form	NN	O
,	,	O
whereas	IN	O
anti-Br	NN	O
(	-LRB-	O
b	NN	O
)	-RRB-	O
(	-LRB-	O
HPA-5a	NN	O
)	-RRB-	O
reacted	VBD	O
with	IN	O
both	CC	O
Glu	NN	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
and	CC	O
Glu	NN	O
(	-LRB-	O
505	CD	O
)	-RRB-	O
Met	NNP	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
isoforms	NNS	O
.	.	O

These	DT	O
results	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
Met	NNP	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
is	VBZ	O
responsible	JJ	O
for	IN	O
formation	NN	O
of	IN	O
the	DT	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
alloantigenic	JJ	O
determinants	NNS	O
,	,	O
whereas	IN	O
amino	NN	O
acid	NN	O
505	CD	O
(	-LRB-	O
Lys	NNP	O
or	CC	O
Glu	NNP	O
)	-RRB-	O
specifically	RB	O
controls	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
Br	NN	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
and	CC	O
Br	NN	O
(	-LRB-	O
b	NN	O
)	-RRB-	O
epitopes	NNS	O
,	,	O
respectively	RB	O
.	.	O

Platelet	NN	O
aggregation	NN	O
responses	NNS	O
of	IN	O
Sit	NNP	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
individuals	NNS	O
were	VBD	O
diminished	VBN	O
in	IN	O
response	NN	O
to	TO	O
collagen	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
Thr	NN	O
(	-LRB-	O
799	CD	O
)	-RRB-	O
Met	NNP	O
mutation	NN	O
affects	VBZ	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
GPIa/IIa	NN	O
complex	NN	O

Estimation	NN	O
of	IN	O
the	DT	O
male	NN	O
to	TO	O
female	JJ	O
ratio	NN	O
of	IN	O
mutation	NN	O
rates	NNS	O
from	IN	O
the	DT	O
segregation	NN	O
of	IN	O
X-chromosomal	JJ	O
DNA	NN	O
haplotypes	NNS	O
in	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
families	NNS	O
.	.	O

A	DT	O
novel	JJ	O
procedure	NN	O
is	VBZ	O
presented	VBN	O
to	TO	O
estimate	VB	O
the	DT	O
ratio	NN	O
of	IN	O
male	NN	O
to	TO	O
female	JJ	O
mutation	NN	O
rates	NNS	O
for	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

X-specific	JJ	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
are	VBP	O
used	VBN	O
to	TO	O
establish	VB	O
DNA	NN	O
haplotypes	NNS	O
in	IN	O
three-generation	JJ	O
DMD	NNP	B-Disease
families	NNS	O
.	.	O

From	IN	O
the	DT	O
proportion	NN	O
of	IN	O
DMD	NN	B-Disease
patients	NNS	O
who	WP	O
have	VBP	O
inherited	VBN	O
their	PRP$	O
maternal	JJ	O
grandfathers	NNS	O
X	NN	O
chromosome	NN	O
,	,	O
the	DT	O
ratio	NN	O
of	IN	O
mutation	NN	O
rates	NNS	O
can	MD	O
be	VB	O
calculated	VBN	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
classical	JJ	O
methods	NNS	O
,	,	O
the	DT	O
proposed	VBN	O
procedure	NN	O
is	VBZ	O
not	RB	O
restricted	JJ	O
to	TO	O
sporadic	JJ	O
or	CC	O
familiar	JJ	O
cases	NNS	O
nor	CC	O
is	VBZ	O
any	DT	O
information	NN	O
on	IN	O
the	DT	O
carrier	NN	O
status	NN	O
of	IN	O
female	JJ	O
relatives	NNS	O
required	VBN	O
.	.	O

.	.	O

Genetic	JJ	O
analysis	NN	O
of	IN	O
an	DT	O
inherited	VBN	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
third	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
Brittany	NNP	O
spaniel	NNP	O
dogs	NNS	O
.	.	O

Genetically	RB	O
determined	VBN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Brittany	NNP	O
spaniel	NNP	O
dogs	VBZ	O
shares	NNS	O
a	DT	O
number	NN	O
of	IN	O
biochemical	JJ	O
and	CC	O
clinical	JJ	O
characteristics	NNS	O
with	IN	O
the	DT	O
human	JJ	O
disorder	NN	O
.	.	O

In	IN	O
humans	NNS	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
null	JJ	O
gene	NN	O
that	WDT	O
is	VBZ	O
allelic	JJ	O
to	TO	O
the	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
C3	NN	O
and	CC	O
is	VBZ	O
not	RB	O
linked	VBN	O
to	TO	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
locus	NN	O
.	.	O

The	DT	O
current	JJ	O
study	NN	O
used	VBD	O
allotype	JJ	O
analysis	NN	O
of	IN	O
canine	JJ	O
C3	NN	O
in	IN	O
order	NN	O
to	TO	O
demonstrate	VB	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
these	DT	O
dogs	NNS	O
is	VBZ	O
also	RB	O
a	DT	O
null	JJ	O
gene	NN	O
allelic	JJ	O
to	TO	O
the	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
C3	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
preliminary	JJ	O
pedigree	NN	O
analysis	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
gene	NN	O
for	IN	O
canine	JJ	O
C3	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
apparently	RB	O
not	RB	O
closely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
of	IN	O
the	DT	O
dog	NN	O
.	.	O

Thus	RB	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Brittany	NNP	O
spaniel	NNP	O
dogs	VBZ	O
not	RB	O
only	JJ	O
shares	NNS	O
biochemical	JJ	O
and	CC	O
clinical	JJ	O
features	NNS	O
with	IN	O
C3	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
humans	NNS	O
,	,	O
but	CC	O
also	RB	O
shares	VBZ	O
some	DT	O
genetic	JJ	O
characteristics	NNS	O
with	IN	O
the	DT	O
human	JJ	O
disorder	NN	O
.	.	O

.	.	O

A	DT	O
novel	JJ	O
frameshift	NN	O
mutation	NN	O
in	IN	O
the	DT	O
McLeod	NNP	B-Disease
syndrome	NN	I-Disease
gene	NN	O
in	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
XK	NN	O
gene	NN	O
(	-LRB-	O
XK	NN	O
)	-RRB-	O
in	IN	O
a	DT	O
Japanese	JJ	O
patient	NN	O
with	IN	O
McLeod	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

A	DT	O
50-year-old	JJ	O
man	NN	O
showed	VBD	O
progressive	JJ	O
muscular	JJ	B-Disease
atrophy	NN	I-Disease
,	,	O
choreic	JJ	B-Disease
movement	NN	I-Disease
,	,	O
elevated	JJ	O
level	NN	O
of	IN	O
serum	NN	O
creatinine	NN	O
kinase	NN	O
,	,	O
and	CC	O
acanthocytosis	NN	B-Disease
.	.	O

The	DT	O
expression	NN	O
level	NN	O
of	IN	O
all	PDT	O
the	DT	O
Kell	NN	O
antigens	NNS	O
in	IN	O
erythrocyte	NN	O
was	VBD	O
decreased	VBN	O
and	CC	O
molecular	JJ	O
analysis	NN	O
revealed	VBD	O
a	DT	O
single-base	NN	O
(	-LRB-	O
T	NN	O
)	-RRB-	O
deletion	NN	O
at	IN	O
the	DT	O
nucleotide	NN	O
position	NN	O
1095	CD	O
in	IN	O
XK	NN	O
.	.	O

This	DT	O
deletion	NN	O
caused	VBD	O
a	DT	O
frameshift	NN	O
in	IN	O
translation	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
at	IN	O
the	DT	O
amino	NN	O
acid	NN	O
position	NN	O
408	CD	O
.	.	O

We	PRP	O
conclude	VBP	O
this	DT	O
single-base	JJ	O
deletion	NN	O
causes	VBZ	O
defective	JJ	O
Kx	NN	O
protein	NN	O
,	,	O
which	WDT	O
is	VBZ	O
responsible	JJ	O
for	IN	O
the	DT	O
McLeod	NNP	B-Disease
phenotype	NN	O
in	IN	O
this	DT	O
patient	NN	O
.	.	O

.	.	O

Alpha-cardiac	JJ	O
actin	NN	O
is	VBZ	O
a	DT	O
novel	JJ	O
disease	NN	O
gene	NN	O
in	IN	O
familial	JJ	B-Disease
hypertrophic	JJ	I-Disease
cardiomyopathy	NN	I-Disease
.	.	O

We	PRP	O
identified	VBD	O
the	DT	O
alpha-cardiac	JJ	O
actin	NN	O
gene	NN	O
(	-LRB-	O
ACTC	NN	O
)	-RRB-	O
as	IN	O
a	DT	O
novel	JJ	O
disease	NN	O
gene	NN	O
in	IN	O
a	DT	O
pedigree	NN	O
suffering	NN	O
from	IN	O
familial	JJ	B-Disease
hypertrophic	JJ	I-Disease
cardiomyopathy	NN	I-Disease
(	-LRB-	O
FHC	NN	B-Disease
)	-RRB-	O
.	.	O

Linkage	NN	O
analyses	NNS	O
excluded	VBN	O
all	PDT	O
the	DT	O
previously	RB	O
reported	VBN	O
FHC	NN	B-Disease
loci	NNS	O
as	IN	O
possible	JJ	O
disease	NN	O
loci	NNS	O
in	IN	O
the	DT	O
family	NN	O
studied	VBN	O
,	,	O
with	IN	O
lod	NN	O
scores	NNS	O
varying	VBG	O
between	IN	O
-2	CD	O
.	.	O

5	CD	O
and	CC	O
-6	CD	O
.	.	O

0	CD	O
0	CD	O
.	.	O

Further	JJ	O
linkage	NN	O
analyses	NNS	O
of	IN	O
plausible	JJ	O
candidate	NN	O
genes	NNS	O
highly	RB	O
expressed	VBN	O
in	IN	O
the	DT	O
adult	JJ	O
human	JJ	O
heart	NN	O
identified	VBD	O
ACTC	NN	O
as	IN	O
the	DT	O
most	RBS	O
likely	JJ	O
disease	NN	O
gene	NN	O
,	,	O
showing	VBG	O
a	DT	O
maximal	JJ	O
lod	NN	O
score	NN	O
of	IN	O
3	CD	O
.	.	O

6	CD	O
6	CD	O
.	.	O

Mutation	NN	O
analysis	NN	O
of	IN	O
ACTC	NNP	O
revealed	VBD	O
an	DT	O
Ala295Ser	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
5	CD	O
close	NN	O
to	TO	O
2	CD	O
missense	NN	O
mutations	NNS	O
recently	RB	O
described	VBD	O
to	TO	O
cause	VB	O
the	DT	O
inherited	VBN	O
form	NN	O
of	IN	O
idiopathic	JJ	B-Disease
dilated	JJ	I-Disease
cardiomyopathy	NN	I-Disease
(	-LRB-	O
IDC	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
EWS	NN	O
gene	NN	O
,	,	O
involved	VBN	O
in	IN	O
Ewing	NNP	B-Disease
family	NN	I-Disease
of	IN	I-Disease
tumors	NNS	I-Disease
,	,	O
malignant	JJ	B-Disease
melanoma	NN	I-Disease
of	IN	I-Disease
soft	JJ	I-Disease
parts	NNS	I-Disease
and	CC	O
desmoplastic	JJ	B-Disease
small	JJ	I-Disease
round	NN	I-Disease
cell	NN	I-Disease
tumors	NNS	I-Disease
,	,	O
codes	NNS	O
for	IN	O
an	DT	O
RNA	NN	O
binding	NN	O
protein	NN	O
with	IN	O
novel	JJ	O
regulatory	JJ	O
domains	NNS	O
.	.	O

The	DT	O
EWS	NN	O
gene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
band	NN	O
q12	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
22	CD	O
,	,	O
is	VBZ	O
involved	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
human	JJ	O
solid	JJ	B-Disease
tumors	NNS	I-Disease
including	VBG	O
Ewing	NNP	B-Disease
sarcoma	NN	I-Disease
,	,	O
related	JJ	O
primitive	JJ	O
neuroectodermal	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
malignant	JJ	B-Disease
melanoma	NN	I-Disease
of	IN	I-Disease
soft	JJ	I-Disease
parts	NNS	I-Disease
and	CC	O
desmoplastic	JJ	B-Disease
small	JJ	I-Disease
round	NN	I-Disease
cell	NN	I-Disease
tumors	NNS	I-Disease
.	.	O

In	IN	O
these	DT	O
tumors	NNS	B-Disease
,	,	O
the	DT	O
EWS	NN	O
is	VBZ	O
fused	VBN	O
to	TO	O
genes	NNS	O
encoding	VBG	O
transcriptional	JJ	O
activators/repressors	NNS	O
,	,	O
like	IN	O
Fli-1	NN	O
or	CC	O
erg	NN	O
or	CC	O
ATF	NN	O
1	CD	O
or	CC	O
wt1	CD	O
.	.	O

To	TO	O
better	RBR	O
understand	VB	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
EWS	NN	O
protein	NN	O
,	,	O
we	PRP	O
cloned	VBD	O
the	DT	O
EWS	NN	O
cDNA	NN	O
.	.	O

Sequence	NN	O
analysis	NN	O
of	IN	O
this	DT	O
cDNA	NN	O
revealed	VBD	O
differential	JJ	O
splicing	NN	O
involving	VBG	O
two	CD	O
exons	NNS	O
encoding	VBG	O
72	CD	O
amino	NN	O
acids	NNS	O
.	.	O

Both	DT	O
alternatively	RB	O
spliced	VBN	O
transcripts	NNS	O
,	,	O
EWS	NN	O
and	CC	O
EWS-b	NN	O
,	,	O
are	VBP	O
expressed	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
cells	NNS	O
.	.	O

Because	IN	O
EWS	NN	O
proteins	NNS	O
contain	VBP	O
putative	JJ	O
conserved	VBN	O
RNA	NN	O
binding	NN	O
motifs	NNS	O
,	,	O
we	PRP	O
studied	VBD	O
the	DT	O
RNA	NN	O
binding	NN	O
properties	NNS	O
of	IN	O
the	DT	O
EWS	NN	O
protein	NN	O
.	.	O

The	DT	O
EWS-b	JJ	O
protein	NN	O
binds	VBZ	O
to	TO	O
RNA	NN	O
in	FW	O
vitro	FW	O
and	CC	O
,	,	O
specifically	RB	O
,	,	O
to	TO	O
poly	NN	O
G	NN	O
and	CC	O
poly	NN	O
U	NN	O
.	.	O

The	DT	O
RNA	NN	O
binding	NN	O
activity	NN	O
was	VBD	O
localized	JJ	O
to	TO	O
the	DT	O
carboxy	NN	O
terminal	JJ	O
86	CD	O
amino	NN	O
acids	NNS	O
,	,	O
which	WDT	O
constitute	VBP	O
RGG	NN	O
box	NN	O
.	.	O

Thus	RB	O
the	DT	O
amino	NN	O
terminal	JJ	O
domain	NN	O
of	IN	O
EWS	NN	O
(	-LRB-	O
NTD-EWS	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
involved	VBN	O
in	IN	O
chromosome	NN	O
translocation	NN	O
may	MD	O
regulate	VB	O
the	DT	O
specificity	NN	O
of	IN	O
RNA	NN	O
binding	NN	O
activity	NN	O
of	IN	O
EWS	NN	O
.	.	O

An	DT	O
EWS-erg	NN	O
chimeric	JJ	O
protein	NN	O
,	,	O
which	WDT	O
is	VBZ	O
found	VBN	O
in	IN	O
Ewings	NNP	B-Disease
sarcoma	NN	I-Disease
cells	NNS	O
,	,	O
functions	NNS	O
as	IN	O
a	DT	O
transcriptional	JJ	O
activator	NN	O
.	.	O

Mutational	JJ	O
analysis	NN	O
of	IN	O
EWS-erg	NN	O
chimeric	JJ	O
protein	NN	O
revealed	VBD	O
that	IN	O
NTD-EWS	NN	O
functions	NNS	O
as	IN	O
a	DT	O
regulatory	JJ	O
domain	NN	O
for	IN	O
the	DT	O
transcriptional	JJ	O
activation	NN	O
properties	NNS	O
of	IN	O
EWS-erg	NN	O
chimeric	JJ	O
protein	NN	O
.	.	O

.	.	O

A	DT	O
mutation	NN	O
common	JJ	O
in	IN	O
non-Jewish	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
:	:	O
frequency	NN	O
and	CC	O
RNA	NN	O
studies	NNS	O
.	.	O

Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
TSD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
resulting	VBG	O
from	IN	O
mutation	NN	O
of	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
encoding	VBG	O
the	DT	O
alpha-subunit	NN	O
of	IN	O
the	DT	O
lysosomal	JJ	O
enzyme	NN	O
,	,	O
beta-N-acetylhexosaminidase	NN	O
A	NN	O
(	-LRB-	O
Hex	NN	O
A	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
discovered	VBN	O
that	IN	O
a	DT	O
Tay-Sachs	JJ	B-Disease
mutation	NN	O
,	,	O
IVS-9	NN	O
+	CC	O
1	CD	O
G	NN	O
--	:	O
>	JJR	O
A	NN	O
,	,	O
first	JJ	O
detected	VBN	O
by	IN	O
Akli	NNP	O
et	FW	O
al.	FW	O
(	-LRB-	O
Genomics	NN	O
11	CD	O
124-134	CD	O
,	,	O
1991	CD	O
)	-RRB-	O
,	,	O
is	VBZ	O
a	DT	O
common	JJ	O
disease	NN	O
allele	NN	O
in	IN	O
non-Jewish	JJ	O
Caucasians	NNS	O
(	-LRB-	O
10/58	CD	O
alleles	NNS	O
examined	VBN	O
)	-RRB-	O
.	.	O

A	DT	O
PCR-based	JJ	O
diagnostic	JJ	O
test	NN	O
,	,	O
which	WDT	O
detects	VBZ	O
an	DT	O
NlaIII	NN	O
site	NN	O
generated	VBN	O
by	IN	O
the	DT	O
mutation	NN	O
,	,	O
revealed	VBD	O
a	DT	O
frequency	NN	O
among	IN	O
enzyme-defined	JJ	O
carriers	NNS	O
of	IN	O
9/64	CD	O
(	-LRB-	O
14	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Most	JJS	O
of	IN	O
those	DT	O
carrying	VBG	O
the	DT	O
allele	NN	O
trace	NN	O
their	PRP$	O
origins	NNS	O
to	TO	O
the	DT	O
United	NNP	O
Kingdom	NNP	O
,	,	O
Ireland	NNP	O
,	,	O
or	CC	O
Western	NNP	O
Europe	NNP	O
.	.	O

It	PRP	O
was	VBD	O
not	RB	O
identified	VBN	O
among	IN	O
12	CD	O
Black	JJ	O
American	JJ	O
TSD	NN	B-Disease
alleles	NNS	O
or	CC	O
in	IN	O
any	DT	O
of	IN	O
18	CD	O
Ashkenazi	NNP	O
Jewish	NNP	O
,	,	O
enzyme-defined	JJ	O
carriers	NNS	O
who	WP	O
did	VBD	O
not	RB	O
carry	VB	O
any	DT	O
of	IN	O
the	DT	O
mutations	NNS	O
common	JJ	O
to	TO	O
this	DT	O
population	NN	O
.	.	O

No	DT	O
normally	RB	O
spliced	VBN	O
RNA	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
PCR	NN	O
products	NNS	O
generated	VBN	O
from	IN	O
reverse	JJ	O
transcription	NN	O
of	IN	O
RNA	NN	O
carrying	VBG	O
the	DT	O
IVS-9	NN	O
mutation	NN	O
.	.	O

Instead	RB	O
,	,	O
the	DT	O
low	JJ	O
levels	NNS	O
of	IN	O
mRNA	NN	O
from	IN	O
this	DT	O
allele	NN	O
were	VBD	O
comprised	VBN	O
of	IN	O
aberrant	JJ	O
species	NNS	O
resulting	VBG	O
from	IN	O
the	DT	O
use	NN	O
of	IN	O
either	DT	O
of	IN	O
two	CD	O
cryptic	JJ	O
donor	NN	O
sites	NNS	O
,	,	O
one	CD	O
truncating	JJ	O
exon	NN	O
9	CD	O
and	CC	O
the	DT	O
other	JJ	O
within	IN	O
IVS-9	NN	O
,	,	O
spliced	VBN	O
to	TO	O
exon	NN	O
10	CD	O
.	.	O

Numerous	JJ	O
additional	JJ	O
splice	NN	O
products	NNS	O
were	VBD	O
detected	VBN	O
,	,	O
most	JJS	O
involving	VBG	O
skipping	VBG	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
surrounding	VBG	O
exons	NNS	O
.	.	O

Together	RB	O
with	IN	O
a	DT	O
recently	RB	O
identified	VBN	O
allele	NN	O
responsible	JJ	O
for	IN	O
Hex	NNP	O
A	NNP	O
pseudodeficiency	NN	O
(	-LRB-	O
Triggs-Raine	NN	O
et	FW	O
al	FW	O
.	.	O

Am	VBP	O
J	NN	O
Hum	NNP	O
Genet	NNP	O
,	,	O
1992	CD	O
)	-RRB-	O
,	,	O
these	DT	O
two	CD	O
alleles	NNS	O
accounted	VBD	O
for	IN	O
almost	RB	O
50	CD	O
%	NN	O
(	-LRB-	O
29/64	CD	O
)	-RRB-	O
of	IN	O
TSD	NN	B-Disease
or	CC	O
carrier	NN	O
alleles	NNS	O
ascertained	VBN	O
by	IN	O
enzyme	NN	O
screening	NN	O
tests	NNS	O
in	IN	O
non-Jewish	JJ	O
Caucasians	NNPS	O
.	.	O

.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
region	NN	O
predicts	VBZ	O
multiple	JJ	O
protein	NN	O
isoform-encoding	JJ	O
mRNAs	NNS	O
.	.	O

The	DT	O
mutation	NN	O
underlying	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
has	VBZ	O
been	VBN	O
identified	VBN	O
as	IN	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
polymorphic	JJ	O
CTG-repeat	NN	O
in	IN	O
a	DT	O
gene	NN	O
encoding	NN	O
protein	NN	O
kinase	NN	O
activity	NN	O
.	.	O

Brain	NN	O
and	CC	O
heart	NN	O
transcripts	NNS	O
of	IN	O
the	DT	O
DM-kinase	NN	O
(	-LRB-	O
DMR-B15	NN	O
)	-RRB-	O
gene	NN	O
are	VBP	O
subject	JJ	O
to	TO	O
alternative	JJ	O
RNA	NN	O
splicing	NN	O
in	IN	O
both	CC	O
human	JJ	O
and	CC	O
mouse	NN	O
.	.	O

The	DT	O
unstable	JJ	O
[	-LRB-	O
CTG	NN	O
]	-RRB-	O
5-30	CD	O
motif	NN	O
is	VBZ	O
found	VBN	O
uniquely	RB	O
in	IN	O
humans	NNS	O
,	,	O
although	IN	O
the	DT	O
flanking	JJ	O
nucleotides	NNS	O
are	VBP	O
also	RB	O
present	JJ	O
in	IN	O
mouse	NN	O
.	.	O

Characterization	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
region	NN	O
of	IN	O
both	DT	O
species	NNS	O
reveals	VBZ	O
another	DT	O
active	JJ	O
gene	NN	O
(	-LRB-	O
DMR-N9	NN	O
)	-RRB-	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
kinase	NN	O
gene	NN	O
.	.	O

DMR-N9	NN	O
transcripts	NNS	O
,	,	O
mainly	RB	O
expressed	VBN	O
in	IN	O
brain	NN	O
and	CC	O
testis	NN	O
,	,	O
possess	VBP	O
a	DT	O
single	JJ	O
,	,	O
large	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
,	,	O
but	CC	O
the	DT	O
function	NN	O
of	IN	O
its	PRP$	O
protein	NN	O
product	NN	O
is	VBZ	O
unknown	JJ	O
.	.	O

Clinical	JJ	O
manifestation	NN	O
of	IN	O
DM	NN	B-Disease
may	MD	O
be	VB	O
caused	VBN	O
by	IN	O
the	DT	O
expanded	VBN	O
CTG-repeat	NN	O
compromising	VBG	O
the	DT	O
(	-LRB-	O
alternative	NN	O
)	-RRB-	O
expression	NN	O
of	IN	O
DM-kinase	NN	O
or	CC	O
DMR-N9	NN	O
proteins	NNS	O
.	.	O

.	.	O

Paroxysmal	JJ	B-Disease
nocturnal	JJ	I-Disease
haemoglobinuria	NN	I-Disease
with	IN	O
coexisting	VBG	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
ninth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
:	:	O
lack	NN	O
of	IN	O
massive	JJ	O
haemolytic	JJ	B-Disease
attack	NN	I-Disease
.	.	O

A	DT	O
47-year-old	JJ	O
woman	NN	O
with	IN	O
paroxysmal	JJ	B-Disease
nocturnal	JJ	I-Disease
haemoglobinuria	NN	I-Disease
(	-LRB-	O
PNH	NN	B-Disease
)	-RRB-	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	O
inherited	VBN	B-Disease
deficiency	NN	I-Disease
in	IN	I-Disease
the	DT	I-Disease
ninth	JJ	I-Disease
complement	NN	I-Disease
component	NN	I-Disease
(	-LRB-	O
C9	NN	O
)	-RRB-	O
.	.	O

In	IN	O
complement-sensitivity	JJ	O
lysis	NN	O
tests	NNS	O
,	,	O
80	CD	O
%	NN	O
of	IN	O
her	PRP$	O
erythrocytes	NNS	O
were	VBD	O
markedly	RB	O
complement-sensitive	JJ	O
(	-LRB-	O
PNH-III	NN	O
)	-RRB-	O
.	.	O

Laser	NNP	O
cytofluorimetry	NN	O
with	IN	O
a	DT	O
monoclonal	JJ	O
antibody	NN	O
against	IN	O
decay-accelerating	JJ	O
factor	NN	O
(	-LRB-	O
DAF	NNP	O
)	-RRB-	O
revealed	VBD	O
that	IN	O
95	CD	O
%	NN	O
of	IN	O
her	PRP$	O
erythrocytes	NNS	O
were	VBD	O
DAF-negative	JJ	O
.	.	O

Surprisingly	RB	O
,	,	O
she	PRP	O
has	VBZ	O
suffered	VBN	O
only	RB	O
mild	JJ	O
haemolysis	NN	B-Disease
and	CC	O
has	VBZ	O
never	RB	O
experienced	JJ	O
massive	JJ	O
spontaneous	JJ	O
haemolysis	NN	B-Disease
.	.	O

Gross	NNP	O
haemoglobinuria	NN	B-Disease
and	CC	O
jaundice	NN	B-Disease
occurred	VBD	O
only	RB	O
after	IN	O
receiving	VBG	O
postoperative	JJ	O
transfusion	NN	O
of	IN	O
whole	JJ	O
blood	NN	O
.	.	O

In	IN	O
her	PRP$	O
serum	NN	O
,	,	O
C9	NN	O
was	VBD	O
not	RB	O
detectable	JJ	O
either	CC	O
by	IN	O
immunological	JJ	O
or	CC	O
by	IN	O
functional	JJ	O
assays	NNS	O
.	.	O

Both	CC	O
the	DT	O
Ham	NN	O
test	NN	O
and	CC	O
the	DT	O
sugar	NN	O
water	NN	O
test	NN	O
using	VBG	O
normal	JJ	O
human	JJ	O
serum	NN	O
or	CC	O
plasma	NN	O
yielded	VBD	O
marked	JJ	O
haemolysis	NN	O
of	IN	O
the	DT	O
patients	NNS	O
erythrocytes	NNS	O
.	.	O

When	WRB	O
the	DT	O
patients	NNS	O
serum	NN	O
or	CC	O
plasma	NN	O
was	VBD	O
used	VBN	O
,	,	O
only	RB	O
a	DT	O
trace	NN	O
of	IN	O
lysis	NN	O
was	VBD	O
detected	VBN	O
.	.	O

Addition	NN	O
of	IN	O
purified	VBN	O
human	JJ	O
C9	NN	O
to	TO	O
her	PRP$	O
plasma	NN	O
fully	RB	O
restored	VBD	O
haemolysis	NN	O
.	.	O

These	DT	O
observations	NNS	O
indicated	VBD	O
that	IN	O
C9	NN	O
may	MD	O
play	VB	O
a	DT	O
critical	JJ	O
role	NN	O
in	IN	O
haemolytic	JJ	B-Disease
attacks	NNS	I-Disease
in	IN	O
patients	NNS	O
with	IN	O
PNH	NN	B-Disease
and	CC	O
that	IN	O
characteristic	JJ	O
haemolysis	NN	B-Disease
in	IN	O
PNH	NN	B-Disease
may	MD	O
be	VB	O
tempered	VBN	O
by	IN	O
coexisting	VBG	O
C9	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

BRCA1	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
human	JJ	O
SWI/SNF-related	JJ	O
complex	NN	O
:	:	O
linking	VBG	O
chromatin	NN	O
remodeling	VBG	O
to	TO	O
breast	NN	B-Disease
cancer	NN	I-Disease
.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
,	,	O
BRCA1	NN	O
,	,	O
predispose	VB	O
individuals	NNS	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

Using	VBG	O
a	DT	O
combination	NN	O
of	IN	O
affinity	NN	O
-	:	O
and	CC	O
conventional	JJ	O
chromatographic	JJ	O
techniques	NNS	O
,	,	O
we	PRP	O
have	VBP	O
isolated	VBN	O
a	DT	O
predominant	JJ	O
form	NN	O
of	IN	O
a	DT	O
multiprotein	JJ	O
BRCA1-containing	JJ	O
complex	NN	O
from	IN	O
human	JJ	O
cells	NNS	O
displaying	VBG	O
chromatin-remodeling	JJ	O
activity	NN	O
.	.	O

Mass	JJ	O
spectrometric	JJ	O
sequencing	NN	O
of	IN	O
components	NNS	O
of	IN	O
this	DT	O
complex	NN	O
indicated	VBD	O
that	IN	O
BRCA1	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
SWI/SNF-related	JJ	O
complex	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
BRCA1	NN	O
can	MD	O
directly	RB	O
interact	VB	O
with	IN	O
the	DT	O
BRG1	NN	O
subunit	NN	O
of	IN	O
the	DT	O
SWI/SNF	NN	O
complex	NN	O
.	.	O

Moreover	RB	O
,	,	O
p53-mediated	JJ	O
stimulation	NN	O
of	IN	O
transcription	NN	O
by	IN	O
BRCA1	NN	O
was	VBD	O
completely	RB	O
abrogated	VBN	O
by	IN	O
either	CC	O
a	DT	O
dominant-negative	JJ	O
mutant	NN	O
of	IN	O
BRG1	NN	O
or	CC	O
the	DT	O
cancer-causing	JJ	O
deletion	NN	O
in	IN	O
exon	NN	O
11	CD	O
of	IN	O
BRCA1	NN	O
.	.	O

These	DT	O
findings	NNS	O
reveal	VBP	O
a	DT	O
direct	JJ	O
function	NN	O
for	IN	O
BRCA1	NN	O
in	IN	O
transcriptional	JJ	O
control	NN	O
through	IN	O
modulation	NN	O
of	IN	O
chromatin	NN	O
structure	NN	O
.	.	O

.	.	O

Germinal	JJ	O
mosaicism	NN	O
in	IN	O
a	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
family	NN	O
:	:	O
implications	NNS	O
for	IN	O
genetic	JJ	O
counselling	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
we	PRP	O
describe	VBP	O
a	DT	O
three-generation	JJ	O
family	NN	O
in	IN	O
which	WDT	O
two	CD	O
siblings	NNS	O
were	VBD	O
affected	VBN	O
by	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

Immunohistochemical	JJ	O
analysis	NN	O
of	IN	O
muscle	NN	O
dystrophin	NN	O
and	CC	O
haplotype	NN	O
analysis	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
locus	NN	O
revealed	VBD	O
that	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
carrying	VBG	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
was	VBD	O
transmitted	VBN	O
from	IN	O
the	DT	O
healthy	JJ	O
maternal	JJ	O
grandfather	NN	O
to	TO	O
his	PRP$	O
three	CD	O
daughters	NNS	O
,	,	O
including	VBG	O
the	DT	O
probands	NNS	O
mother	NN	O
.	.	O

These	DT	O
findings	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
grandfather	NN	O
was	VBD	O
a	DT	O
germinal	JJ	O
mosaic	NN	O
for	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

The	DT	O
definition	NN	O
of	IN	O
the	DT	O
carrier	NN	O
status	NN	O
in	IN	O
two	CD	O
possible	JJ	O
carriers	NNS	O
led	VBD	O
us	PRP	O
to	TO	O
give	VB	O
accurate	JJ	O
genetic	JJ	O
counselling	NN	O
and	CC	O
to	TO	O
prevent	VB	O
the	DT	O
birth	NN	O
of	IN	O
an	DT	O
affected	JJ	O
boy	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
this	DT	O
study	NN	O
demonstrate	VBP	O
the	DT	O
usefulness	NN	O
of	IN	O
haplotype	NN	O
analysis	NN	O
and	CC	O
immunohistochemical	JJ	O
muscle	NN	O
dystrophin	NN	O
studies	NNS	O
to	TO	O
detect	VB	O
hidden	JJ	O
germinal	JJ	O
mosaicism	NN	O
and	CC	O
to	TO	O
improve	VB	O
genetic	JJ	O
counselling	NN	O
.	.	O

.	.	O

Centrosome	JJ	O
amplification	NN	O
and	CC	O
a	DT	O
defective	JJ	O
G2-M	NN	O
cell	NN	O
cycle	NN	O
checkpoint	NN	O
induce	VBP	O
genetic	JJ	O
instability	NN	O
in	IN	O
BRCA1	NN	O
exon	NN	O
11	CD	O
isoform-deficient	JJ	O
cells	NNS	O
.	.	O

Germline	NN	O
mutations	NNS	O
of	IN	O
the	DT	O
Brca1	NN	O
tumor	NN	B-Disease
suppressor	NN	O
gene	NN	O
predispose	VB	O
women	NNS	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

To	TO	O
study	VB	O
mechanisms	NNS	O
underlying	VBG	O
BRCA1-related	JJ	O
tumorigenesis	NN	O
,	,	O
we	PRP	O
derived	VBD	O
mouse	NN	O
embryonic	JJ	O
fibroblast	NN	O
cells	NNS	O
carrying	VBG	O
a	DT	O
targeted	VBN	O
deletion	NN	O
of	IN	O
exon	NN	O
11	CD	O
of	IN	O
the	DT	O
Brca1	NN	O
gene	NN	O
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
the	DT	O
mutant	JJ	O
cells	NNS	O
maintain	VBP	O
an	DT	O
intact	JJ	O
G1-S	NN	O
cell	NN	O
cycle	NN	O
checkpoint	NN	O
and	CC	O
proliferate	VBP	O
poorly	RB	O
.	.	O

However	RB	O
,	,	O
a	DT	O
defective	JJ	O
G2-M	NN	O
checkpoint	NN	O
in	IN	O
these	DT	O
cells	NNS	O
is	VBZ	O
accompanied	VBN	O
by	IN	O
extensive	JJ	O
chromosomal	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

Mutant	JJ	O
fibroblasts	NNS	O
contain	VBP	O
multiple	JJ	O
,	,	O
functional	JJ	O
centrosomes	NNS	O
,	,	O
which	WDT	O
lead	VBP	O
to	TO	O
unequal	JJ	O
chromosome	NN	O
segregation	NN	O
,	,	O
abnormal	JJ	O
nuclear	JJ	O
division	NN	O
,	,	O
and	CC	O
aneuploidy	NN	B-Disease
.	.	O

These	DT	O
data	NNS	O
uncover	VBP	O
an	DT	O
essential	JJ	O
role	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
maintaining	VBG	O
genetic	JJ	O
stability	NN	O
through	IN	O
the	DT	O
regulation	NN	O
of	IN	O
centrosome	JJ	O
duplication	NN	O
and	CC	O
the	DT	O
G2-M	NN	O
checkpoint	NN	O
and	CC	O
provide	VB	O
a	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
tumorigenesis	NN	O
.	.	O

.	.	O

Aberrant	JJ	O
splicing	NN	O
of	IN	O
phenylalanine	NN	O
hydroxylase	NN	O
mRNA	NN	O
:	:	O
the	DT	O
major	JJ	O
cause	NN	O
for	IN	O
phenylketonuria	NN	B-Disease
in	IN	O
parts	NNS	O
of	IN	O
southern	JJ	O
Europe	NNP	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
mutation	NN	O
within	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
gene	NN	O
that	WDT	O
causes	VBZ	O
aberrant	JJ	O
splicing	NN	O
of	IN	O
the	DT	O
mRNA	NN	O
and	CC	O
that	DT	O
is	VBZ	O
in	IN	O
tight	JJ	O
association	NN	O
with	IN	O
chromosomal	JJ	O
haplotypes	NNS	O
6	CD	O
,	,	O
10	CD	O
,	,	O
and	CC	O
36	CD	O
.	.	O

Because	IN	O
of	IN	O
the	DT	O
high	JJ	O
frequency	NN	O
of	IN	O
these	DT	O
particular	JJ	O
haplotypes	NNS	O
in	IN	O
Bulgaria	NNP	O
,	,	O
Italy	NNP	O
,	,	O
and	CC	O
Turkey	NNP	O
,	,	O
it	PRP	O
appears	VBZ	O
to	TO	O
be	VB	O
one	CD	O
of	IN	O
the	DT	O
more	RBR	O
frequent	JJ	O
defects	NNS	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
causing	VBG	O
classical	JJ	O
phenylketonuria	NN	B-Disease
in	IN	O
this	DT	O
part	NN	O
of	IN	O
Europe	NNP	O
.	.	O

The	DT	O
mutation	NN	O
is	VBZ	O
a	DT	O
G	NN	O
to	TO	O
A	DT	O
transition	NN	O
at	IN	O
position	NN	O
546	CD	O
in	IN	O
intron	NN	O
10	CD	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
,	,	O
11	CD	O
bp	NN	O
upstream	RB	O
from	IN	O
the	DT	O
intron	NN	O
10/exon	NN	O
11	CD	O
boundary	NN	O
.	.	O

It	PRP	O
activates	VBZ	O
a	DT	O
cryptic	JJ	O
splice	NN	O
site	NN	O
and	CC	O
results	VBZ	O
in	IN	O
an	DT	O
in-frame	RB	O
insertion	NN	O
of	IN	O
9	CD	O
nucleotides	NNS	O
between	IN	O
exon	NN	O
10	CD	O
and	CC	O
exon	NN	O
11	CD	O
of	IN	O
the	DT	O
processed	VBN	O
mRNA	NN	O
.	.	O

Normal	JJ	O
amounts	NNS	O
of	IN	O
liver	NN	O
PAH	NN	O
protein	NN	O
are	VBP	O
present	JJ	O
in	IN	O
homozygous	JJ	O
patients	NNS	O
,	,	O
but	CC	O
no	DT	O
catalytic	JJ	O
activity	NN	O
can	MD	O
be	VB	O
detected	VBN	O
.	.	O

This	DT	O
loss	NN	O
of	IN	O
enzyme	NN	O
activity	NN	O
is	VBZ	O
probably	RB	O
caused	VBN	O
by	IN	O
conformational	JJ	O
changes	NNS	O
resulting	VBG	O
from	IN	O
the	DT	O
insertion	NN	O
of	IN	O
three	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
(	-LRB-	O
Gly-Leu-Gln	NN	O
)	-RRB-	O
between	IN	O
the	DT	O
normal	JJ	O
sequences	NNS	O
encoded	VBN	O
by	IN	O
exon	NN	O
10	CD	O
and	CC	O
exon	NN	O
11	CD	O
.	.	O

.	.	O

Biochemical	JJ	O
and	CC	O
structural	JJ	O
analysis	NN	O
of	IN	O
missense	NN	O
mutations	NNS	O
in	IN	O
N-acetylgalactosamine-6-sulfate	NN	O
sulfatase	NN	O
causing	VBG	O
mucopolysaccharidosis	NN	B-Disease
IVA	NN	I-Disease
phenotypes	NNS	O
.	.	O

Mucopolysaccharidosis	NNP	B-Disease
IVA	NNP	I-Disease
(	-LRB-	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
;	:	O
OMIM	NNP	O
#	#	O
253000	CD	O
)	-RRB-	O
,	,	O
a	DT	O
lysosomal	JJ	B-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
N	NN	I-Disease
-	:	I-Disease
acetylgalactosamine-6-sulfate	NN	I-Disease
sulfatase	NN	I-Disease
(	-LRB-	O
GALNS	NN	O
)	-RRB-	O
,	,	O
has	VBZ	O
variable	JJ	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

To	TO	O
date	NN	O
we	PRP	O
have	VBP	O
identified	VBN	O
65	CD	O
missense	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
GALNS	NN	O
gene	NN	O
from	IN	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
patients	NNS	O
,	,	O
but	CC	O
the	DT	O
correlation	NN	O
between	IN	O
genotype	NN	O
and	CC	O
phenotype	NN	O
has	VBZ	O
remained	VBN	O
unclear	JJ	O
.	.	O

We	PRP	O
studied	VBD	O
17	CD	O
missense	NN	O
mutations	NNS	O
using	VBG	O
biochemical	JJ	O
approaches	NNS	O
and	CC	O
32	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
using	VBG	O
structural	JJ	O
analyses	NNS	O
.	.	O

Fifteen	CD	O
missense	NN	O
mutations	NNS	O
and	CC	O
two	CD	O
newly	RB	O
engineered	VBN	O
active	JJ	O
site	NN	O
mutations	NNS	O
(	-LRB-	O
C79S	NN	O
,	,	O
C79T	NN	O
)	-RRB-	O
were	VBD	O
characterized	VBN	O
by	IN	O
transient	JJ	O
expression	NN	O
analysis	NN	O
.	.	O

Mutant	JJ	O
proteins	NNS	O
,	,	O
except	IN	O
for	IN	O
C79S	NN	O
and	CC	O
C79T	NN	O
,	,	O
were	VBD	O
destabilized	VBN	O
and	CC	O
detected	VBN	O
as	IN	O
insoluble	JJ	O
precursor	NN	O
forms	NNS	O
while	IN	O
the	DT	O
C79S	NN	O
and	CC	O
C79T	NN	O
mutants	NNS	O
were	VBD	O
of	IN	O
a	DT	O
soluble	JJ	O
mature	JJ	O
size	NN	O
.	.	O

Mutants	NNS	O
found	VBN	O
in	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
had	VBD	O
no	DT	O
activity	NN	O
.	.	O

Mutants	NNS	O
found	VBN	O
in	IN	O
the	DT	O
mild	JJ	O
phenotype	NN	O
had	VBD	O
a	DT	O
considerable	JJ	O
residual	JJ	O
activity	NN	O
(	-LRB-	O
1	CD	O
.	.	O

3-13	CD	O
.	.	O

3	CD	O
%	NN	O
of	IN	O
wild-type	JJ	O
GALNS	NN	O
activity	NN	O
)	-RRB-	O
.	.	O

Sulfatases	NNP	O
,	,	O
including	VBG	O
GALNS	NNP	O
,	,	O
are	VBP	O
members	NNS	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
gene	NN	O
family	NN	O
sharing	VBG	O
an	DT	O
extensive	JJ	O
sequence	NN	O
homology	NN	O
.	.	O

Thus	RB	O
,	,	O
a	DT	O
tertiary	JJ	O
structural	JJ	O
model	NN	O
of	IN	O
human	JJ	O
GALNS	NN	O
was	VBD	O
constructed	VBN	O
from	IN	O
the	DT	O
X-ray	NN	O
crystal	NN	O
structure	NN	O
of	IN	O
N	NN	O
-	:	O
acetylgalacto-samine-4-sulfatase	NN	O
and	CC	O
arylsulfatase	NN	O
A	NN	O
,	,	O
using	VBG	O
homology	NN	O
modeling	NN	O
,	,	O
and	CC	O
32	CD	O
missense	NN	O
mutations	NNS	O
were	VBD	O
investigated	VBN	O
.	.	O

Consequently	RB	O
,	,	O
we	PRP	O
propose	VBP	O
that	IN	O
there	EX	O
are	VBP	O
at	IN	O
least	JJS	O
three	CD	O
different	JJ	O
reasons	NNS	O
for	IN	O
the	DT	O
severe	JJ	O
phenotype	NN	O
(	-LRB-	O
i	LS	O
)	-RRB-	O
destruction	NN	O
of	IN	O
the	DT	O
hydrophobic	JJ	O
core	NN	O
or	CC	O
modification	NN	O
of	IN	O
the	DT	O
packing	NN	O
;	:	O
(	-LRB-	O
ii	LS	O
)	-RRB-	O
removal	NN	O
of	IN	O
a	DT	O
salt	NN	O
bridge	NN	O
to	TO	O
destabilize	VB	O
the	DT	O
entire	JJ	O
conformation	NN	O
;	:	O
(	-LRB-	O
iii	LS	O
)	-RRB-	O
modification	NN	O
of	IN	O
the	DT	O
active	JJ	O
site	NN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
mild	JJ	O
mutations	NNS	O
were	VBD	O
mostly	RB	O
located	JJ	O
on	IN	O
the	DT	O
surface	NN	O
of	IN	O
the	DT	O
GALNS	NN	O
protein	NN	O
.	.	O

These	DT	O
studies	NNS	O
shed	VBD	O
further	RBR	O
light	JJ	O
on	IN	O
the	DT	O
genotype-phenotype	JJ	O
correlation	NN	O
of	IN	O
MPS	NNP	B-Disease
IVA	NNP	I-Disease
and	CC	O
structure-function	JJ	O
relationship	NN	O
in	IN	O
the	DT	O
sulfatase	NN	O
family	NN	O
.	.	O

Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
:	:	O
cellular	JJ	O
impairments	NNS	O
and	CC	O
their	PRP$	O
implication	NN	O
for	IN	O
carrier	NN	O
detection	NN	O
.	.	O

A	DT	O
family	NN	O
in	IN	O
which	WDT	O
two	CD	O
male	JJ	O
siblings	NNS	O
were	VBD	O
affected	VBN	O
with	IN	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
was	VBD	O
studied	VBN	O
using	VBG	O
G-6-PD	NN	O
isoenzymes	NNS	O
as	IN	O
an	DT	O
X-linked	JJ	O
marker	NN	O
in	IN	O
order	NN	O
to	TO	O
investigate	VB	O
the	DT	O
nature	NN	O
of	IN	O
cellular	JJ	O
abnormalities	NNS	O
.	.	O

Isolated	VBN	O
peripheral	JJ	O
blood	NN	O
cell	NN	O
types	NNS	O
from	IN	O
the	DT	O
doubly	RB	O
heterozygous	JJ	O
mother	NN	O
of	IN	O
the	DT	O
affected	VBN	O
males	NNS	O
seemingly	RB	O
failed	VBD	O
to	TO	O
express	VB	O
the	DT	O
G-6-PD	NN	O
allele	NN	O
in	IN	O
cis	NN	O
position	NN	O
with	IN	O
the	DT	O
WAS	NNP	B-Disease
allele	NN	O
while	IN	O
her	PRP$	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
expressed	VBD	O
both	CC	O
G-6-PD	NN	O
alleles	NNS	O
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
histogram	NN	O
analysis	NN	O
of	IN	O
platelet	NN	O
size	NN	O
revealed	VBD	O
a	DT	O
single	JJ	O
population	NN	O
of	IN	O
abnormally	RB	O
small	JJ	O
platelets	NNS	O
in	IN	O
the	DT	O
affected	VBN	O
propositus	NN	O
,	,	O
whereas	IN	O
the	DT	O
heterozygous	JJ	O
mother	NN	O
had	VBD	O
no	DT	O
appreciable	JJ	O
small	JJ	O
platelet	NN	O
subpopulation	NN	O
.	.	O

In	FW	O
vitro	FW	O
culture	NN	O
of	IN	O
hemopoietic	JJ	O
progenitor	NN	O
cells	NNS	O
of	IN	O
the	DT	O
heterozygous	JJ	O
mother	NN	O
showed	VBD	O
that	IN	O
the	DT	O
majority	NN	O
of	IN	O
progenitor	NN	O
cells	NNS	O
did	VBD	O
not	RB	O
express	VB	O
the	DT	O
WAS	NNP	B-Disease
allele	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
small	JJ	O
number	NN	O
of	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
G-6-PD	NN	O
type	NN	O
linked	VBN	O
with	IN	O
the	DT	O
WAS	NNP	B-Disease
allele	NN	O
were	VBD	O
detected	VBN	O
.	.	O

The	DT	O
proportion	NN	O
of	IN	O
the	DT	O
latter	JJ	O
progenitors	NNS	O
was	VBD	O
significantly	RB	O
higher	JJR	O
among	IN	O
more	JJR	O
primitive	JJ	O
progenitors	NNS	O
(	-LRB-	O
those	DT	O
giving	VBG	O
rise	NN	O
to	TO	O
later	RB	O
appearing	VBG	O
colonies	NNS	O
)	-RRB-	O
.	.	O

This	DT	O
observation	NN	O
suggests	VBZ	O
that	IN	O
selection	NN	O
against	IN	O
cells	NNS	O
expressing	VBG	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
defect	NN	I-Disease
takes	VBZ	O
place	NN	O
in	IN	O
the	DT	O
hemopoietic	JJ	O
system	NN	O
of	IN	O
the	DT	O
heterozygous	JJ	O
female	NN	O
and	CC	O
offers	VBZ	O
a	DT	O
possible	JJ	O
means	NNS	O
of	IN	O
carrier	NN	O
detection	NN	O
in	IN	O
some	DT	O
women	NNS	O
.	.	O

Linkage	NN	O
studies	NNS	O
in	IN	O
this	DT	O
family	NN	O
revealed	VBD	O
one	CD	O
example	NN	O
of	IN	O
probable	JJ	O
recombination	NN	O
between	IN	O
the	DT	O
loci	NNS	O
for	IN	O
WAS	NNP	B-Disease
and	CC	O
G-6-PD	NN	O
among	IN	O
three	CD	O
informative	JJ	O
subjects	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
two	CD	O
loci	NNS	O
may	MD	O
not	RB	O
be	VB	O
closely	RB	O
linked	VBN	O
on	IN	O
the	DT	O
X-chromosome	NN	O
.	.	O

.	.	O

Familial	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
associated	VBN	O
with	IN	O
recurrent	JJ	O
meningococcal	JJ	B-Disease
infections	NNS	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
an	DT	O
11-year-old	JJ	O
girl	NN	O
suffering	NN	O
from	IN	O
recurrent	JJ	B-Disease
meningitis	NN	I-Disease
with	IN	O
a	DT	O
complete	JJ	O
absence	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
seventh	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	O
(	-LRB-	O
C7	NN	O
)	-RRB-	O
.	.	O

Diagnosis	NN	O
was	VBD	O
established	VBN	O
by	IN	O
haemolytic	JJ	O
titration	NN	O
and	CC	O
western	NN	O
blotting	NN	O
.	.	O

The	DT	O
patients	NNS	O
serum	NN	O
lacked	VBD	O
the	DT	O
85	CD	O
kDa	NN	O
C7	NN	O
chain	NN	O
.	.	O

Haemolytic	JJ	O
activity	NN	O
of	IN	O
serum	NN	O
was	VBD	O
reconstituted	VBN	O
with	IN	O
either	CC	O
pooled	VBN	O
normal	JJ	O
human	JJ	O
serum	NN	O
or	CC	O
with	IN	O
purified	VBN	O
C7	NN	O
.	.	O

The	DT	O
relatives	NNS	O
(	-LRB-	O
parents	NNS	O
and	CC	O
one	CD	O
sister	NN	O
)	-RRB-	O
had	VBD	O
half-normal	JJ	O
levels	NNS	O
of	IN	O
both	DT	O
immunochemically	RB	O
and	CC	O
functionally	RB	O
determined	VBN	O
C7	NN	O
,	,	O
indicating	VBG	O
a	DT	O
heterozygous	JJ	O
state	NN	O
for	IN	O
C7	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Non-syndromic	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
associated	VBN	O
with	IN	O
enlarged	JJ	B-Disease
vestibular	JJ	I-Disease
aqueduct	NN	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
PDS	NN	B-Disease
mutations	NNS	O
.	.	O

Enlarged	JJ	B-Disease
vestibular	JJ	I-Disease
aqueduct	NN	I-Disease
(	-LRB-	O
EVA	NN	B-Disease
)	-RRB-	O
,	,	O
known	VBN	O
as	IN	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
inner	JJ	B-Disease
ear	NN	I-Disease
abnormality	NN	I-Disease
,	,	O
has	VBZ	O
recently	RB	O
been	VBN	O
of	IN	O
particular	JJ	O
genetic	JJ	O
interest	NN	O
because	IN	O
this	DT	O
anomaly	NN	O
is	VBZ	O
inherited	VBN	O
in	IN	O
a	DT	O
recessive	JJ	O
manner	NN	O
.	.	O

The	DT	O
locus	NN	O
for	IN	O
non-syndromic	JJ	B-Disease
sensorineural	JJ	I-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
with	IN	O
EVA	NNP	B-Disease
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
same	JJ	O
chromosomal	JJ	O
region	NN	O
,	,	O
7q31	NN	O
,	,	O
as	IN	O
the	DT	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
locus	NN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
seven	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
PDS	NN	B-Disease
gene	NN	O
(	-LRB-	O
PDS	NN	O
)	-RRB-	O
,	,	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
have	VBP	O
been	VBN	O
found	VBN	O
in	IN	O
families	NNS	O
of	IN	O
non-syndromic	JJ	B-Disease
sensorineural	JJ	I-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
with	IN	O
EVA	NNP	B-Disease
.	.	O

One	CD	O
family	NN	O
is	VBZ	O
homozygous	JJ	O
,	,	O
three	CD	O
families	NNS	O
are	VBP	O
compound	JJ	O
heterozygotes	NNS	O
,	,	O
and	CC	O
two	CD	O
families	NNS	O
are	VBP	O
heterozygous	JJ	O
but	CC	O
with	IN	O
no	DT	O
other	JJ	O
mutation	NN	O
detected	VBN	O
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
mutations	NNS	O
in	IN	O
PDS	NN	O
cause	NN	O
both	CC	O
syndromic	JJ	B-Disease
and	CC	I-Disease
non-syndromic	JJ	I-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
.	.	O

.	.	O

Deletions	NNS	O
of	IN	O
a	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
retinoblastomas	NNS	B-Disease
and	CC	O
mesenchymal	JJ	B-Disease
tumors	NNS	I-Disease
:	:	O
organization	NN	O
of	IN	O
the	DT	O
sequence	NN	O
and	CC	O
its	PRP$	O
encoded	VBN	O
protein	NN	O
.	.	O

Retinoblastoma	NN	B-Disease
is	VBZ	O
a	DT	O
childhood	NN	B-Disease
tumor	NN	I-Disease
that	WDT	O
can	MD	O
arise	VB	O
because	IN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
acquired	VBN	O
as	IN	O
somatic	JJ	O
or	CC	O
germinal	JJ	O
mutations	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
allele	NN	O
can	MD	O
be	VB	O
carried	VBN	O
in	IN	O
the	DT	O
germ	NN	O
line	NN	O
.	.	O

The	DT	O
mutations	NNS	O
creating	VBG	O
these	DT	O
alleles	NNS	O
act	VBP	O
by	IN	O
inactivating	VBG	O
copies	NNS	O
of	IN	O
a	DT	O
recessive	JJ	O
oncogene	NN	O
located	JJ	O
within	IN	O
band	NN	O
q14	NN	O
of	IN	O
chromosome	NN	O
13	CD	O
and	CC	O
termed	VBN	O
the	DT	O
RB1	NN	O
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
reported	VBN	O
isolation	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
fragment	NN	O
that	WDT	O
recognizes	VBZ	O
chromosomal	JJ	O
sequences	NNS	O
possessing	VBG	O
many	JJ	O
of	IN	O
the	DT	O
attributes	NNS	O
of	IN	O
the	DT	O
retinoblastoma	NN	B-Disease
gene	NN	O
associated	VBN	O
with	IN	O
the	DT	O
RB1	NN	O
locus	NN	O
.	.	O

We	PRP	O
now	RB	O
report	VBP	O
that	IN	O
this	DT	O
segment	NN	O
is	VBZ	O
additionally	RB	O
the	DT	O
target	NN	O
of	IN	O
somatic	JJ	O
mutations	NNS	O
in	IN	O
mesenchymal	JJ	B-Disease
tumors	NNS	I-Disease
among	IN	O
patients	NNS	O
having	VBG	O
no	DT	O
apparent	JJ	O
predisposition	NN	O
to	TO	O
retinoblastoma	NN	B-Disease
and	CC	O
no	DT	O
previous	JJ	O
evidence	NN	O
of	IN	O
retinoblastoma	NN	B-Disease
.	.	O

These	DT	O
tumors	NNS	B-Disease
provide	VBP	O
additional	JJ	O
evidence	NN	O
that	IN	O
the	DT	O
cloned	VBN	O
sequences	NNS	O
are	VBP	O
representative	JJ	O
of	IN	O
a	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
a	DT	O
frequent	JJ	O
target	NN	O
of	IN	O
inactivation	NN	O
during	IN	O
tumorigenesis	NN	O
.	.	O

Sequence	NN	O
analysis	NN	O
of	IN	O
this	DT	O
cDNA	NN	O
provides	VBZ	O
little	JJ	O
insight	NN	O
into	IN	O
its	PRP$	O
normal	JJ	O
functional	JJ	O
role	NN	O
.	.	O

.	.	O

Genetically	RB	O
determined	VBN	O
low	JJ	O
C4	NN	O
:	:	O
a	DT	O
predisposing	NN	O
factor	NN	O
to	TO	O
autoimmune	JJ	B-Disease
chronic	JJ	I-Disease
active	JJ	I-Disease
hepatitis	NN	I-Disease
.	.	O

Of	IN	O
26	CD	O
patients	NNS	O
with	IN	O
autoimmune	JJ	B-Disease
chronic	JJ	I-Disease
active	JJ	I-Disease
hepatitis	NN	I-Disease
(	-LRB-	O
CAH	NN	B-Disease
)	-RRB-	O
starting	VBG	O
in	IN	O
childhood	NN	O
18	CD	O
(	-LRB-	O
69	CD	O
%	NN	O
)	-RRB-	O
had	VBD	O
low	JJ	O
C4	NN	O
and	CC	O
5	CD	O
(	-LRB-	O
19	CD	O
%	NN	O
)	-RRB-	O
had	VBD	O
low	JJ	O
C3	NN	O
serum	NN	O
levels	NNS	O
.	.	O

Impaired	JJ	O
hepatic	JJ	O
synthesis	NN	O
and	CC	O
immune-consumption	NN	O
were	VBD	O
unlikely	JJ	O
since	IN	O
transferrin	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
in	IN	O
all	DT	O
patients	NNS	O
,	,	O
albumin	NN	O
levels	NNS	O
were	VBD	O
persistently	RB	O
low	JJ	O
in	IN	O
only	RB	O
3	CD	O
,	,	O
and	CC	O
only	RB	O
3	CD	O
had	VBD	O
raised	VBN	O
levels	NNS	O
of	IN	O
activation	NN	O
fragment	NN	O
C3d	NN	O
.	.	O

C4d	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
all	DT	O
patients	NNS	O
studied	VBN	O
.	.	O

In	IN	O
the	DT	O
families	NNS	O
of	IN	O
12	CD	O
probands	NNS	O
with	IN	O
low	JJ	O
C4	NN	O
,	,	O
7	CD	O
parents	NNS	O
had	VBD	O
low	JJ	O
C4	NN	O
and	CC	O
2	CD	O
had	VBD	O
levels	NNS	O
which	WDT	O
were	VBD	O
at	IN	O
the	DT	O
lower	JJR	O
limit	NN	O
of	IN	O
normal	JJ	O
.	.	O

5	CD	O
of	IN	O
10	CD	O
siblings	NNS	O
from	IN	O
5	CD	O
families	NNS	O
had	VBD	O
low	JJ	O
C4	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
low	JJ	O
C4	NN	O
levels	NNS	O
in	IN	O
CAH	NN	B-Disease
are	VBP	O
genetically	RB	O
determined	VBN	O
.	.	O

C4	NN	O
phenotyping	NN	O
in	IN	O
20	CD	O
patients	NNS	O
and	CC	O
in	IN	O
26	CD	O
parents	NNS	O
showed	VBD	O
that	IN	O
90	CD	O
%	NN	O
and	CC	O
81	CD	O
%	NN	O
,	,	O
respectively	RB	O
,	,	O
had	VBD	O
null	JJ	O
allotypes	NNS	O
at	IN	O
either	CC	O
the	DT	O
C4A	NN	O
or	CC	O
C4B	NN	O
locus	NN	O
compared	VBN	O
with	IN	O
59	CD	O
%	NN	O
in	IN	O
controls	NNS	O
,	,	O
indicating	VBG	O
that	IN	O
defective	JJ	O
expression	NN	O
of	IN	O
structural	JJ	O
genes	NNS	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
observed	VBN	O
C4	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

.	.	O

Tight	JJ	O
linkage	NN	O
between	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
and	CC	O
apolipoprotein	NN	O
E	NN	O
genes	NNS	O
revealed	VBD	O
with	IN	O
allele-specific	JJ	O
oligonucleotides	NNS	O
.	.	O

In	IN	O
16	CD	O
families	NNS	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
a	DT	O
novel	JJ	O
approach	NN	O
based	VBN	O
on	IN	O
use	NN	O
of	IN	O
allele-specific	JJ	O
oligonucleotides	NNS	O
has	VBZ	O
been	VBN	O
employed	VBN	O
to	TO	O
study	VB	O
the	DT	O
linkage	NN	O
relationship	NN	O
between	IN	O
the	DT	O
apolipoprotein	NN	O
E	NN	O
(	-LRB-	O
APOE	NN	O
)	-RRB-	O
gene	NN	O
and	CC	O
DM	NN	B-Disease
.	.	O

Synthetic	JJ	O
oligonucleotides	NNS	O
,	,	O
designed	VBN	O
to	TO	O
discriminate	VB	O
between	IN	O
APOE	NNP	O
alleles	NNS	O
epsilon	NN	O
3	CD	O
and	CC	O
epsilon	NN	O
4	CD	O
,	,	O
enabled	VBD	O
us	PRP	O
to	TO	O
distinguish	VB	O
heterozygous	JJ	O
carriers	NNS	O
in	IN	O
a	DT	O
hybridization	NN	O
assay	NN	O
.	.	O

In	IN	O
a	DT	O
subset	NN	O
of	IN	O
families	NNS	O
,	,	O
the	DT	O
relevant	JJ	O
segment	NN	O
of	IN	O
the	DT	O
APOE	NN	O
gene	NN	O
was	VBD	O
enzymatically	RB	O
amplified	VBN	O
to	TO	O
increase	VB	O
the	DT	O
sensitivity	NN	O
of	IN	O
the	DT	O
method	NN	O
.	.	O

For	IN	O
DM	NN	O
and	CC	O
APOE	NN	O
,	,	O
a	DT	O
maximum	NN	O
lod	NN	O
score	NN	O
(	-LRB-	O
zmax	NN	O
of	IN	O
7	CD	O
.	.	O

47	CD	O
was	VBD	O
obtained	VBN	O
at	IN	O
a	DT	O
recombination	NN	O
frequency	NN	O
(	-LRB-	O
theta	NN	O
)	-RRB-	O
of	IN	O
0	CD	O
.	.	O

047	CD	O
(	-LRB-	O
male	NN	O
theta	NN	O
=	JJ	O
female	JJ	O
theta	NN	O
)	-RRB-	O
.	.	O

No	DT	O
recombination	NN	O
(	-LRB-	O
maximum	NN	O
lod	NN	O
score	NN	O
of	IN	O
5	CD	O
.	.	O

61	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

0	CD	O
)	-RRB-	O
was	VBD	O
found	VBN	O
between	IN	O
APOE	NNP	O
and	CC	O
the	DT	O
apolipoprotein	NN	O
CII	NN	O
(	-LRB-	O
APOC2	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
APOC2	NN	O
,	,	O
APOE	NNP	O
is	VBZ	O
a	DT	O
useful	JJ	O
marker	NN	O
for	IN	O
presymptomatic	JJ	O
DM	NN	B-Disease
diagnosis	NN	O
.	.	O

Confirmation	NN	O
of	IN	O
BRCA1	NN	O
by	IN	O
analysis	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
linked	VBN	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
in	IN	O
ten	CD	O
families	NNS	O
.	.	O

We	PRP	O
provide	VBP	O
genetic	JJ	O
evidence	NN	O
supporting	VBG	O
the	DT	O
identity	NN	O
of	IN	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
BRCA1	NN	O
through	IN	O
the	DT	O
characterization	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
63	CD	O
breast	NN	B-Disease
cancer	NN	I-Disease
patients	NNS	O
and	CC	O
10	CD	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
patients	NNS	O
in	IN	O
ten	CD	O
families	NNS	O
with	IN	O
cancer	NN	B-Disease
linked	VBN	O
to	TO	O
chromosome	NN	O
17q21	NN	O
.	.	O

Nine	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
by	IN	O
screening	VBG	O
BRCA1	NN	O
DNA	NN	O
and	CC	O
RNA	NN	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

Seven	CD	O
mutations	NNS	O
lead	VBP	O
to	TO	O
protein	NN	O
truncations	NNS	O
at	IN	O
sites	NNS	O
throughout	IN	O
the	DT	O
gene	NN	O
.	.	O

One	CD	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
which	WDT	O
occurred	VBD	O
independently	RB	O
in	IN	O
two	CD	O
families	NNS	O
)	-RRB-	O
leads	VBZ	O
to	TO	O
loss	NN	O
of	IN	O
a	DT	O
cysteine	NN	O
in	IN	O
the	DT	O
zinc	NN	O
binding	NN	O
domain	NN	O
.	.	O

An	DT	O
intronic	JJ	O
single	JJ	O
basepair	NN	O
substitution	NN	O
destroys	VBZ	O
an	DT	O
acceptor	NN	O
site	NN	O
and	CC	O
activates	VBZ	O
a	DT	O
cryptic	JJ	O
splice	NN	O
site	NN	O
,	,	O
leading	VBG	O
to	TO	O
a	DT	O
59	CD	O
basepair	NN	O
insertion	NN	O
and	CC	O
chain	NN	O
termination	NN	O
.	.	O

The	DT	O
four	CD	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
had	VBD	O
chain	NN	O
termination	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
N-terminal	JJ	O
half	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

.	.	O

Genetic	JJ	O
instability	NN	O
in	IN	O
human	JJ	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
cell	NN	O
lines	NNS	O
.	.	O

We	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
stability	NN	O
of	IN	O
microsatellites	NNS	O
in	IN	O
cell	NN	O
lines	NNS	O
derived	VBN	O
from	IN	O
human	JJ	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
and	CC	O
found	VBD	O
that	IN	O
5	CD	O
out	IN	O
of	IN	O
10	CD	O
of	IN	O
the	DT	O
ovarian	JJ	B-Disease
tumor	NN	I-Disease
cell	NN	O
lines	NNS	O
are	VBP	O
genetically	RB	O
unstable	JJ	O
at	IN	O
the	DT	O
majority	NN	O
of	IN	O
the	DT	O
loci	NNS	O
analyzed	VBN	O
.	.	O

In	IN	O
clones	NNS	O
and	CC	O
subclones	NNS	O
derived	VBN	O
serially	RB	O
from	IN	O
one	CD	O
of	IN	O
these	DT	O
cell	NN	O
lines	NNS	O
(	-LRB-	O
2774	CD	O
;	:	O
serous	JJ	B-Disease
cystadenocarcinoma	NN	I-Disease
)	-RRB-	O
,	,	O
a	DT	O
very	RB	O
high	JJ	O
proportion	NN	O
of	IN	O
microsatellites	NNS	O
distributed	VBN	O
in	IN	O
many	JJ	O
different	JJ	O
regions	NNS	O
of	IN	O
the	DT	O
genome	NN	O
change	VB	O
their	PRP$	O
size	NN	O
in	IN	O
a	DT	O
mercurial	JJ	O
fashion	NN	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
genomic	JJ	O
instability	NN	O
in	IN	O
ovarian	JJ	B-Disease
tumors	NNS	I-Disease
is	VBZ	O
a	DT	O
dynamic	JJ	O
and	CC	O
ongoing	JJ	O
process	NN	O
whose	WP$	O
high	JJ	O
frequency	NN	O
may	MD	O
have	VB	O
been	VBN	O
previously	RB	O
underestimated	VBN	O
by	IN	O
PCR-based	JJ	O
allelotyping	NN	O
of	IN	O
bulk	JJ	O
tumor	NN	B-Disease
tissue	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
the	DT	O
source	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
instability	NN	O
in	IN	O
one	CD	O
ovarian	JJ	B-Disease
tumor	NN	I-Disease
as	IN	O
a	DT	O
point	NN	O
mutation	NN	O
(	-LRB-	O
R524P	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
human	JJ	O
mismatch-repair	NN	O
gene	NN	O
MSH2	NN	O
(	-LRB-	O
Salmonella	FW	O
MutS	NN	O
homologue	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
has	VBZ	O
recently	RB	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
involved	VBN	O
in	IN	O
hereditary	JJ	B-Disease
nonpolyposis	JJ	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Patient	NN	O
2774	CD	O
was	VBD	O
a	DT	O
38-year-old	JJ	O
heterozygote	NN	O
,	,	O
and	CC	O
her	PRP$	O
normal	JJ	O
tissue	NN	O
carried	VBD	O
both	CC	O
mutant	JJ	O
and	CC	O
wild-type	JJ	O
alleles	NNS	O
of	IN	O
the	DT	O
human	JJ	O
MSH2	NN	O
gene	NN	O
.	.	O

However	RB	O
the	DT	O
wild-type	JJ	O
allele	NN	O
was	VBD	O
lost	VBN	O
at	IN	O
some	DT	O
point	NN	O
early	RB	O
during	IN	O
tumorigenesis	NN	O
so	IN	O
that	IN	O
DNA	NN	O
isolated	VBN	O
either	CC	O
from	IN	O
the	DT	O
patients	NNS	O
ovarian	JJ	B-Disease
tumor	NN	I-Disease
or	CC	O
from	IN	O
the	DT	O
2774	CD	O
cell	NN	O
line	NN	O
carries	VBZ	O
only	RB	O
the	DT	O
mutant	JJ	O
allele	NN	O
of	IN	O
the	DT	O
human	JJ	O
MSH2	NN	O
gene	NN	O
.	.	O

The	DT	O
genetic	JJ	O
instability	NN	O
observed	VBN	O
in	IN	O
the	DT	O
tumor	NN	B-Disease
and	CC	O
cell	NN	O
line	NN	O
DNA	NN	O
,	,	O
together	RB	O
with	IN	O
the	DT	O
germ-line	NN	O
mutation	NN	O
in	IN	O
a	DT	O
mismatch-repair	JJ	O
gene	NN	O
,	,	O
suggest	VBP	O
that	IN	O
the	DT	O
MSH2	NN	O
gene	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
onset	NN	O
and/or	CC	O
progression	NN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

.	.	O

Retroviral-mediated	JJ	O
gene	NN	O
transfer	NN	O
of	IN	O
human	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
into	IN	O
NIH	NN	O
3T3	NN	O
and	CC	O
hepatoma	NN	B-Disease
cells	NNS	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
hepatic	JJ	I-Disease
enzyme	NN	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

A	DT	O
full-length	JJ	O
human	JJ	O
PAH	NN	O
cDNA	NN	O
sequence	NN	O
has	VBZ	O
been	VBN	O
inserted	VBN	O
into	IN	O
pzip-neoSV	NN	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
retroviral	JJ	O
vector	NN	O
containing	VBG	O
the	DT	O
bacterial	JJ	O
neo	NN	O
gene	NN	O
.	.	O

The	DT	O
recombinant	JJ	O
has	VBZ	O
been	VBN	O
transfected	VBN	O
into	IN	O
psi	NN	O
2	CD	O
cells	NNS	O
,	,	O
which	WDT	O
provide	VBP	O
synthesis	NN	O
of	IN	O
the	DT	O
retroviral	JJ	O
capsid	NN	O
.	.	O

Recombinant	JJ	O
virus	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
culture	NN	O
medium	NN	O
of	IN	O
the	DT	O
transfected	VBN	O
psi	NN	O
2	CD	O
cells	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
transmitting	VBG	O
the	DT	O
human	JJ	O
PAH	NN	O
gene	NN	O
into	IN	O
mouse	NN	O
NIH	NN	O
3T3	NN	O
cells	NNS	O
by	IN	O
infection	NN	O
leading	VBG	O
to	TO	O
stable	JJ	O
incorporation	NN	O
of	IN	O
the	DT	O
recombinant	JJ	O
provirus	NN	O
.	.	O

Infected	JJ	O
cells	NNS	O
express	VBP	O
PAH	NN	O
mRNA	NN	O
,	,	O
immunoreactive	JJ	O
PAH	NN	O
protein	NN	O
,	,	O
and	CC	O
exhibit	VBP	O
pterin-dependent	JJ	O
phenylalanine	NN	O
hydroxylase	NN	O
activity	NN	O
.	.	O

The	DT	O
recombinant	JJ	O
virus	NN	O
is	VBZ	O
also	RB	O
capable	JJ	O
of	IN	O
infecting	VBG	O
a	DT	O
mouse	NN	O
hepatoma	NN	B-Disease
cell	NN	O
line	NN	O
that	WDT	O
does	VBZ	O
not	RB	O
normally	RB	O
synthesize	VB	O
PAH	NN	O
.	.	O

PAH	NN	O
activity	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
cellular	JJ	O
extracts	NNS	O
and	CC	O
the	DT	O
entire	JJ	O
hydroxylation	NN	O
system	NN	O
is	VBZ	O
reconstituted	VBN	O
in	IN	O
the	DT	O
hepatoma	NN	B-Disease
cells	NNS	O
infected	VBN	O
with	IN	O
the	DT	O
recombinant	JJ	O
viruses	NNS	O
.	.	O

Thus	RB	O
,	,	O
recombinant	JJ	O
viruses	NNS	O
containing	VBG	O
human	JJ	O
PAH	NN	O
cDNA	NN	O
provide	VBP	O
a	DT	O
means	NN	O
for	IN	O
introducing	VBG	O
functional	JJ	O
PAH	NN	O
into	IN	O
mammalian	JJ	O
cells	NNS	O
of	IN	O
hepatic	JJ	O
origin	NN	O
and	CC	O
can	MD	O
potentially	RB	O
be	VB	O
introduced	VBN	O
into	IN	O
whole	JJ	O
animals	NNS	O
as	IN	O
a	DT	O
model	NN	O
for	IN	O
somatic	JJ	O
gene	NN	O
therapy	NN	O
for	IN	O
PKU	NNP	B-Disease
.	.	O

.	.	O

Characterisation	NN	O
of	IN	O
molecular	JJ	O
defects	NNS	O
in	IN	O
X-linked	JJ	B-Disease
amelogenesis	NN	I-Disease
imperfecta	NN	I-Disease
(	-LRB-	O
AIH1	NN	O
)	-RRB-	O
.	.	O

Amelogenins	NNS	O
are	VBP	O
an	DT	O
heterogenous	JJ	O
family	NN	O
of	IN	O
proteins	NNS	O
produced	VBN	O
by	IN	O
ameloblasts	NNS	O
of	IN	O
the	DT	O
enamel	NN	O
organ	NN	O
during	IN	O
tooth	NN	O
development	NN	O
.	.	O

Disturbances	NNS	O
of	IN	O
enamel	NN	O
formation	NN	O
occur	VBP	O
in	IN	O
amelogenesis	NN	B-Disease
imperfecta	NN	I-Disease
,	,	O
a	DT	O
clinically	RB	O
heterogenous	JJ	O
group	NN	O
of	IN	O
inherited	VBN	B-Disease
disorders	NNS	I-Disease
characterised	VBN	O
by	IN	O
defective	JJ	O
enamel	NN	O
biomineralisation	NN	O
.	.	O

An	DT	O
amelogenin	NN	O
gene	NN	O
,	,	O
AMGX	NNP	O
,	,	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
the	DT	O
short	JJ	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
(	-LRB-	O
Xp22	NN	O
.	.	O

1-p22	NN	O
.	.	O

3	LS	O
)	-RRB-	O
and	CC	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
molecular	JJ	O
pathology	NN	O
of	IN	O
X-linked	JJ	B-Disease
amelogenesis	NN	I-Disease
imperfecta	NN	I-Disease
(	-LRB-	O
AIH1	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
three	CD	O
families	NNS	O
exhibiting	VBG	O
AIH1	NN	B-Disease
and	CC	O
screened	VBD	O
the	DT	O
AMGX	NN	O
gene	NN	O
for	IN	O
mutations	NNS	O
using	VBG	O
single-strand	JJ	O
conformational	JJ	O
polymorphism	NN	O
analysis	NN	O
and	CC	O
DNA	NN	O
sequencing	NN	O
.	.	O

Three	CD	O
novel	JJ	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
a	DT	O
C-T	NN	O
substitution	NN	O
in	IN	O
exon	NN	O
5	CD	O
,	,	O
and	CC	O
a	DT	O
G-T	NN	O
substitution	NN	O
and	CC	O
single	JJ	O
cytosine	NN	O
deletion	NN	O
in	IN	O
exon	NN	O
6	CD	O
,	,	O
confirming	VBG	O
the	DT	O
existence	NN	O
of	IN	O
extensive	JJ	O
allelic	JJ	O
heterogeneity	NN	O
in	IN	O
this	DT	O
condition	NN	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
family-specific	JJ	O
mutations	NNS	O
will	MD	O
enable	VB	O
early	JJ	O
identification	NN	O
of	IN	O
affected	JJ	O
individuals	NNS	O
and	CC	O
correlation	NN	O
of	IN	O
clinical	JJ	O
phenotype	NN	O
with	IN	O
genotype	NN	O
will	MD	O
facilitate	VB	O
an	DT	O
objective	JJ	O
system	NN	O
of	IN	O
disease	NN	O
classification	NN	O
.	.	O

The	DT	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
chloride-iodide	NN	O
transport	NN	O
protein	NN	O
.	.	O

Pendred	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
syndromic	JJ	B-Disease
deafness	NN	I-Disease
and	CC	O
characterized	VBN	O
by	IN	O
congenital	JJ	O
sensorineural	JJ	B-Disease
hearing	NN	I-Disease
loss	NN	I-Disease
and	CC	O
goitre	NN	B-Disease
.	.	O

This	DT	O
disorder	NN	O
was	VBD	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
7	CD	O
and	CC	O
the	DT	O
gene	NN	O
causing	VBG	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PDS	NN	B-Disease
)	-RRB-	O
was	VBD	O
subsequently	RB	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	NN	O
.	.	O

PDS	NN	O
encodes	VBZ	O
a	DT	O
putative	JJ	O
transmembrane	NN	O
protein	NN	O
designated	VBN	O
pendrin	NN	O
.	.	O

Pendrin	NNP	O
is	VBZ	O
closely	RB	O
related	JJ	O
to	TO	O
a	DT	O
family	NN	O
of	IN	O
sulfate	NN	O
transport	NN	O
proteins	NNS	O
that	WDT	O
includes	VBZ	O
the	DT	O
rat	NN	O
sulfate-anion	JJ	O
transporter	NN	O
(	-LRB-	O
encoded	VBN	O
by	IN	O
Sat-1	NN	O
;	:	O
29	CD	O
%	NN	O
amino	NN	O
acid	NN	O
sequence	NN	O
identity	NN	O
)	-RRB-	O
,	,	O
the	DT	O
human	JJ	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
sulfate	NN	O
transporter	NN	O
(	-LRB-	O
encoded	VBN	O
by	IN	O
DTD	NN	O
;	:	O
32	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
human	JJ	O
sulfate	NN	O
transporter	NN	O
downregulated	VBD	O
in	IN	O
adenoma	NN	B-Disease
(	-LRB-	O
encoded	VBN	O
by	IN	O
DRA	NN	O
;	:	O
45	CD	O
%	NN	O
)	-RRB-	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
this	DT	O
homology	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
slightly	RB	O
modified	VBN	O
sulfate-transporter	JJ	O
signature	NN	O
sequence	NN	O
comprising	VBG	O
its	PRP$	O
putative	JJ	O
second	JJ	O
transmembrane	NN	O
domain	NN	O
,	,	O
pendrin	NN	O
has	VBZ	O
been	VBN	O
proposed	VBN	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
sulfate	NN	O
transporter	NN	O
.	.	O

We	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
detect	VB	O
evidence	NN	O
of	IN	O
sulfate	NN	O
transport	NN	O
following	VBG	O
the	DT	O
expression	NN	O
of	IN	O
pendrin	NN	O
in	IN	O
Xenopus	NN	O
laevis	NN	O
oocytes	NNS	O
by	IN	O
microinjection	NN	O
of	IN	O
PDS	NN	O
cRNA	NN	O
or	CC	O
in	IN	O
Sf9	NN	O
cells	NNS	O
following	VBG	O
infection	NN	O
with	IN	O
PDS-recombinant	JJ	O
baculovirus	NN	O
.	.	O

The	DT	O
rates	NNS	O
of	IN	O
transport	NN	O
for	IN	O
iodide	NN	O
and	CC	O
chloride	NN	O
were	VBD	O
significantly	RB	O
increased	VBN	O
following	VBG	O
the	DT	O
expression	NN	O
of	IN	O
pendrin	NN	O
in	IN	O
both	DT	O
cell	NN	O
systems	NNS	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
pendrin	NN	O
functions	NNS	O
as	IN	O
a	DT	O
transporter	NN	O
of	IN	O
chloride	NN	O
and	CC	O
iodide	NN	O
,	,	O
but	CC	O
not	RB	O
sulfate	NN	O
,	,	O
and	CC	O
may	MD	O
provide	VB	O
insight	NN	O
into	IN	O
thyroid	NN	O
physiology	NN	O
and	CC	O
the	DT	O
pathophysiology	NN	O
of	IN	O
Pendred	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

Linkage	NN	O
relationship	NN	O
of	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
HLA	NN	O
and	CC	O
glyoxalase	NN	O
I	PRP	O
loci	NNS	O
.	.	O

Immunogenetic	JJ	O
analysis	NN	O
of	IN	O
a	DT	O
homozygous	JJ	O
C2-deficient	JJ	B-Disease
individual	NN	O
and	CC	O
family	NN	O
members	NNS	O
demonstrated	VBD	O
linkage	NN	O
of	IN	O
HLA-A25	NN	O
,	,	O
B18	NN	O
and	CC	O
C2o	NN	O
.	.	O

HLA-D	NN	O
typing	NN	O
showed	VBD	O
that	IN	O
5	CD	O
members	NNS	O
typed	VBN	O
with	IN	O
homozygous	JJ	O
Dw2	NN	O
typing	NN	O
cells	NNS	O
from	IN	O
an	DT	O
individual	JJ	O
with	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
but	CC	O
not	RB	O
with	IN	O
Dw2	NN	O
typing	NN	O
cells	NNS	O
from	IN	O
2	CD	O
individuals	NNS	O
with	IN	O
normal	JJ	O
C2	NN	O
.	.	O

The	DT	O
homozygous	JJ	O
C2-deficient	JJ	B-Disease
propositus	NN	O
and	CC	O
brother	NN	O
were	VBD	O
HLA-A	NN	O
and	CC	O
B	NN	O
homozygous	JJ	O
but	CC	O
heterozygous	JJ	O
at	IN	O
the	DT	O
HLA-D	NN	O
and	CC	O
glyoxalase	NN	O
I	PRP	O
loci	NNS	O
.	.	O

Therefore	RB	O
,	,	O
in	IN	O
this	DT	O
family	NN	O
,	,	O
the	DT	O
C2o	NN	O
gene	NN	O
is	VBZ	O
linked	VBN	O
with	IN	O
two	CD	O
distinct	JJ	O
haplotypes	NNS	O
HLA-A25	NN	O
,	,	O
B18	NN	O
,	,	O
Dw2	NN	O
,	,	O
GLO1	NN	O
and	CC	O
HLA-A25	NN	O
,	,	O
B18	NN	O
,	,	O
D	NN	O
unknown	JJ	O
,	,	O
GL02	NN	O
.	.	O

These	DT	O
results	NNS	O
could	MD	O
be	VB	O
explained	VBN	O
by	IN	O
an	DT	O
ancestral	JJ	O
recombinant	JJ	O
event	NN	O
,	,	O
which	WDT	O
occurred	VBD	O
between	IN	O
the	DT	O
C2o	NN	O
locus	NN	O
and	CC	O
HLA-D	NN	O
locus	NN	O
in	IN	O
which	WDT	O
C2o	NN	O
segregated	VBD	O
with	IN	O
HLA-B	NN	O
.	.	O

This	DT	O
would	MD	O
suggest	VB	O
that	IN	O
the	DT	O
locus	NN	O
for	IN	O
the	DT	O
C2o	NN	O
gene	NN	O
maps	NNS	O
between	IN	O
HLA-B	NN	O
and	CC	O
HLA-D	NN	O
on	IN	O
the	DT	O
sixth	JJ	O
chromosome	NN	O
.	.	O

.	.	O

A	DT	O
71-kilodalton	JJ	O
protein	NN	O
is	VBZ	O
a	DT	O
major	JJ	O
product	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
in	IN	O
brain	NN	O
and	CC	O
other	JJ	O
nonmuscle	JJ	O
tissues	NNS	O
.	.	O

The	DT	O
known	JJ	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
products	NNS	O
,	,	O
the	DT	O
muscle	NN	O
-	:	O
and	CC	O
brain-type	JJ	O
dystrophin	NN	O
isoforms	NNS	O
,	,	O
are	VBP	O
427-kDa	JJ	O
proteins	NNS	O
translated	VBN	O
from	IN	O
14-kilobase	JJ	O
(	-LRB-	O
kb	NN	O
)	-RRB-	O
mRNAs	NNS	O
.	.	O

Recently	RB	O
we	PRP	O
described	VBD	O
a	DT	O
6	CD	O
.	.	O

5-kb	JJ	O
mRNA	NN	O
that	WDT	O
also	RB	O
is	VBZ	O
transcribed	VBN	O
from	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

Cloning	NN	O
and	CC	O
in	FW	O
vitro	FW	O
transcription	NN	O
and	CC	O
translation	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
show	VBP	O
that	IN	O
the	DT	O
6	CD	O
.	.	O

5-kb	JJ	O
mRNA	NN	O
encodes	VBZ	O
a	DT	O
70	CD	O
.	.	O

8-kDa	JJ	O
protein	NN	O
that	WDT	O
is	VBZ	O
a	DT	O
major	JJ	O
product	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
.	.	O

It	PRP	O
contains	VBZ	O
the	DT	O
C-terminal	JJ	O
and	CC	O
the	DT	O
cysteine-rich	JJ	O
domains	NNS	O
of	IN	O
dystrophin	NN	O
,	,	O
seven	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
at	IN	O
the	DT	O
N	NN	O
terminus	NN	O
,	,	O
and	CC	O
some	DT	O
modifications	NNS	O
formed	VBN	O
by	IN	O
alternative	JJ	O
splicing	NN	O
in	IN	O
the	DT	O
C-terminal	JJ	O
domain	NN	O
.	.	O

It	PRP	O
lacks	VBZ	O
the	DT	O
entire	JJ	O
large	JJ	O
domain	NN	O
of	IN	O
spectrin-like	JJ	O
repeats	NNS	O
and	CC	O
the	DT	O
actin-binding	JJ	O
N-terminal	JJ	O
domain	NN	O
of	IN	O
dystrophin	NN	O
.	.	O

This	DT	O
protein	NN	O
is	VBZ	O
the	DT	O
major	JJ	O
DMD	NN	B-Disease
gene	NN	O
product	NN	O
in	IN	O
brain	NN	O
and	CC	O
other	JJ	O
nonmuscle	JJ	O
tissues	NNS	O
but	CC	O
is	VBZ	O
undetectable	JJ	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
extracts	NNS	O
.	.	O

Histidinemia	NNP	B-Disease
.	.	O

Classical	JJ	O
and	CC	O
atypical	JJ	O
form	NN	O
in	IN	O
siblings	NNS	O
.	.	O

Two	CD	O
brothers	NNS	O
,	,	O
6	CD	O
and	CC	O
13	CD	O
years	NNS	O
old	JJ	O
,	,	O
had	VBD	O
histidinemia	NN	B-Disease
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
observations	NNS	O
,	,	O
the	DT	O
younger	JJR	O
boy	NN	O
was	VBD	O
considered	VBN	O
to	TO	O
have	VB	O
a	DT	O
classical	JJ	O
type	NN	O
of	IN	O
the	DT	O
disease	NN	O
,	,	O
while	IN	O
the	DT	O
older	JJR	O
boy	NN	O
had	VBD	O
an	DT	O
atypical	JJ	O
form	NN	O
characterized	VBN	O
by	IN	O
partial	JJ	O
impairment	NN	O
of	IN	O
the	DT	O
skin	NN	O
histidase	NN	O
activity	NN	O
and	CC	O
a	DT	O
moderately	RB	O
prolonged	JJ	O
half-life	NN	O
of	IN	O
blood	NN	O
histidine	NN	O
.	.	O

The	DT	O
mother	NN	O
is	VBZ	O
a	DT	O
heterozygous	JJ	O
carrier	NN	O
,	,	O
while	IN	O
the	DT	O
father	NN	O
and	CC	O
sister	NN	O
seem	VBP	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O

.	.	O

Hypoxanthine-guanine	JJ	B-Disease
phosphoribosyltransferase	NN	I-Disease
deficiency	NN	I-Disease
:	:	O
analysis	NN	O
of	IN	O
HPRT	NN	O
mutations	NNS	O
by	IN	O
direct	JJ	O
sequencing	NN	O
and	CC	O
allele-specific	JJ	O
amplification	NN	O
.	.	O

The	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
severe	JJ	O
X	NN	B-Disease
chromosome-linked	JJ	I-Disease
human	JJ	I-Disease
disease	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
virtual	JJ	O
absence	NN	B-Disease
of	IN	I-Disease
hypoxanthine-guanine	JJ	I-Disease
phosphoribosyltransferase	NN	I-Disease
(	-LRB-	I-Disease
HPRT	NN	I-Disease
)	-RRB-	I-Disease
activity	NN	I-Disease
.	.	O

A	DT	O
partial	JJ	O
deficiency	NN	O
in	IN	O
the	DT	O
activity	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
can	MD	O
result	VB	O
in	IN	O
gouty	JJ	B-Disease
arthritis	NN	I-Disease
.	.	O

To	TO	O
determine	VB	O
the	DT	O
genetic	JJ	O
basis	NN	O
for	IN	O
reduction	NN	O
or	CC	O
loss	NN	O
of	IN	O
enzyme	NN	O
activity	NN	O
,	,	O
we	PRP	O
have	VBP	O
amplified	VBN	O
and	CC	O
sequenced	VBN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
HPRT	NNP	O
cDNA	NN	O
from	IN	O
four	CD	O
patients	NNS	O
one	CD	O
with	IN	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
HPRTPerth	NN	O
)	-RRB-	O
and	CC	O
three	CD	O
with	IN	O
partial	JJ	B-Disease
deficiencies	NNS	I-Disease
of	IN	I-Disease
HPRT	NN	I-Disease
activity	NN	I-Disease
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
designated	VBN	O
HPRTUrangan	NN	O
,	,	O
HPRTSwan	NN	O
and	CC	O
HPRTToowong	NN	O
.	.	O

In	IN	O
all	DT	O
four	CD	O
patients	NNS	O
,	,	O
the	DT	O
only	JJ	O
mutation	NN	O
identified	VBD	O
was	VBD	O
a	DT	O
single	JJ	O
base	NN	O
substitution	NN	O
in	IN	O
exons	NNS	O
2	CD	O
or	CC	O
3	CD	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
,	,	O
which	WDT	O
in	IN	O
each	DT	O
case	NN	O
predicts	VBZ	O
a	DT	O
single	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
in	IN	O
the	DT	O
translated	VBN	O
protein	NN	O
.	.	O

Each	DT	O
base	NN	O
change	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
allele-specific	JJ	O
amplification	NN	O
of	IN	O
the	DT	O
patients	NNS	O
genomic	JJ	O
DNA	NN	O
.	.	O

It	PRP	O
is	VBZ	O
interesting	JJ	O
to	TO	O
note	VB	O
that	IN	O
the	DT	O
mutation	NN	O
found	VBN	O
for	IN	O
HPRTPerth	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
reported	VBN	O
for	IN	O
HPRTFlint	NN	O
.	.	O

It	PRP	O
appears	VBZ	O
that	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
are	VBP	O
de	FW	O
novo	FW	O
events	NNS	O
.	.	O

.	.	O

Sjogren-Larsson	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

Impaired	JJ	O
fatty	JJ	O
alcohol	NN	O
oxidation	NN	O
in	IN	O
cultured	VBN	O
fibroblasts	NNS	O
due	JJ	O
to	TO	O
deficient	JJ	O
fatty	JJ	O
alcohol	NN	O
:	:	O
nicotinamide	NN	O
adenine	NN	O
dinucleotide	NN	O
oxidoreductase	NN	O
activity	NN	O
.	.	O

Lipid	NN	O
metabolism	NN	O
was	VBD	O
studied	VBN	O
in	IN	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
,	,	O
Sjogren-Larsson	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
SLS	NN	B-Disease
)	-RRB-	O
.	.	O

Intact	JJ	O
SLS	NN	B-Disease
fibroblasts	NNS	O
incubated	VBN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
[	-LRB-	O
1-14C	NN	O
]	-RRB-	O
palmitate	NN	O
accumulated	VBN	O
more	RBR	O
radioactive	JJ	O
hexadecanol	NN	O
than	IN	O
did	VBD	O
normal	JJ	O
cells	NNS	O
,	,	O
whereas	IN	O
incorporation	NN	O
of	IN	O
radioactivity	NN	O
into	IN	O
other	JJ	O
cellular	JJ	O
lipids	NNS	O
was	VBD	O
unaltered	JJ	O
.	.	O

The	DT	O
hexadecanol	NN	O
content	NN	O
of	IN	O
SLS	NN	B-Disease
fibroblasts	NNS	O
was	VBD	O
abnormally	RB	O
elevated	JJ	O
.	.	O

Hexadecanol	NNP	O
accumulation	NN	O
was	VBD	O
not	RB	O
due	JJ	O
to	TO	O
increased	VBN	O
fatty	JJ	O
alcohol	NN	O
synthesis	NN	O
nor	CC	O
its	PRP$	O
deficient	JJ	O
utilization	NN	O
for	IN	O
glycerol	NN	O
ether	NN	O
synthesis	NN	O
.	.	O

The	DT	O
half-life	NN	O
of	IN	O
intracellular	JJ	O
hexadecanol	NN	O
loaded	VBN	O
into	IN	O
SLS	NN	B-Disease
fibroblasts	NNS	O
was	VBD	O
increased	VBN	O
(	-LRB-	O
70	CD	O
min	NN	O
)	-RRB-	O
compared	VBN	O
with	IN	O
normal	JJ	O
(	-LRB-	O
15	CD	O
min	NN	O
)	-RRB-	O
,	,	O
and	CC	O
intact	JJ	O
SLS	NN	B-Disease
fibroblasts	NNS	O
showed	VBD	O
impaired	JJ	O
oxidation	NN	O
of	IN	O
[	-LRB-	O
14C	NN	O
]	-RRB-	O
-	:	O
hexadecanol	NN	O
to	TO	O
fatty	JJ	O
acid	NN	O
.	.	O

Fatty	JJ	O
alcohol	NN	O
NAD	NNP	O
+	CC	O
oxidoreductase	NN	O
,	,	O
the	DT	O
enzyme	NN	O
catalyzing	VBG	O
this	DT	O
reaction	NN	O
,	,	O
was	VBD	O
deficient	JJ	O
in	IN	O
SLS	NN	B-Disease
fibroblasts	NNS	O
.	.	O

Mean	NN	O
total	NN	O
activity	NN	O
in	IN	O
SLS	NN	B-Disease
fibroblasts	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
5	CD	O
)	-RRB-	O
was	VBD	O
13	CD	O
%	NN	O
of	IN	O
that	DT	O
in	IN	O
normal	JJ	O
fibroblasts	NNS	O
,	,	O
and	CC	O
palmitoyl	NN	O
CoA-inhibitable	JJ	O
activity	NN	O
was	VBD	O
1	CD	O
%	NN	O
of	IN	O
normal	JJ	O
.	.	O

Fibroblasts	NNS	O
from	IN	O
two	CD	O
obligate	JJ	O
SLS	NN	B-Disease
heterozygotes	NNS	O
had	VBD	O
enzyme	NN	O
activities	NNS	O
intermediate	JJ	O
between	IN	O
that	DT	O
in	IN	O
normal	JJ	O
fibroblasts	NNS	O
and	CC	O
individuals	NNS	O
with	IN	O
SLS	NN	B-Disease
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
primary	JJ	O
defect	NN	O
in	IN	O
SLS	NNP	B-Disease
is	VBZ	O
deficiency	NN	B-Disease
of	IN	I-Disease
fatty	JJ	I-Disease
alcohol	NN	I-Disease
NAD	NNP	I-Disease
+	CC	I-Disease
oxidoreductase	NN	I-Disease
.	.	O

SLS	NN	B-Disease
represents	VBZ	O
the	DT	O
first	JJ	O
inherited	VBN	B-Disease
disorder	NN	I-Disease
in	IN	O
man	NN	O
associated	VBN	O
with	IN	O
an	DT	O
isolated	VBN	O
abnormality	NN	B-Disease
in	IN	I-Disease
fatty	JJ	I-Disease
alcohol	NN	I-Disease
metabolism	NN	I-Disease
.	.	O

.	.	O

Glycerol	NN	O
as	IN	O
a	DT	O
correlate	NN	O
of	IN	O
impaired	JJ	B-Disease
glucose	NN	I-Disease
tolerance	NN	I-Disease
:	:	O
dissection	NN	O
of	IN	O
a	DT	O
complex	JJ	O
system	NN	O
by	IN	O
use	NN	O
of	IN	O
a	DT	O
simple	JJ	O
genetic	JJ	O
trait	NN	O
.	.	O

Glycerol	NN	O
kinase	NN	O
(	-LRB-	O
GK	NN	O
)	-RRB-	O
represents	VBZ	O
the	DT	O
primary	JJ	O
entry	NN	O
of	IN	O
glycerol	NN	O
into	IN	O
glucose	NN	O
and	CC	O
triglyceride	NN	O
metabolism	NN	O
.	.	O

Impaired	JJ	B-Disease
glucose	NN	I-Disease
tolerance	NN	I-Disease
(	-LRB-	O
IGT	NN	B-Disease
)	-RRB-	O
and	CC	O
hypertriglyceridemia	NN	B-Disease
are	VBP	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
diabetes	NN	B-Disease
mellitus	NN	I-Disease
and	CC	O
cardiovascular	JJ	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
relationship	NN	O
between	IN	O
glycerol	NN	O
and	CC	O
the	DT	O
risk	NN	O
of	IN	O
IGT	NNP	B-Disease
,	,	O
however	RB	O
,	,	O
is	VBZ	O
poorly	RB	O
understood	VBN	O
.	.	O

We	PRP	O
therefore	RB	O
undertook	VBD	O
the	DT	O
study	NN	O
of	IN	O
fasting	VBG	O
plasma	NN	O
glycerol	NN	O
levels	NNS	O
in	IN	O
a	DT	O
cohort	NN	O
of	IN	O
1	CD	O
,	,	O
056	CD	O
unrelated	JJ	O
men	NNS	O
and	CC	O
women	NNS	O
of	IN	O
French-Canadian	JJ	O
descent	NN	O
.	.	O

Family	NNP	O
screening	NN	O
in	IN	O
the	DT	O
initial	JJ	O
cohort	NN	O
identified	VBN	O
18	CD	O
men	NNS	O
from	IN	O
five	CD	O
families	NNS	O
with	IN	O
severe	JJ	O
hyperglycerolemia	NN	B-Disease
(	-LRB-	O
values	NNS	O
above	IN	O
2	CD	O
.	.	O

0	CD	O
mmol/liter	NN	O
)	-RRB-	O
and	CC	O
demonstrated	VBD	O
an	DT	O
X-linked	JJ	O
pattern	NN	O
of	IN	O
inheritance	NN	O
.	.	O

Linkage	NN	O
analysis	NN	O
of	IN	O
the	DT	O
data	NNS	O
from	IN	O
12	CD	O
microsatellite	NN	O
markers	NNS	O
surrounding	VBG	O
the	DT	O
Xp21	NN	O
.	.	O

3	CD	O
GK	NN	O
gene	NN	O
resulted	VBD	O
in	IN	O
a	DT	O
peak	JJ	O
LOD	NN	O
score	NN	O
of	IN	O
3	CD	O
.	.	O

46	CD	O
,	,	O
centered	VBN	O
around	IN	O
marker	NN	O
DXS8039	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
since	IN	O
all	DT	O
of	IN	O
the	DT	O
families	NNS	O
originated	VBP	O
in	IN	O
a	DT	O
population	NN	O
with	IN	O
a	DT	O
proven	JJ	O
founder	NN	O
effect-the	JJ	O
Saguenay	NNP	O
Lac-St	NN	O
.	.	O

-	:	O
Jean	NNP	O
region	NN	O
of	IN	O
Quebec-a	NNP	O
common	JJ	O
disease	NN	O
haplotype	NN	O
was	VBD	O
sought	VBN	O
.	.	O

Indeed	RB	O
,	,	O
a	DT	O
six-marker	JJ	O
haplotype	NN	O
extending	VBG	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
5	CD	O
.	.	O

5	CD	O
cM	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
all	DT	O
families	NNS	O
.	.	O

Resequencing	NN	O
of	IN	O
the	DT	O
GK	NNP	O
gene	NN	O
in	IN	O
family	NN	O
members	NNS	O
led	VBD	O
to	TO	O
the	DT	O
discovery	NN	O
of	IN	O
a	DT	O
N288D	NN	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
10	CD	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
asparagine	NN	O
residue	NN	O
by	IN	O
a	DT	O
negatively	RB	O
charged	VBN	O
aspartic	JJ	O
acid	NN	O
.	.	O

Assignment	NN	O
of	IN	O
the	DT	O
aspartylglucosaminidase	NN	O
gene	NN	O
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
to	TO	O
4q33	VB	O
----	:	O
q35	NN	O
based	VBN	O
on	IN	O
decreased	VBN	O
activity	NN	O
in	IN	O
a	DT	O
girl	NN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XX	NNP	O
,	,	O
del	FW	O
(	-LRB-	O
4	LS	O
)	-RRB-	O
(	-LRB-	O
q33	NN	O
)	-RRB-	O
karyotype	NN	O
.	.	O

Aspartylglucosaminuria	NN	B-Disease
(	-LRB-	O
AGU	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
recessive	JJ	O
autosomally	RB	O
inherited	VBN	O
lysosomal	JJ	B-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
due	JJ	O
to	TO	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
enzyme	NN	I-Disease
aspartylglucosaminidase	NN	I-Disease
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
.	.	O

The	DT	O
structural	JJ	O
gene	NN	O
for	IN	O
this	DT	O
human	JJ	O
enzyme	NN	O
(	-LRB-	O
AGA	NN	O
)	-RRB-	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
the	DT	O
region	NN	O
4q21	NN	O
----	:	O
qter	NN	O
.	.	O

We	PRP	O
determined	VBD	O
the	DT	O
AGA	NN	O
activity	NN	O
in	IN	O
cultured	VBN	O
fibroblasts	NNS	O
of	IN	O
a	DT	O
girl	NN	O
with	IN	O
a	DT	O
46	CD	O
,	,	O
XX	NNP	O
,	,	O
del	FW	O
(	-LRB-	O
4	LS	O
)	-RRB-	O
(	-LRB-	O
q33	NN	O
)	-RRB-	O
karyotype	NN	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
girl	NN	O
is	VBZ	O
a	DT	O
hemizygote	NN	O
for	IN	O
AGA	NNP	O
,	,	O
permitting	VBG	O
the	DT	O
assignment	NN	O
of	IN	O
human	JJ	O
AGA	NNP	O
to	TO	O
the	DT	O
region	NN	O
4q33	NN	O
----	:	O
qter	NN	O
.	.	O

.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
fibrinogen	NN	O
aalpha	NN	O
gene	NN	O
account	NN	O
for	IN	O
the	DT	O
majority	NN	O
of	IN	O
cases	NNS	O
of	IN	O
congenital	JJ	B-Disease
afibrinogenemia	NN	I-Disease
.	.	O

Congenital	JJ	B-Disease
afibrinogenemia	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
,	,	O
autosomal	JJ	B-Disease
,	,	I-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
detectable	JJ	O
fibrinogen	NN	O
.	.	O

We	PRP	O
previously	RB	O
identified	VBD	O
the	DT	O
first	JJ	O
causative	JJ	O
mutations	NNS	O
in	IN	O
a	DT	O
nonconsanguineous	JJ	O
Swiss	JJ	O
family	NN	O
;	:	O
the	DT	O
4	CD	O
affected	VBN	O
persons	NNS	O
have	VBP	O
homozygous	JJ	O
deletions	NNS	O
of	IN	O
approximately	RB	O
11	CD	O
kb	NN	O
of	IN	O
the	DT	O
fibrinogen	NN	O
alpha	NN	O
(	-LRB-	O
FGA	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

Haplotype	NN	O
data	NNS	O
implied	VBD	O
that	IN	O
these	DT	O
deletions	NNS	O
occurred	VBD	O
on	IN	O
distinct	JJ	O
ancestral	JJ	O
chromosomes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
region	NN	O
may	MD	O
be	VB	O
susceptible	JJ	O
to	TO	O
deletion	NN	O
by	IN	O
a	DT	O
common	JJ	O
mechanism	NN	O
.	.	O

We	PRP	O
subsequently	RB	O
showed	VBD	O
that	IN	O
all	PDT	O
the	DT	O
deletions	NNS	O
were	VBD	O
identical	JJ	O
to	TO	O
the	DT	O
base	NN	O
pair	NN	O
and	CC	O
probably	RB	O
resulted	VBD	O
from	IN	O
a	DT	O
nonhomologous	JJ	O
recombination	NN	O
mediated	VBN	O
by	IN	O
7-bp	JJ	O
direct	JJ	O
repeats	NNS	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
collected	VBN	O
data	NNS	O
on	IN	O
13	CD	O
additional	JJ	O
unrelated	JJ	O
patients	NNS	O
to	TO	O
identify	VB	O
the	DT	O
causative	JJ	O
mutations	NNS	O
and	CC	O
to	TO	O
determine	VB	O
the	DT	O
prevalence	NN	O
of	IN	O
the	DT	O
11-kb	JJ	O
deletion	NN	O
.	.	O

A	DT	O
common	JJ	O
recurrent	JJ	O
mutation	NN	O
,	,	O
at	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
of	IN	O
FGA	NNP	O
intron	NN	O
4	CD	O
(	-LRB-	O
IVS4	NN	O
+	CC	O
1	CD	O
G	NN	O
>	JJR	O
T	NN	O
)	-RRB-	O
,	,	O
accounted	VBD	O
for	IN	O
14	CD	O
of	IN	O
the	DT	O
26	CD	O
(	-LRB-	O
54	CD	O
%	NN	O
)	-RRB-	O
alleles	NNS	O
.	.	O

One	CD	O
patient	NN	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
previously	RB	O
identified	VBN	O
deletion	NN	O
.	.	O

Three	CD	O
more	JJR	O
frameshift	NN	O
mutations	NNS	O
,	,	O
2	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
and	CC	O
a	DT	O
second	JJ	O
splice	NN	O
site	NN	O
mutation	NN	O
were	VBD	O
also	RB	O
identified	VBN	O
.	.	O

Consequently	RB	O
,	,	O
86	CD	O
%	NN	O
of	IN	O
afibrinogenemia	JJ	B-Disease
alleles	NNS	O
analyzed	VBN	O
to	TO	O
date	NN	O
have	VBP	O
truncating	JJ	O
mutations	NNS	O
of	IN	O
FGA	NNP	O
,	,	O
though	IN	O
mutations	NNS	O
in	IN	O
all	DT	O
3	CD	O
fibrinogen	NN	O
genes	NNS	O
,	,	O
FGG	NN	O
,	,	O
FGA	NN	O
,	,	O
and	CC	O
FGB	NNP	O
,	,	O
might	MD	O
be	VB	O
predicted	VBN	O
to	TO	O
cause	VB	O
congenital	JJ	B-Disease
afibrinogenemia	NN	I-Disease
.	.	O

.	.	O

Utilization	NN	O
of	IN	O
purines	NNS	O
by	IN	O
an	DT	O
HPRT	NN	O
variant	NN	O
in	IN	O
an	DT	O
intelligent	JJ	O
,	,	O
nonmutilative	JJ	O
patient	NN	O
with	IN	O
features	NNS	O
of	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
patient	NN	O
,	,	O
H.	NNP	O
Chr	NN	O
.	.	O

B.	NNP	O
,	,	O
was	VBD	O
among	IN	O
the	DT	O
first	JJ	O
reported	VBN	O
with	IN	O
hyperuricemia	NN	B-Disease
and	CC	O
central	JJ	B-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
symptoms	NNS	I-Disease
.	.	O

He	PRP	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
variant	NN	O
of	IN	O
hypoxanthine	NN	O
guanine	NN	O
phosphoribosyl	NN	O
transferase	NN	O
(	-LRB-	O
HPRT	NN	O
;	:	O
E.	NNP	O
C.	NNP	O
2	CD	O
.	.	O

4	LS	O
.	.	O

2	LS	O
.	.	O

8	CD	O
)	-RRB-	O
distinct	JJ	O
from	IN	O
the	DT	O
enzyme	NN	O
present	JJ	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
patient	NN	O
had	VBD	O
chroeoathetosis	NN	B-Disease
,	,	O
spasticity	NN	B-Disease
,	,	O
dysarthric	JJ	B-Disease
speech	NN	I-Disease
,	,	O
and	CC	O
hyperuricemia	NN	B-Disease
.	.	O

However	RB	O
,	,	O
his	PRP$	O
intelligence	NN	O
was	VBD	O
normal	JJ	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
self-mutilation	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
activity	NN	O
of	IN	O
HPRT	NNP	O
in	IN	O
the	DT	O
lysates	NNS	O
of	IN	O
erythrocytes	NNS	O
and	CC	O
cultured	VBN	O
fibroblasts	NNS	O
when	WRB	O
analyzed	VBN	O
in	IN	O
the	DT	O
usual	JJ	O
manner	NN	O
.	.	O

Using	VBG	O
a	DT	O
newly	RB	O
developed	VBN	O
method	NN	O
for	IN	O
the	DT	O
study	NN	O
of	IN	O
purine	NN	O
metabolism	NN	O
in	IN	O
intact	JJ	O
cultured	VBN	O
cells	NNS	O
,	,	O
this	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
metabolize	VB	O
some	DT	O
9	CD	O
%	NN	O
of	IN	O
8-14C-hypoxanthine	NN	O
,	,	O
and	CC	O
90	CD	O
%	NN	O
of	IN	O
the	DT	O
isotope	NN	O
utilized	VBD	O
was	VBD	O
converted	VBN	O
to	TO	O
adenine	VB	O
and	CC	O
guanine	JJ	O
nucleotides	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease
were	VBD	O
virtually	RB	O
completely	RB	O
unable	JJ	O
to	TO	O
convert	VB	O
hypoxanthine	NN	O
to	TO	O
nucleotides	NNS	O
.	.	O

The	DT	O
patients	NNS	O
fibroblasts	NNS	O
were	VBD	O
even	RB	O
more	RBR	O
efficient	JJ	O
in	IN	O
the	DT	O
metabolism	NN	O
of	IN	O
8-14C-guanine	NN	O
,	,	O
which	WDT	O
was	VBD	O
utilized	VBN	O
to	TO	O
the	DT	O
extent	NN	O
of	IN	O
27	CD	O
%	NN	O
,	,	O
over	IN	O
80	CD	O
%	NN	O
of	IN	O
which	WDT	O
was	VBD	O
converted	VBN	O
to	TO	O
guanine	NN	O
and	CC	O
adenine	NN	O
nucleotides	NNS	O
.	.	O

The	DT	O
growth	NN	O
of	IN	O
the	DT	O
cultured	VBN	O
fibroblasts	NNS	O
of	IN	O
this	DT	O
patient	NN	O
was	VBD	O
intermediate	JJ	O
in	IN	O
media	NNS	O
containing	VBG	O
hypoxanthine	NN	O
aminopterin	NN	O
thymidine	NN	O
(	-LRB-	O
HAT	NN	O
)	-RRB-	O
,	,	O
whereas	IN	O
the	DT	O
growth	NN	O
of	IN	O
Lesch-Nyhan	JJ	B-Disease
cells	NNS	O
was	VBD	O
inhibited	VBN	O
and	CC	O
normal	JJ	O
cells	NNS	O
grew	VBD	O
normally	RB	O
.	.	O

Similarly	RB	O
in	IN	O
8-azaguanine	NN	O
,	,	O
6-thioguanine	NN	O
,	,	O
and	CC	O
8-azahypoxanthine	NN	O
,	,	O
the	DT	O
growth	NN	O
of	IN	O
the	DT	O
patients	NNS	O
cells	NNS	O
was	VBD	O
intermediate	JJ	O
between	IN	O
normal	JJ	O
and	CC	O
Lesch-Nyhan	JJ	B-Disease
cells	NNS	O
.	.	O

These	DT	O
observations	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
genetic	JJ	O
heterogeneity	NN	O
among	IN	O
patients	NNS	O
with	IN	O
disorders	NNS	O
in	IN	O
purine	NN	O
metabolism	NN	O
involving	VBG	O
the	DT	O
HPRT	NN	O
gene	NN	O
.	.	O

They	PRP	O
document	VBP	O
that	IN	O
this	DT	O
famous	JJ	O
patient	NN	O
did	VBD	O
not	RB	O
have	VB	O
the	DT	O
Lesch-Nyhan	JJ	B-Disease
syndrome	NN	I-Disease

Canavan	NN	B-Disease
disease	NN	I-Disease
:	:	O
mutations	NNS	O
among	IN	O
Jewish	JJ	O
and	CC	O
non-Jewish	JJ	O
patients	NNS	O
.	.	O

Canavan	NN	B-Disease
disease	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
leukodystrophy	NN	I-Disease
caused	VBN	O
by	IN	O
the	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
aspartoacylase	NN	I-Disease
(	-LRB-	O
ASPA	NN	O
)	-RRB-	O
.	.	O

Sixty-four	CD	O
probands	NNS	O
were	VBD	O
analyzed	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ASPA	NN	O
gene	NN	O
.	.	O

Three	CD	O
point	NN	O
mutations	NNS	O
--	:	O
693C	NN	O
--	:	O
>	JJR	O
A	NN	O
,	,	O
854A	NN	O
--	:	O
>	JJR	O
C	NN	O
,	,	O
and	CC	O
914C	NN	O
--	:	O
>	JJR	O
A	DT	O
--	:	O
were	VBD	O
identified	VBN	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O

The	DT	O
693C	NN	O
--	:	O
>	JJR	O
A	DT	O
and	CC	O
914C	NN	O
--	:	O
>	JJR	O
A	DT	O
base	NN	O
changes	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
nonsense	NN	O
tyr231	NN	O
--	:	O
>	JJR	O
ter	NN	O
and	CC	O
missense	NN	O
ala305	NN	O
--	:	O
>	JJR	O
glu	NN	O
mutations	NNS	O
,	,	O
respectively	RB	O
,	,	O
lead	VBP	O
to	TO	O
complete	JJ	O
loss	NN	O
of	IN	O
ASPA	NN	O
activity	NN	O
in	IN	O
in	FW	O
vitro	FW	O
expression	NN	O
studies	NNS	O
.	.	O

The	DT	O
854A	NN	O
--	:	O
>	JJR	O
C	NN	O
transversion	NN	O
converted	VBD	O
glu	NN	O
to	TO	O
ala	NN	O
in	IN	O
codon	NN	O
285	CD	O
.	.	O

The	DT	O
glu285	NN	O
--	:	O
>	JJR	O
ala	NN	O
mutant	JJ	O
ASPA	NN	O
has	VBZ	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
the	DT	O
activity	NN	O
expressed	VBN	O
by	IN	O
the	DT	O
wild-type	JJ	O
enzyme	NN	O
.	.	O

A	DT	O
fourth	JJ	O
mutation	NN	O
,	,	O
433	CD	O
--	:	O
2	CD	O
(	-LRB-	O
A	DT	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
transition	NN	O
,	,	O
was	VBD	O
identified	VBN	O
at	IN	O
the	DT	O
splice-acceptor	NN	O
site	NN	O
in	IN	O
intron	NN	O
2	CD	O
.	.	O

The	DT	O
splice-site	NN	O
mutation	NN	O
would	MD	O
lead	VB	O
to	TO	O
skipping	VBG	O
of	IN	O
exon	NN	O
3	CD	O
,	,	O
accompanied	VBN	O
by	IN	O
a	DT	O
frameshift	NN	O
,	,	O
and	CC	O
thus	RB	O
would	MD	O
produce	VB	O
aberrant	JJ	O
ASPA	NN	O
.	.	O

Of	IN	O
the	DT	O
128	CD	O
unrelated	JJ	O
Canavan	NN	B-Disease
chromosomes	NNS	O
analyzed	VBN	O
,	,	O
88	CD	O
were	VBD	O
from	IN	O
probands	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
descent	NN	O
.	.	O

The	DT	O
glu285	NN	O
--	:	O
>	JJR	O
ala	NN	O
mutation	NN	O
was	VBD	O
predominant	JJ	O
(	-LRB-	O
82	CD	O
.	.	O

9	CD	O
%	NN	O
)	-RRB-	O
in	IN	O
this	DT	O
population	NN	O
,	,	O
followed	VBN	O
by	IN	O
the	DT	O
tyr231	NN	O
--	:	O
>	JJR	O
ter	NN	O
(	-LRB-	O
14	CD	O
.	.	O

8	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
433	CD	O
--	:	O
2	CD	O
(	-LRB-	O
A	DT	O
--	:	O
>	JJR	O
G	NN	O
)	-RRB-	O
(	-LRB-	O
1	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
mutations	NNS	O
.	.	O

The	DT	O
three	CD	O
mutations	NNS	O
account	VBP	O
for	IN	O
98	CD	O
.	.	O

8	CD	O
%	NN	O
of	IN	O
the	DT	O
Canavan	NNP	B-Disease
chromosomes	NNS	O
of	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
origin	NN	O
.	.	O

The	DT	O
ala305	NN	O
--	:	O
>	JJR	O
glu	NN	O
mutation	NN	O
was	VBD	O
found	VBN	O
exclusively	RB	O
in	IN	O
non-Jewish	JJ	O
probands	NNS	O
of	IN	O
European	JJ	O
descent	NN	O
and	CC	O
constituted	VBD	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
40	CD	O
mutant	JJ	O
chromosomes	NNS	O
.	.	O

Predominant	JJ	O
occurrence	NN	O
of	IN	O
certain	JJ	O
mutations	NNS	O
among	IN	O
Ashkenazi	NNP	O
Jewish	NNP	O
and	CC	O
non-Jewish	JJ	O
patients	NNS	O
with	IN	O
Canavan	NN	B-Disease
disease	NN	I-Disease
would	MD	O
suggest	VB	O
a	DT	O
founding-father	JJ	O
effect	NN	O
in	IN	O
propagation	NN	O
of	IN	O
these	DT	O
mutant	JJ	O
chromosomes	NNS	O

Identification	NN	O
of	IN	O
deletion	NN	O
mutations	NNS	O
and	CC	O
three	CD	O
new	JJ	O
genes	NNS	O
at	IN	O
the	DT	O
familial	JJ	B-Disease
polyposis	NN	I-Disease
locus	NN	O
.	.	O

Small	JJ	O
(	-LRB-	O
100-260	CD	O
kb	NN	O
)	-RRB-	O
,	,	O
nested	JJ	O
deletions	NNS	O
were	VBD	O
characterized	VBN	O
in	IN	O
DNA	NN	O
from	IN	O
two	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
.	.	O

Three	CD	O
candidate	NN	O
genes	NNS	O
located	JJ	O
within	IN	O
the	DT	O
deleted	VBN	O
region	NN	O
were	VBD	O
ascertained	VBN	O
and	CC	O
a	DT	O
previous	JJ	O
candidate	NN	O
gene	NN	O
,	,	O
MCC	NN	O
,	,	O
was	VBD	O
shown	VBN	O
to	TO	O
be	VB	O
located	JJ	O
outside	IN	O
the	DT	O
deleted	VBN	O
region	NN	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
new	JJ	O
genes	NNS	O
contained	VBN	O
sequence	NN	O
identical	JJ	O
to	TO	O
SRP19	NN	O
,	,	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
the	DT	O
19	CD	O
kd	NN	O
component	NN	O
of	IN	O
the	DT	O
ribosomal	JJ	O
signal	NN	O
recognition	NN	O
particle	NN	O
.	.	O

The	DT	O
second	JJ	O
,	,	O
provisionally	RB	O
designated	VBN	O
DP1	NN	O
(	-LRB-	O
deleted	VBN	O
in	IN	O
polyposis	NN	O
1	CD	O
)	-RRB-	O
,	,	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
transcribed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
orientation	NN	O
as	IN	O
MCC	NN	O
.	.	O

Two	CD	O
other	JJ	O
cDNAs	NNS	O
,	,	O
DP2	NN	O
and	CC	O
DP3	NN	O
,	,	O
were	VBD	O
found	VBN	O
to	TO	O
overlap	VB	O
,	,	O
forming	VBG	O
a	DT	O
single	JJ	O
gene	NN	O
,	,	O
DP2	NN	O
.	.	O

5	CD	O
,	,	O
that	DT	O
is	VBZ	O
transcribed	VBN	O
in	IN	O
the	DT	O
same	JJ	O
orientation	NN	O
as	IN	O
SRP19	NN	O
.	.	O

Genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
families	NNS	O
with	IN	O
deletions	NNS	O
in	IN	O
the	DT	O
von	NN	B-Disease
Hippel-Lindau	NN	I-Disease
(	-LRB-	O
VHL	NN	B-Disease
)	-RRB-	O
gene	NN	O
.	.	O

Von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
(	-LRB-	I-Disease
VHL	NN	I-Disease
)	-RRB-	I-Disease
disease	NN	I-Disease
is	VBZ	O
a	DT	O
hereditary	JJ	B-Disease
tumor	NN	I-Disease
syndrome	NN	I-Disease
characterized	VBN	O
by	IN	O
predisposition	NN	O
for	IN	O
bilateral	JJ	B-Disease
and	CC	I-Disease
multi-centric	JJ	I-Disease
hemangioblastoma	NN	I-Disease
in	IN	O
the	DT	O
retina	NN	O
and	CC	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
pheochromocytoma	NN	B-Disease
,	,	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
,	,	O
and	CC	O
cysts	NNS	B-Disease
in	IN	I-Disease
the	DT	I-Disease
kidney	NN	I-Disease
,	,	I-Disease
pancreas	NN	I-Disease
,	,	I-Disease
and	CC	I-Disease
epididymis	NN	I-Disease
.	.	O

We	PRP	O
describe	VBP	O
five	CD	O
families	NNS	O
for	IN	O
which	WDT	O
direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
had	VBD	O
failed	VBN	O
to	TO	O
identify	VB	O
the	DT	O
family-specific	JJ	O
mutation	NN	O
.	.	O

Further	JJ	O
molecular	JJ	O
analysis	NN	O
revealed	VBD	O
deletions	NNS	O
involving	VBG	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
in	IN	O
each	DT	O
of	IN	O
these	DT	O
families	NNS	O
.	.	O

In	IN	O
four	CD	O
families	NNS	O
,	,	O
partial	JJ	O
deletions	NNS	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
exons	NNS	O
were	VBD	O
detected	VBN	O
by	IN	O
Southern	NN	O
blot	NN	O
analysis	NN	O
.	.	O

In	IN	O
the	DT	O
fifth	JJ	O
family	NN	O
,	,	O
FISH	NN	O
analysis	NN	O
demonstrated	VBD	O
the	DT	O
deletion	NN	O
of	IN	O
the	DT	O
entire	JJ	O
VHL	NN	B-Disease
gene	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
(	-LRB-	O
quantitative	JJ	O
)	-RRB-	O
Southern	NN	O
blot	NN	O
analysis	NN	O
is	VBZ	O
a	DT	O
sensitive	JJ	O
method	NN	O
for	IN	O
detecting	VBG	O
germline	NN	O
deletions	NNS	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
and	CC	O
should	MD	O
be	VB	O
implemented	VBN	O
in	IN	O
routine	JJ	O
DNA	NN	O
diagnosis	NN	O
for	IN	O
VHL	NN	B-Disease
disease	NN	I-Disease
.	.	O

Our	PRP$	O
data	NNS	O
support	VBP	O
the	DT	O
previously	RB	O
established	VBN	O
observation	NN	O
that	IN	O
families	NNS	O
with	IN	O
a	DT	O
germline	NN	O
deletion	NN	O
have	VBP	O
a	DT	O
low	JJ	O
risk	NN	O
for	IN	O
pheochromocytoma	NN	B-Disease
.	.	O

Further	JJ	O
unraveling	NN	O
of	IN	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
VHL	NN	B-Disease
disease	NN	I-Disease
has	VBZ	O
revealed	VBN	O
that	IN	O
families	NNS	O
with	IN	O
a	DT	O
full	JJ	O
or	CC	O
partial	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
exhibit	VBP	O
a	DT	O
phenotype	NN	O
with	IN	O
a	DT	O
preponderance	NN	O
of	IN	O
central	JJ	B-Disease
nervous	JJ	I-Disease
system	NN	I-Disease
hemangioblastoma	NN	I-Disease
.	.	O

.	.	O

Understanding	VBG	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

Fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
a	DT	O
common	JJ	O
form	NN	O
of	IN	O
inherited	VBN	B-Disease
mental	JJ	I-Disease
retardation	NN	I-Disease
,	,	O
is	VBZ	O
mainly	RB	O
caused	VBN	O
by	IN	O
massive	JJ	O
expansion	NN	O
of	IN	O
CGG	NN	O
triplet	NN	O
repeats	NNS	O
located	JJ	O
in	IN	O
the	DT	O
5-untranslated	JJ	O
region	NN	O
of	IN	O
the	DT	O
fragile	JJ	B-Disease
X	NN	I-Disease
mental	JJ	I-Disease
retardation-1	NN	O
(	-LRB-	O
FMR1	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

In	IN	O
patients	NNS	O
with	IN	O
fragile	JJ	B-Disease
X	NN	I-Disease
syndrome	NN	I-Disease
,	,	O
the	DT	O
expanded	VBN	O
CGG	NN	O
triplet	NN	O
repeats	NNS	O
are	VBP	O
hypermethylated	VBN	O
and	CC	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
FMR1	NN	O
gene	NN	O
is	VBZ	O
repressed	VBN	O
,	,	O
which	WDT	O
leads	VBZ	O
to	TO	O
the	DT	O
absence	NN	O
of	IN	O
FMR1	NN	O
protein	NN	O
(	-LRB-	O
FMRP	NN	O
)	-RRB-	O
and	CC	O
subsequent	JJ	O
mental	JJ	B-Disease
retardation	NN	I-Disease
.	.	O

FMRP	NN	O
is	VBZ	O
an	DT	O
RNA-binding	JJ	O
protein	NN	O
that	WDT	O
shuttles	VBZ	O
between	IN	O
the	DT	O
nucleus	NN	O
and	CC	O
cytoplasm	NN	O
.	.	O

This	DT	O
protein	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
protein	NN	O
translation	NN	O
as	IN	O
it	PRP	O
is	VBZ	O
found	VBN	O
associated	VBN	O
with	IN	O
polyribosomes	NNS	O
and	CC	O
the	DT	O
rough	JJ	O
endoplasmic	JJ	O
reticulum	NN	O
.	.	O

We	PRP	O
discuss	VBP	O
here	RB	O
the	DT	O
recent	JJ	O
progress	NN	O
made	VBD	O
towards	IN	O
understanding	VBG	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
of	IN	O
CGG	NN	O
repeat	NN	O
expansion	NN	O
and	CC	O
physiological	JJ	O
function	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
of	IN	O
FMRP	NN	O
.	.	O

These	DT	O
studies	NNS	O
will	MD	O
not	RB	O
only	RB	O
help	VB	O
to	TO	O
illuminate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
general	JJ	O
class	NN	O
of	IN	O
human	JJ	O
diseases	NNS	O
with	IN	O
trinucleotide	JJ	O
repeat	NN	O
expansion	NN	O
but	CC	O
also	RB	O
provide	VBP	O
an	DT	O
avenue	NN	O
to	TO	O
understand	VB	O
aspects	NNS	O
of	IN	O
human	JJ	O
cognition	NN	O
and	CC	O
intelligence	NN	O
.	.	O

.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

The	DT	O
description	NN	O
of	IN	O
13	CD	O
new	JJ	O
variants	NNS	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
362	CD	O
males	NNS	O
from	IN	O
various	JJ	O
regions	NNS	O
of	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
were	VBD	O
screened	VBN	O
for	IN	O
red	JJ	O
cell	NN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
activity	NN	O
.	.	O

Twenty-six	CD	O
G6PD	NN	B-Disease
deficient	JJ	I-Disease
individuals	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

Biochemical	JJ	O
characterization	NN	O
of	IN	O
G6PD	NN	O
purified	VBN	O
from	IN	O
these	DT	O
subjects	NNS	O
has	VBZ	O
revealed	VBN	O
13	CD	O
new	JJ	O
variants	NNS	O
and	CC	O
several	JJ	O
copies	NNS	O
of	IN	O
previously	RB	O
described	VBN	O
forms	NNS	O
of	IN	O
G6PD	NN	O
.	.	O

This	DT	O
study	NN	O
illustrates	VBZ	O
the	DT	O
extreme	JJ	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
among	IN	O
the	DT	O
people	NNS	O
of	IN	O
Papua	NNP	O
New	NNP	O
Guinea	NNP	O
.	.	O

.	.	O

Regional	NNP	O
mapping	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
and	CC	O
the	DT	O
phenylketonuria	NN	B-Disease
locus	NN	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
of	IN	O
amino	NN	O
acid	NN	O
metabolism	NN	O
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
hepatic	JJ	I-Disease
enzyme	NN	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
;	:	O
phenylalanine	NN	O
4-monooxygenase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

14	CD	O
.	.	O

16	CD	O
.	.	O

1	LS	O
)	-RRB-	O
.	.	O

A	DT	O
cDNA	NN	O
clone	NN	O
for	IN	O
human	JJ	O
PAH	NN	O
has	VBZ	O
previously	RB	O
been	VBN	O
used	VBN	O
to	TO	O
assign	VB	O
the	DT	O
corresponding	JJ	O
gene	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
12	CD	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
regional	JJ	O
map	NN	O
position	NN	O
of	IN	O
the	DT	O
disease	NN	O
locus	NN	O
and	CC	O
the	DT	O
PAH	NN	O
gene	NN	O
on	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
,	,	O
DNA	NN	O
was	VBD	O
isolated	VBN	O
from	IN	O
human-hamster	JJ	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
with	IN	O
various	JJ	O
deletions	NNS	O
of	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O
and	CC	O
was	VBD	O
analyzed	VBN	O
by	IN	O
Southern	NN	O
blot	NN	O
analysis	NN	O
using	VBG	O
the	DT	O
human	JJ	O
cDNA	NN	O
PAH	NN	O
clone	NN	O
as	IN	O
a	DT	O
hybridization	NN	O
probe	NN	O
.	.	O

From	IN	O
these	DT	O
results	NNS	O
,	,	O
together	RB	O
with	IN	O
detailed	JJ	O
biochemical	JJ	O
and	CC	O
cytogenetic	JJ	O
characterization	NN	O
of	IN	O
the	DT	O
hybrid	NN	O
cells	NNS	O
,	,	O
the	DT	O
region	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
containing	VBG	O
the	DT	O
human	JJ	O
PAH	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
defined	VBN	O
as	IN	O
12q14	NN	O
.	.	O

3	CD	O
----	:	O
qter	NN	O
3	CD	O
----	:	O
qter	NN	O
.	.	O

The	DT	O
PAH	NN	O
map	NN	O
position	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
was	VBD	O
further	JJ	O
localized	JJ	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
of	IN	O
125I-labeled	JJ	O
human	JJ	O
PAH	NN	O
cDNA	NN	O
to	TO	O
chromosomes	NNS	O
prepared	VBN	O
from	IN	O
a	DT	O
human	JJ	O
lymphoblastoid	JJ	O
cell	NN	O
line	NN	O
.	.	O

Results	NNS	O
of	IN	O
these	DT	O
experiments	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
region	NN	O
on	IN	O
chromosome	NN	O
12	CD	O
containing	VBG	O
the	DT	O
PAH	NN	O
gene	NN	O
and	CC	O
the	DT	O
PKU	NN	B-Disease
locus	NN	O
in	IN	O
man	NN	O
is	VBZ	O
12q22	NN	O
----	:	O
12q24	NN	O
.	.	O

1	LS	O
.	.	O

These	DT	O
results	NNS	O
not	RB	O
only	RB	O
provide	VB	O
a	DT	O
regionalized	JJ	O
map	NN	O
position	NN	O
for	IN	O
a	DT	O
major	JJ	O
human	JJ	O
disease	NN	O
locus	NN	O
but	CC	O
also	RB	O
can	MD	O
serve	VB	O
as	IN	O
a	DT	O
reference	NN	O
point	NN	O
for	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
other	JJ	O
DNA	NN	O
markers	NNS	O
on	IN	O
human	JJ	O
chromosome	NN	O
12	CD	O

Total	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
plasma	NN	I-Disease
cholesteryl	NN	I-Disease
ester	NN	I-Disease
transfer	NN	I-Disease
protein	NN	I-Disease
in	IN	O
subjects	NNS	O
homozygous	JJ	O
and	CC	O
heterozygous	JJ	O
for	IN	O
the	DT	O
intron	NN	O
14	CD	O
splicing	NN	O
defect	NN	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
cholesteryl	NN	B-Disease
ester	NN	I-Disease
transfer	NN	I-Disease
protein	NN	I-Disease
(	-LRB-	I-Disease
CETP	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
was	VBD	O
investigated	VBN	O
in	IN	O
4	CD	O
unrelated	JJ	O
CETP-deficient	JJ	B-Disease
families	NNS	O
.	.	O

The	DT	O
high	JJ	O
density	NN	O
lipoprotein-cholesterol	NN	O
levels	NNS	O
of	IN	O
the	DT	O
probands	NNS	O
exceeded	VBD	O
150	CD	O
mg/dl	NN	O
.	.	O

The	DT	O
plasma	NN	O
of	IN	O
the	DT	O
probands	NNS	O
was	VBD	O
totally	RB	O
deficient	JJ	O
in	IN	O
CETP	NN	O
activity	NN	O
and	CC	O
mass	NN	O
.	.	O

The	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
the	DT	O
patients	NNS	O
was	VBD	O
amplified	VBN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
using	VBG	O
two	CD	O
oligonucleotide	NN	O
primers	NNS	O
located	JJ	O
in	IN	O
the	DT	O
intron	NN	O
12	CD	O
and	CC	O
14	CD	O
of	IN	O
the	DT	O
CETP	NN	O
gene	NN	O
,	,	O
and	CC	O
the	DT	O
amplified	VBN	O
products	NNS	O
were	VBD	O
directly	RB	O
sequenced	VBN	O
.	.	O

Two	CD	O
patients	NNS	O
were	VBD	O
homozygous	JJ	O
for	IN	O
a	DT	O
G-to-A	JJ	O
change	NN	O
at	IN	O
the	DT	O
5-splice	JJ	O
donor	NN	O
site	NN	O
of	IN	O
the	DT	O
intron	NN	O
14	CD	O
.	.	O

The	DT	O
G-to-A	JJ	O
change	NN	O
would	MD	O
cause	VB	O
impaired	JJ	O
splicing	NN	O
of	IN	O
pre-messenger	JJ	O
RNA	NN	O
.	.	O

The	DT	O
other	JJ	O
two	CD	O
probands	NNS	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
mutation	NN	O
,	,	O
but	CC	O
totally	RB	O
lacked	VBD	O
CETP	NNP	O
.	.	O

Their	PRP$	O
lipoprotein	NN	O
patterns	NNS	O
were	VBD	O
also	RB	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
the	DT	O
two	CD	O
homozygotes	NNS	O
.	.	O

Thus	RB	O
,	,	O
other	JJ	O
genetic	JJ	B-Disease
defects	NNS	I-Disease
or	CC	O
metabolic	JJ	O
factors	NNS	O
influencing	VBG	O
CETP	NN	O
expression	NN	O
are	VBP	O
implicated	VBN	O
.	.	O

The	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
G-to-A	NN	O
mutation	NN	O
may	MD	O
be	VB	O
common	JJ	O
in	IN	O
human	JJ	O
plasma	NN	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Furthermore	RB	O
,	,	O
there	EX	O
could	MD	O
be	VB	O
compound	JJ	O
heterozygotes	NNS	O
who	WP	O
totally	RB	O
lack	VBP	O
plasma	NN	O
CETP	NN	O
and	CC	O
have	VBP	O
lipoprotein	NN	O
profiles	NNS	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
homozygotes	NNS	O
.	.	O

.	.	O

Heterogeneity	NN	O
of	IN	O
type	NN	B-Disease
I	CD	I-Disease
von	NN	I-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
subgroup	NN	O
with	IN	O
an	DT	O
abnormal	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
.	.	O

Type	NN	B-Disease
I	CD	I-Disease
von	NN	I-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
(	-LRB-	O
vWD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
characterized	VBN	O
by	IN	O
equally	RB	O
low	JJ	O
plasma	NN	O
concentrations	NNS	O
of	IN	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
antigen	NN	O
(	-LRB-	O
vWF	NN	O
Ag	NN	O
)	-RRB-	O
and	CC	O
ristocetin	NN	O
cofactor	NN	O
(	-LRB-	O
RiCof	NN	O
)	-RRB-	O
and	CC	O
by	IN	O
the	DT	O
presence	NN	O
of	IN	O
all	DT	O
vWF	NN	O
multimers	NNS	O
in	IN	O
sodium	NN	O
dodecyl	NN	O
sulfate	NN	O
(	-LRB-	O
SDS	NN	O
)	-RRB-	O
-	:	O
agarose	NN	O
gel	NN	O
electrophoresis	NN	O
.	.	O

For	IN	O
17	CD	O
patients	NNS	O
(	-LRB-	O
13	CD	O
kindreds	NNS	O
)	-RRB-	O
diagnosed	VBN	O
with	IN	O
these	DT	O
criteria	NNS	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
platelet	NN	O
contents	NNS	O
of	IN	O
vWF	NN	O
Ag	NN	O
and	CC	O
RiCof	NN	O
and	CC	O
the	DT	O
changes	NNS	O
of	IN	O
these	DT	O
in	IN	O
plasma	NN	O
after	IN	O
DDAVP	NNP	O
infusion	NN	O
.	.	O

Platelet	NN	O
vWF	NN	O
Ag	NN	O
and	CC	O
RiCof	NN	O
were	VBD	O
normal	JJ	O
in	IN	O
four	CD	O
kindreds	NNS	O
(	-LRB-	O
called	VBN	O
"	''	O
platelet	NN	O
normal	JJ	O
"	''	O
subgroup	NN	O
)	-RRB-	O
;	:	O
following	VBG	O
1-deamino-8-D-arginine	JJ	O
vasopressin	NN	O
;	:	O
plasma	NN	O
vWF	NN	O
Ag	NN	O
,	,	O
RiCof	NN	O
and	CC	O
the	DT	O
bleeding	JJ	O
time	NN	O
(	-LRB-	O
BT	NNP	O
)	-RRB-	O
became	VBD	O
normal	JJ	O
.	.	O

In	IN	O
six	CD	O
kindreds	NNS	O
,	,	O
platelet	NN	O
vWF	NN	O
Ag	NN	O
and	CC	O
RiCof	NN	O
were	VBD	O
equally	RB	O
low	JJ	O
(	-LRB-	O
platelet	NN	O
low	NN	O
)	-RRB-	O
;	:	O
after	IN	O
DDAVP	NNP	O
,	,	O
plasma	NN	O
vWF	NN	O
Ag	NN	O
and	CC	O
RiCof	NN	O
remained	VBD	O
low	JJ	O
,	,	O
and	CC	O
the	DT	O
BT	NNP	O
was	VBD	O
prolonged	VBN	O
.	.	O

In	IN	O
three	CD	O
additional	JJ	O
kindreds	NNS	O
,	,	O
platelets	NNS	O
contained	VBD	O
normal	JJ	O
concentrations	NNS	O
of	IN	O
vWF	NN	O
Ag	NN	O
,	,	O
but	CC	O
RiCof	NNP	O
was	VBD	O
very	RB	O
low	JJ	O
(	-LRB-	O
platelet	NN	O
discordant	JJ	O
)	-RRB-	O
;	:	O
even	RB	O
though	IN	O
a	DT	O
complete	JJ	O
set	NN	O
of	IN	O
multimers	NNS	O
was	VBD	O
found	VBN	O
in	IN	O
plasma	NN	O
and	CC	O
platelets	NNS	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
relatively	RB	O
small	JJ	O
amount	NN	O
of	IN	O
large	JJ	O
multimers	NNS	O
.	.	O

After	IN	O
DDAVP	NNP	O
,	,	O
plasma	NN	O
vWF	NN	O
Ag	NN	O
became	VBD	O
normal	JJ	O
,	,	O
but	CC	O
RiCof	NNP	O
remained	VBD	O
low	JJ	O
and	CC	O
the	DT	O
BT	NNP	O
was	VBD	O
very	RB	O
prolonged	JJ	O
.	.	O

These	DT	O
findings	NNS	O
demonstrated	VBD	O
that	IN	O
there	EX	O
can	MD	O
be	VB	O
an	DT	O
abnormal	JJ	O
vWF	NN	O
(	-LRB-	O
RiCof	NN	O
less	JJR	O
than	IN	O
vWF	NN	O
Ag	NN	O
)	-RRB-	O
even	RB	O
in	IN	O
type	NN	B-Disease
I	CD	I-Disease
vWD	NN	I-Disease
,	,	O
coexisting	VBG	O
with	IN	O
a	DT	O
complete	JJ	O
set	NN	O
of	IN	O
vWF	NN	O
multimers	NNS	O
(	-LRB-	O
platelet	NN	O
discordant	JJ	O
)	-RRB-	O
;	:	O
that	IN	O
the	DT	O
abnormal	JJ	O
vWF	NN	O
can	MD	O
be	VB	O
shown	VBN	O
more	RBR	O
clearly	RB	O
in	IN	O
platelets	NNS	O
than	IN	O
in	IN	O
plasma	NN	O
or	CC	O
else	RB	O
in	IN	O
plasma	NN	O
after	IN	O
DDAVP	NNP	O
infusion	NN	O
;	:	O
and	CC	O
that	IN	O
DDAVP	NN	O
normalizes	VBZ	O
the	DT	O
BT	NNP	O
only	RB	O
in	IN	O
those	DT	O
patients	NNS	O
with	IN	O
normal	JJ	O
platelet	NN	O
levels	NNS	O
of	IN	O
both	DT	O
vWF	NN	O
Ag	NN	O
and	CC	O
RiCof	NN	O
(	-LRB-	O
platelet	NN	O
normal	JJ	O
)	-RRB-	O
.	.	O

.	.	O

Characterization	NN	O
of	IN	O
a	DT	O
YAC	NN	O
containing	VBG	O
part	NN	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
locus	NN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
from	IN	O
pulsed-field	JJ	O
gel	NN	O
electrophoresis	NN	O
(	-LRB-	O
PFGE	NN	O
)	-RRB-	O
that	IN	O
the	DT	O
monoamine	NN	O
oxidase	NN	O
genes	NNS	O
A	DT	O
and	CC	O
B	NN	O
(	-LRB-	O
MAOA	NNP	O
&	CC	O
MAOB	NNP	O
)	-RRB-	O
and	CC	O
DXS7	NN	O
loci	NNS	O
are	VBP	O
physically	RB	O
very	RB	O
close	RB	O
.	.	O

We	PRP	O
have	VBP	O
therefore	RB	O
extended	JJ	O
studies	NNS	O
on	IN	O
their	PRP$	O
relationship	NN	O
through	IN	O
the	DT	O
characterisation	NN	O
of	IN	O
a	DT	O
650	CD	O
kb	NN	O
YAC	NN	O
isolated	VBN	O
using	VBG	O
L1	NN	O
.	.	O

28	CD	O
(	-LRB-	O
recognising	VBG	O
the	DT	O
DXS7	NN	O
locus	NN	O
)	-RRB-	O
as	IN	O
a	DT	O
probe	NN	O
.	.	O

Restriction	NN	O
mapping	NN	O
of	IN	O
the	DT	O
YAC	NN	O
indicates	VBZ	O
that	IN	O
it	PRP	O
contains	VBZ	O
both	CC	O
MAOA	NN	O
and	CC	O
MAOB	NN	O
genes	NNS	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	O
DXS7	NN	O
locus	NN	O
.	.	O

The	DT	O
map	NN	O
derived	VBN	O
from	IN	O
the	DT	O
YL1	NN	O
.	.	O

28-YAC	NN	O
is	VBZ	O
compatible	JJ	O
both	CC	O
with	IN	O
the	DT	O
map	NN	O
from	IN	O
an	DT	O
independently	RB	O
derived	VBN	O
YAC	NN	O
carrying	VBG	O
MAOA	NN	O
and	CC	O
B	NN	O
genes	NNS	O
and	CC	O
with	IN	O
the	DT	O
long	JJ	O
range	NN	O
genomic	JJ	O
map	NN	O
for	IN	O
the	DT	O
region	NN	O
.	.	O

A	DT	O
series	NN	O
of	IN	O
subclones	NNS	O
prepared	VBN	O
from	IN	O
a	DT	O
phage	NN	O
library	NN	O
(	-LRB-	O
lambda	NN	O
DASH	NN	O
II	CD	O
)	-RRB-	O
of	IN	O
the	DT	O
YAC	NN	O
have	VBP	O
been	VBN	O
characterised	VBN	O
and	CC	O
have	VBP	O
been	VBN	O
employed	VBN	O
to	TO	O
determine	VB	O
the	DT	O
end	NN	O
point	NN	O
of	IN	O
the	DT	O
deletion	NN	O
of	IN	O
a	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
NDP	NN	B-Disease
)	-RRB-	O
patient	NN	O
who	WP	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
lack	VB	O
both	CC	O
DXS7	NN	O
and	CC	O
MAO	NN	O
coding	NN	O
sequences	NNS	O
.	.	O

The	DT	O
pattern	NN	O
of	IN	O
retention	NN	O
of	IN	O
subclones	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
patient	NN	O
place	VBP	O
the	DT	O
end	NN	O
point	NN	O
of	IN	O
the	DT	O
deletion	NN	O
within	IN	O
30-130	CD	O
kb	NN	O
of	IN	O
the	DT	O
proximal	JJ	O
end	NN	O
of	IN	O
the	DT	O
YAC	NN	O
.	.	O

By	IN	O
combining	VBG	O
the	DT	O
data	NNS	O
with	IN	O
established	JJ	O
recombination	NN	O
analysis	NN	O
,	,	O
we	PRP	O
provide	VBP	O
evidence	NN	O
that	IN	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
the	DT	O
NDP	NN	O
lies	VBZ	O
in	IN	O
the	DT	O
interval	NN	O
of	IN	O
approximately	RB	O
250kb	JJ	O
within	IN	O
the	DT	O
YAC	NN	O
.	.	O

Identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
Danish	JJ	O
choroideremia	NN	B-Disease
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
searched	VBN	O
for	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
choroideremia	NN	B-Disease
gene	NN	O
(	-LRB-	O
CHM	NN	B-Disease
)	-RRB-	O
in	IN	O
patients	NNS	O
from	IN	O
12	CD	O
Danish	JJ	O
families	NNS	O
in	IN	O
which	WDT	O
CHM	NNP	B-Disease
is	VBZ	O
segregating	VBG	O
.	.	O

Employing	VBG	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
,	,	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
analysis	NN	O
,	,	O
and	CC	O
direct	JJ	O
DNA	NN	O
sequencing	NN	O
,	,	O
different	JJ	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
6	CD	O
patients	NNS	O
.	.	O

All	PDT	O
the	DT	O
mutations	NNS	O
will	MD	O
interfere	VB	O
with	IN	O
the	DT	O
correct	JJ	O
translation	NN	O
of	IN	O
the	DT	O
mRNA	NN	O
predicting	VBG	O
a	DT	O
truncated	VBN	O
protein	NN	O
or	CC	O
no	DT	O
gene	NN	O
product	NN	O
at	IN	O
all	DT	O
.	.	O

.	.	O

G130V	NN	O
,	,	O
a	DT	O
common	JJ	O
FRDA	NN	B-Disease
point	NN	O
mutation	NN	O
,	,	O
appears	VBZ	O
to	TO	O
have	VB	O
arisen	VBN	O
from	IN	O
a	DT	O
common	JJ	O
founder	NN	O
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
inherited	VBN	B-Disease
ataxia	NN	I-Disease
.	.	O

About	IN	O
98	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
affected	VBN	O
gene	NN	O
,	,	O
FRDA	NN	O
.	.	O

The	DT	O
other	JJ	O
2	CD	O
%	NN	O
are	VBP	O
point	NN	O
mutations	NNS	O
.	.	O

Of	IN	O
the	DT	O
17	CD	O
point	NN	O
mutations	NNS	O
so	RB	O
far	RB	O
described	VBN	O
,	,	O
three	CD	O
appear	VBP	O
to	TO	O
be	VB	O
more	RBR	O
common	JJ	O
.	.	O

One	CD	O
of	IN	O
these	DT	O
is	VBZ	O
the	DT	O
G130V	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
4	CD	O
of	IN	O
FRDA	NN	O
.	.	O

G130V	NN	O
,	,	O
when	WRB	O
present	JJ	O
with	IN	O
an	DT	O
expanded	VBN	O
GAA	NNP	O
repeat	NN	O
on	IN	O
the	DT	O
other	JJ	O
allele	NN	O
,	,	O
is	VBZ	O
associated	VBN	O
with	IN	O
an	DT	O
atypical	JJ	O
FRDA	NN	B-Disease
phenotype	NN	O
.	.	O

Haplotype	NN	O
analysis	NN	O
was	VBD	O
undertaken	VBN	O
on	IN	O
the	DT	O
four	CD	O
families	NNS	O
who	WP	O
have	VBP	O
been	VBN	O
described	VBN	O
with	IN	O
this	DT	O
mutation	NN	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
common	JJ	O
founder	NN	O
for	IN	O
this	DT	O
mutation	NN	O
.	.	O

Although	IN	O
marked	JJ	O
differences	NNS	O
in	IN	O
extragenic	JJ	O
marker	NN	O
haplotypes	NNS	O
were	VBD	O
seen	VBN	O
in	IN	O
one	CD	O
family	NN	O
,	,	O
similar	JJ	O
intragenic	JJ	O
haplotyping	NN	O
suggests	VBZ	O
the	DT	O
same	JJ	O
mutation	NN	O
founder	NN	O
for	IN	O
this	DT	O
family	NN	O
with	IN	O
the	DT	O
differences	NNS	O
explicable	JJ	O
by	IN	O
two	CD	O
recombination	NN	O
events	NNS	O
.	.	O

.	.	O

Frequency	NN	O
of	IN	O
exon	NN	O
15	CD	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
442D	NN	O
:	:	O
G	NN	O
)	-RRB-	O
in	IN	O
cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	NN	O
gene	NN	O
in	IN	O
hyperalphalipoproteinemic	JJ	B-Disease
Japanese	JJ	O
subjects	NNS	O
.	.	O

Cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	NN	O
(	-LRB-	O
CETP	NN	O
)	-RRB-	O
transfers	NNS	O
cholesteryl	NN	O
ester	NN	O
from	IN	O
high	JJ	O
density	NN	O
lipoprotein	NN	O
(	-LRB-	O
HDL	NN	O
)	-RRB-	O
to	TO	O
apo	VB	O
B-containing	JJ	O
lipoproteins	NNS	O
.	.	O

The	DT	O
hyperalphalipoproteinemia	NN	B-Disease
caused	VBN	O
by	IN	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
fairly	RB	O
common	JJ	O
in	IN	O
Japan	NNP	O
and	CC	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
common	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
CETP	NN	O
gene	NN	O
is	VBZ	O
the	DT	O
splicing	NN	O
defect	NN	O
of	IN	O
the	DT	O
intron	NN	O
14	CD	O
,	,	O
the	DT	O
allelic	JJ	O
frequency	NN	O
of	IN	O
which	WDT	O
has	VBZ	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
0	CD	O
.	.	O

0049	CD	O
in	IN	O
the	DT	O
Japanese	JJ	O
general	JJ	O
population	NN	O
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
have	VBP	O
reported	VBN	O
a	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
exon	NN	O
15	CD	O
of	IN	O
the	DT	O
CETP	NN	O
gene	NN	O
(	-LRB-	O
442D	CD	O
G	NN	O
)	-RRB-	O
,	,	O
showing	VBG	O
a	DT	O
dominant	JJ	O
effect	NN	O
on	IN	O
the	DT	O
CETP	NN	O
activity	NN	O
and	CC	O
HDL-cholesterol	NN	O
level	NN	O
.	.	O

In	IN	O
the	DT	O
current	JJ	O
study	NN	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
frequency	NN	O
of	IN	O
this	DT	O
new	JJ	O
mutation	NN	O
in	IN	O
Japanese	JJ	O
hyperalphalipoproteinemic	JJ	B-Disease
(	-LRB-	O
HDL-cholesterol	NN	O
>	JJR	O
or	CC	O
=	JJ	O
100	CD	O
mg/dl	NN	O
)	-RRB-	O
subjects	NNS	O
.	.	O

A	DT	O
rapid	JJ	O
and	CC	O
easy	JJ	O
screening	NN	O
method	NN	O
for	IN	O
this	DT	O
new	JJ	O
mutation	NN	O
was	VBD	O
developed	VBN	O
using	VBG	O
a	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
-	:	O
mediated	VBN	O
site-directed	JJ	O
mutagenesis	NN	O
.	.	O

Among	IN	O
117	CD	O
Japanese	JJ	O
hyperalphalipoproteinemic	JJ	B-Disease
subjects	NNS	O
(	-LRB-	O
HDL-cholesterol	NN	O
;	:	O
116	CD	O
.	.	O

7	CD	O
+	CC	O
/	:	O
-	:	O
16	CD	O
.	.	O

5	CD	O
mg/dl	NN	O
,	,	O
mean	NN	O
+	CC	O
/	:	O
-	:	O
S.	NNP	O
D.	NNP	O
)	-RRB-	O
without	IN	O
the	DT	O
intron	NN	O
14	CD	O
splice	NN	O
defect	NN	O
,	,	O
three	CD	O
homozygotes	NNS	O
(	-LRB-	O
2	CD	O
.	.	O

5	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
34	CD	O
heterozygotes	NNS	O
(	-LRB-	O
29	CD	O
.	.	O

1	CD	O
%	NN	O
)	-RRB-	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
the	DT	O
442D	NN	O
G	NN	O
mutation	NN	O
.	.	O

The	DT	O
relative	JJ	O
allelic	JJ	O
frequency	NN	O
of	IN	O
this	DT	O
mutation	NN	O
was	VBD	O
calculated	VBN	O
to	TO	O
be	VB	O
0	CD	O
.	.	O

17	CD	O
.	.	O

One	CD	O
of	IN	O
the	DT	O
homozygotes	NNS	O
for	IN	O
the	DT	O
442D	NN	O
G	NN	O
mutation	NN	O
was	VBD	O
the	DT	O
patient	NN	O
previously	RB	O
described	VBN	O
by	IN	O
us	PRP	O
as	IN	O
having	VBG	O
hyperalphalipoproteinemia	NN	B-Disease
with	IN	O
corneal	NN	B-Disease
opacity	NN	I-Disease
and	CC	O
coronary	JJ	B-Disease
heart	NN	I-Disease
disease	NN	I-Disease
.	.	O

This	DT	O
was	VBD	O
the	DT	O
first	JJ	O
reported	VBN	O
subject	JJ	O
homozygous	JJ	O
for	IN	O
the	DT	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
who	WP	O
also	RB	O
demonstrated	VBD	O
atherosclerotic	JJ	B-Disease
symptoms	NNS	I-Disease
.	.	O

In	IN	O
homozygous	JJ	O
subjects	NNS	O
,	,	O
CETP	NN	O
activity	NN	O
ranged	VBD	O
from	IN	O
37	CD	O
%	NN	O
to	TO	O
62	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
value	NN	O
,	,	O
which	WDT	O
was	VBD	O
consistent	JJ	O
with	IN	O
the	DT	O
results	NNS	O
obtained	VBN	O
from	IN	O
the	DT	O
transient	JJ	O
expression	NN	O
experiment	NN	O
previously	RB	O
reported	VBN	O
;	:	O
however	RB	O
,	,	O
the	DT	O
specific	JJ	O
activity	NN	O
of	IN	O
CETP	NN	O
was	VBD	O
not	RB	O
as	RB	O
low	JJ	O
as	IN	O
expected	VBN	O
.	.	O

(	-LRB-	O
ABSTRACT	NN	O
TRUNCATED	VBN	O
AT	IN	O
250	CD	O
WORDS	NNS	O
)	-RRB-	O

Fibroblast	NN	O
growth	NN	O
factor	NN	O
homologous	JJ	O
factor	NN	O
2	CD	O
(	-LRB-	O
FHF2	NN	O
)	-RRB-	O
:	:	O
gene	NN	O
structure	NN	O
,	,	O
expression	NN	O
and	CC	O
mapping	VBG	O
to	TO	O
the	DT	O
Borjeson-Forssman-Lehmann	NNP	B-Disease
syndrome	NN	I-Disease
region	NN	O
in	IN	O
Xq26	NN	O
delineated	VBN	O
by	IN	O
a	DT	O
duplication	NN	O
breakpoint	NN	O
in	IN	O
a	DT	O
BFLS-like	JJ	O
patient	NN	O
.	.	O

Borjeson-Forssman-Lehmann	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
BFLS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
syndromal	JJ	O
X-linked	JJ	B-Disease
mental	JJ	I-Disease
retardation	NN	I-Disease
,	,	O
which	WDT	O
maps	VBZ	O
by	IN	O
linkage	NN	O
to	TO	O
the	DT	O
q26	NN	O
region	NN	O
of	IN	O
the	DT	O
human	JJ	O
X	NN	O
chromosome	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
male	JJ	O
patient	NN	O
with	IN	O
BFLS-like	JJ	O
features	NNS	O
and	CC	O
a	DT	O
duplication	NN	O
,	,	O
46	CD	O
,	,	O
Y	NN	O
,	,	O
dup	NN	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
(	-LRB-	O
q26q28	NN	O
)	-RRB-	O
,	,	O
inherited	VBN	O
from	IN	O
his	PRP$	O
phenotypically	RB	O
normal	JJ	O
mother	NN	O
.	.	O

Fluorescence	NN	O
in	FW	O
situ	FW	O
hybridisation	NN	O
using	VBG	O
yeast	NN	O
artificial	JJ	O
chromosome	NN	O
clones	NNS	O
from	IN	O
Xq26	NN	O
localised	VBD	O
the	DT	O
duplication	NN	O
breakpoint	NN	O
to	TO	O
an	DT	O
approximately	RB	O
400-kb	JJ	O
interval	NN	O
in	IN	O
the	DT	O
Xq26	NN	O
.	.	O

3	CD	O
region	NN	O
between	IN	O
DXS155	NN	O
and	CC	O
DXS294/DXS730	NN	O
.	.	O

Database	NN	O
searches	NNS	O
and	CC	O
analysis	NN	O
of	IN	O
available	JJ	O
genomic	JJ	O
DNA	NN	O
sequence	NN	O
from	IN	O
the	DT	O
region	NN	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
fibroblast	NN	O
growth	NN	O
factor	NN	O
homologous	JJ	O
factor	NN	O
gene	NN	O
,	,	O
FHF2	NN	O
,	,	O
within	IN	O
the	DT	O
duplication	NN	O
breakpoint	NN	O
interval	NN	O
.	.	O

The	DT	O
gene	NN	O
structure	NN	O
of	IN	O
FHF2	NN	O
was	VBD	O
determined	VBN	O
and	CC	O
two	CD	O
new	JJ	O
exons	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
including	VBG	O
a	DT	O
new	JJ	O
5	CD	O
end	NN	O
exon	NN	O
,	,	O
1B	NN	O
.	.	O

FHF2	NN	O
is	VBZ	O
a	DT	O
large	JJ	O
gene	NN	O
extending	VBG	O
over	IN	O
approximately	RB	O
200	CD	O
kb	NN	O
in	IN	O
Xq26	NN	O
.	.	O

3	CD	O
and	CC	O
is	VBZ	O
composed	VBN	O
of	IN	O
at	IN	O
least	JJS	O
seven	CD	O
exons	NNS	O
.	.	O

It	PRP	O
shows	VBZ	O
tissue-specific	JJ	O
alternative	JJ	O
splicing	NN	O
and	CC	O
alternative	JJ	O
transcription	NN	O
starts	VBZ	O
.	.	O

Northern	NN	O
blot	NN	O
hybridisation	NN	O
showed	VBD	O
highest	JJS	O
expression	NN	O
in	IN	O
brain	NN	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
.	.	O

The	DT	O
FHF2	NN	O
gene	NN	O
localisation	NN	O
and	CC	O
tissue-specific	JJ	O
expression	NN	O
pattern	NN	O
suggest	VBP	O
it	PRP	O
to	TO	O
be	VB	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
familial	JJ	O
cases	NNS	O
of	IN	O
the	DT	O
BFLS	NN	B-Disease
syndrome	NN	I-Disease
and	CC	O
other	JJ	O
syndromal	JJ	O
and	CC	O
non-specific	JJ	O
forms	NNS	O
of	IN	O
X-linked	JJ	B-Disease
mental	JJ	I-Disease
retardation	NN	I-Disease
mapping	VBG	O
to	TO	O
the	DT	O
region	NN	O
.	.	O

Illegitimate	JJ	O
transcription	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
in	IN	O
lymphocytes	NNS	O
for	IN	O
identification	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
phenylketonuria	NN	B-Disease
.	.	O

Taking	VBG	O
advantage	NN	O
of	IN	O
the	DT	O
illegitimate	JJ	O
transcription	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
gene	NN	O
,	,	O
we	PRP	O
have	VBP	O
been	VBN	O
able	JJ	O
to	TO	O
analyse	VB	O
the	DT	O
PAH	NN	O
cDNA	NN	O
sequence	NN	O
of	IN	O
hyperphenylalaninemic	JJ	B-Disease
children	NNS	O
in	IN	O
circulating	VBG	O
lymphocytes	NNS	O
.	.	O

Using	VBG	O
this	DT	O
approach	NN	O
,	,	O
we	PRP	O
have	VBP	O
also	RB	O
identified	VBN	O
3	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
cDNA	NN	O
from	IN	O
liver	NN	O
and	CC	O
lymphocytes	NNS	O
of	IN	O
two	CD	O
patients	NNS	O
.	.	O

One	CD	O
mutation	NN	O
,	,	O
detected	VBN	O
by	IN	O
the	DT	O
abnormal	JJ	O
pattern	NN	O
of	IN	O
migration	NN	O
of	IN	O
an	DT	O
amplified	VBN	O
fragment	NN	O
,	,	O
is	VBZ	O
a	DT	O
C	NN	O
to	TO	O
T	NN	O
transition	NN	O
in	IN	O
the	DT	O
splice	NN	O
acceptor	NN	O
site	NN	O
of	IN	O
intron	NN	O
10	CD	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
the	DT	O
skipping	VBG	O
of	IN	O
exon	NN	O
11	CD	O
with	IN	O
the	DT	O
premature	JJ	O
termination	NN	O
of	IN	O
RNA	NN	O
translation	NN	O
downstream	RB	O
from	IN	O
exon	NN	O
12	CD	O
(	-LRB-	O
-3	CD	O
IVS10	NN	O
)	-RRB-	O
.	.	O

The	DT	O
other	JJ	O
two	CD	O
mutations	NNS	O
are	VBP	O
missense	NN	O
mutations	NNS	O
in	IN	O
exons	NNS	O
10	CD	O
and	CC	O
11	CD	O
(	-LRB-	O
respectively	RB	O
,	,	O
L333F	NN	O
and	CC	O
E390G	NN	O
)	-RRB-	O
.	.	O

The	DT	O
present	JJ	O
study	NN	O
supports	VBZ	O
the	DT	O
view	NN	O
that	IN	O
circulating	VBG	O
lymphocytes	NNS	O
give	VBP	O
easy	JJ	O
access	NN	O
to	TO	O
PAH	NN	O
gene	NN	O
transcripts	NNS	O
whose	WP$	O
nucleotide	NN	O
sequence	NN	O
is	VBZ	O
identical	JJ	O
to	TO	O
that	DT	O
reported	VBN	O
in	IN	O
liver	NN	O
and	CC	O
therefore	RB	O
represent	VBP	O
a	DT	O
useful	JJ	O
tool	NN	O
for	IN	O
molecular	JJ	O
genetic	JJ	O
studies	NNS	O
in	IN	O
phenylketonuria	NN	B-Disease
.	.	O

.	.	O

Function	NN	O
of	IN	O
an	DT	O
axonal	JJ	O
chemoattractant	NN	O
modulated	VBN	O
by	IN	O
metalloprotease	NN	O
activity	NN	O
.	.	O

The	DT	O
axonal	JJ	O
chemoattractant	NN	O
netrin-1	NN	O
guides	NNS	O
spinal	JJ	O
commissural	JJ	O
axons	NNS	O
by	IN	O
activating	VBG	O
its	PRP$	O
receptor	NN	O
DCC	NN	O
(	-LRB-	O
Deleted	JJ	O
in	IN	O
Colorectal	JJ	B-Disease
Cancer	NN	I-Disease
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
chemical	NN	O
inhibitors	NNS	O
of	IN	O
metalloproteases	NNS	O
potentiate	VBP	O
netrin-mediated	JJ	O
axon	NN	O
outgrowth	NN	O
in	FW	O
vitro	FW	O
.	.	O

We	PRP	O
have	VBP	O
also	RB	O
found	VBN	O
that	IN	O
DCC	NNP	O
is	VBZ	O
a	DT	O
substrate	NN	O
for	IN	O
metalloprotease-dependent	JJ	O
ectodomain	NN	O
shedding	VBG	O
,	,	O
and	CC	O
that	IN	O
the	DT	O
inhibitors	NNS	O
block	VBP	O
proteolytic	JJ	O
processing	NN	O
of	IN	O
DCC	NNP	O
and	CC	O
cause	VB	O
an	DT	O
increase	NN	O
in	IN	O
DCC	NN	O
protein	NN	O
levels	NNS	O
on	IN	O
axons	NNS	O
within	IN	O
spinal	JJ	O
cord	NN	O
explants	NNS	O
.	.	O

Thus	RB	O
,	,	O
potentiation	NN	O
of	IN	O
netrin	NN	O
activity	NN	O
by	IN	O
inhibitors	NNS	O
may	MD	O
result	VB	O
from	IN	O
stabilization	NN	O
of	IN	O
DCC	NN	O
on	IN	O
the	DT	O
axons	NNS	O
,	,	O
and	CC	O
proteolytic	JJ	O
activity	NN	O
may	MD	O
regulate	VB	O
axon	JJ	O
migration	NN	O
by	IN	O
controlling	VBG	O
the	DT	O
number	NN	O
of	IN	O
functional	JJ	O
extracellular	JJ	O
axon	NN	O
guidance	NN	O
receptors	NNS	O
.	.	O

.	.	O

Choroideremia	NNP	B-Disease
:	:	O
close	JJ	O
linkage	NN	O
to	TO	O
DXYS1	NN	O
and	CC	O
DXYS12	NN	O
demonstrated	VBN	O
by	IN	O
segregation	NN	O
analysis	NN	O
and	CC	O
historical-genealogical	JJ	O
evidence	NN	O
.	.	O

Linkage	NN	O
studies	NNS	O
using	VBG	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
were	VBD	O
conducted	VBN	O
in	IN	O
the	DT	O
X-linked	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
choroideremia	NN	B-Disease
,	,	O
designated	VBN	O
TCD	NN	B-Disease
for	IN	O
Progressive	NNP	B-Disease
Tapeto-Choroidal	NNP	I-Disease
Dystrophy	NN	I-Disease
.	.	O

Previously	RB	O
demonstrated	VBN	O
close	JJ	O
linkage	NN	O
with	IN	O
locus	NN	O
DXYS1	NN	O
was	VBD	O
confirmed	VBN	O
(	-LRB-	O
lod	NN	O
11	CD	O
.	.	O

44	CD	O
at	IN	O
0	CD	O
recombination	NN	O
distance	NN	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
locus	NN	O
DXYS12	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
closely	RB	O
linked	VBN	O
with	IN	O
TCD	NN	B-Disease
(	-LRB-	O
lod	NN	O
3	CD	O
.	.	O

31	CD	O
at	IN	O
0	CD	O
recombination	NN	O
distance	NN	O
)	-RRB-	O
.	.	O

The	DT	O
disease	NN	O
mainly	RB	O
occurs	VBZ	O
in	IN	O
three	CD	O
large	JJ	O
kindreds	NNS	O
in	IN	O
remote	JJ	O
Northern	JJ	O
Finland	NN	O
.	.	O

While	IN	O
formal	JJ	O
genealogical	JJ	O
proof	NN	O
is	VBZ	O
lacking	VBG	O
,	,	O
all	DT	O
presently	RB	O
living	NN	O
(	-LRB-	O
more	JJR	O
than	IN	O
80	CD	O
affected	VBD	O
males	NNS	O
and	CC	O
120	CD	O
carrier	NN	O
females	NNS	O
)	-RRB-	O
probably	RB	O
originate	VB	O
from	IN	O
a	DT	O
common	JJ	O
founder	NN	O
couple	NN	O
born	VBN	O
in	IN	O
1644	CD	O
and	CC	O
1646	CD	O
,	,	O
twelve	CD	O
generations	NNS	O
ago	RB	O
.	.	O

All	DT	O
36	CD	O
patients	NNS	O
and	CC	O
48	CD	O
carriers	NNS	O
tested	VBN	O
from	IN	O
the	DT	O
three	CD	O
kindreds	NNS	O
had	VBD	O
the	DT	O
same	JJ	O
haplotype	NN	O
(	-LRB-	O
TCD/DXYS1	NN	O
,	,	O
11kb/DXYS12	NN	O
,	,	O
1	CD	O
.	.	O

6kb	JJ	O
)	-RRB-	O
.	.	O

Given	VBN	O
that	IN	O
at	IN	O
least	JJS	O
105	CD	O
female	JJ	O
meioses	NNS	O
transmitting	VBG	O
TCD	NN	B-Disease
have	VBP	O
occurred	VBN	O
since	IN	O
1650	CD	O
in	IN	O
these	DT	O
kindreds	NNS	O
,	,	O
extremely	RB	O
close	JJ	O
linkage	NN	O
between	IN	O
TCD	NNP	B-Disease
,	,	O
DXYS1	NN	O
and	CC	O
DXYS12	NN	O
is	VBZ	O
suggested	VBN	O
.	.	O

The	DT	O
above	JJ	O
haplotype	NN	O
is	VBZ	O
a	DT	O
very	RB	O
useful	JJ	O
diagnostic	JJ	O
tool	NN	O
in	IN	O
these	DT	O
TCD	NN	B-Disease
families	NNS	O
.	.	O

We	PRP	O
suggest	VBP	O
that	IN	O
our	PRP$	O
historical-genealogical	JJ	O
approach	NN	O
to	TO	O
linkage	NN	O
analysis	NN	O
may	MD	O
be	VB	O
possible	JJ	O
elsewhere	RB	O
in	IN	O
similar	JJ	O
isolated	VBN	O
populations	NNS	O

Functional	JJ	O
consequences	NNS	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
early	JJ	O
growth	NN	O
response	NN	O
2	CD	O
gene	NN	O
(	-LRB-	O
EGR2	NN	O
)	-RRB-	O
correlate	VBP	O
with	IN	O
severity	NN	O
of	IN	O
human	JJ	O
myelinopathies	NNS	B-Disease
.	.	O

The	DT	O
early	JJ	O
growth	NN	O
response	NN	O
2	CD	O
gene	NN	O
(	-LRB-	O
EGR2	NN	O
)	-RRB-	O
is	VBZ	O
a	DT	O
Cys2His2zinc	NN	O
finger	NN	O
transcription	NN	O
factor	NN	O
which	WDT	O
is	VBZ	O
thought	VBN	O
to	TO	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
regulation	NN	O
of	IN	O
peripheral	JJ	O
nervous	JJ	O
system	NN	O
myelination	NN	O
.	.	O

This	DT	O
idea	NN	O
is	VBZ	O
based	VBN	O
partly	RB	O
on	IN	O
the	DT	O
phenotype	NN	O
of	IN	O
homozygous	JJ	O
Krox20	NN	O
(	-LRB-	O
Egr2	NN	O
)	-RRB-	O
knockout	JJ	O
mice	NNS	O
,	,	O
which	WDT	O
display	VBP	O
hypomyelination	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
PNS	NN	I-Disease
and	CC	O
a	DT	O
block	NN	O
of	IN	O
Schwann	NN	O
cells	NNS	O
at	IN	O
an	DT	O
early	JJ	O
stage	NN	O
of	IN	O
differentiation	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
human	JJ	O
EGR2	NN	O
gene	NN	O
have	VBP	O
recently	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
inherited	VBN	B-Disease
peripheral	JJ	I-Disease
neuropathies	NNS	I-Disease
Charcot-Marie-Tooth	NNP	B-Disease
type	NN	I-Disease
1	CD	I-Disease
,	,	O
Dejerine-Sottas	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
congenital	JJ	B-Disease
hypomyelinating	NN	I-Disease
neuropathy	NN	I-Disease
.	.	O

Three	CD	O
of	IN	O
the	DT	O
four	CD	O
EGR2	NN	O
mutations	NNS	O
are	VBP	O
dominant	JJ	O
and	CC	O
occur	VBP	O
within	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
DNA-binding	JJ	O
domain	NN	O
.	.	O

The	DT	O
fourth	JJ	O
mutation	NN	O
is	VBZ	O
recessive	JJ	O
and	CC	O
affects	VBZ	O
the	DT	O
inhibitory	JJ	O
domain	NN	O
(	-LRB-	O
R1	NN	O
)	-RRB-	O
that	WDT	O
binds	VBZ	O
the	DT	O
NAB	NN	O
transcriptional	JJ	O
co-repressors	NNS	O
.	.	O

A	DT	O
combination	NN	O
of	IN	O
DNA-binding	JJ	O
assays	NNS	O
and	CC	O
transcriptional	JJ	O
analysis	NN	O
was	VBD	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
functional	JJ	O
consequences	NNS	O
of	IN	O
these	DT	O
mutations	NNS	O
.	.	O

The	DT	O
zinc	NN	O
finger	NN	O
mutations	NNS	O
affect	VBP	O
DNA	NN	O
binding	NN	O
and	CC	O
the	DT	O
amount	NN	O
of	IN	O
residual	JJ	O
binding	NN	O
directly	RB	O
correlates	VBZ	O
with	IN	O
disease	NN	O
severity	NN	O
.	.	O

The	DT	O
R1	NN	O
domain	NN	O
mutation	NN	O
prevents	VBZ	O
interaction	NN	O
of	IN	O
EGR2	NN	O
with	IN	O
the	DT	O
NAB	NNP	O
co-repressors	NNS	O
and	CC	O
thereby	RB	O
increases	VBZ	O
transcriptional	JJ	O
activity	NN	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
insight	NN	O
into	IN	O
the	DT	O
possible	JJ	O
disease	NN	O
mechanisms	NNS	O
underlying	VBG	O
EGR2	NN	O
mutations	NNS	O
and	CC	O
the	DT	O
reason	NN	O
for	IN	O
varying	VBG	O
severity	NN	O
and	CC	O
differences	NNS	O
in	IN	O
inheritance	NN	O
patterns	NNS	O
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
human	JJ	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
:	:	O
analysis	NN	O
of	IN	O
platelet	NN	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
mRNA	NN	O
.	.	O

von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
(	-LRB-	O
vWD	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
inherited	VBN	B-Disease
bleeding	JJ	I-Disease
disorder	NN	I-Disease
in	IN	O
humans	NNS	O
,	,	O
can	MD	O
result	VB	O
from	IN	O
either	CC	O
a	DT	O
quantitative	JJ	O
or	CC	O
a	DT	O
qualitative	JJ	O
defect	NN	O
in	IN	O
the	DT	O
adhesive	JJ	O
glycoprotein	NN	O
,	,	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
(	-LRB-	O
vWF	NN	O
)	-RRB-	O
.	.	O

Molecular	JJ	O
studies	NNS	O
of	IN	O
vWD	NN	B-Disease
have	VBP	O
been	VBN	O
limited	VBN	O
by	IN	O
the	DT	O
large	JJ	O
size	NN	O
of	IN	O
the	DT	O
vWF	NN	O
gene	NN	O
and	CC	O
difficulty	NN	O
in	IN	O
obtaining	VBG	O
the	DT	O
vWF	NN	O
mRNA	NN	O
from	IN	O
patients	NNS	O
.	.	O

By	IN	O
use	NN	O
of	IN	O
an	DT	O
adaptation	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
vWF	NN	O
mRNA	NN	O
was	VBD	O
amplified	VBN	O
and	CC	O
sequenced	VBN	O
from	IN	O
peripheral	JJ	O
blood	NN	O
platelets	NNS	O
.	.	O

A	DT	O
silent	JJ	O
vWF	NN	O
allele	NN	O
was	VBD	O
identified	VBN	O
,	,	O
resulting	VBG	O
from	IN	O
a	DT	O
cis	NN	O
defect	NN	O
in	IN	O
vWF	NN	O
mRNA	NN	O
transcription	NN	O
or	CC	O
processing	NN	O
.	.	O

In	IN	O
two	CD	O
type	NN	B-Disease
IIA	NN	I-Disease
vWD	NN	I-Disease
patients	NNS	O
,	,	O
two	CD	O
different	JJ	O
but	CC	O
adjacent	JJ	O
missense	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
the	DT	O
locations	NNS	O
of	IN	O
which	WDT	O
may	MD	O
identify	VB	O
an	DT	O
important	JJ	O
vWF	NN	O
functional	JJ	O
domain	NN	O
.	.	O

Expression	NN	O
in	IN	O
heterologous	JJ	O
cells	NNS	O
of	IN	O
recombinant	JJ	O
vWF	NN	O
containing	VBG	O
one	CD	O
of	IN	O
these	DT	O
latter	JJ	O
mutations	NNS	O
reproduced	VBD	O
the	DT	O
characteristic	JJ	O
structural	JJ	O
abnormality	NN	O
seen	VBN	O
in	IN	O
type	NN	B-Disease
IIA	NN	I-Disease
vWD	NN	I-Disease
plasma	NN	O
.	.	O

.	.	O

A	DT	O
transgene	NN	O
insertion	NN	O
creating	VBG	O
a	DT	O
heritable	JJ	O
chromosome	NN	O
deletion	NN	O
mouse	NN	O
model	NN	O
of	IN	O
Prader-Willi	NNP	B-Disease
and	CC	I-Disease
angelman	JJ	I-Disease
syndromes	NNS	I-Disease
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
and	CC	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
result	VBP	O
from	IN	O
the	DT	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
imprinted	JJ	O
genes	NNS	O
in	IN	O
human	JJ	O
chromosome	NN	O
15q11-q13	NN	O
.	.	O

The	DT	O
central	JJ	O
part	NN	O
of	IN	O
mouse	NN	O
chromosome	NN	O
7	CD	O
is	VBZ	O
homologous	JJ	O
to	TO	O
human	JJ	O
15q11-q13	NN	O
,	,	O
with	IN	O
conservation	NN	O
of	IN	O
both	CC	O
gene	NN	O
order	NN	O
and	CC	O
imprinted	JJ	O
features	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
characterization	NN	O
of	IN	O
a	DT	O
transgene	NN	O
insertion	NN	O
(	-LRB-	O
Epstein-Barr	JJ	O
virus	NN	O
Latent	JJ	O
Membrane	NN	O
Protein	NN	O
2A	NN	O
,	,	O
LMP2A	NN	O
)	-RRB-	O
into	IN	O
mouse	NN	O
chromosome	NN	O
7C	NN	O
,	,	O
which	WDT	O
has	VBZ	O
resulted	VBN	O
in	IN	O
mouse	NN	O
models	NNS	O
for	IN	O
PWS	NN	B-Disease
and	CC	O
AS	JJ	B-Disease
dependent	JJ	O
on	IN	O
the	DT	O
sex	NN	O
of	IN	O
the	DT	O
transmitting	VBG	O
parent	NN	O
.	.	O

Epigenotype	NN	O
(	-LRB-	O
allelic	JJ	O
expression	NN	O
and	CC	O
DNA	NN	O
methylation	NN	O
)	-RRB-	O
and	CC	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
analyses	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
transgene-induced	JJ	O
mutation	NN	O
has	VBZ	O
generated	VBN	O
a	DT	O
complete	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
PWS/AS-homologous	JJ	O
region	NN	O
but	CC	O
has	VBZ	O
not	RB	O
deleted	VBN	O
flanking	JJ	O
loci	NNS	O
.	.	O

Because	IN	O
the	DT	O
intact	JJ	O
chromosome	NN	O
7	CD	O
,	,	O
opposite	IN	O
the	DT	O
deleted	VBN	O
homolog	NN	O
,	,	O
maintains	VBZ	O
the	DT	O
correct	JJ	O
imprint	NN	O
in	IN	O
somatic	JJ	O
cells	NNS	O
of	IN	O
PWS	NN	B-Disease
and	CC	O
AS	JJ	B-Disease
mice	NNS	O
and	CC	O
establishes	VBZ	O
the	DT	O
correct	JJ	O
imprint	NN	O
in	IN	O
male	JJ	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
of	IN	O
AS	JJ	B-Disease
mice	NNS	O
,	,	O
homologous	JJ	O
association	NN	O
and	CC	O
replication	NN	O
asynchrony	NN	O
are	VBP	O
not	RB	O
part	NN	O
of	IN	O
the	DT	O
imprinting	VBG	O
mechanism	NN	O
.	.	O

This	DT	O
heritable-deletion	JJ	O
mouse	NN	O
model	NN	O
will	MD	O
be	VB	O
particularly	RB	O
useful	JJ	O
for	IN	O
the	DT	O
identification	NN	O
of	IN	O
the	DT	O
etiological	JJ	O
genes	NNS	O
and	CC	O
mechanisms	NNS	O
,	,	O
phenotypic	JJ	O
basis	NN	O
,	,	O
and	CC	O
investigation	NN	O
of	IN	O
therapeutic	JJ	O
approaches	NNS	O
for	IN	O
PWS	NNP	B-Disease
.	.	O

.	.	O

Transgenic	JJ	O
mice	NNS	O
expressing	VBG	O
a	DT	O
truncated	VBN	O
form	NN	O
of	IN	O
the	DT	O
high	JJ	O
mobility	NN	O
group	NN	O
I-C	NN	O
protein	NN	O
develop	VBP	O
adiposity	NN	O
and	CC	O
an	DT	O
abnormally	RB	O
high	JJ	O
prevalence	NN	O
of	IN	O
lipomas	NNS	B-Disease
.	.	O

Chromosomal	JJ	O
translocations	NNS	O
in	IN	O
human	JJ	O
lipomas	NNS	B-Disease
frequently	RB	O
create	VBP	O
fusion	NN	O
transcripts	NNS	O
encoding	VBG	O
high	JJ	O
mobility	NN	O
group	NN	O
(	-LRB-	O
HMG	NN	O
)	-RRB-	O
I-C	NN	O
DNA-binding	JJ	O
domains	NNS	O
and	CC	O
C-terminal	JJ	O
sequences	NNS	O
from	IN	O
different	JJ	O
presumed	JJ	O
transcription	NN	O
factors	NNS	O
,	,	O
suggesting	VBG	O
a	DT	O
potential	JJ	O
role	NN	O
for	IN	O
HMG	NN	O
I-C	NN	O
in	IN	O
the	DT	O
development	NN	O
of	IN	O
lipomas	NNS	B-Disease
.	.	O

To	TO	O
evaluate	VB	O
the	DT	O
role	NN	O
of	IN	O
the	DT	O
HMG	NN	O
I-C	NN	O
component	NN	O
,	,	O
the	DT	O
three	CD	O
DNA-binding	JJ	O
domains	NNS	O
of	IN	O
HMG	NN	O
I-C	NN	O
have	VBP	O
now	RB	O
been	VBN	O
expressed	VBN	O
in	IN	O
transgenic	JJ	O
mice	NNS	O
.	.	O

Despite	IN	O
the	DT	O
ubiquitous	JJ	O
expression	NN	O
of	IN	O
the	DT	O
truncated	VBN	O
HMG	NN	O
I-C	NN	O
protein	NN	O
,	,	O
the	DT	O
transgenic	JJ	O
mice	NNS	O
develop	VBP	O
a	DT	O
selective	JJ	O
abundance	NN	O
of	IN	O
fat	JJ	O
tissue	NN	O
early	RB	O
in	IN	O
life	NN	O
,	,	O
show	VBP	O
marked	JJ	O
adipose	NN	B-Disease
tissue	NN	I-Disease
inflammation	NN	I-Disease
,	,	O
and	CC	O
have	VBP	O
an	DT	O
abnormally	RB	O
high	JJ	O
incidence	NN	O
of	IN	O
lipomas	NNS	B-Disease
.	.	O

These	DT	O
findings	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
DNA-binding	JJ	O
domains	NNS	O
of	IN	O
HMG	NN	O
I-C	NN	O
,	,	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
a	DT	O
C-terminal	JJ	O
fusion	NN	O
partner	NN	O
,	,	O
are	VBP	O
sufficient	JJ	O
to	TO	O
perturb	VB	O
adipogenesis	NN	O
and	CC	O
predispose	VB	O
to	TO	O
lipomas	NNS	B-Disease
.	.	O

We	PRP	O
provide	VBP	O
data	NNS	O
supporting	VBG	O
the	DT	O
central	JJ	O
utility	NN	O
of	IN	O
this	DT	O
animal	NN	O
model	NN	O
as	IN	O
a	DT	O
tool	NN	O
to	TO	O
understand	VB	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
underlying	VBG	O
the	DT	O
development	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
most	RBS	O
common	JJ	O
kind	NN	O
of	IN	O
human	JJ	O
benign	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

.	.	O

A	DT	O
common	JJ	O
MSH2	NN	O
mutation	NN	O
in	IN	O
English	NNP	O
and	CC	O
North	NNP	O
American	NNP	O
HNPCC	NNP	B-Disease
families	NNS	O
:	:	O
origin	NN	O
,	,	O
phenotypic	JJ	O
expression	NN	O
,	,	O
and	CC	O
sex	NN	O
specific	JJ	O
differences	NNS	O
in	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
frequency	NN	O
,	,	O
origin	NN	O
,	,	O
and	CC	O
phenotypic	JJ	O
expression	NN	O
of	IN	O
a	DT	O
germline	NN	O
MSH2	NN	O
gene	NN	O
mutation	NN	O
previously	RB	O
identified	VBN	O
in	IN	O
seven	CD	O
kindreds	NNS	O
with	IN	O
hereditary	JJ	B-Disease
non-polyposis	JJ	I-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
HNPCC	NN	B-Disease
)	-RRB-	O
was	VBD	O
investigated	VBN	O
.	.	O

The	DT	O
mutation	NN	O
(	-LRB-	O
A	NN	O
--	:	O
>	JJR	O
T	NN	O
at	IN	O
nt943	NN	O
+	CC	O
3	LS	O
)	-RRB-	O
disrupts	VBZ	O
the	DT	O
3	CD	O
splice	NN	O
site	NN	O
of	IN	O
exon	NN	O
5	CD	O
leading	VBG	O
to	TO	O
the	DT	O
deletion	NN	O
of	IN	O
this	DT	O
exon	NN	O
from	IN	O
MSH2	NN	O
mRNA	NN	O
and	CC	O
represents	VBZ	O
the	DT	O
only	JJ	O
frequent	JJ	O
MSH2	NN	O
mutation	NN	O
so	RB	O
far	RB	O
reported	VBN	O
.	.	O

Although	IN	O
this	DT	O
mutation	NN	O
was	VBD	O
initially	RB	O
detected	VBN	O
in	IN	O
four	CD	O
of	IN	O
33	CD	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
analysed	VBN	O
from	IN	O
eastern	JJ	O
England	NNP	O
,	,	O
more	RBR	O
extensive	JJ	O
analysis	NN	O
has	VBZ	O
reduced	VBN	O
the	DT	O
frequency	NN	O
to	TO	O
four	CD	O
of	IN	O
52	CD	O
(	-LRB-	O
8	CD	O
%	NN	O
)	-RRB-	O
English	JJ	O
HNPCC	NN	B-Disease
kindreds	NNS	O
analysed	VBN	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
the	DT	O
MSH2	NN	O
mutation	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
10	CD	O
of	IN	O
20	CD	O
(	-LRB-	O
50	CD	O
%	NN	O
)	-RRB-	O
separately	RB	O
identified	VBD	O
colorectal	JJ	B-Disease
families	NNS	O
from	IN	O
Newfoundland	NNP	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
origin	NN	O
of	IN	O
this	DT	O
mutation	NN	O
in	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
from	IN	O
England	NNP	O
(	-LRB-	O
n	NN	O
=	JJ	O
4	CD	O
)	-RRB-	O
,	,	O
Newfoundland	NNP	O
(	-LRB-	O
n	NN	O
=	JJ	O
10	CD	O
)	-RRB-	O
,	,	O
and	CC	O
the	DT	O
United	NNP	O
States	NNPS	O
(	-LRB-	O
n	NN	O
=	JJ	O
3	CD	O
)	-RRB-	O
,	,	O
haplotype	NN	O
analysis	NN	O
using	VBG	O
microsatellite	NN	O
markers	NNS	O
linked	VBN	O
to	TO	O
MSH2	NN	O
was	VBD	O
performed	VBN	O
.	.	O

Within	IN	O
the	DT	O
English	NNP	O
and	CC	O
US	NNP	O
families	NNS	O
there	EX	O
was	VBD	O
little	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
recent	JJ	O
common	JJ	O
origin	NN	O
of	IN	O
the	DT	O
MSH2	NN	O
splice	NN	O
site	NN	O
mutation	NN	O
in	IN	O
most	JJS	O
families	NNS	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
a	DT	O
common	JJ	O
haplotype	NN	O
was	VBD	O
identified	VBN	O
at	IN	O
the	DT	O
two	CD	O
flanking	JJ	O
markers	NNS	O
(	-LRB-	O
CA5	NN	O
and	CC	O
D2S288	NN	O
)	-RRB-	O
in	IN	O
eight	CD	O
of	IN	O
the	DT	O
Newfoundland	NNP	O
families	NNS	O
.	.	O

These	DT	O
findings	NNS	O
suggested	VBD	O
a	DT	O
founder	NN	O
effect	NN	O
within	IN	O
Newfoundland	NNP	O
similar	JJ	O
to	TO	O
that	DT	O
reported	VBN	O
by	IN	O
others	NNS	O
for	IN	O
two	CD	O
MLH1	NN	O
mutations	NNS	O
in	IN	O
Finnish	JJ	O
HNPCC	NN	B-Disease
families	NNS	O
.	.	O

We	PRP	O
calculated	VBD	O
age	NN	O
related	JJ	O
risks	NNS	O
of	IN	O
all	DT	O
,	,	O
colorectal	JJ	B-Disease
,	,	I-Disease
endometrial	JJ	I-Disease
,	,	I-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
in	IN	O
nt943	NN	O
+	CC	O
3	CD	O
A	DT	O
--	:	O
>	JJR	O
T	NN	O
MSH2	NN	O
mutation	NN	O
carriers	NNS	O
(	-LRB-	O
n	NN	O
=	JJ	O
76	CD	O
)	-RRB-	O
for	IN	O
all	DT	O
patients	NNS	O
and	CC	O
for	IN	O
men	NNS	O
and	CC	O
women	NNS	O
separately	RB	O
.	.	O

For	IN	O
both	DT	O
sexes	NNS	O
combined	VBN	O
,	,	O
the	DT	O
penetrances	NNS	O
at	IN	O
age	NN	O
60	CD	O
years	NNS	O
for	IN	O
all	DT	O
cancers	NNS	B-Disease
and	CC	O
for	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
were	VBD	O
0	CD	O
.	.	O

86	CD	O
and	CC	O
0	CD	O
.	.	O

57	CD	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
risk	NN	O
of	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
was	VBD	O
significantly	RB	O
higher	JJR	O
(	-LRB-	O
p	NN	O
<	JJR	O
0	CD	O
.	.	O

01	NN	O
)	-RRB-	O
in	IN	O
males	NNS	O
than	IN	O
females	NNS	O
(	-LRB-	O
0	CD	O
.	.	O

63	CD	O
v	LS	O
0	CD	O
.	.	O

30	CD	O
and	CC	O
0	CD	O
.	.	O

84	CD	O
v	LS	O
0	CD	O
.	.	O

44	CD	O
at	IN	O
ages	NNS	O
50	CD	O
and	CC	O
60	CD	O
years	NNS	O
,	,	O
respectively	RB	O
)	-RRB-	O
.	.	O

For	IN	O
females	NNS	O
there	EX	O
was	VBD	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
endometrial	JJ	B-Disease
cancer	NN	I-Disease
(	-LRB-	O
0	CD	O
.	.	O

5	CD	O
at	IN	O
age	NN	O
60	CD	O
years	NNS	O
)	-RRB-	O
and	CC	O
premenopausal	JJ	B-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
(	-LRB-	O
0	CD	O
.	.	O

2	CD	O
at	IN	O
50	CD	O
years	NNS	O
)	-RRB-	O
.	.	O

These	DT	O
intersex	NN	O
differences	NNS	O
in	IN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
risks	NNS	O
have	VBP	O
implications	NNS	O
for	IN	O
screening	VBG	O
programmes	NNS	O
and	CC	O
for	IN	O
attempts	NNS	O
to	TO	O
identify	VB	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
susceptibility	NN	O
modifiers	NNS	O
.	.	O

Novel	JJ	O
mutation	NN	O
at	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
in	IN	O
the	DT	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
families	NNS	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
new	JJ	O
mutation	NN	O
of	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
ND	NN	B-Disease
)	-RRB-	O
gene	NN	O
in	IN	O
two	CD	O
Japanese	JJ	O
males	NNS	O
from	IN	O
unrelated	JJ	O
families	NNS	O
;	:	O
they	PRP	O
showed	VBD	O
typical	JJ	O
ocular	JJ	O
features	NNS	O
of	IN	O
ND	NN	B-Disease
but	CC	O
no	DT	O
mental	JJ	B-Disease
retardation	NN	I-Disease
or	CC	O
hearing	NN	B-Disease
impairment	NN	I-Disease
.	.	O

A	DT	O
mutation	NN	O
was	VBD	O
found	VBN	O
in	IN	O
both	DT	O
patients	NNS	O
at	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
of	IN	O
exon	NN	O
2	CD	O
of	IN	O
the	DT	O
ND	NN	B-Disease
gene	NN	O
(	-LRB-	O
ATG	NN	O
to	TO	O
GTG	NNP	O
)	-RRB-	O
,	,	O
with	IN	O
otherwise	RB	O
normal	JJ	O
nucleotide	NN	O
sequences	NNS	O
.	.	O

Their	PRP$	O
mothers	NNS	O
had	VBD	O
the	DT	O
normal	JJ	O
and	CC	O
mutant	JJ	O
types	NNS	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
which	WDT	O
was	VBD	O
expected	VBN	O
for	IN	O
heterozygotes	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
mutation	NN	O
of	IN	O
the	DT	O
initiation	NN	O
codon	NN	O
would	MD	O
cause	VB	O
the	DT	O
failure	NN	O
of	IN	O
ND	NN	B-Disease
gene	NN	O
expression	NN	O
or	CC	O
a	DT	O
defect	NN	O
in	IN	O
translation	NN	O
thereby	RB	O
truncating	JJ	O
the	DT	O
amino	NN	O
terminus	NN	O
of	IN	O
ND	NN	B-Disease
protein	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
rarity	NN	O
and	CC	O
marked	JJ	O
heterogeneity	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ND	NN	B-Disease
gene	NN	O
,	,	O
the	DT	O
present	JJ	O
apparently	RB	O
unrelated	JJ	O
Japanese	JJ	O
families	NNS	O
who	WP	O
have	VBP	O
lived	VBN	O
in	IN	O
the	DT	O
same	JJ	O
area	NN	O
for	IN	O
over	IN	O
two	CD	O
centuries	NNS	O
presumably	RB	O
share	VBP	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
mutation	NN	O
.	.	O

.	.	O

Haplotype	NN	O
and	CC	O
phenotype	NN	O
analysis	NN	O
of	IN	O
six	CD	O
recurrent	JJ	O
BRCA1	NN	O
mutations	NNS	O
in	IN	O
61	CD	O
families	NNS	O
:	:	O
results	NNS	O
of	IN	O
an	DT	O
international	JJ	O
study	NN	O
.	.	O

Several	JJ	O
BRCA1	NN	O
mutations	NNS	O
have	VBP	O
now	RB	O
been	VBN	O
found	VBN	O
to	TO	O
occur	VB	O
in	IN	O
geographically	RB	O
diverse	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
.	.	O

To	TO	O
investigate	VB	O
mutation	NN	O
origin	NN	O
and	CC	O
mutation-specific	JJ	O
phenotypes	NNS	O
due	JJ	O
to	TO	O
BRCA1	NN	O
,	,	O
we	PRP	O
constructed	VBD	O
a	DT	O
haplotype	NN	O
of	IN	O
nine	CD	O
polymorphic	JJ	O
markers	NNS	O
within	IN	O
or	CC	O
immediately	RB	O
flanking	VBG	O
the	DT	O
BRCA1	NN	O
locus	NN	O
in	IN	O
a	DT	O
set	NN	O
of	IN	O
61	CD	O
breast/ovarian	JJ	B-Disease
cancer	NN	I-Disease
families	NNS	O
selected	VBN	O
for	IN	O
having	VBG	O
one	CD	O
of	IN	O
six	CD	O
recurrent	JJ	O
BRCA1	NN	O
mutations	NNS	O
.	.	O

Tests	NNS	O
of	IN	O
both	DT	O
mutations	NNS	O
and	CC	O
family-specific	JJ	O
differences	NNS	O
in	IN	O
age	NN	O
at	IN	O
diagnosis	NN	O
were	VBD	O
not	RB	O
significant	JJ	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
six	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
relative	JJ	O
proportions	NNS	O
of	IN	O
cases	NNS	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
was	VBD	O
suggestive	JJ	O
of	IN	O
an	DT	O
effect	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

069	CD	O
)	-RRB-	O
,	,	O
with	IN	O
57	CD	O
%	NN	O
of	IN	O
women	NNS	O
presumed	VBN	O
affected	VBD	O
because	IN	O
of	IN	O
the	DT	O
1294	CD	O
del	FW	O
40	CD	O
BRCA1	NN	O
mutation	NN	O
having	VBG	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
compared	VBN	O
with	IN	O
14	CD	O
%	NN	O
of	IN	O
affected	JJ	O
women	NNS	O
with	IN	O
the	DT	O
splice-site	NN	O
mutation	NN	O
in	IN	O
intron	NN	O
5	CD	O
of	IN	O
BRCA1	NN	O
.	.	O

For	IN	O
the	DT	O
BRCA1	NN	O
mutations	NNS	O
studied	VBN	O
here	RB	O
,	,	O
the	DT	O
individual	JJ	O
mutations	NNS	O
are	VBP	O
estimated	VBN	O
to	TO	O
have	VB	O
arisen	VBN	O
9-170	CD	O
generations	NNS	O
ago	RB	O
.	.	O

In	IN	O
general	JJ	O
,	,	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
haplotype	NN	O
conservation	NN	O
across	IN	O
the	DT	O
region	NN	O
was	VBD	O
observed	VBN	O
,	,	O
with	IN	O
haplotype	NN	O
differences	NNS	O
most	RBS	O
often	RB	O
due	JJ	O
to	TO	O
mutations	NNS	O
in	IN	O
the	DT	O
short-tandem-repeat	NN	O
markers	NNS	O
,	,	O
although	IN	O
some	DT	O
likely	JJ	O
instances	NNS	O
of	IN	O
recombination	NN	O
also	RB	O
were	VBD	O
observed	VBN	O
.	.	O

For	IN	O
several	JJ	O
of	IN	O
the	DT	O
instances	NNS	O
,	,	O
there	EX	O
was	VBD	O
evidence	NN	O
for	IN	O
multiple	JJ	O
,	,	O
independent	JJ	O
,	,	O
BRCA1	NN	O
mutational	JJ	O
events	NNS	O
.	.	O

A	DT	O
new	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
variant	NN	O
(	-LRB-	O
G6PD	NN	O
Nagano	NNP	O
)	-RRB-	O
associated	VBN	O
with	IN	O
congenital	JJ	B-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
.	.	O

A	DT	O
new	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
variant	NN	O
associated	VBN	O
with	IN	O
chronic	JJ	B-Disease
nonspherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
was	VBD	O
reported	VBN	O
.	.	O

The	DT	O
patient	NN	O
,	,	O
a	DT	O
6-year-old	JJ	O
Japanese	JJ	O
male	NN	O
,	,	O
was	VBD	O
noticed	VBN	O
to	TO	O
have	VB	O
hemolytic	JJ	B-Disease
anemia	NN	I-Disease
soon	RB	O
after	IN	O
birth	NN	O
,	,	O
and	CC	O
a	DT	O
diagnosis	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
made	VBN	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
2	CD	O
.	.	O

He	PRP	O
had	VBD	O
episodes	NNS	O
of	IN	O
hemolytic	JJ	B-Disease
crisis	NN	I-Disease
several	JJ	O
times	NNS	O
after	IN	O
upper	JJ	B-Disease
respiratory	JJ	I-Disease
infection	NN	I-Disease
.	.	O

G6PD	NN	O
activity	NN	O
of	IN	O
the	DT	O
patient	NN	O
was	VBD	O
5	CD	O
.	.	O

5	CD	O
%	NN	O
of	IN	O
normal	JJ	O
.	.	O

The	DT	O
enzymatic	JJ	O
characteristics	NNS	O
were	VBD	O
examined	VBN	O
when	WRB	O
he	PRP	O
was	VBD	O
5	CD	O
years	NNS	O
old	JJ	O
,	,	O
and	CC	O
his	PRP$	O
G6PD	NN	O
showed	VBD	O
faster-than-normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
low	JJ	O
Km	NN	O
G6P	NN	O
,	,	O
high	JJ	O
Km	NN	O
NADP	NN	O
,	,	O
low	JJ	O
Ki	NN	O
NADPH	NN	O
,	,	O
normal	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
,	,	O
heat	NN	O
instability	NN	O
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
pH	NN	O
optimum	JJ	O
curve	NN	O
.	.	O

From	IN	O
these	DT	O
results	NNS	O
,	,	O
this	DT	O
was	VBD	O
considered	VBN	O
to	TO	O
be	VB	O
a	DT	O
new	JJ	O
variant	NN	O
and	CC	O
was	VBD	O
designated	VBN	O
G6PD	NN	O
Nagano	NNP	O
.	.	O

Infection-induced	JJ	O
hemolysis	NN	B-Disease
and	CC	O
chronic	JJ	B-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
seem	VBP	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
markedly	RB	O
impaired	JJ	O
enzyme	NN	O
activity	NN	O
and	CC	O
thermal	JJ	O
instability	NN	O
.	.	O

Craniofrontonasal	JJ	B-Disease
dysplasia	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
nine	CD	O
patients	NNS	O
with	IN	O
craniofrontonasal	JJ	B-Disease
dysplasia	NN	I-Disease
(	-LRB-	O
CFND	NN	B-Disease
)	-RRB-	O
.	.	O

Seven	CD	O
classical	JJ	O
cases	NNS	O
had	VBD	O
facial	JJ	O
features	NNS	O
suggestive	JJ	O
of	IN	O
frontonasal	JJ	B-Disease
dysplasia	NN	I-Disease
and	CC	O
coronal	JJ	B-Disease
craniosynostosis	NNS	I-Disease
.	.	O

Extracranial	JJ	B-Disease
abnormalities	NNS	I-Disease
such	JJ	O
as	IN	O
brittle	JJ	B-Disease
nails	NNS	I-Disease
with	IN	I-Disease
prominent	JJ	I-Disease
longitudinal	JJ	I-Disease
grooves	NNS	I-Disease
or	CC	O
syndactyly	NN	B-Disease
of	IN	I-Disease
fingers	NNS	I-Disease
and	CC	I-Disease
toes	NNS	I-Disease
were	VBD	O
observed	VBN	O
in	IN	O
individual	JJ	O
patients	NNS	O
.	.	O

In	IN	O
two	CD	O
families	NNS	O
the	DT	O
father	NN	O
of	IN	O
classical	JJ	O
cases	NNS	O
showed	VBD	O
a	DT	O
milder	JJ	O
pattern	NN	O
of	IN	O
abnormalities	NNS	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
diagnosis	NN	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
2	LS	O
-	:	O
to	TO	O
13-year	JJ	O
follow-up	NN	O
on	IN	O
our	PRP$	O
patients	NNS	O
.	.	O

Hypotonia	NN	B-Disease
and	CC	O
laxity	NN	B-Disease
of	IN	I-Disease
joints	NNS	I-Disease
are	VBP	O
common	JJ	O
and	CC	O
may	MD	O
necessitate	VB	O
supportive	JJ	O
measures	NNS	O
.	.	O

Mild	JJ	O
developmental	JJ	B-Disease
delay	NN	I-Disease
was	VBD	O
noted	VBN	O
in	IN	O
three	CD	O
out	IN	O
of	IN	O
six	CD	O
classical	JJ	O
cases	NNS	O
studied	VBN	O
in	IN	O
detail	NN	O
.	.	O

Unlike	IN	O
almost	RB	O
all	DT	O
other	JJ	O
X-linked	JJ	B-Disease
disorders	NNS	I-Disease
,	,	O
clinical	JJ	O
expression	NN	O
in	IN	O
CFND	NNP	B-Disease
is	VBZ	O
generally	RB	O
much	RB	O
more	RBR	O
severe	JJ	O
in	IN	O
females	NNS	O
than	IN	O
in	IN	O
males	NNS	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
previous	JJ	O
reports	NNS	O
of	IN	O
this	DT	O
condition	NN	O
,	,	O
one	CD	O
of	IN	O
our	PRP$	O
severely	RB	O
affected	VBN	O
cases	NNS	O
is	VBZ	O
a	DT	O
male	NN	O
.	.	O

.	.	O

A	DT	O
new	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
gene	NN	O
in	IN	O
a	DT	O
German	JJ	O
family	NN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

A	DT	O
C-to-T	JJ	O
transition	NN	O
in	IN	O
exon	NN	O
4	CD	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
was	VBD	O
found	VBN	O
in	IN	O
2	CD	O
affected	VBD	O
males	NNS	O
and	CC	O
two	CD	O
obligate	JJ	O
carriers	NNS	O
in	IN	O
a	DT	O
German	JJ	O
family	NN	O
with	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
.	.	O

The	DT	O
mutation	NN	O
,	,	O
which	WDT	O
causes	VBZ	O
loss	NN	O
of	IN	O
an	DT	O
HphI	NN	O
site	NN	O
and	CC	O
changes	NNS	O
amino	NN	O
acid	NN	O
155	CD	O
from	IN	O
threonine	NN	O
to	TO	O
isoleucine	NN	O
,	,	O
was	VBD	O
absent	JJ	O
from	IN	O
108	CD	O
normal	JJ	O
chromosomes	NNS	O
.	.	O

There	EX	O
are	VBP	O
5	CD	O
concordances	NNS	O
and	CC	O
1	CD	O
discrepancy	NN	O
between	IN	O
these	DT	O
results	NNS	O
and	CC	O
those	DT	O
obtained	VBN	O
by	IN	O
magnetic	JJ	O
resonance	NN	O
imaging	NN	O
in	IN	O
this	DT	O
family	NN	O
.	.	O

.	.	O

The	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
X-linked	JJ	B-Disease
congenital	JJ	I-Disease
thrombocytopenia	NN	I-Disease
are	VBP	O
caused	VBN	O
by	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

The	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
thrombocytopenia	NN	B-Disease
,	,	O
small	JJ	O
platelets	NNS	O
,	,	O
eczema	NN	B-Disease
,	,	O
recurrent	JJ	O
infections	NNS	O
,	,	O
and	CC	O
immunodeficiency	NN	B-Disease
.	.	O

Besides	IN	O
the	DT	O
classic	JJ	O
WAS	NNP	B-Disease
phenotype	NN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
group	NN	O
of	IN	O
patients	NNS	O
with	IN	O
congenital	JJ	B-Disease
X-linked	JJ	I-Disease
thrombocytopenia	NN	I-Disease
(	-LRB-	O
XLT	NN	B-Disease
)	-RRB-	O
who	WP	O
have	VBP	O
small	JJ	O
platelets	NNS	O
but	CC	O
only	RB	O
transient	JJ	O
eczema	NN	B-Disease
,	,	O
if	IN	O
any	DT	O
,	,	O
and	CC	O
minimal	JJ	O
immune	JJ	B-Disease
deficiency	NN	I-Disease
.	.	O

Because	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
WAS	NNP	B-Disease
has	VBZ	O
been	VBN	O
sequenced	VBN	O
,	,	O
it	PRP	O
was	VBD	O
possible	JJ	O
to	TO	O
correlate	VB	O
the	DT	O
WAS	NNP	B-Disease
phenotypes	NNS	O
with	IN	O
WAS	NN	B-Disease
gene	NN	O
mutations	NNS	O
.	.	O

Using	VBG	O
a	DT	O
fingerprinting	VBG	O
screening	NN	O
technique	NN	O
,	,	O
we	PRP	O
determined	VBD	O
the	DT	O
approximate	JJ	O
location	NN	O
of	IN	O
the	DT	O
mutation	NN	O
in	IN	O
13	CD	O
unrelated	JJ	O
WAS	NN	B-Disease
patients	NNS	O
with	IN	O
mild	JJ	O
to	TO	O
severe	JJ	O
clinical	JJ	O
symptoms	NNS	O
.	.	O

Direct	JJ	O
sequence	NN	O
analysis	NN	O
of	IN	O
cDNA	NN	O
and	CC	O
genomic	JJ	O
DNA	NN	O
obtained	VBN	O
from	IN	O
patient-derived	JJ	O
cell	NN	O
lines	NNS	O
showed	VBD	O
12	CD	O
unique	JJ	O
mutations	NNS	O
distributed	VBN	O
throughout	IN	O
the	DT	O
WAS	NNP	B-Disease
gene	NN	O
,	,	O
including	VBG	O
insertions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
and	CC	O
point	NN	O
mutations	NNS	O
resulting	VBG	O
in	IN	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
termination	NN	O
,	,	O
exon	NN	O
skipping	VBG	O
,	,	O
or	CC	O
splicing	NN	O
defects	NNS	O
.	.	O

Of	IN	O
4	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
the	DT	O
XLT	NNP	B-Disease
phenotype	NN	O
,	,	O
3	CD	O
had	VBD	O
missense	NN	O
mutations	NNS	O
affecting	VBG	O
exon	NN	O
2	CD	O
and	CC	O
1	CD	O
had	VBD	O
a	DT	O
splice-site	JJ	O
mutation	NN	O
affecting	VBG	O
exon	NN	O
9	CD	O
.	.	O

Patients	NNS	O
with	IN	O
classic	JJ	O
WAS	NNP	B-Disease
had	VBD	O
more	RBR	O
complex	JJ	O
mutations	NNS	O
,	,	O
resulting	VBG	O
in	IN	O
termination	NN	O
codons	NNS	O
,	,	O
frameshift	NN	O
,	,	O
and	CC	O
early	JJ	O
termination	NN	O
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
direct	JJ	O
evidence	NN	O
that	IN	O
XLT	NNP	B-Disease
and	CC	O
WAS	NNP	B-Disease
are	VBP	O
caused	VBN	O
by	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
same	JJ	O
gene	NN	O
and	CC	O
suggest	VBP	O
that	IN	O
severe	JJ	O
clinical	JJ	O
phenotypes	NNS	O
are	VBP	O
associated	VBN	O
with	IN	O
complex	JJ	O
mutations	NNS	O
.	.	O

.	.	O

A	DT	O
3-base	JJ	O
pair	NN	O
in-frame	RB	O
deletion	NN	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
results	VBZ	O
in	IN	O
a	DT	O
kinetic	JJ	O
variant	NN	O
of	IN	O
phenylketonuria	NN	B-Disease
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disease	NN	I-Disease
due	JJ	O
to	TO	O
deficiency	NN	B-Disease
of	IN	I-Disease
a	DT	I-Disease
hepatic	JJ	I-Disease
enzyme	NN	I-Disease
,	,	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

The	DT	O
absence	NN	O
of	IN	O
PAH	NN	O
activity	NN	O
results	VBZ	O
in	IN	O
typical	JJ	O
PKU	NN	B-Disease
while	IN	O
persistence	NN	O
of	IN	O
a	DT	O
residual	JJ	O
enzyme	NN	O
activity	NN	O
gives	VBZ	O
rise	NN	O
to	TO	O
variant	JJ	O
forms	NNS	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
a	DT	O
3-base	JJ	O
pair	NN	O
in-frame	RB	O
deletion	NN	O
of	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
(	-LRB-	O
delta	NN	O
194	CD	O
)	-RRB-	O
in	IN	O
a	DT	O
mild	JJ	O
variant	NN	O
,	,	O
with	IN	O
markedly	RB	O
reduced	VBN	O
affinity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
for	IN	O
phenylalanine	NN	O
(	-LRB-	O
Km	NN	O
=	JJ	O
160	CD	O
nM	NN	O
)	-RRB-	O
,	,	O
and	CC	O
we	PRP	O
provide	VBP	O
functional	JJ	O
evidence	NN	O
for	IN	O
responsibility	NN	O
of	IN	O
the	DT	O
deletion	NN	O
in	IN	O
the	DT	O
mutant	JJ	O
phenotype	NN	O
.	.	O

Since	IN	O
the	DT	O
deletion	NN	O
was	VBD	O
located	JJ	O
in	IN	O
the	DT	O
third	JJ	O
exon	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
which	WDT	O
presents	VBZ	O
no	DT	O
homology	NN	O
with	IN	O
other	JJ	O
hydroxylases	NNS	O
,	,	O
we	PRP	O
suggest	VBP	O
that	IN	O
exon	NN	O
3	CD	O
is	VBZ	O
involved	VBN	O
in	IN	O
the	DT	O
specificity	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
for	IN	O
phenylalanine	NN	O
.	.	O

Finally	RB	O
,	,	O
since	IN	O
none	NN	O
of	IN	O
the	DT	O
98	CD	O
PKU	NN	B-Disease
patients	NNS	O
tested	VBN	O
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
this	DT	O
particular	JJ	O
deletion	NN	O
,	,	O
our	PRP$	O
study	NN	O
suggests	VBZ	O
that	IN	O
this	DT	O
molecular	JJ	O
event	NN	O
probably	RB	O
occurred	VBD	O
recently	RB	O
on	IN	O
the	DT	O
background	NN	O
of	IN	O
a	DT	O
haplotype	NN	O
2	CD	O
gene	NN	O
in	IN	O
Portugal	NNP	O
.	.	O

.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
:	:	O
an	DT	O
overview	NN	O
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
,	,	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
neurodegenerative	JJ	I-Disease
disease	NN	I-Disease
,	,	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
of	IN	O
the	DT	O
inherited	VBN	B-Disease
ataxias	NNS	I-Disease
.	.	O

The	DT	O
recent	JJ	O
discovery	NN	O
of	IN	O
the	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
mutated	VBN	O
in	IN	O
this	DT	O
condition	NN	O
,	,	O
FRDA	NN	O
,	,	O
has	VBZ	O
led	VBN	O
to	TO	O
rapid	JJ	O
advances	NNS	O
in	IN	O
the	DT	O
understanding	NN	O
of	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
.	.	O

About	IN	O
98	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

This	DT	O
leads	VBZ	O
to	TO	O
reduced	VBN	O
levels	NNS	O
of	IN	O
the	DT	O
protein	NN	O
,	,	O
frataxin	NN	O
.	.	O

There	EX	O
is	VBZ	O
mounting	VBG	O
evidence	NN	O
to	TO	O
suggest	VB	O
that	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
is	VBZ	O
the	DT	O
result	NN	O
of	IN	O
accumulation	NN	O
of	IN	O
iron	NN	O
in	IN	O
mitochondria	NN	O
leading	VBG	O
to	TO	O
excess	JJ	O
production	NN	O
of	IN	O
free	JJ	O
radicals	NNS	O
,	,	O
which	WDT	O
then	RB	O
results	VBZ	O
in	IN	O
cellular	JJ	O
damage	NN	O
and	CC	O
death	NN	O
.	.	O

Currently	RB	O
there	EX	O
is	VBZ	O
no	DT	O
known	JJ	O
treatment	NN	O
that	WDT	O
alters	VBZ	O
the	DT	O
natural	JJ	O
course	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

The	DT	O
discovery	NN	O
of	IN	O
the	DT	O
FRDA	NN	B-Disease
gene	NN	O
and	CC	O
its	PRP$	O
possible	JJ	O
function	NN	O
has	VBZ	O
raised	VBN	O
hope	NN	O
that	IN	O
rational	JJ	O
therapeutic	JJ	O
strategies	NNS	O
will	MD	O
be	VB	O
developed	VBN	O
.	.	O

.	.	O

Clinical	JJ	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
of	IN	O
primary	JJ	B-Disease
dystonias	NNS	I-Disease
.	.	O

Primary	JJ	B-Disease
dystonias	NNS	I-Disease
are	VBP	O
movement	NN	B-Disease
disorders	NNS	I-Disease
with	IN	O
dystonia	NN	B-Disease
as	IN	O
a	DT	O
major	JJ	O
symptom	NN	O
.	.	O

They	PRP	O
are	VBP	O
frequently	RB	O
inherited	VBN	O
as	IN	O
Mendelian	JJ	O
traits	NNS	O
.	.	O

There	EX	O
are	VBP	O
at	IN	O
least	JJS	O
eight	CD	O
clinically	RB	O
distinct	JJ	O
autosomal	JJ	O
dominant	JJ	O
and	CC	O
two	CD	O
X-linked	JJ	O
recessive	JJ	O
forms	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
pedigree	NN	O
analyses	NNS	O
suggest	VBP	O
the	DT	O
occurrence	NN	O
of	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
variant	NN	O
.	.	O

The	DT	O
clinical	JJ	O
classification	NN	O
is	VBZ	O
increasingly	RB	O
being	VBG	O
replaced	VBN	O
by	IN	O
a	DT	O
genetic	JJ	O
one	CD	O
.	.	O

To	TO	O
date	NN	O
gene	NN	O
loci	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
at	IN	O
least	JJS	O
six	CD	O
autosomal	JJ	O
dominant	JJ	O
forms	NNS	O
,	,	O
i.	FW	O
e.	FW	O
,	,	O
in	IN	O
idiopathic	JJ	B-Disease
torsion	NN	I-Disease
dystonia	NN	I-Disease
(	-LRB-	O
9q34	NN	O
)	-RRB-	O
,	,	O
focal	JJ	B-Disease
dystonia	NN	I-Disease
(	-LRB-	O
18p	NN	O
)	-RRB-	O
,	,	O
adult-onset	JJ	O
idiopathic	JJ	B-Disease
torsion	NN	I-Disease
dystonia	NN	I-Disease
of	IN	O
mixed	JJ	O
type	NN	O
(	-LRB-	O
8p21-q22	NN	O
)	-RRB-	O
,	,	O
dopa-responsive	JJ	B-Disease
dystonia	NN	I-Disease
(	-LRB-	O
14q22	NN	O
.	.	O

1-q22	NN	O
.	.	O

2	LS	O
)	-RRB-	O
,	,	O
and	CC	O
paroxysmal	JJ	B-Disease
dystonic	JJ	I-Disease
choreoathetosis	NN	I-Disease
(	-LRB-	O
2q25-q33	NN	O
;	:	O
1p21-p13	NN	O
.	.	O

3	LS	O
)	-RRB-	O
.	.	O

Gene	NNP	O
loci	NNS	O
in	IN	O
the	DT	O
X-linked	JJ	O
recessive	JJ	O
forms	NNS	O
have	VBP	O
been	VBN	O
assigned	VBN	O
to	TO	O
Xq13	NN	O
.	.	O

1	CD	O
in	IN	O
the	DT	O
X-linked	JJ	B-Disease
dystonia	NN	I-Disease
parkinsonism	NN	I-Disease
syndrome	NN	I-Disease
and	CC	O
to	TO	O
Xq22	NN	O
in	IN	O
X-linked	JJ	B-Disease
sensorineural	JJ	I-Disease
deafness	NN	I-Disease
,	,	O
dystonia	NN	B-Disease
,	,	O
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
.	.	O

The	DT	O
disease	NN	O
genes	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
two	CD	O
autosomal	JJ	O
dominant	JJ	O
forms	NNS	O
and	CC	O
in	IN	O
one	CD	O
X-linked	JJ	O
recessive	JJ	O
form	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
a	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
an	DT	O
ATP-binding	JJ	O
protein	NN	O
were	VBD	O
detected	VBN	O
in	IN	O
idiopathic	JJ	B-Disease
torsion	NN	I-Disease
dystonia	NN	I-Disease
(	-LRB-	O
DYT1	NN	O
)	-RRB-	O
,	,	O
and	CC	O
the	DT	O
GTP	NN	O
cyclohydrolase	NN	O
1	CD	O
gene	NN	O
is	VBZ	O
mutated	VBN	O
in	IN	O
dopa-responsive	JJ	B-Disease
dystonia	NN	I-Disease
(	-LRB-	O
DYT5	NN	O
)	-RRB-	O
.	.	O

In	IN	O
sensorineural	JJ	B-Disease
deafness	NN	I-Disease
,	,	O
dystonia	NN	B-Disease
,	,	O
and	CC	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
gene	NN	O
DDP	NN	O
coding	VBG	O
for	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

This	DT	O
article	NN	O
reviews	VBZ	O
the	DT	O
clinical	JJ	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
of	IN	O
primary	JJ	B-Disease
dystonias	NNS	I-Disease
,	,	O
critically	RB	O
discusses	VBZ	O
present	JJ	O
findings	NNS	O
,	,	O
and	CC	O
proposes	VBZ	O
referring	VBG	O
to	TO	O
the	DT	O
known	JJ	O
forms	NNS	O
,	,	O
most	JJS	O
of	IN	O
which	WDT	O
can	MD	O
be	VB	O
distinguished	VBN	O
by	IN	O
genetic	JJ	O
criteria	NNS	O
,	,	O
as	IN	O
dystonias	NNS	B-Disease
1-12	CD	I-Disease
.	.	O

Clinical	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
in	IN	O
an	DT	O
Australian	JJ	O
population	NN	O
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
FRDA	NN	B-Disease
gene	NN	O
that	WDT	O
encodes	VBZ	O
a	DT	O
210-amino	JJ	O
acid	NN	O
protein	NN	O
called	VBN	O
frataxin	NN	O
.	.	O

An	DT	O
expansion	NN	O
of	IN	O
a	DT	O
GAA	NNP	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
intron	NN	O
1	CD	O
of	IN	O
the	DT	O
gene	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
more	JJR	O
than	IN	O
95	CD	O
%	NN	O
of	IN	O
mutant	JJ	O
alleles	NNS	O
.	.	O

Of	IN	O
the	DT	O
83	CD	O
people	NNS	O
we	PRP	O
studied	VBD	O
who	WP	O
have	VBP	O
mutations	NNS	O
in	IN	O
FRDA	NNP	O
,	,	O
78	CD	O
are	VBP	O
homozygous	JJ	O
for	IN	O
an	DT	O
expanded	VBN	O
GAA	NNP	O
repeat	NN	O
;	:	O
the	DT	O
other	JJ	O
five	CD	O
patients	NNS	O
have	VBP	O
an	DT	O
expansion	NN	O
in	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
point	NN	O
mutation	NN	O
in	IN	O
the	DT	O
other	JJ	O
.	.	O

Here	RB	O
we	PRP	O
present	VBP	O
a	DT	O
detailed	JJ	O
clinical	JJ	O
and	CC	O
genetic	JJ	O
study	NN	O
of	IN	O
a	DT	O
subset	NN	O
of	IN	O
51	CD	O
patients	NNS	O
homozygous	JJ	O
for	IN	O
an	DT	O
expansion	NN	O
of	IN	O
the	DT	O
GAA	NNP	O
repeat	NN	O
.	.	O

We	PRP	O
found	VBD	O
a	DT	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
smaller	JJR	O
of	IN	O
the	DT	O
two	CD	O
expanded	VBN	O
alleles	NNS	O
and	CC	O
age	NN	O
at	IN	O
onset	NN	O
,	,	O
age	NN	O
into	IN	O
wheelchair	NN	O
,	,	O
scoliosis	NN	B-Disease
,	,	O
impaired	JJ	O
vibration	NN	O
sense	NN	O
,	,	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
foot	NN	B-Disease
deformity	NN	I-Disease
.	.	O

There	EX	O
was	VBD	O
no	DT	O
significant	JJ	O
correlation	NN	O
between	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	O
smaller	JJR	O
allele	NN	O
and	CC	O
cardiomyopathy	NN	B-Disease
,	,	O
diabetes	NN	B-Disease
mellitus	NN	I-Disease
,	,	O
loss	NN	B-Disease
of	IN	I-Disease
proprioception	NN	I-Disease
,	,	O
or	CC	O
bladder	NN	B-Disease
symptoms	NNS	I-Disease
.	.	O

The	DT	O
larger	JJR	O
allele	NN	O
size	NN	O
correlated	VBD	O
with	IN	O
bladder	NN	B-Disease
symptoms	NNS	I-Disease
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
foot	NN	B-Disease
deformity	NN	I-Disease
.	.	O

The	DT	O
duration	NN	O
of	IN	O
disease	NN	O
is	VBZ	O
correlated	VBN	O
with	IN	O
wheelchair	NN	O
use	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
diabetes	NN	B-Disease
,	,	O
scoliosis	NN	B-Disease
,	,	O
bladder	NN	B-Disease
symptoms	NNS	I-Disease
and	CC	O
impaired	JJ	B-Disease
proprioception	NN	I-Disease
,	,	O
and	CC	O
vibration	NN	O
sense	NN	O
but	CC	O
no	DT	O
other	JJ	O
complications	NNS	O
studied	VBN	O
.	.	O

.	.	O

Recurrent	JJ	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
with	IN	O
absence	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
sixth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
:	:	O
an	DT	O
evaluation	NN	O
of	IN	O
underlying	VBG	O
immunologic	JJ	O
mechanisms	NNS	O
.	.	O

A	DT	O
51/2-year-old	JJ	O
black	JJ	O
girl	NN	O
with	IN	O
recurrent	JJ	O
meningococcal	JJ	B-Disease
meningitis	NN	I-Disease
and	CC	O
absence	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
sixth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C6	NN	O
)	-RRB-	O
is	VBZ	O
reported	VBN	O
.	.	O

To	TO	O
explore	VB	O
the	DT	O
pathogenesis	NN	O
of	IN	O
recurrent	JJ	O
neisserial	JJ	B-Disease
infections	NNS	I-Disease
in	IN	O
C6	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
a	DT	O
detailed	JJ	O
analysis	NN	O
of	IN	O
her	PRP$	O
immune	JJ	O
competence	NN	O
was	VBD	O
conducted	VBN	O
.	.	O

Her	PRP$	O
serum	NN	O
had	VBD	O
normal	JJ	O
chemotactic	JJ	O
,	,	O
opsonic	JJ	O
,	,	O
alternative	JJ	O
complement	NN	O
pathway	NN	O
,	,	O
and	CC	O
specific	JJ	O
antibody	NN	O
activity	NN	O
,	,	O
but	CC	O
lacked	VBD	O
complement-mediated	JJ	O
bacteriolytic	JJ	O
activity	NN	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
her	PRP$	O
C6-deficient	JJ	B-Disease
serum	NN	O
was	VBD	O
indistinguishable	JJ	O
from	IN	O
normal	JJ	O
serum	NN	O
in	IN	O
a	DT	O
complement-dependent	JJ	O
assay	NN	O
of	IN	O
phagocyte	NN	O
bactericidal	JJ	O
activity	NN	O
.	.	O

Absent	JJ	O
bacteriolysis	NN	O
remains	VBZ	O
the	DT	O
only	JJ	O
consistent	JJ	O
defect	NN	O
associated	VBN	O
with	IN	O
recurrent	JJ	O
neisserial	JJ	B-Disease
infections	NNS	I-Disease
and	CC	O
absence	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
late-acting	JJ	O
complement	NN	O
components	NNS	O
.	.	O

.	.	O

Mutation	NN	O
of	IN	O
the	DT	O
sterol	NN	O
27-hydroxylase	JJ	O
gene	NN	O
(	-LRB-	O
CYP27	NN	O
)	-RRB-	O
results	VBZ	O
in	IN	O
truncation	NN	O
of	IN	O
mRNA	NN	O
expressed	VBN	O
in	IN	O
leucocytes	NNS	O
in	IN	O
a	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
.	.	O

OBJECTIVES	NNS	O
A	DT	O
Japanese	JJ	O
family	NN	O
with	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
was	VBD	O
investigated	VBN	O
for	IN	O
a	DT	O
sequence	NN	O
alteration	NN	O
in	IN	O
the	DT	O
sterol	NN	O
27-hydroxylase	JJ	O
gene	NN	O
(	-LRB-	O
CYP27	NN	O
)	-RRB-	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
CYP27	NN	O
has	VBZ	O
been	VBN	O
mostly	RB	O
explored	VBN	O
using	VBG	O
cultured	VBN	O
fibroblasts	NNS	O
,	,	O
prompting	VBG	O
the	DT	O
examination	NN	O
of	IN	O
the	DT	O
transcripts	NNS	O
from	IN	O
blood	NN	O
leucocytes	NNS	O
as	IN	O
a	DT	O
simple	JJ	O
and	CC	O
rapid	JJ	O
technique	NN	O
.	.	O

METHODS	NNS	O
An	DT	O
alteration	NN	O
in	IN	O
CYP27	NN	O
of	IN	O
the	DT	O
proband	NN	O
was	VBD	O
searched	VBN	O
for	IN	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction-single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
PCR-SSCP	NN	O
)	-RRB-	O
analysis	NN	O
and	CC	O
subsequent	JJ	O
sequencing	NN	O
.	.	O

Samples	NNS	O
of	IN	O
RNA	NN	O
were	VBD	O
subjected	VBN	O
to	TO	O
reverse	VB	O
transcription	NN	O
PCR	NN	O
(	-LRB-	O
RT-PCR	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
proband	NN	O
was	VBD	O
amplified	VBN	O
with	IN	O
nested	JJ	O
primers	NNS	O
and	CC	O
sequenced	VBN	O
.	.	O

RESULTS	NNS	O
A	DT	O
homozygous	JJ	O
G	NN	O
to	TO	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
intron	NN	O
7	CD	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
patient	NN	O
.	.	O

In	IN	O
RT-PCR	NN	O
analysis	NN	O
,	,	O
only	RB	O
a	DT	O
truncated	VBN	O
transcript	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
patient	NN	O
,	,	O
whereas	IN	O
both	CC	O
normal	JJ	O
and	CC	O
truncated	VBN	O
transcripts	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
siblings	NNS	O
.	.	O

The	DT	O
sequencing	NN	O
of	IN	O
the	DT	O
patients	NNS	O
cDNA	NN	O
fragment	NN	O
disclosed	VBD	O
a	DT	O
direct	JJ	O
conjuction	NN	O
of	IN	O
exon	NN	O
6	CD	O
and	CC	O
exon	NN	O
8	CD	O
.	.	O

CONCLUSION	NN	O
The	DT	O
mutation	NN	O
at	IN	O
splice	NN	O
donor	NN	O
site	NN	O
and	CC	O
the	DT	O
truncation	NN	O
of	IN	O
mRNA	NN	O
were	VBD	O
identical	JJ	O
with	IN	O
those	DT	O
of	IN	O
a	DT	O
recently	RB	O
reported	VBN	O
Italian	JJ	O
patient	NN	O
,	,	O
although	IN	O
different	JJ	O
in	IN	O
symptomatology	NN	O
.	.	O

The	DT	O
application	NN	O
of	IN	O
blood	NN	O
leucocytes	NNS	O
can	MD	O
be	VB	O
a	DT	O
simple	JJ	O
technique	NN	O
on	IN	O
analysing	VBG	O
a	DT	O
constructive	JJ	O
abnormality	NN	B-Disease
of	IN	I-Disease
CYP27	NN	I-Disease
mRNA	NN	O
.	.	O

.	.	O

Frequent	JJ	O
detection	NN	O
of	IN	O
codon	NN	O
877	CD	O
mutation	NN	O
in	IN	O
the	DT	O
androgen	NN	O
receptor	NN	O
gene	NN	O
in	IN	O
advanced	JJ	B-Disease
prostate	NN	I-Disease
cancers	NNS	I-Disease
.	.	O

Prostatic	JJ	O
tissue	NN	O
specimens	NNS	O
derived	VBN	O
from	IN	O
transurethral	JJ	O
resections	NNS	O
of	IN	O
patients	NNS	O
with	IN	O
metastatic	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
were	VBD	O
analyzed	VBN	O
for	IN	O
genetic	JJ	O
alterations	NNS	O
in	IN	O
the	DT	O
hormone-binding	JJ	O
domain	NN	O
of	IN	O
the	DT	O
androgen	NN	O
receptor	NN	O
(	-LRB-	O
AR	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

Direct	JJ	O
sequencing	NN	O
of	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction-derived	JJ	O
DNAs	NNS	O
of	IN	O
6	CD	O
of	IN	O
24	CD	O
specimens	NNS	O
revealed	VBD	O
a	DT	O
codon	NN	O
877	CD	O
mutation	NN	O
(	-LRB-	O
ACT	NN	O
--	:	O
>	JJR	O
GCT	NN	O
,	,	O
Thr	NNP	O
--	:	O
>	JJR	O
Ala	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
hormone-binding	JJ	O
domain	NN	O
of	IN	O
the	DT	O
AR	NN	O
gene	NN	O
.	.	O

This	DT	O
same	JJ	O
AR	NN	O
mutation	NN	O
has	VBZ	O
been	VBN	O
reported	VBN	O
previously	RB	O
in	IN	O
a	DT	O
metastatic	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
cell	NN	O
line	NN	O
,	,	O
LNCaP	NN	O
,	,	O
where	WRB	O
this	DT	O
mutation	NN	O
confers	VBZ	O
upon	IN	O
the	DT	O
AR	NNS	O
an	DT	O
altered	JJ	O
ligand-binding	JJ	O
specificity	NN	O
which	WDT	O
is	VBZ	O
stimulated	VBN	O
by	IN	O
estrogens	NNS	O
,	,	O
progestagens	NNS	O
,	,	O
and	CC	O
antiandrogens	NNS	O
.	.	O

It	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
analogous	JJ	O
to	TO	O
an	DT	O
activated/altered	VBN	O
growth	NN	O
factor	NN	O
receptor	NN	O
oncogene	NN	O
,	,	O
codon	NN	O
877	CD	O
mutant	JJ	O
AR	NNS	O
with	IN	O
altered	JJ	O
ligand	NN	O
binding	NN	O
may	MD	O
provide	VB	O
a	DT	O
selective	JJ	O
growth	NN	O
advantage	NN	O
in	IN	O
the	DT	O
genesis	NN	O
of	IN	O
a	DT	O
subset	NN	O
of	IN	O
advanced	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
.	.	O

Although	IN	O
estrogens	NNS	O
are	VBP	O
used	VBN	O
infrequently	RB	O
,	,	O
antiandrogens	NNS	O
are	VBP	O
used	VBN	O
increasingly	RB	O
in	IN	O
hormonal	JJ	O
therapy	NN	O
for	IN	O
patients	NNS	O
with	IN	O
advanced	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
.	.	O

The	DT	O
stimulatory	JJ	O
effect	NN	O
of	IN	O
these	DT	O
therapeutic	JJ	O
agents	NNS	O
on	IN	O
the	DT	O
codon	NN	O
877	CD	O
mutant	JJ	O
AR	NNS	O
further	RB	O
suggests	VBZ	O
that	IN	O
this	DT	O
frequently	RB	O
observed	VBN	O
AR	NN	O
mutation	NN	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
treatment	NN	O
refractory	JJ	O
disease	NN	O
.	.	O

.	.	O

ATM-dependent	JJ	O
phosphorylation	NN	O
of	IN	O
nibrin	NN	O
in	IN	O
response	NN	O
to	TO	O
radiation	NN	O
exposure	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
ATM	NNP	O
are	VBP	O
responsible	JJ	O
for	IN	O
the	DT	O
genetic	JJ	B-Disease
disorder	NN	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
characterized	VBN	O
by	IN	O
cerebellar	NN	B-Disease
dysfunction	NN	I-Disease
,	,	O
radiosensitivity	NN	O
,	,	O
chromosomal	JJ	O
instability	NN	O
and	CC	O
cancer	NN	B-Disease
predisposition	NN	O
.	.	O

Both	CC	O
the	DT	O
A-T	NN	B-Disease
phenotype	NN	O
and	CC	O
the	DT	O
similarity	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
protein	NN	O
to	TO	O
other	JJ	O
DNA-damage	JJ	O
sensors	NNS	O
suggests	VBZ	O
a	DT	O
role	NN	O
for	IN	O
ATM	NNP	O
in	IN	O
biochemical	JJ	O
pathways	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
recognition	NN	O
,	,	O
signalling	NN	O
and	CC	O
repair	NN	O
of	IN	O
DNA	NN	O
double-strand	NN	O
breaks	NNS	O
(	-LRB-	O
DSBs	NNS	O
)	-RRB-	O
.	.	O

There	EX	O
are	VBP	O
strong	JJ	O
parallels	NNS	O
between	IN	O
the	DT	O
pattern	NN	O
of	IN	O
radiosensitivity	NN	O
,	,	O
chromosomal	JJ	O
instability	NN	O
and	CC	O
cancer	NN	B-Disease
predisposition	NN	O
in	IN	O
A-T	NN	B-Disease
patients	NNS	O
and	CC	O
that	IN	O
in	IN	O
patients	NNS	O
with	IN	O
Nijmegen	NN	B-Disease
breakage	NN	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
NBS	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
protein	NN	O
defective	JJ	O
in	IN	O
NBS	NNP	B-Disease
,	,	O
nibrin	NN	O
(	-LRB-	O
encoded	VBN	O
by	IN	O
NBS1	NN	O
)	-RRB-	O
,	,	O
forms	VBZ	O
a	DT	O
complex	NN	O
with	IN	O
MRE11	NN	O
and	CC	O
RAD50	NN	O
(	-LRB-	O
refs	NNS	O
1	CD	O
,	,	O
2	CD	O
)	-RRB-	O
.	.	O

This	DT	O
complex	NN	O
localizes	VBZ	O
to	TO	O
DSBs	NNS	O
within	IN	O
30	CD	O
minutes	NNS	O
after	IN	O
cellular	JJ	O
exposure	NN	O
to	TO	O
ionizing	VBG	O
radiation	NN	O
(	-LRB-	O
IR	NN	O
)	-RRB-	O
and	CC	O
is	VBZ	O
observed	VBN	O
in	IN	O
brightly	RB	O
staining	VBG	O
nuclear	JJ	O
foci	NNS	O
after	IN	O
a	DT	O
longer	JJR	O
period	NN	O
of	IN	O
time	NN	O
.	.	O

The	DT	O
overlap	VBP	O
between	IN	O
clinical	JJ	O
and	CC	O
cellular	JJ	O
phenotypes	NNS	O
in	IN	O
A-T	NN	B-Disease
and	CC	O
NBS	NN	B-Disease
suggests	VBZ	O
that	IN	O
ATM	NNP	O
and	CC	O
nibrin	NN	O
may	MD	O
function	VB	O
in	IN	O
the	DT	O
same	JJ	O
biochemical	JJ	O
pathway	NN	O
.	.	O

Here	RB	O
we	PRP	O
demonstrate	VBP	O
that	IN	O
nibrin	NN	O
is	VBZ	O
phosphorylated	VBN	O
within	IN	O
one	CD	O
hour	NN	O
of	IN	O
treatment	NN	O
of	IN	O
cells	NNS	O
with	IN	O
IR	NN	O
.	.	O

This	DT	O
response	NN	O
is	VBZ	O
abrogated	VBN	O
in	IN	O
A-T	NN	B-Disease
cells	NNS	O
that	WDT	O
either	CC	O
do	VBP	O
not	RB	O
express	VB	O
ATM	NNP	O
protein	NN	O
or	CC	O
express	VB	O
near	IN	O
full-length	JJ	O
mutant	JJ	O
protein	NN	O
.	.	O

We	PRP	O
also	RB	O
show	VBP	O
that	IN	O
ATM	NNP	O
physically	RB	O
interacts	VBZ	O
with	IN	O
and	CC	O
phosphorylates	VBZ	O
nibrin	NN	O
on	IN	O
serine	NN	O
343	CD	O
both	CC	O
in	FW	O
vivo	FW	O
and	CC	O
in	FW	O
vitro	FW	O
.	.	O

Phosphorylation	NN	O
of	IN	O
this	DT	O
site	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
functionally	RB	O
important	JJ	O
because	IN	O
mutated	VBN	O
nibrin	NN	O
(	-LRB-	O
S343A	NN	O
)	-RRB-	O
does	VBZ	O
not	RB	O
completely	RB	O
complement	NN	O
radiosensitivity	NN	O
in	IN	O
NBS	NN	B-Disease
cells	NNS	O
.	.	O

ATM	NNP	O
phosphorylation	NN	O
of	IN	O
nibrin	NN	O
does	VBZ	O
not	RB	O
affect	VB	O
nibrin-MRE11-RAD50	JJ	O
association	NN	O
as	IN	O
revealed	VBN	O
by	IN	O
radiation-induced	JJ	O
foci	NNS	O
formation	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VBP	O
a	DT	O
biochemical	JJ	O
explanation	NN	O
for	IN	O
the	DT	O
similarity	NN	O
in	IN	O
phenotype	NN	O
between	IN	O
A-T	NN	B-Disease
and	CC	O
NBS	NN	B-Disease
.	.	O

.	.	O

Detection	NN	O
of	IN	O
an	DT	O
unstable	JJ	O
fragment	NN	O
of	IN	O
DNA	NN	O
specific	JJ	O
to	TO	O
individuals	NNS	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
form	NN	O
of	IN	O
adult	JJ	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
with	IN	O
a	DT	O
prevalence	NN	O
of	IN	O
2-14	CD	O
per	IN	O
100	CD	O
,	,	O
000	CD	O
individuals	NNS	O
.	.	O

The	DT	O
disease	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
progressive	JJ	O
muscle	NN	B-Disease
weakness	NN	I-Disease
and	CC	O
sustained	JJ	B-Disease
muscle	NN	I-Disease
contraction	NN	I-Disease
,	,	O
often	RB	O
with	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
accompanying	VBG	O
symptoms	NNS	O
.	.	O

The	DT	O
age	NN	O
at	IN	O
onset	NN	O
and	CC	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
show	NN	O
extreme	JJ	O
variation	NN	O
,	,	O
both	CC	O
within	IN	O
and	CC	O
between	IN	O
families	NNS	O
.	.	O

Despite	IN	O
its	PRP$	O
clinical	JJ	O
variability	NN	O
,	,	O
this	DT	O
dominant	JJ	O
condition	NN	O
segregates	VBZ	O
as	IN	O
a	DT	O
single	JJ	O
locus	NN	O
at	IN	O
chromosome	NN	O
19q13	NN	O
.	.	O

3	CD	O
in	IN	O
every	DT	O
population	NN	O
studied	VBN	O
.	.	O

It	PRP	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
tightly	RB	O
linked	VBN	O
genetic	JJ	O
markers	NNS	O
ERCC1	NN	O
proximally	RB	O
and	CC	O
D19S51	NN	O
distally	RB	O
;	:	O
these	DT	O
define	VBP	O
the	DT	O
DM	NN	B-Disease
critical	JJ	O
region	NN	O
.	.	O

We	PRP	O
report	VBP	O
the	DT	O
isolation	NN	O
of	IN	O
an	DT	O
expressed	VBN	O
sequence	NN	O
from	IN	O
this	DT	O
region	NN	O
which	WDT	O
detects	VBZ	O
a	DT	O
DNA	NN	O
fragment	NN	O
that	WDT	O
is	VBZ	O
larger	JJR	O
in	IN	O
affected	VBN	O
individuals	NNS	O
than	IN	O
in	IN	O
normal	JJ	O
siblings	NNS	O
or	CC	O
unaffected	JJ	O
controls	NNS	O
.	.	O

The	DT	O
size	NN	O
of	IN	O
this	DT	O
fragment	NN	O
varies	VBZ	O
between	IN	O
affected	JJ	O
siblings	NNS	O
,	,	O
and	CC	O
increases	VBZ	O
in	IN	O
size	NN	O
through	IN	O
generations	NNS	O
in	IN	O
parallel	NN	O
with	IN	O
increasing	VBG	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
this	DT	O
unstable	JJ	O
DNA	NN	O
sequence	NN	O
is	VBZ	O
the	DT	O
molecular	JJ	O
feature	NN	O
that	WDT	O
underlies	VBZ	O
DM	NN	B-Disease
.	.	O

Detection	NN	O
of	IN	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
and	CC	O
second	JJ	O
recurrent	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
CACNA1A	NN	O
gene	NN	O
in	IN	O
individuals	NNS	O
with	IN	O
EA-2	NN	B-Disease
and	CC	O
FHM	NN	B-Disease
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
brain	NN	O
specific	JJ	O
P/Q	NN	O
type	NN	O
Ca2	NN	O
+	CC	O
channel	NN	O
alpha1	NN	O
subunit	NN	O
gene	NN	O
,	,	O
CACNA1A	NN	O
,	,	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
three	CD	O
clinically	RB	O
distinct	JJ	O
disorders	NNS	O
,	,	O
viz	NN	O
.	.	O

episodic	JJ	B-Disease
ataxia	NN	I-Disease
type	NN	I-Disease
2	CD	I-Disease
(	-LRB-	O
EA-2	NN	B-Disease
)	-RRB-	O
,	,	O
familial	JJ	B-Disease
hemiplegic	JJ	I-Disease
migraine	NN	I-Disease
(	-LRB-	O
FHM	NN	B-Disease
)	-RRB-	O
and	CC	O
spinocerebellar	NN	B-Disease
ataxia	NN	I-Disease
6	CD	I-Disease
(	-LRB-	O
SCA6	NN	B-Disease
)	-RRB-	O
.	.	O

For	IN	O
individuals	NNS	O
with	IN	O
EA-2	NN	B-Disease
,	,	O
the	DT	O
mutations	NNS	O
described	VBD	O
thus	RB	O
far	RB	O
are	VBP	O
presumed	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
truncated	VBN	O
protein	NN	O
product	NN	O
.	.	O

Several	JJ	O
different	JJ	O
missense	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
FHM	NN	B-Disease
.	.	O

At	IN	O
least	JJS	O
two	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
on	IN	O
two	CD	O
different	JJ	O
chromosome	NN	O
19p13	NN	O
haplotypes	NNS	O
and	CC	O
thus	RB	O
represent	VBP	O
recurrent	JJ	O
mutations	NNS	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
study	NN	O
,	,	O
we	PRP	O
have	VBP	O
screened	VBN	O
several	JJ	O
individuals	NNS	O
for	IN	O
mutations	NNS	O
in	IN	O
all	DT	O
47	CD	O
exons	NNS	O
in	IN	O
the	DT	O
CACNA1A	NN	O
gene	NN	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
analysis	NN	O
.	.	O

We	PRP	O
have	VBP	O
characterised	VBN	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
,	,	O
G5260A	NN	O
,	,	O
in	IN	O
exon	NN	O
32	CD	O
in	IN	O
a	DT	O
family	NN	O
segregating	VBG	O
for	IN	O
EA-2	NN	B-Disease
.	.	O

The	DT	O
consequence	NN	O
of	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
an	DT	O
amino	NN	O
acid	NN	O
substitution	NN	O
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
position	NN	O
within	IN	O
the	DT	O
CACNA1A	NN	O
gene	NN	O
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
point	NN	O
mutation	NN	O
not	RB	O
resulting	VBG	O
in	IN	O
a	DT	O
proposed	VBN	O
truncated	VBN	O
protein	NN	O
.	.	O

Furthermore	RB	O
,	,	O
this	DT	O
mutation	NN	O
has	VBZ	O
been	VBN	O
detected	VBN	O
in	IN	O
a	DT	O
family	NN	O
member	NN	O
with	IN	O
mild	JJ	O
clinical	JJ	O
signs	NNS	O
including	VBG	O
only	JJ	O
migraine	NN	B-Disease
.	.	O

Additionally	RB	O
,	,	O
a	DT	O
second	JJ	O
previously	RB	O
identified	VBN	O
recurrent	JJ	O
muta	NN	O
tion	NN	O
,	,	O
C2272T	NN	O
,	,	O
in	IN	O
exon	NN	O
16	CD	O
has	VBZ	O
been	VBN	O
discovered	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
FHM	NNP	B-Disease
.	.	O

.	.	O

Dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
the	DT	O
APC1309	NN	O
mutation	NN	O
:	:	O
a	DT	O
possible	JJ	O
explanation	NN	O
for	IN	O
genotype-phenotype	JJ	O
correlations	NNS	O
in	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
.	.	O

Inactivation	NN	O
of	IN	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
product	NN	O
initiates	VBZ	O
colorectal	JJ	O
tumorigenesis	NN	O
.	.	O

Patients	NNS	O
with	IN	O
familial	JJ	B-Disease
APC	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
carry	VBP	O
germ-line	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
and	CC	O
develop	VB	O
multiple	JJ	O
colorectal	JJ	B-Disease
adenomas	NNS	I-Disease
and	CC	O
subsequent	JJ	O
carcinomas	NNS	B-Disease
early	RB	O
in	IN	O
life	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
correlates	VBZ	O
with	IN	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
inherited	VBN	O
APC	NN	B-Disease
mutation	NN	O
(	-LRB-	O
genotype-phenotype	JJ	O
correlation	NN	O
)	-RRB-	O
.	.	O

Together	RB	O
with	IN	O
the	DT	O
fact	NN	O
that	IN	O
both	CC	O
germ-line	NN	O
and	CC	O
sporadic	JJ	O
APC	NN	B-Disease
mutations	NNS	O
cluster	NN	O
in	IN	O
the	DT	O
central	JJ	O
region	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
,	,	O
this	DT	O
points	NNS	O
to	TO	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
certain	JJ	O
APC	NN	B-Disease
mutants	NNS	O
.	.	O

Loss	NN	O
of	IN	O
APC	NN	B-Disease
function	NN	O
was	VBD	O
recently	RB	O
shown	VBN	O
to	TO	O
result	VB	O
in	IN	O
enhanced	VBN	O
beta-catenin	NN	O
-	:	O
/	:	O
Tcf-mediated	JJ	O
transcription	NN	O
in	IN	O
colon	NN	O
epithelial	JJ	O
cells	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
provide	VBP	O
experimental	JJ	O
evidence	NN	O
for	IN	O
a	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
APC	NN	B-Disease
gene	NN	O
products	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	O
polyposis	NN	B-Disease
.	.	O

Wild-type	JJ	O
APC	NN	B-Disease
activity	NN	O
in	IN	O
beta-catenin	NN	O
-	:	O
/	:	O
Tcf-mediated	JJ	O
transcription	NN	O
was	VBD	O
strongly	RB	O
inhibited	VBN	O
by	IN	O
a	DT	O
mutant	JJ	O
APC	NN	B-Disease
that	WDT	O
is	VBZ	O
truncated	VBN	O
at	IN	O
codon	NN	O
1309	CD	O
.	.	O

In	IN	O
contrast	NN	O
,	,	O
mutant	JJ	O
APC	NN	B-Disease
gene	NN	O
products	NNS	O
that	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
attenuated	VBN	B-Disease
polyposis	NN	I-Disease
(	-LRB-	O
codon	NN	O
386	CD	O
or	CC	O
1465	CD	O
)	-RRB-	O
interfered	VBD	O
only	RB	O
weakly	RB	O
with	IN	O
wild-type	JJ	O
APC	NN	B-Disease
activity	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
a	DT	O
molecular	JJ	O
explanation	NN	O
for	IN	O
the	DT	O
genotype-phenotype	JJ	O
correlation	NN	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
and	CC	O
support	VBP	O
the	DT	O
idea	NN	O
that	IN	O
colorectal	JJ	B-Disease
tumor	NN	I-Disease
growth	NN	O
might	MD	O
be	VB	O
,	,	O
in	IN	O
part	NN	O
,	,	O
driven	VBN	O
by	IN	O
selection	NN	O
for	IN	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
mutation	NN	O
cluster	NN	O
region	NN	O
.	.	O

.	.	O

Mutation	NN	O
of	IN	O
the	DT	O
KIT	NN	O
(	-LRB-	O
mast/stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
receptor	NN	O
)	-RRB-	O
protooncogene	NN	O
in	IN	O
human	JJ	O
piebaldism	NN	B-Disease
.	.	O

Piebaldism	NNP	B-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
cogenital	JJ	O
patches	NNS	O
of	IN	O
skin	NN	O
and	CC	O
hair	NN	O
from	IN	O
which	WDT	O
melanocytes	NNS	O
are	VBP	O
completely	RB	O
absent	JJ	O
.	.	O

A	DT	O
similar	JJ	O
disorder	NN	O
of	IN	O
mouse	NN	O
,	,	O
dominant	JJ	O
white	JJ	O
spotting	VBG	O
(	-LRB-	O
W	NN	O
)	-RRB-	O
,	,	O
results	VBZ	O
from	IN	O
mutations	NNS	O
of	IN	O
the	DT	O
c-Kit	NN	O
protooncogene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
and	CC	O
receptor	NN	O
for	IN	O
mast/stem	NN	O
cell	NN	O
growth	NN	O
factor	NN	O
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
KIT	NN	O
gene	NN	O
mutation	NN	O
in	IN	O
a	DT	O
proband	NN	O
with	IN	O
classic	JJ	O
autosomal	JJ	O
dominant	JJ	O
piebaldism	NN	B-Disease
.	.	O

This	DT	O
mutation	NN	O
results	VBZ	O
in	IN	O
a	DT	O
Gly	NNP	O
----	:	O
Arg	NN	O
substitution	NN	O
at	IN	O
codon	NN	O
664	CD	O
,	,	O
within	IN	O
the	DT	O
tyrosine	NN	O
kinase	NN	O
domain	NN	O
.	.	O

This	DT	O
substitution	NN	O
was	VBD	O
not	RB	O
seen	VBN	O
in	IN	O
any	DT	O
normal	JJ	O
individuals	NNS	O
and	CC	O
was	VBD	O
completely	RB	O
linked	VBN	O
to	TO	O
the	DT	O
piebald	NN	B-Disease
phenotype	NN	O
in	IN	O
the	DT	O
probands	NNS	O
family	NN	O
.	.	O

Piebaldism	NNP	B-Disease
in	IN	O
this	DT	O
family	NN	O
thus	RB	O
appears	VBZ	O
to	TO	O
be	VB	O
the	DT	O
human	JJ	O
homologue	NN	O
to	TO	O
dominant	JJ	O
white	JJ	O
spotting	VBG	O
(	-LRB-	O
W	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
mouse	NN	O
.	.	O

.	.	O

An	DT	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
T274M	NN	O
)	-RRB-	O
causing	VBG	O
late-infantile	JJ	B-Disease
metachromatic	JJ	I-Disease
leukodystrophy	NN	I-Disease
.	.	O

Metachromatic	JJ	B-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
lysosomal	JJ	I-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
arylsulfatase	NN	I-Disease
A	NN	I-Disease
(	-LRB-	O
ARSA	NN	O
;	:	O
EC	NNP	O
3	CD	O
.	.	O

1	LS	O
.	.	O

6	CD	O
.	.	O

8	CD	O
)	-RRB-	O
.	.	O

The	DT	O
8	CD	O
ARSA	NN	O
exons	NNS	O
and	CC	O
adjacent	JJ	O
intron	NN	O
boundaries	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
late-infantile	JJ	B-Disease
metachromatic	JJ	I-Disease
leukodystrophy	NN	I-Disease
were	VBD	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
amplified	VBN	O
in	IN	O
seven	CD	O
discrete	JJ	O
reactions	NNS	O
.	.	O

Amplified	VBN	O
ARSA	NN	O
exons	NNS	O
were	VBD	O
analysed	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
sequence	NN	O
alterations	NNS	O
by	IN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
analysis	NN	O
,	,	O
followed	VBN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
of	IN	O
PCR	NN	O
products	NNS	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
C	NN	O
--	:	O
>	JJR	O
T	NN	O
transition	NN	O
in	IN	O
exon	NN	O
IV	CD	O
that	WDT	O
results	VBZ	O
in	IN	O
the	DT	O
substitution	NN	O
of	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
threonine	NN	O
residue	NN	O
at	IN	O
amino	NN	O
acid	NN	O
274	CD	O
with	IN	O
a	DT	O
methionine	NN	O
(	-LRB-	O
T274M	NN	O
)	-RRB-	O
.	.	O

Analysis	NN	O
of	IN	O
a	DT	O
further	JJ	O
29	CD	O
MLD	NN	B-Disease
patients	NNS	O
revealed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
five	CD	O
additional	JJ	O
homozygotes	NNS	O
for	IN	O
T274M	NN	O
.	.	O

All	DT	O
6	CD	O
T274M	NN	O
homozygotes	NNS	O
(	-LRB-	O
representing	VBG	O
four	CD	O
families	NNS	O
)	-RRB-	O
were	VBD	O
of	IN	O
Lebanese	JJ	O
descent	NN	O
,	,	O
and	CC	O
all	DT	O
were	VBD	O
known	VBN	O
to	TO	O
be	VB	O
the	DT	O
result	NN	O
of	IN	O
consanguineous	JJ	O
marriages	NNS	O
.	.	O

The	DT	O
altered	JJ	O
amino	NN	O
acid	NN	O
is	VBZ	O
rigidly	RB	O
conserved	VBN	O
among	IN	O
10	CD	O
sulfatases	NNS	O
from	IN	O
Escherichia	FW	O
coli	FW	O
to	TO	O
humans	NNS	O
;	:	O
therefore	RB	O
,	,	O
it	PRP	O
is	VBZ	O
most	RBS	O
likely	JJ	O
that	IN	O
the	DT	O
resultant	JJ	O
mutant	JJ	O
protein	NN	O
will	MD	O
have	VB	O
little	JJ	O
or	CC	O
no	DT	O
enzyme	NN	O
activity	NN	O
.	.	O

This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
very	RB	O
low	JJ	O
ARSA	NN	O
activity	NN	O
measured	VBN	O
in	IN	O
these	DT	O
patients	NNS	O
and	CC	O
their	PRP$	O
uniformly	RB	O
severe	JJ	O
clinical	JJ	O
presentation	NN	O

Mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
for	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
in	IN	O
patients	NNS	O
with	IN	O
different	JJ	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

Recently	RB	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
most	RBS	O
common	JJ	O
peroxisomal	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
X-ALD	NN	B-Disease
)	-RRB-	O
,	,	O
has	VBZ	O
been	VBN	O
described	VBN	O
encoding	VBG	O
a	DT	O
peroxisomal	JJ	O
membrane	NN	O
transporter	NN	O
protein	NN	O
.	.	O

We	PRP	O
analyzed	VBD	O
the	DT	O
entire	JJ	O
protein-coding	JJ	O
sequence	NN	O
of	IN	O
this	DT	O
gene	NN	O
by	IN	O
reverse-transcription	JJ	O
PCR	NN	O
,	,	O
SSCP	NN	O
,	,	O
and	CC	O
DNA	NN	O
sequencing	NN	O
in	IN	O
five	CD	O
patients	NNS	O
with	IN	O
different	JJ	O
clinical	JJ	O
expression	NN	O
of	IN	O
X-ALD	NN	B-Disease
and	CC	O
in	IN	O
their	PRP$	O
female	JJ	O
relatives	NNS	O
;	:	O
these	DT	O
clinical	JJ	O
expressions	NNS	O
were	VBD	O
cerebral	JJ	O
childhood	NN	O
ALD	NN	B-Disease
,	,	O
adrenomyeloneuropathy	NN	B-Disease
(	-LRB-	O
AMN	NN	B-Disease
)	-RRB-	O
,	,	O
and	CC	O
"	''	O
Addison	NNP	B-Disease
disease	NN	I-Disease
only	RB	I-Disease
"	''	O
(	-LRB-	O
ADO	NNP	B-Disease
)	-RRB-	O
phenotype	NN	O
.	.	O

In	IN	O
the	DT	O
three	CD	O
patients	NNS	O
exhibiting	VBG	O
the	DT	O
classical	JJ	O
picture	NN	O
of	IN	O
severe	JJ	O
childhood	NN	O
ALD	NN	B-Disease
we	PRP	O
identified	VBD	O
in	IN	O
the	DT	O
5	CD	O
portion	NN	O
of	IN	O
the	DT	O
X-ALD	NN	B-Disease
gene	NN	O
a	DT	O
38-bp	JJ	O
deletion	NN	O
that	WDT	O
causes	VBZ	O
a	DT	O
frameshift	NN	O
mutation	NN	O
,	,	O
a	DT	O
3-bp	JJ	O
deletion	NN	O
leading	VBG	O
to	TO	O
a	DT	O
deletion	NN	O
of	IN	O
an	DT	O
amino	NN	O
acid	NN	O
in	IN	O
the	DT	O
ATP-binding	JJ	O
domain	NN	O
of	IN	O
the	DT	O
ALD	NN	B-Disease
protein	NN	O
,	,	O
and	CC	O
a	DT	O
missense	NN	O
mutation	NN	O
.	.	O

In	IN	O
the	DT	O
patient	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
phenotype	NN	O
of	IN	O
AMN	NNP	B-Disease
,	,	O
a	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
codon	NN	O
212	CD	O
,	,	O
along	IN	O
with	IN	O
a	DT	O
second	JJ	O
site	NN	O
mutation	NN	O
at	IN	O
codon	NN	O
178	CD	O
,	,	O
was	VBD	O
observed	VBN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
patient	NN	O
with	IN	O
the	DT	O
ADO	NNP	B-Disease
phenotype	NN	O
revealed	VBD	O
a	DT	O
further	JJ	O
missense	NN	O
mutation	NN	O
at	IN	O
a	DT	O
highly	RB	O
conserved	VBN	O
position	NN	O
in	IN	O
the	DT	O
ALDP/PMP70	NN	O
comparison	NN	O
.	.	O

The	DT	O
disruptive	JJ	O
nature	NN	O
of	IN	O
two	CD	O
mutations	NNS	O
(	-LRB-	O
i.	FW	O
e.	FW	O
,	,	O
the	DT	O
frameshift	NN	O
and	CC	O
the	DT	O
nonsense	NN	O
mutation	NN	O
)	-RRB-	O
in	IN	O
patients	NNS	O
with	IN	O
biochemically	RB	O
proved	VBN	O
childhood	NN	O
ALD	NN	B-Disease
and	CC	O
AMN	NNP	B-Disease
further	RBR	O
strongly	RB	O
supports	VBZ	O
the	DT	O
hypothesis	NN	O
that	IN	O
alterations	NNS	O
in	IN	O
this	DT	O
gene	NN	O
play	VB	O
a	DT	O
crucial	JJ	O
role	NN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
X-ALD	NN	B-Disease
.	.	O

Since	IN	O
the	DT	O
current	JJ	O
biochemical	JJ	O
techniques	NNS	O
for	IN	O
X-ALD	NN	B-Disease
carrier	NN	O
detection	NN	O
in	IN	O
affected	JJ	O
families	NNS	O
lack	VBP	O
sufficient	JJ	O
reliability	NN	O
,	,	O
our	PRP$	O
procedure	NN	O
described	VBN	O
for	IN	O
systematic	JJ	O
mutation	NN	O
scanning	NN	O
is	VBZ	O
also	RB	O
capable	JJ	O
of	IN	O
improving	VBG	O
genetic	JJ	O
counseling	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O

Atelosteogenesis	NNP	B-Disease
type	NN	I-Disease
II	CD	I-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
sulfate-transporter	NN	O
gene	NN	O
(	-LRB-	O
DTDST	NN	O
)	-RRB-	O
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
phenotypic	JJ	O
series	NN	O
involving	VBG	O
three	CD	O
chondrodysplasias	NNS	B-Disease
.	.	O

Atelosteogenesis	NNP	B-Disease
type	NN	I-Disease
II	CD	I-Disease
(	-LRB-	O
AO	JJ	B-Disease
II	CD	I-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
neonatally	RB	O
lethal	JJ	O
chondrodysplasia	NN	B-Disease
whose	WP$	O
clinical	JJ	O
and	CC	O
histological	JJ	O
characteristics	NNS	O
resemble	VBP	O
those	DT	O
of	IN	O
another	DT	O
chondrodysplasia	NN	B-Disease
,	,	O
the	DT	O
much	JJ	O
less	RBR	O
severe	JJ	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
(	-LRB-	O
DTD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
similarity	NN	O
suggests	VBZ	O
a	DT	O
shared	JJ	O
pathogenesis	NN	O
involving	VBG	O
lesions	NNS	O
in	IN	O
the	DT	O
same	JJ	O
biochemical	JJ	O
pathway	NN	O
and	CC	O
perhaps	RB	O
the	DT	O
same	JJ	O
gene	NN	O
.	.	O

DTD	NNP	B-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
recently	RB	O
identified	VBN	O
diastrophic	JJ	B-Disease
dysplasia	NN	I-Disease
sulfate-transporter	NN	O
gene	NN	O
(	-LRB-	O
DTDST	NN	O
)	-RRB-	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
report	VBP	O
that	IN	O
AOII	NN	B-Disease
patients	NNS	O
also	RB	O
have	VBP	O
DTDST	NN	O
mutations	NNS	O
,	,	O
which	WDT	O
lead	VBP	O
to	TO	O
defective	JJ	O
uptake	NN	O
of	IN	O
inorganic	JJ	O
sulfate	NN	O
and	CC	O
insufficient	JJ	O
sulfation	NN	O
of	IN	O
macromolecules	NNS	O
by	IN	O
patient	NN	O
mesenchymal	JJ	O
cells	NNS	O
in	FW	O
vitro	FW	O
.	.	O

Together	RB	O
with	IN	O
our	PRP$	O
recent	JJ	O
observation	NN	O
that	IN	O
a	DT	O
third	JJ	O
even	RB	O
more	RBR	O
severe	JJ	O
chondrodysplasia	NN	B-Disease
,	,	O
achondrogenesis	NN	O
type	NN	O
IB	NNP	O
,	,	O
is	VBZ	O
also	RB	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
DTDST	NNP	O
,	,	O
these	DT	O
results	NNS	O
demonstrate	VBP	O
a	DT	O
phenotypic	JJ	O
series	NN	O
of	IN	O
three	CD	O
chondrodysplasias	NNS	B-Disease
of	IN	O
increasing	VBG	O
severity	NN	O
caused	VBN	O
by	IN	O
lesions	NNS	O
in	IN	O
a	DT	O
single	JJ	O
sulfate-transporter	JJ	O
gene	NN	O
.	.	O

The	DT	O
severity	NN	O
of	IN	O
the	DT	O
phenotype	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
correlated	VBN	O
with	IN	O
the	DT	O
predicted	VBN	O
effect	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
on	IN	O
the	DT	O
residual	JJ	O
activity	NN	O
of	IN	O
the	DT	O
DTDST	NN	O
protein	NN	O
.	.	O

.	.	O

Emerin	NNP	B-Disease
,	,	I-Disease
deficiency	NN	I-Disease
of	IN	O
which	WDT	O
causes	VBZ	O
Emery-Dreifuss	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
,	,	O
is	VBZ	O
localized	JJ	O
at	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
.	.	O

X-linked	JJ	B-Disease
recessive	JJ	I-Disease
Emery-Dreifuss	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
EDMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	B-Disease
muscle	NN	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
the	DT	O
clinical	JJ	O
triad	NN	O
of	IN	O
progressive	JJ	O
wasting	NN	B-Disease
of	IN	I-Disease
humero-peroneal	JJ	I-Disease
muscles	NNS	I-Disease
,	,	O
early	JJ	O
contractures	NNS	B-Disease
of	IN	I-Disease
the	DT	I-Disease
elbows	NNS	I-Disease
,	,	I-Disease
Achilles	NNPS	I-Disease
tendons	NNS	I-Disease
and	CC	I-Disease
postcervical	JJ	I-Disease
muscles	NNS	I-Disease
,	,	O
and	CC	O
cardiac	JJ	B-Disease
conduction	NN	I-Disease
block	NN	I-Disease
with	IN	O
a	DT	O
high	JJ	O
risk	NN	O
of	IN	O
sudden	JJ	B-Disease
death	NN	I-Disease
.	.	O

The	DT	O
gene	NN	O
for	IN	O
EDMD	NN	B-Disease
on	IN	O
Xq28	NN	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
protein	NN	O
named	VBN	O
emerin	NN	O
that	WDT	O
localizes	VBZ	O
at	IN	O
the	DT	O
nuclear	JJ	O
membrane	NN	O
of	IN	O
skeletal	JJ	O
,	,	O
cardiac	JJ	O
and	CC	O
smooth	JJ	O
muscles	NNS	O
and	CC	O
some	DT	O
other	JJ	O
non-muscle	JJ	O
tissues	NNS	O
.	.	O

To	TO	O
investigate	VB	O
a	DT	O
possible	JJ	O
physiological	JJ	O
role	NN	O
for	IN	O
emerin	NN	O
,	,	O
we	PRP	O
examined	VBD	O
the	DT	O
ultrastructural	JJ	O
localization	NN	O
of	IN	O
the	DT	O
protein	NN	O
in	IN	O
human	JJ	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
HeLa	NN	O
cells	NNS	O
,	,	O
using	VBG	O
ultrathin	JJ	O
cryosections	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
the	DT	O
immune-labeled	JJ	O
colloidal	NN	O
gold	NN	O
particles	NNS	O
were	VBD	O
localized	JJ	O
on	IN	O
the	DT	O
nucleoplasmic	JJ	O
surface	NN	O
of	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
,	,	O
but	CC	O
not	RB	O
on	IN	O
the	DT	O
nuclear	JJ	O
pore	NN	O
.	.	O

Emerin	NNP	O
stayed	VBD	O
on	IN	O
the	DT	O
cytoplasmic	JJ	O
surface	NN	O
of	IN	O
the	DT	O
nuclear	JJ	O
lamina	NN	O
,	,	O
even	RB	O
after	IN	O
detergent	NN	O
treatment	NN	O
that	WDT	O
solubilizes	VBZ	O
membrane	NN	O
lipids	NNS	O
and	CC	O
washes	VBZ	O
out	RP	O
membrane	NN	O
proteins	NNS	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
emerin	NN	O
anchors	NNS	O
at	IN	O
the	DT	O
inner	JJ	O
nuclear	JJ	O
membrane	NN	O
through	IN	O
the	DT	O
hydrophobic	JJ	O
stretch	NN	O
,	,	O
and	CC	O
protrudes	VBZ	O
from	IN	O
the	DT	O
hydrophilic	JJ	O
region	NN	O
to	TO	O
the	DT	O
nucleoplasm	NN	O
where	WRB	O
it	PRP	O
interacts	VBZ	O
with	IN	O
the	DT	O
nuclear	JJ	O
lamina	NN	O
.	.	O

We	PRP	O
speculate	VBP	O
that	IN	O
emerin	NN	O
contributes	VBZ	O
to	TO	O
maintain	VB	O
the	DT	O
nuclear	JJ	O
structure	NN	O
and	CC	O
stability	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
nuclear	JJ	O
functions	NNS	O
,	,	O
particularly	RB	O
in	IN	O
muscle	NN	O
tissues	NNS	O
that	WDT	O
have	VBP	O
severe	JJ	O
stress	NN	O
with	IN	O
rigorous	JJ	O
contraction-relaxation	NN	O
movements	NNS	O
and	CC	O
calcium	NN	O
flux	NN	O
.	.	O

.	.	O

Identification	NN	O
of	IN	O
a	DT	O
common	JJ	O
PEX1	NN	O
mutation	NN	O
in	IN	O
Zellweger	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
Zellweger	NNP	B-Disease
spectrum	NN	I-Disease
of	IN	I-Disease
disease	NN	I-Disease
,	,	O
encompassing	VBG	O
Zellweger	NNP	B-Disease
syndrome	NN	I-Disease
and	CC	O
the	DT	O
progressively	RB	O
milder	JJ	O
phenotypes	NNS	O
of	IN	O
neonatal	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
and	CC	O
infantile	JJ	B-Disease
Refsum	NN	I-Disease
disease	NN	I-Disease
,	,	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
failure	NN	O
to	TO	O
form	VB	O
functional	JJ	O
peroxisomes	NNS	O
.	.	O

Cell	NN	O
fusion	NN	O
complementation	NN	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
these	DT	O
diseases	NNS	O
are	VBP	O
genetically	RB	O
heterogeneous	JJ	O
,	,	O
with	IN	O
two-thirds	NNS	O
of	IN	O
all	DT	O
patients	NNS	O
lying	VBG	O
within	IN	O
a	DT	O
single	JJ	O
complementation	NN	O
group	NN	O
,	,	O
CG1	NN	O
.	.	O

Molecular	JJ	O
genetic	JJ	O
and	CC	O
cell	NN	O
biology	NN	O
studies	NNS	O
have	VBP	O
shown	VBN	O
that	IN	O
PEX1	NN	O
is	VBZ	O
deficient	JJ	O
in	IN	O
many	JJ	O
CG1	NN	O
patients	NNS	O
.	.	O

However	RB	O
,	,	O
previous	JJ	O
studies	NNS	O
have	VBP	O
focused	VBN	O
on	IN	O
mildly	RB	O
affected	VBN	O
patients	NNS	O
and	CC	O
there	EX	O
is	VBZ	O
still	RB	O
no	DT	O
report	NN	O
of	IN	O
two	CD	O
mutant	JJ	O
PEX1	NN	O
alleles	NNS	O
in	IN	O
any	DT	O
Zellweger	NN	B-Disease
syndrome	NN	I-Disease
patient	NN	O
.	.	O

Furthermore	RB	O
,	,	O
mutations	NNS	O
in	IN	O
the	DT	O
PMP70	NN	O
gene	NN	O
have	VBP	O
also	RB	O
been	VBN	O
identified	VBN	O
in	IN	O
two	CD	O
Zellweger	NN	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
from	IN	O
CG1	NN	O
,	,	O
raising	VBG	O
the	DT	O
possibility	NN	O
that	IN	O
CG1	NN	O
patients	NNS	O
may	MD	O
represent	VB	O
a	DT	O
mixture	NN	O
of	IN	O
PEX1-deficient	JJ	O
and	CC	O
PMP70-deficient	JJ	O
individuals	NNS	O
.	.	O

To	TO	O
address	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
disease	NN	O
in	IN	O
Zellweger	NNP	B-Disease
syndrome	NN	I-Disease
patients	NNS	O
from	IN	O
CG1	NN	O
,	,	O
we	PRP	O
examined	VBD	O
all	DT	O
24	CD	O
PEX1	NN	O
exons	NNS	O
in	IN	O
four	CD	O
patients	NNS	O
,	,	O
including	VBG	O
both	DT	O
patients	NNS	O
that	WDT	O
have	VBP	O
mutations	NNS	O
in	IN	O
PMP70	NN	O
.	.	O

PEX1	NN	O
mutations	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
all	DT	O
four	CD	O
patients	NNS	O
,	,	O
including	VBG	O
a	DT	O
1-bp	JJ	O
insertion	NN	O
(	-LRB-	O
c.	NN	O
2097insT	NN	O
)	-RRB-	O
in	IN	O
exon	NN	O
13	CD	O
that	WDT	O
was	VBD	O
present	JJ	O
in	IN	O
three	CD	O
of	IN	O
the	DT	O
four	CD	O
patients	NNS	O
.	.	O

Subsequent	JJ	O
studies	NNS	O
demonstrated	VBD	O
that	IN	O
this	DT	O
mutation	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
one-half	NN	O
of	IN	O
all	DT	O
CG1	NN	O
patients	NNS	O
and	CC	O
correlates	VBZ	O
with	IN	O
the	DT	O
Zellweger	NNP	B-Disease
syndrome	NN	I-Disease
phenotype	NN	O
.	.	O

As	IN	O
this	DT	O
mutation	NN	O
leads	VBZ	O
to	TO	O
a	DT	O
loss	NN	O
of	IN	O
protein	NN	O
function	NN	O
its	PRP$	O
frequency	NN	O
makes	VBZ	O
it	PRP	O
the	DT	O
most	RBS	O
common	JJ	O
cause	NN	O
of	IN	O
Zellweger	NNP	B-Disease
syndrome	NN	I-Disease
,	,	O
helping	VBG	O
to	TO	O
explain	VB	O
the	DT	O
high	JJ	O
percentage	NN	O
of	IN	O
patients	NNS	O
that	IN	O
belong	VBP	O
to	TO	O
CG1	NN	O
.	.	O

Polymorphisms	NNS	O
of	IN	O
the	DT	O
CYP2D6	NN	O
gene	NN	O
increase	NN	O
susceptibility	NN	O
to	TO	O
ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
.	.	O

Ankylosing	VBG	B-Disease
spondylitis	NNS	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
common	JJ	O
and	CC	O
highly	RB	O
familial	JJ	O
rheumatic	JJ	B-Disease
disorder	NN	I-Disease
.	.	O

The	DT	O
sibling	NN	O
recurrence	NN	O
risk	NN	O
ratio	NN	O
for	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
63	CD	O
and	CC	O
heritability	NN	O
assessed	VBN	O
in	IN	O
twins	NNS	O
>	JJR	O
90	CD	O
%	NN	O
.	.	O

Although	IN	O
MHC	NN	O
genes	NNS	O
,	,	O
including	VBG	O
HLA-B27	NN	O
,	,	O
contribute	VBP	O
only	RB	O
20-50	CD	O
%	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
risk	NN	O
for	IN	O
the	DT	O
disease	NN	O
,	,	O
no	DT	O
non-MHC	JJ	O
gene	NN	O
has	VBZ	O
yet	RB	O
been	VBN	O
convincingly	RB	O
demonstrated	VBN	O
to	TO	O
influence	VB	O
either	CC	O
susceptibility	NN	O
to	TO	O
the	DT	O
disease	NN	O
or	CC	O
its	PRP$	O
phenotypic	JJ	O
expression	NN	O
.	.	O

Previous	JJ	O
linkage	NN	O
and	CC	O
association	NN	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
AS	JJ	B-Disease
close	NN	O
to	TO	O
,	,	O
or	CC	O
within	IN	O
,	,	O
the	DT	O
cytochrome	NN	O
P450	NN	O
2D6	NN	O
gene	NN	O
(	-LRB-	O
CYP2D6	NN	O
,	,	O
debrisoquine	NN	O
hydroxylase	NN	O
)	-RRB-	O
located	JJ	O
at	IN	O
chromosome	NN	O
22q13	NN	O
.1	NN	O
.	.	O

We	PRP	O
performed	VBD	O
a	DT	O
linkage	NN	O
study	NN	O
of	IN	O
chromosome	NN	O
22	CD	O
in	IN	O
200	CD	O
families	NNS	O
with	IN	O
AS	JJ	B-Disease
affected	JJ	O
sibling-pairs	NNS	O
.	.	O

Association	NNP	O
of	IN	O
alleles	NNS	O
of	IN	O
the	DT	O
CYP2D6	NN	O
gene	NN	O
was	VBD	O
examined	VBN	O
by	IN	O
both	CC	O
case-control	JJ	O
and	CC	O
within-family	JJ	O
means	NNS	O
.	.	O

For	IN	O
case-control	JJ	O
studies	NNS	O
,	,	O
617	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
AS	JJ	B-Disease
(	-LRB-	O
361	CD	O
probands	NNS	O
from	IN	O
sibling-pair	JJ	O
and	CC	O
parent-case	JJ	O
trio	NN	O
families	NNS	O
and	CC	O
256	CD	O
unrelated	JJ	O
non-familial	JJ	O
sporadic	JJ	O
cases	NNS	O
)	-RRB-	O
and	CC	O
402	CD	O
healthy	JJ	O
ethnically	RB	O
matched	VBN	O
controls	NNS	O
were	VBD	O
employed	VBN	O
.	.	O

For	IN	O
within-family	JJ	O
association	NN	O
studies	NNS	O
,	,	O
361	CD	O
families	NNS	O
including	VBG	O
161	CD	O
parent-case	JJ	O
trios	NNS	O
and	CC	O
200	CD	O
affected	VBN	O
sibling-pair	JJ	O
families	NNS	O
were	VBD	O
employed	VBN	O
.	.	O

Homozygosity	NNP	O
for	IN	O
poor	JJ	O
metabolizer	NN	O
alleles	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
AS	JJ	B-Disease
.	.	O

Heterozygosity	NN	O
for	IN	O
the	DT	O
most	RBS	O
frequent	JJ	O
poor	JJ	O
metabolizer	NN	O
allele	NN	O
(	-LRB-	O
CYP2D6	NN	O
*	SYM	O
4	LS	O
)	-RRB-	O
was	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
increased	VBN	O
susceptibility	NN	O
to	TO	O
AS	JJ	B-Disease
.	.	O

Significant	JJ	O
within-family	NN	O
association	NN	O
of	IN	O
CYP2D6	NN	O
*	SYM	O
4	CD	O
alleles	NNS	O
and	CC	O
AS	JJ	B-Disease
was	VBD	O
demonstrated	VBN	O
.	.	O

Weak	JJ	O
linkage	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
between	IN	O
CYP2D6	NN	O
and	CC	O
AS	JJ	B-Disease
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
altered	JJ	O
metabolism	NN	O
of	IN	O
a	DT	O
natural	JJ	O
toxin	NN	O
or	CC	O
antigen	NN	O
by	IN	O
the	DT	O
CYP2D6	NN	O
gene	NN	O
may	MD	O
increase	VB	O
susceptibility	NN	O
to	TO	O
AS	JJ	B-Disease
.	.	O

Molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
genotype-phenotype	JJ	O
relationship	NN	O
in	IN	O
factor	NN	B-Disease
X	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Factor	NN	B-Disease
X	NN	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
haemorrhagic	JJ	B-Disease
condition	NN	I-Disease
,	,	O
normally	RB	O
inherited	VBN	O
as	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
,	,	O
in	IN	O
which	WDT	O
a	DT	O
variable	JJ	O
clinical	JJ	O
presentation	NN	O
correlates	VBZ	O
poorly	RB	O
with	IN	O
laboratory	NN	O
phenotype	NN	O
.	.	O

The	DT	O
factor	NN	O
X	NN	O
(	-LRB-	O
F10	NN	O
)	-RRB-	O
genes	NNS	O
of	IN	O
14	CD	O
unrelated	JJ	O
individuals	NNS	O
with	IN	O
factor	NN	B-Disease
X	NN	I-Disease
deficiency	NN	I-Disease
(	-LRB-	O
12	CD	O
familial	JJ	O
and	CC	O
two	CD	O
sporadic	JJ	O
cases	NNS	O
)	-RRB-	O
were	VBD	O
sequenced	VBN	O
yielding	VBG	O
a	DT	O
total	NN	O
of	IN	O
13	CD	O
novel	JJ	O
mutations	NNS	O
.	.	O

Family	NNP	O
studies	NNS	O
were	VBD	O
performed	VBN	O
in	IN	O
order	NN	O
to	TO	O
distinguish	VB	O
the	DT	O
contributions	NNS	O
of	IN	O
individual	JJ	O
mutant	JJ	O
F10	NN	O
alleles	NNS	O
to	TO	O
the	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
phenotypes	NNS	O
.	.	O

Missense	NN	O
mutations	NNS	O
were	VBD	O
studied	VBN	O
by	IN	O
means	NNS	O
of	IN	O
molecular	JJ	O
modelling	NN	O
,	,	O
whereas	IN	O
single	JJ	O
basepair	NN	O
substitutions	NNS	O
in	IN	O
splice	NN	O
sites	NNS	O
and	CC	O
the	DT	O
5	CD	O
flanking	JJ	O
region	NN	O
were	VBD	O
examined	VBN	O
by	IN	O
in	FW	O
vitro	FW	O
splicing	NN	O
assay	NN	O
and	CC	O
luciferase	NN	O
reporter	NN	O
gene	NN	O
assay	NN	O
respectively	RB	O
.	.	O

The	DT	O
deletion	NN	O
allele	NN	O
of	IN	O
a	DT	O
novel	JJ	O
hexanucleotide	NN	O
insertion/deletion	NN	O
polymorphism	NN	O
in	IN	O
the	DT	O
F10	NN	O
gene	NN	O
promoter	NN	O
region	NN	O
was	VBD	O
shown	VBN	O
by	IN	O
reporter	NN	O
gene	NN	O
assay	NN	O
,	,	O
to	TO	O
reduce	VB	O
promoter	NN	O
activity	NN	O
by	IN	O
approximately	RB	O
20	CD	O
%	NN	O
.	.	O

One	CD	O
family	NN	O
manifesting	VBG	O
an	DT	O
autosomal	JJ	O
dominant	JJ	O
pattern	NN	O
of	IN	O
inheritance	NN	O
possessed	VBD	O
three	CD	O
clinically	RB	O
affected	VBN	O
members	NNS	O
who	WP	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
a	DT	O
splice-site	NN	O
mutation	NN	O
that	WDT	O
was	VBD	O
predicted	VBN	O
to	TO	O
lead	VB	O
to	TO	O
the	DT	O
production	NN	O
of	IN	O
a	DT	O
truncated	VBN	O
protein	NN	O
product	NN	O
.	.	O

A	DT	O
model	NN	O
which	WDT	O
accounts	VBZ	O
for	IN	O
the	DT	O
dominant	JJ	O
negative	JJ	O
effect	NN	O
of	IN	O
this	DT	O
lesion	NN	O
is	VBZ	O
presented	VBN	O
.	.	O

Variation	NN	O
in	IN	O
the	DT	O
antigen	NN	O
level	NN	O
of	IN	O
heterozygous	JJ	O
relatives	NNS	O
of	IN	O
probands	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
significantly	RB	O
higher	JJR	O
between	IN	O
families	NNS	O
than	IN	O
within	IN	O
families	NNS	O
,	,	O
consistent	JJ	O
with	IN	O
the	DT	O
view	NN	O
that	IN	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
F10	NN	O
lesion	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
segregating	VBG	O
in	IN	O
a	DT	O
given	VBN	O
family	NN	O
is	VBZ	O
a	DT	O
prime	JJ	O
determinant	NN	O
of	IN	O
the	DT	O
laboratory	NN	O
phenotype	NN	O
.	.	O

By	IN	O
contrast	NN	O
,	,	O
no	DT	O
such	JJ	O
relationship	NN	O
could	MD	O
be	VB	O
discerned	VBN	O
between	IN	O
laboratory	NN	O
phenotype	NN	O
and	CC	O
polymorphism	NN	O
genotype	NN	O
.	.	O

.	.	O

Restoration	NN	O
of	IN	O
photoreceptor	NN	O
ultrastructure	NN	O
and	CC	O
function	NN	O
in	IN	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
slow	JJ	O
mice	NNS	O
by	IN	O
gene	NN	O
therapy	NN	O
.	.	O

The	DT	O
gene	NN	O
Prph2	NN	O
encodes	VBZ	O
a	DT	O
photoreceptor-specific	JJ	O
membrane	NN	O
glycoprotein	NN	O
,	,	O
peripherin-2	NN	O
(	-LRB-	O
also	RB	O
known	VBN	O
as	IN	O
peripherin/rds	NNS	O
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
inserted	VBN	O
into	IN	O
the	DT	O
rims	NNS	O
of	IN	O
photoreceptor	NN	O
outer	JJ	O
segment	NN	O
discs	NNS	O
in	IN	O
a	DT	O
complex	NN	O
with	IN	O
rom-1	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

2	LS	O
)	-RRB-	O
.	.	O

The	DT	O
complex	NN	O
is	VBZ	O
necessary	JJ	O
for	IN	O
the	DT	O
stabilization	NN	O
of	IN	O
the	DT	O
discs	NNS	O
,	,	O
which	WDT	O
are	VBP	O
renewed	VBN	O
constantly	RB	O
throughout	IN	O
life	NN	O
,	,	O
and	CC	O
which	WDT	O
contain	VBP	O
the	DT	O
visual	JJ	O
pigments	NNS	O
necessary	JJ	O
for	IN	O
photon	NN	O
capture	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
Prph2	NN	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
photoreceptor	NN	B-Disease
dystrophies	NNS	I-Disease
,	,	O
including	VBG	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
retinitis	NN	I-Disease
pigmentosa	NN	I-Disease
and	CC	O
macular	JJ	B-Disease
dystrophy	NN	I-Disease
.	.	O

A	DT	O
common	JJ	O
feature	NN	O
of	IN	O
these	DT	O
diseases	NNS	O
is	VBZ	O
the	DT	O
loss	NN	O
of	IN	O
photoreceptor	NN	O
function	NN	O
,	,	O
also	RB	O
seen	VBN	O
in	IN	O
the	DT	O
retinal	JJ	B-Disease
degeneration	NN	I-Disease
slow	JJ	O
(	-LRB-	O
rds	NNS	O
or	CC	O
Prph2	NN	O
Rd2/Rd2	NN	O
)	-RRB-	O
mouse	NN	O
,	,	O
which	WDT	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
null	JJ	O
mutation	NN	O
in	IN	O
Prph2	NN	O
.	.	O

It	PRP	O
is	VBZ	O
characterized	VBN	O
by	IN	O
a	DT	O
complete	JJ	O
failure	NN	O
to	TO	O
develop	VB	O
photoreceptor	NN	O
discs	NNS	O
and	CC	O
outer	JJ	O
segments	NNS	O
,	,	O
downregulation	NN	O
of	IN	O
rhodopsin	NN	O
and	CC	O
apoptotic	JJ	O
loss	NN	O
of	IN	O
photoreceptor	NN	O
cells	NNS	O
.	.	O

The	DT	O
electroretinograms	NNS	O
(	-LRB-	O
ERGs	NNS	O
)	-RRB-	O
of	IN	O
Prph2Rd2/Rd2	NN	O
mice	NNS	O
have	VBP	O
greatly	RB	O
diminished	VBN	O
a-wave	NN	O
and	CC	O
b-wave	NN	O
amplitudes	NNS	O
,	,	O
which	WDT	O
decline	VBP	O
to	TO	O
virtually	RB	O
undetectable	JJ	O
concentrations	NNS	O
by	IN	O
two	CD	O
months	NNS	O
.	.	O

Subretinal	JJ	O
injection	NN	O
of	IN	O
recombinant	JJ	O
adeno-associated	JJ	O
virus	NN	O
(	-LRB-	O
AAV	NN	O
)	-RRB-	O
encoding	VBG	O
a	DT	O
Prph2	NN	O
transgene	NN	O
results	VBZ	O
in	IN	O
stable	JJ	O
generation	NN	O
of	IN	O
outer	JJ	O
segment	NN	O
structures	NNS	O
and	CC	O
formation	NN	O
of	IN	O
new	JJ	O
stacks	NNS	O
of	IN	O
discs	NNS	O
containing	VBG	O
both	CC	O
perpherin-2	NN	O
and	CC	O
rhodopsin	NN	O
,	,	O
which	WDT	O
in	IN	O
many	JJ	O
cases	NNS	O
are	VBP	O
morphologically	RB	O
similar	JJ	O
to	TO	O
normal	JJ	O
outer	JJ	O
segments	NNS	O
.	.	O

Moreover	RB	O
,	,	O
the	DT	O
re-establishment	NN	O
of	IN	O
the	DT	O
structural	JJ	O
integrity	NN	O
of	IN	O
the	DT	O
photoreceptor	NN	O
layer	NN	O
also	RB	O
results	VBZ	O
in	IN	O
electrophysiological	JJ	O
correction	NN	O
.	.	O

These	DT	O
studies	NNS	O
demonstrate	VBP	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
that	IN	O
a	DT	O
complex	JJ	O
ultrastructural	JJ	O
cell	NN	O
defect	NN	O
can	MD	O
be	VB	O
corrected	VBN	O
both	DT	O
morphologically	RB	O
and	CC	O
functionally	RB	O
by	IN	O
in	FW	O
vivo	FW	O
gene	NN	O
transfer	NN	O
.	.	O

.	.	O

Phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
haplotypes	NNS	O
in	IN	O
Polynesians	NNPS	O
:	:	O
evolutionary	JJ	O
origins	NNS	O
and	CC	O
absence	NN	O
of	IN	O
alleles	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	O
phenylketonuria	NN	B-Disease
.	.	O

A	DT	O
total	NN	O
of	IN	O
630	CD	O
haplotypes	NNS	O
for	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
gene	NN	O
locus	NN	O
were	VBD	O
established	VBN	O
in	IN	O
five	CD	O
groups	NNS	O
of	IN	O
Polynesians	NNPS	O
comprising	VBG	O
Samoans	NNP	O
,	,	O
Tongans	NNP	O
,	,	O
Cook	NNP	O
Islanders	NNPS	O
,	,	O
Maori	NNP	O
,	,	O
and	CC	O
Niueans	NNPS	O
.	.	O

Considerable	JJ	O
genetic	JJ	O
continuity	NN	O
was	VBD	O
demonstrated	VBN	O
between	IN	O
these	DT	O
widely	RB	O
dispersed	JJ	O
populations	NNS	O
,	,	O
since	IN	O
three	CD	O
common	JJ	O
haplotypes	NNS	O
(	-LRB-	O
4	CD	O
,	,	O
1	CD	O
,	,	O
and	CC	O
7	CD	O
)	-RRB-	O
constituted	VBN	O
over	IN	O
95	CD	O
%	NN	O
of	IN	O
alleles	NNS	O
.	.	O

A	DT	O
control	NN	O
group	NN	O
of	IN	O
individuals	NNS	O
from	IN	O
Southeast	NNP	O
Asia	NNP	O
shared	VBD	O
the	DT	O
same	JJ	O
major	JJ	O
haplotypes	NNS	O
,	,	O
4	CD	O
,	,	O
1	CD	O
,	,	O
and	CC	O
7	CD	O
,	,	O
with	IN	O
Polynesians	NNPS	O
.	.	O

These	DT	O
data	NNS	O
provide	VBP	O
further	JJ	O
support	NN	O
for	IN	O
the	DT	O
theories	NNS	O
of	IN	O
genetic	JJ	O
homogeneity	NN	O
and	CC	O
of	IN	O
Asian	JJ	O
affinities	NNS	O
of	IN	O
the	DT	O
Polynesian	JJ	O
precursor	NN	O
populations	NNS	O
.	.	O

The	DT	O
absence	NN	O
of	IN	O
severe	JJ	O
phenylketonuria	NN	B-Disease
(	-LRB-	O
PKU	NN	B-Disease
)	-RRB-	O
in	IN	O
both	CC	O
Polynesians	NNPS	O
and	CC	O
Southeast	NNP	O
Asians	NNPS	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
lack	NN	O
of	IN	O
PAH	NN	O
haplotypes	NNS	O
2	CD	O
and	CC	O
3	CD	O
,	,	O
on	IN	O
which	WDT	O
the	DT	O
severe	JJ	O
PKU	NN	B-Disease
mutants	NNS	O
have	VBP	O
arisen	VBN	O
among	IN	O
Caucasians	NNPS	O
.	.	O

.	.	O

cDNA	NN	O
microarrays	NNS	O
detect	VBP	O
activation	NN	O
of	IN	O
a	DT	O
myogenic	JJ	O
transcription	NN	O
program	NN	O
by	IN	O
the	DT	O
PAX3-FKHR	NN	O
fusion	NN	O
oncogene	NN	O
.	.	O

Alveolar	JJ	B-Disease
rhabdomyosarcoma	NN	I-Disease
is	VBZ	O
an	DT	O
aggressive	JJ	O
pediatric	JJ	B-Disease
cancer	NN	I-Disease
of	IN	I-Disease
striated	JJ	I-Disease
muscle	NN	I-Disease
characterized	VBN	O
in	IN	O
60	CD	O
%	NN	O
of	IN	O
cases	NNS	O
by	IN	O
a	DT	O
t	NN	O
(	-LRB-	O
2	CD	O
;	:	O
13	CD	O
)	-RRB-	O
(	-LRB-	O
q35	NN	O
;	:	O
q14	NN	O
)	-RRB-	O
.	.	O

This	DT	O
results	VBZ	O
in	IN	O
the	DT	O
fusion	NN	O
of	IN	O
PAX3	NN	O
,	,	O
a	DT	O
developmental	JJ	O
transcription	NN	O
factor	NN	O
required	VBN	O
for	IN	O
limb	NN	O
myogenesis	NN	O
,	,	O
with	IN	O
FKHR	NN	O
,	,	O
a	DT	O
member	NN	O
of	IN	O
the	DT	O
forkhead	NN	O
family	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
.	.	O

The	DT	O
resultant	JJ	O
PAX3-FKHR	NN	O
gene	NN	O
possesses	VBZ	O
transforming	VBG	O
properties	NNS	O
;	:	O
however	RB	O
,	,	O
the	DT	O
effects	NNS	O
of	IN	O
this	DT	O
chimeric	JJ	O
oncogene	NN	O
on	IN	O
gene	NN	O
expression	NN	O
are	VBP	O
largely	RB	O
unknown	JJ	O
.	.	O

To	TO	O
investigate	VB	O
the	DT	O
actions	NNS	O
of	IN	O
these	DT	O
transcription	NN	O
factors	NNS	O
,	,	O
both	DT	O
Pax3	NN	O
and	CC	O
PAX3-FKHR	NN	O
were	VBD	O
introduced	VBN	O
into	IN	O
NIH	NN	O
3T3	NN	O
cells	NNS	O
,	,	O
and	CC	O
the	DT	O
resultant	JJ	O
gene	NN	O
expression	NN	O
changes	NNS	O
were	VBD	O
analyzed	VBN	O
with	IN	O
a	DT	O
murine	JJ	O
cDNA	NN	O
microarray	NN	O
containing	VBG	O
2	CD	O
,	,	O
225	CD	O
elements	NNS	O
.	.	O

We	PRP	O
found	VBD	O
that	IN	O
PAX3-FKHR	NN	O
but	CC	O
not	RB	O
PAX3	NN	O
activated	VBD	O
a	DT	O
myogenic	JJ	O
transcription	NN	O
program	NN	O
including	VBG	O
the	DT	O
induction	NN	O
of	IN	O
transcription	NN	O
factors	NNS	O
MyoD	NN	O
,	,	O
Myogenin	NN	O
,	,	O
Six1	NN	O
,	,	O
and	CC	O
Slug	NNP	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
battery	NN	O
of	IN	O
genes	NNS	O
involved	VBN	O
in	IN	O
several	JJ	O
aspects	NNS	O
of	IN	O
muscle	NN	O
function	NN	O
.	.	O

Notable	JJ	O
among	IN	O
this	DT	O
group	NN	O
were	VBD	O
the	DT	O
growth	NN	O
factor	NN	O
gene	NN	O
Igf2	NN	O
and	CC	O
its	PRP$	O
binding	NN	O
protein	NN	O
Igfbp5	NN	O
.	.	O

Relevance	NN	O
of	IN	O
this	DT	O
model	NN	O
was	VBD	O
suggested	VBN	O
by	IN	O
verification	NN	O
that	IN	O
three	CD	O
of	IN	O
these	DT	O
genes	NNS	O
(	-LRB-	O
IGFBP5	NN	O
,	,	O
HSIX1	NN	O
,	,	O
and	CC	O
Slug	NN	O
)	-RRB-	O
were	VBD	O
also	RB	O
expressed	VBN	O
in	IN	O
alveolar	JJ	B-Disease
rhabdomyosarcoma	NN	I-Disease
cell	NN	O
lines	NNS	O
.	.	O

This	DT	O
study	NN	O
utilizes	VBZ	O
cDNA	NN	O
microarrays	NNS	O
to	TO	O
elucidate	VB	O
the	DT	O
pattern	NN	O
of	IN	O
gene	NN	O
expression	NN	O
induced	VBN	O
by	IN	O
an	DT	O
oncogenic	JJ	O
transcription	NN	O
factor	NN	O
and	CC	O
demonstrates	VBZ	O
the	DT	O
profound	JJ	O
myogenic	JJ	O
properties	NNS	O
of	IN	O
PAX3-FKHR	NN	O
in	IN	O
NIH	NN	O
3T3	NN	O
cells	NNS	O
.	.	O

.	.	O

Re-evaluation	NN	O
of	IN	O
the	DT	O
sublocalization	NN	O
of	IN	O
esterase	NN	O
D	NN	O
and	CC	O
its	PRP$	O
relation	NN	O
to	TO	O
the	DT	O
retinoblastoma	NN	B-Disease
locus	NN	O
by	IN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

In	FW	O
situ	FW	O
hybridization	NN	O
of	IN	O
a	DT	O
cDNA	NN	O
probe	NN	O
for	IN	O
the	DT	O
esterase	NN	O
D	NN	O
gene	NN	O
(	-LRB-	O
ESD	NN	O
)	-RRB-	O
was	VBD	O
carried	VBN	O
out	RP	O
on	IN	O
human	JJ	O
chromosomes	NNS	O
.	.	O

The	DT	O
probe	NN	O
hybridized	VBD	O
most	RBS	O
strongly	RB	O
to	TO	O
13q14	NN	O
.	.	O

2	CD	O
and	CC	O
13q14	NN	O
.	.	O

3	LS	O
.	.	O

This	DT	O
observation	NN	O
raises	VBZ	O
doubts	NNS	O
concerning	VBG	O
the	DT	O
most	RBS	O
recently	RB	O
published	VBN	O
assignment	NN	O
of	IN	O
ESD	NN	O
to	TO	O
13q14	NN	O
.	.	O

1	LS	O
.	.	O

A	DT	O
deletion	NN	O
in	IN	O
an	DT	O
individual	JJ	O
with	IN	O
retinoblastoma	NN	B-Disease
was	VBD	O
reported	VBN	O
to	TO	O
separate	VB	O
the	DT	O
closely	RB	O
linked	VBN	O
ESD	NN	O
and	CC	O
retinoblastoma	NN	B-Disease
(	-LRB-	O
RB1	NN	O
)	-RRB-	O
loci	NNS	O
,	,	O
placing	VBG	O
ESD	NNP	O
proximal	JJ	O
to	TO	O
RB1	NN	O
.	.	O

Quantitative	JJ	O
in	FW	O
situ	FW	O
hybridization	NN	O
studies	NNS	O
of	IN	O
this	DT	O
deletion	NN	O
do	VBP	O
not	RB	O
confirm	VB	O
this	DT	O
interpretation	NN	O
.	.	O

Rather	RB	O
,	,	O
they	PRP	O
suggest	VBP	O
that	IN	O
ESD	NN	O
is	VBZ	O
missing	VBG	O
from	IN	O
the	DT	O
deleted	VBN	O
chromosome	NN	O
13	CD	O
and	CC	O
duplicated	JJ	O
on	IN	O
the	DT	O
normal	JJ	O
homolog	NN	O
.	.	O

From	IN	O
these	DT	O
findings	NNS	O
,	,	O
we	PRP	O
conclude	VBP	O
that	IN	O
the	DT	O
deletion	NN	O
in	IN	O
this	DT	O
individual	NN	O
can	MD	O
not	RB	O
be	VB	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
orientation	NN	O
nor	CC	O
the	DT	O
sublocalization	NN	O
of	IN	O
ESD	NN	O
and	CC	O
RB1	NN	O
within	IN	O
the	DT	O
13q14	NN	O
region	NN	O
.	.	O

The	DT	O
DNA	NN	O
double-strand	NN	O
break	NN	O
repair	NN	O
gene	NN	O
hMRE11	NN	O
is	VBZ	O
mutated	VBN	O
in	IN	O
individuals	NNS	O
with	IN	O
an	DT	O
ataxia-telangiectasia-like	JJ	B-Disease
disorder	NN	I-Disease
.	.	O

We	PRP	O
show	VBP	O
that	IN	O
hypomorphic	JJ	O
mutations	NNS	O
in	IN	O
hMRE11	NN	O
,	,	O
but	CC	O
not	RB	O
in	IN	O
ATM	NNP	O
,	,	O
are	VBP	O
present	JJ	O
in	IN	O
certain	JJ	O
individuals	NNS	O
with	IN	O
an	DT	O
ataxia-telangiectasia-like	JJ	B-Disease
disorder	NN	I-Disease
(	-LRB-	O
ATLD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
cellular	JJ	O
features	NNS	O
resulting	VBG	O
from	IN	O
these	DT	O
hMRE11	NN	O
mutations	NNS	O
are	VBP	O
similar	JJ	O
to	TO	O
those	DT	O
seen	VBN	O
in	IN	O
A-T	NN	B-Disease
as	RB	O
well	RB	O
as	IN	O
NBS	NN	B-Disease
and	CC	O
include	VBP	O
hypersensitivity	NN	B-Disease
to	TO	I-Disease
ionizing	VBG	I-Disease
radiation	NN	I-Disease
,	,	O
radioresistant	JJ	O
DNA	NN	O
synthesis	NN	O
,	,	O
and	CC	O
abrogation	NN	O
of	IN	O
ATM-dependent	JJ	O
events	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
activation	NN	O
of	IN	O
Jun	NN	O
kinase	NN	O
following	VBG	O
exposure	NN	O
to	TO	O
gamma	NN	O
irradiation	NN	O
.	.	O

Although	IN	O
the	DT	O
mutant	JJ	O
hMre11	NN	O
proteins	NNS	O
retain	VBP	O
some	DT	O
ability	NN	O
to	TO	O
interact	VB	O
with	IN	O
hRad50	NN	O
and	CC	O
Nbs1	NN	O
,	,	O
formation	NN	O
of	IN	O
ionizing	VBG	O
radiation-induced	JJ	O
hMre11	NN	O
and	CC	O
Nbs1	NN	O
foci	NNS	O
was	VBD	O
absent	JJ	O
in	IN	O
hMRE11	NN	O
mutant	JJ	O
cells	NNS	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
ATM	NNP	O
and	CC	O
the	DT	O
hMre11/hRad50/Nbs1	NN	O
protein	NN	O
complex	NN	O
act	NN	O
in	IN	O
the	DT	O
same	JJ	O
DNA	NN	O
damage	NN	O
response	NN	O
pathway	NN	O
and	CC	O
link	NN	O
hMre11	NN	O
to	TO	O
the	DT	O
complex	NN	O
pathology	NN	O
of	IN	O
A-T	NN	B-Disease
.	.	O

.	.	O

Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
expression	NN	O
in	IN	O
normal	JJ	O
and	CC	O
diseased	JJ	O
human	JJ	O
muscle	NN	O
.	.	O

A	DT	O
probe	NN	O
for	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
was	VBD	O
used	VBN	O
to	TO	O
study	VB	O
expression	NN	O
of	IN	O
the	DT	O
gene	NN	O
in	IN	O
normal	JJ	O
human	JJ	O
muscle	NN	O
,	,	O
myogenic	JJ	O
cell	NN	O
cultures	NNS	O
,	,	O
and	CC	O
muscle	NN	O
from	IN	O
patients	NNS	O
with	IN	O
DMD	NN	B-Disease
.	.	O

Expression	NN	O
was	VBD	O
found	VBN	O
in	IN	O
RNA	NN	O
from	IN	O
normal	JJ	O
fetal	JJ	O
muscle	NN	O
,	,	O
adult	JJ	O
cardiac	JJ	O
and	CC	O
skeletal	JJ	O
muscle	NN	O
,	,	O
and	CC	O
cultured	VBN	O
muscle	NN	O
after	IN	O
myoblast	NN	O
fusion	NN	O
.	.	O

In	IN	O
DMD	NN	B-Disease
muscle	NN	O
,	,	O
expression	NN	O
of	IN	O
this	DT	O
portion	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
also	RB	O
revealed	VBN	O
by	IN	O
in	FW	O
situ	FW	O
RNA	NN	O
hybridization	NN	O
,	,	O
particularly	RB	O
in	IN	O
regenerating	VBG	O
muscle	NN	O
fibers	NNS	O
.	.	O

.	.	O

Localisation	NN	O
of	IN	O
the	DT	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
by	IN	O
linkage	NN	O
to	TO	O
cloned	VBN	O
DNA	NN	O
sequences	NNS	O
.	.	O

A	DT	O
linkage	NN	O
study	NN	O
in	IN	O
30	CD	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
BMD	NN	B-Disease
)	-RRB-	O
kindreds	NNS	O
using	VBG	O
three	CD	O
cloned	VBN	O
DNA	NN	O
sequences	NNS	O
from	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
which	WDT	O
demonstrate	VBP	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
(	-LRB-	O
RFLPs	NNS	O
)	-RRB-	O
,	,	O
suggests	VBZ	O
that	IN	O
the	DT	O
BMD	NN	B-Disease
gene	NN	O
is	VBZ	O
located	JJ	O
on	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
,	,	O
in	IN	O
the	DT	O
p21	NN	O
region	NN	O
.	.	O

The	DT	O
genes	NNS	O
for	IN	O
Becker	NNP	B-Disease
and	CC	I-Disease
Duchenne	NNP	I-Disease
dystrophies	NNS	I-Disease
must	MD	O
therefore	RB	O
be	VB	O
closely	RB	O
linked	VBN	O
,	,	O
if	IN	O
not	RB	O
allelic	JJ	O
,	,	O
and	CC	O
any	DT	O
future	JJ	O
DNA	NN	O
probes	NNS	O
found	VBN	O
to	TO	O
be	VB	O
of	IN	O
practical	JJ	O
use	NN	O
in	IN	O
one	CD	O
disorder	NN	O
should	MD	O
be	VB	O
equally	RB	O
applicable	JJ	O
to	TO	O
the	DT	O
other	JJ	O
.	.	O

The	DT	O
linkage	NN	O
analysis	NN	O
also	RB	O
provides	VBZ	O
data	NNS	O
on	IN	O
the	DT	O
frequency	NN	O
of	IN	O
recombination	NN	O
along	IN	O
the	DT	O
short	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
,	,	O
and	CC	O
across	IN	O
the	DT	O
centromeric	JJ	O
region	NN	O
.	.	O

.	.	O

Age	NN	O
of	IN	O
the	DT	O
intronic	JJ	O
GAA	NN	O
triplet	NN	O
repeat	NN	O
expansion	NN	O
mutation	NN	O
in	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
frequently	RB	O
inherited	VBN	B-Disease
ataxia	NN	I-Disease
,	,	O
is	VBZ	O
due	JJ	O
in	IN	O
the	DT	O
vast	JJ	O
majority	NN	O
of	IN	O
cases	NNS	O
to	TO	O
a	DT	O
large	JJ	O
expansion	NN	O
of	IN	O
an	DT	O
intronic	JJ	O
GAA	NN	O
repeat	NN	O
.	.	O

Using	VBG	O
linkage	NN	O
disequilibrium	NN	O
analysis	NN	O
based	VBN	O
on	IN	O
haplotype	NN	O
data	NNS	O
of	IN	O
seven	CD	O
polymorphic	JJ	O
markers	NNS	O
close	RB	O
to	TO	O
the	DT	O
frataxin	NN	O
gene	NN	O
,	,	O
the	DT	O
age	NN	O
of	IN	O
FRDA	NN	B-Disease
founding	NN	O
mutational	JJ	O
event	NN	O
(	-LRB-	O
s	NNS	O
)	-RRB-	O
is	VBZ	O
estimated	VBN	O
to	TO	O
be	VB	O
at	IN	O
least	JJS	O
682	CD	O
+	CC	O
/	:	O
-203	CD	O
generations	NNS	O
(	-LRB-	O
95	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
564-801	CD	O
g	NN	O
)	-RRB-	O
,	,	O
a	DT	O
dating	VBG	O
which	WDT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
little	JJ	O
or	CC	O
no	DT	O
negative	JJ	O
selection	NN	O
and	CC	O
provides	VBZ	O
further	JJ	O
evidence	NN	O
for	IN	O
an	DT	O
ancient	JJ	O
spread	NN	O
of	IN	O
a	DT	O
pre-mutation	JJ	O
(	-LRB-	O
at-risk	JJ	O
alleles	NNS	O
)	-RRB-	O
in	IN	O
western	JJ	O
Europe	NNP	O
.	.	O

.	.	O

The	DT	O
human	JJ	O
MAGEL2	NN	O
gene	NN	O
and	CC	O
its	PRP$	O
mouse	NN	O
homologue	NN	O
are	VBP	O
paternally	RB	O
expressed	VBN	O
and	CC	O
mapped	VBN	O
to	TO	O
the	DT	O
Prader-Willi	NNP	B-Disease
region	NN	O
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
complex	JJ	O
neurogenetic	JJ	B-Disease
disorder	NN	I-Disease
.	.	O

The	DT	O
phenotype	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
be	VB	O
a	DT	O
contiguous	JJ	B-Disease
gene	NN	I-Disease
syndrome	NN	I-Disease
involving	VBG	O
genes	NNS	O
which	WDT	O
are	VBP	O
paternally	RB	O
expressed	VBN	O
only	RB	O
,	,	O
located	JJ	O
in	IN	O
the	DT	O
human	JJ	O
15q11-q13	NN	O
region	NN	O
.	.	O

Four	CD	O
mouse	NN	O
models	NNS	O
of	IN	O
PWS	NNP	B-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
but	CC	O
these	DT	O
do	VBP	O
not	RB	O
definitively	RB	O
allow	VB	O
the	DT	O
delineation	NN	O
of	IN	O
the	DT	O
critical	JJ	O
region	NN	O
and	CC	O
the	DT	O
associated	JJ	O
genes	NNS	O
involved	VBN	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

Moreover	RB	O
,	,	O
targeted	JJ	O
mutagenesis	NN	O
of	IN	O
mouse	NN	O
homologues	NNS	O
of	IN	O
the	DT	O
human	JJ	O
candidate	NN	O
PWS	NN	B-Disease
genes	NNS	O
does	VBZ	O
not	RB	O
appear	VB	O
to	TO	O
result	VB	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
features	NNS	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

Therefore	RB	O
,	,	O
the	DT	O
isolation	NN	O
of	IN	O
new	JJ	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
remains	VBZ	O
crucial	JJ	O
for	IN	O
a	DT	O
better	JJR	O
understanding	NN	O
of	IN	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
PWS	NNP	B-Disease
.	.	O

In	IN	O
this	DT	O
manuscript	NN	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
characterization	NN	O
of	IN	O
MAGEL2	NN	O
and	CC	O
its	PRP$	O
mouse	NN	O
homologue	NN	O
Magel2	NN	O
.	.	O

These	DT	O
are	VBP	O
located	JJ	O
in	IN	O
the	DT	O
human	JJ	O
15q11-q13	NN	O
and	CC	O
mouse	NN	O
7C	NN	O
regions	NNS	O
,	,	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
NDN/Ndn	NNP	O
.	.	O

By	IN	O
northern	JJ	O
blot	NN	O
analysis	NN	O
we	PRP	O
did	VBD	O
not	RB	O
detect	VB	O
any	DT	O
expression	NN	O
of	IN	O
MAGEL2/Magel2	NN	O
but	CC	O
by	IN	O
RT-PCR	NN	O
analysis	NN	O
,	,	O
specific	JJ	O
expression	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
fetal	JJ	O
and	CC	O
adult	JJ	O
brain	NN	O
and	CC	O
in	IN	O
placenta	NN	O
.	.	O

Both	DT	O
genes	NNS	O
are	VBP	O
intronless	JJ	O
with	IN	O
tandem	JJ	O
direct	JJ	O
repeat	NN	O
sequences	NNS	O
contained	VBD	O
within	IN	O
a	DT	O
CpG	NN	O
island	NN	O
in	IN	O
the	DT	O
5-untranscribed	JJ	O
region	NN	O
.	.	O

The	DT	O
transcripts	NNS	O
encode	VBP	O
putative	JJ	O
proteins	NNS	O
that	WDT	O
are	VBP	O
homologous	JJ	O
to	TO	O
the	DT	O
MAGE	NN	O
proteins	NNS	O
and	CC	O
NDN	NNP	O
.	.	O

Moreover	RB	O
,	,	O
MAGEL2/Magel2	NN	O
are	VBP	O
expressed	VBN	O
only	RB	O
from	IN	O
the	DT	O
paternal	JJ	O
allele	NN	O
in	IN	O
brain	NN	O
,	,	O
suggesting	VBG	O
a	DT	O
potential	JJ	O
role	NN	O
in	IN	O
the	DT	O
aetiology	NN	O
of	IN	O
PWS	NN	B-Disease
and	CC	O
its	PRP$	O
mouse	NN	O
model	NN	O
,	,	O
respectively	RB	O
.	.	O

.	.	O

Multiple	JJ	O
origins	NNS	O
for	IN	O
phenylketonuria	NN	B-Disease
in	IN	O
Europe	NNP	O
.	.	O

Phenylketonuria	NNP	B-Disease
(	-LRB-	O
PKU	NNP	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
disorder	NN	B-Disease
of	IN	I-Disease
amino	NN	I-Disease
acid	NN	I-Disease
metabolism	NN	I-Disease
prevalent	JJ	O
among	IN	O
Caucasians	NNPS	O
and	CC	O
other	JJ	O
ethnic	JJ	O
groups	NNS	O
,	,	O
is	VBZ	O
caused	VBN	O
primarily	RB	O
by	IN	O
a	DT	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
hepatic	JJ	I-Disease
enzyme	NN	I-Disease
phenylalanine	NN	I-Disease
hydroxylase	NN	I-Disease
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
.	.	O

PKU	NNP	B-Disease
is	VBZ	O
a	DT	O
highly	RB	O
heterogeneous	JJ	O
disorder	NN	O
,	,	O
with	IN	O
more	JJR	O
than	IN	O
60	CD	O
molecular	JJ	O
lesions	NNS	O
identified	VBN	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
.	.	O

The	DT	O
haplotype	NN	O
associations	NNS	O
,	,	O
relative	JJ	O
frequencies	NNS	O
,	,	O
and	CC	O
distributions	NNS	O
of	IN	O
five	CD	O
prevalent	JJ	O
PAH	NN	O
mutations	NNS	O
(	-LRB-	O
R158Q	NN	O
,	,	O
R261Q	NN	O
,	,	O
IVS10nt546	NN	O
,	,	O
R408W	NN	O
,	,	O
and	CC	O
IVS12n1	NN	O
)	-RRB-	O
were	VBD	O
established	VBN	O
in	IN	O
a	DT	O
comprehensive	JJ	O
European	JJ	O
sample	NN	O
population	NN	O
and	CC	O
subsequently	RB	O
were	VBD	O
examined	VBN	O
to	TO	O
determine	VB	O
the	DT	O
potential	JJ	O
roles	NNS	O
of	IN	O
several	JJ	O
genetic	JJ	O
mechanisms	NNS	O
in	IN	O
explaining	VBG	O
the	DT	O
present	JJ	O
distribution	NN	O
of	IN	O
the	DT	O
major	JJ	O
PKU	NN	B-Disease
alleles	NNS	O
.	.	O

Each	DT	O
of	IN	O
these	DT	O
five	CD	O
mutations	NNS	O
was	VBD	O
strongly	RB	O
associated	VBN	O
with	IN	O
only	RB	O
one	CD	O
of	IN	O
the	DT	O
more	JJR	O
than	IN	O
70	CD	O
chromosomal	JJ	O
haplotypes	NNS	O
defined	VBN	O
by	IN	O
eight	CD	O
RFLPs	NNS	O
in	IN	O
or	CC	O
near	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
.	.	O

These	DT	O
findings	NNS	O
suggest	VBP	O
that	IN	O
each	DT	O
of	IN	O
these	DT	O
mutations	NNS	O
arose	VBD	O
through	IN	O
a	DT	O
single	JJ	O
founding	NN	O
event	NN	O
that	WDT	O
occurred	VBD	O
within	IN	O
time	NN	O
periods	NNS	O
ranging	VBG	O
from	IN	O
several	JJ	O
hundred	CD	O
to	TO	O
several	JJ	O
thousand	CD	O
years	NNS	O
ago	RB	O
.	.	O

From	IN	O
the	DT	O
significant	JJ	O
differences	NNS	O
observed	VBN	O
in	IN	O
the	DT	O
relative	JJ	O
frequencies	NNS	O
and	CC	O
distributions	NNS	O
of	IN	O
these	DT	O
five	CD	O
alleles	NNS	O
throughout	IN	O
Europe	NNP	O
,	,	O
four	CD	O
of	IN	O
these	DT	O
putative	JJ	O
founding	NN	O
events	NNS	O
could	MD	O
be	VB	O
localized	JJ	O
to	TO	O
specific	JJ	O
ethnic	JJ	O
subgroups	NNS	O
.	.	O

Together	RB	O
,	,	O
these	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
there	EX	O
were	VBD	O
multiple	JJ	O
,	,	O
geographically	RB	O
and	CC	O
ethnically	RB	O
distinct	JJ	O
origins	NNS	O
for	IN	O
PKU	NN	B-Disease
within	IN	O
the	DT	O
European	JJ	O
population	NN	O
.	.	O

.	.	O

Autoinhibition	NN	O
and	CC	O
activation	NN	O
mechanisms	NNS	O
of	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
protein	NN	O
.	.	O

The	DT	O
Rho-family	JJ	O
GTPase	NN	O
,	,	O
Cdc42	NN	O
,	,	O
can	MD	O
regulate	VB	O
the	DT	O
actin	NN	O
cytoskeleton	NN	O
through	IN	O
activation	NN	O
of	IN	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
protein	NN	O
(	-LRB-	O
WASP	NNP	O
)	-RRB-	O
family	NN	O
members	NNS	O
.	.	O

Activation	NN	O
relieves	VBZ	O
an	DT	O
autoinhibitory	JJ	O
contact	NN	O
between	IN	O
the	DT	O
GTPase-binding	JJ	O
domain	NN	O
and	CC	O
the	DT	O
carboxy-terminal	JJ	O
region	NN	O
of	IN	O
WASP	NNP	O
proteins	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
the	DT	O
autoinhibited	JJ	O
structure	NN	O
of	IN	O
the	DT	O
GTPase-binding	JJ	O
domain	NN	O
of	IN	O
WASP	NNP	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
induced	VBN	O
by	IN	O
the	DT	O
C-terminal	JJ	O
region	NN	O
or	CC	O
by	IN	O
organic	JJ	O
co-solvents	NNS	O
.	.	O

In	IN	O
the	DT	O
autoinhibited	JJ	O
complex	NN	O
,	,	O
intramolecular	JJ	O
interactions	NNS	O
with	IN	O
the	DT	O
GTPase-binding	JJ	O
domain	NN	O
occlude	NN	O
residues	NNS	O
of	IN	O
the	DT	O
C	NN	O
terminus	NN	O
that	WDT	O
regulate	VBP	O
the	DT	O
Arp2/3	NN	O
actin-nucleating	NN	O
complex	NN	O
.	.	O

Binding	NN	O
of	IN	O
Cdc42	NN	O
to	TO	O
the	DT	O
GTPase-binding	JJ	O
domain	NN	O
causes	VBZ	O
a	DT	O
dramatic	JJ	O
conformational	JJ	O
change	NN	O
,	,	O
resulting	VBG	O
in	IN	O
disruption	NN	O
of	IN	O
the	DT	O
hydrophobic	JJ	O
core	NN	O
and	CC	O
release	NN	O
of	IN	O
the	DT	O
C	NN	O
terminus	NN	O
,	,	O
enabling	VBG	O
its	PRP$	O
interaction	NN	O
with	IN	O
the	DT	O
actin	NN	O
regulatory	JJ	O
machinery	NN	O
.	.	O

These	DT	O
data	NNS	O
show	VBP	O
that	IN	O
intrinsically	RB	O
unstructured	JJ	O
peptides	NNS	O
such	JJ	O
as	IN	O
the	DT	O
GTPase-binding	JJ	O
domain	NN	O
of	IN	O
WASP	NNP	O
can	MD	O
be	VB	O
induced	VBN	O
into	IN	O
distinct	JJ	O
structural	JJ	O
and	CC	O
functional	JJ	O
states	NNS	O
depending	VBG	O
on	IN	O
context	NN	O
.	.	O

.	.	O

Localisation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
to	TO	O
between	IN	O
DXS7	NN	O
and	CC	O
DXS426	NN	O
on	IN	O
Xp	NN	O
.	.	O

A	DT	O
highly	RB	O
informative	JJ	O
microsatellite	NN	O
marker	NN	O
,	,	O
DXS426	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
proximal	JJ	O
to	TO	O
DXS7	NN	O
in	IN	O
the	DT	O
interval	JJ	O
Xp11	NN	O
.	.	O

4-Xp11	NN	O
4-Xp11	NN	O
.	.	O

23	CD	O
,	,	O
has	VBZ	O
been	VBN	O
used	VBN	O
to	TO	O
refine	VB	O
further	RB	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
NDP	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
results	NNS	O
from	IN	O
a	DT	O
multiply	VBP	O
informative	JJ	O
crossover	NN	O
localize	VB	O
the	DT	O
NDP	NN	B-Disease
gene	NN	O
proximal	JJ	O
to	TO	O
DXS7	NN	O
.	.	O

In	IN	O
conjunction	NN	O
with	IN	O
information	NN	O
from	IN	O
2	CD	O
NDP	NN	B-Disease
patients	NNS	O
who	WP	O
have	VBP	O
a	DT	O
deletion	NN	O
for	IN	O
DXS7	NN	O
but	CC	O
not	RB	O
for	IN	O
DSX426	NN	O
,	,	O
our	PRP$	O
data	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
NDP	NN	B-Disease
gene	NN	O
lies	VBZ	O
between	IN	O
DXS7	NN	O
and	CC	O
DXS426	NN	O
on	IN	O
proximal	JJ	O
Xp	NN	O
.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
human	JJ	O
mitochondrial	JJ	O
very-long-chain	JJ	B-Disease
acyl-CoA	NN	I-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
causing	VBG	O
cardiomyopathy	NN	B-Disease
and	CC	O
sudden	JJ	B-Disease
death	NN	I-Disease
in	IN	O
childhood	NN	O
.	.	O

beta-Oxidation	NN	O
of	IN	O
long-chain	JJ	O
fatty	JJ	O
acids	NNS	O
provides	VBZ	O
the	DT	O
major	JJ	O
source	NN	O
of	IN	O
energy	NN	O
in	IN	O
the	DT	O
heart	NN	O
.	.	O

Defects	NNS	O
in	IN	O
enzymes	NNS	O
of	IN	O
the	DT	O
beta-oxidation	NN	O
pathway	NN	O
cause	NN	O
sudden	JJ	B-Disease
,	,	I-Disease
unexplained	JJ	I-Disease
death	NN	I-Disease
in	IN	O
childhood	NN	O
,	,	O
acute	JJ	O
hepatic	JJ	B-Disease
encephalopathy	NN	I-Disease
or	CC	O
liver	NN	B-Disease
failure	NN	I-Disease
,	,	O
skeletal	JJ	B-Disease
myopathy	NN	I-Disease
,	,	O
and	CC	O
cardiomyopathy	NN	B-Disease
.	.	O

Very-long-chain	JJ	O
acyl-CoA	NN	O
dehydrogenase	NN	O
[	-LRB-	O
VLCAD	NN	O
;	:	O
very-long-chain-acyl-CoA	NN	O
(	-LRB-	O
acceptor	NN	O
)	-RRB-	O
2	CD	O
,	,	O
3-oxidoreductase	NN	O
,	,	O
EC	NNP	O
1	CD	O
.	.	O

3	CD	O
3	CD	O
.	.	O

99	CD	O
99	CD	O
.	.	O

13	CD	O
]	-RRB-	O
catalyzes	VBZ	O
the	DT	O
first	JJ	O
step	NN	O
in	IN	O
beta-oxidation	NN	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
the	DT	O
human	JJ	O
VLCAD	NN	O
cDNA	NN	O
and	CC	O
gene	NN	O
and	CC	O
determined	VBD	O
the	DT	O
complete	JJ	O
nucleotide	NN	O
sequences	NNS	O
.	.	O

Polymerase	NN	O
chain	NN	O
reaction	NN	O
amplification	NN	O
of	IN	O
VLCAD	NN	O
mRNA	NN	O
and	CC	O
genomic	JJ	O
exons	NNS	O
defined	VBD	O
the	DT	O
molecular	JJ	O
defects	NNS	O
in	IN	O
two	CD	O
patients	NNS	O
with	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
who	WP	O
presented	VBD	O
with	IN	O
unexplained	JJ	O
cardiac	JJ	B-Disease
arrest	NN	I-Disease
and	CC	O
cardiomyopathy	NN	B-Disease
.	.	O

In	IN	O
one	CD	O
,	,	O
a	DT	O
homozygous	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
consensus	NN	O
dinucleotide	NN	O
of	IN	O
the	DT	O
donor	NN	O
splice	NN	O
site	NN	O
(	-LRB-	O
g	NN	O
+	CC	O
1	CD	O
--	:	O
>	JJR	O
a	DT	O
)	-RRB-	O
was	VBD	O
associated	VBN	O
with	IN	O
universal	JJ	O
skipping	VBG	O
of	IN	O
the	DT	O
prior	JJ	O
exon	NN	O
(	-LRB-	O
exon	NN	O
11	CD	O
)	-RRB-	O
.	.	O

The	DT	O
second	JJ	O
patient	NN	O
was	VBD	O
a	DT	O
compound	NN	O
heterozygote	NN	O
,	,	O
with	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
,	,	O
C1837	NN	O
--	:	O
>	JJR	O
T	NN	O
,	,	O
changing	VBG	O
the	DT	O
arginine	NN	O
at	IN	O
residue	NN	O
613	CD	O
to	TO	O
tryptophan	NN	O
on	IN	O
one	CD	O
allele	NN	O
and	CC	O
a	DT	O
single	JJ	O
base	NN	O
deletion	NN	O
at	IN	O
the	DT	O
intron-exon	JJ	O
6	CD	O
boundary	NN	O
as	IN	O
the	DT	O
second	JJ	O
mutation	NN	O
.	.	O

This	DT	O
initial	JJ	O
delineation	NN	O
of	IN	O
human	JJ	O
mutations	NNS	O
in	IN	O
VLCAD	NN	O
suggests	VBZ	O
that	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
reduces	VBZ	O
myocardial	JJ	O
fatty	JJ	O
acid	NN	O
beta-oxidation	NN	O
and	CC	O
energy	NN	O
production	NN	O
and	CC	O
is	VBZ	O
associated	VBN	O
with	IN	O
cardiomyopathy	NN	B-Disease
and	CC	O
sudden	JJ	B-Disease
death	NN	I-Disease
in	IN	O
childhood	NN	O
.	.	O

An	DT	O
error	NN	O
in	IN	O
dystrophin	NN	O
mRNA	NN	O
processing	NN	O
in	IN	O
golden	JJ	B-Disease
retriever	NN	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
,	,	O
an	DT	O
animal	NN	O
homologue	NN	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Golden	NNP	B-Disease
retriever	NN	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
GRMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
spontaneous	JJ	O
,	,	O
X-linked	JJ	O
,	,	O
progressively	RB	O
fatal	JJ	O
disease	NN	O
of	IN	O
dogs	NNS	O
and	CC	O
is	VBZ	O
also	RB	O
a	DT	O
homologue	NN	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

Two-thirds	NNS	O
of	IN	O
DMD	NN	B-Disease
patients	NNS	O
carry	VBP	O
detectable	JJ	O
deletions	NNS	O
in	IN	O
their	PRP$	O
dystrophin	NN	O
gene	NN	O
.	.	O

The	DT	O
defect	NN	O
underlying	VBG	O
the	DT	O
remaining	VBG	O
one-third	NN	O
of	IN	O
DMD	NN	B-Disease
patients	NNS	O
is	VBZ	O
undetermined	JJ	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
canine	JJ	O
dystrophin	NN	O
gene	NN	O
in	IN	O
normal	JJ	O
and	CC	O
GRMD	JJ	B-Disease
dogs	NNS	O
has	VBZ	O
failed	VBN	O
to	TO	O
demonstrate	VB	O
any	DT	O
detectable	JJ	O
loss	NN	O
of	IN	O
exons	NNS	O
.	.	O

Here	RB	O
,	,	O
we	PRP	O
have	VBP	O
demonstrated	VBN	O
a	DT	O
RNA	NN	O
processing	NN	O
error	NN	O
in	IN	O
GRMD	NN	B-Disease
that	WDT	O
results	VBZ	O
from	IN	O
a	DT	O
single	JJ	O
base	NN	O
change	NN	O
in	IN	O
the	DT	O
3	CD	O
consensus	NN	O
splice	NN	O
site	NN	O
of	IN	O
intron	NN	O
6	CD	O
.	.	O

The	DT	O
seventh	JJ	O
exon	NN	O
is	VBZ	O
then	RB	O
skipped	VBN	O
,	,	O
which	WDT	O
predicts	VBZ	O
a	DT	O
termination	NN	O
of	IN	O
the	DT	O
dystrophin	NN	O
reading	NN	O
frame	NN	O
within	IN	O
its	PRP$	O
N-terminal	JJ	O
domain	NN	O
in	IN	O
exon	NN	O
8	CD	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
dystrophin	NN	B-Disease
deficiency	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
splice-site	NN	O
mutation	NN	O
.	.	O

.	.	O

Serum	NN	O
amyloid	NN	O
A	NN	O
and	CC	O
P	NN	O
protein	NN	O
genes	NNS	O
in	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
.	.	O

Two	CD	O
recent	JJ	O
studies	NNS	O
have	VBP	O
suggested	VBN	O
the	DT	O
involvement	NN	O
of	IN	O
serum	NN	O
amyloid	NN	O
A	NN	O
(	-LRB-	O
SAA	NN	O
)	-RRB-	O
and	CC	O
P	NN	O
(	-LRB-	O
APCS	NN	O
)	-RRB-	O
genes	NNS	O
in	IN	O
familial	JJ	B-Disease
Mediterranean	JJ	I-Disease
fever	NN	I-Disease
(	-LRB-	O
MEF	NN	B-Disease
)	-RRB-	O
.	.	O

To	TO	O
test	VB	O
the	DT	O
role	NN	O
of	IN	O
SAA	NNP	O
and	CC	O
APCS	NNP	O
in	IN	O
MEF	NNP	B-Disease
and	CC	O
MEF-amyloidosis	NNP	B-Disease
,	,	O
we	PRP	O
studied	VBD	O
17	CD	O
informative	JJ	O
families	NNS	O
(	-LRB-	O
15	CD	O
Armenians	NNPS	O
,	,	O
2	CD	O
non-Ashkenazi	JJ	O
Jews	NNS	O
)	-RRB-	O
and	CC	O
8	CD	O
MEF	NN	B-Disease
patients	NNS	O
with	IN	O
amyloidosis	NN	B-Disease
using	VBG	O
a	DT	O
candidate	NN	O
gene	NN	O
approach	NN	O
.	.	O

No	DT	O
evidence	NN	O
for	IN	O
any	DT	O
MEF-associated	JJ	O
polymorphism	NN	O
was	VBD	O
found	VBN	O
in	IN	O
any	DT	O
of	IN	O
the	DT	O
41	CD	O
Armenian	JJ	O
and	CC	O
Jewish	JJ	O
MEF	NN	B-Disease
patients	NNS	O
tested	VBN	O
.	.	O

Our	PRP$	O
family	NN	O
studies	NNS	O
allowed	VBD	O
us	PRP	O
to	TO	O
rule	VB	O
out	RP	O
tight	JJ	O
linkage	NN	O
between	IN	O
SAA	NNP	O
and	CC	O
MEF	NNP	B-Disease
(	-LRB-	O
lod	JJ	O
score	NN	O
=	JJ	O
-2	CD	O
.	.	O

16	CD	O
,	,	O
theta	RB	O
less	JJR	O
than	IN	O
or	CC	O
equal	JJ	O
to	TO	O
0	CD	O
.	.	O

06	NN	O
)	-RRB-	O
.	.	O

For	IN	O
APCS	NN	O
we	PRP	O
found	VBD	O
that	IN	O
the	DT	O
allele	NN	O
frequency	NN	O
in	IN	O
the	DT	O
MEF-amyloidosis	NN	B-Disease
patients	NNS	O
was	VBD	O
similar	JJ	O
to	TO	O
that	DT	O
in	IN	O
18	CD	O
unrelated	JJ	O
MEF	NN	B-Disease
patients	NNS	O
without	IN	O
amyloidosis	NN	B-Disease
and	CC	O
their	PRP$	O
33	CD	O
healthy	JJ	O
parents	NNS	O
.	.	O

Glucose-6-phosphate	JJ	O
dehydrogenase	NN	O
variants	NNS	O
from	IN	O
Italian	JJ	O
subjects	NNS	O
associated	VBN	O
with	IN	O
severe	JJ	B-Disease
neonatal	JJ	I-Disease
jaundice	NN	I-Disease
.	.	O

Screening	VBG	O
for	IN	O
the	DT	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
was	VBD	O
carried	VBN	O
out	RP	O
at	IN	O
the	DT	O
Maternity	NNP	O
Division	NNP	O
of	IN	O
the	DT	O
Galliera	NNP	O
Hospital	NNP	O
in	IN	O
Genoa	NNP	O
,	,	O
Italy	NNP	O
.	.	O

Two	CD	O
groups	NNS	O
of	IN	O
subjects	NNS	O
with	IN	O
hyperbilirubinaemia	NN	B-Disease
of	IN	O
non-immunological	JJ	O
origin	NN	O
were	VBD	O
examined	VBN	O
(	-LRB-	O
a	DT	O
)	-RRB-	O
302	CD	O
newborn	JJ	O
babies	NNS	O
of	IN	O
Sardinian	JJ	O
extraction	NN	O
(	-LRB-	O
on	IN	O
cord	NN	O
blood	NN	O
)	-RRB-	O
and	CC	O
(	-LRB-	O
b	LS	O
)	-RRB-	O
201	CD	O
newborn	JJ	O
babies	NNS	O
of	IN	O
south	JJ	O
Italian	JJ	O
ancestry	NN	O
(	-LRB-	O
on	IN	O
peripheral	JJ	O
blood	NN	O
)	-RRB-	O
.	.	O

Among	IN	O
503	CD	O
subjects	NNS	O
,	,	O
43	CD	O
showed	VBD	O
an	DT	O
enzyme	NN	O
deficiency	NN	O
;	:	O
in	IN	O
39	CD	O
the	DT	O
defect	NN	O
was	VBD	O
of	IN	O
the	DT	O
Mediterranean	NNP	O
type	NN	O
.	.	O

In	IN	O
one	CD	O
case	NN	O
,	,	O
previously	RB	O
described	VBN	O
,	,	O
the	DT	O
enzyme	NN	O
was	VBD	O
of	IN	O
the	DT	O
A	NN	O
-	:	O
type	NN	O
.	.	O

In	IN	O
the	DT	O
remaining	VBG	O
cases	NNS	O
three	CD	O
different	JJ	O
variants	NNS	O
were	VBD	O
identified	VBN	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
work	NN	O
these	DT	O
three	CD	O
cases	NNS	O
,	,	O
each	DT	O
with	IN	O
severe	JJ	B-Disease
neonatal	JJ	I-Disease
jaundice	NN	I-Disease
,	,	O
are	VBP	O
reported	VBN	O
.	.	O

Their	PRP$	O
parents	NNS	O
originated	VBN	O
from	IN	O
Calabria	NNP	O
,	,	O
from	IN	O
Sardinia	NNP	O
and	CC	O
from	IN	O
Sicily	NNP	O
.	.	O

The	DT	O
abnormal	JJ	O
enzymes	NNS	O
are	VBP	O
respectively	RB	O
designated	VBN	O
as	IN	O
GdDcbrousse-like	JJ	O
,	,	O
GdGallura	NNP	O
and	CC	O
GdAgrigento	NNP	O
.	.	O

.	.	O

Loss	NN	O
of	IN	O
normal	JJ	O
allele	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
in	IN	O
an	DT	O
adrenocortical	JJ	B-Disease
carcinoma	NN	I-Disease
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
.	.	O

Endocrine	JJ	B-Disease
neoplasms	NNS	I-Disease
have	VBP	O
been	VBN	O
reported	VBN	O
occasionally	RB	O
in	IN	O
patients	NNS	O
with	IN	O
familial	JJ	B-Disease
adenomatous	JJ	I-Disease
polyposis	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

An	DT	O
adrenocorotical	JJ	B-Disease
carcinoma	NN	I-Disease
was	VBD	O
studied	VBN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
FAP	NN	B-Disease
.	.	O

Loss	NN	O
of	IN	O
heterozygosity	NN	O
(	-LRB-	O
LOH	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
region	NN	O
close	JJ	O
to	TO	O
the	DT	O
adenomatous	JJ	B-Disease
polyposis	NN	I-Disease
coli	NN	I-Disease
(	-LRB-	O
APC	NN	B-Disease
)	-RRB-	O
gene	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
this	DT	O
carcinoma	NN	B-Disease
,	,	O
and	CC	O
evidence	NN	O
was	VBD	O
obtained	VBN	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	O
loss	NN	O
of	IN	O
the	DT	O
normal	JJ	O
allele	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
demonstration	NN	O
of	IN	O
LOH	NN	O
at	IN	O
the	DT	O
APC	NN	B-Disease
locus	NN	O
in	IN	O
adrenocortical	JJ	B-Disease
tumors	NNS	I-Disease
.	.	O

The	DT	O
present	JJ	O
results	NNS	O
and	CC	O
our	PRP$	O
previous	JJ	O
data	NNS	O
on	IN	O
LOH	NN	O
in	IN	O
a	DT	O
recurring	VBG	O
desmoid	JJ	B-Disease
tumor	NN	I-Disease
suggest	VBP	O
that	IN	O
the	DT	O
heterozygous	JJ	O
mutant/wild-type	JJ	O
condition	NN	O
of	IN	O
the	DT	O
APC	NN	B-Disease
gene	NN	O
may	MD	O
give	VB	O
rise	VB	O
to	TO	O
benign	JJ	B-Disease
tumors	NNS	I-Disease
,	,	O
and	CC	O
that	IN	O
functional	JJ	O
loss	NN	O
of	IN	O
this	DT	O
gene	NN	O
leads	VBZ	O
to	TO	O
development	NN	O
of	IN	O
tumors	NNS	B-Disease
not	RB	O
only	RB	O
in	IN	O
the	DT	O
colon	NN	O
but	CC	O
also	RB	O
in	IN	O
other	JJ	O
various	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
body	NN	O
in	IN	O
FAP	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

Heterozygous	JJ	O
C2-deficiency	NN	B-Disease
and	CC	O
myasthenia	NN	B-Disease
gravis	NN	I-Disease
.	.	O

Complement	NN	B-Disease
deficiency	NN	I-Disease
states	NNS	O
in	IN	O
myasthenia	NN	B-Disease
gravis	NN	I-Disease
(	-LRB-	O
MG	NN	B-Disease
)	-RRB-	O
have	VBP	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
19-year-old	JJ	O
woman	NN	O
with	IN	O
typical	JJ	O
MG	NN	B-Disease
and	CC	O
heterozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
along	IN	O
with	IN	O
HLA	NN	O
typing	NN	O
of	IN	O
the	DT	O
patient	NN	O
and	CC	O
her	PRP$	O
immediate	JJ	O
family	NN	O
.	.	O

.	.	O

Large	JJ	O
heterozygous	JJ	O
deletion	NN	O
masquerading	VBG	O
as	IN	O
homozygous	JJ	O
missense	NN	O
mutation	NN	O
:	:	O
a	DT	O
pitfall	NN	O
in	IN	O
diagnostic	JJ	O
mutation	NN	O
analysis	NN	O
.	.	O

The	DT	O
clinical	JJ	O
use	NN	O
of	IN	O
molecular	JJ	O
analyses	NNS	O
in	IN	O
recessive	JJ	B-Disease
disorders	NNS	I-Disease
relies	VBZ	O
on	IN	O
the	DT	O
exact	JJ	O
characterization	NN	O
of	IN	O
both	CC	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
the	DT	O
affected	JJ	O
patient	NN	O
.	.	O

This	DT	O
can	MD	O
be	VB	O
problematic	JJ	O
when	WRB	O
only	RB	O
part	NN	O
of	IN	O
the	DT	O
gene	NN	O
is	VBZ	O
examined	VBN	O
or	CC	O
when	WRB	O
relevant	JJ	O
DNA	NN	O
alterations	NNS	O
are	VBP	O
not	RB	O
recognized	VBN	O
by	IN	O
standard	JJ	O
methods	NNS	O
.	.	O

We	PRP	O
present	VBP	O
a	DT	O
child	NN	O
in	IN	O
whom	WP	O
phenylketonuria	NN	B-Disease
was	VBD	O
apparently	RB	O
caused	VBN	O
by	IN	O
homozygosity	NN	O
for	IN	O
the	DT	O
mutation	NN	O
E390G	NN	O
in	IN	O
exon	NN	O
11	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
(	-LRB-	O
PAH	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
clinical	JJ	O
severity	NN	O
of	IN	O
the	DT	O
disease	NN	O
was	VBD	O
not	RB	O
quite	RB	O
as	IN	O
mild	JJ	O
as	IN	O
expected	VBN	O
,	,	O
the	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
identified	VBN	O
in	IN	O
the	DT	O
father	NN	O
despite	IN	O
confirmed	VBN	O
paternity	NN	O
,	,	O
and	CC	O
the	DT	O
paternal	JJ	O
allele	NN	O
showed	VBD	O
a	DT	O
highly	RB	O
unusual	JJ	O
pattern	NN	O
of	IN	O
polymorphic	JJ	O
markers	NNS	O
in	IN	O
the	DT	O
PAH	NN	O
gene	NN	O
.	.	O

Presence	NN	O
of	IN	O
a	DT	O
large	JJ	O
deletion	NN	O
involving	VBG	O
exons	NNS	O
9	CD	O
,	,	O
10	CD	O
and	CC	O
11	CD	O
of	IN	O
the	DT	O
phenylalanine	NN	O
hydroxylase	NN	O
gene	NN	O
was	VBD	O
confirmed	VBN	O
by	IN	O
long-range	JJ	O
PCR	NN	O
.	.	O

Diagnostic	JJ	O
DNA	NN	O
analyses	NNS	O
should	MD	O
include	VB	O
a	DT	O
comprehensive	JJ	O
examination	NN	O
of	IN	O
the	DT	O
whole	JJ	O
relevant	JJ	O
gene	NN	O
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
confirmation	NN	O
of	IN	O
carrier	NN	O
status	NN	O
in	IN	O
both	CC	O
parents	NNS	O
.	.	O

.	.	O

Two	CD	O
point	NN	O
mutations	NNS	O
are	VBP	O
responsible	JJ	O
for	IN	O
G6PD	NN	O
polymorphism	NN	O
in	IN	O
Sardinia	NNP	O
.	.	O

The	DT	O
human	JJ	O
X-linked	JJ	O
gene	NN	O
encoding	VBG	O
glucose	NN	O
6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
is	VBZ	O
highly	RB	O
polymorphic	JJ	O
;	:	O
more	JJR	O
than	IN	O
300	CD	O
G6PD	NN	O
variants	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
.	.	O

G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
different	JJ	O
geographical	JJ	O
areas	NNS	O
appears	VBZ	O
to	TO	O
have	VB	O
arisen	VBN	O
through	IN	O
independent	JJ	O
mutational	JJ	O
events	NNS	O
,	,	O
but	CC	O
within	IN	O
the	DT	O
same	JJ	O
population	NN	O
it	PRP	O
may	MD	O
also	RB	O
be	VB	O
heterogeneous	JJ	O
.	.	O

One	CD	O
example	NN	O
is	VBZ	O
the	DT	O
island	NN	O
of	IN	O
Sardinia	NNP	O
,	,	O
where	WRB	O
careful	JJ	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
studies	NNS	O
have	VBP	O
identified	VBN	O
four	CD	O
different	JJ	O
G6PD	NN	O
variants	NNS	O
.	.	O

We	PRP	O
cloned	VBD	O
and	CC	O
sequenced	VBD	O
the	DT	O
four	CD	O
G6PD	NN	O
variants	NNS	O
from	IN	O
Sardinia	NNP	O
and	CC	O
found	VBD	O
that	IN	O
only	RB	O
two	CD	O
mutations	NNS	O
are	VBP	O
responsible	JJ	O
for	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
this	DT	O
area	NN	O
one	CD	O
mutation	NN	O
is	VBZ	O
the	DT	O
cause	NN	O
of	IN	O
the	DT	O
G6PD	NN	B-Disease
Seattle-like	JJ	I-Disease
phenotype	NN	I-Disease
,	,	O
a	DT	O
milder	JJ	O
form	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
;	:	O
the	DT	O
other	JJ	O
mutation	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
all	DT	O
forms	NNS	O
of	IN	O
very	RB	O
severe	JJ	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Sardinia	NNP	O
and	CC	O
,	,	O
possibly	RB	O
,	,	O
in	IN	O
the	DT	O
Mediterranean	NNP	O
.	.	O

.	.	O

Familial	JJ	B-Disease
discoid	NN	I-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
associated	VBN	O
with	IN	O
heterozygote	NN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Two	CD	O
siblings	NNS	O
with	IN	O
chronic	JJ	B-Disease
discoid	JJ	I-Disease
lupus	NN	I-Disease
erythematosus	NN	I-Disease
and	CC	O
several	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
found	VBN	O
with	IN	O
heterozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

An	DT	O
association	NN	O
with	IN	O
histocompatibility	NN	O
markers	NNS	O
HLA-B18	NN	O
and	CC	O
HLA-Dw2	NN	O
was	VBD	O
demonstrated	VBN	O
,	,	O
and	CC	O
the	DT	O
slow	JJ	O
allotype	NN	O
of	IN	O
factor	NN	O
B	NN	O
was	VBD	O
present	JJ	O
.	.	O

Linkage	NN	O
studies	NNS	O
in	IN	O
this	DT	O
family	NN	O
suggested	VBD	O
a	DT	O
close	JJ	O
linkage	NN	O
between	IN	O
the	DT	O
C2	NN	B-Disease
deficiency	NN	I-Disease
gene	NN	O
and	CC	O
genes	NNS	O
coding	VBG	O
for	IN	O
B18	NN	O
,	,	O
Dw2	NN	O
,	,	O
and	CC	O
BfS	NN	O
antigens	NNS	O
.	.	O

One	CD	O
HLA-ACB/DBf	NN	O
recombinant	NN	O
was	VBD	O
observed	VBN	O
showing	VBG	O
closer	JJR	O
linkage	NN	O
between	IN	O
HLA-D	NN	O
and	CC	O
Bf	NN	O
than	IN	O
between	IN	O
HLA-B	NN	O
and	CC	O
Bf	NN	O
.	.	O

.	.	O

A	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
BRCA1	NN	O
.	.	O

A	DT	O
strong	JJ	O
candidate	NN	O
for	IN	O
the	DT	O
17q-linked	JJ	O
BRCA1	NN	O
gene	NN	O
,	,	O
which	WDT	O
influences	VBZ	O
susceptibility	NN	O
to	TO	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
has	VBZ	O
been	VBN	O
identified	VBN	O
by	IN	O
positional	JJ	O
cloning	NN	O
methods	NNS	O
.	.	O

Probable	NNP	O
predisposing	VBG	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
five	CD	O
of	IN	O
eight	CD	O
kindreds	NNS	O
presumed	VBN	O
to	TO	O
segregate	VB	O
BRCA1	NN	O
susceptibility	NN	O
alleles	NNS	O
.	.	O

The	DT	O
mutations	NNS	O
include	VBP	O
an	DT	O
11-base	JJ	O
pair	NN	O
deletion	NN	O
,	,	O
a	DT	O
1-base	JJ	O
pair	NN	O
insertion	NN	O
,	,	O
a	DT	O
stop	NN	O
codon	NN	O
,	,	O
a	DT	O
missense	NN	O
substitution	NN	O
,	,	O
and	CC	O
an	DT	O
inferred	VBN	O
regulatory	JJ	O
mutation	NN	O
.	.	O

The	DT	O
BRCA1	NN	O
gene	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
numerous	JJ	O
tissues	NNS	O
,	,	O
including	VBG	O
breast	NN	O
and	CC	O
ovary	NN	O
,	,	O
and	CC	O
encodes	VBZ	O
a	DT	O
predicted	VBN	O
protein	NN	O
of	IN	O
1863	CD	O
amino	NN	O
acids	NNS	O
.	.	O

This	DT	O
protein	NN	O
contains	VBZ	O
a	DT	O
zinc	NN	O
finger	NN	O
domain	NN	O
in	IN	O
its	PRP$	O
amino-terminal	JJ	O
region	NN	O
,	,	O
but	CC	O
is	VBZ	O
otherwise	RB	O
unrelated	JJ	O
to	TO	O
previously	RB	O
described	VBN	O
proteins	NNS	O
.	.	O

Identification	NN	O
of	IN	O
BRCA1	NN	O
should	MD	O
facilitate	VB	O
early	JJ	O
diagnosis	NN	O
of	IN	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
in	IN	O
some	DT	O
individuals	NNS	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
better	JJR	O
understanding	NN	O
of	IN	O
breast	NN	B-Disease
cancer	NN	I-Disease
biology	NN	O
.	.	O

.	.	O

Recombinations	NNS	O
in	IN	O
individuals	NNS	O
homozygous	JJ	O
by	IN	O
descent	NN	O
localize	VBP	O
the	DT	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
locus	NN	O
in	IN	O
a	DT	O
cloned	VBN	O
450-kb	JJ	O
interval	NN	O
.	.	O

The	DT	O
locus	NN	O
for	IN	O
Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
,	,	O
a	DT	O
severe	JJ	O
neurodegenerative	JJ	B-Disease
disease	NN	I-Disease
,	,	O
is	VBZ	O
tightly	RB	O
linked	VBN	O
to	TO	O
markers	NNS	O
D9S5	NN	O
and	CC	O
D9S15	NN	O
,	,	O
and	CC	O
analysis	NN	O
of	IN	O
rare	JJ	O
recombination	NN	O
events	NNS	O
has	VBZ	O
suggested	VBN	O
the	DT	O
order	NN	O
cen-FRDA-D9S5-D9S15-qter	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
construction	NN	O
of	IN	O
a	DT	O
YAC	NN	O
contig	NN	O
extending	VBG	O
800	CD	O
kb	NN	O
centromeric	JJ	O
to	TO	O
D9S5	NN	O
and	CC	O
the	DT	O
isolation	NN	O
of	IN	O
five	CD	O
new	JJ	O
microsatellite	NN	O
markers	NNS	O
from	IN	O
this	DT	O
region	NN	O
.	.	O

In	IN	O
order	NN	O
to	TO	O
map	VB	O
these	DT	O
markers	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
FRDA	NN	B-Disease
locus	NN	O
,	,	O
all	DT	O
within	IN	O
a	DT	O
1-cM	NN	O
confidence	NN	O
interval	NN	O
,	,	O
we	PRP	O
sought	VBD	O
to	TO	O
increase	VB	O
the	DT	O
genetic	JJ	O
information	NN	O
of	IN	O
available	JJ	O
FRDA	NN	B-Disease
families	NNS	O
by	IN	O
considering	VBG	O
homozygosity	NN	O
by	IN	O
descent	NN	O
and	CC	O
association	NN	O
with	IN	O
founder	NN	O
haplotypes	NNS	O
in	IN	O
isolated	VBN	O
populations	NNS	O
.	.	O

This	DT	O
approach	NN	O
allowed	VBD	O
us	PRP	O
to	TO	O
identify	VB	O
one	CD	O
phase-known	JJ	O
recombination	NN	O
and	CC	O
one	CD	O
probable	JJ	O
historic	JJ	O
recombination	NN	O
on	IN	O
haplotypes	NNS	O
from	IN	O
Reunion	NNP	O
Island	NNP	O
patients	NNS	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
place	NN	O
three	CD	O
of	IN	O
the	DT	O
five	CD	O
markers	NNS	O
proximal	JJ	O
to	TO	O
FRDA	NNP	B-Disease
.	.	O

This	DT	O
represents	VBZ	O
the	DT	O
first	JJ	O
identification	NN	O
of	IN	O
close	JJ	O
FRDA	NN	B-Disease
flanking	NN	O
markers	NNS	O
on	IN	O
the	DT	O
centromeric	JJ	O
side	NN	O
.	.	O

The	DT	O
two	CD	O
other	JJ	O
markers	NNS	O
allowed	VBD	O
us	PRP	O
to	TO	O
narrow	VB	O
the	DT	O
breakpoint	NN	O
of	IN	O
a	DT	O
previously	RB	O
identified	VBN	O
distal	JJ	O
recombination	NN	O
that	WDT	O
is	VBZ	O
>	JJR	O
180	CD	O
kb	NN	O
from	IN	O
D9S5	NN	O
(	-LRB-	O
26P	NN	O
)	-RRB-	O
.	.	O

Taken	VBN	O
together	RB	O
,	,	O
the	DT	O
results	NNS	O
place	VBP	O
the	DT	O
FRDA	NN	B-Disease
locus	NN	O
in	IN	O
a	DT	O
450-kb	JJ	O
interval	NN	O
,	,	O
which	WDT	O
is	VBZ	O
small	JJ	O
enough	RB	O
for	IN	O
direct	JJ	O
search	NN	O
of	IN	O
candidate	NN	O
genes	NNS	O
.	.	O

A	DT	O
detailed	JJ	O
rare	JJ	O
cutter	NN	O
restriction	NN	O
map	NN	O
and	CC	O
a	DT	O
cosmid	JJ	O
contig	NN	O
covering	VBG	O
this	DT	O
interval	NN	O
were	VBD	O
constructed	VBN	O
and	CC	O
should	MD	O
facilitate	VB	O
the	DT	O
search	NN	O
of	IN	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
.	.	O

.	.	O

Further	JJ	O
mapping	NN	O
of	IN	O
an	DT	O
ataxia-telangiectasia	NN	B-Disease
locus	NN	O
to	TO	O
the	DT	O
chromosome	NN	O
11q23	NN	O
region	NN	O
.	.	O

We	PRP	O
recently	RB	O
mapped	VBD	O
the	DT	O
gene	NN	O
for	IN	O
ataxia-telangiectasia	NN	B-Disease
group	NN	O
A	NN	O
(	-LRB-	O
ATA	NN	O
)	-RRB-	O
to	TO	O
chromosome	NN	O
11q22-23	NN	O
by	IN	O
linkage	NN	O
analysis	NN	O
,	,	O
using	VBG	O
the	DT	O
genetic	JJ	O
markers	NNS	O
THY1	NN	O
and	CC	O
pYNB3	NN	O
.	.	O

12	CD	O
(	-LRB-	O
D11S144	NN	O
)	-RRB-	O
.	.	O

The	DT	O
most	RBS	O
likely	JJ	O
order	NN	O
was	VBD	O
cent-AT-S144-THY1	NN	O
.	.	O

The	DT	O
present	JJ	O
paper	NN	O
describes	VBZ	O
further	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
AT	NNP	B-Disease
locus	NN	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
panel	NN	O
of	IN	O
10	CD	O
markers	NNS	O
that	WDT	O
span	VBP	O
approximately	RB	O
60	CD	O
cM	NN	O
in	IN	O
the	DT	O
11q22-23	JJ	O
region	NN	O
centered	VBN	O
around	IN	O
S144	NN	O
and	CC	O
THY1	NN	O
.	.	O

Location	NNP	O
scores	NNS	O
indicate	VBP	O
that	IN	O
three	CD	O
contiguous	JJ	O
subsegments	NNS	O
within	IN	O
the	DT	O
[	-LRB-	O
S144-THY1	NN	O
]	-RRB-	O
segment	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
three	CD	O
contiguous	JJ	O
segments	NNS	O
telomeric	JJ	O
to	TO	O
THY1	NN	O
,	,	O
are	VBP	O
each	DT	O
unlikely	JJ	O
to	TO	O
contain	VB	O
the	DT	O
AT	NNP	B-Disease
locus	NN	O
,	,	O
while	IN	O
the	DT	O
more	RBR	O
centromeric	JJ	O
[	-LRB-	O
STMY-S144	NN	O
]	-RRB-	O
segment	NN	O
is	VBZ	O
most	RBS	O
likely	JJ	O
to	TO	O
contain	VB	O
the	DT	O
AT	NNP	B-Disease
locus	NN	O
.	.	O

These	DT	O
data	NNS	O
,	,	O
together	RB	O
with	IN	O
recent	JJ	O
refinements	NNS	O
in	IN	O
the	DT	O
linkage	NN	O
and	CC	O
physical	JJ	O
maps	NNS	O
of	IN	O
11q22-23	NN	O
,	,	O
place	VBP	O
the	DT	O
AT	NNP	B-Disease
locus	NN	O
at	IN	O
11q23	NN	O
.	.	O

Proliferation-related	JJ	O
expression	NN	O
of	IN	O
p19/nm23	NN	O
nucleoside	NN	O
diphosphate	NN	O
kinase	NN	O
.	.	O

High	JJ	O
level	NN	O
expression	NN	O
of	IN	O
the	DT	O
nm23-H1	NN	O
gene	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
for	IN	O
a	DT	O
nucleoside	NN	O
diphosphate	NN	O
kinase	NN	O
,	,	O
has	VBZ	O
been	VBN	O
found	VBN	O
to	TO	O
correlate	VB	O
with	IN	O
diminished	VBN	O
metastasis	NN	O
in	IN	O
some	DT	O
tumors	NNS	B-Disease
but	CC	O
not	RB	O
in	IN	O
others	NNS	O
.	.	O

We	PRP	O
have	VBP	O
previously	RB	O
identified	VBN	O
the	DT	O
protein	NN	O
product	NN	O
of	IN	O
the	DT	O
nm23-H1	NN	O
gene	NN	O
in	IN	O
two-dimensional	JJ	O
electrophoretic	JJ	O
gels	NNS	O
and	CC	O
have	VBP	O
designated	VBN	O
it	PRP	O
p19/nm23	NN	O
.	.	O

In	IN	O
neuroblastoma	NN	B-Disease
,	,	O
higher	JJR	O
levels	NNS	O
of	IN	O
p19/nm23	NN	O
,	,	O
which	WDT	O
are	VBP	O
associated	VBN	O
with	IN	O
amplification	NN	O
of	IN	O
the	DT	O
N-myc	NN	O
oncogene	NN	O
,	,	O
large	JJ	O
tumor	NN	B-Disease
mass	NN	O
,	,	O
and	CC	O
metastasis	NN	O
,	,	O
were	VBD	O
observed	VBN	O
in	IN	O
advanced	JJ	O
stage	NN	O
tumors	NNS	B-Disease
compared	VBN	O
with	IN	O
limited	JJ	O
stage	NN	O
disease	NN	O
.	.	O

Because	IN	O
of	IN	O
the	DT	O
variable	JJ	O
expression	NN	O
of	IN	O
nm23-H1	NN	O
in	IN	O
different	JJ	O
tumors	NNS	B-Disease
,	,	O
we	PRP	O
have	VBP	O
investigated	VBN	O
the	DT	O
relationship	NN	O
between	IN	O
amounts	NNS	O
of	IN	O
the	DT	O
protein	NN	O
and	CC	O
cell	NN	O
proliferation	NN	O
.	.	O

The	DT	O
levels	NNS	O
of	IN	O
p19/nm23	NN	O
were	VBD	O
compared	VBN	O
between	IN	O
resting	VBG	O
and	CC	O
mitotically	RB	O
stimulated	VBN	O
normal	JJ	O
human	JJ	O
PBLs	NNS	O
and	CC	O
in	IN	O
leukemia	NN	B-Disease
cells	NNS	O
.	.	O

The	DT	O
amount	NN	O
of	IN	O
p19/nm23	NN	O
increased	VBN	O
in	IN	O
normal	JJ	O
lymphocytes	NNS	O
in	IN	O
response	NN	O
to	TO	O
mitotic	JJ	O
stimulation	NN	O
and	CC	O
paralleled	VBD	O
the	DT	O
increase	NN	O
in	IN	O
DNA	NN	O
synthesis	NN	O
.	.	O

In	IN	O
leukemia	NN	B-Disease
cells	NNS	O
obtained	VBN	O
from	IN	O
patients	NNS	O
with	IN	O
different	JJ	O
subtypes	NNS	O
of	IN	O
acute	JJ	B-Disease
leukemia	NN	I-Disease
,	,	O
p19/nm23	NN	O
levels	NNS	O
were	VBD	O
also	RB	O
increased	VBN	O
relative	JJ	O
to	TO	O
resting	VBG	O
normal	JJ	O
lymphocytes	NNS	O
.	.	O

Treatment	NN	O
of	IN	O
mitotically	RB	O
stimulated	VBN	O
lymphocytes	NNS	O
with	IN	O
cyclosporin	NN	O
,	,	O
which	WDT	O
inhibits	VBZ	O
proliferation	NN	O
,	,	O
blocked	VBD	O
the	DT	O
increase	NN	O
in	IN	O
p19/nm23	NN	O
;	:	O
treatment	NN	O
of	IN	O
the	DT	O
leukemia	NN	B-Disease
cell	NN	O
line	NN	O
HL-60	NN	O
with	IN	O
dimethylsulfoxide	NN	O
,	,	O
which	WDT	O
induces	VBZ	O
terminal	JJ	O
differentiation	NN	O
,	,	O
resulted	VBD	O
in	IN	O
diminished	VBN	O
levels	NNS	O
of	IN	O
p19/nm23	NN	O
.	.	O

Our	PRP$	O
data	NNS	O
therefore	RB	O
provide	VBP	O
evidence	NN	O
that	IN	O
nm23-H1	NN	O
expression	NN	O
is	VBZ	O
related	VBN	O
to	TO	O
cell	NN	O
proliferative	JJ	O
activity	NN	O
.	.	O

.	.	O

Carrier	NN	O
detection	NN	O
of	IN	O
pyruvate	NN	B-Disease
carboxylase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
fibroblasts	NNS	O
and	CC	O
lymphocytes	NNS	O
.	.	O

Pyruvate	NN	O
carboxylase	NN	O
(	-LRB-	O
E.	NNP	O
C.	NNP	O
6	CD	O
.	.	O

4	LS	O
.	.	O

1	LS	O
.	.	O

1	LS	O
)	-RRB-	O
activity	NN	O
was	VBD	O
determined	VBN	O
in	IN	O
the	DT	O
circulating	VBG	O
peripheral	JJ	O
lymphocytes	NNS	O
and	CC	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
the	DT	O
family	NN	O
of	IN	O
a	DT	O
patient	NN	O
with	IN	O
hepatic	JJ	O
,	,	O
cerebral	JJ	O
,	,	O
renal	JJ	O
cortical	JJ	O
,	,	O
leukocyte	NN	O
,	,	O
and	CC	O
fibroblast	NN	O
pyruvate	NN	B-Disease
carboxylase	NN	I-Disease
deficiency	NN	I-Disease
(	-LRB-	O
PC	NN	B-Disease
Portland	NNP	I-Disease
deficiency	NN	I-Disease
)	-RRB-	O
.	.	O

Lymphocyte	NN	O
activities	NNS	O
were	VBD	O
mother	NN	O
,	,	O
33	CD	O
--	:	O
39	CD	O
%	NN	O
;	:	O
father	NN	O
,	,	O
11	CD	O
--	:	O
29	CD	O
%	NN	O
;	:	O
brother	NN	O
,	,	O
82	CD	O
--	:	O
103	CD	O
%	NN	O
;	:	O
and	CC	O
sister	NN	O
,	,	O
38	CD	O
--	:	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
lowest	JJS	O
normal	JJ	O
.	.	O

Fibroblasts	NNS	O
from	IN	O
the	DT	O
patients	NNS	O
mother	NN	O
and	CC	O
father	NN	O
had	VBD	O
42	CD	O
and	CC	O
34	CD	O
%	NN	O
,	,	O
respectively	RB	O
,	,	O
of	IN	O
the	DT	O
activity	NN	O
of	IN	O
the	DT	O
lowest	JJS	O
normal	JJ	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
disease	NN	O
is	VBZ	O
inherited	VBN	O
in	IN	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
manner	NN	O
and	CC	O
that	IN	O
lymphocytes	NNS	O
and	CC	O
fibroblasts	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
detect	VB	O
carriers	NNS	O
.	.	O

Neither	DT	O
pyruvate	NN	O
carboxylase	NN	O
nor	CC	O
mitochondrial	JJ	O
PEPCK	NN	O
activity	NN	O
in	IN	O
lymphocytes	NNS	O
was	VBD	O
increased	VBN	O
by	IN	O
a	DT	O
21-hr	JJ	O
fast	JJ	O
.	.	O

Complex	NN	B-Disease
glycerol	NN	I-Disease
kinase	NN	I-Disease
deficiency	NN	I-Disease
:	:	O
molecular-genetic	JJ	O
,	,	O
cytogenetic	JJ	O
,	,	O
and	CC	O
clinical	JJ	O
studies	NNS	O
of	IN	O
five	CD	O
Japanese	JJ	O
patients	NNS	O
.	.	O

Five	CD	O
male	JJ	O
Japanese	JJ	O
patients	NNS	O
with	IN	O
complex	JJ	B-Disease
glycerol	NN	I-Disease
kinase	NN	I-Disease
deficiency	NN	I-Disease
(	-LRB-	O
CGKD	NN	B-Disease
)	-RRB-	O
and	CC	O
their	PRP$	O
relatives	NNS	O
were	VBD	O
studied	VBN	O
clinically	RB	O
,	,	O
cytogenetically	RB	O
,	,	O
and	CC	O
molecular-genetically	RB	O
.	.	O

All	DT	O
patients	NNS	O
had	VBD	O
muscular	JJ	B-Disease
dystrophy	NN	I-Disease
or	CC	O
muscle	NN	B-Disease
weakness	NN	I-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
congenital	JJ	B-Disease
adrenal	JJ	I-Disease
hypoplasia	NN	I-Disease
,	,	O
and	CC	O
glycerol	NN	B-Disease
kinase	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

High-resolution	JJ	O
GTG-banded	JJ	O
chromosomes	NNS	O
showed	VBD	O
a	DT	O
microdeletion	NN	O
in	IN	O
the	DT	O
Xp21	NN	O
region	NN	O
in	IN	O
all	DT	O
four	CD	O
patients	NNS	O
examined	VBN	O
and	CC	O
in	IN	O
all	DT	O
five	CD	O
mothers	NNS	O
.	.	O

Southern	NNP	O
hybridizations	NNS	O
,	,	O
after	IN	O
digestions	NNS	O
by	IN	O
restriction	NN	O
endonucleases	NNS	O
,	,	O
with	IN	O
various	JJ	O
cloned	VBN	O
DNAs	NNS	O
(	-LRB-	O
D2	NN	O
,	,	O
99-6	CD	O
,	,	O
B24	NN	O
,	,	O
C7	NN	O
,	,	O
L1-4	NN	O
,	,	O
cDMD13-14	NN	O
,	,	O
J66-HI	NN	O
,	,	O
P20	NN	O
,	,	O
J-Bir	NN	O
,	,	O
ERT87-30	NN	O
,	,	O
ERT87-15	NN	O
,	,	O
ERT87-8	NN	O
,	,	O
ERT87-1	NN	O
,	,	O
XJ-1	NN	O
.	.	O

1	CD	O
,	,	O
754	CD	O
,	,	O
cx5	NN	O
.	.	O

7	CD	O
,	,	O
and	CC	O
OTC-1	NN	O
)	-RRB-	O
that	WDT	O
are	VBP	O
located	JJ	O
around	IN	O
Xp21	NN	O
also	RB	O
showed	VBD	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
genome	NN	O
of	IN	O
all	DT	O
patients	NNS	O
and	CC	O
mothers	NNS	O
.	.	O

Although	IN	O
the	DT	O
deletion	NN	O
differed	VBD	O
in	IN	O
size	NN	O
among	IN	O
patients	NNS	O
,	,	O
a	DT	O
segment	NN	O
commonly	RB	O
absent	JJ	O
was	VBD	O
located	JJ	O
between	IN	O
the	DT	O
genomic	JJ	O
sequences	NNS	O
corresponding	VBG	O
to	TO	O
L1-4	NN	O
and	CC	O
cDMD13-14	NN	O
.	.	O

This	DT	O
finding	NN	O
indicated	VBD	O
that	IN	O
the	DT	O
gene	NN	O
coding	VBG	O
for	IN	O
glycerol	NN	O
kinase	NN	O
(	-LRB-	O
GK	NN	O
)	-RRB-	O
is	VBZ	O
located	JJ	O
within	IN	O
this	DT	O
segment	NN	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
the	DT	O
present	JJ	O
five	CD	O
patients	NNS	O
and	CC	O
reported	VBD	O
CGKD	NN	B-Disease
or	CC	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
patients	NNS	O
with	IN	O
DNA	NN	O
deletion	NN	O
suggests	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
a	DT	O
certain	JJ	O
gene	NN	O
responsible	JJ	O
for	IN	O
gonadotropin	NN	B-Disease
deficiency	NN	I-Disease
(	-LRB-	O
GTD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
result	NN	O
of	IN	O
the	DT	O
present	JJ	O
study	NN	O
and	CC	O
results	NNS	O
of	IN	O
previous	JJ	O
studies	NNS	O
suggest	VBP	O
that	IN	O
genes	NNS	O
for	IN	O
ornithine	NN	O
transcarbamylase	NN	O
(	-LRB-	O
OTC	NNP	O
)	-RRB-	O
,	,	O
DMD	NNP	B-Disease
,	,	O
and	CC	O
GK	NNP	O
and	CC	O
putative	JJ	O
genes	NNS	O
responsible	JJ	O
for	IN	O
congenital	JJ	B-Disease
adrenal	JJ	I-Disease
hypoplasia	NN	I-Disease
(	-LRB-	O
AHC	NN	B-Disease
)	-RRB-	O
and	CC	O
GTD	NN	B-Disease
are	VBP	O
arranged	VBN	O
from	IN	O
telomere	NN	O
to	TO	O
centromere	NN	O
as	IN	O
pter	NN	O
--	:	O
GTD	NN	O
--	:	O
AHC	NNP	O
--	:	O
GK	NNP	O
--	:	O
DMD	NNP	O
--	:	O
OTC	NNP	O
--	:	O
cen	NN	O

Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
and	CC	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
in	IN	O
the	DT	O
same	JJ	O
patient	NN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
the	DT	O
first	JJ	O
patient	NN	O
identified	VBN	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
and	CC	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
family	NN	O
of	IN	O
the	DT	O
propositus	NN	O
had	VBD	O
a	DT	O
strong	JJ	O
history	NN	O
of	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
and	CC	O
there	EX	O
was	VBD	O
an	DT	O
intrafamilial	JJ	O
pathological	JJ	O
expansion	NN	O
of	IN	O
the	DT	O
responsible	JJ	O
CTG	NNP	O
repeat	NN	O
between	IN	O
the	DT	O
mildly	RB	O
affected	VBN	O
mother	NN	O
(	-LRB-	O
160	CD	O
repeats	NNS	O
;	:	O
normal	JJ	O
27	CD	O
repeats	NNS	O
)	-RRB-	O
and	CC	O
her	PRP$	O
more	JJR	O
severely	RB	O
affected	JJ	O
son	NN	O
(	-LRB-	O
650	CD	O
repeats	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
his	PRP$	O
sister	NN	O
(	-LRB-	O
650	CD	O
repeats	NNS	O
)	-RRB-	O
.	.	O

The	DT	O
propositus	NN	O
was	VBD	O
an	DT	O
isolated	VBN	O
case	NN	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
with	IN	O
marked	JJ	O
dystrophin	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
muscle	NN	O
biopsy	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
still	RB	O
ambulatory	JJ	O
post	NN	O
age	NN	O
16	CD	O
.	.	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
could	MD	O
interfere	VB	O
to	TO	O
some	DT	O
extent	NN	O
with	IN	O
the	DT	O
progression	NN	O
of	IN	O
Duchenne	NNP	B-Disease
dystrophy	NN	I-Disease
.	.	O

However	RB	O
,	,	O
other	JJ	O
interpretations	NNS	O
are	VBP	O
possible	JJ	O
.	.	O

Twelve	CD	O
percent	NN	O
of	IN	O
dystrophin	NN	O
revertant	NN	O
fibers	NNS	O
as	IN	O
observed	VBN	O
by	IN	O
immunohistochemistry	NN	O
could	MD	O
be	VB	O
sufficient	JJ	O
to	TO	O
ameliorate	VB	O
typical	JJ	O
DMD	NNP	B-Disease
clinical	JJ	O
severity	NN	O
,	,	O
or	CC	O
the	DT	O
patient	NN	O
may	MD	O
present	VB	O
a	DT	O
somatic	JJ	O
mosaic	NN	O
.	.	O

The	DT	O
pathophysiological	JJ	O
interactions	NNS	O
of	IN	O
these	DT	O
two	CD	O
unlinked	JJ	O
disorders	NNS	O
are	VBP	O
discussed	VBN	O
at	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
histopathological	JJ	O
levels	NNS	O
.	.	O

.	.	O

Autosomal	JJ	O
recessive	JJ	O
transmission	NN	O
of	IN	O
hemophilia	NN	B-Disease
A	NN	I-Disease
due	JJ	O
to	TO	O
a	DT	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
mutation	NN	O
.	.	O

The	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
the	DT	O
genetic	JJ	B-Disease
bleeding	NN	I-Disease
disorders	NNS	I-Disease
,	,	O
hemophilia	NN	B-Disease
A	NN	I-Disease
and	CC	O
von	NN	B-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
,	,	O
is	VBZ	O
occasionally	RB	O
confounded	VBN	O
by	IN	O
the	DT	O
close	JJ	O
molecular	JJ	O
relationship	NN	O
of	IN	O
coagulation	NN	O
factor	NN	O
VIII	CD	O
and	CC	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
(	-LRB-	O
vWF	NN	O
)	-RRB-	O
.	.	O

This	DT	O
report	NN	O
describes	VBZ	O
the	DT	O
autosomal	JJ	O
inheritance	NN	O
of	IN	O
a	DT	O
hemophilia	NN	B-Disease
A	NN	I-Disease
phenotype	NN	O
due	JJ	O
to	TO	O
a	DT	O
mutation	NN	O
of	IN	O
vWF	NN	O
that	WDT	O
results	VBZ	O
in	IN	O
defective	JJ	O
factor	NN	O
VIII	CD	O
binding	NN	O
.	.	O

The	DT	O
proband	NN	O
was	VBD	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
low	JJ	O
levels	NNS	O
of	IN	O
factor	NN	O
VIII	CD	O
activity	NN	O
.	.	O

Polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
amplification	NN	O
and	CC	O
DNA	NN	O
sequencing	NN	O
were	VBD	O
employed	VBN	O
to	TO	O
examine	VB	O
exons	NNS	O
encoding	VBG	O
the	DT	O
putative	JJ	O
factor	NN	O
VIII	CD	O
binding	NN	O
domain	NN	O
of	IN	O
vWF	NN	O
.	.	O

The	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
point	NN	O
mutation	NN	O
causing	VBG	O
a	DT	O
Thr	NNP	O
--	:	O
>	JJR	O
Met	NNP	O
substitution	NN	O
at	IN	O
amino	NN	O
acid	NN	O
position	NN	O
28	CD	O
in	IN	O
the	DT	O
mature	JJ	O
vWF	NN	O
subunit	NN	O
.	.	O

The	DT	O
phenotypic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
determined	VBN	O
to	TO	O
be	VB	O
recessive	JJ	O
because	IN	O
heterozygous	JJ	O
family	NN	O
members	NNS	O
were	VBD	O
clinically	RB	O
unaffected	JJ	O
.	.	O

Recombinant	JJ	O
vWF	NN	O
containing	VBG	O
the	DT	O
observed	VBN	O
amino	NN	O
acid	NN	O
substitution	NN	O
was	VBD	O
expressed	VBN	O
in	IN	O
COS-1	NN	O
cells	NNS	O
.	.	O

The	DT	O
mutant	JJ	O
vWF	NN	O
was	VBD	O
processed	VBN	O
and	CC	O
secreted	VBN	O
normally	RB	O
,	,	O
and	CC	O
was	VBD	O
functionally	RB	O
equivalent	JJ	O
to	TO	O
wild-type	JJ	O
vWF	NN	O
in	IN	O
its	PRP$	O
ability	NN	O
to	TO	O
bind	VB	O
to	TO	O
platelets	NNS	O
.	.	O

However	RB	O
,	,	O
the	DT	O
mutant	JJ	O
failed	VBD	O
to	TO	O
bind	VB	O
factor	NN	O
VIII	NNP	O
,	,	O
demonstrating	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
was	VBD	O
functionally	RB	O
related	JJ	O
to	TO	O
the	DT	O
observed	VBN	O
hemophilia	NN	B-Disease
phenotype	NN	O
.	.	O

The	DT	O
family	NN	O
we	PRP	O
describe	VBP	O
demonstrates	VBZ	O
the	DT	O
recessive	JJ	O
inheritance	NN	O
of	IN	O
a	DT	O
recently	RB	O
recognized	VBN	O
class	NN	O
of	IN	O
genetic	JJ	O
bleeding	NN	O
disorders	NNS	O
,	,	O
we	PRP	O
call	VBP	O
"	''	O
autosomal	JJ	O
hemophilia	NN	B-Disease
.	.	O
"	''	O

We	PRP	O
conclude	VBP	O
that	IN	O
vWF	NN	O
mutation	NN	O
may	MD	O
be	VB	O
an	DT	O
under	IN	O
recognized	VBN	O
cause	NN	O
of	IN	O
hemophilia	NN	B-Disease
,	,	O
especially	RB	O
in	IN	O
cases	NNS	O
where	WRB	O
the	DT	O
inheritance	NN	O
pattern	NN	O
is	VBZ	O
not	RB	O
consistent	JJ	O
with	IN	O
X-linked	JJ	O
transmission	NN	O
.	.	O

Determination	NN	O
of	IN	O
30	CD	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
mutations	NNS	O
,	,	O
including	VBG	O
15	CD	O
not	RB	O
previously	RB	O
described	VBN	O
.	.	O

X-linked	JJ	B-Disease
Adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
X-ALD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
the	DT	O
most	RBS	O
frequent	JJ	O
peroxisomal	JJ	B-Disease
disease	NN	I-Disease
.	.	O

It	PRP	O
mainly	RB	O
involves	VBZ	O
the	DT	O
nervous	JJ	O
system	NN	O
white	JJ	O
matter	NN	O
,	,	O
adrenal	JJ	O
cortex	NN	O
and	CC	O
testes	NNS	O
.	.	O

Several	JJ	O
distinct	JJ	O
clinical	JJ	O
phenotypes	NNS	O
are	VBP	O
known	VBN	O
.	.	O

The	DT	O
principal	JJ	O
biochemical	JJ	O
abnormality	NN	O
is	VBZ	O
the	DT	O
accumulation	NN	O
of	IN	O
saturated	JJ	O
very-long-chain	JJ	O
fatty	JJ	O
acids	NNS	O
(	-LRB-	O
VLCFAs	NNS	O
>	JJR	O
C22	NN	O
0	CD	O
,	,	O
mainly	RB	O
C26	NN	O
0	CD	O
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
due	JJ	O
to	TO	O
impaired	JJ	O
capacity	NN	O
for	IN	O
beta-oxidation	NN	O
in	IN	O
peroxisomes	NNS	O
.	.	O

Diagnosis	NN	O
is	VBZ	O
usually	RB	O
based	VBN	O
on	IN	O
the	DT	O
VLCFA	NN	O
levels	NNS	O
in	IN	O
plasma	NN	O
or	CC	O
cultured	VBN	O
skin	NN	O
fibroblasts	NNS	O
in	IN	O
both	DT	O
patients	NNS	O
and	CC	O
carriers	NNS	O
.	.	O

In	IN	O
0	CD	O
.	.	O

1	CD	O
%	NN	O
of	IN	O
affected	VBN	O
males	NNS	O
,	,	O
however	RB	O
,	,	O
the	DT	O
plasma	NN	O
C26	NN	O
0	CD	O
level	NN	O
is	VBZ	O
borderline	JJ	O
normal	JJ	O
,	,	O
and	CC	O
15	CD	O
%	NN	O
of	IN	O
obligate	JJ	O
female	JJ	O
carriers	NNS	O
have	VBP	O
normal	JJ	O
results	NNS	O
.	.	O

Effective	JJ	O
mutation	NN	O
detection	NN	O
in	IN	O
these	DT	O
families	NNS	O
is	VBZ	O
therefore	RB	O
fundamental	JJ	O
to	TO	O
unambiguously	RB	O
determine	VB	O
the	DT	O
genetic	JJ	O
status	NN	O
of	IN	O
each	DT	O
individual	NN	O
at	IN	O
risk	NN	O
.	.	O

Of	IN	O
particular	JJ	O
concern	NN	O
are	VBP	O
female	JJ	O
members	NNS	O
of	IN	O
kindreds	NNS	O
segregating	VBG	O
X-ALD	NN	B-Disease
mutations	NNS	O
,	,	O
because	IN	O
normal	JJ	O
VLCFA	NN	O
levels	NNS	O
do	VBP	O
not	RB	O
guarantee	VB	O
lack	NN	O
of	IN	O
carrier	NN	O
status	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
fast	JJ	O
method	NN	O
for	IN	O
detection	NN	O
of	IN	O
X-ALD	NN	B-Disease
mutations	NNS	O
.	.	O

The	DT	O
method	NN	O
is	VBZ	O
based	VBN	O
on	IN	O
SSCP	NN	O
analysis	NN	O
of	IN	O
nested	JJ	O
PCR	NN	O
fragments	NNS	O
followed	VBN	O
by	IN	O
sequence-determination	NN	O
reactions	NNS	O
.	.	O

Using	VBG	O
this	DT	O
methodology	NN	O
we	PRP	O
have	VBP	O
found	VBN	O
X-ALD	NN	B-Disease
mutations	NNS	O
in	IN	O
30	CD	O
kindreds	NNS	O
,	,	O
including	VBG	O
15	CD	O
not	RB	O
previously	RB	O
reported	VBN	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
in	IN	O
families	NNS	O
with	IN	O
early-onset	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

We	PRP	O
analysed	VBD	O
50	CD	O
probands	NNS	O
with	IN	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
breast	NN	B-Disease
and/or	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
for	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
candidate	NN	O
gene	NN	O
,	,	O
using	VBG	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
analysis	NN	O
on	IN	O
PCR-amplified	JJ	O
genomic	JJ	O
DNA	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
eight	CD	O
putative	JJ	O
disease-causing	JJ	O
alterations	NNS	O
were	VBD	O
identified	VBN	O
four	CD	O
of	IN	O
these	DT	O
are	VBP	O
frameshifts	NNS	O
and	CC	O
two	CD	O
are	VBP	O
nonsense	JJ	O
mutations	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
found	VBD	O
two	CD	O
missense	NN	O
mutations	NNS	O
,	,	O
one	CD	O
of	IN	O
which	WDT	O
changes	VBZ	O
the	DT	O
final	JJ	O
cysteine	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
zinc	NN	O
finger	NN	O
motif	NN	O
to	TO	O
glycine	NN	O
.	.	O

These	DT	O
data	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
tumour	NN	B-Disease
suppressor	NN	O
model	NN	O
,	,	O
and	CC	O
support	VBP	O
the	DT	O
notion	NN	O
that	IN	O
this	DT	O
candidate	NN	O
gene	NN	O
is	VBZ	O
in	IN	O
fact	NN	O
BRCA1	NN	O
.	.	O

The	DT	O
heterogeneity	NN	O
of	IN	O
mutations	NNS	O
,	,	O
coupled	VBN	O
with	IN	O
the	DT	O
large	JJ	O
size	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
indicates	VBZ	O
that	IN	O
clinical	JJ	O
application	NN	O
of	IN	O
BRCA1	NN	O
mutation	NN	O
testing	NN	O
will	MD	O
be	VB	O
technically	RB	O
challenging	JJ	O
.	.	O

.	.	O

Screening	VBG	O
for	IN	O
carriers	NNS	O
of	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
among	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
.	.	O

A	DT	O
comparison	NN	O
of	IN	O
DNA-based	JJ	O
and	CC	O
enzyme-based	JJ	O
tests	NNS	O
.	.	O

BACKGROUND	NN	O
AND	CC	O
METHODS	NNS	O
.	.	O

The	DT	O
prevention	NN	O
of	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
GM2	NN	B-Disease
gangliosidosis	NN	I-Disease
,	,	I-Disease
type	NN	I-Disease
1	CD	I-Disease
)	-RRB-	O
depends	VBZ	O
on	IN	O
the	DT	O
identification	NN	O
of	IN	O
carriers	NNS	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
this	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
.	.	O

We	PRP	O
compared	VBD	O
the	DT	O
enzyme-based	JJ	O
test	NN	O
widely	RB	O
used	VBN	O
in	IN	O
screening	VBG	O
for	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
with	IN	O
a	DT	O
test	NN	O
based	VBN	O
on	IN	O
analysis	NN	O
of	IN	O
DNA	NN	O
.	.	O

We	PRP	O
developed	VBD	O
methods	NNS	O
to	TO	O
detect	VB	O
the	DT	O
three	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
HEXA	NN	O
gene	NN	O
that	WDT	O
occur	VBP	O
with	IN	O
high	JJ	O
frequency	NN	O
among	IN	O
Ashkenazi	NNP	O
Jews	NNPS	O
two	CD	O
mutations	NNS	O
cause	VBP	O
infantile	JJ	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
,	,	O
and	CC	O
the	DT	O
third	JJ	O
causes	VBZ	O
the	DT	O
adult-onset	JJ	O
form	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

DNA	NN	O
segments	NNS	O
containing	VBG	O
these	DT	O
mutation	NN	O
sites	NNS	O
were	VBD	O
amplified	VBN	O
with	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
and	CC	O
analyzed	VBN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
mutations	NNS	O
.	.	O

RESULTS	NNS	O
.	.	O

Among	IN	O
62	CD	O
Ashkenazi	NNS	O
obligate	JJ	O
carriers	NNS	O
of	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
,	,	O
the	DT	O
three	CD	O
specific	JJ	O
mutations	NNS	O
accounted	VBD	O
for	IN	O
all	DT	O
but	IN	O
one	CD	O
of	IN	O
the	DT	O
mutant	JJ	O
alleles	NNS	O
(	-LRB-	O
98	CD	O
percent	NN	O
)	-RRB-	O
.	.	O

In	IN	O
216	CD	O
Ashkenazi	NN	O
carriers	NNS	O
identified	VBN	O
by	IN	O
the	DT	O
enzyme	NN	O
test	NN	O
,	,	O
DNA	NN	O
analysis	NN	O
showed	VBD	O
that	IN	O
177	CD	O
(	-LRB-	O
82	CD	O
percent	NN	O
)	-RRB-	O
had	VBD	O
one	CD	O
of	IN	O
the	DT	O
identified	VBN	O
mutations	NNS	O
.	.	O

Of	IN	O
the	DT	O
177	CD	O
,	,	O
79	CD	O
percent	NN	O
had	VBD	O
the	DT	O
exon	NN	O
11	CD	O
insertion	NN	O
mutation	NN	O
,	,	O
18	CD	O
percent	NN	O
had	VBD	O
the	DT	O
intron	NN	O
12	CD	O
splice-junction	NN	O
mutation	NN	O
,	,	O
and	CC	O
3	CD	O
percent	NN	O
had	VBD	O
the	DT	O
less	RBR	O
severe	JJ	O
exon	NN	O
7	CD	O
mutation	NN	O
associated	VBN	O
with	IN	O
adult-onset	JJ	O
disease	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
tests	NNS	O
in	IN	O
the	DT	O
39	CD	O
subjects	NNS	O
(	-LRB-	O
18	CD	O
percent	NN	O
)	-RRB-	O
who	WP	O
were	VBD	O
defined	VBN	O
as	IN	O
carriers	NNS	O
but	CC	O
in	IN	O
whom	WP	O
DNA	NN	O
analysis	NN	O
did	VBD	O
not	RB	O
identify	VB	O
a	DT	O
mutant	JJ	O
allele	NN	O
were	VBD	O
probably	RB	O
false	JJ	O
positive	JJ	O
(	-LRB-	O
although	IN	O
there	EX	O
remains	VBZ	O
some	DT	O
possibility	NN	O
of	IN	O
unidentified	JJ	O
mutations	NNS	O
)	-RRB-	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
of	IN	O
152	CD	O
persons	NNS	O
defined	VBN	O
as	IN	O
noncarriers	NNS	O
by	IN	O
the	DT	O
enzyme-based	JJ	O
test	NN	O
,	,	O
1	CD	O
was	VBD	O
identified	VBN	O
as	IN	O
a	DT	O
carrier	NN	O
by	IN	O
DNA	NN	O
analysis	NN	O
(	-LRB-	O
i.	NN	O
e	SYM	O
e.	FW	O
,	,	O
a	DT	O
false	JJ	O
negative	JJ	O
enzyme-test	JJ	O
result	NN	O
)	-RRB-	O
.	.	O

CONCLUSIONS	NNS	O
.	.	O

The	DT	O
increased	VBN	O
specificity	NN	O
and	CC	O
predictive	JJ	O
value	NN	O
of	IN	O
the	DT	O
DNA-based	JJ	O
test	NN	O
make	VB	O
it	PRP	O
a	DT	O
useful	JJ	O
adjunct	NN	O
to	TO	O
the	DT	O
diagnostic	JJ	O
tests	NNS	O
currently	RB	O
used	VBN	O
to	TO	O
screen	VB	O
for	IN	O
carriers	NNS	O
of	IN	O
Tay-Sachs	JJ	B-Disease
disease	NN	I-Disease
.	.	O

Adrenoleukodystrophy	NN	B-Disease
gene	NN	O
encodes	VBZ	O
an	DT	O
80	CD	O
kDa	NN	O
membrane	NN	O
protein	NN	O
.	.	O

An	DT	O
antibody	NN	O
against	IN	O
the	DT	O
synthetic	JJ	O
C-terminal	JJ	O
peptides	NNS	O
deduced	VBN	O
from	IN	O
the	DT	O
cDNA	NN	O
of	IN	O
the	DT	O
gene	NN	O
responsible	JJ	O
for	IN	O
X-linked	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
was	VBD	O
produced	VBN	O
to	TO	O
characterize	VB	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
.	.	O

The	DT	O
antibody	NN	O
reacted	VBD	O
with	IN	O
the	DT	O
80	CD	O
kDa	NN	O
band	NN	O
protein	NN	O
in	IN	O
control	JJ	O
fibroblasts	NNS	O
,	,	O
while	IN	O
no	DT	O
bands	NNS	O
were	VBD	O
detected	VBN	O
in	IN	O
the	DT	O
fibroblasts	NNS	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
ALD	NN	B-Disease
(	-LRB-	O
#	#	O
163	CD	O
)	-RRB-	O
,	,	O
in	IN	O
which	WDT	O
mRNA	NN	O
of	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
was	VBD	O
undetectable	JJ	O
based	VBN	O
on	IN	O
Northern	NN	O
blot	NN	O
analysis	NN	O
.	.	O

The	DT	O
293T	NN	O
cells	NNS	O
transfected	VBN	O
with	IN	O
the	DT	O
full-coding	JJ	O
cDNA	NN	O
inserted	VBN	O
in	IN	O
the	DT	O
expression	NN	O
vector	NN	O
produced	VBD	O
a	DT	O
new	JJ	O
80	CD	O
kDa	NN	O
protein	NN	O
,	,	O
as	IN	O
detected	VBN	O
by	IN	O
Western	NN	O
blot	NN	O
.	.	O

In	IN	O
an	DT	O
immunocytological	JJ	O
study	NN	O
,	,	O
the	DT	O
staining	NN	O
was	VBD	O
in	IN	O
a	DT	O
punctate	NN	O
pattern	NN	O
,	,	O
in	IN	O
the	DT	O
normal	JJ	O
fibroblasts	NNS	O
.	.	O

However	RB	O
,	,	O
there	EX	O
was	VBD	O
no	DT	O
punctate	NN	O
staining	NN	O
in	IN	O
the	DT	O
#	#	O
163	CD	O
cells	NNS	O
.	.	O

These	DT	O
data	NNS	O
thus	RB	O
indicate	VBP	O
that	IN	O
the	DT	O
ALD	NN	B-Disease
gene	NN	O
encodes	VBZ	O
an	DT	O
80	CD	O
kDa	NN	O
membrane	NN	O
protein	NN	O
.	.	O

.	.	O

Preferential	JJ	O
germline	NN	O
mutation	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
allele	NN	O
in	IN	O
retinoblastoma	NN	B-Disease
.	.	O

The	DT	O
event	NN	O
triggering	VBG	O
malignant	JJ	O
proliferation	NN	O
in	IN	O
70	CD	O
%	NN	O
of	IN	O
retinoblastoma	NN	B-Disease
tumours	NNS	I-Disease
is	VBZ	O
loss	NN	O
of	IN	O
heterozygosity	NN	O
for	IN	O
chromosome	NN	O
13q14	NN	O
,	,	O
whereby	WRB	O
the	DT	O
normal	JJ	O
retinoblastoma	NN	B-Disease
gene	NN	O
(	-LRB-	O
RB1	NN	O
)	-RRB-	O
allele	NN	O
is	VBZ	O
lost	VBN	O
and	CC	O
an	DT	O
already	RB	O
mutated	VBN	O
RB1	NN	O
allele	NN	O
remains	VBZ	O
in	IN	O
the	DT	O
tumour	NN	B-Disease
.	.	O

The	DT	O
first	JJ	O
allele	NN	O
suffers	VBZ	O
a	DT	O
mutational	JJ	O
event	NN	O
--	:	O
deletion	NN	O
,	,	O
duplication	NN	O
or	CC	O
point	NN	O
mutation	NN	O
(	-LRB-	O
manuscript	NN	O
in	IN	O
preparation	NN	O
)	-RRB-	O
--	:	O
either	RB	O
in	IN	O
the	DT	O
germ	NN	O
line	NN	O
(	-LRB-	O
all	DT	O
bilateral	JJ	O
patients	NNS	O
)	-RRB-	O
or	CC	O
in	IN	O
a	DT	O
somatic	JJ	O
retinal	JJ	O
cell	NN	O
(	-LRB-	O
most	RBS	O
unilateral	JJ	O
patients	NNS	O
)	-RRB-	O
.	.	O

Most	JJS	O
bilateral	JJ	O
patients	NNS	O
have	VBP	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
retinoblastoma	NN	B-Disease
and	CC	O
are	VBP	O
presumed	VBN	O
to	TO	O
have	VB	O
new	JJ	O
germline	NN	O
mutations	NNS	O
which	WDT	O
arose	VBD	O
in	IN	O
the	DT	O
egg	NN	O
,	,	O
sperm	NN	O
or	CC	O
early	JJ	O
embryo	NN	O
.	.	O

We	PRP	O
have	VBP	O
determined	VBN	O
the	DT	O
parental	JJ	O
origin	NN	O
of	IN	O
the	DT	O
retained	VBN	O
allele	NN	O
in	IN	O
nine	CD	O
retinoblastoma	NN	B-Disease
tumours	NNS	I-Disease
from	IN	O
eight	CD	O
unrelated	JJ	O
non-familial	JJ	O
cases	NNS	O
by	IN	O
using	VBG	O
RB1-linked	JJ	O
genetic	JJ	O
markers	NNS	O
.	.	O

Six	CD	O
tumours	NNS	B-Disease
retained	VBD	O
the	DT	O
paternal	JJ	O
allele	NN	O
and	CC	O
three	CD	O
retained	VBD	O
the	DT	O
maternal	JJ	O
allele	NN	O
.	.	O

Of	IN	O
the	DT	O
three	CD	O
unilateral	JJ	B-Disease
tumours	NNS	I-Disease
,	,	O
only	RB	O
one	CD	O
retained	VBD	O
the	DT	O
paternal	JJ	O
RB1	NN	O
allele	NN	O
.	.	O

Thus	RB	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
that	IN	O
the	DT	O
paternal	JJ	O
RB1	NN	O
allele	NN	O
is	VBZ	O
preferentially	RB	O
retained	VBN	O
in	IN	O
retinoblastoma	NN	B-Disease
,	,	O
as	IN	O
has	VBZ	O
been	VBN	O
suggested	VBN	O
to	TO	O
be	VB	O
the	DT	O
case	NN	O
in	IN	O
osteosarcoma	NN	B-Disease
.	.	O

By	IN	O
contrast	NN	O
,	,	O
tumours	NNS	B-Disease
from	IN	O
four	CD	O
of	IN	O
the	DT	O
five	CD	O
bilateral	JJ	O
patients	NNS	O
retained	VBD	O
the	DT	O
paternal	JJ	O
RB1	NN	O
allele	NN	O
.	.	O

This	DT	O
suggests	VBZ	O
either	CC	O
that	IN	O
new	JJ	O
germline	NN	O
RB1	NN	O
mutations	NNS	O
arise	VBP	O
more	RBR	O
frequently	RB	O
during	IN	O
spermatogenesis	NN	O
than	IN	O
during	IN	O
oogenesis	NN	O
,	,	O
or	CC	O
that	IN	O
imprinting	VBG	O
in	IN	O
the	DT	O
early	JJ	O
embryo	NN	O
affects	VBZ	O
chromosomal	JJ	O
susceptibility	NN	O
to	TO	O
mutation	NN	O
.	.	O

.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
locus	NN	O
and	CC	O
clinical	JJ	O
phenotypes	NNS	O
of	IN	O
A-T	NN	B-Disease
patients	NNS	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
locus	NN	O
on	IN	O
chromosome	NN	O
band	NN	O
11q22	NN	O
cause	VBP	O
a	DT	O
distinctive	JJ	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
syndrome	NN	I-Disease
in	IN	O
homozygotes	NNS	O
and	CC	O
predispose	VB	O
heterozygotes	NNS	O
to	TO	O
cancer	NN	B-Disease
,	,	O
ischemic	JJ	B-Disease
heart	NN	I-Disease
disease	NN	I-Disease
,	,	O
and	CC	O
early	JJ	O
mortality	NN	O
.	.	O

PCR	NN	O
amplification	NN	O
from	IN	O
genomic	JJ	O
DNA	NN	O
and	CC	O
automated	VBN	O
sequencing	NN	O
of	IN	O
the	DT	O
entire	JJ	O
coding	NN	O
region	NN	O
(	-LRB-	O
66	CD	O
exons	NNS	O
)	-RRB-	O
and	CC	O
splice	NN	O
junctions	NNS	O
detected	VBD	O
77	CD	O
mutations	NNS	O
(	-LRB-	O
85	CD	O
%	NN	O
)	-RRB-	O
in	IN	O
90	CD	O
A-T	NN	B-Disease
chromosomes	NNS	O
.	.	O

Heteroduplex	JJ	O
analysis	NN	O
detected	VBD	O
another	DT	O
42	CD	O
mutations	NNS	O
at	IN	O
the	DT	O
A-T	NN	B-Disease
locus	NN	O
.	.	O

Out	IN	O
of	IN	O
a	DT	O
total	NN	O
of	IN	O
71	CD	O
unique	JJ	O
mutations	NNS	O
,	,	O
50	CD	O
were	VBD	O
found	VBN	O
only	RB	O
in	IN	O
a	DT	O
single	JJ	O
family	NN	O
,	,	O
and	CC	O
51	CD	O
had	VBD	O
not	RB	O
been	VBN	O
reported	VBN	O
previously	RB	O
.	.	O

Most	JJS	O
(	-LRB-	O
58/71	CD	O
,	,	O
82	CD	O
%	NN	O
)	-RRB-	O
mutations	NNS	O
were	VBD	O
frameshift	NN	O
and	CC	O
nonsense	NN	O
mutations	NNS	O
that	WDT	O
are	VBP	O
predicted	VBN	O
to	TO	O
cause	VB	O
truncation	NN	O
of	IN	O
the	DT	O
A-T	NN	B-Disease
protein	NN	O
;	:	O
the	DT	O
less	JJR	O
common	JJ	O
mutation	NN	O
types	NNS	O
were	VBD	O
missense	NN	O
(	-LRB-	O
9/71	CD	O
,	,	O
13	CD	O
%	NN	O
)	-RRB-	O
,	,	O
splicing	NN	O
(	-LRB-	O
3/71	CD	O
,	,	O
4	CD	O
%	NN	O
)	-RRB-	O
and	CC	O
one	CD	O
in-frame	RB	O
deletion	NN	O
,	,	O
2546	CD	O
3	CD	O
(	-LRB-	O
1/71	CD	O
,	,	O
1	CD	O
%	NN	O
)	-RRB-	O
.	.	O

The	DT	O
mean	JJ	O
survival	NN	O
and	CC	O
height	NN	O
distribution	NN	O
of	IN	O
134	CD	O
A-T	NN	B-Disease
patients	NNS	O
correlated	VBD	O
significantly	RB	O
with	IN	O
the	DT	O
specific	JJ	O
mutations	NNS	O
present	JJ	O
in	IN	O
the	DT	O
patients	NNS	O
.	.	O

Patients	NNS	O
homozygous	JJ	O
for	IN	O
a	DT	O
single	JJ	O
truncating	JJ	O
mutation	NN	O
,	,	O
typically	RB	O
near	IN	O
the	DT	O
N-terminal	JJ	O
end	NN	O
of	IN	O
the	DT	O
gene	NN	O
,	,	O
or	CC	O
heterozygous	JJ	O
for	IN	O
the	DT	O
in-frame	RB	O
deletion	NN	O
2546	CD	O
3	CD	O
,	,	O
were	VBD	O
shorter	JJR	O
and	CC	O
had	VBD	O
significantly	RB	O
shorter	JJR	O
survival	NN	O
than	IN	O
those	DT	O
heterozygous	JJ	O
for	IN	O
a	DT	O
splice	NN	O
site	NN	O
or	CC	O
missense	NN	O
mutation	NN	O
,	,	O
or	CC	O
heterozygous	JJ	O
for	IN	O
two	CD	O
truncating	JJ	O
mutations	NNS	O
.	.	O

Alterations	NNS	O
of	IN	O
the	DT	O
length	NN	O
or	CC	O
amino	NN	O
acid	NN	O
composition	NN	O
of	IN	O
the	DT	O
A-T	NN	B-Disease
gene	NN	O
product	NN	O
affect	VBP	O
the	DT	O
A-T	NN	B-Disease
clinical	JJ	O
phenotype	NN	O
in	IN	O
different	JJ	O
ways	NNS	O
.	.	O

Mutation	NN	O
analysis	NN	O
at	IN	O
the	DT	O
A-T	NN	B-Disease
locus	NN	O
may	MD	O
help	VB	O
estimate	VB	O
the	DT	O
prognosis	NN	O
of	IN	O
A-T	NN	B-Disease
patients	NNS	O
.	.	O

.	.	O

Anticipation	NN	O
resulting	VBG	O
in	IN	O
elimination	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
gene	NN	O
:	:	O
a	DT	O
follow	VB	O
up	RP	O
study	NN	O
of	IN	O
one	CD	O
extended	VBD	O
family	NN	O
.	.	O

We	PRP	O
have	VBP	O
re-examined	VBN	O
an	DT	O
extended	JJ	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
family	NN	O
,	,	O
previously	RB	O
described	VBN	O
in	IN	O
1955	CD	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
study	VB	O
the	DT	O
long	JJ	O
term	NN	O
effects	NNS	O
of	IN	O
anticipation	NN	O
in	IN	O
DM	NN	B-Disease
and	CC	O
in	IN	O
particular	JJ	O
the	DT	O
implications	NNS	O
for	IN	O
families	NNS	O
affected	VBN	O
by	IN	O
this	DT	O
disease	NN	O
.	.	O

This	DT	O
follow	VB	O
up	RP	O
study	NN	O
provides	VBZ	O
data	NNS	O
on	IN	O
35	CD	O
gene	NN	O
carriers	NNS	O
and	CC	O
46	CD	O
asymptomatic	JJ	O
at	IN	O
risk	NN	O
family	NN	O
members	NNS	O
in	IN	O
five	CD	O
generations	NNS	O
.	.	O

Clinical	JJ	O
anticipation	NN	O
,	,	O
defined	VBN	O
as	IN	O
the	DT	O
cascade	NN	O
of	IN	O
mild	JJ	O
,	,	O
adult	JJ	O
,	,	O
childhood	NN	O
,	,	O
or	CC	O
congenital	JJ	B-Disease
disease	NN	I-Disease
in	IN	O
subsequent	JJ	O
generations	NNS	O
,	,	O
appeared	VBD	O
to	TO	O
be	VB	O
a	DT	O
relentless	JJ	O
process	NN	O
,	,	O
occurring	VBG	O
in	IN	O
all	DT	O
affected	VBN	O
branches	NNS	O
of	IN	O
the	DT	O
family	NN	O
.	.	O

The	DT	O
cascade	NN	O
was	VBD	O
found	VBN	O
to	TO	O
proceed	VB	O
asynchronously	RB	O
in	IN	O
the	DT	O
different	JJ	O
branches	NNS	O
,	,	O
mainly	RB	O
because	IN	O
of	IN	O
an	DT	O
unequal	JJ	O
number	NN	O
of	IN	O
generations	NNS	O
with	IN	O
mild	JJ	O
disease	NN	O
.	.	O

The	DT	O
transition	NN	O
from	IN	O
the	DT	O
mild	JJ	O
to	TO	O
the	DT	O
adult	JJ	O
type	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
transmission	NN	O
through	IN	O
a	DT	O
male	JJ	O
parent	NN	O
.	.	O

Stable	JJ	O
transmission	NN	O
of	IN	O
the	DT	O
asymptomatic/mild	JJ	O
phenotype	NN	O
showed	VBD	O
a	DT	O
female	JJ	O
transmission	NN	O
bias	NN	O
.	.	O

We	PRP	O
further	RB	O
examined	VBD	O
the	DT	O
extent	NN	O
and	CC	O
causes	NNS	O
of	IN	O
gene	NN	O
loss	NN	O
in	IN	O
this	DT	O
pedigree	NN	O
.	.	O

Gene	NNP	O
loss	NN	O
in	IN	O
the	DT	O
patient	NN	O
group	NN	O
was	VBD	O
complete	JJ	O
,	,	O
owing	VBG	O
to	TO	O
infertility	NN	B-Disease
of	IN	O
the	DT	O
male	JJ	O
patients	NNS	O
with	IN	O
adult	JJ	O
onset	NN	O
disease	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
mentally	RB	B-Disease
retarded	JJ	I-Disease
patients	NNS	O
did	VBD	O
not	RB	O
procreate	VB	O
.	.	O

Out	IN	O
of	IN	O
the	DT	O
46	CD	O
at	IN	O
risk	NN	O
subjects	NNS	O
in	IN	O
the	DT	O
two	CD	O
youngest	JJS	O
generations	NNS	O
,	,	O
only	RB	O
one	CD	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
full	JJ	O
mutation	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
only	JJ	O
subject	NN	O
who	WP	O
may	MD	O
transmit	VB	O
the	DT	O
gene	NN	O
to	TO	O
the	DT	O
sixth	JJ	O
generation	NN	O
.	.	O

No	DT	O
protomutation	NN	O
carriers	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
fourth	JJ	O
and	CC	O
fifth	JJ	O
generations	NNS	O
.	.	O

Therefore	RB	O
it	PRP	O
is	VBZ	O
highly	RB	O
probable	JJ	O
that	IN	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
will	MD	O
be	VB	O
eliminated	VBN	O
from	IN	O
this	DT	O
pedigree	NN	O
within	IN	O
one	CD	O
generation	NN	O
.	.	O

The	DT	O
high	JJ	O
population	NN	O
frequency	NN	O
of	IN	O
DM	NN	B-Disease
can	MD	O
at	IN	O
present	JJ	O
not	RB	O
be	VB	O
explained	VBN	O
by	IN	O
the	DT	O
contribution	NN	O
of	IN	O
asymptomatic	JJ	O
cases	NNS	O
in	IN	O
the	DT	O
younger	JJR	O
generations	NNS	O
of	IN	O
known	JJ	O
families	NNS	O
,	,	O
but	CC	O
is	VBZ	O
probably	RB	O
caused	VBN	O
by	IN	O
the	DT	O
events	NNS	O
in	IN	O
the	DT	O
ancestral	JJ	O
generations	NNS	O
.	.	O

.	.	O

Exon	NN	O
9	CD	O
mutations	NNS	O
in	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
,	,	O
without	IN	O
influencing	VBG	O
KTS	NNS	O
splice	NN	O
isoforms	NNS	O
,	,	O
are	VBP	O
also	RB	O
responsible	JJ	O
for	IN	O
Frasier	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

We	PRP	O
report	VBP	O
new	JJ	O
mutations	NNS	O
in	IN	O
exon	NN	O
9	CD	O
of	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
that	WDT	O
did	VBD	O
not	RB	O
alter	VB	O
the	DT	O
ratio	NN	O
of	IN	O
+	CC	O
/	:	O
-	:	O
KTS	NNS	O
splice	NN	O
isoforms	NNS	O
in	IN	O
two	CD	O
unrelated	JJ	O
patients	NNS	O
with	IN	O
Frasier	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
FS	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
mutation	NN	O
of	IN	O
intron	NN	O
9	CD	O
inducing	VBG	O
defective	JJ	O
alternative	JJ	O
splicing	NN	O
was	VBD	O
reported	VBN	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
this	DT	O
syndrome	NN	O
.	.	O

The	DT	O
mutations	NNS	O
found	VBN	O
in	IN	O
our	PRP$	O
cases	NNS	O
occurred	VBD	O
in	IN	O
the	DT	O
same	JJ	O
exon	NN	O
of	IN	O
the	DT	O
WT1	NN	O
gene	NN	O
as	IN	O
detected	VBN	O
in	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
DDS	NN	B-Disease
)	-RRB-	O
and	CC	O
could	MD	O
not	RB	O
be	VB	O
explained	VBN	O
by	IN	O
the	DT	O
previously	RB	O
proposed	VBN	O
mechanism	NN	O
.	.	O

The	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
the	DT	O
two	CD	O
syndromes	NNS	O
originate	VB	O
from	IN	O
the	DT	O
same	JJ	O
WT1	NN	B-Disease
gene	NN	I-Disease
abnormality	NN	I-Disease
.	.	O

From	IN	O
a	DT	O
molecular	JJ	O
biological	JJ	O
point	NN	O
of	IN	O
view	NN	O
,	,	O
we	PRP	O
concluded	VBD	O
that	IN	O
the	DT	O
two	CD	O
diseases	NNS	O
were	VBD	O
not	RB	O
separable	JJ	O
,	,	O
and	CC	O
that	IN	O
FS	NN	B-Disease
should	MD	O
be	VB	O
included	VBN	O
as	IN	O
an	DT	O
atypical	JJ	O
form	NN	O
of	IN	O
DDS	NN	B-Disease
.	.	O

.	.	O

Deficit	NN	O
of	IN	O
in	FW	O
vivo	FW	O
mitochondrial	JJ	O
ATP	NN	O
production	NN	O
in	IN	O
patients	NNS	O
with	IN	O
Friedreich	NN	B-Disease
ataxia	NN	I-Disease
.	.	O

Friedreich	NNP	B-Disease
ataxia	NN	I-Disease
(	-LRB-	O
FRDA	NN	B-Disease
)	-RRB-	O
,	,	O
the	DT	O
most	RBS	O
common	JJ	O
of	IN	O
the	DT	O
inherited	VBN	B-Disease
ataxias	NNS	I-Disease
,	,	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
degenerative	JJ	I-Disease
disorder	NN	I-Disease
,	,	O
characterized	VBN	O
clinically	RB	O
by	IN	O
onset	NN	O
before	IN	O
the	DT	O
age	NN	O
of	IN	O
25	CD	O
of	IN	O
progressive	JJ	B-Disease
gait	NN	I-Disease
and	CC	I-Disease
limb	NN	I-Disease
ataxia	NN	I-Disease
,	,	O
absence	NN	B-Disease
of	IN	I-Disease
deep	JJ	I-Disease
tendon	NN	I-Disease
reflexes	NNS	I-Disease
,	,	O
extensor	NN	B-Disease
plantar	JJ	I-Disease
responses	NNS	I-Disease
,	,	O
and	CC	O
loss	NN	B-Disease
of	IN	I-Disease
position	NN	I-Disease
and	CC	I-Disease
vibration	NN	I-Disease
sense	NN	I-Disease
in	IN	O
the	DT	O
lower	JJR	O
limbs	NNS	O
.	.	O

FRDA	NNP	B-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
GAA	NN	O
triplet	NN	O
expansion	NN	O
in	IN	O
the	DT	O
first	JJ	O
intron	NN	O
of	IN	O
the	DT	O
FRDA	NN	B-Disease
gene	NN	O
on	IN	O
chromosome	NN	O
9q13	NN	O
in	IN	O
97	CD	O
%	NN	O
of	IN	O
patients	NNS	O
.	.	O

The	DT	O
FRDA	NN	B-Disease
gene	NN	O
encodes	VBZ	O
a	DT	O
widely	RB	O
expressed	VBN	O
210-aa	JJ	O
protein	NN	O
,	,	O
frataxin	NN	O
,	,	O
which	WDT	O
is	VBZ	O
located	JJ	O
in	IN	O
mitochondria	NN	O
and	CC	O
is	VBZ	O
severely	RB	O
reduced	VBN	O
in	IN	O
FRDA	NN	B-Disease
patients	NNS	O
.	.	O

Frataxin	NN	O
function	NN	O
is	VBZ	O
still	RB	O
unknown	JJ	O
but	CC	O
the	DT	O
knockout	NN	O
of	IN	O
the	DT	O
yeast	NN	O
frataxin	NN	O
homologue	NN	O
gene	NN	O
(	-LRB-	O
YFH1	NN	O
)	-RRB-	O
showed	VBD	O
a	DT	O
severe	JJ	O
defect	NN	O
of	IN	O
mitochondrial	JJ	O
respiration	NN	O
and	CC	O
loss	NN	O
of	IN	O
mtDNA	NN	O
associated	VBN	O
with	IN	O
elevated	JJ	O
intramitochondrial	JJ	O
iron	NN	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
in	FW	O
vivo	FW	O
evidence	NN	O
of	IN	O
impaired	JJ	O
mitochondrial	JJ	O
respiration	NN	O
in	IN	O
skeletal	JJ	O
muscle	NN	O
of	IN	O
FRDA	NN	B-Disease
patients	NNS	O
.	.	O

Using	VBG	O
phosphorus	NN	O
magnetic	JJ	O
resonance	NN	O
spectroscopy	NN	O
we	PRP	O
demonstrated	VBD	O
a	DT	O
maximum	NN	O
rate	NN	O
of	IN	O
muscle	NN	O
mitochondrial	JJ	O
ATP	NN	O
production	NN	O
(	-LRB-	O
V	NN	O
(	-LRB-	O
max	NN	O
)	-RRB-	O
)	-RRB-	O
below	IN	O
the	DT	O
normal	JJ	O
range	NN	O
in	IN	O
all	DT	O
12	CD	O
FRDA	NN	B-Disease
patients	NNS	O
and	CC	O
a	DT	O
strong	JJ	O
negative	JJ	O
correlation	NN	O
between	IN	O
mitochondrial	JJ	O
V	NN	O
(	-LRB-	O
max	NN	O
)	-RRB-	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
GAA	NNP	O
repeats	NNS	O
in	IN	O
the	DT	O
smaller	JJR	O
allele	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
show	VBP	O
that	IN	O
FRDA	NN	B-Disease
is	VBZ	O
a	DT	O
nuclear-encoded	JJ	O
mitochondrial	JJ	B-Disease
disorder	NN	I-Disease
affecting	VBG	O
oxidative	JJ	O
phosphorylation	NN	O
and	CC	O
give	VB	O
a	DT	O
rationale	NN	O
for	IN	O
treatments	NNS	O
aimed	VBN	O
to	TO	O
improve	VB	O
mitochondrial	JJ	O
function	NN	O
in	IN	O
this	DT	O
condition	NN	O
.	.	O

.	.	O

Chronic	JJ	B-Disease
nonspherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
(	-LRB-	O
CNSHA	NN	B-Disease
)	-RRB-	O
and	CC	O
glucose	NN	B-Disease
6	CD	I-Disease
phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
familial	JJ	B-Disease
amyloidotic	JJ	I-Disease
polyneuropathy	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

Molecular	JJ	O
study	NN	O
of	IN	O
a	DT	O
new	JJ	O
variant	NN	O
(	-LRB-	O
G6PD	NN	O
Clinic	NNP	O
)	-RRB-	O
with	IN	O
markedly	RB	O
acidic	JJ	O
pH	NN	O
optimum	NN	O
.	.	O

A	DT	O
new	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
variant	NN	O
with	IN	O
severe	JJ	O
erythrocytic	JJ	B-Disease
G6PD	NN	I-Disease
deficiency	NN	I-Disease
and	CC	O
a	DT	O
unique	JJ	O
pH	NN	O
optimum	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
a	DT	O
young	JJ	O
patient	NN	O
with	IN	O
chronic	JJ	B-Disease
nonspherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
(	-LRB-	O
CNSHA	NN	B-Disease
)	-RRB-	O
and	CC	O
familial	JJ	B-Disease
amyloidotic	JJ	I-Disease
polyneuropathy	NN	I-Disease
(	-LRB-	O
FAP	NN	B-Disease
)	-RRB-	O
.	.	O

Chronic	JJ	B-Disease
hemolysis	NN	I-Disease
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
infections	NNS	O
,	,	O
oxidant	JJ	O
drugs	NNS	O
or	CC	O
ingestion	NN	O
of	IN	O
faba	NN	O
beans	NNS	O
.	.	O

Residual	JJ	O
enzyme	NN	O
activity	NN	O
was	VBD	O
about	IN	O
2	CD	O
.	.	O

6	CD	O
%	NN	O
and	CC	O
63	CD	O
%	NN	O
of	IN	O
normal	JJ	O
activity	NN	O
in	IN	O
erythrocytes	NNS	O
and	CC	O
leucocytes	NNS	O
,	,	O
respectively	RB	O
.	.	O

A	DT	O
molecular	JJ	O
study	NN	O
using	VBG	O
standard	JJ	O
methods	NNS	O
showed	VBD	O
G6PD	NN	O
in	IN	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
(	-LRB-	O
at	IN	O
pH	NN	O
7	CD	O
.	.	O

0	CD	O
,	,	O
8	CD	O
.	.	O

0	CD	O
and	CC	O
8	CD	O
.	.	O

8	CD	O
)	-RRB-	O
,	,	O
normal	JJ	O
apparent	JJ	O
affinity	NN	O
for	IN	O
substrates	NNS	O
(	-LRB-	O
Km	NN	O
,	,	O
G6P	NN	O
and	CC	O
NADP	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
slightly	RB	O
abnormal	JJ	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
(	-LRB-	O
decreased	VBN	O
deamino-NADP	NN	O
and	CC	O
increased	VBD	O
2-deoxyglucose-6-phosphate	JJ	O
utilization	NN	O
)	-RRB-	O
.	.	O

Heat	NN	O
stability	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
markedly	RB	O
decreased	VBN	O
(	-LRB-	O
8	CD	O
%	NN	O
of	IN	O
residual	JJ	O
activity	NN	O
after	IN	O
20	CD	O
min	NN	O
of	IN	O
incubation	NN	O
at	IN	O
46	CD	O
degrees	NNS	O
C	NN	O
)	-RRB-	O
and	CC	O
a	DT	O
particular	JJ	O
characteristic	NN	O
of	IN	O
this	DT	O
enzyme	NN	O
was	VBD	O
a	DT	O
biphasic	JJ	O
pH	NN	O
curve	NN	O
with	IN	O
a	DT	O
greatly	RB	O
increased	VBN	O
activity	NN	O
at	IN	O
low	JJ	O
pH.	NNP	O
Although	IN	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
this	DT	O
variant	NN	O
closely	RB	O
resemble	VBP	O
those	DT	O
of	IN	O
G6PD	NN	O
Bangkok	NNP	O
and	CC	O
G6PD	NNP	O
Duarte	NNP	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
distinguished	VBN	O
from	IN	O
these	DT	O
and	CC	O
all	DT	O
other	JJ	O
previously	RB	O
reported	VBN	O
variants	NNS	O
by	IN	O
virtue	NN	O
of	IN	O
its	PRP$	O
unusual	JJ	O
pH	NN	O
curve	NN	O
.	.	O

Therefore	RB	O
the	DT	O
present	JJ	O
variant	NN	O
has	VBZ	O
been	VBN	O
designated	VBN	O
G6PD	NN	O
Clinic	NNP	O
to	TO	O
distinguish	VB	O
it	PRP	O
from	IN	O
other	JJ	O
G6PD	NN	O
variants	NNS	O
previously	RB	O
described	VBN	O

Regional	NNP	O
localization	NN	O
of	IN	O
polymorphic	JJ	O
DNA	NN	O
loci	NNS	O
on	IN	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
using	VBG	O
deletions	NNS	O
associated	VBN	O
with	IN	O
choroideremia	NN	B-Disease
.	.	O

In	IN	O
two	CD	O
unrelated	JJ	O
families	NNS	O
,	,	O
males	NNS	O
have	VBP	O
been	VBN	O
identified	VBN	O
who	WP	O
suffer	VBP	O
from	IN	O
choroideremia	NN	B-Disease
and	CC	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
have	VBP	O
an	DT	O
interstitial	JJ	O
deletion	NN	O
on	IN	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
the	DT	O
X	NN	O
chromosome	NN	O
.	.	O

By	IN	O
high-resolution	JJ	O
banding	NN	O
we	PRP	O
have	VBP	O
characterized	VBN	O
the	DT	O
deletion	NN	O
chromosomes	NNS	O
as	IN	O
del	DT	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
(	-LRB-	O
q21	NN	O
.	.	O

1-q21	JJ	O
1-q21	NN	O
.	.	O

33	CD	O
)	-RRB-	O
and	CC	O
del	DT	O
(	-LRB-	O
X	NN	O
)	-RRB-	O
(	-LRB-	O
q21	NN	O
.	.	O

2-q21	JJ	O
2-q21	NN	O
.	.	O

31	CD	O
)	-RRB-	O
respectively	RB	O
.	.	O

By	IN	O
Southern	NN	O
blot	NN	O
analysis	NN	O
we	PRP	O
have	VBP	O
mapped	VBN	O
ten	CD	O
different	JJ	O
polymorphic	JJ	O
DNA	NN	O
loci	NNS	O
relative	JJ	O
to	TO	O
the	DT	O
position	NN	O
of	IN	O
the	DT	O
deletion	NN	O
and	CC	O
the	DT	O
choroideremia	NN	B-Disease
locus	NN	O
TCD	NN	O
.	.	O

One	CD	O
probe	NN	O
,	,	O
p31	NN	O
,	,	O
was	VBD	O
shown	VBN	O
to	TO	O
cover	VB	O
one	CD	O
of	IN	O
the	DT	O
breakpoints	NNS	O
of	IN	O
the	DT	O
smallest	JJS	O
deletion	NN	O
.	.	O

The	DT	O
following	VBG	O
order	NN	O
of	IN	O
the	DT	O
loci	NNS	O
was	VBD	O
suggested	VBN	O
by	IN	O
deletion	NN	O
mapping	NN	O
cen-DXS106-DXS72-TCD	NN	O
-	:	O
(	-LRB-	O
DXYS1/DXYS23/DXYS5	NN	O
)	-RRB-	O
-	:	O
DXYS2	NN	O
-	:	O
(	-LRB-	O
DXYS12/DXS3	NN	O
)	-RRB-	O
-	:	O
(	-LRB-	O
DXS17/DXS101	NN	O
)	-RRB-	O
-	:	O
Xqter	NN	O
.	.	O

A	DT	O
de	FW	O
novo	FW	O
unbalanced	JJ	O
reciprocal	JJ	O
translocation	NN	O
identified	VBN	O
as	IN	O
paternal	JJ	O
in	IN	O
origin	NN	O
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

Interstitial	JJ	O
cytogenetic	JJ	O
deletions	NNS	O
involving	VBG	O
the	DT	O
paternally	RB	O
derived	VBN	O
chromosome	NN	O
15q11-13	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

We	PRP	O
report	VBP	O
a	DT	O
child	NN	O
with	IN	O
PWS	NN	B-Disease
and	CC	O
a	DT	O
de	FW	O
novo	FW	O
unbalanced	JJ	O
karyotype	NN	O
-45	CD	O
,	,	O
XY	NN	O
,	,	O
-9	CD	O
,	,	O
-15	CD	O
,	,	O
+	CC	O
der	NN	O
(	-LRB-	O
9	CD	O
)	-RRB-	O
t	NN	O
(	-LRB-	O
9	CD	O
;	:	O
15	CD	O
)	-RRB-	O
(	-LRB-	O
q34	NN	O
;	:	O
q13	NN	O
)	-RRB-	O
.	.	O

Molecular	JJ	O
studies	NNS	O
with	IN	O
the	DT	O
DNA	NN	O
probe	NN	O
pML34	NN	O
confirmed	VBD	O
that	IN	O
only	RB	O
a	DT	O
single	JJ	O
Prader	NNP	B-Disease
Willi	NNP	I-Disease
critical	JJ	O
region	NN	O
(	-LRB-	O
PWCR	NN	O
15q11	NN	O
.	.	O

2-q12	NN	O
)	-RRB-	O
copy	NN	O
was	VBD	O
present	JJ	O
.	.	O

Hybridisation	NN	O
of	IN	O
patient	NN	O
and	CC	O
parental	JJ	O
DNA	NN	O
with	IN	O
the	DT	O
multi-allelic	JJ	O
probe	NN	O
CMW1	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
pter-15q13	NN	O
,	,	O
showed	VBD	O
that	IN	O
the	DT	O
chromosome	NN	O
involved	VBN	O
in	IN	O
the	DT	O
translocation	NN	O
was	VBD	O
paternal	JJ	O
in	IN	O
origin	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
paternally-derived	JJ	O
PWCR	NN	O
allele	NN	O
loss	NN	O
caused	VBN	O
by	IN	O
an	DT	O
unbalanced	JJ	O
translocation	NN	O
that	WDT	O
has	VBZ	O
arisen	VBN	O
de	FW	O
novo	FW	O
.	.	O

Clinicopathologic	JJ	O
features	NNS	O
of	IN	O
BRCA-linked	JJ	B-Disease
and	CC	I-Disease
sporadic	JJ	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

CONTEXT	NNP	O
Most	JJS	O
hereditary	JJ	B-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
are	VBP	O
associated	VBN	O
with	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
.	.	O

Attempts	NNS	O
to	TO	O
define	VB	O
the	DT	O
clinical	JJ	O
significance	NN	O
of	IN	O
BRCA	NN	O
mutation	NN	O
status	NN	O
in	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
have	VBP	O
produced	VBN	O
conflicting	JJ	O
results	NNS	O
,	,	O
especially	RB	O
regarding	VBG	O
survival	NN	O
.	.	O

OBJECTIVE	NN	O
To	TO	O
determine	VB	O
whether	IN	O
hereditary	JJ	B-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
have	VBP	O
distinct	JJ	O
clinical	JJ	O
and	CC	O
pathological	JJ	O
features	NNS	O
compared	VBN	O
with	IN	O
sporadic	JJ	B-Disease
(	-LRB-	I-Disease
nonhereditary	JJ	I-Disease
)	-RRB-	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

DESIGN	NN	O
AND	CC	O
SETTING	VBG	O
Retrospective	JJ	O
cohort	NN	O
study	NN	O
of	IN	O
a	DT	O
consecutive	JJ	O
series	NN	O
of	IN	O
933	CD	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
diagnosed	VBD	O
and	CC	O
treated	VBN	O
at	IN	O
our	PRP$	O
institution	NN	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
comprehensive	JJ	O
cancer	NN	B-Disease
center	NN	O
as	IN	O
designated	VBN	O
by	IN	O
the	DT	O
National	NNP	O
Cancer	NNP	B-Disease
Institute	NNP	O
,	,	O
over	IN	O
a	DT	O
12-year	JJ	O
period	NN	O
(	-LRB-	O
December	NNP	O
1986	CD	O
to	TO	O
August	NNP	O
1998	CD	O
)	-RRB-	O
.	.	O

PATIENTS	NNS	O
The	DT	O
study	NN	O
was	VBD	O
restricted	JJ	O
to	TO	O
patients	NNS	O
of	IN	O
Jewish	JJ	O
origin	NN	O
because	IN	O
of	IN	O
the	DT	O
ease	NN	O
of	IN	O
BRCA1	NN	O
and	CC	O
BRCA2	NN	O
genotyping	NN	O
in	IN	O
this	DT	O
ethnic	JJ	O
group	NN	O
.	.	O

From	IN	O
the	DT	O
189	CD	O
patients	NNS	O
who	WP	O
identified	VBD	O
themselves	PRP	O
as	IN	O
Jewish	JJ	O
,	,	O
88	CD	O
hereditary	JJ	O
cases	NNS	O
were	VBD	O
identified	VBN	O
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
germline	NN	O
founder	NN	O
mutation	NN	O
in	IN	O
BRCA1	NN	O
or	CC	O
BRCA2	NN	O
.	.	O

The	DT	O
remaining	VBG	O
101	CD	O
cases	NNS	O
from	IN	O
the	DT	O
same	JJ	O
series	NN	O
not	RB	O
associated	VBN	O
with	IN	O
a	DT	O
BRCA	NN	O
mutation	NN	O
and	CC	O
2	CD	O
additional	JJ	O
groups	NNS	O
(	-LRB-	O
Gynecologic	JJ	O
Oncology	NNP	O
Group	NNP	O
protocols	NNS	O
52	CD	O
and	CC	O
111	CD	O
)	-RRB-	O
with	IN	O
ovarian	JJ	B-Disease
cancer	NN	I-Disease
from	IN	O
clinical	JJ	O
trials	NNS	O
(	-LRB-	O
for	IN	O
the	DT	O
survival	NN	O
analysis	NN	O
)	-RRB-	O
were	VBD	O
included	VBN	O
for	IN	O
comparison	NN	O
.	.	O

MAIN	NNP	O
OUTCOME	NNP	O
MEASURES	NNP	O
Age	NNP	O
at	IN	O
diagnosis	NN	O
,	,	O
surgical	JJ	O
stage	NN	O
,	,	O
histologic	JJ	O
cell	NN	O
type	NN	O
and	CC	O
grade	NN	O
,	,	O
and	CC	O
surgical	JJ	O
outcome	NN	O
;	:	O
and	CC	O
response	NN	O
to	TO	O
chemotherapy	NN	O
and	CC	O
survival	NN	O
for	IN	O
advanced-stage	NN	O
(	-LRB-	O
II	CD	O
and	CC	O
IV	CD	O
)	-RRB-	O
cases	NNS	O
.	.	O

RESULTS	NNS	O
Hereditary	JJ	B-Disease
cancers	NNS	I-Disease
were	VBD	O
rarely	RB	O
diagnosed	VBN	O
before	IN	O
age	NN	O
40	CD	O
years	NNS	O
and	CC	O
were	VBD	O
common	JJ	O
after	IN	O
age	NN	O
60	CD	O
years	NNS	O
,	,	O
with	IN	O
mean	NN	O
age	NN	O
at	IN	O
diagnosis	NN	O
being	VBG	O
significantly	RB	O
younger	JJR	O
for	IN	O
BRCA1	NN	O
-	:	O
vs	CC	O
BRCA2-linked	JJ	O
patients	NNS	O
(	-LRB-	O
54	CD	O
vs	CC	O
62	CD	O
years	NNS	O
;	:	O
P	NN	O
=	JJ	O
.	.	O

04	NN	O
)	-RRB-	O
.	.	O

Histology	NNP	O
,	,	O
grade	NN	O
,	,	O
stage	NN	O
,	,	O
and	CC	O
success	NN	O
of	IN	O
cytoreductive	JJ	O
surgery	NN	O
were	VBD	O
similar	JJ	O
for	IN	O
hereditary	JJ	O
and	CC	O
sporadic	JJ	O
cases	NNS	O
.	.	O

The	DT	O
hereditary	JJ	O
group	NN	O
had	VBD	O
a	DT	O
longer	RBR	O
disease-free	JJ	O
interval	NN	O
following	VBG	O
primary	JJ	O
chemotherapy	NN	O
in	IN	O
comparison	NN	O
with	IN	O
the	DT	O
nonhereditary	JJ	O
group	NN	O
,	,	O
with	IN	O
a	DT	O
median	JJ	O
time	NN	O
to	TO	O
recurrence	NN	O
of	IN	O
14	CD	O
months	NNS	O
and	CC	O
7	CD	O
months	NNS	O
,	,	O
respectively	RB	O
(	-LRB-	O
P	NN	O
<	JJR	O
.	.	O

001	CD	O
)	-RRB-	O
.	.	O

Those	DT	O
with	IN	O
hereditary	JJ	B-Disease
cancers	NNS	I-Disease
had	VBD	O
improved	VBN	O
survival	NN	O
compared	VBN	O
with	IN	O
the	DT	O
nonhereditary	JJ	O
group	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

004	CD	O
)	-RRB-	O
.	.	O

For	IN	O
stage	NN	B-Disease
III	CD	I-Disease
cancers	NNS	I-Disease
,	,	O
BRCA	NN	O
mutation	NN	O
status	NN	O
was	VBD	O
an	DT	O
independent	JJ	O
prognostic	JJ	O
variable	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

03	NN	O
)	-RRB-	O
.	.	O

CONCLUSIONS	NNS	O
Although	IN	O
BRCA-associated	JJ	B-Disease
hereditary	JJ	I-Disease
ovarian	JJ	I-Disease
cancers	NNS	I-Disease
in	IN	O
this	DT	O
population	NN	O
have	VBP	O
surgical	JJ	O
and	CC	O
pathological	JJ	O
characteristics	NNS	O
similar	JJ	O
to	TO	O
those	DT	O
of	IN	O
sporadic	JJ	B-Disease
cancers	NNS	I-Disease
,	,	O
advanced-stage	JJ	B-Disease
hereditary	JJ	I-Disease
cancer	NN	I-Disease
patients	NNS	O
survive	VBP	O
longer	JJR	O
than	IN	O
nonhereditary	JJ	B-Disease
cancer	NN	I-Disease
patients	NNS	O
.	.	O

Age	NNP	O
penetrance	NN	O
is	VBZ	O
greater	JJR	O
for	IN	O
BRCA1-linked	JJ	B-Disease
than	IN	I-Disease
for	IN	I-Disease
BRCA2-linked	JJ	I-Disease
cancers	NNS	I-Disease
in	IN	O
this	DT	O
population	NN	O
.	.	O

Germline	NN	O
intronic	JJ	O
and	CC	O
exonic	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NN	B-Disease
'	POS	I-Disease
tumour	NN	I-Disease
gene	NN	O
(	-LRB-	O
WT1	NN	O
)	-RRB-	O
affecting	VBG	O
urogenital	JJ	O
development	NN	O
.	.	O

Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
human	JJ	O
developmental	JJ	B-Disease
disorder	NN	I-Disease
affecting	VBG	O
the	DT	O
urogenital	JJ	O
system	NN	O
and	CC	O
leading	VBG	O
to	TO	O
renal	JJ	B-Disease
failure	NN	I-Disease
,	,	O
intersex	NN	B-Disease
disorders	NNS	I-Disease
and	CC	O
Wilms	NN	B-Disease
tumour	NN	I-Disease
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
four	CD	O
individuals	NNS	O
with	IN	O
this	DT	O
syndrome	NN	O
are	VBP	O
described	VBN	O
carrying	VBG	O
germline	NN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NN	B-Disease
tumour	NN	I-Disease
suppressor	NN	O
gene	NN	O
,	,	O
WT1	NN	O
.	.	O

Three	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
were	VBD	O
in	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
domains	NNS	O
of	IN	O
WT1	NN	O
.	.	O

The	DT	O
fourth	JJ	O
occurred	VBD	O
within	IN	O
intron	NN	O
9	CD	O
,	,	O
preventing	VBG	O
splicing	NN	O
at	IN	O
one	CD	O
of	IN	O
the	DT	O
alternatively	RB	O
chosen	VBN	O
splice	NN	O
donor	NN	O
sites	NNS	O
of	IN	O
exon	NN	O
9	CD	O
when	WRB	O
assayed	VBN	O
in	FW	O
vitro	FW	O
.	.	O

These	DT	O
results	NNS	O
provide	VBP	O
genetic	JJ	O
evidence	NN	O
for	IN	O
distinct	JJ	O
functional	JJ	O
roles	NNS	O
of	IN	O
the	DT	O
WT1	NN	O
isoforms	NNS	O
in	IN	O
urogenital	JJ	O
development	NN	O
.	.	O

.	.	O

Analysis	NN	O
of	IN	O
deletions	NNS	O
in	IN	O
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
Becker	NNP	B-Disease
and	CC	I-Disease
Duchenne	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
genetic	JJ	I-Disease
disorder	NN	I-Disease
for	IN	O
which	WDT	O
the	DT	O
biochemical	JJ	O
defect	NN	O
is	VBZ	O
as	RB	O
yet	RB	O
unknown	JJ	O
.	.	O

Recently	RB	O
,	,	O
two	CD	O
cloned	VBN	O
segments	NNS	O
of	IN	O
human	JJ	O
X-chromosome	NN	O
DNA	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
which	WDT	O
detect	VBP	O
structural	JJ	O
alterations	NNS	O
within	IN	O
or	CC	O
near	IN	O
the	DT	O
genetic	JJ	O
locus	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
disorder	NN	O
.	.	O

Both	DT	O
of	IN	O
these	DT	O
cloned	VBN	O
segments	NNS	O
were	VBD	O
described	VBN	O
as	IN	O
tightly	RB	O
linked	VBN	O
to	TO	O
the	DT	O
locus	NN	O
and	CC	O
were	VBD	O
capable	JJ	O
of	IN	O
detecting	VBG	O
deletions	NNS	O
in	IN	O
the	DT	O
DNA	NN	O
of	IN	O
boys	NNS	O
affected	VBN	O
with	IN	O
DMD	NN	B-Disease
.	.	O

In	IN	O
an	DT	O
attempt	NN	O
to	TO	O
determine	VB	O
more	RBR	O
precisely	RB	O
the	DT	O
occurrence	NN	O
of	IN	O
these	DT	O
deletions	NNS	O
within	IN	O
a	DT	O
large	JJ	O
population	NN	O
of	IN	O
DMD	NN	B-Disease
patients	NNS	O
and	CC	O
the	DT	O
accuracy	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
segments	NNS	O
,	,	O
DXS164	NN	O
(	-LRB-	O
pERT87	NN	O
)	-RRB-	O
,	,	O
in	IN	O
determining	VBG	O
the	DT	O
inheritance	NN	O
of	IN	O
the	DT	O
DMD	NN	B-Disease
X	NN	O
chromosome	NN	O
,	,	O
the	DT	O
subclones	NNS	O
1	CD	O
,	,	O
8	CD	O
and	CC	O
15	CD	O
were	VBD	O
made	VBN	O
available	JJ	O
to	TO	O
many	JJ	O
investigators	NNS	O
throughout	IN	O
the	DT	O
world	NN	O
.	.	O

Here	RB	O
we	PRP	O
describe	VBP	O
the	DT	O
combined	VBN	O
results	NNS	O
of	IN	O
more	JJR	O
than	IN	O
20	CD	O
research	NN	O
laboratories	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
occurrence	NN	O
of	IN	O
deletions	NNS	O
at	IN	O
the	DT	O
DXS164	NN	O
locus	NN	O
in	IN	O
DNA	NN	O
samples	NNS	O
isolated	VBN	O
from	IN	O
patients	NNS	O
with	IN	O
DMD	NN	B-Disease
and	CC	O
Becker	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
BMD	NN	B-Disease
)	-RRB-	O
.	.	O

The	DT	O
results	NNS	O
indicate	VBP	O
that	IN	O
the	DT	O
DXS164	NN	O
locus	NN	O
apparently	RB	O
recombines	VBZ	O
with	IN	O
DMD	NNP	B-Disease
5	CD	O
%	NN	O
of	IN	O
the	DT	O
time	NN	O
,	,	O
but	CC	O
is	VBZ	O
probably	RB	O
located	JJ	O
between	IN	O
independent	JJ	O
sites	NNS	O
of	IN	O
mutation	NN	O
which	WDT	O
yield	VBP	O
DMD	NNP	B-Disease
.	.	O

The	DT	O
breakpoints	NNS	O
of	IN	O
some	DT	O
deletions	NNS	O
are	VBP	O
delineated	VBN	O
within	IN	O
the	DT	O
DXS164	NN	O
locus	NN	O
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
evident	JJ	O
that	IN	O
the	DT	O
deletions	NNS	O
at	IN	O
the	DT	O
DMD	NNP	B-Disease
locus	NN	O
are	VBP	O
frequent	JJ	O
and	CC	O
extremely	RB	O
large	JJ	O
.	.	O

.	.	O

Additional	JJ	O
case	NN	O
of	IN	O
female	JJ	O
monozygotic	JJ	O
twins	NNS	O
discordant	JJ	O
for	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
due	JJ	O
to	TO	O
opposite	JJ	O
X-chromosome	NN	O
inactivation	NN	O
.	.	O

A	DT	O
pair	NN	O
of	IN	O
female	JJ	O
monozygotic	JJ	O
(	-LRB-	O
MZ	JJ	O
)	-RRB-	O
twins	NNS	O
,	,	O
heterozygous	JJ	O
carriers	NNS	O
for	IN	O
a	DT	O
deletion	NN	O
in	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
and	CC	O
discordant	JJ	O
for	IN	O
the	DT	O
clinical	JJ	O
manifestations	NNS	O
of	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
,	,	O
were	VBD	O
analyzed	VBN	O
by	IN	O
molecular	JJ	O
studies	NNS	O
,	,	O
in	FW	O
situ	FW	O
hybridization	NN	O
,	,	O
and	CC	O
methylation	NN	O
pattern	NN	O
of	IN	O
X	NN	O
chromosomes	NNS	O
to	TO	O
search	VB	O
for	IN	O
opposite	JJ	O
X	NN	O
inactivation	NN	O
as	IN	O
an	DT	O
explanation	NN	O
of	IN	O
their	PRP$	O
clinical	JJ	O
discordance	NN	O
.	.	O

Results	NNS	O
in	IN	O
lymphocytes	NNS	O
and	CC	O
skin	NN	O
fibroblast	NN	O
cell	NN	O
lines	NNS	O
suggest	VBP	O
a	DT	O
partial	JJ	O
mirror	NN	O
inactivation	NN	O
with	IN	O
the	DT	O
normal	JJ	O
X	NN	O
chromosome	NN	O
preferentially	RB	O
active	JJ	O
in	IN	O
the	DT	O
unaffected	JJ	O
twin	NN	O
,	,	O
and	CC	O
the	DT	O
maternal	JJ	O
deleted	VBN	O
X	NN	O
chromosome	NN	O
preferentially	RB	O
active	JJ	O
in	IN	O
the	DT	O
affected	VBN	O
twin	NN	O
.	.	O

A	DT	O
review	NN	O
shows	VBZ	O
that	IN	O
MZ	JJ	O
female	JJ	O
twins	NNS	O
discordant	JJ	O
for	IN	O
X-linked	JJ	B-Disease
diseases	NNS	I-Disease
are	VBP	O
not	RB	O
uncommon	JJ	O
.	.	O

Twinning	VBG	O
and	CC	O
X	NN	O
inactivation	NN	O
may	MD	O
be	VB	O
interrelated	VBN	O
and	CC	O
could	MD	O
explain	VB	O
the	DT	O
female	JJ	O
twins	NNS	O
discordant	JJ	O
for	IN	O
X-linked	JJ	O
traits	NNS	O
.	.	O

.	.	O

Analbuminemia	NNP	B-Disease
in	IN	O
a	DT	O
neonate	NN	O
.	.	O

A	DT	O
small-for-gestational-age	JJ	O
infant	NN	O
,	,	O
found	VBN	O
to	TO	O
have	VB	O
analbuminemia	NN	B-Disease
in	IN	O
the	DT	O
neonatal	JJ	O
period	NN	O
,	,	O
is	VBZ	O
reported	VBN	O
and	CC	O
the	DT	O
twelve	CD	O
cases	NNS	O
recorded	VBN	O
in	IN	O
the	DT	O
world	NN	O
literature	NN	O
are	VBP	O
reviewed	VBN	O
.	.	O

Patients	NNS	O
lacking	VBG	O
this	DT	O
serum	NN	O
protein	NN	O
are	VBP	O
essentially	RB	O
asymptomatic	JJ	O
,	,	O
apart	RB	O
from	IN	O
minimal	JJ	O
ankle	NN	B-Disease
edema	NN	I-Disease
and	CC	O
ease	NN	B-Disease
of	IN	I-Disease
fatigue	NN	I-Disease
.	.	O

Apparent	JJ	O
compensatory	JJ	O
mechanisms	NNS	O
which	WDT	O
come	VBP	O
into	IN	O
play	NN	O
when	WRB	O
serum	NN	O
albumin	NN	O
is	VBZ	O
low	JJ	O
include	VBP	O
prolonged	JJ	O
half-life	NN	O
of	IN	O
albumin	NN	O
and	CC	O
transferrin	NN	O
,	,	O
an	DT	O
increase	NN	O
in	IN	O
serum	NN	O
globulins	NNS	O
,	,	O
beta	NN	O
lipoprotein	NN	O
,	,	O
and	CC	O
glycoproteins	NNS	O
,	,	O
arterial	JJ	B-Disease
hypotension	NN	I-Disease
with	IN	O
reduced	VBN	O
capillary	JJ	O
hydrostatic	JJ	O
pressure	NN	O
,	,	O
and	CC	O
the	DT	O
ability	NN	O
to	TO	O
respond	VB	O
with	IN	O
rapid	JJ	O
sodium	NN	O
and	CC	O
chloride	NN	O
diuresis	NN	O
in	IN	O
response	NN	O
to	TO	O
small	JJ	O
volume	NN	O
changes	NNS	O
.	.	O

Examination	NN	O
of	IN	O
plasma	NN	O
amino	NN	O
acids	NNS	O
,	,	O
an	DT	O
investigation	NN	O
not	RB	O
previously	RB	O
reported	VBN	O
,	,	O
revealed	VBD	O
an	DT	O
extremely	RB	O
low	JJ	O
plasma	NN	O
tryptophan	NN	O
level	NN	O
,	,	O
a	DT	O
finding	NN	O
which	WDT	O
may	MD	O
be	VB	O
important	JJ	O
in	IN	O
view	NN	O
of	IN	O
the	DT	O
role	NN	O
of	IN	O
tryptophan	NN	O
in	IN	O
albumin	NN	O
synthesis	NN	O
.	.	O

.	.	O

Homozygous	JJ	O
presence	NN	O
of	IN	O
the	DT	O
crossover	NN	O
(	-LRB-	O
fusion	NN	O
gene	NN	O
)	-RRB-	O
mutation	NN	O
identified	VBN	O
in	IN	O
a	DT	O
type	NN	B-Disease
II	CD	I-Disease
Gaucher	NN	I-Disease
disease	NN	I-Disease
fetus	NN	O
:	:	O
is	VBZ	O
this	DT	O
analogous	JJ	O
to	TO	O
the	DT	O
Gaucher	NN	O
knock-out	JJ	O
mouse	NN	O
model	NN	O
?	.	O

Gaucher	NN	B-Disease
disease	NN	I-Disease
(	-LRB-	O
GD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
inherited	VBN	O
deficiency	NN	B-Disease
of	IN	I-Disease
beta-glucocerebrosidase	NN	I-Disease
(	-LRB-	O
EC	NN	O
3	CD	O
.	.	O

1	LS	O
.	.	O

2	LS	O
.	.	O

45	CD	O
,	,	O
gene	NN	O
symbol	NN	O
GBA	NNP	O
)	-RRB-	O
.	.	O

In	IN	O
type	NN	B-Disease
I	CD	I-Disease
GD	NN	I-Disease
,	,	O
the	DT	O
CNS	NN	O
is	VBZ	O
not	RB	O
involved	VBN	O
(	-LRB-	O
nonneuronopathic	JJ	O
)	-RRB-	O
,	,	O
whereas	IN	O
in	IN	O
type	NN	B-Disease
II	CD	I-Disease
GD	NN	I-Disease
(	-LRB-	O
acute	JJ	O
neuronopathic	JJ	O
)	-RRB-	O
CNS	NN	O
involvement	NN	O
is	VBZ	O
early	JJ	O
and	CC	O
rapidly	RB	O
progressive	JJ	O
,	,	O
while	IN	O
in	IN	O
type	NN	B-Disease
III	CD	I-Disease
GD	NN	I-Disease
(	-LRB-	O
subacute	JJ	O
neuronopathic	JJ	O
)	-RRB-	O
CNS	NN	O
involvement	NN	O
occurs	VBZ	O
later	RB	O
and	CC	O
is	VBZ	O
slowly	RB	O
progressive	JJ	O
.	.	O

The	DT	O
T6433C	NN	O
(	-LRB-	O
L444P	NN	O
)	-RRB-	O
substitution	NN	O
is	VBZ	O
prevalent	JJ	O
in	IN	O
type	NN	B-Disease
GD	NN	I-Disease
II	CD	I-Disease
.	.	O

It	PRP	O
may	MD	O
occur	VB	O
alone	RB	O
as	IN	O
a	DT	O
single	JJ	O
base-pair	NN	O
mutation	NN	O
but	CC	O
often	RB	O
is	VBZ	O
found	VBN	O
as	IN	O
part	NN	O
of	IN	O
a	DT	O
complex	JJ	O
allele	NN	O
containing	VBG	O
additional	JJ	O
GBA	NN	O
nucleotide	NN	O
substitutions	NNS	O
,	,	O
G6468C	NN	O
(	-LRB-	O
A456P	NN	O
)	-RRB-	O
and	CC	O
G6482C	NN	O
(	-LRB-	O
V460V	NN	O
)	-RRB-	O
,	,	O
without	IN	O
(	-LRB-	O
recNciI	NN	O
)	-RRB-	O
or	CC	O
with	IN	O
(	-LRB-	O
recTL	NN	O
)	-RRB-	O
G5957C	NN	O
(	-LRB-	O
D409H	NN	O
)	-RRB-	O
.	.	O

This	DT	O
complex	NN	O
allele	NN	O
is	VBZ	O
presumed	VBN	O
to	TO	O
have	VB	O
formed	VBN	O
by	IN	O
recombination	NN	O
(	-LRB-	O
crossover	NN	O
,	,	O
fusion	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
structural	JJ	O
gene	NN	O
with	IN	O
the	DT	O
pseudogene	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
the	DT	O
mutated	VBN	O
sequences	NNS	O
.	.	O

Two	CD	O
complex	JJ	O
alleles	NNS	O
have	VBP	O
never	RB	O
been	VBN	O
demonstrated	VBN	O
to	TO	O
coexist	VB	O
in	IN	O
any	DT	O
individual	NN	O
.	.	O

We	PRP	O
devised	VBD	O
a	DT	O
selective	JJ	O
PCR	NN	O
method	NN	O
for	IN	O
the	DT	O
specific	JJ	O
amplification	NN	O
of	IN	O
the	DT	O
normal	JJ	O
and/or	CC	O
fusion	NN	O
gene	NN	O
.	.	O

Using	VBG	O
this	DT	O
procedure	NN	O
we	PRP	O
demonstrated	VBD	O
the	DT	O
fusion	NN	O
gene	NN	O
in	IN	O
homozygous	JJ	O
form	NN	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
,	,	O
in	IN	O
a	DT	O
Macedonian/Ashkenazi	NNP	O
Jewish	NNP	O
GD	NN	B-Disease
type	NN	I-Disease
II	CD	I-Disease
fetus	NN	O
.	.	O

Both	DT	O
parents	NNS	O
were	VBD	O
carriers	NNS	O
of	IN	O
the	DT	O
recombination	NN	O
.	.	O

This	DT	O
was	VBD	O
confirmed	VBN	O
by	IN	O
direct	JJ	O
sequence	NN	O
analysis	NN	O
.	.	O

A	DT	O
previous	JJ	O
conceptus	NN	O
in	IN	O
this	DT	O
family	NN	O
was	VBD	O
stillborn	VBN	B-Disease
at	IN	O
36	CD	O
weeks	NNS	O
,	,	O
with	IN	O
features	NNS	O
of	IN	O
severe	JJ	O
type	NN	B-Disease
II	CD	I-Disease
GD	NN	I-Disease
.	.	O

Neonates	NNS	O
showing	VBG	O
a	DT	O
severe	JJ	O
clinical	JJ	O
phenotype	NN	O
,	,	O
analogous	JJ	O
to	TO	O
the	DT	O
early	JJ	O
neonatal	JJ	O
lethal	JJ	O
disease	NN	O
occurring	VBG	O
in	IN	O
mice	NNS	O
homozygous	JJ	O
for	IN	O
a	DT	O
null	JJ	O
allele	NN	O
produced	VBN	O
by	IN	O
targeted	JJ	O
disruption	NN	O
of	IN	O
GBA	NNP	O
,	,	O
have	VBP	O
been	VBN	O
described	VBN	O
elsewhere	RB	O
,	,	O
but	CC	O
the	DT	O
specific	JJ	O
mutations	NNS	O
in	IN	O
these	DT	O
cases	NNS	O
have	VBP	O
not	RB	O
yet	RB	O
been	VBN	O
characterized	VBN	O
.	.	O

(	-LRB-	O
ABSTRACT	NN	O
TRUNCATED	VBN	O
AT	IN	O
250	CD	O
WORDS	NNS	O
)	-RRB-	O

Decrease	NN	O
in	IN	O
GTP	NN	O
cyclohydrolase	NN	O
I	NN	O
gene	NN	O
expression	NN	O
caused	VBN	O
by	IN	O
inactivation	NN	O
of	IN	O
one	CD	O
allele	NN	O
in	IN	O
hereditary	JJ	B-Disease
progressive	JJ	I-Disease
dystonia	NN	I-Disease
with	IN	O
marked	JJ	O
diurnal	JJ	O
fluctuation	NN	O
.	.	O

Hereditary	JJ	B-Disease
progressive	JJ	I-Disease
dystonia	NN	I-Disease
with	IN	O
marked	JJ	O
diurnal	JJ	O
fluctuation	NN	O
(	-LRB-	O
HPD	NN	B-Disease
;	:	O
dopa-responsive	JJ	B-Disease
dystonia	NN	I-Disease
,	,	O
DRD	NN	B-Disease
)	-RRB-	O
have	VBP	O
been	VBN	O
recently	RB	O
found	VBN	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
a	DT	O
genetic	JJ	B-Disease
defect	NN	I-Disease
in	IN	O
the	DT	O
GTP	NN	O
cyclohydrolase	NN	O
I	NN	O
(	-LRB-	O
GCH1	NN	O
)	-RRB-	O
gene	NN	O
.	.	O

In	IN	O
this	DT	O
study	NN	O
,	,	O
we	PRP	O
quantified	VBD	O
the	DT	O
mRNA	NN	O
level	NN	O
of	IN	O
GCH1	NN	O
in	IN	O
phytohemagglutinin	NN	O
(	-LRB-	O
PHA	NN	O
)	-RRB-	O
-	:	O
stimulated	VBN	O
mononuclear	JJ	O
blood	NN	O
cells	NNS	O
from	IN	O
one	CD	O
Japanese	JJ	O
family	NN	O
that	WDT	O
do	VBP	O
not	RB	O
have	VB	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
coding	VBG	O
region	NN	O
or	CC	O
splice	NN	O
junctions	NNS	O
of	IN	O
the	DT	O
gene	NN	O
.	.	O

The	DT	O
results	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
amounts	NNS	O
of	IN	O
the	DT	O
GCH1	NN	O
mRNA	NN	O
were	VBD	O
decreased	VBN	O
to	TO	O
about	IN	O
40	CD	O
%	NN	O
of	IN	O
the	DT	O
normal	JJ	O
level	NN	O
in	IN	O
both	DT	O
patients	NNS	O
and	CC	O
carriers	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
the	DT	O
GCH1	NN	O
mRNA	NN	O
was	VBD	O
transcribed	VBN	O
from	IN	O
only	RB	O
one	CD	O
allele	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
other	JJ	O
allele	NN	O
was	VBD	O
in	IN	O
an	DT	O
inactive	JJ	O
state	NN	O
.	.	O

These	DT	O
results	NNS	O
suggest	VBP	O
that	IN	O
some	DT	O
novel	JJ	O
mutations	NNS	O
should	MD	O
exist	VB	O
on	IN	O
one	CD	O
of	IN	O
the	DT	O
alleles	NNS	O
in	IN	O
some	DT	O
unknown	JJ	O
region	NN	O
of	IN	O
the	DT	O
GCH1	NN	O
gene	NN	O
,	,	O
and	CC	O
may	MD	O
decrease	VB	O
the	DT	O
GCH1	NN	O
mRNA	NN	O
causing	VBG	O
the	DT	O
HPD/DRD	NN	O
symptoms	NNS	O
.	.	O

.	.	O

Novel	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
protein	NN	O
gene	NN	O
and	CC	O
their	PRP$	O
effects	NNS	O
on	IN	O
transcriptional	JJ	O
,	,	O
translational	JJ	O
,	,	O
and	CC	O
clinical	JJ	O
phenotypes	NNS	O
.	.	O

Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
recessive	JJ	I-Disease
immunodeficiency	NN	I-Disease
characterized	VBN	O
by	IN	O
thrombocytopenia	NN	B-Disease
,	,	O
eczema	NN	B-Disease
,	,	O
and	CC	O
recurrent	JJ	O
infections	NNS	O
,	,	O
and	CC	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
WAS	NNP	B-Disease
protein	NN	O
(	-LRB-	O
WASP	NNP	O
)	-RRB-	O
gene	NN	O
.	.	O

WASP	NNP	O
contains	VBZ	O
several	JJ	O
functional	JJ	O
domains	NNS	O
through	IN	O
which	WDT	O
it	PRP	O
interacts	VBZ	O
with	IN	O
proteins	NNS	O
involved	VBN	O
in	IN	O
intracellular	JJ	O
signaling	NN	O
and	CC	O
regulation	NN	O
of	IN	O
the	DT	O
actin	NN	O
cytoskeleton	NN	O
.	.	O

In	IN	O
this	DT	O
report	NN	O
,	,	O
17	CD	O
WASP	NNP	O
gene	NN	O
mutations	NNS	O
were	VBD	O
identified	VBN	O
,	,	O
12	CD	O
of	IN	O
which	WDT	O
are	VBP	O
novel	JJ	O
.	.	O

DNA	NN	O
of	IN	O
affected	VBN	O
males	NNS	O
and	CC	O
obligate	JJ	O
carriers	NNS	O
was	VBD	O
PCR	NN	O
amplified	VBN	O
and	CC	O
analyzed	VBN	O
by	IN	O
SSCA	NNP	O
,	,	O
heteroduplex	JJ	O
analysis	NN	O
,	,	O
and	CC	O
direct	JJ	O
sequencing	NN	O
.	.	O

The	DT	O
effects	NNS	O
of	IN	O
the	DT	O
mutations	NNS	O
at	IN	O
the	DT	O
mRNA	NN	O
and	CC	O
protein	NN	O
level	NN	O
were	VBD	O
ascertained	VBN	O
by	IN	O
RT-PCR	NN	O
and	CC	O
Western	NN	O
blot	NN	O
analyses	NNS	O
.	.	O

All	DT	O
missense	NN	O
mutations	NNS	O
were	VBD	O
located	VBN	O
in	IN	O
exons	NNS	O
1-4	CD	O
.	.	O

Most	JJS	O
of	IN	O
the	DT	O
nonsense	NN	O
,	,	O
frameshift	NN	O
and	CC	O
splice	NN	O
site	NN	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
exons	NNS	O
6-11	CD	O
.	.	O

Mutations	NNS	O
that	WDT	O
alter	VBP	O
splice	NN	O
sites	NNS	O
led	VBD	O
to	TO	O
the	DT	O
synthesis	NN	O
of	IN	O
several	JJ	O
types	NNS	O
of	IN	O
mRNAs	NNS	O
,	,	O
a	DT	O
fraction	NN	O
of	IN	O
which	WDT	O
represented	VBD	O
the	DT	O
normally	RB	O
spliced	VBN	O
product	NN	O
.	.	O

The	DT	O
presence	NN	O
of	IN	O
normally	RB	O
spliced	VBN	O
transcripts	NNS	O
was	VBD	O
correlated	VBN	O
with	IN	O
a	DT	O
milder	JJR	O
phenotype	NN	O
.	.	O

When	WRB	O
one	CD	O
such	JJ	O
case	NN	O
was	VBD	O
studied	VBN	O
by	IN	O
Western	NN	O
blotting	NN	O
,	,	O
reduced	VBN	O
amounts	NNS	O
of	IN	O
normal-size	JJ	O
WASP	NNP	O
were	VBD	O
present	JJ	O
.	.	O

In	IN	O
other	JJ	O
cases	NNS	O
as	RB	O
well	RB	O
,	,	O
a	DT	O
correlation	NN	O
was	VBD	O
found	VBN	O
between	IN	O
the	DT	O
amount	NN	O
of	IN	O
normal	JJ	O
or	CC	O
mutant	JJ	O
WASP	NNP	O
present	JJ	O
and	CC	O
the	DT	O
phenotypes	NNS	O
of	IN	O
the	DT	O
affected	VBN	O
individuals	NNS	O
.	.	O

No	DT	O
protein	NN	O
was	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
individuals	NNS	O
with	IN	O
severe	JJ	O
WAS	NNP	B-Disease
.	.	O

Reduced	VBN	O
levels	NNS	O
of	IN	O
a	DT	O
normal-size	JJ	O
WASP	NNP	O
with	IN	O
a	DT	O
missense	NN	O
mutation	NN	O
were	VBD	O
seen	VBN	O
in	IN	O
two	CD	O
individuals	NNS	O
with	IN	O
XLT	NNP	B-Disease
.	.	O

It	PRP	O
is	VBZ	O
concluded	VBN	O
that	IN	O
mutation	NN	O
analysis	NN	O
at	IN	O
the	DT	O
DNA	NN	O
level	NN	O
is	VBZ	O
not	RB	O
sufficient	JJ	O
for	IN	O
predicting	VBG	O
clinical	JJ	O
course	NN	O
.	.	O

Studies	NNS	O
at	IN	O
the	DT	O
transcript	NN	O
and	CC	O
protein	NN	O
level	NN	O
are	VBP	O
needed	VBN	O
for	IN	O
a	DT	O
better	JJR	O
assessment	NN	O
.	.	O

.	.	O

Incidence	NN	O
and	CC	O
characteristics	NNS	O
of	IN	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
variants	NNS	O
in	IN	O
Japan	NNP	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
3000	CD	O
men	NNS	O
living	VBG	O
in	IN	O
Yamaguchi	NNP	O
were	VBD	O
screened	VBN	O
for	IN	O
glucose-6-phosphate	NN	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
using	VBG	O
Beutlers	NNP	O
spot	NN	O
test	NN	O
and	CC	O
three	CD	O
types	NNS	O
of	IN	O
starch	NN	O
gel	NN	O
electrophoresis	NN	O
.	.	O

These	DT	O
electrophoresis	NN	O
used	VBD	O
a	DT	O
phosphate	NN	O
buffer	NN	O
system	NN	O
at	IN	O
pH	NN	O
7	CD	O
.	.	O

0	CD	O
,	,	O
a	DT	O
TRIS-EDTA-borate	JJ	O
buffer	NN	O
system	NN	O
at	IN	O
pH	NN	O
8	CD	O
.	.	O

6	CD	O
,	,	O
and	CC	O
a	DT	O
TRIS-hydrochloride	NN	O
buffer	NN	O
system	NN	O
at	IN	O
pH	NN	O
8	CD	O
.	.	O

.	.	O

Fifteen	CD	O
G6PD-deficient	JJ	B-Disease
variants	NNS	O
were	VBD	O
found	VBN	O
at	IN	O
the	DT	O
rate	NN	O
of	IN	O
0	CD	O
.	.	O

5	CD	O
%	NN	O
and	CC	O
classified	VBN	O
into	IN	O
four	CD	O
groups	NNS	O
.	.	O

As	IN	O
new	JJ	O
variants	NNS	O
,	,	O
G6PD	NNP	O
Konan	NNP	O
,	,	O
Kamiube	NNP	O
,	,	O
and	CC	O
Kiwa	NNP	O
were	VBD	O
identified	VBN	O
.	.	O

These	DT	O
three	CD	O
variants	NNS	O
had	VBD	O
a	DT	O
mild	JJ	O
to	TO	O
moderate	JJ	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
were	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
any	DT	O
clinical	JJ	O
signs	NNS	O
.	.	O

G6PD	NNP	O
Konan	NNP	O
had	VBD	O
fast	JJ	O
electrophoretic	JJ	O
mobility	NN	O
as	IN	O
compared	VBN	O
with	IN	O
normal	JJ	O
levels	NNS	O
,	,	O
G6PD	NN	O
Kiwa	NN	O
had	VBD	O
slightly	RB	O
elevated	JJ	O
electrophoretic	JJ	O
mobility	NN	O
,	,	O
and	CC	O
G6PD	NN	O
Kamiube	NN	O
had	VBD	O
normal	JJ	O
electrophoretic	JJ	O
mobility	NN	O
.	.	O

These	DT	O
three	CD	O
variants	NNS	O
had	VBD	O
normal	JJ	O
levels	NNS	O
of	IN	O
Km	NN	O
G6P	NN	O
,	,	O
Km	NN	O
NADP	NN	O
,	,	O
and	CC	O
Ki	NN	O
NADPH	NN	O
,	,	O
normal	JJ	O
utilizations	NNS	O
of	IN	O
both	DT	O
2-deoxy-G6P	NN	O
and	CC	O
deamino-NAPD	NN	O
,	,	O
normal	JJ	O
heat	NN	O
stability	NN	O
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
pH	NN	O
curve	NN	O
.	.	O

The	DT	O
other	JJ	O
variant	NN	O
was	VBD	O
G6PD	NNP	O
Ube	NNP	O
,	,	O
which	WDT	O
we	PRP	O
had	VBD	O
previously	RB	O
found	VBN	O
in	IN	O
Yamaguchi	NNP	O
(	-LRB-	O
Nakashima	NNP	O
et	FW	O
al.	FW	O
,	,	O
1977	CD	O
)	-RRB-	O
.	.	O

One	CD	O
boy	NN	O
with	IN	O
G6PD	NN	O
Ube	NN	O
was	VBD	O
Korean	JJ	O

Difference	NN	O
in	IN	O
methylation	NN	O
patterns	NNS	O
within	IN	O
the	DT	O
D15S9	NN	O
region	NN	O
of	IN	O
chromosome	NN	O
15q11-13	NN	O
in	IN	O
first	JJ	O
cousins	NNS	O
with	IN	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
and	CC	O
Prader-Willi	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

Abnormalities	NNS	O
of	IN	O
chromosome	NN	O
region	NN	O
15q11-13	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
and	CC	O
Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

Differences	NNS	O
between	IN	O
the	DT	O
methylation	NN	O
patterns	NNS	O
of	IN	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
15q11-13	NN	O
which	WDT	O
hybridizes	VBZ	O
to	TO	O
the	DT	O
highly	RB	O
conserved	VBN	O
DNA	NN	O
,	,	O
DN34	NN	O
,	,	O
in	IN	O
normal	JJ	O
individuals	NNS	O
and	CC	O
in	IN	O
patients	NNS	O
with	IN	O
AS	JJ	B-Disease
and	CC	O
PWS	NN	B-Disease
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O

We	PRP	O
report	VBP	O
on	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
first	JJ	O
cousins	NNS	O
are	VBP	O
affected	VBN	O
by	IN	O
AS	JJ	B-Disease
and	CC	O
PWS	NN	B-Disease
as	IN	O
a	DT	O
result	NN	O
of	IN	O
a	DT	O
familial	JJ	O
paracentric	JJ	O
inversion	NN	O
of	IN	O
15q11-q13	NN	O
.	.	O

The	DT	O
results	NNS	O
of	IN	O
the	DT	O
studies	NNS	O
on	IN	O
this	DT	O
family	NN	O
demonstrate	VBP	O
the	DT	O
differences	NNS	O
in	IN	O
the	DT	O
methylation	NN	O
patterns	NNS	O
in	IN	O
the	DT	O
2	CD	O
conditions	NNS	O
and	CC	O
the	DT	O
phenomenon	NN	O
of	IN	O
genomic	JJ	O
imprinting	VBG	O
,	,	O
whereby	WRB	O
genetic	JJ	O
information	NN	O
is	VBZ	O
expressed	VBN	O
differently	RB	O
dependent	JJ	O
on	IN	O
the	DT	O
parent	NN	O
of	IN	O
origin	NN	O
.	.	O

.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
.	.	O

Recently	RB	O
,	,	O
we	PRP	O
and	CC	O
others	NNS	O
have	VBP	O
isolated	VBN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
X	NN	B-Disease
linked	VBN	I-Disease
Norrie	NNP	I-Disease
disease	NN	I-Disease
(	-LRB-	O
ND	NN	B-Disease
)	-RRB-	O
which	WDT	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
deleted	VBN	O
or	CC	O
disrupted	VBN	O
in	IN	O
several	JJ	O
patients	NNS	O
.	.	O

As	IN	O
a	DT	O
prerequisite	NN	O
for	IN	O
the	DT	O
identification	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
ND	NN	B-Disease
gene	NN	O
we	PRP	O
have	VBP	O
established	VBN	O
the	DT	O
exon-intron	JJ	O
structure	NN	O
of	IN	O
this	DT	O
gene	NN	O
.	.	O

In	IN	O
17	CD	O
unrelated	JJ	O
patients	NNS	O
and	CC	O
15	CD	O
controls	NNS	O
,	,	O
PCR	NN	O
products	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
promoter	NN	O
region	NN	O
,	,	O
exons	NNS	O
1	CD	O
and	CC	O
2	CD	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
coding	VBG	O
part	NN	O
of	IN	O
exon	NN	O
3	CD	O
were	VBD	O
analysed	VBN	O
with	IN	O
the	DT	O
single	JJ	O
strand	NN	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
technique	NN	O
.	.	O

In	IN	O
12	CD	O
patients	NNS	O
altered	JJ	O
PCR	NN	O
fragments	NNS	O
were	VBD	O
detected	VBN	O
which	WDT	O
were	VBD	O
studied	VBN	O
in	IN	O
detail	NN	O
by	IN	O
direct	JJ	O
sequencing	NN	O
.	.	O

Eleven	CD	O
different	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
,	,	O
and	CC	O
all	DT	O
but	CC	O
one	CD	O
are	VBP	O
likely	JJ	O
to	TO	O
give	VB	O
rise	NN	O
to	TO	O
significant	JJ	O
structural	JJ	O
changes	NNS	O
in	IN	O
the	DT	O
predicted	VBN	O
protein	NN	O
.	.	O

These	DT	O
findings	NNS	O
,	,	O
and	CC	O
the	DT	O
absence	NN	O
of	IN	O
functionally	RB	O
relevant	JJ	O
base	NN	O
changes	NNS	O
in	IN	O
healthy	JJ	O
controls	NNS	O
,	,	O
emphasize	VBP	O
the	DT	O
causal	JJ	O
role	NN	O
of	IN	O
this	DT	O
candidate	NN	O
gene	NN	O
in	IN	O
Norrie	NNP	B-Disease
disease	NN	I-Disease
and	CC	O
pave	VB	O
the	DT	O
way	NN	O
for	IN	O
reliable	JJ	O
diagnosis	NN	O
and	CC	O
carrier	NN	O
detection	NN	O
.	.	O

.	.	O

A	DT	O
single	JJ	O
amino	NN	O
acid	NN	O
substitution	NN	O
(	-LRB-	O
G103D	NN	O
)	-RRB-	O
in	IN	O
the	DT	O
type	NN	O
II	CD	O
collagen	NN	O
triple	JJ	O
helix	NN	O
produces	VBZ	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
.	.	O

Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
is	VBZ	O
a	DT	O
moderately	RB	O
severe	JJ	O
chondrodysplasia	NN	B-Disease
phenotype	NN	O
that	WDT	O
results	VBZ	O
from	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
gene	NN	O
for	IN	O
type	NN	O
II	CD	O
collagen	NN	O
,	,	O
COL2A1	NN	O
.	.	O

Characteristics	NNS	O
of	IN	O
the	DT	O
disorder	NN	O
include	VBP	O
a	DT	O
short	JJ	B-Disease
trunk	NN	I-Disease
and	CC	I-Disease
extremities	NNS	I-Disease
,	,	O
mid-face	JJ	B-Disease
hypoplasia	NN	I-Disease
,	,	O
cleft	NN	B-Disease
palate	NN	I-Disease
,	,	O
myopia	NN	B-Disease
,	,	O
retinal	JJ	B-Disease
detachment	NN	I-Disease
,	,	O
and	CC	O
hearing	NN	B-Disease
loss	NN	I-Disease
.	.	O

Recently	RB	O
,	,	O
deletions	NNS	O
of	IN	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
exon	NN	O
12	CD	O
have	VBP	O
been	VBN	O
identified	VBN	O
in	IN	O
individuals	NNS	O
with	IN	O
Kniest	NN	B-Disease
dysplasia	NN	I-Disease
,	,	O
suggesting	VBG	O
that	IN	O
mutations	NNS	O
within	IN	O
this	DT	O
region	NN	O
of	IN	O
the	DT	O
protein	NN	O
may	MD	O
primarily	RB	O
result	VB	O
in	IN	O
the	DT	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
phenotype	NN	O
.	.	O

We	PRP	O
used	VBD	O
SSCP	NN	O
to	TO	O
analyze	VB	O
an	DT	O
amplified	VBN	O
genomic	JJ	O
DNA	NN	O
fragment	NN	O
containing	VBG	O
exon	NN	O
12	CD	O
from	IN	O
seven	CD	O
individuals	NNS	O
with	IN	O
Kniest	NN	B-Disease
dysplasia	NN	I-Disease
.	.	O

An	DT	O
abnormality	NN	O
was	VBD	O
identified	VBN	O
in	IN	O
one	CD	O
patient	NN	O
.	.	O

DNA	NN	O
sequence	NN	O
analysis	NN	O
demonstrated	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
heterozygous	JJ	O
for	IN	O
a	DT	O
G	NN	O
to	TO	O
A	DT	O
transition	NN	O
that	WDT	O
implied	VBD	O
substitution	NN	O
of	IN	O
glycine103	NN	O
of	IN	O
the	DT	O
triple	JJ	O
helical	JJ	O
domain	NN	O
by	IN	O
aspartate	NN	O
.	.	O

The	DT	O
mutation	NN	O
was	VBD	O
not	RB	O
observed	VBN	O
in	IN	O
DNA	NN	O
from	IN	O
either	DT	O
of	IN	O
the	DT	O
clinically	RB	O
unaffected	JJ	O
parents	NNS	O
of	IN	O
the	DT	O
proband	NN	O
.	.	O

Protein	NN	O
microsequencing	NN	O
demonstrated	VBD	O
expression	NN	O
of	IN	O
the	DT	O
abnormal	JJ	O
allele	NN	O
in	IN	O
cartilage	NN	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
point	NN	O
mutations	NNS	O
which	WDT	O
result	VBP	O
in	IN	O
single	JJ	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
can	MD	O
produce	VB	O
Kniest	NNP	B-Disease
dysplasia	NN	I-Disease
and	CC	O
further	JJ	O
support	NN	O
the	DT	O
hypothesis	NN	O
that	IN	O
alteration	NN	O
of	IN	O
a	DT	O
domain	NN	O
,	,	O
which	WDT	O
includes	VBZ	O
the	DT	O
region	NN	O
encoded	VBN	O
by	IN	O
exon	NN	O
12	CD	O
,	,	O
in	IN	O
the	DT	O
type	NN	O
II	CD	O
collagen	NN	O
protein	NN	O
leads	VBZ	O
to	TO	O
this	DT	O
disorder	NN	O
.	.	O

.	.	O

Linkage	NN	O
analysis	NN	O
of	IN	O
5	CD	O
novel	JJ	O
van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
kindreds	NNS	O
to	TO	O
1q32-q41	JJ	O
markers	NNS	O
further	RB	O
supports	VBZ	O
locus	NN	O
homogeneity	NN	O
of	IN	O
the	DT	O
disease	NN	O
trait	NN	O
.	.	O

van	NN	B-Disease
der	FW	I-Disease
Woude	FW	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
vWS	NN	B-Disease
,	,	O
MIM	NNP	O
119300	CD	O
)	-RRB-	O
is	VBZ	O
a	DT	O
rare	JJ	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
clefting	JJ	I-Disease
condition	NN	I-Disease
with	IN	O
cardinal	JJ	O
features	NNS	O
of	IN	O
mucous	JJ	B-Disease
cysts	NNS	I-Disease
(	-LRB-	O
lower-lip	JJ	B-Disease
pits	NNS	I-Disease
)	-RRB-	O
and	CC	O
clefts	NNS	B-Disease
to	TO	I-Disease
the	DT	I-Disease
lip	NN	I-Disease
and/or	CC	I-Disease
palate	NN	I-Disease
.	.	O

The	DT	O
vWS	NN	B-Disease
gene	NN	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
to	TO	O
a	DT	O
locus	NN	O
in	IN	O
1q32-q41	NN	O
by	IN	O
linkage	NN	O
analysis	NN	O
and	CC	O
physical	JJ	O
mapping	NN	O
.	.	O

We	PRP	O
have	VBP	O
investigated	VBN	O
5	CD	O
novel	JJ	O
vWS	NN	B-Disease
families	NNS	O
through	IN	O
probands	NNS	O
attended	VBD	O
for	IN	O
cleft	NN	B-Disease
lip	NN	I-Disease
and/or	CC	I-Disease
palate	NN	I-Disease
repair	NN	O
at	IN	O
the	DT	O
Department	NNP	O
of	IN	O
Maxillofacial	NNP	O
Surgery	NNP	O
of	IN	O
Hopital	NNP	O
Trousseau	NNP	O
,	,	O
Paris	NNP	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
tentatively	RB	O
refine	VB	O
the	DT	O
genetic	JJ	O
map	NN	O
of	IN	O
the	DT	O
vWS	NN	B-Disease
region	NN	O
in	IN	O
1q32-q41	NN	O
and	CC	O
possibly	RB	O
identify	VB	O
unlinked	JJ	O
pedigrees	NNS	O
.	.	O

Linkage	NN	O
analysis	NN	O
was	VBD	O
carried	VBN	O
out	RP	O
to	TO	O
6	CD	O
microsatellite	NN	O
markers	NNS	O
(	-LRB-	O
D1S249	NN	O
,	,	O
D1S425	NN	O
,	,	O
D1S491	NN	O
,	,	O
D1S205	NN	O
,	,	O
D1S414	NN	O
,	,	O
D1S425	NN	O
)	-RRB-	O
,	,	O
yielding	VBG	O
a	DT	O
maximum	NN	O
cumulative	JJ	O
LOD	NN	O
score	NN	O
of	IN	O
Z	NN	O
=	JJ	O
3	CD	O
.	.	O

27	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
for	IN	O
D1S245	NN	O
.	.	O

The	DT	O
innermost	JJS	O
four	CD	O
markers	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
tightly	RB	O
linked	VBN	O
to	TO	O
one	CD	O
another	DT	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
for	IN	O
recombination	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
support	VBP	O
linkage	NN	O
of	IN	O
vWS	NN	B-Disease
within	IN	O
a	DT	O
region	NN	O
of	IN	O
tightly	RB	O
linked	VBN	O
markers	NNS	O
and	CC	O
do	VBP	O
not	RB	O
favour	VB	O
locus	NN	O
heterogeneity	NN	O
of	IN	O
the	DT	O
disease	NN	O
trait	NN	O
.	.	O

Hypopigmentation	NN	B-Disease
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

Cutaneous	JJ	B-Disease
and	CC	I-Disease
ocular	JJ	I-Disease
pigmentation	NN	I-Disease
were	VBD	O
evaluated	VBN	O
in	IN	O
29	CD	O
individuals	NNS	O
with	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

Criteria	NNS	O
for	IN	O
hypopigmentation	NN	B-Disease
included	VBD	O
the	DT	O
presence	NN	O
of	IN	O
type	NN	O
I	CD	O
or	CC	O
II	CD	O
skin	NN	O
,	,	O
the	DT	O
lightest	JJS	O
skin	NN	O
type	NN	O
in	IN	O
the	DT	O
family	NN	O
by	IN	O
history	NN	O
,	,	O
and	CC	O
iris	NN	O
translucency	NN	O
on	IN	O
globe	NN	O
transillumination	NN	O
.	.	O

On	IN	O
the	DT	O
basis	NN	O
of	IN	O
these	DT	O
criteria	NNS	O
,	,	O
48	CD	O
%	NN	O
of	IN	O
the	DT	O
PWS	NN	B-Disease
individuals	NNS	O
were	VBD	O
hypopigmented	JJ	B-Disease
.	.	O

The	DT	O
presence	NN	O
of	IN	O
hypopigmentation	NN	B-Disease
correlated	VBD	O
with	IN	O
a	DT	O
small	JJ	O
interstitial	JJ	O
deletion	NN	O
on	IN	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
15	CD	O
;	:	O
however	RB	O
,	,	O
this	DT	O
deletion	NN	O
was	VBD	O
also	RB	O
found	VBN	O
in	IN	O
individuals	NNS	O
who	WP	O
did	VBD	O
not	RB	O
meet	VB	O
the	DT	O
full	JJ	O
criteria	NNS	O
for	IN	O
hypopigmentation	NN	B-Disease
.	.	O

Hairbulb	NNP	O
tyrosinase	NN	O
activity	NN	O
and	CC	O
glutathione	NN	O
content	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
urine	NN	O
cysteinyldopa	NN	O
excretion	NN	O
,	,	O
were	VBD	O
low	JJ	O
in	IN	O
PWS	NN	B-Disease
individuals	NNS	O
with	IN	O
and	CC	O
without	IN	O
hypopigmentation	NN	B-Disease
and	CC	O
did	VBD	O
not	RB	O
separate	JJ	O
these	DT	O
two	CD	O
groups	NNS	O
.	.	O

We	PRP	O
conclude	VBP	O
that	IN	O
hypopigmentation	NN	B-Disease
is	VBZ	O
found	VBN	O
in	IN	O
a	DT	O
significant	JJ	O
proportion	NN	O
of	IN	O
individuals	NNS	O
with	IN	O
PWS	NN	B-Disease
and	CC	O
that	IN	O
the	DT	O
hypopigmentation	NN	B-Disease
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
chromosome	NN	O
15	CD	O
.	.	O

The	DT	O
mechanism	NN	O
for	IN	O
the	DT	O
hypopigmentation	NN	B-Disease
is	VBZ	O
unknown	JJ	O
.	.	O

.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
in	IN	O
human	JJ	O
subjects	NNS	O
.	.	O

Clinical	JJ	O
,	,	O
genetic	JJ	O
and	CC	O
immunologic	JJ	O
studies	NNS	O
in	IN	O
a	DT	O
large	JJ	O
kindred	NN	O
.	.	O

The	DT	O
discovery	NN	O
of	IN	O
a	DT	O
large	JJ	O
kindred	NN	O
with	IN	O
a	DT	O
heritable	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
fifth	JJ	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
(	-LRB-	O
C5	NN	O
)	-RRB-	O
has	VBZ	O
permitted	VBN	O
the	DT	O
accumulation	NN	O
of	IN	O
new	JJ	O
clinical	JJ	O
,	,	O
genetic	JJ	O
and	CC	O
immunologic	JJ	O
data	NNS	O
concerning	VBG	O
the	DT	O
role	NN	O
of	IN	O
C5	NN	O
in	IN	O
human	JJ	O
subjects	NNS	O
.	.	O

The	DT	O
proband	NN	O
,	,	O
who	WP	O
has	VBZ	O
had	VBN	O
nine	CD	O
episodes	NNS	O
of	IN	O
disseminated	VBN	O
gonococcal	JJ	B-Disease
infection	NN	I-Disease
,	,	O
has	VBZ	O
a	DT	O
hemolytic	JJ	O
C5	NN	O
level	NN	O
of	IN	O
approximately	RB	O
0	CD	O
.	.	O

5	CD	O
per	IN	O
cent	NN	O
of	IN	O
normal	JJ	O
.	.	O

No	DT	O
C5	NN	O
protein	NN	O
was	VBD	O
detectable	JJ	O
,	,	O
but	CC	O
low	JJ	O
levels	NNS	O
of	IN	O
functional	JJ	O
C5	NN	O
activity	NN	O
could	MD	O
be	VB	O
found	VBN	O
using	VBG	O
a	DT	O
sensitive	JJ	O
bactericidal	JJ	O
assay	NN	O
.	.	O

The	DT	O
probands	NNS	O
twin	NN	O
as	RB	O
well	RB	O
as	IN	O
another	DT	O
sister	NN	O
also	RB	O
had	VBD	O
extremely	RB	O
low	JJ	O
levels	NNS	O
of	IN	O
hemolytic	JJ	O
C5	NN	O
(	-LRB-	O
approximately	RB	O
0	CD	O
.	.	O

5	CD	O
per	IN	O
cent	NN	O
normal	JJ	O
)	-RRB-	O
,	,	O
but	CC	O
both	DT	O
these	DT	O
subjects	NNS	O
have	VBP	O
been	VBN	O
healthy	JJ	O
.	.	O

Hemolytic	JJ	O
complement	NN	O
and	CC	O
bacteriolytic	JJ	O
activity	NN	O
could	MD	O
be	VB	O
restored	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
purified	VBN	O
C5	NN	O
.	.	O

No	DT	O
chemotactic	JJ	O
activity	NN	O
for	IN	O
polymorphonuclear	JJ	O
leukocytes	NNS	O
could	MD	O
be	VB	O
generated	VBN	O
in	IN	O
the	DT	O
C5-deficient	JJ	B-Disease
serums	NNS	O
upon	IN	O
activation	NN	O
of	IN	O
either	CC	O
the	DT	O
classic	JJ	O
or	CC	O
alternative	JJ	O
pathways	NNS	O
,	,	O
again	RB	O
demonstrating	VBG	O
the	DT	O
importance	NN	O
of	IN	O
C5	NN	O
in	IN	O
human	JJ	O
subjects	NNS	O
for	IN	O
the	DT	O
production	NN	O
of	IN	O
chemotactic	JJ	O
factors	NNS	O
.	.	O

The	DT	O
chemotactic	JJ	O
responsiveness	NN	O
of	IN	O
the	DT	O
patients	NNS	O
polymorphonuclear	JJ	O
leukocytes	NNS	O
and	CC	O
monocytes	NNS	O
to	TO	O
preformed	JJ	O
chemotactic	JJ	O
factors	NNS	O
was	VBD	O
not	RB	O
depressed	VBN	O
.	.	O

Twenty-two	CD	O
of	IN	O
32	CD	O
other	JJ	O
family	NN	O
members	NNS	O
from	IN	O
three	CD	O
generations	NNS	O
had	VBD	O
depressed	VBN	O
whole	JJ	O
hemolytic	JJ	O
complement	NN	O
levels	NNS	O
.	.	O

In	IN	O
19	CD	O
of	IN	O
30	CD	O
family	NN	O
members	NNS	O
,	,	O
levels	NNS	O
of	IN	O
hemolytic	JJ	O
C5	NN	O
ranged	VBD	O
from	IN	O
13	CD	O
to	TO	O
64	CD	O
per	IN	O
cent	NN	O
of	IN	O
normal	JJ	O
.	.	O

No	DT	O
linkage	NN	O
for	IN	O
C5	NN	B-Disease
deficiency	NN	I-Disease
and	CC	O
the	DT	O
A	NN	O
or	CC	O
B	NN	O
loci	NNS	O
of	IN	O
the	DT	O
major	JJ	O
histocompatibility	NN	O
complex	NN	O
could	MD	O
be	VB	O
found	VBN	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
an	DT	O
autosomal	JJ	O
codominant	JJ	O
mode	NN	O
of	IN	O
inheritance	NN	O
of	IN	O
C5	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
C5	NN	I-Disease
is	VBZ	O
compatible	JJ	O
with	IN	O
good	JJ	O
health	NN	O
,	,	O
but	CC	O
it	PRP	O
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
repeated	VBN	O
disseminated	VBN	O
gonococcal	JJ	B-Disease
infection	NN	I-Disease

A	DT	O
new	JJ	O
glucose-6-phosphate	NN	O
dehydrogenase	NN	O
variant	NN	O
,	,	O
G6PD	NN	O
Orissa	NNP	O
(	-LRB-	O
44	CD	O
Ala	NN	O
--	:	O
>	JJR	O
Gly	NN	O
)	-RRB-	O
,	,	O
is	VBZ	O
the	DT	O
major	JJ	O
polymorphic	JJ	O
variant	NN	O
in	IN	O
tribal	JJ	O
populations	NNS	O
in	IN	O
India	NNP	O
.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
glucose-6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	O
G6PD	NN	O
)	-RRB-	O
is	VBZ	O
usually	RB	O
found	VBN	O
at	IN	O
high	JJ	O
frequencies	NNS	O
in	IN	O
areas	NNS	O
of	IN	O
the	DT	O
world	NN	O
where	WRB	O
malaria	NN	B-Disease
has	VBZ	O
been	VBN	O
endemic	JJ	O
.	.	O

The	DT	O
frequency	NN	O
and	CC	O
genetic	JJ	O
basis	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
have	VBP	O
been	VBN	O
studied	VBN	O
in	IN	O
Africa	NNP	O
,	,	O
around	IN	O
the	DT	O
Mediterranean	NNP	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
Far	NNP	O
East	NNP	O
,	,	O
but	CC	O
little	RB	O
such	JJ	O
information	NN	O
is	VBZ	O
available	JJ	O
about	IN	O
the	DT	O
situation	NN	O
in	IN	O
India	NNP	O
.	.	O

To	TO	O
determine	VB	O
the	DT	O
extent	NN	O
of	IN	O
heterogeneity	NN	O
of	IN	O
G6PD	NN	O
,	,	O
we	PRP	O
have	VBP	O
studied	VBN	O
several	JJ	O
different	JJ	O
Indian	JJ	O
populations	NNS	O
by	IN	O
screening	VBG	O
for	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
followed	VBN	O
by	IN	O
molecular	JJ	O
analysis	NN	O
of	IN	O
deficient	JJ	O
alleles	NNS	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
varies	VBZ	O
between	IN	O
3	CD	O
%	NN	O
and	CC	O
15	CD	O
%	NN	O
in	IN	O
different	JJ	O
tribal	JJ	O
and	CC	O
urban	JJ	O
groups	NNS	O
.	.	O

Remarkably	RB	O
,	,	O
a	DT	O
previously	RB	O
unreported	JJ	O
deficient	JJ	O
variant	NN	O
,	,	O
G6PD	NN	O
Orissa	NNP	O
(	-LRB-	O
44	CD	O
Ala	NN	O
--	:	O
>	JJR	O
Gly	NN	O
)	-RRB-	O
,	,	O
is	VBZ	O
responsible	JJ	O
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
tribal	JJ	O
Indian	JJ	O
populations	NNS	O
but	CC	O
is	VBZ	O
not	RB	O
found	VBN	O
in	IN	O
urban	JJ	O
populations	NNS	O
,	,	O
where	WRB	O
most	JJS	O
of	IN	O
the	DT	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
is	VBZ	O
due	JJ	O
to	TO	O
the	DT	O
G6PD	NN	O
Mediterranean	JJ	O
(	-LRB-	O
188	CD	O
Ser	NN	O
--	:	O
>	JJR	O
Phe	NN	O
)	-RRB-	O
variant	NN	O
.	.	O

The	DT	O
KmNADP	NN	O
of	IN	O
G6PD	NN	O
Orissa	NNP	O
is	VBZ	O
fivefold	RB	O
higher	JJR	O
than	IN	O
that	DT	O
of	IN	O
the	DT	O
normal	JJ	O
enzyme	NN	O
.	.	O

This	DT	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
alanine	NN	O
residue	NN	O
that	WDT	O
is	VBZ	O
replaced	VBN	O
by	IN	O
glycine	NN	O
is	VBZ	O
part	NN	O
of	IN	O
a	DT	O
putative	JJ	O
coenzyme-binding	JJ	O
site	NN	O
.	.	O

.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
Wilms	NN	B-Disease
'	POS	I-Disease
tumor	NN	I-Disease
suppressor	NN	O
gene	NN	O
are	VBP	O
associated	VBN	O
with	IN	O
abnormal	JJ	O
urogenital	JJ	O
development	NN	O
in	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
.	.	O

Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
a	DT	O
rare	JJ	O
human	JJ	O
condition	NN	O
in	IN	O
which	WDT	O
severe	JJ	O
urogenital	JJ	B-Disease
aberrations	NNS	I-Disease
result	VBP	O
in	IN	O
renal	JJ	B-Disease
failure	NN	I-Disease
,	,	O
pseudohermaphroditism	NN	B-Disease
,	,	O
and	CC	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
(	-LRB-	O
nephroblastoma	NN	B-Disease
)	-RRB-	O
.	.	O

To	TO	O
investigate	VB	O
its	PRP$	O
possible	JJ	O
role	NN	O
,	,	O
we	PRP	O
have	VBP	O
analyzed	VBN	O
the	DT	O
coding	VBG	O
exons	NNS	O
of	IN	O
the	DT	O
Wilms	NN	B-Disease
tumor	NN	I-Disease
suppressor	NN	O
gene	NN	O
(	-LRB-	O
WT1	NN	O
)	-RRB-	O
for	IN	O
germline	NN	O
mutations	NNS	O
.	.	O

In	IN	O
ten	CD	O
independent	JJ	O
cases	NNS	O
of	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
point	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
zinc	NN	O
finger	NN	O
domains	NNS	O
of	IN	O
one	CD	O
WT1	NN	O
gene	NN	O
copy	NN	O
were	VBD	O
found	VBN	O
.	.	O

Nine	CD	O
of	IN	O
these	DT	O
mutations	NNS	O
are	VBP	O
found	VBN	O
within	IN	O
exon	NN	O
9	CD	O
(	-LRB-	O
zinc	NN	O
finger	NN	O
III	CD	O
)	-RRB-	O
;	:	O
the	DT	O
remaining	VBG	O
mutation	NN	O
is	VBZ	O
in	IN	O
exon	NN	O
8	CD	O
(	-LRB-	O
zinc	NN	O
finger	NN	O
II	CD	O
)	-RRB-	O
.	.	O

These	DT	O
mutations	NNS	O
directly	RB	O
affect	VBP	O
DNA	NN	O
sequence	NN	O
recognition	NN	O
.	.	O

In	IN	O
two	CD	O
families	NNS	O
analyzed	VBN	O
,	,	O
the	DT	O
mutations	NNS	O
were	VBD	O
shown	VBN	O
to	TO	O
arise	VB	O
de	FW	O
novo	FW	O
.	.	O

Wilms	NN	B-Disease
tumors	NNS	I-Disease
from	IN	O
three	CD	O
individuals	NNS	O
and	CC	O
one	CD	O
juvenile	JJ	O
granulosa	NN	O
cell	NN	O
tumor	NN	B-Disease
demonstrate	VBP	O
reduction	NN	O
to	TO	O
homozygosity	NN	O
for	IN	O
the	DT	O
mutated	VBN	O
WT1	NN	O
allele	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
provide	VBP	O
evidence	NN	O
of	IN	O
a	DT	O
direct	JJ	O
role	NN	O
for	IN	O
WT1	NN	O
in	IN	O
Denys-Drash	JJ	B-Disease
syndrome	NN	I-Disease
and	CC	O
thus	RB	O
urogenital	JJ	O
system	NN	O
development	NN	O
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
feline	JJ	O
beta-glucuronidase	NN	B-Disease
deficiency	NN	I-Disease
:	:	O
an	DT	O
animal	NN	O
model	NN	O
of	IN	O
mucopolysaccharidosis	NN	B-Disease
VII	NN	I-Disease
.	.	O

A	DT	O
family	NN	O
of	IN	O
domestic	JJ	O
cats	NNS	O
was	VBD	O
found	VBN	O
that	IN	O
exhibited	VBD	O
clinical	JJ	O
and	CC	O
biochemical	JJ	O
abnormalities	NNS	O
consistent	JJ	O
with	IN	O
mucopolysaccharidosis	NN	B-Disease
VII	NN	I-Disease
,	,	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
lysosomal	JJ	I-Disease
storage	NN	I-Disease
disorder	NN	I-Disease
caused	VBN	O
by	IN	O
beta-glucuronidase	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

beta-Glucuronidase	NN	O
activity	NN	O
was	VBD	O
undetectable	JJ	O
in	IN	O
affected	JJ	O
cat	NN	O
fibroblasts	NNS	O
and	CC	O
restored	VBN	O
by	IN	O
retroviral	JJ	O
gene	NN	O
transfer	NN	O
of	IN	O
rat	NN	O
beta-glucuronidase	NN	O
cDNA	NN	O
.	.	O

beta-Glucuronidase	NN	O
mRNA	NN	O
was	VBD	O
normal	JJ	O
in	IN	O
affected	JJ	O
cat	NN	O
testis	NN	O
by	IN	O
Northern	NN	O
blot	NN	O
analysis	NN	O
.	.	O

Normal	JJ	O
feline	JJ	O
beta-glucuronidase	NN	O
cDNA	NN	O
was	VBD	O
cloned	VBN	O
and	CC	O
characterized	VBN	O
,	,	O
and	CC	O
amplified	VBN	O
from	IN	O
affected	VBN	O
cat	NN	O
fibroblasts	NNS	O
by	IN	O
reverse	JJ	O
transcription	NN	O
coupled	VBN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

There	EX	O
was	VBD	O
a	DT	O
G-to-A	JJ	O
transition	NN	O
in	IN	O
the	DT	O
affected	VBN	O
cat	NN	O
cDNA	NN	O
that	WDT	O
predicted	VBD	O
an	DT	O
E351K	NN	O
substitution	NN	O
,	,	O
destroyed	VBD	O
a	DT	O
BssSI	NN	O
site	NN	O
,	,	O
and	CC	O
eliminated	VBD	O
GUSB	NN	O
enzymatic	JJ	O
activity	NN	O
in	IN	O
expression	NN	O
studies	NNS	O
.	.	O

Multiple	JJ	O
species	NNS	O
comparison	NN	O
and	CC	O
the	DT	O
crystal	NN	O
structure	NN	O
of	IN	O
human	JJ	O
beta-glucuronidase	NN	O
indicated	VBD	O
that	IN	O
E351	NN	O
is	VBZ	O
a	DT	O
highly	RB	O
conserved	VBN	O
residue	NN	O
most	RBS	O
likely	JJ	O
essential	JJ	O
in	IN	O
maintenance	NN	O
of	IN	O
the	DT	O
enzymes	NNS	O
conformation	NN	O
.	.	O

BssSI	NN	O
digestion	NN	O
of	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
products	NNS	O
amplified	VBN	O
from	IN	O
genomic	JJ	O
DNA	NN	O
indicated	VBD	O
that	IN	O
affected	VBN	O
cats	NNS	O
were	VBD	O
homozygous	JJ	O
and	CC	O
cats	NNS	O
with	IN	O
half-normal	JJ	O
beta-glucuronidase	NN	O
activity	NN	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
the	DT	O
missense	NN	O
mutation	NN	O
.	.	O

Carriers	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
manner	NN	O
produced	VBD	O
affected	VBN	O
kittens	NNS	O
in	IN	O
prospective	JJ	O
breedings	NNS	O
,	,	O
and	CC	O
a	DT	O
feline	JJ	O
MPS	NNP	B-Disease
VII	NN	I-Disease
breeding	VBG	O
colony	NN	O
has	VBZ	O
been	VBN	O
established	VBN	O
.	.	O

.	.	O

Loss-of-function	JJ	O
mutations	NNS	O
in	IN	O
the	DT	O
cathepsin	NN	O
C	NN	O
gene	NN	O
result	NN	O
in	IN	O
periodontal	JJ	B-Disease
disease	NN	I-Disease
and	CC	O
palmoplantar	NN	B-Disease
keratosis	NN	I-Disease
.	.	O

Papillon-Lefevre	JJ	B-Disease
syndrome	NN	I-Disease
,	,	O
or	CC	O
keratosis	NN	B-Disease
palmoplantaris	NN	I-Disease
with	IN	O
periodontopathia	NN	B-Disease
(	-LRB-	O
PLS	NN	B-Disease
,	,	O
MIM	NNP	O
245000	CD	O
)	-RRB-	O
,	,	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
that	WDT	O
is	VBZ	O
mainly	RB	O
ascertained	VBN	O
by	IN	O
dentists	NNS	O
because	IN	O
of	IN	O
the	DT	O
severe	JJ	O
periodontitis	NN	B-Disease
that	WDT	O
afflicts	VBZ	O
patients	NNS	O
.	.	O

Both	CC	O
the	DT	O
deciduous	JJ	O
and	CC	O
permanent	JJ	O
dentitions	NNS	O
are	VBP	O
affected	VBN	O
,	,	O
resulting	VBG	O
in	IN	O
premature	JJ	O
tooth	NN	B-Disease
loss	NN	I-Disease
.	.	O

Palmoplantar	JJ	B-Disease
keratosis	NN	I-Disease
,	,	O
varying	VBG	O
from	IN	O
mild	JJ	O
psoriasiform	NN	O
scaly	NN	O
skin	NN	O
to	TO	O
overt	JJ	O
hyperkeratosis	NN	B-Disease
,	,	O
typically	RB	O
develops	VBZ	O
within	IN	O
the	DT	O
first	JJ	O
three	CD	O
years	NNS	O
of	IN	O
life	NN	O
.	.	O

Keratosis	NNP	B-Disease
also	RB	O
affects	VBZ	O
other	JJ	O
sites	NNS	O
such	JJ	O
as	IN	O
elbows	NNS	O
and	CC	O
knees	NNS	O
.	.	O

Most	JJS	O
PLS	NN	B-Disease
patients	NNS	O
display	VBP	O
both	CC	O
periodontitis	NN	B-Disease
and	CC	O
hyperkeratosis	NN	B-Disease
.	.	O

Some	DT	O
patients	NNS	O
have	VBP	O
only	RB	O
palmoplantar	JJ	B-Disease
keratosis	NN	I-Disease
or	CC	O
periodontitis	NN	B-Disease
,	,	O
and	CC	O
in	IN	O
rare	JJ	O
individuals	NNS	O
the	DT	O
periodontitis	NN	B-Disease
is	VBZ	O
mild	JJ	O
and	CC	O
of	IN	O
late	JJ	O
onset	NN	O
.	.	O

The	DT	O
PLS	NN	O
locus	NN	O
has	VBZ	O
been	VBN	O
mapped	VBN	O
to	TO	O
chromosome	NN	O
11q14-q21	NN	O
(	-LRB-	O
refs	NNS	O
7	CD	O
,	,	O
8	CD	O
,	,	O
9	CD	O
)	-RRB-	O
.	.	O

Using	VBG	O
homozygosity	NN	O
mapping	NN	O
in	IN	O
eight	CD	O
small	JJ	O
consanguineous	JJ	O
families	NNS	O
,	,	O
we	PRP	O
have	VBP	O
narrowed	VBN	O
the	DT	O
candidate	NN	O
region	NN	O
to	TO	O
a	DT	O
1	CD	O
.	.	O

2-cM	JJ	O
interval	NN	O
between	IN	O
D11S4082	NN	O
and	CC	O
D11S931	NN	O
.	.	O

The	DT	O
gene	NN	O
(	-LRB-	O
CTSC	NN	O
)	-RRB-	O
encoding	VBG	O
the	DT	O
lysosomal	JJ	O
protease	NN	O
cathepsin	NN	O
C	NN	O
(	-LRB-	O
or	CC	O
dipeptidyl	NN	O
aminopeptidase	NN	O
I	NN	O
)	-RRB-	O
lies	VBZ	O
within	IN	O
this	DT	O
interval	NN	O
.	.	O

We	PRP	O
defined	VBD	O
the	DT	O
genomic	JJ	O
structure	NN	O
of	IN	O
CTSC	NN	O
and	CC	O
found	VBD	O
mutations	NNS	O
in	IN	O
all	DT	O
eight	CD	O
families	NNS	O
.	.	O

In	IN	O
two	CD	O
of	IN	O
these	DT	O
families	NNS	O
we	PRP	O
used	VBD	O
a	DT	O
functional	JJ	O
assay	NN	O
to	TO	O
demonstrate	VB	O
an	DT	O
almost	RB	O
total	JJ	O
loss	NN	O
of	IN	O
cathepsin	NN	O
C	NN	O
activity	NN	O
in	IN	O
PLS	NN	B-Disease
patients	NNS	O
and	CC	O
reduced	VBN	O
activity	NN	O
in	IN	O
obligate	JJ	O
carriers	NNS	O
.	.	O

Brca1	NN	B-Disease
deficiency	NN	I-Disease
results	VBZ	O
in	IN	O
early	JJ	O
embryonic	JJ	B-Disease
lethality	NN	I-Disease
characterized	VBN	O
by	IN	O
neuroepithelial	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

The	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
,	,	O
BRCA1	NN	O
,	,	O
has	VBZ	O
been	VBN	O
cloned	VBN	O
and	CC	O
shown	VBN	O
to	TO	O
encode	VB	O
a	DT	O
zinc-finger	JJ	O
protein	NN	O
of	IN	O
unknown	JJ	O
function	NN	O
.	.	O

Mutations	NNS	O
in	IN	O
BRCA1	NN	O
account	NN	O
for	IN	O
at	IN	O
least	JJS	O
80	CD	O
%	NN	O
of	IN	O
families	NNS	O
with	IN	O
both	DT	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
as	RB	O
well	RB	O
as	IN	O
some	DT	O
non-familial	JJ	O
sporadic	JJ	O
ovarian	JJ	B-Disease
cancers	NNS	I-Disease
.	.	O

The	DT	O
loss	NN	O
of	IN	O
wild-type	JJ	O
BRCA1	NN	O
in	IN	O
tumours	NNS	B-Disease
of	IN	O
individuals	NNS	O
carrying	VBG	O
one	CD	O
nonfunctional	JJ	O
BRCA1	NN	O
allele	NN	O
suggests	VBZ	O
that	IN	O
BRCA1	NN	O
encodes	VBZ	O
a	DT	O
tumour	NN	B-Disease
suppressor	NN	O
that	WDT	O
may	MD	O
inhibit	VB	O
the	DT	O
proliferation	NN	O
of	IN	O
mammary	JJ	O
epithelial	JJ	O
cells	NNS	O
.	.	O

To	TO	O
examine	VB	O
the	DT	O
role	NN	O
of	IN	O
BRCA1	NN	O
in	IN	O
normal	JJ	O
tissue	NN	O
growth	NN	O
and	CC	O
differentiation	NN	O
,	,	O
and	CC	O
to	TO	O
generate	VB	O
a	DT	O
potential	JJ	O
model	NN	O
for	IN	O
the	DT	O
cancer	NN	B-Disease
susceptibility	NN	O
associated	VBN	O
with	IN	O
loss	NN	O
of	IN	O
BRCA1	NN	O
function	NN	O
,	,	O
we	PRP	O
have	VBP	O
created	VBN	O
a	DT	O
mouse	NN	O
line	NN	O
carrying	VBG	O
a	DT	O
mutation	NN	O
in	IN	O
one	CD	O
Brca1	NN	O
allele	NN	O
.	.	O

Analysis	NN	O
of	IN	O
mice	NNS	O
homozygous	JJ	O
for	IN	O
the	DT	O
mutant	JJ	O
allele	NN	O
indicate	VBP	O
that	IN	O
Brca1	NN	O
is	VBZ	O
critical	JJ	O
for	IN	O
normal	JJ	O
development	NN	O
,	,	O
as	IN	O
these	DT	O
mice	NNS	O
died	VBD	O
in	IN	O
utero	NN	O
between	IN	O
10	CD	O
and	CC	O
13	CD	O
days	NNS	O
of	IN	O
gestation	NN	O
(	-LRB-	O
E10-E13	NN	O
)	-RRB-	O
.	.	O

Abnormalities	NNS	O
in	IN	O
Brca1-deficient	JJ	B-Disease
embryos	NNS	O
were	VBD	O
most	RBS	O
evident	JJ	O
in	IN	O
the	DT	O
neural	JJ	O
tube	NN	O
,	,	O
with	IN	O
40	CD	O
%	NN	O
of	IN	O
the	DT	O
embryos	NNS	O
presenting	VBG	O
with	IN	O
varying	VBG	O
degrees	NNS	O
of	IN	O
spina	NN	B-Disease
bifida	NN	I-Disease
and	CC	O
anencephaly	NN	B-Disease
.	.	O

In	IN	O
addition	NN	O
,	,	O
the	DT	O
neuroepithelium	NN	O
in	IN	O
Brca1-deficient	JJ	B-Disease
embryos	NNS	O
appeared	VBD	O
disorganized	JJ	O
,	,	O
with	IN	O
signs	NNS	O
of	IN	O
both	DT	O
rapid	JJ	O
proliferation	NN	O
and	CC	O
excessive	JJ	O
cell	NN	O
death	NN	O
.	.	O

.	.	O

X	NN	B-Disease
linked	VBD	I-Disease
recessive	JJ	I-Disease
thrombocytopenia	NN	I-Disease
.	.	O

A	DT	O
Saudi	JJ	O
Arab	NNP	O
boy	NN	O
presented	VBN	O
in	IN	O
early	JJ	O
childhood	NN	O
with	IN	O
thrombocytopenia	NN	B-Disease
,	,	O
morphologically	RB	O
large	JJ	O
and	CC	O
normal	JJ	O
sized	VBN	O
platelets	NNS	O
,	,	O
increased	VBD	O
mean	NN	O
platelet	NN	O
volume	NN	O
,	,	O
and	CC	O
a	DT	O
hypermegakaryocytic	JJ	O
bone	NN	O
marrow	NN	O
.	.	O

There	EX	O
was	VBD	O
no	DT	O
clinical	JJ	O
and	CC	O
laboratory	JJ	O
evidence	NN	O
of	IN	O
any	DT	O
significant	JJ	O
immunological	JJ	B-Disease
abnormalities	NNS	I-Disease
.	.	O

Similar	JJ	O
findings	NNS	O
in	IN	O
two	CD	O
other	JJ	O
brothers	NNS	O
suggested	VBD	O
strongly	RB	O
that	IN	O
they	PRP	O
were	VBD	O
all	DT	O
suffering	VBG	O
from	IN	O
an	DT	O
X	NN	B-Disease
linked	VBN	I-Disease
recessive	JJ	I-Disease
thrombocytopenic	JJ	I-Disease
disorder	NN	I-Disease
.	.	O

Results	NNS	O
of	IN	O
DNA	NN	O
analysis	NN	O
with	IN	O
the	DT	O
probe	NN	O
M27	NN	O
beta	NN	O
are	VBP	O
consistent	JJ	O
with	IN	O
X	NN	O
linkage	NN	O
and	CC	O
indicate	VBP	O
also	RB	O
that	IN	O
the	DT	O
locus	NN	O
of	IN	O
the	DT	O
relevant	JJ	O
gene	NN	O
lies	VBZ	O
close	RB	O
to	TO	O
or	CC	O
is	VBZ	O
identical	JJ	O
to	TO	O
the	DT	O
locus	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
the	DT	O
Wiskott-Aldrich	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
WAS	NN	B-Disease
)	-RRB-	O
.	.	O

Because	IN	O
of	IN	O
various	JJ	O
features	NNS	O
which	WDT	O
include	VBP	O
the	DT	O
presence	NN	O
of	IN	O
large	JJ	O
and	CC	O
normal	JJ	O
sized	VBN	O
platelets	NNS	O
(	-LRB-	O
rather	RB	O
than	IN	O
small	JJ	O
platelets	NNS	O
)	-RRB-	O
and	CC	O
freedom	NN	O
from	IN	O
significant	JJ	O
immune	JJ	B-Disease
deficiencies	NNS	I-Disease
,	,	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
the	DT	O
X	NN	B-Disease
linked	VBN	I-Disease
recessive	JJ	I-Disease
thrombocytopenia	NN	I-Disease
in	IN	O
this	DT	O
family	NN	O
is	VBZ	O
an	DT	O
isolated	VBN	O
entity	NN	O
quite	RB	O
distinct	JJ	O
from	IN	O
the	DT	O
classical	JJ	O
WAS	NNP	B-Disease
phenotype	NN	O
.	.	O

However	RB	O
,	,	O
a	DT	O
modified	VBN	O
expression	NN	O
of	IN	O
the	DT	O
WAS	NNP	B-Disease
gene	NN	O
producing	VBG	O
a	DT	O
mild	JJ	O
phenotypic	JJ	O
variant	NN	O
can	MD	O
not	RB	O
be	VB	O
excluded	VBN	O
entirely	RB	O
.	.	O

.	.	O

Genetics	NNP	O
of	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
:	:	O
an	DT	O
autosomal	JJ	O
recessive	JJ	O
trait	NN	O
with	IN	O
high	JJ	O
gene	NN	O
frequency	NN	O
in	IN	O
Sephardim	NNP	O
of	IN	O
Moroccan	NNP	O
origin	NN	O
.	.	O

We	PRP	O
described	VBD	O
6	CD	O
patients	NNS	O
(	-LRB-	O
from	IN	O
3	CD	O
families	NNS	O
)	-RRB-	O
affected	VBN	O
with	IN	O
cerebrotendinous	JJ	B-Disease
xanthomatosis	NN	I-Disease
(	-LRB-	O
CTX	NN	B-Disease
)	-RRB-	O
.	.	O

All	DT	O
are	VBP	O
Sephardic	JJ	O
Jews	NNS	O
of	IN	O
Moroccan	JJ	O
extraction	NN	O
.	.	O

In	IN	O
view	NN	O
of	IN	O
the	DT	O
small	JJ	O
number	NN	O
of	IN	O
CTX	NN	B-Disease
patients	NNS	O
diagnosed	VBD	O
in	IN	O
the	DT	O
world	NN	O
(	-LRB-	O
a	DT	O
total	NN	O
of	IN	O
50	CD	O
including	VBG	O
our	PRP$	O
6	CD	O
patients	NNS	O
)	-RRB-	O
,	,	O
we	PRP	O
are	VBP	O
probably	RB	O
dealing	VBG	O
with	IN	O
an	DT	O
ethnic	JJ	O
subgroup	NN	O
with	IN	O
a	DT	O
high	JJ	O
CTX	NN	O
gene	NN	O
frequency	NN	O
,	,	O
which	WDT	O
we	PRP	O
have	VBP	O
estimated	VBN	O
to	TO	O
be	VB	O
1/108	CD	O
.	.	O

Since	IN	O
there	EX	O
are	VBP	O
differences	NNS	O
in	IN	O
expression	NN	O
in	IN	O
this	DT	O
disease	NN	O
,	,	O
we	PRP	O
recommend	VBP	O
cholestanol	NN	O
study	NN	O
in	IN	O
cases	NNS	O
of	IN	O
undiagnosed	JJ	O
cataract	NN	B-Disease
or	CC	O
tendinous	JJ	B-Disease
xanthomas	NNS	I-Disease
in	IN	O
childhood	NN	O
or	CC	O
early	JJ	O
adolescence	NN	O
.	.	O

The	DT	O
diagnosis	NN	O
in	IN	O
CTX	NNP	B-Disease
is	VBZ	O
important	JJ	O
not	RB	O
only	RB	O
for	IN	O
genetic	JJ	O
counseling	NN	O
,	,	O
but	CC	O
also	RB	O
in	IN	O
veiw	NN	O
of	IN	O
possible	JJ	O
treatment	NN	O
.	.	O

.	.	O

A	DT	O
missense	NN	O
mutation	NN	O
in	IN	O
the	DT	O
cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	NN	O
gene	NN	O
with	IN	O
possible	JJ	O
dominant	JJ	O
effects	NNS	O
on	IN	O
plasma	NN	O
high	JJ	O
density	NN	O
lipoproteins	NNS	O
.	.	O

Plasma	NN	O
HDL	NN	O
are	VBP	O
a	DT	O
negative	JJ	O
risk	NN	O
factor	NN	O
for	IN	O
atherosclerosis	NN	B-Disease
.	.	O

Cholesteryl	NN	O
ester	NN	O
transfer	NN	O
protein	NN	O
(	-LRB-	O
CETP	NN	O
;	:	O
476	CD	O
amino	NN	O
acids	NNS	O
)	-RRB-	O
transfers	NNS	O
cholesteryl	NN	O
ester	NN	O
from	IN	O
HDL	NN	O
to	TO	O
other	JJ	O
lipoproteins	NNS	O
.	.	O

Subjects	NNS	O
with	IN	O
homozygous	JJ	O
CETP	NN	B-Disease
deficiency	NN	I-Disease
caused	VBN	O
by	IN	O
a	DT	O
gene	NN	O
splicing	NN	O
defect	NN	O
have	VBP	O
markedly	RB	O
elevated	JJ	O
HDL	NN	O
;	:	O
however	RB	O
,	,	O
heterozygotes	NNS	O
have	VBP	O
only	RB	O
mild	JJ	O
increases	NNS	O
in	IN	O
HDL	NN	O
.	.	O

We	PRP	O
describe	VBP	O
two	CD	O
probands	NNS	O
with	IN	O
a	DT	O
CETP	NN	O
missense	NN	O
mutation	NN	O
(	-LRB-	O
442	CD	O
D	NN	O
G	NN	O
)	-RRB-	O
.	.	O

Although	IN	O
heterozygous	JJ	O
,	,	O
they	PRP	O
have	VBP	O
threefold	JJ	O
increases	NNS	O
in	IN	O
HDL	NN	O
concentration	NN	O
and	CC	O
markedly	RB	O
decreased	VBD	O
plasma	NN	O
CETP	NN	O
mass	NN	O
and	CC	O
activity	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
has	VBZ	O
dominant	JJ	O
effects	NNS	O
on	IN	O
CETP	NN	O
and	CC	O
HDL	NN	O
in	FW	O
vivo	FW	O
.	.	O

Cellular	JJ	O
expression	NN	O
of	IN	O
mutant	JJ	O
cDNA	NN	O
results	VBZ	O
in	IN	O
secretion	NN	O
of	IN	O
only	RB	O
30	CD	O
%	NN	O
of	IN	O
wild	JJ	O
type	NN	O
CETP	NN	O
activity	NN	O
.	.	O

Moreover	RB	O
,	,	O
coexpression	NN	O
of	IN	O
wild	JJ	O
type	NN	O
and	CC	O
mutant	JJ	O
cDNAs	NNS	O
leads	VBZ	O
to	TO	O
inhibition	NN	O
of	IN	O
wild	JJ	O
type	NN	O
secretion	NN	O
and	CC	O
activity	NN	O
.	.	O

The	DT	O
dominant	JJ	O
effects	NNS	O
of	IN	O
the	DT	O
CETP	NN	O
missense	NN	O
mutation	NN	O
during	IN	O
cellular	JJ	O
expression	NN	O
probably	RB	O
explains	VBZ	O
why	WRB	O
the	DT	O
probands	NNS	O
have	VBP	O
markedly	RB	O
increased	VBN	O
HDL	NN	O
in	IN	O
the	DT	O
heterozygous	JJ	O
state	NN	O
,	,	O
and	CC	O
suggests	VBZ	O
that	IN	O
the	DT	O
active	JJ	O
molecular	JJ	O
species	NNS	O
of	IN	O
CETP	NN	O
may	MD	O
be	VB	O
multimeric	JJ	O
.	.	O

.	.	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
:	:	O
no	DT	O
evidence	NN	O
for	IN	O
locus	NN	O
heterogeneity	NN	O
.	.	O

A	DT	O
total	NN	O
of	IN	O
63	CD	O
families	NNS	O
with	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
were	VBD	O
examined	VBN	O
for	IN	O
linkage	NN	O
between	IN	O
HD	NN	B-Disease
and	CC	O
G8	NN	O
(	-LRB-	O
D4S10	NN	O
)	-RRB-	O
.	.	O

The	DT	O
families	NNS	O
included	VBD	O
57	CD	O
Caucasian	JJ	O
,	,	O
four	CD	O
Black	JJ	O
American	JJ	O
,	,	O
and	CC	O
two	CD	O
Japanese	NNS	O
.	.	O

The	DT	O
combined	JJ	O
maximum	NN	O
lod	NN	O
score	NN	O
was	VBD	O
87	CD	O
.	.	O

69	CD	O
at	IN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

04	NN	O
(	-LRB-	O
99	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
0	CD	O
.	.	O

018-0	NN	O
.	.	O

071	CD	O
)	-RRB-	O
.	.	O

The	DT	O
maximum	JJ	O
frequency	NN	O
of	IN	O
recombination	NN	O
was	VBD	O
0	CD	O
.	.	O

03	NN	O
in	IN	O
males	NNS	O
and	CC	O
0	CD	O
.	.	O

05	NN	O
in	IN	O
females	NNS	O
.	.	O

Fifty-seven	CD	O
families	NNS	O
gave	VBD	O
positive	JJ	O
lod	NN	O
scores	NNS	O
;	:	O
five	CD	O
small	JJ	O
families	NNS	O
gave	VBD	O
mildly	RB	O
negative	JJ	O
lod	NN	O
scores	NNS	O
.	.	O

The	DT	O
maximum	NN	O
likelihood	NN	O
estimate	NN	O
of	IN	O
alpha	NN	O
,	,	O
the	DT	O
proportion	NN	O
of	IN	O
linked	VBN	O
loci	NNS	O
,	,	O
was	VBD	O
1	CD	O
.	.	O

0	CD	O
with	IN	O
a	DT	O
lower	JJR	O
99	CD	O
%	NN	O
confidence	NN	O
interval	NN	O
of	IN	O
0	CD	O
.	.	O

88	CD	O
.	.	O

These	DT	O
data	NNS	O
suggest	VBP	O
that	IN	O
there	EX	O
is	VBZ	O
only	RB	O
one	CD	O
HD	NN	B-Disease
locus	NN	O
,	,	O
although	IN	O
a	DT	O
second	JJ	O
rare	JJ	O
locus	NN	O
can	MD	O
not	RB	O
be	VB	O
ruled	VBN	O
out	RP	O
.	.	O

Homozygous	JJ	O
and	CC	O
heterozygous	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
gene	NN	O
in	IN	O
patients	NNS	O
and	CC	O
carriers	NNS	O
of	IN	O
severe	JJ	B-Disease
von	NN	I-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
.	.	O

Severe	JJ	B-Disease
von	NN	I-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
undetectable	JJ	O
or	CC	O
trace	NN	O
quantities	NNS	O
of	IN	O
von	NN	B-Disease
Willebrand	NN	I-Disease
factor	NN	O
in	IN	O
plasma	NN	O
and	CC	O
tissue	NN	O
stores	NNS	O
.	.	O

We	PRP	O
have	VBP	O
studied	VBN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
10	CD	O
affected	JJ	O
individuals	NNS	O
from	IN	O
six	CD	O
families	NNS	O
with	IN	O
this	DT	O
disorder	NN	O
using	VBG	O
probes	NNS	O
from	IN	O
the	DT	O
5	CD	O
and	CC	O
3	CD	O
ends	NNS	O
of	IN	O
the	DT	O
vWF	NN	O
cDNA	NN	O
and	CC	O
with	IN	O
a	DT	O
probe	NN	O
extending	VBG	O
from	IN	O
the	DT	O
5	CD	O
end	NN	O
into	IN	O
the	DT	O
central	JJ	O
region	NN	O
.	.	O

Southern	NN	O
blots	NNS	O
of	IN	O
restriction	NN	O
endonuclease	NN	O
digests	NNS	O
and	CC	O
gene	NN	O
dosage	NN	O
analysis	NN	O
measurements	NNS	O
carried	VBD	O
out	RP	O
with	IN	O
quantitative	JJ	O
slot	NN	O
blots	NNS	O
of	IN	O
undigested	JJ	O
genomic	JJ	O
DNA	NN	O
separated	VBN	O
these	DT	O
patients	NNS	O
into	IN	O
three	CD	O
groups	NNS	O
.	.	O

The	DT	O
first	JJ	O
group	NN	O
consisted	VBD	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
complete	JJ	O
homozygous	JJ	O
deletions	NNS	O
of	IN	O
the	DT	O
vWF	NN	O
gene	NN	O
in	IN	O
the	DT	O
four	CD	O
probands	NNS	O
.	.	O

Gene	NNP	O
dosage	NN	O
analysis	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
heterozygous	JJ	O
deletions	NNS	O
in	IN	O
both	DT	O
of	IN	O
the	DT	O
asymptomatic	JJ	O
parents	NNS	O
and	CC	O
four	CD	O
asymptomatic	JJ	O
siblings	NNS	O
of	IN	O
this	DT	O
kindred	NN	O
(	-LRB-	O
P	NN	O
less	JJR	O
than	IN	O
0	CD	O
.	.	O

01	NN	O
)	-RRB-	O
.	.	O

The	DT	O
second	JJ	O
group	NN	O
was	VBD	O
comprised	VBN	O
of	IN	O
a	DT	O
family	NN	O
in	IN	O
which	WDT	O
there	EX	O
was	VBD	O
a	DT	O
complete	JJ	O
heterozygous	JJ	O
deletion	NN	O
of	IN	O
the	DT	O
vWF	NN	O
gene	NN	O
in	IN	O
the	DT	O
proband	NN	O
and	CC	O
one	CD	O
asymptomatic	JJ	O
parent	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
a	DT	O
different	JJ	O
type	NN	O
of	IN	O
genetic	JJ	B-Disease
abnormality	NN	I-Disease
was	VBD	O
inherited	VBN	O
from	IN	O
the	DT	O
other	JJ	O
parent	NN	O
.	.	O

Thus	RB	O
,	,	O
the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
doubly	RB	O
heterozygous	JJ	O
for	IN	O
interacting	VBG	O
genetic	JJ	B-Disease
abnormalities	NNS	I-Disease
affecting	VBG	O
vWF	NN	O
expression	NN	O
.	.	O

In	IN	O
the	DT	O
third	JJ	O
group	NN	O
,	,	O
no	DT	O
gene	NN	O
deletions	NNS	O
could	MD	O
be	VB	O
detected	VBN	O
.	.	O

Alloantibodies	NNS	O
developed	VBD	O
only	RB	O
in	IN	O
the	DT	O
kindred	NN	O
with	IN	O
homozygous	JJ	O
deletions	NNS	O
.	.	O

These	DT	O
techniques	NNS	O
should	MD	O
prove	VB	O
useful	JJ	O
in	IN	O
identifying	VBG	O
carriers	NNS	O
of	IN	O
severe	JJ	B-Disease
von	NN	I-Disease
Willebrand	NN	I-Disease
disease	NN	I-Disease
and	CC	O
also	RB	O
in	IN	O
defining	VBG	O
patients	NNS	O
predictably	RB	O
at	IN	O
risk	NN	O
of	IN	O
developing	VBG	O
alloantibodies	NNS	O
to	TO	O
vWF	NN	O
.	.	O

Spectrum	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
:	:	O
a	DT	O
study	NN	O
of	IN	O
232	CD	O
patients	NNS	O
with	IN	O
hereditary	JJ	B-Disease
and	CC	I-Disease
non	JJ	I-Disease
hereditary	JJ	I-Disease
retinoblastoma	NN	I-Disease
.	.	O

Germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
confer	VBP	O
hereditary	JJ	O
predisposition	NN	O
to	TO	O
retinoblastoma	NN	B-Disease
.	.	O

We	PRP	O
have	VBP	O
performed	VBN	O
a	DT	O
mutation	NN	O
survey	NN	O
of	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
in	IN	O
232	CD	O
patients	NNS	O
with	IN	O
hereditary	JJ	B-Disease
or	CC	I-Disease
non	JJ	I-Disease
hereditary	JJ	I-Disease
retinoblastoma	NN	I-Disease
.	.	O

We	PRP	O
systematically	RB	O
explored	VBD	O
all	DT	O
27	CD	O
exons	NNS	O
and	CC	O
flanking	JJ	O
sequences	NNS	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
promotor	NN	O
.	.	O

All	DT	O
types	NNS	O
of	IN	O
point	NN	O
mutations	NNS	O
are	VBP	O
represented	VBN	O
and	CC	O
are	VBP	O
found	VBN	O
unequally	RB	O
distributed	VBN	O
along	IN	O
the	DT	O
RB1	NN	O
gene	NN	O
sequence	NN	O
.	.	O

In	IN	O
the	DT	O
population	NN	O
we	PRP	O
studied	VBD	O
,	,	O
exons	NNS	O
3	CD	O
,	,	O
8	CD	O
,	,	O
18	CD	O
and	CC	O
19	CD	O
are	VBP	O
preferentially	RB	O
altered	VBN	O
.	.	O

The	DT	O
range	NN	O
of	IN	O
frequency	NN	O
of	IN	O
detection	NN	O
of	IN	O
germline	NN	O
mutations	NNS	O
is	VBZ	O
about	IN	O
20	CD	O
%	NN	O
,	,	O
indicating	VBG	O
that	IN	O
other	JJ	O
mechanisms	NNS	O
of	IN	O
inactivation	NN	O
of	IN	O
RB1	NN	O
should	MD	O
be	VB	O
involved	VBN	O
.	.	O

The	DT	O
spectrum	NN	O
of	IN	O
mutations	NNS	O
presented	VBN	O
here	RB	O
should	MD	O
help	VB	O
to	TO	O
improve	VB	O
the	DT	O
clinical	JJ	O
management	NN	O
of	IN	O
retinoblastoma	NN	B-Disease
and	CC	O
to	TO	O
understand	VB	O
the	DT	O
molecular	JJ	O
mechanisms	NNS	O
leading	VBG	O
to	TO	O
tumorigenesis	NN	O
.	.	O

.	.	O

Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
:	:	O
an	DT	O
X-linked	JJ	B-Disease
neurologic	JJ	I-Disease
disorder	NN	I-Disease
of	IN	I-Disease
myelin	JJ	I-Disease
metabolism	NN	I-Disease
with	IN	O
a	DT	O
novel	JJ	O
mutation	NN	O
in	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
proteolipid	NN	O
protein	NN	O
.	.	O

The	DT	O
nosology	NN	O
of	IN	O
the	DT	O
inborn	JJ	B-Disease
errors	NNS	I-Disease
of	IN	I-Disease
myelin	JJ	I-Disease
metabolism	NN	I-Disease
has	VBZ	O
been	VBN	O
stymied	VBN	O
by	IN	O
the	DT	O
lack	NN	O
of	IN	O
molecular	JJ	O
genetic	JJ	O
analysis	NN	O
.	.	O

Historically	NNP	O
,	,	O
Pelizaeus-Merzbacher	NNP	B-Disease
disease	NN	I-Disease
has	VBZ	O
encompassed	VBN	O
a	DT	O
host	NN	O
of	IN	O
neurologic	JJ	B-Disease
disorders	NNS	I-Disease
that	WDT	O
present	VBP	O
with	IN	O
a	DT	O
deficit	NN	B-Disease
of	IN	I-Disease
myelin	JJ	I-Disease
,	,	O
the	DT	O
membrane	NN	O
elaborated	VBN	O
by	IN	O
glial	JJ	O
cells	NNS	O
that	WDT	O
encircles	VBZ	O
and	CC	O
successively	RB	O
enwraps	VBZ	O
axons	NNS	O
.	.	O

We	PRP	O
describe	VBP	O
here	RB	O
a	DT	O
Pelizaeus-Merzbacher	JJ	B-Disease
pedigree	NN	O
of	IN	O
the	DT	O
classical	JJ	O
type	NN	O
,	,	O
with	IN	O
X-linked	JJ	O
inheritance	NN	O
,	,	O
a	DT	O
typical	JJ	O
clinical	JJ	O
progression	NN	O
,	,	O
and	CC	O
a	DT	O
pathologic	JJ	O
loss	NN	O
of	IN	O
myelinating	JJ	O
cells	NNS	O
and	CC	O
myelin	JJ	O
in	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
.	.	O

To	TO	O
discriminate	VB	O
variants	NNS	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
,	,	O
a	DT	O
set	NN	O
of	IN	O
oligonucleotide	NN	O
primers	NNS	O
was	VBD	O
constructed	VBN	O
to	TO	O
polymerase-chain-reaction	JJ	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
amplify	VBP	O
and	CC	O
sequence	NN	O
the	DT	O
gene	NN	O
encoding	VBG	O
proteolipid	NN	O
protein	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
,	,	O
a	DT	O
structural	JJ	O
protein	NN	O
that	WDT	O
comprises	VBZ	O
half	NN	O
of	IN	O
the	DT	O
protein	NN	O
of	IN	O
the	DT	O
myelin	JJ	O
sheath	NN	O
.	.	O

The	DT	O
PLP	NN	O
gene	NN	O
in	IN	O
one	CD	O
of	IN	O
two	CD	O
affected	JJ	O
males	NNS	O
and	CC	O
the	DT	O
carrier	NN	O
mother	NN	O
of	IN	O
this	DT	O
family	NN	O
exhibited	VBD	O
a	DT	O
single	JJ	O
base	NN	O
difference	NN	O
in	IN	O
the	DT	O
more	JJR	O
than	IN	O
2	CD	O
kb	NN	O
of	IN	O
the	DT	O
PLP	NN	O
gene	NN	O
sequenced	VBN	O
,	,	O
a	DT	O
C	NN	O
----	:	O
T	NN	O
transition	NN	O
that	WDT	O
would	MD	O
create	VB	O
a	DT	O
serine	NN	O
substitution	NN	O
for	IN	O
proline	NN	O
at	IN	O
the	DT	O
carboxy	NN	O
end	NN	O
of	IN	O
the	DT	O
protein	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
delineate	VBP	O
the	DT	O
clinical	JJ	O
features	NNS	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
,	,	O
define	VB	O
the	DT	O
possible	JJ	O
molecular	JJ	O
pathology	NN	O
of	IN	O
this	DT	O
dysmyelinating	JJ	B-Disease
disorder	NN	I-Disease
,	,	O
and	CC	O
address	VB	O
the	DT	O
molecular	JJ	O
classification	NN	O
of	IN	O
inborn	JJ	B-Disease
errors	NNS	I-Disease
of	IN	I-Disease
myelin	JJ	I-Disease
metabolism	NN	I-Disease
.	.	O

Patients	NNS	O
with	IN	O
the	DT	O
classical	JJ	O
form	NN	O
(	-LRB-	O
type	NN	O
I	CD	O
)	-RRB-	O
and	CC	O
the	DT	O
more	RBR	O
severely	RB	O
affected	VBN	O
,	,	O
connatal	JJ	O
variant	NN	O
of	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	I-Disease
type	NN	I-Disease
II	CD	I-Disease
)	-RRB-	I-Disease
would	MD	O
be	VB	O
predicted	VBN	O
to	TO	O
display	VB	O
mutation	NN	O
at	IN	O
the	DT	O
PLP	NN	O
locus	NN	O
.	.	O

The	DT	O
other	JJ	O
variants	NNS	O
(	-LRB-	O
types	NNS	O
III-VI	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
have	VBP	O
sometimes	RB	O
been	VBN	O
categorized	VBN	O
as	IN	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
,	,	O
may	MD	O
represent	VB	O
mutations	NNS	O
in	IN	O
genes	NNS	O
encoding	VBG	O
other	JJ	O
structural	JJ	O
myelin	JJ	O
proteins	NNS	O
or	CC	O
proteins	NNS	O
critical	JJ	O
to	TO	O
myelination	NN	O
.	.	O

.	.	O

CAG	NN	O
expansions	NNS	O
in	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
for	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
at	IN	O
chromosome	NN	O
14q32	NN	O
.1	NN	O
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
novel	JJ	O
gene	NN	O
containing	VBG	O
CAG	NN	O
repeats	NNS	O
and	CC	O
mapped	VBD	O
it	PRP	O
to	TO	O
chromosome	NN	O
14q32	NN	O
.	.	O

1	CD	O
,	,	O
the	DT	O
genetic	JJ	O
locus	NN	O
for	IN	O
Machado-Joseph	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
MJD	NN	B-Disease
)	-RRB-	O
.	.	O

In	IN	O
normal	JJ	O
individuals	NNS	O
the	DT	O
gene	NN	O
contains	VBZ	O
between	IN	O
13	CD	O
and	CC	O
36	CD	O
CAG	NN	O
repeats	NNS	O
,	,	O
whereas	IN	O
most	JJS	O
of	IN	O
the	DT	O
clinically	RB	O
diagnosed	VBN	O
patients	NNS	O
and	CC	O
all	DT	O
of	IN	O
the	DT	O
affected	VBN	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
pathological	JJ	O
diagnosis	NN	O
of	IN	O
MJD	NN	B-Disease
show	VBP	O
expansion	NN	O
of	IN	O
the	DT	O
repeat-number	NN	O
(	-LRB-	O
from	IN	O
68-79	CD	O
)	-RRB-	O
.	.	O

Southern	NN	O
blot	NN	O
analyses	NNS	O
and	CC	O
genomic	JJ	O
cloning	NN	O
demonstrates	VBZ	O
the	DT	O
existence	NN	O
of	IN	O
related	JJ	O
genes	NNS	O
.	.	O

These	DT	O
results	NNS	O
raise	VBP	O
the	DT	O
possibility	NN	O
that	IN	O
similar	JJ	O
abnormalities	NNS	O
in	IN	O
related	JJ	O
genes	NNS	O
may	MD	O
give	VB	O
rise	VB	O
to	TO	O
diseases	NNS	O
similar	JJ	O
to	TO	O
MJD	NN	B-Disease
.	.	O

Conservation	NNP	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
in	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
.	.	O

A	DT	O
portion	NN	O
of	IN	O
the	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
transcript	NN	O
from	IN	O
human	JJ	O
fetal	JJ	O
skeletal	JJ	O
muscle	NN	O
and	CC	O
mouse	NN	O
adult	JJ	O
heart	NN	O
was	VBD	O
sequenced	VBN	O
,	,	O
representing	VBG	O
approximately	RB	O
25	CD	O
percent	NN	O
of	IN	O
the	DT	O
total	NN	O
,	,	O
14-kb	JJ	O
DMD	NN	B-Disease
transcript	NN	O
.	.	O

The	DT	O
nucleic	JJ	O
acid	NN	O
and	CC	O
predicted	VBD	O
amino	NN	O
acid	NN	O
sequences	NNS	O
from	IN	O
the	DT	O
two	CD	O
species	NNS	O
are	VBP	O
nearly	RB	O
90	CD	O
percent	NN	O
homologous	JJ	O
.	.	O

The	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
that	WDT	O
is	VBZ	O
predicted	VBN	O
from	IN	O
this	DT	O
portion	NN	O
of	IN	O
the	DT	O
DMD	NNP	B-Disease
gene	NN	O
indicates	VBZ	O
that	IN	O
the	DT	O
protein	NN	O
product	NN	O
might	MD	O
serve	VB	O
a	DT	O
structural	JJ	O
role	NN	O
in	IN	O
muscle	NN	O
,	,	O
but	CC	O
the	DT	O
abundance	NN	O
and	CC	O
tissue	NN	O
distribution	NN	O
of	IN	O
the	DT	O
messenger	NN	O
RNA	NN	O
suggests	VBZ	O
that	IN	O
the	DT	O
DMD	NNP	B-Disease
protein	NN	O
is	VBZ	O
not	RB	O
nebulin	NN	O
.	.	O

.	.	O

Deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
murine	JJ	I-Disease
fifth	JJ	I-Disease
complement	NN	I-Disease
component	NN	I-Disease
(	-LRB-	I-Disease
C5	NN	I-Disease
)	-RRB-	I-Disease
.	.	O

A	DT	O
2-base	JJ	O
pair	NN	O
gene	NN	O
deletion	NN	O
in	IN	O
a	DT	O
5	CD	O
'	''	O
-	:	O
exon	NN	O
.	.	O

To	TO	O
ascertain	VB	O
the	DT	O
molecular	JJ	O
mechanism	NN	O
that	WDT	O
causes	VBZ	O
murine	JJ	O
C5	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
genomic	JJ	O
and	CC	O
cDNA	NN	O
libraries	NNS	O
were	VBD	O
constructed	VBN	O
from	IN	O
mouse	NN	O
liver	NN	O
DNA	NN	O
and	CC	O
mRNA	NN	O
employing	VBG	O
the	DT	O
congenic	JJ	O
strains	NNS	O
B10	NN	O
.	.	O

D2/nSnJ	NN	O
and	CC	O
B10	NN	O
.	.	O

D2/oSnJ	NN	O
that	WDT	O
are	VBP	O
sufficient	JJ	O
and	CC	O
deficient	JJ	B-Disease
for	IN	I-Disease
C5	NN	I-Disease
,	,	O
respectively	RB	O
.	.	O

Genomic	JJ	O
fragments	NNS	O
were	VBD	O
isolated	VBN	O
which	WDT	O
correspond	VBP	O
to	TO	O
PvuII	NN	O
and	CC	O
HindIII	NN	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
associated	VBN	O
with	IN	O
C5	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Sequence	NN	O
analyses	NNS	O
demonstrated	VBD	O
that	IN	O
each	DT	O
of	IN	O
these	DT	O
polymorphisms	NNS	O
resulted	VBD	O
from	IN	O
single	JJ	O
base	NN	O
pair	NN	O
substitutions	NNS	O
and	CC	O
that	IN	O
neither	CC	O
substitution	NN	O
would	MD	O
probably	RB	O
cause	VB	O
or	CC	O
contribute	VB	O
to	TO	O
the	DT	O
C5	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

Sequence	NN	O
analyses	NNS	O
of	IN	O
C5	NN	O
sufficient	JJ	O
and	CC	O
deficient	JJ	O
cDNAs	NNS	O
revealed	VBD	O
a	DT	O
2	CD	O
base-pair	NN	O
deletion	NN	O
in	IN	O
the	DT	O
deficient	JJ	O
cDNAs	NNS	O
.	.	O

The	DT	O
"	''	O
TA	NNP	O
"	''	O
deletion	NN	O
was	VBD	O
located	JJ	O
near	IN	O
the	DT	O
5	CD	O
end	NN	O
of	IN	O
the	DT	O
cDNA	NN	O
.	.	O

This	DT	O
deletion	NN	O
shifts	VBZ	O
the	DT	O
reading	NN	O
frame	NN	O
of	IN	O
the	DT	O
C5	NN	O
mRNA	NN	O
so	IN	O
that	IN	O
the	DT	O
termination	NN	O
codon	NN	O
UGA	NNP	O
is	VBZ	O
present	JJ	O
4	CD	O
base	NN	O
pairs	NNS	O
downstream	RB	O
from	IN	O
the	DT	O
deletion	NN	O
.	.	O

Genomic	JJ	O
DNA	NN	O
was	VBD	O
amplified	VBN	O
and	CC	O
sequenced	VBN	O
corresponding	VBG	O
to	TO	O
the	DT	O
area	NN	O
surrounding	VBG	O
the	DT	O
2-base	JJ	O
pair	NN	O
deletion	NN	O
.	.	O

Six	CD	O
C5-deficient	JJ	B-Disease
strains	NNS	O
,	,	O
A/HeJ	NN	O
,	,	O
AKR/J	NN	O
,	,	O
DBA/2J	NN	O
,	,	O
NZB/B1NJ	NN	O
,	,	O
SWR/J	NN	O
,	,	O
and	CC	O
B10	NN	O
.	.	O

D2/oSnJ	NN	O
,	,	O
and	CC	O
four	CD	O
C5-sufficient	JJ	O
strains	NNS	O
,	,	O
Balb/CJ	NN	O
,	,	O
C57Bl/6J	NN	O
,	,	O
DBA/1J	NN	O
,	,	O
and	CC	O
B10	NN	O
.	.	O

D2/nSnJ	NN	O
,	,	O
were	VBD	O
analyzed	VBN	O
.	.	O

The	DT	O
sequencing	NN	O
data	NNS	O
revealed	VBD	O
that	IN	O
the	DT	O
2	CD	O
base	NN	O
pairs	NNS	O
were	VBD	O
deleted	VBN	O
from	IN	O
the	DT	O
C5	NN	O
gene	NN	O
of	IN	O
each	DT	O
deficient	JJ	O
mouse	NN	O
tested	VBN	O
but	CC	O
not	RB	O
from	IN	O
the	DT	O
C5	NN	O
gene	NN	O
of	IN	O
any	DT	O
sufficient	JJ	O
mouse	NN	O
.	.	O

These	DT	O
data	NNS	O
demonstrate	VBP	O
that	IN	O
1	LS	O
)	-RRB-	O
there	EX	O
is	VBZ	O
an	DT	O
identical	JJ	O
2-base	NN	O
pair	NN	O
deletion	NN	O
in	IN	O
an	DT	O
exon	NN	O
of	IN	O
the	DT	O
C5	NN	O
gene	NN	O
in	IN	O
several	JJ	O
different	JJ	O
C5-deficient	JJ	B-Disease
mouse	NN	O
strains	NNS	O
;	:	O
2	LS	O
)	-RRB-	O
the	DT	O
mRNA	NN	O
transcribed	VBN	O
from	IN	O
the	DT	O
C5D	NN	O
gene	NN	O
retains	VBZ	O
this	DT	O
deletion	NN	O
;	:	O
and	CC	O
3	LS	O
)	-RRB-	O
this	DT	O
mutation	NN	O
should	MD	O
result	VB	O
in	IN	O
C5	NN	B-Disease
protein	NN	I-Disease
deficiency	NN	I-Disease
.	.	O

Recurrent	JJ	O
meningitis	NN	B-Disease
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
congenital	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
C9	NN	I-Disease
component	NN	I-Disease
of	IN	I-Disease
complement	NN	I-Disease
.	.	O

First	NNP	O
case	NN	O
of	IN	O
C9	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Europe	NNP	O
.	.	O

We	PRP	O
describe	VBP	O
the	DT	O
first	JJ	O
cases	NNS	O
,	,	O
to	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
of	IN	O
C9	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
Europe	NNP	O
that	WDT	O
were	VBD	O
detected	VBN	O
in	IN	O
a	DT	O
Swiss	JJ	O
family	NN	O
,	,	O
of	IN	O
which	WDT	O
two	CD	O
members	NNS	O
--	:	O
one	CD	O
with	IN	O
a	DT	O
complete	JJ	O
deficiency	NN	O
and	CC	O
the	DT	O
other	JJ	O
with	IN	O
approximately	RB	O
half-normal	JJ	O
C9	NN	O
levels	NNS	O
--	:	O
experienced	JJ	O
bacterial	JJ	B-Disease
meningitis	NN	I-Disease
.	.	O

The	DT	O
index	NN	O
patient	NN	O
,	,	O
a	DT	O
56-year-old	JJ	O
white	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
purulent	JJ	B-Disease
meningitis	NN	I-Disease
at	IN	O
the	DT	O
age	NN	O
of	IN	O
23	CD	O
years	NNS	O
,	,	O
presented	VBN	O
with	IN	O
an	DT	O
acute	JJ	B-Disease
meningococcal	JJ	I-Disease
meningitis	NN	I-Disease
.	.	O

No	DT	O
impairment	NN	B-Disease
of	IN	I-Disease
cellular	JJ	I-Disease
immunity	NN	I-Disease
or	CC	O
immunoglobulin	NN	B-Disease
deficiency	NN	I-Disease
could	MD	O
be	VB	O
found	VBN	O
.	.	O

Complement	NN	O
assays	NNS	O
showed	VBD	O
a	DT	O
complete	JJ	B-Disease
deficiency	NN	I-Disease
of	IN	I-Disease
the	DT	I-Disease
C9	NN	I-Disease
component	NN	I-Disease
,	,	O
while	IN	O
the	DT	O
other	JJ	O
individual	JJ	O
component	NN	O
levels	NNS	O
were	VBD	O
normal	JJ	O
and	CC	O
the	DT	O
hemolytic	JJ	O
activity	NN	O
(	-LRB-	O
measured	VBN	O
using	VBG	O
the	DT	O
CH50	NN	O
assay	NN	O
)	-RRB-	O
was	VBD	O
only	RB	O
slightly	RB	O
reduced	VBN	O
.	.	O

A	DT	O
family	NN	O
study	NN	O
revealed	VBD	O
complete	JJ	B-Disease
C9	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
the	DT	O
patients	NNS	O
healthy	JJ	O
brother	NN	O
and	CC	O
half-normal	JJ	O
C9	NN	O
concentrations	NNS	O
in	IN	O
his	PRP$	O
sister	NN	O
,	,	O
his	PRP$	O
son	NN	O
(	-LRB-	O
who	WP	O
also	RB	O
had	VBD	O
experienced	VBN	O
an	DT	O
episode	NN	O
of	IN	O
bacterial	JJ	B-Disease
meningitis	NN	I-Disease
)	-RRB-	O
,	,	O
and	CC	O
his	PRP$	O
niece	NN	O
,	,	O
consistent	JJ	O
with	IN	O
an	DT	O
inherited	VBN	O
C9	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

This	DT	O
first	JJ	O
case	NN	O
of	IN	O
recurrent	JJ	B-Disease
meningitis	NN	I-Disease
in	IN	O
a	DT	O
white	JJ	O
patient	NN	O
with	IN	O
complete	JJ	B-Disease
C9	NN	I-Disease
deficiency	NN	I-Disease
suggests	VBZ	O
that	IN	O
this	DT	O
complement	NN	B-Disease
defect	NN	I-Disease
may	MD	O
also	RB	O
be	VB	O
a	DT	O
risk	NN	O
factor	NN	O
for	IN	O
bacterial	JJ	B-Disease
,	,	I-Disease
especially	RB	I-Disease
neisserial	JJ	I-Disease
,	,	I-Disease
infections	NNS	I-Disease
.	.	O

.	.	O

Bone	NN	O
marrow	NN	O
transplant	NN	O
in	IN	O
adrenoleukodystrophy	NN	B-Disease
.	.	O

An	DT	O
allogeneic	JJ	O
bone	NN	O
marrow	NN	O
transplant	NN	O
(	-LRB-	O
BMT	NN	O
)	-RRB-	O
from	IN	O
a	DT	O
normal	JJ	O
HLA	NN	O
identical	JJ	O
sibling	NN	O
donor	NN	O
was	VBD	O
performed	VBN	O
in	IN	O
a	DT	O
13-year-old	JJ	O
boy	NN	O
with	IN	O
rapidly	RB	O
progressive	JJ	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
.	.	O

Engraftment	NNP	O
and	CC	O
complete	JJ	O
hematologic	JJ	O
recovery	NN	O
occurred	VBD	O
within	IN	O
4	CD	O
weeks	NNS	O
,	,	O
but	CC	O
neurologic	JJ	B-Disease
deterioration	NN	I-Disease
continued	VBD	O
.	.	O

The	DT	O
patient	NN	O
died	VBD	O
of	IN	O
an	DT	O
adenovirus	NN	B-Disease
infection	NN	I-Disease
141	CD	O
days	NNS	O
after	IN	O
BMT	NN	O
.	.	O

ALD	NN	B-Disease
is	VBZ	O
characterized	VBN	O
by	IN	O
abnormally	RB	O
high	JJ	O
plasma	NN	O
levels	NNS	O
of	IN	O
very	RB	O
long	JJ	O
chain	NN	O
fatty	JJ	O
acids	NNS	O
(	-LRB-	O
VLCFA	NN	O
)	-RRB-	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
impaired	JJ	O
capacity	NN	O
to	TO	O
degrade	VB	O
them	PRP	O
.	.	O

Ten	CD	O
days	NNS	O
after	IN	O
BMT	NN	O
,	,	O
the	DT	O
white	JJ	O
blood	NN	O
cell	NN	O
VLCFA	NN	O
levels	NNS	O
and	CC	O
enzyme	NN	O
activity	NN	O
became	VBD	O
normal	JJ	O
;	:	O
after	IN	O
3	CD	O
months	NNS	O
,	,	O
there	EX	O
was	VBD	O
progressive	JJ	O
reduction	NN	O
of	IN	O
plasma	NN	O
VLCFA	NN	O
to	TO	O
levels	NNS	O
only	RB	O
slightly	RB	O
above	IN	O
normal	JJ	O
.	.	O

.	.	O

Increased	VBN	O
incidence	NN	O
of	IN	O
cataracts	NNS	B-Disease
in	IN	O
male	JJ	O
subjects	NNS	O
deficient	JJ	B-Disease
in	IN	I-Disease
glucose-6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
.	.	O

Glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
RBCs	NNS	O
was	VBD	O
found	VBN	O
significantly	RB	O
more	RBR	O
frequently	RB	O
in	IN	O
210	CD	O
male	JJ	O
cataractous	JJ	B-Disease
patients	NNS	O
than	IN	O
in	IN	O
672	CD	O
control	JJ	O
subjects	NNS	O
of	IN	O
Sardinian	JJ	O
origin	NN	O
.	.	O

The	DT	O
frequency	NN	O
of	IN	O
the	DT	O
deficiency	NN	O
was	VBD	O
increasingly	RB	O
higher	JJR	O
in	IN	O
presenile	JJ	O
cataracts	NNS	B-Disease
.	.	O

In	IN	O
the	DT	O
G6PD-deficient	JJ	B-Disease
group	NN	O
,	,	O
the	DT	O
incidence	NN	O
of	IN	O
cortical	JJ	B-Disease
and	CC	I-Disease
total	JJ	I-Disease
cataracts	NNS	I-Disease
was	VBD	O
also	RB	O
increased	VBN	O
.	.	O

It	PRP	O
is	VBZ	O
suggested	VBN	O
that	IN	O
decrease	NN	O
of	IN	O
the	DT	O
G6PD	NN	O
activity	NN	O
in	IN	O
the	DT	O
lens	NN	O
,	,	O
which	WDT	O
accompanies	VBZ	O
its	PRP$	O
deficiency	NN	O
in	IN	O
the	DT	O
erythrocyte	NN	O
,	,	O
might	MD	O
play	VB	O
a	DT	O
role	NN	O
in	IN	O
the	DT	O
cataracto-genesis	NN	O
of	IN	O
these	DT	O
patients	NNS	O
.	.	O

Moreover	RB	O
,	,	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
should	MD	O
be	VB	O
added	VBN	O
to	TO	O
other	JJ	O
conditions	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
galactosemic	JJ	B-Disease
states	NNS	O
and	CC	O
riboflavin	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
where	WRB	O
cataracts	NNS	B-Disease
represent	VBP	O
a	DT	O
sensitive	JJ	O
indicator	NN	O
of	IN	O
metabolic	JJ	B-Disease
abnormalities	NNS	I-Disease
of	IN	O
the	DT	O
RBC	NN	O
.	.	O

.	.	O

Von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
disease	NN	I-Disease
maps	VBZ	O
to	TO	O
the	DT	O
region	NN	O
of	IN	O
chromosome	NN	O
3	CD	O
associated	VBN	O
with	IN	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
.	.	O

Von	NNP	B-Disease
Hippel-Lindau	NNP	I-Disease
disease	NN	I-Disease
(	-LRB-	O
VHL	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
disorder	NN	I-Disease
with	IN	O
inherited	VBN	O
susceptibility	NN	O
to	TO	O
various	JJ	O
forms	NNS	O
of	IN	O
cancer	NN	B-Disease
,	,	O
including	VBG	O
hemangioblastomas	NNS	B-Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
phaeochromocytomas	NN	B-Disease
,	,	O
pancreatic	JJ	B-Disease
malignancies	NNS	I-Disease
,	,	O
and	CC	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
.	.	O

Renal	JJ	B-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
constitute	VBP	O
a	DT	O
particularly	RB	O
frequent	JJ	O
cause	NN	O
of	IN	O
death	NN	O
in	IN	O
this	DT	O
disorder	NN	O
,	,	O
occurring	VBG	O
as	IN	O
bilateral	JJ	B-Disease
and	CC	I-Disease
multifocal	JJ	I-Disease
tumours	NNS	I-Disease
,	,	O
and	CC	O
presenting	VBG	O
at	IN	O
an	DT	O
earlier	JJR	O
age	NN	O
than	IN	O
in	IN	O
sporadic	JJ	O
,	,	O
non-familial	JJ	O
cases	NNS	O
of	IN	O
this	DT	O
tumour	NN	B-Disease
type	NN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
that	IN	O
the	DT	O
VHL	NN	B-Disease
gene	NN	O
is	VBZ	O
linked	VBN	O
to	TO	O
the	DT	O
locus	NN	O
encoding	VBG	O
the	DT	O
human	JJ	O
homologoue	NN	O
of	IN	O
the	DT	O
RAF1	NN	O
oncogene	NN	O
,	,	O
which	WDT	O
maps	VBZ	O
to	TO	O
chromosome	NN	O
3p25	CD	O
(	-LRB-	O
ref	NN	O
.	.	O

4	LS	O
)	-RRB-	O
.	.	O

Crossovers	NNS	O
with	IN	O
the	DT	O
VHL	NN	B-Disease
locus	NN	O
suggest	VBP	O
that	IN	O
the	DT	O
defect	NN	O
responsible	JJ	O
for	IN	O
the	DT	O
VHL	NN	B-Disease
phenotype	NN	O
is	VBZ	O
not	RB	O
a	DT	O
mutation	NN	O
in	IN	O
the	DT	O
RAF1	NN	O
gene	NN	O
itself	PRP	O
.	.	O

An	DT	O
alternative	JJ	O
or	CC	O
prior	JJ	O
event	NN	O
to	TO	O
oncogene	NN	O
activation	NN	O
in	IN	O
tumour	NN	B-Disease
formation	NN	O
may	MD	O
be	VB	O
the	DT	O
inactivation	NN	O
of	IN	O
a	DT	O
putative	JJ	O
tumour	NN	B-Disease
suppressor	NN	O
which	WDT	O
can	MD	O
be	VB	O
associated	VBN	O
with	IN	O
both	CC	O
the	DT	O
inherited	VBN	B-Disease
and	CC	I-Disease
sporadic	JJ	I-Disease
forms	NNS	I-Disease
of	IN	I-Disease
the	DT	I-Disease
cancer	NN	I-Disease
.	.	O

Sporadic	JJ	B-Disease
renal	JJ	I-Disease
cell	NN	I-Disease
carcinomas	NNS	I-Disease
have	VBP	O
previously	RB	O
been	VBN	O
associated	VBN	O
with	IN	O
the	DT	O
loss	NN	O
of	IN	O
regions	NNS	O
on	IN	O
chromosome	NN	O
3p	NN	O
(	-LRB-	O
refs	NNS	O
5	CD	O
,	,	O
6	CD	O
)	-RRB-	O
.	.	O

Consequently	RB	O
,	,	O
sporadic	JJ	O
and	CC	O
VHL-associated	JJ	O
forms	NNS	O
of	IN	O
renal	JJ	B-Disease
cell	NN	I-Disease
carcinoma	NN	I-Disease
might	MD	O
both	DT	O
result	VBP	O
from	IN	O
alterations	NNS	O
causing	VBG	O
loss	NN	O
of	IN	O
function	NN	O
of	IN	O
the	DT	O
same	JJ	O
tumour	NN	B-Disease
suppressor	NN	O
gene	NN	O
on	IN	O
this	DT	O
chromosome	NN	O
.	.	O

.	.	O

Tightly	RB	O
linked	VBN	O
flanking	JJ	O
markers	NNS	O
for	IN	O
the	DT	O
Lowe	NNP	B-Disease
oculocerebrorenal	JJ	I-Disease
syndrome	NN	I-Disease
,	,	O
with	IN	O
application	NN	O
to	TO	O
carrier	NN	O
assessment	NN	O
.	.	O

The	DT	O
Lowe	NNP	B-Disease
oculocerebrorenal	JJ	I-Disease
syndrome	NN	I-Disease
(	-LRB-	O
OCRL	NN	B-Disease
)	-RRB-	O
is	VBZ	O
characterized	VBN	O
by	IN	O
congenital	JJ	O
cataract	NN	B-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
and	CC	O
defective	JJ	B-Disease
renal	JJ	I-Disease
tubular	JJ	I-Disease
function	NN	I-Disease
.	.	O

A	DT	O
map	NN	O
assignment	NN	O
of	IN	O
OCRL	NN	B-Disease
to	TO	O
Xq24-q26	NN	O
has	VBZ	O
been	VBN	O
made	VBN	O
previously	RB	O
by	IN	O
linkage	NN	O
analysis	NN	O
with	IN	O
DXS42	NN	O
at	IN	O
Xq24-q26	NN	O
(	-LRB-	O
theta	NN	O
=	JJ	O
0	CD	O
,	,	O
z	SYM	O
=	JJ	O
5	CD	O
.	.	O

09	NN	O
)	-RRB-	O
and	CC	O
with	IN	O
DXS10	NN	O
at	IN	O
Xq26	NN	O
(	-LRB-	O
theta	NN	O
=	JJ	O
0	CD	O
,	,	O
z	SYM	O
=	SYM	O
6	CD	O
.	.	O

45	CD	O
)	-RRB-	O
.	.	O

Two	CD	O
additional	JJ	O
families	NNS	O
were	VBD	O
studied	VBN	O
and	CC	O
three	CD	O
additional	JJ	O
polymorphisms	NNS	O
were	VBD	O
identified	VBN	O
at	IN	O
DXS42	NN	O
by	IN	O
using	VBG	O
a	DT	O
35-kb	JJ	O
sequence	NN	O
isolated	VBN	O
with	IN	O
the	DT	O
probe	NN	O
detecting	VBG	O
the	DT	O
original	JJ	O
polymorphism	NN	O
at	IN	O
DXS42	NN	O
.	.	O

With	IN	O
additional	JJ	O
OCRL	NN	B-Disease
families	NNS	O
made	VBD	O
informative	JJ	O
for	IN	O
DXS42	NN	O
,	,	O
theta	NN	O
remained	VBD	O
0	CD	O
with	IN	O
z	SYM	O
=	SYM	O
6	CD	O
.	.	O

63	CD	O
;	:	O
and	CC	O
for	IN	O
DXS10	NN	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

03	NN	O
and	CC	O
z	SYM	O
=	JJ	O
7	CD	O
.	.	O

07	RB	O
.	.	O

Evidence	NN	O
for	IN	O
placing	VBG	O
OCRL	NN	O
at	IN	O
Xq25	NN	O
also	RB	O
comes	VBZ	O
from	IN	O
a	DT	O
female	JJ	O
with	IN	O
Lowe	NNP	B-Disease
syndrome	NN	I-Disease
and	CC	O
an	DT	O
X	NN	O
;	:	O
3	CD	O
translocation	NN	O
.	.	O

We	PRP	O
have	VBP	O
used	VBN	O
the	DT	O
Xq25	NN	O
breakpoint	NN	O
in	IN	O
this	DT	O
patient	NN	O
to	TO	O
determine	VB	O
the	DT	O
position	NN	O
of	IN	O
OCRL	NN	O
relative	JJ	O
to	TO	O
the	DT	O
two	CD	O
linked	VBN	O
markers	NNS	O
.	.	O

Each	DT	O
derivative	NN	O
chromosome	NN	O
was	VBD	O
isolated	VBN	O
away	RB	O
from	IN	O
its	PRP$	O
normal	JJ	O
counterpart	NN	O
in	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

DXS42	NN	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
derivative	NN	O
chromosome	NN	O
X	NN	O
containing	VBG	O
Xpterq25	NN	O
,	,	O
and	CC	O
DXS10	NN	O
was	VBD	O
mapped	VBN	O
to	TO	O
the	DT	O
derivative	NN	O
chromosome	NN	O
3	CD	O
containing	VBG	O
Xq25-qter	NN	O
.	.	O

The	DT	O
markers	NNS	O
DXS10	NN	O
and	CC	O
DXS42	NN	O
therefore	RB	O
show	VBP	O
tight	JJ	O
linkage	NN	O
with	IN	O
OCRL	NN	B-Disease
in	IN	O
six	CD	O
families	NNS	O
and	CC	O
flank	VB	O
the	DT	O
Xq25	NN	O
breakpoint	NN	O
in	IN	O
a	DT	O
female	JJ	O
patient	NN	O
with	IN	O
an	DT	O
X	NN	O
;	:	O
3	CD	O
translocation	NN	O
.	.	O

Linkage	NN	O
analysis	NN	O
with	IN	O
flanking	JJ	O
markers	NNS	O
was	VBD	O
used	VBN	O
to	TO	O
assess	VB	O
OCRL	NN	B-Disease
carrier	NN	O
status	NN	O
in	IN	O
women	NNS	O
at	IN	O
risk	NN	O
.	.	O

Results	NNS	O
,	,	O
when	WRB	O
compared	VBN	O
with	IN	O
carrier	NN	O
determination	NN	O
by	IN	O
ophthalmologic	JJ	O
examination	NN	O
,	,	O
indicated	VBD	O
that	IN	O
the	DT	O
slit-lamp	JJ	O
exam	NN	O
can	MD	O
be	VB	O
a	DT	O
sensitive	JJ	O
and	CC	O
specific	JJ	O
method	NN	O
of	IN	O
carrier	NN	O
determination	NN	O
in	IN	O
many	JJ	O
cases	NNS	O

Abnormal	JJ	O
development	NN	O
of	IN	O
Purkinje	NN	O
cells	NNS	O
and	CC	O
lymphocytes	NNS	O
in	IN	O
Atm	NN	O
mutant	JJ	O
mice	NNS	O
.	.	O

Motor	NNP	B-Disease
incoordination	NN	I-Disease
,	,	O
immune	JJ	B-Disease
deficiencies	NNS	I-Disease
,	,	O
and	CC	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
cancer	NN	B-Disease
are	VBP	O
the	DT	O
characteristic	JJ	O
features	NNS	O
of	IN	O
the	DT	O
hereditary	JJ	B-Disease
disease	NN	I-Disease
ataxia-telangiectasia	NN	B-Disease
(	-LRB-	O
A-T	NN	B-Disease
)	-RRB-	O
,	,	O
which	WDT	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Through	IN	O
gene	NN	O
targeting	NN	O
,	,	O
we	PRP	O
have	VBP	O
generated	VBN	O
a	DT	O
line	NN	O
of	IN	O
Atm	NN	O
mutant	JJ	O
mice	NNS	O
,	,	O
Atm	NN	O
(	-LRB-	O
y/y	NN	O
)	-RRB-	O
mice	NNS	O
.	.	O

In	IN	O
contrast	NN	O
to	TO	O
other	JJ	O
Atm	NN	O
mutant	JJ	O
mice	NNS	O
,	,	O
Atm	NN	O
(	-LRB-	O
y/y	NN	O
)	-RRB-	O
mice	NNS	O
show	VBP	O
a	DT	O
lower	JJR	O
incidence	NN	O
of	IN	O
thymic	JJ	B-Disease
lymphoma	NN	I-Disease
and	CC	O
survive	VBP	O
beyond	IN	O
a	DT	O
few	JJ	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

Atm	NN	O
(	-LRB-	O
y/y	NN	O
)	-RRB-	O
mice	NNS	O
exhibit	VBP	O
deficits	NNS	O
in	IN	O
motor	NN	O
learning	NN	O
indicative	JJ	O
of	IN	O
cerebellar	NN	B-Disease
dysfunction	NN	I-Disease
.	.	O

Even	RB	O
though	IN	O
we	PRP	O
found	VBD	O
no	DT	O
gross	JJ	O
cerebellar	NN	B-Disease
degeneration	NN	I-Disease
in	IN	O
older	JJR	O
Atm	NN	O
(	-LRB-	O
y/y	NN	O
)	-RRB-	O
animals	NNS	O
,	,	O
ectopic	JJ	O
and	CC	O
abnormally	RB	O
differentiated	VBN	O
Purkinje	NN	O
cells	NNS	O
were	VBD	O
apparent	JJ	O
in	IN	O
mutant	JJ	O
mice	NNS	O
of	IN	O
all	DT	O
ages	NNS	O
.	.	O

These	DT	O
findings	NNS	O
establish	VBP	O
that	IN	O
some	DT	O
neuropathological	JJ	B-Disease
abnormalities	NNS	I-Disease
seen	VBN	O
in	IN	O
A-T	NN	B-Disease
patients	NNS	O
also	RB	O
are	VBP	O
present	JJ	O
in	IN	O
Atm	NNP	O
mutant	JJ	O
mice	NNS	O
.	.	O

In	IN	O
addition	NN	O
,	,	O
we	PRP	O
report	VBP	O
a	DT	O
previously	RB	O
unrecognized	JJ	O
effect	NN	O
of	IN	O
Atm	NN	B-Disease
deficiency	NN	I-Disease
on	IN	O
development	NN	O
or	CC	O
maintenance	NN	O
of	IN	O
CD4	NN	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
8	CD	O
(	-LRB-	O
+	CC	O
)	-RRB-	O
thymocytes	NNS	O
.	.	O

We	PRP	O
discuss	VBP	O
these	DT	O
findings	NNS	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
the	DT	O
hypothesis	NN	O
that	IN	O
abnormal	JJ	O
development	NN	O
of	IN	O
Purkinje	NN	O
cells	NNS	O
and	CC	O
lymphocytes	NNS	O
contributes	VBZ	O
to	TO	O
the	DT	O
pathogenesis	NN	O
of	IN	O
A-T	NN	B-Disease
.	.	O

.	.	O

Both	DT	O
mutations	NNS	O
in	IN	O
G6PD	NN	O
A	NN	O
-	:	O
are	VBP	O
necessary	JJ	O
to	TO	O
produce	VB	O
the	DT	O
G6PD	NN	B-Disease
deficient	JJ	I-Disease
phenotype	NN	O
.	.	O

The	DT	O
high	JJ	O
prevalence	NN	O
of	IN	O
glucose	NN	B-Disease
6-phosphate	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
in	IN	O
African	JJ	O
populations	NNS	O
is	VBZ	O
due	JJ	O
almost	RB	O
entirely	RB	O
to	TO	O
the	DT	O
enzyme	NN	O
variant	NN	O
A	NN	O
-	:	O
,	,	O
which	WDT	O
differs	VBZ	O
from	IN	O
the	DT	O
wild-type	JJ	O
G6PD	NN	O
B	NN	O
by	IN	O
two	CD	O
amino	NN	O
acid	NN	O
replacements	NNS	O
,	,	O
68	CD	O
Val	NN	O
--	:	O
>	JJR	O
Met	NNP	O
and	CC	O
126	CD	O
Asn	NN	O
--	:	O
>	JJR	O
Asp	NN	O
.	.	O

The	DT	O
non-deficient	JJ	O
polymorphic	JJ	O
variant	JJ	O
G6PD	NN	O
A	NN	O
contains	VBZ	O
only	RB	O
the	DT	O
mutation	NN	O
126	CD	O
Asn	NN	O
--	:	O
>	JJR	O
Asp	NN	O
.	.	O

The	DT	O
frequencies	NNS	O
of	IN	O
the	DT	O
G6PD	NN	O
A	NN	O
and	CC	O
of	IN	O
the	DT	O
G6PD	NN	O
A	NN	O
-	:	O
genes	NNS	O
in	IN	O
parts	NNS	O
of	IN	O
Africa	NNP	O
are	VBP	O
both	DT	O
about	IN	O
0	CD	O
.	.	O

2	LS	O
.	.	O

The	DT	O
68	CD	O
Val	NN	O
--	:	O
>	JJR	O
Met	NNP	O
mutation	NN	O
has	VBZ	O
not	RB	O
been	VBN	O
found	VBN	O
in	IN	O
a	DT	O
B	NN	O
background	NN	O
.	.	O

This	DT	O
could	MD	O
be	VB	O
because	IN	O
the	DT	O
68	CD	O
Val	NN	O
--	:	O
>	JJR	O
Met	NNP	O
mutation	NN	O
happened	VBD	O
to	TO	O
arise	VB	O
in	IN	O
an	DT	O
A	NN	O
gene	NN	O
in	IN	O
the	DT	O
first	JJ	O
instance	NN	O
,	,	O
or	CC	O
because	IN	O
the	DT	O
68	CD	O
Val	NN	O
--	:	O
>	JJR	O
Met	NNP	O
mutation	NN	O
alone	RB	O
is	VBZ	O
not	RB	O
sufficient	JJ	O
to	TO	O
cause	VB	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
approached	VBN	O
this	DT	O
question	NN	O
by	IN	O
producing	VBG	O
G6PD	NN	O
B	NN	O
,	,	O
A	DT	O
,	,	O
A	DT	O
-	:	O
,	,	O
and	CC	O
G6PD	NN	O
68	CD	O
Val	NN	O
--	:	O
>	JJR	O
Met	NNP	O
in	IN	O
a	DT	O
bacterial	JJ	O
expression	NN	O
system	NN	O
and	CC	O
analysing	VBG	O
their	PRP$	O
biochemical	JJ	O
properties	NNS	O
.	.	O

With	IN	O
each	DT	O
single	JJ	O
mutation	NN	O
we	PRP	O
found	VBD	O
a	DT	O
slight	JJ	O
decrease	NN	O
in	IN	O
both	CC	O
the	DT	O
specific	JJ	O
activity	NN	O
and	CC	O
the	DT	O
yield	NN	O
of	IN	O
enzyme	NN	O
when	WRB	O
compared	VBN	O
to	TO	O
G6PD	NN	O
B	NN	O
.	.	O

When	WRB	O
both	DT	O
mutations	NNS	O
were	VBD	O
introduced	VBN	O
together	RB	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
roughly	RB	O
additive	JJ	O
effect	NN	O
on	IN	O
specific	JJ	O
activity	NN	O
,	,	O
but	CC	O
a	DT	O
much	RB	O
more	RBR	O
drastic	JJ	O
effect	NN	O
on	IN	O
enzyme	NN	O
yield	NN	O
(	-LRB-	O
4	CD	O
%	NN	O
of	IN	O
normal	JJ	O
)	-RRB-	O
.	.	O

This	DT	O
synergistic	JJ	O
effect	NN	O
was	VBD	O
also	RB	O
demonstrated	VBN	O
on	IN	O
thermal	JJ	O
stability	NN	O
,	,	O
especially	RB	O
at	IN	O
low	JJ	O
NADP	NN	O
concentrations	NNS	O
.	.	O

Comparable	JJ	O
results	NNS	O
were	VBD	O
produced	VBN	O
when	WRB	O
the	DT	O
replacement	NN	O
119	CD	O
Gln	NN	O
--	:	O
>	JJR	O
Glu	NN	O
was	VBD	O
studied	VBN	O
instead	RB	O
of	IN	O
126	CD	O
Asn	NN	O
--	:	O
>	JJR	O
Asp	NN	O
.	.	O

We	PRP	O
infer	VBP	O
that	IN	O
the	DT	O
coexistence	NN	O
of	IN	O
the	DT	O
two	CD	O
mutations	NNS	O
is	VBZ	O
responsible	JJ	O
for	IN	O
enzyme	NN	B-Disease
deficiency	NN	I-Disease
in	IN	I-Disease
G6PD	NN	I-Disease
A	NN	O
-	:	O
because	IN	O
they	PRP	O
act	VBP	O
synergistically	RB	O
in	IN	O
causing	VBG	O
instability	NN	O
of	IN	O
the	DT	O
enzyme	NN	O
.	.	O

Detection	NN	O
of	IN	O
98	CD	O
%	NN	O
of	IN	O
DMD/BMD	NN	O
gene	NN	O
deletions	NNS	O
by	IN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
.	.	O

We	PRP	O
describe	VBP	O
oligonucleotide	NN	O
primer	NN	O
sequences	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
amplify	VB	O
eight	CD	O
exons	NNS	O
plus	CC	O
the	DT	O
muscle	NN	O
promoter	NN	O
of	IN	O
the	DT	O
dystrophin	NN	O
gene	NN	O
in	IN	O
a	DT	O
single	JJ	O
multiplex	JJ	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
.	.	O

When	WRB	O
used	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
an	DT	O
existing	VBG	O
primer	NN	O
set	NN	O
,	,	O
these	DT	O
two	CD	O
multiplex	JJ	O
reactions	NNS	O
detect	VBP	O
about	IN	O
98	CD	O
%	NN	O
of	IN	O
deletions	NNS	O
in	IN	O
patients	NNS	O
with	IN	O
Duchenne	NN	B-Disease
or	CC	I-Disease
Becker	NNP	I-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
,	,	O
BMD	NN	B-Disease
)	-RRB-	O
.	.	O

Furthermore	RB	O
,	,	O
these	DT	O
primers	NNS	O
amplify	VBP	O
most	JJS	O
of	IN	O
the	DT	O
exons	NNS	O
in	IN	O
the	DT	O
deletion	NN	O
prone	JJ	O
"	''	O
hot	JJ	O
spot	NN	O
"	''	O
region	NN	O
around	IN	O
exons	NNS	O
44	CD	O
to	TO	O
53	CD	O
,	,	O
allowing	VBG	O
determination	NN	O
of	IN	O
deletion	NN	O
endpoints	NNS	O
and	CC	O
prediction	NN	O
of	IN	O
mutational	JJ	O
effects	NNS	O
on	IN	O
the	DT	O
translational	JJ	O
reading	NN	O
frame	NN	O
.	.	O

Thus	RB	O
,	,	O
use	NN	O
of	IN	O
these	DT	O
PCR-based	JJ	O
assays	NNS	O
will	MD	O
allow	VB	O
deletion	NN	O
detection	NN	O
and	CC	O
prenatal	JJ	O
diagnosis	NN	O
for	IN	O
most	JJS	O
DMD/BMD	NN	O
patients	NNS	O
in	IN	O
a	DT	O
fraction	NN	O
of	IN	O
the	DT	O
time	NN	O
required	VBN	O
for	IN	O
Southern	NN	O
blot	NN	O
analysis	NN	O
.	.	O

.	.	O

Recombination	NN	O
events	NNS	O
that	WDT	O
locate	VBP	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
distal	JJ	O
to	TO	O
APOC2	NN	O
on	IN	O
19q	NN	O
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
a	DT	O
recombination	NN	O
in	IN	O
an	DT	O
individual	JJ	O
with	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
which	WDT	O
placed	VBD	O
the	DT	O
markers	NNS	O
D19S19	NN	O
and	CC	O
APOC2	NN	O
on	IN	O
the	DT	O
same	JJ	O
side	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
.	.	O

Haplotyping	NN	O
of	IN	O
this	DT	O
family	NN	O
with	IN	O
more	RBR	O
recently	RB	O
characterized	VBN	O
probes	NNS	O
which	WDT	O
are	VBP	O
either	RB	O
tightly	RB	O
linked	VBN	O
to	TO	O
DM	NN	B-Disease
or	CC	O
distal	JJ	O
to	TO	O
the	DT	O
linkage	NN	O
group	NN	O
at	IN	O
q13	NN	O
.	.	O

2	CD	O
shows	NNS	O
that	IN	O
the	DT	O
DM	NN	B-Disease
locus	NN	O
is	VBZ	O
distal	JJ	O
to	TO	O
APOC2	NN	O
.	.	O

This	DT	O
is	VBZ	O
confirmed	VBN	O
by	IN	O
other	JJ	O
recombinants	NNS	O
where	WRB	O
DM	NN	B-Disease
segregates	VBZ	O
with	IN	O
distal	JJ	O
probes	NNS	O
.	.	O

Additional	JJ	O
marker	NN	O
to	TO	O
marker	NN	O
recombinations	NNS	O
in	IN	O
unaffected	JJ	O
individuals	NNS	O
are	VBP	O
reported	VBN	O
and	CC	O
support	VBP	O
the	DT	O
order	NN	O
and	CC	O
orientation	NN	O
of	IN	O
the	DT	O
DM	NN	B-Disease
linkage	NN	O
group	NN	O
as	IN	O
pter	NN	O
-	:	O
(	-LRB-	O
INSR	NNP	O
,	,	O
LDLR	NNP	O
,	,	O
S9	NNP	O
)	-RRB-	O
-	:	O
(	-LRB-	O
S19	NN	O
,	,	O
BCL3	NN	O
,	,	O
APOC2	NN	O
)	-RRB-	O
-	:	O
(	-LRB-	O
CKMM	NNP	O
,	,	O
DM	NN	O
)	-RRB-	O
-	:	O
(	-LRB-	O
S22	NN	O
,	,	O
+	CC	O
+	CC	O
+	CC	O
PRKCG	NN	O
)	-RRB-	O
-	:	O
qter	NN	O
.	.	O

The	DT	O
data	NNS	O
presented	VBN	O
here	RB	O
can	MD	O
not	RB	O
determine	VB	O
whether	IN	O
DM	NN	B-Disease
is	VBZ	O
proximal	JJ	O
or	CC	O
distal	JJ	O
to	TO	O
CKMM	NNP	O
.	.	O

The	DT	O
consequences	NNS	O
of	IN	O
this	DT	O
probe	NN	O
order	NN	O
for	IN	O
antenatal	JJ	O
diagnosis	NN	O
and	CC	O
future	JJ	O
research	NN	O
aiming	VBG	O
to	TO	O
isolate	VB	O
the	DT	O
gene	NN	O
which	WDT	O
is	VBZ	O
affected	VBN	O
in	IN	O
DM	NN	B-Disease
are	VBP	O
discussed	VBN	O
.	.	O

New	NNP	O
mutations	NNS	O
,	,	O
polymorphisms	NNS	O
,	,	O
and	CC	O
rare	JJ	O
variants	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
detected	VBN	O
by	IN	O
a	DT	O
novel	JJ	O
SSCP	NN	O
strategy	NN	O
.	.	O

The	DT	O
gene	NN	O
for	IN	O
ataxia-telangiectasia	NN	B-Disease
,	,	O
ATM	NNP	O
,	,	O
spans	VBZ	O
about	IN	O
150	CD	O
kb	NN	O
of	IN	O
genomic	JJ	O
DNA	NN	O
.	.	O

ATM	NNP	O
mutations	NNS	O
are	VBP	O
found	VBN	O
along	IN	O
the	DT	O
entire	JJ	O
gene	NN	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	O
mutational	JJ	O
hot	JJ	O
spot	NN	O
.	.	O

Using	VBG	O
DNA	NN	O
as	IN	O
the	DT	O
starting	VBG	O
material	NN	O
,	,	O
we	PRP	O
screened	VBD	O
the	DT	O
ATM	NNP	O
gene	NN	O
in	IN	O
92	CD	O
A-T	NN	B-Disease
patients	NNS	O
,	,	O
using	VBG	O
an	DT	O
optimized	VBN	O
single-strand	JJ	O
conformation	NN	O
polymorphism	NN	O
(	-LRB-	O
SSCP	NN	O
)	-RRB-	O
technique	NN	O
that	WDT	O
detected	VBD	O
all	DT	O
previously	RB	O
known	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
(	-LRB-	O
PCR	NN	O
)	-RRB-	O
segments	NNS	O
being	VBG	O
analyzed	VBN	O
.	.	O

To	TO	O
expedite	VB	O
screening	NN	O
,	,	O
we	PRP	O
sequentially	RB	O
loaded	VBD	O
the	DT	O
SSCP	NN	O
gels	NNS	O
with	IN	O
three	CD	O
different	JJ	O
sets	NNS	O
of	IN	O
PCR	NN	O
products	NNS	O
that	WDT	O
were	VBD	O
pretested	VBN	O
to	TO	O
avoid	VB	O
overlapping	VBG	O
patterns	NNS	O
.	.	O

Many	JJ	O
of	IN	O
the	DT	O
DNA	NN	O
changes	NNS	O
we	PRP	O
detected	VBD	O
were	VBD	O
intragenic	JJ	O
polymorphisms	NNS	O
.	.	O

Of	IN	O
an	DT	O
expected	VBN	O
177	CD	O
unknown	JJ	O
mutations	NNS	O
,	,	O
we	PRP	O
detected	VBD	O
approximately	RB	O
70	CD	O
%	NN	O
,	,	O
mostly	RB	O
protein	NN	O
truncating	JJ	O
mutations	NNS	O
(	-LRB-	O
that	WDT	O
would	MD	O
have	VB	O
been	VBN	O
detectable	JJ	O
by	IN	O
protein	NN	O
truncation	NN	O
testing	NN	O
if	IN	O
RNA	NN	O
starting	VBG	O
material	NN	O
had	VBD	O
been	VBN	O
available	JJ	O
)	-RRB-	O
.	.	O

Mutations	NNS	O
have	VBP	O
now	RB	O
been	VBN	O
defined	VBN	O
for	IN	O
every	DT	O
exon	NN	O
of	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

Herein	RB	O
,	,	O
we	PRP	O
present	VBP	O
35	CD	O
new	JJ	O
mutations	NNS	O
and	CC	O
34	CD	O
new	JJ	O
intragenic	JJ	O
polymorphisms	NNS	O
or	CC	O
rare	JJ	O
variants	NNS	O
within	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
.	.	O

This	DT	O
is	VBZ	O
the	DT	O
most	RBS	O
comprehensive	JJ	O
compilation	NN	O
of	IN	O
ATM	NNP	O
polymorphisms	NNS	O
assembled	VBD	O
to	TO	O
date	NN	O
.	.	O

Defining	VBG	O
polymorphic	JJ	O
sites	NNS	O
as	RB	O
well	RB	O
as	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
ATM	NNP	O
gene	NN	O
will	MD	O
be	VB	O
of	IN	O
great	JJ	O
importance	NN	O
in	IN	O
designing	VBG	O
automated	VBN	O
methods	NNS	O
for	IN	O
detecting	VBG	O
mutations	NNS	O
.	.	O

.	.	O

Chromosome	NN	O
breakage	NN	O
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
and	CC	I-Disease
Angelman	NNP	I-Disease
syndromes	NNS	I-Disease
involves	VBZ	O
recombination	NN	O
between	IN	O
large	JJ	O
,	,	O
transcribed	VBN	O
repeats	NNS	O
at	IN	O
proximal	JJ	O
and	CC	O
distal	JJ	O
breakpoints	NNS	O
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
and	CC	O
Angelman	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
AS	JJ	B-Disease
)	-RRB-	O
are	VBP	O
distinct	JJ	O
neurobehavioral	JJ	B-Disease
disorders	NNS	I-Disease
that	IN	O
most	JJS	O
often	RB	O
arise	VB	O
from	IN	O
a	DT	O
4-Mb	JJ	O
deletion	NN	O
of	IN	O
chromosome	NN	O
15q11-q13	NN	O
during	IN	O
paternal	JJ	O
or	CC	O
maternal	JJ	O
gametogenesis	NN	O
,	,	O
respectively	RB	O
.	.	O

At	IN	O
a	DT	O
de	FW	O
novo	FW	O
frequency	NN	O
of	IN	O
approximately	RB	O
.	.	O

67-1/10	CD	O
,	,	O
000	CD	O
births	NNS	O
,	,	O
these	DT	O
deletions	NNS	O
represent	VBP	O
a	DT	O
common	JJ	O
structural	JJ	O
chromosome	NN	O
change	NN	O
in	IN	O
the	DT	O
human	JJ	O
genome	NN	O
.	.	O

To	TO	O
elucidate	VB	O
the	DT	O
mechanism	NN	O
underlying	VBG	O
these	DT	O
events	NNS	O
,	,	O
we	PRP	O
characterized	VBD	O
the	DT	O
regions	NNS	O
that	WDT	O
contain	VBP	O
two	CD	O
proximal	JJ	O
breakpoint	NN	O
clusters	NNS	O
and	CC	O
a	DT	O
distal	JJ	O
cluster	NN	O
.	.	O

Novel	JJ	O
DNA	NN	O
sequences	NNS	O
potentially	RB	O
associated	VBN	O
with	IN	O
the	DT	O
breakpoints	NNS	O
were	VBD	O
positionally	RB	O
cloned	VBN	O
from	IN	O
YACs	NNS	O
within	IN	O
or	CC	O
near	IN	O
these	DT	O
regions	NNS	O
.	.	O

Analyses	NNS	O
of	IN	O
rodent-human	JJ	O
somatic-cell	JJ	O
hybrids	NNS	O
,	,	O
YAC	NN	O
contigs	NNS	O
,	,	O
and	CC	O
FISH	NN	O
of	IN	O
normal	JJ	O
or	CC	O
rearranged	JJ	O
chromosomes	NNS	O
15	CD	O
identified	VBN	O
duplicated	JJ	O
sequences	NNS	O
(	-LRB-	O
the	DT	O
END	NN	O
repeats	NNS	O
)	-RRB-	O
at	IN	O
or	CC	O
near	IN	O
the	DT	O
breakpoints	NNS	O
.	.	O

The	DT	O
END-repeat	NN	O
units	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
large	JJ	O
genomic	JJ	O
duplications	NNS	O
of	IN	O
a	DT	O
novel	JJ	O
gene	NN	O
(	-LRB-	O
HERC2	NN	O
)	-RRB-	O
,	,	O
many	JJ	O
copies	NNS	O
of	IN	O
which	WDT	O
are	VBP	O
transcriptionally	RB	O
active	JJ	O
in	IN	O
germline	NN	O
tissues	NNS	O
.	.	O

One	CD	O
of	IN	O
five	CD	O
PWS/AS	NN	O
patients	NNS	O
analyzed	VBN	O
to	TO	O
date	NN	O
has	VBZ	O
an	DT	O
identifiable	JJ	O
,	,	O
rearranged	JJ	O
HERC2	NN	O
transcript	NN	O
derived	VBN	O
from	IN	O
the	DT	O
deletion	NN	O
event	NN	O
.	.	O

We	PRP	O
postulate	VBP	O
that	IN	O
the	DT	O
END	NN	O
repeats	NNS	O
flanking	VBG	O
15q11-q13	JJ	O
mediate	VBP	O
homologous	JJ	O
recombination	NN	O
resulting	VBG	O
in	IN	O
deletion	NN	O
.	.	O

Furthermore	RB	O
,	,	O
we	PRP	O
propose	VBP	O
that	IN	O
active	JJ	O
transcription	NN	O
of	IN	O
these	DT	O
repeats	NNS	O
in	IN	O
male	JJ	O
and	CC	O
female	JJ	O
germ	NN	O
cells	NNS	O
may	MD	O
facilitate	VB	O
the	DT	O
homologous	JJ	O
recombination	NN	O
process	NN	O
.	.	O

A	DT	O
4-megabase	JJ	O
YAC	NN	O
contig	NN	O
that	WDT	O
spans	VBZ	O
the	DT	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
region	NN	O
on	IN	O
human	JJ	O
chromosome	NN	O
8q24	NN	O
.1	CD	O
:	:	O
use	VB	O
in	IN	O
refining	VBG	O
the	DT	O
location	NN	O
of	IN	O
the	DT	O
trichorhinophalangeal	NN	B-Disease
syndrome	NN	I-Disease
and	CC	O
multiple	JJ	O
exostoses	NNS	O
genes	NNS	O
(	-LRB-	O
TRPS1	NN	O
and	CC	O
EXT1	NN	O
)	-RRB-	O
.	.	O

We	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
physical	JJ	O
map	NN	O
covering	VBG	O
over	IN	O
4	CD	O
Mb	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
8q24	NN	O
.	.	O

1	CD	O
and	CC	O
used	VBN	O
this	DT	O
map	NN	O
to	TO	O
refine	VB	O
the	DT	O
locations	NNS	O
of	IN	O
the	DT	O
genes	NNS	O
responsible	JJ	O
for	IN	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
map	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
overlapping	VBG	O
YAC	NN	O
clones	NNS	O
that	WDT	O
were	VBD	O
identified	VBN	O
and	CC	O
ordered	VBN	O
in	IN	O
relation	NN	O
to	TO	O
sequence	NN	O
tagged	VBD	O
sites	NNS	O
mapped	VBN	O
to	TO	O
the	DT	O
Langer-Giedion	NN	O
chromosomal	JJ	O
region	NN	O
on	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

The	DT	O
minimal	JJ	O
region	NN	O
of	IN	O
overlap	VBP	O
of	IN	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
deletions	NNS	O
,	,	O
previously	RB	O
identified	VBN	O
by	IN	O
analysis	NN	O
of	IN	O
15	CD	O
patients	NNS	O
,	,	O
was	VBD	O
placed	VBN	O
on	IN	O
the	DT	O
map	NN	O
by	IN	O
analysis	NN	O
of	IN	O
2	CD	O
patients	NNS	O
whose	WP$	O
deletions	NNS	O
define	VBP	O
the	DT	O
endpoints	NNS	O
.	.	O

The	DT	O
chromosome	NN	O
8	CD	O
breakpoint	NN	O
of	IN	O
a	DT	O
balanced	JJ	O
t	NN	O
(	-LRB-	O
8	CD	O
;	:	O
9	CD	O
)	-RRB-	O
(	-LRB-	O
q24	NN	O
.	.	O

11	CD	O
;	:	O
q33	NN	O
.	.	O

3	LS	O
)	-RRB-	O
translocation	NN	O
from	IN	O
a	DT	O
patient	NN	O
with	IN	O
trichorhinophalangeal	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
TRPS	NN	B-Disease
I	NN	O
)	-RRB-	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
located	JJ	O
just	RB	O
within	IN	O
the	DT	O
proximal	JJ	O
end	NN	O
of	IN	O
the	DT	O
minimal	JJ	O
deletion	NN	O
region	NN	O
.	.	O

A	DT	O
deletion	NN	O
of	IN	O
8q24	NN	O
.	.	O

11-q24	NN	O
.	.	O

3	CD	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
multiple	JJ	O
exostoses	NNS	O
was	VBD	O
found	VBN	O
to	TO	O
overlap	VB	O
the	DT	O
distal	JJ	O
end	NN	O
of	IN	O
the	DT	O
LGS	NNP	B-Disease
deletion	NN	O
region	NN	O
,	,	O
indicating	VBG	O
that	IN	O
the	DT	O
EXT1	NN	O
gene	NN	O
is	VBZ	O
distal	JJ	O
to	TO	O
the	DT	O
TRPS1	NN	O
gene	NN	O
and	CC	O
supporting	VBG	O
the	DT	O
hypothesis	NN	O
that	IN	O
Langer-Giedion	NN	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
due	JJ	O
to	TO	O
loss	NN	O
of	IN	O
functional	JJ	O
copies	NNS	O
of	IN	O
both	CC	O
the	DT	O
TRPS1	NN	O
and	CC	O
the	DT	O
EXT1	NN	O
genes	NNS	O

Genetic	JJ	O
mapping	NN	O
of	IN	O
the	DT	O
breast-ovarian	JJ	B-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
to	TO	O
a	DT	O
small	JJ	O
interval	NN	O
on	IN	O
chromosome	NN	O
17q12-21	NN	O
:	:	O
exclusion	NN	O
of	IN	O
candidate	NN	O
genes	NNS	O
EDH17B2	NN	O
and	CC	O
RARA	NN	O
.	.	O

A	DT	O
susceptibility	NN	O
gene	NN	O
for	IN	O
hereditary	JJ	B-Disease
breast-ovarian	JJ	I-Disease
cancer	NN	I-Disease
,	,	O
BRCA1	NN	O
,	,	O
has	VBZ	O
been	VBN	O
assigned	VBN	O
by	IN	O
linkage	NN	O
analysis	NN	O
to	TO	O
chromosome	NN	O
17q21	NN	O
.	.	O

Candidate	NN	O
genes	NNS	O
in	IN	O
this	DT	O
region	NN	O
include	VBP	O
EDH17B2	NN	O
,	,	O
which	WDT	O
encodes	VBZ	O
estradiol	NN	O
17	CD	O
beta-hydroxysteroid	NN	O
dehydrogenase	NN	O
II	CD	O
(	-LRB-	O
17	CD	O
beta-HSD	NN	O
II	CD	O
)	-RRB-	O
,	,	O
and	CC	O
RARA	NN	O
,	,	O
the	DT	O
gene	NN	O
for	IN	O
retinoic	JJ	O
acid	NN	O
receptor	NN	O
alpha	NN	O
.	.	O

We	PRP	O
have	VBP	O
typed	VBN	O
22	CD	O
breast	NN	B-Disease
and	CC	I-Disease
breast-ovarian	JJ	I-Disease
cancer	NN	I-Disease
families	NNS	O
with	IN	O
eight	CD	O
polymorphisms	NNS	O
from	IN	O
the	DT	O
chromosome	NN	O
17q12-21	NN	O
region	NN	O
,	,	O
including	VBG	O
two	CD	O
in	IN	O
the	DT	O
EDH17B2	NN	O
gene	NN	O
.	.	O

Genetic	JJ	O
recombination	NN	O
with	IN	O
the	DT	O
breast	NN	B-Disease
cancer	NN	I-Disease
trait	NN	O
excludes	VBZ	O
RARA	NN	O
from	IN	O
further	JJ	O
consideration	NN	O
as	IN	O
a	DT	O
candidate	NN	O
gene	NN	O
for	IN	O
BRCA1	NN	O
.	.	O

Both	DT	O
BRCA1	NN	O
and	CC	O
EDH17B2	NN	O
map	NN	O
to	TO	O
a	DT	O
6	CD	O
cM	NN	O
interval	NN	O
(	-LRB-	O
between	IN	O
THRA1	NN	O
and	CC	O
D17S579	NN	O
)	-RRB-	O
and	CC	O
no	DT	O
recombination	NN	O
was	VBD	O
observed	VBN	O
between	IN	O
the	DT	O
two	CD	O
genes	NNS	O
.	.	O

However	RB	O
,	,	O
direct	JJ	O
sequencing	NN	O
of	IN	O
overlapping	VBG	O
PCR	NN	O
products	NNS	O
containing	VBG	O
the	DT	O
entire	JJ	O
EDH17B2	NN	O
gene	NN	O
in	IN	O
four	CD	O
unrelated	JJ	O
affected	JJ	O
women	NNS	O
did	VBD	O
not	RB	O
uncover	VB	O
any	DT	O
sequence	NN	O
variation	NN	O
,	,	O
other	JJ	O
than	IN	O
previously	RB	O
described	VBN	O
polymorphisms	NNS	O
.	.	O

Mutations	NNS	O
in	IN	O
the	DT	O
EDH17B2	NN	O
gene	NN	O
,	,	O
therefore	RB	O
do	VBP	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
responsible	JJ	O
for	IN	O
the	DT	O
hereditary	JJ	B-Disease
breast-ovarian	JJ	I-Disease
cancer	NN	I-Disease
syndrome	NN	I-Disease
.	.	O

Single	JJ	O
meiotic	JJ	O
crossovers	NNS	O
in	IN	O
affected	JJ	O
women	NNS	O
suggest	VBP	O
that	IN	O
BRCA1	NN	O
is	VBZ	O
flanked	VBN	O
by	IN	O
the	DT	O
loci	NNS	O
RARA	NN	O
and	CC	O
D17S78	NN	O
.	.	O

.	.	O

Hereditary	JJ	B-Disease
C2	NN	I-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
common	JJ	O
variable	JJ	O
immunodeficiency	NN	B-Disease
.	.	O

Homozygous	JJ	O
C2	NN	B-Disease
deficiency	NN	I-Disease
in	IN	O
a	DT	O
19-year-old	JJ	O
boy	NN	O
was	VBD	O
associated	VBN	O
with	IN	O
variable	JJ	O
immunodeficiency	NN	B-Disease
manifested	VBN	O
by	IN	O
marked	JJ	O
hypoimmunoglobulinemia	NN	B-Disease
and	CC	O
impaired	JJ	O
antibody	NN	O
responses	NNS	O
,	,	O
normal	JJ	O
circulating	VBG	O
B	NN	O
lymphocytes	NNS	O
,	,	O
and	CC	O
subnormal	JJ	O
T-cell	NN	O
functions	NNS	O
.	.	O

Neither	DT	O
antilymphocytic	JJ	O
autoantibodies	NNS	O
nor	CC	O
chromosomal	JJ	B-Disease
abnormalities	NNS	I-Disease
were	VBD	O
found	VBN	O
.	.	O

Serum	NN	O
immunoglobulin	NN	O
levels	NNS	O
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
in	IN	O
his	PRP$	O
parents	NNS	O
and	CC	O
brother	NN	O
who	WP	O
were	VBD	O
heterozygous	JJ	O
for	IN	O
C2	NN	B-Disease
deficiency	NN	I-Disease
.	.	O

The	DT	O
patients	NNS	O
lymphocytes	NNS	O
were	VBD	O
homozygous	JJ	O
at	IN	O
the	DT	O
HLA-D	NN	O
locus	NN	O
but	CC	O
expressed	VBD	O
an	DT	O
antigen	NN	O
different	JJ	O
from	IN	O
DW2	NN	O
.	.	O

.	.	O

Isolation	NN	O
of	IN	O
molecular	JJ	O
probes	NNS	O
associated	VBN	O
with	IN	O
the	DT	O
chromosome	NN	O
15	CD	O
instability	NN	O
in	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

Flow	NN	O
cytometry	NN	O
and	CC	O
recombinant	JJ	O
DNA	NN	O
techniques	NNS	O
have	VBP	O
been	VBN	O
used	VBN	O
to	TO	O
obtain	VB	O
reagents	NNS	O
for	IN	O
a	DT	O
molecular	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
Prader-Willi	NNP	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
.	.	O

HindIII	NN	O
total-digest	JJ	O
libraries	NNS	O
were	VBD	O
prepared	VBN	O
in	IN	O
lambda	NN	O
phage	NN	O
Charon	NNP	O
21A	NNP	O
from	IN	O
flow-sorted	JJ	O
inverted	JJ	O
duplicated	JJ	O
no.	NN	O
15	CD	O
human	JJ	O
chromosomes	NNS	O
and	CC	O
propagated	VBN	O
on	IN	O
recombination-proficient	JJ	O
(	-LRB-	O
LE392	NN	O
)	-RRB-	O
and	CC	O
recBC	NN	O
-	:	O
,	,	O
sbcB	NN	O
-	:	O
(	-LRB-	O
DB1257	NN	O
)	-RRB-	O
bacteria	NNS	O
.	.	O

Twelve	CD	O
distinct	JJ	O
chromosome	NN	O
15-specific	JJ	O
probes	NNS	O
have	VBP	O
been	VBN	O
isolated	VBN	O
.	.	O

Eight	CD	O
localized	JJ	O
to	TO	O
the	DT	O
region	NN	O
15q11	NN	O
----	:	O
13	CD	O
.	.	O

Four	CD	O
of	IN	O
these	DT	O
eight	CD	O
sublocalized	VBN	O
to	TO	O
band	NN	O
15q11	NN	O
.	.	O

2	CD	O
and	CC	O
are	VBP	O
shown	VBN	O
to	TO	O
be	VB	O
deleted	VBN	O
in	IN	O
DNA	NN	O
of	IN	O
one	CD	O
of	IN	O
two	CD	O
patients	NNS	O
examined	VBN	O
with	IN	O
the	DT	O
PWS	NNP	B-Disease
.	.	O

Heteroduplex	JJ	O
analysis	NN	O
of	IN	O
two	CD	O
of	IN	O
these	DT	O
clones	NNS	O
,	,	O
which	WDT	O
grew	VBD	O
on	IN	O
DB1257	NN	O
but	CC	O
not	RB	O
on	IN	O
LE392	NN	O
,	,	O
revealed	VBD	O
stem-loop	JJ	O
structures	NNS	O
in	IN	O
the	DT	O
inserts	NNS	O
,	,	O
indicative	JJ	O
of	IN	O
inverted	JJ	O
,	,	O
repeated	JJ	O
DNA	NN	O
elements	NNS	O
.	.	O

Such	JJ	O
DNA	NN	O
repeats	NNS	O
might	MD	O
account	VB	O
for	IN	O
some	DT	O
of	IN	O
the	DT	O
cloning	NN	O
instability	NN	O
of	IN	O
DNA	NN	O
segments	NNS	O
from	IN	O
proximal	JJ	O
15q	NN	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
genetic	JJ	O
and	CC	O
physical	JJ	O
instability	NN	O
associated	VBN	O
with	IN	O
the	DT	O
repeated	VBN	O
sequences	NNS	O
we	PRP	O
have	VBP	O
isolated	VBN	O
from	IN	O
band	NN	O
15q11	NN	O
.	.	O

2	CD	O
may	MD	O
elucidate	VB	O
the	DT	O
molecular	JJ	O
basis	NN	O
for	IN	O
the	DT	O
instability	NN	O
of	IN	O
this	DT	O
chromosomal	JJ	O
region	NN	O
in	IN	O
patients	NNS	O
with	IN	O
the	DT	O
PWS	NN	B-Disease
or	CC	O
other	JJ	O
diseases	NNS	O
associated	VBN	O
with	IN	O
chromosomal	JJ	B-Disease
abnormalities	NNS	I-Disease
in	IN	O
the	DT	O
proximal	JJ	O
long	JJ	O
arm	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
15	CD	O

Myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
:	:	O
evidence	NN	O
for	IN	O
a	DT	O
possible	JJ	O
dominant-negative	JJ	O
RNA	NN	O
mutation	NN	O
.	.	O

The	DT	O
trinucleotide	JJ	O
expansion	NN	O
mutation	NN	O
causing	VBG	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
is	VBZ	O
in	IN	O
the	DT	O
3	CD	O
untranslated	JJ	O
region	NN	O
of	IN	O
a	DT	O
protein	NN	O
kinase	NN	O
gene	NN	O
.	.	O

The	DT	O
molecular	JJ	O
mechanisms	NNS	O
by	IN	O
which	WDT	O
the	DT	O
expanded	VBN	O
repeat	NN	O
causes	VBZ	O
the	DT	O
clinically	RB	O
variable	JJ	O
and	CC	O
multisystemic	JJ	B-Disease
disease	NN	I-Disease
,	,	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
are	VBP	O
not	RB	O
understood	VBN	O
.	.	O

It	PRP	O
has	VBZ	O
been	VBN	O
particularly	RB	O
difficult	JJ	O
to	TO	O
rationalize	VB	O
the	DT	O
dominant	JJ	O
inheritance	NN	O
with	IN	O
the	DT	O
fact	NN	O
that	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
lies	VBZ	O
outside	IN	O
of	IN	O
the	DT	O
protein-encoding	JJ	O
gene	NN	O
elements	NNS	O
,	,	O
and	CC	O
should	MD	O
not	RB	O
be	VB	O
translated	VBN	O
into	IN	O
protein	NN	O
.	.	O

Here	RB	O
we	PRP	O
use	VBP	O
muscle	NN	O
biopsies	NNS	O
from	IN	O
classical	JJ	O
adult-onset	JJ	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
patients	NNS	O
to	TO	O
study	VB	O
the	DT	O
accumulation	NN	O
of	IN	O
transcripts	NNS	O
from	IN	O
both	CC	O
the	DT	O
normal	JJ	O
and	CC	O
expanded	VBN	O
DM	NN	B-Disease
kinase	NN	O
genes	NNS	O
in	IN	O
patient	NN	O
muscle	NN	O
,	,	O
and	CC	O
compare	VB	O
the	DT	O
results	NNS	O
to	TO	O
normal	JJ	O
and	CC	O
myopathic	JJ	B-Disease
controls	NNS	O
.	.	O

We	PRP	O
found	VBD	O
relatively	RB	O
small	JJ	O
decreases	NNS	O
of	IN	O
DM	NN	B-Disease
kinase	NN	O
RNA	NN	O
in	IN	O
the	DT	O
total	JJ	O
RNA	NN	O
pool	NN	O
from	IN	O
muscle	NN	O
;	:	O
however	RB	O
,	,	O
these	DT	O
reductions	NNS	O
were	VBD	O
not	RB	O
disease	NN	O
specific	JJ	O
.	.	O

Analysis	NN	O
of	IN	O
poly	NN	O
(	-LRB-	O
A	NN	O
)	-RRB-	O
+	CC	O
RNA	NN	O
showed	VBD	O
dramatic	JJ	O
decreases	NNS	O
of	IN	O
both	CC	O
the	DT	O
mutant	JJ	O
and	CC	O
normal	JJ	O
DM	NN	B-Disease
kinase	NN	O
RNAs	NNS	O
,	,	O
and	CC	O
these	DT	O
changes	NNS	O
were	VBD	O
disease-specific	JJ	O
.	.	O

Our	PRP$	O
findings	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
a	DT	O
novel	JJ	O
molecular	JJ	O
pathogenetic	JJ	O
mechanism	NN	O
for	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
both	CC	O
the	DT	O
normal	JJ	O
and	CC	O
expanded	VBN	O
DM	NN	B-Disease
kinase	NN	O
genes	NNS	O
are	VBP	O
transcribed	VBN	O
in	IN	O
patient	NN	O
muscle	NN	O
,	,	O
but	CC	O
the	DT	O
abnormal	JJ	O
expansion-containing	JJ	O
RNA	NN	O
has	VBZ	O
a	DT	O
dominant	JJ	O
effect	NN	O
on	IN	O
RNA	NN	O
metabolism	NN	O
by	IN	O
preventing	VBG	O
the	DT	O
accumulation	NN	O
of	IN	O
poly	NN	O
(	-LRB-	O
A	NN	O
)	-RRB-	O
+	CC	O
RNA	NN	O
.	.	O

The	DT	O
ability	NN	O
of	IN	O
the	DT	O
expansion	NN	O
mutation	NN	O
to	TO	O
alter	VB	O
accumulation	NN	O
of	IN	O
poly	NN	O
(	-LRB-	O
A	NN	O
)	-RRB-	O
+	CC	O
RNA	NN	O
in	IN	O
trans	JJ	O
suggests	VBZ	O
that	IN	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
may	MD	O
be	VB	O
the	DT	O
first	JJ	O
example	NN	O
of	IN	O
a	DT	O
dominant-negative	JJ	O
mutation	NN	O
manifested	VBN	O
at	IN	O
the	DT	O
RNA	NN	O
level	NN	O
.	.	O

.	.	O

Isolation	NN	O
of	IN	O
the	DT	O
gene	NN	O
for	IN	O
McLeod	NNP	B-Disease
syndrome	NN	I-Disease
that	WDT	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
membrane	NN	O
transport	NN	O
protein	NN	O
.	.	O

McLeod	NNP	B-Disease
syndrome	NN	I-Disease
is	VBZ	O
an	DT	O
X-linked	JJ	B-Disease
multisystem	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
abnormalities	NNS	O
in	IN	O
the	DT	O
neuromuscular	JJ	O
and	CC	O
hematopoietic	JJ	O
systems	NNS	O
.	.	O

We	PRP	O
have	VBP	O
assembled	VBN	O
a	DT	O
cosmid	JJ	O
contig	NN	O
of	IN	O
360	CD	O
kb	NN	O
that	WDT	O
encompasses	VBZ	O
the	DT	O
McLeod	NNP	B-Disease
gene	NN	O
locus	NN	O
.	.	O

A	DT	O
50	CD	O
kb	NN	O
deletion	NN	O
was	VBD	O
detected	VBN	O
by	IN	O
screening	VBG	O
DNA	NN	O
from	IN	O
patients	NNS	O
with	IN	O
radiolabeled	VBN	O
whole	JJ	O
cosmids	NNS	O
,	,	O
and	CC	O
two	CD	O
transcription	NN	O
units	NNS	O
were	VBD	O
identified	VBN	O
within	IN	O
this	DT	O
deletion	NN	O
.	.	O

The	DT	O
mRNA	NN	O
expression	NN	O
pattern	NN	O
of	IN	O
one	CD	O
of	IN	O
them	PRP	O
,	,	O
designated	VBN	O
as	IN	O
XK	NN	O
,	,	O
correlates	VBZ	O
closely	RB	O
to	TO	O
the	DT	O
McLeod	NNP	B-Disease
phenotype	NN	O
.	.	O

XK	NN	O
encodes	VBZ	O
a	DT	O
novel	JJ	O
protein	NN	O
with	IN	O
structural	JJ	O
characteristics	NNS	O
of	IN	O
prokaryotic	JJ	O
and	CC	O
eukaryotic	JJ	O
membrane	NN	O
transport	NN	O
proteins	NNS	O
.	.	O

Nucleotide	NN	O
sequence	NN	O
analysis	NN	O
of	IN	O
XK	NN	O
from	IN	O
two	CD	O
unrelated	JJ	O
McLeod	NNP	B-Disease
patients	NNS	O
has	VBZ	O
identified	VBN	O
point	NN	O
mutations	NNS	O
at	IN	O
conserved	VBN	O
splice	NN	O
donor	NN	O
and	CC	O
acceptor	NN	O
sites	NNS	O
.	.	O

These	DT	O
findings	NNS	O
provide	VBP	O
direct	JJ	O
evidence	NN	O
that	IN	O
XK	NN	O
is	VBZ	O
responsible	JJ	O
for	IN	O
McLeod	NNP	B-Disease
syndrome	NN	I-Disease
.	.	O

.	.	O

Molecular	JJ	O
basis	NN	O
of	IN	O
very	RB	B-Disease
long	JJ	I-Disease
chain	NN	I-Disease
acyl-CoA	NN	I-Disease
dehydrogenase	NN	I-Disease
deficiency	NN	I-Disease
in	IN	O
three	CD	O
Israeli	JJ	O
patients	NNS	O
:	:	O
identification	NN	O
of	IN	O
a	DT	O
complex	NN	O
mutant	JJ	O
allele	NN	O
with	IN	O
P65L	NN	O
and	CC	O
K247Q	NN	O
mutations	NNS	O
,	,	O
the	DT	O
former	JJ	O
being	VBG	O
an	DT	O
exonic	JJ	O
mutation	NN	O
causing	VBG	O
exon	NN	O
3	CD	O
skipping	VBG	O
.	.	O

Very	RB	B-Disease
long	JJ	I-Disease
chain	NN	I-Disease
acyl-CoA	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
VLCAD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
is	VBZ	O
a	DT	O
life-threatening	JJ	O
disorder	NN	O
of	IN	O
mitochondrial	JJ	O
fatty	JJ	O
acid	NN	O
beta-oxidation	NN	O
.	.	O

We	PRP	O
identified	VBD	O
four	CD	O
novel	JJ	O
mutations	NNS	O
in	IN	O
three	CD	O
unrelated	JJ	O
patients	NNS	O
.	.	O

All	DT	O
patients	NNS	O
had	VBD	O
the	DT	O
severe	JJ	O
childhood	NN	O
form	NN	O
of	IN	O
VLCAD	NN	B-Disease
deficiency	NN	I-Disease
with	IN	O
early	JJ	O
onset	NN	O
and	CC	O
high	JJ	O
mortality	NN	O
.	.	O

Immunoblot	NN	O
analysis	NN	O
revealed	VBD	O
that	IN	O
VLCAD	NN	O
protein	NN	O
was	VBD	O
undetectable	JJ	O
in	IN	O
patients	NNS	O
2	CD	O
and	CC	O
3	CD	O
,	,	O
whereas	IN	O
normal-size	JJ	O
VLCAD	NN	O
protein	NN	O
and	CC	O
an	DT	O
aberrant	JJ	O
form	NN	O
of	IN	O
VLCAD	NN	O
(	-LRB-	O
4kDa	JJ	O
smaller	JJR	O
)	-RRB-	O
were	VBD	O
detected	VBN	O
in	IN	O
patient	NN	O
1	CD	O
.	.	O

As	IN	O
expected	VBN	O
,	,	O
null	JJ	O
mutations	NNS	O
were	VBD	O
found	VBN	O
in	IN	O
patients	NNS	O
2	CD	O
and	CC	O
3	CD	O
patient	NN	O
2	CD	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
frameshift	NN	O
mutation	NN	O
,	,	O
del	DT	O
4	CD	O
bp	NN	O
at	IN	O
798-801	CD	O
,	,	O
and	CC	O
patient	NN	O
3	CD	O
is	VBZ	O
homozygous	JJ	O
for	IN	O
a	DT	O
nonsense	NN	O
mutation	NN	O
65C	NN	O
>	JJR	O
A	NN	O
(	-LRB-	O
S22X	NN	O
)	-RRB-	O
.	.	O

Patient	NN	O
1	CD	O
was	VBD	O
homozygous	JJ	O
for	IN	O
a	DT	O
complex	NN	O
mutant	JJ	O
allele	NN	O
containing	VBG	O
two	CD	O
alterations	NNS	O
,	,	O
including	VBG	O
a	DT	O
194C	NN	O
>	JJR	O
T	NN	O
transition	NN	O
(	-LRB-	O
P65L	NN	O
)	-RRB-	O
and	CC	O
739A	NN	O
>	JJR	O
C	NN	O
transversion	NN	O
(	-LRB-	O
K247Q	NN	O
)	-RRB-	O
;	:	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
P65L	NN	O
,	,	O
the	DT	O
amino	NN	O
acid	NN	O
change	NN	O
does	VBZ	O
not	RB	O
reduce	VB	O
enzyme	NN	O
activity	NN	O
.	.	O

However	RB	O
,	,	O
the	DT	O
nucleotide	NN	O
change	NN	O
resulted	VBD	O
in	IN	O
exon	NN	O
3	CD	O
skipping	VBG	O
,	,	O
whereas	IN	O
the	DT	O
latter	JJ	O
K247Q	NN	O
mutation	NN	O
had	VBD	O
a	DT	O
drastic	JJ	O
effect	NN	O
on	IN	O
enzyme	NN	O
activity	NN	O
.	.	O

We	PRP	O
verified	VBD	O
these	DT	O
events	NNS	O
by	IN	O
in	FW	O
vivo	FW	O
splicing	NN	O
experiments	NNS	O
and	CC	O
transient	JJ	O
expression	NN	O
analysis	NN	O
of	IN	O
mutant	JJ	O
cDNAs	NNS	O
.	.	O

The	DT	O
P65L	NN	O
mutation	NN	O
locates	VBZ	O
11	CD	O
bases	NNS	O
upstream	RB	O
of	IN	O
a	DT	O
splice	NN	O
donor	NN	O
site	NN	O
of	IN	O
intron	NN	O
3	CD	O
.	.	O

This	DT	O
is	VBZ	O
an	DT	O
example	NN	O
of	IN	O
an	DT	O
exonic	JJ	O
mutation	NN	O
which	WDT	O
affects	VBZ	O
exon-splicing	JJ	O
.	.	O

.	.	O

Amino-terminal	JJ	O
fragments	NNS	O
of	IN	O
mutant	JJ	O
huntingtin	NN	O
show	NN	O
selective	JJ	O
accumulation	NN	O
in	IN	O
striatal	JJ	O
neurons	NNS	O
and	CC	O
synaptic	JJ	O
toxicity	NN	O
.	.	O

Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
is	VBZ	O
caused	VBN	O
by	IN	O
expansion	NN	O
of	IN	O
a	DT	O
glutamine	NN	O
repeat	NN	O
in	IN	O
the	DT	O
amino-terminal	JJ	O
region	NN	O
of	IN	O
huntingtin	NN	O
.	.	O

Despite	IN	O
its	PRP$	O
widespread	JJ	O
expression	NN	O
,	,	O
mutant	JJ	O
huntingtin	NN	O
induces	VBZ	O
selective	JJ	O
neuronal	JJ	O
loss	NN	O
in	IN	O
striatal	JJ	O
neurons	NNS	O
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
that	IN	O
,	,	O
in	IN	O
mutant	JJ	O
mice	NNS	O
expressing	VBG	O
HD	NN	B-Disease
repeats	NNS	O
,	,	O
the	DT	O
production	NN	O
and	CC	O
aggregation	NN	O
of	IN	O
N-terminal	JJ	O
huntingtin	NN	O
fragments	NNS	O
preferentially	RB	O
occur	VBP	O
in	IN	O
HD-affected	JJ	O
neurons	NNS	O
and	CC	O
their	PRP$	O
processes	NNS	O
and	CC	O
axonal	JJ	O
terminals	NNS	O
.	.	O

N-terminal	JJ	O
fragments	NNS	O
of	IN	O
mutant	JJ	O
huntingtin	NN	O
form	NN	O
aggregates	NNS	O
and	CC	O
induce	VBP	O
neuritic	JJ	B-Disease
degeneration	NN	I-Disease
in	IN	O
cultured	VBN	O
striatal	JJ	O
neurons	NNS	O
.	.	O

N-terminal	JJ	O
mutant	JJ	O
huntingtin	NN	O
also	RB	O
binds	VBZ	O
to	TO	O
synaptic	JJ	O
vesicles	NNS	O
and	CC	O
inhibits	VBZ	O
their	PRP$	O
glutamate	JJ	O
uptake	NN	O
in	FW	O
vitro	FW	O
.	.	O

The	DT	O
specific	JJ	O
processing	NN	O
and	CC	O
accumulation	NN	O
of	IN	O
toxic	JJ	O
fragments	NNS	O
of	IN	O
N-terminal	JJ	O
huntingtin	NN	O
in	IN	O
HD-affected	JJ	O
striatal	JJ	O
neurons	NNS	O
,	,	O
especially	RB	O
in	IN	O
their	PRP$	O
neuronal	JJ	O
processes	NNS	O
and	CC	O
axonal	JJ	O
terminals	NNS	O
,	,	O
may	MD	O
contribute	VB	O
to	TO	O
the	DT	O
selective	JJ	O
neuropathology	NN	O
of	IN	O
HD	NN	B-Disease
.	.	O

.	.	O

Phenotypic	JJ	O
variation	NN	O
including	VBG	O
retinitis	NN	B-Disease
pigmentosa	NN	I-Disease
,	,	O
pattern	NN	B-Disease
dystrophy	NN	I-Disease
,	,	O
and	CC	O
fundus	NN	B-Disease
flavimaculatus	NN	I-Disease
in	IN	O
a	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin/RDS	NN	O
gene	NN	O
.	.	O

BACKGROUND	NN	O
AND	CC	O
OBJECTIVES	NNS	O
Mutations	NNS	O
of	IN	O
the	DT	O
peripherin/RDS	NN	O
gene	NN	O
have	VBP	O
been	VBN	O
reported	VBN	O
in	IN	O
autosomal	JJ	B-Disease
dominant	JJ	I-Disease
retinitis	NN	I-Disease
pigmentosa	NN	I-Disease
,	,	O
pattern	NN	O
macular	JJ	B-Disease
dystrophy	NN	I-Disease
,	,	O
and	CC	O
retinitis	NN	B-Disease
punctata	NN	I-Disease
albescens	NNS	I-Disease
.	.	O

We	PRP	O
report	VBP	O
herein	RB	O
the	DT	O
occurrence	NN	O
of	IN	O
three	CD	O
separate	JJ	O
phenotypes	NNS	O
within	IN	O
a	DT	O
single	JJ	O
family	NN	O
with	IN	O
a	DT	O
novel	JJ	O
3-base	NN	O
pair	NN	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin/RDS	NN	O
gene	NN	O
.	.	O

DESIGN	NN	O
Case	NN	O
reports	NNS	O
with	IN	O
clinical	JJ	O
features	NNS	O
,	,	O
fluorescein	NN	O
angiography	NN	O
,	,	O
kinetic	JJ	O
perimetry	NN	O
,	,	O
electrophysiological	JJ	O
studies	NNS	O
,	,	O
and	CC	O
molecular	JJ	O
genetics	NNS	O
.	.	O

SETTING	NNP	O
University	NNP	O
medical	JJ	O
centers	NNS	O
.	.	O

PATIENTS	NNS	O
A	DT	O
75-year-old	CD	O
woman	NN	O
,	,	O
her	PRP$	O
two	CD	O
daughters	NNS	O
(	-LRB-	O
aged	JJ	O
44	CD	O
and	CC	O
50	CD	O
years	NNS	O
)	-RRB-	O
,	,	O
and	CC	O
her	PRP$	O
49-year-old	JJ	O
son	NN	O
were	VBD	O
screened	VBN	O
for	IN	O
peripherin/RDS	NN	O
mutations	NNS	O
because	IN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
multiple	JJ	O
phenotypes	NNS	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O

RESULTS	NNS	O
The	DT	O
mother	NN	O
presented	VBN	O
at	IN	O
age	NN	O
63	CD	O
years	NNS	O
with	IN	O
a	DT	O
profoundly	RB	O
abnormal	JJ	O
electroretinogram	NN	O
(	-LRB-	O
ERG	NN	O
)	-RRB-	O
and	CC	O
adult-onset	JJ	O
retinitis	NN	B-Disease
pigmentosa	NN	I-Disease
that	WDT	O
progressed	VBD	O
dramatically	RB	O
over	IN	O
12	CD	O
years	NNS	O
,	,	O
with	IN	O
marked	JJ	O
loss	NN	O
of	IN	O
peripheral	JJ	O
visual	JJ	O
field	NN	O
.	.	O

One	CD	O
daughter	NN	O
developed	VBD	O
pattern	NN	B-Disease
macular	JJ	I-Disease
dystrophy	NN	I-Disease
at	IN	O
age	NN	O
31	CD	O
years	NNS	O
.	.	O

At	IN	O
age	NN	O
44	CD	O
years	NNS	O
,	,	O
her	PRP$	O
ERG	NN	O
was	VBD	O
moderately	RB	O
abnormal	JJ	O
but	CC	O
her	PRP$	O
clinical	JJ	O
disease	NN	O
was	VBD	O
limited	VBN	O
to	TO	O
the	DT	O
macula	NN	O
.	.	O

Another	DT	O
daughter	NN	O
presented	VBN	O
at	IN	O
age	NN	O
42	CD	O
years	NNS	O
with	IN	O
macular	JJ	B-Disease
degeneration	NN	I-Disease
and	CC	O
over	IN	O
10	CD	O
years	NNS	O
developed	VBD	O
the	DT	O
clinical	JJ	O
picture	NN	O
of	IN	O
fundus	NN	B-Disease
flavimaculatus	NN	I-Disease
.	.	O

Her	PRP$	O
peripheral	JJ	O
visual	JJ	O
field	NN	O
was	VBD	O
preserved	VBN	O
but	CC	O
her	PRP$	O
ERG	NN	O
was	VBD	O
moderately	RB	O
abnormal	JJ	O
.	.	O

The	DT	O
son	NN	O
had	VBD	O
onset	NN	O
of	IN	O
macular	JJ	B-Disease
degeneration	NN	I-Disease
at	IN	O
age	NN	O
44	CD	O
years	NNS	O
.	.	O

Pericentral	JJ	B-Disease
scotomas	NNS	I-Disease
were	VBD	O
present	JJ	O
and	CC	O
the	DT	O
ERG	NNP	O
was	VBD	O
markedly	RB	O
abnormal	JJ	O
.	.	O

Fluorescein	NN	O
angiography	NN	O
revealed	VBD	O
punctate	NN	O
pigment	NN	O
epithelial	JJ	O
transmission	NN	O
defects	NNS	O
.	.	O

CONCLUSIONS	NNS	O
A	DT	O
3-base	JJ	O
pair	NN	O
deletion	NN	O
of	IN	O
codon	NN	O
153	CD	O
or	CC	O
154	CD	O
of	IN	O
the	DT	O
peripherin/RDS	NN	O
gene	NN	O
can	MD	O
produce	VB	O
clinically	RB	O
disparate	JJ	O
phenotypes	NNS	O
even	RB	O
within	IN	O
the	DT	O
same	JJ	O
family	NN	O
.	.	O

.	.	O

Missense	NN	O
mutation	NN	O
in	IN	O
the	DT	O
alternative	JJ	O
splice	NN	O
region	NN	O
of	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
in	IN	O
eye	NN	B-Disease
anomalies	NNS	I-Disease
.	.	O

The	DT	O
PAX6	NN	O
gene	NN	O
is	VBZ	O
involved	VBN	O
in	IN	O
ocular	JJ	O
morphogenesis	NN	O
,	,	O
and	CC	O
PAX6	NN	O
mutations	NNS	O
have	VBP	O
been	VBN	O
detected	VBN	O
in	IN	O
various	JJ	O
types	NNS	O
of	IN	O
ocular	JJ	B-Disease
anomalies	NNS	I-Disease
,	,	O
including	VBG	O
aniridia	NN	B-Disease
,	,	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
,	,	O
corneal	NN	B-Disease
dystrophy	NN	I-Disease
,	,	O
congenital	JJ	B-Disease
cataract	NN	I-Disease
,	,	O
and	CC	O
foveal	JJ	B-Disease
hypoplasia	NN	I-Disease
.	.	O

The	DT	O
gene	NN	O
encodes	VBZ	O
a	DT	O
transcriptional	JJ	O
regulator	NN	O
that	WDT	O
recognizes	VBZ	O
target	NN	O
genes	NNS	O
through	IN	O
its	PRP$	O
paired-type	JJ	O
DNA-binding	JJ	O
domain	NN	O
.	.	O

The	DT	O
paired	JJ	O
domain	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
two	CD	O
distinct	JJ	O
DNA-binding	JJ	O
subdomains	NNS	O
,	,	O
the	DT	O
N-terminal	JJ	O
subdomain	NN	O
(	-LRB-	O
NTS	NNS	O
)	-RRB-	O
and	CC	O
the	DT	O
C-terminal	JJ	O
subdomain	NN	O
(	-LRB-	O
CTS	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
bind	VBP	O
respective	JJ	O
consensus	NN	O
DNA	NN	O
sequences	NNS	O
.	.	O

The	DT	O
human	JJ	O
PAX6	NN	O
gene	NN	O
produces	VBZ	O
two	CD	O
alternative	JJ	O
splice	NN	O
isoforms	NNS	O
that	WDT	O
have	VBP	O
the	DT	O
distinct	JJ	O
structure	NN	O
of	IN	O
the	DT	O
paired	JJ	O
domain	NN	O
.	.	O

The	DT	O
insertion	NN	O
,	,	O
into	IN	O
the	DT	O
NTS	NNS	O
,	,	O
of	IN	O
14	CD	O
additional	JJ	O
amino	NN	O
acids	NNS	O
encoded	VBN	O
by	IN	O
exon	NN	O
5a	NN	O
abolishes	VBZ	O
the	DT	O
DNA-binding	JJ	O
activity	NN	O
of	IN	O
the	DT	O
NTS	NNS	O
and	CC	O
unmasks	VBZ	O
the	DT	O
DNA-binding	JJ	O
ability	NN	O
of	IN	O
the	DT	O
CTS	NNP	O
.	.	O

Thus	RB	O
,	,	O
exon	NN	O
5a	NN	O
appears	VBZ	O
to	TO	O
function	VB	O
as	IN	O
a	DT	O
molecular	JJ	O
switch	NN	O
that	WDT	O
specifies	VBZ	O
target	NN	O
genes	NNS	O
.	.	O

We	PRP	O
ascertained	VBD	O
a	DT	O
novel	JJ	O
missense	NN	O
mutation	NN	O
in	IN	O
four	CD	O
pedigrees	NNS	O
with	IN	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
,	,	O
congenital	JJ	B-Disease
cataract	NN	I-Disease
,	,	O
Axenfeldt	NNP	B-Disease
anomaly	RB	I-Disease
,	,	O
and/or	CC	O
foveal	NN	B-Disease
hypoplasia	NN	I-Disease
,	,	O
which	WDT	O
,	,	O
to	TO	O
our	PRP$	O
knowledge	NN	O
,	,	O
is	VBZ	O
the	DT	O
first	JJ	O
mutation	NN	O
identified	VBN	O
in	IN	O
the	DT	O
splice-variant	JJ	O
region	NN	O
.	.	O

A	DT	O
T	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
at	IN	O
the	DT	O
20th	JJ	O
nucleotide	NN	O
position	NN	O
of	IN	O
exon	NN	O
5a	NN	O
results	VBZ	O
in	IN	O
a	DT	O
Val	NN	O
--	:	O
>	JJR	O
Asp	NN	O
(	-LRB-	O
GTC	NN	O
--	:	O
>	JJR	O
GAC	NN	O
)	-RRB-	O
substitution	NN	O
at	IN	O
the	DT	O
7th	JJ	O
codon	NN	O
of	IN	O
the	DT	O
alternative	JJ	O
splice	NN	O
region	NN	O
.	.	O

Functional	JJ	O
analyses	NNS	O
demonstrated	VBD	O
that	IN	O
the	DT	O
V54D	NN	O
mutation	NN	O
slightly	RB	O
increased	VBD	O
NTS	NN	O
binding	NN	O
and	CC	O
decreased	VBD	O
CTS	NN	O
transactivation	NN	O
activity	NN	O
to	TO	O
almost	RB	O
half	NN	O
.	.	O

.	.	O

A	DT	O
detailed	JJ	O
multipoint	JJ	O
map	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
4	CD	O
provides	VBZ	O
evidence	NN	O
for	IN	O
linkage	NN	O
heterogeneity	NN	O
and	CC	O
position-specific	JJ	O
recombination	NN	O
rates	NNS	O
.	.	O

Utilizing	VBG	O
the	DT	O
CEPH	NN	O
reference	NN	O
panel	NN	O
and	CC	O
genotypic	JJ	O
data	NNS	O
for	IN	O
53	CD	O
markers	NNS	O
,	,	O
we	PRP	O
have	VBP	O
constructed	VBN	O
a	DT	O
20-locus	JJ	O
multipoint	JJ	O
genetic	JJ	O
map	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
4	CD	O
.	.	O

New	NNP	O
RFLPs	NNS	O
are	VBP	O
reported	VBN	O
for	IN	O
four	CD	O
loci	NNS	O
.	.	O

The	DT	O
map	NN	O
integrates	VBZ	O
a	DT	O
high-resolution	JJ	O
genetic	JJ	O
map	NN	O
of	IN	O
4p16	NN	O
into	IN	O
a	DT	O
continuous	JJ	O
map	NN	O
extending	VBG	O
to	TO	O
4q31	NN	O
and	CC	O
an	DT	O
unlinked	JJ	O
cluster	NN	O
of	IN	O
three	CD	O
loci	NNS	O
at	IN	O
4q35	CD	O
.	.	O

The	DT	O
20	CD	O
linked	VBN	O
markers	NNS	O
form	VBP	O
a	DT	O
continuous	JJ	O
linkage	NN	O
group	NN	O
of	IN	O
152	CD	O
cM	NN	O
in	IN	O
males	NNS	O
and	CC	O
202	CD	O
cM	NN	O
in	IN	O
females	NNS	O
.	.	O

Likely	RB	O
genetic	JJ	O
locations	NNS	O
are	VBP	O
provided	VBN	O
for	IN	O
25	CD	O
polymorphic	JJ	O
anonymous	JJ	O
sequences	NNS	O
and	CC	O
28	CD	O
gene-specific	JJ	O
RFLPs	NNS	O
.	.	O

The	DT	O
map	NN	O
was	VBD	O
constructed	VBN	O
employing	VBG	O
the	DT	O
LINKAGE	NN	O
and	CC	O
CRIMAP	NN	O
computational	JJ	O
methodologies	NNS	O
to	TO	O
build	VB	O
the	DT	O
multipoint	JJ	O
map	NN	O
via	IN	O
a	DT	O
stepwise	JJ	O
algorithm	NN	O
.	.	O

A	DT	O
detailed	JJ	O
10-point	JJ	O
map	NN	O
of	IN	O
the	DT	O
4p16	NN	O
region	NN	O
constructed	VBN	O
from	IN	O
the	DT	O
CEPH	NN	O
panel	NN	O
provides	VBZ	O
evidence	NN	O
for	IN	O
heterogeneity	NN	O
in	IN	O
the	DT	O
linkage	NN	O
maps	VBZ	O
constructed	VBN	O
from	IN	O
families	NNS	O
segregating	VBG	O
for	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
.	.	O

It	PRP	O
additionally	RB	O
provides	VBZ	O
evidence	NN	O
for	IN	O
position-specific	JJ	O
recombination	NN	O
frequencies	NNS	O
in	IN	O
the	DT	O
telomeric	JJ	O
region	NN	O
of	IN	O
4p	NN	O
.	.	O

.	.	O

The	DT	O
murine	JJ	O
homolog	NN	O
of	IN	O
the	DT	O
human	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
Brca1	NN	O
maps	VBZ	O
to	TO	O
mouse	NN	O
chromosome	NN	O
11D	NN	O
.	.	O

The	DT	O
recently	RB	O
cloned	VBN	O
human	JJ	O
breast	NN	B-Disease
and	CC	I-Disease
ovarian	JJ	I-Disease
cancer	NN	I-Disease
susceptibility	NN	O
gene	NN	O
,	,	O
BRCA1	NN	O
,	,	O
is	VBZ	O
located	JJ	O
on	IN	O
human	JJ	O
chromosome	NN	O
17q21	NN	O
.	.	O

We	PRP	O
have	VBP	O
isolated	VBN	O
murine	JJ	O
genomic	JJ	O
clones	NNS	O
containing	VBG	O
Brca1	NN	O
as	IN	O
a	DT	O
first	JJ	O
step	NN	O
in	IN	O
generating	VBG	O
a	DT	O
mouse	NN	O
model	NN	O
for	IN	O
the	DT	O
loss	NN	O
of	IN	O
BRCA1	NN	O
function	NN	O
.	.	O

A	DT	O
mouse	NN	O
genomic	JJ	O
library	NN	O
was	VBD	O
screened	VBN	O
using	VBG	O
probes	NNS	O
corresponding	VBG	O
to	TO	O
exon	NN	O
11	CD	O
of	IN	O
the	DT	O
human	JJ	O
BRCA1	NN	O
gene	NN	O
.	.	O

Two	CD	O
overlapping	VBG	O
mouse	NN	O
clones	NNS	O
were	VBD	O
identified	VBN	O
that	WDT	O
hybridized	VBD	O
to	TO	O
human	JJ	O
BRCA1	NN	O
exons	NNS	O
9-12	CD	O
.	.	O

Sequence	NN	O
analysis	NN	O
of	IN	O
1	CD	O
.	.	O

4	CD	O
kb	NN	O
of	IN	O
the	DT	O
region	NN	O
of	IN	O
these	DT	O
clones	NNS	O
corresponding	VBG	O
to	TO	O
part	NN	O
of	IN	O
human	JJ	O
exon	NN	O
11	CD	O
revealed	VBD	O
72	CD	O
%	NN	O
nucleic	JJ	O
acid	NN	O
identity	NN	O
but	CC	O
only	RB	O
50	CD	O
%	NN	O
amino	NN	O
acid	NN	O
identity	NN	O
with	IN	O
the	DT	O
human	JJ	O
gene	NN	O
.	.	O

The	DT	O
longest	JJS	O
of	IN	O
the	DT	O
mouse	NN	O
Brca1	NN	O
genomic	JJ	O
clones	NNS	O
maps	VBZ	O
to	TO	O
chromosome	NN	O
11D	NN	O
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
two-color	JJ	O
fluorescence	NN	O
in	FW	O
situ	FW	O
hybridization	NN	O
.	.	O

The	DT	O
synteny	NN	O
to	TO	O
human	JJ	O
chromosome	NN	O
17	CD	O
was	VBD	O
confirmed	VBN	O
by	IN	O
cohybridization	NN	O
with	IN	O
the	DT	O
mouse	NN	O
probe	NN	O
for	IN	O
the	DT	O
NF1-gene	NN	O
.	.	O

This	DT	O
comparative	JJ	O
study	NN	O
confirms	VBZ	O
that	IN	O
the	DT	O
relative	JJ	O
location	NN	O
of	IN	O
the	DT	O
BRCA1	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
conserved	VBN	O
between	IN	O
mice	NNS	O
and	CC	O
humans	NNS	O
.	.	O

High	JJ	O
residual	JJ	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
activity	NN	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
late-infantile	JJ	B-Disease
metachromatic	JJ	I-Disease
leukodystrophy	NN	I-Disease
.	.	O

We	PRP	O
identified	VBD	O
a	DT	O
patient	NN	O
suffering	NN	O
from	IN	O
late-infantile	JJ	B-Disease
metachromatic	JJ	I-Disease
leukodystrophy	NN	I-Disease
(	-LRB-	O
MLD	NN	B-Disease
)	-RRB-	O
who	WP	O
has	VBZ	O
a	DT	O
residual	JJ	O
arylsulfatase	NN	O
A	NN	O
(	-LRB-	O
ARSA	NN	O
)	-RRB-	O
activity	NN	O
of	IN	O
about	IN	O
10	CD	O
%	NN	O
.	.	O

Fibroblasts	NNS	O
of	IN	O
the	DT	O
patient	NN	O
show	NN	O
significant	JJ	O
sulfatide	NN	O
degradation	NN	O
activity	NN	O
exceeding	VBG	O
that	IN	O
of	IN	O
adult	JJ	B-Disease
MLD	NN	I-Disease
patients	NNS	O
.	.	O

Analysis	NN	O
of	IN	O
the	DT	O
ARSA	NNP	O
gene	NN	O
in	IN	O
this	DT	O
patient	NN	O
revealed	VBD	O
heterozygosity	NN	O
for	IN	O
two	CD	O
new	JJ	O
mutant	JJ	O
alleles	NNS	O
in	IN	O
one	CD	O
allele	NN	O
,	,	O
deletion	NN	O
of	IN	O
C	NN	O
447	CD	O
in	IN	O
exon	NN	O
2	CD	O
leads	VBZ	O
to	TO	O
a	DT	O
frameshift	NN	O
and	CC	O
to	TO	O
a	DT	O
premature	JJ	O
stop	NN	O
codon	NN	O
at	IN	O
amino	NN	O
acid	NN	O
position	NN	O
105	CD	O
;	:	O
in	IN	O
the	DT	O
second	JJ	O
allele	NN	O
,	,	O
a	DT	O
G	NN	O
--	:	O
>	JJR	O
A	DT	O
transition	NN	O
in	IN	O
exon	NN	O
5	CD	O
causes	VBZ	O
a	DT	O
Gly309	NN	O
--	:	O
>	JJR	O
Ser	NN	O
substitution	NN	O
.	.	O

Transient	JJ	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
Ser309-ARSA	NN	O
resulted	VBD	O
in	IN	O
only	RB	O
13	CD	O
%	NN	O
enzyme	NN	O
activity	NN	O
of	IN	O
that	DT	O
observed	VBN	O
in	IN	O
cells	NNS	O
expressing	VBG	O
normal	JJ	O
ARSA	NNP	O
.	.	O

The	DT	O
mutant	JJ	O
ARSA	NNP	O
is	VBZ	O
correctly	RB	O
targeted	VBN	O
to	TO	O
the	DT	O
lysosomes	NNS	O
but	CC	O
is	VBZ	O
unstable	JJ	O
.	.	O

These	DT	O
findings	NNS	O
are	VBP	O
in	IN	O
contrast	NN	O
to	TO	O
previous	JJ	O
results	NNS	O
showing	VBG	O
that	IN	O
the	DT	O
late-infantile	JJ	B-Disease
type	NN	I-Disease
of	IN	I-Disease
MLD	NN	I-Disease
is	VBZ	O
always	RB	O
associated	VBN	O
with	IN	O
the	DT	O
complete	JJ	O
absence	NN	O
of	IN	O
ARSA	NN	O
activity	NN	O
.	.	O

The	DT	O
expression	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
ARSA	NN	O
protein	NN	O
may	MD	O
be	VB	O
influenced	VBN	O
by	IN	O
particular	JJ	O
features	NNS	O
of	IN	O
oligodendrocytes	NNS	O
,	,	O
such	JJ	O
that	IN	O
the	DT	O
level	NN	O
of	IN	O
mutant	JJ	O
enzyme	NN	O
is	VBZ	O
lower	JJR	O
in	IN	O
these	DT	O
cells	NNS	O
than	IN	O
in	IN	O
others	NNS	O
.	.	O

.	.	O

De	NNP	O
novo	FW	O
deletions	NNS	O
of	IN	O
SNRPN	NNP	O
exon	NN	O
1	CD	O
in	IN	O
early	JJ	O
human	JJ	O
and	CC	O
mouse	NN	O
embryos	NNS	O
result	VBP	O
in	IN	O
a	DT	O
paternal	JJ	O
to	TO	O
maternal	JJ	O
imprint	NN	O
switch	NN	O
.	.	O

Prader-Willi	JJ	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
PWS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
a	DT	O
neurogenetic	JJ	B-Disease
disease	NN	I-Disease
characterized	VBN	O
by	IN	O
infantile	JJ	B-Disease
hypotonia	NN	I-Disease
,	,	O
gonadal	JJ	B-Disease
hypoplasia	NN	I-Disease
,	,	O
obsessive	JJ	O
behaviour	NN	O
and	CC	O
neonatal	JJ	O
feeding	NN	O
difficulties	NNS	O
followed	VBN	O
by	IN	O
hyperphagia	NN	B-Disease
,	,	O
leading	VBG	O
to	TO	O
profound	JJ	O
obesity	NN	B-Disease
.	.	O

PWS	NN	B-Disease
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
lack	NN	O
of	IN	O
paternal	JJ	O
genetic	JJ	O
information	NN	O
at	IN	O
15q11-q13	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

2	LS	O
)	-RRB-	O
.	.	O

Five	CD	O
imprinted	JJ	O
,	,	O
paternally	RB	O
expressed	VBN	O
genes	NNS	O
map	VBP	O
to	TO	O
the	DT	O
PWS	NN	B-Disease
region	NN	O
,	,	O
MKRN3	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

3	LS	O
)	-RRB-	O
,	,	O
NDN	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

4	LS	O
)	-RRB-	O
,	,	O
NDNL1	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

5	LS	O
)	-RRB-	O
,	,	O
SNRPN	NN	O
(	-LRB-	O
refs	NNS	O
6-8	CD	O
)	-RRB-	O
and	CC	O
IPW	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

9	CD	O
)	-RRB-	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
two	CD	O
poorly	RB	O
characterized	VBN	O
framents	NNS	O
designated	VBN	O
PAR-1	NN	O
and	CC	O
PAR-5	NN	O
(	-LRB-	O
ref	NN	O
.	.	O

10	CD	O
)	-RRB-	O
.	.	O

Imprinting	NN	O
of	IN	O
this	DT	O
region	NN	O
involves	VBZ	O
a	DT	O
bipartite	JJ	O
imprinting	VBG	O
centre	NN	O
(	-LRB-	O
IC	NN	O
)	-RRB-	O
,	,	O
which	WDT	O
overlaps	VBZ	O
SNRPN	NNP	O
(	-LRB-	O
refs	NNS	O
10	CD	O
,	,	O
11	CD	O
)	-RRB-	O
.	.	O

Deletion	NN	O
of	IN	O
the	DT	O
SNRPN	NNP	O
promoter/exon	NN	O
1	CD	O
region	NN	O
(	-LRB-	O
the	DT	O
PWS	NN	B-Disease
IC	NN	O
element	NN	O
)	-RRB-	O
appears	VBZ	O
to	TO	O
impair	VB	O
the	DT	O
establishment	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
imprint	NN	O
in	IN	O
the	DT	O
male	JJ	O
germ	NN	O
line	NN	O
and	CC	O
leads	VBZ	O
to	TO	O
PWS	NNP	B-Disease
.	.	O

Here	RB	O
we	PRP	O
report	VBP	O
a	DT	O
PWS	NN	B-Disease
family	NN	O
in	IN	O
which	WDT	O
the	DT	O
father	NN	O
is	VBZ	O
mosaic	JJ	O
for	IN	O
an	DT	O
IC	NN	O
deletion	NN	O
on	IN	O
his	PRP$	O
paternal	JJ	O
chromosome	NN	O
.	.	O

The	DT	O
deletion	NN	O
chromosome	NN	O
has	VBZ	O
acquired	VBN	O
a	DT	O
maternal	JJ	O
methylation	NN	O
imprint	NN	O
in	IN	O
his	PRP$	O
somatic	JJ	O
cells	NNS	O
.	.	O

We	PRP	O
have	VBP	O
made	VBN	O
identical	JJ	O
findings	NNS	O
in	IN	O
chimaeric	JJ	O
mice	NNS	O
generated	VBN	O
from	IN	O
two	CD	O
independent	JJ	O
embryonic	JJ	O
stem	NN	O
(	-LRB-	O
ES	NN	O
)	-RRB-	O
cell	NN	O
lines	NNS	O
harbouring	VBG	O
a	DT	O
similar	JJ	O
deletion	NN	O
.	.	O

Our	PRP$	O
studies	NNS	O
demonstrate	VBP	O
that	IN	O
the	DT	O
PWS	NNP	B-Disease
IC	NN	O
element	NN	O
is	VBZ	O
not	RB	O
only	RB	O
required	VBN	O
for	IN	O
the	DT	O
establishment	NN	O
of	IN	O
the	DT	O
paternal	JJ	O
imprint	NN	O
,	,	O
but	CC	O
also	RB	O
for	IN	O
its	PRP$	O
postzygotic	JJ	O
maintenance	NN	O
.	.	O

.	.	O

Molecular	JJ	O
characterization	NN	O
of	IN	O
two	CD	O
galactosemia	NN	B-Disease
mutations	NNS	O
:	:	O
correlation	NN	O
of	IN	O
mutations	NNS	O
with	IN	O
highly	RB	O
conserved	VBN	O
domains	NNS	O
in	IN	O
galactose-1-phosphate	JJ	O
uridyl	NN	O
transferase	NN	O
.	.	O

Galactosemia	NNP	B-Disease
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
of	IN	I-Disease
human	JJ	I-Disease
galactose	NN	I-Disease
metabolism	NN	I-Disease
caused	VBN	O
by	IN	O
deficiency	NN	B-Disease
of	IN	I-Disease
the	DT	I-Disease
enzyme	NN	I-Disease
galactose-1-phosphate	NN	I-Disease
uridyl	NN	I-Disease
transferase	NN	I-Disease
(	-LRB-	O
GALT	NN	O
)	-RRB-	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
this	DT	O
disorder	NN	O
is	VBZ	O
at	IN	O
present	JJ	O
not	RB	O
well	RB	O
understood	VBN	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
two	CD	O
missense	NN	O
mutations	NNS	O
which	WDT	O
result	VBP	O
in	IN	O
low	JJ	O
or	CC	O
undetectable	JJ	O
enzymatic	JJ	O
activity	NN	O
.	.	O

First	RB	O
,	,	O
we	PRP	O
identified	VBD	O
at	IN	O
nucleotide	NN	O
591	CD	O
a	DT	O
transition	NN	O
which	WDT	O
substitutes	VBZ	O
glutamine	NN	O
188	CD	O
by	IN	O
arginine	NN	O
.	.	O

The	DT	O
mutated	VBN	O
glutamine	NN	O
is	VBZ	O
not	RB	O
only	RB	O
highly	RB	O
conserved	VBN	O
in	IN	O
evolution	NN	O
(	-LRB-	O
conserved	VBN	O
also	RB	O
in	IN	O
Escherichia	FW	O
coli	FW	O
and	CC	O
Saccharomyces	FW	O
cerevisiae	FW	O
)	-RRB-	O
,	,	O
but	CC	O
is	VBZ	O
also	RB	O
two	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
downstream	RB	O
from	IN	O
the	DT	O
active	JJ	O
site	NN	O
histidine-proline-histidine	JJ	O
triad	NN	O
and	CC	O
results	VBZ	O
in	IN	O
about	RB	O
10	CD	O
%	NN	O
of	IN	O
normal	JJ	O
enzymatic	JJ	O
activity	NN	O
.	.	O

The	DT	O
arginine	NN	O
188	CD	O
mutation	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
common	JJ	O
galactosemia	NN	B-Disease
mutation	NN	O
characterized	VBN	O
to	TO	O
date	NN	O
.	.	O

It	PRP	O
accounts	VBZ	O
for	IN	O
one-fourth	NN	O
of	IN	O
the	DT	O
galactosemia	NN	B-Disease
alleles	NNS	O
studied	VBN	O
.	.	O

Second	RB	O
,	,	O
we	PRP	O
report	VBP	O
the	DT	O
substitution	NN	O
of	IN	O
arginine	NN	O
333	CD	O
by	IN	O
tryptophan	NN	O
,	,	O
caused	VBN	O
by	IN	O
a	DT	O
transition	NN	O
at	IN	O
nucleotide	NN	O
1025	CD	O
.	.	O

The	DT	O
area	NN	O
surrounding	VBG	O
this	DT	O
missense	NN	O
mutation	NN	O
is	VBZ	O
the	DT	O
most	RBS	O
highly	RB	O
conserved	VBN	O
domain	NN	O
in	IN	O
the	DT	O
homologous	JJ	O
enzymes	NNS	O
from	IN	O
E.	FW	O
coli	FW	O
,	,	O
yeast	NN	O
,	,	O
and	CC	O
humans	NNS	O
,	,	O
and	CC	O
this	DT	O
mutation	NN	O
results	VBZ	O
in	IN	O
undetectable	JJ	O
enzymatic	JJ	O
activity	NN	O
,	,	O
suggesting	VBG	O
that	IN	O
this	DT	O
is	VBZ	O
a	DT	O
severe	JJ	O
mutation	NN	O
.	.	O

This	DT	O
second	JJ	O
mutation	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
rare	JJ	O
,	,	O
since	IN	O
it	PRP	O
was	VBD	O
found	VBN	O
only	RB	O
in	IN	O
the	DT	O
patient	NN	O
we	PRP	O
sequenced	VBD	O
.	.	O

Our	PRP$	O
data	NNS	O
provide	VBP	O
further	JJ	O
evidence	NN	O
for	IN	O
the	DT	O
heterogeneity	NN	O
of	IN	O
galactosemia	NN	B-Disease
at	IN	O
the	DT	O
molecular	JJ	O
level	NN	O
,	,	O
heterogeneity	NN	O
which	WDT	O
might	MD	O
be	VB	O
related	VBN	O
to	TO	O
the	DT	O
variable	JJ	O
clinical	JJ	O
outcome	NN	O
observed	VBN	O
in	IN	O
this	DT	O
disorder	NN	O
.	.	O

.	.	O

Neurophysiologic	JJ	O
follow-up	NN	O
of	IN	O
long-term	JJ	O
dietary	JJ	O
treatment	NN	O
in	IN	O
adult-onset	JJ	O
adrenoleukodystrophy	NN	B-Disease
.	.	O

OBJECTIVE	NN	O
To	TO	O
monitor	VB	O
the	DT	O
effects	NNS	O
of	IN	O
dietary	JJ	O
treatment	NN	O
in	IN	O
adult-onset	JJ	O
adrenoleukodystrophy	NN	B-Disease
(	-LRB-	O
ALD	NN	B-Disease
)	-RRB-	O
by	IN	O
means	NNS	O
of	IN	O
somatosensory	NN	O
evoked	VBD	O
potentials	NNS	O
(	-LRB-	O
SEPs	NNS	O
)	-RRB-	O
and	CC	O
motor	NN	O
evoked	VBD	O
potentials	NNS	O
(	-LRB-	O
MEPs	NNS	O
)	-RRB-	O
.	.	O

BACKGROUND	NN	O
SEPs	NNS	O
and	CC	O
MEPs	NNS	O
have	VBP	O
proved	VBN	O
useful	JJ	O
in	IN	O
revealing	VBG	O
signs	NNS	O
of	IN	O
progressively	RB	O
severe	JJ	O
,	,	O
central	JJ	O
dying-back	NN	B-Disease
axonopathy	NN	I-Disease
in	IN	O
early	JJ	O
stages	NNS	O
of	IN	O
adult-onset	JJ	O
ALD	NN	B-Disease
.	.	O

METHODS	NNS	O
Eight	CD	O
patients	NNS	O
with	IN	O
adult-onset	JJ	O
ALD	NN	B-Disease
underwent	VBD	O
clinical	JJ	O
examination	NN	O
,	,	O
brain	NN	O
and	CC	O
spine	NN	O
MRI	NNP	O
,	,	O
and	CC	O
SEP	NN	O
and	CC	O
MEP	NN	O
studies	NNS	O
before	IN	O
and	CC	O
after	IN	O
3	CD	O
years	NNS	O
of	IN	O
Lorenzos	NNP	O
oil	NN	O
dietary	JJ	O
therapy	NN	O
.	.	O

RESULTS	NNS	O
Before	IN	O
treatment	NN	O
,	,	O
brain	NN	O
MRI	NNP	O
was	VBD	O
normal	JJ	O
in	IN	O
five	CD	O
patients	NNS	O
.	.	O

Three	CD	O
of	IN	O
these	DT	O
patients	NNS	O
had	VBD	O
pure	JJ	O
spinal	JJ	B-Disease
SEP	NN	I-Disease
abnormalities	NNS	I-Disease
and	CC	O
in	IN	O
the	DT	O
remaining	VBG	O
two	CD	O
patients	NNS	O
SEPs	NNS	O
showed	VBD	O
signs	NNS	O
of	IN	O
involvement	NN	O
of	IN	O
both	CC	O
the	DT	O
spinal	JJ	O
and	CC	O
cerebral	JJ	O
somatosensory	NN	O
tracts	NNS	O
.	.	O

After	IN	O
treatment	NN	O
,	,	O
the	DT	O
three	CD	O
patients	NNS	O
with	IN	O
pure	JJ	O
spinal	JJ	B-Disease
abnormalities	NNS	I-Disease
showed	VBD	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
worsening	NN	O
,	,	O
whereas	IN	O
the	DT	O
two	CD	O
patients	NNS	O
with	IN	O
a	DT	O
more	RBR	O
advanced	JJ	O
stage	NN	O
of	IN	O
disease	NN	O
(	-LRB-	O
exhibited	VBN	O
by	IN	O
SEPs	NNS	O
)	-RRB-	O
showed	VBD	O
substantially	RB	O
unchanged	JJ	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
features	NNS	O
.	.	O

The	DT	O
patients	NNS	O
with	IN	O
abnormal	JJ	O
brain	NN	O
MRI	NNP	O
at	IN	O
the	DT	O
onset	NN	O
of	IN	O
treatment	NN	O
showed	VBD	O
clinical	JJ	O
and	CC	O
neurophysiologic	JJ	O
worsening	NN	O
.	.	O

CONCLUSIONS	NNS	O
Lorenzos	NNS	O
oil	NN	O
therapy	NN	O
had	VBD	O
no	DT	O
effect	NN	O
on	IN	O
patients	NNS	O
with	IN	O
evidence	NN	O
of	IN	O
inflammatory	JJ	B-Disease
brain	NN	I-Disease
lesions	NNS	I-Disease
.	.	O

Moreover	RB	O
,	,	O
in	IN	O
patients	NNS	O
without	IN	O
clear	JJ	O
signs	NNS	O
of	IN	O
inflammatory	JJ	O
damage	NN	O
,	,	O
this	DT	O
treatment	NN	O
does	VBZ	O
not	RB	O
modify	VB	O
significantly	RB	O
the	DT	O
natural	JJ	O
course	NN	O
of	IN	O
the	DT	O
disease	NN	O
.	.	O

However	RB	O
,	,	O
because	IN	O
effective	JJ	O
treatments	NNS	O
should	MD	O
begin	VB	O
before	IN	O
the	DT	O
onset	NN	O
of	IN	O
severe	JJ	O
neurologic	JJ	O
symptoms	NNS	O
,	,	O
SEPs	NNS	O
and	CC	O
MEPs	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
effectiveness	NN	O
of	IN	O
other	JJ	O
experimental	JJ	O
treatments	NNS	O
in	IN	O
the	DT	O
patient	NN	O
with	IN	O
a	DT	O
negative	JJ	O
brain	NN	O
MRI	NNP	O
.	.	O

The	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
Sjogren-Larsson	NN	B-Disease
syndrome	NN	I-Disease
:	:	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
fatty	NN	O
aldehyde	NN	O
dehydrogenase	NN	O
gene	NN	O
.	.	O

Sjogren-Larsson	NN	B-Disease
syndrome	NN	I-Disease
(	-LRB-	O
SLS	NN	B-Disease
)	-RRB-	O
is	VBZ	O
an	DT	O
autosomal	JJ	B-Disease
recessive	JJ	I-Disease
disorder	NN	I-Disease
characterized	VBN	O
by	IN	O
ichthyosis	NN	B-Disease
,	,	O
mental	JJ	B-Disease
retardation	NN	I-Disease
,	,	O
spasticity	NN	B-Disease
,	,	O
and	CC	O
deficient	JJ	B-Disease
activity	NN	I-Disease
of	IN	I-Disease
fatty	NN	I-Disease
aldehyde	NN	I-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	O
FALDH	NN	O
)	-RRB-	O
.	.	O

To	TO	O
define	VB	O
the	DT	O
molecular	JJ	O
defects	NNS	O
causing	VBG	O
SLS	NNP	B-Disease
,	,	O
we	PRP	O
performed	VBD	O
mutation	NN	O
analysis	NN	O
of	IN	O
the	DT	O
FALDH	NN	O
gene	NN	O
in	IN	O
probands	NNS	O
from	IN	O
63	CD	O
kindreds	NNS	O
with	IN	O
SLS	NN	B-Disease
.	.	O

Among	IN	O
these	DT	O
patients	NNS	O
,	,	O
49	CD	O
different	JJ	O
mutations-including	JJ	O
10	CD	O
deletions	NNS	O
,	,	O
2	CD	O
insertions	NNS	O
,	,	O
22	CD	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
3	CD	O
nonsense	NN	O
mutations	NNS	O
,	,	O
9	CD	O
splice-site	NN	O
defects	NNS	O
,	,	O
and	CC	O
3	CD	O
complex	NN	O
mutations-were	JJ	O
found	VBN	O
.	.	O

All	DT	O
of	IN	O
the	DT	O
patients	NNS	O
with	IN	O
SLS	NN	B-Disease
were	VBD	O
found	VBN	O
to	TO	O
carry	VB	O
mutations	NNS	O
.	.	O

Nineteen	CD	O
of	IN	O
the	DT	O
missense	NN	O
mutations	NNS	O
resulted	VBD	O
in	IN	O
a	DT	O
severe	JJ	O
reduction	NN	O
of	IN	O
FALDH	NN	O
enzyme	NN	O
catalytic	JJ	O
activity	NN	O
when	WRB	O
expressed	VBN	O
in	IN	O
mammalian	JJ	O
cells	NNS	O
,	,	O
but	CC	O
one	CD	O
mutation	NN	O
(	-LRB-	O
798G	NN	O
--	:	O
>	JJR	O
C	NN	O
[	-LRB-	O
K266N	NN	O
]	-RRB-	O
)	-RRB-	O
seemed	VBD	O
to	TO	O
have	VB	O
a	DT	O
greater	JJR	O
effect	NN	O
on	IN	O
mRNA	NN	O
stability	NN	O
.	.	O

The	DT	O
splice-site	JJ	O
mutations	NNS	O
led	VBD	O
to	TO	O
exon	NN	O
skipping	VBG	O
or	CC	O
utilization	NN	O
of	IN	O
cryptic	JJ	O
acceptor-splice	NN	O
sites	NNS	O
.	.	O

Thirty-seven	CD	O
mutations	NNS	O
were	VBD	O
private	JJ	O
,	,	O
and	CC	O
12	CD	O
mutations	NNS	O
were	VBD	O
seen	VBN	O
in	IN	O
two	CD	O
or	CC	O
more	JJR	O
probands	NNS	O
of	IN	O
European	JJ	O
or	CC	O
Middle	NNP	O
Eastern	NNP	O
descent	NN	O
.	.	O

Four	CD	O
single-nucleotide	JJ	O
polymorphisms	NNS	O
(	-LRB-	O
SNPs	NNS	O
)	-RRB-	O
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
FALDH	NN	O
gene	NN	O
.	.	O

At	IN	O
least	JJS	O
four	CD	O
of	IN	O
the	DT	O
common	JJ	O
mutations	NNS	O
(	-LRB-	O
551C	NN	O
--	:	O
>	JJR	O
T	NN	O
,	,	O
682C	NN	O
--	:	O
>	JJR	O
T	NN	O
,	,	O
733G	NNP	O
--	:	O
>	JJR	O
A	DT	O
,	,	O
and	CC	O
798	CD	O
+	CC	O
1delG	NN	O
)	-RRB-	O
were	VBD	O
associated	VBN	O
with	IN	O
multiple	JJ	O
SNP	NN	O
haplotypes	NNS	O
,	,	O
suggesting	VBG	O
that	IN	O
these	DT	O
mutations	NNS	O
originated	VBD	O
independently	RB	O
on	IN	O
more	JJR	O
than	IN	O
one	CD	O
occasion	NN	O
or	CC	O
were	VBD	O
ancient	JJ	O
SLS	NN	B-Disease
genes	NNS	O
that	WDT	O
had	VBD	O
undergone	VBN	O
intragenic	JJ	O
recombination	NN	O
.	.	O

Our	PRP$	O
results	NNS	O
demonstrate	VBP	O
that	IN	O
SLS	NN	B-Disease
is	VBZ	O
caused	VBN	O
by	IN	O
a	DT	O
strikingly	RB	O
heterogeneous	JJ	O
group	NN	O
of	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
FALDH	NN	O
gene	NN	O
and	CC	O
provide	VB	O
a	DT	O
framework	NN	O
for	IN	O
understanding	VBG	O
the	DT	O
genetic	JJ	O
basis	NN	O
of	IN	O
SLS	NN	B-Disease
and	CC	O
the	DT	O
development	NN	O
of	IN	O
DNA-based	JJ	O
diagnostic	JJ	O
tests	NNS	O
.	.	O

.	.	O

Severe-glucose-6-phosphate	JJ	B-Disease
dehydrogenase	NN	I-Disease
(	-LRB-	I-Disease
G6PD	NN	I-Disease
)	-RRB-	I-Disease
deficiency	NN	I-Disease
associated	VBN	O
with	IN	O
chronic	JJ	O
hemolytic	JJ	B-Disease
anemia	NN	I-Disease
,	,	O
granulocyte	NN	B-Disease
dysfunction	NN	I-Disease
,	,	O
and	CC	O
increased	VBD	O
susceptibility	NN	O
to	TO	O
infections	NNS	O
:	:	O
description	NN	O
of	IN	O
a	DT	O
new	JJ	O
molecular	JJ	O
variant	NN	O
(	-LRB-	O
G6PD	NN	O
Barcelona	NNP	O
)	-RRB-	O
.	.	O

Molecular	JJ	O
,	,	O
kinetic	JJ	O
,	,	O
and	CC	O
functional	JJ	O
studies	NNS	O
were	VBD	O
carried	VBN	O
out	RP	O
on	IN	O
erythrocytes	NNS	O
and	CC	O
leukocytes	NNS	O
in	IN	O
a	DT	O
Spanish	JJ	O
male	NN	O
with	IN	O
G6PD	NN	B-Disease
deficiency	NN	I-Disease
,	,	O
congenital	JJ	B-Disease
nonspherocytic	JJ	I-Disease
hemolytic	JJ	I-Disease
anemia	NN	I-Disease
(	-LRB-	O
CNSHA	NN	B-Disease
)	-RRB-	O
,	,	O
and	CC	O
increased	VBD	O
susceptibility	NN	O
to	TO	O
infections	NNS	O
.	.	O

G6PD	NN	O
activity	NN	O
was	VBD	O
absent	JJ	O
in	IN	O
patients	NNS	O
red	JJ	O
cells	NNS	O
and	CC	O
was	VBD	O
about	RB	O
2	CD	O
%	NN	O
of	IN	O
normal	JJ	O
in	IN	O
leukocytes	NNS	O
.	.	O

Molecular	JJ	O
studies	NNS	O
using	VBG	O
standard	JJ	O
methods	NNS	O
(	-LRB-	O
WHO	WP	O
,	,	O
1967	CD	O
)	-RRB-	O
showed	VBD	O
G6PD	NN	O
in	IN	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
a	DT	O
slightly	RB	O
fast	JJ	O
electrophoretic	JJ	O
mobility	NN	O
at	IN	O
pH	NN	O
8	CD	O
.	.	O

0	CD	O
with	IN	O
otherwise	RB	O
normal	JJ	O
properties	NNS	O
(	-LRB-	O
heat	NN	O
stability	NN	O
at	IN	O
46	CD	O
degrees	NNS	O
C	NN	O
,	,	O
apparent	JJ	O
affinity	NN	O
for	IN	O
substrates	NNS	O
,	,	O
optimum	JJ	O
pH	NN	O
,	,	O
and	CC	O
utilization	NN	O
of	IN	O
substrate	NN	O
analogues	NNS	O
)	-RRB-	O
.	.	O

Other	JJ	O
tests	NNS	O
showed	VBD	O
the	DT	O
patients	NNS	O
granulocytes	NNS	O
to	TO	O
engulf	VB	O
latex	JJ	O
particles	NNS	O
normally	RB	O
,	,	O
but	CC	O
to	TO	O
have	VB	O
impaired	JJ	O
reduction	NN	O
of	IN	O
nitroblue	JJ	O
tetrazolium	NN	O
and	CC	O
ferricytochrome-c	JJ	O
as	RB	O
well	RB	O
as	IN	O
reduced	VBN	O
iodination	NN	O
.	.	O

Chemotaxis	NN	O
and	CC	O
random	JJ	O
migration	NN	O
of	IN	O
the	DT	O
patients	NNS	O
granulocytes	NNS	O
were	VBD	O
normal	JJ	O
as	IN	O
were	VBD	O
myeloperoxidase	NN	O
,	,	O
leukocyte	NN	O
alkaline	NN	O
phosphatase	NN	O
(	-LRB-	O
LAP	NN	O
)	-RRB-	O
,	,	O
and	CC	O
ultrastructural	JJ	O
features	NNS	O
.	.	O

The	DT	O
molecular	JJ	O
characteristics	NNS	O
of	IN	O
G6PD	NN	O
in	IN	O
the	DT	O
patient	NN	O
differed	VBD	O
from	IN	O
those	DT	O
of	IN	O
all	DT	O
previously	RB	O
reported	VBN	O
variants	NNS	O
associated	VBN	O
with	IN	O
CNSHA	NN	B-Disease
,	,	O
so	IN	O
the	DT	O
present	JJ	O
variant	NN	O
was	VBD	O
provisionally	RB	O
called	VBN	O
G6PD	NNP	O
Barcelona	NNP	O
to	TO	O
distinguish	VB	O
it	PRP	O
from	IN	O
other	JJ	O
G6PD	NN	O
variants	NNS	O
previously	RB	O
described	VBN	O
.	.	O

Possible	JJ	O
mechanisms	NNS	O
for	IN	O
the	DT	O
severe	JJ	O
deficiency	NN	B-Disease
of	IN	I-Disease
G6PD	NN	I-Disease
in	IN	O
erythrocytes	NNS	O
and	CC	O
granulocytes	NNS	O
was	VBD	O
investigated	VBN	O
by	IN	O
studies	NNS	O
on	IN	O
the	DT	O
immunologic	JJ	O
specific	JJ	O
activity	NN	O
of	IN	O
the	DT	O
mutant	JJ	O
enzyme	NN	O
.	.	O

Mutations	NNS	O
at	IN	O
the	DT	O
PAX6	NN	O
locus	NN	O
are	VBP	O
found	VBN	O
in	IN	O
heterogeneous	JJ	O
anterior	JJ	B-Disease
segment	NN	I-Disease
malformations	NNS	I-Disease
including	VBG	O
Peters	NNP	B-Disease
'	POS	I-Disease
anomaly	NN	I-Disease
.	.	O

Mutation	NN	O
or	CC	O
deletion	NN	O
of	IN	O
the	DT	O
PAX6	NN	O
gene	NN	O
underlies	VBZ	O
many	JJ	O
cases	NNS	O
of	IN	O
aniridia	NN	B-Disease
.	.	O

Three	CD	O
lines	NNS	O
of	IN	O
evidence	NN	O
now	RB	O
converge	VBP	O
to	TO	O
implicate	VB	O
PAX6	NN	O
more	RBR	O
widely	RB	O
in	IN	O
anterior	JJ	B-Disease
segment	NN	I-Disease
malformations	NNS	I-Disease
including	VBG	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
.	.	O

First	RB	O
,	,	O
a	DT	O
child	NN	O
with	IN	O
Peters	NNP	B-Disease
anomaly	NN	I-Disease
is	VBZ	O
deleted	VBN	O
for	IN	O
one	CD	O
copy	NN	O
of	IN	O
PAX6	NN	O
.	.	O

Second	RB	O
,	,	O
affected	VBD	O
members	NNS	O
of	IN	O
a	DT	O
family	NN	O
with	IN	O
dominantly	RB	O
inherited	VBN	O
anterior	JJ	B-Disease
segment	NN	I-Disease
malformations	NNS	I-Disease
,	,	O
including	VBG	O
Peters	NNP	B-Disease
anomaly	NN	I-Disease
are	VBP	O
heterozygous	JJ	O
for	IN	O
an	DT	O
R26G	NN	O
mutation	NN	O
in	IN	O
the	DT	O
PAX6	NN	O
paired	JJ	O
box	NN	O
.	.	O

Third	NNP	O
,	,	O
a	DT	O
proportion	NN	O
of	IN	O
Sey	NN	O
/	:	O
+	CC	O
Smalleye	NNP	O
mice	NNS	O
,	,	O
heterozygous	JJ	O
for	IN	O
a	DT	O
nonsense	NN	O
mutation	NN	O
in	IN	O
murine	JJ	O
Pax-6	NN	O
,	,	O
have	VBP	O
an	DT	O
ocular	JJ	O
phenotype	NN	O
resembling	VBG	O
Peters	NNP	B-Disease
anomaly	RB	I-Disease
.	.	O

We	PRP	O
therefore	RB	O
propose	VBP	O
that	IN	O
a	DT	O
variety	NN	O
of	IN	O
anterior	JJ	B-Disease
segment	NN	I-Disease
anomalies	NNS	I-Disease
may	MD	O
be	VB	O
associated	VBN	O
with	IN	O
PAX6	NN	O
mutations	NNS	O
.	.	O

.	.	O

In	IN	O
Swedish	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
,	,	O
linkage	NN	O
to	TO	O
the	DT	O
HPC1	NN	O
locus	NN	O
on	IN	O
chromosome	NN	O
1q24-25	CD	O
is	VBZ	O
restricted	JJ	O
to	TO	O
families	NNS	O
with	IN	O
early-onset	JJ	O
prostate	NN	B-Disease
cancer	NN	I-Disease
.	.	O

Prostate	NN	B-Disease
cancer	NN	I-Disease
clusters	NNS	O
in	IN	O
some	DT	O
families	NNS	O
,	,	O
and	CC	O
an	DT	O
estimated	VBN	O
5	CD	O
%	NN	O
-10	CD	O
%	NN	O
of	IN	O
all	DT	O
cases	NNS	O
are	VBP	O
estimated	VBN	O
to	TO	O
result	VB	O
from	IN	O
inheritance	NN	O
of	IN	O
prostate	NN	O
cancer-susceptibility	NN	O
genes	NNS	O
.	.	O

We	PRP	O
previously	RB	O
reported	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
1q24-25	CD	O
region	NN	O
(	-LRB-	O
HPC1	NN	O
)	-RRB-	O
in	IN	O
91	CD	O
North	JJ	O
American	JJ	O
and	CC	O
Swedish	JJ	O
families	NNS	O
each	DT	O
with	IN	O
multiple	JJ	O
cases	NNS	O
of	IN	O
prostate	NN	B-Disease
cancer	NN	I-Disease
(	-LRB-	O
Smith	NNP	O
et	FW	O
al.	FW	O
1996	CD	O
)	-RRB-	O
.	.	O

In	IN	O
the	DT	O
present	JJ	O
report	NN	O
we	PRP	O
analyze	VBP	O
40	CD	O
(	-LRB-	O
12	CD	O
original	JJ	O
and	CC	O
28	CD	O
newly	RB	O
identified	VBN	O
)	-RRB-	O
Swedish	JJ	O
families	NNS	O
with	IN	O
hereditary	JJ	B-Disease
prostate	NN	I-Disease
cancer	NN	I-Disease
(	-LRB-	O
HPC	NN	B-Disease
)	-RRB-	O
that	WDT	O
,	,	O
on	IN	O
the	DT	O
basis	NN	O
of	IN	O
40	CD	O
markers	NNS	O
spanning	VBG	O
a	DT	O
25-cM	JJ	O
interval	NN	O
within	IN	O
1q24-25	CD	O
,	,	O
have	VBP	O
evidence	NN	O
of	IN	O
linkage	NN	O
.	.	O

In	IN	O
the	DT	O
complete	JJ	O
set	NN	O
of	IN	O
families	NNS	O
,	,	O
a	DT	O
maximum	NN	O
two-point	JJ	O
LOD	NN	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

10	CD	O
was	VBD	O
observed	VBN	O
at	IN	O
D1S413	NN	O
(	-LRB-	O
at	IN	O
a	DT	O
recombination	NN	O
fraction	NN	O
[	-LRB-	O
theta	NN	O
]	-RRB-	O
of	IN	O
.	.	O

1	LS	O
)	-RRB-	O
,	,	O
with	IN	O
a	DT	O
maximum	NN	O
NPL	NN	O
(	-LRB-	O
nonparametric	JJ	O
linkage	NN	O
)	-RRB-	O
Z	NN	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

64	CD	O
at	IN	O
D1S202	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

05	NN	O
)	-RRB-	O
.	.	O

The	DT	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
this	DT	O
region	NN	O
originated	VBD	O
almost	RB	O
exclusively	RB	O
from	IN	O
the	DT	O
subset	NN	O
of	IN	O
12	CD	O
early-onset	JJ	O
(	-LRB-	O
age	NN	O
<	JJR	O
65	CD	O
years	NNS	O
)	-RRB-	O
families	NNS	O
,	,	O
which	WDT	O
yielded	VBD	O
a	DT	O
maximum	NN	O
LOD	NN	O
score	NN	O
of	IN	O
2	CD	O
.	.	O

38	CD	O
at	IN	O
D1S413	NN	O
(	-LRB-	O
straight	JJ	O
theta	NN	O
=	JJ	O
0	CD	O
)	-RRB-	O
and	CC	O
an	DT	O
NPL	NN	O
Z	NN	O
score	NN	O
of	IN	O
1	CD	O
.	.	O

95	CD	O
at	IN	O
D1S422	NN	O
(	-LRB-	O
P	NN	O
=	JJ	O
.	.	O

03	NN	O
)	-RRB-	O
.	.	O

Estimates	NNS	O
from	IN	O
heterogeneity	NN	O
tests	NNS	O
suggest	VBP	O
that	IN	O
,	,	O
within	IN	O
Sweden	NNP	O
,	,	O
as	RB	O
many	JJ	O
as	IN	O
50	CD	O
%	NN	O
of	IN	O
early-onset	JJ	O
families	NNS	O
had	VBD	O
evidence	NN	O
of	IN	O
linkage	NN	O
to	TO	O
the	DT	O
HPC1	NN	O
region	NN	O
.	.	O

These	DT	O
results	NNS	O
are	VBP	O
consistent	JJ	O
with	IN	O
the	DT	O
hypothesis	NN	O
of	IN	O
linkage	NN	O
to	TO	O
HPC1	NN	O
in	IN	O
a	DT	O
subset	NN	O
of	IN	O
families	NNS	O
with	IN	O
prostate	NN	B-Disease
cancer	NN	I-Disease
,	,	O
particularly	RB	O
those	DT	O
with	IN	O
an	DT	O
early	JJ	O
age	NN	O
at	IN	O
diagnosis	NN	O
.	.	O

Localisation	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
locus	NN	O
to	TO	O
19q13.2-19q13	JJ	O
.3	NN	O
and	CC	O
its	PRP$	O
relationship	NN	O
to	TO	O
twelve	CD	O
polymorphic	JJ	O
loci	NNS	O
on	IN	O
19q	NN	O
.	.	O

The	DT	O
order	NN	O
of	IN	O
fourteen	CD	O
polymorphic	JJ	O
markers	NNS	O
localised	VBD	O
to	TO	O
the	DT	O
long	JJ	O
arm	NN	O
of	IN	O
human	JJ	O
chromosome	NN	O
19	CD	O
has	VBZ	O
been	VBN	O
established	VBN	O
by	IN	O
multipoint	JJ	O
mapping	NN	O
in	IN	O
a	DT	O
set	NN	O
of	IN	O
40	CD	O
CEPH	NN	O
(	-LRB-	O
Centre	NNP	O
dEtude	NNP	O
de	IN	O
Polymorphisme	NNP	O
Humain	NNP	O
,	,	O
Paris	NNP	O
)	-RRB-	O
reference	NN	O
families	NNS	O
.	.	O

We	PRP	O
report	VBP	O
here	RB	O
the	DT	O
linkage	NN	O
relationship	NN	O
of	IN	O
the	DT	O
myotonic	JJ	B-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DM	NN	B-Disease
)	-RRB-	O
locus	NN	O
to	TO	O
twelve	CD	O
of	IN	O
these	DT	O
markers	NNS	O
as	IN	O
studied	VBN	O
in	IN	O
45	CD	O
families	NNS	O
with	IN	O
DM	NN	B-Disease
.	.	O

The	DT	O
resulting	VBG	O
genetic	JJ	O
map	NN	O
is	VBZ	O
supported	VBN	O
by	IN	O
the	DT	O
localisation	NN	O
of	IN	O
the	DT	O
DNA	NN	O
markers	NNS	O
in	IN	O
a	DT	O
panel	NN	O
of	IN	O
somatic	JJ	O
cell	NN	O
hybrids	NNS	O
.	.	O

Ten	CD	O
of	IN	O
the	DT	O
twelve	CD	O
markers	NNS	O
have	VBP	O
been	VBN	O
shown	VBN	O
to	TO	O
be	VB	O
proximal	JJ	O
to	TO	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
and	CC	O
two	CD	O
,	,	O
PRKCG	NN	O
and	CC	O
D19S22	NN	O
,	,	O
distal	JJ	O
but	CC	O
at	IN	O
distances	NNS	O
of	IN	O
approximately	RB	O
25	CD	O
cM	NN	O
and	CC	O
15	CD	O
cM	NN	O
,	,	O
respectively	RB	O
.	.	O

The	DT	O
closest	JJS	O
proximal	JJ	O
markers	NNS	O
are	VBP	O
APOC2	NN	O
(	-LRB-	O
apolipoprotein	NN	O
C-II	NN	O
)	-RRB-	O
and	CC	O
CKM	NN	O
(	-LRB-	O
creatine	NN	O
kinase	NN	O
,	,	O
muscle	NN	O
)	-RRB-	O
approximately	RB	O
3	CD	O
cM	NN	O
and	CC	O
2	CD	O
cM	NN	O
from	IN	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
respectively	RB	O
,	,	O
in	IN	O
the	DT	O
order	NN	O
APOC2-CKM-DM	NN	O
.	.	O

The	DT	O
distance	NN	O
between	IN	O
APOC2	NN	O
,	,	O
CKM	NN	O
and	CC	O
DM	NN	B-Disease
(	-LRB-	O
of	IN	O
the	DT	O
order	NN	O
of	IN	O
2	CD	O
million	CD	O
base	NN	O
pairs	NNS	O
)	-RRB-	O
and	CC	O
their	PRP$	O
known	JJ	O
orientation	NN	O
should	MD	O
permit	VB	O
directional	JJ	O
chromosome	NN	O
walking	NN	O
and	CC	O
jumping	VBG	O
.	.	O

The	DT	O
data	NNS	O
presented	VBN	O
here	RB	O
should	MD	O
enable	VB	O
us	PRP	O
to	TO	O
determine	VB	O
whether	IN	O
or	CC	O
not	RB	O
new	JJ	O
markers	NNS	O
are	VBP	O
distal	JJ	O
to	TO	O
APOC2/CKM	NN	O
and	CC	O
thus	RB	O
potentially	RB	O
flank	VB	O
the	DT	O
DM	NN	B-Disease
gene	NN	O
.	.	O

.	.	O

A	DT	O
recurrent	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
allele	NN	O
with	IN	O
36	CD	O
CAG	NN	O
repeats	NNS	O
causes	VBZ	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
in	IN	O
two	CD	O
sisters	NNS	O
.	.	O

Large	JJ	O
intergenerational	JJ	O
repeat	NN	O
expansions	NNS	O
of	IN	O
the	DT	O
CAG	NN	O
trinucleotide	NN	O
repeat	NN	O
in	IN	O
the	DT	O
HD	NN	B-Disease
gene	NN	O
have	VBP	O
been	VBN	O
well	RB	O
documented	VBN	O
for	IN	O
the	DT	O
male	JJ	O
germline	NN	O
.	.	O

We	PRP	O
describe	VBP	O
a	DT	O
recurrent	JJ	O
large	JJ	O
expansion	NN	O
of	IN	O
a	DT	O
maternal	JJ	O
allele	NN	O
with	IN	O
36	CD	O
CAG	NN	O
repeats	NNS	O
(	-LRB-	O
to	TO	O
66	CD	O
and	CC	O
57	CD	O
repeats	NNS	O
,	,	O
respectively	RB	O
,	,	O
in	IN	O
two	CD	O
daughters	NNS	O
)	-RRB-	O
associated	VBN	O
with	IN	O
onset	NN	O
of	IN	O
Huntington	NNP	B-Disease
disease	NN	I-Disease
(	-LRB-	O
HD	NN	B-Disease
)	-RRB-	O
in	IN	O
the	DT	O
second	JJ	O
and	CC	O
third	JJ	O
decade	NN	O
in	IN	O
a	DT	O
family	NN	O
without	IN	O
history	NN	O
of	IN	O
HD	NN	B-Disease
.	.	O

Our	PRP$	O
findings	NNS	O
give	VBP	O
evidence	NN	O
of	IN	O
a	DT	O
gonadal	JJ	O
mosaicism	NN	O
in	IN	O
the	DT	O
unaffected	JJ	O
mother	NN	O
.	.	O

We	PRP	O
hypothesize	VBP	O
that	IN	O
large	JJ	O
expansions	NNS	O
also	RB	O
occur	VBP	O
in	IN	O
the	DT	O
female	JJ	O
germline	NN	O
and	CC	O
that	IN	O
a	DT	O
negative	JJ	O
selection	NN	O
of	IN	O
oocytes	NNS	O
with	IN	O
long	JJ	O
repeats	NNS	O
might	MD	O
explain	VB	O
the	DT	O
different	JJ	O
instability	NN	O
behavior	NN	O
of	IN	O
the	DT	O
male	NN	O
and	CC	O
the	DT	O
female	JJ	O
germlines	NNS	O
.	.	O

.	.	O

Germline	NN	O
E-cadherin	NN	O
gene	NN	O
(	-LRB-	O
CDH1	NN	O
)	-RRB-	O
mutations	NNS	O
predispose	VBP	O
to	TO	O
familial	JJ	B-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
and	CC	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Inherited	VBN	O
mutations	NNS	O
in	IN	O
the	DT	O
E-cadherin	NN	O
gene	NN	O
(	-LRB-	O
CDH1	NN	O
)	-RRB-	O
were	VBD	O
described	VBN	O
recently	RB	O
in	IN	O
three	CD	O
Maori	NNP	O
kindreds	NNS	O
with	IN	O
familial	JJ	B-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
.	.	O

Familial	JJ	B-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
is	VBZ	O
genetically	RB	O
heterogeneous	JJ	O
and	CC	O
it	PRP	O
is	VBZ	O
not	RB	O
clear	JJ	O
what	WP	O
proportion	NN	O
of	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
susceptibility	NN	O
in	IN	O
non-Maori	JJ	O
populations	NNS	O
is	VBZ	O
due	JJ	O
to	TO	O
germline	NN	O
CDH1	NN	O
mutations	NNS	O
.	.	O

Therefore	RB	O
,	,	O
we	PRP	O
screened	VBD	O
eight	CD	O
familial	JJ	B-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
kindreds	NNS	O
of	IN	O
British	JJ	O
and	CC	O
Irish	JJ	O
origin	NN	O
for	IN	O
germline	NN	O
CDH1	NN	O
mutations	NNS	O
,	,	O
by	IN	O
SSCP	NN	O
analysis	NN	O
of	IN	O
all	DT	O
16	CD	O
exons	NNS	O
and	CC	O
flanking	JJ	O
sequences	NNS	O
.	.	O

Each	DT	O
family	NN	O
contained	VBD	O
(	-LRB-	O
i	LS	O
)	-RRB-	O
two	CD	O
cases	NNS	O
of	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
in	IN	O
first	JJ	O
degree	NN	O
relatives	NNS	O
with	IN	O
one	CD	O
affected	VBN	O
before	IN	O
age	NN	O
50	CD	O
years	NNS	O
;	:	O
or	CC	O
(	-LRB-	O
ii	LS	O
)	-RRB-	O
three	CD	O
or	CC	O
more	JJR	O
cases	NNS	O
of	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Novel	JJ	O
germline	NN	O
CDH1	NN	O
mutations	NNS	O
(	-LRB-	O
a	DT	O
nonsense	NN	O
and	CC	O
a	DT	O
splice	NN	O
site	NN	O
)	-RRB-	O
were	VBD	O
detected	VBN	O
in	IN	O
two	CD	O
families	NNS	O
(	-LRB-	O
25	CD	O
%	NN	O
)	-RRB-	O
.	.	O

Both	DT	O
mutations	NNS	O
were	VBD	O
predicted	VBN	O
to	TO	O
truncate	VB	O
the	DT	O
E-cadherin	NN	O
protein	NN	O
in	IN	O
the	DT	O
signal	NN	O
peptide	NN	O
domain	NN	O
.	.	O

In	IN	O
one	CD	O
family	NN	O
there	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
non-penetrance	JJ	O
and	CC	O
susceptibility	NN	O
to	TO	O
both	DT	O
gastric	JJ	B-Disease
and	CC	I-Disease
colorectal	JJ	I-Disease
cancer	NN	I-Disease
;	:	O
thus	RB	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
six	CD	O
cases	NNS	O
of	IN	O
gastric	JJ	B-Disease
cancer	NN	I-Disease
,	,	O
a	DT	O
CDH1	NN	O
mutation	NN	O
carrier	NN	O
developed	VBD	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
at	IN	O
age	NN	O
30	CD	O
years	NNS	O
.	.	O

We	PRP	O
have	VBP	O
confirmed	VBN	O
that	IN	O
germline	NN	O
mutations	NNS	O
in	IN	O
the	DT	O
CDH1	NN	O
gene	NN	O
cause	NN	O
familial	JJ	B-Disease
gastric	JJ	I-Disease
cancer	NN	I-Disease
in	IN	O
non-Maori	JJ	O
populations	NNS	O
.	.	O

However	RB	O
,	,	O
only	RB	O
a	DT	O
minority	NN	O
of	IN	O
familial	JJ	O
gastric	JJ	B-Disease
cancers	NNS	I-Disease
can	MD	O
be	VB	O
accounted	VBN	O
for	IN	O
by	IN	O
CDH1	NN	O
mutations	NNS	O
.	.	O

Loss	NN	O
of	IN	O
E-cadherin	NN	O
function	NN	O
has	VBZ	O
been	VBN	O
implicated	VBN	O
in	IN	O
the	DT	O
pathogenesis	NN	O
of	IN	O
sporadic	JJ	O
colorectal	JJ	B-Disease
and	CC	I-Disease
other	JJ	I-Disease
cancers	NNS	I-Disease
,	,	O
and	CC	O
our	PRP$	O
findings	NNS	O
provide	VBP	O
evidence	NN	O
that	IN	O
germline	NN	O
CDH1	NN	O
mutations	NNS	O
predispose	VBP	O
to	TO	O
early	JJ	O
onset	NN	O
colorectal	JJ	B-Disease
cancer	NN	I-Disease
.	.	O

Thus	RB	O
,	,	O
CDH1	NN	O
should	MD	O
be	VB	O
investigated	VBN	O
as	IN	O
a	DT	O
cause	NN	O
of	IN	O
inherited	VBN	O
susceptibility	NN	O
to	TO	O
both	DT	O
gastric	JJ	B-Disease
and	CC	I-Disease
colorectal	JJ	I-Disease
cancers	NNS	I-Disease
.	.	O

Germinal	JJ	O
mosaicism	NN	O
in	IN	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
.	.	O

We	PRP	O
have	VBP	O
identified	VBN	O
a	DT	O
Duchenne	NNP	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
pedigree	NN	O
where	WRB	O
the	DT	O
disease	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
a	DT	O
molecular	JJ	O
deletion	NN	O
within	IN	O
the	DT	O
DMD	NNP	B-Disease
locus	NN	O
.	.	O

We	PRP	O
have	VBP	O
examined	VBN	O
the	DT	O
meiotic	JJ	O
segregation	NN	O
products	NNS	O
of	IN	O
the	DT	O
common	JJ	O
female	NN	O
ancestor	NN	O
using	VBG	O
marker	NN	O
restriction	NN	O
fragment	NN	O
length	NN	O
polymorphisms	NNS	O
(	-LRB-	O
RFLPs	NNS	O
)	-RRB-	O
detected	VBN	O
by	IN	O
probes	NNS	O
that	WDT	O
lie	VBP	O
within	IN	O
this	DT	O
deletion	NN	O
.	.	O

These	DT	O
studies	NNS	O
show	VBP	O
that	IN	O
this	DT	O
female	NN	O
has	VBZ	O
transmitted	VBN	O
three	CD	O
distinct	JJ	O
types	NNS	O
of	IN	O
X	NN	O
chromosome	NN	O
to	TO	O
her	PRP$	O
offspring	NN	O
.	.	O

This	DT	O
observation	NN	O
may	MD	O
be	VB	O
explained	VBN	O
by	IN	O
postulating	VBG	O
that	IN	O
the	DT	O
mutation	NN	O
arose	VBD	O
as	IN	O
a	DT	O
postzygotic	JJ	O
deletion	NN	O
within	IN	O
this	DT	O
common	JJ	O
ancestor	NN	O
,	,	O
who	WP	O
was	VBD	O
consequently	RB	O
germinally	RB	O
mosaic	JJ	O
.	.	O

.	.	O

Expression	NN	O
of	IN	O
the	DT	O
murine	JJ	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
gene	NN	O
in	IN	O
muscle	NN	O
and	CC	O
brain	NN	O
.	.	O

Complementary	JJ	O
DNA	NN	O
clones	NNS	O
were	VBD	O
isolated	VBN	O
that	IN	O
represent	VBP	O
the	DT	O
5	CD	O
terminal	JJ	O
2	CD	O
.	.	O

5	CD	O
kilobases	NNS	O
of	IN	O
the	DT	O
murine	JJ	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
Dmd	NN	O
)	-RRB-	O
messenger	NN	O
RNA	NN	O
(	-LRB-	O
mRNA	NN	O
)	-RRB-	O
.	.	O

Mouse	NN	O
Dmd	NN	O
mRNA	NN	O
was	VBD	O
detectable	JJ	O
in	IN	O
skeletal	JJ	O
and	CC	O
cardiac	JJ	O
muscle	NN	O
and	CC	O
at	IN	O
a	DT	O
level	NN	O
approximately	RB	O
90	CD	O
percent	NN	O
lower	JJR	O
in	IN	O
brain	NN	O
.	.	O

Dmd	NN	O
mRNA	NN	O
is	VBZ	O
also	RB	O
present	JJ	O
,	,	O
but	CC	O
at	IN	O
much	RB	O
lower	JJR	O
than	IN	O
normal	JJ	O
levels	NNS	O
,	,	O
in	IN	O
both	CC	O
the	DT	O
muscle	NN	O
and	CC	O
brain	NN	O
of	IN	O
three	CD	O
different	JJ	O
strains	NNS	O
of	IN	O
dystrophic	JJ	B-Disease
mdx	NN	O
mice	NNS	O
.	.	O

The	DT	O
identification	NN	O
of	IN	O
Dmd	NN	O
mRNA	NN	O
in	IN	O
brain	NN	O
raises	VBZ	O
the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
relation	NN	O
between	IN	O
human	JJ	O
Duchenne	NN	B-Disease
muscular	JJ	I-Disease
dystrophy	NN	I-Disease
(	-LRB-	O
DMD	NN	B-Disease
)	-RRB-	O
gene	NN	O
expression	NN	O
and	CC	O
the	DT	O
mental	JJ	B-Disease
retardation	NN	I-Disease
found	VBN	O
in	IN	O
some	DT	O
DMD	NNP	B-Disease
males	NNS	O
.	.	O

These	DT	O
results	NNS	O
also	RB	O
provide	VBP	O
evidence	NN	O
that	IN	O
the	DT	O
mdx	NN	O
mutations	NNS	O
are	VBP	O
allelic	JJ	O
variants	NNS	O
of	IN	O
mouse	NN	O
Dmd	NN	O
gene	NN	O
mutations	NNS	O
.	.	O

Human	JJ	O
peroxisomal	JJ	O
targeting	VBG	O
signal-1	NN	O
receptor	NN	O
restores	VBZ	O
peroxisomal	JJ	O
protein	NN	O
import	NN	O
in	IN	O
cells	NNS	O
from	IN	O
patients	NNS	O
with	IN	O
fatal	JJ	O
peroxisomal	JJ	B-Disease
disorders	NNS	I-Disease
.	.	O

Two	CD	O
peroxisomal	JJ	O
targeting	NN	O
signals	NNS	O
,	,	O
PTS1	NN	O
and	CC	O
PTS2	NN	O
,	,	O
are	VBP	O
involved	VBN	O
in	IN	O
the	DT	O
import	NN	O
of	IN	O
proteins	NNS	O
into	IN	O
the	DT	O
peroxisome	NN	O
matrix	NN	O
.	.	O

Human	JJ	O
patients	NNS	O
with	IN	O
fatal	JJ	O
generalized	VBN	O
peroxisomal	JJ	B-Disease
deficiency	NN	I-Disease
disorders	NNS	I-Disease
fall	VBP	O
into	IN	O
at	IN	O
least	JJS	O
nine	CD	O
genetic	JJ	O
complementation	NN	O
groups	NNS	O
.	.	O

Cells	NNS	O
from	IN	O
many	JJ	O
of	IN	O
these	DT	O
patients	NNS	O
are	VBP	O
deficient	JJ	O
in	IN	O
the	DT	O
import	NN	O
of	IN	O
PTS1-containing	JJ	O
proteins	NNS	O
,	,	O
but	CC	O
the	DT	O
causes	NNS	O
of	IN	O
the	DT	O
protein-import	JJ	O
defect	NN	O
in	IN	O
these	DT	O
patients	NNS	O
are	VBP	O
unknown	JJ	O
.	.	O

We	PRP	O
have	VBP	O
cloned	VBN	O
and	CC	O
sequenced	VBN	O
the	DT	O
human	JJ	O
cDNA	NN	O
homologue	NN	O
(	-LRB-	O
PTS1R	NN	O
)	-RRB-	O
of	IN	O
the	DT	O
Pichia	NN	O
pastoris	NN	O
PAS8	NN	O
gene	NN	O
,	,	O
the	DT	O
PTS1	NN	O
receptor	NN	O
(	-LRB-	O
McCollum	NN	O
,	,	O
D.	NNP	O
,	,	O
E.	NNP	O
Monosov	NNP	O
,	,	O
and	CC	O
S.	NNP	O
Subramani	NNP	O
.	.	O

1993	CD	O
.	.	O

J.	NNP	O
Cell	NNP	O
Biol	NNP	O
.	.	O

121	CD	O
761-774	CD	O
)	-RRB-	O
.	.	O

The	DT	O
PTS1R	NN	O
mRNA	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
all	DT	O
human	JJ	O
tissues	NNS	O
examined	VBN	O
.	.	O

Antibodies	NNS	O
to	TO	O
the	DT	O
human	JJ	O
PTS1R	NN	O
recognize	VBP	O
this	DT	O
protein	NN	O
in	IN	O
human	JJ	O
,	,	O
monkey	NN	O
,	,	O
rat	NN	O
,	,	O
and	CC	O
hamster	NN	O
cells	NNS	O
.	.	O

The	DT	O
protein	NN	O
is	VBZ	O
localized	JJ	O
mainly	RB	O
in	IN	O
the	DT	O
cytosol	NN	O
but	CC	O
is	VBZ	O
also	RB	O
found	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
peroxisomes	NNS	O
.	.	O

Part	NN	O
of	IN	O
the	DT	O
peroxisomal	JJ	O
PTS1R	NN	O
protein	NN	O
is	VBZ	O
tightly	RB	O
bound	VBN	O
to	TO	O
the	DT	O
peroxisomal	JJ	O
membrane	NN	O
.	.	O

Antibodies	NNS	O
to	TO	O
PTS1R	NN	O
inhibit	VBP	O
peroxisomal	JJ	O
protein-import	NN	O
of	IN	O
PTS1-containing	JJ	O
proteins	NNS	O
in	IN	O
a	DT	O
permeabilized	JJ	O
CHO	NN	O
cell	NN	O
system	NN	O
.	.	O

In	IN	O
vitro-translated	JJ	O
PTS1R	NN	O
protein	NN	O
specifically	RB	O
binds	VBZ	O
a	DT	O
serine-lysine-leucine-peptide	NN	O
.	.	O

A	DT	O
PAS8-PTS1R	NN	O
fusion	NN	O
protein	NN	O
complements	VBZ	O
the	DT	O
P.	NNP	O
pastoris	NN	O
pas8	NN	O
mutant	NN	O
.	.	O

The	DT	O
PTS1R	NN	O
cDNA	NN	O
also	RB	O
complements	VBZ	O
the	DT	O
PTS1	NN	B-Disease
protein-import	JJ	I-Disease
defect	NN	I-Disease
in	IN	O
skin	NN	O
fibroblasts	NNS	O
from	IN	O
patients	NNS	O
--	:	O
belonging	VBG	O
to	TO	O
complementation	NN	O
group	NN	O
two	CD	O
--	:	O
diagnosed	VBD	O
as	IN	O
having	VBG	O
neonatal	JJ	B-Disease
adrenoleukodystrophy	NN	I-Disease
or	CC	O
Zellweger	NN	B-Disease
syndrome	NN	I-Disease
.	.	O

The	DT	O
PTS1R	NN	O
gene	NN	O
has	VBZ	O
been	VBN	O
localized	JJ	O
to	TO	O
a	DT	O
chromosomal	JJ	O
location	NN	O
where	WRB	O
no	DT	O
other	JJ	O
peroxisomal	JJ	B-Disease
disorder	NN	I-Disease
genes	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
map	VB	O
.	.	O

Our	PRP$	O
findings	NNS	O
represent	VBP	O
the	DT	O
only	JJ	O
case	NN	O
in	IN	O
which	WDT	O
the	DT	O
molecular	JJ	O
basis	NN	O
of	IN	O
the	DT	O
protein-import	JJ	B-Disease
deficiency	NN	I-Disease
in	IN	O
human	JJ	O
peroxisomal	JJ	B-Disease
disorders	NNS	I-Disease
is	VBZ	O
understood	VBN	O
.	.	O

X-linked	JJ	B-Disease
spastic	JJ	I-Disease
paraplegia	NN	I-Disease
and	CC	O
Pelizaeus-Merzbacher	NN	B-Disease
disease	NN	I-Disease
are	VBP	O
allelic	JJ	B-Disease
disorders	NNS	I-Disease
at	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
locus	NN	O
.	.	O

Three	CD	O
forms	NNS	O
of	IN	O
X-linked	JJ	B-Disease
spastic	JJ	I-Disease
paraplegia	NN	I-Disease
(	-LRB-	O
SPG	NN	B-Disease
)	-RRB-	O
have	VBP	O
been	VBN	O
defined	VBN	O
.	.	O

One	CD	O
locus	NN	O
(	-LRB-	O
SPG	NN	O
1	CD	O
)	-RRB-	O
maps	VBZ	O
to	TO	O
Xq28	NN	O
while	IN	O
two	CD	O
clinically	RB	O
distinct	JJ	O
forms	NNS	O
map	VBP	O
to	TO	O
Xq22	NN	O
(	-LRB-	O
SPG2	NN	O
)	-RRB-	O
.	.	O

A	DT	O
rare	JJ	O
X-linked	JJ	B-Disease
dysmyelinating	JJ	I-Disease
disorder	NN	I-Disease
of	IN	O
the	DT	O
central	JJ	O
nervous	JJ	O
system	NN	O
,	,	O
Pelizaeus-Merzbacher	JJ	B-Disease
disease	NN	I-Disease
(	-LRB-	O
PMD	NN	B-Disease
)	-RRB-	O
,	,	O
has	VBZ	O
also	RB	O
been	VBN	O
mapped	VBN	O
to	TO	O
Xq21-q22	NN	O
,	,	O
and	CC	O
is	VBZ	O
caused	VBN	O
by	IN	O
mutations	NNS	O
in	IN	O
the	DT	O
proteolipid	NN	O
protein	NN	O
gene	NN	O
(	-LRB-	O
PLP	NN	O
)	-RRB-	O
which	WDT	O
encodes	VBZ	O
two	CD	O
myelin	JJ	O
proteins	NNS	O
,	,	O
PLP	NN	O
and	CC	O
DM20	NN	O
.	.	O

While	IN	O
narrowing	VBG	O
the	DT	O
genetic	JJ	O
interval	NN	O
containing	VBG	O
SPG2	NN	O
in	IN	O
a	DT	O
large	JJ	O
pedigree	NN	O
,	,	O
we	PRP	O
found	VBD	O
that	IN	O
PLP	NN	O
was	VBD	O
the	DT	O
closest	JJS	O
marker	NN	O
to	TO	O
the	DT	O
disease	NN	O
locus	NN	O
,	,	O
implicating	VBG	O
PLP	NN	O
as	IN	O
a	DT	O
possible	JJ	O
candidate	NN	O
gene	NN	O
.	.	O

We	PRP	O
have	VBP	O
found	VBN	O
that	IN	O
a	DT	O
point	NN	O
mutation	NN	O
(	-LRB-	O
His139Tyr	NN	O
)	-RRB-	O
in	IN	O
exon	NN	O
3B	NN	O
of	IN	O
an	DT	O
affected	VBN	O
male	NN	O
produces	VBZ	O
a	DT	O
mutant	JJ	O
PLP	NN	O
but	CC	O
a	DT	O
normal	JJ	O
DM20	NN	O
,	,	O
and	CC	O
segregates	VBZ	O
with	IN	O
the	DT	O
disease	NN	O
(	-LRB-	O
Zmax	NN	O
=	JJ	O
6	CD	O
.	.	O

63	CD	O
,	,	O
theta	NN	O
=	JJ	O
0	CD	O
.	.	O

00	CD	O
)	-RRB-	O
.	.	O

It	PRP	O
appears	VBZ	O
,	,	O
therefore	RB	O
,	,	O
that	IN	O
SPG2	NN	O
and	CC	O
PMD	NN	B-Disease
are	VBP	O
allelic	JJ	B-Disease
disorders	NNS	I-Disease

